0001193125-23-053980.txt : 20230228 0001193125-23-053980.hdr.sgml : 20230228 20230228163359 ACCESSION NUMBER: 0001193125-23-053980 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 119 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230228 DATE AS OF CHANGE: 20230228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SLR Investment Corp. CENTRAL INDEX KEY: 0001418076 IRS NUMBER: 261381340 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 814-00754 FILM NUMBER: 23686099 BUSINESS ADDRESS: STREET 1: 500 PARK AVENUE STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 993-1670 MAIL ADDRESS: STREET 1: 500 PARK AVENUE STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: Solar Capital Ltd. DATE OF NAME CHANGE: 20071109 10-K 1 d437884d10k.htm 10-K 10-K
falseFY0001418076NYhttp://fasb.org/us-gaap/2022#UnrealizedGainLossOnInvestmentshttp://fasb.org/us-gaap/2022#UnrealizedGainLossOnInvestmentsIndicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SUNS SPV LLC (the “SUNS SPV”). Such investments are pledged as collateral under the Senior Secured Revolving SPV Credit Facility (the “SPV Credit Facility”) (see Note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company.Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR, SOFR or PRIME rate. These instruments are often subject to a LIBOR, SOFR or PRIME rate floor.Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2021, on a fair value basis, non-qualifying assets in the portfolio represented 23.1% of the total assets of the Company.Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2022 in these controlled investments are as follows:AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers. Amerimark may elect to defer up to 8.00% of the coupon as PIK.Investment is on non-accrual status.Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2021 in these controlled investments are as follows:Interest is paid in kind (“PIK”).Spread is 5.75% Cash / 0.50% PIK.Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of December 31, 2021.OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are co-borrowers.Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or PRIME rate. These instruments are often subject to a LIBOR or PRIME rate floor.SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary and NEFPASS LLC, a wholly-owned consolidated subsidiary.Non-income producing security.AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers.Indicates an investment that is wholly held by the Company through NEFPASS LLC.Denotes a subsidiary of SLR Equipment Finance.Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2022, on a fair value basis, non-qualifying assets in the portfolio represented 24.2% of the total assets of the Company.BridgeBio Pharma, Inc. may elect to defer up to 3.00% of the coupon as PIK.Vapotherm, Inc. may elect to defer up to 8.00% of the coupon as PIK.OmniGuide Holdings, Inc. may elect to defer up to 10.00% of the coupon as PIK.The Company’s investment in SOINT, LLC includes a one dollar investment in common shares.The Company’s investments in SOAGG, LLC and SOINT, LLC include a two and one dollar investment in common shares, respectively.Denotes a Level 1 investment.Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation.Spread is 2.50% Cash / 12.50% PIK.Spread is 5.50% Cash / 0.50% PIK.Spread is 6.00% Cash / 2.00% PIK.See note 12 to the consolidated financial statements.See note 19 to the consolidated financial statements.See note 15 to the consolidated financial statements.See note 10 to the consolidated financial statements.See note 16 to the consolidated financial statements.See note 14 to the consolidated financial statements.In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP. See Note 19 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members.On April 1, 2022, in connection with the Mergers (as defined in Note 1 “Organization”), the Company acquired net assets of $244,691 for the total stock consideration of $226,839. For further details, refer to Note 17 “Merger with SUNS”. Based on the market price at closing of $18.13, adjusted for transaction costs.The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of December 31, 2022, asset coverage was 191.5%.The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it.Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented.NAV per share is determined as of the last day in the relevant quarter and therefore may not reflect the NAV per share on the date of the high and low sales prices. The net asset values shown are based on outstanding shares at the end of each period.Calculated as of the respective high or low closing price divided by NAV and subtracting 1.Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014 and 2013 periods was $100,175, $98,196, $94,301 and $93,392, respectively.In the event that the shares of common stock are sold to or through underwriters, a corresponding prospectus supplement will disclose the applicable sales load and the “Example” will be updated accordingly.The prospectus supplement corresponding to each offering will disclose the applicable offering expenses and total stockholder transaction expenses.The expenses of the dividend reinvestment plan are included in “other expenses.”Our 1.50% base management fee under the Investment Advisory and Management Agreement (giving effect to the Letter Agreement) is based on our gross assets, which is defined as all the assets of SLRC, excluding temporary assets, including those acquired using borrowings for investment purposes, and assumes our gross assets remain consistent with gross assets for the fiscal year ended December 31, 2022. The base management fee is reduced to 1.00% on gross assets that exceed 200% of total net assets as of the immediately preceding quarter.Assumes that annual incentive fees earned by our investment adviser, SLR Capital Partners, remain consistent with the incentive fees earned by SLR Capital Partners for the fiscal year ended December 31, 2022.We have historically and will in the future borrow funds from time to time to make investments to the extent we determine that the economic situation is conducive to doing so. The costs associated with our outstanding borrowings are indirectly borne by our investors. For purposes of this section, we have computed interest expense using the average consolidated balance outstanding for borrowings during the fiscal year ended December 31, 2022. We used the Secured Overnight Financing Rate (“SOFR”) or similar base rate on December 31, 2022 and the interest rate on the Credit Facility, the SPV Credit Facility, the 2027 Series F Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes, the 2024 Unsecured Notes and the 2023 Unsecured Notes on December 31, 2022. We have also included, as applicable, the estimated market discount or amortization of fees incurred in establishing the Credit Facility, the SPV Credit Facility, the 2027 Series F Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes, the 2024 Unsecured Notes and the 2023 Unsecured Notes as of December 31, 2022. Additionally, we included the estimated cost of commitment fees for unused balances on the Credit Facility and the SPV Credit Facility. As of December 31, 2022, we had $393.0 million outstanding under the Credit Facility, $155.2 million outstanding under the SPV Credit Facility and $135 million, $50 million, $75 million, $125 million, $85 million, and $75 million outstanding under the 2027 Series F Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes, the 2024 Unsecured Notes and the 2023 Unsecured Notes, respectively. We may also issue preferred stock, subject to our compliance with applicable requirements under the 1940 Act, although we have no immediate intention to do so.The holders of shares of our common stock indirectly bear the expenses of our investment in SLR Senior Lending Program LLC (“SSLP”). No management fee is charged on our investments in SSLP in connection with the administrative services provided to SSLP. Future expenses for SSLP may be substantially higher or lower because certain expenses may fluctuate over time.“Other expenses” are based on estimated amounts for the current fiscal year, which considers the amounts incurred for the fiscal year ended December 31, 2022 and include our overhead expenses, including payments under our Administration Agreement based on our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement. 0001418076 2022-01-01 2022-12-31 0001418076 2021-01-01 2021-12-31 0001418076 2020-01-01 2020-12-31 0001418076 2021-12-31 0001418076 2022-12-31 0001418076 2023-02-24 0001418076 2022-06-30 0001418076 2022-12-31 2022-12-31 0001418076 2022-04-01 2022-04-01 0001418076 2022-05-03 0001418076 2022-05-23 2022-05-23 0001418076 2020-12-31 0001418076 2019-12-31 0001418076 2018-12-31 0001418076 2018-01-01 2018-12-31 0001418076 2019-01-01 2019-12-31 0001418076 2021-12-28 2021-12-31 0001418076 2022-10-01 2022-12-31 0001418076 2021-01-01 2021-03-31 0001418076 2021-04-01 2021-06-30 0001418076 2021-10-01 2021-12-31 0001418076 2021-07-01 2021-09-30 0001418076 2022-07-01 2022-09-30 0001418076 2022-04-01 2022-06-30 0001418076 2022-01-01 2022-03-31 0001418076 2016-01-01 2016-12-31 0001418076 2015-01-01 2015-12-31 0001418076 2017-01-01 2017-12-31 0001418076 2013-01-01 2013-12-31 0001418076 2014-01-01 2014-12-31 0001418076 2017-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2022-12-31 0001418076 slrc:RdHoldcoIncClassBMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-12-31 0001418076 slrc:SlrBusinessCreditMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-12-31 0001418076 slrc:SlrCreditSolutionsMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-12-31 0001418076 slrc:SlrHealthcareAblMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-12-31 0001418076 slrc:SpectrumPharmaceuticalsInc.WarrantsMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-12-31 0001418076 slrc:VapothermIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-12-31 0001418076 slrc:VenusConceptLtdMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-12-31 0001418076 slrc:RdHoldcoIncWarrantsMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-12-31 0001418076 slrc:SenseonicsHoldingsIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-12-31 0001418076 slrc:SointLlcMember slrc:PreferredEquityzeroPointFourPercentMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SlrEquipmentFinanceEquityInterestsMember 2022-12-31 0001418076 slrc:CardioFocusIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-12-31 0001418076 slrc:AtyrPharmaIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-12-31 0001418076 slrc:CentrexionTherapeuticsIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-12-31 0001418076 slrc:EssenceGroupHoldingsCorporationLumerisMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-12-31 0001418076 slrc:DelphinusMedicalTechnologiesIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-12-31 0001418076 slrc:ConventusOrthopaedicsIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-12-31 0001418076 slrc:KbhTopcoLlcKingsbridgeMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-12-31 0001418076 slrc:MeditrinaIncWarrantsMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-12-31 0001418076 slrc:RdHoldcoIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-12-31 0001418076 slrc:LuxuryAssetCapitalLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:MauricesIncorporatedMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:MontefioreNyackHospitalMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:NacHoldingsCorporationJaguarMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:NationalSpineAndPainCentersLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:OneTouchDirectLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:ShoHoldingICorporationShoesForCrewsMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:SouthernOrthodonticPartnersManagementLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:SparMarketingForceInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:StrytenResourcesLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:OrthopedicCarePartnersManagementLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:PediatricHomeRespiratoryServicesLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:SunmedGroupHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:AmericanTeleconferencingServicesLtd.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:AmericanTeleconferencingServicesLtdOneMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:AmerimarkIntermediateHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:TaucManagementLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:TilleyDistributionIncMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:UltimateBakedGoodsMidcoLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:VesscoMidcoHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:WorldInsuranceAssociatesLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:AcresCommercialMortgageLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SecondLienAssetbasedSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:RdHoldcoInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SecondLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:KoreWirelessGroupInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:LogixHoldingCompanyLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:PptManagementHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:RqmCorp.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:RscAcquisitionIncMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:RxsenseHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcBluefinMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:EnverusHoldingsIncFkaDrillingInfoHoldingsMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:ErieConstructionMidwestLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:GsmAcquisitionCorpMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:HigginbothamInsuranceAgencyIncMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:HighStreetBuyerIncMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:HumanInterestIncMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:IcimsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:IvyFertilityServicesLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:KaseyaIncMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:KidDistroHoldingsLlcDistroKidMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:PeterCFoyandAssociatesInsuranceServicesLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:PhynetDermatologyLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:PinnacleTreatmentCentersInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:PlasticsManagementLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:AegisToxicologySciencesCorporationMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:AllStateAgPartsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:EnhancedPermanentCapitalLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:CopperRiverSeafoodsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:CompositeTechnologyAcquisitionCorp.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:BdgMediaInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:BaymarkHealthServicesIncMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:BasicFunInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:AtriaWealthSolutionsIncMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:ApexServicesPartnersLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AeroOperatingLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AfgDallasIiiLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AirMethodsCorporationMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:ClubcorpHoldingsIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:BoartLongyearCompanyMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:BowmanEnergySolutionsLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:CapitalCityJetCenterIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:ChampionAirLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:CkdHoldingsInc.Member 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AmeraMexInternationalIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:HawkeyeContractingCompanyLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:HtiLogisticsCorporationMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:InternationalAutomotiveComponentsGroupNorthAmericaIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:KoolPakLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:GmtCorporationMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:FreightsolLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:GardaClTechnicalServicesIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:GeorgiaJetIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EasyPakLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EnergyDrillingServicesLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EnvironmentalProtectionImprovementCompanyLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EquipmentOperatingLeasesLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:FirstAmericanCommercialBancorpIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:FirstNationalCapitalLlcMember 2022-12-31 0001418076 slrc:U.s.TreasuryBillMember slrc:CashEquivalentsAtFortyOnePointEightMember 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SpectrumPharmaceuticalsInc.Member 2022-12-31 0001418076 slrc:VapothermInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:GlookoInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:NeuroneticsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:OmniguideHoldingsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:DeepintentInc.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ScpEyeCareLlcMember 2022-12-31 0001418076 slrc:CerapedicsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:InternationalAutomotiveComponentsGroupNorthAmericaIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:KoolPakLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:DongwonAutopartTechnologyIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LuxVendingLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:MountainAirHelicoptersIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SuperiorTransportationIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:StarCoachesIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:StCoachesLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SmileyLiftingSolutionsLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SlrEquipmentFinanceMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:TrinityEquipmentRentalsIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:TheSmedleyCompanySmedleyServicesIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WombleCompanyIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WindRiverEnvironmentalLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:UpTruckingServicesLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WorldwideFlightServicesInc.Member 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RaneLightMetalCastingsIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RangoIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RoyalCoachLinesIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RoyalExpressIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LoyerCapitalLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LuxCreditConsultantsLlcMember 2022-12-31 0001418076 slrc:LoyerCapitalLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:LuxCreditConsultantsLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:LuxVendingLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:MountainAirHelicoptersIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:BridgebioPharmaInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:CentrexionTherapeuticsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:ArdelyxInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:ArcutisBiotherapeuticsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:AlimeraSciencesInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:ApeelTechnologyIncMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:GmtCorporationMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:HaljoeCoachesUsaLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:HtiLogisticsCorporationMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:HawkeyeContractingCompanyLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:ZamborelliEnterprisesPacificSoutherFoundationMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:U.s.CraneAndRiggingLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:SignetMarineCorporationMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:RottenRockHardscapingAndTreeServiceMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:PcxAerostructuresLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:OzziesIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:GardaClTechnicalServicesIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:FreightsolLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:FirstNationalCapitalLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:FirstAmericanCommercialBancorpIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:EquipmentOperatingLeasesLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:EnvironmentalProtectionImprovementCompanyLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:EasyPakLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:DongwonAutopartTechnologyIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:ClubcorpHoldingsIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:ChampionAirLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:SturgeonServicesInternationalIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:SuperiorTransportationIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:TailwindsLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:TheSmedleyCompanySmedleyServicesIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:OutsetMedicalInc.Member 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:MeditrinaInc.Member 2022-12-31 0001418076 slrc:TrinityEquipmentRentalsIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:GeorgiaJetIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:LocPerformanceProductsLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:DrillersChoiceIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:CPortStoneLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:BazziniLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:TrolleysIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:UpTruckingServicesLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:StCoachesLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:StaffordLogisticsIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:StarCoachesIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:CapitalCityJetCenterIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:BoartLongyearCompanyMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:BlackhawkMiningLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:AmeraMexInternationalIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:AirMethodsCorporationMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:AeroOperatingLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:WarriorCraneServicesLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:WombleCompanyIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:WindRiverEnvironmentalLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:RaneLightMetalCastingsIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:RangoIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:RosscoCraneRiggingIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:RoyalCoachLinesIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:RoyalExpressIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:SouthTexasOilfieldSolutionsLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:SidelinesTreeServiceLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2022-12-31 0001418076 slrc:TotalInvestmentMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001418076 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:PreferredEquityMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:EquipmentFinancingMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member slrc:EquipmentFinancingMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member slrc:EquipmentFinancingMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member slrc:InvestmentInSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001418076 us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001418076 slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001418076 us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001418076 slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001418076 slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001418076 us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001418076 us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember slrc:InvestmentInSeniorSecuredLoansMember srt:MinimumMember 2022-12-31 0001418076 us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember slrc:InvestmentInSeniorSecuredLoansMember srt:MaximumMember 2022-12-31 0001418076 us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember slrc:InvestmentInSeniorSecuredLoansMember srt:WeightedAverageMember 2022-12-31 0001418076 slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember slrc:InvestmentInSeniorSecuredLoansMember srt:MinimumMember 2022-12-31 0001418076 slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember slrc:InvestmentInSeniorSecuredLoansMember srt:MaximumMember 2022-12-31 0001418076 slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember slrc:InvestmentInSeniorSecuredLoansMember srt:WeightedAverageMember 2022-12-31 0001418076 us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember slrc:EquipmentFinancingMember srt:MinimumMember 2022-12-31 0001418076 us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember slrc:EquipmentFinancingMember srt:MaximumMember 2022-12-31 0001418076 us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember slrc:EquipmentFinancingMember srt:WeightedAverageMember 2022-12-31 0001418076 slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember slrc:EquipmentFinancingMember srt:MinimumMember 2022-12-31 0001418076 slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember slrc:EquipmentFinancingMember srt:MaximumMember 2022-12-31 0001418076 slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember slrc:EquipmentFinancingMember srt:WeightedAverageMember 2022-12-31 0001418076 srt:MinimumMember slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember 2022-12-31 0001418076 srt:MaximumMember slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember 2022-12-31 0001418076 srt:WeightedAverageMember slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember 2022-12-31 0001418076 srt:MinimumMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 srt:MaximumMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 srt:WeightedAverageMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 srt:MinimumMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 srt:MaximumMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 srt:WeightedAverageMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member slrc:BlackScholesPricingModelMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember 2022-12-31 0001418076 slrc:CreditFacilityOneMember 2022-12-31 0001418076 slrc:NmcSeniorCreditFacilityMember 2022-12-31 0001418076 slrc:SeniorSecuredCommitmentsMember slrc:SlrBusinessCreditMember 2022-12-31 0001418076 slrc:SlrBusinessCreditMember 2022-12-31 0001418076 slrc:KbhtMember 2022-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheOneMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheTwoMember 2022-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2022-12-31 0001418076 slrc:SeniorSecuredCommitmentsMember 2022-12-31 0001418076 slrc:SeniorSecuredCommitmentsMember slrc:SlrHealthcareAblCreditMember 2022-12-31 0001418076 slrc:AmerimarkMember 2022-12-31 0001418076 slrc:BridgeBioPharmaIncMember 2022-12-31 0001418076 slrc:OmniGuideHoldingsIncMember 2022-12-31 0001418076 slrc:VapothermInc.Member 2022-12-31 0001418076 slrc:IcimsInc.Member 2022-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:CreditFacilityMember slrc:CitiBankNaMember 2022-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2022-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember us-gaap:LineOfCreditMember 2022-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember slrc:TermLoanMember 2022-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-12-31 0001418076 slrc:SlrEquipmentFinanceMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:EnsHoldingsIiiCorpLlcMember 2022-12-31 0001418076 slrc:MontefioreNyackHospitalMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ScpEyeCareLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:DeepintentInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MeditrinaInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CerapedicsInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OutsetMedicalInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:RqmCorp.Member 2022-12-31 0001418076 slrc:EnverusHoldingsIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrEquipmentFinanceMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ErieConstructionMidwestLlcMember 2022-12-31 0001418076 slrc:PeterC.FoyAssociatesInsuranceServicesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AmericanTeleconferencingServicesLtd.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SunmedGroupHoldingsLlcMember 2022-12-31 0001418076 slrc:GsmAcquisitionCorpMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:TilleyDistributionIncMember 2022-12-31 0001418076 slrc:BaymarkHealthServicesIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:HighStreetBuyerIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AllStateAgPartsLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BridgebioPharmaInc.Member 2022-12-31 0001418076 slrc:TaucManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:RezoluteIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SocTelemedInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:InszoneMidLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MmitHoldingsLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:NeuroneticsInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrCreditSolutionsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:LuxuryAssetCapitalLlcMember 2022-12-31 0001418076 slrc:RscAcquisitionIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:ArdelyxIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:KaseyaIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:VesscoMidcoHoldingsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MauricesIncorporatedMember 2022-12-31 0001418076 slrc:BdgMediaInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OneTouchDirectLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CopperRiverSeafoodsInc.Member 2022-12-31 0001418076 slrc:BasicFunInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:KidDistroHoldingsLlcDistroKidMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:FoundationConsumerBrandsLlcMember 2022-12-31 0001418076 slrc:SouthernOrthodonticPartnersManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PediatricHomeRespiratoryServicesLlcMember 2022-12-31 0001418076 slrc:PlasticsManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UltimateBakedGoodsMidcoLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OrthopedicCarePartnersManagementLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:IvyFertilityServicesLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PinnacleTreatmentCentersInc.Member 2022-12-31 0001418076 slrc:CompositeTechnologyAcquisitionCorpMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:NacHoldingsCorporationMember 2022-12-31 0001418076 slrc:SlrHealthcareAblMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SparMarketingForceInc.Member 2022-12-31 0001418076 slrc:RxsenseHoldingsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:ApeelTechnologyIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2022-12-31 0001418076 slrc:HumanInterestIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:GlookoInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:WorldInsuranceAssociatesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:IcimsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:SpectrumPharmaceuticalsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ArcutisBiotherapeuticsInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AtriaWealthSolutionsIncMember 2022-12-31 0001418076 slrc:MultiSectorHoldingsMember 2022-12-31 0001418076 slrc:HealthCareProvidersAndServicesMember 2022-12-31 0001418076 slrc:FootwearMember 2022-12-31 0001418076 slrc:HotelsRestaurantsAndLeisureMember 2022-12-31 0001418076 slrc:ContainersAndPackagingMember 2022-12-31 0001418076 slrc:OilGasAndConsumableFuelsMember 2022-12-31 0001418076 slrc:EnergyEquipmentAndServicesMember 2022-12-31 0001418076 slrc:TransportationInfrastructureMember 2022-12-31 0001418076 slrc:FoodProductsMember 2022-12-31 0001418076 slrc:HealthCareEquipmentAndSuppliesMember 2022-12-31 0001418076 slrc:PharmaceuticalsMember 2022-12-31 0001418076 slrc:SoftwareMember 2022-12-31 0001418076 slrc:InsuranceMember 2022-12-31 0001418076 slrc:BiotechnologyMember 2022-12-31 0001418076 slrc:DiversifiedConsumerServicesMember 2022-12-31 0001418076 slrc:MediaMember 2022-12-31 0001418076 slrc:RoadAndRailMember 2022-12-31 0001418076 slrc:PersonalProductsMember 2022-12-31 0001418076 slrc:CapitalMarketsMember 2022-12-31 0001418076 slrc:ThriftsMortgageFinanceMember 2022-12-31 0001418076 slrc:LifeSciencesToolsAndServicesMember 2022-12-31 0001418076 slrc:AutoPartsAndEquipmentMember 2022-12-31 0001418076 slrc:PackagedFoodsAndMeatsMember 2022-12-31 0001418076 slrc:WirelessTelecommunicationServicesMember 2022-12-31 0001418076 slrc:BuildingProductsMember 2022-12-31 0001418076 slrc:InternetAndCatalogRetailMember 2022-12-31 0001418076 slrc:ItServicesMember 2022-12-31 0001418076 slrc:AirlinesMember 2022-12-31 0001418076 slrc:AutoComponentsMember 2022-12-31 0001418076 slrc:LeisureEquipmentAndProductsMember 2022-12-31 0001418076 slrc:SpecialtyRetailMember 2022-12-31 0001418076 slrc:CommunicationsEquipmentMember 2022-12-31 0001418076 slrc:HealthCareTechnologyMember 2022-12-31 0001418076 slrc:CommercialServicesAndSuppliesMember 2022-12-31 0001418076 slrc:InternetSoftwareServicesMember 2022-12-31 0001418076 slrc:TradingCompaniesAndDistributorsMember 2022-12-31 0001418076 slrc:ConstructionAndEngineeringMember 2022-12-31 0001418076 slrc:WaterUtilitiesMember 2022-12-31 0001418076 slrc:ConsumerFinanceMember 2022-12-31 0001418076 slrc:DiversifiedFinancialServicesMember 2022-12-31 0001418076 slrc:AerospaceAndDefenseMember 2022-12-31 0001418076 slrc:MetalsAndMiningMember 2022-12-31 0001418076 slrc:MachineryMember 2022-12-31 0001418076 us-gaap:AssetManagement1Member 2022-12-31 0001418076 slrc:FoodAndStaplesRetailingMember 2022-12-31 0001418076 slrc:SunsCompanyMergerMember 2022-12-31 0001418076 us-gaap:TechnologySectorMember slrc:KidDistroHoldingsLlcDistroKidMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:PersonalProductsMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:InsuranceMember slrc:HighStreetBuyerIncMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:IvyFertilityServicesLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 us-gaap:HealthcareSectorMember slrc:BaymarkHealthServicesIncMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 us-gaap:FinancialServicesSectorMember slrc:AtriaWealthSolutionsIncMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:TradingCompaniesDistributorsMember slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember srt:ManagementMember 2022-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember us-gaap:InvestorMember 2022-12-31 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:CardioFocusIncMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:AtyrPharmaIncMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:KbhTopcoLlcKingsbridgeMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:RdHoldcoIncClassBMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:RdHoldcoIncMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:RdHoldcoIncWarrantsMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:EssenceGroupHoldingsCorporationLumerisMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:DelphinusMedicalTechnologiesIncMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:VenusConceptLtdMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:SenseonicsHoldingsIncMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:SlrCreditSolutionsMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:CentrexionTherapeuticsIncMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:ConventusOrthopaedicsIncMember 2021-12-31 0001418076 slrc:SlrEquipmentFinanceEquityInterestsMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-12-31 0001418076 slrc:PreferredEquityZeroPointSevenPercentMember slrc:SoaggLlcMember 2021-12-31 0001418076 slrc:SointLlcMember slrc:PreferredEquityZeroPointSevenPercentMember 2021-12-31 0001418076 slrc:PhymedManagementLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:SecondLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:VarileaseFinanceInc.Member 2021-12-31 0001418076 slrc:AcresCommercialMortgageLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:SecondLienAssetbasedSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:RugDoctorLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:SecondLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:BridgebioPharmaInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:AxcellaHealthIncMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:ArdelyxInc.Member 2021-12-31 0001418076 slrc:ArcutisBiotherapeuticsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AlimeraSciencesInc.Member 2021-12-31 0001418076 slrc:OmniguideHoldingsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:CentrexionTherapeuticsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:NeuroneticsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:GlookoInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:DelphinusMedicalTechnologiesInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:CerapedicsInc.Member 2021-12-31 0001418076 slrc:RezoluteIncMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:SocTelemedInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:ScpharmaceuticalsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:RubiusTherapeuticsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:UltimateBakedGoodsMidcoLlcMember 2021-12-31 0001418076 slrc:UsrParentInc.StaplesMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:RqmCorp.Member 2021-12-31 0001418076 slrc:StrytenEnergyLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:SunmedGroupHoldingsLlcMember 2021-12-31 0001418076 slrc:PptManagementHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:MmitHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:NacHoldingsCorporationJaguarMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:OneTouchDirectLlcMember 2021-12-31 0001418076 slrc:PhynetDermatologyLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:PinnacleTreatmentCentersInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:MauricesIncorporatedMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:KidDistroHoldingsLlcDistroKidMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:KingsbridgeHoldingsLlcMember 2021-12-31 0001418076 slrc:KoreWirelessGroupInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:LogixHoldingCompanyLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:AmericanTeleconferencingServicesLtdOneMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:AmerimarkIntermediateHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:AtriaWealthSolutionsIncMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:AmericanTeleconferencingServicesLtd.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:AlteonHealthLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:AegisToxicologySciencesCorporationMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:EnhancedPermanentCapitalLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:IcimsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:InszoneMidLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:IvyFertilityServicesLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:CommunityBrandsParentcoLlcFkaMinistryBrandsMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:BasicFunInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:CashEquivalentsAtThirtyEightPointZeroMember slrc:U.s.TreasuryBillMember 2021-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:SecondLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:SecondLienAssetbasedSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:TotalInvestmentMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember 2021-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-12-31 0001418076 slrc:PreferredEquityZeroPointSevenPercentMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2021-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:EquitySecuritiesMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member slrc:EquipmentFinancingMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel3Member slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-12-31 0001418076 slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001418076 srt:MinimumMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember slrc:InvestmentInSeniorSecuredLoansMember 2021-12-31 0001418076 srt:MaximumMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember slrc:InvestmentInSeniorSecuredLoansMember 2021-12-31 0001418076 srt:WeightedAverageMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember slrc:InvestmentInSeniorSecuredLoansMember 2021-12-31 0001418076 srt:MinimumMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember slrc:InvestmentInSeniorSecuredLoansMember us-gaap:MeasurementInputEbitdaMultipleMember 2021-12-31 0001418076 srt:MaximumMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember slrc:InvestmentInSeniorSecuredLoansMember us-gaap:MeasurementInputEbitdaMultipleMember 2021-12-31 0001418076 srt:WeightedAverageMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember slrc:InvestmentInSeniorSecuredLoansMember us-gaap:MeasurementInputEbitdaMultipleMember 2021-12-31 0001418076 srt:MinimumMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember slrc:InvestmentInSeniorSecuredLoansMember slrc:BlackScholesPricingModelMember 2021-12-31 0001418076 srt:MaximumMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember slrc:InvestmentInSeniorSecuredLoansMember slrc:BlackScholesPricingModelMember 2021-12-31 0001418076 srt:WeightedAverageMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember slrc:InvestmentInSeniorSecuredLoansMember slrc:BlackScholesPricingModelMember 2021-12-31 0001418076 srt:MinimumMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember slrc:EquipmentFinancingMember 2021-12-31 0001418076 srt:MaximumMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember slrc:EquipmentFinancingMember 2021-12-31 0001418076 srt:WeightedAverageMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember slrc:EquipmentFinancingMember 2021-12-31 0001418076 srt:MinimumMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember slrc:EquipmentFinancingMember 2021-12-31 0001418076 srt:MaximumMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember slrc:EquipmentFinancingMember 2021-12-31 0001418076 srt:WeightedAverageMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember slrc:EquipmentFinancingMember 2021-12-31 0001418076 srt:MinimumMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember slrc:PreferredEquityMember 2021-12-31 0001418076 srt:MaximumMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember slrc:PreferredEquityMember 2021-12-31 0001418076 srt:WeightedAverageMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember slrc:PreferredEquityMember 2021-12-31 0001418076 srt:MinimumMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember us-gaap:EquitySecuritiesMember 2021-12-31 0001418076 srt:MaximumMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember us-gaap:EquitySecuritiesMember 2021-12-31 0001418076 srt:WeightedAverageMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember us-gaap:EquitySecuritiesMember 2021-12-31 0001418076 srt:MinimumMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember us-gaap:EquitySecuritiesMember 2021-12-31 0001418076 srt:MaximumMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember us-gaap:EquitySecuritiesMember 2021-12-31 0001418076 srt:WeightedAverageMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember us-gaap:EquitySecuritiesMember 2021-12-31 0001418076 srt:MinimumMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-12-31 0001418076 srt:MaximumMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-12-31 0001418076 srt:WeightedAverageMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel3Member slrc:BlackScholesPricingModelMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2021-12-31 0001418076 slrc:CreditFacilityOneMember 2021-12-31 0001418076 slrc:SeniorSecuredCommitmentsMember slrc:SlrBusinessCreditMember 2021-12-31 0001418076 slrc:SlrBusinessCreditMember 2021-12-31 0001418076 slrc:NmcSeniorCreditFacilityMember 2021-12-31 0001418076 slrc:KbhtMember 2021-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheOneMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheTwoMember 2021-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2021-12-31 0001418076 slrc:SeniorSecuredCommitmentsMember 2021-12-31 0001418076 slrc:SlrHealthcareAblCreditMember slrc:SeniorSecuredCommitmentsMember 2021-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember 2021-12-31 0001418076 slrc:SlrEquipmentFinanceMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:NeuroneticsInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:EnsHoldingsIiiCorpLlcMember 2021-12-31 0001418076 slrc:MontefioreNyackHospitalMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ScpEyeCareLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:DeepintentInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MeditrinaInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CerapedicsInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OutsetMedicalInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AmericanTeleconferencingServicesLtd.Member 2021-12-31 0001418076 slrc:ErieConstructionMidwestLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:RxsenseHoldingsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:SlrHealthcareAblMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:PeterC.FoyAssociatesInsuranceServicesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrEquipmentFinanceMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SunmedGroupHoldingsLlcMember 2021-12-31 0001418076 slrc:EnverusHoldingsIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:TilleyDistributionIncMember 2021-12-31 0001418076 slrc:BaymarkHealthServicesIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:GsmAcquisitionCorpMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:HighStreetBuyerIncMember 2021-12-31 0001418076 slrc:TaucManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AllStateAgPartsLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BridgebioPharmaInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:InszoneMidLlcMember 2021-12-31 0001418076 slrc:RezoluteIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SocTelemedInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:RqmCorp.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MmitHoldingsLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrCreditSolutionsMember 2021-12-31 0001418076 slrc:ArdelyxIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:LuxuryAssetCapitalLlcMember 2021-12-31 0001418076 slrc:RscAcquisitionIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MauricesIncorporatedMember 2021-12-31 0001418076 slrc:KaseyaIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:VesscoMidcoHoldingsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CopperRiverSeafoodsInc.Member 2021-12-31 0001418076 slrc:BdgMediaInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OneTouchDirectLlcMember 2021-12-31 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BasicFunInc.Member 2021-12-31 0001418076 slrc:KidDistroHoldingsLlcDistroKidMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:PlasticsManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:SouthernOrthodonticPartnersManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PediatricHomeRespiratoryServicesLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PinnacleTreatmentCentersInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UltimateBakedGoodsMidcoLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OrthopedicCarePartnersManagementLlcMember 2021-12-31 0001418076 slrc:CompositeTechnologyAcquisitionCorpMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:NacHoldingsCorporationMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:IvyFertilityServicesLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SparMarketingForceInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2021-12-31 0001418076 slrc:ApeelTechnologyIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:GlookoInc.Member 2021-12-31 0001418076 slrc:WorldInsuranceAssociatesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:HumanInterestIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:SpectrumPharmaceuticalsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ArcutisBiotherapeuticsInc.Member 2021-12-31 0001418076 slrc:IcimsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AtriaWealthSolutionsIncMember 2021-12-31 0001418076 slrc:CapitalMarketsMember 2021-12-31 0001418076 slrc:AutoPartsAndEquipmentMember 2021-12-31 0001418076 slrc:InternetAndCatalogRetailMember 2021-12-31 0001418076 slrc:PackagedFoodsAndMeatsMember 2021-12-31 0001418076 slrc:LifeSciencesToolsAndServicesMember 2021-12-31 0001418076 slrc:CommunicationsEquipmentMember 2021-12-31 0001418076 slrc:SpecialtyRetailMember 2021-12-31 0001418076 slrc:AutoComponentsMember 2021-12-31 0001418076 slrc:AirlinesMember 2021-12-31 0001418076 slrc:MultiSectorHoldingsMember 2021-12-31 0001418076 slrc:DiversifiedFinancialServicesMember 2021-12-31 0001418076 slrc:HealthCareProvidersAndServicesMember 2021-12-31 0001418076 slrc:PharmaceuticalsMember 2021-12-31 0001418076 slrc:SoftwareMember 2021-12-31 0001418076 slrc:HealthCareEquipmentAndSuppliesMember 2021-12-31 0001418076 slrc:BiotechnologyMember 2021-12-31 0001418076 slrc:WirelessTelecommunicationServicesMember 2021-12-31 0001418076 slrc:PersonalProductsMember 2021-12-31 0001418076 slrc:RoadAndRailMember 2021-12-31 0001418076 slrc:ItServicesMember 2021-12-31 0001418076 slrc:DiversifiedConsumerServicesMember 2021-12-31 0001418076 slrc:InsuranceMember 2021-12-31 0001418076 slrc:CommercialServicesAndSuppliesMember 2021-12-31 0001418076 slrc:HealthCareTechnologyMember 2021-12-31 0001418076 slrc:MachineryMember 2021-12-31 0001418076 slrc:AerospaceAndDefenseMember 2021-12-31 0001418076 slrc:MetalsAndMiningMember 2021-12-31 0001418076 slrc:HotelsRestaurantsAndLeisureMember 2021-12-31 0001418076 slrc:ConsumerFinanceMember 2021-12-31 0001418076 slrc:AirFreightAndLogisticsMember 2021-12-31 0001418076 slrc:EnergyEquipmentAndServicesMember 2021-12-31 0001418076 slrc:OilGasAndConsumableFuelsMember 2021-12-31 0001418076 slrc:ConstructionAndEngineeringMember 2021-12-31 0001418076 slrc:ContainersAndPackagingMember 2021-12-31 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2020-01-01 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2020-01-01 2020-12-31 0001418076 slrc:AdvisoryAgreementMember 2020-01-01 2020-12-31 0001418076 slrc:SlrBusinessCreditMember 2020-01-01 2020-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember 2020-01-01 2020-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2020-01-01 2020-12-31 0001418076 slrc:SlrEquipmentFinanceMember 2020-01-01 2020-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember 2020-01-01 2020-12-31 0001418076 slrc:CreditFacilityMember 2020-01-01 2020-12-31 0001418076 slrc:NefpassFacilityMember 2020-01-01 2020-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2020-01-01 2020-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2020-01-01 2020-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2020-01-01 2020-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2020-01-01 2020-12-31 0001418076 slrc:TermLoansMember 2020-01-01 2020-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2020-01-01 2020-12-31 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-01-01 2021-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:RubiusTherapeuticsInc.Member 2021-01-01 2021-12-31 0001418076 slrc:ScpharmaceuticalsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:RezoluteIncMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:AxcellaHealthIncMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SlrEquipmentFinanceEquityInterestsMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:InszoneMidLlcMember 2021-01-01 2021-12-31 0001418076 slrc:IcimsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:EnhancedPermanentCapitalLlcMember 2021-01-01 2021-12-31 0001418076 slrc:BasicFunInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:CommunityBrandsParentcoLlcFkaMinistryBrandsMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:AmerimarkIntermediateHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:ArcutisBiotherapeuticsInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AlimeraSciencesInc.Member 2021-01-01 2021-12-31 0001418076 slrc:CentrexionTherapeuticsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:BridgebioPharmaInc.Member 2021-01-01 2021-12-31 0001418076 slrc:ArdelyxInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:AmericanTeleconferencingServicesLtdOneMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:KidDistroHoldingsLlcDistroKidMember 2021-01-01 2021-12-31 0001418076 slrc:NacHoldingsCorporationJaguarMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:MmitHoldingsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:MauricesIncorporatedMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:UsrParentInc.StaplesMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:PreferredEquityZeroPointSevenPercentMember slrc:SointLlcMember 2021-01-01 2021-12-31 0001418076 slrc:PreferredEquityZeroPointSevenPercentMember slrc:SoaggLlcMember 2021-01-01 2021-12-31 0001418076 slrc:AegisToxicologySciencesCorporationMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:AlteonHealthLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:AmericanTeleconferencingServicesLtd.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:AtriaWealthSolutionsIncMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:IvyFertilityServicesLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:KoreWirelessGroupInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:EasyPakLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:LogixHoldingCompanyLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:OneTouchDirectLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:PhynetDermatologyLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:PinnacleTreatmentCentersInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:PptManagementHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:RqmCorp.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:StrytenEnergyLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:SunmedGroupHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:UltimateBakedGoodsMidcoLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:AcresCommercialMortgageLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:SecondLienAssetbasedSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:VarileaseFinanceInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:SecondLienAssetbasedSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:PhymedManagementLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:SecondLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:RugDoctorLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:SecondLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:CerapedicsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:DelphinusMedicalTechnologiesInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:GlookoInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:NeuroneticsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:OmniguideHoldingsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:SocTelemedInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:VenusConceptLtdMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember 2021-01-01 2021-12-31 0001418076 slrc:SlrCreditSolutionsMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember 2021-01-01 2021-12-31 0001418076 slrc:SenseonicsHoldingsIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember 2021-01-01 2021-12-31 0001418076 slrc:WombleCompanyIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:WindRiverEnvironmentalLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:RdHoldcoIncWarrantsMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:RdHoldcoIncClassBMember 2021-01-01 2021-12-31 0001418076 slrc:RdHoldcoIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember 2021-01-01 2021-12-31 0001418076 slrc:KbhTopcoLlcKingsbridgeMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember 2021-01-01 2021-12-31 0001418076 slrc:EssenceGroupHoldingsCorporationLumerisMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember 2021-01-01 2021-12-31 0001418076 slrc:DelphinusMedicalTechnologiesIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember 2021-01-01 2021-12-31 0001418076 slrc:ConventusOrthopaedicsIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:CentrexionTherapeuticsIncMember 2021-01-01 2021-12-31 0001418076 slrc:CardioFocusIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember 2021-01-01 2021-12-31 0001418076 slrc:AtyrPharmaIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember 2021-01-01 2021-12-31 0001418076 slrc:WarriorCraneServicesLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:UpTruckingServicesLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:TrolleysIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:TrinityEquipmentRentalsIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:TheSmedleyCompanySmedleyServicesIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:TailwindsLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:SuperiorTransportationIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:SturgeonServicesInternationalIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:StarCoachesIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:StaffordLogisticsIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:StCoachesLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:SouthTexasOilfieldSolutionsLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SidelinesTreeServiceLlcMember 2021-01-01 2021-12-31 0001418076 slrc:RoyalExpressIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:RoyalCoachLinesIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:RosscoCraneRiggingIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:RangoIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:RaneLightMetalCastingsIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:MountainAirHelicoptersIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:LuxVendingLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:LuxCreditConsultantsLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:LoyerCapitalLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:KoolPakLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:InternationalAutomotiveComponentsGroupNorthAmericaIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:HtiLogisticsCorporationMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:HawkeyeContractingCompanyLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:HaljoeCoachesUsaLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:GmtCorporationMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:GeorgiaJetIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:GardaClTechnicalServicesIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:FreightsolLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:FirstNationalCapitalLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:FirstAmericanCommercialBancorpIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentOperatingLeasesLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:EnvironmentalProtectionImprovementCompanyLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:DongwonAutopartTechnologyIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:ClubcorpHoldingsIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:ChampionAirLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:CapitalCityJetCenterIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:BoartLongyearCompanyMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:BlackhawkMiningLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:AmeraMexInternationalIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:AirMethodsCorporationMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:AeroOperatingLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:TrinityEquipmentRentalsIncMember srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:TrinityEquipmentRentalsIncMember srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:TheSmedleyCompanySmedleyServicesIncMember srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:TheSmedleyCompanySmedleyServicesIncMember srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:TailwindsLlcMember srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:TailwindsLlcMember srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:SuperiorTransportationIncMember srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:SuperiorTransportationIncMember srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:StCoachesLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:StCoachesLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:SouthTexasOilfieldSolutionsLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SouthTexasOilfieldSolutionsLlcMember srt:MinimumMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:RangoIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AirMethodsCorporationMember srt:MaximumMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AirMethodsCorporationMember srt:MinimumMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AeroOperatingLlcMember srt:MaximumMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AeroOperatingLlcMember srt:MinimumMember 2021-01-01 2021-12-31 0001418076 slrc:BoartLongyearCompanyMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember srt:MaximumMember 2021-01-01 2021-12-31 0001418076 slrc:BoartLongyearCompanyMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember srt:MinimumMember 2021-01-01 2021-12-31 0001418076 slrc:BlackhawkMiningLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember srt:MaximumMember 2021-01-01 2021-12-31 0001418076 slrc:BlackhawkMiningLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember srt:MinimumMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:RangoIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:WindRiverEnvironmentalLlcMember srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:WindRiverEnvironmentalLlcMember srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LuxVendingLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LuxVendingLlcMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LuxCreditConsultantsLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LuxCreditConsultantsLlcMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LoyerCapitalLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LoyerCapitalLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:HtiLogisticsCorporationMember srt:MaximumMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:HtiLogisticsCorporationMember srt:MinimumMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:GardaClTechnicalServicesIncMember srt:MaximumMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:GardaClTechnicalServicesIncMember srt:MinimumMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:FreightsolLlcMember srt:MaximumMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:FreightsolLlcMember srt:MinimumMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:EquipmentOperatingLeasesLlcMember srt:MaximumMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:EquipmentOperatingLeasesLlcMember srt:MinimumMember 2021-01-01 2021-12-31 0001418076 slrc:ClubcorpHoldingsIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember srt:MaximumMember 2021-01-01 2021-12-31 0001418076 slrc:ClubcorpHoldingsIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember srt:MinimumMember 2021-01-01 2021-12-31 0001418076 slrc:CashEquivalentsAtThirtyEightPointZeroMember slrc:U.s.TreasuryBillMember 2021-01-01 2021-12-31 0001418076 slrc:CapitalCityJetCenterIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember srt:MinimumMember 2021-01-01 2021-12-31 0001418076 slrc:CapitalCityJetCenterIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember srt:MaximumMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:WarriorCraneServicesLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:WarriorCraneServicesLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:AdvisoryAgreementMember 2021-01-01 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingMember 2021-01-01 2021-12-31 0001418076 slrc:PreferredEquityMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-01-01 2021-12-31 0001418076 slrc:SpreadThreeMember 2021-01-01 2021-12-31 0001418076 slrc:SpreadOneMember 2021-01-01 2021-12-31 0001418076 slrc:SpreadTwoMember 2021-01-01 2021-12-31 0001418076 slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-12-31 0001418076 slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-12-31 0001418076 slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-12-31 0001418076 slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-12-31 0001418076 slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-12-31 0001418076 slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-12-31 0001418076 slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-12-31 0001418076 slrc:SlrBusinessCreditMember 2021-01-01 2021-12-31 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2021-01-01 2021-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RugDoctorLlcMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:AviatorcapSiiLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2021-01-01 2021-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember 2021-01-01 2021-12-31 0001418076 slrc:SlrEquipmentFinanceMember 2021-01-01 2021-12-31 0001418076 slrc:CreditFacilityMember 2021-01-01 2021-12-31 0001418076 slrc:NefpassFacilityMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-01-01 2021-12-31 0001418076 slrc:TermLoansMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-12-31 0001418076 slrc:AllStateAgPartsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:AegisToxicologySciencesCorporationMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:IcimsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:IvyFertilityServicesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:KoreWirelessGroupInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:KaseyaIncMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:KidDistroHoldingsLlcDistroKidMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:RdHoldcoInc.Member 2022-01-01 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:AcresCommercialMortgageLlcMember 2022-01-01 2022-12-31 0001418076 slrc:AmericanTeleconferencingServicesLtd.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:AmericanTeleconferencingServicesLtdOneMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:AmerimarkIntermediateHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:ApexServicesPartnersLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:AtriaWealthSolutionsIncMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:BasicFunInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:BaymarkHealthServicesIncMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:BdgMediaInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:CompositeTechnologyAcquisitionCorp.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:CopperRiverSeafoodsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:EnhancedPermanentCapitalLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcBluefinMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:EnverusHoldingsIncFkaDrillingInfoHoldingsMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:ErieConstructionMidwestLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:GsmAcquisitionCorpMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:HigginbothamInsuranceAgencyIncMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:HighStreetBuyerIncMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:HumanInterestIncMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:LogixHoldingCompanyLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:LuxuryAssetCapitalLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:MauricesIncorporatedMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:MontefioreNyackHospitalMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:NacHoldingsCorporationJaguarMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:NationalSpineAndPainCentersLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:OneTouchDirectLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:OrthopedicCarePartnersManagementLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:PediatricHomeRespiratoryServicesLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:PeterCFoyandAssociatesInsuranceServicesLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:PhynetDermatologyLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:PinnacleTreatmentCentersInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:PlasticsManagementLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:PptManagementHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:RqmCorp.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:RscAcquisitionIncMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:WorldInsuranceAssociatesLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:RxsenseHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:ShoHoldingICorporationShoesForCrewsMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:SouthernOrthodonticPartnersManagementLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:SparMarketingForceInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:StrytenResourcesLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:SunmedGroupHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:TaucManagementLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:TilleyDistributionIncMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:UltimateBakedGoodsMidcoLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:VesscoMidcoHoldingsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:RaneLightMetalCastingsIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:CerapedicsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:GlookoInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:MeditrinaInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ScpEyeCareLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:DeepintentInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:NeuroneticsInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:OmniguideHoldingsInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:OutsetMedicalInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:VapothermInc.Member 2022-01-01 2022-12-31 0001418076 slrc:LoyerCapitalLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:LuxCreditConsultantsLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:LuxVendingLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:MountainAirHelicoptersIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:RangoIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AlimeraSciencesInc.Member 2022-01-01 2022-12-31 0001418076 slrc:ArdelyxInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:CentrexionTherapeuticsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:BridgebioPharmaInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ArcutisBiotherapeuticsInc.Member 2022-01-01 2022-12-31 0001418076 slrc:U.s.TreasuryBillMember slrc:CashEquivalentsAtFortyOnePointEightMember 2022-01-01 2022-12-31 0001418076 slrc:ApeelTechnologyIncMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SpectrumPharmaceuticalsInc.Member 2022-01-01 2022-12-31 0001418076 slrc:ChampionAirLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:CapitalCityJetCenterIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:AirMethodsCorporationMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:BazziniLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:CPortStoneLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:DrillersChoiceIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:GmtCorporationMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:GeorgiaJetIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:LocPerformanceProductsLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:OzziesIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:PcxAerostructuresLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:RottenRockHardscapingAndTreeServiceMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:SignetMarineCorporationMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:U.s.CraneAndRiggingLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:ZamborelliEnterprisesPacificSoutherFoundationMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:PreferredEquityzeroPointFourPercentMember slrc:SointLlcMember 2022-01-01 2022-12-31 0001418076 slrc:AeroOperatingLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:AfgDallasIiiLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:AmeraMexInternationalIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:BoartLongyearCompanyMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:BowmanEnergySolutionsLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:CkdHoldingsInc.Member slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:ClubcorpHoldingsIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:DongwonAutopartTechnologyIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:EasyPakLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:EnergyDrillingServicesLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:EnvironmentalProtectionImprovementCompanyLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentOperatingLeasesLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:FirstAmericanCommercialBancorpIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:FirstNationalCapitalLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:FreightsolLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:GardaClTechnicalServicesIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:HawkeyeContractingCompanyLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:HtiLogisticsCorporationMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:InternationalAutomotiveComponentsGroupNorthAmericaIncMember 2022-01-01 2022-12-31 0001418076 slrc:KoolPakLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:AtyrPharmaIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-01-01 2022-12-31 0001418076 slrc:CardioFocusIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-01-01 2022-12-31 0001418076 slrc:CentrexionTherapeuticsIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-01-01 2022-12-31 0001418076 slrc:ConventusOrthopaedicsIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-01-01 2022-12-31 0001418076 slrc:DelphinusMedicalTechnologiesIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-01-01 2022-12-31 0001418076 slrc:EssenceGroupHoldingsCorporationLumerisMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-01-01 2022-12-31 0001418076 slrc:KbhTopcoLlcKingsbridgeMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-01-01 2022-12-31 0001418076 slrc:MeditrinaIncWarrantsMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-01-01 2022-12-31 0001418076 slrc:CashEquivalentsAtThirtyEightPointZeroMember slrc:U.s.TreasuryBillMember 2022-01-01 2022-12-31 0001418076 slrc:VenusConceptLtdMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-01-01 2022-12-31 0001418076 slrc:VapothermIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-01-01 2022-12-31 0001418076 slrc:SpectrumPharmaceuticalsInc.WarrantsMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-01-01 2022-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-01-01 2022-12-31 0001418076 slrc:SlrHealthcareAblMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-01-01 2022-12-31 0001418076 slrc:SlrCreditSolutionsMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-01-01 2022-12-31 0001418076 slrc:SlrBusinessCreditMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-01-01 2022-12-31 0001418076 slrc:SenseonicsHoldingsIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-01-01 2022-12-31 0001418076 slrc:RdHoldcoIncWarrantsMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-01-01 2022-12-31 0001418076 slrc:RdHoldcoIncClassBMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-01-01 2022-12-31 0001418076 slrc:RdHoldcoIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-01-01 2022-12-31 0001418076 slrc:SlrEquipmentFinanceEquityInterestsMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:WorldwideFlightServicesInc.Member slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:WombleCompanyIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WindRiverEnvironmentalLlcMember 2022-01-01 2022-12-31 0001418076 slrc:UpTruckingServicesLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:TrinityEquipmentRentalsIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:TheSmedleyCompanySmedleyServicesIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:SuperiorTransportationIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:StarCoachesIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:StCoachesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:SmileyLiftingSolutionsLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:SlrEquipmentFinanceMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:RoyalExpressIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:RoyalCoachLinesIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:ClubcorpHoldingsIncMember srt:MinimumMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:CkdHoldingsInc.Member srt:MaximumMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:CkdHoldingsInc.Member srt:MinimumMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:BoartLongyearCompanyMember srt:MaximumMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:BoartLongyearCompanyMember srt:MinimumMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AirMethodsCorporationMember srt:MaximumMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:AirMethodsCorporationMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AeroOperatingLlcMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AeroOperatingLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:ClubcorpHoldingsIncMember srt:MaximumMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EnergyDrillingServicesLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EnergyDrillingServicesLlcMember srt:MaximumMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:FirstAmericanCommercialBancorpIncMember srt:MinimumMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:FirstAmericanCommercialBancorpIncMember srt:MaximumMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:GardaClTechnicalServicesIncMember srt:MinimumMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:GardaClTechnicalServicesIncMember srt:MaximumMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:HtiLogisticsCorporationMember srt:MinimumMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:HtiLogisticsCorporationMember srt:MaximumMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:FreightsolLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FreightsolLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MaximumMember 2022-01-01 2022-12-31 0001418076 slrc:LoyerCapitalLlcMember srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:LoyerCapitalLlcMember srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:LuxCreditConsultantsLlcMember srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:LuxCreditConsultantsLlcMember srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:LuxVendingLlcMember srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:LuxVendingLlcMember srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:RangoIncMember srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:RangoIncMember srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MinimumMember slrc:SmileyLiftingSolutionsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:SmileyLiftingSolutionsLlcMember srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:StCoachesLlcMember srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WorldwideFlightServicesInc.Member srt:MinimumMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WorldwideFlightServicesInc.Member srt:MaximumMember 2022-01-01 2022-12-31 0001418076 slrc:StCoachesLlcMember srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:SuperiorTransportationIncMember srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:SuperiorTransportationIncMember srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:TrinityEquipmentRentalsIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:TrinityEquipmentRentalsIncMember srt:MaximumMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WindRiverEnvironmentalLlcMember srt:MinimumMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WindRiverEnvironmentalLlcMember srt:MaximumMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:CapitalCityJetCenterIncMember srt:MaximumMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MinimumMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AfgDallasIiiLlcMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AfgDallasIiiLlcMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember 2022-01-01 2022-12-31 0001418076 slrc:AdvisoryAgreementMember srt:MaximumMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:AdvisoryAgreementMember 2022-01-01 2022-12-31 0001418076 slrc:AdvisoryAgreementMember 2022-01-01 2022-12-31 0001418076 slrc:PreferredEquityMember 2022-01-01 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingMember 2022-01-01 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-01-01 2022-12-31 0001418076 slrc:SpreadOneMember 2022-01-01 2022-12-31 0001418076 slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001418076 slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001418076 slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001418076 slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001418076 slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001418076 slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001418076 slrc:NmcSeniorCreditFacilityMember 2022-01-01 2022-12-31 0001418076 slrc:SlrBusinessCreditMember 2022-01-01 2022-12-31 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2022-01-01 2022-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CreditFacilityOneMember 2022-01-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-01-01 2022-12-31 0001418076 slrc:CitiBankNaMember slrc:SunsSpvLlcMember slrc:TermLoanAndCreditFacilityMember 2022-01-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2022-01-01 2022-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2022-01-01 2022-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentOperatingLeasesLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-12-31 0001418076 slrc:SlrEquipmentFinanceDebtMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-12-31 0001418076 slrc:SlrHealthcareAblMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-12-31 0001418076 slrc:SoaggLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-12-31 0001418076 slrc:SointLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-12-31 0001418076 slrc:SlrCreditSolutionsMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-12-31 0001418076 slrc:SlrEquipmentFinanceEquityMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-12-31 0001418076 slrc:RdHoldcoIncClassBMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-12-31 0001418076 slrc:RdHoldcoIncWarrantsMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-12-31 0001418076 slrc:SlrBusinessCreditMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-12-31 0001418076 slrc:RdHoldcoIncDebtMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-12-31 0001418076 slrc:RdHoldcoIncCommonEquityMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-12-31 0001418076 slrc:LoyerCapitalLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-12-31 0001418076 slrc:KbhTopcoLlcKingsbridgeMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:CitiBankNaMember slrc:SunsSpvLlcMember srt:MinimumMember 2022-01-01 2022-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember srt:MaximumMember 2022-01-01 2022-12-31 0001418076 slrc:SlrEquipmentFinanceMember 2022-01-01 2022-12-31 0001418076 us-gaap:RevolvingCreditFacilityMember slrc:SlrBusinessCreditFacilityMember 2022-01-01 2022-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-01-01 2022-12-31 0001418076 slrc:RisksRelatingToOurInvestmentsMember 2022-01-01 2022-12-31 0001418076 slrc:RisksRelatingToAnInvestmentInOurSecuritiesMember 2022-01-01 2022-12-31 0001418076 slrc:RisksRelatingToOurBusinessAndStructureMember 2022-01-01 2022-12-31 0001418076 slrc:CreditFacilityMember 2022-01-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2022-01-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2022-01-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2022-01-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2022-01-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-01-01 2022-12-31 0001418076 slrc:CreditFacilityOneMember 2022-01-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-01-01 2022-12-31 0001418076 slrc:TermLoansMember 2022-01-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2022-01-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2022-01-01 2022-12-31 0001418076 slrc:OnAOneThousandInvestmentMember 2022-01-01 2022-12-31 0001418076 us-gaap:FinancialServicesSectorMember slrc:AtriaWealthSolutionsIncMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:TradingCompaniesDistributorsMember slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 us-gaap:HealthcareSectorMember slrc:BaymarkHealthServicesIncMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:IvyFertilityServicesLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:InsuranceMember slrc:HighStreetBuyerIncMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:PersonalProductsMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 us-gaap:TechnologySectorMember slrc:KidDistroHoldingsLlcDistroKidMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 us-gaap:CommonStockMember 2022-12-31 2022-12-31 0001418076 us-gaap:PrivatePlacementMember 2010-02-10 2010-02-10 0001418076 us-gaap:IPOMember 2010-02-10 2010-02-10 0001418076 us-gaap:OverAllotmentOptionMember 2010-02-10 0001418076 us-gaap:PrivatePlacementMember 2010-02-10 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-09-30 0001418076 slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-09-30 0001418076 us-gaap:CommonStockMember slrc:SunsCompanyMergerMember 2022-04-01 0001418076 slrc:CreditFacilityOneMember 2022-04-01 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-01-06 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2021-09-14 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2019-12-18 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2019-12-18 0001418076 slrc:TrancheTwoMember slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2016-11-08 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheTwoMember 2016-11-08 2017-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheOneMember 2022-06-30 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheTwoMember 2022-06-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:CitiBankNaMember slrc:SunsSpvLlcMember srt:MaximumMember 2011-08-26 0001418076 slrc:TermLoanAndCreditFacilityMember srt:MinimumMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2011-08-26 0001418076 slrc:TermLoanAndCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember slrc:CitiBankNaMember srt:MaximumMember 2011-08-26 2011-12-31 0001418076 us-gaap:LondonInterbankOfferedRateLIBORMember slrc:CitiBankNaMember slrc:TermLoanAndCreditFacilityMember srt:MinimumMember 2011-08-26 2011-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember slrc:TermLoanMember 2021-12-28 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember us-gaap:LineOfCreditMember 2021-12-28 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2021-12-28 0001418076 slrc:TermLoanAndCreditFacilityMember srt:MinimumMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2021-12-28 2021-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember srt:MaximumMember 2021-12-28 2021-12-31 0001418076 slrc:SlrHealthcareAblMember srt:MaximumMember 2022-09-30 0001418076 slrc:SlrHealthcareAblMember srt:MinimumMember 2022-09-30 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheOneMember 2017-02-15 0001418076 slrc:CreditFacilityMember 2019-01-01 2019-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2019-01-01 2019-12-31 0001418076 slrc:SslpFacilityMember 2019-01-01 2019-12-31 0001418076 slrc:NefpassFacilityMember 2019-01-01 2019-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2019-01-01 2019-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2019-01-01 2019-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2019-01-01 2019-12-31 0001418076 slrc:TermLoansMember 2019-01-01 2019-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2019-01-01 2019-12-31 0001418076 slrc:CreditFacilityMember 2018-01-01 2018-12-31 0001418076 slrc:NefpassFacilityMember 2018-01-01 2018-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2018-01-01 2018-12-31 0001418076 slrc:SslpFacilityMember 2018-01-01 2018-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2018-01-01 2018-12-31 0001418076 slrc:TermLoansMember 2018-01-01 2018-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2018-01-01 2018-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember slrc:CrystalFinancialMember 2012-11-30 2012-11-30 0001418076 slrc:CrystalFinancialMember 2012-11-30 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2012-12-28 2012-12-28 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2012-12-28 0001418076 us-gaap:RevolvingCreditFacilityMember 2012-12-28 0001418076 slrc:SlrBusinessCreditFacilityMember 2016-07-28 2016-07-28 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2016-07-28 0001418076 slrc:SlrBusinessCreditFacilityMember slrc:CrystalCapitalFinancialHoldingsLlcMember 2016-07-28 0001418076 slrc:SlrEquipmentFinanceMember 2017-07-31 0001418076 slrc:SlrEquipmentFinanceMember 2019-09-30 2019-09-30 0001418076 slrc:SlrEquipmentFinanceMember 2019-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2020-11-03 2020-11-03 0001418076 srt:MinimumMember slrc:KingsbridgeHoldingsLlcMember 2020-11-03 0001418076 slrc:KingsbridgeHoldingsLlcMember srt:MaximumMember 2020-11-03 0001418076 slrc:KingsbridgeHoldingsLlcMember 2020-11-03 0001418076 slrc:SlrHealthcareAblMember 2013-09-30 0001418076 srt:MaximumMember slrc:SlrHealthcareAblCreditMember 2013-09-30 0001418076 srt:MinimumMember slrc:SlrHealthcareAblCreditMember 2013-09-30 0001418076 srt:MinimumMember slrc:SlrHealthcareAblCreditMember 2014-03-31 0001418076 slrc:SlrHealthcareAblCreditMember 2016-05-27 2016-05-27 0001418076 srt:MinimumMember slrc:SlrHealthcareAblCreditMember 2016-05-27 0001418076 srt:MaximumMember slrc:SlrHealthcareAblCreditMember 2016-05-27 0001418076 slrc:SlrHealthcareAblCreditMember 2019-06-28 2019-06-28 0001418076 slrc:SummitFinancialResourcesMember 2019-06-28 0001418076 slrc:NmHoldcoMember 2019-06-28 0001418076 slrc:NmcsCreditFacilityMember 2019-06-28 0001418076 slrc:SlrHealthcareAblCreditMember 2019-06-28 0001418076 slrc:EspSscCorporationMember 2017-10-20 0001418076 slrc:NorthMillCapitalLlcMember 2017-10-20 0001418076 slrc:NorthMillCapitalLlcMember 2018-05-01 0001418076 slrc:EspSscCorporationMember 2018-05-01 0001418076 slrc:FastPayPartnersLlcMember 2021-06-03 2021-06-03 0001418076 slrc:NmcsCreditFacilityMember 2021-06-03 0001418076 slrc:SunsMember 2021-06-03 0001418076 slrc:FastPayPartnersLlcMember 2021-06-03 0001418076 us-gaap:CommonStockMember slrc:SunsCompanyMergerMember 2022-04-01 2022-04-01 0001418076 srt:MinimumMember slrc:AdvisoryAgreementMember 2022-04-01 2022-04-01 0001418076 slrc:AdvisoryAgreementMember srt:MaximumMember 2022-04-01 2022-04-01 0001418076 slrc:BoardMember us-gaap:SubsequentEventMember 2023-01-10 0001418076 us-gaap:SubsequentEventMember slrc:BoardMember 2023-02-02 0001418076 slrc:BoardMember us-gaap:SubsequentEventMember 2023-02-28 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2019-12-18 2019-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2019-12-18 2019-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2017-12-28 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2017-11-22 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2017-11-22 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheOneMember 2017-02-15 2017-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2013-09-30 2013-09-30 0001418076 srt:MaximumMember slrc:SlrHealthcareAblCreditMember 2014-06-27 0001418076 slrc:CreditFacilityMember 2017-01-01 2017-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2017-01-01 2017-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2017-01-01 2017-12-31 0001418076 slrc:TermLoansMember 2017-01-01 2017-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2017-01-01 2017-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2017-01-01 2017-12-31 0001418076 slrc:SeniorSecuredNotesMember 2017-01-01 2017-12-31 0001418076 slrc:CreditFacilityMember 2016-01-01 2016-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2016-01-01 2016-12-31 0001418076 slrc:TermLoansMember 2016-01-01 2016-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2016-01-01 2016-12-31 0001418076 slrc:SeniorSecuredNotesMember 2016-01-01 2016-12-31 0001418076 slrc:CreditFacilityMember 2015-01-01 2015-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2015-01-01 2015-12-31 0001418076 slrc:TermLoansMember 2015-01-01 2015-12-31 0001418076 slrc:SeniorSecuredNotesMember 2015-01-01 2015-12-31 0001418076 slrc:CreditFacilityMember 2014-01-01 2014-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2014-01-01 2014-12-31 0001418076 slrc:SeniorSecuredNotesMember 2014-01-01 2014-12-31 0001418076 slrc:TermLoansMember 2014-01-01 2014-12-31 0001418076 slrc:CreditFacilityMember 2013-01-01 2013-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2013-01-01 2013-12-31 0001418076 slrc:SeniorSecuredNotesMember 2013-01-01 2013-12-31 0001418076 slrc:TermLoansMember 2013-01-01 2013-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2022-12-01 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrSeniorLendingProgramLlcMember 2022-10-12 0001418076 srt:ManagementMember slrc:SlrSeniorLendingProgramLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-10-12 0001418076 us-gaap:InvestorMember slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrSeniorLendingProgramLlcMember 2022-10-12 0001418076 slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramSpvLlcMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-12 0001418076 slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramSpvLlcMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-12 2022-12-12 0001418076 slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramSpvLlcMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-12 2022-12-12 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramSpvLlcMember 2022-12-12 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember 2020-12-31 0001418076 slrc:PreferredEquityMember 2020-12-31 0001418076 slrc:EquipmentFinancingMember 2020-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2020-12-31 0001418076 slrc:LoyerCapitalLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2020-12-31 0001418076 slrc:RdHoldcoIncWarrantsMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2020-12-31 0001418076 slrc:AviatorcapSiiLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RugDoctorLlcMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RugDoctorLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2021-12-31 0001418076 slrc:AviatorcapSiiLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember 2021-12-31 0001418076 slrc:PreferredEquityMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:SlrBusinessCreditMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:RdHoldcoIncDebtMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:SlrHealthcareAblMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:KbhTopcoLlcKingsbridgeMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:SlrEquipmentFinanceDebtMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:SointLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:SoaggLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:SlrHealthcareAblMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:SlrBusinessCreditMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:RdHoldcoIncDebtMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:RdHoldcoIncWarrantsMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:RdHoldcoIncClassBMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:SlrEquipmentFinanceEquityMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:SlrCreditSolutionsMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:LoyerCapitalLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:RdHoldcoIncCommonEquityMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:EquipmentOperatingLeasesLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 slrc:PreferredEquityMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2022-12-31 iso4217:USD xbrli:shares xbrli:pure utr:Day utr:Year iso4217:USD xbrli:shares slrc:basispoints slrc:issuers slrc:loans slrc:fund slrc:Customers
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
 
FORM
10-K
 
 
 
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE FISCAL YEAR ENDED DECEMBER 31, 2022
OR
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM
                    
TO
                    
COMMISSION FILE NUMBER:
814-00754
 
 
SLR INVESTMENT CORP.
(Exact name of registrant as specified in its charter)
 
 
 
Maryland

 
26-1381340
(State of Incorporation)
 
(I.R.S. Employer
Identification Number)
500 Park Avenue
New York, N.Y.
 
10022
(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code:
(212993-1670
Securities registered pursuant to Section 12(b) of the Act:
 
Title of Each Class
 
Trading Symbol
 
Name of Each Exchange on Which Registered
Common Stock, par value $0.01 per share
 
SLRC
 
The NASDAQ Global Select Market
Securities registered pursuant to Section 12(g) of the Act: None
 
 
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    
Yes
 ☒    No  ☐
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes ☐    
No
  ☒
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    
Yes
 ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    
Yes
 ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
Large accelerated filer      Accelerated filer  
       
Non-accelerated
filer
     Smaller Reporting Company  
       
         Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.    Yes 
    No  ☐
If securities are registered pursuant to Section 12(b) of the Exchange Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.  ☐
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to
§240.10D-1(b).  ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Act)    Yes ☐    No  
The aggregate market value of common stock held by
non-affiliates
of the Registrant on June 30, 2022 based on the closing price on that date of $14.63 on the NASDAQ Global Select Market was approximately $741.8 million. For the purposes of calculating this amount only, all directors and executive officers of the Registrant have been treated as affiliates. There were 54,554,634 shares of the Registrant’s common stock outstanding as of February 24, 2023.
 
Auditor Firm Id: 185
  
Auditor Name: KPMG LLP
  
Auditor Location: New York, NY

 
 

SLR INVESTMENT CORP.
FORM
10-K
FOR THE FISCAL YEAR ENDED DECEMBER 31, 2022
TABLE OF CONTENTS
 
 
 
 
  
Page
 
 
 
  
 
 
Item 1.
 
  
 
1
 
Item 1A.
 
  
 
24
 
Item 1B.
 
  
 
55
 
Item 2.
 
  
 
55
 
Item 3.
 
  
 
55
 
Item 4.
 
  
 
55
 
 
 
  
 
 
Item 5.
 
  
 
56
 
Item 6.
 
  
 
61
 
Item 7.
 
  
 
62
 
Item 7A.
 
  
 
83
 
Item 8.
 
  
 
84
 
Item 9.
 
  
 
125
 
Item 9A.
 
  
 
125
 
Item 9B.
 
  
 
125
 
Item 9C.
 
  
 
125
 
 
 
  
 
 
Item 10.
 
  
 
126
 
Item 11.
 
  
 
131
 
Item 12.
 
  
 
132
 
Item 13.
 
  
 
134
 
Item 14.
 
  
 
136
 
 
 
  
 
 
Item 15.
 
  
 
138
 
Item 16.
 
  
 
142
 
 
  
 
143
 
 

PART I
 
Item 1.
Business
SLR Investment Corp. (the “Company”, “SLRC”, “we” or “our”), a Maryland corporation formed in November 2007, is a
closed-end,
externally managed,
non-diversified
management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Furthermore, as the Company is an investment company, it continues to apply the guidance in FASB Accounting Standards Codification (“ASC”) Topic 946. In addition, for U.S. federal income tax purposes, the Company has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).
In February 2010, we completed our initial public offering and a concurrent private offering of shares to our senior management team.
We invest primarily in privately held U.S. middle-market companies, where we believe the supply of primary capital is limited and the investment opportunities are most attractive. Our investment objective is to generate both current income and capital appreciation through debt and equity investments. We invest primarily in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. We define “middle market” to refer to companies with annual revenues typically between $50 million and $1 billion. From time to time, we may also invest directly in the debt and equity of public companies that are thinly traded and such investments will not be limited to any minimum or maximum market capitalization. In addition, we may invest in foreign markets, including emerging markets. Our business is focused primarily on the direct origination of investments through portfolio companies or their financial sponsors. Our investments generally range between $5 million and $100 million each, although we expect that this investment size will vary proportionately with the size of our capital base and/or with strategic initiatives.
In addition, we may invest a portion of our portfolio in other types of investments, which we refer to as opportunistic investments, which are not our primary focus but are intended to enhance our overall returns. These investments may include, but are not limited to, direct investments in public companies that are not thinly traded and securities of leveraged companies located in select countries outside of the United States. The securities that we invest in are typically rated below investment grade. Securities rated below investment grade are often referred to as “leveraged loans,” “high yield” or “junk” securities, and may be considered “high risk” compared to debt instruments that are rated investment grade. In addition, some of our debt investments will not fully amortize during their lifetime, which means that a borrower may be unable to payoff its debt due to bankruptcy or other reasons and therefore we may
write-off
such debt investment prior to its scheduled maturity. Upon such an occurrence, we may realize a loss or a substantial amount of unpaid principal and interest due upon maturity.
Our investment activities are managed by SLR Capital Partners, LLC (“SLR Capital Partners” or the “Investment Adviser”) and supervised by our board of directors (the “Board” or “board of directors”), a majority of whom are
non-interested,
as such term is defined in section 2(a)(19) of the 1940 Act. SLR Capital Management, LLC (“SLR Capital Management”) provides the administrative services necessary for us to operate.
As of December 31, 2022, our investment portfolio totaled $2.1 billion and our net asset value was $999.7 million. Our portfolio was comprised of debt and equity investments in 139 portfolio companies.
SUNS Merger
On April 1, 2022, we completed our previously announced acquisition of SLR Senior Investment Corp., a Maryland corporation (“SUNS”). Pursuant to that certain Agreement and Plan of Merger (the “Merger Agreement”) by and among us, SUNS, Solstice Merger Sub, Inc., a Maryland corporation and our wholly-owned subsidiary (“Merger Sub”), and, solely for the limited purposes set forth therein, the Investment Adviser, dated as of December 1, 2021, Merger Sub was first merged with and into SUNS, with SUNS as the surviving corporation, and, immediately following the Merger, SUNS was then merged with and into us, with us as the surviving company. In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each outstanding share of SUNS’s common stock was converted into the right to receive 0.7796 shares of our common stock (with SUNS’s stockholders receiving cash in lieu of fractional shares of our common stock). As a result of the Mergers, we issued an aggregate of 12,511,825 shares of our common stock to former SUNS stockholders.
The Mergers are accounted for as an asset acquisition of SLR Senior Investment Corp. by the Company in accordance with the asset acquisition method of accounting as detailed in ASC
805-50,
Business Combinations – Related Issues, with the fair value of total consideration paid in conjunction with the Mergers allocated to the assets acquired and liabilities assumed based on their relative fair values as of the date of the Mergers. Generally, under asset acquisition accounting, acquiring assets in groups not only requires ascertaining the cost of the asset (or net assets), but also allocating that cost to the individual assets (or individual assets and liabilities) that make up the group. The cost of the group of assets acquired in an asset acquisition is allocated to the individual assets acquired or liabilities assumed based on their relative fair values of net identifiable assets acquired other than certain
“non-qualifying”
assets (for example cash) and does not give rise to goodwill. The Company is the accounting survivor of the Mergers. The Mergers were considered a
tax-free
reorganization and the historical cost basis of the acquired SUNS investments are carried forward for tax purposes.
 
1

Letter Agreement
On April 1, 2022, in connection with the consummation of the Mergers, we entered into a letter agreement (the “Letter Agreement”) pursuant to which the Investment Adviser voluntarily agreed to a permanent 25 basis point reduction of the annual base management fee rate payable by us to the Investment Adviser pursuant to the investment advisory and management agreement between us and the Investment Adviser (the “Advisory Agreement”), resulting in an annual base management fee rate payable by us to the Investment Adviser of 1.50% on gross assets up to 200% of our total net assets. We retained the annual base management fee rate payable by us to the Investment Adviser of 1.00% on gross assets that exceed 200% of our total net assets.
SLR Capital Partners
SLR Capital Partners, our investment adviser, is controlled and led by Michael S. Gross, our Chairman and
Co-Chief
Executive Officer, and Bruce Spohler, our
Co-Chief
Executive Officer and Chief Operating Officer. They are supported by a team of investment professionals. SLR Capital Partners’ investment team has extensive experience in leveraged lending and private equity, as well as significant contacts with financial sponsors.
In addition, SLR Capital Partners currently serves as investment adviser to private funds and managed accounts as well as to SCP Private Credit Income BDC LLC, an unlisted BDC that primarily invests in first lien loans to upper middle market private leveraged companies, SLR HC BDC LLC, an unlisted BDC that primarily invests in first lien healthcare cash flow loans and life science loans, and SLR Private Credit BDC II LLC, an unlisted BDC focused on first lien senior secured floating rate loans. As of February 24, 2023, Mr. Gross and Mr. Spohler beneficially owned, either directly or indirectly, approximately 7.5% of our outstanding common stock.
Mr. Gross has over 25 years of experience in the private equity, distressed debt and mezzanine (i.e., actually or structurally subordinated) lending businesses and has been involved in originating, structuring, negotiating, consummating and managing private equity, distressed debt and mezzanine lending transactions. Prior to his current role as our Chairman,
Co-Chief
Executive Officer and President, Mr. Gross founded Apollo Investment Corporation, a publicly traded BDC. He served as its chairman from February 2004 to July 2006 and its chief executive officer from February 2004 to February 2006. Under his management, Apollo Investment Corporation raised approximately $930 million in gross proceeds in an initial public offering in April 2004, built a dedicated investment team and infrastructure and invested approximately $2.3 billion in over 65 companies in conjunction with 50 different private equity sponsors. Mr. Gross is also a founder and a former senior partner of Apollo Global Management, a leading private equity firm. During his tenure at Apollo Global Management, Mr. Gross was a member of the investment committee that was responsible for overseeing more than $13 billion of investments in over 150 companies.
Mr. Gross also has served on the boards of directors of more than 20 public and private companies. As a result, Mr. Gross has developed an extensive network of private equity sponsor relationships as well as relationships with management teams of public and private companies, investment bankers, attorneys and accountants that we believe should provide us with significant business opportunities.
We also rely on the over 25 years of experience of Mr. Spohler, who has served as our Chief Operating Officer and a partner of SLR Capital Partners since its inception and as
Co-Chief
Executive Officer since June 2019. Previously, Mr. Spohler was a managing director and a former
co-head
of U.S. Leveraged Finance for CIBC World Markets. He held numerous senior roles at CIBC World Markets, including serving on the U.S. Management Committee, Global Executive Committee and the Deals Committee, which approves all of CIBC World Markets’ U.S. corporate finance debt capital decisions. During Mr. Spohler’s tenure, he was responsible for senior loan, high yield and mezzanine origination and execution, as well as CIBC World Markets’ below investment grade loan portfolio in the United States. As a
co-head
of U.S. Leveraged Finance, Mr. Spohler oversaw over 300 capital raising and merger and acquisition transactions, comprising over $40 billion in market capitalization.
SLR Capital Partners’ senior investment professionals have been active participants in the primary and secondary leveraged credit markets throughout their careers. They have effectively managed portfolios of senior secured, distressed and mezzanine debt as well as other investment types. The depth of their prior experience and credit market experience has led them through various stages of the economic cycle as well as several market disruptions.
 
2

SLR Capital Management
Pursuant to an administration agreement (the “Administration Agreement”), SLR Capital Management furnishes us with office facilities, equipment and clerical, bookkeeping and record keeping services at such facilities. Under the Administration Agreement, SLR Capital Management also performs, or oversees the performance of, our required administrative services, which include, among other things, being responsible for the financial records which we are required to maintain and preparing reports to our stockholders. In addition, SLR Capital Management assists us in determining and publishing our net asset value, oversees the preparation and filing of our tax returns and the printing and dissemination of reports to our stockholders, and generally oversees the payment of our expenses and the performance of administrative and professional services rendered to us by others. SLR Capital Management also provides managerial assistance, if any, on our behalf to those portfolio companies that request such assistance.
License Agreement
We have entered into a license agreement with SLR Capital Partners pursuant to which SLR Capital Partners has agreed to grant us a
non-exclusive,
royalty-free license to use the name “SLR” and “SOLAR”. Under this agreement, we have a right to use the SLR and SOLAR name for so long as the Investment Advisory and Management Agreement with our investment adviser is in effect. Other than with respect to this limited license, we will have no legal right to the “SLR” or “SOLAR” name.
Market Opportunity
The Company invests directly and indirectly in leveraged middle-market companies, including in senior secured loans, and to a lesser extent, unsecured loans and equity securities. We believe that the size of this market, coupled with leveraged companies’ need for flexible sources of capital at attractive terms and rates, creates an attractive investment environment for us.
 
   
Middle-market companies continue to face increasing difficulty in accessing the capital markets.
While many middle-market companies were formerly able to raise funds by issuing high-yield bonds, we believe this approach to financing has become more difficult in recent years as institutional investors have sought to invest in larger, more liquid offerings. In addition, many private finance companies that historically financed their lending and investing activities through securitization transactions have lost that source of funding and reduced lending significantly. Moreover, consolidation of lenders and market participants and the illiquid nature of investments have resulted in fewer middle-market lenders and market participants.
 
   
There is a large pool of uninvested private equity capital likely to seek additional capital to support their investments.
We believe there is more than $500 billion of uninvested private equity capital seeking debt financing to support acquisitions.
 
   
The significant amount of debt maturing through 2024 should provide additional demand for capital.
A high volume of financings are expected to mature over the next few years. We believe that this supply of prospective lending opportunities coupled with a lack of available credit in the middle-market lending space may offer attractive risk-adjusted returns to investors. Risk-adjusted return compares returns against the amount of risk incurred. The term “risk-adjusted return” does not imply that an investment is no risk or low risk.
 
   
Investing in private middle-market debt provides an attractive risk reward profile.
In general, terms for illiquid, middle-market subordinated debt have been more attractive than those for larger corporations which are typically more liquid. We believe this is because fewer institutions are able to invest in illiquid asset classes.
Therefore, we believe that there is an attractive opportunity to invest in leveraged middle-market companies, including in senior secured loans, unitranche loans and to a lesser extent, unsecured loans and equity securities, and that we are well positioned to serve this market.
Competitive Advantages and Strategy
We believe that we have the following competitive advantages over other providers of financing to leveraged companies.
 
3

Management Experience
As managing partner, Mr. Gross has principal management responsibility for SLR Capital Partners, to which he currently dedicates substantially all of his time. Mr. Gross has over 25 years of experience in leveraged finance, private equity and distressed debt investing. Mr. Spohler, our
Co-Chief
Executive Officer, Chief Operating Officer and a partner of SLR Capital Partners, has over 25 years of experience in evaluating and executing leveraged finance transactions.
Investment Capacity
The proceeds from our public offerings and the Concurrent Private Placement, the borrowing capacities under the senior secured credit facility led by Citibank, N.A. (the “Credit Facility”) and the SUNS SPV LLC senior secured credit facility (the “SPV Credit Facility”), our $75 million of unsecured senior notes due 2023 (the “2023 Unsecured Notes”), our $125 million of unsecured notes due 2024 (the “2024 Unsecured Notes”), our $85 million of unsecured notes due 2025 (the “2025 Unsecured Notes”), our $75 million of unsecured notes due 2026 (the “2026 Unsecured Notes”), our $50 million of unsecured senior notes due 2027 (the “2027 Unsecured Notes”), our $135 million of unsecured notes due 2027 (the “2027 Series F Unsecured Notes”), the available capital at our significant subsidiaries and the expected repayments of existing portfolio company investments provide us with a substantial amount of capital available for deployment into new investment opportunities. We believe we are well positioned for the current marketplace.
The Company’s Leverage
As of December 31, 2022, we had total outstanding borrowings of approximately $1,093.2 million. Under the provisions of the 1940 Act, we are permitted to issue senior securities in amounts such that our asset coverage ratio, as defined in the 1940 Act, equals at least 150% of gross assets less all liabilities and indebtedness not represented by senior securities, after each issuance of senior securities. As of December 31, 2022, our asset coverage ratio was 191.5%. We believe our relatively low level of leverage provides us with a competitive advantage as proceeds from our investments are available for reinvestment as opposed to being consumed by debt repayment. We may increase our relative level of debt in the future. However, we do not currently anticipate operating with a substantial amount of debt relative to our total assets.
Proprietary Sourcing and Origination
We believe that SLR Capital Partners’ senior investment professionals’ longstanding relationships with financial sponsors, commercial and investment banks, management teams and other financial intermediaries provide us with a strong pipeline of proprietary origination opportunities. We expect to continue leveraging the relationships Mr. Gross established while sourcing and originating investments at Apollo Investment Corporation as well as the financial sponsor relationships Mr. Spohler developed while he was a
co-head
of CIBC World Markets’ U.S. Leveraged Finance Group.
Versatile Transaction Structuring and Flexibility of Capital
We believe SLR Capital Partners’ senior investment team’s broad experience and ability to draw upon its extensive experience enable us to identify, assess and structure investments successfully across all levels of a company’s capital structure and to manage potential risk and return at all stages of the economic cycle. The attempt to manage risk does not imply low risk or no risk. While we are subject to significant regulation as a BDC, we are not subject to many of the regulatory limitations that govern traditional lending institutions such as banks. As a result, we believe that we can be more flexible than such lending institutions in selecting and structuring investments, adjusting investment criteria, transaction structures and, in some cases, the types of securities in which we invest.
Emphasis on Achieving Strong Risk-Adjusted Returns
SLR Capital Partners uses a structured investment and risk management process that emphasizes research and analysis. SLR Capital Partners seeks to build our portfolio on a
“bottom-up”
basis, choosing and sizing individual positions based on their relative risk/reward profiles as a function of the associated downside risk, volatility, correlation with the existing portfolio and liquidity. At the same time, SLR Capital Partners takes into consideration a variety of factors in managing our portfolio and imposes portfolio-based risk constraints promoting a more diverse portfolio of investments and limiting issuer and industry concentration. We do not pursue short-term origination targets. We believe this approach enables us to build an attractive investment portfolio that meets our return and value criteria over the long term. We believe it is critical to conduct extensive due diligence on investment targets. In evaluating new investments we, through SLR Capital Partners, conduct a rigorous due diligence process.
 
4

Dedication of Resources to Industries with Substantial Information Flow
We dedicate our investing resources to industries characterized by strong cash flow and in which SLR Capital Partners’ investment professionals have deep investment experience. As a result of their investment experience, Messrs. Gross and Spohler, together with SLR Capital Partners’ other senior investment professionals, have long-term relationships with management consultants and management teams in the industries we target, as well as substantial information concerning those industries.
Longer Investment Horizon
Unlike private equity and venture capital funds, we will not be subject to standard periodic capital return requirements. Such requirements typically stipulate that the capital of these funds, together with any capital gains on such invested funds, can only be invested once and must be returned to investors after a
pre-agreed
time period. We believe that our flexibility to make investments with a long-term view and without the capital return requirements of traditional private investment vehicles provides us with the opportunity to generate favorable returns relative to the risks of our invested capital and enables us to be a better long-term partner for our portfolio companies.
Investments
The Company seeks to create a diverse portfolio that includes senior secured loans, and to a lesser extent unsecured loans and equity securities by investing approximately $5 million to $100 million of capital, on average, in the securities of leveraged companies, including middle-market companies. We expect that this investment size will vary with the size of our capital base and/or for strategic initiatives. Structurally, unsecured loans usually rank subordinate in priority of payment to senior debt, such as senior bank debt. As such, other creditors may rank senior to us in the event of insolvency. However, unsecured loans rank senior to common and preferred equity in a borrower’s capital structure. Due to its higher risk profile and often less restrictive covenants as compared to senior loans, unsecured loans generally earn a higher return than senior secured loans.
In addition to senior secured loans and unsecured loans, we may invest a portion of our portfolio in opportunistic investments, which are not our primary focus, but are intended to enhance our returns to our investors. These investments may include direct investments in public companies that are not thinly traded and securities of leveraged companies located in select countries outside of the United States. The securities that we invest in are typically rated below investment grade. Securities rated below investment grade are speculative and are often referred to as “leveraged loans,” “high yield” or “junk” securities, and may be considered “high risk” compared to debt instruments that are rated investment grade. In addition, some of our debt investments will not fully amortize during their lifetime, which means that a borrower may be unable to payoff its debt due to bankruptcy or other reasons and therefore we may
write-off
such debt investment prior to its scheduled maturity. Upon such an occurrence, we may realize a loss or a substantial amount of unpaid principal and interest due upon maturity. We may invest up to 30% of our total assets in such opportunistic investments, including loans issued by
non-U.S.
issuers, subject to compliance with our regulatory obligations as a BDC under the 1940 Act.
We have and will continue to borrow funds to make investments. As a result, we will be exposed to the risks of leverage, which may be considered a speculative investment technique. The use of leverage magnifies the potential for loss on amounts invested and therefore increases the risks associated with investing in our securities. In addition, the costs associated with our borrowings, including any increase in management fees payable to our investment adviser, SLR Capital Partners, will be borne by our common stockholders.
Moreover, we may acquire investments in the secondary market and, in analyzing such investments, we will seek to employ a substantially similar analytical process as we use for our primary investments.
We may utilize instruments such as forward contracts, currency options and interest rate swaps, caps, collars and floors to seek to hedge against fluctuations in the relative values of our portfolio positions from changes in currency exchange rates and market interest rates. Hedging against a decline in the values of our portfolio positions does not eliminate the possibility of fluctuations in the values of such positions or prevent losses if the values of such positions decline. However, such hedging can establish other positions designed to gain from those same developments, thereby offsetting the decline in the value of such portfolio positions. Such hedging transactions may also limit the opportunity for gain if the values of the underlying portfolio positions should increase. It may not be possible to hedge against an exchange rate or interest rate fluctuation that is so generally anticipated that we are not able to enter into a hedging transaction at an acceptable price. Moreover, for a variety of reasons, we may not seek to establish a perfect correlation between such hedging instruments and the portfolio holdings being hedged. Any such imperfect correlation may prevent us from achieving the intended hedge and expose us to risk of loss. In addition, it may not be possible to hedge fully or perfectly against currency fluctuations affecting the value of securities denominated in
non-U.S.
currencies because the value of those securities is likely to fluctuate as a result of factors not related to currency fluctuations.
 
5

Our principal focus is to provide senior secured loans to leveraged companies in a variety of industries. We generally seek to target companies that generate positive cash flows and/or have substantial assets that secure our loans. We generally seek to invest in companies from the broad variety of industries in which our investment adviser has direct experience.
The following is a representative list of the industries in which we may invest:
 
•  Aerospace & Defense
 
•  Air Freight & Logistics
 
•  Airlines
 
•  Asset Management
 
•  Automobiles
 
•  Auto Components
 
•  Auto Parts & Equipment
 
•  Biotechnology
 
•  Building Products
 
•  Capital Markets
 
•  Chemicals
 
•  Commercial Services & Supplies
 
•  Communications Equipment
 
•  Construction & Engineering
 
•  Consumer Finance
 
•  Containers & Packaging
 
•  Distributors
 
•  Diversified Consumer Services
 
•  Diversified Financial Services
 
•  Diversified Real Estate Activities
 
•  Diversified Telecommunications Services
 
•  Education Services
 
•  Energy Equipment & Services
 
•  Food Products
 
•  Food & Staples Retailing
 
•  Footwear
 
•  Health Care Equipment & Supplies
 
•  Health Care Facilities
 
•  Health Care Providers & Services
 
•  Health Care Technology
 
•  Hotels, Restaurants & Leisure
 
     
•  Household & Personal Products
 
•  Industrial Conglomerates
 
•  Insurance
 
•  Internet & Catalog Retail
 
•  Internet Software & Services
 
•  IT Services
 
•  Leisure Equipment & Products
 
•  Life Sciences Tools & Services
 
•  Machinery
 
•  Media
 
•  Metals & Mining
 
•  Multiline Retail
 
•  Multi-Sector Holdings
 
•  Oil, Gas & Consumable Fuels
 
•  Packaged Foods & Meats
 
•  Paper & Forest Products
 
•  Personal Products
 
•  Pharmaceuticals
 
•  Professional Services
 
•  Research & Consulting Services
 
•  Road & Rail
 
•  Software
 
•  Specialty Retail
 
•  Textiles, Apparel & Luxury Goods
 
•  Thrifts & Mortgage Finance
 
•  Trading Companies & Distributors
 
•  Transportation Infrastructure
 
•  Water Utilities
 
•  Wireless Telecommunications Services
We may also invest in other industries if we are presented with attractive opportunities.
We may invest, to the extent permitted by law, in the securities and instruments of other investment companies, including private funds. We may also participate in negotiated
co-investment
transactions with certain affiliates, each of whose investment adviser is SLR Capital Partners, or an investment adviser controlling, controlled by or under common control with SLR Capital Partners and is registered as an investment adviser under the Investment Advisers Act of 1940, as amended (the “Advisers Act”), in a manner consistent with our investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, and pursuant to the conditions of the most recent exemptive order obtained from the SEC on June 13, 2017 (the “Exemptive Order”). Pursuant to the Exemptive Order, we are permitted
to co-invest with
our affiliates if a “required majority” (as defined in Section 57(o) of the 1940 Act) of our independent directors make certain conclusions in connection with
a co-investment transaction,
including, but not limited to, that (1) the terms of the
potential co-investment transaction,
including the consideration to be paid, are reasonable and fair to us and our stockholders and do not involve overreaching in respect of us or our stockholders on the part of any person concerned, and (2) the
potential co-investment transaction
is consistent with the interests of our stockholders and is consistent with our then-current investment objective and strategies.
At December 31, 2022, our portfolio consisted of 139 portfolio companies and was invested 30.8% in cash flow senior secured loans, 30.0% in asset-based senior secured loans / SLR Credit Solutions (“SLR Credit”) / SLR Healthcare ABL / SLR Business Credit, 23.7% in equipment senior secured financings / SLR Equipment Finance (“SLR Equipment”) / Kingsbridge Holdings, LLC (“KBH”) and 15.5% in life science senior secured loans, in each case, measured at fair value. We expect that our portfolio will
 
6

continue to include primarily senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. In addition, we also expect to invest a portion of our portfolio in opportunistic investments, which are not our primary focus, but are intended to enhance our risk-adjusted returns to stockholders. These investments may include, but are not limited to, securities of public companies and debt and equity securities of companies located outside of the United States.
While our primary investment objective is to maximize current income and capital appreciation through investments in U.S. senior and subordinated loans, other debt securities and equity, we may also invest a portion of the portfolio in opportunistic investments, including foreign securities.
Listed below are our top ten portfolio companies and industries based on their fair value and represented as a percentage of total assets as of December 31, 2022 and December 31, 2021:
TOP TEN PORTFOLIO COMPANIES AND INDUSTRIES AS OF DECEMBER 31, 2022
 
Portfolio Company
  
% of

Total Assets
 
SLR Credit Solutions*
     11.4
Kingsbridge Holdings, LLC*
     9.0
SLR Equipment Finance*
     5.0
SLR Business Credit*
     3.5
Arcutis Biotherapeutics, Inc.
     2.7
BridgeBio Pharma, Inc.
     1.6
Foundation Consumer Brands, LLC
     1.4
Enhanced Capital Group, LLC
     1.4
Outset Medical, Inc.
     1.4
Vapotherm, Inc.
     1.4
 
*
Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment.
 
Industry
  
% of

Total Assets
 
Diversified Financial Services
     18.2
Multi-Sector Holdings
     14.4
Health Care Providers & Services
     6.4
Health Care Equipment & Supplies
     5.4
Pharmaceuticals
     4.5
Software
     3.6
Insurance
     3.5
Biotechnology
     3.2
Diversified Consumer Services
     2.2
Media
     1.6
TOP TEN PORTFOLIO COMPANIES AND INDUSTRIES AS OF DECEMBER 31, 2021
 
Portfolio Company
  
% of

Total Assets
 
SLR Credit Solutions*
     14.9
Kingsbridge Holdings, LLC*
     11.2
SLR Equipment Finance*
     6.4
Rubius Therapeutics, Inc.
     2.0
PhyMed Management LLC
     1.8
KORE Wireless Group, Inc.
     1.8
Community Brands ParentCo, LLC
     1.7
BridgeBio Pharma, Inc.
     1.7
Foundation Consumer Brands, LLC
     1.7
SOC Telemed, Inc.
     1.6
 
*
Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment.
 
7

Industry
  
% of

Total Assets
 
Multi-Sector Holdings
     20.6
Diversified Financial Services
     17.2
Health Care Providers & Services
     8.0
Pharmaceuticals
     6.4
Software
     4.1
Health Care Equipment & Supplies
     4.1
Biotechnology
     2.0
Wireless Telecommunication Services
     1.8
Personal Products
     1.7
Road & Rail
     1.5
Set forth below is a brief description of each portfolio company in which we have made an investment that represents greater than 5% of our total assets as of December 31, 2022.
SLR Credit Solutions
We invested in SLR Credit as an independent commercial finance company that provides primarily senior secured loans for both asset-based and cash flow financings to middle-market companies. Its team of experienced, responsive professionals has underwritten, closed and managed more than $20 billion in secured debt commitments across a wide range of industries. As of December 31, 2022, SLR Credit had 29 funded commitments to 25 different issuers with total funded loans of approximately $439.5 million on total assets of $460.7 million. SLR Credit’s competitors include other specialty finance companies and small banks. As with most finance companies, SLR Credit is exposed to interest rate risk, which it mostly mitigates by issuing loans with floating rates.
SLR Equipment Finance
On July 31, 2017, the Company completed the acquisition of NEF Holdings, which conducts its business through its wholly-owned subsidiary Nations Equipment Finance, LLC. Effective February 25, 2021, Nations Equipment Finance, LLC and its related companies are doing business as SLR Equipment Finance. SLR Equipment is an independent equipment finance company that provides senior secured loans and leases primarily to U.S. based companies. The Company invested $209.9 million in cash to effect the transaction, of which $145.0 million was invested in the equity of SLR Equipment through our wholly-owned consolidated taxable subsidiary NEFCORP LLC and our wholly-owned consolidated subsidiary NEFPASS LLC and $64.9 million was used to purchase certain leases and loans held by SLR Equipment through NEFPASS LLC. As of December 31, 2022, SLR Equipment had 131 funded equipment-backed leases and loans to 59 different customers with a total net investment in leases and loans of approximately $190.8 million on total assets of $241.8 million.
Kingsbridge Holdings, LLC
On November 3, 2020, the Company acquired 87.5% of the equity securities of Kingsbridge Holdings, LLC (“KBH”) through KBH Topco LLC (“KBHT”), a Delaware corporation. KBH is a residual focused independent
mid-ticket
lessor of equipment primarily to U.S. investment grade companies. The Company invested $216.6 million to effect the transaction, of which $136.6 million was invested to acquire 87.5% of KBHT’s equity and $80.0 million in KBH’s debt. The existing management team of KBH committed to continuing to lead KBH after the transaction. Post the transaction, the Company owns 87.5% of KBHT equity and the KBH management team owns the remaining 12.5% of KBHT’s equity. As of December 31, 2022, KBHT had total assets of $777.2 million.
 
8

Investment Selection Process
SLR Capital Partners is committed to and utilizes a value-oriented investment philosophy with a focus on the preservation of capital and a commitment to managing downside exposure.
Portfolio Company Characteristics
We have identified several criteria that we believe are important in identifying and investing in prospective portfolio companies. These criteria provide general guidelines for our investment decisions; however, not all of these criteria will be met by each prospective portfolio company in which we choose to invest.
Stable Earnings and Strong Free Cash Flow.
We seek to invest in companies that have demonstrated stable earnings through economic cycles. We target companies that can
de-lever
through consistent generation of cash flows rather than relying solely on growth to service and repay our loans.
Value Orientation.
Our investment philosophy places a premium on fundamental analysis from an investor’s perspective and has a distinct value orientation. We focus on companies in which we can invest at relatively low multiples of operating cash flow and that are profitable at the time of investment on an operating cash flow basis.
Value of Assets.
The prospective value of the assets, if any, that collateralizes the loans in which we invest, is an important factor in our credit analysis. Our analysis emphasizes both tangible assets, such as accounts receivable, inventory, equipment and real estate, and intangible assets, such as intellectual property, customer lists, networks and databases. In some of our transactions the company’s fundings may be derived from a borrowing base determined by the value of the company’s assets.
Strong Competitive Position in Industry.
We seek to invest in target companies that have developed leading market positions within their respective markets and are well positioned to capitalize on growth opportunities. We seek companies that demonstrate significant competitive advantages versus their competitors, which we believe should help to protect their market position and profitability.
Diversified Customer and Supplier Base.
We seek to invest in businesses that have a diversified customer and supplier base. We believe that companies with a diversified customer and supplier base are generally better able to endure economic downturns, industry consolidation, changing business preferences and other factors that may negatively impact their customers, suppliers and competitors.
Exit Strategy.
We predominantly invest in companies that provide multiple alternatives for an eventual exit. We look for opportunities that provide an exit typically within three years of the initial capital commitment.
We generally seek companies that we believe will have or provide a steady stream of cash flow to repay our loans and reinvest in their respective businesses. We believe that such internally generated cash flow, leading to the payment of our interest, and the repayment of our principal, represents a key means by which we will be able to exit from our investments over time.
In addition, we also seek to invest in companies whose business models and expected future cash flows or cash positions offer attractive exit possibilities. These companies include candidates for strategic acquisition by other industry participants and companies that may repay our investments through an initial public offering of common stock or another capital market transaction. We underwrite our investments on a
held-to-maturity
basis, but expensive capital is often repaid prior to stated maturity.
Experienced and Committed Management.
We generally require that portfolio companies have an experienced management team. We also require portfolio companies have in place proper incentives to induce management to succeed and to act in concert with our interests as investors, including having significant equity interests.
Strong Sponsorship.
We generally aim to invest alongside other sophisticated investors. We typically seek to partner with successful financial sponsors who have historically generated high returns. We believe that investing in these sponsors’ portfolio companies enables us to benefit from their direct involvement and due diligence.
SLR Capital Partners’ investment team works in concert with sponsors to proactively manage investment opportunities by acting as a partner throughout the investment process. We actively focus on the middle-market financial sponsor community, with a particular focus on the
upper-end
of the middle-market (sponsors with equity funds of $500 million to $5 billion). We favor such sponsors because they typically:
 
   
buy larger companies with strong business franchises;
 
9

   
invest significant amounts of equity in their portfolio companies;
 
   
value flexibility and creativity in structuring their transactions;
 
   
possess longer track records over multiple investment funds;
 
   
have a deeper management bench;
 
   
have better ability to withstand downturns; and
 
   
possess the ability to support portfolio companies with additional capital.
We divide our coverage of these sponsors among our more senior investment professionals, who are responsible for
day-to-day
interaction with financial sponsors. Our coverage approach aims to act proactively, consider all investments in the capital structure, provide quick feedback, deliver on commitments, and are constructive throughout the life cycle of an investment.
Due Diligence
Our “private equity” approach to credit investing typically incorporates extensive
in-depth
due diligence often alongside the private equity sponsor. In conducting due diligence, we will use publicly available information as well as information from relationships with former and current management teams, consultants, competitors and investment bankers. We believe that our due diligence methodology allows us to screen a high volume of potential investment opportunities on a consistent and thorough basis.
Our due diligence typically includes:
 
   
review of historical and prospective financial information;
 
   
review and valuation of assets;
 
   
research relating to the company’s management, industry, markets, products and services and competitors;
 
   
on-site
visits;
 
   
discussions with management, employees, customers or vendors of the potential portfolio company;
 
   
review of senior loan documents; and
 
   
background investigations.
We also expect to evaluate the private equity sponsor making the investment. Further, due to SLR Capital Partners’ considerable repeat business with sponsors, we have direct experience with the management teams of many sponsors. A private equity sponsor is typically the controlling stockholder upon completion of an investment and as such is considered critical to the success of the investment. The equity sponsor is evaluated along several key criteria, including:
 
   
investment track record;
 
   
industry experience;
 
   
capacity and willingness to provide additional financial support to the company through additional capital contributions, if necessary; and
 
   
reference checks.
Throughout the due diligence process, a deal team is in constant dialogue with the management team of the company in which we are considering investing to ensure that any concerns are addressed as early as possible through the process and that unsuitable investments are filtered out before considerable time has been invested.
Upon the completion of due diligence and a decision to proceed with an investment in a company, the investment professionals leading the investment present the investment opportunity to SLR Capital Partners’ investment committee, which then determines whether to pursue the potential investment. Additional due diligence with respect to any investment may be conducted on our behalf by attorneys and independent accountants prior to the closing of the investment, as well as other outside advisers, as appropriate.
 
10

The Investment Committee
All new investments are required to be approved by a consensus of the investment committee of SLR Capital Partners, which is led by Messrs. Gross and Spohler. The members of SLR Capital Partners’ investment committee receive no compensation from us. Such members may be employees or partners of SLR Capital Partners and may receive compensation or profit distributions from SLR Capital Partners.
Investment Structure
Once we determine that a prospective portfolio company is suitable for investment, we work with the management of that company and its other capital providers, including senior, junior and equity capital providers, to structure an investment. We negotiate among these parties to agree on how our investment is expected to perform relative to the other capital in the portfolio company’s capital structure.
The Company seeks to create a diverse portfolio that includes senior secured loans and to a lesser extent, unsecured loans and equity securities by investing approximately $5 million to $100 million of capital. With respect to our senior secured loans, we seek to obtain security interests in the assets of our portfolio companies that serve as collateral in support of the repayment of these loans. This collateral may take the form of first or second priority liens on the assets of a portfolio company.
We structure our unsecured loans primarily subordinated loans that provide for relatively high, fixed or floating interest rates that provide us with significant current interest income. These loans typically have interest-only payments in the early years, with amortization of principal, if any, deferred to the later years of the unsecured loans. In some cases, we may enter into loans that, by their terms, convert into equity or additional debt securities or defer payments of interest for the first few years after our investment. Also, in some cases our unsecured loans may be collateralized by a subordinated lien on some or all of the assets of the borrower.
Typically, our senior secured and unsecured loans have final maturities of five to ten years. However, we expect that our portfolio companies often may repay these loans early, generally within three to four years from the date of initial investment. In some cases and when available, we seek to structure these loans with prepayment premiums to capture foregone interest.
In the case of our senior secured and unsecured loan investments, we tailor the terms of the investment to the facts and circumstances of the transaction and the prospective portfolio company, negotiating a structure that protects our rights and manages our risk while creating incentives for the portfolio company to achieve its business plan and improve its profitability. For example, in addition to seeking a senior or fulcrum position in the capital structure of our portfolio companies, we will seek to limit the downside potential of our investments by:
 
   
requiring a total return on our investments (including both interest and potential capital appreciation) that compensates us for credit risk;
 
   
incorporating “put” rights and call protection into the investment structure; and
 
   
negotiating covenants in connection with our investments that afford our portfolio companies as much flexibility in managing their businesses as possible, consistent with preservation of our capital. Such restrictions may include affirmative and negative covenants, default penalties, lien protection, change of control provisions and board rights, including either observation or participation rights.
Our investments may include equity features, such as warrants or options to buy a minority interest in the portfolio company. Any warrants we receive with our debt securities generally require only a nominal cost to exercise, and thus, as a portfolio company appreciates in value, we may achieve additional investment return from this equity interest. We may structure the warrants to provide provisions protecting our rights as a minority interest holder, as well as puts, or rights to sell such securities back to the company, upon the occurrence of specified events. In many cases, we also obtain registration rights in connection with these equity securities, which may include demand and “piggyback” registration rights. In addition, we may from time to time make direct equity investments in portfolio companies.
We generally seek to hold most of our investments to maturity or repayment, but will sell our investments earlier, including if a liquidity event takes place such as the sale or recapitalization of a portfolio company.
 
11

Ongoing Relationships with Portfolio Companies
SLR Capital Partners monitors our portfolio companies on an ongoing basis. SLR Capital Partners monitors the financial trends of each portfolio company to determine if it is meeting its business plan and to assess the appropriate course of action for each company.
SLR Capital Partners has several methods of evaluating and monitoring the performance and fair value of our investments, which include the following:
 
   
Assessment of success in adhering to each portfolio company’s business plan and compliance with covenants;
 
   
Periodic and regular contact with portfolio company management and, if appropriate, the financial or strategic sponsor, to discuss financial position, requirements and accomplishments;
 
   
Comparisons to other SLR invested portfolio companies in the industry, if any;
 
   
Attendance at and participation in board meetings; and
 
   
Review of monthly and quarterly financial statements and financial projections for portfolio companies.
In addition to various risk management and monitoring tools, SLR Capital Partners also uses an investment rating system to characterize and monitor our expected level of returns on each investment in our portfolio.
We use an investment rating scale of 1 to 4. The following is a description of the conditions associated with each investment rating:
 
Investment
Rating
  
Summary Description
1    Involves the least amount of risk in our portfolio, the portfolio company is performing above expectations, and the trends and risk factors are generally favorable (including a potential exit)
2    Risk that is similar to the risk at the time of origination, the portfolio company is performing as expected, and the risk factors are neutral to favorable; all new investments are initially assessed a grade of 2
3    The portfolio company is performing below expectations, may be out of compliance with debt covenants, and requires procedures for closer monitoring
4    The investment is performing well below expectations and is not anticipated to be repaid in full
SLR Capital Partners monitors and, when appropriate, changes the investment ratings assigned to each investment in our portfolio. As of December 31, 2022 and December 31, 2021 the weighted average investment rating on the fair market value of our portfolio was a 2. In connection with our valuation process, SLR Capital Partners reviews these investment ratings on a quarterly basis.
Valuation Procedures
In December 2020, the SEC adopted new Rule
2a-5
under the 1940 Act addressing fair valuation of fund investments. The new rule sets forth requirements for good faith determinations of fair value, as well as for the performance of fair value determinations, including related oversight and reporting obligations. The new rule also defines “readily available market quotations” for purposes of the definition of “value” under the 1940 Act, and the SEC noted that this definition will apply in all contexts under the 1940 Act. The Company will comply with Rule
2a-5’s
valuation requirements.
We conduct the valuation of our assets, pursuant to which our net asset value is determined, at all times consistent with U.S. generally accepted accounting principles (“GAAP”), and the 1940 Act. Our valuation procedures are set forth in more detail below:
Under procedures established by the Board, we value investments, including certain senior secured debt, subordinated debt and other debt securities with maturities greater than 60 days, for which market quotations are readily available, at such market quotations (unless they are deemed not to represent fair value). A market quotation is readily available for a security only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided
 
12

that a quotation will not be readily available if it is not reliable. If the Company anticipates using a market quotation for a security, it will also monitor for circumstances that may necessitate the use of fair value, such as significant events that may cause concern over the reliability of a market quotation. We attempt to obtain market quotations from at least two brokers or dealers (if available, otherwise from a principal market maker or a primary market dealer or other independent pricing service). We utilize
mid-market
pricing as a practical expedient for fair value unless a different point within the range is more representative. If and when market quotations are deemed not to represent fair value, we may utilize independent third-party valuation firms to assist us in determining the fair value of material assets. Accordingly, such investments go through our multi-step valuation process as described below. In each such case, independent valuation firms, which may from time to time be engaged by the Board, consider observable market inputs together with significant unobservable inputs in arriving at their valuation recommendations. Debt investments with maturities of 60 days or less shall each be valued at cost plus accreted discount, or minus amortized premium, which is expected to approximate fair value, unless such valuation, in the judgment of the Investment Adviser, does not represent fair value, in which case such investments shall be valued at fair value as determined in good faith by or under the direction of the Board. Investments that are not publicly traded or whose market quotations are not readily available are valued at fair value as determined in good faith by or under the direction of the Board. Such determination of fair values involves subjective judgments and estimates.
With respect to investments for which market quotations are not readily available or when such market quotations are deemed not to represent fair value, the Board has approved a multi-step valuation process each quarter, as described below:
 
  (1)
our quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of the Investment Adviser responsible for the portfolio investment;
 
  (2)
preliminary valuation conclusions are then documented and discussed with senior management of the Investment Adviser;
 
  (3)
independent valuation firms engaged by the Board conduct independent appraisals and review the Investment Adviser’s preliminary valuations and make their own independent assessment for all material assets;
 
  (4)
the audit committee of the Board reviews the preliminary valuation of the Investment Adviser and that of the independent valuation firm and responds to the valuation recommendation of the independent valuation firm, if any, to reflect any comments; and
 
  (5)
the Board discusses valuations and determines the fair value of each investment in our portfolio in good faith based on the input of the Investment Adviser, the respective independent valuation firm, if any, and the audit committee.
Investments in all asset classes are valued utilizing a market approach, an income approach, or both approaches, as appropriate. However, in accordance with ASC
820-10,
certain investments that qualify as investment companies in accordance with ASC 946, may be valued using net asset value as a practical expedient for fair value. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities (including a business). The income approach uses valuation approaches to convert future amounts (for example, cash flows or earnings) to a single present amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. In following these approaches, the types of factors that we may take into account in fair value pricing our investments include, as relevant: available current market data, including relevant and applicable market trading and transaction comparables, applicable market yields and multiples, security covenants, call protection provisions, the nature and realizable value of any collateral, the portfolio company’s ability to make payments, its earnings and discounted cash flows, the markets in which the portfolio company does business, comparisons of financial ratios of peer companies that are public, M&A comparables, our principal market (as the reporting entity) and enterprise values, among other factors. When available, broker quotations and/or quotations provided by pricing services are considered as an input in the valuation process. For the fiscal year ended December 31, 2022, there has been no change to the Company’s valuation approaches or techniques and the nature of the related inputs considered in the valuation process.
Accounting Standards Codification (“ASC”) Topic 820 classifies the inputs used to measure these fair values into the following hierarchy:
Level
 1
: Unadjusted quoted prices in active markets for identical assets or liabilities, accessible by the Company at the measurement date.
Level
 2
: Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices.
Level
 3
: Unobservable inputs for the asset or liability.
In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The exercise of judgment is based in part on our knowledge of the asset class and our prior experience.
 
13

Determination of fair value involves subjective judgments and estimates. Accordingly, the notes to our consolidated financial statements express the uncertainty with respect to the possible effect of such valuations, and any change in such valuations, on our consolidated financial statements.
Competition
Our primary competitors provide financing to middle-market companies and include other business development companies, commercial and investment banks, commercial financing companies and, to the extent they provide an alternative form of financing, private equity funds. Additionally, alternative investment vehicles, such as hedge funds, frequently invest in middle-market companies. As a result, competition for investment opportunities at middle-market companies can be intense. While many middle-market companies were previously able to raise senior debt financing through traditional large financial institutions, we believe this approach to financing will become more difficult as implementation of U.S. and international financial reforms limits the capacity of large financial institutions to hold
non-investment
grade leveraged loans on their balance sheets. We believe that many of these financial institutions have
de-emphasized
their service and product offerings to middle-market companies in particular.
Many of our competitors are substantially larger and have considerably greater financial, technical and marketing resources than we do. For example, some competitors may have a lower cost of funds and access to funding sources that are not available to us. In addition, some of our competitors may have higher risk tolerances or different risk assessments, which could allow them to consider a wider variety of investments and establish more relationships than us. Furthermore, many of our competitors are not subject to the regulatory restrictions that the 1940 Act imposes on us as a BDC. We use the industry information available to Messrs. Gross and Spohler and the other investment professionals of SLR Capital Partners to assess investment risks and determine appropriate pricing for our investments in portfolio companies. In addition, we believe that the relationships of Messrs. Gross and Spohler and the other investment professionals of our investment adviser enable us to learn about, and compete effectively for, financing opportunities with attractive leveraged companies in the industries in which we seek to invest.
Staffing
We do not currently have any employees. Mr. Gross, our Chairman and
Co-Chief
Executive Officer and President, and Mr. Spohler, our
Co-Chief
Executive Officer and Chief Operating Officer and board member, are managing members and senior investment professionals of, and have financial and controlling interests in, SLR Capital Partners. In addition, Mr. Richard Peteka, our Chief Financial Officer, Treasurer and Secretary serves as the Chief Financial Officer for SLR Capital Partners. Guy Talarico, our Chief Compliance Officer, is a Managing Director of ACA Group, LLC, and performs his functions as our Chief Compliance Officer under the terms of an agreement between SLR Capital Management and ACA Group, LLC. SLR Capital Management has retained Mr. Talarico and ACA Group, LLC pursuant to its obligations under our Administration Agreement.
Our
day-to-day
investment operations are managed by SLR Capital Partners. Based upon its needs, SLR Capital Partners may hire additional investment professionals. In addition, we will reimburse SLR Capital Management for the allocable portion of overhead and other expenses incurred by it in performing its obligations under the Administration Agreement, including rent, and the allocable portion of the cost of the company’s chief compliance officer and chief financial officer and their respective staffs.
Sarbanes-Oxley Act of 2002
The Sarbanes-Oxley Act of 2002 imposes a wide variety of regulatory requirements on publicly-held companies and their insiders. Many of these requirements affect us. For example:
 
   
pursuant to
Rule 13a-14
of the Securites Exchange Act of 1934 (the “1934 Act”), our
co-chief
executive officers and chief financial officer must certify the accuracy of the financial statements contained in our periodic reports;
 
   
pursuant to Item 307 of
Regulation S-K,
our periodic reports must disclose our conclusions about the effectiveness of our disclosure controls and procedures;
 
   
pursuant to Rule
13a-15
of the 1934 Act, our management is required to prepare an annual report regarding its assessment of our internal control over financial reporting and to obtain an audit of the effectiveness of internal control over financial reporting performed by our independent registered public accounting firm; and
 
   
pursuant to Item 308 of
Regulation S-K
and
Rule 13a-15
of the 1934 Act, our periodic reports must disclose whether there were significant changes in our internal controls over financial reporting or in other factors that could significantly affect these controls subsequent to the date of their evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.
 
14

The Sarbanes-Oxley Act of 2002 requires us to review our current policies and procedures to determine whether we comply with the Sarbanes-Oxley Act of 2002 and the regulations promulgated thereunder. We will continue to monitor our compliance with all regulations that are adopted under the Sarbanes-Oxley Act of 2002 and will take actions necessary to ensure that we are in compliance therewith.
Business Development Company Regulations
A BDC is regulated by the 1940 Act. A BDC must be organized in the United States for the purpose of investing in or lending to primarily private companies and making significant managerial assistance available to those investments that constitute qualifying assets (as discussed below). A BDC may use capital provided by public stockholders and from other sources to make long-term, private investments in businesses. A BDC provides stockholders the ability to retain the liquidity of a publicly-traded stock while sharing in the possible benefits, if any, of investing in primarily privately owned companies.
We may not change the nature of our business so as to cease to be, or withdraw our election as, a BDC unless authorized by vote of a majority of our outstanding voting securities, as required by the 1940 Act. A majority of the outstanding voting securities of a company is defined under the 1940 Act as the lesser of: (a) 67% or more of such company’s voting securities present at a meeting if more than 50% of the outstanding voting securities of such company are present or represented by proxy, or (b) more than 50% of the outstanding voting securities of such company. We do not anticipate any substantial change in the nature of our business.
As with other companies regulated by the 1940 Act, a BDC must adhere to certain substantive regulatory requirements. A majority of our directors must be persons who are not interested persons, as that term is defined in the 1940 Act. Additionally, we are required to provide and maintain a bond issued by a reputable fidelity insurance company to protect the BDC. Furthermore, as a BDC, we are prohibited from protecting any director or officer against any liability to us or our stockholders arising from willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of such person’s office.
As a BDC, we are required to meet an asset coverage ratio, reflecting the value of our total assets to our total senior securities, which include all of our borrowings and any preferred stock we may issue in the future, of at least 150%. We may also be prohibited under the 1940 Act from knowingly participating in certain transactions with our affiliates without the prior approval of our directors who are not interested persons and, in some cases, prior approval by the SEC.
We are generally not able to issue and sell our common stock at a price below net asset value per share without annual stockholder approval. We may, however, sell our common stock, or warrants, options or rights to acquire our common stock, at a price below the then-current net asset value of our common stock if the Board determines that such sale is in our best interests and the best interests of our stockholders, and our stockholders approve such sale. At this time, we do not have stockholder approval for such sales.
As a BDC, we were substantially limited in our ability to
co-invest
in privately negotiated transactions with affiliated funds until we obtained an exemptive order from the SEC. The most recent exemptive order, received on June 13, 2017 (the “Exemptive Order”), permits us to participate in negotiated
co-investment
transactions with certain affiliates, each of whose investment adviser is an investment adviser that controls, is controlled by or is under common control with SLR Capital Partners and is registered as an investment adviser under the Advisers Act, in a manner consistent with our investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, and pursuant to the conditions to the Exemptive Order. If we are unable to rely on the Exemptive Order for a particular opportunity, such opportunity will be allocated first to the entity whose investment strategy is the most consistent with the opportunity being allocated, and second, if the terms of the opportunity are consistent with more than one entity’s investment strategy, on an alternating basis. Although our investment professionals will endeavor to allocate investment opportunities in a fair and equitable manner, we and our common stockholders could be adversely affected to the extent investment opportunities are allocated among us and other investment vehicles managed or sponsored by, or affiliated with, our executive officers, directors and members of our investment adviser.
We will be periodically examined by the SEC for compliance with the federal securities laws, including the 1940 Act.
Qualifying Assets
Under the 1940 Act, a BDC may not acquire any asset other than assets of the type listed in Section 55(a) of the 1940 Act, which are referred to as qualifying assets, unless, at the time the acquisition is made, qualifying assets represent at least 70% of the BDC’s total assets. The principal categories of qualifying assets relevant to our business are the following:
(1) Securities purchased in transactions not involving any public offering from the issuer of such securities, which issuer (subject to certain limited exceptions) is an eligible portfolio company, or from any person who is, or has been during the preceding 13 months, an affiliated person of an eligible portfolio company, or from any other person, subject to such rules as may be prescribed by the SEC. An eligible portfolio company is defined in the 1940 Act as any issuer which:
 
15

(a) is organized under the laws of, and has its principal place of business in, the United States;
(b) is not an investment company (other than a small business investment company wholly owned by the BDC); and
(c) satisfies any of the following:
i. does not have any class of securities that is traded on a national securities exchange;
ii. has a class of securities listed on a national securities exchange, but has an aggregate market value of outstanding voting and
non-voting
common equity of less than $250 million;
iii. is controlled by a BDC or a group of companies including a BDC and the BDC has an affiliated person who is a director of the eligible portfolio company; or
iv. is a small and solvent company having total assets of not more than $4.0 million and capital and surplus of not less than $2.0 million.
(2) Securities of any eligible portfolio company which we control, which, as defined by the 1940 Act, is presumed to exist where a BDC beneficially owns more than 25% of the outstanding voting securities of the portfolio company.
(3) Securities purchased in a private transaction from a U.S. issuer that is not an investment company or from an affiliated person of the issuer, or in transactions incident thereto, if the issuer is in bankruptcy and subject to reorganization or if the issuer, immediately prior to the purchase of its securities, was unable to meet its obligations as they came due without material assistance other than conventional lending or financing arrangements.
(4) Securities of an eligible portfolio company purchased from any person in a private transaction if there is no ready market for such securities and we already own 60% of the outstanding equity of the eligible portfolio company.
(5) Securities received in exchange for or distributed on or with respect to securities described in (1) through (4) above, or pursuant to the exercise of warrants or rights relating to such securities.
(6) Cash, cash equivalents, U.S. government securities or high-quality debt securities maturing in one year or less from the time of investment.
(7) Office furniture and equipment, interests in real estate and leasehold improvements and facilities maintained to conduct the business operations of the BDC, deferred organization and operating expenses, and other noninvestment assets necessary and appropriate to its operations as a BDC, including notes of indebtedness of directors, officers, employees, and general partners held by a BDC as payment for securities of such company issued in connection with an executive compensation plan described in Section 57(j) of the 1940 Act.
Under Section 55(b) of the 1940 Act, the value of a BDC’s assets shall be determined as of the date of the most recent financial statements filed by such company with the SEC pursuant to Section 13 of the 1934 Act, and shall be determined no less frequently than annually.
Significant Managerial Assistance to Portfolio Companies
As a BDC, we offer, and must provide upon request, significant managerial assistance to our portfolio companies that constitute qualifying assets. This assistance could involve, among other things, monitoring the operations of our portfolio companies, participating in board and management meetings, consulting with and advising officers of portfolio companies and providing other organizational and financial guidance. We may also receive fees for these services. SLR Capital Management provides such managerial assistance, if any, on our behalf to portfolio companies that request this assistance.
Temporary Investments
Pending investment in other types of “qualifying assets,” as described above, our investments may consist of cash, cash equivalents, U.S. government securities or high-quality investment grade debt securities maturing in one year or less from the time of investment, which we refer to, collectively, as temporary investments, so that 70% of our assets are qualifying assets. Typically, we will invest in U.S. Treasury bills or in repurchase agreements, provided that such repurchase agreements are fully collateralized by cash or securities issued by the U.S. government or its agencies. A repurchase agreement involves the purchase by an investor, such as us, of a specified security and the simultaneous agreement by the seller to repurchase it at an agreed-upon future date and at a price that is greater than the purchase price by an amount that reflects an agreed-upon interest rate. There is no percentage restriction on the proportion of our assets that may be invested in such repurchase agreements. However, if more than 25% of our total assets constitute repurchase agreements from a single counterparty, we would not meet the diversification tests in order to qualify as a RIC for U.S. federal income tax purposes. Thus, we do not intend to enter into repurchase agreements with a single counterparty in excess of this limit. SLR Capital Partners will monitor the creditworthiness of the counterparties with which we enter into repurchase agreement transactions.
 
16

Senior Securities
We are permitted, under specified conditions, to issue multiple classes of indebtedness and one class of stock senior to our common stock if our asset coverage, as defined in the 1940 Act, is at least equal to 150% immediately after each such issuance. In addition, while certain senior securities remain outstanding, we may be required to make provisions to prohibit any distribution to our stockholders or the repurchase of such securities or shares unless we meet the applicable asset coverage ratios at the time of the distribution or repurchase. We may also borrow amounts up to 5% of the value of our total assets for temporary purposes without regard to asset coverage. We may borrow money, which would magnify the potential for gain or loss on amounts invested and may increase the risk of investing in us.
Code of Ethics
We and SLR Capital Partners have each adopted a code of ethics pursuant to Rule
17j-1
under the 1940 Act and Rule
204A-1
under the Advisers Act, respectively, that establishes procedures for personal investments and restricts certain transactions by our personnel. Our codes of ethics generally do not permit investments by our employees in securities that may be purchased or held by us. Each code of ethics is available on the EDGAR Database on the SEC’s Internet site at http://www.sec.gov. You may also obtain copies of the codes of ethics, after paying a duplicating fee, by electronic request at the following Email address: publicinfo@sec.gov.
Compliance Policies and Procedures
We and our investment adviser have adopted and implemented written policies and procedures reasonably designed to detect and prevent violation of the federal securities laws. We are required to review these compliance policies and procedures annually for their adequacy and the effectiveness of their implementation and to designate a chief compliance officer to be responsible for their administration. Guy Talarico currently serves as our Chief Compliance Officer.
Proxy Voting Policies and Procedures
We have delegated our proxy voting responsibility to our investment adviser. A summary of the Proxy Voting Policies and Procedures of our adviser are set forth below. The guidelines are reviewed periodically by the adviser and our
non-interested
directors, and, accordingly, are subject to change.
As an investment adviser registered under the Advisers Act, SLR Capital Partners has a fiduciary duty to act solely in the best interests of its clients. As part of this duty, it recognizes that it must vote securities held by its clients in a timely manner free of conflicts of interest. These policies and procedures for voting proxies for investment advisory clients are intended to comply with Section 206 of, and Rule
206(4)-6
under, the Advisers Act.
Our investment adviser votes proxies relating to our portfolio securities in the best interest of our stockholders. SLR Capital Partners reviews on a
case-by-case
basis each proposal submitted for a proxy vote to determine its impact on our investments. Although it generally votes against proposals that may have a negative impact on our investments, it may vote for such a proposal if there exists compelling long-term reasons to do so. The proxy voting decisions of our investment adviser are made by the senior investment professionals who are responsible for monitoring each of our investments. To ensure that our vote is not the product of a conflict of interest, it requires that: (i) anyone involved in the decision making process disclose to a managing member of SLR Capital Partners any potential conflict that he or she is aware of and any contact that he or she has had with any interested party regarding a proxy vote, and (ii) employees involved in the decision making process or vote administration are prohibited from revealing how we intend to vote on a proposal in order to reduce any attempted influence from interested parties.
You may obtain information about how we voted proxies by making a written request for proxy voting information to: SLR Capital Partners, LLC, 500 Park Avenue, New York, NY 10022.
Privacy Principles
We endeavor to maintain the privacy of our recordholders and to safeguard their
non-public
personal information. The following information is provided to help you understand what personal information we collect, how we protect that information and why, in certain cases, we may share such information with select other parties.
Generally, we will not receive any
non-public
personal information about the recordholders of the common stock of the Company, although certain of our recordholders’
non-public
information may become available to us. The
non-public
personal information that we may receive falls into the following categories:
 
17

   
Information we receive from recordholders, whether we receive it orally, in writing or electronically. This includes recordholders’ communications to us concerning their investment;
 
   
Information about recordholders’ transaction history with us; and
 
   
Other general information that we may obtain about recordholders, such as demographic and contact information such as address.
We disclose
non-public
person information about recordholders:
 
   
to our affiliates (such as SLR and our administrator) and their employees for everyday business purposes;
 
   
to our service providers (such as our accountants, attorneys, custodians, transfer agent, underwriter and proxy solicitors) and their employees as is necessary to service recordholder accounts or otherwise provide the applicable service;
 
   
to comply with court orders, subpoenas, lawful discovery requests, or other legal or regulatory requirements; or
 
   
as allowed or required by applicable law or regulation.
When the Company shares
non-public
recordholder personal information referred to above, the information is made available for limited business purposes and under controlled circumstances designed to protect our recordholders’ privacy. The Company does not permit use of recordholder information for any
non-
business or marketing purpose, nor does the Company permit third parties to rent, sell, trade or otherwise release or disclose information to any other party.
The Company’s service providers, such as SLR, its administrator, and its transfer agent, are required to maintain physical, electronic, and procedural safeguards to protect recordholder
non-public
personal information; to prevent unauthorized access or use; and to dispose of such information when it is no longer required.
Personnel of affiliates may access recordholder information only for business purposes. The degree of access is based on the sensitivity of the information and on personnel need for the information to service a recordholder’s account or comply with legal requirements.
If a recordholder ceases to be a recordholder, we will adhere to the privacy policies and practices as described above. We may choose to modify our privacy policies at any time. Before we do so, we will notify recordholders and provide a description of our privacy policy.
Taxation as a Regulated Investment Company
As a BDC, we elected to be treated, and intend to qualify annually, as a RIC under Subchapter M of the Code. As a RIC, we generally will not have to pay corporate-level U.S. federal income taxes on any ordinary income or capital gains that we timely distribute to our stockholders as dividends. To continue to qualify as a RIC, we must, among other things, meet certain
source-of-income
and asset diversification requirements (as described below). In addition, to qualify for RIC tax treatment we must distribute to our stockholders, for each taxable year, at least 90% of our “investment company taxable income,” which generally is our ordinary income plus the excess of our realized net short-term capital gains over our realized net long-term capital losses (the “Annual Distribution Requirement”). If we qualify as a RIC and satisfy the Annual Distribution Requirement, then we will not be subject to U.S. federal income tax on the portion of our investment company taxable income and net capital gain (i.e., realized net long-term capital gains in excess of realized net short-term capital losses) we distribute (or are deemed to distribute) to stockholders. We will be subject to U.S. federal income tax at the regular corporate rates on any ordinary income or capital gain not distributed (or deemed not distributed) to our stockholders.
We will be subject to a 4% nondeductible U.S. federal excise tax on certain undistributed income unless we distribute in a timely manner an amount at least equal to the sum of (1) 98% of our ordinary income for each calendar year, (2) 98.2% of our capital gain net income for the
one-year
period ending October 31 in that calendar year and (3) any ordinary income and net capital gains that we recognized in preceding years, but were not distributed during such years, and on which we paid no U.S. federal income tax (the “Excise Tax Avoidance Requirement”).
 
18

In order to qualify as a RIC for U.S. federal income tax purposes, we must, among other things:
 
   
at all times during each taxable year, have in effect an election to be treated as a BDC under the 1940 Act;
 
   
derive in each taxable year at least 90% of our gross income from (a) dividends, interest, payments with respect to certain securities loans, gains from the sale of stock or other securities or currencies, or other income derived with respect to our business of investing in such stock, securities or currencies and (b) net income derived from an interest in a “qualified publicly traded partnership;” and
 
   
diversify our holdings so that at the end of each quarter of the taxable year:
 
   
at least 50% of the value of our assets consists of cash, cash equivalents, U.S. government securities, securities of other RICs, and other securities if such other securities of any one issuer do not represent more than 5% of the value of our assets or more than 10% of the outstanding voting securities of the issuer; and
 
   
no more than 25% of the value of our assets is invested in (i) the securities, other than U.S. government securities or securities of other RICs, of one issuer, (ii) the securities of two or more issuers that are controlled, as determined under applicable tax rules, by us and that are engaged in the same or similar or related trades or businesses or (iii) the securities of one or more “qualified publicly traded partnerships.”
We may be required to recognize taxable income in circumstances in which we do not receive cash. For example, if we hold debt obligations that are treated under applicable tax rules as having original issue discount (such as debt instruments with
payment-in-kind
(“PIK”) income or, in certain cases, increasing interest rates or debt instruments issued with warrants), we must include in income each year a portion of the original issue discount that accrues over the life of the obligation, regardless of whether cash representing such income is received by us in the same taxable year. Because any original issue discount accrued will be included in our investment company taxable income for the year of accrual, we may be required to make a distribution to our stockholders in order to satisfy the Annual Distribution Requirement, even though we will not have received any corresponding cash amount.
Because we may use debt financing, we will be subject to certain asset coverage ratio requirements under the 1940 Act and financial covenants under loan and credit agreements that could, under certain circumstances, restrict us from making distributions necessary to satisfy the Annual Distribution Requirement. If we are unable to obtain cash from other sources or are otherwise limited in our ability to make distributions, we could fail to qualify for RIC tax treatment and thus become subject to corporate-level U.S. federal income tax.
Certain of our investment practices may be subject to special and complex U.S. federal income tax provisions that may, among other things: (i) disallow, suspend or otherwise limit the allowance of certain losses or deductions; (ii) convert lower taxed long-term capital gain into higher taxed short-term capital gain or ordinary income; (iii) convert an ordinary loss or a deduction into a capital loss (the deductibility of which is more limited); (iv) cause us to recognize income or gain without a corresponding receipt of cash; (v) adversely affect the time as to when a purchase or sale of securities is deemed to occur; (vi) adversely alter the characterization of certain complex financial transactions; and (vii) produce income that will not be qualifying income for purposes of the 90% gross income test described above. We will monitor our transactions and may make certain tax elections in order to mitigate the potential adverse effect of these provisions.
Gain or loss realized by us from the sale or exchange of warrants acquired by us as well as any loss attributable to the lapse of such warrants generally will be treated as capital gain or loss. The treatment of such gain or loss as long-term or short-term will depend on how long we have held a particular warrant. Upon the exercise of a warrant acquired by us, our tax basis in the stock purchased under the warrant will equal the sum of the amount paid for the warrant plus the strike price paid on the exercise of the warrant.
Failure to Qualify as a Regulated Investment Company
If we were unable to qualify for treatment as a RIC, we would be subject to U.S. federal income tax on all of our taxable income at regular corporate rates. We would not be able to deduct distributions to stockholders, nor would distributions be required. Such distributions would be taxable to our stockholders as dividends and, provided certain holding period and other requirements were met, could qualify for treatment as “qualified dividend income” in the hands of
non-corporate
stockholders (and thus eligible for the current 20% maximum rate) to the extent of our current and accumulated earnings and profits. Subject to certain limitations under the Code, corporate distributees would be eligible for the dividends received deduction. Distributions in excess of our current and accumulated earnings and profits would be treated first as a return of capital to the extent of the stockholder’s tax basis, and any remaining distributions would be treated as a capital gain. To requalify as a RIC in a subsequent taxable year, we would be required to satisfy the RIC qualification requirements for that year and dispose of any earnings and profits from any year in which we failed to qualify as a RIC. Subject to a limited exception applicable to RICs that qualified as such under Subchapter M of the Code for at least one year prior to disqualification and that requalify as a RIC no later than the second year following the
non-qualifying
year, we could be subject to tax on any unrealized net
built-in
gains in the assets held by us during the period in which we failed to qualify as a RIC that are recognized within the subsequent 5 years, unless we made a special election to pay corporate-level U.S. federal income tax on such
built-in
gain at the time of our requalification as a RIC.
 
19

Investment Advisory Fees
Pursuant to the Advisory Agreement, we have agreed to pay SLR Capital Partners a fee for investment advisory and management services consisting of two components — a base management fee and a performance-based incentive fee.
The base management fee is determined by taking the average value of the Company’s gross assets at the end of the two most recently completed calendar quarters calculated at an annual rate of 1.50% on gross assets up to 200% of the Company’s total net assets as of the immediately preceding quarter end and 1.00% on gross assets that exceed 200% of the Company’s total net assets as of the immediately preceding quarter end. For purposes of computing the base management fee, gross assets exclude temporary assets acquired at the end of each fiscal quarter for purposes of preserving investment flexibility in the next fiscal quarter. Temporary assets include, but are not limited to, U.S. treasury bills, other short-term U.S. government or government agency securities, repurchase agreements or cash borrowings.
The performance-based incentive fee has two parts, as follows: one is calculated and payable quarterly in arrears based on our
pre-incentive
fee net investment income for the immediately preceding calendar quarter. For this purpose,
pre-incentive
fee net investment income means interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that we receive from portfolio companies) accrued during the calendar quarter, minus our operating expenses for the quarter (including the base management fee, expenses payable under the Administration Agreement to SLR Capital Management, and any interest expense and dividend paid on any issued and outstanding preferred stock, but excluding the performance-based incentive fee).
Pre-incentive
fee net investment income includes, in the case of investments with a deferred interest feature (such as original issue discount, debt instruments with pay in kind income and zero coupon securities), accrued income that we have not yet received in cash.
Pre-incentive
fee net investment income does not include any realized capital gains, computed net of all realized capital losses or unrealized capital appreciation or depreciation.
Pre-incentive
fee net investment income, expressed as a rate of return on the value of our net assets at the end of the immediately preceding calendar quarter, is compared to a hurdle of 1.75% per quarter (7.00% annualized). Our net investment income used to calculate this part of the incentive fee is also included in the amount of our gross assets used to calculate the 1.50% base management fee. We pay SLR Capital Partners an incentive fee with respect to our
pre-incentive
fee net investment income in each calendar quarter as follows:
 
   
no performance-based incentive fee in any calendar quarter in which our
pre-incentive
fee net investment income does not exceed the hurdle of 1.75%;
 
   
100% of our
pre-incentive
fee net investment income with respect to that portion of such
pre-incentive
fee net investment income, if any, that exceeds the hurdle but is less than 2.1875% in any calendar quarter (8.75% annualized). We refer to this portion of our
pre-incentive
fee net investment income (which exceeds the hurdle but is less than 2.1875%) as the
“catch-up.”
The
“catch-up”
is meant to provide our investment adviser with 20% of our
pre-incentive
fee net investment income as if a hurdle did not apply if this net investment income exceeds 2.1875% in any calendar quarter; and
 
   
20% of the amount of our
pre-incentive
fee net investment income, if any, that exceeds 2.1875% in any calendar quarter (8.75% annualized) is payable to SLR Capital Partners (once the hurdle is reached and the
catch-up
is achieved, 20% of all
pre-incentive
fee investment income thereafter is allocated to SLR Capital Partners).
The following is a graphical representation of the calculation of the income-related portion of the performance-based incentive fee:
Quarterly Incentive Fee Based on Net Investment Income
Pre-incentive
fee net investment income
(expressed as a percentage of the value of net assets)
 

 
20

Percentage of
pre-incentive
fee net investment income
allocated to SLR Capital Partners
These calculations are appropriately
pro-rated
for any period of less than three months. You should be aware that a rise in the general level of interest rates can be expected to lead to higher interest rates applicable to our debt investments. Accordingly, an increase in interest rates would make it easier for us to meet or exceed the incentive fee hurdle rate and may result in a substantial increase of the amount of incentive fees payable to our investment adviser with respect to
pre-incentive
fee net investment income.
The second part of the incentive fee is determined and payable in arrears as of the end of each calendar year (or upon termination of the Investment Advisory and Management Agreement, as of the termination date), and equals 20% of our realized capital gains, if any, on a cumulative basis from inception through the end of each calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees with respect to each of the investments in our portfolio.
Examples of Quarterly Incentive Fee Calculation
Example 1: Income Related Portion of Incentive Fee (*):
Alternative 1:
Assumptions
Investment income (including interest, dividends, fees, etc.) = 1.25%
Hurdle rate
(1)
 = 1.75%
Management fee
(2)
 = 0.375%
Other expenses (legal, accounting, custodian, transfer agent, etc.)
(3)
 = 0.20%
Pre-incentive
fee net investment income
(investment income – (management fee + other expenses)) = 0.675%
Pre-incentive
net investment income does not exceed hurdle rate, therefore there is no incentive fee.
Alternative 2:
Assumptions
Investment income (including interest, dividends, fees, etc.) = 2.70%
Hurdle rate
(1)
 = 1.75%
Management fee
(2)
 = 0.375%
Other expenses (legal, accounting, custodian, transfer agent, etc.)
(3)
 = 0.20%
Pre-incentive
fee net investment income
(investment income – (management fee + other expenses)) = 2.125%
Incentive fee = 100% ×
pre-incentive
fee net investment income, subject to the
“catch-up”
(4)
= 100% × (2.125% – 1.75%)
= 0.375%
Alternative 3:
Assumptions
Investment income (including interest, dividends, fees, etc.) = 3.00%
Hurdle rate
(1)
 = 1.75%
Management fee
(2)
 = 0.375%
Other expenses (legal, accounting, custodian, transfer agent, etc.)
(3)
 = 0.20%
Pre-incentive
fee net investment income
(investment income – (management fee + other expenses)) = 2.425%
Incentive fee = 20% ×
pre-incentive
fee net investment income, subject to
“catch-up”
(4)
Incentive fee = 100% ×
“catch-up”
+ (20% ×
(pre-incentive
fee net investment income – 2.1875%))
Catch-up
= 2.1875% – 1.75%
 
21

= 0.4375%
Incentive fee = (100% × 0.4375%) + (20% × (2.425% – 2.1875%))
= 0.4375% + (20% × 0.2375%)
= 0.4375% + 0.0475%
= 0.485%
 
 
(*)    The hypothetical amount of
pre-incentive
fee net investment income shown is based on a percentage of total net assets.
(1)
 
   Represents 7% annualized hurdle rate.
(2)
 
   Represents 1.50% annualized management fee.
(3)
 
   Excludes organizational and offering expenses.
(4)
 
   The
“catch-up”
provision is intended to provide our investment adviser with an incentive fee of 20% on all of our
pre-incentive
fee net investment income as if a hurdle rate did not apply when our net investment income exceeds 2.1875% in any calendar quarter.
Example 2: Capital Gains Portion of Incentive Fee:
Alternative 1:
Assumptions
 
   
Year 1: $20 million investment made in Company A (“Investment A”), and $30 million investment made in Company B (“Investment B”)
 
   
Year 2: Investment A sold for $50 million and fair market value (“FMV”) of Investment B was determined to be $32 million
 
   
Year 3: FMV of Investment B determined to be $25 million
 
   
Year 4: Investment B sold for $31 million
The capital gains portion of the incentive fee would be:
 
   
Year 1: None
 
   
Year 2: Capital gains incentive fee of $6 million ($30 million realized capital gains on the sale of Investment A multiplied by 20%)
 
   
Year 3: None
$5 million (20% multiplied by ($30 million cumulative capital gains less $5 million cumulative capital depreciation)) less $6 million (previous capital gains fee paid in Year 2)
 
   
Year 4: Capital gains incentive fee of $200,000
$6.2 million ($31 million cumulative realized capital gains multiplied by 20%) less $6 million (capital gains fee taken in Year 2)
Alternative 2:
Assumptions
 
   
Year 1: $20 million investment made in Company A (“Investment A”), $30 million investment made in Company B (“Investment B”) and $25 million investment made in Company C (“Investment C”)
 
   
Year 2: Investment A sold for $50 million, FMV of Investment B determined to be $25 million and FMV of Investment C determined to be $25 million
 
   
Year 3: FMV of Investment B determined to be $27 million and Investment C sold for $30 million
 
22

   
Year 4: FMV of Investment B determined to be $24 million
 
   
Year 5: Investment B sold for $20 million
The capital gains incentive fee, if any, would be:
 
   
Year 1: None
 
   
Year 2: $5 million capital gains incentive fee
20% multiplied by $25 million ($30 million realized capital gains on Investment A less unrealized capital depreciation on Investment B)
 
   
Year 3: $1.4 million capital gains incentive fee
(1)
$6.4 million (20% multiplied by $32 million ($35 million cumulative realized capital gains less $3 million unrealized capital depreciation)) less $5 million capital gains fee received in Year 2
 
   
Year 4: None
 
   
Year 5: None
$5 million (20% multiplied by $25 million (cumulative realized capital gains of $35 million less realized capital losses of $10 million)) less $6.4 million cumulative capital gains fee paid in Year 2 and Year 3
 
(1)
 
As illustrated in Year 3 of Alternative 2 above, if the Company were to be wound up on a date other than December 31 of any year, the Company may have paid aggregate capital gain incentive fees that are more than the amount of such fees that would be payable if the Company had been wound up on December 31 of such year.
Payment of Our Expenses
All investment professionals of the investment adviser and their respective staffs, when and to the extent engaged in providing investment advisory and management services, and the compensation and routine overhead expenses of such personnel allocable to such services, are provided and paid for by SLR Capital Partners. We bear all other costs and expenses of our operations and transactions, including (without limitation):
 
   
the cost of our organization and public offerings;
 
   
the cost of calculating our net asset value, including the cost of any third-party valuation services;
 
   
the cost of effecting sales and repurchases of our shares and other securities;
 
   
interest payable on debt, if any, to finance our investments;
 
   
fees payable to third parties relating to, or associated with, making investments, including fees and expenses associated with performing due diligence reviews of prospective investments and advisory fees;
 
   
transfer agent and custodial fees;
 
   
fees and expenses associated with marketing efforts;
 
   
federal and state registration fees, any stock exchange listing fees;
 
   
federal, state and local taxes;
 
   
independent directors’ fees and expenses;
 
   
brokerage commissions;
 
   
fidelity bond, directors and officers errors and omissions liability insurance and other insurance premiums;
 
   
direct costs and expenses of administration, including printing, mailing, long distance telephone and staff;
 
23

   
fees and expenses associated with independent audits and outside legal costs;
 
   
costs associated with our reporting and compliance obligations under the 1940 Act and applicable federal and state securities laws; and
 
   
all other expenses incurred by either SLR Capital Management or us in connection with administering our business, including payments under the Administration Agreement that will be based upon our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions, and our allocable portion of the costs of compensation and related expenses of our chief compliance officer and our chief financial officer and their respective staffs.
Available Information
The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. The address of that site is
(http://www.sec.gov)
.
Our internet address is
www.slrinvestmentcorp.com
. We make available free of charge on our website our annual report on
Form 10-K,
quarterly reports on
Form 10-Q,
current reports on
Form 8-K
and amendments to those reports as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. Information contained on our website is not incorporated by reference into this annual report on
Form 10-K,
and you should not consider information contained on our website to be part of this annual report on
Form 10-K.
Item 1A. Risk Factors
Before you invest in our securities, you should be aware of various risks, including those described below. You should carefully consider these risk factors, together with all of the other information included in this annual report
on Form 10-K before you
decide whether to make an investment in our securities. The risks described in this document and set out below are not the only risks we face. If any of the following events occur, our business, financial condition and results of operations could be materially adversely affected. In such case, our net asset value and the trading price of our common stock could decline or the value of our preferred stock, debt securities, subscription rights or warrants may decline, and you may lose all or part of your investment.
SUMMARY RISK FACTORS
Risks Relating to Our Investments
 
   
We operate in a highly competitive market for investment opportunities.
 
   
Our investments are very risky and highly speculative.
 
   
The lack of liquidity in our investments may make it difficult for us to dispose of our investments at a favorable price, which may adversely affect our ability to meet our investment objectives.
 
   
Our portfolio may be concentrated in a limited number of portfolio companies and industries, which will subject us to a risk of significant loss if any of these companies performs poorly or defaults on its obligations under any of its debt instruments or if there is a downturn in a particular industry.
 
   
Economic sanction laws in the United States and other jurisdictions may prohibit us and our affiliates from transacting with certain countries, individuals and companies.
 
   
If we cannot obtain additional capital because of either regulatory or market price constraints, we could be forced to curtail or cease our new lending and investment activities, our net asset value could decrease and our level of distributions and liquidity could be affected adversely.
 
   
We may suffer a loss if a portfolio company defaults on a loan and the underlying collateral is not sufficient.
 
   
Prepayments of our debt investments by our portfolio companies could adversely impact our results of operations and reduce our return on equity.
 
   
We may be exposed to higher risks with respect to our investments that include original issue discount or PIK interest.
 
24

Risks Relating to an Investment in Our Securities
 
   
Our shares may trade at a substantial discount from net asset value and may continue to do so over the long term.
 
   
Our common stock price may be volatile and may decrease substantially.
 
   
Our business and operation could be negatively affected if we become subject to any securities litigation or shareholder activism, which could cause us to incur significant expense, hinder execution of investment strategy and impact our stock price.
 
   
If the current period of capital market disruption and instability continues for an extended period of time, there is a risk that investors in our equity securities may not receive distributions consistent with historical levels or at all or that our distributions may not grow over time and a portion of our distributions may be a return of capital.
 
   
Due to disruptions in the economy, we may reduce or defer our dividends and choose to incur U.S. federal excise tax in order to preserve cash and maintain flexibility.
 
   
We may choose to pay distributions in our own common stock, in which case our stockholders may be required to pay U.S. federal income taxes in excess of the cash distributions they receive.
 
   
Sales of substantial amounts of our common stock in the public market may have an adverse effect on the market price of our common stock.
 
   
The net asset value per share of our common stock may be diluted if we issue or sell shares of our common stock at prices below the then current net asset value per share of our common stock or securities to subscribe for or convertible into shares of our common stock.
 
   
To the extent we use debt or preferred stock to finance our investments, changes in interest rates will affect our cost of capital and net investment income.
Risks Relating to Our Business and Structure
 
   
We are dependent upon SLR Capital Partners’ key personnel for our future success.
 
   
Our business model depends to a significant extent upon strong referral relationships with financial sponsors, and the inability of the senior investment professionals of our Investment Adviser to maintain or develop these relationships, or the failure of these relationships to generate investment opportunities, could adversely affect our business.
 
   
Our financial condition and results of operations will depend on SLR Capital Partners’ ability to manage our future growth effectively by identifying, investing in and monitoring companies that meet our investment criteria.
 
   
We may need to raise additional capital to grow because we must distribute most of our income.
 
   
Any failure on our part to maintain our status as a BDC would reduce our operating flexibility and we may be limited in our investment choices as a BDC.
 
   
Regulations governing our operation as a BDC affect our ability to, and the way in which we will, raise additional capital. As a BDC, the necessity of raising additional capital may expose us to risks, including the typical risks associated with leverage.
 
   
We have and will continue to borrow money, which would magnify the potential for loss on amounts invested and may increase the risk of investing in us.
 
   
It is likely that the terms of any current or future long-term or revolving credit or warehouse facility we may enter into in the future could constrain our ability to grow our business.
 
   
There will be uncertainty as to the value of our portfolio investments, which may impact our net asset value.
 
   
There are significant potential conflicts of interest, including SLR Capital Partners’ management of other investment funds such as SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC, which could impact our investment returns, and an investment in SLR Investment Corp. is not an investment in SCP Private Credit Income BDC LLC, SLR HC BDC LLC, or SLR Private Credit BDC II LLC.
 
   
We may be obligated to pay our Investment Adviser incentive compensation even if we incur a loss.
 
25

 
Our incentive fee may induce SLR Capital Partners to pursue speculative investments.
 
 
 
We may become subject to corporate-level U.S. federal income tax if we are unable to qualify and maintain our qualification for tax treatment as a regulated investment company under Subchapter M of the Code.
 
 
The failure in cyber security systems, as well as the occurrence of events unanticipated in our disaster recovery systems and management continuity planning could impair our ability to conduct business effectively.
 
Our business is subject to increasingly complex corporate governance, public disclosure and accounting requirements that could adversely affect our business and financial results.
RISK FACTORS
Risks Relating to Our Investments
We operate in a highly competitive market for investment opportunities.
A number of entities compete with us to make the types of investments that we target in leveraged companies. We compete with other BDCs, public and private funds, commercial and investment banks, commercial financing companies and, to the extent they provide an alternative form of financing, private equity funds. Many of our competitors are substantially larger and have considerably greater financial, technical and marketing resources than we do. For example, some competitors may have a lower cost of funds and access to funding sources that are not available to us. In addition, some of our competitors may have higher risk tolerances or different risk assessments than we have, which could allow them to consider a wider variety of investments and establish more relationships and offer better pricing and a more flexible structure than we are able to do. Furthermore, many of our potential competitors are not subject to the regulatory restrictions that the 1940 Act imposes on us as a BDC. If we are unable to source attractive investments, we may hold a greater percentage of our assets in cash and cash equivalents than anticipated, which could impact potential returns on our portfolio. We cannot assure you that the competitive pressures we face will not have a material adverse effect on our business, financial condition and results of operations. Also, as a result of this competition, we may not be able to take advantage of attractive investment opportunities from time to time, and we can offer no assurance that we will be able to identify and make investments that are consistent with our investment objective.
Participants in our industry compete on several factors, including price, flexibility in transaction structure, customer service, reputation, market knowledge and speed in decision-making. We do not seek to compete primarily based on the interest rates we will offer, and we believe that some of our competitors may make loans with interest rates that will be comparable to or lower than the rates we offer. We may lose investment opportunities if we do not match our competitors’ pricing, terms and structure. However, if we match our competitors’ pricing, terms and structure, we may experience decreased net interest income and increased risk of credit loss.
Our investments are very risky and highly speculative.
We invest primarily in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities.
Senior Secured Loans.
 When we make a senior secured term loan investment in a portfolio company, we generally take a security interest in the available assets of the portfolio company, including the equity interests of its subsidiaries, which we expect to help mitigate the risk that we will not be repaid. However, there is a risk that the collateral securing our loans may decrease in value over time, may be difficult to sell in a timely manner, may be difficult to appraise and may fluctuate in value based upon the success of the business and market conditions, including as a result of the inability of the portfolio company to raise additional capital, and, in some circumstances, our lien could be subordinated to claims of other creditors. In addition, deterioration in a portfolio company’s financial condition and prospects, including its inability to raise additional capital, may be accompanied by deterioration in the value of the collateral for the loan. Consequently, the fact that a loan is secured does not guarantee that we will receive principal and interest payments according to the loan’s terms, or at all, or that we will be able to collect on the loan should we be forced to enforce our remedies.
Unsecured Loans and Preferred Securities.
 Our unsecured and preferred investments are generally subordinated to senior loans and are generally unsecured. As such, other creditors may rank senior to us in the event of an insolvency. This may result in an above average amount of risk and loss of principal.
Equity Investments.
 When we invest in senior secured loans, unitranche loans, unsecured loans or preferred securities, we may acquire common equity securities as well. In certain other unique circumstances we may also make equity investments in businesses that make senior loans and/or leases, such as our investments in Kingsbridge Holdings, LLC, SLR Credit Solutions, SLR Equipment
 
26

Finance, SLR Business Credit and SLR Healthcare ABL. In addition, we may invest directly in the equity securities of portfolio companies without limitation as to market capitalization. For instance, we may invest in thinly traded companies, the prices of which may be subject to erratic market movement. Our goal is ultimately to exit such equity interests and realize gains upon our disposition of such interests. However, the equity interests we receive may not appreciate in value and, in fact, may decline in value. Accordingly, we may not be able to realize gains from our equity interests, and any gains that we do realize on the disposition of any equity interests may not be sufficient to offset any other losses we experience.
In addition, investing in middle-market companies involves a number of significant risks, including:
 
   
these companies may have limited financial resources and may be unable to meet their obligations under their debt securities that we hold, which may be accompanied by a deterioration in the value of any collateral and a reduction in the likelihood of us realizing any guarantees we may have obtained in connection with our investment;
 
   
they typically have shorter operating histories, narrower product lines and smaller market shares than larger businesses, which tend to render them more vulnerable to competitors’ actions and market conditions, as well as general economic downturns;
 
   
they are more likely to depend on the management talents and efforts of a small group of persons; therefore, the death, disability, resignation or termination of one or more of these persons could have a material adverse impact on our portfolio company and, in turn, on us;
 
   
they generally have less predictable operating results, may from time to time be parties to litigation, may be engaged in rapidly changing businesses with products subject to a substantial risk of obsolescence, and may require substantial additional capital to support their operations, finance expansion or maintain their competitive position. In addition, our executive officers, directors and our Investment Adviser may, in the ordinary course of business, be named as defendants in litigation arising from our investments in the portfolio companies; and
 
   
they may have difficulty accessing the capital markets to meet future capital needs, which may limit their ability to grow or to repay their outstanding indebtedness upon maturity.
The lack of liquidity in our investments may make it difficult for us to dispose of our investments at a favorable price, which may adversely affect our ability to meet our investment objectives.
We generally make investments in private companies. We invest and expect to continue investing in companies whose securities have no established trading market and whose securities are and will be subject to legal and other restrictions on resale or whose securities are and will be less liquid than are publicly-traded securities. Investments purchased by us that are liquid at the time of purchase may subsequently become illiquid due to events relating to the issuer of the investments, market events, economic conditions or investor perceptions. The illiquidity of our investments may make it difficult for us to sell such investments if the need arises. In addition, if we are required to liquidate all or a portion of our portfolio quickly, we may realize significantly less than the value at which we have previously recorded our investments. As a result, we do not expect to achieve liquidity in our investments in the near-term. However, to maintain our qualification as a BDC and as a RIC, we may have to dispose of investments if we do not satisfy one or more of the applicable criteria under the respective regulatory frameworks. Domestic and foreign markets are complex and interrelated, so that events in one sector of the world markets or economy, or in one geographical region, can reverberate and have materially negative consequences for other markets, economic or regional sectors in a manner that may not be foreseen and which may negatively impact the liquidity of our investments and materially harm our business. In addition, we may face other restrictions on our ability to liquidate an investment in a portfolio company to the extent that we
have material non-public information regarding
such portfolio company.
Our portfolio may be concentrated in a limited number of portfolio companies and industries, which will subject us to a risk of significant loss if any of these companies performs poorly or defaults on its obligations under any of its debt instruments or if there is a downturn in a particular industry.
Our portfolio may be concentrated in a limited number of portfolio companies and industries. For example, as of December 31, 2022, our investments in SLR Credit Solutions, Kingsbridge Holdings, LLC and SLR Equipment Finance comprised 11.4%, 9.0% and 5.0%, respectively, of our total assets and our investments in diversified financial services and multi-sector holdings industries comprised 18.2% and 14.4%, respectively, of our total assets. Beyond the asset diversification requirements associated with our qualification as a RIC under Subchapter M of the Code, we do not have fixed guidelines for diversification, and while we are not targeting any specific industries, our investments may be concentrated in relatively few industries or portfolio companies. As a result, the aggregate returns we realize may be significantly adversely affected if a small number of investments perform poorly or if we need to write down the value of any one investment. Additionally, a downturn in any particular industry in which we are invested could also significantly impact the aggregate returns we realize.
 
27

Our investments in securities rated below investment grade are speculative in nature and are subject to additional risk factors such as the increased possibility of default, illiquidity of the security, and changes in value based on changes in interest rates.
The securities that we invest in are typically rated below investment grade. Securities rated below investment grade are speculative and are often referred to as “leveraged loans,” “high yield” or “junk” securities, and may be considered “high risk” compared to debt instruments that are rated investment grade. High yield securities are regarded as having predominantly speculative characteristics with respect to the issuer’s capacity to pay interest and repay principal in accordance with the terms of the obligations and involve major risk exposure to adverse conditions. In addition, high yield securities generally offer a higher current yield than that available from higher grade issues, but typically involve greater risk. These securities are especially sensitive to adverse changes in general economic conditions, to changes in the financial condition of their issuers and to price fluctuation in response to changes in interest rates. During periods of economic downturn or rising interest rates, such as the current economic period, issuers of below investment grade instruments may experience financial stress that could adversely affect their ability to make payments of principal and interest and increase the possibility of default. The secondary market for high yield securities may not be as liquid as the secondary market for more highly rated securities. In addition, many of our debt investments will not fully amortize during their lifetime, which means that a borrower may be unable to payoff its debt due to bankruptcy or other reasons and therefore
we may write-off such debt
investment prior to its scheduled maturity. Upon such an occurrence, we may realize a loss or a substantial amount of unpaid principal and interest due upon maturity.
Price declines and illiquidity in the corporate debt markets have adversely affected, and may continue to adversely affect, the fair value of our portfolio investments, reducing our net asset value through increased net unrealized depreciation. Any unrealized depreciation that we experience on our loan portfolio may be an indication of future realized losses, which could reduce our income available for distribution and could adversely affect our ability to service our outstanding borrowings.
As a BDC, we are required to carry our investments at market value or, if no market value is ascertainable, at fair value as determined in good faith by or under the direction of our board of directors. Decreases in the market values or fair values of our investments are recorded as unrealized depreciation. Any unrealized depreciation in our loan portfolio could be an indication of a portfolio company’s inability to meet its repayment obligations to us with respect to the affected loans. This could result in realized losses in the future and ultimately in reductions of our income available for distribution in future periods and could materially adversely affect our ability to service our outstanding borrowings. Depending on market conditions, we could incur substantial losses in future periods, which could further reduce our net asset value and have a material adverse impact on our business, financial condition and results of operations.
Economic sanction laws in the United States and other jurisdictions may prohibit us and our affiliates from transacting with certain countries, individuals and companies.
Economic sanction laws in the United States and other jurisdictions may prohibit us or our affiliates from transacting with certain countries, individuals and companies. In the United States, the U.S. Department of the Treasury’s Office of Foreign Assets Control administers and enforces laws, executive orders and regulations establishing U.S. economic and trade sanctions, which prohibit, among other things, transactions with, and the provision of
services to, certain non-U.S. countries, territories, entities
and individuals. These types of sanctions may significantly restrict or completely prohibit investment activities in certain jurisdictions, and if we, our portfolio companies or other issuers in which we invest were to violate any such laws or regulations, we may face significant legal and monetary penalties.
The Foreign Corrupt Practices Act, or FCPA, and other anti-corruption laws and regulations, as well as anti-boycott regulations, may also apply to and restrict our activities, our portfolio companies and other issuers of our investments. If an issuer or we were to violate any such laws or regulations, such issuer or we may face significant legal and monetary penalties. The U.S. government has indicated that it is particularly focused on FCPA enforcement, which may increase the risk that an issuer or us becomes the subject of such actual or threatened enforcement. In addition, certain commentators have suggested that private investment firms and the funds that they manage may face increased scrutiny and/or liability with respect to the activities of their underlying portfolio companies. As such, a violation of the FCPA or other applicable regulations by us or an issuer of our portfolio investments could have a material adverse effect on us. We are committed to complying with the FCPA and other anti-corruption laws and regulations, as well as anti-boycott regulations, to which it is subject. As a result, we may be adversely affected because of our unwillingness to enter into transactions that violate any such laws or regulations.
 
28

If we cannot obtain additional capital because of either regulatory or market price constraints, we could be forced to curtail or cease our new lending and investment activities, our net asset value could decrease and our level of distributions and liquidity could be affected adversely.
Our ability to secure additional financing and satisfy our financial obligations under indebtedness outstanding from time to time will depend upon our future operating performance, which is subject to the prevailing general economic and credit market conditions, including interest rate levels and the availability of credit generally, and financial, business and other factors, many of which are beyond our control. The worsening of current economic and capital market conditions could have a material adverse effect on our ability to secure financing on favorable terms, if at all.
If we are unable to obtain debt capital, then our equity investors will not benefit from the potential for increased returns on equity resulting from leverage to the extent that our investment strategy is successful and we may be limited in our ability to make new commitments or fundings to our portfolio companies.
We may suffer a loss if a portfolio company defaults on a loan and the underlying collateral is not sufficient.
In the event of a default by a portfolio company on a secured loan, we will only have recourse to the assets collateralizing the loan. If the underlying collateral value is less than the loan amount, we will suffer a loss. In addition, we sometimes make loans that are unsecured, which are subject to the risk that other lenders may be directly secured by the assets of the portfolio company. In the event of a default, those collateralized lenders would have priority over us with respect to the proceeds of a sale of the underlying assets. In cases described above, we may lack control over the underlying asset collateralizing our loan or the underlying assets of the portfolio company prior to a default, and as a result the value of the collateral may be reduced by acts or omissions by owners or managers of the assets.
In the event of bankruptcy of a portfolio company, we may not have full recourse to its assets in order to satisfy our loan, or our loan may be subject to equitable subordination. In addition, certain of our loans are subordinate to other debt of the portfolio company. If a portfolio company defaults on our loan or on debt senior to our loan, or in the event of a portfolio company bankruptcy, our loan will be satisfied only after the senior debt receives payment. Where debt senior to our loan exists, the presence of inter-creditor arrangements may limit our ability to amend our loan documents, assign our loans, accept prepayments, exercise our remedies (through “standstill” periods) and control decisions made in bankruptcy proceedings relating to the portfolio company. Bankruptcy and portfolio company litigation can significantly increase collection losses and the time needed for us to acquire the underlying collateral in the event of a default, during which time the collateral may decline in value, causing us to suffer further losses.
If the value of the collateral underlying our loan declines or interest rates increase during the term of our loan, a portfolio company may not be able to obtain the necessary funds to repay our loan at maturity through refinancing. Decreasing collateral value and/or periods of increasing interest rates, such as the current economic period, may hinder a portfolio company’s ability to refinance our loan because the underlying collateral cannot satisfy the debt service coverage requirements necessary to obtain new financing. If a borrower is unable to repay our loan at maturity, we could suffer a loss which may adversely impact our financial performance.
The business, financial condition and results of operations of our portfolio companies could be adversely affected by worldwide economic conditions, as well as political and economic conditions in the countries in which they conduct business.
The business and operating results of our portfolio companies may be impacted by worldwide economic conditions, such as the economic impact that
the COVID-19 pandemic
and the Russian invasion of Ukraine have imposed, and may continue to impose, on the U.S. and worldwide economy. Any deterioration of general economic conditions may lead to significant declines in corporate earnings or loan performance, and the ability of corporate borrowers to service their debt, any of which could trigger a period of global economic slowdown, and have an adverse impact on our performance and financial results, and the value and the liquidity of our investments. In an economic downturn, we could
have non-performing assets
or an increase
in non-performing assets,
and we would anticipate that the value of our portfolio would decrease during these periods. For instance, concerns of economic slowdown in China and other emerging markets and signs of deteriorating sovereign debt conditions in Europe could lead to disruption and instability in the global financial markets. The significant debt in the United States and European countries is expected to hinder growth in those countries for the foreseeable future. In the future, the U.S. government may not be able to meet its debt payments unless the federal debt ceiling is raised. If legislation increasing the debt ceiling is not enacted, as needed, and the debt ceiling is reached, the U.S. federal government may stop or delay making payments on its obligations. Any default by the U.S. government on its obligations or any prolonged U.S. government shutdown could negatively impact the U.S. economy and our portfolio companies. Multiple factors relating to the international operations of some of our portfolio companies and to particular countries in which they operate could negatively impact their business, financial condition and results of operations.
Some of the products of our portfolio companies are developed, manufactured, assembled, tested or marketed outside the United States. Any conflict or uncertainty in these countries, including due to natural disasters, public health concerns (including
the global COVID-19 pandemic), political
unrest or safety concerns, could harm their business, financial condition and results of operations. In addition, if the government of any country in which their products are developed, manufactured or sold sets technical or regulatory standards for products developed or manufactured in or imported into their country that are not widely shared, it may lead some of their customers to suspend imports of their products into that country, require manufacturers or developers in that country to manufacture or develop products with different technical or regulatory standards and disrupt cross-border manufacturing, marketing or business relationships which, in each case, could harm their businesses.
 
29

Our failure
to make follow-on investments in
our portfolio companies could impair the value of our portfolio.
Following an initial investment in a portfolio company, we may make additional investments in that portfolio
company as “follow-on” investments, in
order to: (i) increase or maintain in whole or in part our ownership percentage; (ii) exercise warrants, options or convertible securities that were acquired in the original or subsequent financing; or (iii) attempt to preserve or enhance the value of our investment. We may elect not
to make follow-on investments or
otherwise lack sufficient funds to make those investments. We will have the discretion to
make any follow-on investments, subject
to the availability of capital resources. The failure
to make follow-on investments may,
in some circumstances, jeopardize the continued viability of a portfolio company and our initial investment, or may result in a missed opportunity for us to increase our participation in a successful operation. Even if we have sufficient capital to make
a desired follow-on investment, we
may elect not to
make a follow-on investment because
we may not want to increase our concentration of risk, either because we prefer other opportunities or because we are subject to BDC requirements that would
prevent such follow-on investments or
the desire to maintain our RIC tax treatment.
Where we do not hold controlling equity interests in our portfolio companies, we may not be in a position to exercise control over our portfolio companies or to prevent decisions by management of our portfolio companies that could decrease the value of our investments.
Although we hold controlling equity positions in some of our portfolio companies, we do not currently hold controlling equity positions in the majority of our portfolio companies. As a result, we are subject to the risk that a portfolio company in which we do not have a controlling interest may make business decisions with which we disagree, and that the management and/or stockholders of such portfolio company may take risks or otherwise act in ways that are adverse to our interests. Due to the lack of liquidity of the debt and equity investments that we typically hold in our portfolio companies, we may not be able to dispose of our investments in the event we disagree with the actions of a portfolio company and may therefore suffer a decrease in the value of our investments.
Prepayments of our debt investments by our portfolio companies could adversely impact our results of operations and reduce our return on equity.
We are subject to the risk that the investments we make in our portfolio companies may be prepaid prior to maturity. When this occurs, we may reduce our borrowings outstanding or reinvest these proceeds in temporary investments, pending their future investment in new portfolio companies. These temporary investments, if any, will typically have substantially lower yields than the debt investment being prepaid and we could experience significant delays in reinvesting these amounts. Any future investment in a new portfolio company may also be at lower yields than the debt investment that was prepaid. As a result, our results of operations could be materially adversely affected if one or more of our portfolio companies elect to prepay amounts owed to us. Additionally, prepayments could negatively impact our return on equity, which could result in a decline in the market price of our common stock.
We may choose to waive or defer enforcement of covenants in the debt securities held in our portfolio, which may cause us to lose all or part of our investment in these companies.
We structure the debt investments in our portfolio companies to include business and financial covenants placing affirmative and negative obligations on the operation of the company’s business and its financial condition. However, from time to time we may elect to waive breaches of these covenants, including our right to payment, or waive or defer enforcement of remedies, such as acceleration of obligations or foreclosure on collateral, depending upon the financial condition and prospects of the particular portfolio company. These actions may reduce the likelihood of our receiving the full amount of future payments of interest or principal and be accompanied by a deterioration in the value of the underlying collateral as many of these companies may have limited financial resources, may be unable to meet future obligations and may go bankrupt. This could negatively impact our ability to pay distributions, could adversely affect our results of operation and financial condition and cause the loss of all or part of your investment.
In addition, some of the loans in which we may invest may be “covenant-lite” loans. We use the term “covenant-lite” loans to refer generally to loans that do not have a complete set of financial maintenance covenants.
Generally, “covenant-lite” loans provide borrower companies more freedom to negatively impact lenders because their covenants are incurrence-based, which means they are only tested and can only be breached following an affirmative action of the borrower, rather than by a deterioration in the borrower’s financial condition. Accordingly, to the extent we invest in “covenant-lite” loans, we may have fewer rights against a borrower and may have a greater risk of loss on such investments as compared to investments in or exposure to loans with financial maintenance covenants.
 
30

Our loans could be subject to equitable subordination by a court which would increase our risk of loss with respect to such loans.
Courts may apply the doctrine of equitable subordination to subordinate the claim or lien of a lender against a borrower to claims or liens of other creditors of the borrower, when the lender or its affiliates is found to have engaged in unfair, inequitable or fraudulent conduct. The courts have also applied the doctrine of equitable subordination when a lender or its affiliates is found to have exerted inappropriate control over a client, including control resulting from the ownership of equity interests in a client. We have made direct equity investments or received warrants in connection with loans. Payments on one or more of our loans, particularly a loan to a client in which we may also hold an equity interest, may be subject to claims of equitable subordination. If we were deemed to have the ability to control or otherwise exercise influence over the business and affairs of one or more of our portfolio companies resulting in economic hardship to other creditors of that company, this control or influence may constitute grounds for equitable subordination and a court may treat one or more of our loans as if it were unsecured or common equity in the portfolio company. In that case, if the portfolio company were to liquidate, we would be entitled to repayment of our loan
on a pro-rata basis with
other unsecured debt or, if the effect of subordination was to place us at the level of common equity, then on an equal basis with other holders of the portfolio company’s common equity only after all of its obligations relating to its debt and preferred securities had been satisfied.
An investment strategy focused primarily on privately held companies presents certain challenges, including the lack of available information about these companies, a dependence on the talents and efforts of only a few key portfolio company personnel and a greater vulnerability to economic downturns.
We invest primarily in privately held companies. Generally, little public information exists about these companies, and we are required to rely on the ability of SLR Capital Partners’ investment professionals to obtain adequate information to evaluate the potential returns from investing in these companies. If we are unable to uncover all material information about these companies, we may not make a fully informed investment decision, and we may lose money on our investments. Also, smaller privately held companies frequently have less diverse product lines and smaller market presence than larger competitors. These factors could adversely affect our investment returns as compared to companies investing primarily in the securities of public companies.
Our portfolio companies may incur debt that ranks equally with, or senior to, our investments in such companies.
We invest primarily in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. Our portfolio companies typically have, or may be permitted to incur, other debt that ranks equally with, or senior to, the debt securities in which we invest. By their terms, such debt instruments may provide that the holders are entitled to receive payment of interest or principal on or before the dates on which we are entitled to receive payments in respect of the debt securities in which we invest. Also, in the event of insolvency, liquidation, dissolution, reorganization or bankruptcy of a portfolio company, holders of debt instruments ranking senior to our investment in that portfolio company would typically be entitled to receive payment in full before we receive any distribution in respect of our investment. After repaying such senior creditors, such portfolio company may not have any remaining assets to use for repaying its obligation to us. In the case of debt ranking equally with debt securities in which we invest, we would have to share on an equal basis any distributions with other creditors holding such debt in the event of an insolvency, liquidation, dissolution, reorganization or bankruptcy of the relevant portfolio company. Any such limitations on the ability of our portfolio companies to make principal or interest payments to us, if at all, may reduce our net asset value and have a negative material adverse impact to our business, financial condition and results of operation.
Our investments in foreign securities may involve significant risks in addition to the risks inherent in U.S. investments.
Our investment strategy contemplates potential investments in debt securities of foreign companies, including emerging market companies. Investing in foreign companies may expose us to additional risks not typically associated with investing in U.S. companies. These risks include changes in exchange control regulations, political and social instability, expropriation, imposition of foreign taxes, less liquid markets and less available information than is generally the case in the United States, higher transaction costs, less government supervision of exchanges, brokers and issuers, less developed bankruptcy laws, difficulty in enforcing contractual obligations, lack of uniform accounting and auditing standards and greater price volatility. These risks may be more pronounced for portfolio companies located or operating primarily in emerging markets, whose economies, markets and legal systems may be less developed.
Although most of our investments will be U.S. dollar-denominated, any investments denominated in a foreign currency will be subject to the risk that the value of a particular currency will change in relation to one or more other currencies. Among the factors that may affect currency values are trade balances, the level of short-term interest rates, differences in relative values of similar assets in different currencies, long-term opportunities for investment and capital appreciation, and political developments. We may employ hedging techniques to minimize these risks, but we can offer no assurance that we will, in fact, hedge currency risk, or that if we do, such strategies will be effective.
 
31

We may expose ourselves to risks if we engage in hedging transactions.
If we engage in hedging transactions, we may expose ourselves to risks associated with such transactions. We may utilize instruments such as forward contracts, currency options and interest rate swaps, caps, collars and floors to seek to hedge against fluctuations in the relative values of our portfolio positions from changes in currency exchange rates and market interest rates. Hedging against a decline in the values of our portfolio positions does not eliminate the possibility of fluctuations in the values of such positions or prevent losses if the values of such positions decline. However, such hedging can establish other positions designed to gain from those same developments, thereby offsetting the decline in the value of such portfolio positions. Such hedging transactions may also limit the opportunity for gain if the values of the underlying portfolio positions should increase. It may not be possible to hedge against an exchange rate or interest rate fluctuation that is so generally anticipated that we are not able to enter into a hedging transaction at an acceptable price.
The success of our hedging transactions will depend on our ability to correctly predict movements in currencies and interest rates. Therefore, while we may enter into such transactions to seek to reduce currency exchange rate and interest rate risks, unanticipated changes in currency exchange rates or interest rates may result in poorer overall investment performance than if we had not engaged in any such hedging transactions. In addition, the degree of correlation between price movements of the instruments used in a hedging strategy and price movements in the portfolio positions being hedged may vary. Moreover, for a variety of reasons, we may not seek to establish a perfect correlation between such hedging instruments and the portfolio holdings being hedged. Any such imperfect correlation may prevent us from achieving the intended hedge and expose us to risk of loss. In addition, it may not be possible to hedge fully or perfectly against currency fluctuations affecting the value of securities
denominated in non-U.S. currencies because
the value of those securities is likely to fluctuate as a result of factors not related to currency fluctuations. To the extent we engage in hedging transactions, we also face the risk that counterparties to the derivative instruments we hold may default, which may expose us to unexpected losses from positions where we believed that our risk had been appropriately hedged.
Our Investment Adviser may not be able to achieve the same or similar returns as those achieved for other funds it currently manages or by our senior investment professionals while they were employed at prior positions.
Our Investment Adviser manages other funds, including other BDCs, and may manage other entities in the future. The track record and achievements of these other entities are not necessarily indicative of future results that will be achieved by our Investment Adviser because these other entities may have investment objectives and strategies that differ from ours. Additionally, although in the past our senior investment professionals held senior positions at a number of investment firms, their track record and achievements are not necessarily indicative of future results that will be achieved by our Investment Adviser. In their roles at such other firms, our senior investment professionals were part of investment teams, and they were not solely responsible for generating investment ideas. In addition, such investment teams arrived at investment decisions by consensus.
We may be exposed to higher risks with respect to our investments that include original issue discount or PIK interest.
Zero-coupon bonds pay interest only at maturity rather than at intervals during the life of the security. Deferred interest rate bonds generally provide for a period of delay before the regular payment of interest begins. PIK securities are debt obligations that pay “interest” in the form of other debt obligations, instead of in cash. Each of these instruments
 is normally issued and traded at a deep discount from face value. Zero-coupon bonds, deferred interest rate bonds and PIKs allow an issuer to avoid or delay the need to generate cash to meet current interest payments and, as a result, may involve greater credit risk than bonds that pay interest currently or in cash. In addition, such investments experience greater volatility in market value due to changes in interest rates than debt obligations that provide for regular payments of interest.
To the extent we invest in original issue discount instruments, including PIK, zero coupon bonds, and debt securities with attached warrants, investors will be exposed to the risks associated with the inclusion of
such non-cash income
in taxable and accounting income prior to receipt of cash, including the following:
 
 
The interest payments deferred on a PIK loan are subject to the risk that the borrower may default when the deferred payments are due in cash at the maturity of the loan;
 
 
The interest rates on PIK loans are higher to reflect the time-value of money on deferred interest payments and the higher credit risk of borrowers who may need to defer interest payments;
 
 
PIK instruments may have unreliable valuations because the accruals require judgments about ultimate collectability of the deferred payments and the value of the associated collateral;
 
 
An election to defer PIK income payments by adding them to principal increases our gross assets and, thus, increases future base fees to the Investment Adviser and, because income payments will then be payable on a larger principal amount, the PIK election also increases the Investment Adviser’s future income incentive fees at a compounding rate;
 
 
Market prices of original issue discount instruments are more volatile because they are affected to a greater extent by interest rate changes than instruments that pay interest periodically in cash;
 
32

The deferral of interest on a PIK loan increases
its loan-to-value ratio,
which is a measure of the riskiness of a loan; and
 
 
Original issue discount creates the risk
of non-refundable cash
payments to the Investment Adviser based
on non-cash accruals
that may never be realized.
Risks Relating to an Investment in Our Securities
Our shares may trade at a substantial discount from net asset value and may continue to do so over the long term.
Shares of BDCs may trade at a market price that is less than the net asset value that is attributable to those shares. The possibility that our shares of common stock will trade at a substantial discount from net asset value over the long term is separate and distinct from the risk that our net asset value will decrease. We cannot predict whether shares of our common stock will trade above, at or below our net asset value in the future. If our common stock trades below its net asset value, we will generally not be able to issue additional shares or sell our common stock at its market price without first obtaining the approval for such issuance from our stockholders and our independent directors. If additional funds are not available to us, we could be forced to curtail or cease our new lending and investment activities, and our net asset value could decrease and our level of distributions could be impacted.
Our common stock price may be volatile and may decrease substantially.
The trading price of our common stock may fluctuate substantially. The price of our common stock that will prevail in the market may be higher or lower than the price you pay, depending on many factors, some of which are beyond our control and may not be directly related to our operating performance. These factors include, but are not limited to, the following:
 
 
price and volume fluctuations in the overall stock market from time to time;
 
 
investor demand for our shares;
 
 
significant volatility in the market price and trading volume of securities of BDCs or other companies in our sector, which are not necessarily related to the operating performance of these companies;
 
 
exclusion of our common stock from certain market indices, such as the Russell 2000 Financial Services Index, which could reduce the ability of certain investment funds to own our common stock and put short-term selling pressure on our common stock;
 
 
changes in regulatory policies or tax guidelines with respect to RICs or BDCs;
 
 
failure to qualify as a RIC, or the loss of RIC tax treatment;
 
 
any shortfall in revenue or net income or any increase in losses from levels expected by investors or securities analysts;
 
 
changes, or perceived changes, in the value of our portfolio investments;
 
 
departures of SLR Capital Partners’ key personnel;
 
 
operating performance of companies comparable to us;
 
 
changes in the prevailing interest rates;
 
 
loss of a major funding source; or
 
 
general economic conditions and trends and other external factors.
Our businesses may be adversely affected by litigation and regulatory proceedings.
From time to time, we may be subject to legal actions as well as various regulatory, governmental and law enforcement inquiries, investigations and subpoenas. In any such claims or actions, demands for substantial monetary damages may be asserted against us and may result in financial liability or an adverse effect on our reputation among investors. In connection with acquisitions of, and investments in, businesses complementary to our business, we have been and may be in the future subject to securities litigation or shareholder activism in connection with such acquisitions or investments. Securities litigation and shareholder activism, including potential proxy contests, could result in substantial costs and divert management’s and our board of directors’ attention and resources from our business. We may be unable to accurately estimate our exposure to litigation risk when we record balance sheet reserves for probable loss contingencies. As a result, any reserves we establish to cover any settlements or judgments may not be sufficient to cover our actual financial exposure, which may have a material impact on our results of operations or financial condition. In regulatory enforcement matters, claims for disgorgement, the imposition of penalties and the imposition of other remedial sanctions are possible.
 
33

If the current period of capital market disruption and instability continues for an extended period of time, there is a risk that investors in our equity securities may not receive distributions consistent with historical levels or at all or that our distributions may not grow over time and a portion of our distributions may be a return of capital.
We intend to make distributions on a monthly basis to our stockholders out of assets legally available for distribution. We cannot assure you that we will achieve investment results that will allow us to make a specified level of cash distributions. Our ability to pay distributions might be adversely affected by the impact of one or more of the risk factors described in this annual report. If we violate certain covenants under our existing or future credit facilities or other leverage, we may be limited in our ability to make distributions. If we declare a distribution and if more stockholders opt to receive cash distributions rather than participate in our dividend reinvestment plan, we may be forced to sell some of our investments in order to make cash distribution payments. To the extent we make distributions to stockholders that include a return of capital, such portion of the distribution essentially constitutes a return of the stockholder’s investment. Although such return of capital may not be taxable, such distributions would generally decrease a stockholder’s basis in our common stock and may therefore increase such stockholder’s tax liability for capital gains upon the future sale of such stock. A return of capital distribution may cause a stockholder to recognize a capital gain from the sale of our common stock even if the stockholder sells its shares for less than the original purchase price.
As a RIC, if we do not distribute a certain percentage of our income annually, we may suffer adverse tax consequences,
including
possibly losing the U.S. federal income tax benefits allowable to RICs. We cannot assure you that you will receive distributions at a particular level or at all.
In certain cases, we may recognize income before or without receiving the accompanying cash. Depending on the amount of noncash income, this could result in difficulty satisfying the annual distribution requirement applicable to RICs. Accordingly, we may have to sell some portfolio investments at times it would not consider advantageous, raise additional debt or equity capital or reduce new investments to meet these distribution requirements.
Due to disruptions in the economy, we may reduce or defer our dividends and choose to incur U.S. federal excise tax in order to preserve cash and maintain flexibility.
In order to maintain our tax treatment as a RIC, we must distribute to shareholders for each taxable year at least 90% of our investment company taxable income (i.e., net ordinary income plus realized net short-term capital gains in excess of realized net long-term capital losses). If we qualify for taxation as a RIC, we generally will not be subject to corporate-level US federal income tax on our investment company taxable income and net capital gains (i.e., realized net long-term capital gains in excess of realized net short-term capital losses) that we timely distribute to shareholders. We will be subject to a 4% U.S. federal excise tax on undistributed earnings of a RIC unless we distribute each calendar year at least the sum of (i) 98.0% of our ordinary income for the calendar year, (ii) 98.2% of our capital gains in excess of
capital losses for the one-year period ending on October 31
of the calendar year, and (iii) any ordinary income and net capital gains that were recognized for preceding years, but were not distributed during such years and on which we paid no U.S. federal income tax. Any net operating losses that we incur in periods during which we qualify as a RIC will not offset net capital gains (i.e., net realized long-term capital gains in excess of net realized short-term capital losses) that we are otherwise required to distribute, and we cannot pass such net operating losses through to our stockholders. In addition, net operating losses that we carry over to a taxable year in which we qualify as a RIC normally cannot offset ordinary income or capital gains.
Under the Code, we may satisfy certain of our RIC distributions with dividends paid after the end of the current year. In particular, if we pay a distribution in January of the following year that was declared in October, November, or December of the current year and is payable to shareholders of record in the current year, the dividend will be treated for all US federal income tax purposes as if it were paid on December 31 of the current year. In addition, under the Code, we may pay dividends, referred to as “spillover dividends,” that are paid during the following taxable year that will allow us to maintain our qualification for taxation as a RIC and eliminate our liability for corporate-level U.S. federal income tax. Under these spillover dividend procedures, we may defer distribution of income earned during the current year until December of the following year. For example, we may defer distributions of income earned during 2023 until as late as December 31, 2024. If we choose to pay a spillover dividend, we will incur the 4% U.S. federal excise tax on some or all of the distribution.
Due to events such as
the COVID-19 pandemic,
the Russian invasion of Ukraine or other disruptions in the economy, such as the current inflationary environment, we may take certain actions with respect to the timing and amounts of our distributions in order to preserve cash and maintain flexibility. For example, we may reduce our dividends and/or defer dividends to the following taxable year. If we defer our dividends, we may choose to utilize the spillover dividend rules discussed above and incur the 4% U.S. federal excise tax on such amounts. To further preserve cash, we may combine these reductions or deferrals of dividends with one or more distributions that are payable partially in our stock as discussed below under “
We may choose to pay
 distributions in our own stock, in which case our stockholders may be required to pay U.S. federal income taxes in excess of the cash distributions they receive.”
 
34

We may choose to pay distributions in our own common stock, in which case our stockholders may be required to pay U.S. federal income taxes in excess of the cash distributions they receive.
We may distribute taxable distributions that are payable in part in shares of our common stock. Under certain applicable provisions of the Code and the published guidance, distributions of a publicly offered RIC that are in cash or in shares of stock at the election of stockholders may be treated as taxable distributions. The Internal Revenue Service has issued a revenue procedure indicating that this rule will apply if the total amount of cash to be distributed is not less than 20% of the total distribution. Under this revenue procedure, if too many stockholders elect to receive their distributions in cash, the cash available for distribution must be allocated among the stockholders electing to receive cash (with the balance of distributions paid in stock). In no event will any stockholder electing to receive cash, receive less than the lesser of (a) the portion of the distribution such stockholder has elected to receive in cash or (b) an amount equal to his or her entire distribution times the percentage limitation on cash available for distribution. If we decide to make any distributions consistent with this revenue procedure that are payable in part in our stock, taxable stockholders receiving such distributions will be required to include the full amount of the distribution (whether received in cash, our stock, or a combination thereof) as ordinary income (or as long-term capital gain to the extent such distribution is properly reported as a capital gain distribution) to the extent of our current and accumulated earnings and profits for U.S. federal income tax purposes. As a result, a U.S. stockholder may be required to pay tax with respect to such distributions in excess of any cash received. If a U.S. stockholder sells the stock it receives as a distribution in order to pay this tax, the sales proceeds may be less than the amount included in income with respect to the distribution, depending on the market price of our stock at the time of the sale. Furthermore, with respect to
non-U.S.
stockholders, we may be required to withhold U.S. tax with respect to such distributions, including in respect of all or a portion of such distribution that is payable in stock. If a significant number of our stockholders determine to sell shares of our stock in order to pay taxes owed on distributions, it may put downward pressure on the trading price of our stock.
Sales of substantial amounts of our common stock in the public market may have an adverse effect on the market price of our common stock.
The shares of our common stock beneficially owned by each of Messrs. Gross and Spohler immediately prior to completion of our initial public offering, including any shares that are attributable to such shares issued pursuant to our dividend reinvestment plan, are no longer
subject to lock-up restrictions that
each of Messrs. Gross and Spohler agreed to in connection with our initial public offering, and are generally available for resale without restriction, subject to the provisions of Rule 144 promulgated under the Securities Act. In addition, on November 30, 2010, Messrs. Gross and Spohler jointly acquired 115,000 shares of our common stock in a private placement transaction conducted in accordance with Regulation D under the Securities Act. Such shares are generally available for resale without restriction, subject to the provisions of Rule 144 promulgated under the Securities Act. Sales of substantial amounts of our common stock, or the availability of such common stock for sale, could adversely affect the prevailing market prices for our common stock. If this occurs and continues, it could impair our ability to raise additional capital through the sale of securities should we desire to do so.
We may be unable to invest the net proceeds raised from any offerings on acceptable terms or allocate net proceeds from any offering of our securities in ways with which you may not agree.
We cannot assure you that we will be able to find enough appropriate investments that meet our investment criteria or that any investment we complete using the proceeds from any securities offering will produce a sufficient return. Until we identify new investment opportunities, we intend to either invest the net proceeds of future offerings in cash equivalents, U.S. government securities and other high-quality debt investments that mature in one year or less or use the net proceeds from such offerings to reduce then-outstanding obligations.
We have significant flexibility in investing the net proceeds of any offering of our securities and may use the net proceeds from an offering in ways with which you may not agree or for purposes other than those contemplated at the time of the offering.
The net asset value per share of our common stock may be diluted if we issue or sell shares of our common stock at prices below the then current net asset value per share of our common stock or securities to subscribe for or convertible into shares of our common stock.
We will generally not be able to issue additional shares or sell our common stock at its market price without first obtaining the approval for such issuance from our stockholders and our independent directors. Any offering of our common stock that requires stockholder approval must occur, if at all, within one year after receiving such stockholder approval. At our 2011 Annual Stockholders Meeting, our stockholders authorized us to sell or otherwise issue warrants or securities to subscribe for or convertible into shares of our common stock subject to certain limitations (including, without limitation, that the number of shares issuable does not exceed 25% of our then outstanding common stock and that the exercise or conversion price thereof is not, at the date of issuance, less than the market value per share of our common stock). Such authorization has no expiration.
 
35

We may also use newly issued shares to implement our dividend reinvestment plan, whether our shares are trading at a premium or at a discount to our then current net asset value per share. Any decision to issue or sell shares of our common stock below our then current net asset value per share or securities to subscribe for or convertible into shares of our common stock would be subject to the determination by our board of directors that such issuance or sale is in our and our stockholders’ best interests.
If we were to issue or sell shares of our common stock below our then current net asset value per share, such issuances or sales would result in an immediate dilution to the net asset value per share of our common stock.
This dilution would occur as a result of the issuance or sale of shares at a price below the then current net asset value per share of our common stock and a proportionately greater decrease in the stockholders’ interest in our earnings and assets and their voting interest in us than the increase in our assets resulting from such issuance or sale. Because the number of shares of common stock that could be so issued and the timing of any issuance is not currently known, the actual dilutive effect cannot be predicted.
In addition, if we issue warrants or securities to subscribe for or convertible into shares of our common stock, subject to certain limitations, the exercise or conversion price per share could be less than net asset value per share at the time of exercise or conversion (including through the operation of anti-dilution protections).
Because we would incur expenses in connection with any issuance of such securities, such issuance could result in a dilution of the net asset value per share at the time of exercise or conversion. This dilution would include reduction in net asset value per share as a result of the proportionately greater decrease in the stockholders’ interest in our earnings and assets and their voting interest than the increase in our assets resulting from such issuance.
Further, if our current stockholders do not purchase any shares to maintain their percentage interest, regardless of whether such offering is above or below the then current net asset value per share, their voting power will be diluted. For example, if we sell an additional 10% of our common stock at a 5% discount from net asset value, a stockholder who does not participate in that offering for its proportionate interest will suffer net asset value dilution of up to 0.5% or $5 per $1,000 of net asset value.
Similarly, all distributions declared in cash payable to stockholders that are participants in our dividend reinvestment plan are automatically reinvested in shares of our common stock. As a result, stockholders that opt out of the dividend reinvestment plan may experience dilution over time. Stockholders who do not elect to receive distributions in shares of common stock may experience accretion to the net asset value of their shares if our shares are trading at a premium and dilution if our shares are trading at a discount. The level of accretion or discount would depend on various factors, including the proportion of our stockholders who participate in the plan, the level of premium or discount at which our shares are trading and the amount of the distribution payable to a stockholder.
If we issue preferred stock, the net asset value and market value of our common stock may become more volatile.
We cannot assure you that the issuance of preferred stock would result in a higher yield or return to the holders of the common stock. The issuance of preferred stock would likely cause the net asset value and market value of the common stock to become more volatile. If the distribution rate on the preferred stock were to approach the net rate of return on our investment portfolio, the benefit of leverage to the holders of the common stock would be reduced. If the distribution rate on the preferred stock were to exceed the net rate of return on our portfolio, the leverage would result in a lower rate of return to the holders of common stock than if we had not issued preferred stock. Any decline in the net asset value of our investments would be borne entirely by the holders of common stock. Therefore, if the market value of our portfolio were to decline, the leverage would result in a greater decrease in net asset value to the holders of common stock than if we were not leveraged through the issuance of preferred stock. This greater net asset value decrease would also tend to cause a greater decline in the market price for the common stock. We might be in danger of failing to maintain the required asset coverage of the preferred stock or of losing our ratings on the preferred stock or, in an extreme case, our current investment income might not be sufficient to meet the distribution requirements on the preferred stock. In order to counteract such an event, we might need to liquidate investments in order to fund a redemption of some or all of the preferred stock. In addition, we would pay (and the holders of common stock would bear) all costs and expenses relating to the issuance and ongoing maintenance of the preferred stock, including higher advisory fees if our total return exceeds the distribution rate on the preferred stock. Holders of preferred stock may have different interests than holders of common stock and may at times have disproportionate influence over our affairs.
Our board of directors is authorized to reclassify any unissued shares of common stock into one or more classes of preferred stock, which could convey special rights and privileges to its owners.
Under Maryland General Corporation Law and our charter, our board of directors is authorized to classify and reclassify any authorized but unissued shares of stock into one or more classes of stock, including preferred stock. Prior to issuance of shares of each class or series, the board of directors is required by Maryland law and our charter to set the preferences, conversion or other rights,
 
36

voting powers, restrictions, limitations as to other distributions, qualifications and terms or conditions of redemption for each class or series. Thus, the board of directors could authorize the issuance of shares of preferred stock with terms and conditions which could have the effect of delaying, deferring or preventing a transaction or a change in control that might involve a premium price for holders of our common stock or otherwise be in their best interest. The cost of any such reclassification would be borne by our existing common stockholders. The issuance of shares of preferred stock convertible into shares of common stock might also reduce the net income and net asset value per share of our common stock upon conversion, provided, that we will only be permitted to issue such convertible preferred stock to the extent we comply with the requirements of Section 61 of the 1940 Act, including obtaining common stockholder approval. These effects, among others, could have an adverse effect on your investment in our common stock.
Certain matters under the 1940 Act require the separate vote of the holders of any issued and outstanding preferred stock. For example, holders of preferred stock would vote separately from the holders of common stock on a proposal to cease operations as a BDC. In addition, the 1940 Act provides that holders of preferred stock are entitled to vote separately from holders of common stock to elect two preferred stock directors. In the event distributions become two full years in arrears, holders of any preferred stock would have the right to elect a majority of the directors until such arrearage is completely eliminated. Preferred stockholders also have class voting rights on certain matters, including changes in fundamental investment restrictions and
conversion to open-end status, and
accordingly can veto any such changes. Restrictions imposed on the declarations and payment of distributions to the holders of our common stock and preferred stock, both by the 1940 Act and by requirements imposed by rating agencies or the terms of our credit facilities, might impair our ability to maintain our qualification for tax treatment as a RIC for U.S. federal income tax purposes. While we would intend to redeem our preferred stock to the extent necessary to enable us to distribute our income as required to maintain our qualification as a RIC, there can be no assurance that such actions could be effected in time to meet the tax requirements.
To the extent we use debt or preferred stock to finance our investments, changes in interest rates will affect our cost of capital and net investment income.
To the extent we borrow money, or issue preferred stock, to make investments, our net investment income will depend, in part, upon the difference between the rate at which we borrow funds or pay distributions on preferred stock and the rate at which we invest those funds. In addition, many of our debt investments and borrowings have floating interest rates that reset on a periodic basis, and many of our investments are subject to interest rate floors. As a result, we can offer no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income in the event we use debt to finance our investments. In periods of rising interest rates, such as the current economic period, our cost of funds have increased, and could continue to increase, because the interest rates on the amounts borrowed under our credit facilities or certain other financing arrangements are typically floating, except to the extent we issue fixed rate debt or preferred stock, which could reduce our net investment income, and the interest rate on investments with an interest rate floor (such as a SOFR floor) above current levels will not increase until interest rates exceed the applicable floor. We expect that our long-term fixed-rate investments will generally be financed with equity and long-term debt.
We may use interest rate risk management techniques in an effort to limit our exposure to interest rate fluctuations. Such techniques may include various interest rate hedging activities to the extent permitted by the 1940 Act. These activities could limit our ability to participate in the benefits of lower interest rates with respect to the hedged borrowings. Adverse developments resulting from changes in interest rates or hedging transactions could have a material adverse effect on our business, financial condition and results of operations.
You should also be aware that the rise in the general level of interest rates can be expected to lead to higher interest rates applicable to our debt investments. Accordingly, such increase in interest rates makes it easier for us to meet or exceed the incentive fee hurdle rate and may result in a substantial increase of the amount of incentive fees payable to our Investment Adviser with respect to our
pre-incentive
fee net investment income. Also, an increase in interest rates available to investors could make an investment in our common stock less attractive if we are not able to increase our distribution rate, which could reduce the value of our common stock.
We may in the future determine to fund a portion of our investments with preferred stock, which would magnify the potential for loss and the risks of investing in us in a similar way as our borrowings.
Preferred stock, which is another form of leverage, has the same risks to our common stockholders as borrowings because the distributions on any preferred stock we issue must be cumulative. Payment of such distributions and repayment of the liquidation preference of such preferred stock must take preference over any distributions or other payments to our common stockholders, and preferred stockholders are not subject to any of our expenses or losses and are not entitled to participate in any income or appreciation in excess of their stated preference.
 
37

Risks Relating to Our Business and Structure
We are dependent upon SLR Capital Partners’ key personnel for our future success.
We depend on the diligence, skill and network of business contacts of Messrs. Gross and Spohler, who serve as the managing partners of SLR Capital Partners and who lead SLR Capital Partners’ investment team. Messrs. Gross and Spohler, together with the other dedicated investment professionals available to SLR Capital Partners, evaluate, negotiate, structure, close and monitor our investments. Our future success will depend on the diligence, skill, network of business contacts and continued service of Messrs. Gross and Spohler and the other investment professionals available to SLR Capital Partners. We cannot assure you that unforeseen business, medical, personal or other circumstances would not lead any such individual to terminate his relationship with us. The loss of Mr. Gross or Mr. Spohler, or any of the other senior investment professionals who serve on SLR Capital Partners’ investment team, could have a material adverse effect on our ability to achieve our investment objective as well as on our financial condition and results of operations. In addition, we can offer no assurance that SLR Capital Partners will remain our Investment Adviser.
The senior investment professionals of SLR Capital Partners are and may in the future become affiliated with entities engaged in business activities similar to those intended to be conducted by us, and may have conflicts of interest in allocating their time. We expect that Messrs. Gross and Spohler will dedicate a significant portion of their time to the activities of SLR Investment Corp.; however, they may be engaged in other business activities which could divert their time and attention in the future. Specifically, Mr. Gross
serves as Co-Chief Executive Officer
and President of SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC. In addition, Mr. Spohler
serves as Co-Chief Executive Officer
and Chief Operating Officer of SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC.
Our business model depends to a significant extent upon strong referral relationships with financial sponsors, and the inability of the senior investment professionals of our Investment Adviser to maintain or develop these relationships, or the failure of these relationships to generate investment opportunities, could adversely affect our business.
We expect that the principals of our Investment Adviser will maintain and develop their relationships with financial sponsors, and we will rely to a significant extent upon these relationships to provide us with potential investment opportunities. If the senior investment professionals of our Investment Adviser fail to maintain their existing relationships or develop new relationships with other sponsors or sources of investment opportunities, we will not be able to grow our investment portfolio. In addition, individuals with whom the senior investment professionals of our Investment Adviser have relationships are not obligated to provide us with investment opportunities, and, therefore, there is no assurance that such relationships will generate investment opportunities for us. If our Investment Adviser is unable to source investment opportunities, we may hold a greater percentage of our assets in cash and cash equivalents than anticipated, which could impact potential returns on our portfolio.
A disruption in the capital markets and the credit markets could negatively affect our business.
As a BDC, we must maintain our ability to raise additional capital for investment purposes. Without sufficient access to the capital markets or credit markets, we may be forced to curtail our business operations or we may not be able to pursue new business opportunities. Disruptive conditions in the financial industry and the impact of new legislation in response to those conditions could restrict our business operations and could adversely impact our results of operations and financial condition.
If the fair value of our assets declines substantially, we may fail to maintain the asset coverage ratios imposed upon us by the 1940 Act and our existing credit facilities. Any such failure could result in an event of default and all of our debt being declared immediately due and payable and would affect our ability to issue senior securities, including borrowings, and pay distributions, which could materially impair our business operations. Our liquidity could be impaired further by an inability to access the capital markets or to draw on our credit facilities. For example, we cannot be certain that we will be able to renew our existing credit facilities as they mature or to consummate new borrowing facilities to provide capital for normal operations, including new originations. Reflecting concern about the stability of the financial markets, many lenders and institutional investors have reduced or ceased providing funding to borrowers. This market turmoil and tightening of credit have led to increased market volatility and widespread reduction of business activity generally.
If we are unable to renew or replace our existing credit facilities and consummate new facilities on commercially reasonable terms, our liquidity will be reduced significantly. If we consummate new facilities but are then unable to repay amounts outstanding under such facilities and are declared in default or are unable to renew or refinance these facilities, we would not be able to initiate significant originations or to operate our business in the normal course. These situations may arise due to circumstances that we may be unable to control, such as inaccessibility to the credit markets, a severe decline in the value of the U.S. dollar, a further economic downturn or an operational problem that affects third parties or us, and could materially damage our business. Moreover, we are unable to predict when economic and market conditions may become more favorable. Even if such conditions improve broadly and significantly over the long term, adverse conditions in particular sectors of the financial markets could adversely impact our business.
 
38

Our financial condition and results of operations will depend on SLR Capital Partners’ ability to manage our future growth effectively by identifying, investing in and monitoring companies that meet our investment criteria.
Our ability to achieve our investment objective and to grow depends on SLR Capital Partners’ ability to identify, invest in and monitor companies that meet our investment criteria. Accomplishing this result on a cost-effective basis is largely a function of SLR Capital Partners’ structuring of the investment process, its ability to provide competent, attentive and efficient services to us and its ability to access financing for us on acceptable terms. The investment team of SLR Capital Partners has substantial responsibilities under the Advisory Agreement, and they may also be called upon to provide managerial assistance to our portfolio companies as the principals of our administrator. In addition, the members of SLR Capital Partners’ investment team have similar responsibilities with respect to the management of other investment portfolios, including the investment portfolios of SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC. Such demands on their time may distract them or slow our rate of investment. In order to grow, we and SLR Capital Partners will need to retain, train, supervise and manage new investment professionals. However, we can offer no assurance that any such investment professionals will contribute effectively to the work of the Investment Adviser. Any failure to manage our future growth effectively could have a material adverse effect on our business, financial condition and results of operations.
We may need to raise additional capital to grow because we must distribute most of our income.
We may need additional capital to fund growth in our investments. We expect to issue equity securities and expect to borrow from financial institutions in the future. A reduction in the availability of new capital could limit our ability to grow. We must distribute at least 90% of our investment company taxable income to our stockholders to maintain our tax treatment as a RIC. As a result, any such cash earnings may not be available to fund investment originations. We expect to borrow from financial institutions and issue additional debt and equity securities. If we fail to obtain funds from such sources or from other sources to fund our investments, it could limit our ability to grow, which may have an adverse effect on the value of our securities. In addition, as a BDC, our ability to borrow or issue additional preferred stock may be restricted if our total assets are less than 150% of our total borrowings and preferred stock.
Any failure on our part to maintain our status as a BDC would reduce our operating flexibility and we may be limited in our investment choices as a BDC.
The 1940 Act imposes numerous constraints on the operations of BDCs. For example, BDCs are required to invest at least 70% of their total assets in specified types of securities, primarily in private companies or thinly-traded U.S. public companies, cash, cash equivalents, U.S. government securities and other high quality debt investments that mature in one year or less. Furthermore, any failure to comply with the requirements imposed on BDCs by the 1940 Act could cause the SEC to bring an enforcement action against us and/or expose us to claims of private litigants. In addition, upon approval of a majority of our stockholders, we may elect to withdraw our status as a BDC. If we decide to withdraw our election, or if we otherwise fail to qualify, or maintain our qualification, as a BDC, we may be subject to the substantially greater regulation under the 1940 Act
as a closed-end investment company.
Compliance with such regulations would significantly decrease our operating flexibility, and could have a material adverse effect on our business, financial condition and results of operations.
Regulations governing our operation as a BDC affect our ability to, and the way in which we will, raise additional capital. As a BDC, the necessity of raising additional capital may expose us to risks, including the typical risks associated with leverage.
In order to satisfy the tax requirements applicable to a RIC, to avoid payment of excise taxes and to minimize or avoid payment of income taxes, we intend to distribute to our stockholders substantially all of our ordinary income and realized net capital gains except for certain realized net long-term capital gains, which we may retain, pay applicable income taxes with respect thereto and elect to treat as deemed distributions to our stockholders. We may issue debt securities or preferred stock and/or borrow money from banks or other financial institutions, which we refer to collectively as “senior securities,” up to the maximum amount permitted by the 1940 Act. Under the provisions of the 1940 Act, we had been permitted, as a BDC, to issue senior securities in amounts such that our asset coverage ratio, as defined in the 1940 Act, equals at least 200% of gross assets less all liabilities and indebtedness not represented by senior securities, after each issuance of senior securities. However, our stockholders have approved a resolution permitting us to be subject to a 150% asset coverage ratio effective as of October 12, 2018. If the value of our assets declines, we may be unable to satisfy the asset coverage test. If that happens, we may be required to sell a portion of our investments and, depending on the nature of our leverage, repay a portion of our indebtedness at a time when such sales may be disadvantageous. Also, any amounts that we use to service our indebtedness would not be available for distributions to our common stockholders. Furthermore, as a result of issuing senior securities, we would also be exposed to typical risks associated with leverage, including an increased risk of loss. In addition, because our management fee is calculated as a percentage of our gross assets, which includes any borrowings for investment purposes, the management fee expenses will increase if we incur additional indebtedness.
 
39

As of December 31, 2022, we had $393.0 million outstanding under the Credit Facility, composed of $293.0 million of revolving credit and $100.0 million outstanding of term loans, and $155.2 million outstanding under our SPV Credit Facility. We also had $135.0 million outstanding of the Series F 2027 Unsecured Notes, $50.0 million outstanding of the 2027 Unsecured Notes, $75.0 million outstanding of the 2026 Unsecured Notes, $85.0 million outstanding of the 2025 Unsecured Notes, $125.0 million outstanding of the 2024 Unsecured Notes, and $75.0 million outstanding of the 2023 Unsecured Notes. If we issue preferred stock, the preferred stock would rank “senior” to common stock in our capital structure, preferred stockholders would generally vote together with common stockholders but would have separate voting rights on certain matters and might have other rights, preferences, or privileges more favorable than those of our common stockholders, and the issuance of preferred stock could have the effect of delaying, deferring or preventing a transaction or a change of control that might involve a premium price for holders of our common stock or otherwise be in your best interest.
We are not generally able to issue and sell our common stock at a price below net asset value per share. We may, however, sell our common stock, or warrants, options or rights to acquire our common stock, at a price below the then-current net asset value per share of our common stock if our board of directors determines that such sale is in the best interests of SLR Investment Corp. and its stockholders, and our stockholders approve such sale. In any such case, the price at which our securities are to be issued and sold may not be less than a price that, in the determination of our board of directors, closely approximates the market value of such securities (less any distributing commission or discount). If we raise additional funds by issuing more common stock or senior securities convertible into, or exchangeable for, our common stock, then the percentage ownership of our stockholders at that time will decrease, and you might experience dilution. This dilution would occur as a result of a proportionately greater decrease in a stockholder’s interest in our earnings and assets and voting interest in us than the increase in our assets resulting from such issuance. Because the number of future shares of common stock that may be issued below our net asset value per share and the price and timing of such issuances are not currently known, we cannot predict the actual dilutive effect of any such issuance. We cannot determine the resulting reduction in our net asset value per share of any such issuance. We also cannot predict whether shares of our common stock will trade above, at or below our net asset value.
Our credit ratings may not reflect all risks of an investment in our debt securities.
Our credit ratings are an assessment by third parties of our ability to pay our obligations. Consequently, real or anticipated changes in our credit ratings will generally affect the market value of our publicly issued debt securities. Our credit ratings, however, may not reflect the potential impact of risks related to market conditions generally or other factors discussed above on the market value of, or trading market for, any publicly issued debt securities.
Our stockholders may experience dilution in their ownership percentage if they opt out of our dividend reinvestment plan.
All distributions declared in cash payable to stockholders that are participants in our dividend reinvestment plan are automatically reinvested in shares of our common stock. In the event we issue new shares in connection with our dividend reinvestment plan, our stockholders that do not elect to receive distributions in shares of common stock may experience dilution in their ownership percentage over time as a result of such issuance.
We have and will continue to borrow money, which would magnify the potential for loss on amounts invested and may increase the risk of investing in us.
We borrow money as part of our business plan. Borrowings, also known as leverage, magnify the potential for loss on amounts invested and, therefore, increase the risks associated with investing in our securities. As of December 31, 2022, we had $393.0 million outstanding under the Credit Facility, composed of $293.0 million of revolving credit and $100.0 million outstanding of term loans, and $155.2 million outstanding under our SPV Credit Facility. We also had $135.0 million outstanding of the Series F 2027 Unsecured Notes, $50.0 million outstanding of the 2027 Unsecured Notes, $75.0 million outstanding of the 2026 Unsecured Notes, $85.0 million outstanding of the 2025 Unsecured Notes, $125.0 million outstanding of the 2024 Unsecured Notes, and $75.0 million outstanding of the 2023 Unsecured Notes. We may borrow from and issue senior debt securities to banks, insurance companies and other lenders in the future. Lenders of these senior securities, including the Credit Facility, the SPV Credit Facility, the Series F 2027 Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes, the 2024 Unsecured Notes, and the 2023 Unsecured Notes, will have fixed dollar claims on our assets that are superior to the claims of our common stockholders, and we would expect such lenders to seek recovery against our assets in the event of a default. If the value of our assets increases, then leveraging would cause the net asset value attributable to our common stock to increase more sharply than it would have had we not leveraged. Conversely, if the value of our assets decreases, leveraging would cause net asset value to decline more sharply than it otherwise would have had we not leveraged. Similarly, any decrease in our income would cause net income to decline more sharply than it would have had we not borrowed. Also, any increase in our income in excess of interest payable on the borrowed funds would cause our net investment income to increase more than it would without the leverage, while any decrease in our income would cause net investment income to decline more sharply than it would have had we not borrowed. Such a decline could also negatively affect
 
40
our ability to make distribution payments on our common stock, scheduled debt payments or other payments related to our securities. Leverage is generally considered a speculative investment technique. Our ability to service any debt that we incur will depend largely on our financial performance and will be subject to prevailing economic conditions and competitive pressures. Moreover, as the management fee payable to our Investment Adviser, SLR Capital Partners, will be payable based on our gross assets, including those assets acquired through the use of leverage, SLR Capital Partners will have a financial incentive to incur leverage which may not be consistent with our stockholders’ interests. In addition, our common stockholders will bear the burden of any increase in our expenses as a result of leverage, including any increase in the management fee payable to SLR Capital Partners.
As a BDC, we had generally been required to meet a coverage ratio of total assets to total borrowings and other senior securities, which include all of our borrowings and any preferred stock that we may issue in the future, of at least 200%. However, our stockholders have approved a resolution permitting us to be subject to a 150% asset coverage ratio effective as of October 12, 2018. Even though we are subject to a 150% asset coverage ratio effective as of October 12, 2018, contractual leverage limitations under our existing credit facilities or future borrowings may limit our ability to incur additional indebtedness. On August 28, 2019, we entered into the Credit Agreement, which was amended on December 28, 2021, which permits 150% asset coverage. Some of our wholly and/or substantially owned portfolio companies, including Kingsbridge Holdings, LLC, SLR Credit Solutions, SLR Equipment Finance, SLR Business Credit and SLR Healthcare ABL, may incur significantly more leverage than we can but we do not consolidate Kingsbridge Holdings, LLC, SLR Credit Solutions, SLR Equipment Finance, SLR Business Credit and SLR Healthcare ABL and their
leverage is non-recourse to us.
Additionally, the Credit Facility and the SPV Credit Facility require us to comply with certain financial and other restrictive covenants including maintaining an asset coverage ratio of not less than 150% at any time. Failure to maintain compliance with these covenants could result in an event of default and all of our debt being declared immediately due and payable. If this ratio declines below 150%, we may not be able to incur additional debt and could be required by law to sell a portion of our investments to repay some debt when it is disadvantageous to do so, which could have a material adverse effect on our operations, and we may not be able to make distributions. The amount of leverage that we employ will depend on our Investment Adviser’s and our board of directors’ assessment of the market and other factors at the time of any proposed borrowing. We cannot assure you that we will be able to obtain credit at all or on terms acceptable to us.
In addition, our credit facilities impose, and any other debt facility into which we may enter would likely impose, financial and operating covenants that restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain RIC tax treatment under Subchapter M of the Code.
The debt securities that we may issue will be governed by an indenture or other instrument containing covenants restricting our operating flexibility. We, and indirectly our stockholders, bear the cost of issuing and servicing such debt securities. Any convertible or exchangeable securities that we issue in the future may have rights, preferences and privileges more favorable than those of our common stock.
Illustration.
 The following table illustrates the effect of leverage on returns from an investment in our common stock assuming various annual returns on our portfolio, net of interest expense. The calculations in the table below are hypothetical and actual returns may be higher or lower than those appearing in the table below.
 
    
Assumed total return
(net of interest expense)
 
    
(10)%
   
(5)%
   
0%
   
5%
   
10%
 
Corresponding return to stockholder(1)
     (29.9 )%      (17.2 )%      (4.5 )%      8.2     20.9
 
(1)
Assumes $2.5 billion in total assets and $1.1 billion in total debt outstanding, which reflects our total assets and total debt outstanding as of December 31, 2022, and a cost of funds of
4.09%. Excludes non-leverage related expenses.
In
 
order for us to cover our annual interest payments on our outstanding indebtedness at December 31, 2022, we must achieve annual returns on our December 31, 2022 total assets of at least 1.8%.
It is likely that the terms of any current or future long-term or revolving credit or warehouse facility we may enter into in the future could constrain our ability to grow our business.
Our current lenders have, and any future lender or lenders may have, fixed dollar claims on our assets that are senior to the claims of our stockholders and, thus, will have a preference over our stockholders with respect to our assets in the collateral pool. Our current credit facilities and borrowings also subject us to various financial and operating covenants, including, but not limited to, maintaining certain financial ratios and minimum tangible net worth amounts. Future credit facilities and borrowings will likely subject us to similar or additional covenants. In addition, we may grant a security interest in our assets in connection with any such credit facilities and borrowings.
 
41

Our credit facilities generally contain customary default provisions such as a minimum net worth amount, a profitability test, and a restriction on changing our business and loan quality standards. In addition, our credit facilities require or are expected to require the repayment of all outstanding debt on the maturity, which may disrupt our business and potentially the business of our portfolio companies that are financed through our credit facilities. An event of default under our credit facilities would likely result, among other things, in termination of the availability of further funds under our credit facilities and accelerated maturity dates for all amounts outstanding under our credit facilities, which would likely disrupt our business and, potentially, the business of the portfolio companies whose loans we finance through our credit facilities. This could reduce our revenues and, by delaying any cash payment allowed to us under our credit facilities until the lender has been paid in full, reduce our liquidity and cash flow and impair our ability to grow our business and maintain RIC tax treatment.
The terms of future available financing may place limits on our financial and operational flexibility. If we are unable to obtain sufficient capital in the future, we may be forced to reduce or discontinue our operations, not be able to make new investments, or otherwise respond to changing business conditions or competitive pressures.
Our quarterly and annual operating results are subject to fluctuation as a result of the nature of our business, and if we fail to achieve our investment objective, the net asset value of our common stock may decline.
We could experience fluctuations in our quarterly and annual operating results due to a number of factors, some of which are beyond our control, including, but not limited to, the interest rate payable on the debt securities that we acquire, the default rate on such securities, the level of our expenses, variations in and the timing of the recognition of realized and unrealized gains or losses, changes in our portfolio composition, the degree to which we encounter competition in our markets, market volatility in our publicly traded securities and the securities of our portfolio companies, and general economic conditions. As a result of these factors, results for any period should not be relied upon as being indicative of performance in future periods. In addition, any of these factors could negatively impact our ability to achieve our investment objectives, which may cause our net asset value of our common stock to decline.
Our investments may be in portfolio companies that may have limited operating histories and financial resources.
We expect that our portfolio will continue to consist of investments that may have relatively limited operating histories. These companies may be particularly vulnerable to U.S. and foreign economic downturns such as the U.S. recession that
began in mid-2007, the European
financial crisis,
and the COVID-19 related economic
downturn, may have more limited access to capital and higher funding costs, may have a weaker financial position and may need more capital to expand or compete. These businesses also may experience substantial variations in operating results. They may face intense competition, including from companies with greater financial, technical and marketing resources. Furthermore, some of these companies do business in regulated industries and could be affected by changes in government regulation. Accordingly, these factors could impair their cash flow or result in other events, such as bankruptcy, which could limit their ability to repay their obligations to us, and may adversely affect the return on, or the recovery of, our investment in these companies. We cannot assure you that any of our investments in our portfolio companies will be successful. Our portfolio companies compete with larger, more established companies with greater access to, and resources for, further development in these new technologies. Therefore, we may lose our entire investment in any or all of our portfolio companies.
There will be uncertainty as to the value of our portfolio investments, which may impact our net asset value.
A large percentage of our portfolio investments are in the form of securities that are not publicly traded. The fair value of securities and other investments that are not publicly traded may not be readily determinable. We value these securities on a quarterly basis in accordance with our valuation policy, which is at all times consistent with GAAP. Our board of directors will (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services; (5) oversee the reporting required by Rule
2a-5
under the 1940 Act; and (6) maintain recordkeeping requirements under Rule
2a-5.
Our board of directors utilizes the services of third-party valuation firms to aid it in determining the fair value of material assets. The board of directors discusses valuations and determines the fair value in good faith based on the input of our Investment Adviser and, when utilized, the respective third-party valuation firms. The factors that may be considered in fair value pricing our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments and its earnings, the markets in which the portfolio company does business, comparisons to publicly traded companies, discounted cash flow and other relevant factors. Because such valuations, and particularly valuations of private securities and private companies, are inherently uncertain, may fluctuate over short periods of time and may be based on estimates, our determinations of fair value may differ materially from the values that would have been used if a ready market for these securities existed. Our net asset value could be adversely affected if our determinations regarding the fair value of our investments were materially higher than the values that we ultimately realize upon the disposal of such securities.
 
42

Our equity ownership in a portfolio company may represent a control investment. Our ability to exit an investment in a timely manner because we are in a control position or have access to inside information in the portfolio company could result in a realized loss on the investment.
If we obtain a control investment in a portfolio company our ability to divest ourselves from a debt or equity investment could be restricted due to illiquidity in a private stock, limited trading volume on a public company’s stock, inside information on a company’s performance, insider blackout periods, or other factors that could prohibit us from disposing of the investment as we would if it were not a control investment. Additionally, we may choose not to take certain actions to protect a debt investment in a control investment portfolio company. As a result, we could experience a decrease in the value of our portfolio company holdings and potentially incur a realized loss on the investment.
There are significant potential conflicts of interest, including SLR Capital Partners’ management of other investment funds such as SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC, which could impact our investment returns, and an investment in SLR Investment Corp. is not an investment in SCP Private Credit Income BDC LLC, SLR HC BDC LLC, or SLR Private Credit BDC II LLC.
Our executive officers and directors, as well as the current and future partners of our Investment Adviser, SLR Capital Partners, may serve as officers, directors or principals of entities that operate in the same or a related line of business as we do. For example, SLR Capital Partners presently serves as the Investment Adviser to (i) SCP Private Credit Income BDC LLC, an unlisted BDC that focuses on investing primarily in senior secured
loans, including non-traditional asset-based loans
and first lien loans, (ii) SLR HC BDC LLC, an unlisted BDC whose principal focus is to invest directly and indirectly in senior secured loans and other debt instruments typically to middle market companies within the healthcare industry, and (iii) SLR Private Credit BDC II LLC, an unlisted BDC whose principal focus is to invest in first lien senior secured floating rate loans primarily to upper middle market leveraged companies with EBITDA between approximately $25 million and $250 million that have significant free cash flow and are in
non-cyclical
industries in which the Investment Adviser has significant experience. In addition, Michael S. Gross,
our Chairman, Co-Chief Executive Officer
and President, Bruce
Spohler, our Co-Chief Executive Officer
and Chief Operating Officer and board member, and Richard L. Peteka, our Chief Financial Officer, serve in similar capacities for SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC. Accordingly, they may have obligations to investors in those entities, the fulfillment of which obligations might not be in the best interests of us or our stockholders. In addition, we note that any affiliated investment vehicle formed in the future and managed by our Investment Adviser or its affiliates may, notwithstanding different stated investment objectives, have overlapping investment objectives with our own and, accordingly, may invest in asset classes similar to those targeted by us. As a result, SLR Capital Partners may face conflicts in allocating investment opportunities between us and such other entities. Although SLR Capital Partners will endeavor to allocate investment opportunities in a fair and equitable manner, it is possible that, in the future, we may not be given the opportunity to participate in investments made by investment funds managed by our Investment Adviser or an investment manager affiliated with our Investment Adviser. In any such case, when SLR Capital Partners identifies an investment, it will be forced to choose which investment fund should make the investment.
As a BDC, we were substantially limited in our
ability to co-invest in privately
negotiated transactions with affiliated funds until we obtained an exemptive order from the SEC. The most recent exemptive order, received on June 13, 2017 (the “Exemptive Order”), permits us to participate
in negotiated co-investment transactions with
certain affiliates, each of whose investment adviser is an investment adviser that controls, is controlled by or is under common control with SLR Capital Partners and is registered as an Investment Adviser under the Advisers Act, in a manner consistent with our investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, and pursuant to the conditions to the Exemptive Order. If we are unable to rely on the Exemptive Order for a particular opportunity, such opportunity will be allocated first to the entity whose investment strategy is the most consistent with the opportunity being allocated, and second, if the terms of the opportunity are consistent with more than one entity’s investment strategy, on an alternating basis. Although our investment professionals will endeavor to allocate investment opportunities in a fair and equitable manner, we and our common stockholders could be adversely affected to the extent investment opportunities are allocated among us and other investment vehicles managed or sponsored by, or affiliated with, our executive officers, directors and members of our Investment Adviser.
SLR Capital Partners and certain investment advisory affiliates may determine that an investment is appropriate for us and for one or more of those other funds. In such event, depending on the availability of such investment and other appropriate factors, SLR Capital Partners or its affiliates may determine that we
should invest side-by-side with one
or more other funds. Any such investments will be made only to the extent permitted by applicable law and interpretive positions of the SEC and its staff, and consistent with SLR Capital Partners’ allocation procedures. Related party transactions may occur among SLR Investment Corp., SLR Credit Solutions, Equipment Operating Leases LLC, Loyer Capital LLC, SLR Equipment Finance, SLR Business Credit, SLR Healthcare ABL, SLR Senior Lending Program LLC and SLR Senior Lending Program SPV LLC. These transactions may occur in the normal course of business. No administrative or other fees are paid to SLR Capital Partners by SLR Credit Solutions, Equipment Operating Leases LLC, Loyer Capital LLC, SLR Equipment Finance, SLR Business Credit, SLR Healthcare ABL, SLR Senior Lending Program LLC and SLR Senior Lending Program SPV LLC.
 
43

In the ordinary course of our investing activities, we pay management and incentive fees to SLR Capital Partners and reimburse SLR Capital Partners for certain expenses it incurs. As a result, investors in our common stock will invest on a “gross” basis and receive distributions on a “net” basis after expenses, resulting in a lower rate of return than an investor might achieve through direct investments. Accordingly, there may be times when the management team of SLR Capital Partners has interests that differ from those of our stockholders, giving rise to a conflict.
We entered into an amended and restated royalty-free license agreement on February 25, 2021 with our Investment Adviser, pursuant to which our Investment Adviser has granted
us a non-exclusive license to
use the marks “SOLAR” and “SLR.” Under the license agreement, we have the right to use the “SLR Investment” name for so long as SLR Capital Partners or one of its affiliates remains our Investment Adviser. In addition, we pay SLR Capital Management, an affiliate of SLR Capital Partners, our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions, and our allocable portion of the compensation of our chief compliance officer and our chief financial officer and their respective staffs. These arrangements create conflicts of interest that our board of directors must monitor.
Our ability to enter into transactions involving derivatives and financial commitment transactions may be limited.
Through comprehensive new global regulatory regimes impacting derivatives (
e.g.
, the Dodd-Frank Act, European Market Infrastructure Regulation (“EMIR”), Markets in Financial Investments Regulation (“MIFIR”)/Markets in Financial Instruments Directive (“MIFID II”)), certain
over-the-counter
derivatives transactions in which we may engage are either now or will soon be subject to various requirements, such as mandatory central clearing of transactions which include additional margin requirements and in certain cases trading on electronic platforms,
pre-and
post-trade transparency reporting requirements and mandatory
bi-lateral
exchange of initial margin for
non-cleared
swaps. The Dodd-Frank Act also created new categories of regulated market participants, such as “swap dealers,” “security-based swap dealers,” “major swap participants,” and “major security-based swap participants” who are subject to significant new capital, registration, recordkeeping, reporting, disclosure, business conduct and other regulatory requirements. The EU and some other jurisdictions are implementing similar requirements. Because these requirements are new and evolving (and some of the rules are not yet final), their ultimate impact remains unclear. However, even if we are not located in a particular jurisdiction or directly subject to the jurisdiction’s derivatives regulations, we may still be impacted to the extent we enter into a derivatives transaction with a regulated market participant or counterparty that is organized in that jurisdiction or otherwise subject to that jurisdiction’s derivatives regulations.
Based on information available as of the date of this annual report
on Form 10-K, the effect
of such requirements will be likely to (directly or indirectly) increase our overall costs of entering into derivatives transactions. In particular, new margin requirements, position limits and significantly higher capital charges resulting from new global capital regulations, even if not directly applicable to us, may cause an increase in the pricing of derivatives transactions entered into by market participants to whom such requirements apply or affect our overall ability to enter into derivatives transactions with certain counterparties. Such new global capital regulations and the need to satisfy the various requirements by counterparties are resulting in increased funding costs, increased overall transaction costs, and significantly affecting balance sheets, thereby resulting in changes to financing terms and potentially impacting our ability to obtain financing. Administrative costs, due to new requirements such as registration, recordkeeping, reporting, and compliance, even if not directly applicable to us, may also be reflected in our derivatives transactions. New requirements to trade certain derivatives transactions on electronic trading platforms and trade reporting requirements may lead to (among other things) fragmentation of the markets, higher transaction costs or reduced availability of derivatives, and/or a reduced ability to hedge, all of which could adversely affect the performance of certain of our trading strategies. In addition, changes to derivatives regulations may impact the tax and/or accounting treatment of certain derivatives, which could adversely impact us.
In November 2020, the SEC adopted new rules regarding the ability of a BDC (or a registered investment company) to use derivatives and other transactions that create future payment or delivery obligations. BDCs that use derivatives would be subject
to a value-at-risk leverage limit,
certain other derivatives risk management program and testing requirements and requirements related to board reporting. These new requirements would apply unless the BDC qualified as a “limited derivatives user,” as defined in the SEC’s adopted rules. A BDC that enters into reverse repurchase agreements or similar financing transactions would need to aggregate the amount of indebtedness associated with the reverse repurchase agreements or similar financing transactions could either (i) comply with the asset coverage requirements of the Section 18 of the 1940 Act when engaging in reverse repurchase agreements or (ii) choose to treat such agreements as derivative transactions under the adopted rule. Under the adopted rule, a BDC may enter into an unfunded commitment agreement that is not a derivatives transaction, such as an agreement to provide financing to a portfolio company, if the BDC has a reasonable belief, at the time it enters into such an agreement, that it will have sufficient cash and cash equivalents to meet its obligations with respect to all of its unfunded commitment agreements, in each case as it becomes due. If the BDC cannot meet this test, it is required to treat unfunded commitments as a derivatives transaction subject to the requirements of the rule. Collectively, these requirements may limit our ability to use derivatives and/or enter into certain other financial contracts.
 
44

We may be obligated to pay our Investment Adviser incentive compensation even if we incur a loss.
Our Investment Adviser will be entitled to incentive compensation for each fiscal quarter in an amount equal to a percentage of the excess
of our pre-incentive fee net
investment income for that quarter (before deducting incentive compensation) above a performance threshold for that quarter. Accordingly, since the performance threshold is based on a percentage of our net asset value, decreases in our net asset value make it easier to achieve the performance
threshold. Our pre-incentive fee net
investment income for incentive compensation purposes excludes realized and unrealized capital losses or depreciation that we may incur in the fiscal quarter, even if such capital losses or depreciation result in a net loss on our statement of operations for that quarter.
Thus, we may be required to pay SLR Capital Partners incentive compensation for a fiscal quarter even if there is a decline in the value of our portfolio or we incur a net loss for that quarter.
Our incentive fee may induce SLR Capital Partners to pursue speculative investments.
The incentive fee payable by us to SLR Capital Partners may create an incentive for SLR Capital Partners to pursue investments on our behalf that are riskier or more speculative than would be the case in the absence of such compensation arrangement. The incentive fee payable to our Investment Adviser is calculated based on a percentage of our return on invested capital. This may encourage our Investment Adviser to use leverage to increase the return on our investments. Under certain circumstances, the use of leverage may increase the likelihood of default, which would impair the value of our common stock. In addition, our Investment Adviser receives the incentive fee based, in part, upon net capital gains realized on our investments. Unlike that portion of the incentive fee based on income, there is no hurdle rate applicable to the portion of the incentive fee based on net capital gains. As a result, our Investment Adviser may have a tendency to invest more capital in investments that are likely to result in capital gains as compared to income producing securities. Such a practice could result in our investing in more speculative securities than would otherwise be the case, which could result in higher investment losses, particularly during economic downturns.
The incentive fee payable by us to our Investment Adviser also may induce SLR Capital Partners to invest on our behalf in instruments that have a deferred interest feature, even if such deferred payments would not provide the cash necessary to enable us to pay current distributions to our stockholders. Under these investments, we would accrue interest over the life of the investment but would not receive the cash income from the investment until the end of the term. Our net investment income used to calculate the income portion of our investment fee, however, includes accrued interest. Thus, a portion of this incentive fee would be based on income that we have not received in cash. In
addition, the “catch-up” portion of
the incentive fee may encourage SLR Capital Partners to accelerate or defer interest payable by portfolio companies from one calendar quarter to another, potentially resulting in fluctuations in timing and distribution amounts.
We may invest, to the extent permitted by law, in the securities and instruments of other investment companies, including private funds, and, to the extent we so invest, will bear our ratable share of any such investment company’s expenses, including management and performance fees. We will also remain obligated to pay management and incentive fees to SLR Capital Partners with respect to the assets invested in the securities and instruments of other investment companies. With respect to each of these investments, each of our stockholders will bear his or her share of the management and incentive fee of SLR Capital Partners as well as indirectly bearing the management and performance fees and other expenses of any investment companies in which we invest.
We may become subject to corporate-level U.S. federal income tax if we are unable to qualify and maintain our qualification for tax treatment as a regulated investment company under Subchapter M of the Code.
Although we have elected to be treated as a RIC under Subchapter M of the Code, no assurance can be given that we will continue to be able to qualify for and maintain RIC tax treatment. To maintain RIC tax treatment under the Code, we must meet the following annual distribution, income source and asset diversification requirements on an ongoing basis.
 
 
The Annual Distribution Requirement for a RIC will be satisfied if we distribute to our stockholders on an annual basis at least 90% of our net ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any. Because we may use debt financing, we are subject to certain asset coverage ratio requirements under the 1940 Act and financial covenants under loan and credit agreements that could, under certain circumstances, restrict us from making distributions necessary to satisfy the Annual Distribution Requirement. If we are unable to obtain cash from other sources, we could fail to qualify for RIC tax treatment and become subject to corporate-level U.S federal income tax.
 
45

 
The income source requirement will be satisfied if we obtain at least 90% of our income for each year from certain passive investments, including interest, dividends, gains from the sale of stock or securities, or similar sources.
 
 
The asset diversification requirement will be satisfied if we meet certain asset diversification requirements at the end of each quarter of our taxable year. Failure to meet those requirements may result in our having to dispose of certain investments quickly in order to prevent the loss of RIC tax treatment. Because most of our investments will be relatively illiquid, any such dispositions could be made at disadvantageous prices and could result in substantial losses.
If we fail to qualify for RIC tax treatment for any reason and become subject to corporate income tax, the resulting corporate taxes could substantially reduce our net assets, the amount of income available for distribution and the amount of our distributions. Such a failure could have a material adverse effect on us, the net asset value of our common stock and the total return, if any, obtainable from your investment in our common stock.
We may have difficulty satisfying the Annual Distribution Requirement in order to qualify and maintain RIC tax treatment if we recognize income before or without receiving cash representing such income.
In accordance with GAAP and tax requirements, we include in income certain amounts that we have not yet received in cash, such as contractual PIK interest, which represents contractual interest added to a loan balance and due at the end of such loan’s term. In addition to the cash yields received on our loans, in some instances, certain loans may also include any of
the following: end-of-term payments, exit
fees, balloon payment fees or prepayment fees. The increases in loan balances as a result of contractual PIK arrangements are included in income for the period in which such PIK interest was accrued, which is often in advance of receiving a cash payment, and are separately identified on our statements of cash flows. We also may be required to include in income certain other amounts prior to receiving the related cash.
Any warrants that we receive in connection with our debt investments will generally be valued as part of the negotiation process with the particular portfolio company. As a result, a portion of the aggregate purchase price for the debt investments and warrants will be allocated to the warrants that we receive. This will generally result in “original issue discount” for U.S. federal income tax purposes, which we must recognize as ordinary income, increasing the amount that we are required to distribute to qualify for the U.S. federal income tax benefits applicable to RICs. Because these warrants generally will not produce distributable cash for us at the same time as we are required to make distributions in respect of the related original issue discount, we would need to obtain cash from other sources or to pay a portion of our distributions using shares of newly issued common stock, consistent with Internal Revenue Service requirements, to satisfy the Annual Distribution and Excise Tax Avoidance requirements.
Other features of the debt instruments that we hold may also cause such instruments to generate original issue discount, resulting in a distribution requirement in excess of current cash interest received. Since in certain cases we may recognize income before or without receiving cash representing such income, we may have difficulty meeting the RIC tax requirement to distribute at least 90% of our net ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any. Under such circumstances, we may have to sell some of our investments at times we would not consider advantageous, raise additional debt or equity capital or reduce new investment originations to meet these distribution requirements. If we are unable to obtain cash from other sources and are otherwise unable to satisfy such distribution requirements, we may fail to qualify for the U.S. federal income tax benefits allowable to RICs and, thus, become subject to a corporate-level U.S. federal income tax on all our income.
Provisions of the Maryland General Corporation Law and of our charter and bylaws could deter takeover attempts and have an adverse impact on the price of our common stock.
The Maryland General Corporation Law and our charter and bylaws contain provisions that may discourage, delay or make more difficult a change in control of SLR Investment Corp. or the removal of our directors. We are subject to the Maryland Business Combination Act, subject to any applicable requirements of the 1940 Act. Our board of directors has adopted a resolution exempting from the Maryland Business Combination Act any business combination between us and any other person, subject to prior approval of such business combination by our board of directors, including approval by a majority of our disinterested directors. If the resolution exempting business combinations is repealed or our board of directors does not approve a business combination, the Maryland Business Combination Act may discourage third parties from trying to acquire control of us and increase the difficulty of consummating such an offer. Our bylaws exempt from the Maryland Control Share Acquisition Act (the “Control Share Act”) acquisitions of our stock by any person. If we amend our bylaws to repeal the exemption from the Control Share Act, the Control Share Act also may make it more difficult for a third party to obtain control of us and increase the difficulty of consummating such a transaction. The SEC staff has rescinded its position that, under the 1940 Act, an investment company may not avail itself of the Control Share Act. As a result, we will amend our bylaws to be subject to the Control Share Act only if our board of directors determines that it would be in our best interests.
 
46

We have also adopted measures that may make it difficult for a third party to obtain control of us, including provisions of our charter classifying our board of directors in three classes serving staggered three-year terms, and authorizing our board of directors to classify or reclassify shares of our stock in one or more classes or series, to cause the issuance of additional shares of our stock and to amend our charter without stockholder approval to increase or decrease the number of shares of stock that we have authority to issue. These provisions, as well as other provisions of our charter and bylaws, may delay, defer or prevent a transaction or a change in control that might otherwise be in the best interests of our stockholders.
The foregoing provisions are expected to discourage certain coercive takeover practices and inadequate takeover bids and to encourage persons seeking to acquire control of us to negotiate first with our board of directors. However, these provisions may deprive a stockholder of the opportunity to sell such stockholder’s shares at a premium to a potential acquirer. We believe that the benefits of these provisions outweigh the potential disadvantages of discouraging any such acquisition proposals because, among other things, the negotiation of such proposals may improve their terms. Our board of directors has considered both the positive and negative effects of the foregoing provisions and determined that they are in the best interest of our stockholders.
Our bylaws designate the Circuit Court for Baltimore City, Maryland as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders and provide that claims relating to causes of action under the Securities Act may only be brought in federal district courts, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers or agents, if any, and could discourage lawsuits against us and our directors, officers and agents, if any.
Our bylaws provide that, unless we consent in writing to the selection of an alternative forum, the Circuit Court for Baltimore City, Maryland, or, if that court does not have jurisdiction, the United States District Court for the District of Maryland, Northern Division, will be the sole and exclusive forum for (a) any Internal Corporate Claim, as such term is defined in the MGCL, (b) any derivative action or proceeding brought on our behalf (other than actions arising under federal securities laws), (c) any action asserting a claim of breach of any duty owed by any of our directors, officers or other agents to us or to our stockholders, (d) any action asserting a claim against us or any of our directors, officers or other agents arising pursuant to any provision of the MGCL or our charter or bylaws or (e) any other action asserting a claim against us or any of our directors, officers or other employees that is governed by the internal affairs doctrine. With respect to any proceeding described in the foregoing sentence that is in the Circuit Court for Baltimore City, Maryland, our stockholders consent to the assignment of the proceeding to the Business and Technology Case Management Program pursuant to Maryland
Rule 16-308 or
any successor thereof. None of the foregoing actions, claims or proceedings may be brought in any court sitting outside the State of Maryland unless we consent in writing to such court. Our bylaws do not apply to lawsuits asserting claims brought to enforce a duty or liability arising exclusively under the Securities Act, the 1934 Act, or the 1940 Act, or any other claim for which the federal courts have exclusive jurisdiction.
Unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States of America shall, to the fullest extent permitted by law, be the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. This paragraph does not apply to claims arising exclusively under the 1934 Act or the 1940 Act, or any other claim for which the federal courts have exclusive jurisdiction. These exclusive forum provisions may limit the ability of our stockholders to bring a claim in a judicial forum that such stockholders find favorable for disputes with us or our directors, officers, or agents, if any, which may discourage such lawsuits against us and our directors, officers, and agents, if any. Alternatively, if a court were to find the choice of forum provisions contained in our bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could materially adversely affect our business, financial condition, and operating results. For example, under the Securities Act, federal courts have concurrent jurisdiction over all suits brought to enforce any duty or liability created by the Securities Act, and investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder.
The failure in cyber security systems, as well as the occurrence of events unanticipated in our disaster recovery systems and management continuity planning could impair our ability to conduct business effectively.
The occurrence of a disaster, such as a cyber-attack against us or against a third party that has access to our data or networks, a natural catastrophe, an industrial accident, failure of our disaster recovery systems, or consequential employee error, could have an adverse effect on our ability to communicate or conduct business, negatively impacting our operations and financial condition. This adverse effect can become particularly acute if those events affect our electronic data processing, transmission, storage, and retrieval systems, or impact the availability, integrity, or confidentiality of our data.
We depend heavily upon computer systems to perform necessary business functions. Despite our implementation of a variety of security measures, our computer systems, networks, and data, like those of other companies, could be subject to cyber-attacks and unauthorized access, use, alteration, or destruction, such as from physical
and electronic break-ins or unauthorized
tampering. If one or more of these events occurs, it could potentially jeopardize the confidential, proprietary, and other information processed, stored in,
 
47

and transmitted through our computer systems and networks. Such an attack could cause interruptions or malfunctions in our operations, which could result in financial losses, litigation, regulatory penalties, client dissatisfaction or loss, reputational damage, and increased costs associated with mitigation of damages and remediation. If unauthorized parties gain access to such information and technology systems, they may be able to steal, publish, delete or modify private and sensitive information, including nonpublic personal information related to stockholders (and their beneficial owners) and material nonpublic information. The systems we have implemented to manage risks relating to these types of events could prove to be inadequate and, if compromised, could become inoperable for extended periods of time, cease to function properly or fail to adequately secure private information. Breaches such as those involving covertly introduced malware, impersonation of authorized users and industrial or other espionage may not be identified even with sophisticated prevention and detection systems, potentially resulting in further harm and preventing them from being addressed appropriately. The failure of these systems or of disaster recovery plans for any reason could cause significant interruptions in our and our Investment Adviser’s operations and result in a failure to maintain the security, confidentiality or privacy of sensitive data, including personal information relating to stockholders, material nonpublic information and other sensitive information in our possession.
A disaster or a disruption in the infrastructure that supports our business, including a disruption involving electronic communications or other services used by us or third parties with whom we conduct business, or directly affecting our headquarters, could have a material adverse impact on our ability to continue to operate our business without interruption. Our disaster recovery programs may not be sufficient to mitigate the harm that may result from such a disaster or disruption. In addition, insurance and other safeguards might only partially reimburse us for our losses, if at all.
Third parties with which we do business may also be sources of cybersecurity or other technological risk. We outsource certain functions and these relationships allow for the storage and processing of our information, as well as client, counterparty, employee, and borrower information. While we engage in actions to reduce our exposure resulting from outsourcing, ongoing threats may result in unauthorized access, loss, exposure, destruction, or other cybersecurity incident that affects our data, resulting in increased costs and other consequences as described above.
In addition, cybersecurity has become a top priority for global lawmakers and regulators around the world, and some jurisdictions have proposed or enacted laws requiring companies to notify regulators and individuals of data security breaches involving certain types of personal data. In particular, state and federal laws and regulations related to cybersecurity compliance continue to evolve and change, which may require substantial investments in new technology, software and personnel, which could affect the Company’s profitability. These changes may also result in enhanced and unforeseen consequences for cyber-related breaches and incidents, which may further adversely affect the Company’s profitability. If we fail to comply with the relevant and increasing laws and regulations, we could suffer financial losses, a disruption of our businesses, liability to investors, regulatory intervention or reputational damage.
We and our service providers may be impacted by quarantines and similar measures being enacted by governments in response to
the global COVID-19 pandemic, which
are obstructing the regular functioning of business workforces (including requiring employees to work from external locations and their homes). Policies of remote working, whether by us or by our service providers, could strain technology resources, introduce operational risks and otherwise heighten the risks described above. Remote working environments may be less secure and more susceptible to hacking attacks, including phishing and social engineering attempts.
We, our Investment Adviser and our portfolio companies are subject to risks associated with “phishing” and other cyber-attacks.
Our business and the business of our portfolio companies rely upon secure information technology systems for data processing, storage and reporting. Despite careful security and controls design, implementation and updating, ours and our portfolio companies’ information technology systems could become subject to cyber-attacks. Cyber-attacks include, but are not limited to, gaining unauthorized access to digital systems (e.g., through “hacking”, malicious software coding, social engineering or “phishing” attempts) for purposes of misappropriating assets or sensitive information, corrupting data, or causing operational disruption. The risk of a security breach or disruption, particularly through cyber-attacks or cyber intrusions, including by computer hackers, nation-state affiliated actors, and cyber terrorists, has generally increased as the number, intensity and sophistication of attempted attacks and intrusions from around the world have increased. Cyber-attacks may also be carried out in a manner that does not require gaining unauthorized access, such
as causing denial-of service attacks
on websites (i.e., efforts to make network services unavailable to intended users). Our Investment Adviser’s employees have been and expect to continue to be the target of fraudulent calls, emails and other forms of potentially malicious or otherwise negatively impacting activities and attempts to gain unauthorized access to confidential, personal or other sensitive information. The result of these incidents may include disrupted operations, misstated or unreliable financial data, liability for stolen information, investigations, misappropriation of assets, increased cybersecurity protection and insurance costs, litigation and damage to our business relationships, regulatory fines or penalties, or other adverse effects on our business, financial condition or results of operations. In addition, we may be required to expend significant additional resources to modify our protective measures and to investigate and remediate vulnerabilities or other exposures arising from operational and security risks related to cyber-attacks.
 
48

Our Investment Adviser’s and other service providers’ increased use of mobile and cloud technologies could heighten the risk of a cyber-attack as well as other operational risks, as certain aspects of the security of such technologies may be complex, unpredictable or beyond their control. Our Investment Adviser’s and other service providers’ reliance on mobile or cloud technology or any failure by mobile technology and cloud service providers to adequately safeguard their systems and prevent cyber-attacks could disrupt their operations and result in misappropriation, corruption or loss of personal, confidential or proprietary information. In addition, there is a risk that encryption and other protective measures against cyber-attacks may be circumvented, particularly to the extent that new computing technologies increase the speed and computing power available. Even the most well-protected information, networks, systems and facilities remain potentially vulnerable because the techniques used in such attempted security breaches evolve and generally are not recognized until launched against a target, and in some cases are designed not to be detected and, in fact, may not be detected. Accordingly, we and our service providers may be unable to anticipate these techniques or to implement adequate security barriers or other preventative measures, and thus it is impossible for us and our service providers to entirely mitigate this risk. Cybersecurity risks require continuous and increasing attention and other resources from us to, among other actions, identify and quantify these risks, upgrade and expand our technologies, systems and processes to adequately address such risks. Such attention diverts time and other resources from other activities and there is no assurance that our efforts will be effective.
Cybersecurity incidents may adversely impact us and our stockholders. There is no guarantee that we, the Investment Adviser, and/or their respective service providers will be successful in protecting against cybersecurity incidents.
We can be highly dependent on information systems and systems failures could significantly disrupt our business, which may, in turn, negatively affect the market price of our common stock and our ability to pay distributions.
Our business is highly dependent upon our and third parties’ communications and information systems. Any failure or interruption of those systems, including as a result of the termination of an agreement with any third-party service providers, could cause delays or other problems in our activities. Our financial, accounting, data processing, backup or other operating systems and facilities may fail to operate properly or become disabled or damaged as a result of a number of factors including events that are wholly or partially beyond our control and adversely affect our business. There could be:
 
 
sudden electrical or telecommunications outages;
 
 
natural disasters such as earthquakes, tornadoes and hurricanes;
 
 
events arising from local or larger scale political or social matters, including terrorist acts; and
 
 
cyber-attacks.
These events, in turn, could have a material adverse effect on our operating results and negatively affect the market price of our common stock and our ability to pay distributions to our stockholders.
Communications with shareholders may be delivered electronically and there may be certain costs and possible risks associated with such electronic delivery. Moreover, the Investment Adviser cannot provide any assurance that these communication methods are secure and will not be responsible for any computer viruses, problems or malfunctions resulting from the use of such communication methods.
Our board of directors may change our investment objective, operating policies and strategies without prior notice or stockholder approval.
Our board of directors has the authority to modify or waive certain of our operating policies and strategies without prior notice (except as required by the 1940 Act) and without stockholder approval. However, absent stockholder approval, we may not change the nature of our business so as to cease to be, or withdraw our election as a BDC. We cannot predict the effect any changes to our current operating policies and strategies would have on our business, operating results and the value of our stock. Nevertheless, the effects may adversely affect our business and impact our ability to make distributions.
Our business is subject to increasingly complex corporate governance, public disclosure and accounting requirements that could adversely affect our business and financial results.
We are subject to changing rules and regulations of federal and state government as well as the stock exchange on which our common stock is listed. These entities, including the Public Company Accounting Oversight Board, the SEC and the NASDAQ Stock Market, have issued a significant number of new and increasingly complex requirements and regulations over the course of the last several years and continue to develop additional regulations and requirements in response to laws enacted by Congress. Our efforts to comply with these existing requirements, or any revised or amended requirements, have resulted in, and are likely to continue to result in, an increase in expenses and a diversion of management’s time from other business activities.
 
49

Changes in laws or regulations governing our operations may adversely affect our business.
Changes in the laws or regulations, or the interpretations of the laws and regulations, which govern BDCs,
RICs or non-depository commercial lenders
could significantly affect our operations and our cost of doing business. We are subject to federal, state and local laws and regulations and are subject to judicial and administrative decisions that affect our operations, including our loan originations, maximum interest rates, fees and other charges, disclosures to portfolio companies, the terms of secured transactions, collection and foreclosure procedures, and other trade practices. If these laws, regulations or decisions change, or if we expand our business into jurisdictions that have adopted more stringent requirements than those in which we currently conduct business, then we may have to incur significant expenses in order to comply or we may have to restrict our operations. In addition, if we do not comply with applicable laws, regulations and decisions, then we may lose licenses needed for the conduct of our business and be subject to civil fines and criminal penalties, any of which could have a material adverse effect upon our business results of operations or financial condition.
Changes to United States tariff and import/export regulations may have a negative effect on our portfolio companies and, in turn, harm us.
There has been ongoing discussion and commentary regarding potential significant changes to United States trade policies, treaties and tariffs. The current administration, along with Congress, has created significant uncertainty about the future relationship between the United States and other countries with respect to the trade policies, treaties and tariffs. These developments, or the perception that any of them could occur, may have a material adverse effect on global economic conditions and the stability of global financial markets, and may significantly reduce global trade and, in particular, trade between the impacted nations and the United States. Any of these factors could depress economic activity and restrict our portfolio companies’ access to suppliers or customers and have a material adverse effect on their business, financial condition and results of operations, which in turn would negatively impact us.
Our Investment Adviser can resign on 60 days’ notice, and we may not be able to find a suitable replacement within that time, resulting in a disruption in our operations that could adversely affect our financial condition, business and results of operations.
Our Investment Adviser has the right, under the Advisory Agreement, to resign at any time upon 60 days written notice, whether we have found a replacement or not. If our Investment Adviser resigns, we may not be able to find a new investment adviser or hire internal management with similar experience and ability to provide the same or equivalent services on acceptable terms within 60 days, or at all. If we are unable to do so quickly, our operations are likely to experience a disruption, our financial condition, business and results of operations as well as our ability to pay distributions are likely to be adversely affected and the market price of our shares may decline. In addition, the coordination of our internal management and investment activities is likely to suffer if we are unable to identify and reach an agreement with a single institution or group of executives having the experience possessed by our Investment Adviser and its affiliates. Even if we are able to retain comparable management, whether internal or external, the integration of such management and their lack of familiarity with our investment objective may result in additional costs and time delays that may adversely affect our financial condition, business and results of operations.
General Risk Factors
Volatility or a prolonged disruption in the credit markets could materially damage our business.
We are required to record our assets at fair value, as determined in good faith by our board of directors, in accordance with our valuation policy. As a result, volatility in the capital markets may have a material adverse effect on our valuations and our net asset value, even if we hold investments to maturity. Volatility or dislocation in the capital markets may depress our stock price below our net asset value per share and create a challenging environment in which to raise equity and debt capital. These conditions could continue for a prolonged period of time or worsen in the future. While these conditions persist, we and other companies in the financial services sector may have to access, if available, alternative markets for debt and equity capital. Equity capital may be difficult to raise because, subject to some limited exceptions which apply to us, as a BDC we are generally not able to issue additional shares of our common stock at a price less than net asset value without first obtaining approval for such issuance from our stockholders and our independent directors. Any offering of our common stock that requires stockholder approval must occur, if at all, within one year after receiving such stockholder approval. In addition, our ability to incur indebtedness (including by issuing preferred stock) is limited by applicable regulations such that our asset coverage, as defined in the 1940 Act, must equal at least 150% immediately after each time we incur indebtedness. The debt capital that will be available, if at all, may be at a higher cost and on less favorable terms and conditions in the future. Any inability to raise capital could have a negative effect on our business, financial condition and results of operations.
 
50

Additionally, our ability to incur indebtedness is limited by the asset coverage ratio for a BDC, as defined under the 1940 Act. Declining portfolio values negatively impact our ability to borrow additional funds because our net asset value is reduced for purposes of the asset coverage ratio. If the fair value of our assets declines substantially, we may fail to maintain the asset coverage ratio stipulated by the 1940 Act, which could, in turn, cause us to lose our status as a BDC and materially impair our business operations. A lengthy disruption in the credit markets could also materially decrease demand for our investments.
The significant disruption in the capital markets experienced in the past, including the disruption caused
by the COVID-19 pandemic
and the Russian invasion of Ukraine, have had, and may in the future have, a negative effect on the valuations of our investments and on the potential for liquidity events involving our investments. The debt capital that may be available to us in the future may be at a higher cost and have less favorable terms and conditions than those currently in effect. If our financing costs increase and we have no increase in interest income, then our net investment income will decrease. A prolonged inability to raise capital may require us to reduce the volume of investments we originate and could have a material adverse impact on our business, financial condition and results of operations. This may also increase the probability that other structural risks will negatively impact us. These situations may arise due to circumstances that we may be unable to control, such as a lengthy disruption in the credit markets, a severe decline in the value of the U.S. dollar, a sharp economic downturn or recession or an operational problem that affects third parties or us, and could materially damage our business, financial condition and results of operations.
Global economic, regulatory and market conditions may adversely affect our business, results of operations and financial condition, including our revenue growth and profitability.
We and our portfolio companies are subject to regulation by laws at the U.S. federal, state and local levels. These laws and regulations, as well as their interpretation, could change from time to time, including as the result of interpretive guidance or other directives from the U.S. President and others in the executive branch, and new laws, regulations and interpretations could also come into effect. Any such new or changed laws or regulations could have a material adverse effect on our business, and political uncertainty could increase regulatory uncertainty in the near term.
The effects of legislative and regulatory proposals directed at the financial services industry or affecting taxation, could negatively impact the operations, cash flows or financial condition of us and our portfolio companies, impose additional costs on us or our portfolio companies, intensify the regulatory supervision of us or our portfolio companies or otherwise adversely affect our business or the business of our portfolio companies. In addition, if we do not comply with applicable laws and regulations, we could lose any licenses that we then hold for the conduct of business and could be subject to civil fines and criminal penalties.
Over the last several years, there also has been an increase in regulatory attention to the extension of credit outside of the traditional banking sector, raising the possibility that some portion
of the non-bank financial sector
will be subject to new regulation. While it cannot be known at this time whether any regulation will be implemented or what form it will take, increased
regulation of non-bank credit extension
could negatively impact our operations, cash flows or financial condition, impose additional costs on us, intensify the regulatory supervision of us or otherwise adversely affect our business, financial condition and results of operations.
Although we cannot predict the impact, if any, of these changes to our business, they could adversely affect our business, financial condition, operating results and cash flows. Until we know what policy changes are made and how those changes impact business and the business of our competitors over the long term, we will not know if, overall, it will benefit from them or be negatively affected by them.
Deterioration in the economic conditions in the Eurozone and other regions or countries globally and the resulting instability in global financial markets may pose a risk to our business. Financial markets have been affected at times by a number of global macroeconomic events, including the following: large sovereign debts and fiscal deficits of several countries in Europe and in emerging markets jurisdictions, levels of
non-performing
loans on the balance sheets of European banks, the effect of the United Kingdom leaving the European Union, instability in the Chinese capital markets and the
COVID-19
pandemic.
Various social and political circumstances in the U.S. and around the world (including wars and other forms of conflict, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics), may also contribute to increased market volatility and economic uncertainties or deterioration in the U.S. and worldwide. Such events, including rising trade tensions between the United States and China, other uncertainties regarding actual and potential shifts in U.S. and foreign, trade, economic and other policies with other countries, the large-scale invasion of Ukraine by Russia that began in February 2022 and resulting sanctions or other restrictive actions that the United States and other countries have imposed against Russia, and
the COVID-19 pandemic,
could adversely affect our business, financial condition or results of operations. These market and economic disruptions could negatively impact the operating results of our portfolio companies.
 
51

In addition, Russia’s invasion of Ukraine and corresponding events have had, and could continue to have, severe adverse effects on regional and global economic markets. Following Russia’s actions, various governments, including the United States, have issued broad-ranging economic sanctions against Russia, including, among other actions, a prohibition on doing business with certain Russian companies, large financial institutions, officials and oligarchs; a commitment by certain countries and the European Union to remove selected Russian banks from the Society for Worldwide Interbank Financial Telecommunications, the electronic banking network that connects banks globally; and restrictive measures to prevent the Russian Central Bank from undermining the impact of the sanctions. The duration of hostilities and the vast array of sanctions and related events (including cyberattacks and espionage) cannot be predicted. Furthermore, the conflict between the two nations and the varying involvement of the United States and other NATO countries could preclude prediction as to their ultimate adverse impact on global economic and market conditions, and, as a result, presents material uncertainty and risk with respect to markets globally, which pose potential adverse risks to us and the performance of our investments and operations, and our ability to achieve our investment objectives. Additionally, to the extent that third parties, investors, or related customer bases have material operations or assets in Russia or Ukraine, they may have adverse consequences related to the ongoing conflict. Any such market disruptions could affect our portfolio companies’ operations and, as a result, could have a material adverse effect on our business, financial condition and results of operations.
Additionally, the Federal Reserve raised the Federal Funds Rate in 2022 and in 2023, and may raise or announce its intention to raise the Federal Funds Rate further. These developments, along with the United States government’s credit and deficit concerns, global economic uncertainties and market volatility and the impacts
of COVID-19, could
cause interest rates to be volatile, which may negatively impact our ability to access the debt markets and capital markets on favorable terms.
Events outside of our control, including
the COVID-19 public
health crises, could negatively affect our portfolio companies and our results of our operations.
Periods of market volatility have occurred and could continue to occur in response to pandemics or other events outside of our control. These types of events have adversely affected and could continue to adversely affect operating results for us and for our portfolio companies. For example, the
COVID-19
pandemic has adversely impacted global commercial activity and contributed to significant volatility in the equity and debt markets. The
COVID-19
pandemic and restrictive measures taken to contain or mitigate its spread have caused, and may continue to cause, business shutdowns, or the
re-introduction
of business shutdowns, cancellations of events and restrictions on travel, significant reductions in demand for certain goods and services, reductions in business activity and financial transactions, supply chain interruptions, labor shortages, increased inflationary pressure and overall economic and financial market instability both globally and in the United States. Many states, including those in which we and portfolio companies in which we invest may operate, have previously issued orders requiring the closure of, or certain restrictions on the operation of, certain businesses. The ultimate duration and severity of the
COVID-19
pandemic, including
COVID-19
variants, remain uncertain. While several countries, as well as certain states, counties and cities in the United States, relaxed the public health restrictions throughout 2021 partly as a result of the introduction of vaccines, recurring
COVID-19
outbreaks caused by different virus variants continue to lead to the
re-introduction
of certain restrictions in certain states in the United States and globally. Even after the
COVID-19
pandemic subsides, the U.S. economy and most other major global economies may continue to experience a recession, and our business and operations, as well as the business and operations of the portfolio companies in which we invest, could be materially adversely affected by a prolonged recession in the U.S. and other major markets.
Despite actions of the U.S. federal government and foreign governments, the uncertainty surrounding the
COVID-19
pandemic, including uncertainty regarding existing or future variants and other factors, has contributed to significant volatility in the global public equity markets and global debt capital markets.
The continued uncertainty related to the sustainability and pace of economic recovery in the U.S. and globally could have a negative impact on our business.
Our business is directly influenced by the economic cycle, and could be negatively impacted by a downturn in economic activity in the U.S. as well as globally. Fiscal and monetary actions taken by
U.S. and non-U.S. government and
regulatory authorities could have a material adverse impact on our business. To the extent uncertainty regarding the U.S. or global economy, including as a result of
the global COVID-19 pandemic, negatively
impacts consumer confidence and consumer credit factors, our business, financial condition and results of operations could be adversely affected. Moreover, Federal Reserve policy, including with respect to certain interest rates and the decision to end its quantitative easing policy, along with the general policies of the current Presidential administration, may also adversely affect the value, volatility and liquidity of dividend- and interest-paying securities. Market volatility, periods of rising interest rates, such as the current economic period, and/or a return to unfavorable economic conditions could adversely affect our business.
 
52

There is uncertainty surrounding potential legal, regulatory and policy changes by new presidential administrations in the United States that may directly affect financial institutions and the global economy.
The current administration has called for significant changes to U.S. trade, healthcare, immigration, foreign and government regulatory policy. In this regard, there is significant uncertainty with respect to legislation, regulation and government policy at the federal level, as well as the state and local levels. Recent events have created a climate of heightened uncertainty and introduced new and
difficult-to-quantify
macroeconomic and political risks with potentially
far-reaching
implications. There has been a corresponding meaningful increase in the uncertainty surrounding interest rates, inflation, foreign exchange rates, trade volumes and fiscal and monetary policy. To the extent the U.S. Congress or the current administration implements changes to U.S. policy, those changes may impact, among other things, the U.S. and global economy, international trade and relations, unemployment, immigration, corporate taxes, healthcare, the U.S. regulatory environment, inflation and other areas. Although we cannot predict the impact, if any, of these changes to our business, they could adversely affect our business, financial condition, operating results and cash flows. Until we know what policy changes are made and how those changes impact our business and the business of our competitors over the long term, we will not know if, overall, we will benefit from them or be negatively affected by them.
We are exposed to risks associated with changes in interest rates, including the transition away from LIBOR and the adoption of alternative reference rates.
Although we no longer intend to lend at rates based on the London Interbank Offered Rate (“LIBOR”), we may acquire loans that continue to use LIBOR. While many LIBOR rates were phased out at the end of 2021, a selection of widely used U.S.-dollar LIBOR rates will continue to be published until June 2023. On July 29, 2021, the U.S. Federal Reserve System, in conjunction with the Alternative Reference Rates Committee, a steering committee comprised of large U.S. financial institutions, formally recommended replacing U.S.-dollar LIBOR with the Secured Overnight Financing Rate (“SOFR”), a new index calculated by short-term repurchase agreements, backed by Treasury securities. Further, on March 15, 2022, the Consolidation Appropriations Act of 2022, which includes the Adjustable Interest Rate (LIBOR) Act (“LIBOR Act”), was signed into law in the U.S. This legislation establishes a uniform benchmark replacement process for financial contracts that mature after June 30, 2023 which do not contain clearly defined or practicable fallback provisions. The legislation also creates a safe harbor that shields lenders from litigation if they choose to utilize a replacement rate recommended by the Board of Governors of the Federal Reserve. Although the transition process away from LIBOR has become increasingly well-defined (e.g. the LIBOR Act now provides a uniform benchmark replacement for LIBOR-based instruments in the U.S.), the transition process may involve, among other things, increased volatility or illiquidity in markets for instruments that currently rely on LIBOR and may result in a reduction in the value of certain instruments that we may acquire. Further, disruptions related to loans in the marketplace could have a material adverse effect on the ability of the Investment Adviser or its affiliates to enter into loans in the future in accordance with our investment strategy and have a material adverse effect on us.
Inflation and a rising interest rate environment may adversely affect the business, results of operations and financial condition of us and our portfolio companies.
The current macroeconomic environment is characterized by record-high inflation, supply chain challenges, labor shortages, high interest rates, foreign currency exchange volatility, volatility in global capital markets and growing recession risk. The risks associated with the Company’s and our portfolio companies’ businesses are more severe during periods of economic slowdown or recession.
Any disruptions in the capital markets, as a result of inflation and a rising interest environment or otherwise, may increase the spread between the yields realized on risk-free and higher risk securities and can result in illiquidity in parts of the capital markets, significant write-offs in the financial sector and
re-pricing
of credit risk in the broadly syndicated market. These and any other unfavorable economic conditions could increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us.
In addition, market conditions (including inflation, supply chain issues and decreased consumer demand) have adversely impacted, and could in the future further impact, the operations of certain of our portfolio companies. If the financial results of middle-market companies, like those in which we invest, experience deterioration, it could ultimately lead to difficulty in meeting debt service requirements and an increase in defaults, and further deterioration in market conditions will further depress the outlook for those companies. Further, adverse economic conditions decreased and may in the future decrease the value of collateral securing some of our loans and the value of our equity investments. Such conditions have required and may in the future require us to modify the payment terms of our investments, including changes in PIK interest provisions and/or cash interest rates. The performance of certain of our portfolio companies has been, and in the future may be, negatively impacted by these economic or other conditions, which can result in our receipt of reduced interest income from our portfolio companies and/or realized and unrealized losses related to our investments, and, in turn, may adversely affect distributable income and have a material adverse effect on our results of operations.
Inflation may cause the real value of our investments to decline.
Inflation risk results from the variation in the value of cash flows from a security due to inflation, as measured in terms of purchasing power. We are exposed to inflation risk with respect to any fixed rate investments that we make, if any, because the interest rate the issuer has to pay us is fixed for the life of the security. To the extent that interest rates reflect the expected inflation rate, floating rate loans have a lower level of inflation risk.
 
53

Technological innovations and industry disruptions may negatively impact us.
Technological innovations have disrupted traditional approaches in multiple industries and can permit younger companies to achieve success and in the process disrupt markets and market practices. We can provide no assurance that new businesses and approaches will not be created that would compete with us and/or our portfolio companies or alter the market practices in which SLR Capital Partners and its affiliates and us have been designed to function within and on which we depend on for our investment return. New approaches could damage our investments, disrupt the market in which we operate and subject us to increased competition, which could materially and adversely affect our business, financial condition and results of investments.
We are subject to risks related to corporate social responsibility.
Our business (including that of our portfolio companies) faces increasing public scrutiny related to environmental, social and governance (“ESG”) activities, which are increasingly considered to contribute to reducing a company’s operational risk, market risk and reputational risk, which may in turn impact the long-term sustainability of a company’s performance. A variety of organizations measure the performance of companies on ESG topics, and the results of these assessments are widely publicized. In addition, investment in funds that specialize in companies that perform well in such assessments are increasingly popular, and major institutional investors have publicly emphasized the importance of such ESG measures to their investment decisions. We risk damage to our brand and reputation if we fail to act responsibly in a number of areas, including, but not limited to, diversity, equity and inclusion, human rights, climate change, environmental stewardship, corporate governance and considering ESG factors in our investment processes. Adverse incidents with respect to ESG activities could impact the value of our brand, our relationship with existing and future portfolio companies, the cost of our operations and relationships with investors, all of which could adversely affect our business and results of operations.
However, regional and investor specific sentiment may differ in what constitutes a material positive or negative ESG corporate practice. There is no guarantee that the Company’s corporate social responsibility practices will uniformly fit every investor’s definition of best practices for all environmental, social and governance considerations across geographies and investor types.
There is also a growing regulatory interest across jurisdictions in improving transparency regarding the definition, measurement and disclosure of ESG factors in order to allow investors to validate and better understand sustainability claims. For example, the SEC has proposed, or has announced that it is working on proposals for, rules that, among other matters, would establish a framework for reporting of climate-related risks, corporate and fund carbon emissions, broad diversity and capital management. At this time, there is uncertainty regarding the scope of such proposals or when they would become effective (if at all). In addition, in 2021 the SEC established an enforcement task force to look into ESG practices and disclosures by public companies and investment managers and has started to bring enforcement actions based on ESG disclosures not matching actual investment processes. We and our portfolio companies are subject to the risk that similar measures might be introduced in other jurisdictions in the future. Additionally, compliance with any new laws or regulations increases our regulatory burden and could make compliance more difficult and expensive, affect the manner in which we or our portfolio companies conduct our businesses and adversely affect our profitability.
The effect of global climate change may impact the operations of our portfolio companies.
There may be evidence of global climate change. Climate change creates physical and financial risk and some of our portfolio companies may be adversely affected by climate change. For example, the needs of customers of energy companies vary with weather conditions, primarily temperature and humidity. To the extent weather conditions are affected by climate change, energy use could increase or decrease depending on the duration and magnitude of any changes. Increases in the cost of energy could adversely affect the cost of operations of our portfolio companies if the use of energy products or services is material to their business. A decrease in energy use due to weather changes may affect some of our portfolio companies’ financial condition, through decreased revenues. Extreme weather conditions in general require more system backup, adding to costs, and can contribute to increased system stresses, including service interruptions. Energy companies could also be affected by the potential for lawsuits against or taxes or other regulatory costs imposed on greenhouse gas emitters, based on links drawn between greenhouse gas emissions and climate change.
In December 2015, the United Nations, of which the U.S. is a member, adopted a climate accord with the long-term goal of limiting global warming and the short-term goal of significantly reducing greenhouse gas emissions. As a result, some of our portfolio companies may become subject to new or strengthened regulations or legislation, which could increase their operating costs and/or decrease their revenues.
 
54

We cannot predict how changes in tax law will affect us, our investments, or our stockholders, and any such legislation could adversely affect our business.
Legislative or other actions relating to taxes could have a negative effect on us. The rules dealing with U.S. federal income taxation are constantly under review by persons involved in the legislative process and by the Internal Revenue Service and the U.S. Treasury Department. New legislation and any other tax law developments, including new or revised U.S. Treasury regulations, administrative interpretations or court decisions, could negatively and perhaps retroactively affect our ability to qualify for tax treatment as a RIC or the U.S. federal income tax consequences to us and our shareholders, or could have other adverse consequences. Investors are urged to consult with their tax advisor regarding tax legislative, regulatory, or administrative developments and proposals and their potential effect on an investment in our common stock.
Uncertainty about U.S. government initiatives could negatively impact our business, financial condition and results of operations.
The U.S. government has recently called for significant changes to U.S. trade, healthcare, immigration, foreign and government regulatory policy. In this regard, there is significant uncertainty with respect to legislation, regulation and government policy at the federal level, as well as the state and local levels. Recent events have created a climate of heightened uncertainty and introduced
new and difficult-to-quantify macroeconomic and
political risks
with potentially far-reaching implications. There
has been a corresponding meaningful increase in the uncertainty surrounding interest rates, inflation, foreign exchange rates, trade volumes and fiscal and monetary policy. To the extent the U.S. Congress or the current administration implements changes to U.S. policy, those changes may impact, among other things, the U.S. and global economy, international trade and relations, unemployment, immigration, corporate taxes, healthcare, the U.S. regulatory environment, inflation and other areas.
A particular area identified as subject to potential change, amendment or repeal includes the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the “Dodd-Frank Act,” including the Volcker Rule and various swaps and derivatives regulations, credit risk retention requirements and the authorities of the Federal Reserve, the Financial Stability Oversight Council and the SEC. Given the uncertainty associated with the manner in which and whether the provisions of the Dodd-Frank Act will be implemented, repealed, amended, or replaced, the full impact such requirements will have on our business, results of operations or financial condition is unclear. The changes resulting from the Dodd-Frank Act or any changes to the regulations already implemented thereunder may require us to invest significant management attention and resources to evaluate and make necessary changes in order to comply with new statutory and regulatory requirements. Failure to comply with any such laws, regulations or principles, or changes thereto, may negatively impact our business, results of operations or financial condition. While we cannot predict what effect any changes in the laws or regulations or their interpretations would have on us as a result of recent financial reform legislation, these changes could be materially adverse to us and our stockholders.
 
Item 1B.
Unresolved Staff Comments
None
 
Item 2.
Properties
Our offices are located at 500 Park Avenue, New York, New York 10022, and are provided by SLR Capital Management in accordance with the terms of the Administration Agreement. We believe that our office facilities are suitable and adequate for our business as it is presently conducted.
 
Item 3.
Legal Proceedings
We and our consolidated subsidiaries are not currently subject to any material legal proceedings, nor, to our knowledge, is any material legal proceeding threatened against us or our consolidated subsidiaries. From time to time, we and our consolidated subsidiaries may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of our rights under contracts with our portfolio companies. While the outcome of these legal proceedings cannot be predicted with certainty, we do not expect that these proceedings will have a material effect upon our financial condition or results of operations.
 
Item 4.
Mine Safety Disclosures
Not applicable.
 
55

PART II
 
Item 5.
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Common Stock
Our common stock is traded on the NASDAQ Global Select Market under
the
symbol “SLRC”. The following table sets forth, for each fiscal quarter during the last two fiscal years, the net asset value (“NAV”) per share of our common stock, the high and low closing sales prices for our common stock, such sales prices as a percentage of NAV per share and distributions per share.
 
 
  
NAV
(1)
 
  
Price Range
 
  
Premium or

(Discount)

of High Closing

Price to NAV
(2)
 
 
Premium or

(Discount)

of

Low Closing

Price to

NAV
(2)
 
 
Declared

Distributions
 (3)
 
 
  
High
 
  
Low
 
Fiscal 2022
                                                   
Fourth Quarter
   $ 18.33      $ 15.03      $ 12.50        (18.0 )%      (31.8 )%    $ 0.41  
Third Quarter
     18.37        15.76        12.32        (14.2     (32.9     0.41  
Second Quarter
     18.53        18.19        14.17        (1.8     (23.5     0.41  
First Quarter
     19.56        19.26        17.68        (1.5     (9.6     0.41  
Fiscal 2021
                                                   
Fourth Quarter
   $ 19.93      $ 19.90      $ 17.55        (0.2 )%      (11.9 )%    $ 0.41  
Third Quarter
     20.20        19.75        18.42        (2.2     (8.8     0.41  
Second Quarter
     20.29        19.58        17.88        (3.5     (11.9     0.41  
First Quarter
     20.26        19.35        17.35        (4.5     (14.4     0.41  
 
(1)
 
NAV per share is determined as of the last day in the relevant quarter and therefore may not reflect the NAV per share on the date of the high and low sales prices. The net asset values shown are based on outstanding shares at the end of each period.
(2)
 
Calculated as of the respective high or low closing price divided by NAV and subtracting 1.
(3)
 
Represents the cash distribution for the specified quarter.
On February 22, 2023 the last reported sales price of our common stock was $14.73 per share. As of February 22, 2023, we had 19 shareholders of record.
Shares of BDCs may trade at a market price that is less than the value of the net assets attributable to those shares. The possibility that our shares of common stock will trade at a discount from net asset value or at premiums that are unsustainable over the long term is separate and distinct from the risk that our net asset value will decrease. Since our IPO on February 9, 2010, our shares of common stock have traded at both a discount and a premium to the net assets attributable to those shares. As of February 22, 2023, our shares of common stock traded at a discount equal to approximately 19.6% of the net assets attributable to those shares based upon our net asset value as of December 31, 2022. It is not possible to predict whether the shares offered hereby will trade at, above, or below net asset value.
 
56

DISTRIBUTIONS
Tax characteristics of all distributions will be reported to stockholders on Form 1099 after the end of the calendar year. Future distributions, if any, will be determined by the Board. We expect that our distributions to stockholders will generally be from accumulated net investment income, from net realized capital gains or
 
non-taxable
 
return of capital, if any, as applicable.
We have elected to be taxed as a RIC under Subchapter M of the Code. To maintain our RIC tax treatment, we must distribute at least 90% of our ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any, out of the assets legally available for distribution. In addition, although we currently intend to distribute realized net capital gains (
i.e.
, net long-term capital gains in excess of short-term capital losses), if any, at least annually, out of the assets legally available for such distributions, we may in the future decide to retain such capital gains for investment.
We maintain an “opt out” dividend reinvestment plan for our common stockholders. As a result, if we declare a distribution, then stockholders’ cash distributions will be automatically reinvested in additional shares of our common stock, unless they specifically “opt out” of the dividend reinvestment plan so as to receive cash distributions.
We may not be able to achieve operating results that will allow us to make distributions at a specific level or to increase the amount of these distributions from time to time. In addition, due to the asset coverage test applicable to us as a business development company, we may in the future be limited in our ability to make distributions. Also, our revolving credit facility may limit our ability to declare distributions if we default under certain provisions. If we do not distribute a certain percentage of our income annually, we will suffer adverse tax consequences, including possible loss of the tax benefits available to us as a regulated investment company. In addition, in accordance with GAAP and tax regulations, we include in income certain amounts that we have not yet received in cash, such as contractual
payment-in-kind
income, which represents contractual income added to the loan balance that becomes due at the end of the loan term, or the accrual of original issue or market discount. Since we may recognize income before or without receiving cash representing such income, we may have difficulty meeting the requirement to distribute at least 90% of our investment company taxable income to obtain tax benefits as a regulated investment company.
With respect to the distributions to stockholders, income from origination, structuring, closing and certain other upfront fees associated with investments in portfolio companies are treated as taxable income and accordingly, distributed to stockholders.
We cannot assure stockholders that they will receive any distributions at a particular level.
All distributions declared in cash payable to stockholders that are participants in our dividend reinvestment plan are generally automatically reinvested in shares of our common stock. As a result, stockholders that do not participate in the dividend reinvestment plan may experience dilution over time. Stockholders who do not elect to receive distributions in shares of common stock may experience accretion to the net asset value of their shares if our shares are trading at a premium and dilution if our shares are trading at a discount. The level of accretion or discount would depend on various factors, including the proportion of our stockholders who participate in the plan, the level of premium or discount at which our shares are trading and the amount of the distribution payable to a stockholder.
Recent Sales of Unregistered Securities
None.
Issuer Purchases of Equity Securities
 
Period
  
Total Number
of Shares
Purchased
 
  
Average Price
Paid per
Share
 
  
Total Number of
Shares Purchased
as Part of
Publicly
Announced Plans
or Programs
 
  
Approximate
Dollar Value
of Shares that
May Yet
Be Purchased
Under the
Plans or
Programs (a)
(in thousands)
 
October 1, 2022 to October 31, 2022
  
 
—  
 
  
$
—  
 
  
 
—  
 
  
$
50,000
 
November 1, 2022 to November 30, 2022
  
 
27,813
 
  
$
14.06
 
  
 
27,813
 
  
$
49,609
 
December 1, 2022 to December 31, 2022
  
 
189,458
 
  
$
13.97
 
  
 
189,458
 
  
$
46,962
 
  
 
 
 
  
  
 
 
 
  
Total
  
 
217,271
 
  
  
 
217,271
 
  
 
(a)
On May 3, 2022, the Board authorized a program to repurchase up to $50 million of our outstanding shares of common stock. Under the repurchase program, we may, but are not obligated to, repurchase shares of our outstanding common stock in the open market from time to time provided that we comply with our code of ethics and the guidelines specified in Rule
10b-18
of the 1934 Act, including certain price, market volume and timing constraints. In addition, any repurchases will be conducted in accordance with the 1940 Act. Unless amended or extended by our Board, we expect the repurchase program to be in place until the earlier of May 1, 2023 or until $50 million of our outstanding shares of common stock have been repurchased. The timing and number of shares to be repurchased will depend on a number of factors, including market conditions. There are no assurances that we will engage in any repurchases.
 
57

STOCK PERFORMANCE GRAPH
This graph compares the cumulative total return on our common stock with that of the Standard & Poor’s BDC Index, Standard & Poor’s 500 Stock Index and the Russell 2000 Financial Services Index, for the period from December 31, 2017 through December 31, 2022. The graph assumes that a person invested $10,000 in each of the following: our common stock (SLRC), the S&P BDC Index, the S&P 500 Index, and the Russell 2000 Financial Services Index. The graph measures total stockholder return, which takes into account both changes in stock price and dividends. It assumes that dividends paid are invested in additional shares of the same class of equity securities at the frequency with which dividends are paid of such securities during the applicable fiscal year.
 

The graph and other information furnished under this Part II Item 5 of this Form
10-K
shall not be deemed to be “soliciting material” or to be “filed” with the SEC or subject to Regulation 14A or 14C, or to the liabilities of Section 18 of the 1934 Act. The stock price performance included in the above graph is not necessarily indicative of future stock price performance.
 
58

FEES AND EXPENSES
The following table is intended to assist an investor in understanding the costs and expenses that you will bear directly or indirectly. We caution you that some of the percentages indicated in the table below are estimates and may vary. Except where the context suggests otherwise, whenever this report contains a reference to fees or expenses paid by “us” or “SLRC,” or that “we” will pay fees or expenses, you will indirectly bear such fees or expenses as an investor in SLR Investment Corp.
 
Stockholder transaction expenses:
        
Sales load (as a percentage of offering price)
        %
(1)
 
Offering expenses (as a percentage of offering price)
        %
(2)
 
Dividend reinvestment plan expenses
        %
(3)
 
Total stockholder transaction expenses (as a percentage of offering price)
        %
(2)
 
Annual expenses (as a percentage of net assets attributable to common stock)
(4)
:
        
Base management fee
     3.00 %
(5)
 
Incentive fees payable under our Investment Advisory and Management Agreement (up to 20%)
     1.51 %
(6)
 
Interest payments on borrowed funds
     4.61 %
(7)
 
Acquired fund fees and expenses
     0.02 %
(8)
 
Other expenses (estimated)
     1.15 %
(9)
 
Total annual expenses
     10.29
 
(1)
 
In the event that the shares of common stock are sold to or through underwriters, a corresponding prospectus supplement will disclose the applicable sales load and the “Example” will be updated accordingly.
(2)
 
The prospectus supplement corresponding to each offering will disclose the applicable offering expenses and total stockholder transaction expenses.
(3)
 
The expenses of the dividend reinvestment plan are included in “other expenses.”
(4)
Annual Expenses are presented in this manner because common shareholders will bear all costs of running the Company.
(5)
 
Our 1.50% base management fee under the Investment Advisory and Management Agreement (giving effect to the Letter Agreement) is based on our gross assets, which is defined as all the assets of SLRC, excluding temporary assets, including those acquired using borrowings for investment purposes, and assumes our gross assets remain consistent with gross assets for the fiscal year ended December 31, 2022. The base management fee is reduced to 1.00% on gross assets that exceed 200% of total net assets as of the immediately preceding quarter.
(6)
Assumes that annual incentive fees earned by our investment adviser, SLR Capital Partners, remain consistent with the incentive fees earned by SLR Capital Partners for the fiscal year ended December 31, 2022. The incentive fee consists of two parts:
 
59

The first part, which is payable quarterly in arrears, equals 20% of the excess, if any, of our
“Pre-Incentive
Fee Net Investment Income” that exceeds a 1.75% quarterly (7.00% annualized) hurdle rate, which we refer to as the Hurdle, subject to a
“catch-up”
provision measured at the end of each calendar quarter. The first part of the incentive fee is computed and paid on income that may include interest that is accrued but not yet received in cash. The operation of the first part of the incentive fee for each quarter is as follows:
 
 
no incentive fee is payable to our investment adviser in any calendar quarter in which our
Pre-Incentive
Fee Net Investment Income does not exceed the Hurdle of 1.75%;
 
 
100% of our
Pre-Incentive
Fee Net Investment Income with respect to that portion of such
Pre-Incentive
Fee Net Investment Income, if any, that exceeds the Hurdle but is less than 2.1875% in any calendar quarter (8.75% annualized) is payable to our investment adviser. We refer to this portion of our
Pre-Incentive
Fee Net Investment Income (which exceeds the Hurdle but is less than 2.1875%) as the
“catch-up.”
The
“catch-up”
is meant to provide our investment adviser with 20% of our
Pre-Incentive
Fee Net Investment Income, as if a Hurdle did not apply when our
Pre-Incentive
Fee Net Investment Income exceeds 2.1875% in any calendar quarter; and
 
 
20% of the amount of our
Pre-Incentive
Fee Net Investment Income, if any, that exceeds 2.1875% in any calendar quarter (8.75% annualized) is payable to our investment adviser (once the Hurdle is reached and the
catch-up
is achieved, 20% of all
Pre-Incentive
Fee Investment Income thereafter is allocated to our investment adviser).
The second part of the incentive fee equals 20% of our “Incentive Fee Capital Gains,” if any, which equals our realized capital gains on a cumulative basis from inception through the end of each calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees. The second part of the incentive fee is payable, in arrears, at the end of each calendar year (or upon termination of the Investment Advisory and Management Agreement, as of the termination date).
 
(7)
 
We have historically and will in the future borrow funds from time to time to make investments to the extent we determine that the economic situation is conducive to doing so. The costs associated with our outstanding borrowings are indirectly borne by our investors. For purposes of this section, we have computed interest expense using the average consolidated balance outstanding for borrowings during the fiscal year ended December 31, 2022. We used the Secured Overnight Financing Rate (“SOFR”) or similar base rate on December 31, 2022 and the interest rate on the Credit Facility, the SPV Credit Facility, the 2027 Series F Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes, the 2024 Unsecured Notes and the 2023 Unsecured Notes on December 31, 2022. We have also included, as applicable, the estimated market discount or amortization of fees incurred in establishing the Credit Facility, the SPV Credit Facility, the 2027 Series F Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes, the 2024 Unsecured Notes and the 2023 Unsecured Notes as of December 31, 2022. Additionally, we included the estimated cost of commitment fees for unused balances on the Credit Facility and the SPV Credit Facility. As of December 31, 2022, we had $393.0 million outstanding under the Credit Facility, $155.2 million outstanding under the SPV Credit Facility and $135 million, $50 million, $75 million, $125 million, $85 million, and $75 million outstanding under the 2027 Series F Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes, the 2024 Unsecured Notes and the 2023 Unsecured Notes, respectively. We may also issue preferred stock, subject to our compliance with applicable requirements under the 1940 Act, although we have no immediate intention to do so.
(8)
 
The holders of shares of our common stock indirectly bear the expenses of our investment in SLR Senior Lending Program LLC (“SSLP”). No management fee is charged on our investments in SSLP in connection with the administrative services provided to SSLP. Future expenses for SSLP may be substantially higher or lower because certain expenses may fluctuate over time.
(9)
 
“Other expenses” are based on estimated amounts for the current fiscal year, which considers the amounts incurred for the fiscal year ended December 31, 2022 and include our overhead expenses, including payments under our Administration Agreement based on our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement.
 
6
0

Example
The following example demonstrates the projected dollar amount of total cumulative expenses that would be incurred over various periods with respect to a hypothetical investment in our common stock. In calculating the following expense amounts, we have assumed that our annual operating expenses would remain at the levels set forth in the table above and have excluded performance-based incentive fees. As such, the below example is based on an annual expense ratio of 8.78%. See Note 7 above for additional information regarding certain assumptions regarding our level of leverage. In the event that shares are sold to or through underwriters, a corresponding prospectus supplement will restate this example to reflect the applicable sales load.
 
    
1 Year
    
3 Years
    
5 Years
    
10 Years
 
You would pay the following expenses on a $1,000 investment, assuming a 5% annual return
   $ 88      $ 253      $ 407      $ 743  
The example and the expenses in the tables above should not be considered a representation of our future expenses, and actual expenses may be greater or less than those shown.
While the example assumes, as required by the SEC, a 5% annual return, our performance will vary and may result in a return greater or less than 5%. The incentive fee under the Investment Advisory and Management Agreement, which, assuming a 5% annual return, would either not be payable or would have an insignificant impact on the expense amounts shown above, is not included in the example. This illustration assumes that we will not realize any capital gains (computed net of all realized capital losses and unrealized capital depreciation) in any of the indicated time periods. If we achieve sufficient returns on our investments, including through the realization of capital gains, to trigger an incentive fee of a material amount, our expenses and returns to our investors would be higher. For example, if we assumed that we received our 5% annual return completely in the form of net realized capital gains on our investments, computed net of all cumulative unrealized depreciation on our investments, the projected dollar amount of total cumulative expenses set forth in the above illustration would be as follows:
 
    
1 Year
    
3 Years
    
5 Years
    
10 Years
 
You would pay the following expenses on a $1,000 investment, assuming a 5% annual return
   $ 98      $ 279      $ 444      $ 792  
In addition, the example assumes no sales load. Also, while the example assumes reinvestment of all distributions at net asset value, participants in our dividend reinvestment plan will receive a number of shares of our common stock, determined by dividing the total dollar amount of the distribution payable to a participant by the market price per share of our common stock at the close of trading on the distribution payment date, which may be at, above or below net asset value unless the company makes open market purchases and the shares received will be determined based on the average price paid by our agent, plus commissions.
 
Item 6.
Reserved
 
6
1

Item 7.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
The information contained in this section should be read in conjunction with our Consolidated Financial Statements and notes thereto appearing elsewhere in this report.
Some of the statements in this report constitute forward-looking statements, which relate to future events or our future performance or financial condition. The forward-looking statements contained herein involve risks and uncertainties, including statements as to:
 
 
 
our future operating results, including our ability to achieve objectives;
 
 
 
our business prospects and the prospects of our portfolio companies;
 
 
 
the impact of investments that we expect to make;
 
 
 
our contractual arrangements and relationships with third parties;
 
 
 
the dependence of our future success on the general economy and its impact on the industries in which we invest;
 
 
 
the impact of any protracted decline in the liquidity of credit markets on our business;
 
 
 
the ability of our portfolio companies to achieve their objectives;
 
 
 
the valuation of our investments in portfolio companies, particularly those having no liquid trading market;
 
 
 
market conditions and our ability to access different debt markets and additional debt and equity capital;
 
 
 
our expected financings and investments;
 
 
 
the adequacy of our cash resources and working capital;
 
 
 
the timing of cash flows, if any, from the operations of our portfolio companies;
 
 
 
the ability of our investment adviser to locate suitable investments for us and to monitor and administer our investments;
 
 
 
changes in the political conditions and relations between the United States, Russia, Ukraine and other nations, the interest rate environment or conditions affecting the financial and capital markets;
 
 
 
changes in the general economy, slowing economy, rising inflation, risk of recession and risks in respect of a failure to increase the U.S. debt ceiling; and
 
 
 
our ability to anticipate and identify evolving market expectations with respect to environmental, social and governance matters, including the environmental impacts of our portfolio companies’ supply chain and operations.
These statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including without limitation:
 
 
 
an economic downturn could impair our portfolio companies’ ability to continue to operate, which could lead to the loss of some or all of our investments in such portfolio companies;
 
 
 
a contraction of available credit and/or an inability to access the equity markets could impair our lending and investment activities;
 
 
 
interest rate volatility could adversely affect our results, particularly because we use leverage as part of our investment strategy;
 
 
 
currency fluctuations could adversely affect the results of our investments in foreign companies, particularly to the extent that we receive payments denominated in foreign currency rather than U.S. dollars;
 
 
 
the risks, uncertainties and other factors we identify in Item 1A. — Risk Factors contained in this Annual Report on Form
10-K
for the year ended December 31, 2022 and in our other filings with the SEC.
We generally use words such as “anticipates,” “believes,” “expects,” “intends” and similar expressions to identify forward-looking statements. Our actual results could differ materially from those projected in the forward-looking statements for any reason, including any factors set forth in “Risk Factors” and elsewhere in this report.
We have based the forward-looking statements included in this report on information available to us on the date of this report, and we assume no obligation to update any such forward-looking statements. Although we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, you are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the SEC, including any annual reports on Form
10-K,
quarterly reports on Form
10-Q
and current reports on Form
8-K.
Overview
Solar Capital LLC, a Maryland limited liability company, was formed in February 2007 and commenced operations on March 13, 2007 with initial capital of $1.2 billion of which 47.04% was funded by affiliated parties.
 
62

SLR Investment Corp. (the “Company”, “SLRC”, “we” or “our”), a Maryland corporation formed in November 2007, is a
closed-end,
externally managed,
non-diversified
management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Furthermore, as the Company is an investment company, it continues to apply the guidance in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946. In addition, for U.S federal income tax purposes, the Company has elected to be treated as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).
On February 9, 2010, we priced our initial public offering, selling 5.68 million shares of our common stock. Concurrent with our initial public offering, Michael S. Gross, our Chairman,
Co-Chief
Executive Officer and President, and Bruce Spohler, our Co-Chief Executive Officer and Chief Operating Officer, collectively purchased an additional 0.6 million shares of our common stock through a private placement transaction exempt from registration under the Securities Act.
We invest primarily in privately held U.S. middle-market companies, where we believe the supply of primary capital is limited and the investment opportunities are most attractive. Our investment objective is to generate both current income and capital appreciation through debt and equity investments. We invest primarily in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. From time to time, we may also invest in public companies that are thinly traded. Our business is focused primarily on the direct origination of investments through portfolio companies or their financial sponsors. Our investments generally range between $5 million and $100 million each, although we expect that this investment size will vary proportionately with the size of our capital base and/or with strategic initiatives. Our investment activities are managed by SLR Capital Partners, LLC (the “Investment Adviser”) and supervised by the board of directors (the “Board)”, a majority of whom are
non-interested,
as such term is defined in the 1940 Act. SLR Capital Management, LLC (the “Administrator”) provides the administrative services necessary for us to operate.
In addition, we may invest a portion of our portfolio in other types of investments, which we refer to as opportunistic investments, which are not our primary focus but are intended to enhance our overall returns. These investments may include, but are not limited to, direct investments in public companies that are not thinly traded and securities of leveraged companies located in select countries outside of the United States.
SUNS Merger
On April 1, 2022, we completed our previously announced acquisition of SLR Senior Investment Corp., a Maryland corporation (“SUNS”). Pursuant to that certain Agreement and Plan of Merger (the “Merger Agreement”) by and among us, SUNS, Solstice Merger Sub, Inc., a Maryland corporation and our wholly-owned subsidiary (“Merger Sub”), and, solely for the limited purposes set forth therein, the Investment Adviser, dated as of December 1, 2021, Merger Sub was first merged with and into SUNS, with SUNS as the surviving corporation, and, immediately following the Merger, SUNS was then merged with and into us, with us as the surviving company. In accordance with the terms of the Merger Agreement, at the effective time of the Mergers, each outstanding share of SUNS’s common stock was converted into the right to receive 0.7796 shares of our common stock (with SUNS’s stockholders receiving cash in lieu of fractional shares of our common stock). As a result of the Mergers, we issued an aggregate of 12,511,825 shares of our common stock to former SUNS stockholders.
The Mergers are accounted for as an asset acquisition of SLR Senior Investment Corp. by the Company in accordance with the asset acquisition method of accounting as detailed in ASC
805-50,
Business Combinations – Related Issues, with the fair value of total consideration paid in conjunction with the Mergers allocated to the assets acquired and liabilities assumed based on their relative fair values as of the date of the Mergers. Generally, under asset acquisition accounting, acquiring assets in groups not only requires ascertaining the cost of the asset (or net assets), but also allocating that cost to the individual assets (or individual assets and liabilities) that make up the group. The cost of the group of assets acquired in an asset acquisition is allocated to the individual assets acquired or liabilities assumed based on their relative fair values of net identifiable assets acquired other than certain
“non-qualifying”
assets (for example cash) and does not give rise to goodwill. The Company is the accounting survivor of the Mergers. The Mergers were considered a
tax-free
reorganization and the historical cost basis of the acquired SUNS investments are carried forward for tax purposes.
Letter Agreement
On April 1, 2022, in connection with the consummation of the Mergers, we entered into a letter agreement (the “Letter Agreement”) pursuant to which the Investment Adviser voluntarily agreed to a permanent 25 basis point reduction of the annual base management fee rate payable by us to the Investment Adviser pursuant to the Advisory Agreement, resulting in an annual base management fee rate payable by us to the Investment Adviser of 1.50% on gross assets up to 200% of our total net assets. We retained the annual base management fee rate payable by us to the Investment Adviser of 1.00% on gross assets that exceed 200% of our total net assets.
 
63

Recent Developments
On January 10, 2023, the Board declared a monthly distribution of $0.136667 per share payable on February 2, 2023 to holders of record as of January 26, 2023.
On February 2, 2023, the Board declared a monthly distribution of $0.136667 per share payable on March 1, 2023 to holders of record as of February 16, 2023.
On February 28, 2023, the Board declared a monthly distribution of $0.136667 per share payable on April 4, 2023 to holders of record as of March 23, 2023.
Investments
Our level of investment activity can and does vary
substantially
from period to period depending on many factors, including the amount of debt and equity capital available to middle market companies, the level of merger and acquisition activity for such companies, the general economic environment and the competitive environment for the types of investments we make. As a BDC, we must not acquire any assets other than “qualifying assets” specified in the 1940 Act unless, at the time the acquisition is made, at least 70% of our total assets are qualifying assets (with certain limited exceptions). Qualifying assets include investments in “eligible portfolio companies.” The definition of “eligible portfolio company” includes certain public companies that do not have any securities listed on a national securities exchange and companies whose securities are listed on a national securities exchange but whose market capitalization is less than $250 million.
Revenue
We generate revenue primarily in the form of interest and dividend income from the securities we hold and capital gains, if any, on investment securities that we may sell. Our debt investments generally have a stated term of three to seven years and typically bear interest at a floating rate usually determined on the basis of a benchmark London interbank offered rate (“LIBOR”), the Secured Overnight Financing Rate (“SOFR”), commercial paper rate, or the prime rate. Interest on our debt investments is generally payable monthly or quarterly but may be
bi-monthly
or semi-annually. In addition, our investments may provide
payment-in-kind
(“PIK”) income. Such amounts of accrued PIK income are added to the cost of the investment on the respective capitalization dates and generally become due at maturity of the investment or upon the investment being called by the issuer. We may also generate revenue in the form of commitment, origination, structuring fees, fees for providing managerial assistance and, if applicable, consulting fees, etc.
Expenses
All investment professionals of the investment adviser and their respective staffs, when and to the extent engaged in providing investment advisory and management services, and the compensation and routine overhead expenses of such personnel allocable to such services, are provided and paid for by the Investment Adviser. We bear all other costs and expenses of our operations and transactions, including (without limitation):
 
 
the cost of our organization and public offerings;
 
 
the cost of calculating our net asset value, including the cost of any third-party valuation services;
 
 
the cost of effecting sales and repurchases of our shares and other securities;
 
 
interest payable on debt, if any, to finance our investments;
 
 
fees payable to third parties relating to, or associated with, making investments, including fees and expenses associated with performing due diligence reviews of prospective investments and advisory fees;
 
 
transfer agent and custodial fees;
 
 
fees and expenses associated with marketing efforts;
 
64

federal and state registration fees, any stock exchange listing fees;
 
 
federal, state and local taxes;
 
 
independent directors’ fees and expenses;
 
 
brokerage commissions;
 
 
fidelity bond, directors and officers errors and omissions liability insurance and other insurance premiums;
 
 
direct costs and expenses of administration, including printing, mailing, long distance telephone and staff;
 
 
fees and expenses associated with independent audits and outside legal costs;
 
 
costs associated with our reporting and compliance obligations under the 1940 Act and applicable federal and state securities laws; and
 
 
all other expenses incurred by either SLR Capital Management or us in connection with administering our business, including payments under the Administration Agreement that will be based upon our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions, and our allocable portion of the costs of compensation and related expenses of our chief compliance officer and our chief financial officer and their respective staffs.
We expect our general and administrative operating expenses related to our ongoing operations to increase moderately in dollar terms. During periods of asset growth, we generally expect our general and administrative operating expenses to decline as a percentage of our total assets and increase during periods of asset declines. Incentive fees, interest expense and costs relating to future offerings of securities, among others, may also increase or reduce overall operating expenses based on portfolio performance, interest rate benchmarks, and offerings of our securities relative to comparative periods, among other factors.
Macroeconomic Environment
Credit markets continued to be under pressure during 2022 amid a
risk-off
environment and sustained macro-economic uncertainty due to record-high inflation, tighter financial conditions and growing recession risk. Central banks have remained focused on restoring price stability by raising interest rates and have signaled that growth may be hindered until inflation comes under control.
Portfolio and Investment Activity
During the year ended December 31, 2022, exclusive of the assets acquired through the Mergers, we invested approximately $610 million across 77 portfolio companies. This compares to investing approximately $596 million across 52 portfolio companies for the year ended December 31, 2021. Investments sold, prepaid or repaid during the year ended December 31, 2022 totaled approximately $532 million versus approximately $468 million for the year ended December 31, 2021.
At December 31, 2022, our portfolio consisted of 139 portfolio companies and was invested 30.8% in cash flow senior secured loans, 30.0% in asset-based senior secured loans / SLR Credit Solutions (“SLR Credit”) / SLR Healthcare ABL / SLR Business Credit, 23.7% in equipment senior secured financings / SLR Equipment Finance (“SLR Equipment”) / Kingsbridge Holdings, LLC (“KBH”) and 15.5% in life science senior secured loans, in each case, measured at fair value, versus 106 portfolio companies invested 26.7% in cash flow senior secured loans, 27.0% in asset-based senior secured loans / SLR Credit, 29.9% in equipment senior secured financings / SLR Equipment / KBH, and 16.4% in life science senior secured loans, in each case, measured at fair value, at December 31, 2021.
At December 31, 2022, 77.7% or $1.61 billion of our income producing investment portfolio
*
is floating rate and 22.3% or $464.5 million is fixed rate, measured at fair value. At December 31, 2021, 79.4% or $1.20 billion of our income producing investment portfolio
*
is floating rate and 20.6% or $313.4 million is fixed rate, measured at fair value. As of December 31, 2022 and 2021, we had two and one issuers on
non-accrual
status, respectively.
 
6
5

*
We have included SLR Credit Solutions, SLR Equipment Finance, SLR Healthcare ABL, SLR Business Credit and Kingsbridge Holdings, LLC within our income producing investment portfolio.
SLR Credit Solutions
On December 28, 2012, we acquired an equity interest in Crystal Capital Financial Holdings LLC (“Crystal Financial”) for $275 million in cash. Crystal Financial owned approximately 98% of the outstanding ownership interest in SLR Credit Solutions (“SLR Credit”), f/k/a Crystal Financial LLC. The remaining financial interest was held by various employees of SLR Credit, through their investment in Crystal Management LP. SLR Credit had a diversified portfolio of 23 loans having a total par value of approximately $400 million at November 30, 2012 and a $275 million committed revolving credit facility. On July 28, 2016, the Company purchased Crystal Management LP’s approximately 2% equity interest in SLR Credit for approximately $5.7 million. Upon the closing of this transaction, the Company holds 100% of the equity interest in SLR Credit. On September 30, 2016, Crystal Capital Financial Holdings LLC was dissolved. As of December 31, 2022, total commitments to the revolving credit facility are $285 million.
As of December 31, 2022, SLR Credit had 29 funded commitments to 25 different issuers with total funded loans of approximately $439.5 million on total assets of $460.7 million. As of December 31, 2021, SLR Credit had 22 funded commitments to 19 different issuers with total funded loans of approximately $287.4 million on total assets of $347.8 million. As of December 31, 2022 and December 31, 2021, the largest loan outstanding totaled $33.4 million and $35.0 million, respectively. For the same periods, the average exposure per issuer was $17.6 million and $15.1 million, respectively. SLR Credit’s credit facility, which is
non-recourse
to the Company, had approximately $224.3 million and $100.7 million of borrowings outstanding at December 31, 2022 and December 31, 2021, respectively. For the years ended December 31, 2022 and 2021, SLR Credit had net income of $7.5 million and $14.2 million, respectively, on gross income of $30.3 million and $34.0 million, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Credit will be able to maintain consistent dividend payments to us. SLR Credit’s consolidated financial statements for the fiscal years ended December 31, 2022 and December 31, 2021 are attached as an exhibit to this annual report on Form
10-K.
SLR Equipment Finance
On July 31, 2017, we acquired a 100% equity interest in NEF Holdings, LLC, which conducts its business through its wholly-owned subsidiary Nations Equipment Finance, LLC. Effective February 25, 2021, Nations Equipment Finance, LLC and its related companies are doing business as SLR Equipment Finance (“SLR Equipment”). SLR Equipment is an independent equipment finance company that provides senior secured loans and leases primarily to U.S. based companies. We invested $209.9 million in cash to effect the transaction, of which $145.0 million was invested in the equity of SLR Equipment through our wholly-owned consolidated taxable subsidiary NEFCORP LLC and our wholly-owned consolidated subsidiary NEFPASS LLC and $64.9 million was used to purchase certain leases and loans held by SLR Equipment through NEFPASS LLC. Concurrent with the transaction, SLR Equipment refinanced its existing senior secured credit facility into a $150.0 million
non-recourse
facility with an accordion feature to expand up to $250.0 million. In September 2019, SLR Equipment amended the facility, increasing commitments to $214.0 million with an accordion feature to expand up to $314.0, million and extended the maturity date of the facility to July 31, 2023.
As of December 31, 2022, SLR Equipment had 131 funded equipment-backed leases and loans to 59 different customers with a total net investment in leases and loans of approximately $190.8 million on total assets of $241.8 million. As of December 31, 2021, SLR Equipment had 135 funded equipment-backed leases and loans to 61 different customers with a total net investment in leases and loans of approximately $211.0 million on total assets of $264.0 million. As of December 31, 2022 and December 31, 2021, the largest position outstanding totaled $19.3 million and $19.2 million, respectively. For the same periods, the average exposure per customer was $3.2 million and $3.5 million, respectively. SLR Equipment’s credit facility, which is
non-recourse
to the Company, had approximately $115.0 million and $118.0 million of borrowings outstanding at December 31, 2022 and December 31, 2021, respectively. For the years ended December 31, 2022 and 2021, SLR Equipment had net losses of $2.9 million and $9.7 million, respectively, on gross income of $20.4 million and $22.9 million, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Equipment’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Equipment will be able to maintain consistent dividend payments to us. SLR Equipment’s consolidated financial statements for the fiscal years ended December 31, 2022 and December 31, 2021 are attached as an exhibit to this annual report on Form
10-K.
Kingsbridge Holdings, LLC
On November 3, 2020, the Company acquired 87.5% of the equity securities of Kingsbridge Holdings, LLC (“KBH”) through KBH Topco LLC (“KBHT”), a Delaware corporation. KBH is a residual focused independent
mid-ticket
lessor of equipment primarily to U.S. investment grade companies. The Company invested $216.6 million to effect the transaction, of which $136.6 million was invested to acquire 87.5% of KBHT’s equity and $80.0 million in KBH’s debt. The existing management team of KBH committed to continuing to lead KBH after the transaction. Following the transaction, the Company owns 87.5% of KBHT equity and the KBH management team owns the remaining 12.5% of KBHT’s equity.
 
66

As of December 31, 2022 and 2021, KBHT had total assets of $777.2 million and $738.4 million, respectively. For the same periods, debt recourse to KBHT totaled $222.1 million and $216.9 million, respectively, and
non-recourse
debt totaled $353.1 million and $323.8 million, respectively. None of the debt is recourse to the Company. For the years ended December 31, 2022 and December 31, 2021, KBHT had net income of $13.3 million and $12.2 million, respectively, on gross income of $298.8 million and $245.9 million, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us. KBHT’s consolidated financial statements for the years ended December 31, 2022 and December 31, 2021 are attached as an exhibit to this annual report on Form
10-K.
SLR Healthcare ABL
SUNS acquired an equity interest in SLR Healthcare ABL, f/k/a Gemino Healthcare Finance, LLC (“SLR Healthcare”) on September 30, 2013. SLR Healthcare is a commercial finance company that originates, underwrites, and manages primarily secured, asset-based loans for small and
mid-sized
companies operating in the healthcare industry. SUNS initial investment in SLR Healthcare ABL was $32.8 million. The management team of SLR Healthcare
co-invested
in the transaction and continues to lead SLR Healthcare. As of September 30, 2022, SLR Healthcare’s management team and the Company own approximately 7% and 93% of the equity in SLR Healthcare, respectively. SLRC acquired SLR Healthcare in connection with the Mergers on April 1, 2022.
Concurrent with the closing of the transaction, SLR Healthcare entered into a new, four-year,
non-recourse,
$100 million credit facility with
non-affiliates,
which was expandable to $150 million under its accordion feature. Effective March 31, 2014, the credit facility was expanded to $105 million and again on June 27, 2014 to $110 million. On May 27, 2016, SLR Healthcare entered into a new $125 million credit facility which replaced the previously existing facility. The new facility has similar terms as compared to the previous facility and includes an accordion feature increase to $200 million and had a maturity date of May 27, 2020. On June 28, 2019, this $125 million facility was amended, extending the maturity date to June 28, 2023.
SLR Healthcare currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of December 31, 2022, the portfolio totaled approximately $242.1 million of commitments with a total net investment in loans of $92.4 million on total assets of $108.7 million. As of December 31, 2021, the portfolio totaled approximately $183.5 million of commitments with a total net investment in loans of $81.6 million on total assets of $91.3 million. At December 31, 2022, the portfolio consisted of 41 issuers with an average balance of approximately $2.3 million versus 36 issuers with an average balance of approximately $2.3 million at December 31, 2021. All of the commitments in SLR Healthcare’s portfolio are floating-rate, senior-secured,
cash-pay
loans. SLR Healthcare’s credit facility, which is
non-recourse
to us, had approximately $77 million and $60 million of borrowings outstanding at December 31, 2022 and December 31, 2021, respectively. For the years ended December 31, 2022 and 2021, SLR Healthcare had net income of $3.5 million and $0.7 million, respectively, on gross income of $11.6 million and $10.1 million, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Healthcare’s funded commitments, the timing of originations, and the repayment of financings, the Company cannot guarantee that SLR Healthcare will be able to maintain consistent dividend payments to us. SLR Healthcare’s consolidated financial statements for the fiscal years ended December 31, 2022 and December 31, 2021 are attached as an exhibit to this annual report on Form
10-K.
SLR Business Credit
SUNS acquired 100% of the equity interests of North Mill Capital LLC (“NMC”) on October 20, 2017. NMC is a leading asset-backed lending commercial finance company that provides senior secured asset-backed financings to U.S. based
small-to-medium-sized
businesses primarily in the manufacturing, services and distribution industries. SUNS invested approximately $51.0 million to effect the transaction. Subsequently, SUNS contributed 1% of its equity interest in NMC to ESP SSC Corporation. Immediately thereafter, SUNS and ESP SSC Corporation contributed their equity interests to NorthMill LLC (“North Mill”). On May 1, 2018, North Mill merged with and into NMC, with NMC being the surviving company. SUNS and ESP SSC Corporation then owned 99% and 1% of the equity interests of NMC, respectively. The management team of NMC continues to lead NMC. On June 28, 2019, North Mill Holdco LLC (“NM Holdco”), a newly formed entity and ESP SSC Corporation acquired 100% of Summit Financial Resources, a Salt Lake City-based provider of asset-backed financing to small and
medium-sized
businesses. As part of this transaction, SUNS 99% interest in the equity of NMC was contributed to NM Holdco. This approximately $15.5 million transaction was financed with borrowings on NMC’s credit facility. Effective February 25, 2021, NMC and its related companies are doing business as SLR Business Credit. On June 3, 2021, NMC acquired 100% of Fast Pay Partners LLC, a Los Angeles-based provider of asset-backed financing to digital media companies. The transaction purchase price of $66.7 million was financed with equity from SUNS of $19.0 million and borrowings on NMC’s credit facility of $47.7 million. SLRC acquired SLR Business Credit in connection with the Mergers on April 1, 2022.
 
67

SLR Business Credit currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of December 31, 2022, the portfolio totaled approximately $603.4 million of commitments, of which $286.0 million were funded, on total assets of $
332.2 million
. As of December 31, 2021, the portfolio totaled approximately $513.9 million of commitments, of which $248.7 million were funded, on total assets of $290.8 million. At December 31, 2022, the portfolio consisted of 108 issuers with an average balance of approximately $2.6 million versus 125 issuers with an average balance of approximately $2.0 million at December 31, 2021. NMC has a senior credit facility with a bank lending group for $285.3 million, which expires on November 13, 2025. Borrowings are secured by substantially all of NMC’s assets. NMC’s credit facility, which is
non-recourse
to us, had approximately $214.4 million and $183.3 million of borrowings outstanding at December 31, 2022 and December 31, 2021, respectively. For the years ended December 31, 2022 and 2021, SLR Business Credit had net income of $3.9 million and $7.3 million, respectively, on gross income of $29.4 million and $24.0 million, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Business Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Business Credit will be able to maintain consistent dividend payments to us. SLR Business Credit’s consolidated financial statements for the fiscal years ended December 31, 2022 and December 31, 2021 are attached as an exhibit to this annual report on Form
10-K.
Stock Repurchase Program
On May 3, 2022, our Board authorized a program for the purpose of repurchasing up to $50 million of our outstanding shares of common stock. Under the repurchase program, we may, but are not obligated to, repurchase shares of our outstanding common stock in the open market from time to time provided that we comply with our code of ethics and the guidelines specified in Rule
10b-18
of the 1934 Act, including certain price, market volume and timing constraints. In addition, any repurchases will be conducted in accordance with the 1940 Act. Unless amended or extended by our Board, we expect the repurchase program to be in place until the earlier of May 1, 2023 or until $50 million of our outstanding shares of common stock have been repurchased. The timing and number of shares to be repurchased will depend on a number of factors, including market conditions. There are no assurances that we will engage in any repurchases beyond what is reported herein. During the fiscal year ended December 31, 2022, the Company repurchased 217,271 shares at an average price of approximately $13.98 per share, inclusive of commissions. The total dollar amount of shares repurchased was $3.0 million.
SLR Senior Lending Program LLC
On October 12, 2022, the Company entered into an amended and restated limited liability company agreement with Sunstone Senior Credit L.P. (the “Investor”) to create a joint venture vehicle, SLR Senior Lending Program LLC (“SSLP”). SSLP is expected to invest primarily in senior secured cash flow loans. The Company and the Investor each have made initial equity commitments of $50 million, resulting in a total equity commitment of $100 million. Investment decisions and all material decisions in respect of SSLP must be approved by representatives of the Company and the Investor.
On December 1, 2022, SSLP commenced operations. On December 12, 2022, SSLP as servicer and SLR Senior Lending Program SPV LLC (“SSLP SPV”), a newly formed wholly owned subsidiary of SSLP, as borrower entered into a $100 million senior secured revolving credit facility (the “SSLP Facility”) with Goldman Sachs Bank USA acting as administrative agent. The SSLP Facility is scheduled to mature on December 12, 2027. The SSLP Facility generally bears interest at a rate of SOFR plus 3.25%. SSLP and SSLP SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SSLP Facility also includes usual and customary events of default for credit facilities of this nature. There were no borrowings during the period December 12, 2022 and December 31, 2022.
As of December 31, 2022 the Company and the Investor had contributed combined equity capital in the amount of $19.0 million. As of December 31, 2022, the Company and the Investor’s remaining commitments to SSLP totaled $40.5 million and $40.5 million, respectively. The Company, along with the Investor, controls the funding of SSLP, and SSLP may not call the unfunded commitments of the Company or the Investor without approval of both the Company and the Investor.
As of December 31, 2022, SSLP had total assets of $19.1 million. SSLP’s portfolio consisted of floating rate senior secured loans to seven (7) different borrowers. For the period December 1, 2022 (commencement of operations) through December 31, 2022, SSLP invested $18.1 million in seven (7) portfolio companies. Investments prepaid totaled $0.1 million for the same period.
 
68

SSLP Portfolio as of December 31, 2022 (dollar amounts in thousands)
 
Description
  
Industry
  
Spread
Above
Index
(1)
 
  
Floor
 
 
Interest
Rate
(2)
 
 
Maturity
Date
 
  
Par
Amount
 
  
Cost
 
  
Fair
Value
(3)
 
Atria Wealth Solutions, Inc.
(4)
  
Diversified Financial Services
  
 
S+600
 
  
 
1.00%
 
 
 
10.84%
 
 
 
2/29/24
 
  
$
2,494
 
  
$
2,494
 
  
$
2,494
 
BayMark Health Services, Inc.
(4)
  
Health Care Providers & Services
  
 
L+500
 
  
 
1.00%
 
 
 
9.73%
 
 
 
6/11/27
 
  
 
2,992
 
  
 
2,992
 
  
 
2,992
 
ENS Holdings III Corp. & ES Opco USA LLC
(4)
  
Trading Companies & Distributors
  
 
L+475
 
  
 
1.00%
 
 
 
9.43%
 
 
 
12/31/25
 
  
 
1,097
 
  
 
1,097
 
  
 
1,097
 
Foundation Consumer Brands, LLC
(4)
  
Personal Products
  
 
L+550
 
  
 
1.00%
 
 
 
10.15%
 
 
 
2/12/27
 
  
 
2,963
 
  
 
2,963
 
  
 
2,963
 
High Street Buyer, Inc.
(4)
  
Insurance
  
 
L+600
 
  
 
0.75%
 
 
 
10.73%
 
 
 
4/16/28
 
  
 
2,494
 
  
 
2,494
 
  
 
2,494
 
Ivy Fertility Services, LLC
(4)
  
Health Care Providers & Services
  
 
L+625
 
  
 
1.00%
 
 
 
10.39%
 
 
 
2/25/26
 
  
 
3,000
 
  
 
3,000
 
  
 
3,030
 
Kid Distro Holdings, LLC
(4)
  
Software
  
 
L+575
 
  
 
1.00%
 
 
 
10.48%
 
 
 
10/1/27
 
  
 
2,992
 
  
 
2,992
 
  
 
2,992
 
  
  
  
 
 
  
  
 
 
 
  
 
 
 
  
  
  
 
 
  
  
$
18,032
 
  
$
18,062
 
  
  
  
 
 
  
  
 
 
 
  
 
 
 
 
(1)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or SOFR. These instruments are typically subject to a LIBOR or SOFR floor.
(2)
Floating rate debt investments typically bear interest at a rate determined by reference to either the LIBOR (“L”) or SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022.
(3)
Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
(4)
The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
Below is certain summarized financial information for SSLP as of December 31, 2022 and for the period December 1, 2022 (commencement of operations) through December 31, 2022:
 
 
  
December 31,
2022
 
Selected Balance Sheet Information for SSLP (in thousands):
  
Investments at fair value (cost $18,032)
  
$
18,062
 
Cash and other assets
  
 
1,043
 
  
 
 
 
Total assets
  
$
19,105
 
  
 
 
 
Debt outstanding
  
$
—  
 
Interest payable and other credit facility related expenses
  
 
165
 
Accrued expenses and other payables
  
 
89
 
  
 
 
 
Total liabilities
  
$
254
 
  
 
 
 
Members’ equity
  
$
18,851
 
  
 
 
 
Total liabilities and members’ equity
  
$
19,105
 
  
 
 
 
 
69

    
For the Period
December 1, 2022
(commencement of
operations) through
December 31, 2022
 
Selected Income Statement Information for SSLP (in thousands):
  
Interest income
   $ 152  
  
 
 
 
Service fees*
   $ 4  
Interest and other credit facility expenses
     166  
Organizational costs
     73  
Other general and administrative expenses
     88  
  
 
 
 
Total expenses
     331  
  
 
 
 
Net investment loss
   $ (179
  
 
 
 
Realized gain on investments
     —    
Net change in unrealized gain on investments
     30  
  
 
 
 
Net realized and unrealized gain on investments
     30  
  
 
 
 
Net loss
   $ (149
  
 
 
 
 
*
Service fees are included within the Company’s Consolidated Statements of Operations as other income.
Critical Accounting Policies
The preparation of consolidated financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and revenues and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following items as critical accounting policies. Within the context of these critical accounting policies and disclosed subsequent events herein, we are not currently aware of any other reasonably likely events or circumstances that would result in materially different amounts being reported.
Valuation of Portfolio Investments
In December 2020, the SEC adopted new Rule
2a-5
under the 1940 Act addressing fair valuation of fund investments. The new rule sets forth requirements for good faith determinations of fair value, as well as for the performance of fair value determinations, including related oversight and reporting obligations. The new rule also defines “readily available market quotations” for purposes of the definition of “value” under the 1940 Act, and the SEC noted that this definition will apply in all contexts under the 1940 Act. The Company will comply with Rule
2a-5’s
valuation requirements.
We conduct the valuation of our assets, pursuant to which our net asset value is determined, at all times consistent with GAAP, and the 1940 Act. The Board will (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services, as applicable; (5) oversee the reporting required by Rule
2a-5
under the 1940 Act; and (6) maintain recordkeeping requirements under Rule
2a-5.
It is anticipated that in respect of many of the Company’s assets, readily available market quotations will not be obtainable and that such assets will be valued at fair value. A market quotation is readily available for a security only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. If the Company anticipates using a market quotation for a security, it will also monitor for circumstances that may necessitate the use of fair value, such as significant events that may cause concern over the reliability of a market quotation.
Our valuation procedures are set forth in more detail in Note 2(b) to the Company’s Consolidated Financial Statements Determination of fair value involves subjective judgments and estimates. Accordingly, the notes to our consolidated financial statements express the uncertainty with respect to the possible effect of such valuations, and any change in such valuations, on our consolidated financial statements.
 
70

Revenue Recognition
The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Investments that are expected to pay regularly scheduled interest and/or dividends in cash are generally placed on
non-accrual
status when principal or interest/dividend cash payments are past due 30 days or more (90 days or more for equipment financing) and/or when it is no longer probable that principal or interest/dividend cash payments will be collected. Such
non-accrual
investments are restored to accrual status if past due principal and interest or dividends are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining interest or dividend obligations. Interest or dividend cash payments received on investments may be recognized as income or applied to principal depending upon management’s judgment. Some of our investments may have contractual PIK income. PIK income computed at the contractual rate, as applicable, is accrued and reflected as a receivable up to the capitalization date. PIK investments offer issuers the option at each payment date of making payments in cash or in additional securities. When additional securities are received, they typically have the same terms, including maturity dates and interest rates as the original securities issued. On these payment dates, the Company capitalizes the accrued interest or dividends receivable (reflecting such amounts as the basis in the additional securities received). PIK generally becomes due at the maturity of the investment or upon the investment being called by the issuer. At the point the Company believes PIK is not expected to be realized, the PIK investment will be placed on
non-accrual
status. When a PIK investment is placed on
non-accrual
status, the accrued, uncapitalized interest or dividends is reversed from the related receivable through interest or dividend income, respectively. The Company does not reverse previously capitalized PIK income. Upon capitalization, PIK is subject to the fair value estimates associated with their related investments. PIK investments on
non-accrual
status are restored to accrual status if the Company again believes that PIK is expected to be realized. Loan origination fees, original issue discount, and market discounts are capitalized and amortized into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record prepayment premiums on loans and other investments as interest income when we receive such amounts. Capital structuring fees are recorded as other income when earned.
The typically higher yields and interest rates on PIK securities, to the extent we invested, reflects the payment deferral and increased credit risk associated with such instruments and that such investments may represent a significantly higher credit risk than coupon loans. PIK securities may have unreliable valuations because their continuing accruals require continuing judgments about the collectability of the deferred payments and the value of any associated collateral. PIK income has the effect of generating investment income and increasing the incentive fees payable at a compounding rate. In addition, the deferral of PIK income also increases the
loan-to-value
ratio at a compounding rate. PIK securities create the risk that incentive fees will be paid to the Investment Adviser based on
non-cash
accruals that ultimately may not be realized, but the Investment Adviser will be under no obligation to reimburse the Company for these fees. For the fiscal years ended December 31, 2022 and 2021, capitalized PIK income totaled $4.3 million and $7.6 million, respectively.
Net Realized Gain or Loss and Net Change in Unrealized Gain or Loss
We generally measure realized gain or loss by the difference between the net proceeds from the repayment or sale and the amortized cost basis of the investment, without regard to unrealized appreciation or depreciation previously recognized, but considering unamortized origination or commitment fees and prepayment penalties. The net change in unrealized gain or loss reflects the change in portfolio investment values during the reporting period, including the reversal of previously recorded unrealized gain or loss, when gains or losses are realized. Gains or losses on investments are calculated by using the specific identification method.
Income Taxes
SLRC, a U.S. corporation, has elected to be treated, and intends to qualify annually, as a RIC under Subchapter M of the Code. In order to qualify for U.S. federal income taxation as a RIC, the Company is required, among other things, to timely distribute to its stockholders at least 90% of investment company taxable income, as defined by the Code, for each year. Depending on the level of taxable income earned in a given tax year, we may choose to carry forward taxable income in excess of current year distributions into the next tax year and pay a nondeductible 4% U.S. federal excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income will be in excess of estimated current year distributions, the Company accrues an estimated excise tax, if any, on estimated excess taxable income.
Recent Accounting Pronouncements
In March 2020, the FASB issued Accounting Standards Update
No. 2020-04,
“Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The guidance provides optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships and other transactions, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued because of the reference rate reform. ASU
2020-04
is effective for all entities as of March 12, 2020 through December 31, 2022. The Company has determined that the adoption of this guidance has not had a material impact on the Company’s consolidated financial statements and disclosures.
 
71

RESULTS OF OPERATIONS
Results comparisons are for the fiscal years ended December 31, 2022 and December 31, 2021. Results for the fiscal year ended December 31, 2020 can be found in Item 7 of the Company’s report on Form
10-K
filed on March 1, 2022, which is incorporated by reference herein.
Investment Income
For the fiscal years ended December 31, 2022 and 2021, gross investment income totaled $177.5 million and $139.4 million, respectively. The increase in gross investment income for the year over year period was primarily due to a larger portfolio size as a result of the Mergers coupled with organic growth, as well as due to an increase in loan reference rates.
Expenses
Net expenses totaled $101.1 million and $78.4 million, respectively, for the fiscal years ended December 31, 2022 and 2021, of which $45.1 million and $38.6 million, respectively, were base management fees and performance-based incentive fees and $46.1 million and $29.9 million, respectively, were interest and other credit facility expenses. Other general and administrative expenses totaled $11.5 million and $10.0 million, respectively, for the fiscal years ended December 31, 2022 and 2021. Over the same periods, $1.5 million and $0.0 million of performance-based incentive fees were waived. Expenses generally consist of management and performance-based incentive fees, interest and other credit facility expenses, administrative services fees, insurance expenses, legal fees, directors’ fees, transfer agency fees, printing and proxy expenses, audit and tax services expenses, and other general and administrative expenses. Interest and other credit facility expenses generally consist of interest, unused fees, agency fees and loan origination fees, if any, among others. The increase in expenses for the year over year period was primarily due to higher interest expense associated with an increase in borrowings to fund new investments as well as the increase in reference rates.
Net Investment Income
The Company’s net investment income totaled $76.4 million and $60.9 million, or $1.48 and $1.44, per average share, respectively, for the fiscal years ended December 31, 2022 and 2021.
Net Realized Gain (Loss)
The Company had investment sales and prepayments totaling approximately $532 million and $468 million, respectively, for the fiscal years ended December 31, 2022 and 2021. Net realized gain (loss) over the same periods were ($36.5) million and $0.03 million, respectively. Net realized losses for fiscal year 2022 were primarily related to the exit of our investment in PhyMed Management, LLC. Net realized gain for fiscal year 2021 was de minimis.
Net Change in Unrealized Loss
For the fiscal years ended December 31, 2022 and 2021, net change in unrealized loss on the Company’s assets and liabilities totaled $21.5 million and $1.4 million, respectively. Net unrealized loss for the fiscal year ended December 31, 2022 is primarily due to depreciation in the value of our investments in American Teleconferencing Services, Ltd., RD Holdco, Inc., SLR Credit Solutions and SLR Equipment Finance, among others, partially offset by the reversal of previously recognized unrealized depreciation on our investment in PhyMed Management LLC as well as appreciation on the value of our investments in SLR Business Credit and KBH Topco, LLC in addition to unrealized appreciation on assets acquired in the Mergers due to the accounting treatment of the purchase discount. Net unrealized loss for the fiscal year ended December 31, 2021 is primarily due to depreciation in the value of our investments in American Teleconferencing Services, Ltd., Rug Doctor and SOAGG LLC, among others, partially offset by appreciation in the value of our investments in KBH Topco, LLC, SLR Credit Solutions and PhyMed Management LLC, among others.
Net Increase in Net Assets From Operations
For the fiscal years ended December 31, 2022 and 2021, the Company had a net increase in net assets resulting from operations of $18.3 million and $59.6 million, respectively. For the fiscal years ended December 31, 2022 and 2021, earnings per average share were $0.35 and $1.41, respectively.
 
72

LIQUIDITY AND CAPITAL RESOURCES
The Company’s liquidity and capital resources are generated and generally available through its Credit Facility and SPV Credit Facility (as defined below), the 2023 Unsecured Notes, the 2024 Unsecured Notes, the 2025 Unsecured Notes, the 2026 Unsecured Notes, the 2027 Unsecured Notes and the 2027 Series F Unsecured Notes, through cash flows from operations, investment sales, prepayments of senior and subordinated loans, income earned on investments and cash equivalents, and periodic
follow-on
equity and/or debt offerings. As of December 31, 2022, we had a total of $401.8 million of unused borrowing capacity under the Credit Facility and SPV Credit Facility, subject to borrowing base limits.
We may from time to time issue equity and/or debt securities in either public or private offerings. The issuance of such securities will depend on future market conditions, funding needs and other factors and there can be no assurance that any such issuance will occur or be successful. The primary uses of existing funds and any funds raised in the future is expected to be for investments in portfolio companies, repayment of indebtedness, cash distributions to our stockholders, or for other general corporate purposes.
On April 1, 2022, we entered into an assumption agreement (the “CF Assumption Agreement”), effective as of the closing of the Mergers. The CF Assumption Agreement relates to our assumption of the Revolving Credit Facility, originally entered into on August 26, 2011 (as amended from time to time, the “SPV Credit Facility”), by and among SUNS SPV LLC (the “SUNS SPV”), a wholly-owned subsidiary of SUNS, acting as borrower, Citibank, N.A., acting as administrative agent and collateral agent, and the other parties thereto. Currently, the commitment under the SPV Credit Facility is $225 million; however, the commitment can also be expanded up to $600 million. The stated interest rate on the SPV Credit Facility is LIBOR plus
2.00%-2.50%
with no LIBOR floor requirement and the current final maturity date is June 1, 2026. The SPV Credit Facility is secured by all of the assets held by SUNS SPV. Under the terms of the SPV Credit Facility and related transaction documents, we as successor to SUNS, and SUNS SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SPV Credit Facility also includes usual and customary events of default for credit facilities of this nature.
On April 1, 2022, we entered into an assumption agreement (the “Note Assumption Agreement”), effective as of the closing of the Mergers. The Note Assumption Agreement relates to our assumption of $85 million in aggregate principal amount of five-year, 3.90% senior unsecured notes, due March 31, 2025 (the “2025 Unsecured Notes”) and other obligations of SUNS under the Note Purchase Agreement, dated as of March 31, 2020 (the “Note Purchase Agreement”), among SUNS and certain institutional investors. Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30. Pursuant to the Note Assumption Agreement, we expressly assumed on behalf of SUNS the due and punctual payment of the principal of (and premium, if any) and interest on all the 2025 Unsecured Notes outstanding, and the due and punctual performance and observance of every covenant and every condition of the Note Purchase Agreement, to be performed or observed by SUNS.
On January 6, 2022, the Company closed a private offering of $135 million of the 2027 Series F Unsecured Notes with a fixed interest rate of 3.33% and a maturity date of January 6, 2027. Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6. The 2027 Series F Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 28, 2021, the Company closed on Amendment No. 1 to its August 28, 2019 senior secured credit agreement (the “Credit Facility”). Following the amendment and a November 2022 upsizing, the Credit Facility is composed of $625 million of revolving credit and $100 million of term loans. Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of
1.75%-2.00%
or the alternate base rate plus
0.75%-1.00%.
The Credit Facility has a 0% floor and matures in December 2026 and includes ratable amortization in the final year.
On September 14, 2021, the Company closed a private offering of $50 million of the 2027 Unsecured Notes with a fixed interest rate of 2.95% and a maturity date of March 14, 2027. Interest on the 2027 Unsecured Notes is due semi-annually on March 14 and September 14. The 2027 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $125 million of the 2024 Unsecured Notes with a fixed interest rate of 4.20% and a maturity date of December 15, 2024. Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15. The 2024 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $75 million of the 2026 Unsecured Notes with a fixed interest rate of 4.375% and a maturity date of December 15, 2026. Interest on the 2026 Unsecured Notes is due semi-annually on June 15 and December 15. The 2026 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 28, 2017, the Company closed a private offering of $21 million of the 2022 Tranche C Notes with a fixed interest rate of 4.50% and a maturity date of December 28, 2022. Interest on the 2022 Tranche C Notes is due semi-annually on June 28 and December 28. The 2022 Tranche C Notes were repaid in full at maturity.
 
73

On November 22, 2017, we issued $75 million in aggregate principal amount of publicly registered 2023 Unsecured Notes for net proceeds of $73.8 million. Interest on the 2023 Unsecured Notes is paid semi-annually on January 20 and July 20, at a fixed rate of 4.50% per year, commencing on January 20, 2018. The 2023 Unsecured Notes mature on January 20, 2023.
On February 15, 2017, the Company closed a private offering of $100 million of the 2022 Unsecured Notes with a fixed interest rate of 4.60% and a maturity date of May 8, 2022. Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On November 8, 2016, the Company closed a private offering of $50 million of the 2022 Unsecured Notes with a fixed interest rate of 4.40% and a maturity date of May 8, 2022. Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional buyers. The 2022 Unsecured Notes were repaid in full at maturity.
On January 11, 2013, the Company closed its most recent
follow-on
public equity offering of 6.3 million shares of common stock raising approximately $146.9 million in net proceeds. The primary uses of the funds raised were for investments in portfolio companies, reductions in revolving debt outstanding and for other general corporate purposes.
Cash Equivalents
We deem certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities as cash equivalents. The Company makes purchases that are consistent with its purpose of making investments in securities described in paragraphs 1 through 3 of Section 55(a) of the 1940 Act. From time to time, including at or near the end of each fiscal quarter, we consider using various temporary investment strategies for our business. One strategy includes taking proactive steps by utilizing cash equivalents as temporary assets with the objective of enhancing our investment flexibility pursuant to Section 55 of the 1940 Act. More specifically, from time to time we may purchase U.S. Treasury bills or other high-quality, short-term debt securities at or near the end of the quarter and typically close out the position on a net cash basis subsequent to quarter end. We may also utilize repurchase agreements or other balance sheet transactions, including drawing down on the Credit Facility, as deemed appropriate. The amount of these transactions or such drawn cash for this purpose is excluded from total assets for purposes of computing the asset base upon which the management fee is determined. We held approximately $420 million par amount in cash equivalents as of December 31, 2022.
Debt
Unsecured Notes
On April 1, 2022, we entered into the Note Assumption Agreement, effective as of the closing of the Mergers. The Note Assumption Agreement relates to our assumption of $85 million of the 2025 Unsecured Notes and other obligations of SUNS under the Note Purchase Agreement, among SUNS and certain institutional investors. Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30. Pursuant to the Note Assumption Agreement, we expressly assumed on behalf of SUNS the due and punctual payment of the principal of (and premium, if any) and interest on all the 2025 Unsecured Notes outstanding, and the due and punctual performance and observance of every covenant and every condition of the Note Purchase Agreement, to be performed or observed by SUNS.
On January 6, 2022, the Company closed a private offering of $135 million of the 2027 Series F Unsecured Notes with a fixed interest rate of 3.33% and a maturity date of January 6, 2027. Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6. The 2027 Series F Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On September 14, 2021, the Company closed a private offering of $50 million of the 2027 Unsecured Notes with a fixed interest rate of 2.95% and a maturity date of March 14, 2027. Interest on the 2027 Unsecured Notes is due semi-annually on March 14 and September 14. The 2027 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $125 million of the 2024 Unsecured Notes with a fixed interest rate of 4.20% and a maturity date of December 15, 2024. Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15. The 2024 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $75 million of the 2026 Unsecured Notes with a fixed interest rate of 4.375% and a maturity date of December 15, 2026. Interest on the 2026 Unsecured Notes is due semi-annually on June 15 and December 15. The 2026 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 28, 2017, the Company closed a private offering of $21 million of the 2022 Tranche C Notes with a fixed interest rate of 4.50% and a maturity date of December 28, 2022. Interest on the 2022 Tranche C Notes is due semi-annually on June 28 and December 28. The 2022 Tranche C Notes were repaid in full at maturity.
 
74

On November 22, 2017, we issued $75 million in aggregate principal amount of publicly registered 2023 Unsecured Notes for net proceeds of $73.8 million. Interest on the 2023 Unsecured Notes is paid semi-annually on January 20 and July 20, at a fixed rate of 4.50% per year, commencing on January 20, 2018. The 2023 Unsecured Notes mature on January 20, 2023.
On February 15, 2017, the Company closed a private offering of $100 million of the 2022 Unsecured Notes with a fixed interest rate of 4.60% and a maturity date of May 8, 2022. Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On November 8, 2016, the Company closed a private offering of $50 million of the 2022 Unsecured Notes with a fixed interest rate of 4.40% and a maturity date of May 8, 2022. Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional buyers. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional buyers. The 2022 Unsecured Notes were repaid in full at maturity.
Revolving & Term Loan Facilities
On April 1, 2022, we entered into the CF Assumption Agreement, effective as of the closing of the Mergers. The CF Assumption Agreement relates to our assumption of the SPV Credit Facility, by and among SUNS SPV, a wholly-owned subsidiary of SUNS, acting as borrower, Citibank, N.A., acting as administrative agent and collateral agent, and the other parties thereto. Currently, the commitment under the SPV Credit Facility is $225 million; however, the commitment can also be expanded up to $600 million. The stated interest rate on the SPV Credit Facility is LIBOR plus
2.00%-2.50%
with no LIBOR floor requirement and the current final maturity date is June 1, 2026. The SPV Credit Facility is secured by all of the assets held by SUNS SPV. Under the terms of the SPV Credit Facility and related transaction documents, we as successor to SUNS, and SUNS SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SPV Credit Facility also includes usual and customary events of default for credit facilities of this nature. At December 31, 2022, outstanding USD equivalent borrowings under the SPV Credit Facility totaled $155.2 million.
On December 28, 2021, the Company closed on Amendment No. 1 to the Credit Facility. Following the amendment and a November 2022 upsizing, the Credit Facility is composed of $625 million of revolving credit and $100 million of term loans. Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of
1.75%-2.00%
or the alternate base rate plus
0.75%-1.00%.
The Credit Facility has a 0% floor and matures in December 2026 and includes ratable amortization in the final year. The Credit Facility may be increased up to $800 million with additional new lenders or an increase in commitments from current lenders. The Credit Facility contains certain customary affirmative and negative covenants and events of default. In addition, the Credit Facility contains certain financial covenants that among other things, require the Company to maintain a minimum shareholder’s equity and a minimum asset coverage ratio. At December 31, 2022, outstanding USD equivalent borrowings under the Credit Facility totaled $393.0 million, composed of $293.0 million of revolving credit and $100.0 million of term loans.
Certain covenants on our issued debt may restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a RIC under Subchapter M of the Code. At December 31, 2022, the Company was in compliance with all financial and operational covenants required by the Debt Instruments.
Contractual Obligations
A summary of our significant contractual payment obligations is as follows as of December 31, 2022:
Payments Due by Period (in millions)
 
 
  
Total
 
  
Less than
1 Year
 
  
1-3 Years
 
  
3-5 Years
 
  
More Than
5 Years
 
Revolving credit facilities (1)
  
$
448.2
 
  
$
—  
  
$
—  
 
  
$
448.2
 
  
$
—  
Unsecured senior notes
  
 
545.0
 
  
 
75.0
  
 
210.0
  
 
260.0
  
 
—  
 
Term loans
  
 
100.0
 
  
 
—  
 
  
 
—  
 
  
 
100.0
 
  
 
—  
 
 
(1)
As of December 31, 2022, we had a total of $401.8 million of unused borrowing capacity under our revolving credit facilities, subject to borrowing base limits.
 
7
5

Under the provisions of the 1940 Act, we are permitted, as a BDC, to issue senior securities in amounts such that our asset coverage ratio, as defined in the 1940 Act, equals at least 150% of gross assets less all liabilities and indebtedness not represented by senior securities, after each issuance of senior securities. If the value of our assets declines, we may be unable to satisfy the asset coverage test. If that happens, we may be required to sell a portion of our investments and, depending on the nature of our leverage, repay a portion of our indebtedness at a time when such sales may be disadvantageous. Also, any amounts that we use to service our indebtedness would not be available for distributions to our common stockholders. Furthermore, as a result of issuing senior securities, we would also be exposed to typical risks associated with leverage, including an increased risk of loss.
We have also entered into two contracts under which we have future commitments: the Advisory Agreement, pursuant to which the Investment Adviser has agreed to serve as our investment adviser, and the Administration Agreement, pursuant to which the Administrator has agreed to furnish us with the facilities and administrative services necessary to conduct our
day-to-day
operations and provide on our behalf managerial assistance to those portfolio companies to which we are required to provide such assistance. Payments under the Advisory Agreement are equal to (1) a percentage of the value of our average gross assets and (2) a
two-part
incentive fee. Payments under the Administration Agreement are equal to an amount based upon our allocable portion of the Administrator’s overhead in performing its obligations under the Administration Agreement, including rent, technology systems, insurance and our allocable portion of the costs of our chief financial officer and chief compliance officer and their respective staffs. Either party may terminate each of the Advisory Agreement and administration agreement without penalty upon 60 days written notice to the other. See note 3 to our Consolidated Financial Statements.
On July 31, 2017, the Company, NEFPASS LLC and NEFCORP LLC entered into a servicing agreement. NEFCORP LLC was engaged to provide NEFPASS LLC with administrative services related to the loans and capital leases held by NEFPASS LLC. NEFPASS LLC may terminate this agreement upon 30 days written notice to NEFCORP LLC.
On October 7, 2022, the Company commitment $50 million to SSLP and entered into a servicing agreement. SSLP engaged and retained the Company to provide certain administrative services relating to the facilities, supplies and necessary ongoing overhead support services for the operation of SSLP’s ongoing business affairs in exchange for a fee.
Senior Securities
Information about our senior securities is shown in the following table (in thousands) as of each year ended December 31 for the past ten years, unless otherwise noted. The “—” indicates information which the SEC expressly does not require to be disclosed for certain types of senior securities.
 
Class and Year
  
Total Amount
Outstanding(1)
 
  
Asset
Coverage
Per Unit(2)
 
  
Involuntary
Liquidating
Preference
Per Unit(3)
 
  
Average
Market Value
Per Unit(4)
 
Credit Facility
  
  
  
  
Fiscal 2022
   $ 293,000      $ 513                  N/A  
Fiscal 2021
     222,500        552                  N/A  
Fiscal 2020
     126,000        421                  N/A  
Fiscal 2019
     42,900        182                  N/A  
Fiscal 2018
     96,400        593                  N/A  
Fiscal 2017
     245,600        1,225                  N/A  
Fiscal 2016
     115,200        990                  N/A  
Fiscal 2015
     207,900        1,459                  N/A  
Fiscal 2014
                                   N/A  
Fiscal 2013
                                   N/A  
SPV Credit Facility
                                   
Fiscal 2022
     155,200        272                  N/A  
2022 Unsecured Notes
                                   
Fiscal 2022
                                   N/A  
Fiscal 2021
     150,000        372                  N/A  
Fiscal 2020
     150,000        501                  N/A  
Fiscal 2019
     150,000        638                  N/A  
Fiscal 2018
     150,000        923                  N/A  
Fiscal 2017
     150,000        748                  N/A  
Fiscal 2016
     50,000        430                  N/A  
2022 Tranche C Notes
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7
6

Class and Year
  
Total Amount
Outstanding(1)
 
  
Asset
Coverage
Per Unit(2)
 
  
Involuntary
Liquidating
Preference
Per Unit(3)
 
  
Average
Market Value
Per Unit(4)
 
Fiscal 2022
                                   N/A  
Fiscal 2021
     21,000        52                  N/A  
Fiscal 2020
     21,000        70                  N/A  
Fiscal 2019
     21,000        89                  N/A  
Fiscal 2018
     21,000        129                  N/A  
Fiscal 2017
     21,000        105                  N/A  
2023 Unsecured Notes
                                   
Fiscal 2022
     75,000        131                  N/A  
Fiscal 2021
     75,000        186                  N/A  
Fiscal 2020
     75,000        250                  N/A  
Fiscal 2019
     75,000        319                  N/A  
Fiscal 2018
     75,000        461                  N/A  
Fiscal 2017
     75,000        374                  N/A  
2024 Unsecured Notes
                                   
Fiscal 2022
     125,000        219                  N/A  
Fiscal 2021
     125,000        309                  N/A  
Fiscal 2020
     125,000        417                  N/A  
Fiscal 2019
     125,000        531                  N/A  
2025 Unsecured Notes
                                   
Fiscal 2022
     85,000        149                  N/A  
2026 Unsecured Notes
                                   
Fiscal 2022
     75,000        131                  N/A  
Fiscal 2021
     75,000        186                  N/A  
Fiscal 2020
     75,000        250                  N/A  
Fiscal 2019
     75,000        319                  N/A  
2027 Unsecured Notes
                                   
Fiscal 2022
     50,000        88                  N/A  
Fiscal 2021
     50,000        124                  N/A  
2027 Series F Unsecured Notes
                                   
Fiscal 2022
     135,000        237                  N/A  
2042 Unsecured Notes
                                   
Fiscal 2017
                                   N/A  
Fiscal 2016
     100,000        859                $ 1,002  
Fiscal 2015
     100,000        702                  982  
Fiscal 2014
     100,000        2,294                  943  
Fiscal 2013
     100,000        2,411                  934  
Senior Secured Notes
                                   
Fiscal 2017
                                   N/A  
Fiscal 2016
     75,000        645                  N/A  
Fiscal 2015
     75,000        527                  N/A  
Fiscal 2014
     75,000        1,721                  N/A  
Fiscal 2013
     75,000        1,808                  N/A  
Term Loans
                                   
Fiscal 2022
     100,000        175                  N/A  
Fiscal 2021
     100,000        248                  N/A  
Fiscal 2020
     75,000        250                  N/A  
Fiscal 2019
     75,000        319                  N/A  
Fiscal 2018
     50,000        308                  N/A  
Fiscal 2017
     50,000        250                  N/A  
Fiscal 2016
     50,000        430                  N/A  
Fiscal 2015
     50,000        351                  N/A  
Fiscal 2014
     50,000        1,147                  N/A  
Fiscal 2013
     50,000        1,206                  N/A  
 
7
7

NEFPASS Facility
  
  
  
  
Fiscal 2021
                                   N/A  
Fiscal 2020
     30,000        100                  N/A  
Fiscal 2019
     30,000        128                  N/A  
Fiscal 2018
     30,000        185                  N/A  
SSLP Facility
                                   
Fiscal 2019
                                   N/A  
Fiscal 2018
     53,785        331                  N/A  
Total Senior Securities
                                   
Fiscal 2022
   $ 1,093,200      $ 1,915                  N/A  
Fiscal 2021
     818,500        2,029                  N/A  
Fiscal 2020
     677,000        2,259                  N/A  
Fiscal 2019
     593,900        2,525                  N/A  
Fiscal 2018
     476,185        2,930                  N/A  
Fiscal 2017
     541,600        2,702                  N/A  
Fiscal 2016
     390,200        3,354                  N/A  
Fiscal 2015
     432,900        3,039                  N/A  
Fiscal 2014
     225,000        5,162                  N/A  
Fiscal 2013
     225,000        5,425                  N/A  
 

(1)
Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented.
(2)
The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of December 31, 2022, asset coverage was 1
91
.
5
%.
(3)
The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it.
(4)
Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014 and 2013 periods was $100,175, $98,196, $94,301 and $93,392, respectively.
The following is a schedule of financial highlights for the respective years:
 
 
  
Year ended
December 31,
2017
 
 
Year ended
December 31,
2016
 
 
Year ended
December 31,
2015
 
 
Year ended
December 31,
2014
 
 
Year ended
December 31,
2013
 
Per Share Data: (a)
  
 
 
 
 
Net asset value, beginning of year
  
$
21.74
 
 
$
20.79
 
 
$
22.05
 
 
$
22.50
 
 
$
22.70
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
  
 
1.62
 
 
 
1.68
 
 
 
1.52
 
 
 
1.56
 
 
 
1.91
 
Net realized and unrealized gain (loss)
  
 
0.05
 
 
 
0.84
 
 
 
(1.18
 
 
(0.43
 
 
(0.22
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net increase in net assets resulting from operations
  
 
1.67
 
 
 
2.52
 
 
 
0.34
 
 
 
1.13
 
 
 
1.69
 
Distributions to stockholders (see note 8a):
  
 
 
 
 
From net investment income
  
 
(1.60
 
 
(1.60
 
 
(1.60
 
 
(1.55
 
 
(1.55
From net realized gains
  
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
(0.46
From return of capital
  
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
(0.05
 
 
—  
 
Anti-dilution
  
 
—  
 
 
 
0.03
 
 
 
—  
 
 
 
0.02
 
 
0.12
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net asset value, end of year
  
$
21.81
 
 
$
21.74
 
 
$
20.79
 
 
$
22.05
 
 
$
22.50
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Per share market value, end of year
  
$
20.21
 
 
$
20.82
 
 
$
16.43
 
 
$
18.01
 
 
$
22.55
 
Total Return(b)
  
 
4.47
 
 
37.49
 
 
(0.29
)% 
 
 
(13.58
)% 
 
 
2.82
Net assets, end of year
  
$
921,605
 
 
$
918,507
 
 
$
882,698
 
 
$
936,568
 
 
$
995,637
 
Shares outstanding, end of year
  
 
42,260,826
 
 
 
42,248,525
 
 
 
42,464,762
 
 
 
42,465,162
 
 
 
44,244,195
 
Ratios to average net assets:
  
 
 
 
 
Net investment income
  
 
7.43
 
 
7.91
 
 
6.94
 
 
6.93
 
 
8.43
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Operating expenses
  
 
5.80
 
 
6.25
 
 
3.84
%* 
 
 
4.24
 
 
5.82
Interest and other credit facility expenses**
  
 
2.35
 
 
2.73
 
 
1.68
 
 
1.50
 
 
1.99
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total expenses
  
 
8.15
 
 
8.98
 
 
5.52
%* 
 
 
5.74
 
 
7.81
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Average debt outstanding
  
$
414,264
 
 
$
495,795
 
 
$
262,341
 
 
$
225,000
 
 
$
318,186
 
Portfolio turnover ratio
  
 
24.9
 
 
31.0
 
 
13.0
 
 
53.7
 
 
25.6
 
 
7
8

(a)
Calculated using the average shares outstanding method.
(b)
Total return is based on the change in market price per share during the year and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. Total return does not include a sales load.
*
The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of a voluntary incentive fee waiver (see note 3). For the year ended December 31, 2015, the ratios of operating expenses to average net assets and total expenses to average net assets would be 4.02% and 5.70%, respectively, without the voluntary incentive fee waiver.
**
Ratios shown without the
non-recurring
costs associated with the amendments and establishment of the Credit Facility and 2022 Unsecured Notes would be 2.29%, 2.39%, 1.68%, 1.50% and 1.74%, respectively for the years shown.
Off-Balance
Sheet Arrangements
From time to time and in the normal course of business, the Company may make unfunded capital commitments to current or prospective portfolio companies. Typically, the Company may agree to provide delayed-draw term loans or, to a lesser extent, revolving loan or equity commitments. These unfunded capital commitments always take into account the Company’s liquidity and cash available for investment, portfolio and issuer diversification, and other considerations. Accordingly, the Company had the following unfunded capital commitments at December 31, 2022 and December 31, 2021, respectively:
 
 
  
December 31,
2022
 
  
December 31,
2021
 
(in millions)
 
SLR Credit Solutions*
  
$
44.3
 
  
$
44.3
 
Outset Medical, Inc
  
 
35.1
 
  
 
—  
 
Apeel Technology, Inc
  
 
32.8
 
  
 
—  
 
CC SAG Holdings Corp. (Spectrum Automotive)
  
 
20.7
 
  
 
18.8
 
Human Interest, Inc
  
 
20.1
 
  
 
—  
 
Glooko, Inc
  
 
17.9
 
  
 
25.1
 
World Insurance Associates, LLC
  
 
17.1
 
  
 
—  
 
iCIMS, Inc
  
 
11.4
 
  
 
—  
 
Spectrum Pharmaceuticals, Inc
  
 
8.8
 
  
 
—  
 
Arcutis Biotherapeutics, Inc
  
 
8.4
 
  
 
43.5
 
Atria Wealth Solutions, Inc
  
 
8.2
 
  
 
3.7
 
Ardelyx, Inc
  
 
7.8
 
  
 
—  
 
Luxury Asset Capital, LLC
  
 
7.5
 
  
 
—  
 
RSC Acquisition, Inc
  
 
7.5
 
  
 
—  
 
Cerapedics, Inc
  
 
6.7
 
  
 
—  
 
Maurices, Incorporated
  
 
4.3
 
  
 
5.7
 
Kaseya, Inc
  
 
3.9
 
  
 
—  
 
Vessco Midco Holdings, LLC
  
 
3.9
 
  
 
—  
 
Copper River Seafoods, Inc
  
 
3.6
 
  
 
—  
 
BDG Media, Inc
  
 
3.5
 
  
 
—  
 
Meditrina, Inc
  
 
3.4
 
  
 
—  
 
One Touch Direct, LLC
  
 
3.1
 
  
 
7.2
 
DeepIntent, Inc
  
 
3.1
 
  
 
—  
 
Foundation Consumer Brands, LLC
  
 
3.0
 
  
 
2.3
 
SCP Eye Care, LLC
  
 
2.8
 
  
 
—  
 
Basic Fun, Inc
  
 
2.7
 
  
 
1.9
 
Kid Distro Holdings, LLC
  
 
2.7
 
  
 
2.7
 
Plastics Management, LLC
  
 
2.4
 
  
 
—  
 
Southern Orthodontic Partners Management, LLC
  
 
1.9
 
  
 
—  
 
Pediatric Home Respiratory Services, LLC
  
 
1.8
 
  
 
—  
 
Pinnacle Treatment Centers, Inc
  
 
1.7
 
  
 
1.4
 
Ultimate Baked Goods Midco LLC
  
 
1.6
 
  
 
0.8
 
Orthopedic Care Partners Management, LLC
  
 
1.6
 
  
 
—  
 
Ivy Fertility Services, LLC
  
 
1.6
 
  
 
4.5
 
Composite Technology Acquisition Corp
  
 
1.5
 
  
 
—  
 
NAC Holdings Corporation
  
 
1.5
 
  
 
4.8
 
SLR Healthcare ABL*
  
 
1.4
 
  
 
—  
 
SPAR Marketing Force, Inc
  
 
1.3
 
  
 
—  
 
RxSense Holdings LLC
  
 
1.3
 
  
 
—  
 
Erie Construction
Mid-west,
LLC
  
 
1.3
 
  
 
—  
 
Peter C. Foy & Associates Insurance Services, LLC
  
 
1.1
 
  
 
—  
 
American Teleconferencing Services, Ltd
  
 
1.1
 
  
 
0.6
 
 
79

    
December 31,
2022
    
December 31,
2021
 
(in millions)
 
Montefiore Nyack Hospital
     1.0        —    
Enverus Holdings, Inc
     1.0        —    
SLR Equipment Finance
     1.0        5.0  
SunMed Group Holdings, LLC
     0.8        0.8  
GSM Acquisition Corp
     0.8        —    
Tilley Distribution, Inc
     0.5        —    
BayMark Health Services, Inc
     0.4        —    
High Street Buyer, Inc
     0.3        —    
TAUC Management, LLC
     0.3        —    
ENS Holdings III Corp, LLC
     0.1        —    
All State Ag Parts, LLC
     0.1        —    
BridgeBio Pharma, Inc
     —          23.0  
Inszone Mid, LLC
     —          12.5  
Rezolute, Inc
     —          5.7  
SOC Telemed, Inc
     —          4.4  
RQM+ Corp
     —          3.8  
MMIT Holdings, LLC
     —          2.0  
Neuronetics, Inc
     —          2.2  
  
 
 
    
 
 
 
Total Commitments
   $ 323.7      $ 226.7  
  
 
 
    
 
 
 
 
*
The Company controls the funding of the SLR Credit Solutions and SLR Healthcare commitments and may cancel them at its discretion.
In addition to the above, please see SLR Senior Lending Program LLC herein where the Company has a remaining equity commitment of $40.5 million in which the Company also controls such funding. The credit agreements of the above loan commitments contain customary lending provisions and/or are subject to the portfolio company’s achievement of certain milestones that allow relief to the Company from funding obligations for previously made commitments in instances where the underlying company experiences materially adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. As of December 31, 2022 and December 31, 2021, the Company had sufficient cash available and/or liquid securities available to fund its commitments and had reviewed them for any appropriate fair value adjustment.
In the normal course of business, we invest or trade in various financial instruments and may enter into various investment activities with
off-balance
sheet risk, which may include forward foreign currency contracts. Generally, these financial instruments represent future commitments to purchase or sell other financial instruments at specific terms at future dates. These financial instruments contain varying degrees of
off-balance
sheet risk whereby changes in the market value or our satisfaction of the obligations may exceed the amount recognized in our Consolidated Statements of Assets and Liabilities.
 
80

Distributions
The following table reflects the cash distributions per share on our common stock for the two most recent fiscal years and the current fiscal year to date:
 
Date Declared
  
Record Date
    
Payment Date
    
Amount
 
Fiscal 2023
        
February 28, 2023
     March 23, 2023        April 4, 2023      $ 0.136667  
February 2, 2023
     February 16, 2023        March 1, 2023        0.136667  
January 10, 2023
     January 26, 2023        February 2, 2023        0.136667  
        
 
 
 
Total 2023
         $ 0.41  
        
 
 
 
Fiscal 2022
        
December 6, 2022
     December 22, 2022        January 5, 2023      $ 0.136667  
November 2, 2022
     November 17, 2022        December 1, 2022        0.136667  
October 5, 2022
     October 20, 2022        November 2, 2022        0.136667  
September 2, 2022
     September 20, 2022        October 4, 2022        0.136667  
August 2, 2022
     August 18, 2022        September 1, 2022        0.136667  
July 6, 2022
     July 21, 2022        August 2, 2022        0.136667  
June 3, 2022
     June 23, 2022        July 5, 2022        0.136667  
May 3, 2022
     May 19, 2022        June 2, 2022        0.136667  
April 4, 2022
     April 21, 2022        May 3, 2022        0.136667  
March 1, 2022
     March 18, 2022        April 1, 2022        0.41  
        
 
 
 
Total 2022
         $ 1.64  
        
 
 
 
Fiscal 2021
        
November 3, 2021
     December 16, 2021        January 5, 2022      $ 0.41  
August 3, 2021
     September 23, 2021        October 5, 2021        0.41  
May 5, 2021
     June 23, 2021        July 2, 2021        0.41  
February 24, 2021
     March 18, 2021        April 2, 2021        0.41  
        
 
 
 
Total 2021
         $ 1.64  
        
 
 
 
Tax characteristics of all distributions will be reported to stockholders on Form 1099 after the end of the calendar year. Future distributions, if any, will be determined by the Board. We expect that our distributions to stockholders will generally be from accumulated net investment income, from net realized capital gains or
non-taxable
return of capital, if any, as applicable.
We have elected to be taxed as a RIC under Subchapter M of the Code. To maintain our RIC tax treatment, we must distribute at least
90
% of our ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any, out of the assets legally available for distribution. In addition, although we currently intend to distribute realized net capital gains (
i.e.
, net long-term capital gains in excess of short-term capital losses), if any, at least annually, out of the assets legally available for such distributions, we may in the future decide to retain such capital gains for investment.
We maintain an “opt out” dividend reinvestment plan for our common stockholders. As a result, if we declare a distribution, then stockholders’ cash distributions will be automatically reinvested in additional shares of our common stock, unless they specifically “opt out” of the dividend reinvestment plan so as to receive cash distributions.
We may not be able to achieve operating results that will allow us to make distributions at a specific level or to increase the amount of these distributions from time to time. In addition, due to the asset coverage test applicable to us as a business development company, we may in the future be limited in our ability to make distributions. Also, the Credit Facility may limit our ability to declare distributions if we default under certain provisions. If we do not distribute a certain percentage of our income annually, we will suffer adverse tax consequences, including possible loss of the tax benefits available to us as a regulated investment company. In addition, in accordance with GAAP and tax regulations, we include in income certain amounts that we have not yet received in cash, such as contractual
payment-in-kind
income, which represents contractual income added to the loan balance that becomes due at the end of the loan term, or the accrual of original issue or market discount. Since we may recognize income before or without receiving cash representing such income, we may have difficulty meeting the requirement to distribute at least 90% of our investment company taxable income to obtain tax benefits as a regulated investment company.
With respect to the distributions to stockholders, income from origination, structuring, closing and certain other upfront fees associated with investments in portfolio companies are treated as taxable income and accordingly, distributed to stockholders.
 
81

Related Parties
We have entered into a number of business relationships with affiliated or related parties, including the following:
 
   
We have entered into the Advisory Agreement with the Investment Adviser. Mr. Gross, our Chairman,
Co-Chief
Executive Officer and President and Mr. Spohler, our
Co-Chief
Executive Officer, Chief Operating Officer and board member, are managing members and senior investment professionals of, and have financial and controlling interests in, the Investment Adviser. In addition, Mr. Richard Peteka, our Chief Financial Officer, Treasurer and Secretary serves as the Chief Financial Officer for the Investment Adviser.
 
   
The Administrator provides us with the office facilities and administrative services necessary to conduct
day-to-day
operations pursuant to our Administration Agreement. We reimburse the Administrator for the allocable portion of overhead and other expenses incurred by it in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions, and the compensation of our chief compliance officer, our chief financial officer and their respective staffs.
 
   
We have entered into a license agreement with the Investment Adviser, pursuant to which the Investment Adviser has granted us a
non-exclusive,
royalty-free license to use the licensed marks “SOLAR” and “SLR”.
The Investment Adviser may also manage other funds in the future that may have investment mandates that are similar, in whole and in part, with ours. For example, the Investment Adviser presently serves as investment adviser to SCP Private Credit Income BDC LLC, an unlisted BDC that focuses on investing primarily in senior secured loans, including
non-traditional
asset-based loans and first lien loans, SLR HC BDC LLC, an unlisted BDC whose principal focus is to invest directly and indirectly in senior secured loans and other debt instruments typically to middle market companies within the healthcare industry, and SLR Private Credit BDC II LLC, an unlisted BDC focused on first lien senior secured floating rate loans. In addition, Michael S. Gross, our Chairman,
Co-Chief
Executive Officer and President, Bruce Spohler, our
Co-Chief
Executive Officer and Chief Operating Officer, and Richard L. Peteka, our Chief Financial Officer, serve in similar capacities for SCP Private Credit Income BDC LLC, SLR HC BDC LLC and SLR Private Credit BDC II LLC. The Investment Adviser and certain investment advisory affiliates may determine that an investment is appropriate for us and for one or more of those other funds. In such event, depending on the availability of such investment and other appropriate factors, the Investment Adviser or its affiliates may determine that we should invest
side-by-side
with one or more other funds. Any such investments will be made only to the extent permitted by applicable law and interpretive positions of the SEC and its staff, and consistent with the Investment Adviser’s allocation procedures. On June 13, 2017, the Adviser received an exemptive order that permits the Company to participate in
negotiated co-investment transactions
with certain affiliates, in a manner consistent with the Company’s investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, and pursuant to various conditions (the “Order”). If the Company is unable to rely on the Order for a particular opportunity, such opportunity will be allocated first to the entity whose investment strategy is the most consistent with the opportunity being allocated, and second, if the terms of the opportunity are consistent with more than one entity’s investment strategy, on an alternating basis. Although the Adviser’s investment professionals will endeavor to allocate investment opportunities in a fair and equitable manner, the Company and its stockholders could be adversely affected to the extent investment opportunities are allocated among us and other investment vehicles managed or sponsored by, or affiliated with, our executive officers, directors and members of the Adviser.
Related party transactions may occur among us, SLR Senior Lending Program LLC, SLR Senior Lending Program SPV LLC, SLR Credit, Equipment Operating Leases LLC, KBH, Loyer Capital LLC, SLR Business Credit, SLR Healthcare ABL and SLR Equipment.    These transactions may occur in the normal course of business. No administrative or other fees are paid to the Investment Adviser by SLR Senior Lending Program LLC, SLR Senior Lending Program SPV LLC, SLR Credit, Equipment Operating Leases LLC, KBH, Loyer Capital LLC, SLR Business Credit, SLR Healthcare ABL or SLR Equipment.
In addition, we have adopted a formal code of ethics that governs the conduct of our officers and directors. Our officers and directors also remain subject to the duties imposed by both the 1940 Act and the Maryland General Corporation Law.
 
82

Item 7A.
Quantitative and Qualitative Disclosure About Market Risk
We are subject to financial market risks, including changes in interest rates. Uncertainty with respect to the rising interest rates, inflationary pressures, risks in respect of a failure to increase the U.S. debt ceiling, the war in Ukraine and Russia and health epidemics and pandemics introduced significant volatility in the financial markets, and the effects of this volatility has materially impacted and could continue to materially impact our market risks. Because we fund a portion of our investments with borrowings, our net investment income is affected by the difference between the rate at which we invest and the rate at which we borrow. As a result, there can be no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income. In a low interest rate environment, including a reduction of LIBOR and SOFR to zero, the difference between the total interest income earned on interest earning assets and the total interest expense incurred on interest bearing liabilities may be compressed, reducing our net interest income and potentially adversely affecting our operating results. Conversely, in a rising interest rate environment, such as the current economic environment, such difference could potentially increase thereby increasing our net investment income. During the fiscal year ended December 31, 2022, certain investments in our comprehensive investment portfolio had floating interest rates. These floating rate investments were primarily based on floating LIBOR or SOFR and typically have durations of one to three months after which they reset to current market interest rates. Additionally, some of these investments have floors. The Company also has revolving credit facilities that are generally based on floating SOFR. Assuming no changes to our balance sheet as of December 31, 2022 and no new defaults by portfolio companies, a hypothetical one percent decrease in LIBOR and SOFR on our comprehensive floating rate assets and liabilities would decrease our net investment income by ten cents per average share over the next twelve months. Assuming no changes to our balance sheet as of December 31, 2022 and no new defaults by portfolio companies, a hypothetical one percent increase in LIBOR and SOFR on our comprehensive floating rate assets and liabilities would increase our net investment income by approximately ten cents per average share over the next twelve months. However, we may hedge against interest rate fluctuations from time to time by using standard hedging instruments such as futures, options, swaps and forward contracts subject to the requirements of the 1940 Act. While hedging activities may insulate us against adverse changes in interest rates, they may also limit our ability to participate in any benefits of certain changes in interest rates with respect to our portfolio of investments. At December 31, 2022, we have no interest rate hedging instruments outstanding on our balance sheet.
 
Increase (Decrease) in LIBOR and SOFR
     (1.00 %)      1.00
Increase (Decrease) in Net Investment Income Per Share Per Year
     (0.10   $ 0.10  
We may also have exposure to foreign currencies through various investments. These investments are converted into U.S. dollars at the balance sheet date, exposing us to movements in foreign exchange rates. In order to reduce our exposure to fluctuations in foreign exchange rates, we may borrow from time to time in such currencies under our multi-currency revolving credit facility or enter into forward currency or similar contracts.
 
83

Item 8.
Financial Statements and Supplementary Data
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
 
 
  
Page
 
  
 
85
 
  
 
86
 
  
 
88
 
  
 
89
 
  
 
90
 
  
 
91
 
  
 
92
 
  
 
102
 
 
84

MANAGEMENT’S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING
Management is responsible for establishing and maintaining adequate internal control over financial reporting, and for performing an assessment of the effectiveness of internal control over financial reporting as of December 31, 2022. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. The Company’s internal control over financial reporting includes those policies and procedures that (i) pertain to assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the consolidated financial statements.
Management performed an assessment of the effectiveness of the Company’s internal control over financial reporting as of December 31, 2022 based upon criteria in
Internal Control – Integrated Framework (2013)
 issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). Based on our assessment, management determined that the Company’s internal control over financial reporting was effective as of December 31, 2022 based upon criteria in
Internal Control – Integrated Framework (2013)
 issued by COSO.
The effectiveness of the Company’s internal control over financial reporting as of December 31, 2022 has been audited by KPMG LLP, an independent registered public accounting firm, as stated in their report which appears herein.
 
85

Report of Independent Registered Public Accounting Firm
To the Stockholders and Board of Directors
SLR Investment Corp.:
Opinions on the Consolidated Financial Statements and Internal Control Over Financial Reporting
We have audited the accompanying consolidated statements of assets and liabilities, including the consolidated schedules of investments, of SLR Investment Corp. (and subsidiaries) (the Company) as of December 31, 2022 and 2021, the related consolidated statements of operations, changes in net assets, and cash flows for each of the years in the three-year period ended December 31, 2022, and the related notes (collectively, the consolidated financial statements). We also have audited the Company’s internal control over financial reporting as of December 31, 2022, based on criteria established in
Internal Control – Integrated Framework (2013)
 issued by the Committee of Sponsoring Organizations of the Treadway Commission.
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2022, in conformity with U.S. generally accepted accounting principles. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on criteria established in
Internal Control – Integrated Framework (2013)
 issued by the Committee of Sponsoring Organizations of the Treadway Commission.
Basis for Opinions
The Company’s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying management’s report on internal control over financial reporting. Our responsibility is to express an opinion on the Company’s consolidated financial statements and an opinion on the Company’s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.
Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our procedures included confirmation of securities owned as of December 31, 2022 and 2021, by correspondence with the custodian, portfolio companies or agents. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
 
86

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Fair value of investments and acquired investments
As described in Notes 2 and 6 to the consolidated financial statements, the Company measures its investments at fair value. Further, as described in Note 17, the Company completed an asset acquisition of SLR Senior Investment Corp.’s investments at fair value on April 1, 2022, which required the investments acquired to be measured at fair value as of that date. Investments are valued using a market approach, an income approach, or both approaches, as applicable. In determining the fair value of investments whose market quotations are not readily available, the Company makes subjective judgments and estimates using unobservable inputs.
We identified the assessment of the fair value of investments with no readily determinable market value acquired from SLR Senior Investment Corp. as of April 1, 2022 (acquired investments), and the fair value of investments with no readily determinable market value as of December 31, 2022, as a critical audit matter. A high degree of auditor judgment was required to assess the Company’s fair value assumptions. Specifically, subjective auditor judgment was required to assess the (1) credit risk associated with the borrower and its ability to make interest and principal payments for debt investments and (2) selection of comparable companies and the financial performance multiples of such comparable companies used in the market approach for equity investments. Additionally, the involvement of valuation professionals with specialized skills and knowledge was required to assist in evaluating the Company’s fair value estimates.
The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls over the Company’s process to measure the fair value of investments, including controls related to the development of the above assumptions. For recently purchased investments we evaluated changes in the borrowers’ assessed credit risk and market yields of similar instruments from the purchase date (prior to April 1, 2022 for the acquired investments and prior to December 31, 2022 for investments not acquired from SLR Senior Investment Corp.) to the fair value measurement date of April 1, 2022 and December 31, 2022, respectively. We evaluated the Company’s ability to estimate fair value by comparing dispositions to the Company’s most recent fair value estimate prior to the disposition. We also involved valuation professionals with specialized skills and knowledge, who for a selection of acquired investments and investments as of April 1, 2022 and December 31, 2022, respectively, developed estimates of fair value by assessing available market information using market yields of comparable companies of similar credit risk for debt investments fair valued using an income approach, and financial performance multiples of comparable companies for equity investments fair valued using a market approach, and compared the results to the Company’s fair value estimates.

/s/ KPMG LLP
 
We have served as the Company’s auditor since 2007.
 
New York, New York
February 28, 2023
 
8
7

SLR INVESTMENT CORP.
CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES
(in thousands, except share amounts)
 
    
December 31,
2022
   
December 31,
2021
 
Assets
                
Investments at fair value:
                
Companies less than 5% owned (cost: $1,312,701 and $985,088, respectively)
   $ 1,289,082     $ 964,379  
Companies more than 25% owned (cost: $821,886 and $711,865, respectively)
     797,594       706,203  
Cash
     10,743       2,935  
Cash equivalents (cost: $417,590 and $320,000, respectively)
     417,590       320,000  
Dividends receivable
     11,192       9,028  
Interest receivable
     9,706       6,521  
Receivable for investments sold
     1,124       1,378  
Prepaid expenses and other assets
     664       567  
    
 
 
   
 
 
 
Total assets
   $ 2,537,695     $ 2,011,011  
    
 
 
   
 
 
 
Liabilities
                
Debt ($1,093,200 and $818,500 face amounts, respectively, reported net of unamortized debt issuance costs of $7,202 and $6,462, respectively. See notes 6 and 7)
   $ 1,085,998     $ 812,038  
Payable for investments and cash equivalents purchased
     417,611       320,041  
Distributions payable
     7,481       17,327  
Management fee payable (see note 3)
     7,964       7,435  
Performance-based incentive fee payable (see note 3)
     5,422       1,864  
Interest payable (see note 7)
     7,943       4,492  
Administrative services payable (see note 3)
     1,488       2,689  
Other liabilities and accrued expenses
     4,057       2,844  
    
 
 
   
 
 
 
Total liabilities
   $ 1,537,964     $ 1,168,730  
    
 
 
   
 
 
 
Commitments and contingencies (see note 11)
                
 
 
 
 
 
 
 
 
 
Net Assets
                
Common stock, par value $0.01 per share, 200,000,000 and 200,000,000 common shares authorized, respectively, and 54,555,380 and 42,260,826 shares issued and outstanding, respectively
   $ 546     $ 423  
Paid-in
capital in excess of par (see note 2f)
     1,162,569       936,999  
Accumulated distributable net loss (see note 2f)
     (163,384     (95,141
    
 
 
   
 
 
 
Total net assets
   $ 999,731     $ 842,281  
    
 
 
   
 
 
 
Net Asset Value Per Share
   $ 18.33     $ 19.93  
    
 
 
   
 
 
 
See notes to consolidated financial statements.
 
88

SLR INVESTMENT CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share amounts)
 
    
Year ended December 31,
 
    
2022
   
2021
   
2020
 
INVESTMENT INCOME:
                        
Interest:
                        
Companies less than 5% owned
   $ 121,491     $ 86,122     $ 84,143  
Companies more than 25% owned
     9,515       11,354       8,861  
Dividends:
                        
Companies less than 5% owned
              133       50  
Companies more than 25% owned
     44,383       37,564       26,794  
Other income:
                        
Companies less than 5% owned
     2,116       4,157       1,885  
Companies more than 25% owned
              24       12  
    
 
 
   
 
 
   
 
 
 
Total investment income
     177,505       139,354       121,745  
    
 
 
   
 
 
   
 
 
 
EXPENSES:
                        
Management fees (see note 3)
     29,982       28,277       24,951  
Performance-based incentive fees (see note 3)
     15,097       10,309       2,272  
Interest and other credit facility expenses (see note 7)
     46,087       29,876       27,156  
Administrative services expense (see note 3)
     5,401       5,575       5,215  
Other general and administrative expenses
     6,099       4,390       2,936  
    
 
 
   
 
 
   
 
 
 
Total expenses
     102,666       78,427       62,530  
    
 
 
   
 
 
   
 
 
 
Performance-based incentive fees waived (see note 3)
     (1,527                  
    
 
 
   
 
 
   
 
 
 
Net expenses
     101,139       78,427       62,530  
    
 
 
   
 
 
   
 
 
 
Net investment income
   $ 76,366     $ 60,927     $ 59,215  
    
 
 
   
 
 
   
 
 
 
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND CASH EQUIVALENTS:
                        
Net realized gain (loss) on investments and cash equivalents (companies less than 5% owned)
   $ (36,485   $ 26     $ (26,638
    
 
 
   
 
 
   
 
 
 
Net change in unrealized gain (loss) on investments and cash equivalents:
                        
Companies less than 5% owned
     (2,909     (10,500     8,970  
Companies more than 25% owned
     (18,630     9,113       (26,096
    
 
 
   
 
 
   
 
 
 
Net change in unrealized loss on investments and cash equivalents
     (21,539     (1,387     (17,126
    
 
 
   
 
 
   
 
 
 
Net realized and unrealized loss on investments and cash equivalents
     (58,024     (1,361     (43,764
    
 
 
   
 
 
   
 
 
 
NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS
   $ 18,342     $ 59,566     $ 15,451  
    
 
 
   
 
 
   
 
 
 
EARNINGS PER SHARE (see note 5)
   $ 0.35     $ 1.41     $ 0.37  
    
 
 
   
 
 
   
 
 
 
See notes to consolidated financial statements.
 
89

SLR INVESTMENT CORP.
CONSOLIDATED STATEMENTS OF CHANGES IN NET ASSETS
(in thousands, except share amounts)
 
    
Year ended December 31,
 
    
2022
   
2021
   
2020
 
Increase (decrease) in net assets resulting from operations:
                        
Net investment income
   $ 76,366     $ 60,927     $ 59,215  
Net realized gain (loss)
     (36,485     26       (26,638
Net change in unrealized loss
     (21,539     (1,387     (17,126
    
 
 
   
 
 
   
 
 
 
Net increase in net assets resulting from operations
     18,342       59,566       15,451  
    
 
 
   
 
 
   
 
 
 
Distributions to stockholders (see note 8a):
                        
From distributable earnings
     (57,594     (41,221     (48,795
From return of capital
     (27,099     (28,087     (20,513
    
 
 
   
 
 
   
 
 
 
Net distributions to stockholders
     (84,693     (69,308     (69,308
    
 
 
   
 
 
   
 
 
 
Capital transactions (see note 13):
                        
Issuance of common stock
     226,839                    
Repurchases of common stock
     (3,038                  
    
 
 
   
 
 
   
 
 
 
Net increase in net assets resulting from capital transactions
     223,801                    
    
 
 
   
 
 
   
 
 
 
Total increase (decrease) in net assets
     157,450       (9,742     (53,857
Net assets at beginning of year
     842,281       852,023       905,880  
    
 
 
   
 
 
   
 
 
 
Net assets at end of year
   $ 999,731     $ 842,281     $ 852,023  
    
 
 
   
 
 
   
 
 
 
Capital share activity (see note 13):
                        
Issuance of common stock
     12,511,825                    
Repurchases of common stock
     (217,271                  
    
 
 
   
 
 
   
 
 
 
Net increase from capital share activity
     12,294,554                    
    
 
 
   
 
 
   
 
 
 
See notes to consolidated financial statements.
 
90

SLR INVESTMENT CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
 
    
Year ended December 31,
 
    
2022
   
2021
   
2020
 
Cash Flows from Operating Activities:
                        
Net increase in net assets resulting from operations
   $ 18,342     $ 59,566     $ 15,451  
Adjustments to reconcile net increase in net assets resulting from operations to net cash provided by (used in) operating activities:
                        
Net realized (gain) loss on investments and cash equivalents
     36,485       (26     26,638  
Net change in unrealized loss on investments
     21,539       1,387       17,126  
(Increase) decrease in operating assets:
                        
Purchase of investments
     (609,645     (596,256     (426,897
Proceeds from disposition of investments
     531,389       468,532       357,632  
Net accretion of discount on investments
     (9,850     (6,087     (7,581
Capitalization of
payment-in-kind
income
     (4,282     (7,592     (5,384
Collections of
payment-in-kind
income
     1,286       1,411       1,339  
Receivable for investments sold
     254       (1,123     1,952  
Interest receivable
     (3,185     (43     (1,077
Dividends receivable
     (2,164     (1,101     2,561  
Prepaid expenses and other assets
     (97     4       44  
Cash and other
net
assets acquired in merger
     3,640                    
Increase (decrease) in operating liabilities:
                        
Payable for investments and cash equivalents purchased
     97,570       (59,997     (39,624
Management fee payable
     529       900       (212
Performance-based incentive fee payable
     3,558       1,072       (3,489
Administrative services expense payable
     (1,201     743       (811
Interest payable
     3,451       1,076       (262
Other liabilities and accrued expenses
     1,213       414       (10
Deferred financing costs/market discount
     2,227       2,019       1,234  
    
 
 
   
 
 
   
 
 
 
Net Cash Provided by (Used in) Operating
Activities
     91,059       (135,101     (61,370
    
 
 
   
 
 
   
 
 
 
Cash Flows from Financing Activities:
                        
Cash distributions paid
     (94,539     (69,308     (69,308
Proceeds from unsecured borrowings
     134,914       49,936           
Repayment of unsecured borrowings
     (171,000                  
Proceeds from secured borrowings
     844,002       812,132       337,000  
Repayments of secured borrowings
     (696,000     (723,500     (253,900
Repurchase of common stock
     (3,038                  
    
 
 
   
 
 
   
 
 
 
Net Cash Provided by Financing Activities
     14,339       69,260       13,792  
    
 
 
   
 
 
   
 
 
 
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
     105,398       (65,841     (47,578
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR
     322,935       388,776       436,354  
    
 
 
   
 
 
   
 
 
 
CASH AND CASH EQUIVALENTS AT END OF YEAR
   $ 428,333     $ 322,935     $ 388,776  
    
 
 
   
 
 
   
 
 
 
Supplemental disclosure of cash flow information:
                        
Cash paid for interest
   $ 42,636     $ 28,800     $ 27,418  
Issuance of shares in connection with the
Mergers(1)
     226,839                    
    
 
 
   
 
 
   
 
 
 
 
(1)
On April 1, 2022, in connection with the Mergers (as defined in Note 1 “Organization”), the Company acquired net assets of $244,691 for the total stock consideration of $226,839. For further details, refer to Note 17 “Merger with SUNS”.
See notes to consolidated financial statements.
 
91

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2022
(in thousands, except share/unit amounts)
 
Description
  
Industry
  
Spread
Above
Index
(7)
 
Floor
 
 
Interest
Rate
(1)
 
 
Acquisition
Date
 
  
Maturity

Date
 
  
Par Amount
 
  
Cost
 
  
Fair
Value
 
Senior Secured Loans — 124.6
%
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
First Lien Bank Debt/Senior Secured Loans
                                                                     
 
Aegis Toxicology Sciences Corporation(16)
  
Health Care Providers & Services  
 
L+550
 
 
1.00
 
 
10.09
 
 
5/7/2018
 
  
 
5/9/2025
 
  
$
17,103
 
  
$
16,793
 
  
$
17,103
 
All State Ag Parts, LLC(16)
  
Trading Companies & Distributors
  
 
S+575
 
 
1.00
 
 
10.19
 
 
4/1/2022
 
  
 
9/1/2026
 
  
 
4,197
 
  
 
4,081
 
  
 
4,197
 
American Teleconferencing Services, Ltd.**
  
Communications Equipment
  
 
L+650
 
 
1.00
 
 
  
 
 
 
5/5/2016
 
  
 
9/9/2021
 
  
 
36,135
 
  
 
25,926
 
  
 
  
 
American Teleconferencing Services, Ltd.**
  
Communications Equipment
  
 
L+650
 
 
1.00
 
 
  
 
 
 
9/17/2021
 
  
 
1/31/2023
 
  
 
6,405
 
  
 
6,254
 
  
 
224
 
AmeriMark Intermediate Holdings, LLC(14)
  
Internet & Catalog Retail
  
 
L+800
 
 
1.00
 
 
14.77
 
 
7/28/2021
 
  
 
10/15/2026
 
  
 
24,087
 
  
 
23,711
 
  
 
22,882
 
Apex Services Partners, LLC(16)
  
Diversified Consumer Services
  
 
S+525
 
 
1.00
 
 
9.80
 
 
8/31/2022
 
  
 
7/31/2025
 
  
 
14,021
 
  
 
13,644
 
  
 
14,021
 
Atria Wealth Solutions, Inc.(16)
  
Diversified Financial Services
  
 
S+600
 
 
1.00
 
 
10.84
 
 
9/14/2018
 
  
 
2/29/2024
 
  
 
8,149
 
  
 
8,107
 
  
 
8,149
 
Basic Fun, Inc.(16)
  
Specialty Retail
  
 
L+550
 
 
1.00
 
 
10.27
 
 
10/30/2020
 
  
 
10/30/2023
 
  
 
2,162
 
  
 
2,152
 
  
 
2,162
 
BayMark Health Services, Inc.(16)
  
Health Care Providers & Services
  
 
L+500
 
 
1.00
 
 
9.73
 
 
4/1/2022
 
  
 
6/11/2027
 
  
 
9,432
 
  
 
9,078
 
  
 
9,432
 
BDG Media, Inc
  
Media
  
 
L+900
 
 
0.25
 
 
13.17
 
 
7/18/2022
 
  
 
4/27/2023
 
  
 
14,454
 
  
 
14,454
 
  
 
14,454
 
CC SAG Holdings Corp. (Spectrum Automotive)(16)
  
Diversified Consumer Services
  
 
L+575
 
 
0.75
 
 
10.48
 
 
6/29/2021
 
  
 
6/29/2028
 
  
 
20,427
 
  
 
20,057
 
  
 
20,427
 
Composite Technology Acquisition Corp.(16)
  
Building Products
  
 
L+475
 
 
1.00
 
 
9.73
 
 
4/1/2022
 
  
 
2/1/2025
 
  
 
10,386
 
  
 
9,983
 
  
 
10,386
 
Copper River Seafoods, Inc
  
Food Products
  
 
P+275
 
 
  
 
 
 
10.25
 
 
8/31/2022
 
  
 
4/23/2025
 
  
 
8,405
 
  
 
8,405
 
  
 
8,405
 
DeepIntent, Inc
  
Media
  
 
P+175
 
 
  
 
 
 
9.25
 
 
10/12/2022
 
  
 
3/25/2025
 
  
 
16,951
 
  
 
16,951
 
  
 
16,951
 
Enhanced Permanent Capital, LLC(3)
  
Capital Markets
  
 
L+700
 
 
1.00
 
 
10.13
 
 
12/29/2020
 
  
 
12/29/2025
 
  
 
35,205
 
  
 
34,496
 
  
 
35,205
 
ENS Holdings III Corp. & ES Opco USA LLC (Bluefin)(16)..
  
Trading Companies & Distributors
  
 
S+475
 
 
1.00
 
 
9.43
 
 
4/1/2022
 
  
 
12/31/2025
 
  
 
4,978
 
  
 
4,804
 
  
 
4,978
 
Enverus Holdings, Inc. (fka Drilling
Info Holdings)(16)
  
IT Services
  
 
L+450
 
 
  
 
 
 
8.88
 
 
4/1/2022
 
  
 
7/30/2025
 
  
 
11,598
 
  
 
11,129
 
  
 
11,598
 
Erie Construction
Mid-west,
LLC(16)
  
Building Products
  
 
S+475
 
 
1.00
 
 
9.79
 
 
4/1/2022
 
  
 
7/30/2027
 
  
 
8,915
 
  
 
8,580
 
  
 
8,915
 
Foundation Consumer Brands, LLC(16)
  
Personal Products
  
 
L+550
 
 
1.00
 
 
10.15
 
 
2/12/2021
 
  
 
2/12/2027
 
  
 
35,273
 
  
 
34,421
 
  
 
35,273
 
GSM Acquisition Corp.(16)
  
Leisure Equipment & Products  
 
S+500
 
 
1.00
 
 
9.03
 
 
4/1/2022
 
  
 
11/16/2026
 
  
 
11,022
 
  
 
10,562
 
  
 
10,912
 
Higginbotham Insurance Agency, Inc.(16)
  
Insurance
  
 
L+525
 
 
0.75
 
 
9.63
 
 
4/1/2022
 
  
 
11/25/2026
 
  
 
6,223
 
  
 
5,994
 
  
 
6,223
 
High Street Buyer, Inc.(16)
  
Insurance
  
 
L+600
 
 
0.75
 
 
10.73
 
 
4/1/2022
 
  
 
4/16/2028
 
  
 
5,188
 
  
 
4,900
 
  
 
5,188
 
Human Interest Inc
  
Internet Software & Services
  
 
S+785
 
 
1.00
 
 
11.97
 
 
6/30/2022
 
  
 
7/1/2027
 
  
 
20,104
 
  
 
19,783
 
  
 
20,104
 
iCIMS, Inc.
  
Software
  
 
S+725
 
 
0.75
 
 
11.52
%
(26) 
 
 
8/18/2022
 
  
 
8/18/2028
 
  
 
32,084
 
  
 
31,548
 
  
 
31,522
 
Ivy Fertility Services, LLC
  
Health Care Providers & Services
  
 
L+625
 
 
1.00
 
 
10.39
 
 
12/22/2021
 
  
 
2/25/2026
 
  
 
30,092
 
  
 
29,415
 
  
 
30,393
 
Kaseya, Inc.(16)
  
Software
  
 
S+575
 
 
0.75
 
 
10.33
 
 
6/22/2022
 
  
 
6/23/2029
 
  
 
32,426
 
  
 
31,966
 
  
 
32,426
 
Kid Distro Holdings, LLC (Distro
Kid)(16)
  
Software
  
 
L+575
 
 
1.00
 
 
10.48
 
 
9/24/2021
 
  
 
10/1/2027
 
  
 
26,452
 
  
 
26,015
 
  
 
26,452
 
Kingsbridge Holdings, LLC(2)
  
Multi-Sector Holdings
  
 
L+700
 
 
1.00
 
 
10.75
 
 
12/21/2018
 
  
 
12/21/2024
 
  
 
80,000
 
  
 
79,800
 
  
 
80,000
 
KORE Wireless Group, Inc.(16)
  
Wireless Telecommunication Services
  
 
S+550
 
 
  
 
 
 
10.08
 
 
12/21/2018
 
  
 
12/21/2024
 
  
 
23,588
 
  
 
23,123
 
  
 
23,588
 
Logix Holding Company, LLC(16)
  
Communications Equipment
  
 
L+575
 
 
1.00
 
 
10.13
 
 
9/14/2018
 
  
 
12/22/2024
 
  
 
14,009
 
  
 
13,246
 
  
 
13,449
 
Luxury Asset Capital, LLC(16)
  
Thrifts & Mortgage Finance
  
 
S+675
 
 
1.00
 
 
10.99
 
 
7/15/2022
 
  
 
7/15/2027
 
  
 
27,500
 
  
 
26,991
 
  
 
27,500
 
Maurices, Incorporated(16)
  
Specialty Retail
  
 
S+675
 
 
1.00
 
 
8.74
 
 
8/27/2021
 
  
 
6/1/2024
 
  
 
7,808
 
  
 
7,678
 
  
 
7,808
 
Montefiore Nyack Hospital
  
Health Care Providers & Services
  
 
L+495
 
 
  
 
 
 
9.72
 
 
8/9/2022
 
  
 
11/15/2024
 
  
 
3,966
 
  
 
3,966
 
  
 
3,966
 
NAC Holdings Corporation (Jaguar)(16)
  
Insurance
  
 
S+525
 
 
1.00
 
 
9.45
 
 
7/30/2021
 
  
 
9/28/2024
 
  
 
28,603
 
  
 
28,214
 
  
 
28,603
 
National Spine and Pain Centers, LLC
  
Health Care Providers & Services
  
 
L+500
 
 
1.00
 
 
7.31
 
 
4/1/2022
 
  
 
6/2/2024
 
  
 
2,681
 
  
 
2,564
 
  
 
2,547
 
One Touch Direct, LLC
  
Commercial Services & Supplies
  
 
P+75
 
 
  
 
 
 
8.25
 
 
4/3/2020
 
  
 
3/30/2024
 
  
 
4,431
 
  
 
4,431
 
  
 
4,431
 
Orthopedic Care Partners
Management, LLC
  
Health Care Providers & Services
  
 
S+650
 
 
1.00
 
 
10.91
 
 
8/17/2022
 
  
 
5/16/2024
 
  
 
3,111
 
  
 
3,092
 
  
 
3,111
 
Pediatric Home Respiratory Services,
LLC
  
Health Care Providers & Services
  
 
S+625
 
 
1.00
 
 
10.67
 
 
8/19/2022
 
  
 
12/4/2024
 
  
 
1,327
 
  
 
1,309
 
  
 
1,313
 
Peter C. Foy & Associates Insurance
Services, LLC
  
Insurance
  
 
S+600
 
 
0.75
 
 
10.44
 
 
4/1/2022
 
  
 
11/1/2028
 
  
 
10,854
 
  
 
10,699
 
  
 
10,854
 
PhyNet Dermatology LLC
  
Health Care Providers & Services
  
 
S+625
(15)
 
 
1.00
 
 
9.81
 
 
9/5/2018
 
  
 
8/16/2024
 
  
 
14,458
 
  
 
14,420
 
  
 
14,458
 
Pinnacle Treatment Centers,
Inc.(16)
  
Health Care Providers & Services
  
 
S+650
 
 
1.00
 
 
10.57
 
 
1/22/2020
 
  
 
1/2/2026
 
  
 
27,997
 
  
 
27,528
 
  
 
27,367
 
Plastics Management, LLC(16)
  
Health Care Providers & Services
  
 
S+500
 
 
1.00
 
 
9.89
 
 
4/1/2022
 
  
 
8/18/2027
 
  
 
9,491
 
  
 
9,161
 
  
 
9,491
 
PPT Management Holdings, LLC(16)
  
Health Care Providers & Services
  
 
L+850
(11) 
 
1.00
 
 
12.83
 
 
9/14/2018
 
  
 
1/30/2023
 
  
 
32,163
 
  
 
31,987
 
  
 
25,827
 
RQM+ Corp.(16)
  
Life Sciences Tools & Services
  
 
S+575
 
 
1.00
 
 
10.97
 
 
8/20/2021
 
  
 
8/12/2026
 
  
 
26,823
 
  
 
26,455
 
  
 
26,823
 
RSC Acquisition, Inc.(16)
  
Insurance
  
 
S+550
 
 
0.75
 
 
9.26
 
 
4/1/2022
 
  
 
11/1/2026
 
  
 
6,985
 
  
 
6,813
 
  
 
6,985
 
RxSense Holdings LLC(16)
  
Diversified Consumer Services
  
 
L+500
 
 
1.00
 
 
9.41
 
 
4/1/2022
 
  
 
3/13/2026
 
  
 
11,775
 
  
 
11,357
 
  
 
11,775
 
SCP Eye Care, LLC
  
Health Care Providers & Services
  
 
S+575
 
 
1.00
 
 
9.46
 
 
10/6/2022
 
  
 
10/5/2029
 
  
 
8,314
 
  
 
8,050
 
  
 
8,044
 
SHO Holding I Corporation (Shoes for
Crews)(16)
  
Footwear
  
 
L+523
 
 
1.00
 
 
9.66
 
 
4/1/2022
 
  
 
4/27/2024
 
  
 
5,704
 
  
 
5,361
 
  
 
5,419
 
Southern Orthodontic Partners
Management, LLC(16)
  
Health Care Providers & Services
  
 
S+600
 
 
1.00
 
 
10.77
 
 
6/3/2022
 
  
 
1/27/2026
 
  
 
1,399
 
  
 
1,387
 
  
 
1,399
 
SPAR Marketing Force, Inc
  
Media
  
 
P+95
 
 
  
 
 
 
8.45
 
 
7/18/2022
 
  
 
10/10/2024
 
  
 
9,162
 
  
 
9,162
 
  
 
9,162
 
Stryten Resources LLC
  
Auto Parts & Equipment
  
 
S+800
 
 
1.00
 
 
12.44
 
 
8/11/2021
 
  
 
10/12/2026
 
  
 
25,922
 
  
 
25,506
 
  
 
25,922
 
SunMed Group Holdings, LLC(16)
  
Health Care Equipment & Supplies
  
 
L+575
 
 
0.75
 
 
10.48
 
 
6/16/2021
 
  
 
6/16/2028
 
  
 
24,953
 
  
 
24,446
 
  
 
24,953
 
TAUC Management, LLC(16)
  
Health Care Providers & Services
  
 
L+525
 
 
1.00
 
 
9.98
 
 
4/1/2022
 
  
 
2/12/2027
 
  
 
6,899
 
  
 
6,585
 
  
 
6,864
 
Tilley Distribution, Inc.(16)
  
Trading Companies & Distributors
  
 
S+550
 
 
1.00
 
 
10.14
 
 
4/1/2022
 
  
 
12/31/2026
 
  
 
9,996
 
  
 
9,527
 
  
 
9,996
 
Ultimate Baked Goods Midco LLC
(Rise Baking)(16)
  
Packaged Foods & Meats
  
 
L+650
 
 
1.00
 
 
10.88
 
 
8/12/2021
 
  
 
8/13/2027
 
  
 
24,789
 
  
 
24,038
 
  
 
24,789
 
Vessco Midco Holdings, LLC(16)
  
Water Utilities
  
 
L+450
 
 
1.00
 
 
7.87
 
 
4/1/2022
 
  
 
11/2/2026
 
  
 
1,728
 
  
 
1,668
 
  
 
1,728
 
World Insurance Associates, LLC(16)
  
Insurance
  
 
S+575
 
 
1.00
 
 
9.31
 
 
4/1/2022
 
  
 
4/1/2026
 
  
 
31,624
 
  
 
30,785
 
  
 
30,359
 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Total First Lien Bank Debt/Senior Secured Loans
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
  
 
 
 
  
$
912,558
 
  
$
886,513
 
 
 
  
 
 
 
  
 
 
 
Second Lien Asset-Based Senior
Secured Loans
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
ACRES Commercial Mortgage, LLC
  
Diversified Financial Services
  
 
S+705
 
 
1.00
 
 
11.38
 
 
12/24/2021
 
  
 
8/21/2028
 
  
 
29,925
 
  
$
29,398
 
  
$
29,925
 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Second Lien Bank Debt/Senior
Secured Loans
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
RD Holdco, Inc.** (2)
  
Diversified Consumer Services
  
 
S+975
(11) 
 
1.00
 
 
  
 
 
 
12/23/2013
 
  
 
10/12/2026
 
  
 
13,043
 
  
$
11,791
 
  
$
6,521
 
                                                          
 
 
    
 
 
 
 

See notes to consolidated financial statements.
 
 
92
SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2022
(in thousands, except share/unit amounts)
 
 
Description
  
Industry
  
 
Spread
Above
Index
(7)
 
  
Floor
 
 
Interest
Rate
(1)
 
Acquisition
Date
 
  
Maturity

Date
 
  
Par Amount
 
  
Cost
 
  
Fair
Value
 
Senior Secured Loans (continued) —
  
  
 
 
  
 
 
  
  
  
  
First Lien Life Science Senior Secured Loans
  
  
 
 
  
 
 
  
  
  
  
Alimera Sciences, Inc.(16)
  
Pharmaceuticals  
 
L+765
 
 
  
1.78
 
11.82%
 
 
12/31/2019
 
  
 
7/1/2024
 
  
$
23,159
 
  
$
23,894
 
  
$
24,433
 
Apeel Technology, Inc
  
Biotechnology  
 
S+625
 
 
  
1.00
 
8.75%
 
 
6/29/2022
 
  
 
6/1/2027
 
  
 
3,643
 
  
 
3,620
 
  
 
3,643
 
Arcutis Biotherapeutics, Inc.(3)
  
Pharamceuticals  
 
L+745
 
 
  
0.10
 
11.62%
 
 
12/22/2021
 
  
 
1/1/2027
 
  
 
66,849
 
  
 
67,077
 
  
 
67,685
 
Ardelyx, Inc.(3)
  
Pharmaceuticals  
 
L+795
 
 
  
0.10
 
12.12%
 
 
2/23/2022
 
  
 
3/1/2027
 
  
 
9,475
 
  
 
9,437
 
  
 
9,499
 
BridgeBio Pharma, Inc.(3)
  
Biotechnology  
 
  
 
 
  
  
 
 
9.00%
(22)
 
 
11/17/2021
 
  
 
11/17/2026
 
  
 
39,839
 
  
 
39,340
 
  
 
39,839
 
Centrexion Therapeutics, Inc.
  
Pharmaceuticals  
 
L+725
 
 
  
2.45
 
11.42%
 
 
6/28/2019
 
  
 
1/1/2024
 
  
 
11,844
 
  
 
12,372
 
  
 
12,555
 
Cerapedics, Inc.
  
Biotechnology  
 
S+620
 
 
  
2.75
 
10.52%
 
 
12/27/2022
 
  
 
1/1/2028
 
  
 
26,939
 
  
 
26,874
 
  
 
26,872
 
Glooko, Inc.(16)
  
Health Care Technology  
 
L+790
 
 
  
0.10
 
12.07%
 
 
9/30/2021
 
  
 
10/1/2026
 
  
 
15,883
 
  
 
15,867
 
  
 
15,922
 
Meditrina, Inc.
  
Health Care Equipment & Supplies  
 
S+550
 
 
  
3.45
 
9.82%
 
 
12/20/2022
 
  
 
12/1/2027
 
  
 
3,367
 
  
 
3,338
 
  
 
3,359
 
Neuronetics, Inc.(16)
  
Health Care Equipment & Supplies  
 
L+765
 
 
  
1.66
 
11.82%
 
 
3/2/2020
 
  
 
2/28/2025
 
  
 
18,012
 
  
 
18,450
 
  
 
19,003
 
OmniGuide Holdings, Inc. (13)
  
Health Care Equipment & Supplies  
 
L+1405
 
 
  
0.10
 
18.22%
(23)
 
 
7/30/2018
 
  
 
7/1/2023
 
  
 
19,201
 
  
 
19,380
 
  
 
19,777
 
Outset Medical, Inc.(3)
  
Health Care Equipment & Supplies  
 
S+515
 
 
  
2.75
 
9.33%
 
 
11/3/2022
 
  
 
11/1/2027
 
  
 
35,084
 
  
 
34,880
 
  
 
34,820
 
Spectrum Pharmaceuticals, Inc.(16)
  
Biotechnology  
 
S+570
 
 
  
2.30
 
9.88%
 
 
9/21/2022
 
  
 
9/1/2027
 
  
 
10,525
 
  
 
10,406
 
  
 
10,420
 
Vapotherm, Inc.
  
Health Care Equipment & Supplies  
 
S+830
 
 
  
1.00
 
12.58%
(24)
 
 
2/18/2022
 
  
 
2/1/2027
 
  
 
34,455
 
  
 
34,270
 
  
 
34,628
 
        
 
 
 
                                         
 
 
    
 
 
 
Total First Lien Life Science Senior Secured Loans
$
319,205
 
  
$
322,455
 
      
 
 
    
 
 
 
Total Senior Secured Loans
$
1,272,952
 
  
$
1,245,414
 
      
 
 
    
 
 
 
 
Description
 
 
 
 
 
 
 
 
 
 
 
Industry
 
 
 
 
 
  
Interest
Rate
(1)
 
Acquisition
Date
    
Maturity

Date
    
Par Amount
    
Cost
    
Fair
Value
 
Equipment Financing — 26.6
%
 
 
   
  
 
 
 
 
  
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Aero Operating LLC (10)
  Commercial Services & Supplies    
  
8.47-
9.64
%
 
2/12/2021
 
  
3/1/2025-
12/1/2026
 
  
$
2,264
 
  
$
2,262
 
  
$
2,262
 
AFG Dallas III, LLC (10)
  Diversified Consumer Services    
  
10.00%
 
8/11/2022
 
  
8/11/2026-
8/29/2026
 
  
 
1,036
 
  
 
1,036
 
  
 
1,036
 
Air Methods Corporation (10)
 
Airlines
   
  
7.08-
7.13
%
 
11/3/2021
 
  
11/3/2026-
11/23/2026
 
  
 
3,600
 
  
 
3,660
 
  
 
3,600
 
AmeraMex International, Inc. (10)
  Commercial Services & Supplies    
  
10.00%
 
3/29/2019
 
  
9/15/2024
 
  
 
1,059
 
  
 
1,059
 
  
 
1,069
 
Bazzini, LLC (10)
  Food & Staples Retailing    
  
10.46
%
 
12/23/2022
 
  
1/1/2028
 
  
 
2,365
 
  
 
2,440
 
  
 
2,365
 
Boart Longyear Company (10)
  Metals & Mining    
  
8.31-
10.44
%
 
5/28/2020
 
  
7/1/2024-
10/7/2026
 
  
 
4,568
 
  
 
4,568
 
  
 
4,568
 
Bowman Energy Solutions, LLC (10)
  Commercial Services & Supplies    
  
7.42%
 
7/1/2022
 
  
8/1/2026
 
  
 
153
 
  
 
153
 
  
 
153
 
C-Port/Stone
LLC (10)
  Oil, Gas & Consumable Fuels    
  
8.54
%
 
10/7/2022
 
  
11/1/2027
 
  
 
6,708
 
  
 
6,514
 
  
 
6,507
 
Capital City Jet Center, Inc. (10)
 
Airlines
   
  
10.00%
 
4/4/2018
 
  
10/4/2023-
6/22/2026
 
  
 
2,241
 
  
 
2,241
 
  
 
2,214
 
Champion Air, LLC (10)
 
Airlines
   
  
10.00%
 
3/19/2018
 
  
1/1/2023
 
  
 
1,055
 
  
 
1,055
 
  
 
1,055
 
CKD Holdings, Inc. (10)
  Road & Rail    
  
8.10-
8.60
%
 
9/22/2022
 
  
3/22/2026-
9/22/2027
 
  
 
3,690
 
  
 
3,690
 
  
 
3,690
 
Clubcorp Holdings, Inc. (10)
  Hotels, Restaurants & Leisure    
  
9.36-
13.01
%
 
5/27/2021
 
  
4/1/2025-
1/1/2028
 
  
 
6,539
 
  
 
6,539
 
  
 
6,539
 
Dongwon Autopart Technology Inc. (10)
  Auto Components    
  
7.96%
 
2/2/2021
 
  
1/1/2026
 
  
 
1,828
 
  
 
1,849
 
  
 
1,828
 
Drillers Choice, Inc. (10)
  Commercial Services & Supplies    
  
8.00
%
 
10/31/2022
 
  
11/1/2027
 
  
 
1,589
 
  
 
1,589
 
  
 
1,589
 
EasyPak, LLC (10)
  Containers & Packaging    
  
9.01%
 
1/6/2021
 
  
1/1/2024
 
  
 
276
 
  
 
276
 
  
 
276
 
Energy Drilling Services, LLC (10)
  Diversified Consumer Services    
  
6.58-
9.16
%
 
8/26/2022
 
  
12/9/2025-
9/1/2027
 
  
 
1,321
 
  
 
1,321
 
  
 
1,295
 
Environmental Protection & Improvement Company,
LLC (10)
  Road & Rail    
  
8.25%
 
9/30/2020
 
  
10/1/2027
 
  
 
5,270
 
  
 
5,300
 
  
 
5,270
 
Equipment Operating Leases, LLC (2)(12)
  Multi-Sector Holdings    
  
8.37%
 
4/27/2018
 
  
4/27/2025
 
  
 
3,837
 
  
 
3,837
 
  
 
3,741
 
First American Commercial Bancorp, Inc. (10)
  Diversified Financial Services    
  
7.50-
9.02
%
 
10/28/2021
 
  
10/1/2026-
3/1/2027
 
  
 
2,938
 
  
 
2,941
 
  
 
2,938
 
First National Capital, LLC (10)
  Diversified Financial Services    
  
9.00%
 
11/5/2021
 
  
8/1/2026
 
  
 
7,116
 
  
 
7,116
 
  
 
7,116
 
Freightsol LLC (10)
  Road & Rail    
  
12.51-
12.89
%
 
4/9/2019
 
  
11/1/2023
 
  
 
779
 
  
 
784
 
  
 
779
 
Garda CL Technical Services, Inc. (10)
  Commercial Services & Supplies    
  
8.30-
8.77
%
 
3/22/2018
 
  
6/5/2023-
10/5/2023
 
  
 
469
 
  
 
469
 
  
 
468
 
Georgia Jet, Inc. (10)
 
Airlines
   
  
8.00%
 
12/4/2017
 
  
1/4/2024
 
  
 
425
 
  
 
425
 
  
 
425
 
GMT Corporation (10)
 
Machinery
   
  
10.71%
 
10/23/2018
 
  
1/1/2026
 
  
 
4,801
 
  
 
4,806
 
  
 
4,801
 
Hawkeye Contracting Company, LLC (10)
  Construction & Engineering    
  
10.50%
 
10/8/2021
 
  
11/1/2025
 
  
 
997
 
  
 
997
 
  
 
997
 
HTI Logistics Corporation (10)
  Commercial Services & Supplies    
  
9.69-
9.94
%
 
11/15/2018
 
  
5/1/2024-
9/1/2025
 
  
 
290
 
  
 
290
 
  
 
283
 
International Automotive Components Group, North America, Inc. (10)
  Auto Components    
  
7.95%
 
6/23/2021
 
  
6/23/2025
 
  
 
6,072
 
  
 
6,109
 
  
 
5,951
 
Kool Pak, LLC (10)
  Road & Rail    
  
8.58%
 
2/5/2018
 
  
3/1/2024
 
  
 
194
 
  
 
194
 
  
 
194
 
Loc Performance Products, LLC (10)
  Machinery    
  
10.50
%
 
12/29/2022
 
  
6/1/2027
 
  
 
767
 
  
 
767
 
  
 
767
 
Loyer Capital LLC (2)(12)
  Multi-Sector Holdings    
  
8.73-
11.52
%
 
5/16/2019
 
  
5/16/2024-
9/25/2024
 
  
 
7,500
 
  
 
7,500
 
  
 
7,361
 
Lux Credit Consultants, LLC (10)
  Road & Rail    
  
8.28-
12.09
%
 
6/17/2021
 
  
12/1/2024-
12/1/2026
 
  
 
16,411
 
  
 
16,411
 
  
 
16,411
 
Lux Vending, LLC (10)
  Consumer Finance    
  
12.46-
13.26
%
 
8/20/2021
 
  
8/20/2024-
10/1/2024
 
  
 
1,638
 
  
 
1,663
 
  
 
1,638
 
Mountain Air Helicopters, Inc. (10)
  Commercial Services & Supplies    
  
10.00%
 
7/31/2017
 
  
2/28/2025
 
  
 
369
 
  
 
368
 
  
 
369
 
Ozzies, Inc. (10)
  Commercial Services & Supplies    
  
10.72
%
 
12/23/2022
 
  
1/1/2027
 
  
 
2,005
 
  
 
2,072
 
  
 
2,005
 
PCX Aerostructures LLC (10)
  Aerospace & Defense    
  
9.32
%
 
11/23/2022
 
  
12/1/2028
 
  
 
2,658
 
  
 
2,658
 
  
 
2,658
 
Rane Light Metal Castings Inc. (10)
 
Machinery
   
  
10.00%
 
6/1/2020
 
  
6/1/2024
 
  
 
159
 
  
 
159
 
  
 
159
 
Rango, Inc. (10)
  Commercial Services & Supplies    
  
9.33-
9.79
%
 
9/24/2019
 
  
4/1/2023-
11/1/2024
 
  
 
1,940
 
  
 
1,960
 
  
 
1,904
 
Royal Coach Lines, Inc.(10)
  Road & Rail    
  
9.56%
 
11/21/2019
 
  
8/1/2025
 
  
 
849
 
  
 
849
 
  
 
775
 
Royal Express Inc. (10)
  Road & Rail    
  
9.53%
 
1/17/2019
 
  
2/1/2024
 
  
 
428
 
  
 
431
 
  
 
428
 
Rotten Rock Hardscaping & Tree Service (10)
  Diversified Consumer Services    
  
8.21
%
 
12/6/2022
 
  
12/6/2027
 
  
 
245
 
  
 
245
 
  
 
245
 
Signet Marine Corporation (10)
  Transportation Infrastructure    
  
8.50
%
 
10/31/2022
 
  
7/1/2029
 
  
 
14,102
 
  
 
14,152
 
  
 
14,102
 
SLR Equipment Finance(2)
  Multi-Sector Holdings    
  
8.50%
 
1/24/2022
 
  
1/24/2023
 
  
 
5,000
 
  
 
5,000
 
  
 
5,000
 
Smiley Lifting Solutions, LLC(10)
  Commercial Services & Supplies    
  
7.82-
8.28
%
 
6/30/2022
 
  
9/15/2026-
12/29/2029
 
  
 
4,139
 
  
 
4,139
 
  
 
4,139
 
ST Coaches, LLC (10)
  Road & Rail    
  
8.47-
8.58
%
 
7/31/2017
 
  
7/1/2023-
1/25/2025
 
  
 
1,521
 
  
 
1,521
 
  
 
1,459
 
Star Coaches Inc. (10)
  Road & Rail    
  
8.42%
 
3/9/2018
 
  
4/1/2025
 
  
 
2,887
 
  
 
2,887
 
  
 
2,591
 
Superior Transportation, Inc. (10)
  Road & Rail    
  
10.22-
10.63
%
 
7/31/2017
 
  
1/1/2026
 
  
 
3,369
 
  
 
3,369
 
  
 
3,369
 
The Smedley Company & Smedley Services, Inc. (10)..
  Commercial Services & Supplies    
  
4.07%
 
7/31/2017
 
  
1/15/2028
 
  
 
1,706
 
  
 
1,706
 
  
 
1,706
 
Trinity Equipment Rentals, Inc. (10)
  Commercial Services & Supplies    
  
7.94-
8.75
%
 
10/8/2021
 
  
11/1/202
4
-
12/1/2026
 
  
 
577
 
  
 
577
 
  
 
577
 
U.S. Crane & Rigging, LLC (10)
  Commercial Services & Supplies    
  
10.92
%
 
12/23/2022
 
  
3/1/2027
 
  
 
2,005
 
  
 
2,005
 
  
 
2,005
 
Up Trucking Services, LLC (10)
  Road & Rail    
  
11.21%
 
3/23/2018
 
  
8/1/2024
 
  
 
469
 
  
 
473
 
  
 
469
 
Wind River Environmental, LLC (10)
  Diversified Consumer Services    
  
8.43-
10.00
%
 
7/31/2019
 
  
8/1/2024-
10/5/2025
 
  
 
604
 
  
 
605
 
  
 
604
 
Womble Company, Inc. (10)
  Energy Equipment & Services    
  
9.11%
 
12/27/2019
 
  
1/1/2025
 
  
 
386
 
  
 
386
 
  
 
371
 
Worldwide Flight Services, Inc. (10)
  Transportation Infrastructure    
  
8.32-
9.36
%
 
9/23/2022
 
  
9/23/2027-
10/28/2027
 
  
 
304
 
  
 
308
 
  
 
304
 
Zamborelli Enterprises Pacific Souther Foundation (10)
  Diversified Consumer Services    
  
8.91
%
 
12/7/2022
 
  
1/1/2027
 
  
 
707
 
  
 
714
 
  
 
707
 
                              
Shares/Units
               
SLR Equipment Finance Equity Interests
 
(2)(9)(17)*
  Multi-Sector Holdings    
  
 
 
7/31/2017
 
  
 
 
  
 
200
 
  
 
145,000
 
  
 
120,820
 
                       
 
 
    
 
 
 
Total Equipment Financing
 
 
   
  
 
 
 
 
  
 
 
  
 
 
 
  
$
291,445
 
  
$
265,952
 
                                       
 
 
    
 
 
 
 
See notes to consolidated financial statements.
 
93
SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2022
(in thousands, except share/unit amounts)
 
Description
  
Industry
  
Interest
Rate
(1)
   
Acquisition
Date
    
Maturity

Date
    
Par Amount
    
Cost
    
Fair
Value
 
Preferred Equity – 0.4%
                                                         
SOINT, LLC (2)(3)(4)
   Aerospace & Defense      5.00 %
(11)
 
    6/8/2012        6/30/2023        49,273      $ 4,927      $ 3,801  
                                            
 
 
    
 
 
 
 
Description
  
Industry
  
Acquisition
Date
 
  
Shares/Units
 
  
Cost
 
  
Fair
Value
 
Common Equity/Equity Interests/Warrants—57.1%
 
aTyr Pharma, Inc. Warrants *
  
Pharmaceuticals
  
 
11/18/2016
 
  
 
6,347
 
  
$
106
 
  
$
  
 
CardioFocus, Inc. Warrants *
  
Health Care Equipment &
Supplies
  
 
3/31/2017
 
  
 
90
 
  
 
51
 
  
 
  
 
Centrexion Therapeutics, Inc. Warrants *
  
Pharmaceuticals
  
 
6/28/2019
 
  
 
289,102
 
  
 
136
 
  
 
82
 
Conventus Orthopaedics, Inc. Warrants *
  
Health Care Equipment &
Supplies
  
 
6/15/2016
 
  
 
157,500
 
  
 
65
 
  
 
  
 
Delphinus Medical Technologies, Inc. Warrants *
  
Health Care Equipment &
Supplies
  
 
8/18/2017
 
  
 
444,388
 
  
 
74
 
  
 
103
 
Essence Group Holdings Corporation (Lumeris) Warrants *
  
Health Care Technology
  
 
3/22/2017
 
  
 
260,000
 
  
 
129
 
  
 
366
 
KBH Topco LLC (Kingsbridge) (2)(5)(18)
  
Multi-Sector Holdings
  
 
11/3/2020
 
  
 
73,500,000
 
  
 
136,596
 
  
 
148,444
 
Meditrina, Inc. Warrants *
  
Health Care Equipment &
Supplies
  
 
12/20/2022
 
  
 
29,366
 
  
 
23
 
  
 
23
 
RD Holdco, Inc. (Rug Doctor) (2)*
  
Diversified Consumer
Services
  
 
12/23/2013
 
  
 
231,177
 
  
 
15,683
 
  
 
  
 
RD Holdco, Inc. (Rug Doctor) Class B (2)*
  
Diversified Consumer
Services
  
 
12/23/2013
 
  
 
522
 
  
 
5,216
 
  
 
  
 
RD Holdco, Inc. (Rug Doctor) Warrants (2)*
  
Diversified Consumer
Services
  
 
12/23/2013
 
  
 
30,370
 
  
 
381
 
  
 
  
 
Senseonics Holdings, Inc. (3)(8)*
  
Health Care Equipment &
Supplies
  
 
7/25/2019
 
  
 
469,353
 
  
 
235
 
  
 
483
 
SLR Business Credit (2)(3)(19)
  
Diversified Financial
Services
  
 
4/1/2022
 
  
 
100
 
  
 
81,583
 
  
 
89,370
 
SLR Credit Solutions (2)(3)(20)
  
Diversified Financial
Services
  
 
12/28/2012
 
  
 
280,303
 
  
 
280,737
 
  
 
288,760
 
SLR Healthcare ABL (2)(3)(21)
  
Diversified Financial
Services
  
 
4/1/2022
 
  
 
32,839
 
  
 
34,335
 
  
 
34,350
 
SLR Senior Lending Program LLC (2)(3)(25)
  
Asset Management
  
 
12/1/2022
 
  
 
  
 
  
 
9,500
 
  
 
9,426
 
Spectrum Pharmaceuticals, Inc. Warrants *
  
Biotechnology
  
 
9/21/2022
 
  
 
159,470
 
  
 
51
 
  
 
15
 
Vapotherm, Inc. Warrants*
  
Health Care Equipment &
Supplies
  
 
2/18/2022
 
  
 
36,996
 
  
 
210
 
  
 
87
 
Venus Concept Ltd. Warrants* (f/k/a Restoration Robotics)
  
Health Care Equipment &
Supplies
  
 
5/10/2018
 
  
 
33,430
 
  
 
152
 
  
 
  
 
  
  
  
  
  
  
 
 
 
  
 
 
 
Total Common Equity/Equity Interests/Warrants
 
  
$
565,263
 
  
$
571,509
 
  
  
  
  
  
  
 
 
 
  
 
 
 
Total Investments (6) — 208.7
%
 
  
$
2,134,587
 
  
$
2,086,676
 
  
  
  
  
  
  
 
 
 
  
 
 
 
 
Description
  
Industry
    
Acquisition
Date
    
Maturity

Date
    
Par Amount
               
Cash Equivalents — 41.8%
                                                     
U.S. Treasury Bill
     Government        12/30/2022        2/23/2023      $ 420,000      $ 417,590      $ 417,590  
                                        
 
 
    
 
 
 
Total Investments & Cash Equivalents —
 
250.5%
                                      
$
2,552,177
 
  
$
2,504,266
 
Liabilities in Excess of Other Assets — (150.5%)
                                                  (1,504,535
                                                 
 
 
 
Net Assets — 100.0%
                                               
$
999,731
 
                                                 
 
 
 
 
(1)
Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR” or “L”), the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of December 31, 2022.
(2)
Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2022 in these controlled investments are as follows:
 
Name of Issuer
  
Fair Value at
December 31,
2021
 
  
Gross
Additions
 
  
Gross
Reductions
 
  
Realized
Gain
(Loss)
 
  
Change in
Unrealized
Gain
(Loss)
 
 
Interest/
Dividend
Income
 
 
Fair Value at
December 31,
2022
 
Equipment Operating Leases, LLC
   $ 18,939      $         $ 15,833      $         $ 635     $ 749     $ 3,741  
Kingsbridge Holdings, LLC
     80,000                                      (87     7,402       80,000  
KBH Topco, LLC (Kingsbridge)
     145,996                                      2,448       15,225       148,444  
Loyer Capital LLC
     10,725                  3,500                  136       1,003       7,361  
RD Holdco, Inc. (Rug Doctor, common equity)
                                                                   
RD Holdco, Inc. (Rug Doctor, class B)
     5,216                                      (5,216                  
RD Holdco, Inc. (Rug Doctor, warrants)
                                                                   
RD Holdco, Inc. (debt)
     11,829        685                            (5,280     (18     6,521  
SLR Business Credit
               81,583                            7,787       5,150       89,370  
SLR Credit Solutions
     298,766                                      (10,006     20,500       288,760  
SLR Equipment Finance (equity)
     129,102                                      (8,282              120,820  
SLR Equipment Finance (debt)
               5,000                                     379       5,000  
SLR Healthcare ABL
               34,335                            15       2,595       34,350  
SLR Senior Lending Program LLC
               9,500                            (74              9,426  
SOAGG LLC
     1,121                  447                  (674     647           
SOINT, LLC
     4,509        266        942                  (32     266       3,801  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
     $ 706,203      $ 131,369      $ 20,722      $         $ (18,630   $ 53,898     $ 797,594  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
 
 
See notes to consolidated financial statements.
 

9
4

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2022
(in thousands)

 
(3)
Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making
follow-on
investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2022, on a fair value basis,
non-qualifying
assets in the portfolio represented 24.2% of the total assets of the Company.
(4)
The Company’s investment in SOINT, LLC includes a one dollar investment in common shares.
(5)
Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation.
(6)
Aggregate net unrealized appreciation for U.S. federal income tax purposes is $17,187; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $161,053 and $143,866, respectively, based on a tax cost of $2,069,489. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.
(7)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR, SOFR or PRIME rate. These instruments are often subject to a LIBOR, SOFR or PRIME rate floor.
(8)
Denotes a Level 1 investment.
(9)
SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary and NEFPASS LLC, a wholly-owned consolidated subsidiary.
(10)
Indicates an investment that is wholly held by the Company through NEFPASS LLC.
(11)
Interest is paid in kind (“PIK”).
(12)
Denotes a subsidiary of SLR Equipment Finance.
(13)
OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are
co-borrowers.
(14)
AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each
co-Borrowers.
Amerimark may elect to defer up to 8.00% of the coupon as PIK.
(15)
Spread is 5.75% Cash / 0.50% PIK.
(16)
Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SUNS SPV LLC (the “SUNS SPV”). Such investments are pledged as collateral under the Senior Secured Revolving SPV Credit Facility (the “SPV Credit Facility”) (see Note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company.
(17)
See note 12 to the consolidated financial statements.
(18)
See note 14 to the consolidated financial statements.
(19)
See note 16 to the consolidated financial statements.
(20)
See note 10 to the consolidated financial statements.
(21)
See note 15 to the consolidated financial statements.
(22)
BridgeBio Pharma, Inc. may elect to defer up to 3.00% of the coupon as PIK.
(23)
OmniGuide Holdings, Inc. may elect to defer up to 10.00% of the coupon as PIK.
(24)
Vapotherm, Inc. may elect to defer up to 8.00% of the coupon as PIK.
(25)
See note 19 to the consolidated financial statements.
(26)
iCIMS, Inc. may elect to defer up to 3.875% of the coupon as PIK.
*
Non-income
producing security.
**
Investment is on
non-accrual
status.
 
See notes to consolidated financial statements.
 
9
5
SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2022
(in thousands)
 
Industry Classification
  
Percentage of Total
Investments (at fair value) as
of December 31, 2022
 
Diversified Financial Services (includes SLR Credit Solutions, SLR Business Credit and SLR Healthcare
ABL)
     22.1
Multi-Sector Holdings (includes Kingsbridge Holdings, LLC, SLR Equipment Finance, Equipment
Operating Leases, LLC and Loyer Capital LLC)
     17.5
Health Care Providers & Services
     7.7
Health Care Equipment & Supplies
     6.6
Pharmaceuticals
     5.5
Software
     4.3
Insurance
     4.2
Biotechnology
     3.9
Diversified Consumer Services
     2.7
Media
     1.9
Road & Rail
     1.7
Personal Products
     1.7
Capital Markets
     1.7
Thrifts & Mortgage Finance
     1.3
Life Sciences Tools & Services
     1.3
Auto Parts & Equipment
     1.2
Packaged Foods & Meats
     1.2
Wireless Telecommunication Services
     1.1
Commercial Services & Supplies
     1.1
Internet & Catalog Retail
     1.1
Internet Software & Services
     1.0
Building Products
     0.9
Trading Companies & Distributors
     0.9
Health Care Technology
     0.8
Transportation Infrastructure
     0.7
Communications Equipment
     0.7
IT Services
     0.6
Leisure Equipment & Products
     0.5
Specialty Retail
     0.5
Asset Management
     0.5
Food Products
     0.4
Auto Components
     0.4
Airlines
     0.3
Hotels, Restaurants & Leisure
     0.3
Oil, Gas & Consumable Fuels
     0.3
Aerospace & Defense
     0.3
Machinery
     0.3
Footwear
     0.3
Metals & Mining
     0.2
Food & Staples Retailing
     0.1
Water Utilities
     0.1
Consumer Finance
     0.1
Construction & Engineering
     0.0
Energy Equipment & Services
     0.0
Containers & Packaging
     0.0
    
 
 
 
Total Investments
     100.0
    
 
 
 
 
 
See notes to consolidated financial statements.
 
9
6

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2021
(in thousands, except share/unit amounts
)
 
Description
  
Industry
    
Spread
Above
Index
(7)
 
LIBOR
Floor
 
Interest
Rate
(1)
   
Acquisition
Date
    
Maturity

Date
    
Par Amount
    
Cost
    
Fair
Value
 
Senior Secured Loans — 111.5
%
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
First Lien Bank Debt/Senior Secured Loans
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Aegis
 
Toxicology Sciences Corporation
  
Health Care Providers & Services  
  
L+550
 
1.00 %
 
6.50 %
 
 
5/7/2018
 
  
 
5/9/2025
 
  
$
12,402
 
  
$
12,283
 
  
$
12,402
 
Alteon Health, LLC
  
Health Care Providers & Services  
  
L+650
 
1.00 %
 
7.50 %
 
 
9/14/2018
 
  
 
9/1/2023
 
  
 
14,117
 
  
 
14,079
 
  
 
14,117
 
American Teleconferencing Services, Ltd.**
  
Communications Equipment  
  
L+650
 
1.00 %
 
7.50 %
 
 
5/5/2016
 
  
 
9/9/2021
 
  
 
24,822
 
  
 
24,453
 
  
 
3,345
 
American Teleconferencing Services, Ltd.**
  
Communications Equipment  
  
L+650
 
1.00 %
 
7.50 %
 
 
9/17/2021
 
  
 
3/31/2022
 
  
 
4,576
 
  
 
4,508
 
  
 
4,576
 
AmeriMark Intermediate Holdings, LLC(14)
  
Internet & Catalog Retail  
  
L+600
 
1.00 %
 
7.00 %
 
 
7/28/2021
 
  
 
10/15/2026
 
  
 
25,226
 
  
 
24,739
 
  
 
24,721
 
Atria Wealth Solutions, Inc
  
Diversified Financial Services  
  
L+600
 
1.00 %
 
7.00 %
 
 
9/14/2018
 
  
 
11/30/2022
 
  
 
6,345
 
  
 
6,329
 
  
 
6,345
 
Basic Fun, Inc
  
Specialty Retail  
  
L+550
 
1.00 %
 
6.50 %
 
 
10/30/2020
 
  
 
10/30/2023
 
  
 
2,902
 
  
 
2,871
 
  
 
2,902
 
CC SAG Holdings Corp. (Spectrum Automotive)
  
Diversified Consumer Services  
  
L+575
 
0.75 %
 
6.50 %
 
 
6/29/2021
 
  
 
6/29/2028
 
  
 
12,168
 
  
 
11,995
 
  
 
12,168
 
Community Brands ParentCo, LLC (f/k/a Ministry Brands)
  
Software  
  
L+400
 
1.00 %
 
5.00 %
 
 
7/30/2021
 
  
 
12/2/2022
 
  
 
34,901
 
  
 
34,538
 
  
 
34,901
 
Enhanced Permanent Capital, LLC(3)
  
Capital Markets  
  
L+700
 
1.00 %
 
8.00 %
 
 
12/29/2020
 
  
 
12/29/2025
 
  
 
26,061
 
  
 
25,418
 
  
 
26,061
 
Foundation Consumer Brands, LLC
  
Personal Products  
  
L+638
 
1.00 %
 
7.38 %
 
 
2/12/2021
 
  
 
2/12/2027
 
  
 
33,367
 
  
 
32,633
 
  
 
33,367
 
iCIMS, Inc.
  
Software  
  
L+650
 
1.00 %
 
7.50 %
 
 
9/7/2018
 
  
 
9/12/2024
 
  
 
19,341
 
  
 
19,120
 
  
 
19,341
 
Inszone Mid, LLC
  
Insurance  
  
L+575
 
1.00 %
 
6.75 %
 
 
9/28/2021
 
  
 
6/30/2026
 
  
 
11,141
 
  
 
11,035
 
  
 
11,086
 
Ivy Fertility Services, LLC
  
Health Care Providers & Services  
  
L+625
 
1.00 %
 
7.25 %
 
 
12/22/2021
 
  
 
2/25/2026
 
  
 
21,677
 
  
 
21,299
 
  
 
21,298
 
Kid Distro Holdings, LLC (Distro Kid)
  
Software  
  
L+600
 
1.00 %
 
7.00 %
 
 
9/24/2021
 
  
 
10/1/2027
 
  
 
29,743
 
  
 
29,168
 
  
 
29,148
 
Kingsbridge Holdings, LLC(2)
  
Multi-Sector Holdings  
  
L+700
 
1.00 %
 
8.00 %
 
 
12/21/2018
 
  
 
12/21/2024
 
  
 
80,000
 
  
 
79,713
 
  
 
80,000
 
KORE Wireless Group, Inc.(3)
  
Wireless Telecommunication Services  
  
L+550
 
  
 
 
5.72 %
 
 
12/21/2018
 
  
 
12/21/2024
 
  
 
36,470
 
  
 
36,062
 
  
 
36,470
 
Logix Holding Company, LLC
  
Communications Equipment  
  
L+575
 
1.00 %
 
6.75 %
 
 
9/14/2018
 
  
 
12/22/2024
 
  
 
7,400
 
  
 
7,359
 
  
 
7,178
 
Maurices, Incorporated
  
Specialty Retail  
  
L+675
 
1.00 %
 
7.75 %
 
 
8/27/2021
 
  
 
6/1/2024
 
  
 
5,135
 
  
 
5,044
 
  
 
5,135
 
MMIT Holdings, LLC
  
IT Services  
  
L+625
 
1.00 %
 
7.25 %
 
 
9/21/2021
 
  
 
9/15/2027
 
  
 
31,026
 
  
 
30,541
 
  
 
31,026
 
NAC Holdings Corporation (Jaguar)
  
Insurance  
  
L+525
 
1.00 %
 
6.25 %
 
 
7/30/2021
 
  
 
9/28/2024
 
  
 
15,924
 
  
 
15,730
 
  
 
15,844
 
One Touch Direct, LLC
  
Commercial Services & Supplies  
  
P+75
 
  
 
 
4.00 %
 
 
4/3/2020
 
  
 
9/30/2022
 
  
 
274
 
  
 
274
 
  
 
274
 
PhyNet Dermatology LLC
  
Health Care Providers & Services  
  
L+600
(17)
 
1.00 %
 
7.00 %
 
 
9/5/2018
 
  
 
8/16/2024
 
  
 
14,589
 
  
 
14,529
 
  
 
14,589
 
Pinnacle Treatment Centers, Inc.
  
Health Care Providers & Services  
  
L+575
 
1.00 %
 
6.75 %
 
 
1/22/2020
 
  
 
12/31/2022
 
  
 
11,996
 
  
 
11,953
 
  
 
11,996
 
PPT Management Holdings, LLC
  
Health Care Providers & Services  
  
L+800
(15)
 
1.00 %
 
9.00 %
 
 
9/14/2018
 
  
 
12/16/2022
 
  
 
21,120
 
  
 
21,086
 
  
 
18,374
 
RQM+ Corp
  
Life Sciences Tools & Services  
  
L+575
 
1.00 %
 
6.75 %
 
 
8/20/2021
 
  
 
8/12/2026
 
  
 
16,504
 
  
 
16,349
 
  
 
16,462
 
Stryten Energy LLC
  
Auto Parts & Equipment  
  
L+800
 
1.00 %
 
9.00 %
 
 
8/11/2021
 
  
 
10/12/2026
 
  
 
26,184
 
  
 
25,676
 
  
 
25,923
 
SunMed Group Holdings, LLC
  
Health Care Equipment & Supplies  
  
L+575
 
0.75 %
 
6.50 %
 
 
6/16/2021
 
  
 
6/16/2028
 
  
 
18,536
 
  
 
18,232
 
  
 
18,351
 
Ultimate Baked Goods Midco LLC (Rise Baking)
  
Packaged Foods & Meats  
  
L+625
 
1.00 %
 
7.25 %
 
 
8/12/2021
 
  
 
8/13/2027
 
  
 
19,381
 
  
 
18,920
 
  
 
18,896
 
USR Parent, Inc. (Staples)
  
Specialty Retail  
  
L+884
 
1.00 %
 
9.84 %
 
 
6/3/2020
 
  
 
9/12/2022
 
  
 
3,275
 
  
 
3,275
 
  
 
3,275
 
                                                      
 
 
    
 
 
 
Total First Lien Bank
Debt/Senior Secured Loans
 
  
$
579,211
 
  
$
559,571
 
      
 
 
    
 
 
 
Second Lien Asset-Based Senior Secured Loans
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
ACRES Commercial Mortgage, LLC
  
Diversified Financial Services  
  
S+705
 
1.00 %
 
8.05
 
 
12/24/2021
 
  
 
8/21/2028
 
  
 
29,925
 
  
$
29,328
 
  
$
29,326
 
Varilease Finance, Inc.
  
Multi-Sector Holdings  
  
L+750
 
1.00 %
 
8.50
 
 
8/22/2014
 
  
 
11/15/2025
 
  
 
29,563
 
  
 
29,467
 
  
 
29,563
 
                                                      
 
 
    
 
 
 
Total Second Lien Asset-Based Senior Secured Loans
 
  
$
58,795
 
  
$
58,889
 
      
 
 
    
 
 
 
Second Lien Bank Debt/Senior Secured Loans
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
PhyMed Management LLC
  
Health Care Providers & Services  
  
L+1500
(16)
 
1.00 %
 
16.00
 
 
12/18/2015
 
  
 
9/30/2022
 
  
 
37,819
 
  
$
37,757
 
  
$
36,874
 
Rug Doctor LLC (2)
  
Diversified Consumer Services  
  
L+975
(11)
 
1.50 %
 
11.25
 
 
12/23/2013
 
  
 
5/16/2023
 
  
 
11,828
 
  
 
11,819
 
  
 
11,829
 
                                                      
 
 
    
 
 
 
Total Second Lien Bank
Debt/Senior Secured Loans
 
  
$
49,576
 
  
$
48,703
 
      
 
 
    
 
 
 
First Lien Life Science Senior Secured Loans
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Alimera Sciences, Inc.
  
Pharmaceuticals  
  
L+765
 
1.78 %
 
9.43
 
 
12/31/2019
 
  
 
7/1/2024
 
  
$
20,074
 
  
$
20,512
 
  
$
20,475
 
Arcutis Biotherapeutics, Inc.(3)
  
Pharamceuticals  
  
L+745
 
0.10 %
 
7.55
 
 
12/22/2021
 
  
 
1/1/2027
 
  
 
21,735
 
  
 
21,645
 
  
 
21,637
 
Ardelyx, Inc.
  
Pharmaceuticals  
  
L+745
 
0.25 %
 
7.70
 
 
5/10/2018
 
  
 
11/1/2022
 
  
 
14,972
 
  
 
16,198
 
  
 
16,170
 
Axcella Health Inc
  
Pharmaceuticals  
  
L+860
 
0.10 %
 
8.70
 
 
9/2/2021
 
  
 
9/1/2026
 
  
 
9,278
 
  
 
9,318
 
  
 
9,302
 
BridgeBio Pharma, Inc.(3)
  
Biotechnology  
  
 
 
 
9.00
 
 
11/17/2021
 
  
 
11/17/2026
 
  
 
34,574
 
  
 
34,082
 
  
 
34,055
 
Centrexion Therapeutics, Inc.
  
Pharmaceuticals  
  
L+725
 
2.45 %
 
9.70
 
 
6/28/2019
 
  
 
1/1/2024
 
  
 
16,400
 
  
 
16,693
 
  
 
16,728
 
Cerapedics, Inc.
  
Health Care Equipment & Supplies  
  
L+695
 
2.50 %
 
9.45
 
 
3/22/2019
 
  
 
3/1/2025
 
  
 
26,861
 
  
 
27,518
 
  
 
27,465
 
Delphinus Medical Technologies, Inc.
  
Health Care Equipment & Supplies  
  
L+850
 
1.00 %
 
9.50
 
 
8/18/2017
 
  
 
6/1/2022
 
  
 
1,089
 
  
 
1,414
 
  
 
1,405
 
Glooko, Inc.
  
Health Care Technology  
  
L+790
 
0.10 %
 
8.00
 
 
9/30/2021
 
  
 
10/1/2026
 
  
 
8,364
 
  
 
8,339
 
  
 
8,322
 
Neuronetics, Inc.
  
Health Care Equipment & Supplies  
  
L+765
 
1.66 %
 
9.31
 
 
3/2/2020
 
  
 
2/28/2025
 
  
 
15,613
 
  
 
15,874
 
  
 
15,878
 
OmniGuide Holdings, Inc. (13)
  
Health Care Equipment & Supplies  
  
L+1405
 
0.10 %
 
14.15
 
 
7/30/2018
 
  
 
7/1/2023
 
  
 
18,879
 
  
 
17,845
 
  
 
18,958
 
Rezolute, Inc
  
Biotechnology  
  
L+875
 
0.12 %
 
8.87
 
 
4/14/2021
 
  
 
4/1/2026
 
  
 
5,675
 
  
 
5,663
 
  
 
5,661
 
Rubius Therapeutics, Inc. (3)
  
Pharmaceuticals  
  
L+550
 
2.10 %
 
7.60
 
 
12/21/2018
 
  
 
6/1/2026
 
  
 
40,291
 
  
 
41,103
 
  
 
41,097
 
scPharmaceuticals, Inc.
  
Pharmaceuticals  
  
L+795
 
2.23 %
 
10.18
 
 
9/17/2019
 
  
 
9/17/2023
 
  
 
4,098
 
  
 
4,165
 
  
 
4,160
 
SOC Telemed, Inc.
  
Health Care Providers & Services  
  
L+747
 
0.13 %
 
7.60
 
 
3/26/2021
 
  
 
4/1/2026
 
  
 
31,137
 
  
 
31,211
 
  
 
31,214
 
                                                      
 
 
    
 
 
 
Total First Lien Life
Science Senior Secured Loans
 
  
$
271,580
 
  
$
272,527
 
      
 
 
    
 
 
 
Total Senior Secured Loans
 
  
$
959,162
 
  
$
939,690
 
      
 
 
    
 
 
 
See notes to consolidated financial statements.
 
 
97
SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2021
(in thousands, except share/unit amounts)


Description
  
Industry
  
Interest Rate
(1)
 
 
Acquisition
Date
 
  
Maturity

Date
  
Par Amount
 
Cost
 
Fair
Value
 
Equipment Financing — 
32.5
%
  
 
  
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
Aero Operating LLC (10)
  
Commercial Services & Supplies
  
 
8.47-
9.64
%
 
 
 
2/12/2021
 
  
3/1/2025-
12/1/2026
  
$
3,103
 
$
3,100
 
$
3,100
 
Air Methods Corporation (10)
  
Airlines
  
 
7.08-
7.13
%
 
 
 
11/3/2021
 
  
11/3/2026-
11/23/2026
  
 
4,063
 
 
4,145
 
 
4,063
 
AmeraMex International, Inc. (10)
  
Commercial Services & Supplies
  
 
10.00
%
 
 
 
3/29/2019
 
  
3/28/2022
  
 
3,149
 
 
3,148
 
 
3,180
 
Blackhawk Mining, LLC (10)
  
Oil, Gas & Consumable Fuels
  
 
10.97-
11.16
%
 
 
 
2/16/2018
 
  
3/1/2022-
11/1/2022
  
 
1,642
 
 
1,615
 
 
1,636
 
Boart Longyear Company (10)
  
Metals & Mining
  
 
9.06-
10.44
%
 
 
 
5/28/2020
 
  
7/1/2024-
1/1/2026
  
 
5,374
 
 
5,374
 
 
5,374
 
Capital City Jet Center, Inc. (10)
  
Airlines
  
 
10.00
%
 
 
 
4/4/2018
 
  
10/4/2023-
6/22/26
  
 
3,102
 
 
3,102
 
 
3,053
 
Champion Air, LLC (10)
  
Airlines
  
 
10.00
%
 
 
 
3/19/2018
 
  
1/1/2023
  
 
1,685
 
 
1,685
 
 
1,685
 
Clubcorp Holdings, Inc. (10)
  
Hotels, Restaurants & Leisure
  
 
8.87-
9.41
%
 
 
 
5/27/2021
 
  
6/1/2025-
1/1/2027
  
 
4,326
 
 
4,326
 
 
4,326
 
Dongwon Autopart Technology
 
Inc. (10)
  
Auto Components
  
 
7.96
%
 
 
 
2/2/2021
 
  
1/1/2026
  
 
2,347
 
 
2,382
 
 
2,347
 
EasyPak, LLC (10)
  
Containers & Packaging
  
 
9.01
%
 
 
 
1/6/2021
 
  
1/1/2024
  
 
616
 
 
616
 
 
616
 
Environmental Protection &
 
Improvement
Company, LLC (10)
  
Road & Rail
  
 
8.25
%
 
 
 
9/30/2020
 
  
10/1/2027
  
 
5,921
 
 
5,959
 
 
5,921
 
Equipment Operating Leases,
 
LLC (2)(12)
  
Multi-Sector Holdings
  
 
7.53-
8.37
%
 
 
 
4/27/2018
 
  
8/1/2022-
4/27/2025
  
 
19,671
 
 
19,671
 
 
18,939
 
First American Commercial Bancorp,
 
Inc. (10)
  
Diversified Financial Services
  
 
7.50
%
 
 
 
10/28/2021
 
  
11/1/2026
  
 
2,487
 
 
2,492
 
 
2,487
 
First National Capital, LLC (10)
  
Diversified Financial Services
  
 
9.00
%
 
 
 
11/5/2021
 
  
8/1/2026
  
 
8,681
 
 
8,681
 
 
8,681
 
Freightsol LLC (10)
  
Road & Rail
  
 
12.51-
12.89
%
 
 
 
4/9/2019
 
  
11/1/2023
  
 
1,364
 
 
1,381
 
 
1,364
 
Garda CL Technical Services,
 
Inc. (10)
  
Commercial Services & Supplies
  
 
8.30-
8.77
%
 
 
 
3/22/2018
 
  
6/5/2023-
10/5/2023
  
 
1,245
 
 
1,245
 
 
1,242
 
Georgia Jet, Inc. (10)
  
Airlines
  
 
8.00
%
 
 
 
12/4/2017
 
  
1/4/2024
  
 
795
 
 
795
 
 
795
 
GMT Corporation (10)
  
Machinery
  
 
10.71
%
 
 
 
10/23/2018
 
  
10/1/2025
  
 
5,476
 
 
5,484
 
 
5,476
 
Haljoe Coaches USA, LLC (10)
  
Road & Rail
  
 
8.53
%
 
 
 
7/31/2017
 
  
7/1/2024
  
 
1,061
 
 
1,061
 
 
915
 
Hawkeye Contracting Company,
 
LLC (10)
  
Construction & Engineering
  
 
10.50
%
 
 
 
10/8/2021
 
  
11/1/2025
  
 
1,252
 
 
1,252
 
 
1,252
 
HTI Logistics Corporation (10)
  
Commercial Services & Supplies
  
 
9.69-
9.94
%
 
 
 
11/15/2018
 
  
5/1/2024-
9/1/2025
  
 
414
 
 
414
 
 
404
 
International Automotive Components
 
Group, North
America, Inc. (10)
  
Auto Components
  
 
7.95
%
 
 
 
6/23/2021
 
  
6/23/2025
  
 
8,184
 
 
8,250
 
 
8,184
 
Kool Pak, LLC (10)
  
Road & Rail
  
 
8.58
%
 
 
 
2/5/2018
 
  
3/1/2024
  
 
345
 
 
345
 
 
345
 
Loyer Capital LLC (2)(12)
  
Multi-Sector Holdings
  
 
8.73-
11.52
%
 
 
 
5/16/2019
 
  
5/16/24-
9/25/24
  
 
11,000
 
 
11,000
 
 
10,725
 
Lux Credit Consultants, LLC (10)
  
Road & Rail
  
 
8.28-
9.65
%
 
 
 
6/17/2021
 
  
12/1/2024-
12/1/2025
  
 
9,343
 
 
9,343
 
 
9,343
 
Lux Vending, LLC (10)
  
Consumer Finance
  
 
12.46-
13.26
%
 
 
 
8/20/2021
 
  
8/20/2024-
10/1/2024
  
 
2,526
 
 
2,583
 
 
2,526
 
Mountain Air Helicopters,
 
Inc. (10)
  
Commercial Services & Supplies
  
 
10.00
%
 
 
 
7/31/2017
 
  
2/28/2025
  
 
479
 
 
476
 
 
479
 
Rane Light Metal Castings
 
Inc. (10)
  
Machinery
  
 
10.00
%
 
 
 
6/1/2020
 
  
7/1/2024
  
 
253
 
 
253
 
 
253
 
Rango, Inc. (10)
  
Commercial Services & Supplies
  
 
9.33-
9.79
%
 
 
 
9/24/2019
 
  
4/1/2023-
11/1/2024
  
 
3,615
 
 
3,656
 
 
3,547
 
Rossco Crane & Rigging, Inc. (10)
  
Commercial Services & Supplies
  
 
11.53
%
 
 
 
8/25/2017
 
  
9/1/2022
  
 
126
 
 
126
 
 
126
 
Royal Coach Lines, Inc.(10)
  
Road & Rail
  
 
9.56
%
 
 
 
11/21/2019
 
  
8/1/2025
  
 
1,041
 
 
1,041
 
 
950
 
Royal Express Inc. (10)
  
Road & Rail
  
 
9.53
%
 
 
 
1/17/2019
 
  
2/1/2024
  
 
683
 
 
690
 
 
683
 
Sidelines Tree Service LLC (10)
  
Diversified Consumer Services
  
 
10.25
%
 
 
 
7/31/2017
 
  
10/1/2022
  
 
46
 
 
46
 
 
45
 
South Texas Oilfield Solutions,
 
LLC (10)
  
Energy Equipment & Services
  
 
12.52-
13.76
%
 
 
 
3/29/2018
 
  
9/1/2022-
7/1/2023
  
 
1,363
 
 
1,363
 
 
1,338
 
ST Coaches, LLC (10)
  
Road & Rail
  
 
8.22-
8.58
%
 
 
 
7/31/2017
 
  
10/1/2022-
1/25/2025
  
 
1,951
 
 
1,951
 
 
1,839
 
Stafford Logistics, Inc. (10)
  
Commercial Services & Supplies
  
 
12.62
%
 
 
 
9/11/2019
 
  
2/15/2026
  
 
7,094
 
 
7,094
 
 
7,094
 
Star Coaches Inc. (10)
  
Road & Rail
  
 
8.42
%
 
 
 
3/9/2018
 
  
4/1/2025
  
 
3,401
 
 
3,401
 
 
2,916
 
Sturgeon Services International
 
Inc. (10)
  
Energy Equipment & Services
  
 
18.38
%
 
 
 
7/31/2017
 
  
2/28/2022
  
 
132
 
 
132
 
 
125
 
Superior Transportation, Inc. (10)
  
Road & Rail
  
 
10.22-
10.62
%
 
 
 
7/31/2017
 
  
1/1/2026
  
 
4,578
 
 
4,578
 
 
4,578
 
Tailwinds, LLC (10)
  
Air Freight & Logistics
  
 
8.50-
9.00
%
 
 
 
7/26/2019
 
  
8/1/2024-
10/16/2025
  
 
2,267
 
 
2,267
 
 
2,267
 
The Smedley Company & Smedley
 
Services, Inc.
(10)..
  
Commercial Services & Supplies
  
 
10.21-
15.36
%
 
 
 
7/31/2017
 
  
10/29/2023-
2/10/2024
  
 
3,798
 
 
3,800
 
 
3,536
 
Trinity Equipment Rentals,
 
Inc. (10)
  
Commercial Services & Supplies
  
 
7.94-
8.75
%
 
 
 
10/8/2021
 
  
11/1/2024-
12/1/2026
  
 
777
 
 
777
 
 
777
 
Trolleys, Inc. (10)
  
Road & Rail
  
 
9.99%
 
 
 
7/18/2018
 
  
8/1/2022
  
 
1,573
 
 
1,573
 
 
1,540
 
Up Trucking Services, LLC (10)
  
Road & Rail
  
 
11.21
%
 
 
 
3/23/2018
 
  
8/1/2024
  
 
696
 
 
705
 
 
696
 
Warrior Crane Services, LLC (10)
  
Commercial Services & Supplies
  
 
8.95
%
 
 
 
7/11/2019
 
  
8/1/2024-
8/1/2026
  
 
2,567
 
 
2,567
 
 
2,518
 
Wind River Environmental,
 

LLC (10)
  
Diversified Consumer Services
  
 
8.43-
10.00%
 
 
 
7/31/2019
 
  
8/1/2024-
10/5/25
  
 
870
 
 
873
 
 
870
 
Womble Company, Inc. (10)
  
Energy Equipment & Services
  
 
9.11
%
 
 
 
12/27/2019
 
  
1/1/2025
  
 
547
 
 
547
 
 
537
 
 
  
 
  
 
 
 
 
 
  
 
  
Shares/Units
 
 
 
 
 
SLR Equipment Finance Equity
 
Interests (2)(9)*
  
Multi-Sector Holdings
  
 
 
 
 
 
7/31/2017
 
  
 
  
 
200
 
 
145,000
 
 
129,102
 
 
  
 
  
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
Total Equipment Financing
 
$
292,365
 
$
273,795
 
 
  
 
  
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
Preferred Equity –
0.7
%
  
 
  
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
SOAGG LLC (2)(3)(4)
  
Aerospace & Defense
  
 
8.00%
  
 
 
12/14/2010
 
  
6/30/2023
  
 
446
 
$
446
 
$
1,121
 
SOINT, LLC (2)(3)(4)
  
Aerospace & Defense
  
  
5.00%
(
11)
 
 
 
 
6/8/2012
 
  
6/30/2023
  
 
56,030
 
 
5,603
 
 
4,509
 
 
  
 
  
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
Total Preferred Equity
 
 
$ 6,049
 
 
$ 5,630
 
 
  
 
  
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
See notes to consolidated financial statements.
 
9
8
SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2021
(in thousands, except share/unit amounts
)
 
Description
  
Industry
  
Acquisition
Date
    
Shares/Units
    
Cost
    
Fair
Value
 
Common Equity/Equity Interests/Warrants—53.6%
                                        
aTyr Pharma, Inc. Warrants *
   Pharmaceuticals      11/18/2016        6,347      $ 106      $     
CardioFocus, Inc. Warrants *
   Health Care Equipment &
Supplies
     3/31/2017        90        51            
Centrexion Therapeutics, Inc. Warrants *
   Pharmaceuticals      6/28/2019        289,102        136        65  
Conventus Orthopaedics, Inc. Warrants *
   Health Care Equipment &
Supplies
     6/15/2016        157,500        65            
Delphinus Medical Technologies, Inc. Warrants *
   Health Care Equipment &
Supplies
     8/18/2017        444,388        74        80  
Essence Group Holdings Corporation (Lumeris) Warrants *
   Health Care Technology      3/22/2017        208,000        63        258  
KBH Topco LLC (Kingsbridge) (2)(5)
   Multi-Sector Holdings      11/3/2020        73,500,000        136,596        145,996  
RD Holdco Inc. (Rug Doctor) (2)*
   Diversified Consumer Services      12/23/2013        231,177        15,683            
RD Holdco Inc. (Rug Doctor) Class B (2)*
   Diversified Consumer Services      12/23/2013        522        5,216        5,216  
RD Holdco Inc. (Rug Doctor) Warrants (2)*
   Diversified Consumer Services      12/23/2013        30,370        381            
Senseonics Holdings, Inc. (3)(8)*
   Health Care Equipment &
Supplies
     7/25/2019        406,923        117        1,086  
SLR Credit Solutions (2)(3)
   Diversified Financial Services      12/28/2012        280,303        280,737        298,766  
Venus Concept Ltd. Warrants* (f/k/a Restoration Robotics)
   Health Care Equipment &
Supplies
     5/10/2018        27,352        152            
                           
 
 
    
 
 
 
Total Common Equity/Equity Interests/Warrants
 
  
$
439,377
 
  
$
451,467
 
      
 
 
    
 
 
 
Total Investments (6) — 198.3%
 
  
$
1,696,953
 
  
$
1,670,582
 
                           
 
 
    
 
 
 
 
Description
  
Industry
  
Acquisition
Date
 
  
Maturity

Date
 
  
Par Amount
 
  
 
 
  
 
 
Cash Equivalents — 38.0%
  
  
  
  
  
  
U.S. Treasury Bill
  
Government
  
 
12/31/2021
 
  
 
1/25/2022
 
  
$
320,000
 
  
$
320,000
 
  
$
320,000
 
  
  
  
  
  
 
 
 
  
 
 
 
Total Investments & Cash Equivalents — 236.3%
 
  
  
$
2,016,953
 
  
$
1,990,582
 
Liabilities in Excess of Other Assets — (136.3%)
 
  
  
  
 
(1,148,301
  
  
  
  
  
  
 
 
 
Net Assets — 100.0%
 
  
  
  
$
842,281
 
  
  
  
  
  
  
 
 
 
 
(1)
Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of December 31, 2021. 
(2)
Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2021 in these controlled investments are as follows:
 
Name of Issuer
  
Fair Value at
December 31,
2020
 
  
Gross
Additions
 
  
Gross
Reductions
 
  
Realized
Gain
(Loss)
 
  
Change in
Unrealized
Gain
(Loss)
 
 
Interest/
Dividend
Income
 
  
Fair Value at
December 31,
2021
 
AviatorCap SII, LLC
   $ 2,941      $         $ 2,941      $         $        $ 92      $     
Equipment Operating Leases, LLC
     25,540                  6,667                  66       1,950        18,939  
Kingsbridge Holdings, LLC
     80,000                                      (79     6,568        80,000  
KBH Topco, LLC (Kingsbridge)
     136,596                                      9,400       13,250        145,996  
Loyer Capital LLC
     14,456                  3,731                           1,426        10,725  
RD Holdco Inc. (Rug Doctor, common equity)
     1,226                                      (1,226                   
RD Holdco Inc. (Rug Doctor, class B)
     5,216                                                         5,216  
RD Holdco Inc. (Rug Doctor, warrants)
                                                                    
Rug Doctor LLC
     10,559        1,270                            (6     1,300        11,829  
SLR Credit Solutions
     296,766                                      2,000       22,500        298,766  
SLR Equipment Finance (equity)
     129,102                                                         129,102  
SLR Equipment Finance (debt)
     850                  850                           42            
SOAGG LLC
     2,300                                      (1,179     1,543        1,121  
SOINT, LLC
     4,101        271                            137       271        4,509  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
     $ 709,653      $ 1,541      $ 14,189      $         $ 9,113     $ 48,942      $ 706,203  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
 
 
See notes to consolidated financial statements.
 
99

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December
 
31, 2021
(in thousands)

 
(3)
Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making
follow-on
investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2021, on a fair value basis,
non-qualifying
assets in the portfolio represented 23.1% of the total assets of the Company.
(4)
The Company’s investments in SOAGG, LLC and SOINT, LLC include a two and one dollar investment in common shares, respectively.
(5)
Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation.
(6)
Aggregate net unrealized appreciation for U.S. federal income tax purposes is $19,495; aggregate gross unrealized appreciation and depreciation
for U.S. federal tax purposes is $82,598 and $63,103, respectively, based on a tax cost of $1,651,087. Unless otherwise noted, all of the
Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally
acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”).
These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act.
All investments are Level 3 unless otherwise indicated.
(7)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or PRIME rate. These instruments are often subject to a LIBOR or PRIME rate floor.
(8)
Denotes a Level 1 investment.
(9)
SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary and NEFPASS LLC, a wholly-owned consolidated subsidiary.
(10)
Indicates an investment that is wholly held by the Company through NEFPASS LLC.
(11)
Interest is paid in kind (“PIK”).
(12)
Denotes a subsidiary of SLR Equipment Finance.
(13)
OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are
co-borrowers.
(14)
AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each
co-Borrowers.
(15)
Spread is 6.00% Cash / 2.00% PIK.
(16)
Spread is 2.50% Cash / 12.50% PIK.
(17)
Spread is 5.50% Cash / 0.50% PIK.
*
Non-income
producing security.
**
Investment is on
non-accrual
status.

See notes to consolidated financial statements.
 
10
0

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December
 
31, 2021
(in thousands)
 

Industry Classification
  
Percentage of Total
Investments (at fair value) as
of December 31, 2021
 
Multi-Sector
Holdings (includes Kingsbridge Holdings, LLC, SLR Equipment Finance, Equipment Operating Leases, LLC and Loyer Capital LLC)
     24.8
Diversified Financial Services (includes SLR Credit Solutions)
     20.7
Health Care Providers & Services
     9.6
Pharmaceuticals
     7.8
Software
     5.0
Health Care Equipment & Supplies
     5.0
Biotechnology
     2.4
Wireless Telecommunication Services
     2.2
Personal Products
     2.0
Road & Rail
     1.9
IT Services
     1.9
Diversified Consumer Services
     1.8
Insurance
     1.6
Commercial Services & Supplies
     1.6
Capital Markets
     1.6
Auto Parts & Equipment
     1.5
Internet & Catalog Retail
     1.5
Packaged Foods & Meats
     1.1
Life Sciences Tools & Services
     1.0
Communications Equipment
     0.9
Specialty Retail
     0.7
Auto Components
     0.6
Airlines
     0.6
Health Care Technology
     0.5
Machinery
     0.3
Aerospace & Defense
     0.3
Metals & Mining
     0.3
Hotels, Restaurants & Leisure 

     0.3
Consumer Finance
     0.1
Air Freight & Logistics
     0.1
Energy Equipment & Services
     0.1
Oil, Gas & Consumable Fuels
     0.1
Construction & Engineering
     0.1
Containers & Packaging
     0.0
    
 
 
 
Total Investments
     100.0
    
 
 
 

See notes to consolidated financial statements.
 
10
1
SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022
(in thousands, except share amounts)
Note 1. Organization
Solar Capital LLC, a Maryland limited liability company, was formed in February 2007 and commenced operations on March 13, 2007 with initial capital of $1,200,000 of which 47.04% was funded by affiliated parties.
Immediately prior to our initial public offering, through a series of transactions, SLR Investment Corp. (the “Company”, “we”, “us” or “our”), merged with Solar Capital LLC, leaving SLR Investment Corp. as the surviving entity (the
“Pre-IPO
Merger”). SLR Investment Corp. issued an aggregate of approximately 26.65 million shares of common stock and $125,000 in senior unsecured notes to the existing Solar Capital LLC unit holders in connection with the
Pre-IPO
Merger. SLR Investment Corp. had no assets or operations prior to completion of the
Pre-IPO
Merger and as a result, the historical books and records of Solar Capital LLC have become the books and records of the surviving entity. The number of shares used to calculate weighted average shares for use in computations on a per share basis have been decreased retroactively by a factor of approximately 0.4022 for all periods prior to February 9, 2010. This factor represents the effective impact of the reduction in shares resulting from the
Pre-IPO
Merger.
SLR Investment Corp., a Maryland corporation formed in November 2007, is a
closed-end,
externally managed,
non-diversified
management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Furthermore, as the Company is an investment company, it continues to apply the guidance in FASB Accounting Standards Codification (“ASC”) Topic 946. In addition, for U.S. federal income tax purposes, the Company has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).
On February 9, 2010, the Company priced its initial public offering, selling 5.68 million shares of common stock, including the underwriters’ over-allotment, at a price of $18.50 per share. Concurrent with this offering, the Company’s senior management purchased an additional 600,000 shares through a private placement, also at $18.50 per share.
The Company’s investment objective is to maximize both current income and capital appreciation through debt and equity investments. The Company directly and indirectly invests primarily in leveraged middle market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. From time to time, we may also invest in public companies that are thinly traded.
On April 1, 2022, we acquired SLR Senior Investment Corp., a Maryland corporation (“SUNS”) pursuant to that certain Agreement and Plan of Merger (the “Merger Agreement”), dated as of December 1, 2021, by and among us, SUNS, Solstice Merger Sub, Inc., a Maryland corporation and our wholly-owned subsidiary (“Merger Sub”), and, solely for the limited purposes set forth therein, SLR Capital Partners, LLC (the “Investment Adviser”). Pursuant to the Merger Agreement, Merger Sub merged with and into SUNS, with SUNS continuing as the surviving company and as SUNS’s wholly-owned subsidiary (the “Merger,”) and, immediately thereafter, SUNS merged with and into us, with us continuing as the surviving company (together with the Merger, the “Mergers”). . In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each outstanding share of SUNS’s common stock was converted into the right to receive 0.7796 shares of our common stock (with SUNS’s stockholders receiving cash in lieu of fractional shares of our common stock). As a result of the Mergers, we issued an aggregate of 12,511,825 shares of our common stock to former SUNS stockholders. See Note 17 for additional information.
Note 2. Significant Accounting Policies
The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“GAAP”), and include the accounts of the Company and certain wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications which, in the opinion of management, are necessary for the fair presentation of the results of the operations and financial condition for the periods presented. All significant intercompany balances and transactions have been eliminated. Certain prior period amounts may have been reclassified to conform to the current period presentation.
The preparation of consolidated financial statements in conformity with GAAP and pursuant to the requirements for reporting on Form
10-K
and Regulation
S-X,
as appropriate, also requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reported periods. Changes in the economic environment, financial markets and any other parameters used in determining these estimates could cause actual results to differ materially.
 
 

10
2

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2022
(in thousands, except share amounts)
 
In the opinion of management, all adjustments, which are of a normal recurring nature and considered necessary for the fair presentation of financial statements, have been included.
The significant accounting policies consistently followed by the Company are:
 
  (a)
Investment transactions are accounted for on the trade date;
 
  (b)
Under procedures established by the board of directors (the “Board”), we value investments, including certain senior secured debt, subordinated debt and other debt securities with maturities greater than 60 days, for which market quotations are readily available and deemed to represent fair value under U.S. GAAP, at such market quotations (unless they are deemed not to represent fair value). A market quotation is readily available for a security only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. If the Company anticipates using a market quotation for a security, it will also monitor for circumstances that may necessitate the use of fair value, such as significant events that may cause concern over the reliability of a market quotation. We attempt to obtain market quotations from at least two brokers or dealers (if available, otherwise from a principal market maker or a primary market dealer or other independent pricing service). We utilize
mid-market
pricing as a practical expedient for fair value unless a different point within the range is more representative. If and when market quotations are deemed not to represent fair value, we may utilize independent third-party valuation firms to assist us in determining the fair value of material assets. Accordingly, such investments go through our multi-step valuation process as described below. In each such case, independent valuation firms, that may from time to time be engaged by the Board, consider observable market inputs together with significant unobservable inputs in arriving at their valuation recommendations. Debt investments with maturities of 60 days or less shall each be valued at cost plus accreted discount, or minus amortized premium, which is expected to approximate fair value, unless such valuation, in the judgment of the Investment Adviser, does not represent fair value, in which case such investments shall be valued at fair value as determined in good faith by or under the direction of the Board. Investments that are not publicly traded or whose market quotations are not readily available are valued at fair value as determined in good faith by or under the direction of the Board. Such determination of fair values involves subjective judgments and estimates.
With respect to investments for which market quotations are not readily available or when such market quotations are deemed not to represent fair value under U.S. GAAP, the Board has approved a multi-step valuation process each quarter, as described below:
 
 
(1)
our quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of the Investment Adviser responsible for the portfolio investment;
 
 
(2)
preliminary valuation conclusions are then documented and discussed with senior management of the Investment Adviser;
 
 
(3)
independent valuation firms engaged by the Board conduct independent appraisals and review the Investment Adviser’s preliminary valuations and make their own independent assessment for all material assets;
 
 
(4)
the audit committee of the Board reviews the preliminary valuation of the Investment Adviser and that of the independent valuation firm and responds to the valuation recommendation of the independent valuation firm, if any, to reflect any comments; and
 
 
(5)
the Board discusses valuations and determines the fair value of each investment in our portfolio in good faith based on the input of the Investment Adviser, the respective independent valuation firm, if any, and the audit committee.
 
103

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December
 
31, 2022
(in thousands, except share amounts)

The valuation principles set forth above may be modified from time to time, in whole or in part, as determined by the Board in its sole discretion. The Board will also (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services, as applicable; (5) oversee the reporting required by Rule
2a-5
under the 1940 Act; and (6) maintain recordkeeping requirements under Rule
2a-5.
Investments in all asset classes are valued utilizing a market approach, an income approach, or both approaches, as appropriate. However, in accordance with ASC
820-10,
certain investments that qualify as investment companies in accordance with ASC 946, may be valued using net asset value as a practical expedient for fair value. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities (including a business). The income approach uses valuation approaches to convert future amounts (for example, cash flows or earnings) to a single present amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. In following these approaches, the types of factors that we may take into account in fair value pricing our investments include, as relevant: available current market data, including relevant and applicable market trading and transaction comparables, applicable market yields and multiples, security covenants, call protection provisions, the nature and realizable value of any collateral, the portfolio company’s ability to make payments, its earnings and discounted cash flows, the markets in which the portfolio company does business, comparisons of financial ratios of peer companies that are public, M&A comparables, our principal market (as the reporting entity) and enterprise values, among other factors. When available, broker quotations and/or quotations provided by pricing services are considered as an input in the valuation process. For the fiscal year ended December 31, 2022, there has been no change to the Company’s valuation approaches or techniques and the nature of the related inputs considered in the valuation process.
ASC Topic 820 classifies the inputs used to measure these fair values into the following hierarchy:
Level
 1
: Unadjusted quoted prices in active markets for identical assets or liabilities, accessible by the Company at the measurement date.
Level
 2
: Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices.
Level
 3
: Unobservable inputs for the asset or liability.
In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The exercise of judgment is based in part on our knowledge of the asset class and our prior experience.
 
  (c)
Gains or losses on investments are calculated by using the specific identification method.
 
  (d)
The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Loan origination fees, original issue discount, and market discounts are capitalized and we amortize such amounts into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record call premiums received on loans repaid as interest income when we receive such amounts. Capital structuring fees, amendment fees, consent fees, and any other
non-recurring
fee income as well as a management fee and other fee income for services rendered, if any, are recorded as other income when earned.
 
  (e)
The Company intends to comply with the applicable provisions of the Code pertaining to regulated investment companies to make distributions of taxable income sufficient to relieve it of substantially all U.S. federal income taxes. The Company, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4% excise tax on this income. The Company will accrue excise tax on such estimated excess taxable income as appropriate.
 
104

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2022
(in thousands, except share amounts)
 
  (f)
Book and tax basis differences relating to stockholder distributions and other permanent book and tax differences are typically reclassified among the Company’s capital accounts. In addition, the character of income and gains to be distributed is determined in accordance with income tax regulations that may differ from GAAP; accordingly at December 31, 2022, $28,991 was reclassified on our balance sheet between accumulated distributable net loss and
paid-in
capital in excess of par. Total earnings and net asset value are not affected.
 
  (g)
Distributions to common stockholders are recorded as of the record date. The amount to be paid out as a distribution is determined by the Board. Net realized capital gains, if any, are generally distributed or deemed distributed at least annually.
 
  (h)
In accordance with Regulation
S-X
and ASC Topic 810—
Consolidation
, the Company consolidates its interest in controlled investment company subsidiaries, financing subsidiaries and certain wholly-owned holding companies that serve to facilitate investment in portfolio companies. In addition, the Company may also consolidate any controlled operating companies substantially all of whose business consists of providing services to the Company.
 
  (i)
The accounting records of the Company are maintained in U.S. dollars. Any assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the rate of exchange of such currencies against U.S. dollars on the date of valuation. The Company will not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Such fluctuations would be included with the net unrealized gain or loss from investments. The Company’s investments in foreign securities, if any, may involve certain risks, including without limitation: foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments in terms of U.S. dollars and therefore the earnings of the Company.
 
  (j)
In accordance with ASC
835-30,
the Company reports origination and other expenses related to certain debt issuances as a direct deduction from the carrying amount of the debt liability. Applicable expenses are deferred and amortized using either the effective interest method or the straight-line method over the stated life. The straight-line method may be used on revolving facilities and/or when it approximates the effective yield method.
 
  (k)
The Company may enter into forward exchange contracts in order to hedge against foreign currency risk. These contracts are
marked-to-market
by recognizing the difference between the contract exchange rate and the current market rate as unrealized appreciation or depreciation. Realized gains or losses are recognized when contracts are settled.
 
  (l)
The Company records expenses related to shelf registration statements and applicable equity offering costs as prepaid assets. These expenses are typically charged as a reduction of capital upon the sale of shares or expensed, in accordance with ASC
946-20-25.

  (m)
Investments that are expected to pay regularly scheduled interest in cash are generally placed on
non-accrual
status when principal or interest cash payments are past due 30 days or more (90 days or more for equipment financing) and/or when it is no longer probable that principal or interest cash payments will be collected. Such
non-accrual
investments are restored to accrual status if past due principal and interest are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining principal and interest obligations. Cash interest payments received on such investments may be recognized as income or applied to principal depending on management’s judgment.
 
  (n)
The Company defines cash equivalents as securities that are readily convertible into known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only securities with a maturity of three months or less would qualify, with limited exceptions. The Company believes that certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities would qualify as cash equivalents.
 
10
5

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December
 
31, 2022
(in thousands, except share amounts)

 
Recent Accounting Pronouncements
In March 2020, the FASB issued Accounting Standards Update
No. 2020-04,
“Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The guidance provides optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships and other transactions, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued because of the reference rate reform. ASU
2020-04
is effective for all entities as of March 12, 2020 through December 31, 2022. The Company has determined that the adoption of this guidance has not had a material impact on the Company’s consolidated financial statements and disclosures.
Note 3. Agreements
The Company has an investment advisory and management agreement (the “Advisory Agreement”) with the Investment Adviser, under which the Investment Adviser manages the
day-to-day
operations of, and provides investment advisory services to the Company. For providing these services, the Investment Adviser receives a fee from the Company, consisting of two components—a base management fee and a performance-based incentive fee. The base management fee is determined by taking the average value of the Company’s gross assets at the end of the two most recently completed calendar quarters calculated at an annual rate of 1.50% on gross assets up to 200% of the Company’s total net assets as of the immediately preceding quarter end and 1.00% on gross assets that exceed 200% of the Company’s total net assets as of the immediately preceding quarter end. For purposes of computing the base management fee, gross assets exclude temporary assets acquired at the end of each fiscal quarter for purposes of preserving investment flexibility in the next fiscal quarter. Temporary assets include, but are not limited to, U.S. treasury bills, other short-term U.S. government or government agency securities, repurchase agreements or cash borrowings.
The performance-based incentive fee has two parts, as follows: one part is calculated and payable quarterly in arrears based on the Company’s
pre-incentive
fee net investment income for the immediately preceding calendar quarter. For this purpose,
pre-incentive
fee net investment income means interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that we receive from portfolio companies) accrued during the calendar quarter, minus the Company’s operating expenses for the quarter (including the base management fee, any expenses payable under the Administration Agreement, and any interest expense and distributions paid on any issued and outstanding preferred stock, but excluding the performance-based incentive fee).
Pre-incentive
fee net investment income does not include any realized capital gains or losses, or unrealized capital appreciation or depreciation.
Pre-incentive
fee net investment income, expressed as a rate of return on the value of the Company’s net assets at the end of the immediately preceding calendar quarter, is compared to the hurdle rate of 1.75% per quarter (7% annualized). The Company pays the Investment Adviser a performance-based incentive fee with respect to the Company’s
pre-incentive
fee net investment income in each calendar quarter as follows: (1) no performance-based incentive fee in any calendar quarter in which the Company’s
pre-incentive
fee net investment income does not exceed the hurdle rate; (2) 100% of the Company’s
pre-incentive
fee net investment income with respect to that portion of such
pre-incentive
fee net investment income, if any, that exceeds the hurdle rate but is less than 2.1875% in any calendar quarter; and (3) 20% of the amount of the Company’s
pre-incentive
fee net investment income, if any, that exceeds 2.1875% in any calendar quarter. These calculations are appropriately
pro-rated
for any period of less than three months.
The second part of the performance-based incentive fee is determined and payable in arrears as of the end of each calendar year (or upon termination of the Advisory Agreement, as of the termination date), and will equal 20% of the Company’s cumulative realized capital gains less cumulative realized capital losses, unrealized capital depreciation (unrealized depreciation on a gross
investment-by-investment
basis at the end of each calendar year) and all net capital gains upon which prior performance-based capital gains incentive fee payments were previously made to the Investment Adviser. For financial statement purposes, the second part of the performance-based incentive fee is accrued based upon 20% of cumulative net realized gains and net unrealized capital appreciation. No accrual was required for the fiscal years ended December 31, 2022, 2021 and 2020.
For the fiscal years ended December 31, 2022, 2021 and 2020, the Company recognized $29,982, $28,277 and $24,951, respectively, in base management fees and $15,097, $10,309 and $2,272, respectively, in performance-based incentive fees. For the fiscal years ended December 31, 2022, 2021 and 2020, $1,527, $0 and $0, respectively, of such performance-based incentive fees were waived. The Investment Adviser has agreed to waive incentive fees resulting from income earned due to the accretion of purchase discount allocated to investments acquired as a result of the Mergers. Fees waived pursuant to the above are not subject to recoupment by the Investment Adviser.
 
10
6

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December
 
31, 2022
(in thousands, except share amounts)

 
The
Company has also entered into an Administration Agreement with SLR Capital Management, LLC (the “Administrator”) under which the Administrator provides administrative services to the Company. For providing these services, facilities and personnel, the Company reimburses the Administrator for the Company’s allocable portion of overhead and other expenses incurred by the Administrator in performing its obligations under the Administration Agreement, including rent. The Administrator will also provide, on the Company’s behalf, managerial assistance to those portfolio companies to which the Company is required to provide such assistance. The Company typically reimburses the Administrator on a quarterly basis.
For the fiscal years ended December 31, 2022, 2021 and 2020, the Company recognized expenses under the Administration Agreement of $5,401, $5,575 and $5,215, respectively. No managerial assistance fees were accrued or collected for the fiscal years ended December 31, 2022, 2021 and 2020.
Note 4. Net Asset Value Per Share
At December 31, 2022, the Company’s total net assets and net asset value per share were $999,731 and $18.33, respectively. This compares to total net assets and net asset value per share at December 31, 2021 of $842,281 and $19.93, respectively.
Note 5. Earnings Per Share
The following table sets forth the computation of basic and diluted net increase in net assets per share resulting from operations, pursuant to ASC
260-10,
for the years ended December 31, 2022, 2021 and 2020:
 
    
Year ended
December 31, 2022
    
Year ended
December 31, 2021
    
Year ended
December 31, 2020
 
Earnings per share (basic & diluted)
 
 
 
 
 
 
 
 
 
 
 
 
Numerator - net increase in net assets resulting from operations:

   $ 18,342      $ 59,566      $ 15,451  
Denominator - weighted average shares:

     51,680,522        42,260,826        42,260,826  
Earnings per share:
   $ 0.35      $ 1.41      $ 0.37  
Note 6. Fair Value
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The hierarchy prioritizes the inputs to valuations used to measure fair value into three levels. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows:
Level
 1.
 Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access.
Level
 2.
 Financial assets and liabilities whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following:
 
  a)
Quoted prices for similar assets or liabilities in active markets;
 
  b)
Quoted prices for identical or similar assets or liabilities in
non-active
markets;
 
  c)
Pricing models whose inputs are observable for substantially the full term of the asset or liability; and
 
  d)
Pricing models whose inputs are derived principally from or corroborated by observable market data through correlation or other means for substantially the full term of the asset or liability.
Level
 3.
Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumptions about the assumptions a market participant would use in pricing the asset or liability.
 
10
7

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2022
(in thousands, except share amounts)
 
When the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3).
Gains and losses for assets and liabilities categorized within the Level 3 table below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).
A review of fair value hierarchy classifications is conducted on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. Such reclassifications involving Level 3 assets and liabilities are reported as transfers in/out of Level 3 as of the end of the quarter in which the reclassifications occur. Within the fair value hierarchy tables below, cash and cash equivalents are excluded but could be classified as Level 1.
The following tables present the balances of assets and liabilities measured at fair value on a recurring basis, as of December 31, 2022 and December 31, 2021:
Fair Value Measurements
As of December 31, 2022
 
    
Level 1
    
Level 2
    
Level 3
    
Measured at
Net Asset Value*
    
Total
 
Assets:
                                            
Senior Secured Loans
   $         $         $ 1,245,414      $         $ 1,245,414  
Equipment Financing
                         265,952                  265,952  
Preferred Equity
                         3,801                  3,801  
Common Equity/Equity Interests/Warrants
     483                  561,600        9,426        571,509  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
   $ 483      $         $ 2,076,767      $ 9,426      $ 2,086,676  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
*
In accordance with ASC
820-10,
certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP. See Note 19 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members.
Fair Value Measurements
As of December 31, 2021
 
    
Level 1
    
Level 2
    
Level 3
    
Total
 
Assets:
                                   
Senior Secured Loans
   $      $
     $ 939,690      $ 939,690  
Equipment Financing
                   273,795        273,795  
Preferred Equity
                   5,630        5,630  
Common Equity/Equity Interests/Warrants
     1,086               450,381        451,467  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
   $ 1,086           $ 1,669,496      $ 1,670,582  
    
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities:
                                   
2022 Unsecured Notes
   $     
     $ 150,000      $ 150,000  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
10
8

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2022
(in thousands, except share amounts)
 
The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2022, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2022:
Fair Value Measurements Using Level 3 Inputs
 
    
Senior Secured
Loans
   
Equipment

Financing
   
Preferred Equity
   
Common Equity/
Equity
Interests/
Warrants
   
Total
 
Fair value, December
 31, 2021
   $ 939,690     $ 273,795     $ 5,630     $ 450,381     $ 1,669,496  
Total gains or losses included in earnings:
                                        
Net realized gain (loss)
     (36,244                       6       (36,238
Net change in unrealized loss
     (8,065     (6,924     (706     (5,048     (20,743
Purchase of investment securities(1)
     796,389       84,168       266       116,272       997,095  
Proceeds from dispositions of investment securities
     (446,356     (85,087     (1,389     (11     (532,843
Transfers in/out of Level 3
                                             
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Fair value, December
 31, 2022
   $ 1,245,414     $ 265,952     $ 3,801     $ 561,600     $ 2,076,767  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
                                        
Net change in unrealized loss
   $ (8,920   $ (6,924   $ (706   $ (5,048   $ (21,598
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
Includes positions acquired from SUNS as a result of the Mergers.
The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the year ended December 31, 2022:
 
2022 Unsecured Notes
  
For the year ended
December 31, 2022
 
Beginning fair value
   $ 150,000  
Net realized (gain) loss
         
Net change in unrealized (gain) loss
         
Borrowings
         
Repayments
     (150,000
Transfers in/out of Level 3
         
    
 
 
 
Ending fair value
   $     
    
 
 
 
The Company made an election to apply the fair value option of accounting to the 2022 Unsecured Notes, in accordance with ASC
825-10.
On May 8, 2022, the borrowings were repaid in full. While the Company has not made an election to apply the fair value option of accounting to any of its other debt obligations, if the Company’s debt obligations were carried at fair value at December 31, 2022, the fair value of the Credit Facility, SPV Credit Facility, 2023 Unsecured Notes, 2024 Unsecured Notes, 2025 Unsecured Notes, 2026 Unsecured Notes, 2027 Unsecured Notes and 2027 Series F Unsecured Notes would be $393,000, $155,200, $75,000, $118,750, $79,688, $68,250, $42,875 and $118,125, respectively.
 
1
09
SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2022
(in thousands, except share amounts)
 
The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2021, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2021:
Fair Value Measurements Using Level 3 Inputs
 

 
  
Senior Secured
Loans
 
 
Equipment

Financing
 
 
Preferred Equity
 
 
Common Equity/
Equity
Interests/
Warrants
 
 
Total
 
Fair value, December
 31, 2020
   $ 798,052     $ 284,846     $ 6,401     $ 440,971     $ 1,530,270  
Total gains or losses included in earnings:
                                        
Net realized gain (loss)
              (8              345       337  
Net change in unrealized gain (loss)
     (13,567     1,394       (1,042     9,857       (3,358
Purchase of investment securities
     533,614       76,700       271                610,585  
Proceeds from dispositions of investment securities
     (378,409     (89,137              (675     (468,221
Transfers in/out of Level 3
(1)
                                (117     (117
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Fair value, December
 31, 2021
   $ 939,690     $ 273,795     $ 5,630     $ 450,381     $ 1,669,496  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Unrealized gains (losses) for the period relating to those Level 3
assets that were still held by the Company at the end of the
period:
                                        
Net change in unrealized gain (loss)
   $ (12,837   $ 1,394     $ (1,042   $ 9,597     $ (2,888
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
On February 17, 2021, the Company exercised its warrants in Senseonics Holdings, Inc., receiving shares in the common stock of Senseonics Holdings, Inc. The common stock of Senseonics Holdings, Inc. is publicly traded, so this position is considered to be a Level 1 asset.
The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the year ended December 31, 2021:
 
2022 Unsecured Notes
  
For the year ended
December 31, 2021
 
Beginning fair value
   $ 150,000  
Net realized (gain) loss
         
Net change in unrealized (gain) loss
         
Borrowings
         
Repayments
         
Transfers in/out of Level 3
         
    
 
 
 
Ending fair value
   $ 150,000  
    
 
 
 
The Company made elections to apply the fair value option of accounting to the 2022 Unsecured Notes, in accordance with ASC
825-10.
On December 31, 2021, there were borrowings of $150,000 on the 2022 Unsecured Notes.
 
11
0

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2022
(in thousands, except share amounts)
 
Quantitative Information about Level 3 Fair Value Measurements
The Company typically determines the fair value of its performing debt investments utilizing a yield analysis. In a yield analysis, a price is ascribed for each investment based upon an assessment of current and expected market yields for similar investments and risk profiles. Additional consideration is given to current contractual interest rates, relative maturities and other key terms and risks associated with an investment. Among other factors, a significant determinant of risk is the amount of leverage used by the portfolio company relative to the total enterprise value of the company, and the rights and remedies of our investment within each portfolio company.
Significant unobservable quantitative inputs typically used in the fair value measurement of the Company’s Level 3 assets and liabilities primarily reflect current market yields, including indices, and readily available quotes from brokers, dealers, and pricing services as indicated by comparable assets and liabilities, as well as enterprise values, returns on equity and earnings before income taxes, depreciation and amortization (“EBITDA”) multiples of similar companies, and comparable market transactions for equity securities.
Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2022 is summarized in the table below:
 
    
Asset or
Liability
  
Fair Value at

December 31, 2022
    
Principal Valuation

Technique/Methodology
 
Unobservable Input
  
Range (Weighted

Average)
Senior Secured Loans
   Asset    $
$
1,212,842
32,572
 
 
   Income Approach
Market Multiple
(1)
  Market Yield
Comparable Multiple
  
9.4%
 
 
18.2% (12.0%)
0.1x-21.4x
 
(12.4x)
Equipment Financing
   Asset    $
$
145,132
120,820
 
 
   Income Approach
Market Multiple
(2)
  Market Yield
Comparable Multiple
   8.5% –9.7% (9.7%)
1.1x-1.4x
(1.2x)
Preferred Equity
   Asset    $ 3,801      Income Approach   Market Yield    5.0% –
 
5.0% (5.0%)
Common Equity/Equity Interests/Warrants
   Asset    $
$
149,120
412,480
 
 
   Market Multiple
(3)
Market Approach
  Comparable Multiple
Return on Equity
   7.8x –
 
9.8x (8.8x)
6.6% –
 
35.2% (9.2%)
 
(1)
Investments are valued using a
sum-of-the
parts analysis, using expected revenue multiples for certain segments of the businesses and expected EBITDA multiples for certain segments of the businesses.
(2)
Includes $120,820 of investments valued using
an implied
multiple.
(3)
Includes $676 of investments valued using a Black-Scholes model and $148,444 of investments valued using an EBITDA multiple.
Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2021 is summarized in the table below
:
 

 
  
Asset or
Liability
  
Fair Value at
December 31, 2021
 
  
Principal Valuation
Technique/Methodology
 
Unobservable Input
  
Range (Weighted
Average)
Senior Secured Loans
   Asset    $
$
931,769
7,921
 
 
   Income Approach
Market Multiple
(1)
  Market Yield
Comparable Multiple
   4.0% –
 
19.6% (8.7%)
2.0x-3.0x(2.5x)/2.0x-
3.0x(2.5x)
Equipment Financing
   Asset    $
$
144,693
129,102
 
 
   Income Approach
Market Approach
  Market Yield
Return on Equity
   7.1% –
 
20.3% (9.8%)
4.6%-4.6%
(4.6%)
Preferred Equity
   Asset    $ 5,630      Income Approach   Market Yield    3.5% –
 
8.0% (4.4%)
Common Equity/Equity Interests/Warrants
   Asset    $
$
151,615
298,766
 
 
   Market Multiple
(2)
Market Approach
  Comparable Multiple
Return on Equity
   5.8x –
 
10.5x (9.5x)
6.1% –
 
18.5% (8.6%)
2022 Unsecured Notes
   Liability    $ 150,000      Income Approach   Market Yield    2.2% –
 
4.6% (4.5%)
 
(1)
Investments are valued using a
sum-of-the
parts analysis, using expected EBITDA multiples
(2x-3x)
for certain segments of the business and expected revenue multiples
(2x-3x)
for certain segments of the business.
(2)
Includes $403 of investments valued using a Black-Scholes model and $151,212 of investments valued using an EBITDA multiple.
 
11
1

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2022
(in thousands, except share amounts)
 
Significant increases or decreases in any of the above unobservable inputs in isolation, including unobservable inputs used in deriving
bid-ask
spreads, if applicable, could result in significantly lower or higher fair value measurements for such assets and liabilities. Generally, an increase in market yields or decrease in EBITDA multiples may result in a decrease in the fair value of certain of the Company’s investments.
Note 7. Debt
Our debt obligations consisted of the following as of December 31, 2022 and December 31, 2021:
 
    
December 31, 2022
   
December 31, 2021
 
Facility
  
Face Amount
    
Carrying Value
   
Face Amount
    
Carrying Value
 
Credit Facility
   $ 393,000      $ 388,254
(1)
 
  $ 322,500      $ 318,015
(1)
 
SPV Credit Facility
     155,200        154,302
(2)
 
                  
2022 Unsecured Notes
                        150,000        150,000  
2022 Tranche C Notes
                        21,000        20,964
(3)
 
2023 Unsecured Notes
     75,000        74,979
(4)
 
    75,000        74,592
(4)
 
2024 Unsecured Notes
     125,000        124,421
(5)
 
    125,000        124,143
(5)
 
2025 Unsecured Notes
     85,000        84,613
(6)
 
                  
2026 Unsecured Notes
     75,000        74,498
(7)
 
    75,000        74,384
(7)
 
2027 Unsecured Notes
     50,000        49,953
(8)
 
    50,000        49,940
(8)
 
2027 Series F Unsecured Notes
     135,000        134,978
(9)
 
                  
    
 
 
    
 
 
   
 
 
    
 
 
 
     $ 1,093,200      $ 1,085,998     $ 818,500      $ 812,038  
    
 
 
    
 
 
   
 
 
    
 
 
 
 
(1)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $
4,746
and $
4,485
as of December 31, 2022 and December 31, 2021, respectively.
(2)
Carrying Value equals the Face Amount net of unamortized market discount of $898 as of December 31, 2022.
(3)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $36 as of December 31, 2021.
(4)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $21 and $408 as of December 31, 2022 and December 31, 2021, respectively.
(5)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $579 and $857 as of December 31, 2022 and December 31, 2021, respectively.
(6)
Carrying Value equals the Face Amount net of unamortized market discount of $387 as of December 31, 2022.
(7)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $502 and $616 as of December 31, 2022 and December 31, 2021, respectively.
(8)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $47 and $60 as of December 31, 2022 and December 31, 2021, respectively.
(9)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $22 as of December 31, 2022.
Unsecured Notes
On April 1, 2022, the Company entered into an assumption agreement (the “Note Assumption Agreement”), effective as of the closing of the Mergers. The Note Assumption Agreement relates to the Company’s assumption of $85,000 in aggregate principal amount of five-year, 3.90% senior unsecured notes, due March 31, 2025 (the “2025 Unsecured Notes”) and other obligations of SUNS under the Note Purchase Agreement, dated as of March 31, 2020 (the “Note Purchase Agreement”), among SUNS and certain institutional investors. Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30. Pursuant to the Note Assumption Agreement, the Company expressly assumed on behalf of SUNS the due and punctual payment of the principal of (and premium, if any) and interest on all the 2025 Unsecured Notes outstanding, and the due and punctual performance and observance of every covenant and every condition of the Note Purchase Agreement, to be performed or observed by SUNS.
 
11
2

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2022
(in thousands, except share amounts)
 
On January 6, 2022, the Company closed a private offering of $135,000 of the 2027 Series F Unsecured Notes with a fixed interest rate of 3.33% and a maturity date of January 6, 2027. Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6. The 2027 Series F Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On September 14, 2021, the Company closed a private offering of $50,000 of the 2027 Unsecured Notes with a fixed interest rate of 2.95% and a maturity date of March 14, 2027. Interest on the 2027 Unsecured Notes is due semi-annually on March 14 and September 14. The 2027 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $125,000 of the 2024 Unsecured Notes with a fixed interest rate of 4.20% and a maturity date of December 15, 2024. Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15. The 2024 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $75,000 of the 2026 Unsecured Notes with a fixed interest rate of 4.375% and a maturity date of December 15, 2026. Interest on the 2026 Unsecured Notes is due semi-annually on June 15 and December 15. The 2026 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 28, 2017, the Company closed a private offering of $21,000 of the 2022 Tranche C Notes with a fixed interest rate of 4.50% and a maturity date of December 28, 2022. Interest on the 2022 Tranche C Notes is due semi-annually on June 28 and December 28. The 2022 Tranche C Notes were issued in a private placement only to qualified institutional buyers. The 2022 Tranche C Notes were repaid in full at maturity.
On November 22, 2017, we issued $75,000 in aggregate principal amount of publicly registered 2023 Unsecured Notes for net proceeds of $73,846. Interest on the 2023 Unsecured Notes is paid semi-annually on January 20 and July 20, at a fixed rate of 4.50% per year, commencing on January 20, 2018. The 2023 Unsecured Notes mature on January 20, 2023.
On February 15, 2017, the Company closed a private offering of $100,000 of the 2022 Unsecured Notes with a fixed interest rate of 4.60% and a maturity date of May 8, 2022. Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional
buyers. The 2022 Unsecured Notes were repaid in full at maturity.
On November 8, 2016, the Company closed a private offering of $50,000 of the 2022 Unsecured Notes with a fixed interest rate of 4.40% and a maturity date of May 8, 2022. Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional buyers. The 2022 Unsecured Notes were repaid in full at maturity.
Revolving and Term Loan Facilities
On April 1, 2022, the Company entered into an assumption agreement (the “CF Assumption Agreement”), effective as of the closing of the Mergers. The CF Assumption Agreement relates to the Company’s assumption of the Revolving Credit Facility, originally entered into on August 26, 2011 (as amended from time to time, the “SPV Credit Facility”), by and among SUNS SPV LLC (the “SUNS SPV”), a wholly-owned subsidiary of SUNS, acting as borrower, Citibank, N.A., acting as administrative agent and collateral agent, and the other parties thereto. Currently, the commitment under the SPV Credit Facility is $225,000; however, the commitment can also be expanded up to $600,000. The stated interest rate on the SPV Credit Facility is LIBOR plus
2.00%-2.50%
with no LIBOR floor requirement and the current final maturity date is June 1, 2026. The SPV Credit Facility is secured by all of the assets held by SUNS SPV. Under the terms of the SPV Credit Facility and related transaction documents, the Company as successor to SUNS, and SUNS SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SPV Credit Facility also includes usual and customary events of default for credit facilities of this nature. At December 31, 2022, outstanding USD equivalent borrowings under the SPV Credit Facility totaled $155,200.
 
11
3

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2022
(in thousands, except share amounts)
 
On December 28, 2021, the Company closed on Amendment No. 1 to its August 28, 2019 senior secured credit agreement (the “Credit Facility”). Following the amendment and a November 2022 upsizing, the Credit Facility is composed of $625,000 of revolving credit and $100,000 of term loans. Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of
1.75%-2.00%
or the alternate base rate plus
0.75%-1.00%.
The Credit Facility has a 0% floor and matures in December 2026 and includes ratable amortization in the final year. The Credit Facility may be increased up to $800,000 with additional new lenders or an increase in commitments from current lenders. The Credit Facility contains certain customary affirmative and negative covenants and events of default. In addition, the Credit Facility contains certain financial covenants that among other things, requires the Company to maintain a minimum shareholder’s equity and a minimum asset coverage ratio. At December 31, 2022, outstanding USD equivalent borrowings under the Credit Facility totaled $393,000, composed of $293,000 of revolving credit and $100,000 of term loans.
Certain covenants on our issued debt may restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a RIC under Subchapter M of the Code.
The average annualized interest cost for all borrowings for the year ended December 31, 2022 and the year ended December 31, 2021 was 4.09% and 3.64%, respectively. These costs are exclusive of other credit facility expenses such as unused fees, agency fees and other prepaid expenses related to establishing and/or amending the Credit Facility, the SPV Credit Facility, the 2022 Unsecured Notes, the 2022 Tranche C Notes, the 2023 Unsecured Notes, the 2024 Unsecured Notes, the 2025 Unsecured Notes, the 2026 Unsecured Notes, the 2027 Unsecured Notes and the 2027 Series F Unsecured Notes (collectively the “Debt Instruments”), if any. The maximum amounts borrowed on the Debt Instruments during the year ended December 31, 2022 and the year ended December 31, 2021 were $1,164,200 and $902,550, respectively.
Note 8(a). Income Tax Information and Distributions to Stockholders
The tax character of distributions for the fiscal years ended December 31, 2022, 2021 and 2020 were as follows (1):
 
    
2022
   
2021
   
2020
 
Ordinary income
   $ 50,113        59.2   $ 41,221        59.5   $ 48,795        70.4
Capital gains
               0.0               0.0               0.0
Return of capital
     27,099        32.0     28,087        40.5     20,513        29.6
Distribution recognized in subsequent year
     7,481        8.8               0.0               0.0
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
Total distributions
   $ 84,693        100.0   $ 69,308        100.0   $ 69,308        100.0
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
As of December 31, 2022, 2021 and 2020 the total accumulated earnings (loss) on a tax basis were as follows (1):
 
    
2022
 
2021
    
2020
 
Undistributed ordinary income
   $     
$         $     
Undistributed long-term net capital gains
         
                
    
 
 
 
 
 
    
 
 
 
Total undistributed net earnings
         
                
Post-October capital losses
         
                
Capital loss carryforward
     (127,348 )
(2)

  (68,857      (69,384
Other book/tax temporary differences
     (53,223
  2,332        2,168  
Net unrealized appreciation
     17,187  
  19,495        4,446  
    
 
 
 
 
 
    
 
 
 
Total tax accumulated loss
   $ (163,384
$ (47,030    $ (62,770
    
 
 
 
 
 
    
 
 
 
 
(1)
Tax information for the fiscal years ended December 31, 2022, 2021 and 2020 are/were estimates and are not final until the Company files its tax returns, typically in September or October each year.
(2)
Includes capital loss carryforward acquired from the Mergers which is subject to limitations under IRC Sections 381-384.
 
11
4

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2022
(in thousands, except share amounts)
 
The Company recognizes in its consolidated financial statements the tax effect of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. To the best of our knowledge, we did
not
have any uncertain tax positions that met the recognition or measurement criteria of ASC
740-10-25
nor
did we have any unrecognized tax benefits as of the periods presented herein. Although we file federal and state tax returns, our major tax jurisdiction is federal. Our tax returns for each of our federal tax years since 2019 remain subject to examination by the Internal Revenue Service and the state department of revenue. The capital loss carryforwards shown above do not expire.
Note 8(b). Other Tax Information (unaudited)
For the fiscal years ended December 31, 2022, 2021 and 2020, 0.00%, 0.32% and 0.10%, respectively, of the dividends paid during the year were eligible for qualified dividend income treatment and the dividends received deduction for corporate stockholders. For the fiscal years ended December 31, 2022, 2021, and 2020, 88.05%, 93.05% and 92.05%, respectively, of each of the distributions paid during the year represent interest-related dividends. For the fiscal years ended December 31, 2022, 2021 and 2020, none of the distributions represent short-term capital gains dividends.
Note 9. Financial Highlights
The following is a schedule of financial highlights for the respective years:
 
    
Year ended
December 31,
2022
   
Year ended
December 31,
2021
   
Year ended
December 31,
2020
   
Year ended
December 31,
2019
   
Year ended
December 31,
2018
 
Per Share Data: (a)
                                        
Net asset value, beginning of year
   $ 19.93     $ 20.16     $ 21.44     $ 21.75     $ 21.81  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Net investment income
     1.48       1.44       1.40       1.71       1.77  
Net realized and unrealized loss
     (1.13 )*      (0.03     (1.04     (0.38     (0.19
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Net increase in net assets resulting from operations
     0.35       1.41       0.36       1.33       1.58  
Issuance of common stock in connection with the Mergers
     (0.33                                    
Anti-dilution
     0.02                                      
Distributions to stockholders (see note 8a):
                                        
From distributable earnings
     (1.12     (0.98     (1.15     (1.55     (1.64
From return of capital
     (0.52     (0.66     (0.49     (0.09         
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Net asset value, end of year
   $ 18.33     $ 19.93     $ 20.16     $ 21.44     $ 21.75  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Per share market value, end of year
   $ 13.91     $ 18.43     $ 17.51     $ 20.62     $ 19.19  
Total Return(b)
     (16.09 %)      14.66     (5.72 %)      16.22     2.77
Net assets, end of year
   $ 999,731     $ 842,281     $ 852,023     $ 905,880     $ 919,171  
Shares outstanding, end of year
     54,555,380       42,260,826       42,260,826       42,260,826       42,260,826  
Ratios to average net assets:
                                        
Net investment income
     7.76     7.13     6.93     7.83     8.10
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Operating expenses
     5.60 %**      5.68     4.14     5.76     5.83
Interest and other credit facility expenses
     4.68     3.50     3.18     3.13     2.67
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total expenses
     10.28 %**      9.18     7.32     8.89     8.50
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Average debt outstanding
   $ 994,578     $ 703,670     $ 556,104     $ 561,249     $ 508,445  
Portfolio turnover ratio
     27.4     29.9     26.0     24.1     39.3
 
 
(a)
Calculated using the average shares outstanding method, except for the issuance of common stock in connection with the Mergers, which reflects the actual amount per share for the applicable period.
(b)
Total return is based on the change in market price per share during the year and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. Total return does not include a sales load.
*
The amount shown may not correspond with the aggregate amount for the period as it includes the effect of the timing of the Mergers.
**
The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of the performance-based incentive fee waiver (see note 3). For the year ended December 31, 2022, the ratios of operating expenses to average net assets and total expenses to average net assets would be 5.75% and 10.43%, respectively, without the performance-based incentive fee waiver.
 
11
5

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2022
(in thousands, except share amounts)
 
Note 10. SLR Credit Solutions
On December 28, 2012, we acquired an equity interest in Crystal Capital Financial Holdings LLC (“Crystal Financial”) for $275,000 in cash. Crystal Financial owned approximately 98% of the outstanding ownership interest in SLR Credit Solutions (“SLR Credit”), f/k/a Crystal Financial LLC. The remaining financial interest was held by various employees of SLR Credit, through their investment in Crystal Management LP. SLR Credit had a diversified portfolio of 23 loans having a total par value of approximately $400,000 at November 30, 2012 and a $275,000 committed revolving credit facility. On July 28, 2016, the Company purchased Crystal Management LP’s approximately 2% equity interest in SLR Credit for approximately $5,737. Upon the closing of this transaction, the Company holds 100% of the equity interest in SLR Credit. On September 30, 2016, Crystal Capital Financial Holdings LLC was dissolved. As of December 31, 2022, total commitments to the revolving credit facility are $285,000.
As of December 31, 2022 SLR Credit had 29 funded commitments to 25 different issuers with total funded loans of approximately $439,484 on total assets of $460,683. As of December 31, 2021 SLR Credit had 22 funded commitments to 19 different issuers with total funded loans of approximately $287,375 on total assets of $347,821. As of December 31, 2022 and December 31, 2021, the largest loan outstanding totaled $33,420 and $35,000, respectively. For the same periods, the average exposure per issuer was $17,579 and $15,125, respectively. SLR Credit’s credit facility, which is
non-recourse
to the Company, had approximately $224,325 and $100,742 of borrowings outstanding at December 31, 2022 and December 31, 2021, respectively. For the years ended December 31, 2022, 2021 and 2020 SLR Credit had net income of $7,521, $14,164 and $23,293, respectively, on gross income of $30,324, $33,993 and $45,315, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. SLR Credit’s consolidated financial statements for the fiscal years ended December 31, 2022 and December 31, 2021 are attached as an exhibit to this annual report on Form
10
-K.
 
116

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2022
(in thousands, except share amounts)
 
Note 11. Commitments and Contingencies
Off-Balance
Sheet Arrangements
The Company had unfunded debt and equity commitments to various revolving and delayed-draw term loans as well as to SLR Credit and SLR Healthcare. The total amount of these unfunded commitments as of December 31, 2022 and December 31, 2021 is $323,663 and $226,733, respectively, comprised of the following:
 
    
December 31,
2022
    
December 31,
2021
 
SLR Credit Solutions*
   $ 44,263      $ 44,263  
Outset Medical, Inc
     35,084            
Apeel Technology, Inc
     32,786            
CC SAG Holdings Corp. (Spectrum Automotive)
     20,670        18,827  
Human Interest, Inc
     20,104            
Glooko, Inc
     17,868        25,091  
World Insurance Associates, LLC
     17,117            
iCIMS, Inc
     11,435            
Spectrum Pharmaceuticals, Inc
     8,771            
Arcutis Biotherapeutics, Inc
     8,356        43,470  
Atria Wealth Solutions, Inc
     8,215        3,746  
Ardelyx, Inc
     7,752            
Luxury Asset Capital, LLC
     7,500            
RSC Acquisition, Inc
     7,498            
Cerapedics, Inc
     6,735            
Maurices, Incorporated
     4,314        5,649  
Kaseya, Inc
     3,936            
Vessco Midco Holdings, LLC
     3,892            
Copper River Seafoods, Inc
     3,595            
BDG Media, Inc
     3,546            
Meditrina, Inc
     3,367            
One Touch Direct, LLC
     3,069        7,226  
DeepIntent, Inc
     3,049            
Foundation Consumer Brands, LLC
     3,009        2,269  
SCP Eye Care, LLC
     2,771            
Basic Fun, Inc
     2,675        1,935  
Kid Distro Holdings, LLC
     2,650        2,650  
Plastics Management, LLC
     2,424            
Southern Orthodontic Partners Management, LLC
     1,918            
Pediatric Home Respiratory Services, LLC
     1,805            
Pinnacle Treatment Centers, Inc
     1,745        1,414  
Ultimate Baked Goods Midco LLC
     1,636        801  
Orthopedic Care Partners Management, LLC
     1,620            
Ivy Fertility Services, LLC
     1,571        4,532  
Composite Technology Acquisition Corp
     1,537            
NAC Holdings Corporation
     1,479        4,765  
SLR Healthcare ABL*
     1,400            
SPAR Marketing Force, Inc
     1,338            
RxSense Holdings LLC
     1,250            
Erie Construction
Mid-west,
LLC
     1,248            
Peter C. Foy & Associates Insurance Services, LLC
     1,094            
American Teleconferencing Services, Ltd
     1,090        573  
Montefiore Nyack Hospital
     1,034            
Enverus Holdings, Inc
     1,004            
SLR Equipment Finance
     1,000        5,000  
SunMed Group Holdings, LLC
     843        828  
GSM Acquisition Corp
     784            
Tilley Distribution, Inc
     525            
BayMark Health Services, Inc
     391            
High Street Buyer, Inc
     327            
TAUC Management, LLC
     294            
ENS Holdings III Corp, LLC
     144            
All State Ag Parts, LLC
     135            
BridgeBio Pharma, Inc
               23,049  
Inszone Mid, LLC
               12,465  
Rezolute, Inc
               5,675  
SOC Telemed, Inc
               4,448  
RQM+ Corp
               3,818  
MMIT Holdings, LLC
               2,009  
Neuronetics, Inc
               2,230  
    
 
 
    
 
 
 
Total Commitments
   $ 323,663      $ 226,733  
    
 
 
    
 
 
 
 
*
The Company controls the funding of the SLR Credit Solutions and SLR Healthcare ABL commitments and may cancel them at its discretion.
 
11
7
SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2022
(in thousands, except share amounts)
 
In addition to the above, please see SLR Senior Lending Program LLC herein where the Company has a remaining equity commitment of $40,500 in which the Company also controls such funding. The credit agreements of the above loan commitments contain customary lending provisions and/or are subject to the portfolio company’s achievement of certain milestones that allow relief to the Company from funding obligations for previously made commitments in instances where the underlying company experiences materially adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. As of December 31, 2022 and December 31, 2021, the Company had sufficient cash available and/or liquid securities available to fund its commitments and had reviewed them for any
appropriate
fair value adjustment.
Note 12. SLR Equipment Finance
On July 31, 2017, we acquired a 100% equity interest in NEF Holdings, LLC, which conducts its business through its wholly-owned subsidiary Nations Equipment Finance, LLC. Effective February 25, 2021, Nations Equipment Finance, LLC and its related companies are doing business as SLR Equipment Finance (“SLR Equipment”). SLR Equipment is an independent equipment finance company that provides senior secured loans and leases primarily to U.S. based companies. We invested $209,866 in cash to effect the transaction, of which $145,000 was invested in the equity of SLR Equipment through our wholly-owned consolidated taxable subsidiary NEFCORP LLC and our wholly-owned consolidated subsidiary NEFPASS LLC and $64,866 was used to purchase certain leases and loans held by SLR Equipment through NEFPASS LLC. Concurrent with the transaction, SLR Equipment refinanced its existing senior secured credit facility into a $150,000
non-recourse
facility with an accordion feature to expand up to $250,000. In September 2019, SLR Equipment amended the facility, increasing commitments to $213,957 with an accordion feature to expand up to $313,957 and extended the maturity date of the facility to July 31, 2023.
As of December 31, 2022, SLR Equipment had 131 funded equipment-backed leases and loans to 59 different customers with a total net investment in leases and loans of approximately $190,830 on total assets of $241,813. As of December 31, 2021, SLR Equipment had 135 funded equipment-backed leases and loans to 61 different customers with a total net investment in leases and loans of approximately $210,986 on total assets of $264,007. As of December 31, 2022 and December 31, 2021, the largest position outstanding totaled $19,259 and $19,207, respectively. For the same periods, the average exposure per customer was $3,234 and $3,459, respectively. SLR Equipment’s credit facility, which is
non-recourse
to the Company, had approximately $114,977 and $118,002 of borrowings outstanding at December 31, 2022 and December 31, 2021, respectively. For the years ended December 31, 2022, 2021 and 2020, SLR Equipment had net losses of $2,867, $9,729 and $8,883, respectively on gross income of $20,380, $22,931 and $24,512, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. SLR Equipment’s consolidated financial statements for the fiscal years ended December 31, 2022 and
December 
31, 2021
are
attached as an exhibit to this annual report on Form
10-K.
Note 13. Capital Share Transactions
As of December 31, 2022 and December 31, 2021, 200,000,000 shares of $0.01 par value capital stock were
authorized
.
Transactions in capital stock were as follows:
 
    
Shares
    
Amount
 
    
For the year ended
December 31, 2022
    
For the year ended
December 31, 2021
    
For the year ended
December 31, 2022
    
For the year ended
December 31, 2021
 
Shares issued in connection with the Mergers
     12,511,825                $ 226,839      $     
Shares repurchased
     (217,271                (3,038          
    
 
 
    
 
 
    
 
 
    
 
 
 
Net increase
     12,294,554                $ 223,801      $     
    
 
 
    
 
 
    
 
 
    
 
 
 
 
11
8

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2021
(in thousands, except share amounts)
 
Note 14. Kingsbridge Holdings, LLC
On November 3, 2020, the Company acquired 87.5% of the equity securities of Kingsbridge Holdings, LLC (“KBH”) through KBH Topco LLC (“KBHT”), a Delaware corporation. KBH is a residual focused independent
mid-ticket
lessor of equipment primarily to U.S. investment grade companies. The Company invested $216,596 to effect the transaction, of which $136,596 was invested to acquire 87.5% of KBHT’s equity and $80,000 in KBH’s debt. The existing management team of KBH committed to continuing to lead KBH after the transaction. Following the transaction, the Company owns 87.5% of KBHT equity and the KBH management team owns the remaining 12.5% of KBHT’s equity.
As of December 31, 2022 and December 31, 2021, KBHT had total assets of $777,151 and $738,425, respectively. For the same periods, debt recourse to KBHT totaled $222,094 and $216,881, respectively, and
non-recourse
debt totaled $353,128 and $323,844, respectively. None of the debt is recourse to the Company. For the years ended December 31, 2022, December 31, 2021 and for the period November 3, 2020 through December 31, 2020, KBHT had net income of $13,287, $12,151 and $2,170, respectively, on gross income of $298,760, $245,889 and $43,618, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us. KBHT’s consolidated financial statements for the fiscal years ended December 31, 2022 and December 31, 2021 are attached as an exhibit to this annual
report
on Form
10
-
K.
Note 15. SLR Healthcare ABL
SUNS acquired an equity interest in SLR Healthcare ABL, f/k/a Gemino Healthcare Finance, LLC (“SLR Healthcare”) on September 30, 2013. SLR Healthcare is a commercial finance company that originates, underwrites, and manages primarily secured, asset-based loans for small and
mid-sized
companies operating in the healthcare industry. SUNS initial investment in SLR Healthcare ABL was $32,839. The management team of SLR Healthcare
co-invested
in the transaction and continues to lead SLR Healthcare. As of September 30, 2022, SLR Healthcare’s management team and the Company own approximately 7% and 93% of the equity in SLR Healthcare, respectively. SLRC acquired SLR Healthcare in connection with the Mergers on April 1, 2022.
Concurrent with the closing of the transaction, SLR Healthcare entered into a new, four-year,
non-recourse,
$100,000 credit facility with
non-affiliates,
which was expandable to $150,000 under its accordion feature. Effective March 31, 2014, the credit facility was expanded to $105,000 and again on June 27, 2014 to $110,000. On May 27, 2016, SLR Healthcare entered into a new $125,000 credit facility which replaced the previously existing facility. The new facility has similar terms as compared to the previous facility and includes an accordion feature increase to $200,000 and had a maturity date of May 27, 2020. On June 28, 2019, this $125,000 facility was amended, extending the maturity date to June 28, 2023.
SLR Healthcare currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of December 31, 2022, the portfolio totaled approximately $242,106 of commitments with a total net investment in loans of $92,383 on total assets of $108,705. As of December 31, 2021, the portfolio totaled approximately $183,501 of commitments with a total net investment in loans of $81,604 on total assets of $91,275. At December 31, 2022, the portfolio consisted of 41 issuers with an average balance of approximately $2,253 versus 36 issuers with an average balance of approximately $2,267 at December 31, 2021. All of the commitments in SLR Healthcare’s portfolio are floating-rate, senior-secured,
cash-pay
loans. SLR Healthcare’s credit facility, which is
non-recourse
to us, had approximately $77,000 and $60,000 of borrowings outstanding at December 31, 2022 and December 31, 2021, respectively. For the years ended December 31, 2022, 2021 and 2020, SLR Healthcare had net income of $3,475, $662 and $4,289, respectively, on gross income of $11,593, $10,052 and $10,367, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. SLR Healthcare’s consolidated financial statements for the fiscal years ended December 31, 2022 and December 31, 2021 are attached as an exhibit to this annual report on Form
10-K.
 
1
19

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2022
(in thousands, except share amounts)
 
Note 16. SLR Business Credit
SUNS acquired 100% of the equity interests of North Mill Capital LLC (“NMC”) on October 20, 2017. NMC is a leading asset-backed lending commercial finance company that provides senior secured asset-backed financings to U.S. based
small-to-medium-sized
businesses primarily in the manufacturing, services and distribution industries. SUNS invested approximately $51,000 to effect the transaction. Subsequently, SUNS contributed 1% of its equity interest in NMC to ESP SSC Corporation. Immediately thereafter, SUNS and ESP SSC Corporation contributed their equity interests to NorthMill LLC (“North Mill”). On May 1, 2018, North Mill merged with and into NMC, with NMC being the surviving company. SUNS and ESP SSC Corporation then owned 99% and 1% of the equity interests of NMC, respectively. The management team of NMC continues to lead NMC. On June 28, 2019, North Mill Holdco LLC (“NM Holdco”), a newly formed entity and ESP SSC Corporation acquired 100% of Summit Financial Resources, a Salt Lake City-based provider of asset-backed financing to small and
medium-sized
businesses. As part of this transaction, SUNS 99% interest in the equity of NMC was contributed to NM Holdco. This approximately $15,500 transaction was financed with borrowings on NMC’s credit facility. Effective February 25, 2021, NMC and its related companies are doing business as SLR Business Credit. On June 3, 2021, NMC acquired 100% of Fast Pay Partners LLC, a Los Angeles-based provider of asset-backed financing to digital media companies. The transaction purchase price of $66,671 was financed with equity from SUNS of $19,000 and borrowings on NMC’s credit facility of $47,671. SLRC acquired SLR Business Credit in connection with the Mergers on April 1, 2022.
SLR Business Credit currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of December 31, 2022, the portfolio totaled approximately $603,432 of commitments, of which $286,006 were funded, on total assets of $332,247. As of December 31, 2021, the portfolio totaled approximately $513,869 of commitments, of which $248,652 were funded, on total assets of $290,794. At December 31, 2022, the portfolio consisted of 108 issuers with an average balance of approximately $2,648 versus 125 issuers with an average balance of approximately $1,989 at December 31, 2021. NMC has a senior credit facility with a bank lending group for $285,307
 
which expires on
 
November 13, 2025
. Borrowings are secured by substantially all of NMC’s assets. NMC’s credit facility, which is
non-recourse
to us, had
 
approximately $
214,425
and $
183,252
of borrowings outstanding at December 31, 2022 and December 31, 2021, respectively. For the years ended December 31, 2022, 2021 and 2020, SLR Business Credit had net income of $
3,941
, $
7,295
and $
4,512
, respectively, on gross income of $
29,433
, $
24,021
and $
19,715
, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Business Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Business Credit will be able to maintain consistent dividend payments to us. SLR Business Credit’s consolidated financial statements for the fiscal years ended December 31, 2022 and December 31, 2021 are attached as an exhibit to this annual
report
on Form
10-K.
Note 17. Merger with SUNS
On April 1, 2022, the Company completed its previously announced acquisition of SUNS. Pursuant to the Merger Agreement, Merger Sub was first merged with and into SUNS, with SUNS as the surviving corporation, and, immediately following the Merger, SUNS was then merged with and into the Company, with the Company as the surviving company. In accordance with the terms of the Merger Agreement, at the effective time of the Mergers, each outstanding share of SUNS’s common stock was converted into the right to receive 0.7796 shares of the Company’s common stock (with SUNS’s stockholders receiving cash in lieu of fractional shares of the Company’s common stock). As a result of the Mergers, the Company issued an aggregate of 12,511,825 shares of its common stock to former SUNS stockholders.
The Mergers are accounted for as an asset acquisition of SUNS by the Company in accordance with the asset acquisition method of accounting as detailed in ASC
805-50,
Business Combinations – Related Issues, with the fair value of total consideration paid in conjunction with the Mergers allocated to the assets acquired and liabilities assumed based on their relative fair values as of the date of the Mergers. Generally, under asset acquisition accounting, acquiring assets in groups not only requires ascertaining the cost of the asset (or net assets), but also allocating that cost to the individual assets (or individual assets and liabilities) that make up the group. The cost of the group of assets acquired in an asset acquisition is allocated to the individual assets acquired or liabilities assumed based on their relative fair values of net identifiable assets acquired other than certain
“non-qualifying”
assets (for example cash) and does not give rise to goodwill. The Company is the accounting survivor of the Mergers. The Mergers were considered a
tax-free
reorganization and the historical cost basis of the acquired SUNS investments are carried forward for tax purposes. Prior to the Mergers, SUNS was also managed by the Investment Adviser.
 
12
0

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2022
(in thousands, except share amounts)
 
The following table summarizes the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Mergers:
 
Common stock issued by the Company
(1)
   $ 227,602  
    
 
 
 
Assets acquired:
        
Investments, at fair value
   $ 400,105  
Cash
     2,313  
Other assets
     4,662  
    
 
 
 
Total assets acquired
   $ 407,080  
    
 
 
 
Liabilities assumed:
        
Debt, at fair value
   $ 159,816  
Other liabilities
     2,573  
    
 
 
 
Total liabilities assumed
   $ 162,389  
    
 
 
 
Net assets acquired
   $ 244,691  
    
 
 
 
Total purchase discount
   $ (17,089
    
 
 
 
 
(1)
Based on the market price at closing of $18.13, adjusted for transaction costs.
Letter Agreement
On April 1, 2022, in connection with the consummation of the Mergers, the Company entered into a letter agreement (the “Letter Agreement”) pursuant to which the Investment Adviser voluntarily agreed to a permanent 25 basis point reduction of the annual base management fee rate payable by the Company to the Investment Adviser pursuant to the Advisory Agreement, resulting in an annual base management fee rate payable by the Company to the Investment Adviser of 1.50% on gross assets up to 200% of the Company’s total net assets. The Company retained the annual base management fee rate payable by the Company to the Investment Adviser of 1.00% on gross assets that exceed 200% of the Company’s total net assets.
 
12
1

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2022
(in thousands, except share amounts)
 
Note 18. Stock Repurchase Program
On May 3, 2022, our Board authorized a program for the purpose of repurchasing up to $50,000 of our outstanding shares of common stock. Under the repurchase program, we may, but are not obligated to, repurchase shares of our outstanding common stock in the open market from time to time provided that we comply with our code of ethics and the guidelines specified in Rule
10b-18
of the 1934 Act, including certain price, market volume and timing constraints. In addition, any repurchases will be conducted in accordance with the 1940 Act. Unless amended or extended by our Board, we expect the repurchase program to be in place until the earlier of May 1, 2023 or until $50,000 of our outstanding shares of common stock have been repurchased. The timing and number of shares to be repurchased will depend on a number of factors, including market conditions. There are no assurances that we will engage in any repurchases beyond what is reported herein. During the fiscal year ended December 31, 2022, the Company repurchased 217,271 shares at an average price of approximately $13.98 per share, inclusive of commissions. The total dollar amount of shares repurchased was $3,038.
Note 19. SLR Senior Lending Program LLC
On October 12, 2022, the Company entered into an amended and restated limited liability company agreement with Sunstone Senior Credit L.P. (the “Investor”) to create a joint venture vehicle, SLR Senior Lending Program LLC (“SSLP”). SSLP is expected to invest primarily in senior secured cash flow loans. The Company and the Investor each have made initial equity commitments of $50,000, resulting in a total equity commitment of $100,000. Investment decisions and all material decisions in respect of SSLP must be approved by representatives of the Company and the Investor.
On December 1, 2022, SSLP commenced operations. On December 12, 2022, SSLP as servicer and SLR Senior Lending Program SPV LLC (“SSLP SPV”), a newly formed wholly owned subsidiary of SSLP, as borrower entered into a $100,000 senior secured revolving credit facility (the “SSLP Facility”) with Goldman Sachs Bank USA acting as administrative agent. The SSLP Facility is scheduled to mature on December 12, 2027. The SSLP Facility generally bears interest at a rate of SOFR plus 3.25%. SSLP and SSLP SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SSLP Facility also includes usual and customary events of default for credit facilities of this nature. There were no borrowings during the period December 12, 2022 to December 31, 2022. As of December 31, 2022 the Company and the Investor had contributed combined equity capital in the amount of $19,000. As of December 31, 2022, the Company and the Investors’ remaining commitments to SSLP totaled $40,500 and $40,500, respectively. The Company, along with the Investor, controls the funding of SSLP and SSLP may not call the unfunded commitments of the Company or the Investor without the approval of both the Company and the Investor.
As of December 31, 2022, SSLP had total assets of $19,105. SSLP’s portfolio consisted of floating rate senior secured loans to seven (7) different borrowers. For the period December 1, 2022 (commencement of operations) through December 31, 2022, SSLP invested $18,100 in seven (7) portfolio companies. Investments prepaid totaled $68 for the same period.
 
12
2

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2022
(in thousands, except share amounts)
 
SSLP Portfolio as of December 31, 2022 
 
Description
  
Industry
    
Spread
Above
Index
(1)
    
Floor
   
Interest
Rate
(2)
   
Maturity
Date
    
Par
Amount
    
Cost
    
Fair
Value
(3)
 
Atria Wealth Solutions, Inc.
(4)
     Diversified Financial
Services
 
 
     S+600        1.00     10.84     2/29/24      $ 2,494      $ 2,494      $ 2,494  
BayMark Health Services, Inc.
(4)
     Health Care Providers &
Services
 
 
     L+500        1.00     9.73     6/11/27        2,992        2,992        2,992  
ENS Holdings III Corp. & ES Opco USA LLC
(4)
     Trading Companies &
Distributors
 
 
     L+475        1.00     9.43     12/31/25        1,097        1,097        1,097  
Foundation Consumer Brands, LLC
(4)
     Personal Products        L+550        1.00     10.15     2/12/27        2,963        2,963        2,963  
High Street Buyer, Inc.
(4)
     Insurance        L+600        0.75     10.73     4/16/28        2,494        2,494        2,494  
Ivy Fertility Services, LLC
(4)
     Health Care Providers &
Services
 
 
     L+625        1.00     10.39     2/25/26        3,000        3,000        3,030  
Kid Distro Holdings, LLC
(4)
     Software        L+575        1.00     10.48     10/1/27        2,992        2,992        2,992  
                                                        
 
 
    
 
 
 
                                                         $  18,032      $  18,062  
                                                        
 
 
    
 
 
 
 
(1)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or SOFR. These instruments are typically subject to a LIBOR or SOFR floor.
(2)
Floating rate debt investments typically bear interest at a rate determined by reference to either the LIBOR (“L”) or SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022.
(3)
Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
(4)
The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
Below is certain summarized financial information for SSLP as of December 31, 2022 and for the period December 1, 2022 (commencement of operations) through December 31, 2022:
 
    
December 31,
2022
 
Selected Balance Sheet Information for SSLP:
        
Investments at fair value (cost $18,032)
   $ 18,062  
Cash and other assets
     1,043  
    
 
 
 
Total assets
   $ 19,105  
    
 
 
 
Debt outstanding
   $     
Interest payable and other credit facility related expenses
     165  
Accrued expenses and other payables
     89  
    
 
 
 
Total liabilities
   $ 254  
    
 
 
 
Members’ equity
   $ 18,851  
    
 
 
 
Total liabilities and members’ equity
   $ 19,105  
    
 
 
 
 
12
3

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2022
(in thousands, except share amounts)
 
    
For the Period
December 1, 2022
(commencement of
operations) through
December 31, 2022
 
Selected Income Statement Information for SSLP:
        
Interest income
   $ 152  
    
 
 
 
Service fees*
   $ 4  
Interest and other credit facility expenses
     166  
Organizational costs
     73  
Other general and administrative expenses
     88  
    
 
 
 
Total expenses
     331  
    
 
 
 
Net investment loss
   $ (179
    
 
 
 
Realized gain on investments
         
Net change in unrealized gain on investments
     30  
    
 
 
 
Net realized and unrealized gain on investments
     30  
    
 
 
 
Net loss
   $ (149
    
 
 
 
 
*
Service fees are included within the Company’s Consolidated Statements of Operations as other income.
Note 20. Subsequent Events
The Company has evaluated the need for disclosures and/or adjustments resulting from subsequent events through the date the consolidated financial statements were issued.
On January 10, 2023, the Board declared
a monthly distribution
of $0.136667 per share payable on February 2, 2023 to holders of record as of January 26, 2023.
On February 2, 2023, the Board declared
a monthly distribution of
$0.136667 per share payable on March 1, 2023 to holders of record as of February 16, 2023.
On February 28, 2023, the Board declared
a monthly distribution
of $0.136667 per share payable on April 4, 2023 to holders of record as of March 23, 2023.
 
12
4

Item 9.
Changes in and Disagreements With Accountants on Accounting and Financial Disclosure
None.
 
Item 9A.
Controls and Procedures
(a) Evaluation of Disclosure Controls and Procedures
As of December 31, 2022 (the end of the period covered by this report), we, including our
Co-Chief
Executive Officers and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule
13a-15(e)
of the 1934 Act). Based on that evaluation, our management, including the
Co-Chief
Executive Officers and Chief Financial Officer, concluded that our disclosure controls and procedures were effective and provided reasonable assurance that information required to be disclosed in our periodic SEC filings is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our
Co-Chief
Executive Officers and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. However, in evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of such possible controls and procedures.
(b) Management’s Report on Internal Control Over Financial Reporting
Management’s Report on Internal Control Over Financial Reporting, which appears in Item 8 of this
Form 10-K,
is incorporated by reference herein.
(c) Attestation Report of the Independent Registered Public Accounting Firm
Our independent registered public accounting firm, KPMG LLP, has issued an attestation report on the Company’s internal control over financial reporting, which is set forth above under the heading “Report of Independent Registered Public Accounting Firm” in Item 8.
(d) Changes in Internal Controls Over Financial Reporting
Management has not identified any change in the Company’s internal control over financial reporting that occurred during the fourth fiscal quarter of 2022 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
 
Item 9B.
Other Information
None.
 
Item 9C.
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
Not Applicable.
 
125

PART III
 
Item 10.
Directors, Executive Officers and Corporate Governance
Information about Directors
Certain information with respect to each of the current directors is set forth below, including their names, ages, a brief description of their recent business experience, including present occupations and employment, certain directorships that each person holds, the year in which each person became a director of the Company, and a discussion of their particular experience, qualifications, attributes or skills that lead us to conclude that such individual should serve as a director of the Company, in light of the Company’s business and structure. There were no legal proceedings of the type described in Item 401(f) of Regulation
S-K
in the past 10 years against any of the directors or officers of the Company and none are currently pending. There is no arrangement or understanding between any of the Company’s directors or officers pursuant to which they were selected as directors or officers and the Company or any other person or entity.
Mr. Gross is an “interested person” of the Company as defined in the 1940 Act due to his position as
Co-Chief
Executive Officer and President of the Company and a managing member of SLR Capital Partners, LLC (“SLR Capital Partners”), the Company’s investment adviser. Mr. Spohler is an “interested person” of the Company as defined in the 1940 Act due to his position as
Co-Chief
Executive Officer and Chief Operating Officer of the Company and a managing member of SLR Capital Partners, the Company’s investment adviser. Each of Mr. Wachter, Mr. Hochberg and Mr. Potter is not an “interested person” of the Company as defined in the 1940 Act.
 
Name, Address and Age
(1)
  
Position(s) Held
with Company
  
Terms of Office and
Length of Time
Served
  
Principal
Occupation(s) During
Past 5 Years
  
Other Directorships
Held by Director or
Nominee for Director
During Past 5
Years
(2)
Interested Director
           
Michael S. Gross, 61    Chairman of the Board of Directors,
Co-Chief
Executive Officer and President.
   Class III Director since 2007; Term expires 2024.   
Co-Chief
Executive Officer of SLR Investment Corp. and SCP Private Credit Income BDC LLC since June 2019,
Co-Chief
Executive Officer of SLR HC BDC LLC since September 2020 and
Co-Chief
Executive Officer of SLR Private Credit BDC II LLC since April 2022; President of SLR Investment Corp. since November 2007, President of SCP Private Credit Income BDC LLC since June 2018, President of SLR HC BDC LLC since September 2020 and President of SLR Private Credit BDC II LLC since April 2022; sole Chief Executive Officer of SLR Investment Corp. from November 2007 to June 2019 and sole Chief Executive Officer of SCP Private Credit Income BDC LLC from June 2018 to June 2019. President of SLR Senior Investment Corp. from December 2010 to April 2022, sole Chief Executive Officer of SLR Senior Investment Corp. from December 2010 to June 2019 and
Co-Chief
Executive Officer of SLR Senior Investment Corp. from June 2019 to April 2022. Mr. Gross also currently serves as a managing member of SLR Capital Partners, LLC.
   Chairman of the Board of Directors of SCP Private Credit Income BDC LLC since May 2018, Chairman of the Board of Directors of SLR HC BDC LLC since September 2020 and Chairman of the Board of Directors of SLR Private Credit BDC II LLC since April 2022; Previously served as the Chairman of the Board of Directors of SLR Senior Investment Corp. from December 2010 to April 2022; and Chairman of the Board of Directors of Global Ship Lease Inc.
Mr. Gross’ intimate knowledge of the business and operations of SLR Capital Partners, extensive familiarity with the financial industry and the investment management process in particular, and experience as a director of other public and private companies not only gives the board of directors valuable insight but also positions him well to continue to serve as the Chairman of our board of directors.
 
126

Name, Address and Age
(1)
  
Position(s) Held
with Company
  
Terms of Office and
Length of Time
Served
  
Principal
Occupation(s) During
Past 5 Years
  
Other Directorships
Held by Director or
Nominee for Director
During Past 5
Years
(2)
Interested Director
           
Bruce Spohler, 62   
Co-Chief
Executive Officer, Chief Operating Officer and Director
  
Class II Director
since 2009;
Term expires
2023.
  
Co-Chief Executive
Officer of SLR Investment Corp. and of SCP Private Credit Income BDC LLC since June 2019,
Co-Chief Executive
Officer of SLR HC BDC LLC since September 2020 and
Co-Chief Executive
Officer of SLR Private Credit BDC II LLC since April 2022; Chief Operating Officer of SLR Investment Corp. since December 2007, Chief Operating Officer of SCP Private Credit Income BDC LLC since June 2018, Chief Operating Officer of SLR HC BDC LLC since September 2020 and Chief Operating Officer of SLR Private Credit BDC II LLC since April 2022. Chief Operating Officer of SLR Senior Investment Corp. from December 2010 to April 2022 and
Co-Chief
Executive Officer of SLR Senior Investment Corp. from June 2019 to April 2022. Mr. Spohler also currently serves as a managing member of SLR Capital Partners, LLC.
   Director of SCP Private Credit Income BDC LLC since May 2018, director of SLR HC BDC LLC since September 2020 and director of SLR Private Credit BDC II LLC since April 2022. Previously served as a director of SLR Senior Investment Corp. December 2010 to April 2022.
Mr. Spohler’s depth of experience in managerial positions in investment management, leveraged finance and financial services, as well as his intimate knowledge of The Company’s business and operations, gives the board of directors valuable industry-specific knowledge and experience on these and other matters.
 
127

Name, Address and Age
(1)
  
Position(s) Held
with Company
  
Terms of Office and
Length of Time
Served
  
Principal
Occupation(s) During
Past 5 Years
  
Other Directorships
Held by Director or
Nominee for Director
During Past 5
Years
(2)
Independent Director
           
Steven Hochberg, 61    Director    Class II Director since 2007; Term expires 2023.    Co-founder and
co-general
partner of Triatomic Capital G.P LLC since 2022. Operating Partner of Deerfield Management, a healthcare investment firm, since 2022. Partner of Deerfield Management from 2013 to 2021.
Co-founder
and manager of Ascent Biomedical Ventures, a venture capital firm focused on early stage investment and development of biomedical companies, since 2004.
   Director of SCP Private Credit Income BDC LLC since May 2018, director of SLR HC BDC LLC since September 2020, and director of SLR Private Credit BDC II LLC since 2022. Since 2011, Mr. Hochberg had been the Chairman of the Board of Continuum Health Partners until its merger with Mount Sinai in 2013, where he is a vice chairman of Mount Sinai Health System, a
non-profit
healthcare integrated delivery system in New York City. Director of a number of private healthcare companies, and the Cardiovascular Research Foundation, an organization focused on advancing new technologies and education in the field of cardiovascular medicine. Previously served as a director of SLR Senior Investment Corp. from January 2011 to April 2022.
Mr. Hochberg’s varied experience in investing in medical technology companies provides the board of directors with particular knowledge of this field, and his role as chairman of other companies’ board of directors brings the perspective of a knowledgeable corporate leader.
 
128

Name, Address and Age
(1)
  
Position(s) Held
with Company
  
Terms of Office and
Length of Time
Served
  
Principal
Occupation(s) During
Past 5 Years
  
Other Directorships
Held by Director or
Nominee for Director
During Past 5
Years
(2)
Independent Director
           
Leonard A. Potter, 61    Director    Class III Director since 2009; Term expires 2024.    President and Chief Investment Officer of Wildcat Capital Management, LLC, a registered investment adviser, since 2011;
Co-founder
and Senior Managing Director at Vida Ventures I and II, each a biotech venture fund, since 2017; Managing Director of Soros Private Equity at Soros Fund Management LLC from December 2002 through July 2009.
   Director of SCP Private Credit Income BDC LLC since May 2018, director of SLR HC BDC LLC since September 2020, and director of SLR Private Credit BDC II LLC since April 2022. Director of Hilton Grand Vacations Inc. since 2017, director of SuRo Capital Corp., a publicly-traded BDC, since 2011 (currently lead independent director), and director of several private companies. Previously served as a director of SLR Senior Investment Corp. from January 2011 to April 2022.
Mr. Potter’s experience practicing as a corporate lawyer provides valuable insight to the board of directors on regulatory and risk management issues. In addition, his tenure in private equity and other investments and service as a director of both public and private companies provide industry-specific knowledge and experience to the board of directors.
 
Name, Address and Age
(1)
  
Position(s) Held
with Company
  
Terms of Office and
Length of Time
Served
  
Principal
Occupation(s) During
Past 5 Years
  
Other Directorships
Held by Director or
Nominee for Director
During Past 5
Years
(2)
Independent Director
           
David S. Wachter, 59    Director    Class I Director since 2007; Term expires 2025.    Founding Partner and Managing Partner of W Capital Partners, a private equity fund manager, since 2001.    Director of SCP Private Credit Income BDC LLC since May 2018, director of SLR HC BDC LLC since September 2020, and director of SLR Private Credit BDC II LLC since April 2022. Previously served as a director of SLR Senior Investment Corp. from January 2011 to April 2022.
Mr. Wachter’s extensive knowledge of private equity and investment banking provides the board of directors with the valuable insight of an experienced financial manager.
 
129

 
(1)
The business address of the director nominees and other directors is c/o SLR Investment Corp., 500 Park Avenue, New York, New York 10022.
(2)
All of the Company’s directors also serve as directors of SCP Private Credit Income BDC LLC, SLR HC BDC LLC and SLR Private Credit BDC II LLC, which are investment companies that have each elected to be regulated as a business development company (“BDC”) and for which SLR Capital Partners serves as investment adviser. Mr. Potter also serves as a director of SuRo Capital Corp., which is a
closed-end
management investment company that has elected to be regulated as a BDC.
Information about Executive Officers Who Are Not Directors
The following information, as of December 31, 2022, pertains to our executive officers who are not directors of the Company.
 
Name, Address, and Age
(1)
  
Position(s) Held with
Company
  
Principal Occupation(s) During Past 5 Years
Richard L. Peteka, 61    Chief Financial Officer, Treasurer and Secretary    Chief Financial Officer, Treasurer and Secretary of the Company since May 2012, chief financial officer, treasurer and secretary of SCP Private Credit Income BDC LLC since June 2018, chief financial officer, treasurer and secretary of SLR HC BDC LLC since September 2020 and chief financial officer, treasurer and secretary of SLR Private Credit BDC II LLC since April 2022. Previously served as the chief financial officer, treasurer and secretary of SLR Senior Investment Corp. from May 2012 to April 2022. Mr. Peteka joined the Company from Apollo Investment Corporation, a publicly-traded BDC, where he served from 2004 to 2012 as the chief financial officer and treasurer.
Guy Talarico, 67    Chief Compliance Officer    Chief Compliance Officer of the Company since July 2008, chief compliance officer of SCP Private Credit Income BDC LLC since June 2018, chief compliance officer of SLR HC BDC LLC since September 2020, and chief compliance officer of SLR Private Credit BDC II LLC since April 2022. Mr. Talarico serves as managing director of ACA Group, LLC (successor to Foreside Consulting Services LLC, and ultimate successor to Alaric Compliance Services, LLC, which he founded in December 2005). Previously served as the chief compliance officer of SLR Senior Investment Corp. from December 2010 to April 2022. Mr. Talarico has served and continues to serve as chief compliance officer for other BDCs, funds, and/or investment advisers who are not affiliated with the SLR Capital Partners entities.
 
(1)
The business address of the executive officers is c/o SLR Investment Corp., 500 Park Avenue, New York, New York 10022.
Our common stock is listed on the NASDAQ Global Select Market under the symbol “SLRC.”
Audit Committee
The Audit Committee operates pursuant to a charter approved by our board of directors, a copy of which is available on our website at
http://www.slrinvestmentcorp.com.
The charter sets forth the responsibilities of the Audit Committee. The Audit Committee’s responsibilities include selecting the independent registered public accounting firm for the Company, reviewing with such independent registered public accounting firm the planning, scope and results of their audit of the Company’s financial statements,
pre-approving
the fees for services performed, reviewing with the independent registered public accounting firm the adequacy of internal control systems, reviewing the Company’s annual financial statements and periodic filings and receiving the
 
130

Company’s audit reports and financial statements. The Audit Committee also establishes guidelines and makes recommendations to our board of directors regarding the valuation of our investments. The Audit Committee is responsible for aiding our board of directors in determining the fair value of debt and equity securities that are not publicly traded or for which current market values are not readily available. The board of directors and Audit Committee utilize the services of nationally recognized third-party valuation firms to help determine the fair value of these securities. The Audit Committee is currently composed of Messrs. Hochberg, Wachter and Potter, all of whom are considered independent under the rules of the NASDAQ Stock Market and are not “interested persons” of the Company as that term is defined in Section 2(a)(19) of the 1940 Act. Mr. Hochberg serves as Chairman of the Audit Committee. Our board of directors has determined that Mr. Hochberg is an “audit committee financial expert” as that term is defined under Item 407 of Regulation
S-K,
as promulgated under the 1934 Act. Mr. Hochberg meets the current independence and experience requirements of Rule
10A-3
of the 1934 Act.
Communication with the Board of Directors
Stockholders with questions about the Company are encouraged to contact the Company’s investor relations department. However, if stockholders believe that their questions have not been addressed, they may communicate with the Company’s board of directors by sending their communications to SLR Investment Corp., c/o Richard L. Peteka, Secretary, 500 Park Avenue, New York, New York 10022. All stockholder communications received in this manner will be delivered to one or more members of the board of directors.
Code of Ethics
The Company has adopted a code of ethics that applies to, among others, its senior officers, including its
Co-Chief
Executive Officers and its Chief Financial Officer, as well as every officer, director and employee of the Company. The Company’s code of ethics can be accessed via its website at
http://www.slrinvestmentcorp.com
. The Company intends to disclose amendments to or waivers from a required provision of the code of ethics on Form
8-K.
Nomination of Directors
There have been no material changes to the procedures by which stockholders may recommend nominees to our Board of Directors implemented since the filing of our Proxy Statement for our 2022 Annual Meeting of Stockholders.
 
Item 11.
Executive Compensation
Compensation of Executive Officers
None of our officers receives direct compensation from the Company. As a result, we do not engage any compensation consultants. Mr. Gross, our
Co-Chief
Executive Officer and President, and Mr. Spohler, our
Co-Chief
Executive Officer and Chief Operating Officer, through their ownership interest in SLR Capital Partners, our investment adviser, are entitled to a portion of any profits earned by SLR Capital Partners, which includes any fees payable by us to SLR Capital Partners under the terms of the Advisory Agreement, less expenses incurred by SLR Capital Partners in performing its services under the Advisory Agreement. Messrs. Gross and Spohler do not receive any additional compensation from SLR Capital Partners in connection with the management of our portfolio.
Mr. Richard Peteka, our Chief Financial Officer, Treasurer and Secretary and, through ACA Group, LLC, Guy Talarico, our Chief Compliance Officer, are paid by SLR Capital Management, our administrator, subject to reimbursement by us of an allocable portion of such compensation for services rendered by such persons to the Company. To the extent that SLR Capital Management outsources any of its functions, we will pay the fees associated with such functions on a direct basis without profit to SLR Capital Management.
Compensation of Directors
The following table sets forth the compensation of the Company’s directors, for the year ended December 31, 2022.
 
Name
  
Fees Earned or Paid

in Cash
(1)
    
Stock

Awards
 (2)
    
All Other

Compensation
    
Total
 
Interested Directors
           
Michael S. Gross
     —          —          —          —    
Bruce Spohler
     —          —          —          —    
Independent Directors
           
Steven Hochberg
   $ 145,000        —          —        $ 145,000  
David S. Wachter
   $ 140,000        —          —        $ 140,000  
Leonard A. Potter
   $ 140,000        —          —        $ 140,000  
 
(1)
For a discussion of the independent directors’ compensation, see below.
(2)
We do not maintain a stock or option plan,
non-equity
incentive plan or pension plan for our directors. However, our independent directors have the option to receive all or a portion of the directors’ fees to which they would otherwise be entitled in the form of shares of our common stock issued at a price per share equal to the greater of our then current net asset value per share or the market price at the time of payment. No shares were issued to any of our independent directors in lieu of cash during 2022.
 
131

Our independent directors’ annual fee is $100,000. The independent directors also receive $2,500 ($1,500 if participating telephonically) plus reimbursement of reasonable
out-of-pocket
expenses incurred in connection with attending each board meeting and $1,000 plus reimbursement of reasonable
out-of-pocket
expenses incurred in connection with each committee meeting attended. In addition, the Chairman of the Audit Committee receives an annual fee of $7,500, the Chairman of the Nominating and Corporate Governance Committee receives an annual fee of $2,500 and the Chairman of the Compensation Committee receives an annual fee of $2,500. Further, we purchase directors’ and officers’ liability insurance on behalf of our directors and officers. In addition, no compensation was paid to directors who are interested persons of the Company as defined in the 1940 Act.
Compensation Committee
The Compensation Committee operates pursuant to a charter approved by our board of directors, a copy of which is available on our website at
http://www.slrinvestmentcorp.com.
The charter sets forth the responsibilities of the Compensation Committee. The Compensation Committee is responsible for reviewing and recommending for approval to our board of directors the Advisory Agreement and the Administration Agreement. In addition, although we do not directly compensate our executive officers currently, to the extent that we do so in the future, the Compensation Committee would also be responsible for reviewing and evaluating their compensation and making recommendations to the board of directors regarding their compensation. Lastly, the Compensation Committee would produce a report on our executive compensation practices and policies for inclusion in our proxy statement if required by applicable proxy rules and regulations and, if applicable, make recommendations to the board of directors with matters related to compensation generally. The Compensation Committee has the authority to engage compensation consultants and to delegate their duties and responsibilities to a member or to a subcommittee of the Compensation Committee. The members of the Compensation Committee are Messrs. Hochberg, Wachter and Potter, all of whom are considered independent under the rules of the NASDAQ Stock Market and are not “interested persons” of the Company as that term is defined in Section 2(a)(19) of the 1940 Act. Mr. Potter serves as Chairman of the Compensation Committee.
Compensation Committee Interlocks and Insider Participation
During fiscal year 2022 none of the Company’s executive officers served on the board of directors (or a compensation committee thereof or other board committee performing equivalent functions) of any entities that had one or more executive officers serve on the Compensation Committee of the Company or on the Board of Directors of the Company. No member of the Compensation Committee had any relationship requiring disclosure under any paragraph of Item 404 of Regulation
S-K.
Compensation Committee Report
Currently, none of our executive officers are compensated by the Company, and as such the Company is not required to produce a report on executive officer compensation for inclusion in our annual report on Form
10-K.
 
Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
The following table sets forth, as of February 24, 2023, the beneficial ownership of each current director, the nominees for directors, the Company’s executive officers, each person known to us to beneficially own 5% or more of the outstanding shares of our common stock, and the executive officers and directors as a group.
Beneficial ownership is determined in accordance with the rules of the Securities and Exchange Commission (“SEC”) and includes voting or investment power with respect to the securities. Ownership information for those persons who beneficially own 5% or more of our shares of common stock is based upon reports filed by such persons with the SEC and other information obtained from such persons, if available.
 
132

Unless otherwise indicated, the Company believes that each beneficial owner set forth in the table has voting and investment power and has the same address as the Company. Our address is 500 Park Avenue, New York, New York 10022.
 
Name and Address of Beneficial Owner
  
Number of Shares

Owned Beneficially(1)
    
Percentage

of Class(2)
 
Interested Directors
     
Michael S. Gross(3)(4)
     3,548,685        6.5
Bruce Spohler(3)
     3,329,487        6.1
Independent Directors
     
Steven Hochberg
     22,000   
Leonard A. Potter
     14,872   
David S. Wachter
     53,494        0.1
Executive Officers
     
Richard L. Peteka
     28,872        0.1
Guy Talarico
     10,350   
All executive officers and directors as a group (7 persons)
  
 
4,196,633
 
  
 
7.7
Thornburg Investment Management Inc.(5)
     4,338,599        8.0
 
*
Represents less than one percent.
(1)
Beneficial ownership has been determined in accordance with Rule
13d-3
under the 1934 Act. Assumes no other purchases or sales of our common stock since the most recently available SEC filings. This assumption has been made under the rules and regulations of the SEC and does not reflect any knowledge that we have with respect to the present intent of the beneficial owners of our common stock listed in this table.
(2)
Based on a total of 54,554,634 shares of the Company’s common stock issued and outstanding as of February 24, 2023.
(3)
Includes 1,285,013 shares held by Solar Capital Investors, LLC and 715,000 shares held by Solar Capital Investors II, LLC, 355,107 shares held by Solar Senior Capital Investors, LLC and 77 shares held by SLR Capital Management, LLC, a portion of each which may be deemed to be indirectly beneficially owned by Michael S. Gross, by Bruce Spohler and a grantor retained annuity trust (“GRAT”) setup by and for Mr. Gross by virtue of their collective ownership interest therein. Also includes 455,930 shares held by Solar Capital Partners Employee Stock Plan LLC, which is controlled by SLR Capital Partners, LLC. Mr. Gross and Mr. Spohler may be deemed to beneficially own a portion of the shares held by Solar Capital Partners Employee Stock Plan LLC by virtue of their collective ownership interest in SLR Capital Partners, LLC. Each of Mr. Gross and Mr. Spohler disclaim beneficial ownership of any shares of our common stock directly held by Solar Capital Partners Employee Stock Plan LLC, Solar Capital Investors, LLC, Solar Capital Investors II, LLC, Solar Senior Capital Investors, LLC and SLR Capital Management, LLC, except to the extent of their respective pecuniary interest therein. Also includes 199,466 shares held in a trust of which Bruce Spohler became
co-trustee
in which he and certain members of his immediate family are beneficiaries (the “Spohler Trust”) and 243,021 shares held by a limited liability company in which he owns a pro rata interest (the “Spohler LLC”). Mr. Spohler disclaims beneficial ownership of the shares in the Spohler Trust and the Spohler LLC.
(4)
Includes 152,166 shares directly held by Michael S. Gross’ profit sharing plan (the “Profit Sharing Plan”). Mr. Gross may be deemed to directly beneficially own these shares as the sole participant in the Profit Sharing Plan. Also includes 117,617 shares held by certain trusts for the benefit of family members for which Mr. Gross serves as trustee (the “Family Trusts”). Mr. Gross may be deemed to directly beneficially own these shares by virtue of his control with respect to the Family Trusts, and disclaims beneficial ownership of the securities held by the Family Trusts except to the extent of his pecuniary interest therein.
(5)
Based upon information contained in the Schedule 13G filed February 13, 2023 by Thornburg Investment Management Inc. Such securities are held by certain investment vehicles controlled and/or managed by Thornburg Investment Management Inc. or its affiliates. The address for Thornburg Investment Management Inc. is 2300 North Ridgetop Road, Santa Fe, New Mexico 87506.
Set forth below is the dollar range of equity securities beneficially owned by each of our directors as of February 24, 2023. We are not part of a “family of investment companies,” as that term is defined in the 1940 Act.
 
133

Name of Director
  
Dollar Range

of Equity

Securities

Beneficially

Owned(1)(2)
 
Interested Directors
  
Michael S. Gross
   Over $ 100,000  
Bruce Spohler
   Over $ 100,000  
Independent Directors
  
Steven Hochberg
   Over $ 100,000  
Leonard A. Potter
   Over $ 100,000  
David S. Wachter
   Over $ 100,000  
 
(1)
The dollar ranges are: None,
$1-$10,000,
$10,001-$50,000,
$50,001-$100,000,
or Over $100,000.
(2)
The dollar range of equity securities beneficially owned in us is based on the closing price for our common stock of $14.73 on February 24, 2023 on the NASDAQ Global Select Market. Beneficial ownership has been determined in accordance with Rule
16a-1(a)(2)
of the 1934 Act.
 
Item 13.
Certain Relationships and Related Transactions, and Director Independence
We have entered into the Advisory Agreement with SLR Capital Partners. Mr. Gross, our Chairman,
Co-Chief
Executive Officer and President, and Mr. Spohler, our
Co-Chief
Executive Officer, Chief Operating Officer and board member, are managing members and senior investment professionals of, and have financial and controlling interests in, SLR Capital Partners. In addition, Mr. Richard Peteka, our Chief Financial Officer, Treasurer and Secretary, serves as the Chief Financial Officer for SLR Capital Partners.
SLR Capital Partners and its affiliates may also manage other funds in the future that may have investment mandates that are similar, in whole and in part, with ours. For example, SLR Capital Partners presently serves as investment adviser to private funds and managed accounts as well as to SCP Private Credit Income BDC LLC, an unlisted BDC, which focuses on investing primarily in senior secured loans, including
non-traditional
asset-based loans and first lien loans, SLR HC BDC LLC, an unlisted BDC whose principal focus is to invest directly and indirectly in senior secured loans and other debt instruments typically to middle market companies within the healthcare industry, and SLR Private Credit BDC II LLC, an unlisted BDC whose principal focus is to investment in first lien senior secured floating rate loans primarily to upper middle market leveraged companies with EBITDA between approximately $25 million and $250 million that have significant free cash flow and are in
non-cyclical
industries in which the Investment Adviser has significant experience. In addition, Michael S. Gross, our Chairman and
Co-Chief
Executive Officer, Bruce Spohler, our
Co-Chief
Executive Officer and Chief Operating Officer, and Richard L. Peteka, our Chief Financial Officer, serve in similar capacities for SCP Private Credit Income BDC LLC, SLR HC BDC LLC and SLR Private Credit BDC II LLC.
SLR Capital Partners and certain investment advisory affiliates may determine that an investment is appropriate for us and for one or more of those other funds. In such event, depending on the availability of such investment and other appropriate factors, SLR Capital Partners or its affiliates may determine that we should invest
side-by-side
with one or more other funds. Any such investments will be made only to the extent permitted by applicable law and interpretive positions of the SEC and its staff, and consistent with SLR Capital Partners’ allocation procedures.
Related party transactions may occur among us, SLR Senior Lending Program LLC, SLR Senior Lending Program SPV LLC, SLR Credit, Equipment Operating Leases LLC, KBH, Loyer Capital LLC, SLR Business Credit, SLR Healthcare ABL and SLR Equipment. These transactions may occur in the normal course of business. No administrative or other fees are paid to the Investment Adviser by SLR Senior Lending Program LLC, SLR Senior Lending Program SPV LLC, SLR Credit, Equipment Operating Leases LLC, KBH, Loyer Capital LLC, SLR Business Credit, SLR Healthcare ABL or SLR Equipment.
In addition, we have adopted a formal code of ethics that governs the conduct of our officers and directors. Our officers and directors also remain subject to the duties imposed by both the 1940 Act and the Maryland General Corporation Law.
Regulatory restrictions limit our ability to invest in any portfolio company in which any affiliate currently has an investment. The Company obtained its most recent exemptive order from the SEC on June 13, 2017 (the “Exemptive Order”). The Exemptive Order permits us to participate in negotiated
co-investment
transactions with certain affiliates, each of whose investment adviser is an investment adviser that controls, is controlled by or is under common control with SLR Capital Partners and is registered as an investment adviser under the Advisers Act, in a manner consistent with our investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, and pursuant to the conditions to the Exemptive Order. We
 
134

believe that it will be advantageous for us to
co-invest
with funds managed by SLR Capital Partners where such investment is consistent with the investment objectives, investment positions, investment policies, investment strategy, investment restrictions, regulatory requirements and other pertinent factors applicable to us.
We have entered into a license agreement with SLR Capital Partners, pursuant to which SLR Capital Partners has agreed to grant us a
non-exclusive,
royalty-free license to use the names “SLR” and “SOLAR”. In addition, pursuant to the terms of the Administration Agreement, SLR Capital Management provides us with the office facilities and administrative services necessary to conduct our
day-to-day
operations.
Board Consideration of the Investment Advisory and Management Agreement
Our board of directors determined at a meeting held on November 2, 2022 to approve the Advisory Agreement between the Company and SLR Capital Partners. In its consideration of the approval of the Advisory Agreement, the board of directors focused on information it had received relating to, among other things:
 
   
the nature, extent and quality of advisory and other services provided by SLR Capital Partners, including information about the investment performance of the Company relative to its stated objectives and in comparison to the performance of the Company’s peer group and relevant market indices, and concluded that such advisory and other services are satisfactory and the Company’s investment performance is reasonable;
 
   
the experience and qualifications of the personnel providing such advisory and other services, including information about the backgrounds of the investment personnel, the allocation of responsibilities among such personnel and the process by which investment decisions are made, and concluded that the investment personnel of SLR Capital Partners have extensive experience and are well qualified to provide advisory and other services to the Company;
 
   
the current fee structure, the existence of any fee waivers, and the Company’s anticipated expense ratios in relation to those of other investment companies having comparable investment policies and limitations, and concluded that the current fee structure is reasonable;
 
   
the advisory fees charged by SLR Capital Partners to the Company, to SCP Private Credit Income BDC LLC, to SLR HC BDC LLC, to SLR Private Credit BDC II LLC and comparative data regarding the advisory fees charged by other investment advisers to business development companies with similar investment objectives, and concluded that the advisory fees charged by SLR Capital Partners to the Company are reasonable;
 
   
the direct and indirect costs, including for personnel and office facilities, that are incurred by SLR Capital Partners and its affiliates in performing services for the Company and the basis of determining and allocating these costs, and concluded that the direct and indirect costs, including the allocation of such costs, are reasonable;
 
   
possible economies of scale arising from the Company’s size and/or anticipated growth, and the extent to which such economies of scale are reflected in the advisory fees charged by SLR Capital Partners to the Company, and concluded that some economies of scale may be possible in the future;
 
   
other possible benefits to SLR Capital Partners and its affiliates arising from their relationships with the Company, and concluded that all such other benefits were not material to SLR Capital Partners and its affiliates; and
 
   
possible alternative fee structures or bases for determining fees, and concluded that the Company’s current fee structure and bases for determining fees are satisfactory.
Based on the information reviewed and the discussions detailed above, the board of directors, including a majority of the directors who are not “interested persons” as defined in the 1940 Act, concluded that the fees payable to SLR Capital Partners pursuant to the Advisory Agreement were reasonable, and comparable to the fees paid by other management investment companies with similar investment objectives, in relation to the services to be provided. The board of directors did not assign relative weights to the above factors or the other factors considered by it. Individual members of the board of directors may have given different weights to different factors.
 
135

Director Independence
In accordance with rules of the NASDAQ Stock Market, our board of directors annually determines each director’s independence. We do not consider a director independent unless the board of directors has determined that he has no material relationship with us. We monitor the relationships of our directors and officers through a questionnaire each director completes no less frequently than annually and updates periodically as information provided in the most recent questionnaire changes.
Our governance guidelines require any director who has previously been determined to be independent to inform the Chairman of the board of directors, the Chairman of the Nominating and Corporate Governance Committee and our Secretary of any change in circumstance that may cause his status as an independent director to change. The board of directors limits membership on the Audit Committee, the Nominating and Corporate Governance Committee and the Compensation Committee to independent directors.
In order to evaluate the materiality of any such relationship, the board of directors uses the definition of director independence set forth in the rules promulgated by the NASDAQ Stock Market. Rule 5605(a)(2) provides that a director of a BDC, shall be considered to be independent if he or she is not an “interested person” of such BDC, as defined in Section 2(a)(19) of the 1940 Act.
The board of directors has determined that each of the directors is independent and has no relationship with us, except as a director and stockholder, with the exception of Michael S. Gross, as a result of his positions as the
Co-Chief
Executive Officer and President of the Company and a Managing Member of SLR Capital Partners, and Bruce Spohler, as a result of his positions as the
Co-Chief
Executive Officer and Chief Operating Officer of the Company and a Managing Member of SLR Capital Partners.
Indemnification Agreements
We have entered into indemnification agreements with our directors. The indemnification agreements are intended to provide our directors the maximum indemnification permitted under Maryland law and the 1940 Act. Each indemnification agreement provides that SLR Capital shall indemnify the director who is a party to the agreement (an “Indemnitee”), including the advancement of legal expenses, if, by reason of his or her corporate status, the Indemnitee is, or is threatened to be, made a party to or a witness in any threatened, pending, or completed proceeding, to the maximum extent permitted by Maryland law and the 1940 Act.
 
Item 14.
Principal Accountant Fees and Services
KPMG LLP has advised us that neither the firm nor any present member or associate of it has any material financial interest, direct or indirect, in the Company or its affiliates.
Table below in thousands
 
    
Fiscal Year

Ended

December 31,

2022
    
Fiscal Year

Ended

December 31,

2021
 
Audit Fees
   $ 828.1      $ 689.6  
Audit-Related Fees
     —          —    
Tax Fees
     166.3        170.8  
All Other Fees
     20.0        55.0  
Total Fees:
   $ 1,014.4      $ 915.4  
Audit Fees:
Audit fees consist of fees for professional services rendered for the audit of our
year-end
financial statements and quarterly reviews and services that are normally provided by KPMG LLP in connection with statutory and regulatory filings.
Audit-Related Fees:
Audit-related services consist of fees for assurance and related services that are reasonably related to the performance of the audit or review of our financial statements and are not reported under “Audit Fees.” These services include attest services that are not required by statute or regulation and consultations concerning financial accounting and reporting standards.
Tax Services Fees:
Tax services fees consist of fees for professional tax services. These services also include assistance regarding federal, state, and local tax compliance.
All Other Fees:
Other fees would include fees for products and services other than the services reported above.
 
136

Pre-Approval
Policy
The Audit Committee has established a
pre-approval
policy that describes the permitted audit, audit-related, tax and other services to be provided by KPMG LLP, the Company’s independent registered public accounting firm (“KPMG”). The policy requires that the Audit Committee
pre-approve
the audit and
non-audit
services performed by the independent auditor in order to assure that the provision of such service does not impair the auditor’s independence.
Any requests for audit, audit-related, tax and other services that have not received general
pre-approval
must be submitted to the Audit Committee for specific
pre-approval,
irrespective of the amount, and cannot commence until such approval has been granted. Normally,
pre-approval
is provided at regularly scheduled meetings of the Audit Committee. However, the Audit Committee may delegate
pre-approval
authority to one or more of its members. The member or members to whom such authority is delegated shall report any
pre-approval
decisions to the Audit Committee at its next scheduled meeting. The Audit Committee does not delegate its responsibilities to
pre-approve
services performed by the independent registered public accounting firm to management. During the fiscal year ended December 31, 2022, the Audit Committee
pre-approved
100% of the services described in this policy.
 
137

PART IV
 
Item 15.
Exhibit and Financial Statement Schedules
a. Documents Filed as Part of this Report
The following reports and consolidated financial statements are set forth in Item 8:
 
    
Page
 
     85  
     86  
     88  
     89  
     90  
     91  
     92  
     102  
 
138

b. Exhibits
The following exhibits are filed as part of this report or hereby incorporated by reference to exhibits previously filed with the SEC:
 
Exhibit
Number
  
Description
2.1    Agreement and Plan of Merger among SLR Investment Corp., SLR Senior Investment Corp., Solstice Merger Sub, Inc. and SLR Capital Partners, LLC (for the limited purposes set forth therein), dated as of December 1, 2021(12)
3.1    Articles of Amendment and Restatement(1)
3.2    Articles of Amendment (11)
3.3    Second Amended and Restated Bylaws(12)
4.1    Form of Common Stock Certificate(2)
4.2    Indenture, dated as of November 16, 2012, between the Registrant and U.S. Bank National Association as trustee(3)
4.3    Second Supplemental Indenture, dated November 22, 2017, relating to the 4.50% Notes due 2023, between the Registrant and U.S. Bank National Association as trustee, including the Form of 4.50% Notes due 2023(8)
4.4    Description of Securities(19)
10.1    Dividend Reinvestment Plan(1)
10.2    Form of Senior Secured Credit Agreement dated as of August 28, 2019 (as amended December 28, 2021) among SLR Investment Corp., Citibank, N.A., as Administrative Agent, the lenders party thereto, JPMorgan Chase Bank, N.A., as syndication agent, and Citibank, N.A., J.P. Morgan Securities LLC, and Sumitomo Mitsui Banking Corporation as Joint Lead Bookrunners and Joint Lead Arrangers(13)
10.3    Third Amended and Restated Investment Advisory and Management Agreement by and between the Registrant and SLR Capital Partners, LLC(7)
10.4    Form of Custodian Agreement(6)
10.5    Amended and Restated Administration Agreement by and between Registrant and SLR Capital Management, LLC(5)
10.6    Form of Indemnification Agreement by and between Registrant and each of its directors(1)
10.7    First Amended and Restated Trademark License Agreement by and between Registrant and SLR Capital Partners, LLC(11)
10.8    Form of Share Purchase Agreement by and between Registrant and SLR Capital Investors II, LLC(2)
10.9    Form of Registration Rights Agreement(4)
10.10    Form of Subscription Agreement(4)
10.11    Form of Note Purchase Agreement by and between the Registrant and the lenders party thereto(9)
10.12    Form of First Supplement to Note Purchase Agreement by and between the Registrant and the lenders party thereto(9)
10.13    Form of Second Supplement to Note Purchase Agreement by and between the Registrant and the lenders party thereto(9)
10.14    Form of Third Supplement to Note Purchase Agreement by and between the Registrant and the lenders party thereto(9)
10.15    Form of Fifth Supplement to Note Purchase Agreement(14)
10.16    Form of Contribution Agreement, dated as of August 26, 2011, by and between SUNS SPV LLC, as the contributee, and SLR Senior Investment Corp., as the contributor(15)
 
139

Exhibit
Number
  
Description
10.17    Form of Loan and Servicing Agreement, dated as of August 26, 2011 (as amended through the Tenth Amendment dated as of December 29, 2021), by and among SLR Senior Investment Corp., as the servicer and the transferor, SUNS SPV LLC, as the borrower, each of the conduit lenders from time to time party thereto, each of the liquidity banks from time to time party thereto, each of the lender agents from time to time party thereto, Citibank, N.A., as the administrative agent and collateral agent, and Wells Fargo Bank, N.A., as the account bank, the backup servicer and the collateral custodian(16)
10.18    Letter Agreement, dated as of April 1, 2022, between SLR Investment Corp. and SLR Capital Partners, LLC(17)
10.19    Credit Facility Assumption Agreement, dated as of April 1, 2022, by SLR Investment Corp.(17)
10.20    Assumption Agreement, dated as of April 1, 2022, made by SLR Investment Corp. for the benefit of the holders of Notes issued under the Note Purchase Agreement(17)
10.21    Note Purchase Agreement, dated as of March 31, 2020, between SLR Senior Investment Corp. and the purchasers party thereto(18)
10.22    Form of SLR Senior Lending Program LLC Amended and Restated Limited Liability Company Agreement, dated as of October 7, 2022, by and between SLR Investment Corp. and Sunstone Senior Credit L.P. (20)
14.1    Code of Ethics*
14.2    Code of Business Conduct(5)
21.1    Subsidiaries of SLR Investment Corp.*
23.1    Consent of Independent Registered Public Accounting Firm*
23.2    Consent of Independent Registered Public Accounting Firm*
23.3    Consent of Independent Registered Public Accounting Firm*
23.4    Consent of Independent Registered Public Accounting Firm*
23.5    Consent of Independent Registered Public Accounting Firm*
23.6    Consent of Independent Registered Public Accounting Firm*
31.1    Certification of Co-Chief Executive Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended.*
31.2    Certification of Co-Chief Executive Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended.*
31.3    Certification of Chief Financial Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended.*
32.1    Certification of Co-Chief Executive Officer pursuant to Section 906 of The Sarbanes-Oxley Act of 2002.*
32.2    Certification of Co-Chief Executive Officer pursuant to Section 906 of The Sarbanes-Oxley Act of 2002.*
32.3    Certification of Chief Financial Officer pursuant to Section 906 of The Sarbanes-Oxley Act of 2002.*
99.1    Crystal Financial LLC (A Delaware Limited Liability Company) Consolidated Financial Statements for the years ended December 31, 2022 and December 31, 2021*
 
140

Exhibit
Number
  
Description
99.2    NEF Holdings, LLC and Subsidiaries (A Limited Liability Company) Consolidated Financial Statements for the years ended December 31, 2022 and December 31, 2021*
99.3    KBH Topco, LLC (A Delaware Limited Liability Company) Consolidated Financial Statements for the years ended December 31, 2022 and December 31, 2021*
99.4    Gemino Healthcare Finance, LLC and Subsidiary Consolidated Financial Statements years ended December 31, 2022 and December 31, 2021*
99.5    North Mill Holdco LLC and Subsidiaries Consolidated Financial Report years ended December 31, 2022 and December 31, 2021*
99.6    Report of Independent Registered Public Accounting Firm on Supplemental Information*
101.INS*    Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH*    Inline XBRL Taxonomy Extension Schema Document
101.CAL*    Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*    Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*    Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*    Inline XBRL Taxonomy Extension Presentation Linkbase Document
104    Cover Page Interactive Data File – The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
 
(1)
Previously filed in connection with SLR Investment Corp.’s registration statement on Form
N-2
Pre-Effective
Amendment No. 7 (File
No. 333-148734)
filed on January 7, 2010.
(2)
Previously filed in connection with SLR Investment Corp.’s registration statement on Form
N-2
(File No
333-148734)
filed on February 9, 2010.
(3)
Previously filed in connection with SLR Investment Corp.’s registration statement on Form
N-2
Post-Effective Amendment No. 6 (File
No. 333-172968)
filed on November 16, 2012.
(4)
Previously filed in connection with SLR Investment Corp.’s report on Form
8-K
filed on November 29, 2010.
(5)
Previously filed in connection with SLR Investment Corp.’s registration statement on Form
N-2
Post-Effective Amendment No. 10 (File
No. 333-172968)
filed on November 12, 2013.
(6)
Previously filed in connection with SLR Investment Corp.’s report on Form
10-K
filed on February 25, 2014.
(7)
Previously filed in connection with SLR Investment Corp.’s report on Form
10-Q
filed on August 6, 2018.
(8)
Previously filed in connection with SLR Investment Corp.’s registration statement on Form
N-2
Post-Effective Amendment No. 5 (File
No. 333-194870)
filed on November 22, 2017.
(9)
Previously filed in connection with SLR Investment Corp.’s report on Form
10-K
filed on February 20, 2020.
(10)
Previously filed in connection with SLR Investment Corp.’s report on Form
10-K
filed on February 24, 2021.
(11)
Previously filed in connection with SLR Investment Corp.’s report on Form
8-K
filed on February 25, 2021.
(12)
Previously filed in connection with SLR Investment Corp.’s report on Form
8-K
filed on December 1, 2021.
(13)
Previously filed in connection with SLR Investment Corp.’s report on Form
8-K
filed on January 3, 2022.
(14)
Previously filed in connection with SLR Investment Corp.’s report on Form
8-K
filed on January 12, 2022.
(15)
Previously filed in connection with SLR Senior Investment Corp.’s report on Form
8-K
(File
No. 814-00849)
filed on August 31, 2011.
(16)
Previously filed in connection with SLR Investment Corp.’s report on Form
10-Q
filed on May 3, 2022.
(17)
Previously filed in connection with SLR Investment Corp.’s report on Form
8-K
filed on April 1, 2022.
(18)
Previously filed in connection with SLR Senior Investment Corp.’s report on Form
10-Q
(File
No. 814-00849)
filed on May 7, 2020.
(19)
Previously filed in connection with SLR Investment Corp.’s report on Form
10-K
filed on March 1, 2022.
(20)
Previously filed in connection with SLR Investment Corp.’s report on Form
8-K
filed on October 12, 2022.
*
Filed herewith.
 
141

c. Consolidated Financial Statement Schedules
Separate Financial Statements of Subsidiaries Not Consolidated:
Consolidated Financial Statements for Crystal Financial LLC’s (A Delaware Limited Liability Company) years ended December 31, 2022 and December 31, 2021 are attached as Exhibit 99.1 hereto.
Consolidated Financial Statements for NEF Holdings, LLC’s (A Delaware Limited Liability Company) years ended December 31, 2022 and December 31, 2021 are attached as Exhibit 99.2 hereto.
Consolidated Financial Statements for KBH Topco LLC’s (A Delaware Limited Liability Company) years ended December 31, 2022 and December 31, 2021 are attached as Exhibit 99.3 hereto.
Consolidated Financial Statements for Gemino Healthcare Finance, LLC and Subsidiary year ended December 31, 2022 and December 31, 2021 are attached as Exhibit 99.4 hereto.
Consolidated Financial Statements for North Mill Holdco LLC year ended December 31, 2022 and December 31, 2021 are attached as Exhibit 99.5 hereto.
 
Item 16.
Form
10-K
Summary
None.
 
142

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
SLR INVESTMENT CORP.
By:   
/s/ M
ICHAEL
S. G
ROSS
     
/s/ B
RUCE
J. S
POHLER
  
Michael S. Gross
Co-Chief Executive
Officer, President, Chairman of the Board and Director
Date: February 28, 2023
  
        
  
Bruce J. Spohler
Co-Chief Executive Officer, Chief
Operating Officer and
Director
Date: February 28, 2023
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacity and on the dates indicated.
 
Date
  
Signature
  
Title
February 28, 2023   
/s/ M
ICHAEL
S. G
ROSS
Michael S. Gross
  
Co-Chief
Executive Officer, President, Chairman of the Board and Director (Principal Executive Officer)
February 28, 2023   
/s/ B
RUCE
J. S
POHLER
Bruce J. Spohler
  
Co-Chief
Executive Officer, Chief Operating Officer and Director (Principal Executive Officer)
February 28, 2023   
/s/ S
TEVEN
H
OCHBERG
Steven Hochberg
   Director
February 28, 2023   
/s/ D
AVID
S. W
ACHTER
David S. Wachter
   Director
February 28, 2023   
/s/ L
EONARD
A. P
OTTER
Leonard A. Potter
   Director
February 28, 2023   
/s/ R
ICHARD
L. P
ETEKA
Richard L. Peteka
   Chief Financial Officer (Principal Financial Officer) and Secretary
 
143
EX-14.1 2 d437884dex141.htm EX-14.1 EX-14.1

Exhibit 14.1

Joint Code of Ethics and Insider Trading Policy

 

I.

INTRODUCTION

SLR Capital Partners, LLC (the “Adviser”) seeks to foster and maintain a reputation for honesty, integrity and professionalism. That reputation is a vital business asset. The confidence and trust placed in Adviser are highly valued and must be protected. Adviser has adopted this Code of Ethics (the “Code”) in accordance with Rules 204A-1 under the Investment Advisers Act of 1940 and Rule 17j-l under the Investment Company Act of 1940, as amended. The Code includes Adviser’s policy with respect to personal investment and trading and its insider trading policy and procedures. SLR Investment Corp., SCP Private Credit Income BDC LLC, SLR HC BDC LLC and SLR Private Credit BDC II LLC (collectively referred to as, the “BDC or the “Company”) have similarly and jointly adopted this Code of Ethics. Thus, this Code of Ethics is applicable to all Access Persons (as defined below) of the Adviser and the Company (collectively “SLR Capital”).

 

II.

DEFINITIONS

A. Access Person. The term “Access Person” means (i) any Supervised Person who (1) has access to nonpublic information regarding a Client’s purchase or sale of securities; (2) has access to nonpublic information regarding the portfolio holdings of any Reportable Fund; and/or (3) is involved in making securities recommendations to Clients or who has access to such recommendations that are nonpublic and (ii) all of the directors, officers, employees, members or partners of SLR Capital. By way of example, Access Persons include portfolio management personnel and service representatives who communicate investment advice to Clients. Administrative, technical, and clerical personnel may also be Access Persons if their functions or duties provide them with access to nonpublic information.

B. Advisers Act. The term “Advisers Act” means the Investment Advisers Act of 1940, as amended.

C. Automatic Investment Plan. An “Automatic Investment Plan” is a program in which regular periodic purchases or withdrawals are made automatically in or from investment accounts according to a predetermined schedule and allocation. An Automatic Investment Plan includes a dividend reinvestment plan.

D. Beneficial Ownership Interest. You will be considered to have “Beneficial Ownership Interest” in a Security if: (i) you have a Pecuniary Interest in the Security; (ii) you have voting power with respect to the Security, meaning the power to vote or direct the voting of the Security; or (iii) you have the power to dispose, or direct the disposition of, the Security. If you have any question about whether an interest in a Security or an account constitutes Beneficial Ownership of that Security, you should contact the Chief Compliance Officer.

E. Chief Compliance Officer. The “Chief Compliance Officer” is the Access Person designated respectively by Adviser and BDC for each entity respectively as such, as identified in SLR Capital’s Compliance Policies and Procedures Manual.

F. Client. The term “Client” means any investment entity or account advised or managed or sub-advised by Adviser, including any pooled investment vehicle advised or sub-advised by Adviser.

G. Commission. The term “Commission” means the United States Securities and Exchange Commission.

 

A-1


H. Compliance Officer. The term “Compliance Officer shall mean an Access Person deemed by SLR Capital to be sufficiently experienced to perform senior-level compliance functions, and shall include the Chief Compliance Officer.

I. Disinterested Director. The term “Disinterested Director means a director of the Company who is not an “interested person” of the Company within the meaning of Section 2(a)(19) of the Investment Company Act.

J. Exchange Act. The term “Exchange Act” means the Securities Exchange Act of 1934, as amended.

K. Federal Securities Laws. The term “Federal Securities Laws” means the Securities Act, the Exchange Act, the Sarbanes-Oxley Act of 2002, the Investment Company Act, the Advisers Act, Title V of the Gramm-Leach-Bliley Act, any rules adopted by the Commission under any of these statutes, the Bank Secrecy Act as it applies to funds and investment advisers, and any rules adopted under the Bank Secrecy Act by the Commission or the Department of the Treasury.

L. Fund. The term “Fund” means any pooled investment vehicle, whether registered, required to be registered, or exempt from registration as an “investment company” pursuant to the Investment Company Act.

M. Immediate Family. The term “Immediate Family” includes a Supervised Person’s child, stepchild, grandchild, parent, stepparent, grandparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, and includes any adoptive relationship.

N. Broad-Based Securities. The term “Broad-Based Securities” means interests in exchange-traded funds or derivatives based on broad-based market indices, sectors, or industries. This term does not include custom exchange-traded funds or exchange-traded funds based on less than 5 companies.

O. Initial Public Offering. The term “Initial Public Offering” means an offering of securities registered under the Securities Act, the issuer of which, immediately before the registration, was not subject to the reporting requirements of Sections 13 or 15(d) of the Exchange Act.

P. Investment Company Act. The term “Investment Company Act” means the Investment Company Act of 1940, as amended.

Q. Limited Offering. The term “Limited Offering” means an offering, typically referred to as a “private placement”, that is exempt from registration under the Securities Act.

R. Non-Reportable Securities. The term “Non-Reportable Securities” means: (i) direct obligations of the U.S. Government; (ii) bankers’ acceptances, bank certificates of deposit, commercial paper and high quality short-term debt instruments (defined as any instrument that has a maturity at issuance of less than 366 days and that is rated in one of the two highest rating categories by a Nationally Recognized Statistical Rating Organization), including repurchase agreements; (iii) shares issued by money market funds; (iv) shares issued by open-end funds registered under the Investment Company Act, other than Reportable Funds; and (v) shares issued by unit investment trusts that are invested exclusively in one or more open end funds, none of which are Reportable Funds.

S. Partners. The term “Partners” refers to Michael Gross and Bruce Spohler.

 

A-2


T. Pecuniary Interest. You will be considered to have a “Pecuniary Interest” in a Security if you, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, have the opportunity, directly or indirectly, to profit or share in any profit derived from a transaction in the Security. The term “Pecuniary Interest” is construed very broadly. The following examples illustrate this principle: (i) ordinarily, you will be deemed to have a “Pecuniary Interest” in all Securities owned by members of your Immediate Family who share the same household with you; (ii) if you are a general partner of a general or limited partnership, you will be deemed to have a “Pecuniary Interest” in all Securities held by the partnership; (iii) if you are a shareholder of a corporation or similar business entity, you will be deemed to have a “Pecuniary Interest” in all Securities held by the corporation if you are a controlling shareholder or have or share investment control over the corporation’s investment portfolio; (iv) if you have the right to acquire equity Securities through the exercise or conversion of a derivative Security, you will be deemed to have a Pecuniary Interest in the Securities, whether or not your right is presently exercisable; (v) if you are the sole member or a manager of a limited liability company, you will be deemed to have a Pecuniary Interest in the Securities held by the limited liability company; and (vi) ordinarily, if you are a trustee or beneficiary of a trust, where either you or members of your Immediate Family have a vested interest in the principal or income of the trust, you will be deemed to have a Pecuniary Interest in all Securities held by that trust. If you have any question about whether an interest in a Security or an account constitutes a Pecuniary Interest, you should contact the Chief Compliance Officer.

U. Reportable Fund. The term “Reportable Fund” means (i) any Fund for which Adviser serves as investment adviser; or (ii) any Fund whose investment adviser or principal underwriter controls Adviser, is controlled by Adviser, or is under common control with Adviser. As used in this definition, the term control has the same meaning as it does in Section 2(a)(9) of the Investment Company Act.

V. Reportable Security. The term “Reportable Security” means all Securities other than Non-Reportable Securities. Reportable Securities include Broad-Based Securities, municipal securities and any other securities not specifically included in the definition of a Non-Reportable Security.

W. Restricted List. The “Restricted List” is a list maintained by the Chief Compliance Officer as specified by SLR Capital’s Insider Trading Policies and Procedures.

X. SEC. The term “SEC” means the U.S. Securities and Exchange Commission.

Y. Securities Act. The term “Securities Act” means the Securities Act of 1933, as amended.

Z. Security. The term “Security” has the same meaning as it has in section 202(a)(18) of the Advisers Act. For purposes of this Code, the following are Securities:

Any note, stock, treasury stock, security future, bond, debenture, evidence of indebtedness, certificate of interest or participation in any profit-sharing agreement, collateral-trust certificate, preorganization certificate or subscription, transferable share, investment contract, voting-trust certificate, certificate of deposit for a security, fractional undivided interest in oil, gas, or other mineral rights, any put, call, straddle, option or privilege on any security (including a certificate of deposit) or on any group or index of securities (including any interest therein or based on the value thereof), or any put, call, straddle, option or privilege entered into on a national securities exchange relating to foreign currency, or, in general, any interest or instrument commonly known as a security, or any certificate of interest or participation in, temporary or interim certificate for, receipt for, guarantee of, or warrant or right to subscribe to or purchase, any security.

 

A-3


The following are not Securities:

Commodities, futures and options traded on a commodities exchange, including currency futures, except that (i) options on any group or index of Securities and (ii) futures on any group or narrow-based index of Securities are Securities.

You should note that “Security” includes a right to acquire a Security, as well as an interest in a collective investment vehicle (such as a limited partnership or limited liability company).

AA. Supervised Person. The term “Supervised Person” means (i) any partner, member, officer or director of SLR Capital, or other person occupying a similar status or performing similar function; (ii) any employee of SLR Capital; (iii) any U.S. consultant who has been contracted by SLR Capital for more than ninety (90) days; and (iv) any other person who provides advice on behalf of SLR Capital and is subject to SLR Capital’s supervision and control.

 

III.

ANTI-BRIBERY REQUIREMENTS

The Adviser is committed to complying with the laws and regulations designed to combat bribery and corruption (herein after referred to as “anti-bribery”) and to seeking and retaining business on the basis of merit, not through bribery or corruption.

It is the Adviser’s policy that:

 

   

Personnel may not provide anything of value to obtain or retain business or favored treatment from public officials; candidates for office; employees of state-owned enterprises; clients/customers, or suppliers; any agent of the aforementioned parties; or any other person with whom the Adviser does or anticipates doing business.

 

   

The prohibition against providing “anything of value” to obtain or retain business or favored treatment includes obvious improper payments, such as cash bribes or kickbacks, but also may include other direct or indirect benefits and advantages, such as gifts, meals, entertainment, charitable contributions, and offers of employment or internships that are inappropriate.

 

   

The prohibition extends not only to public officials, but also to corporate clients and other private parties.

 

   

The Adviser prohibits its personnel from requesting or accepting bribes and other improper financial advantages, as well as offering them.

The Adviser maintains written policies, procedures and internal controls reasonably designed to comply with anti-bribery laws (the “Anti-Bribery Program”). The Anti-Bribery Program includes a risk assessment process, education and training, review and approval processes, due diligence procedures, accounting processes and independent testing processes. The Adviser expects all of its agents and vendors to (i) maintain policies and procedures applicable to their circumstances and proportionate to the risks they face and (ii) to act at all times in a manner consistent with the Adviser’s anti-bribery policies.

Personnel who engage in or facilitate bribery, or who fail to comply with all applicate anti-bribery laws, regulations, and the Adviser’s anti-bribery and related policies, may be subject to disciplinary action. The Adviser reserves the right to terminate immediately any business relationship that violates the Adviser’s anti-bribery policies.

 

A-4


The Adviser will conduct targeted email reviews, discussion of the policy will be conducted in code of ethics training. Any exceptions to the policy will be reported to Management.

 

IV.

PERSONAL INVESTMENT AND TRADING POLICY

 

  A.

General Statement

SLR Capital is committed to maintaining the highest standard of business conduct.

SLR Capital and its Supervised Persons must not act or behave in any manner or engage in any activity that (1) involves or creates even the suspicion or appearance of the misuse of material, nonpublic information by SLR Capital or any Supervised Person or (2) gives rise to, or appears to give rise to, any breach of fiduciary duty owed to any Client or investor.

In addition, the Federal Securities Laws require that investment advisers maintain a record of every transaction in any Security, with certain exceptions, as described below, in which any Access Person acquires or disposes of Beneficial Ownership where the Security is or was held in an account over which the Access Person has direct or indirect influence or control. Given the current size of its operations, SLR Capital has chosen to require reporting of transactions, as well as pre-approval of certain transactions, for all Supervised Persons (subject to the specific exceptions in the Code), rather than only Access Persons. Notwithstanding the foregoing, Disinterested Directors are not subject to the preclearance and reporting requirements of the Code. However, with respect to the Company’s securities Disinterested Directors must transact during the window periods and subsequently report the transaction detail to the Company on the day of the transaction.

SLR Capital has developed the following policies and procedures relating to personal trading in Securities and the reporting of such personal trading in Securities in order to ensure that each Supervised Person satisfies the requirements of this Code.

 

  B.

Requirements of this Code

1. Duty to Comply with Applicable Laws.

All Supervised Persons are required to comply with the Federal Securities Laws, the fiduciary duty owed by Adviser to its Clients, as applicable, and this Code.

2. Insider Trading Controls

All Supervised Persons are required to comply with the Insider Trading Policies and Procedures adopted by the Adviser and the BDC which appears as Appendix VII of this Code of Ethics and is incorporated herein by this reference.

3. Duty to Report Violations.

Each Supervised Person is required by law to promptly notify the Chief Compliance Officer or designee in the event he or she knows or has reason to believe that he or she or any other Supervised Person has violated any provision of this Code. If a Supervised Person knows or has reason to believe that the Chief Compliance Officer has violated any provision of this Code, the Supervised Person must promptly notify the Chief Financial Officer and is not required to notify the Chief Compliance Officer.

 

A-5


SLR Capital is committed to fostering a culture of compliance. SLR Capital therefore urges you to contact the Chief Compliance Officer or designee if you have any questions regarding compliance. You will not be penalized and your status at SLR Capital will not be jeopardized by communicating with the Chief Compliance Officer. Reports of violations or a suspected violations also may be submitted anonymously to the Chief Compliance Officer or designee. Any retaliatory action taken against any person who in good faith reports a violation or a suspected violation of this Code is itself a violation of this Code and cause for appropriate corrective action, including dismissal.

4. Supervised Personnel to be Supplied Copies, and Furnish Acknowledgements of Receipt of the Code of Ethics and Any Amendments Thereof.

SLR Capital will provide all Supervised Persons with a copy of this Code and all subsequent amendments. By law, all Supervised Persons must in turn provide written acknowledgement to the Chief Compliance Officer or designee of their initial receipt and review of this Code, their annual review of this Code and their receipt and review of any subsequent amendments to this Code.

C. Restrictions on Supervised Persons Trading in Securities

1. Generally.

Purchases of Reportable Securities (other than Broad-Based Securities) by Supervised Persons and participation by Supervised Persons in an Initial Public Offering or Limited Offering require advance preclearance approval, in writing, by a Compliance Officer together with the specific approval of both Partners.

Sales of Reportable Securities (other than Broad-Based Securities) by Supervised Persons require advance preclearance approval, in writing, by a Compliance Officer together with the specific approval of both Partners.

All Supervised Person personal trading in Securities (other than Broad-Based Securities) is subject to the following further requirements and/or restrictions.

(a) Any transaction in a Security subject to the Restricted List of issuers maintained by SLR Capital is strictly prohibited.

(b) Any transaction in a Security which the Supervised Person knows or has reason to know is being purchased or sold, or is being considered for purchase or sale, by or on behalf of a Client is prohibited until the Client’s transaction has been completed or consideration of the transaction is abandoned. A Security is “being considered for purchase or sale” the earlier of (i) when a recommendation to purchase or sell has been made and communicated or (ii) the Security is placed on Adviser’s research project lists or, (iii) with respect to the Supervised Person making the recommendation, when the Supervised Person seriously considers making such a recommendation.

(c) No Supervised Person may engage in a transaction in a Security, which includes an interest in a Fund, if the Supervised Person’s transaction would otherwise disadvantage or appear to disadvantage a Client or if the Supervised Person would inappropriately profit from or appear to so profit from the transaction, whether or not at the expense of the Client. For the avoidance of doubt, this prohibition applies to any Security held, at the time of a personal transaction, in any Client account.

(d) Any transaction in a Security during the period which begins three days before and ends three days after any Client has traded in that Security is prohibited, unless approved by a Compliance Officer.

 

A-6


(e) No matched purchases and sales, or sales and purchases, in the same Security within a thirty-day period may be transacted without the advance approval of a Compliance Officer. This is requirement is reviewed on a “first-in, first-out” basis. This means that a security that is already in someone’s portfolio may be sold within thirty-days of a purchase if certain shares of that security were in the portfolio prior to the thirty-day period.

(f) Personal account trading must be done on the Supervised Person’s own time without placing undue burden on SLR Capital’s time.

(g) No personal trades should be undertaken which are beyond the financial resources of the Supervised Person.

(h) For the avoidance of doubt:

(i) Supervised Person Transactions in Broad-Based Securities are subject to the reporting, but not the preclearance requirements of this Code.

(ii) Supervised Person Transactions in Reportable Securities other than Broad-Based Securities are subject to both the preclearance and the reporting requirements of this Code.

(iii) Supervised Person Transactions by Disinterested Directors are not subject to the preclearance and reporting requirements of this Code. However, with respect to the Company’s securities Disinterested Directors must transact during the window periods and subsequently report the transaction detail to the Company on the day of the transaction.

2. Accounts of Record

(a) You may not hold, and you may not permit any other person or entity to hold, on your behalf, any publicly traded Reportable Securities in which you have, or by reason of a Supervised Person Purchase Transaction (as hereinafter defined) will acquire, a Beneficial Ownership Interest, except through an “account of record” with the Adviser maintained with a bank or registered broker-dealer custodian (a “custodian”) or a registered investment adviser.

(b) You must provide written notice to a Compliance Officer of your opening of an account with a bank or broker-dealer custodian or an investment adviser through which you (or your investment adviser, acting on your behalf) have the ability to purchase or sell publicly traded Reportable Securities promptly after opening the account, and in any event before the first order for the purchase or sale of such Securities is placed through the account. A Compliance Officer will then ask you to complete and sign a written notice to the account custodian or investment adviser (the forms of which are attached as Appendix IV and Appendix V hereto) which discloses your affiliation with the Adviser and requests that duplicate hard copies of trade confirmations and periodic statements reflecting all holdings and transactions within the account be promptly and confidentially sent to the attention of the Chief Compliance Officer.1 A Compliance Officer will review and, upon approval, transmit the notice to your account custodian or investment adviser.

 

1 

In lieu of using the referenced Appendices requesting the forwarding of hard-copy confirmations and account statements, the Adviser will ordinarily ask, if feasible, that the account custodian agree to establish an automatic electronic feed of all account holding and transaction activity to the Adviser’s area of the Personal Trade Compliance Center (“PTCC”) online “cloud” system which the Adviser has licensed from Compliance Science, Inc.

 

A-7


3. Transactions of Immediate Family Members.

There is a presumption that a Supervised Person can exert some measure of influence or control over accounts held by members of such person’s Immediate Family sharing the same household. Therefore, transactions by Immediate Family members sharing the same household are subject to the policies herein. A Supervised Person may rebut this presumption by presenting convincing evidence, in writing, to the Chief Compliance Officer and request an exemption to one or more policies herein. All exemptions must be approved by the Chief Compliance Officer, in writing.

4. The following are Exempt Transactions that do not require preclearance by a Compliance Officer:

(a) Any transaction in Securities in an account over which a Supervised Person does not have any direct or indirect influence or control (such as a fully discretionary managed account through a registered investment adviser). To rely upon this exemption, Supervised Persons must provide: (1) information about a trustee or third–party manager’s relationship to the Supervised Person (i.e., independent professional versus friend or relative; unaffiliated versus affiliated firm); (2) periodic certifications regarding the Supervised Persons’ influence or control over trusts or accounts (or obtain the certification from the third party manager or trustee when requested); and (3) when requested, reports on holdings and/or transactions made in the trust or discretionary account to identify transactions that would have been prohibited pursuant to the Code of Ethics, absent reliance on the reporting exemption.

(b) Purchases of Securities under Automatic Investment Plans (such as an employer-sponsored 401(k) plan).

(c) Purchases of Securities by exercise of rights issued to the holders of a class of Securities pro rata, to the extent they are issued with respect to Securities in which a Supervised Person has a Beneficial Ownership Interest.

(d) Acquisitions or dispositions of Securities as the result of a stock dividend, stock split, reverse stock split, merger, consolidation, spin-off or other similar corporate distribution or reorganization applicable to all holders of a class of Securities in which a Supervised Person has a Beneficial Ownership Interest.

(e) Such other specific or classes of transactions as may be exempted from time to time by the Chief Compliance Officer based upon a determination that the transactions are unlikely to violate Rule 204A-1 under the Advisers Act.

5. Supervised Person Transaction Preclearance and Execution Procedures

The following procedures shall govern all transactions in which a Supervised Person intends to sell (a “Supervised Person Sale Transaction”) or intends to acquire (a “Supervised Person Purchase Transaction”; together with “Supervised Person Sale Transaction”, a “Supervised Person Transaction”) a Beneficial Ownership Interest and which are subject to the requirement of securing advance preclearance approval, in writing, by a Compliance Officer.

(a) Preclearance.

Requests for preclearance of Supervised Person Transactions are to be delivered, confidentially and in writing (via the Adviser’s email network), to the attention of a Compliance Officer and both Partners. Responses on behalf of such Compliance Officer and both Partners will be conveyed, confidentially and in writing ordinarily via email, within two (2) business days regarding Supervised Person Transaction requests involving publicly traded Reportable Securities and five (5) business days regarding Transaction requests involving other Reportable Securities.

 

A-8


(i) Supervised Person Purchase Transactions.

Preclearance of Supervised Person Purchase Transactions may be withheld for any reason, or no reason, in the sole discretion of the Chief Compliance Officer and both Partners.

(ii) Supervised Person Sale Transactions.

A Supervised Person Sale may be disapproved if it is determined by the Chief Compliance Officer and both Partners that the Supervised Person is unfairly benefiting from, or that the transaction is in conflict with, or appears to be in conflict with, any Client Transaction (as defined below), any of the above-described trading restrictions, or otherwise by this Code. The determination that a Supervised Person may unfairly benefit from, or that a Supervised Person Sale may conflict with or appears to be in conflict with, a Client Transaction will be subjective and individualized, and may include questions about the timely and adequate dissemination of information, availability of bids and offers, and other factors deemed pertinent for an individual Client transaction or series of transactions. It is possible that a disapproval of a Supervised Person Sale could be costly to a Supervised Person or members of a Supervised Person’s family; therefore, each Supervised Person should take great care to adhere to SLR Capital’s trading restrictions and avoid conflicts of interest or the appearance of conflicts of interest.

Any disapproval of a Supervised Person Sale Transaction shall be in writing. A Supervised Person may appeal any such disapproval by written notice to the Partners within two business days after receipt of notice of disapproval.

(b) Executions of Supervised Person Transactions.

(i) Transactions in Publicly Traded Reportable Securities.

Supervised Person Transactions in publicly traded Reportable Securities must, except upon the advance written approval of a Compliance Officer, be executed through an account of record with the Adviser in accordance with Section III.C.3(b).

(ii) Transactions in Other Reportable Securities.

Confirmation of Supervised Person Transactions in all other Reportable Securities must be promptly conveyed, confidentially and in writing, to the attention of the Chief Compliance Officer.

 

V.

REPORTING

A. Reports About Securities Holdings and Transactions

Supervised Persons (other than Disinterested Directors) must submit to the Chief Compliance Officer or designee periodic written reports about their Securities holdings, transactions, and accounts, and the Securities of other persons if the Supervised Person has a Beneficial Ownership Interest in such Securities and the accounts of other persons if the Supervised Person has direct or indirect influence or control over such accounts.2 The obligation to submit these reports and the content of these reports are

 

 

2 

In lieu of employing the referenced Appendices, Supervised Personnel will ordinarily perform required reporting by utilizing the PTCC online system which the Adviser has licensed from Compliance Science, Inc.

 

A-9


governed by the Federal Securities Laws. The reports are intended to identify conflicts of interest that could arise when a Supervised Person invests in a Security or holds accounts that permit these investments, and to promote compliance with this Code. Adviser is sensitive to privacy concerns and will try not to disclose your reports to anyone unnecessarily. Report forms are attached.

Failure to file a timely, accurate, and complete report is a serious breach of Commission rules and this Code. If a Supervised Person is late in filing a report, or files a report that is misleading or incomplete, the Supervised Person may face sanctions including identification by name to the Chief Compliance Officer, withholding of salary or bonuses, or termination of employment.

1. Initial Disclosure Reports: Within ten days after you become a Supervised Person (other than Disinterested Directors), you must submit to the Chief Compliance Officer or designee a securities accounts report (a form of which is attached as Appendix II thereto) and private investments report (a form of which is attached as Appendix VI thereto) based on information that is current as of a date not more than 45 days prior to the date you become a Supervised Person.

(a) The Initial Report of Securities Accounts contains the following:

(i) The name/title and type of Security, and, as applicable, the exchange ticker symbol or CUSIP number, the number of equity shares and principal amount of each Reportable Security in which you had a Beneficial Ownership Interest. You may provide this information by referring to attached copies of broker transaction confirmations or account statements from the applicable record keepers that contain the information.

(ii) The name and address of any broker, dealer, or bank or other institution (such as a general partner of a limited partnership, or transfer agent of a company) that maintained any account holding any Securities in which you have a Beneficial Ownership Interest, and the account numbers and names of the persons for whom the accounts are held.

(iii) An executed statement (and a letter or other evidence) pursuant to which you have instructed each broker, dealer, bank, or other institution to provide duplicate account statements and confirmations of all Securities transactions, unless Adviser indicates that the information is otherwise available to it. The form of this statement is attached as Appendix IV (for personal accounts) and Appendix V (for related accounts) hereto.

(iv) The date you submitted the report.

(b) The Initial Report of Private Investments contains the following:

(i) A description of all private investments in which you have a Beneficial Ownership Interest, the principal amount of those private investments, the approximate dates of acquisition, and whether the private investments involve or are associated with companies that have publicly traded debt or equity.

(ii) The date you submitted the report.

2. Quarterly Transaction Report: Unless, as noted below, the Chief Compliance Officer already receives trade confirmations or account statements for all of your transactions in Reportable Securities, within 30 days after the end of each calendar quarter, you, as a Supervised Person (other than Disinterested Directors), must submit to the Chief Compliance Officer or designee a transaction report, a form of which is attached as Appendix III hereto, that contains:

 

A-10


(a) With respect to any transaction during the quarter in any Reportable Security in which you had, or as a result of the transaction acquired, a Beneficial Ownership Interest:

(i) The date of the transaction, the name/title and as applicable, the exchange ticker symbol or CUSIP number, interest rate and maturity date, the number of equity shares of, or the principal amount of debt represented by, and principal amount of each Reportable Security involved;

(ii) The nature of the transaction, i.e., purchase, sale or other type of acquisition or disposition;

(iii) The price at which the transaction in the Reportable Security was effected;

(iv) The name of the broker, dealer, bank, or other institution with or through which the transaction was effected.

(b) The name and address of any broker, dealer, bank, or other institution, such as a general partner of a limited partnership, or transfer agent of a company, that maintained any account in which any Securities were held during the quarter in which you have a Beneficial Ownership Interest, the account numbers and names of the persons for whom the accounts were held, and the date when each account was established.

(c) An executed statement, and a letter or other evidence, pursuant to which you have instructed each broker, dealer, bank, or other institution that has established a new account over which you have direct or indirect influence or control during the past quarter to provide duplicate account statements and confirmations of all Securities transactions to SLR Capital, unless SLR Capital indicates that the information is otherwise available to it. The form of this statement is attached as Appendix IV and Appendix V hereto.

(d) The date that you submitted the report.

***You need not submit a quarterly transaction report to the Chief Compliance Officer or designee if it would duplicate information contained in trade confirmations or account statements already received by the Chief Compliance Officer or designee, provided that those trade confirmations or statements are received not later than 30 days after the close of the calendar quarter in which the transaction takes place. ***

3. Annual Employee Certification: You (other than Disinterested Directors) must, no later than February 15 of each year, submit to the Chief Compliance Officer or designee an Annual Employee Certification, that is current as of a date no earlier than December 31 of the prior calendar year (the “Annual Report Date”) and that contains:

(a) The name and address of any broker, dealer, investment advisor or bank or other institution, such as a general partner of a limited partnership, or transfer agent of a company, that maintained any account holding any Securities in which you have a Beneficial Ownership Interest on the Annual Report Date, the account numbers and names of the persons for whom the accounts are held, and the date when each account was established; this information may be provided through copies of statements of each such account.

(b) A description of any private investments in which you have a Beneficial Ownership Interest on the Annual Report Date, the principal amount of the investment, the approximate date of the acquisition, and whether the private investment involves or is associated with a company that has publicly trade debt or equity.

 

A-11


(c) The date that you submitted the report.

Exception to requirement to list transactions or holdings subject to IV.2 and IV.3(a) above: You are not required to submit (i) holdings or transactions reports for any account over which you had no direct or indirect influence or control (such as a fully discretionary managed account through a registered investment advisor) or (ii) transaction reports with respect to transactions effected pursuant to an Automatic Investment Plan, unless requested by SLR Capital. You must still identify the existence of the account in your list of accounts. Transactions that override preset schedules or allocations of an automatic investment plan or trades that are directed by you in a fully discretionary managed account, however, must be included in a quarterly transaction report.

In order to take advantage of part (i) of the exception (accounts over which you had no direct or indirect influence or control), Access Persons must provide:

 

   

Information about a trustee or third–party manager’s relationship to the Access Person (i.e., independent professional versus friend or relative; unaffiliated versus affiliated firm);

 

   

periodic certifications regarding the Access Persons’ influence or control over trusts or accounts (or obtain the certification from the third party manager or trustee when requested);

 

   

when requested, reports on holdings and/or transactions made in the trust or discretionary account to identify transactions that would have been prohibited pursuant to the Code of Ethics, absent reliance on the reporting exemption.

4. Please ask the Chief Compliance Officer if you have questions about the above-described disclosure and transaction reporting requirements.

B. Review of Reports and Other Documents

The Chief Compliance Officer or designee will review each report submitted by Supervised Persons, and each account statement or confirmation from institutions that maintain their accounts, as promptly as practicable. In any event all Initial Disclosure Reports will be reviewed within 20 business days of receipt, and the review of all timely-submitted Quarterly Transaction Reports will be completed by the end of the quarter in which received. As part of his or her review, the Chief Compliance Officer or his or her designee will confirm that all necessary pre-approvals have been obtained. To ensure adequate scrutiny, documents concerning a member of the Compliance Office will be reviewed by a different member of the Compliance Office, or if there is only one member of the Compliance Office, by the Chief Financial Officer.

A report documenting the above review and any exceptions noted will be prepared by the Chief Compliance Officer and circulated to the Partners within 60 days of the end of the quarter in which the reports were received.

Review of submitted holding and transaction reports will include not only an assessment of whether the Supervised Person followed all required procedures of this Code, such as preclearance, but may also: compare the personal trading to any restricted lists; assess whether the Supervised Person is trading for his or her own account in the same securities he or she is trading for Clients, and, if so, whether the Clients are receiving terms as favorable as the Supervised Person receives; periodically analyze the Supervised Person’s trading for patterns that may indicate abuse, including market timing; investigate any substantial

 

A-12


disparities between the quality of performance the Supervised Person achieves for his or her own account and that he or she achieves for Clients; and investigate any substantial disparities between the percentage of trades that are profitable when the Supervised Person trades for his or her own account and the percentage that are profitable when he or she places trades for Clients.

 

VI.

POLICY ON GIFTS

Gifts. A Supervised Person is prohibited from improperly using his or her position to obtain an item of value from any person or company that does business with SLR Capital. Supervised Persons must report to a Compliance Officer receipt of any gift greater than $300 in value from any person or company that does business with the Company. Unsolicited business entertainment, including meals or tickets to cultural and sporting events do not need to be reported if: a) they are not so frequent or of such high value as to raise a question of impropriety and b) the person providing the entertainment is present at the event.

Regardless of dollar value, Supervised Persons may not give a gift or provide entertainment that is inappropriate under the circumstances, or inconsistent with applicable law or regulations, to persons associated with securities or financial organizations, exchanges, member firms, commodity firms, news media, or Clients. Persons must obtain clearance from the either Partner and a Compliance Officer prior giving any gift greater than $300 in value to any person or company that does business with the Company.

Supervised Persons should not give or receive gifts or entertainment that would be embarrassing to themselves or to SLR Capital if made public.

 

VII.

COMPLIANCE

A. Certificate of Receipt

Supervised Persons are required to acknowledge receipt of the Compliance Manual and, therefore, your copy of this Code and that you have read and understood the Compliance Manual. A form for this purpose is attached to this Code as Appendix I.

B. Annual Certificate of Compliance

Supervised Persons are required to certify upon becoming a Supervised Person or the effective date of this Code, whichever occurs later, and annually thereafter, that you have read and understand this Code and recognize that you are subject to this Code. Each annual certificate will also state that you have complied with all of the requirements of this Code during the prior year.

C. Remedial Actions

If you violate this Code, including filing a late, inaccurate or incomplete holdings or transaction report, you will be subject to remedial actions, which may include, but are not limited to, any one or more of the following: (1) a warning; (2) disgorgement of profits; (3) imposition of a fine, which may be substantial; (4) demotion, which may be substantial; (5) suspension of employment, with or without pay; (6) termination of employment; or (7) referral to civil or governmental authorities for possible civil or criminal prosecution. If you are normally eligible for a discretionary bonus, any violation of the Code may also reduce or eliminate the discretionary portion of your bonus.

 

VIII.

RETENTION OF RECORDS

The Chief Compliance Officer will maintain, for a period of five years unless specified in further detail below, the records listed below. The records will be maintained at the Adviser’s principal place of business for at least two years and in an easily accessible, but secured, place for the entire five years.

 

A-13


A. A record of the names of persons who are currently, or within the past five years were, Access Persons of Adviser.

B. The Annual Certificate of Compliance signed by all persons subject to this Code acknowledging receipt of copies of the Code and acknowledging they are subject to it and will comply with its terms. All Annual Certificates of each Supervised Person must be kept for five years after the individual ceases to be a Supervised Person.

C. A copy of each Code that has been in effect at any time during the five-year period.

D. A copy of each report made by a Supervised Person pursuant to this Code, including any broker trade confirmations or account statements that were submitted in lieu of the persons’ quarterly transaction reports.

E. A record of all known violations of the Code and of any actions taken as a result thereof, regardless of when the violations were committed.

F. A record of any decision, and the reasons supporting the decision, to approve the acquisition of securities by Supervised Persons, for at least five years after the end of the fiscal year in which the approval is granted.

G. A record of all reports made by the Chief Compliance Officer related to this Code.

 

IX.

NOTICES.

For purposes of this Code, all notices, reports, requests for clearance, questions, contacts, or other communications to the Chief Compliance Officer will be considered delivered if provided to the Chief Compliance Officer via the Adviser’s email network.

 

X.

REVIEW.

This Code will be reviewed by the Chief Compliance Officer on an annual basis to ensure that it is meeting its objectives, is functioning fairly and effectively, and is not unduly burdensome to Adviser or Supervised Persons. The Chief Compliance Officer shall issue a report, in writing, to the Board of Directors of the Company stating his or her findings and recommendations as a result of each such review on no less frequently than an annual basis.

Supervised Persons are encouraged to contact the Chief Compliance Officer with any comments, questions or suggestions regarding implementation or improvement of the Code.

 

A-14


Appendix I

SLR CAPITAL ACKNOWLEDGMENT AND CERTIFICATION

COMPLIANCE POLICIES AND PROCEDURES MANUAL

I hereby certify to SLR Capital that:

(1) I have received and reviewed SLR Capital’s Compliance Policies and Procedures Manual (the “Compliance Manual”);

(2) To the extent I had questions regarding any policy or procedure contained in the Compliance Manual, I received satisfactory answers to those questions from appropriate SLR Capital personnel;

(3) I fully understand the policies and procedures contained in the Compliance Manual;

(4) I understand and acknowledge that I am subject to the Compliance Manual;

(5) I will comply with the policies and procedures contained in the Compliance Manual at all times during my association with SLR Capital, and agree that the Compliance Manual may, under certain circumstances, continue to apply to me subsequent to the termination of my association with SLR Capital.

(6) I understand and acknowledge that if I violate any provision of the Compliance Manual, I will be subject to remedial actions, which may include, but are not limited to, any one or more of the following: (a) a warning; (b) disgorgement of profits; (c) imposition of a fine, which may be substantial; (d) demotion, which may be substantial; (e) suspension of employment, with or without pay; (f) termination of employment; or (g) referral to civil or governmental authorities for possible civil or criminal prosecution. I further understand that, to the extent I would otherwise be eligible for a discretionary bonus, if I violate the Compliance Manual this may reduce or eliminate the discretionary portion of my bonus.

 

Date:

           
       

Signature

         
       

Print Name

 

I-1


Appendix II

SLR CAPITAL

INITIAL REPORT OF SECURITIES ACCOUNTS

In accordance with SLR Capital’s policies and procedures, please indicate whether you maintain securities accounts over which you have influence or control and/or in which any securities are held in which you have a Beneficial Ownership Interest1 (“Securities Accounts”). Securities Accounts include accounts of any kind held at a broker, bank, investment advisor, or money manager.

I do maintain Securities Accounts.

I do not maintain Securities Accounts.

If you indicated above that you do maintain Securities Accounts, please (1) complete the Personal Trading Account and/or Related Trading Account letters of direction (enclosed), (2) provide the information in the following table (use additional paper if necessary), and (3) attach a copy of the most recent account statement listing holdings for each account identified below:

 

Account Name

  

Broker/Institution

Name

  

Account Number

  

Broker/Institution’s

Address

  

Is this account managed by a

3rd party (such as an

investment advisor) on a fully

discretionary basis in which

you do not direct any

transactions? (Yes/No)

I certify that this form is accurate and complete, and I have attached statements (if any) for all of my Securities Accounts.

 

1 

You will be considered to have a “Beneficial Ownership Interest” in a Security if: (i) you have a Pecuniary Interest in the Security; (ii) you have voting power with respect to the Security, meaning the power to vote or direct the voting of the Security; or (iii) you have the power to dispose, or direct the disposition of, the Security. You will be considered to have a “Pecuniary Interest” in a security if you, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, have the opportunity, directly or indirectly, to profit or share in any profit derived from a transaction in the security. The term “Pecuniary Interest” is construed very broadly. The following examples illustrate this principle: (i) ordinarily, you will be deemed to have a “Pecuniary Interest” in all Securities owned by members of your Immediate Family who share the same household with you; (ii) if you are a general partner of a general or limited partnership, you will be deemed to have a “Pecuniary Interest” in all Securities held by the partnership; (iii) if you are a shareholder of a corporation or similar business entity, you will be deemed to have a “Pecuniary Interest” in all Securities held by the corporation if you are a controlling shareholder or have or share investment control over the corporation’s investment portfolio; (iv) if you have the right to acquire equity Securities through the exercise or conversion of a derivative Security, you will be deemed to have a Pecuniary Interest in the Securities, whether or not your right is presently exercisable; (v) if you are the sole member or a manager of a limited liability company, you will be deemed to have a Pecuniary Interest in the Securities held by the limited liability company; and (vi) ordinarily, if you are a trustee or beneficiary of a trust, where either you or members of your Immediate Family have a vested interest in the principal or income of the trust, you will be deemed to have a Pecuniary Interest in all Securities held by that trust.

 

II-1


Appendix II

 

         
       

Signature

           
 

Date:

     

Print Name

 

II-2


Appendix III

SLR CAPITAL

QUARTERLY BROKERAGE ACCOUNT

AND NON-BROKER TRANSACTION REPORT

Notes:

1. Capitalized terms not defined in this report are defined in the Code of Ethics of SLR Capital (the “Code”).

2. You must cause each broker-dealer that maintains an account over which you have influence or control and holds Securities in which you have a Beneficial Ownership Interest to provide to the Chief Compliance Officer, on a timely basis, duplicate copies of confirmations of all transactions in the account and duplicate statements for the account and you must report to the Chief Compliance Officer, within 30 days of the end of each calendar quarter, all transactions effected without the use of a registered broker-dealer in Securities, other than transactions in Non-Reportable Securities.

The undersigned has requested that you receive duplicate statements and confirmations on his or her behalf from the following brokers:

 

Name    Broker    Account Number    Date    Date Account Opened
           

 

  

 

  

 

  

 

  

 

           

 

  

 

  

 

  

 

  

 

           

 

  

 

  

 

  

 

  

 

The following are Securities transactions that have not been reported and/or executed through a broker-dealer, i.e. during the previous calendar quarter.

 

Date    Buy/Sell    Security Name    Amount    Price    Broker/Issuer
              

 

  

 

  

 

  

 

  

 

  

 

              

 

  

 

  

 

  

 

  

 

  

 

              

 

  

 

  

 

  

 

  

 

  

 

By signing this document, I am certifying that I have caused duplicate confirmations and duplicate statements to be sent to the Chief Compliance Officer of SLR Capital for every brokerage account that trades in Securities.

 

           
 

Date:

     

Signature

 

1.

Transactions required to be reported. You should report every transaction in which you acquired or disposed of any Security in which you had a Pecuniary Interest during the calendar quarter. The term “Beneficial Ownership Interest” is the subject of a long history of opinions and releases issued by the Securities and Exchange Commission and generally means that you would receive the pecuniary benefits of owning a Security. The term includes, but is not limited to the following cases and any other examples in the Code:

 

III-1


Appendix III

 

  (A)

Where the Security is held for your benefit by others, such as brokers, custodians, banks and pledgees;

 

  (B)

Where the Security is held for the benefit of members of your Immediate Family sharing the same household;

 

  (C)

Where Securities are held by a corporation, partnership, limited liability company, investment club or other entity in which you have an equity interest if you are a controlling equity holder, or you have or share investment control over the Securities held by the entity;

 

  (D)

Where Securities are held in a trust for which you are a trustee and under which either you or any member of your Immediate Family have a vested interest in the principal or income; and

 

  (E)

Where Securities are held in a trust for which you are the settlor, unless the consent of all of the beneficiaries is required in order for you to revoke the trust.

Notwithstanding the foregoing, the following transactions are not required to be reported:

 

  (A)

Transactions in Securities which are direct obligations of the United States;

 

  (B)

Transactions effected in any account over which you have no direct or indirect influence or control; or

 

  (C)

Shares of registered open-end investment companies.

 

2.

Security Name. State the name of the issuer and the class of the Security, e.g., common stock, preferred stock or designated issue of debt securities, including the interest rate, principal amount and maturity date, if applicable. In the case of the acquisition or disposition of a futures contract, put, call option or other right, referred to as “options,” state the title of the Security subject to the option and the expiration date of the option.

 

3.

Futures Transactions. Please remember that duplicates of all Confirmations, Purchase and Sale Reports, and month-end Statements must be sent to Adviser by your broker. Please double check to be sure this occurs if you report a future transaction.

 

4.

Transaction Date. In the case of a market transaction, state the trade date, not the settlement date.

 

5.

Nature of Transaction (Buy or Sale). State the character of the transaction, e.g., purchase or sale of Security, purchase or sale of option, or exercise of option.

 

6.

Amount of Security Involved (No. of Shares). State the number of shares of stock, the face amount of debt Securities or other units of other Securities. For options, state the amount of Securities subject to the option. If your ownership interest was through a spouse, relative or other natural person or through a partnership, trust, other entity, state the entire amount of Securities involved in the transaction. In such cases, you may also indicate, if you wish, the extent of your interest in the transaction.

 

III-2


Appendix III

 

 

7.

Purchase or Sale Price. State the purchase or sale price per share or other unit, exclusive of brokerage commissions or other costs of execution. In the case of an option, state the price at which it is currently exercisable. No price need be reported for transactions not involving cash.

 

8.

Broker, Dealer or Bank Effecting Transaction. State the name of the broker, dealer or bank with or through whom the transaction was effected.

 

9.

Signature. Sign the form in the space provided.

 

10.

Filing of Report. This report should be filed NO LATER THAN 30 CALENDAR DAYS following the end of each calendar quarter.

 

III-3


Appendix IV

SLR CAPITAL

PERSONAL TRADING ACCOUNT

LETTER OF DIRECTION

To Whom This May Concern:

I,                                                       (print name), currently maintain an investment account with your institution, and hereby request that duplicate trade confirmations and monthly account statements be disseminated to my employer, SLR Capital, at the following address:

Attn: Chief Compliance Officer

SLR Capital

500 Park Avenue, 3rd Floor

New York, NY 10022

If you should have any questions, please do not hesitate to contact me. Thank you for your cooperation.

 

Sincerely,
NAME:    
DATE:    
PHONE:    

 

IV-1


Appendix V

SLR CAPITAL

RELATED TRADING ACCOUNT

LETTER OF DIRECTION

To Whom This May Concern:

I,                                                   (print your name), currently maintain an investment account with your institution. Due to my relationship with                                                               (print employee’s name), who is an employee of SLR Capital, I hereby request that duplicate trade confirmations and monthly account statements be disseminated to the following address:

Attn: Chief Compliance Officer

SLR Capital

500 Park Avenue, 3rd Floor

New York, NY 10022

If you should have any questions, please do not hesitate to contact me. Thank you for your cooperation.

 

Sincerely,
NAME:    
DATE:    
PHONE:    

 

V-1


Appendix VI

SLR CAPITAL

INITIAL REPORT OF PRIVATE INVESTMENTS

In accordance with SLR Capital policies and procedures, please indicate whether you maintain private investments over which you have influence or control and in which any private investments are held in which you have a Beneficial Ownership Interest.1 The term private investment is typically defined as an intangible investment and is very broadly construed by SLR Capital. Examples of private investments may include equity in a business or company, a loan to a business or company, an investment in a hedge fund or limited partnership, or securities held in your home or in a safe deposit box. Examples of investments that generally are not considered private investments are your primary residence, vacation home, automobiles, artwork, jewelry, antiques, stamps, and coins.

I do maintain private investments.

I do not maintain private investments.

If you indicated above that you do maintain private investments, please provide the information in the following table (use additional paper if necessary):

 

Description of Private Investment

 

Value of Private

Investment

 

Approximate

Acquisition Date

  

Does the private investment
involve a company that has
publicly traded debt or equity?
(Yes/No)

I certify that this form and any attachments are accurate and complete and constitute all of my private investments.

 

   
 

Signature

 

 

1 

You will be considered to have a “Beneficial Ownership Interest” in an investment if: (i) you have a Pecuniary Interest in the investment; (ii) you have voting power with respect to the investment, meaning the power to vote or direct the voting of the investment; or (iii) you have the power to dispose, or direct the disposition of, the investment. You will be considered to have a “Pecuniary Interest” in an investment if you, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, have the opportunity, directly or indirectly, to profit or share in any profit derived from a transaction in the investment. The term “Pecuniary Interest” is construed very broadly. The following examples illustrate this principle: (i) ordinarily, you will be deemed to have a “Pecuniary Interest” in all investments owned by members of your Immediate Family who share the same household with you; (ii) if you are a general partner of a general or limited partnership, you will be deemed to have a “Pecuniary Interest” in all investments held by the partnership; (iii) if you are a shareholder of a corporation or similar business entity, you will be deemed to have a “Pecuniary Interest” in all investments held by the corporation if you are a controlling shareholder or have or share investment control over the corporation’s investment portfolio; (iv) if you have the right to acquire equity security through the exercise or conversion of a derivative investment, you will be deemed to have a Pecuniary Interest in the investment, whether or not your right is presently exercisable; (v) if you are the sole member or a manager of a limited liability company, you will be deemed to have a Pecuniary Interest in the investments held by the limited liability company; and (vi) ordinarily, if you are a trustee or beneficiary of a trust, where either you or members of your Immediate Family have a vested interest in the principal or income of the trust, you will be deemed to have a Pecuniary Interest in all investments held by that trust.

 

VI-1


Appendix V

 

           
  Date       Print Name

 

VI-2


Appendix VII

INSIDER TRADING POLICIES AND PROCEDURES

 

I.

BACKGROUND

All personal securities trades are subject to these Insider Trading Policies and Procedures. However, compliance with the trading restrictions imposed by these procedures by no means assures full compliance with the prohibition on trading while in the possession of inside information, as defined in these procedures.

Insider trading — trading Securities while in possession of material, nonpublic information or improperly communicating such information to others — may expose a person to stringent penalties. Criminal sanctions may include a fine of up to $1,000,000 and/or ten years’ imprisonment. The Commission may recover the profits gained, or losses avoided, through insider trading, obtain a penalty of up to three times the illicit gain or avoided loss, and/or issue an order permanently barring any person engaging in insider trading from the securities industry. In addition, investors may sue seeking to recover damages for insider trading violations.

These Insider Trading Policies and Procedures are drafted broadly and will be applied and interpreted in a similar manner. Regardless of whether a federal inquiry occurs, SLR Capital views seriously any violation of these Insider Trading Policies and Procedures. Any violation constitutes grounds for disciplinary sanctions, including dismissal and/or referral to civil or governmental authorities for possible civil or criminal prosecution.

The law of insider trading is complex; a Supervised Person legitimately may be uncertain about the application of these Insider Trading Policies and Procedures in a particular circumstance. A question could forestall disciplinary action or complex legal problems. Supervised Persons should direct any questions relating to these Insider Trading Policies and Procedures to a Compliance Officer. A Supervised Person must also notify a Compliance Officer immediately if he or she knows or has reason to believe that a violation of these Insider Trading Policies and Procedures has occurred or is about to occur.

Any capitalized terms used but not defined in the Insider Trading Policies and Procedures shall have their respective meanings as defined in the Code of Ethics of SLR Capital.

 

II.

STATEMENT OF FIRM POLICY

A. At all times, the interests of SLR Capital’s Clients must prevail over the individual’s interest.

B. Buying or selling Securities in the public markets on the basis of material, nonpublic information is prohibited. Similarly, buying and selling securities in a private transaction on the basis of material, nonpublic information is prohibited, except in the limited circumstance in which the information is obtained in connection with a private transaction with an issuer of securities, in which case the private transaction itself is permitted. A prohibited transaction would include purchasing or selling (i) for a Supervised Person’s own account or one in which the Supervised Person has direct or indirect influence or control, (ii) for a Client’s account, or (iii) for Adviser’s inventory account. If any Supervised Person is uncertain as to whether information is “material” or “nonpublic,” he or she should consult the Chief Compliance Officer.

E. Disclosing material, nonpublic information to inappropriate personnel, whether or not for consideration, i.e., “tipping,” is prohibited. Material, nonpublic information must be disseminated on a “need to know basis” only to appropriate personnel. This would include any confidential discussions between the issuer and personnel of Adviser. The Chief Compliance Officer should be consulted should a question arise as to who is privy to material, nonpublic information.

 

VII-1


Appendix VII

 

F. Assisting anyone transacting business on the basis of material, nonpublic information through a third party is prohibited.

G. In view of the Gabelli & Co./GAMCO Investments, Inc. SEC proceeding, it is clear that when a portfolio manager is in a position, due to his official duties at an issuer, to have access to inside information on a relatively continuous basis, self-reporting procedures are not adequate to detect and prevent insider trading. Accordingly, neither Adviser nor an Adviser employee may trade in any securities issued by any company of which any Adviser employee is an employee or insider. All Supervised Persons must report to the Chief Compliance Officer or designee any affiliation or business relationship they may have with any issuer (a form of which is attached as Appendix A hereto.)

H. Supervised Persons should understand that if SLR Capital becomes aware of material, nonpublic information about the issuer of the underlying securities, even if the particular Supervised Person in question does not himself or herself have such knowledge, or enters into certain transactions for clients, SLR Capital will not bear any losses resulting in personal accounts through the implementation of these Insider Trading Policies and Procedures.

I. It is the Company’s policy that Supervised Persons may purchase or sell Company securities only during the “window period” that generally begins on the second business day after the Company publicly releases quarterly or annual financial results and extends until the 15th day of the last calendar month of the quarter in which the results are announced (or such shorter or longer time that may be designated by the Chief Executive Officer of the BDC (“CEO”) or the Chief Operating Officer of the BDC (“COO”) and the CCO). However, the ability of a Supervised Person to engage in transactions in Company securities during window periods is not automatic or absolute. Circumstances may prevent or delay or accelerate the opening of the window period or cause the window period to be shortened or lengthened. Further, no trades may be made even during a window period by an individual who possesses material, nonpublic information, other than in accordance with a previously approved Trading Plan.

Notwithstanding the foregoing, Supervised Persons may also purchase or sell Company securities pursuant to a Trading Plan. As used herein, the term “Trading Plan” shall mean a prearranged trading plan adopted in accordance with and meeting all of the requirements of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended, that has been approved by the Company’s Chief Compliance Officer. A Trading Plan may only be entered into, modified or terminated (i) prior to expiration by Supervised Persons at a time they would otherwise be permitted to purchase or sell Company securities, and (ii) with the prior approval of the Company’s Chief Compliance Officer. Each Supervised Person shall be responsible for ensuring compliance with the requirements of Rule 10b5-1(c) with respect to any Trading Plan they may enter into, modify or terminate prior to expiration, notwithstanding the prior approval thereof by the Company’s Chief Compliance Officer.

In addition, the Adviser may, subject to regulatory restrictions, award Restricted Stock Units (“RSUs”) representing discretionary bonuses as part of an employee deferred compensation plan (the “award”) during a closed window period provided that (1) the Adviser, the CEO and the COO are not in possession of material non-public information (“MNPI”); (2) the award does not require a purchase of Company securities on the open market but instead represents a transfer or potential transfer of Company securities then held by the Adviser; and (3) the CCO approves the award in advance. To the extent an award represents non-discretionary compensation, the RSUs may only be awarded in open window periods at a time when the Adviser, the CEO and the COO are not in possession of MNPI.

 

VII-2


Appendix VII

 

H. The following reviews principles important to these Insider Trading Policies and Procedures:

1. What is “Material” Information?

Information is “material” when there is a substantial likelihood that a reasonable investor would consider it important in making his or her investment decisions. Generally, information is material if its disclosure will have a substantial effect on the price of a company’s Securities. No simple “bright line” test exists to determine whether information is material; assessments of materiality involve highly fact-specific inquiries. However, if the information you have received is or could be a factor in your trading decision, you must assume that the information is material. Supervised Persons should direct any questions regarding the materiality of information to the Chief Compliance Officer or designee.

Material information often relates to a company’s results and operations, including, for example, dividend changes, earnings results, changes in previously released earnings estimates, significant merger or acquisition proposals or agreements, major litigation, liquidation problems, and extraordinary management developments. Material information may also relate to the market for a Security. Information about a significant order to purchase or sell Securities, in some contexts, may be deemed material; similarly, prepublication information regarding reports in the financial press may also be deemed material.

2. What is “Nonpublic” Information?

Information is “nonpublic” until it has been disseminated broadly to investors in the marketplace. Tangible evidence of this dissemination is the best indication that the information is public. For example, information is public after it has become available to the general public through a public filing with the Commission or some other government agency, or available to the Dow Jones “tape” or The Wall Street Journal or some other general circulation publication, and after sufficient time has passed so that the information has been disseminated widely. If you believe that you have information concerning an issuer which gives you an advantage over other investors, the information is, in all likelihood, non-public.

3. Identifying Inside Information.

Before executing any trade for oneself or others, including Clients, a Supervised Person must determine whether he or she has access to material, nonpublic information. If a Supervised Person believes he or she might have access to material, nonpublic information, he or she should:

a. Immediately alert the Chief Compliance Officer or designee, so that the applicable Security is placed on the Restricted List.

b. Not purchase or sell the Securities on his or her behalf or for others, including Clients (except in the limited circumstance in which the information is obtained in connection with a private transaction with an issuer of securities, in which case the private transaction itself is permitted).

c. Not communicate the information inside or outside of Adviser, other than to the Chief Compliance Officer or designee (or, in the limited circumstance of a private transaction with an issuer of securities, to Supervised Persons within Adviser involved in the transaction with a need to know the information).

The Chief Compliance Officer will review the issue, determine whether the information is material and nonpublic, and, if so, what action Adviser should take.

 

VII-3


Appendix VII

 

4. Contacts With Public Companies.

Contacts with public companies may represent part of Adviser’s research efforts and Adviser may make investment decisions on the basis of its conclusions formed through these contacts and analysis of publicly available information. Difficult legal issues may arise, however, when a Supervised Person, in the course of these contacts, becomes aware of material, nonpublic information. For example, a company’s Chief Financial Officer could prematurely disclose quarterly results, or an investor relations representative could make a selective disclosure of adverse news to certain investors. In these situations, Adviser must make a judgment about its further conduct. To protect oneself, Clients, and Adviser, a Supervised Person should immediately contact the Chief Compliance Officer if he or she believes he or she may have received material, nonpublic information.

5. Tender Offers.

Tender offers represent a particular concern in the law of insider trading for two reasons. First, tender offer activity often produces extraordinary movement in the price of the target company’s securities. Trading during this time is more likely to attract regulatory attention, and produces a disproportionate percentage of insider trading cases. Second, the Commission has adopted a rule expressly forbidding trading and “tipping” while in possession of material, nonpublic information regarding a tender offer received from the company making the tender offer, the target company, or anyone acting on behalf of either. Supervised Persons must exercise particular caution any time they become aware of nonpublic information relating to a tender offer.

 

III.

INSIDER TRADING PROCEDURES APPLICABLE TO ALL SUPERVISED PERSONS

The following procedures have been established to aid Supervised Persons in avoiding insider trading, and to aid Adviser in preventing, detecting and imposing sanctions against insider trading. Every Supervised Person must follow these procedures or risk serious sanctions, including dismissal, substantial personal liability and criminal penalties. If a Supervised Person has any questions about these procedures, he or she should consult the Chief Compliance Officer or designee.

A. Responsibilities of Supervised Persons.

All Supervised Persons must make a diligent effort to ensure that a violation of these Insider Trading Policies and Procedures does not either intentionally or inadvertently occur. In this regard, all Supervised Persons (other than Disinterested Directors) are responsible for:

(a) Reading, understanding and consenting to comply with these Insider Trading Policies and Procedures. Supervised Persons will be required to sign an acknowledgment that they have read and understood the Compliance Manual and therefore their responsibilities under the Code;

(b) Ensuring that no trading occurs for their account, for any account over which they have direct or indirect influence or control or for any Client’s account in Securities included on the Restricted List, or as to which they possess material, nonpublic information, regardless of the Securities being included on the Restricted List (except in the limited circumstance in which the information is obtained in connection with a private transaction with an issuer of securities, in which case the private transaction itself is permitted);

(c) Not disclosing inside information obtained from any source whatsoever to inappropriate persons. Disclosure to family, friends or acquaintances will be grounds for immediate termination and/or referral to civil or governmental authorities for possible civil or criminal prosecution;

 

VII-4


Appendix VII

 

(d) Consulting the Chief Compliance Officer or designee when questions arise regarding insider trading or when potential violations of these Insider Trading Policies and Procedures are suspected;

(e) Ensuring that Adviser receives copies of confirmations and statements from both internal and external brokerage firms for accounts of Supervised Persons and members of the Immediate Family of such Supervised Persons sharing the same household;

(f) Advising the Chief Compliance Officer or designee of all outside business activities, directorships, or ownership of over 5% of the shares of a public company. No Supervised Person may engage in any outside business activities as employee, proprietor, partner, consultant, trustee officer or director without prior written consent of the Chief Compliance Officer, or a designee of the Chief Compliance Officer (a form of which is attached as Appendix A hereto); and

(g) Being aware of, and monitoring, any Clients who are shareholders, directors, and/or senior officers of public companies. Any unusual activity including a purchase or sale of restricted stock must be brought to the attention of the Chief Compliance Officer or designee.

B. Security.

In order to prevent accidental dissemination of material, nonpublic information, personnel must adhere to the following guidelines:

Inform management when unauthorized personnel enter the premises. Lock doors at all times in areas that have confidential and secure files. Refrain from discussing sensitive information in public areas.

Refrain from leaving confidential information on message devices. Maintain control of sensitive documents, including handouts and copies, intended for internal dissemination only.

Ensure that faxes and e-mail messages containing sensitive information are properly sent, and confirm that the recipient has received the intended message.

Do not allow passwords to be given to unauthorized personnel.

 

IV.

SUPERVISORY PROCEDURES

Supervisory procedures can be divided into two classifications — prevention of insider trading and detection of insider trading.

A. Prevention of Insider Trading

To prevent insider trading, the Chief Compliance Officer or designee should:

1. Maintain a Restricted List which includes the name of any company, whether or not a client of Adviser, as to which one or more individuals at Adviser has a fiduciary relationship or may have material information which has not been publicly disclosed. The Restricted List is maintained by the Chief Compliance Officer and his or her designees. The Chief Compliance Officer or such other Compliance Officer as may be designated shall be responsible for: (i) determining whether any particular securities should be included on the Restricted List; (ii) determining when Securities should be removed from the Restricted List; and (iii) ensuring that Securities are timely added to and removed from the Restricted List, as appropriate, no less frequently than on a quarterly basis.

 

VII-5


Appendix VII

 

2. Answer questions regarding SLR Capital’s policies and procedures;

3. Resolve issues of whether information received by an officer, director or employee of SLR Capital constitutes Inside Information and determine what action, if any, should be taken;

4. Review these Insider Trading Policies and Procedures on a regular basis and update them as necessary;

5. When it has been determined that a Supervised Person has Inside Information:

 

  (a)

Implement measures to prevent dissemination of such information other than to appropriate Supervised Persons on a “need to know” basis, and

 

  (b)

Not permit any SLR Capital employee to execute any transaction in any securities of the issuer in question (except in the limited circumstance in which the information is obtained in connection with a private transaction with an issuer of securities, in which case the private transaction itself is permitted);

 

  1.

Implement a program of periodic “reminder” notices regarding insider trading;

 

  2.

Confirm with each trader no less frequently than quarterly whether there are any issuers for whom Adviser has Inside Information; and

 

  3.

Compile and maintain the Restricted List of securities in which no Supervised Person may trade because Adviser as an entity is deemed to have Inside Information concerning the issuers of such securities and determine when to remove securities from the Restricted List.

B. Detection of Insider Trading

To detect insider trading, the Chief Compliance Officer or designee should:

1. Review daily confirmations and quarterly trading activity reports filed by Supervised Persons; and

2. Promptly investigate all reports of any possible violations of these Insider Trading Policies and Procedures.

C. Special Reports to Management

Promptly upon learning of a potential violation of SLR Capital’s Insider Trading Policies and Procedures, the Chief Compliance Officer or designee shall prepare a written report to management providing full details, which may include (1) the name of particular securities involved, if any, (2) the date(s) SLR Capital learned of the potential violation and began investigating; (3) the accounts and individuals involved; (4) actions taken as a result of the investigation, if any; and (5) recommendations for further action.

D. General Reports to Management

At least yearly, the Chief Compliance Officer will prepare a written report to the management of Adviser setting forth some or all of the following:

 

VII-6


Appendix VII

 

 

  1.

A summary of existing procedures to detect and prevent insider trading;

 

  2.

A summary of changes in procedures made in the last year;

 

  3.

Full details of any investigation, whether internal or by a regulatory agency, since the last report r regarding any suspected insider trading, the results of the investigation and a description of any changes in procedures promptly by any such investigation; and

 

  4.

An evaluation of the current procedures and a description of anticipated changes in procedures.

 

VII-7


Appendix VII

 

SLR CAPITAL

INITIAL REPORT OF OUTSIDE BUSINESS ACTIVITIES

In accordance with SLR Capital policies and procedures, please indicate whether you engage in any outside business activities. Outside business activities include, but are not limited to, serving as owner, partner, trustee, officer, director, finder, referrer, or employee of another business organization for compensation, or any activity for compensation outside my usual responsibilities at SLR Capital.5

I do engage in outside business activities

I do not engage in any outside business activities

If you indicated above that you do engage in outside business activities, please complete the following table (use additional paper if necessary):

 

Name of Business

Entity

 

Summary of

Outside Business

Activity

 

Summary of

Compensation

  

Is the Business

Entity Related to a

Publicly Traded Company?

(Yes/No)

I certify that this form and any attachments are accurate and complete and constitute all of my outside business activities.

 

         
       

Signature

           
 

Date

     

Print Name

 

 

5 

Compensation includes salaries, director’s fees, referral fees, stock options, finder’s fees, and anything of present or future value.

 

VII-8

EX-21.1 3 d437884dex211.htm EX-21.1 EX-21.1

Exhibit 21.1

Subsidiaries of SLR Investment Corp.

The following list sets forth our consolidated subsidiaries, the state or country under whose laws the subsidiaries are organized, and the percentage of voting securities or membership interests owned by us in each such subsidiary:

NEFCORP LLC (Delaware) – 100%

NEFPASS LLC (Delaware) – 100%

ESP SSC Corporation (Delaware) – 100%

SUNS SPV LLC (Delaware) – 100%

The subsidiaries listed above are consolidated for financial reporting purposes. We may also be deemed to control certain portfolio companies.

EX-23.1 4 d437884dex231.htm EX-23.1 EX-23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the registration statement on Form N-2 of SLR Investment Corp. of our report dated February 28, 2023, with respect to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in the annual report on Form 10-K of SLR Investment Corp. for the year ended December 31, 2022, and to the use of our report dated February 28, 2023 on the senior securities table included herein as an exhibit to the Form 10-K. We also consent to the reference to our firm under the heading “Controls and Procedures” in the Form 10-K.

/s/ KPMG LLP

New York, New York

February 28, 2023

EX-23.2 5 d437884dex232.htm EX-23.2 EX-23.2

Exhibit 23.2

CONSENT OF INDEPENDENT AUDITOR

SLR Investment Corp.

New York, New York

We consent to the incorporation by reference in the Registration Statement (No. 333-255662) on Form N-2 of SLR Investment Corp. of our report dated February 15, 2023, relating to the consolidated financial statements of KBH Topco, LLC, appearing in this Annual Report on Form 10-K of SLR Investment Corp. dated February 28, 2023.

/s/ FGMK, LLC

Bannockburn, Illinois

February 28, 2023

EX-23.3 6 d437884dex233.htm EX-23.3 EX-23.3

Exhibit 23.3

Consent of Independent Auditor

We hereby consent to the incorporation by reference of our report dated February 16, 2023 on the consolidated financial statements of NEF Holdings, LLC and Subsidiaries, which report appears in the annual report on Form 10-K of SLR Investment Corp. dated February 28, 2023, in the Registration Statement on Form N-2 (No. 333-255662) of SLR Investment Corp.

/s/ Baker Tilly US, LLP

Philadelphia, Pennsylvania

February 28, 2023

EX-23.4 7 d437884dex234.htm EX-23.4 EX-23.4

Exhibit 23.4

Consent of Independent Auditor

We hereby consent to the incorporation by reference of our report dated February 15, 2023 on the consolidated financial statements of Crystal Financial LLC, which report appears in the annual report on Form 10-K of SLR Investment Corp. dated February 28, 2023, in the Registration Statement on Form N-2 (No. 333-255662) of SLR Investment Corp.

/s/ Baker Tilly US, LLP

Philadelphia, Pennsylvania

February 28, 2023

EX-23.5 8 d437884dex235.htm EX-23.5 EX-23.5

Exhibit 23.5

Consent of Independent Auditor

We hereby consent to the incorporation by reference of our report dated February 16, 2023 on the consolidated financial statements of Gemino Healthcare Finance, LLC, which report appears in the annual report on Form 10-K of SLR Investment Corp. dated February 28, 2023, in the Registration Statement on Form N-2 (No. 333-255662) of SLR Investment Corp.

/s/ Baker Tilly US, LLP

Philadelphia, Pennsylvania

February 28, 2023

EX-23.6 9 d437884dex236.htm EX-23.6 EX-23.6

Exhibit 23.6

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statement (No. 333-255662) on Form N-2 of SLR Investment Corp. of our report dated February 21, 2023, relating to the consolidated financial statements of North Mill Holdco LLC and Subsidiaries, appearing in this Annual Report on Form 10-K of SLR Investment Corp. for the year ended December 31, 2022.

/s/ RSM US LLP

Philadelphia, Pennsylvania

February 28, 2023

EX-31.1 10 d437884dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

Certification Pursuant to Section 302

Certification of Co-Chief Executive Officer

I, Michael S. Gross, Co-Chief Executive Officer of SLR Investment Corp., certify that:

1. I have reviewed this annual report on Form 10-K of SLR Investment Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated this 28th day of February 2023.

 

By:  

/S/ MICHAEL S. GROSS

 

Michael S. Gross

Co-Chief Executive Officer

 

EX-31.2 11 d437884dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

Certification Pursuant to Section 302

Certification of Co-Chief Executive Officer

I, Bruce J. Spohler, Co-Chief Executive Officer of SLR Investment Corp., certify that:

1. I have reviewed this annual report on Form 10-K of SLR Investment Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated this 28th day of February 2023.

 

By:  

/S/ BRUCE J. SPOHLER

 

Bruce J. Spohler

Co-Chief Executive Officer

 

EX-31.3 12 d437884dex313.htm EX-31.3 EX-31.3

Exhibit 31.3

Certification Pursuant to Section 302

Certification of Chief Financial Officer

I, Richard L. Peteka, Chief Financial Officer of SLR Investment Corp., certify that:

1. I have reviewed this annual report on Form 10-K of SLR Investment Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated this 28th day of February 2023.

 

By:  

/s/ RICHARD L. PETEKA

 

Richard L. Peteka

Chief Financial Officer

 

EX-32.1 13 d437884dex321.htm EX-32.1 EX-32.1

Exhibit 32.1

Certification of Co-Chief Executive Officer

Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)

In connection with the Annual Report on Form 10-K for the year ended December 31, 2022 (the “Report”) of SLR Investment Corp. (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, I, Michael S. Gross, the Co-Chief Executive Officer of the Registrant, hereby certify, to the best of my knowledge, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

 

/S/ MICHAEL S. GROSS

Name:   Michael S. Gross
Date:   February 28, 2023

 

EX-32.2 14 d437884dex322.htm EX-32.2 EX-32.2

Exhibit 32.2

Certification of Co-Chief Executive Officer

Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)

In connection with the Annual Report on Form 10-K for the year ended December 31, 2022 (the “Report”) of SLR Investment Corp. (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, I, Bruce J. Spohler, the Co-Chief Executive Officer of the Registrant, hereby certify, to the best of my knowledge, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

 

/S/ BRUCE J. SPOHLER

Name:   Bruce J. Spohler
Date:   February 28, 2023

 

EX-32.3 15 d437884dex323.htm EX-32.3 EX-32.3

Exhibit 32.3

Certification of Chief Financial Officer

Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)

In connection with the Annual Report on Form 10-K for the year ended December 31, 2022 (the “Report”) of SLR Investment Corp. (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, I, Richard L. Peteka, the Chief Financial Officer of the Registrant, hereby certify, to the best of my knowledge, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

 

/S/ RICHARD L. PETEKA

Name:   Richard L. Peteka
Date:   February 28, 2023
EX-99.1 16 d437884dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

Crystal Financial LLC

dba SLR Credit Solutions

(A Delaware Limited Liability Company)

Consolidated Financial Statements

Years Ended December 31, 2022 and 2021


Crystal Financial LLC dba SLR Credit Solutions

Index

Years Ended December 31, 2022 and 2021

 

 

     Page(s)  

Independent Auditors’ Report

     1-2  

Consolidated Financial Statements

  

Consolidated Balance Sheets

     3  

Consolidated Statements of Operations

     4  

Consolidated Statements of Changes in Member’s Equity

     5  

Consolidated Statements of Cash Flows

     6  

Notes to Consolidated Financial Statements

     7–18  


Independent Auditors’ Report

To the Board of Managers and Member of

Crystal Financial LLC

Opinion

We have audited the consolidated financial statements of Crystal Financial LLC (the Company), which comprise the consolidated balance sheets as of December 31, 2022 and 2021, and the related consolidated statements of operations, changes in member’s equity and cash flows for the years then ended, and the related notes to the consolidated financial statements.

In our opinion, the accompanying consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021 and the results of their operations and their cash flows for the years then ended in accordance with accounting principles generally accepted in the United States of America (GAAP).

Basis for Opinion

We conducted our audits in accordance with auditing standards generally accepted in the United States of America (GAAS). Our responsibilities under those standards are further described in the Auditors’ Responsibilities for the Audit of the Consolidated Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements relating to our audits. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

Responsibilities of Management for the Consolidated Financial Statements

Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with GAAP, and for the design, implementation and maintenance of internal control relevant to the preparation and fair presentation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the consolidated financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the financial statements are available to be issued.

Auditors’ Responsibilities for the Audit of the Consolidated Financial Statements

Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors’ report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the consolidated financial statements.

 

1


In performing an audit in accordance with GAAS, we:

 

   

Exercise professional judgment and maintain professional skepticism throughout the audit.

 

   

Identify and assess the risks of material misstatement of the consolidated financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements.

 

   

Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control. Accordingly, no such opinion is expressed.

 

   

Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the consolidated financial statements.

 

   

Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for a reasonable period of time.

We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control-related matters that we identified during the audit.

 

LOGO

Philadelphia, Pennsylvania

February 15, 2023

 

2


Crystal Financial LLC dba SLR Credit Solutions

Consolidated Balance Sheets

Years Ended December 31, 2022 and 2021

 

 

     2022     2021  

Assets:

    

Cash and cash equivalents

   $ 1,455,691     $ 40,450,947  

Restricted cash

     20,631,283       14,452,587  

Loan interest and fees receivable

     5,935,984       3,132,347  

Loans

     439,484,085       287,375,244  

Less: Unearned fee income

     (7,117,828     (5,451,202

Allowance for loan losses

     (9,130,536     (7,831,942
  

 

 

   

 

 

 

Total loans, net

     423,235,721       274,092,100  

Property and equipment, net

     16,022       14,908  

Goodwill

     5,156,542       5,156,542  

Investment in Crystal Financial SBIC LP

     2,575,336       8,341,297  

Other assets

     1,676,876       2,180,185  
  

 

 

   

 

 

 

Total assets

   $ 460,683,455     $ 347,820,913  
  

 

 

   

 

 

 

Liabilities:

    

Revolving credit facility, net

   $ 222,093,034     $ 99,251,811  

Accrued expenses

     3,660,447       5,657,835  

Distributions payable

     5,000,000       5,500,000  

Other liabilities

     3,469,397       1,297,639  

Collateral held for borrower obligations

     17,193,751       13,867,551  
  

 

 

   

 

 

 

Total liabilities

     251,416,629       125,574,836  
  

 

 

   

 

 

 

Commitments and Contingencies (Note 8)

    

Member’s equity:

    

Class A units

     279,191,400       279,191,400  

Accumulated deficit

     (69,924,574     (56,945,323
  

 

 

   

 

 

 

Total member’s equity

     209,266,826       222,246,077  
  

 

 

   

 

 

 

Total liabilities and member’s equity

   $ 460,683,455     $ 347,820,913  
  

 

 

   

 

 

 

 

3


Crystal Financial LLC dba SLR Credit Solutions

Consolidated Statements of Operations

Years Ended December 31, 2022 and 2021

 

 

     2022     2021  

Net interest income:

    

Interest income

   $ 35,062,888     $ 35,423,572  

Interest expense

     8,873,508       6,848,728  
  

 

 

   

 

 

 

Net interest income

     26,189,380       28,574,844  

Provision for loan losses

     4,923,481       (461,083
  

 

 

   

 

 

 

Net interest income after provision for loan losses

     21,265,899       29,035,927  
  

 

 

   

 

 

 

Operating expenses:

    

Compensation and benefits

     6,551,451       8,220,438  

Depreciation and amortization

     12,808       3,720,210  

General and administrative expenses

     1,820,712       1,468,948  
  

 

 

   

 

 

 

Total operating expenses

     8,384,971       13,409,596  
  

 

 

   

 

 

 

Other income (loss):

    

(Loss) gain from equity method investment

     (4,738,951     (1,430,559

Realized (loss) gain on investment in equity securities

     (620,223     —    
  

 

 

   

 

 

 

Total other income (loss), net

     (5,359,174     (1,430,559
  

 

 

   

 

 

 

Realized (loss) gain from foreign currency transactions, net

     (121,552     (352,340

Unrealized (loss) gain from foreign currency translations, net

     120,547       321,038  
  

 

 

   

 

 

 

Net income

   $ 7,520,749     $ 14,164,470  
  

 

 

   

 

 

 

 

4


Crystal Financial LLC dba SLR Credit Solutions

Consolidated Statements of Changes in Member’s Equity

Years Ended December 31, 2022 and 2021

 

 

     Class A Units      Accumulated Deficit     Total Member’s Equity  

Balance, December 31, 2020

   $ 279,191,400      $ (48,609,793   $ 230,581,607  

Distributions

     —          (22,500,000     (22,500,000

Net income

     —          14,164,470       14,164,470  
  

 

 

    

 

 

   

 

 

 

Balance, December 31, 2021

     279,191,400        (56,945,323     222,246,077  

Distributions

     —          (20,500,000     (20,500,000

Net income

     —          7,520,749       7,520,749  
  

 

 

    

 

 

   

 

 

 

Balance, December 31, 2022

   $ 279,191,400      $ (69,924,574   $ 209,266,826  
  

 

 

    

 

 

   

 

 

 

 

5


Crystal Financial LLC dba SLR Credit Solutions

Consolidated Statements of Cash Flows

Years Ended December 31, 2022 and 2021

 

 

     2022     2021  

Cash flows from operating activities:

    

Net income

   $ 7,520,749     $ 14,164,470  

Adjustments to reconcile net income to net cash provided by operating activities:

    

Provision for loan losses

     4,923,481       (461,083

Accretion of original issue discount

     (369,719     (553,567

Depreciation

     12,808       20,210  

Amortization of debt issuance costs

     1,134,607       878,889  

Amortization of intangible asset—tradename

     —         3,700,000  

Paid-in-kind interest and fee income

     (895,655     (185,729

Loss from equity method investment

     4,738,951       1,430,559  

Unrealized gain on foreign currency transactions

     (122,735     (322,588

Realized loss (gain) on foreign currency transactions

     121,141       (200,267

Write down of amounts classified as other assets

     496,604       527,365  

Net change in loan interest and fees receivable

     (2,227,312     977,606  

Net change in other assets

     731,670       523,202  

Net change in unearned fees

     1,514,751       (1,114,915

Net change in accrued expenses

     (1,997,388     (589,364

Net change in other liabilities

     2,233,179       172,297  
  

 

 

   

 

 

 

Net cash provided by operating activities

     17,815,132       18,967,085  
  

 

 

   

 

 

 

Cash flows from investing activities:

    

Purchases of property and equipment

     (13,922     (9,522

Investment in term loans

     (205,566,011     (127,381,580

Repayment of term loans

     73,952,547       225,910,237  

Lending on revolving lines of credit, net

     (24,676,942     19,159,864  

Distributions received from Crystal Financial SBIC LP

     1,027,010       8,086,431  

Net change in collateral held for borrower obligations

     3,326,200       6,540,852  
  

 

 

   

 

 

 

Net cash (used in) provided by investing activities

     (151,951,118     132,306,282  
  

 

 

   

 

 

 

Cash flows from financing activities:

    

Net borrowings (repayments) on revolving credit facility

     124,200,000       (82,893,390

Distributions to members

     (21,000,000     (23,000,000

Payment of debt issuance costs

     (1,876,134     (1,084,317

Payment of finance lease obligations

     (4,440     (4,315
  

 

 

   

 

 

 

Net cash provided by (used in) financing activities

     101,319,426       (106,982,022
  

 

 

   

 

 

 

Net change in cash, cash equivalents, and restricted cash

     (32,816,560     44,291,345  

Cash, cash equivalents, and restricted cash at beginning of year

     54,903,534       10,612,189  
  

 

 

   

 

 

 

Cash, cash equivalents and restricted cash at end of year

   $ 22,086,974     $ 54,903,534  
  

 

 

   

 

 

 

Supplemental disclosure of cash flow information:

    

Cash paid for interest

   $ 6,744,449     $ 6,136,922  
  

 

 

   

 

 

 

Supplemental disclosure of non-cash investing and financing activities:

    

Right-of-use assets obtained in exchange for new operating lease liabilities

   $ 1,696,309     $ —    
  

 

 

   

 

 

 

 

6


Crystal Financial LLC dba SLR Credit Solutions

Notes to Consolidated Financial Statements

Years Ended December 31, 2022 and 2021

 

 

1.

Organization

Crystal Financial LLC (“Crystal Financial” or the “Company”), along with its wholly owned subsidiary, Crystal Financial SPV LLC (“Crystal Financial SPV”), is a commercial finance company based in Boston, Massachusetts, that primarily originates, underwrites, and manages secured debt to middle market companies within various industries. The Company was formed in the state of Delaware on March 18, 2010. During 2021, the Company executed a dba filing to do business using the name SLR Credit Solutions.

At December 31, 2022 and 2021, SLR Investment Corp. (“SLR”) owns 100% of the outstanding ownership units of the Company.

 

2.

Summary of Significant Accounting Policies

The following is a summary of significant accounting policies adopted by the Company:

Basis of Accounting

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary Crystal Financial SPV. All inter-company investments, accounts and transactions have been eliminated in these consolidated financial statements.

Use of Estimates

The preparation of consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements as well as the reported amounts of revenues and expenses during the reporting period. Estimates most susceptible to change include the allowance for loan losses and the valuation of intangible assets as determined during impairment testing. Actual results could differ materially from those estimates.

Cash, Cash Equivalents, and Restricted Cash

The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Cash includes all deposits held at banks. Deposits in excess of amounts insured by the Federal Deposit Insurance Corporation (“FDIC”) are exposed to loss in the event of nonperformance by the institution. The Company has had cash deposits in excess of the FDIC insurance coverage and has not experienced any losses on such accounts.

Restricted cash consists of interest and fees collected on those loans held within Crystal Financial SPV that serve as collateral against the Company’s outstanding line of credit. Upon receipt, these funds are restricted from the Company’s access until the fifteenth of the following month. Also included in restricted cash may be funds that serve as collateral against loans outstanding to certain borrowers as well as funds that serve as collateral to outstanding letters of credit.

 

7


Crystal Financial LLC dba SLR Credit Solutions

Notes to Consolidated Financial Statements

Years Ended December 31, 2022 and 2021

 

 

2.

Summary of Significant Accounting Policiescontinued

 

Cash, Cash Equivalents, and Restricted Cash…continued

 

In accordance with Statement of Cash Flows (Topic 230), the Company presents the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash in the consolidated statements of cash flows. Accordingly, amounts generally described as restricted cash will be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the consolidated statements of cash flows.

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheet that sum to the total of the same such amounts shown in the consolidated statements of cash flows.

 

     December 31,  
     2022      2021  

Cash and cash equivalents

   $ 1,455,691      $ 40,450,947  

Restricted cash

     20,631,283        14,452,587  
  

 

 

    

 

 

 

Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows

   $ 22,086,974      $ 54,903,534  
  

 

 

    

 

 

 

Loans

The Company typically classifies all loans as held to maturity. Loans funded by the Company are recorded at the amount of unpaid principal, net of unearned fees, discounts and the allowance for loan losses in the Company’s consolidated balance sheets.

Interest income is recorded on the accrual basis in accordance with the terms of the respective loan. Generally, interest is not accrued on loans with interest or principal payments 90 days or greater past due or on other loans when management believes collection is doubtful. Loans considered impaired, as defined below, are non-accruing. When a loan is placed on nonaccrual status, all interest previously accrued, but not collected, is reversed against current interest income and all future proceeds received will generally be applied against principal or interest, in the judgment of management. Interest on loans classified as nonaccrual is accounted for on the cash basis or cost-recovery method, until qualifying for return to accrual status. Loans are generally returned to accrual status when all of the principal and interest amounts contractually due are brought current and future payments are reasonably assured. There was one loan on nonaccrual status at December 31, 2022 and two loans on nonaccrual status at December 31, 2021. The loans on nonaccrual status at December 31, 2022 and December 31, 2021 are the same loans classified as Criticized, as defined by the Company’s Loan Loss Policy, in the Allowance for Loan Losses footnote (see Note 3).

Allowance for Loan Losses

The allowance for loan losses is maintained at the amount estimated to be sufficient to absorb expected losses, net of recoveries, inherent in the loan portfolio at year end. Internal credit ratings assigned to the loans are periodically evaluated and adjusted to reflect the current credit risk of the loan. In accordance with applicable guidance, for loans not deemed to be impaired, management assigns a general loan allowance based on the borrower’s overall risk rating. All loans in the Company’s portfolio are individually evaluated when determining the overall risk rating. The risk ratings are derived upon consideration of a number of factors related to both the borrower and the borrower’s facility, with those factors related to the borrower’s facility being the key determinant of the overall risk rating. Risk factors of the borrower that are considered include asset and earnings quality, historical and projected financial performance, borrowing liquidity and/or access to capital. Risk factors of the facility that are considered

 

8


Crystal Financial LLC dba SLR Credit Solutions

Notes to Consolidated Financial Statements

Years Ended December 31, 2022 and 2021

 

 

2.

Summary of Significant Accounting Policies…continued

 

Allowance for Loan Losses…continued

 

include collateral coverage and the facility’s position within the overall capital structure. Upon consideration of each of the aforementioned factors, among others, the Company assigns each loan a borrower risk rating and a facility risk rating, which are then collectively used in developing the overall risk rating. The overall risk rating corresponds with an applicable reserve percentage which is applied to the face value of the loan in order to determine the Company’s allowance for loan losses. In establishing the applicable reserve percentages, the Company considers various factors including historical industry loss experience, the credit profile of the Company’s borrowers, as well as economic trends and conditions.

Specific allowances for loan losses are generally applied to impaired loans and are typically measured based on a comparison of the recorded carrying value of the loan to the present value of the loan’s expected cash flow using the loan’s effective interest rate, the loan’s estimated market price, or the estimated fair value of the underlying collateral, if the loan is collateral-dependent. Loans are charged off against the allowance at the earlier of either the substantial completion of the liquidation of assets securing the loan, or when senior management deems the loan to be permanently impaired.

A loan is considered impaired when, based on current information and events, it is probable that the Company will be unable to collect all amounts due in accordance with the contractual terms of the loan agreement. All loans are individually evaluated for impairment according to the Company’s normal loan review process, including overall credit evaluation, nonaccrual status and payment experience. Loans identified as impaired are further evaluated to determine the estimated extent of impairment.

Intangible Assets

The Company typically assesses goodwill for impairment at the end of the third quarter using a qualitative assessment.

Historically, the fair value of the tradename was estimated using the relief from royalty method, which is an income approach based on the present value of royalties the Company would theoretically have had to pay to license the tradename from a third party. During 2021, as part of the rebranding strategy to change its name via the dba filing of SLR Credit Solutions, the Company evaluated the tradename’s indefinite-lived position and elected to change the indefinite-lived intangible asset to a finite-lived intangible asset for the period ending December 31, 2021. Accordingly, the carrying value previously ascribed to the tradename was fully amortized as of December 31, 2021. There was no indefinite- lived intangible asset- tradename recorded on the consolidated balance sheet during the year ended December 31, 2022.

Goodwill recognized in business combinations is assigned to the reporting units that are expected to benefit from the combination as of the acquisition date. Goodwill is not amortized; rather goodwill is tested annually for impairment or more frequently upon the occurrence of certain events or substantive changes in circumstances. The Company has elected to perform a qualitative assessment to determine if an impairment is more likely than not to have occurred. If the conclusion is supported that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then the Company would not need to perform a quantitative impairment test. If the conclusion cannot be supported, or if the Company does not elect to do the qualitative assessment, then the Company will perform a quantitative assessment. If a quantitative goodwill impairment assessment is performed, the Company utilizes a combination of market and income valuation approaches. If the fair value of a reporting unit is less than its carrying value, an impairment loss is recorded to the extent that the fair value of the reporting unit is less than its carrying value. No impairment of goodwill resulted from the annual impairment testing in 2022 or 2021.

 

9


Crystal Financial LLC dba SLR Credit Solutions

Notes to Consolidated Financial Statements

Years Ended December 31, 2022 and 2021

 

 

2.

Summary of Significant Accounting Policies…continued

 

Debt Issuance Costs

Debt issuance costs represent fees and other direct incremental costs incurred in connection with the Company’s borrowings against its revolving credit facility (see Note 5). These amounts are amortized using the straight-line method into earnings as interest expense ratably over the contractual term of the facility. Net unamortized debt issuance costs totaled $2,232,090 and $1,490,563 at December 31, 2022 and 2021 and are recorded as a direct deduction in the carrying amount of the revolving credit facility on the accompanying consolidated balance sheets.

Fee Income Recognition

Certain loans in the Company’s portfolio have been issued at a discount. Income related to the accretion of these discounts totaled $369,719 and $553,567 during the years ended December 31, 2022 and 2021, respectively.

Nonrefundable loan fees and costs associated with the origination or purchase of loans are deferred and included in loans, net, in the consolidated balance sheets. These commitment fees, as well as certain other fees charged to borrowers, such as amendment and prepayment fees, are recorded in interest income, after receipt, over the remaining life of the loan using a method which approximates the interest method. Unused line fees are recorded in interest income when received. Unamortized fees totaling $7,117,828 and $5,451,202 are recorded as a component of unearned fee income on the accompanying consolidated balance sheets at December 31, 2022 and 2021, respectively.

Property and Equipment

Property and equipment are carried at cost. Such items are depreciated or amortized on a straight-line basis over the following useful lives:

 

Furniture and fixtures    5-7 years
Computer equipment    3-5 years
Computer software    3 years
Leasehold improvements   

shorter of remaining lease term or the asset’s

estimated useful life

Lease Accounting

The Company adopted Accounting Standards Update 2016-02, Leases (Topic 842) (ASU 2016-02) effective January 1, 2022 using the modified retrospective approach. The Company’s consolidated financial statements for the year ended December 31, 2021 continue to be accounted for under FASB Topic 840 and have not been adjusted. The Company leases office space and equipment under various operating and finance lease agreements. The leases have varying terms and may include escalation clauses or lease concessions. Lease expense for operating leases is recognized on a straight-line basis over the lease term. Depreciation expense for finance leases is recognized over either the useful life of the asset or the lease term based on the terms of the lease agreement and is recorded as a component of depreciation and amortization on the consolidated statements of operations. At the date of adoption, the Company recorded an operating lease right-of-use asset and lease liability of $1,696,309 and $1,744,135, respectively.

 

10


Crystal Financial LLC dba SLR Credit Solutions

Notes to Consolidated Financial Statements

Years Ended December 31, 2022 and 2021

 

 

2.

Summary of Significant Accounting Policies…continued

 

Lease Accounting…continued

 

The Company recognizes a right-of-use asset and a lease liability in the consolidated balance sheet as of December 31, 2022 for those leases classified as operating or finance leases with a term in excess of twelve months. The lease term is determined at lease commencement and includes any noncancellable period for which the Company has the right to use the underlying asset together with any periods covered by an option to extend the lease, if it is reasonably certain that the Company will exercise the option to extend. The initial determination of the lease liability is calculated as the net present value of the lease payments not yet paid. The discount rate used to determine the present value is the rate implicit in the lease, if present, or if not present, the Company’s incremental borrowing rate. The incremental borrowing rate is defined as the rate that reflects the amount of interest that would have to be paid to borrow funds on a collateralized basis over a similar term to the lease in a similar economic environment. Lease payments include fixed payments less any lease incentives available to the Company plus variable lease payments. (see Note 5).

Investment in Equity Securities

The Company accounts for equity securities in accordance with the guidance set forth in Financial Instruments (Topic 825). The Company recorded a realized loss on LLC units outstanding during the year ended December 31, 2022 totaling $620,223. There were no equity securities outstanding during the year ended December 31, 2021.

Foreign Currency

The functional currency of the Company is the US Dollar. At both December 31, 2022 and 2021, the Company has one loan denominated in a foreign currency in its portfolio. The Company also has the ability to borrow foreign currency denominated funds under its revolving line of credit (see Note 5). Gains and losses arising from exchange rate fluctuations on transactions denominated in currencies other than the US Dollar are included in earnings as incurred. The Company recorded unrealized gains on foreign currency translations totaling $120,547 and $321,038 and realized losses totaling $121,552 and $352,340 during the years ended December 31, 2022 and December 31, 2021, respectively.

Distributions

Distributions to members are recorded as of the date of declaration and are approved by the Company’s Board of Managers. Distributions totaling $5,000,000 and $5,500,000 had been declared by the Company at December 31, 2022 and 2021 respectively, but were not paid until the following year.

Income Taxes

The Company is a single member LLC treated as a disregarded entity for tax purposes. The sole member of Crystal Financial is individually liable for the taxes, if any.

The Company applies the provisions set forth in Accounting for Uncertainty in Income Taxes (Topic 740-10). Topic 740-10 provides a comprehensive model for the recognition, measurement and disclosure of uncertain income tax positions. The Company recognizes the tax effect of certain tax positions when it is more likely than not that the tax position will be sustained upon examination, based solely on the technical merits of the tax position. As of December 31, 2022, the Company does not have any uncertain tax positions that meet the recognition or measurement criteria of Topic 740-10.

As a disregarded entity, the Company has no obligation to file a U.S. federal return for tax periods beginning after July 28, 2016, the date the Company became a disregarded entity for tax purposes. The Company does however continue to file certain state tax returns. As of December 31, 2022, the Company is subject to examination by various state tax authorities for tax years beginning after December 31, 2018.

 

11


Crystal Financial LLC dba SLR Credit Solutions

Notes to Consolidated Financial Statements

Years Ended December 31, 2022 and 2021

 

 

2.

Summary of Significant Accounting Policies…continued

 

Recently Issued Accounting Pronouncements

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update 2016-13, Financial Instruments- Credit Losses (Topic 326) (ASU 2016-13). ASU 2016-13 sets forth a current expected credit loss (“CECL”) model which requires the Company to measure all expected credit losses for financial instruments held at the reporting date based on historical experience, current conditions and reasonable supportable forecasts. This replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost and applies to some off-balance sheet credit exposures. ASU 2016-13 will be effective for the Company for its fiscal year beginning after December 15, 2022. The Company has evaluated the impact that this standard will have on its consolidated balance sheet and consolidated statement of operations, and has determined that the impact will be immaterial to the consolidated financial statements taken as a whole.

In March 2020, the FASB issued Accounting Standards Update 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (ASU 2020-04). The guidance provides optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships and other transactions, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued because of the reference rate reform. ASU 2020-04 is effective for all entities as of March 12, 2020 through December 31, 2022. To date, the Company has been successful in modifying outstanding loan receivable agreements and its outstanding debt facility in order to replace references to LIBOR with SOFR or another alternative reference rate. Application of this pronouncement has not had a material impact on the Company’s consolidated financial statements taken as a whole.

 

3.

Allowance for Loan Losses

At December 31, 2022, one loan with an aggregate principal balance outstanding of $800,000, was deemed to be impaired. The loan was fully reserved for at December 31, 2022. Although not being accrued for at December 31, 2022, interest on the impaired loan is paid-in-kind and therefore there are no interest payments outstanding at December 31, 2022. There are also no principal payments outstanding at December 31, 2022.

At December 31, 2021, two loans with aggregate principal balances outstanding of $4,812,188, were deemed to be impaired. An allowance totaling $2,979,084 has been applied against these loans at December 31, 2021. Although not being accrued for at December 31, 2021, interest on both the impaired loans is paid-in-kind and therefore there are no interest payments outstanding at December 31, 2021. There are also no principal payments outstanding at December 31, 2021.

The Company’s average recorded investment in impaired loans totaled $1,134,349 and $4,812,188 during the years ended December 31, 2022 and 2021, respectively.

Depending on the assigned internal risk rating, loans are classified as either Pass or Criticized. Generally, once a loan is classified as Criticized, a specific reserve analysis is required. One loan, totaling $800,000 is classified as Criticized at December 31, 2022. Two loans, totaling $4,812,188 at December 31, 2021, are classified as Criticized

The Company also maintains an allowance on unfunded revolver and delayed draw term loan commitments. At December 31, 2022 and 2021, an allowance of $422,834 and $478,618, respectively, was recorded relating to these commitments. This amount is recorded as a component of other liabilities on the Company’s consolidated balance sheets with changes recorded in the provision for loan losses on the Company’s consolidated statements of operations. The methodology for determining the allowance for unfunded revolver and delayed draw term loan commitments is consistent with the methodology used for determining the allowance for loan losses, with the exception that only the portion of the outstanding commitment expected to be drawn is applied against the unfunded commitments.

 

12


Crystal Financial LLC dba SLR Credit Solutions

Notes to Consolidated Financial Statements

Years Ended December 31, 2022 and 2021

 

 

3.

Allowance for Loan Losses…continued

 

The summary of changes in the allowance for loan losses relating to funded commitments for the years ended December 31, 2022 and 2021 is as follows:

 

     Year Ended December 31, 2022  
     Revolvers      Term Loans      Total  

Balance, beginning of period

   $ 79,186      $ 7,752,756      $ 7,831,942  

Provision for loan losses-general

     550,776        2,926,902        3,477,678  

Provision for loan losses-specific

     —          1,501,587        1,501,587  

Charge- offs, net of recoveries

     —          (3,680,671      (3,680,671
  

 

 

    

 

 

    

 

 

 

Balance, end of period

   $ 629,962      $ 8,500,574      $ 9,130,536  
  

 

 

    

 

 

    

 

 

 

Balance, end of period- general

   $ 629,962      $ 7,700,574      $ 8,330,536  
  

 

 

    

 

 

    

 

 

 

Balance, end of period- specific

   $ —        $ 800,000      $ 800,000  
  

 

 

    

 

 

    

 

 

 

Loans

        

Loans collectively evaluated with general allowance

   $ 44,557,560      $ 394,126,525      $ 438,684,085  

Loans individually evaluated with specific allowance

     —          800,000        800,000  
  

 

 

    

 

 

    

 

 

 

Total loans

   $ 44,557,560      $ 394,926,525      $ 439,484,085  
  

 

 

    

 

 

    

 

 

 

 

     Year Ended December 31, 2021  
     Revolvers      Term Loans      Total  

Balance, beginning of period

   $ 547,984      $ 7,723,262      $ 8,271,246  

Provision (credit) for loan losses-general

     (393,798      (1,955,691      (2,349,489

Provision for loan losses-specific

     (75,000      1,985,185        1,910,185  

Charge- offs, net of recoveries

     —          —          —    
  

 

 

    

 

 

    

 

 

 

Balance, end of period

   $ 79,186      $ 7,752,756      $ 7,831,942  
  

 

 

    

 

 

    

 

 

 

Balance, end of period- general

   $ 79,186      $ 4,773,672      $ 4,852,858  
  

 

 

    

 

 

    

 

 

 

Balance, end of period- specific

   $ —        $ 2,979,084      $ 2,979,084  
  

 

 

    

 

 

    

 

 

 

Loans

        

Loans collectively evaluated with general allowance

   $ 4,868,123      $ 277,694,933      $ 282,563,056  

Loans individually evaluated with specific allowance

     —          4,812,188        4,812,188  
  

 

 

    

 

 

    

 

 

 

Total loans

   $ 4,868,123      $ 282,507,121      $ 287,375,244  
  

 

 

    

 

 

    

 

 

 

 

13


Crystal Financial LLC dba SLR Credit Solutions

Notes to Consolidated Financial Statements

Years Ended December 31, 2022 and 2021

 

 

4.

Property and Equipment

The cost basis of the Company’s property and equipment as well as the accumulated depreciation at December 31, 2022 and 2021, are as follows:

 

     December 31,  
     2022      2021  

Furniture and fixtures

   $ 26,954      $ 26,954  

Computer equipment

     223,675        214,013  

Computer software

     20,629        20,426  
  

 

 

    

 

 

 
   $ 271,258      $ 261,393  

Less: Accumulated depreciation

     (255,236      (246,485
  

 

 

    

 

 

 
   $ 16,022      $ 14,908  
  

 

 

    

 

 

 

Finance lease assets totaling $17,310 are included as a component of computer equipment in the above schedule at December 31, 2022 and 2021.

Depreciation expense of $12,808 and $20,210 was recognized during the years ended December 31, 2022 and 2021 and is included as a component of depreciation and amortization expense on the accompanying consolidated statements of operations.

 

5.

Debt Obligations and Financings

Revolving Credit Facility

On May 12, 2011, the Company entered into a Loan Financing and Servicing Agreement (the “Credit Agreement”) in the form of a revolving credit facility.

The Company has the ability to borrow funds denominated in certain foreign currencies under the facility. The maximum amount available to be borrowed in foreign denominated currencies is the US Dollar equivalent of $114,000,000. During 2022 and 2021, the Company incurred fees and expenses totaling $1,876,134 and $1,084,317 in connection with certain amendments to the credit facility. These costs were deferred and are being amortized on a straight-line basis over the contractual term of the Credit Agreement as an adjustment to interest expense.

At December 31, 2022, the amount available to be borrowed under the facility is the lesser of (a) $285,000,000 or (b) the amount calculated and available per the Borrowing Base, as defined in the amended Credit Agreement. Borrowings on the facility bear interest at a rate of 2.76448% plus the Lenders’ cost of funds, as defined in the Credit Agreement. The applicable cost of funds varies depending on the currency in which the funds are borrowed. At December 31, 2022, the effective rates were between 6.89% and 7.52%. The Company also pays an undrawn fee on unfunded commitments and an administrative agent fee.

The revolving credit facility is comprised of the following at December 31, 2022 and 2021:    

 

     December 31,  
     2022      2021  

Principal borrowings

   $ 224,325,124      $ 100,742,374  

Unamortized debt issuance costs

     (2,232,090      (1,490,563
  

 

 

    

 

 

 

Revolving credit facility, net

   $ 222,093,034      $ 99,251,811  
  

 

 

    

 

 

 

 

14


Crystal Financial LLC dba SLR Credit Solutions

Notes to Consolidated Financial Statements

Years Ended December 31, 2022 and 2021

 

 

5.

Debt Obligations and Financings…continued

 

Revolving Credit Facility…continued

 

The credit facility terminates on the earlier of August 15, 2025 or upon the occurrence of a Facility Termination Event, as defined in the amended Credit Agreement.

Commencing on February 15, 2024 and continuing every three months until the facility’s termination date, the Company may be required to make principal pay-downs on certain amounts outstanding. The amount to be paid down is contingent upon the future amount outstanding as well as the amount of future non-mandatory prepayments made on the credit facility.

Cash, as well as those of the Company’s loans that are held within Crystal Financial SPV, serve as collateral against the facility. The Company has made certain customary representations and warranties under the facility, and is required to comply with various covenants, reporting requirements, and other customary requirements for similar credit facilities. The Credit Agreement includes usual and customary events of default for credit facilities of this nature. The Company is in compliance with all covenants at December 31, 2022 and 2021.

Leases

At December 31, 2022, the Company has recorded a right-of-use asset and a lease liability for the Company’s operating lease totaling $1,081,490 and $1,121,552, respectively. The operating lease right-of-use asset and liability are recorded as a component of other assets and other liabilities on the accompanying consolidated balance sheet. The lease has a weighted average remaining lease term of 1.67 years and a weighted average discount rate of 3.50%.

The cost of the Company’s operating lease totaled $666,033 during the year ended December 31, 2022.

Future minimum lease commitments under the lease include:

 

     Operating Lease  

2023

   $ 690,346  

2024

     466,023  
  

 

 

 

Total lease payments

     1,156,369  

Less: interest expense

     (34,817
  

 

 

 

Lease liability balance

   $ 1,121,552  
  

 

 

 

 

15


Crystal Financial LLC dba SLR Credit Solutions

Notes to Consolidated Financial Statements

Years Ended December 31, 2022 and 2021

 

 

6.

Related Party Activity

On March 15, 2013, Crystal Financial committed $50,750,000 of capital to Crystal Financial SBIC LP (the “Fund”) in exchange for a 65.91% limited partner interest. Crystal Financial SBIC LP was established to operate as a small business investment company under the Small Business Investment Company (“SBIC”) Act. Of the total amount committed, $21,883,314 remains unfunded at December 31, 2022 and 2021.

Certain of the managing members of the Fund’s general partner, Crystal SBIC GP LLC (the “General Partner”), are also members of Crystal Financial’s management team. Crystal Financial and the General Partner have entered into a Services Agreement whereby Crystal Financial provides certain administrative services to the General Partner in exchange for a waiver of the quarterly management fee that it owes to the General Partner.

The Company accounts for its limited partner interest in the Fund as an equity method investment in the accompanying consolidated financial statements (see Note 9). Crystal Financial did not make any contributions to the Fund during 2022 or 2021. Cash distributions from the Fund totaled $1,027,010 and $8,086,431 during 2022 and 2021, respectively. In accordance with the equity method of accounting, the Company was allocated net losses from the Fund totaling $4,738,951 for the year ended December 31, 2022 and $1,430,559 for the year ended December 31, 2021. These amounts represent the Company’s allocation of the Fund’s net loss in accordance with the Fund’s Limited Partnership Agreement. Crystal Financial’s investment in the Fund is recorded as Investment in Crystal Financial SBIC LP in the accompanying consolidated balance sheets and its share of earnings and losses are recorded as losses from equity method investee on the consolidated statements of operations

 

7.

Member’s Capital

Crystal Financial has issued limited liability company interests, referred to as Class A Units. Each unit entitles its holder to one vote on all matters submitted to a vote of the members. At December 31, 2022 and 2021, the Company has 280,303 outstanding Class A Units, all of which are owned by SLR.

 

8.

Commitments and Contingencies

The Company is party to financial instruments with off-balance sheet risk including unfunded revolver and delayed draw term loan commitments to certain borrowers.

Under the revolving credit and delayed draw term loans, aggregate unfunded commitments total $72,109,377 and $87,838,688 at December 31, 2022 and 2021, respectively. These agreements have fixed expiration dates. The revolving credit agreements typically require payment of a monthly fee equal to a certain percentage times the unused portion of the revolving line of credit. As the unfunded commitments may expire without being drawn upon, the total commitment amounts do not necessarily represent future cash requirements. The amount of credit that can be extended under each of the revolving credit agreements and delayed draw term loan agreements is typically limited to the borrower’s available collateral, which is used in calculating the borrower’s borrowing base at the time of a respective draw.

Effective January 1, 2013, certain employees of Crystal Financial, including members of management, entered into a long- term incentive plan agreement (“LTIP Agreement”). In accordance with the terms of the LTIP Agreement, a bonus pool is calculated each calendar year, and is based upon the achievement of certain operating results during the year. The bonus pool calculated and earned for each calendar year will be paid out two years after the year in which the bonus pool is calculated and earned. The calculated bonus pool is subject to a look-back calculation which could cause the amount that is ultimately paid out to be less than the amount originally calculated. Amounts recorded pursuant to the LTIP Agreement during the years ended December 31, 2022 and 2021, if any, are included as a component of accrued expenses on the accompanying consolidated balance sheets and as a component of compensation and benefits expense on the accompanying consolidated statements of operations.

 

16


Crystal Financial LLC dba SLR Credit Solutions

Notes to Consolidated Financial Statements

Years Ended December 31, 2022 and 2021

 

 

9.

Variable Interest Entity

In accordance with US GAAP, the Company evaluates (a) whether it holds a variable interest in an entity, (b) whether the entity is a variable interest entity (“VIE”) and (c) whether the Company is the primary beneficiary of the VIE. The granting of substantive kick-out rights is a key consideration in determining whether a limited partnership is a VIE and whether or not that entity should be consolidated. In evaluating whether or not Crystal Financial SBIC LP is a VIE of the Company, it is noted that the Limited Partnership Agreement of Crystal Financial SBIC LP does not permit a simple majority of the limited partners to exercise kick-out rights, and therefore these rights are deemed to not be substantive. Accordingly, Crystal Financial SBIC LP is deemed to be a VIE. In assessing whether or not the VIE should be consolidated, it was determined that substantially all of the VIE’s activities are not conducted on behalf of Crystal Financial or its de facto agents. Accordingly, the Company does not consolidate Crystal Financial SBIC LP in the accompanying consolidated financial statements

The following table sets forth the information with respect to the unconsolidated VIE in which the Company holds a variable interest as of December 31, 2022 and 2021.

 

     December 31, 2022      December 31, 2021  

Equity interest included on the Consolidated Balance Sheets

   $ 2,575,336      $ 8,341,297  

Maximum risk of loss (1)

     24,458,650        30,224,611  

 

(1)

includes the equity investment the Company has made, or could be required to make

 

10.

Fair Value of Financial Instruments

Fair Value Measurements (Topic 820) establishes a three-level hierarchy for disclosure of fair value measurements. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. The three levels are defined as follows:

Level 1- inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.

Level 2- inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

Level 3- inputs to the valuation methodology are unobservable and significant to the fair value measurement.

A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

There were no financial assets or financial liabilities measured at fair value on a recurring basis at December 31, 2022 or December 31, 2021.

Financial instruments that are not recorded at fair value on a recurring basis consist of cash, restricted cash, interest receivable, loans receivable, investment in Crystal Financial SBIC LP, collateral held for borrower obligations and the revolving credit facility. Due to the short-term nature of the Company’s cash, restricted cash, interest receivable, and collateral held for borrower obligations, the carrying value approximates fair value.

The Company’s loans receivable are recorded at outstanding principal, net of any deferred fees and costs, unamortized purchase discounts and the allowance for loan losses. If the Company elected the fair value option, the estimated fair value of the Company’s loans receivable would be derived using among other things, a discounted cash flow methodology that considers various factors including the type of loan and related collateral, current market yields for similar debt investments, estimated cash flows, as well as a discount rate that reflects the Company’s assessment of risk inherent in the cash flow estimates.

 

17


Crystal Financial LLC dba SLR Credit Solutions

Notes to Consolidated Financial Statements

Years Ended December 31, 2022 and 2021

 

 

10.

Fair Value of Financial Instruments…continued

 

If the Company elected the fair value option, the estimated fair value of the Company’s investment in Crystal Financial SBIC LP and the revolving credit facility at December 31, 2022 and 2021, would approximate the carrying value. The fair value is estimated based on consideration of current market interest rates for similar debt instruments.

The following table presents the carrying amounts, estimated fair values, and placement in the fair value hierarchy of the Company’s long-term financial instruments, at December 31, 2022 and 2021.

 

December 31, 2022                                   
                   Fair Value Measurements  
     Carrying      Estimated Fair                       
     Amount      Value      Level 1      Level 2      Level 3  

Financial assets:

              

Loans receivable

   $ 439,484,085      $ 438,684,085      $ —        $ —        $ 438,684,085  

Investment in Crystal Financial SBIC LP

     2,575,336        2,575,336        —          —          2,575,336  

Financial liabilities:

              

Revolving credit facility

     224,325,124        224,325,124        —          —          224,325,124  

 

December 31, 2021                                   
                   Fair Value Measurements  
     Carrying      Estimated Fair                       
     Amount      Value      Level 1      Level 2      Level 3  

Financial assets:

              

Loans receivable

   $ 287,375,244      $ 284,396,160      $ —        $ —        $ 284,396,160  

Investment in Crystal Financial SBIC LP

     8,341,297        8,341,297        —          —          8,341,297  

Financial liabilities:

              

Revolving credit facility

     100,742,374        100,742,374        —          —          100,742,374  

 

11.

Subsequent Events

The Company has evaluated subsequent events through February 15, 2023, the date which the financial statements were available to be issued.

On February 9, 2023, the Company executed the 29th amendment to the amended and restated Credit Agreement (see Note 5) which further increased the commitment on the facility from $285,000,000 to $300,000,000.

 

18

EX-99.2 17 d437884dex992.htm EX-99.2 EX-99.2

Exhibit 99.2

CONSOLIDATED FINANCIAL STATEMENTS

NEF Holdings, LLC and Subsidiaries

(A Limited Liability Company)

Years ended December 31, 2022 and December 31, 2021

With Independent Auditors’ Report


NEF Holdings, LLC and Subsidiaries

Consolidated Financial Statements

Years ended December 31, 2022 and December 31, 2021

Contents

 

Independent Auditors’ Report

     1  

Consolidated Balance Sheets

     3  

Consolidated Statements of Operations

     4  

Consolidated Statements of Comprehensive Income/(Loss)

     5  

Consolidated Statements of Changes in Members’ Capital

     6  

Consolidated Statements of Cash Flows

     7  

Notes to the Consolidated Financial Statements

     8  


LOGO

Independent Auditors’ Report

To the Board of Managers and Member of

NEF Holdings, LLC and Subsidiaries

Opinion

We have audited the consolidated financial statements of NEF Holdings, LLC and Subsidiaries (the Company), which comprise the consolidated balance sheets as of December 31, 2022 and 2021, and the related consolidated statements of operations, comprehensive income/(loss), changes in member’s capital, and cash flows for the years then ended, and the related notes to the consolidated financial statements.

In our opinion, the accompanying consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021 and the results of their operations and their cash flows for the years then ended in accordance with accounting principles generally accepted in the United States of America (GAAP).

Basis for Opinion

We conducted our audits in accordance with auditing standards generally accepted in the United States of America (GAAS). Our responsibilities under those standards are further described in the Auditors’ Responsibilities for the Audit of the Consolidated Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements relating to our audits. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

Responsibilities of Management for the Consolidated Financial Statements

Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with GAAP, and for the design, implementation and maintenance of internal control relevant to the preparation and fair presentation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the consolidated financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the financial statements are available to be issued.

Auditors’ Responsibilities for the Audit of the Consolidated Financial Statements

Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors’ report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the consolidated financial statements.

Baker Tilly US, LLP, trading as Baker Tilly, is a member of the global network of Baker Tilly International Ltd., the members of which are separate and independent legal entities.

 

1


In performing an audit in accordance with GAAS, we:

 

   

Exercise professional judgment and maintain professional skepticism throughout the audit.

 

   

Identify and assess the risks of material misstatement of the consolidated financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements.

 

   

Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control. Accordingly, no such opinion is expressed.

 

   

Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the consolidated financial statements.

 

   

Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for a reasonable period of time.

We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control-related matters that we identified during the audit.

Philadelphia, Pennsylvania

February 16, 2023

 

2


NEF Holdings, LLC and Subsidiaries

Consolidated Balance Sheets

At December 31, 2022 and December 31, 2021

(In Thousands)

 

     2022     2021  

Assets

    

Cash

   $ 12,639     $ 8,989  

Restricted cash

     71       71  

Financing receivables:

    

Financing receivables, gross

     195,726       214,325  

Allowance for losses on financing receivables

     (4,896     (3,339
  

 

 

   

 

 

 

Financing receivables, net

     190,830       210,986  

Equipment on lease, net

     —         1,200  

Fixed assets, net

     325       378  

Goodwill

     29,832       29,832  

Other assets held-for-sale

     —         2,450  

Other assets

     8,116       10,101  
  

 

 

   

 

 

 

Total assets

   $ 241,813     $ 264,007  
  

 

 

   

 

 

 

Liabilities and Members’ Capital

    

Liabilities:

    

Senior secured credit facility, net

   $ 115,371     $ 117,483  

Loans from affiliate

     16,342       30,703  

Accounts payable and accrued expenses

     2,705       3,278  

Good faith deposits

     606       998  

Other liabilities

     3,761       6,456  
  

 

 

   

 

 

 

Total liabilities

     138,785       158,918  
  

 

 

   

 

 

 

Members’ capital:

    

Members’ capital

     103,028       105,089  
  

 

 

   

 

 

 

Total members’ capital

     103,028       105,089  
  

 

 

   

 

 

 

Total liabilities & members’ capital

   $ 241,813     $ 264,007  
  

 

 

   

 

 

 

See accompanying notes to the consolidated financial statements.

 

3


NEF Holdings, LLC and Subsidiaries

Consolidated Statements of Operations

For the Years Ended December 31, 2022 and December 31, 2021

(In Thousands)

 

     2022     2021  

Net operating income:

    

Interest income

   $ 14,944     $ 16,906  

Interest expense

     6,938       6,700  
  

 

 

   

 

 

 

Net interest income

     8,006       10,206  

Other income

     5,436       6,025  
  

 

 

   

 

 

 

Net operating income

     13,442       16,231  

Provision for losses and impairments of equipment off lease

     4,137       9,390  
  

 

 

   

 

 

 

Net operating income after provisions and impairments

     9,305       6,841  

Expenses:

    

Compensation and benefits

     8,437       8,649  

General and administrative expenses

     3,311       3,745  

Lease and loan restructuring costs

     338       1,176  

Depreciation and amortization

     86       2,908  

Unrealized loss on equity investment

     —         92  
  

 

 

   

 

 

 

Total expenses

     12,172       16,570  
  

 

 

   

 

 

 

Net income/(loss)

   $ (2,867   $ (9,729
  

 

 

   

 

 

 

See accompanying notes to the consolidated financial statements.

 

4


NEF Holdings, LLC and Subsidiaries

Consolidated Statements of Comprehensive Income/(Loss)

For the Years Ended December 31, 2022 and December 31, 2021

(In Thousands)

 

     2022     2021  

Net income/(loss)

   $ (2,867   $ (9,729

Other comprehensive income/(loss):

    

Derivative instruments designated and qualifying as cash flow hedges:

    

Unrealized holding gain arising during the year

     1,194       —    

Less: reclassification adjustment for gains included in net income/(loss)

     (98     —    
  

 

 

   

 

 

 

Total other comprehensive income/(loss)

     1,096       —    
  

 

 

   

 

 

 

Total comprehensive income/(loss)

   $ (1,771   $ (9,729
  

 

 

   

 

 

 

See accompanying notes to the consolidated financial statements.

 

5


NEF Holdings, LLC and Subsidiaries

Consolidated Statements of Changes in Members’ Capital

For the Years Ended December 31, 2022 and December 31, 2021

(In Thousands)

 

Members’ capital at December 31, 2020

   $ 114,818  

Net income/(loss)

     (9,729
  

 

 

 

Members’ capital at December 31, 2021

   $ 105,089  

Capital distributions

     (290

Other comprehensive income

     1,096  

Net income/(loss)

     (2,867
  

 

 

 

Members’ capital at December 31, 2022

   $ 103,028  
  

 

 

 

See accompanying notes to the consolidated financial statements.

 

6


NEF Holdings, LLC and Subsidiaries

Consolidated Statements of Cash Flows

For the Years Ended December 31, 2022 and December 31, 2021

(In Thousands)

 

     2022     2021  

Cash flows from operating activities

    

Net income/(loss)

   $ (2,867   $ (9,729

Adjustments to reconcile net income/(loss) to net cash provided by operating activities:

    

Provision for losses and impairments of equipment off lease

     4,137       9,390  

Depreciation and amortization of intangible asset

     86       2,908  

Amortization of deferred financing costs

     482       468  

Amortization of upfront fees received and initial direct costs paid

     370       191  

Change in interest rate derivative value

     (462     —    

Unrealized loss on equity investment

     —         92  

Changes in operating assets and liabilities:

    

(Increase)/Decrease in other assets

     1,126       237  

(Increase)/Decrease in interest receivable

     (23     105  

Increase/(Decrease) in interest payable

     403       (19

Increase/(Decrease) in accounts payable and accrued expenses

     (973     1,030  

Increase/(Decrease) in good faith deposits

     (392     102  

Increase/(Decrease) in other liabilities

     (1,740     337  
  

 

 

   

 

 

 

Net cash provided by/(used in) operating activities

     147       5,112  
  

 

 

   

 

 

 

Cash flows from investing activities

    

Investments in secured loans and direct finance leases

     (66,760     (96,647

Collections of principal on secured loans and direct finance leases

     85,096       77,576  

Purchases of secured loans and direct finance leases from an affiliate

     —         (5,499

Non-refundable upfront fees received

     —         22  

Initial direct costs paid

     (326     (540

Proceeds from sales of equipment on lease

     1,200       —    

Proceeds from sales of equipment off lease

     1,824       17,052  

Cash from sale of NEF Auto Transport assets

     150       —    

Cash flows from (purchases)/sales of fixed assets

     (33     (457
  

 

 

   

 

 

 

Net cash provided by/(used in) investing activities

     21,151       (8,493
  

 

 

   

 

 

 

Cash flows from financing activities

    

Borrowings on credit facility and loans from affiliate

     87,542       114,294  

Repayments on credit facility and loans from affiliate

     (104,900     (108,374

Capital distributions

     (290     —    
  

 

 

   

 

 

 

Net cash provided by/(used in) financing activities

     (17,648     5,920  
  

 

 

   

 

 

 

Net increase/(decrease) in cash and restricted cash

     3,650       2,539  

Cash and restricted cash at the beginning of period

     9,060       6,521  
  

 

 

   

 

 

 

Cash and restricted cash at the end of period

   $ 12,710     $ 9,060  
  

 

 

   

 

 

 

Supplemental disclosures of cash flow information

    

Interest paid

   $ 5,967     $ 6,527  
  

 

 

   

 

 

 

Non-cash exchange of right of use assets for lease obligations

   $ —       $ 3,597  
  

 

 

   

 

 

 

See accompanying notes to the consolidated financial statements

 

7


NEF Holdings, LLC and Subsidiaries

Notes to the Consolidated Financial Statements

For the Years Ended December 31, 2022 and December 31, 2021

(In Thousands)

1. Organization and Business

NEF Holdings, Inc. was organized on June 7, 2013 as a Delaware corporation and commenced its operations in June 2013. Effective January 1, 2014, NEF Holdings, Inc. converted from a corporation to a limited liability company (“LLC”), NEF Holdings, LLC (“NEF Holdings”), pursuant to Section 18-214 of the Limited Liability Act in the State of Delaware. Subsequent to the close of business on July 31, 2017, NEF Holdings was acquired by SLR Investment Corp., formerly Solar Capital Ltd. (“SLR”).

As of December 31, 2022 and December 31, 2021, NEF Holdings had five wholly-owned subsidiaries: Nations Fund I, LLC (“Fund I”), Nations Equipment Finance, LLC (“NEF”), Equipment Operating Leases, LLC (“EOL”), NEF Auto Transport, LLC (“NEF Auto Transport”) and Loyer Capital LLC (“Loyer Capital”) (collectively, the “Company”). The Company is headquartered in Wilton, Connecticut.

Nations Fund I, Inc. was organized on September 17, 2010 as a Delaware corporation. Effective January 1, 2014, Nations Fund I, Inc. converted from a corporation to a LLC, Nations Fund I, LLC, pursuant to Section 18-214 of the Limited Liability Act in the State of Delaware. Fund I is a commercial equipment finance company that provides term loans and leases primarily to middle market and privately held companies. Fund I focuses on direct origination of loans and equipment leases secured by equipment collateral, such as trailers, trucks, transportation and construction equipment.

NEF was organized as a LLC under the laws of the State of Delaware and commenced operations on August 24, 2010. NEF, doing business as SLR Equipment Finance, serves as the investment manager for the Company. Services provided by NEF include, among other things, identifying, structuring and negotiating transactions, monitoring, advising and managing investments, exercising control rights, options or warrants, liquidating investments, cash management, accounting, tax, compliance and legal services.

NEF Investments, LLC, a wholly owned subsidiary of NEF Holdings, was organized as a Delaware LLC on January 22, 2018. On April 18, 2018, NEF Investments’ LLC agreement was amended which changed the company’s name to Equipment Operating Leases, LLC. EOL is a commercial equipment finance company that provides term loans and leases primarily to middle market and privately held companies.

NEF Auto Transport was organized as a LLC under the laws of the State of Delaware and commenced operations in December 2018 through the acquisition of a former customer. NEF Auto Transport was an auto transport carrier providing direct auto-hauling services. As discussed in note 4, in February 2022 the Company sold substantial all of the assets of NEF Auto Transport and ceased operations.

Loyer Capital was organized as a LLC under the laws of the State of Delaware and commenced operations in May 2019. Loyer Capital is a commercial equipment finance company that provides term loans and leases primarily to middle market and privately held companies.

 

 

8


NEF Holdings, LLC and Subsidiaries

Notes to the Consolidated Financial Statements (continued)

(In Thousands)

 

2. Summary of Significant Accounting Policies

 

Basis of Presentation

The consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). These consolidated financial statements include the accounts of NEF Holdings and its wholly owned subsidiaries, Fund I, NEF, EOL, Loyer Capital and NEF Auto Transport. All significant intercompany balances and transactions are eliminated in consolidation. Certain amounts in the prior period financial statements have been reclassified to conform to the current year’s presentation.

Use of Estimates

The presentation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that impact the amounts reported in the consolidated financial statements and accompanying notes. Such estimates and assumptions are subject to change in the future as additional information becomes available or as circumstances are modified. Actual results could differ materially from these estimates. Management’s estimates and assumptions are used in estimating an allowance for losses on financing receivables, impairments of equipment off lease, useful lives of leasing equipment and fixed assets, fair values of unguaranteed residual values, intangible assets and fair values of assets acquired and liabilities assumed.

Cash

At December 31, 2022 and December 31, 2021, the Company’s cash balance totaled $12,710, and $9,060, respectively. Included in the Company’s cash balance as of December 31, 2022 and December 31, 2021 is restricted cash of $71, which is maintained in connection with the lease of the Company’s office space.

Financing Receivables

Included in financing receivables in the consolidated balance sheets are the Company’s net investments in direct financing leases and secured loans.

Net investment in direct finance leases is reported net of unearned income, deferred non-refundable fees and initial direct costs associated with their origination, and inclusive of guaranteed and unguaranteed residual values. Direct finance leases are usually long-term in nature, typically ranging for a period of three to seven years and include either a nominal or fair market value purchase option at the end of the lease term. Non-refundable fees received and initial direct costs incurred associated with the origination of direct finance leases are deferred and are recognized as an adjustment to interest income over the contractual life of the direct finance leases using the interest method.

Secured loans are reported at the principal amount outstanding, net of non-refundable fees, initial direct costs and accrued interest. These fees are deferred and recognized as an adjustment to interest income over the contractual life of the loans using the interest method.

 

9


NEF Holdings, LLC and Subsidiaries

Notes to the Consolidated Financial Statements (continued)

(In Thousands)

 

2. Summary of Significant Accounting Policies (continued)

 

Income Recognition

The Company recognizes revenue in accordance with the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers, which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers. The core principle of the revenue model is for an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. While this guidance replaces most existing revenue recognition guidance in U.S. GAAP, ASC 606 is not applicable to financial instruments and, therefore, does not impact most of the Company’s revenues.

For direct finance leases, the difference between the cost of the equipment and the total finance lease receivable plus, where applicable, the unguaranteed or guaranteed residual value is recorded as unearned income. Unearned income is amortized as earned income over the term of the transaction using the interest method. For the years ended December 31, 2022 and December 31, 2021, interest income from direct financing leases totaled $9,504 and $12,349, respectively, which is included in interest income in the consolidated statements of operations. For secured loans, interest income is recorded on the accrual basis in accordance with the terms of the respective loan. For the years ended December 31, 2022 and December 31, 2021, interest income from secured loans totaled $5,440 and $4,004, respectively, which is included in interest income in the consolidated statements of operations.

The Company’s revenue recognition pattern for revenue streams within the scope of ASC 606 include fees for providing administrative and collateral monitoring services, which are earned ratably over the period in which the services are provided, and revenues associated with its auto-hauling operations (see note 4). Such revenues are recognized when evidence of an arrangement exist, the performance obligations are satisfied, collections are probable and the price is fixed or determinable. With respect to the Company’s auto-hauling operations, the sole performance obligation is deemed to be satisfied at a single point in time, that is, when the customer takes physical possession of the automobile.

Other Income

Amounts in other income in the consolidated statements of operations primarily include gains on sales of equipment, fees charged for early terminations of financing arrangements, other miscellaneous fees earned in connection with the administration of such financing arrangements and net impacts of foreign currency translation. Also included in other income in the consolidated statements of operations are the revenues and cost of sales associated with the Company’s auto-hauling business, which was sold in February 2022 (see note 4).

Fixed Assets

Fixed assets consist of furniture and fixtures, software, computers, leasehold improvements, automobiles, telephone and office equipment and auto hauling trucks, and are stated at cost less accumulated depreciation and amortization. Expenditures for repairs and maintenance that do not extend the useful life of the asset are expensed as incurred and are included in general and administrative expenses in the Company’s consolidated statements of operations.

 

10


NEF Holdings, LLC and Subsidiaries

Notes to the Consolidated Financial Statements (continued)

(In Thousands)

 

2. Summary of Significant Accounting Policies (continued)

 

Fixed Assets (continued)

Depreciation and amortization of fixed assets are calculated using the straight-line method over their respective useful lives, and recorded in depreciation and amortization in the consolidated statements of operations.

 

     Useful Life (Years)

Furniture and fixtures

   7

Telephone

   7

Office equipment

   5

Automobile

   5

Auto Hauling Trucks

   5

Computers

   3

Software

   Lesser of 5 years or license period

Leasehold improvements

   Lesser of the life of the asset or

lease term

Good Faith Deposits

Good faith deposits represent cash received from the Company’s customers, when the proposal for a potential transaction is signed. These deposits are used to pay expenses such as third-party appraisals, document fees and travel and related costs incurred by the Company in connection with the origination of the transaction. If the deposit exceeds the expenses incurred by the Company, the excess amount may be refundable to the customer. If the expenses incurred exceed the deposits received, the Company’s customers are liable for the overage. Such overages are included in other assets on the consolidated balance sheets. In the event the Company approves a transaction with a customer and the customer elects not to pursue the transaction, the Company recognizes any remaining good faith deposit into income, as allowed by the agreed upon terms of the signed proposal. Such amounts are included in other income in the consolidated statements of operations.

In certain instances, the Company incurs costs to restructure financing receivables, which are in excess of the customer’s good faith deposit, such as legal fees and other expenses associated with the repossession and liquidation of equipment. If these costs are not collectable from the Company’s customers, then such costs are expensed and recorded as lease and loan restructuring costs on the consolidated statements of operations.

Allowance for Losses on Financing Receivables

The Company maintains an allowance for losses on financing receivables at a level sufficient to absorb probable losses related to its financing receivables as of the date of the consolidated financial statements. In determining its allowance for losses on financing receivables, the Company considers historical loss rates, collateral coverage and remaining term to maturity of the financing arrangement, which are reviewed and updated, as appropriate, on an ongoing basis.

Individually identified non-performing secured loans and direct finance leases are measured based on the specific circumstances of the transaction and a specific allowance is established, if necessary. Amounts determined to be uncollectible are charged directly to provision for losses in the consolidated statements of operations. During the years ended December 31, 2022 and December 31, 2021, provisions for losses of specifically identified financing receivables totaled $1,659 and $0, respectively.

The Company classifies a financing receivable as delinquent when it is overdue by more than 60 days. As of December 31, 2022, financing receivables with an outstanding balance of $0, $0, and $22,995 were between 61-90 days past due, 91-120 days past due and greater than 120 days past due, respectively. As of December 31, 2021, financing receivables with an outstanding balance of $0, $3,501, and $245 were between 61-90 days past due, 91-120 days past due and greater than 120 days past due, respectively.

 

11


NEF Holdings, LLC and Subsidiaries

Notes to the Consolidated Financial Statements (continued)

(In Thousands)

 

2. Summary of Significant Accounting Policies (continued)

 

Non-Accrual Financing Receivables

Income recognition is generally suspended for financing receivables after 90 days of non-payment, or if full recovery becomes doubtful based on the assessment by the Company. Income recognition is resumed when financing receivables are less than 90 days past due. At December 31, 2022 and December 31, 2021, financing receivables with an outstanding balance of $22,995 and $22,030, respectively, were on non-accrual of income.

Equipment on Lease

Leasing equipment is comprised of equipment under operating leases. Leasing equipment is recorded at cost and depreciated on a straight-line basis over the estimated useful life of the equipment. Income is recorded on a straight-line basis over the term of the lease which is included in interest income in the consolidated statements of operations.

The estimated useful lives and residual values of the Company’s leasing equipment are based on independent third-party appraisals and management’s judgment. The Company reviews its depreciation policies on a regular basis to determine whether changes have taken place that would suggest that a change in its depreciation policies, useful lives of its equipment or the assigned residual values is warranted. At December 31, 2022, the Company had no leasing equipment under operating leases. At December 31, 2021, the Company’s leasing equipment is comprised of a crane, which the Company estimates its useful life to be four years.

Leasing equipment is tested for impairment whenever events or changes in circumstances indicate that its carrying amount may not be recovered. Key indicators of impairment on leasing equipment include, among other factors, a sustained decrease in operating profitability, a sustained decrease in utilization, or indications of technological obsolescence.

Equipment off Lease

Equipment off lease arises when the Company repossesses collateral that secured a financing receivable in a customer default scenario. Such equipment is intended to be sold and is classified as assets held for sale, in accordance with the provisions of ASC 360, Property, Plant & Equipment. A write-down of the financing receivable is recorded as a charge-off when the carrying amount exceeds the fair value and the difference relates to credit quality. At the time of repossession, the financing receivable is transferred to equipment off lease at the lower of cost or fair value. At December 31, 2022 and December 31, 2021, the Company had no equipment off lease in the consolidated balance sheets.

A review for impairment of equipment off lease is performed at least annually or when events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. During the years ended December 31, 2022 and December 31, 2021, the Company recorded impairment charges of $2,571 and $8,873, respectively, which are included in provision for losses and impairments of equipment off lease on the consolidated statements of operations.

Derivative Instruments

The Company manages exposure to interest rates through the use of interest rate caps traded in the over-the-counter markets with other financial institutions. The Company does not enter into derivative financial instruments for speculative purposes. Derivative instruments are recognized at fair value and included in other assets in the consolidated balance sheets.

 

12


NEF Holdings, LLC and Subsidiaries

Notes to the Consolidated Financial Statements (continued)

(In Thousands)

 

2. Summary of Significant Accounting Policies (continued)

 

Derivative Instruments (continued)

Interest rate caps are used to manage the Company’s interest rate exposure on its senior secured credit facility. At December 31, 2022 and December 31, 2021, such derivatives had a notional amount of $45,000 and $75,000, respectively, and a fair value of $1,865 and $307, respectively, which are included in other assets in the consolidated balance sheets. For the years ended December 31, 2022 and December 31, 2021, changes in fair value of interest rate caps totaled $1,558 and $86, respectively.

The Company designated certain of these interest rate caps as highly effective hedges. On the date the derivative contract is entered into, the Company formally documents the relationships between the hedging instrument and the hedged item, as well as its risk management objective and strategy for undertaking various hedge transactions. Hedge effectiveness is measured at the hedge’s inception and, on an on-going basis, to determine whether the derivatives are highly effective in offsetting the changes in cash flows of the hedged item.

At December 31, 2022, the Company held two interest rate caps that were deemed highly effective that had a notional value of $30,000 and a fair value of $1,206. Changes in fair values of interest rate caps, which were deemed highly effective, totaled $1,194 and are included in other comprehensive income, offset by reclassification gains into earnings of $98. Reclassifications into earnings are included in interest expense in the consolidated statements of operations. At December 31, 2022, the Company also held an interest rate cap that was not deemed highly effective that had a notional value of $15,000 and a fair value of $659. Changes in fair values of interest rate caps, which were not deemed highly effective, totaled $462 and $86 for the years ended December 31, 2022 and December 31, 2021, respectively, and are included in interest expense in the consolidated statements of operations.

Debt

Senior secured credit facility represents the Company’s principal balance under its long-term revolver, which is carried at amortized cost, along with the related accrued interest payable, net of unamortized deferred financing costs.

Loans from affiliate represent the Company’s unpaid principal balance on term loans, along with the related accrued interest payable to SLR, a related party, as described in note 1. Maturity dates range from January 24, 2023 through April 27, 2025 and carry interest rates ranging from 8.37% to 11.52%. Future scheduled payments on loans from affiliate are $5,457 in 2023, $7,996 in 2024, and $2,884 in 2025.

Deferred Financing Costs

Deferred financing costs represent fees and other incremental costs incurred in connection with the financing of the Company’s senior secured credit facility. Such costs are amortized using the straight-line method into earnings over the contractual term of the facility. The unamortized balance of such costs are included as a reduction to the senior secured credit facility balance.

Contingencies and Commitments

The Company may be subject to various legal proceedings, claims, and litigation, either asserted or unasserted that arise in the ordinary course of business. The Company records accruals for contingent losses when such losses are probable and reasonably estimable. In the event that estimates or assumptions prove to differ from actual results, adjustments are made in subsequent periods to reflect more current information. Legal fees are expensed as incurred.

 

13


NEF Holdings, LLC and Subsidiaries

Notes to the Consolidated Financial Statements (continued)

(In Thousands)

 

2. Summary of Significant Accounting Policies (continued)

 

Financial Asset Transfers

The Company accounts for transfers of financial assets under FASB ASC 860, Transfers and Servicing, utilizing a control oriented, financial components approach to financial asset transfer transactions whereby the Company: (1) recognizes the financial and servicing assets it controls and the liabilities it has incurred; (2) derecognizes financial assets when control has been surrendered; and (3) derecognizes liabilities once they are extinguished. Control is considered to have been surrendered only if: (i) the transferred assets have been isolated from the Company and its creditors, even in the event of bankruptcy or other receivership; (ii) the purchaser has the right to pledge or exchange the transferred assets, or, is a qualifying special purpose entity (as defined) and the holders of beneficial interests in that entity have the right to pledge or exchange those interests; and (iii) the Company does not maintain effective control over the transferred assets through an agreement which both entitles and obligates it to repurchase or redeem those assets prior to maturity, or through an agreement which both entitles or obligates it to repurchase or redeem those assets if they were not readily obtainable elsewhere. If any of these conditions are not met, the Company accounts for the transfer as a secured borrowing.

Foreign Currencies

Assets and liabilities recorded in foreign currencies are translated at the exchange rate on the date of the consolidated balance sheets. Income and expenses are translated at average rates of exchange prevailing during the year. Translation adjustments resulting from this process, which totaled ($19) for both years ended December 31, 2022 and December 31, 2021, are recorded in other income in the consolidated statements of operations. At December 31, 2022 and December 31, 2021, the Company had cash, financing receivables and debt denominated in the Canadian dollar.

Income Taxes

The Company is a LLC and has elected to be taxed as a partnership. Accordingly, the Company is not subject to federal or state income taxes. Taxable income, losses and deductions flow through to the Company’s members.

Fair Value Measurement

Fair value is defined as the amount for which an asset could be exchanged, or a liability settled, between knowledgeable, willing parties in an arm’s length transaction at the measurement date. In determining fair value of financial instruments and intangibles, the Company uses various valuation approaches, which utilize certain assumptions that market participants would use in pricing the asset or liability, including assumptions about risk to the valuation technique. The inputs can be readily observable, market corroborated or generally unobservable internal inputs. The Company utilizes valuation techniques that rely on both observable and unobservable inputs.

Leases

The Company accounts for leases in accordance with ASC 842, Leases. Included in other assets and other liabilities on the consolidated balance sheets as of December 31, 2022 and December 31, 2021, are right of use assets and corresponding lease obligations, associated with the Company’s office spaces, of $3,267 and $4,218, respectively. The Company paid $456 and $579 for the years ended December 31, 2022 and December 31, 2021, respectively, for such leases. The Company’s aggregate scheduled remaining contractual payments under these leases are $385, $393, $401, $409, $417 and $1,637 for 2023, 2024, 2025, 2026, 2027 and thereafter, respectively.

 

14


NEF Holdings, LLC and Subsidiaries

Notes to the Consolidated Financial Statements (continued)

(In Thousands)

 

2. Summary of Significant Accounting Policies (continued)

 

Goodwill and Intangible Asset

Goodwill represents the excess of consideration paid for the Company over the fair value of the related assets acquired and liabilities assumed from the acquisition of the Company on July 31, 2017, as discussed in note 1. As discussed in note 4, in connection with the acquisition of the assets of one of its former customers, the Company acquired an intangible asset related to customer relationships with a five year useful life. For the years ended December 31, 2022 and December 31, 2021, the Company recorded amortization expense of $0 and $1,669, respectively. In February 2022, the Company sold substantially all of the assets of NEF Auto Transport, including the intangible asset related to customer relationships of $767 (see note 4).

The Company assesses goodwill for impairment, annually or more frequently if events or changes in circumstances

occur, by comparing the carrying value to its fair value. If the fair value is less than the carrying value, an impairment charge is recorded in that period. Goodwill recognized in business combinations is assigned to the reporting units that are expected to benefit from the combination as of the acquisition date. Goodwill is not amortized; rather goodwill is tested annually for impairment or more frequently upon the occurrence of certain events or substantive changes in circumstances. The Company has the option to perform a qualitative assessment to determine if an impairment is more likely than not to have occurred. If the conclusion is supported that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then the Company would not need to perform a quantitative impairment test. If the conclusion cannot be supported, or if the Company does not elect to do the qualitative assessment, then the Company will perform a quantitative assessment. If a quantitative goodwill impairment test is performed, the Company utilizes a combination of market and income valuation approaches. If the fair value of a reporting unit is less than its carrying value, an impairment loss is recorded to the extent that the fair value of the reporting unit is less than its carrying value. No impairment of goodwill resulted from the annual impairment assessment in 2022 or 2021.

3. New Accounting Pronouncements

In June 2016, the FASB issued ASU 2016-13Financial Instruments – Credit Losses. This amendment will require companies to broaden the information considered in developing its expected credit loss estimates on financing receivables measured either individually or collectively. In November 2019, the FASB issued ASU 2019-10, Financial Instruments – Credit Losses, which delayed the effective date of ASU 2016-13. This amendment is effective for the Company for the fiscal year beginning after December 15, 2022. The Company has evaluated the impact that this standard will have on its consolidated balance sheets and consolidated statements of operations, and has determined that the impact will be immaterial to the consolidated financial statements as a whole.

4. Business Combinations

On December 11, 2018, the Company, through its wholly owned subsidiary NEF Auto Transport, acquired the assets of a privately held auto transport hauler. The entity, which was one of the Company’s former customers, was acquired out of bankruptcy in satisfaction of all of the amounts due to the Company. Total consideration of $7,082 (of which $250 was in the form of cash) was allocated to the fair value of the identifiable assets acquired and liabilities assumed. In connection with the acquisition, the Company recorded an intangible asset of $3,950, which was included in other assets in the consolidated balance sheets, net of accumulated amortization.

 

15


NEF Holdings, LLC and Subsidiaries

Notes to the Consolidated Financial Statements (continued)

(In Thousands)

 

4. Business Combinations (continued)

 

On January 17, 2019, the Company, through its wholly owned subsidiary NEF Auto Transport, acquired a privately owned auto transport carrier based in Enumclaw, Washington. Total consideration of $975 was allocated to the fair value of the identifiable assets acquired and liabilities assumed, which included cash of $33, receivables of $197, fixed assets of $788, other assets of $37, and payables of $80.

During 2019, the Company integrated the operations of both auto transport carriers to form one business and reporting unit. For the years ended December 31, 2022 and December 31, 2021 such operations generated net losses of $17 and $4,367, respectively, which included revenues of $517 and $3,350, respectively and direct costs of $534 and $3,519, respectively.

In February 2022, the Company sold substantially all of the assets of NEF Auto Transport for gross proceeds of $2,850, which included $150 of cash at closing and the remainder in the form of a note from the buyer which is included in financing receivables in the consolidated balance sheets. The assets sold included auto hauling trucks and ancillary equipment of $1,683 and an intangible asset related to customer relationships of $767, both of which are included in other assets held for sale on the consolidated balance sheets at December 31, 2021. Subsequent to the sale, the Company ceased all operations of NEF Auto Transport.

5. Financing Receivables

Net investment in direct finance leases consists of the following at December 31, 2022 and December 31, 2021:

 

     2022      2021  

Gross finance lease receivables

   $ 106,866      $ 120,036  

Guaranteed residuals

     15,108        22,729  

Unguaranteed residuals

     12,088        18,838  

Unearned income

     (22,425      (27,317

Deferred non-refundable fees collected

     (281      (370

Deferred initial direct costs paid

     480        549  
  

 

 

    

 

 

 
     111,836        134,465  

Purchase accounting valuation adjustment

     (112      (112
  

 

 

    

 

 

 

Total net investment in direct finance leases

   $ 111,724      $ 134,353  
  

 

 

    

 

 

 

Secured loans, net, consist of the following at December 31, 2022 and December 31, 2021:

 

     2022      2021  

Secured loans, principal

   $ 84,294      $ 80,252  

Accrued interest receivable

     336        314  
  

 

 

    

 

 

 

Total secured loans, gross

     84,630        80,566  

Deferred non-refundable fees collected

     (54      (67

Deferred initial direct costs paid

     402        449  
  

 

 

    

 

 

 
     84,978        80,948  

Purchase accounting valuation adjustment

     (976      (976
  

 

 

    

 

 

 

Total secured loans, net

   $ 84,002      $ 79,972  
  

 

 

    

 

 

 

 

16


NEF Holdings, LLC and Subsidiaries

Notes to the Consolidated Financial Statements (continued)

(In Thousands)

 

5. Financing Receivables (continued)

 

Aggregate scheduled payments, contractual maturities including guaranteed residuals and unguaranteed residuals by year on the fixed and floating-rate secured loans and direct finance leases at December 31, 2022, are as follows:

 

     2023      2024      2025      2026      2027      Thereafter      Total  

Secured loans:

                    

Fixed Rate

   $ 34,884      $ 17,084      $ 9,764      $ 12,283      $ 6,723      $ —        $ 80,738  

Floating Rate

     3,556        —          —          —          —          —          3,556  

Direct Finance Leases

     37,514        28,047        32,104        22,537        5,186        8,674        134,062  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 75,954      $ 45,131      $ 41,868      $ 34,820      $ 11,909      $ 8,674      $ 218,356  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

6. Allowance for Losses on Financing Receivables

The Company monitors the internal risk rating of each customer. The internal risk rating was developed by the Company and is fully described in the Company’s credit policies and procedures. The internal risk rating gives heavy weighting to collateral coverage and fixed charge coverage of the customer. It also takes into account the customer’s leverage as well as subjective factors including industry cyclicality, quality of management and liquidity.

A financing receivable is considered impaired when it is probable that the Company will be unable to collect all amounts due according to the contractual terms of the agreement. As of December 31, 2022 and December 31, 2021, the Company maintained a specific allowance for losses of $1,659 and $0 on financing receivables of $4,318 and $0, respectively, and a general allowance for losses of $3,237 and $3,339, respectively, on the remaining portfolio of financing receivables.

7. Equipment on Lease, net

At December 31, 2022, the Company had no equipment under operating lease. At December 31, 2021, equipment under operating lease consists of a crane with a cost basis of $1,470, net of accumulated depreciation of $270 for a net balance of $1,200. Total depreciation expense relating to equipment under operating leases for the years ended December 31, 2022 and December 31, 2021 was $0 and $342, respectively, and is included in depreciation and amortization expense on the consolidated statements of operations. Income from operating leases totaled $0 and $553 for the years ended December 31, 2022 and December 31, 2021, respectively.

8. Fixed Assets, net

At December 31, 2022 and December 31, 2021, fixed assets, net consists of the following:

 

     2022      2021  

Leasehold improvements

   $ 153      $ 153  

Furniture and fixtures

     141        148  

Automobile

     59        59  

Office equipment

     45        40  

Computers

     35        53  

Software

     30        34  
  

 

 

    

 

 

 

Fixed assets, gross

     463        487  

Accumulated depreciation

     (138      (109
  

 

 

    

 

 

 

Fixed assets, net

   $ 325      $ 378  
  

 

 

    

 

 

 

 

17


NEF Holdings, LLC and Subsidiaries

Notes to the Consolidated Financial Statements (continued)

(In Thousands)

 

8. Fixed Assets, net (continued)

 

Depreciation and amortization expense related to fixed assets totaled $86 and $897 for the years ended December 31, 2022 and December 31, 2021, respectively. For the years ending 2023, 2024 and 2025, the Company will recognize annual amortization expense related to software of $8, $6, and $2, respectively.

9. Senior Secured Credit Facility

Senior secured credit facility consists of the following at December 31, 2022 and December 31, 2021:

 

     2022      2021  

Senior secured credit facility, principal

   $ 114,977      $ 118,002  

Accrued interest payable

     674        242  

Unamortized deferred financing costs

     (280      (761
  

 

 

    

 

 

 

Total senior secured credit facility

   $ 115,371      $ 117,483  
  

 

 

    

 

 

 

At December 31, 2022 and December 31, 2021, Fund I maintained a revolving credit facility (the “Facility”) which consists of two separate revolvers, one for U.S. dollars and one for Canadian dollars. The total availability on the U.S. dollar revolver is $180,000 and the total availability on the Canadian dollar revolver is the lesser of CAD 45,000 and the U.S. dollar equivalent of $33,957. Interest is based on London Interbank Offering Rate (“LIBOR”), plus an applicable margin. The applicable margin ranges from 2.25% to 2.50% based on Fund I’s leverage ratio. The leverage ratio represents the ratio of the outstanding balance of the Facility to Fund I’s total member’s capital, as described in the Facility agreement. All assets of Fund I are pledged as collateral under the Facility. Fund I is also required to pay a 0.375% per annum unused line fee. The Facility requires Fund I and the Company to maintain certain periodic financial covenants surrounding capitalization, cash flow and default, delinquency and charge-off ratios. The Company provides a limited guaranty to the Facility for all interest, fees and expenses that cannot otherwise be charged to Fund I. The Facility has a contractual maturity date of July 31, 2023, with the principal payable in full at maturity. The Company expects to renew the facility in early 2023.

10. Employee Compensation and Benefit Plans

As of December 31, 2022, the Company employed personnel at its headquarters in Wilton, Connecticut and regional offices throughout the United States. Employee compensation and benefits are comprised of base salaries, discretionary bonuses, health care benefits, employer 401(k) contributions and payroll taxes. As a part of their employment agreements, certain members of senior management are eligible for an annual bonus amount, which is calculated as a percentage of their annual salaries, based on certain financial performance metrics, as described in their employment agreements.

Effective August 1, 2017, the Company formed a Long-Term Incentive Plan (“LTIP”) that provides for an annual bonus pool to certain members of senior management based on the Company achieving certain performance criteria.

The Company sponsors a 401(k) plan, where the Company contributes a defined percentage of employees’ annual earnings up to the maximum annual contribution amount as determined by the Internal Revenue Service.

 

18


NEF Holdings, LLC and Subsidiaries

Notes to the Consolidated Financial Statements (continued)

(In Thousands)

 

11. Fair Value of Financial Instruments

 

FASB ASC 820, Fair Value Measurements (“ASC 820”), establishes a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect management’s market assumptions.

These two types of inputs create the following fair value hierarchy:

Level 1 – Quoted prices for identical instruments in active markets.

Level 2 – Observable inputs other than quoted prices in active markets for identical assets and liabilities, such as interest rates and foreign exchange rates that are observable at commonly quoted intervals. Financial assets utilizing Level 2 inputs include interest rate caps.

Level 3 – Unobservable inputs.

As of December 31, 2022 and December 31, 2021, the Company measured its interest rate caps at fair value on a recurring basis. Total fair value of such derivative instruments as of December 31, 2022 and December 31, 2021 was $1,865 and $307, respectively, which was classified as Level 2 in the fair value hierarchy by the Company. The fair value of interest rate caps are measured using discounted cash flow calculations based on observable inputs from the relevant interest/exchange rate curves in effect at December 31, 2022 and December 31, 2021.

ASC 820 also requires that the Company disclose estimated fair values for its financial instruments. No quoted market exists for the Company’s financial instruments. Therefore, fair value estimates are based on judgments, risk characteristics of various financial instruments and other factors. Changes in these assumptions could significantly affect the estimates.

The Company estimates the carrying amounts of cash approximated its fair values as of December 31, 2022 and December 31, 2021. Since there is no liquid secondary market for the Company’s financing receivables, the Company estimates the fair value of its secured loans and net investment in direct finance leases by comparing the average yield of the portfolio to recent issuances of similar loans and leases. Further, based on the Company’s review of the terms of the Facility and its loans from affiliate, as well as valuations from its lenders, management determined that the carrying value of its senior secured credit facility approximated fair value.

The carrying amount and estimated fair values of the Company’s financial instruments at December 31, 2022 and December 31, 2021 were as follows:

 

     2022      2021  
     Carrying
Amount
     Estimated
Fair Value
     Carrying
Amount
     Estimated
Fair Value
 

Financial assets:

           

Cash and restricted cash

   $ 12,710      $ 12,710      $ 9,060      $ 9,060  

Net investment in direct finance leases

     108,264        108,130        132,370        132,491  

Secured loans, net

     82,566        81,157        78,616        78,814  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total financing receivables, net of allowances

     190,830        189,287        210,986        211,305  

Financial liabilities:

           

Senior secured credit facility

   $ 115,371      $ 115,371      $ 117,483      $ 116,571  

Loans from Affiliate

     16,342        16,482        30,703        30,703  

 

19


NEF Holdings, LLC and Subsidiaries

Notes to the Consolidated Financial Statements (continued)

(In Thousands)

 

12. Concentration of Credit Risk

 

Financing receivables subject the Company to credit risk. The Company monitors its portfolios by evaluating each of the customer’s financial condition and collateral. The Company’s maximum exposure to credit risk at December 31, 2022 and December 31, 2021, without considering the underlying collateral, is represented by the carrying value of the financing receivables in the consolidated balance sheets. The Company monitors its financing receivables for geographic concentrations.

The following table reflects such concentrations as of December 31, 2022 and December 31, 2021:

 

Geographic Concentration  
     2022           2021  

Texas

   $ 32,153      Colorado    $ 26,904  

New York

     23,935      Texas      24,079  

Colorado

     22,564      Washington      23,010  

Louisiana

     16,759      Louisiana      19,410  

Kentucky

     13,635      New York      17,622  

Missouri

     13,301      Missouri      13,564  

Tennessee

     8,032      Pennsylvania      9,777  

Pennsylvania

     6,883      Florida      7,750  

British Columbia (Canada)

     6,440      Kentucky      6,219  

Florida

     6,377      North Carolina      5,476  

Washington

     4,678      Wisconsin      5,028  

Wisconsin

     4,520      Massachusetts      4,791  

Maine

     4,318      Maine      4,440  

Other U.S. states / Canada

     32,131      Other U.S. states / Canada      46,255  
  

 

 

       

 

 

 

Total financing receivables, gross

   $ 195,726      Total financing receivables, gross    $ 214,325  
  

 

 

       

 

 

 

The amount and type of collateral required depends on an assessment of the credit risk of the counterparty. Guidelines are implemented regarding the acceptability of types of collateral and valuation parameters. Typically, the Company obtains access to collateral either through direct ownership or by a first lien security interest.

The Company also monitors its financing receivables for collateral concentrations. The following tables reflect such concentrations as of December 31, 2022 and December 31, 2021:

 

Collateral Concentrations  
     2022           2021  

Tractors

   $ 23,051      Tow boats    $ 23,010  

Barge rigs

     18,283      Tractors      20,097  

Trucks

     13,947      Barge rigs      18,283  

Loaders

     13,732      Helicopters      18,112  

Barges

     13,224      Cranes      17,751  

Aircraft

     12,671      Aircraft      12,594  

Package sorting equipment

     11,439      Flight Simulators      11,785  

All other

     89,379      All other      92,693  
  

 

 

       

 

 

 

Total financing receivables, gross

   $ 195,726      Total financing receivables, gross    $ 214,325  
  

 

 

       

 

 

 

At December 31, 2022 and December 31, 2021, the Company had financing receivables outstanding to one customer that approximated 9% and 9%, respectively, of total financing receivables for each period.

 

20


NEF Holdings, LLC and Subsidiaries

Notes to the Consolidated Financial Statements (continued)

(In Thousands)

 

13. Contingencies and Commitments

 

As of December 31, 2022, the Company had a U.S. and a Canadian revolver financing arrangement with a total outstanding balance of $3,593 and CAD 637 respectively, which are included in financing receivables, net in the consolidated balance sheets. As of December 31, 2021, the Company had a U.S. and a Canadian revolver financing arrangements with a total outstanding balance of $3,530 and CAD 455 respectively, which are included in financing receivables, net in the consolidated balance sheets. The Company’s maximum commitments under the U.S. and Canadian revolvers were $4,000 and CAD 1,500, respectively, for both years ending December 31, 2022 and December 31, 2021.

14. Member’s Capital

At December 31, 2022 and December 31, 2021, NEFCORP owns 100 Class A units and NEFPASS owns 100 Class B units, which represent the entire capital of the Company.

15. Subsequent Events

The Company has evaluated subsequent events through February 16, 2023, the issuing date of the consolidated financial statements.

 

21

EX-99.3 18 d437884dex993.htm EX-99.3 EX-99.3

Exhibit 99.3

KBH Topco, LLC

Consolidated Financial Statements and

Independent Auditor’s Report

December 31, 2022 and 2021


KBH TOPCO, LLC

TABLE OF CONTENTS

 

 

 

     Page  

INDEPENDENT AUDITOR’S REPORT

     1 - 2  

CONSOLIDATED FINANCIAL STATEMENTS

  

Consolidated Balance Sheets

     3  

Consolidated Statements of Comprehensive Income

     4  

Consolidated Statements of Changes in Members’ Equity

     5  

Consolidated Statements of Cash Flows

     6  

Notes to the Consolidated Financial Statements

     7 - 18  


LOGO

INDEPENDENT AUDITOR’S REPORT

To the Management of

KBH Topco, LLC

Opinion

We have audited the accompanying consolidated financial statements of KBH Topco, LLC, which comprise the consolidated balance sheets as of December 31, 2022 and 2021, and the related consolidated statements of comprehensive income, changes in members’ equity, and cash flows for the years ended December 31, 2022 and 2021, and the related notes to the consolidated financial statements.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of KBH Topco, LLC as of December 31, 2022 and 2021, and the results of its operations and its cash flows for the years then ended, in accordance with accounting principles generally accepted in the United States of America.

Basis for Opinion

We conducted our audits in accordance with auditing standards generally accepted in the United States of America. Our responsibilities under those standards are further described in the Auditor’s Responsibilities for the Audit of the Consolidated Financial Statements section of our report. We are required to be independent of KBH Topco, LLC and to meet our other ethical responsibilities in accordance with the relevant ethical requirements relating to our audits. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

Responsibilities of Management for the Consolidated Financial Statements

Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with

accounting principles generally accepted in the United States of America, and for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the consolidated financial statements, management is required to evaluate whether there are conditions or events considered in the aggregate, that raise substantial doubt about KBH Topco, LLC’s ability to continue as a going concern within one year after the date that the consolidated financial statements are available to be issued.

Auditor’s Responsibilities for the Audit of the Consolidated Financial Statements

Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with generally accepted auditing standards will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the consolidated financial statements.

 

LOGO


In performing an audit in accordance with generally accepted auditing standards, we:

 

   

Exercise professional judgment and maintain professional skepticism throughout the audit.

 

   

Identify and assess the risks of material misstatement of the consolidated financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements.

 

   

Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of KBH Topco, LLC’s internal control. Accordingly, no such opinion is expressed.

 

   

Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the consolidated financial statements.

 

   

Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about KBH Topco, LLC’s ability to continue as a going concern for a reasonable period of time.

We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control related matters that we identified during the audit.

 

LOGO

Bannockburn, Illinois

February 15, 2023


KBH TOPCO, LLC

CONSOLIDATED BALANCE SHEETS

DECEMBER 31, 2022 AND 2021

 

ASSETS  
     2022      2021  

Cash

   $ 6,155,829      $ 7,049,803  

Accounts receivable, net

     15,652,128        16,503,537  

Inventory, prepaid expenses, deposits and other assets

     6,277,886        8,079,273  

Investment in sales-type and direct finance leases, net

     79,084,973        80,796,043  

Equipment under operating leases at cost, net of accumulated depreciation of $144,939,920 and $88,877,030 as of December 31, 2022 and 2021, respectively

     530,350,075        490,109,858  

Equipment used in operations at cost, net of accumulated depreciation of $323,402 and $178,018 as of December 31, 2022 and 2021, respectively

     541,173        521,899  

Right-of-use assets, real estate used in operations

     3,724,781        —    

Goodwill

     135,364,402        135,364,402  
  

 

 

    

 

 

 
   $ 777,151,247      $ 738,424,815  
  

 

 

    

 

 

 
LIABILITIES AND MEMBERS’ EQUITY  

LIABILITIES

     

Accounts payable and accrued expenses

   $ 15,685,699      $ 13,840,502  

Leased equipment accounts payable

     19,879,045        17,648,150  

Customer deposits and advanced payments

     2,361,870        6,600,875  

Lease liabilities, real estate used in operations

     3,795,511        —    

Distributions payable

     4,500,000        4,000,000  

Deferred income tax liability

     9,637,123        5,042,391  

Notes payable - Recourse

     135,252,630        125,094,236  

Secured borrowings

     63,134,022        102,353,580  

Notes payable - Non-recourse

     296,835,798        233,276,889  

Senior secured debt - Related-party

     80,000,000        80,000,000  
  

 

 

    

 

 

 
     631,081,698        587,856,623  

MEMBERS’ EQUITY

     146,069,549        150,568,192  
  

 

 

    

 

 

 
   $ 777,151,247      $ 738,424,815  
  

 

 

    

 

 

 

 

The accompanying notes are an integral part of these statements.

 

Page 3


KBH TOPCO, LLC

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

YEARS ENDED DECEMBER 31, 2022 AND 2021

 

     2022     2021  

REVENUE

    

Leasing revenues

   $ 177,594,714     $ 164,829,634  

Sales of equipment and software

     111,468,003       74,367,255  

Transfers of financial assets

     3,619,883       5,392,972  

Service revenues

     1,365,200       1,201,238  

Other income

     4,712,363       97,399  
  

 

 

   

 

 

 
     298,760,163       245,888,498  
  

 

 

   

 

 

 

DIRECT LEASING EXPENSES AND COST OF EQUIPMENT SOLD

    

Depreciation of equipment

     83,870,441       85,447,004  

Interest expense - Recourse debt

     5,964,426       4,518,691  

Interest expense - Secured borrowings

     4,093,820       6,086,340  

Interest expense - Non-recourse debt

     10,547,276       8,438,114  

Interest expense - Senior secured debt - related party

     7,315,080       6,488,889  

Cost of goods and services sold

     128,513,108       88,145,805  
  

 

 

   

 

 

 
     240,304,151       199,124,843  
  

 

 

   

 

 

 

GROSS MARGIN

     58,456,012       46,763,655  

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

     40,326,719       30,277,701  
  

 

 

   

 

 

 

INCOME BEFORE INCOME TAX PROVISION

     18,129,293       16,485,954  

INCOME TAX PROVISION

     4,841,905       4,334,549  
  

 

 

   

 

 

 

NET INCOME

     13,287,388       12,151,405  

OTHER COMPREHENSIVE LOSS

    

Foreign currency translation adjustment

     (386,031     (158,345
  

 

 

   

 

 

 

COMPREHENSIVE INCOME

   $ 12,901,357     $ 11,993,060  
  

 

 

   

 

 

 

 

The accompanying notes are an integral part of these statements.

 

Page 4


KBH TOPCO, LLC

CONSOLIDATED STATEMENTS OF CHANGES IN MEMBERS’ EQUITY

YEARS ENDED DECEMBER 31, 2022 AND 2021

 

                  Accumulated        
                  Other        
     Common Units     Comprehensive        
     Units      Amount     Income (loss)     Total  

BALANCE - JANUARY 1, 2021

     84,000,000      $ 155,670,420     $ 247,570     $ 155,917,990  

Net income

     —          12,151,405       —         12,151,405  

Other comprehensive loss

     —          —         (158,345     (158,345

Distributions

     —          (17,342,858     —         (17,342,858
  

 

 

    

 

 

   

 

 

   

 

 

 

BALANCE - DECEMBER 31, 2021

     84,000,000        150,478,967       89,225       150,568,192  

Net income

     —          13,287,388       —         13,287,388  

Other comprehensive loss

     —          —         (386,031     (386,031

Distributions

     —          (17,400,000     —         ( 17,400,000
  

 

 

    

 

 

   

 

 

   

 

 

 

BALANCE - DECEMBER 31, 2022

     84,000,000      $ 146,366,355     $ (296,806   $ 146,069,549  
  

 

 

    

 

 

   

 

 

   

 

 

 

 

The accompanying notes are an integral part of these statements.

 

Page 5


KBH TOPCO, LLC

CONSOLIDATED STATEMENTS OF CASH FLOWS

YEARS ENDED DECEMBER 31, 2022 AND 2021

 

     2022     2021  

CASH FLOWS FROM OPERATING ACTIVITIES

    

Net income

   $ 13,287,388     $ 12,151,405  

Adjustments to reconcile net income to net cash provided by operating activities:

    

Sales-type and direct finance lease receipts

     33,708,587       40,404,348  

Earned income from sales-type and direct finance leases

     (4,375,939     (5,157,268

Depreciation and amortization

     84,031,835       85,617,265  

Non-cash lease expense, real estate used in operations

     733,593       —    

Provision for losses and impairments of equipment off lease

     14,430,739       15,224,574  

Deferred income taxes

     4,594,732       4,283,422  

Changes in operating assets and liabilities:

    

Accounts receivable

     851,409       1,188,541  

Inventory, prepaid expenses, deposits and other assets

     859,297       618,299  

Accounts payable and accrued expenses

     1,845,197       2,968,563  

Customer deposits and advanced payments

     (4,239,005     (788,729

Lease liabilities, real estate used in operations

     (662,863     —    
  

 

 

   

 

 

 

Net Cash Provided By Operating Activities

     145,064,970       156,510,420  
  

 

 

   

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES

    

Investment in sales-type and direct finance leases

     (30,745,196     (30,298,539

Purchases of equipment under operating leases

     (200,232,804     (149,176,126

Proceeds from sales of equipment and software

     68,007,509       49,299,822  

Purchases of equipment used in operations

     (200,167     (96,134
  

 

 

   

 

 

 

Net Cash Used In Investing Activities

     (163,170,658     (130,270,977
  

 

 

   

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

    

Proceeds from notes payable - recourse

     326,431,257       233,345,186  

Principal payments on notes payable - recourse

     (316,272,863     (232,795,537

Principal payments on secured borrowings

     ( 39,219,558     (40,993,404

Proceeds from notes payable - non-recourse

     196,829,996       185,871,270  

Principal payments on notes payable - non-recourse

     (133,271,087     (159,645,661

Distributions paid

     (16,900,000     (13,342,858
  

 

 

   

 

 

 

Net Cash Provided By (Used In) Financing Activities

     17,597,745       (27,561,004
  

 

 

   

 

 

 

EFFECTS OF CURRENCY TRANSLATION

     (386,031     ( 158,345
  

 

 

   

 

 

 

NET CHANGE IN CASH

     (893,974     (1,479,906

CASH - BEGINNING OF YEAR

     7,049,803       8,529,709  
  

 

 

   

 

 

 

CASH - END OF YEAR

   $ 6,155,829     $ 7,049,803  
  

 

 

   

 

 

 

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION

    

Interest paid

   $ 27,710,221     $ 26,747,795  
  

 

 

   

 

 

 

SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING ACTIVITIES

    

Business combination measurement period adjustments

   $ —       $ 1,450,621  
  

 

 

   

 

 

 

 

The accompanying notes are an integral part of these statements.

 

Page 6


KBH TOPCO, LLC

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 – DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation and Financial Reporting. The accompanying consolidated financial statements include the accounts of KBH Topco, LLC, a Delaware limited liability company (“KBHT”) formed on October 29, 2020, and its wholly-owned subsidiaries (each organized as either a Nevada limited liability company or a Delaware limited liability company), collectively referred to as the “Company.” All significant intercompany accounts and transactions have been eliminated in consolidation. In November 2020, 87.50% of the Company was acquired by SLR Investment Corp. f/k/a Solar Capital Ltd. (“SLR”).

Description of Business. The Company leases, rents, sells, manages, and remarkets technology, industrial, healthcare, and other general equipment and software. Their customers are located throughout the United States, Canada, France, Spain, Italy, and the United Kingdom.

Management Estimates and Assumptions. The preparation of these consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates. Significant estimates and assumptions are used for, but not limited to: (1) estimated useful lives and residual values of equipment under operating and sales-type leases; (2) classification of leases; (3) impairment of equipment; (4) impairment of goodwill; (5) revenue recognition; (6) allowance for doubtful accounts; and (7) valuation of net deferred income tax assets or liabilities. Future events and their effects cannot be predicted with certainty; accordingly, accounting estimates require the exercise of judgment. Accounting estimates used in the preparation of these consolidated financial statements change as new events occur, as more experience is acquired, as additional information is obtained, and as the operating environment changes.

Concentration of Credit Risk. The Company regularly maintains bank balances that exceed Federal Deposit Insurance Corporation limits.

Leases. The Company adopted Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 842, Leases on January 1, 2022. The standard modifies the accounting, presentation and disclosures for both lessors and lessees. The Company elected the optional transition method to apply the transition provisions from the effective date of adoption, which requires the Company to report the cumulative effect of the standard on the date of adoption with no changes to the prior period balances. There was no cumulative effect to beginning members’ equity as of January 1, 2022, from the adoption of FASB ASC 842. Pursuant to the practical expedients, the Company elected not to reassess: (i) whether expired or existing contracts are or contain leases, (ii) the lease classification for any expired or existing leases, or (iii) initial direct costs for any existing leases.

Lessor Accounting - Leases not classified as a sales-type or direct finance lease are classified as operating leases. If a lease meets one or more of the following five criteria at lease commencement, the lease is classified as a sales-types lease:

 

   

The lease transfers ownership of the underlying asset to the lessee by the end of the lease term;

 

   

The lease grants the lessee an option to purchase the underlying asset that the lessee is reasonably certain to exercise;

 

   

The lease term is for a major part of the remaining estimated economic life of the underlying asset;

 

   

The present value of the sum of the lease payments and any residual value guaranteed by the lessee that is not already reflected in the lease payments equals or exceeds substantially all of the fair value of the underlying asset; or

 

   

The underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end of the lease.

When none of the sales-type lease criteria have been met, leases are classified as operating leases unless both of the following criteria are met, in which case the lessor shall classify the leases as direct finance leases: (1) the present value of the sum of the lease payments and any residual value guaranteed by the lessee and/or third party unrelated to the lessor equals or exceeds substantially all of the fair value of the underlying asset and (2) it is probable that the lessor will collect the lease payments plus any amount necessary to satisfy a residual value guarantee.

 

 

(Continued)

The accompanying notes are an integral part of these statements.

 

Page 7


KBH TOPCO, LLC

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 – DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Leases. Lessor Accounting (Concluded) – Residual Values - The estimated residual values of equipment at the end of the useful life are recorded at the inception of each lease. The estimated residual values vary as a percentage of the original equipment cost and depend upon the equipment type. Residual values for sales-type and direct finance leases are recorded at their net present value and the unearned income is amortized over the life of the lease using the effective interest method. The residual values for operating leases are included in the leased equipment’s net book value. The Company manages and evaluates residual value risk by performing periodic reviews and any impairment, other than temporary, is recorded in the period in which the impairment is determined. No upward revision of residual values is made subsequent to lease inception.

Property taxes paid by the lessor which are reimbursed be the lessee are considered to be lessor costs of owning the asset and are recorded gross with revenue in other income and expense recorded in selling, general and administrative expenses. The Company elected a lessor accounting policy to exclude sales taxes and other similar taxes on lease revenue-producing transactions collected from the lessee from revenue and expenses.

Lessor accounting was not fundamentally changed by FASB ASC 842 and remains similar to FASB ASC 840 and did not have a significant impact on classification of leases between sales-type, direct finance and operating.

Lessee Accounting - Operating lease right-of-use assets and operating lease liabilities are recognized at the present value of the future lease payments, generally for the base non-cancelable lease term, at the lease commencement date for each lease. The Company has elected a policy to use a risk-free rate as the discount rate used to determine the present value of the future lease payments because the interest rate implicit in most of the Company’s leases is not readily determinable. The Company’s lease agreements may contain lease and non-lease components. Variable lease payments are not included in the measurement of the right-of-use asset and lease liability, and they are recognized as lease expense is incurred.

Leases may contain options to renew or terminate lease terms. The exercise of these lease options is generally at the Company’s sole discretion and included in the right-of-use asset and lease liability. The Company elected to apply the short-term lease measurement and recognition exemption to its leases where applicable.

Variable lease payments predominantly relate to variable operating expenses including common area maintenance, property taxes and other operating expenses. The Company records the amortization of the right-of-use asset and the interest accretion on the lease liability for operating leases as a component of selling, general, and administrative expenses in the statement of comprehensive income.

When lease agreements provide allowances for leasehold improvements, the Company assesses whether it is the owner of the leasehold improvements for accounting purposes. When the Company concludes that it is the owner, it capitalizes the leasehold improvement assets and recognizes the related amortization expense on a straight-line basis over the lesser of the related lease term, including renewals that are reasonably assured of being exercised, or the estimated useful life of the asset. Additionally, the Company recognizes the amounts of allowances to be received from the lessor as a reduction of the lease liability and the associated right-of-use asset. When the Company concludes that it is not the owner, the payments that the Company makes towards the leasehold improvements are accounted for as a component of the lease payments.

Revenue Recognition. The Company recognizes revenue in accordance with the following accounting standards: (1) FASB ASC 842, Leases (FASB ASC 840 for the year ended December 31, 2021), (2) FASB ASC 860, Transfers and Servicing, and (3) FASB ASC 606, Revenue from Contracts with Customers.

Revenue from Leasing Transactions under FASB ASC 842 - The Company accounts for certain leasing revenues in accordance with FASB ASC 842. The accounting for revenue is different depending on the type of lease.

 

(Continued)

The accompanying notes are an integral part of these statements.

 

Page 8


KBH TOPCO, LLC

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 – DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Revenue Recognition (Continued). Revenue from Leasing Transactions under FASB ASC 842 (Concluded) - For sales-type and direct finance leases, the Company records the net investment in leases, which consists of the sum of the minimum lease payments, initial direct costs, and unguaranteed residual value for sales-type leases and guaranteed residual value for direct finance leases (gross investment) less the unearned income. Revenue for sales-type and direct finance leases is recognized as the unearned income is amortized over the life of the lease using the effective interest method. For operating leases, rental amounts are accrued on a straight-line basis over the lease term and are recognized as leasing revenue.

Leasing revenues consist of rentals due under operating leases and the amortization of unearned income on sales-type and direct finance leases. Equipment under operating leases is recorded at cost and depreciated on a straight-line basis over the useful life.

Revenue from the Transfer of Financial Assets under FASB ASC 860 - The Company enters into arrangements to transfer the contractual payments due under sales-type and direct finance leases, which are accounted for in accordance with FASB ASC 860. These transfers are accounted for as either a pledge of collateral in a secured borrowing or a sale. For transfers accounted for as a secured borrowing, the corresponding investments serve as collateral for recourse and non-recourse notes payable. For transfers accounted for as sales, the Company derecognizes the carrying value of the asset transferred plus any liability and recognizes a net gain or loss on the sale, which are presented as transfers of financial assets in the consolidated statements of comprehensive income.

Revenue from Sales of Equipment, Software and Services under FASB ASC 606 - Under FASB ASC 606, revenue is recognized when the Company satisfies its performance obligations, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services.

Revenue from contracts with customers is measured based on the consideration specified in the contract with the customer, and excludes any sales incentives and amounts collected on behalf of third parties. Contracts with customers may include multiple promises that are distinct performance obligations. For such arrangements, the Company allocates the transaction price to each performance obligation based on its relative standalone selling price. A performance obligation is a promise in a contract to transfer a distinct good or service to a customer. The Company recognizes revenue when it satisfies a performance obligation by transferring control over a product or service to a customer. The amount of revenue recognized reflects the consideration the Company expects to be entitled to in exchange for such goods or services. After completion of the performance obligation, the Company has an unconditional right to consideration as outlined in the contract.

Service Revenues - The Company maintains service contracts for maintenance and repair services to customers for the customer owned equipment. The Company’s arrangement is typically a single performance obligation comprised of a series of distinct services that are substantially the same and that have the same pattern of transfer. The Company typically recognizes sales from these services on a straight-line basis over the period services are provided. Payments are typically due within 30 days after an invoice is sent to the customer. Invoices for services are typically sent in advance.

Equipment and Software Sales - The Company sells equipment and software to both current lessees and third parties for leased equipment, brokerage of equipment, and lease transaction sales. Sales revenue is recorded at the amount of gross consideration received. Revenue is recognized at a point in time when the Company satisfies its performance obligations. Payments are typically due upon receipt of the invoice. Invoices for equipment and software sales are typically sent in advance.

The Company has adopted certain practical expedients under FASB ASC 606 with significant items disclosed herein. The Company has elected to apply the portfolio approach practical expedient allowed under FASB ASC 606 to evaluate contracts with customers that share the same revenue recognition patterns as the result of evaluating them as a group will have substantially the same result as evaluating them individually.

 

(Continued)

The accompanying notes are an integral part of these statements.

 

Page 9


KBH TOPCO, LLC

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 – DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Revenue Recognition (Concluded). Disaggregation of Revenue - The table below summarizes the Company’s revenues as presented in the consolidated statement of comprehensive income for the year ended December 31, 2022 by revenue type and by the applicable accounting standard:

 

     Year Ended December 31, 2022  
     FASB ASC 842      FASB ASC 860      FASB ASC 606      Total  

Operating lease revenues

   $ 173,218,775      $ —        $ —        $ 173,218,775  

Sales-type and direct finance lease revenues

     4,375,939        —          —          4,375,939  

Sales of equipment and software

     —          —          111,468,003        111,468,003  

Transfers of financial assets

     —          3,619,883        —          3,619,883  

Service revenues

     —          —          1,365,200        1,365,200  

Other income

     4,580,006        —          132,357        4,712,363  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total revenue

   $ 182,174,720      $ 3,619,883      $ 112,965,560      $ 298,760,163  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total revenue subject to FASB ASC 606 recognized at a point in time and over time was $111,600,360 and $1,365,200, respectively, for the year ended December 31, 2022.

The table below summarizes the Company’s revenues as presented in the consolidated statement of comprehensive income for the year ended December 31, 2021 by revenue type and by the applicable accounting standard:

 

     Year Ended December 31, 2021  
     FASB ASC 840      FASB ASC 860      FASB ASC 606      Total  

Leasing revenues

   $ 164,829,634      $ —        $ —        $ 164,829,634  

Sales of equipment and software

     —          —          74,367,255        74,367,255  

Transfers of financial assets

     —          5,392,972        —          5,392,972  

Service revenues

     —          —          1,201,238        1,201,238  

Other income

     —          —          97,399        97,399  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total revenue

   $ 164,829,634      $ 5,392,972      $ 75,665,892      $ 245,888,498  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total revenue subject to FASB ASC 606 recognized at a point in time and over time was $74,464,654 and $1,201,238, respectively, for the year ended December 31, 2021.

Accounts Receivable and Allowance for Doubtful Accounts. Accounts receivable represent customer obligations, which include base monthly, quarterly, and annual rentals due under the terms of each respective customer’s lease and equipment sales. The carrying amount of accounts receivable is reduced by an allowance that reflects management’s best estimate of amounts that will not be collected. The allowance for doubtful accounts was $162,739 and $11,759 as of December 31, 2022 and 2021, respectively.

Depreciation and Amortization. Depreciation provisions for revenue-producing equipment are computed using the straight-line method over the related useful life of the equipment, after giving effect to an estimated residual value. The useful lives for leased equipment range from approximately six and ten years. For other equipment used in operations, depreciation and amortization is computed using the straight-line method over the estimated useful lives of the assets, ranging from approximately three to eight years.

 

(Continued)

The accompanying notes are an integral part of these statements.

 

Page 10


KBH TOPCO, LLC

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 – DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Goodwill. Goodwill represents the excess of the consideration paid over the estimated fair value of the net assets acquired in a business combination. The Company performs an annual impairment test for goodwill at the entity level. There were no impairment charges or triggering events for the years ended December 31, 2022 or 2021.

Foreign Operations. The functional currencies for the consolidated foreign operations are the Canadian dollar, Euro, and British pound. The translation of the applicable foreign currencies into U.S. dollars is performed for monetary balance sheet accounts using current exchange rates in effect at the balance sheet date and for revenue and expense accounts using a weighted average exchange rate during the period. Nonmonetary balance sheet accounts and related revenue, expense, gain and loss accounts are remeasured using historical rates to produce the same results as if the items had been initially recorded in U.S. dollars. The gains or losses resulting from such translation of the Canadian dollar, Euro, and British pound are included as a component of accumulated other comprehensive income in members’ equity. Assets located outside the United States and subject to foreign currency denominated transactions totaled $9,008,605 and $7,888,439 as of December 31, 2022 and 2021, respectively.

Income Taxes. The Company was formed as a limited liability company and elected to be taxed as a C-Corporation. Deferred income taxes are provided using the liability method whereby deferred income tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred income tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred income tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred income tax assets will not be realized. Deferred income tax assets and liabilities are adjusted for the effects of the changes in tax laws and rates at the date of enactment. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred income tax assets and liabilities.

KBHT’s wholly-owned subsidiaries are disregarded entities for income tax purposes. Their operations are combined with the operations of KBHT and reported together in one income tax return.

Fair Value Measurements. Fair value accounting guidance defines fair value, establishes a framework for measuring fair value under GAAP, and expands disclosures about fair value measurements for both financial and non-financial assets. It also provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). The three levels of the fair value hierarchy are described as follows:

 

  Level 1.

Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access.

 

  Level 2.

Inputs to the valuation methodology include the following:

 

   

Quoted prices for similar assets or liabilities in active markets;

 

   

Quoted prices for identical or similar assets or liabilities in inactive markets;

 

   

Inputs other than quoted prices that are observable for the asset or liability;

 

   

Inputs that are derived principally from, or corroborated by, observable market data by correlation or other means.

If the asset or liability has a specified (contractual) term, the level 2 input must be observable for substantially the full term of the asset or liability.

 

  Level 3.

Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

 

(Continued)

The accompanying notes are an integral part of these statements.

 

Page 11


KBH TOPCO, LLC

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 – DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Concluded)

 

Fair Value Measurements (Concluded). The asset’s or liability’s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.

Certain assets are measured at fair value on a nonrecurring basis subsequent to initial recognition. These assets are not measured at fair value on an ongoing basis but are subject to fair value adjustments only under certain circumstances, as GAAP does not permit the recording of unrealized appreciation of equipment held for sale and leased equipment.

In certain circumstances, these assets were written down to estimated fair value when it is determined that net realizable value is below cost. Adjustments to write down certain equipment held for sale and leased equipment to their net realizable value totaled approximately $15,900,000 and $4,200,000 for the years ended December 31, 2022 and 2021, respectively, and are included within cost of equipment and software sold on the consolidated statements of comprehensive income. Equipment held for sale totaled approximately $4,100,000 and $5,300,000 as December 31, 2022 and 2021, respectively, and is included within inventory, prepaid expenses, deposits and other assets on the consolidated balance sheets.

The Company records the assets acquired and liabilities assumed, including contingent liabilities, at estimated fair value on the date of the acquisition. The transactions were recorded under the acquisition method of accounting whereby the assets acquired and liabilities assumed were recognized at estimated fair value using level 3 inputs. The estimated fair values of assets acquired and liabilities assumed are preliminary, pending the completion of various analyses and the finalization of estimates. During the measurement period (which is not to exceed one year from each acquisition date), additional assets or liabilities may be recognized if new information is obtained about facts and circumstances that existed as of the acquisition dates that, if known, would have resulted in the recognition of those assets or liabilities as of each respective date. The preliminary allocations may be adjusted after obtaining additional information regarding, among other things, asset valuations, liabilities assumed and revisions of previous estimates.

Recent Accounting Pronouncements. In January 2017, FASB issued ASU 2017-04, Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. This ASU removes the second step of the test where the Company compares the implied fair value of goodwill with the carrying amount of that goodwill for that reporting unit. An impairment charge equal to the amount by which the carrying amount of goodwill for the reporting unit exceeds the implied fair value of that goodwill is recorded, limited to the amount of goodwill allocated to that reporting unit. An entity will apply a one-step quantitative test and record the amount of goodwill impairment as the excess of a reporting unit’s carrying amount over its fair value, not to exceed the total amount of goodwill allocated to the reporting unit. The new guidance does not amend the optional qualitative assessment of goodwill impairment. The new guidance is effective for fiscal years beginning after December 15, 2021, with early adoption permitted. Adoption of this standard had no material impact to the accompanying consolidated financial statements.

In June 2016, FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, to revise the criteria for the measurement, recognition, and reporting of credit losses on financial instruments to be recognized when expected. This update is effective for fiscal years beginning after December 15, 2022, with early adoption permitted. Management is currently evaluating this standard.

Reclassification. Certain reclassifications were made to the 2021 financial statements to conform with the 2022 presentation. Such reclassifications had no impact on previously reported consolidated net income or members’ equity.

 

The accompanying notes are an integral part of these statements.

 

Page 12


KBH TOPCO, LLC

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

 

NOTE 2 – INVESTMENT SALES-TYPE AND DIRECT FINANCE LEASES, NET

The investment in sales-type and direct finance leases consisted of the following as of December 31:

 

     2022      2021  

Minimum lease payments

   $ 79,264,530      $ 79,388,382  

Estimated residual value

     10,415,588        9,605,695  
  

 

 

    

 

 

 

Subtotal

     89,680,118        88,994,077  

Less: Unearned lease income

     10,595,145        8,198,034  
  

 

 

    

 

 

 

Investment in sales-type and direct finance leases, net

   $ 79,084,973      $ 80,796,043  
  

 

 

    

 

 

 

NOTE 3 – FUTURE MINIMUM LEASE PAYMENTS TO BE RECEIVED

Approximate future minimum lease payments to be received under the terms of the non-cancelable operating, sales-type and direct finance leases as of December 31, 2022 were as follows:

 

Year Ending December 31

   Sales-type and
direct finance
     Operating      Total  

2023

   $ 25,560,000      $ 106,309,000      $ 131,869,000  

2024

     18,870,000        75,869,000        94,739,000  

2025

     13,820,000        49,239,000        63,059,000  

2026

     10,190,000        29,059,000        39,249,000  

2027

     7,114,000        20,619,000        27,733,000  

Thereafter

     3,711,000        19,452,000        23,163,000  
  

 

 

    

 

 

    

 

 

 

Total minimum lease payments

     79,265,000      $ 300,547,000      $ 379,812,000  
     

 

 

    

 

 

 

Less: Unearned Income

     10,595,000        
  

 

 

       

Sales-type and direct finance lease receivable, at present value

   $ 68,670,000        
  

 

 

       

NOTE 4 – DEBT

Secured Borrowings. The Company enters into arrangements to transfer the contractual payments due under sales-type, direct finance and operating leases. Due to the rights retained on certain lease participations sold, the Company is deemed to have retained effective control over these leases and therefore these transfers are accounted for as secured borrowings. As of December 31, 2022, the Company has secured borrowing agreements totaling $63,134,022 of which $6,841,422 was recourse and $56,292,600 was non-recourse. As of December 31, 2021, secured borrowing agreements totaled $102,353,580 of which $11,786,767 was recourse and $90,566,813 was non-recourse. These secured borrowing agreements have various maturity dates through 2028 and interest rates ranging from 3.20% and 5.28%. The investment in sales-type and direct finance leases and the equipment under operating leases pledged under these secured borrowing agreements were $1,616,955 and $79,928,883, respectively, as of December 31, 2022 and $5,781,120 and $115,961,247, respectively, as of December 31, 2021.

 

 

(Continued)

The accompanying notes are an integral part of these statements.

 

Page 13


KBH TOPCO, LLC

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

NOTE 4 – DEBT (Continued)

 

Secured Borrowings (Concluded). Principal payments on secured borrowings as of December 31, 2022 were due as follows:

 

Year Ending December 31

   Amount  

2023

   $ 25,405,717  

2024

     19,212,021  

2025

     14,783,966  

2026

     3,436,662  

2027

     226,913  

Thereafter

     68,743  
  

 

 

 
   $ 63,134,022  
  

 

 

 

Notes Payable - Recourse. The Company has recourse borrowing arrangements with various financial institutions with $135,252,630 and $125,094,236 of recourse debt outstanding as of December 31, 2022 and 2021, respectively. Various rate structures for each line pricing exist, based upon either the U.S. prime rate (7.50% at December 31, 2022, “Prime”) plus a spread, or based upon 30-day Secured Overnight Financing Rate (“SOFR”) plus a spread, or the like term swap rate for the investment period, plus 2.50% to 4.50%. Borrowings are collateralized by either a first lien on the equipment and assignment of rent or a second lien on the equipment representing the leased equipment’s residual values.

Under a $30,000,000 facility, maturing in August 2024, principal payments are determined by the maturities of the underlying equipment leases, of which $19,951,536 and $23,582,986 was outstanding as of December 31, 2022 and 2021, respectively. Balances are priced at Prime plus 1.50%, with a floor of 5.00%. Outstanding balances as of December 31, 2022 were due between January 2023 and December 2025. The debt agreement includes covenants for minimum tangible net worth and leverage.

Under a $55,000,000 facility maturing in July 2024, $45,000,000 of the facility was secured by a first lien on the equipment, with principal payments due based on the following schedule: the first two months of borrowing are interest only, after which 1.00% of the original principal is due on the first of each month, and then at six months from the date of the individual borrowing for the purchase of the equipment, the remaining principal balance is due. On this facility, $28,903,069 and $32,541,965 was outstanding as of December 31, 2022 and 2021, respectively. Additionally, $10,000,000 of this facility was able to be used for borrowings on a term basis, secured by a first lien on the equipment representing the leased equipment’s residual values and assignment of rent, of which $471,312 and $412,067 was outstanding as of December 31, 2022 and 2021, respectively. The debt agreement includes covenants for minimum tangible net worth.

Under a $50,000,000 facility maturing in November 2024, principal payments are due based on the following schedule: the first two months of borrowing are interest only, after which 1.00% of the original principal is due on the first of each month, and then at six months from the date of the individual borrowing for the purchase of the equipment, the remaining principal balance is due. On this facility, $27,944,804 and $18,858,589 was outstanding as of December 31, 2022 and 2021, respectively. Additionally, $10,000,000 of this facility is able to be used for borrowings on a term basis, secured by a second lien on the equipment representing the leased equipment’s residual values, of which $6,580,105 and $5,859,129 was outstanding as of December 31, 2022 and 2021, respectively. The debt agreement includes covenants for minimum tangible net worth.

Under a $27,000,000 facility, subject to annual review, borrowings are collateralized by either a first lien on the equipment and assignment of rents or a second lien on the equipment representing the leased equipment’s residual values subject to a cap on residuals of $8,000,000. On this facility, $3,154,227 and $3,836,082 was outstanding as of December 31, 2022 and 2021, respectively. Outstanding balances as of December 31, 2022 were due between January 2023 and January 2028.

 

(Continued)

The accompanying notes are an integral part of these statements.

 

Page 14


KBH TOPCO, LLC

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

NOTE 4 – DEBT (Continued)

 

Notes Payable - Recourse (Continued). Under a $7,000,000 facility, subject to annual review, borrowings are collateralized by a combination of first lien on the equipment and assignment of rents and a second lien on the equipment representing the leased equipment’s residual values. On this facility, $481,950 and $2,776,787 was outstanding as of December 31, 2022 and 2021, respectively. Outstanding balances as of December 31, 2022 were due between January 2023 and September 2025.

Under a $10,000,000 facility, subject to annual review, borrowings are collateralized by a combination of first lien on the equipment and assignment of rents and a second lien on the equipment representing the leased equipment’s residual values. Rates are determined at the time of discounting based on the underlying lease term. On this facility, $2,703,153 and $3,365,554 was outstanding as of December 31, 2022 and 2021, respectively. Outstanding balances as of December 31, 2022 were due between January 2023 and July 2026. Management is currently in the processes of renewing this facility with the financial institution.

Under a $15,000,000 facility, subject to annual review, borrowings are collateralized by a combination of first lien on the equipment and assignment of rents and a second lien on the equipment representing the leased equipment’s residual values. On this facility, $3,681,997 and $4,122,105 was outstanding as of December 31, 2022 and 2021, respectively. Additionally, the same financial institution provided a $9,000,000 facility for borrowings collateralized by the Company’s equipment leases with a subsidiary, secured by both the rental stream and equipment residual values. On this portion of the facility, $4,026,637 and $4,431,018 was outstanding as of December 31, 2022 and 2021, respectively. Outstanding balances as of December 31, 2022 were due between January 2023 and December 2026. The debt agreement includes covenants for minimum tangible net worth.

Under a $3,000,000 facility, subject to annual review, borrowings are collateralized by a combination of first lien on the equipment and assignment of rents and a second lien on the equipment representing the leased equipment’s residual values. On this facility, $1,984,246 and $1,706,853 was outstanding as of December 31, 2022 and 2021, respectively. Outstanding balances as of December 31, 2022 were due between January 2023 and October 2026.

Under a $28,000,000 facility, subject to annual review in September 2023, the Company may borrow either funding against lease stream payments or equity residual in equipment. The periodic payments are determined by the underlying equipment lease streams and/or residual values of equipment, with both interest rate and principal payments being determined at the time of line draw by the financial institution. Rates on borrowings from this facility range from 200 to 450 basis points over the like term swap rate at the time of borrowing, with $8,271,743 and $9,311,551 outstanding as of December 31, 2022 and 2021, respectively. Borrowings for equity residuals are priced at 2.00% over the corresponding non-recourse stream rate for the underlying transaction. Outstanding balances as of December 31, 2022 were due between January 2023 and December 2026. There are additional loans with this financial institution of which $288,855 and $132,154 was outstanding as of December 31, 2022 and 2021, respectively. In addition, the Company provides a $400,000 corporate guarantee on the corporate credit cards issued by this financial institution for use by a Company subsidiary. The debt agreement includes covenants for minimum tangible net worth.

The Company has a borrowing arrangement collateralized by a first lien on the equipment and assignment of rents on a pool of lease transactions totaling $87,920,095 and $66,190,220 outstanding as of December 31, 2022 and 2021, respectively, at a borrowing rate ranging from 3.50% to 6.15%. Of the total transactions, $15,270,372 and $11,912,337 as of December 31, 2022 and 2021, respectively, is secured on a recourse basis for a portion of the equipment’s residual values. The recourse portion of this transaction will amortize with cash flow from residual values. Management estimates that this obligation will fully amortize by October 2025. An additional $13,000,000 was provided on a recourse basis at 5.52% of which $11,538,624 and $2,245,059 was outstanding as of December 31, 2022 and 2021, respectively.

 

(Continued)

The accompanying notes are an integral part of these statements.

 

Page 15


KBH TOPCO, LLC

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

NOTE 4 – DEBT (Concluded)

 

Notes Payable - Recourse (Concluded). Principal payments on recourse notes payable as of December 31, 2022 were due as follows:

 

Year Ending December 31

   Amount  

2023

   $ 86,850,708  

2024

     15,435,577  

2025

     13,050,618  

2026

     8,186,819  

2027

     5,180,172  

Thereafter

     6,548,736  
  

 

 

 
   $ 135,252,630  
  

 

 

 

Senior Secured Debt - Related-Party. During 2020, the Company borrowed $80,000,000 under a recourse senior secured debt facility with SLR. The interest rate on the facility is floating at 90-day London Inter-Bank Offered Rate (“LIBOR”) plus 7.00%. Interest payments are due quarterly until maturity in December 2024. The debt is collateralized by a subordinated lien on the Company’s leased assets and the Company’s outstanding rollover equity interests. The debt agreement includes covenants for minimum tangible net worth and leverage. The outstanding balance including accrued interest was $80,000,000 as of December 31, 2022 and 2021. Related-party interest expense was approximately $7,315,000 and $6,489,000 for the years ended December 31, 2022 and 2021, respectively.

Notes Payable - Non-Recourse. Non-recourse notes payable are collateralized by the assignment of rent and the equipment value under lease. The financial institutions have a first lien on the underlying leased equipment with no further recourse against the Company in the event of default by lessee. Interest rates range from 1.20% to 8.20%. Under these arrangements, each lease is financed under a separate borrowing. Non-recourse debt and related interest expense is paid by funds from assigned committed term lease payments with various financial institutions. The outstanding balance was $296,835,798 and $233,276,889 as of December 31, 2022 and 2021, respectively, of which $11,376,355 and $-0- with an interest of 9.50% was due to a related party under common control as of December 31, 2022 and 2021, respectively.

Principal payments on non-recourse notes payable as of December 31, 2022 were due as follows:

 

Year Ending December 31

   Amount  

2023

   $ 112,158,729  

2024

     65,119,869  

2025

     43,687,358  

2026

     33,252,573  

2027

     21,987,267  

Thereafter

     20,630,002  
  

 

 

 
   $ 296,835,798  
  

 

 

 

NOTE 5 – MEMBERS’ EQUITY

All members of the Company have the same rights, preferences, and privileges. Profits, losses, and distributions are allocated in accordance with the Operating Agreement.

The Company has two classes of units: Common units and Preferred units. There were no Preferred units issued and outstanding as of December 31, 2022 and 2021.

 

The accompanying notes are an integral part of these statements.

 

Page 16


KBH TOPCO, LLC

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

 

NOTE 6 – OPERATING LEASES

The Company leases various facilities under the terms of non-cancelable operating leases which expire from February 2023 through July 2028 which call for monthly rental payments ranging from approximately $2,000 to $30,000 per month. The Company does not believe it will exercise the options to extend the leases. The office leases generally require the Company to pay taxes, insurance, utilities, and maintenance costs in addition to base rent.

The components of lease expense were as follows for the year ended December 31, 2022:

 

     Amount  

Fixed operating lease cost

   $ 733,593  

Variable and short-term lease costs

     419,623  
  

 

 

 

Total lease expense

   $ 1,153,216  
  

 

 

 

Other information related to lease was as follows for the year ended December 31, 2022:

 

Weighted-average remaining lease term (in years)

     4.69  

Weighted-average discount rate

     2.89

Cash flows related to leases were as follows for the year ended December 31, 2022:

 

     Amount  

Cash flows from operating activities:

  

Cash paid for amounts included in the measurement of operating lease liabilities

   $ 662,863  

Supplemental disclosure of cash flow information:

  

Right-of-use assets obtained in exchange for operating lease obligations

   $ 4,395,457  

Approximate future maturities of lease liabilities under non-cancelable operating leases were as follows as of December 31, 2022:

 

Year Ending December 31

   Amount  

2023

   $ 914,000  

2024

     897,000  

2025

     781,000  

2026

     710,000  

2027

     635,000  

Thereafter

     137,000  
  

 

 

 
     4,074,000  

Less: imputed interest

     278,000  
  

 

 

 
   $ 3,796,000  
  

 

 

 

 

(Continued)

The accompanying notes are an integral part of these statements.

 

Page 17


KBH TOPCO, LLC

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

NOTE 6 – OPERATING LEASES (Concluded)

 

During the year ended December 31, 2021, the Company accounted for its operating leases under FASB ASC 840, Leases. Rent expense under non-cancelable operating leases was approximately $1,040,000 for the year ended December 31, 2021.

NOTE 7 – INCOME TAXES

The income tax provision consisted of the following components for the years ended December 31:

 

     2022      2021  

Deferred

   $ 4,594,732      $ 4,283,422  

Current

     247,173        51,127  
  

 

 

    

 

 

 
   $ 4,841,905      $ 4,334,549  
  

 

 

    

 

 

 

The Company’s deferred income tax assets and liabilities consisted of the following components as of December 31:

 

     2022      2021  

Deferred income tax asset (liability)

     

Depreciation and amortization

   $ (30,452,940    $ (20,201,065

Allowance for doubtful accounts

     41,998        3,035  

Interest expense carryforward

     3,431,247        —    

Net operating loss

     17,342,572        15,155,639  
  

 

 

    

 

 

 

Net deferred income tax liability

   $ (9,637,123    $ (5,042,391
  

 

 

    

 

 

 

The Company’s effective income tax rate was approximately 26.71% and 26.30% for the years ended December 31, 2022 and 2021, respectively.

NOTE 8 – LITIGATION

From time to time, the Company is subject to litigation arising in the ordinary course of business. It is the opinion of the Company’s management that any claims pending are either covered by insurance or that there is no material exposure to the Company in connection with any proceedings.

NOTE 9 – SUBSEQUENT EVENTS

Management has evaluated all known subsequent events from December 31, 2022 through February 15, 2023, the date the accompanying consolidated financial statements were available to be issued and is not aware of any material subsequent events occurring during this period.

 

The accompanying notes are an integral part of these statements.

 

Page 18

EX-99.4 19 d437884dex994.htm EX-99.4 EX-99.4

Exhibit 99.4

Gemino Healthcare Finance, LLC

d/b/a SLR Healthcare ABL

Consolidated Financial Statements

Years Ended December 31, 2022 and 2021


Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL

 

Table of Contents

Years Ended December 31, 2022 and 2021

 

     Page  

Independent Auditors’ Report

     1  

Consolidated Financial Statements

  

Consolidated Balance Sheets

     3  

Consolidated Statements of Operations

     4  

Consolidated Statements of Changes in Members’ Equity

     5  

Consolidated Statements of Cash Flows

     6  

Notes to Consolidated Financial Statements

     7  


LOGO

Independent Auditors’ Report

To the Board of Managers of

Gemino Healthcare Finance, LLC and Subsidiary

Opinion

We have audited the consolidated financial statements of Gemino Healthcare Finance, LLC and Subsidiary d/b/a SLR Healthcare ABL (the Company), which comprise the consolidated balance sheets as of December 31, 2022 and 2021, and the related consolidated statements of operations, changes in members’ equity and cash flows for the years then ended, and the related notes to the consolidated financial statements.

In our opinion, the accompanying consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021 and the results of its operations and its cash flows for the years then ended in accordance with accounting principles generally accepted in the United States of America (GAAP).

Basis for Opinion

We conducted our audits in accordance with auditing standards generally accepted in the United States of America (GAAS). Our responsibilities under those standards are further described in the Auditors’ Responsibilities for the Audit of the Consolidated Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements relating to our audits. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

Responsibilities of Management for the Consolidated Financial Statements

Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with GAAP, and for the design, implementation and maintenance of internal control relevant to the preparation and fair presentation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the consolidated financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the financial statements are available to be issued.

Baker Tilly US, LLP, trading as Baker Tilly, is a member of the global network of Baker Tilly International Ltd., the members of which are separate and independent legal entities. © 2020-2022 Baker Tilly US, LLP


Auditors’ Responsibilities for the Audit of the Consolidated Financial Statements

Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors’ report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the consolidated financial statements.

In performing an audit in accordance with GAAS, we:

 

   

Exercise professional judgment and maintain professional skepticism throughout the audit.

 

   

Identify and assess the risks of material misstatement of the consolidated financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements.

 

   

Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control. Accordingly, no such opinion is expressed.

 

   

Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the consolidated financial statements.

 

   

Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for a reasonable period of time.

We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control-related matters that we identified during the audit.

 

LOGO

Philadelphia, Pennsylvania

February 16, 2023

 

2


Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL

 

Consolidated Balance Sheets

December 31, 2022 and 2021

 

     2022     2021  
Assets     

Assets

    

Cash and cash equivalents

   $ 9,319,837     $ 3,256,256  

Loans receivable, net

     92,383,159       81,603,569  

Accrued interest receivable

     1,181,464       664,127  

Goodwill

     5,663,531       5,663,531  

Furniture and equipment, net

     35,725       14,319  

Other assets

     121,706       72,954  
  

 

 

   

 

 

 

Total assets

   $ 108,705,422     $ 91,274,756  
  

 

 

   

 

 

 
Liabilities and Members’ Equity     

Liabilities

    

Credit facility, net

   $ 76,639,027     $ 59,398,378  

Accounts payable and accrued expenses

     2,929,111       2,491,180  

Dividend payable

     529,029       529,058  
  

 

 

   

 

 

 

Total liabilities

     80,097,167       62,418,616  
  

 

 

   

 

 

 

Members’ equity

    

Units, $1,000 par value, issued and outstanding 35,264 and 35,270, respectively

     32,814,339       32,820,783  

Accumulated deficit

     (4,206,084     (3,964,643
  

 

 

   

 

 

 

Total members’ equity

     28,608,255       28,856,140  
  

 

 

   

 

 

 

Total liabilities and members’ equity

   $ 108,705,422     $ 91,274,756  
  

 

 

   

 

 

 

See notes to consolidated financial statements

 

3


Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL

 

Consolidated Statements of Operations

Years Ended December 31, 2022 and 2021

 

     2022      2021  

Interest income:

     

Interest income

   $ 7,919,047      $ 5,583,832  

Interest expense

     3,191,098        1,634,855  
  

 

 

    

 

 

 

Net interest income

     4,727,949        3,948,977  

Provision for loan losses

     117,149        426,428  
  

 

 

    

 

 

 

Net interest income after provision for loan losses

     4,610,800        3,522,549  

Other income

     3,673,619        4,468,588  

Operating expenses:

     

Compensation and benefits

     3,934,044        3,819,816  

Depreciation and amortization

     22,248        2,811,730  

General and administrative

     853,453        697,811  
  

 

 

    

 

 

 

Total operating expenses

     4,809,745        7,329,357  

Net income

   $ 3,474,674      $ 661,780  
  

 

 

    

 

 

 

See notes to consolidated financial statements

 

4


Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL

 

Consolidated Statements of Changes in Members’ Equity

Years Ended December 31, 2022 and 2021

 

Balance at December 31, 2020

   $ 31,910,475  

Dividends declared

     (3,716,115

Net income

     661,780  
  

 

 

 

Balance at December 31, 2021

   $ 28,856,140  

Capital distributions

     (6,444

Dividends declared

     (3,716,115

Net income

     3,474,674  
  

 

 

 

Balance at December 31, 2022

   $ 28,608,255  
  

 

 

 

See notes to consolidated financial statements

 

5


Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL

 

Consolidated Statements of Cash Flows

Years Ended December 31, 2022 and 2021

 

     2022     2021  

Cash Flows from Operating Activities

    

Net income

   $ 3,474,674     $ 661,780  

Adjustments to reconcile net income to net cash provided by operating activities:

    

Depreciation

     22,248       11,730  

Amortization of intangible asset – trade name

     —         2,800,000  

Amortization of deferred origination fees and costs

     (421,113     (590,858

Amortization of debt issuance costs

     240,649       229,084  

Provision for loan losses

     117,149       426,428  

Changes in assets and liabilities:

    

Increase in accrued interest receivable

     (517,337     (36,146

Increase in other assets

     (48,752     (1,627

Increase in deferred origination fees and costs

     721,951       507,863  

Increase in accounts payable and accrued expenses

     437,931       251,379  
  

 

 

   

 

 

 

Net cash provided by operating activities

     4,027,400       4,259,633  
  

 

 

   

 

 

 

Cash Flows from Investing Activities

    

Increase in loans receivable, net

     (11,197,577     (42,606,642

Purchase of furniture and equipment

     (43,654     (4,949
  

 

 

   

 

 

 

Net cash used in investing activities

     (11,241,231     (42,611,591
  

 

 

   

 

 

 

Cash Flows from Financing Activities

    

Proceeds from credit facility, net

     17,000,000       35,000,000  

Debt issuance costs paid

     —         (32,590

Dividends paid

     (3,716,144     (3,716,086

Capital distributions

     (6,444     —    
  

 

 

   

 

 

 

Net cash provided by financing activities

     13,277,412       31,251,324  
  

 

 

   

 

 

 

Net increase (decrease) in cash and cash equivalents

     6,063,581       (7,100,634

Cash and cash equivalents, beginning of the year

     3,256,256       10,356,890  
  

 

 

   

 

 

 

Cash and cash equivalents, end of the year

   $ 9,319,837     $ 3,256,256  
  

 

 

   

 

 

 

Supplemental Disclosure of Cash Flow Information

    

Interest paid

   $ 2,669,380     $ 1,359,195  
  

 

 

   

 

 

 

See notes to consolidated financial statements

 

6


Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL

 

Notes to Consolidated Financial Statements

Years Ended December 31, 2022 and 2021

 

1.

Description of Business

Gemino Healthcare Finance, LLC is a Delaware limited liability company formed in December 2006. In February 2021, the Company filed a d/b/a in the name of SLR Healthcare ABL (“SLR Healthcare”). SLR Healthcare is a commercial finance company that originates, underwrites and manages primarily secured, asset-based loans for small and mid-sized companies operating across the U.S. in the healthcare industry. SLR Healthcare’s loans are primarily in the form of revolving lines of credit, secured by accounts receivable of the borrowers. The accounts receivable serving as collateral are primarily third party obligations from government payers, such as Medicare or Medicaid, and commercial insurers.

In certain cases, SLR Healthcare may provide senior term loan financing, including real estate financing to qualified borrowers in addition to a revolving line of credit. Senior term loans, including real estate loans are typically secured by accounts receivable and all other assets of the borrowers, such as inventory, equipment and real estate.

Gemino Healthcare Funding, LLC (“Gemino Funding”) is a wholly-owned special purpose limited liability company that purchases and holds certain eligible loans and related property from SLR Healthcare (collectively, the “Company”).

On September 30, 2013, SLR Senior Investment Corp. formerly known as Solar Senior Capital Ltd. (“SLR Senior”), a Maryland corporation, acquired a controlling interest in SLR Healthcare. On April 1, 2022, SLR Senior merged with the surviving affiliated entity, SLR Investment Corp. (“SLR Investment”), a Maryland corporation. The remaining interest of SLR Healthcare is held by the management team of SLR Healthcare.

 

2.

Summary of Significant Accounting Policies

Principles of Consolidation

The consolidated financial statements include the accounts of SLR Healthcare and Gemino Funding. All significant intercompany balances have been eliminated in consolidation.

Use of Estimates

The preparation of consolidated financial statements in conformity with generally accepted accounting principles in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and to report amounts of revenues and expenses during the reporting period. Actual results could differ materially from these estimates. The allowance for loan losses represents an estimate that is particularly susceptible to material change.

Cash and Cash Equivalents

Cash and cash equivalents include funds deposited with financial institutions and short-term, liquid investments in money market accounts with original maturities of three months or less.

 

 

7


Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL

 

Notes to Consolidated Financial Statements

Years Ended December 31, 2022 and 2021

 

2.

Summary of Significant Accounting Policies…continued

 

Loans Receivable

Loans receivable that management has the intent and ability to hold for the foreseeable future or until maturity or payoff are reported at their outstanding unpaid principal balances less the allowance for loan losses and any deferred fees or costs.

Commitment terms of the Company’s financing agreements generally range from two to five years with interest charged on a floating rate basis. Funding under revolving loan commitments is subject to the Company’s estimation of the value of the accounts receivable pledged as collateral.

Revenue Recognition

Income on loans receivable is recognized using the simple interest method. Revolving loan origination fees and costs are deferred and amortized on a straight-line basis over the terms of the related loan commitments as an adjustment to interest income on loans. Term loan origination fees and costs are deferred and amortized using either the effective interest method or the straight-line method over the life of the loan as an adjustment to interest income. The straight-line method may be used for term loan facilities when it approximates the effective interest method. Other fees, such as unused balance and collateral monitoring fees, are recognized when the services are provided. Termination fees are recognized when a loan is terminated. These other fees are included in other income.

The accrual of interest on loans is discontinued at the time the loan is 90 days delinquent unless the loan is secured. Typically, loans are placed on non-accrual or charged off at an earlier date if collection of principal or interest is considered doubtful. When a loan is placed on non-accrual status, all interest previously accrued, but not collected, is reversed against current interest income and all future proceeds received will generally be applied against principal or interest, in the judgment of management. Loans are returned to accrual status when all principal and interest amounts contractually due are reasonably assured.

The Company recognizes revenue in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers, which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers. The core principle of the revenue model is for an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services.

ASC 606 is not applicable to financial instruments and, therefore, does not impact the Company’s revenues. The Company has evaluated the nature of its contracts with customers and fully satisfies its performance obligations on its contracts as services are rendered and the transaction prices are typically fixed; they are charged either on a periodic basis or based on activity.

 

8


Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL

 

Notes to Consolidated Financial Statements

Years Ended December 31, 2022 and 2021

 

2.

Summary of Significant Accounting Policies…continued

 

Impaired Loans

A loan is considered impaired when, based on current information and events, it is probable that the Company will be unable to collect all amounts due in accordance with the contractual terms of the loan agreement. Loans are evaluated for impairment by the Company based on an ongoing analysis of each borrower’s repayment capacity, the value of the collateral support and the strength of any guarantees. Loans identified as impaired are further evaluated to determine the estimated extent of impairment.

Allowance for Loan Loss

The allowance for loan loss represents the Company’s recognition of the assumed risks of extending credit. The allowance is maintained at a level considered adequate to provide for probable losses inherent in the loan portfolio. Management establishes a general portfolio reserve for unimpaired loans based on various factors including historical loss experience, the overall credit quality of the loan portfolio, economic trends and conditions, and the regulatory environment.

The overall credit quality of the Company’s borrowers is reflected in the individual and weighted average credit risk ratings of the loans in the portfolio. Credit risk ratings for each borrower are established based on a number of qualitative and quantitative factors including an assessment of management and strategy, historical and projected repayment capacity, collateral coverage and performance, financial condition and sponsorship, strength of guarantees and any contingencies.

Specific allowances for loan losses on impaired loans are typically measured based on a comparison of the recorded carrying value of the loan to the present value of the loan’s expected cash flow using the loan’s effective interest rate, the loan’s estimated market price or the estimated fair value of the underlying collateral, if the loan is collateral-dependent combined with the strength of any guarantee arrangements. Specific allowances are recorded when the discounted cash flows, collateral value, or aggregate market price of the impaired loan is lower than the carrying value of that loan.

Loans are charged off when collection is questionable and when the Company can no longer justify maintaining the loan as an asset on the consolidated balance sheet. Loans qualify for charge off when, after thorough analysis, all possible sources of collection are determined to be insufficient to repay the loan. These include impairment of potential future cash flow, value of collateral and/or financial strength of guarantors. Recoveries of previous charge-offs are recorded when received. For the years ended December 31, 2022 and 2021, there were no recoveries of previous charge-offs.

 

9


Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL

 

Notes to Consolidated Financial Statements

Years Ended December 31, 2022 and 2021

 

2.

Summary of Significant Accounting Policies…continued

 

Goodwill and Intangible Asset

Goodwill and intangible asset—trade name arose from the acquisition of the Company on September 30, 2013 (Note 1). Goodwill represents the excess of the purchase price over the fair value of those acquired net assets. Goodwill is not amortized, but instead is reviewed for impairment annually typically in December of each year or more frequently upon the occurrence of certain events or substantive changes in circumstances. The Company assesses goodwill for impairment by comparing the carrying value of the Company to its fair value. The Company has the option to perform a qualitative assessment to determine if an impairment is more likely than not to have occurred. If the conclusion is supported that it is more likely than not that the fair value is less than its carrying amount, then the Company would need to perform a quantitative impairment test. If the conclusion cannot be supported, or if the Company does not elect to do the qualitative assessment, then the Company will perform a quantitative assessment. If a quantitative goodwill impairment assessment is performed, the Company utilizes a combination of market and income valuation approaches. No impairment of goodwill resulted for the years ended December 31, 2022 and 2021, respectively.

The Company assessed its indefinite-lived intangible asset – trade name for impairment by comparing the carrying value of the asset to its fair value. The fair value of intangible asset—trade name was estimated using the relief from royalty method, which is an income approach based on the present value of royalties the Company would theoretically have had to pay to license the trade name from a third party. During 2021 as part of the rebranding strategy to change its name via the d/b/a filing to SLR Healthcare ABL, the Company evaluated the trade name’s indefinite-lived position and elected to change the indefinite-lived intangible asset – trade name to a finite-lived intangible asset – trade name for the period ending December 31, 2021. Accordingly, the carrying value previously ascribed to the intangible asset – trade name was fully amortized as of December 31, 2021.

Furniture and Equipment

Furniture and equipment are recorded at cost, net of accumulated depreciation, and are depreciated on a straight-line basis over their estimated useful lives ranging from three to five years.

Debt Issuance Costs

The Company reports origination and other costs related to debt issuances as a direct deduction from the carrying amount of the debt liability. These expenses are deferred and amortized using either the effective interest method or the straight-line method over the stated life as an adjustment to interest expense. The straight-line method may be used on revolving facilities when it approximates the effective interest method.

 

10


Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL

 

Notes to Consolidated Financial Statements

Years Ended December 31, 2022 and 2021

 

2.

Summary of Significant Accounting Policies…continued

 

Income Taxes

The Company is not subject to federal or state income taxes. Members of the Company have elected to report the taxable income or loss on their individual tax returns. Accordingly, no provision for income taxes has been recorded in the accompanying consolidated financial statements.

The Company applies authoritative guidance relating to the accounting for uncertain tax positions. Accordingly, a provision for uncertain tax positions and related penalties and interest is recognized when it is more-likely-than-not, based on the technical merits, that the tax position will not be realized or sustained upon examination by the appropriate taxing authority. Management determined there were no tax uncertainties that met the recognition threshold in 2022 and 2021.

The Company files both federal and state income tax returns. The Company remains subject to examination by taxing authorities for the years 2019 and after.

Recent Accounting Pronouncements

In June 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-13, Financial Instruments – Credit Losses (Topic 326) to replace the incurred loss model, which is referred to as the current expected credit loss (“CECL”) model. The CECL model is applicable to the measurement of credit losses on financial assets measured at amortized cost, including loans receivable and held-to maturity debt securities. It also applies to off-balance sheet credit exposures including loan commitments, standby letters of credit, financial guarantees, and other similar instruments. For the assets within the scope of CECL, a cumulative-effect adjustment will be recognized in retained earnings as of the beginning of the first reporting period in which the guidance is effective. This new standard is effective for fiscal years beginning after December 15, 2022. The Company has evaluated the impact that this standard will have on its consolidated financial statements, and has determined that the impact will be immaterial to the consolidated financial statements as a whole.

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (ASU 2020-04). The guidance provides optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships and other transactions, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued because of the reference rate reform. ASU 2020-04 is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is modifying its outstanding loans receivable agreements and its outstanding credit facility in order to replace references to LIBOR with SOFR or another alternative reference rate. The Company is currently evaluating the impact this new standard will have on its consolidated financial statements.

Basis of Presentation

Certain amounts in the prior year consolidated financial statements have been reclassified whenever necessary to conform with the current year presentation. These reclassifications had no effect on the reported results of operations.

 

11


Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL

 

Notes to Consolidated Financial Statements

Years Ended December 31, 2022 and 2021

 

 

3.

Loans Receivable

The following table shows the composition of loans receivable, net as of December 31, 2022 and 2021:

 

     2022      2021  

Revolving loans receivable

   $ 94,198,839      $ 83,001,262  

Less allowance for loan losses

     (953,803      (836,654

Less deferred origination fees and costs, net

     (861,877      (561,039
  

 

 

    

 

 

 

Loans receivable, net

   $ 92,383,159      $ 81,603,569  
  

 

 

    

 

 

 

 

4.

Allowance for Loan Losses and Recorded Investment in Loans Receivables

The following table summarizes the activity in the allowance for loan losses by revolving loans for the respective years ended December 31, 2022 and 2021:

 

     2022      2021  

Beginning balance

   $ 836,654      $ 410,226  

Provision for loan losses

     117,149        426,428  
  

 

 

    

 

 

 

Ending balance

   $ 953,803      $ 836,654  
  

 

 

    

 

 

 

Collectively evaluated for impairment

   $ 952,745      $ 830,643  
  

 

 

    

 

 

 

Individually evaluated for impairment

   $ 1,058      $ 6,011  
  

 

 

    

 

 

 

The following table presents revolving loans collectively and individually evaluated for impairment at December 31, 2022 and 2021:

 

     2022      2021  

Revolving loans

   $ 94,198,839      $ 83,001,262  
  

 

 

    

 

 

 

Collectively evaluated for impairment

   $ 94,093,002      $ 82,400,125  
  

 

 

    

 

 

 

Individually evaluated for impairment

   $ 105,837      $ 601,137  
  

 

 

    

 

 

 

The following table summarizes the non-accrual revolving loans at December 31, 2022 and 2021:

 

     2022      2021  

Recorded investment

   $ 105,837      $ 601,137  
  

 

 

    

 

 

 

Unpaid principal

   $ 105,837      $ 601,137  
  

 

 

    

 

 

 

Related allowance

   $ 1,058      $ 6,011  
  

 

 

    

 

 

 

 

12


Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL

 

Notes to Consolidated Financial Statements

Years Ended December 31, 2022 and 2021

 

4.

Allowance for Loan Losses and Recorded Investment in Loans Receivables…continued

 

Credit Quality Indicators

The following table summarizes the loan portfolio by the Company’s internal credit rating (scale: 1 to 7) as of December 31, 2022 and 2021: Loans with a rating of 4 or better generally pose minimal risk to the Company as they exhibit, among other things, one or more of the following attributes: (1) secured collateral position; (2) satisfactory cash flows; and (3) history of timely payment of debt obligations. Loans credit rated below 4 are considered “watchlist” loans; an overall degree of risk exists with these loans that warrants management’s review each quarter.

 

     December 31, 2022  
     2022      2021  

Rated 4 or better

   $ 88,001,460      $ 82,400,125  

Rated 5

     6,091,542        —    

Rated 6

     105,837        601,137  
  

 

 

    

 

 

 

Total revolving loans

   $ 94,198,839      $ 83,001,262  
  

 

 

    

 

 

 

 

5.

Furniture and Equipment

Furniture and equipment are comprised of the following at December 31, 2022 and 2021:

 

     2022      2021  

Computer software and equipment

   $ 136,837      $ 93,183  

Furniture and fixtures

     41,032        41,032  

Leasehold improvement

     21,551        21,551  
  

 

 

    

 

 

 

Total

     199,420        155,766  

Less accumulated depreciation

     (163,695      (141,447
  

 

 

    

 

 

 

Furniture and equipment, net

   $ 35,725      $ 14,319  
  

 

 

    

 

 

 

Depreciation expense was $22,248 and $11,730 for the years ended December 31, 2022 and 2021, respectively.

 

13


Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL

 

Notes to Consolidated Financial Statements

Years Ended December 31, 2022 and 2021

 

 

6.

Debt

On May 27, 2016, the Company entered into a four-year, non-recourse $125,000,000 secured revolving credit facility, which is expandable to $200,000,000 under its accordion feature. On June 28, 2019, the credit facility was amended and has a maturity date of June 28, 2023. Under the terms of the credit facility, the Company has made certain customary representations and warranties, and is required to comply with various covenants, including financial and reporting requirements and other customary requirements for similar credit facilities. The credit facility also includes usual and customary events of default for credit facilities of this nature.

Amounts available to borrow under the credit facility are also subject to compliance with a borrowing base that applies different advance rates to different types of assets in the Company’s portfolio that are pledged as collateral. As of December 31, 2022 and 2021, there were principal borrowings of $77,000,000 and $60,000,000 outstanding, respectively, under the credit facility which is collateralized by eligible loans and related securities.

Interest on the credit facility accrues at a variable rate per annum of one-month LIBOR plus 2.25% approximating 6.64% and 2.35% at December 31, 2022 and 2021, respectively. The Company also pays other customary loan fees for the credit facility.

The credit facility is comprised of the following at December 31, 2022 and 2021:

 

     2022      2021  

Principal borrowings

   $ 77,000,000      $ 60,000,000  

Unamortized debt issuance costs

     (360,973      (601,622
  

 

 

    

 

 

 

Credit facility, net

   $ 76,639,027      $ 59,398,378  
  

 

 

    

 

 

 

 

7.

Commitments and Concentrations

At December 31, 2022 and 2021, the Company has committed facilities to its borrowers totaling approximately $242,106,000 and $183,501,000, respectively, of which approximately $147,907,000 and $100,500,000, respectively, was unused. Borrowers may borrow up to the lesser of (i) the committed facility or (ii) the underlying collateral value multiplied by the advance rate. Of the unused committed facility amount at December 31, 2022 and 2021, borrowers could borrow up to approximately $43,954,000 and $27,414,000, respectively. As of December 31, 2022 and 2021, the Company had sufficient cash available and/or availability under its credit facility to fund its commitments.

At December 31, 2022, the Company had two loans approximating 16% and 12% of the total loans receivable and at December 31, 2021, the Company had two loans approximating 29% and 16% of the total loans receivable, respectively.

 

14


Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL

 

Notes to Consolidated Financial Statements

Years Ended December 31, 2022 and 2021

 

 

8.

Employee Benefit Plans

The Company sponsors a 401(k) savings plan, where the Company contributes a defined percentage of employees’ earnings up to the maximum contribution amount as determined by the Internal Revenue Service.

The Company formed a Long-Term Incentive Plan (“LTIP”) that provides for an annual bonus pool to employees based on the Company achieving certain performance criteria.

 

9.

Fair Value Disclosure

Fair value is the exchange price that would be received for an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. There are three levels of inputs that may be used to measure fair values:

Level 1: Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date.

Level 2: Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.

Level 3: Significant unobservable inputs that reflect a company’s own assumptions about the assumptions that market participants would use in pricing an asset or liability.

The following information should not be interpreted as an estimate of the fair value of the entire Company, since a fair value calculation is only provided for a limited portion of the Company’s assets and liabilities. Assets and liabilities measured at fair value on a recurring basis are summarized in the table below at December 31, 2022 and 2021.

 

     2022  
     Carrying Value      Fair Value  

Financial assets:

     

Cash and cash equivalents (Level 1)

   $ 9,319,837      $ 9,319,837  

Loans receivable, net (Level 3)

     92,383,159        93,245,036  

Financial liabilities:

     

Credit facility, net (Level 2)

     76,639,027        77,000,000  

 

     2021  
     Carrying Value      Fair Value  

Financial assets:

     

Cash and cash equivalents (Level 1)

   $ 3,256,256      $ 3,256,256  

Loans receivable, net (Level 3)

     81,603,569        82,020,335  

Financial liabilities:

     

Credit facility, net (Level 2)

     59,398,378        60,000,000  

 

15


Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL

 

Notes to Consolidated Financial Statements

Years Ended December 31, 2022 and 2021

 

 

10.

Related Parties

An employee of an affiliated entity provides marketing and sales services to the Company for which the Company reimburses the affiliated entity. Such reimbursements have been included in compensation and benefits expenses.

The Company sold a participation in a loan agreement to SLR Investment. The participation was sold in August 2022 for a total commitment of $5,000,000 and the outstanding loans receivable balance at December 31, 2021 was $3,966,336.

 

11.

Subsequent Events

The Company evaluated subsequent events for recognition or disclosure through

February 16, 2023, which was the date the consolidated financial statements were available to be issued.

 

16

EX-99.5 20 d437884dex995.htm EX-99.5 EX-99.5

Exhibit 99.5

North Mill Holdco LLC

and Subsidiaries

Consolidated Financial Report

December 31, 2022


North Mill Holdco LLC and Subsidiaries

 

Independent Auditor’s Report

     1-2  

Consolidated Balance Sheets

     3  

Consolidated Statements of Operations

     4  

Consolidated Statements of Members’ Equity

     5  

Consolidated Statements of Cash Flows

     6  

Notes to Consolidated Financial Statements

     7  


LOGO

Independent Auditor’s Report

Audit Committee

North Mill Holdco LLC

Opinion

We have audited the consolidated financial statements of North Mill Holdco LLC and its subsidiaries (the Company), which comprise the consolidated balance sheets as of December 31, 2022 and 2021, the related consolidated statements of income, members’ equity, and cash flows for the years then ended, and the related notes to the consolidated financial statements (collectively, the financial statements).

In our opinion, the accompanying financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of their operations and their cash flows for the years then ended in accordance with accounting principles generally accepted in the United States of America.

Basis for Opinion

We conducted our audits in accordance with auditing standards generally accepted in the United States of America (GAAS). Our responsibilities under those standards are further described in the Auditor’s Responsibilities for the Audit of the Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements relating to our audits. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

Responsibilities of Management for the Financial Statements

Management is responsible for the preparation and fair presentation of the financial statements in accordance with accounting principles generally accepted in the United States of America, and for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the financial statements are issued or available to be issued.

Auditor’s Responsibilities for the Audit of the Financial Statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the financial statements.

 

LOGO

 

LOGO


In performing an audit in accordance with GAAS, we:

 

   

Exercise professional judgment and maintain professional skepticism throughout the audit.

 

   

Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.

 

   

Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control. Accordingly, no such opinion is expressed.

 

   

Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the financial statements.

 

   

Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for a reasonable period of time.

We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control-related matters that we identified during the audit.

/s/ RSM US LLP

Philadelphia, Pennsylvania

February 21, 2023


North Mill Holdco LLC and Subsidiaries

Consolidated Balance Sheets

December 31, 2022 and 2021

 

 

     2022      2021  

Assets

     

Cash

   $ 7,396,967      $ 5,187,429  

Finance receivables:

     

Loans receivable

     154,062,897        110,975,999  

Less: unearned fee income

     284,640        35,927  
  

 

 

    

 

 

 
     153,778,257        110,940,072  

Accounts receivable

     131,942,768        137,675,981  

Less: allowance for uncollectible finance receivables

     1,834,061        1,834,061  
  

 

 

    

 

 

 

Finance receivables, net

     283,886,964        246,781,992  

Goodwill

     36,187,729        36,187,729  

Accrued interest receivable

     1,735,159        845,561  

Other assets

     256,914        329,828  

Furniture and equipment, net

     545,337        282,006  

Right of use asset

     2,238,007        1,179,246  
  

 

 

    

 

 

 

Total assets

   $ 332,247,077      $ 290,793,791  
  

 

 

    

 

 

 

Liabilities and Members’ Equity

     

Liabilities:

     

Note payable, net of issuance costs (Note 7)

   $ 213,141,607      $ 182,536,660  

Due to factoring clients

     34,200,052        27,944,605  

Accounts payable and accrued expenses

     3,401,465        2,030,084  

Lease liability

     2,238,007        1,179,246  
     

Total liabilities

     252,981,131        213,690,595  
  

 

 

    

 

 

 

Commitments (Note 8)

     

Members’ equity

     79,265,946        77,103,196  
  

 

 

    

 

 

 

Total liabilities and members’ equity

   $ 332,247,077      $ 290,793,791  
  

 

 

    

 

 

 

See notes to consolidated financial statements.

 

3


North Mill Holdco LLC and Subsidiaries

Consolidated Statements of Income

Years Ended December 31, 2022 and 2021

 

 

     Year Ended
December 31, 2022
     Year Ended
December 31, 2021
 

Interest and finance charges

   $ 26,815,365      $ 20,192,516  

Less: interest expense

     8,306,061        3,921,934  
  

 

 

    

 

 

 

Net interest income

     18,509,304        16,270,582  

Service fees and other finance charges

     2,617,984        3,828,782  
  

 

 

    

 

 

 

Net interest and other non-interest income

     21,127,288        20,099,364  
  

 

 

    

 

 

 

Expenses:

     

Personnel

     9,984,711        9,232,239  

Acquisition expenses

     3,699,997        529,552  

General and administrative

     3,048,501        2,799,572  

Legal and professional fees

     453,413        242,785  
  

 

 

    

 

 

 
     17,186,622        12,804,148  
  

 

 

    

 

 

 

Net income

   $ 3,940,666      $ 7,295,216  
  

 

 

    

 

 

 

See notes to consolidated financial statements.

 

4


North Mill Holdco LLC and Subsidiaries

Consolidated Statements of Members’ Equity

Years Ended December 31, 2022 and 2021

 

 

Balance, January 1, 2021

   $ 55,108,597  

Net income

     7,295,216  

SLR contributions

     20,000,000  

Distribution to members

     (5,300,617
  

 

 

 

Balance, December 31, 2021

     77,103,196  

Net income

     3,940,666  

SLR contributions

     5,000,000  

Distribution to members

     (6,777,916
  

 

 

 

Balance, December 31, 2022

   $ 79,265,946  
  

 

 

 

See notes to consolidated financial statements.

 

5


North Mill Holdco LLC and Subsidiaries

Consolidated Statements of Cash Flows

 

Years Ended December 31, 2022 and 2021

 

 

     Year Ended
December 31, 2022
    Year Ended
December 31, 2021
 

Cash flows from operating activities:

    

Net income

   $ 3,940,666     $ 7,295,216  

Adjustments to reconcile net income to net cash provided by operating activities:

    

Depreciation

     149,413       120,067  

Amortization of deferred financing costs

     367,771       472,437  

Changes in assets and liabilities:

    

(Increase) decrease in:

    

Accrued interest receivable

     (889,598     34,213  

Other assets

     72,915       (47,924

Increase in:

    

Unearned fee income

     248,713       16,957  

Accounts payable and accrued expenses

     1,371,381       13,766  

Due to factoring clients

     6,255,447       6,964,158  
  

 

 

   

 

 

 

Net cash provided by operating activities

     11,516,708       14,868,890  

Cash flows from investing activities:

    

Increase in finance receivables, net

     (37,353,685     (33,742,591

Acquisition of business

     —         (66,670,894

Purchases of furniture and equipment

     (412,744     (189,212
  

 

 

   

 

 

 

Net cash used in investing activities

     (37,766,429     (100,602,697
  

 

 

   

 

 

 

Cash flows from financing activities:

    

Net proceeds from note payable

     31,173,335       72,160,557  

SLR contributions

     5,000,000       20,000,000  

Payment of debt issuance costs

     (936,160     (322,216

Distribution to members

     (6,777,916     (5,300,617
  

 

 

   

 

 

 

Net cash provided by financing activities

     28,459,259       86,537,724  
  

 

 

   

 

 

 

Net increase in cash

     2,209,538       803,917  

Cash:

    

Beginning

     5,187,429       4,383,512  
  

 

 

   

 

 

 

Ending

   $ 7,396,967     $ 5,187,429  
  

 

 

   

 

 

 

Supplemental disclosure of cash flow information:

    

Cash paid for interest

   $ 6,993,995     $ 3,204,430  
  

 

 

   

 

 

 

Non-Cash Disclosure:

    

Right of use asset and lease liability

   $ 1,451,570     $ 877,449  
  

 

 

   

 

 

 

Assets and liabilities acquired in business combination:

    

Accounts receivable

   $ —       $ 66,217,916  

Due to factoring clients

     —         11,256,734  
  

 

 

   

 

 

 

See notes to consolidated financial statements.

 

6


North Mill Holdco LLC and Subsidiaries

Notes to Consolidated Financial Statements

 

 

Note 1.

Nature of the Business

The operations of North Mill Holdco LLC (“Holdco”) and Subsidiaries (collectively, the Company) consist primarily of those financial activities common to the commercial asset-based finance industry.

Holdco, a subsidiary of SLR Investment Corp. (“SLR”), was formed on May 17, 2019 in connection with the acquisition of Summit Financial Resources, LLC (“Summit”).

North Mill Capital LLC (“NMC”) was formed as a single-member Delaware limited liability company on August 18, 2010 and commenced operations on October 29, 2010. SLR acquired a controlling interest in NMC on October 20, 2017. SLR contributed its interests in NMC to Holdco on June 28, 2019. NMC is a wholly owned subsidiary of Holdco.

NMC is a specialty finance company engaged in providing asset-based commercial financing to small and medium-sized businesses. The Company’s core business is providing and servicing loans ranging from $200,000 to $40,000,000 secured by accounts receivable, inventory, and equipment. Borrowers are located throughout the United States.

PrinSource Capital Companies, LLC, a wholly owned subsidiary of NMC, and their wholly owned subsidiary Partner Plus, LLC (collectively, “PrinSource”), were acquired by NMC on December 30, 2011. Summit was acquired by Holdco on June 28, 2019. PrinSource, Summit, and Fast Pay Partners LLC (“Fast Pay”) (Note 2) provide financial services through the funding and financing of working capital assets, primarily accounts receivable and inventory.

 

Note 2:

Acquisition

On June 3, 2021, NMC acquired a 100% equity interest in Fast Pay. The total purchase price was $66,670,894. The acquisition was accounted for as a business combination and the assets acquired and liabilities assumed were recorded at their respective fair values as of the date of the acquisition. The excess of the purchase price over the fair value of assets acquired and liabilities assumed has been recorded as goodwill on the accompanying consolidated balance sheet.

 

Assets Acquired

  

Accounts receivable

   $ 66,217,916  
  

 

 

 

Liabilities Assumed

  

Due to factoring clients

     11,256,734  
  

 

 

 

Identifiable net assets

     54,961,182  

Goodwill

     11,709,713  
  

 

 

 

Purchase price

   $  66,670,894  
  

 

 

 

Upon allocating the purchase price to the fair value of assets acquired and liabilities assumed, the book value of intangible assets, consisting of goodwill, increased by $11,709,713. The accounts receivable were recorded at fair value with no allowance for loan losses established at the acquisition date.

 

 

7


North Mill Holdco LLC and Subsidiaries

Notes to Consolidated Financial Statements

 

 

Acquisition related costs of $529,552, including legal, professional and other expenses, were recorded during 2021 and not included in the purchase price.

An additional earn out payment of $3,699,997 was made in 2022 in connection with the acquisition and was based on reaching certain loan balances for a six month period subsequent to the acquisition date. The payment has been recorded as acquisition expense in the accompanying consolidated statements of income.

 

Note 3:

Significant Accounting Policies

Significant accounting policies are as follows:

Principles of consolidation: The financial statements include the accounts of NMC and its subsidiaries. All material intercompany accounts and transactions have been eliminated in consolidation.

Revenue recognition: The Company recognizes interest and fee income in accordance with ASC 310, Receivables and ASC 825, Interest. Interest income is recognized as earned based on the terms of the underlying loan agreement.    Fees received for the origination of loans are deferred and amortized into income over the contractual lives of the loans and annual fees received for loans are deferred and amortized into income over a twelve-month period using the straight-line method, which approximates the effective interest rate method. Unamortized amounts are recognized as income at the time that loans are paid in full. Interest income on loans receivable is recognized using the interest method. Interest and fee income are accrued based on the outstanding loan balance and charged monthly to the loan balance as earned, except in instances that a reasonable doubt exists as to the collectability of interest, in which case the accrual of income may be suspended.

The Company recognizes and measures revenue recognition on other fee income in accordance with ASC 606, Revenue from Contracts With Customers. Other fee income, which includes wire transfers, field examination charges, late reporting fees and other items charged to borrowers, is recognized as charged.

Cash: The Company maintains its cash balances at several financial institutions which at various times during the year have exceeded the threshold for insurance provided by the Federal Deposit Insurance Corporation.

Loans and accounts receivable: The Company provides asset-based financing primarily in the form of revolving credit facilities collateralized by the borrower’s assets, including, but not limited to, accounts receivable, inventory, equipment and general intangibles. The loan term is generally two years and management has the intention and ability to hold until maturity or payoff. Provisions for credit losses for loans receivable are charged to operations in amounts sufficient to maintain the allowance for credit losses at an amount considered adequate to cover the estimated losses of principal and accrued interest in the existing loan portfolio. The Company’s charge-off policy is based on a loan-by-loan review for all receivables. Management periodically evaluates the adequacy of the allowance for credit losses by reviewing credit loss experience, change in size and character of credit risks, the value of collateral and general economic conditions. Loans are charged off against the allowance when management determines the loan to be permanently impaired.

 

8


North Mill Holdco LLC and Subsidiaries

Notes to Consolidated Financial Statements

 

 

Specific allowances for loan losses are generally applied to impaired loans and are typically measured based on a comparison of the recorded value of the loan to the present value of the loan’s expected future cash flows from the liquidation of the underlying collateral.

Finance receivables are stated at cost, net of an allowance for credit losses. The allowance for credit losses is based on management’s assessment of the collectability of specific customer accounts, the aging of the accounts receivable, historical experience and other currently available evidence. If there is a deterioration of a major customer’s credit worthiness or actual defaults are higher than the historical experience, management’s estimates of the recoverability of amounts due to the Company could be adversely affected.

When the Company determines there is insufficient collateral to support an outstanding loan or accounts receivable balance and believes it is no longer probable that principal and/or interest payments will be collected, the Company will place the loan on non-accrual status. Such non-accrual loans may be restored to accrual status if past due principal and interest are paid in cash, and, in management’s judgment, are likely to continue.

Participation funding: The Company enters into participation funding and servicing arrangements with other lending institutions whereby the other institutions pay the Company a processing fee for servicing financing arrangements that the other institutions have entered into with their customers. Under these arrangements, the Company, as the participant, assumes the risk related to their percentage share of the arrangement. The Company pays the lending institutions a pro rata percentage of the fee income earned. The arrangements are presented in accounts receivable in the accompanying consolidated balance sheet net of the amount due to the institution.

The Company enters into participation funding arrangements with third-party lending institutions, whereby those institutions participate in loans originated by the Company. These arrangements are used by the Company to manage risk associated with loans and accounts receivable that may potentially exceed funding limits. Transfers of financial assets are accounted for as sales, when control over the assets has been surrendered. Control over transferred assets is deemed to be surrendered when: the assets have been isolated from the Company – put presumptively beyond the reach of the transferor and its creditors, even in bankruptcy or other receivership; the transferee obtains the right (free of conditions that constrain it from taking advantage of that right) to pledge or exchange the transferred assets; and the Company does not maintain effective control over the transferred assets through an agreement to repurchase them before their maturity or the ability to unilaterally cause the holder to return specific assets, other than through a cleanup call.

Furniture and Equipment: Property and equipment acquired in acquisitions is recorded at fair value. Additions are recorded at cost and stated net of accumulated depreciation. Depreciation and amortization are provided using the straight-line method over the estimated lives of the assets, which is generally three to five years for equipment and ten years for furniture and fixtures.

 

9


North Mill Holdco LLC and Subsidiaries

Notes to Consolidated Financial Statements

 

 

Debt issuance costs: Costs incurred in connection with the placement of the revolving credit facility have been capitalized and recorded as a reduction to the note payable on the balance sheets. These costs are amortized as interest expense over the life of the facility using the effective interest method or straight line method if it approximates the effective interest method.

Impairment of long-lived assets: The Company reviews long-lived assets, including furniture and equipment and intangible assets, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. An impairment loss would be recognized when undiscounted future cash flows expected to result from the use of the asset and its eventual disposition is less than the carrying amount. No impairments have occurred to date.

Goodwill: Goodwill represents the excess of consideration paid for an acquired business over the fair value of the related assets acquired and liabilities assumed. Goodwill arose from the acquisition of the Company on October 20, 2017, Summit, and Fast Pay (Note 2). The Company is required to assess its goodwill for impairment annually, or more frequently if events or changes in circumstances indicate impairment may have occurred.

The Company assesses goodwill for impairment by comparing the carrying value of the Company to its fair value. If the fair value were less than the carrying value, an impairment loss would be recorded for the difference between the fair value and carrying value. For the years ended December 31, 2022 and 2021, there was no impairment.

Income taxes: No provision has been made for income taxes, if any, as these are the obligation of the members. The Company files income tax returns as a partnership in the U.S. federal jurisdiction and in various state jurisdictions.

The Company applies authoritative guidance relating to the accounting for uncertain tax positions. Accordingly, a provision for uncertain tax positions and related penalties and interest is recognized when it is more likely-than-not, based on the technical merits, that the tax position will be realized or sustained upon examination. The term more-likely-than-not means a likelihood or more than 50%. A tax position that meets the more-likely-than-not recognition threshold is initially and subsequently measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon settlement with a taxing authority that has full knowledge of all relevant information. The determination of whether or not a tax position has met the more-likely-than-not recognition threshold considers the facts, circumstances, and information available at the reporting date and is subject to management’s judgment.

Interest rate risk: Inherent in the Company’s principal business activities is the potential for the Company to assume interest rate risks that result from differences in the maturities and re-pricing characteristics of certain assets and liabilities.

Use of estimates: The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.

 

10


North Mill Holdco LLC and Subsidiaries

Notes to Consolidated Financial Statements

 

 

Leases: The Company recognizes and measures its leases in accordance with FASB ASC 842, Leases. The Company is a lessee in several non-cancellable operating leases for office space. The Company determines if an arrangement is a lease, or contains a lease, at inception of a contract and when the terms of an existing contract are changed. The Company recognizes a right of use (ROU) asset and a lease liability asset, initially and subsequently, based on the present value of its future lease payments. The discount rate is the implicit rate, if it is readily determinable, or otherwise the Company uses its incremental borrowing rate. The implicit rates of the Company’s leases are not readily determinable and accordingly, the Company uses an incremental borrowing rate based on the information available at the commencement date for all leases. The Company’s incremental borrowing rate for a lease is the rate of interest it would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms and in a similar economic environment. The Company used a weighted average discount rate of 3.70% and the weighted average remaining lease terms is 4.18 years. The ROU asset is subsequently measured throughout the lease term at the amount of the remeasured lease liability (i.e., present value of the remaining lease payments), plus unamortized initial direct costs, plus (minus) any prepared (accrued) lease payments, less the unamortized balance of lease incentives received, and any impairment recognized.

Subsequent events: The Company has evaluated its subsequent events (events occurring after December 31, 2022) through February 21, 2023, which represents the date the financial statements were available to be issued, and determined that there were no material subsequent events requiring adjustment to, or disclosure in the consolidated financial statements for the year ended December 31, 2022.

Recent Accounting Pronouncement: In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 sets forth a current expected credit loss model requiring the Company to measure all expected credit losses for financial instruments held at the reporting date based on historical experience, current conditions, and reasonable supportable forecasts. This replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost. ASU 2016-13 will be effective for the Company for its fiscal year beginning after December 15, 2022. The Company is evaluating the impact using a model that incorporates portfolio characteristics, risk rating, historical losses, and current economic conditions. Management is in the process of finalizing the model and significant assumptions used with the model.

In January 2017, the FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment (Topic 350), which simplifies how an entity is required to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. ASU 2017-04 is effective for annual or any interim goodwill impairment tests in fiscal year 2023, with early adoption permitted for annual or interim tests performed on testing dates after January 1, 2017. The amendments included in this ASU are to be applied prospectively. The Company does not expect implementation of this new standard to have a material impact on its consolidated financial statements.

 

11


North Mill Holdco LLC and Subsidiaries

Notes to Consolidated Financial Statements

 

 

In January 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, March 2020, to provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to alternative reference rates, such as the Secured Overnight Financing Rate. Entities can elect not to apply certain modification accounting requirements to contracts affected by what the guidance calls “reference rate reform” if certain criteria are met. An entity that makes this election would not have to remeasure the contracts at the modification date or reassess a previous accounting determination. Also, entities can elect various optional expedients that would allow them to continue applying hedge accounting for hedging relationships affected by reference rate reform if certain criteria are met, and can make a one-time election to sell and/or reclassify held-to-maturity debt securities that reference an interest rate affected by reference rate reform. In December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (Topic 848), Deferral of the Sunset date of Topic 848, which defers the sunset date in Topic 848 from December 31, 2022 to December 31, 2024. The amendments in this ASU apply to all entities (subject to meeting certain criteria) that have contracts, hedging relationships, or other transactions that reference the London Interbank Offered Rate (LIBOR) or another reference rate expected to be discontinued because of reference rate reform. The Company is currently evaluating the impact the adoption of the standard will have on the Company’s financial position and results of operations.

 

Note 4.

Fair Value of Financial Instruments

FASB ASC 820, Fair Value Measurements (“ASC 820”), establishes a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect management’s market assumptions.

These two types of inputs create the following fair value hierarchy:

Level 1 – Quoted prices for identical instruments in active markets.

Level 2 – Observable inputs other than quoted prices in active markets for identical assets and liabilities, such as interest rates and foreign exchange rates that are observable at commonly quoted intervals. Financial assets utilizing Level 2 inputs include currency swaps and interest rate caps.

Level 3 – Unobservable inputs.

ASC 820 also requires that the Company disclose estimated fair values for its financial instruments. No quoted market exists for the Company’s financial instruments. Therefore, fair market estimates are based on judgments, risk characteristics of various financial instruments and other factors. Changes in these assumptions could significantly affect the estimates.

The Company estimates the carrying amounts of cash approximated its fair value as of December 31, 2022 and 2021. Since there is no liquid secondary market for the Company’s financing receivables, the Company estimated the fair value of its secured loans by comparing the average yield of the portfolio to recent issuances of similar loans. The Company has determined that the secured loans and note payable are considered level three under the fair value hierarchy described above.

 

12


North Mill Holdco LLC and Subsidiaries

Notes to Consolidated Financial Statements

 

 

The carrying amount and estimated fair values of the Company’s financial instruments at December 31, 2022 and 2021 were as follows:

 

     December 31, 2022      December 31, 2021  
     Carrying Amount      Estimated Fair
Value
     Carrying Amount      Estimated Fair
Value
 

Financial assets:

           

Cash

   $ 7,396,967      $ 7,396,967      $ 5,187,429      $ 5,187,429  

Finance receivables: Net of allowance

     283,886,964        283,886,964        246,781,991        246,781,991  

Liabilities:

           

Note Payable

   $  213,141,607      $  213,141,607      $  182,536,660      $  182,536,660  

 

Note 5.

Loans and Accounts Receivable and Allowance for Credit Losses

Loans receivable at December 31, 2022 and 2021 consist of revolving lines of credit to commercial customers that range from one to three years and are secured by accounts receivable, inventory and equipment. There are commitments to borrowers that are dependent on the borrowing base. The commitments are generally limited to 85% of the collateral being presented.

Changes in the allowance for credit losses for loans receivable and accounts receivable are as follows:

 

Balance, January 1, 2021

   $  1,834,061  

Provision for uncollectible finance receivables

     —    
  

 

 

 

Balance, December 31, 2021

     1,834,061  

Provision for uncollectible finance receivables

     —    
  

 

 

 

Balance, December 31, 2022

   $ 1,834,061  
  

 

 

 

All balances were individually evaluated for impairment.

The Company has implemented and adheres to an internal review system and credit loss allowance methodology designed to provide for the detection of problem receivables and an adequate allowance to cover credit losses. At least quarterly, a risk rating is assigned to individual balances. Management assigns a higher risk rating when they determine that their credit exposure has increased. Management assigns these risk ratings based on a number of factors including, but not limited to, the profitability, cash flow position, tangible net worth, strength of collateral performance and coverage, the probability of a loss being realized and results of internal audits and verifications related to each specific receivable.

The Company typically classifies all loans as held to maturity. Any acquired loans are recorded at their estimated Acquisition Date fair values. The estimated fair values include consideration of discounted cash flows as well as various other factors including the type of loan and related collateral, estimated future cash flows, as well as a discount rate that reflects the Company’s assessment of risk inherent in the cash flow estimates. The fair value of the loans acquired effectively remove the Company’s allowance for loan losses for such acquired loans. Loans funded subsequent to an acquisition are recorded at the amount of unpaid principal, net of unearned fees, discounts and includes an allowance for loan losses.

 

13


North Mill Holdco LLC and Subsidiaries

Notes to Consolidated Financial Statements

 

 

A loan is considered impaired when, based on current information and events, it is probable that the Company will be unable to collect the scheduled payments in accordance with the contractual terms of the loan. Factors considered in determining impairment include payment status, collateral value and the probability of collecting payments when due. The significance of payment delays and/or shortfalls is determined on a case-by-case basis. All circumstances surrounding the loan are taken into account. Such factors include the length of the delinquency, the underlying reasons and the borrower’s prior payment record.    Impairment is measured on these loans on a loan-by-loan basis. Impaired loans include non-accrual loans and other loans deemed to be impaired based on the aforementioned factors.

NMC did not have any loans or accounts receivable that are non-performing, impaired, modified or past due as of December 31, 2022 and December 31, 2021.

 

Note 6.

Furniture and Equipment

Furniture and equipment consists of the following at December 31, 2022 and 2021:

 

     2022      2021  

Furniture and fixtures

   $ 457,122      $ 275,011  

Equipment

     2,138,407        1,907,774  
  

 

 

    

 

 

 
     2,595,529        2,182,785  

Accumulated depreciation

     2,050,192        1,900,779  
  

 

 

    

 

 

 
   $ 545,337      $ 282,006  
  

 

 

    

 

 

 

Depreciation expense was $149,413 for the year ended December 31, 2022 and $120,067 for the year ended December 31, 2021.

 

Note 7.

Note Payable

The Company has entered into a $285,307,000 credit facility which expires November 13, 2025. Borrowings are secured by substantially all of the Company’s assets. Interest on borrowings under the facility is payable monthly and is based on the SOFR plus an applicable margin, as defined. The interest rate is 4.12 percent as of December 31, 2022. Outstanding borrowings under the credit facility are generally limited to 85 percent of eligible receivables, less any reserves established by the bank, as defined. The Company is required to maintain specified financial ratios and to comply with other covenants. The balance outstanding under this credit facility was $214,425,205 at December 31, 2022 and $183,251,870 at December 31, 2021.    Note payable as of December 31, 2022 and 2021 consist of the following:

 

14


North Mill Holdco LLC and Subsidiaries

Notes to Consolidated Financial Statements

 

 

     2022      2021  

Outstanding principal balance

   $  214,425,205      $  183,251,870  

Less: debt issuance costs, net of accumulated amortization of $1,732,358 and $1,364,587, respectively

     1,283,598        715,210  
  

 

 

    

 

 

 
   $ 213,141,607      $ 182,536,660  
  

 

 

    

 

 

 

Total interest expense related to note payable was $7,837,581 and $3,310,394 for the years ended December 31, 2022 and 2021, respectively. Amortization of deferred costs of $367,771 and $472,437 for the years ended December 31, 2022 and 2021, respectively, is included in interest expense in the Consolidated Statements of Income.

 

Note 8.

Commitments

Employment agreements: The Company has entered into service agreements with certain members of management. Annual base compensation due under these agreements is included in personnel expenses in the consolidated statements of operations. The annual base compensation is subject to review and adjustment by the Company. The employees are also eligible to receive bonus compensation at the discretion of the Board of Managers. The agreements can be terminated by either the Company or the employees at any time upon written notice. Certain additional amounts may be paid to the employees, contingent upon the circumstances surrounding the termination, as defined in the service agreements.

Operating lease: The Company rents its office space under non-cancelable operating leases that expire through December 2027. Base rents due under the leases escalate throughout the term of the leases. These leases generally contain renewal options but the Company is not reasonably certain to exercise these options. The optionable periods are not included in determining the lease term and the associated payments under the renewal options are excluded from lease payments.

The total minimum rental commitment at December 31, 2022, is due as follows:

Years ending December 31:

 

2023

   $ 583,152  

2024

     548,135  

2025

     512,349  

2026

     492,379  

2027

     208,377  
  

 

 

 

Total lease commitments

     2,344,392  

Less: interest

     (106,385
  

 

 

 

Present value of lease liability

   $  2,238,007  
  

 

 

 

Rent expense was $586,007 and $499,517 for the years ended December 31, 2022 and 2021, respectively.

 

15


North Mill Holdco LLC and Subsidiaries

Notes to Consolidated Financial Statements

 

 

Note 9.

Related Party Transactions

An employee of NMC provides marketing and sales services to an affiliated entity for which NMC was reimbursed. Such reimbursements have been recorded in the Company’s Statement of Operations as a reduction of Personnel expenses.

NMC has sold participations in several loan agreements to SLR. The participations sold for a total commitment of $68 million and the amount outstanding at December 31, 2022 was $53.4 million.

 

16

EX-99.6 21 d437884dex996.htm EX-99.6 EX-99.6

Exhibit 99.6

Report of Independent Registered Public Accounting Firm on Supplemental Information

To the Stockholders and Board of Directors

SLR Investment Corp.:

We have audited and reported separately herein on the consolidated financial statements of SLR Investment Corp. (and subsidiaries) (the Company) as of December 31, 2022 and 2021 and for each of the years in the three-year period ended December 31, 2022.

We have also previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated statements of assets and liabilities of the Company, including the consolidated schedules of investments, as of December 31, 2020, 2019, 2018, 2017, 2016, 2015, 2014, and 2013, and the related consolidated statements of operations, changes in net assets, and cash flows for the years ended December 31, 2019, 2018, 2017, 2016, 2015, 2014, and 2013, (none of which is presented herein), and we expressed unqualified opinions on those consolidated financial statements.

The senior securities table included in Part II, Item 7 of the Annual Report on Form 10-K of the Company for the year ended December 31, 2022, under the caption “Senior Securities” (the Senior Securities Table) has been subjected to audit procedures performed in conjunction with the audits of the Company’s respective consolidated financial statements. The Senior Securities Table is the responsibility of the Company’s management. Our audit procedures included determining whether the Senior Securities Table reconciles to the respective consolidated financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the Senior Securities Table. In forming our opinion on the Senior Securities Table, we evaluated whether the Senior Securities Table, including its form and content, is presented in conformity with the instructions to Form N-2. In our opinion, the Senior Securities Table is fairly stated, in all material respects, in relation to the respective consolidated financial statements as a whole.

/s/ KPMG LLP

New York, NY

February 28, 2023

EX-101.SCH 22 slrc-20221231.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Consolidated Statements of Assets And Liabilities link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Consolidated Statements of Assets And Liabilities (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Consolidated Statements of Operations link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Consolidated Statements of Changes In Net Assets link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1007 - Statement - Consolidated Statements of Cash Flows (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1008 - Statement - Consolidated Schedule of Investments link:presentationLink link:definitionLink link:calculationLink 1009 - Statement - Consolidated Schedule of Investments (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 999001 - Disclosure - Organization link:presentationLink link:definitionLink link:calculationLink 999002 - Disclosure - Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 999003 - Disclosure - Agreements link:presentationLink link:definitionLink link:calculationLink 999004 - Disclosure - Net Asset Value Per Share link:presentationLink link:definitionLink link:calculationLink 999005 - Disclosure - Earnings Per Share link:presentationLink link:definitionLink link:calculationLink 999006 - Disclosure - Fair Value link:presentationLink link:definitionLink link:calculationLink 999007 - Disclosure - Debt link:presentationLink link:definitionLink link:calculationLink 999008 - Disclosure - Income Tax Information and Distributions to Stockholders and Other Tax Information link:presentationLink link:definitionLink link:calculationLink 999009 - Disclosure - Financial Highlights link:presentationLink link:definitionLink link:calculationLink 999010 - Disclosure - SLR Credit Solutions link:presentationLink link:definitionLink link:calculationLink 999011 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 999012 - Disclosure - SLR Equipment Finance link:presentationLink link:definitionLink link:calculationLink 999013 - Disclosure - Capital Share Transactions link:presentationLink link:definitionLink link:calculationLink 999014 - Disclosure - Kingsbridge Holdings, LLC link:presentationLink link:definitionLink link:calculationLink 999015 - Disclosure - SLR Healthcare ABL link:presentationLink link:definitionLink link:calculationLink 999016 - Disclosure - SLR Business Credit link:presentationLink link:definitionLink link:calculationLink 999017 - Disclosure - Merger with SUNS link:presentationLink link:definitionLink link:calculationLink 999018 - Disclosure - Stock Repurchase Program link:presentationLink link:definitionLink link:calculationLink 999019 - Disclosure - SLR Senior Lending Program LLC link:presentationLink link:definitionLink link:calculationLink 999020 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 999021 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 999022 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:definitionLink link:calculationLink 999023 - Disclosure - Fair Value (Tables) link:presentationLink link:definitionLink link:calculationLink 999024 - Disclosure - Debt (Tables) link:presentationLink link:definitionLink link:calculationLink 999025 - Disclosure - Income Tax Information and Distributions to Stockholders and Other Tax Information (Tables) link:presentationLink link:definitionLink link:calculationLink 999026 - Disclosure - Financial Highlights (Tables) link:presentationLink link:definitionLink link:calculationLink 999027 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:definitionLink link:calculationLink 999028 - Disclosure - Capital Share Transactions (Tables) link:presentationLink link:definitionLink link:calculationLink 999029 - Disclosure - Merger with SUNS (Tables) link:presentationLink link:definitionLink link:calculationLink 999030 - Disclosure - SLR Senior Lending Program LLC (Tables) link:presentationLink link:definitionLink link:calculationLink 999031 - Disclosure - Organization - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999032 - Disclosure - Significant Accounting Policies - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999033 - Disclosure - Agreements - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999034 - Disclosure - Net Asset Value Per Share - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999035 - Disclosure - Earnings Per Share - Summary of Computation of Basic and Diluted Net (Detail) link:presentationLink link:definitionLink link:calculationLink 999036 - Disclosure - Fair Value - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) link:presentationLink link:definitionLink link:calculationLink 999037 - Disclosure - Fair Value - Summary of Changes in Fair Value of Level 3 Assets and Liabilities (Details) link:presentationLink link:definitionLink link:calculationLink 999038 - Disclosure - Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Details) link:presentationLink link:definitionLink link:calculationLink 999039 - Disclosure - Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Parenthetical) (Details) link:presentationLink link:definitionLink link:calculationLink 999040 - Disclosure - Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Details) link:presentationLink link:definitionLink link:calculationLink 999041 - Disclosure - Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Parenthetical) (Details) link:presentationLink link:definitionLink link:calculationLink 999042 - Disclosure - Debt - Schedule of Long-term Debt Instruments (Details) link:presentationLink link:definitionLink link:calculationLink 999043 - Disclosure - Debt - Schedule of Long-term Debt Instruments (Parenthetical) (Details) link:presentationLink link:definitionLink link:calculationLink 999044 - Disclosure - Debt - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999045 - Disclosure - Income Tax Information and Distributions to Stockholders and Other Tax Information - Summary of distributions to shareholders (Details) link:presentationLink link:definitionLink link:calculationLink 999046 - Disclosure - Income Tax Information and Distributions to Stockholders and Other Tax Information - Summary of total accumulated earnings (loss) on a tax basis (Details) link:presentationLink link:definitionLink link:calculationLink 999047 - Disclosure - Income Tax Information and Distributions to Stockholders and Other Tax Information - Additional information (Details) link:presentationLink link:definitionLink link:calculationLink 999048 - Disclosure - Financial Highlights - Schedule of Financial Highlights (Details) link:presentationLink link:definitionLink link:calculationLink 999049 - Disclosure - Financial Highlights - Schedule of Financial Highlights (Parentheticals) (Details) link:presentationLink link:definitionLink link:calculationLink 999050 - Disclosure - SLR Credit Solutions - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999051 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999052 - Disclosure - Commitments and Contingencies - Summary of Unfunded Debt and Equity Commitments (Details) link:presentationLink link:definitionLink link:calculationLink 999053 - Disclosure - SLR Equipment Finance - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999054 - Disclosure - Capital Share Transactions - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999055 - Disclosure - Capital Share Transactions - Summary of Transactions In Capital Stock (Details) link:presentationLink link:definitionLink link:calculationLink 999056 - Disclosure - Kingsbridge Holdings, LLC - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999057 - Disclosure - SLR Healthcare ABL - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999058 - Disclosure - SLR Business Credit - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999059 - Disclosure - Merger with SUNS - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999060 - Disclosure - Merger with SUNS - Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger (Detail) link:presentationLink link:definitionLink link:calculationLink 999061 - Disclosure - Merger with SUNS - Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger (Parenthetical) (Detail) link:presentationLink link:definitionLink link:calculationLink 999062 - Disclosure - Stock Repurchase Program - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999063 - Disclosure - SLR Senior Lending Program LLC - Summary of SSLP's portfolio (Details) link:presentationLink link:definitionLink link:calculationLink 999064 - Disclosure - SLR Senior Lending Program LLC - Summary financial information for SSLP (Details) link:presentationLink link:definitionLink link:calculationLink 999065 - Disclosure - SLR Senior Lending Program LLC - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999066 - Disclosure - Subsequent Events - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 23 slrc-20221231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 24 slrc-20221231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 25 slrc-20221231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 26 slrc-20221231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 27 g437884dsp00199.jpg GRAPHIC begin 644 g437884dsp00199.jpg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g437884dsp199.jpg GRAPHIC begin 644 g437884dsp199.jpg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g437884dsp220.jpg GRAPHIC begin 644 g437884dsp220.jpg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g437884g0223102720734.jpg GRAPHIC begin 644 g437884g0223102720734.jpg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g437884g0223103923385.jpg GRAPHIC begin 644 g437884g0223103923385.jpg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end GRAPHIC 32 g437884g08d23.jpg GRAPHIC begin 644 g437884g08d23.jpg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g437884page61.jpg GRAPHIC begin 644 g437884page61.jpg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end GRAPHIC 34 g437884rsm.jpg GRAPHIC begin 644 g437884rsm.jpg M_]C_X 02D9)1@ ! 0$ D "0 #_X1$ 17AI9@ 34T *@ @ ! $[ ( M 2 (2H=I 0 ! (7)R= $ D 0U.H< < @, /@ M !SJ " M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M ,C R,SHP,CHR." Q,SHU-SHU- R,#(S M.C R.C(X(#$S.C4W.C4T 5@!E &X 80 @ $@ <@!Y ', ;P!U &P ; !A M &L :0!S _^$+)&AT=' Z+R]N&%P+S$N,"\ /#]X M<&%C:V5T(&)E9VEN/2?ON[\G(&ED/2=7-4TP37!#96AI2'IR95-Z3E1C>FMC M.60G/SX-"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B/CQR M9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO&UL;G,Z&UP;65T83X-"B @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @ M(" @(" @(" @/#]X<&%C:V5T(&5N9#TG=R<_/O_; $, !P4%!@4$!P8%!@@' M!P@*$0L*"0D*%0\0#!$8%1H9&!48%QL>)R$;'24=%Q@B+B(E*"DK+"L:("\S M+RHR)RHK*O_; $,!!P@("@D*% L+%"H<&!PJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*O_ !$( 'D D ,!(@ " M$0$#$0'_Q ? !!0$! 0$! 0 0(#! 4&!P@)"@O_Q "U$ " M 0,# @0#!04$! 7T! @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1 M\"0S8G*""0H6%Q@9&B4F)R@I*C0U-CH.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:W MN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q ? M 0 # 0$! 0$! 0$! 0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$ M! ! G< 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3% MQL?(RKR\_3U]O?X^?K_V@ , P$ A$#$0 _ M /=]8\5:=H=XMM?&7S&C$@V)D8)(_H:CTSQCI>K:A'9VAF\V0$KNCP.!GU]J MX[XE?\C)!_UZ+_Z&]4O G_(X6G^[)_Z :8'H?B#Q3IWAK[/_ &D91]HW;/+3 M=]W&<_\ ?0K&_P"%H^'?6Z_[\_\ UZQ/C#UT?_MO_P"TZ\SKQ\3C*M*JX1V/ M-KXF<*CBCV?_ (6CX=];K_OS_P#7J>S^(^A7U]!:0&Y\V>18TW18&2<#O[UX MC6IX9_Y&S2?^OV'_ -#%8QQ]9R2=C..+J.21[GKNO6?AW3UO-1\P1-((QY:[ MCD@G^E<[_P +4\.>MU_WY_\ KU'\6O\ D3XO^OQ/_06KQBOO,!E]'$4>>=[W M/*S7-L1A,1[*G:UENCVO_A:GASUNO^_/_P!>C_A:GASUNO\ OS_]>O%**[O[ M(PWG]YY?^L&,\ON_X)[7_P +4\.>MU_WY_\ KT?\+4\.>MU_WY_^O7BE%']D M8;S^\/\ 6#&>7W?\$]K_ .%J>'/6Z_[\_P#UZ/\ A:GASUNO^_/_ ->O%**/ M[(PWG]X?ZP8SR^[_ ()[7_PM3PYZW7_?G_Z]'_"U/#GK=?\ ?G_Z]>*44?V1 MAO/[P_U@QGE]W_!/:_\ A:GASUNO^_/_ ->NET76;77M-6^L-_DLQ4;UP<@X M/%?-]>X?"_\ Y$:#_KM)_P"A5P9A@*.'H\\+WN>ME.:XC%XATZEK6OHO0O:_ MX/MO$%^EU<7,T3)$(PJ 8P"3W^M0Z-X'M-&U2*^ANII'C! 5P,'((_K73T5X M)]2<_P"*?"-MXJ^R_:KF6#[-OV^6!SNQUS_NUS__ J/3?\ H(W?Y+_A7H%% M83P]*2//_P#A4>F_]!&[_)?\*L:?\+M/T_4K:]CO[EWMY5E5 M6"X)4YQT]J[BBI6%HIW41+#TD[V,?Q-X=@\3Z6MC_%4?^$L\._\ 0>TS M_P #(_\ &O3I8NO2CRPE9&-? 8;$3YZL+LY+_A3^F?\ 02N_R7_"C_A3^F?] M!*[_ "7_ KLK;Q!HU[,(K/5K&>0]$BN48G\ :T:U_M#%?SF']D8'_GVOQ// M/^%/Z9_T$KO\E_PH_P"%/Z9_T$KO\E_PKN;[4['3(A+J-Y!:H3@--($!^F:R ME\=>&&?:-;M,^[X'YT?VABOYP_LG _\ /M?BZM8V\Z8W12W**R MY&1D$YZ&C^T,5_.']D8'_GVOQ.-_X4_IG_02N_R7_"C_ (4_IG_02N_R7_"N M\M+VUU"W$]A>?\*?TS_H)7?Y M+_A77^'="A\.Z.FGV\KS(C,P:3&>3GM4EWX@T:PN6M[[5K&VF7&Z.:Y1&&1D M9!.:LVE[:ZA;B>PN8;F$D@20N'4D=>1657%UZT>6I*Z-Z& PV'GSTH69/111 M7,=H4444 %%%% ' ?&/_ )$J'_K]3_T%Z\^\'?#^;Q?I]Q=1:@EJ(9?+VM$6 MSP#GJ/6O0?C'_P B5#_U^I_Z"]87PVU^T\->!=2U#4%E>%;Y4(B4%LE1ZD4^ M@C \5?#/4?#.EMJ(NX;RVC($A52C)DX!P>HS@=>]=K\)_%%UJ6CWECJ,C3/8 M!7CD-OB?IVO>&YM+TJUN0;@KYDDZJH50P;@ G)XJ[\&- M'F2WU'5+B(K#.%@A)'WP"2Q'MT&?KZ4 <"7U/QYXO1))@UU>2%4WL=D2\G ] M !G_ /77<_\ "D&V_P#(?&['3['Q_P"AUR7B+PMK/@G6S=6ZS"WBDWVU[$,@ M#/&3V/;!Z^XK=TOXS:M;!4U6RM[U0,%T)B<^YZC\@*8'8^ ? ][X0O\ 4'NK MF"XBN$18VCR&X)Z@CCKZFO,_B=_R4;4_^V7_ **2O9?#'C+2O%<+G3Y&2>,9 MDMY1AU'KZ$>X_'%>-?$WGXCZG]8O_124@.J^"^M;9+[196X8?:81[\*X_P#0 M?R->KRRI!"\LS!(XU+,QZ #DFOGJ/S? 7Q'7<6*65SR>I>%A_,HWYUZK\4-; M&F^!Y4@?]YJ!$"%3_">6/TV@C_@0H&>):[JCZUKUYJ,N0:OI,GA#Q>;6]@2ZCMI5D595^6 MXCSD9^HX/OGTKZ&T:]L]1T6TN]+"BTEB!B5 $']W Z8Z8[8KF?B-X-?Q1I< M4VGHIU*V/[O)"^8AZJ2?S'X^M5/AMHWB3PXMQI^LVJK8O^\B<3(WEOW& M[^&WC'3]0EFTP"3>Y8/:W00\G_:*FH)O OC[4=L5]#+Y74>^-YH$9 M_P .)IH?B!IGV?)+NR. >JE3G].?PJ3XF?\ )2-2^L7_ **2O2/ ?PY'ABX. MHZG-'<7Y4JBQ@[(0>N">22.,\=ZYSQOX \0ZUXTO=0T^T22VF,>QC,BYPB@\ M$YZ@T 2_&/07>ZT[5K:,LTW^B2!>[=4_$_,/P%<[\0KB5M3TOP]&[3G2;2.V M.!G?*5&['Y*/PKW.]LX;RV5;B'SO*=9D7/\ &A#+C\17EGAWP!K\GCR/6?$5 MM''$)VNI")E;+Y)4 G^+!^@H 3XE:2FA^ ?#^FIC_1Y-K$=&;;EC^))-=1\ M)O\ D0+?_KM)_P"A4GQ-\-ZGXETJRATB%9I(9B[AI N!MQW-:'P_T:]T'PC# M8ZG&(KA9'8J'#<$Y'(HZ#.FHHHI %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%9FLZI/IK6<=I:+=37<_DHKS>6!\C-DG![+0!I MT5R__"9%OLT,=@JWU &[17,Z=XRCU+PQJ>M16;+'8O(JQF3F4*H8'.., M@].:LZIXG32KR:&2U>18M/:]+(W) 8+MQCWSG- &[169IFIW%[9R7-Q:PQ(% M#1M#="99!@]P!C_Z]03>(A%X2M];^S9$R0MY/F=/,95^]CMN].<4 ;5%9>L: MM<:?<6-O9V:W4UY(R*KS>6%VJ6)SM/85-HVIC5M.%SY+0.)'BDC+!MKHQ4@$ M<$9'6@"]1110 4444 %%%% !1110 5EZUH<&N-9+=[6@MYS*\3+D2?(RX]N6 MS^%:E% '-Q^&;BWT&'28)M/EMHBXVW=CYFY2O\2R%<=O>NOHH PK?PO%#H^KZ=YV(=1ED9=B8\I614 M 'KC;20:'J"W\FH7&H6\EY]E%K"5M2(U7=N)9=Y+$X'0C%;U% &'HWAUM,FU M"=Y;JJF.UM_)C3:",[=QY.[DY[53/AK5)/#*Z+-J5H88HXDB=;1@P,;JP M+?/@\+CC'6NHHH PKKP_-JTMDVN2VMRMK,\ACCMRJR H5 (+'D$YS6Q;6L%E 4;);VD,<$*#"QQJ%4?@*EHH __]D! end GRAPHIC 35 g437884rsm2.jpg GRAPHIC begin 644 g437884rsm2.jpg M_]C_X 02D9)1@ ! 0$ D "0 #_X1$ 17AI9@ 34T *@ @ ! $[ ( M 2 (2H=I 0 ! (7)R= $ D 0U.H< < @, /@ M !SJ " M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M ,C R,SHP,CHR." Q-#HP,#HR-@ R,#(S M.C R.C(X(#$T.C P.C(V 5@!E &X 80 @ $@ <@!Y ', ;P!U &P ; !A M &L :0!S _^$+)&AT=' Z+R]N&%P+S$N,"\ /#]X M<&%C:V5T(&)E9VEN/2?ON[\G(&ED/2=7-4TP37!#96AI2'IR95-Z3E1C>FMC M.60G/SX-"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B/CQR M9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO&UL;G,Z&UP;65T83X-"B @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @ M(" @(" @(" @/#]X<&%C:V5T(&5N9#TG=R<_/O_; $, !P4%!@4$!P8%!@@' M!P@*$0L*"0D*%0\0#!$8%1H9&!48%QL>)R$;'24=%Q@B+B(E*"DK+"L:("\S M+RHR)RHK*O_; $,!!P@("@D*% L+%"H<&!PJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*O_ !$( "0"K ,!(@ " M$0$#$0'_Q ? !!0$! 0$! 0 0(#! 4&!P@)"@O_Q "U$ " M 0,# @0#!04$! 7T! @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1 M\"0S8G*""0H6%Q@9&B4F)R@I*C0U-CH.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:W MN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q ? M 0 # 0$! 0$! 0$! 0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$ M! ! G< 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3% MQL?(RKR\_3U]O?X^?K_V@ , P$ A$#$0 _ M /HV6=( #(3SZ*3_ "IC7MNF=TF%W!=Y!VDDA0,],Y(%)=VBW<>UG=/E(!1B M",_3K]#Q4,NF+.[^:Z^6XPR1J5W<@Y//)XZ]: +2W$3-(JR*6C8(X!^ZQ (! M_ C\Z074)F\I6W/W"J3CDCG'3D'KZ&H8K$PVQ02[I68.TC+]Y@
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g437884thepower.jpg GRAPHIC begin 644 g437884thepower.jpg M_]C_X 02D9)1@ ! 0$ D "0 #_X1$ 17AI9@ 34T *@ @ ! $[ ( M 2 (2H=I 0 ! (7)R= $ D 0U.H< < @, /@ M !SJ " M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M ,C R,SHP,CHR." Q,SHU.3HU- R,#(S M.C R.C(X(#$S.C4Y.C4T 5@!E &X 80 @ $@ <@!Y ', ;P!U &P ; !A M &L :0!S _^$+)&AT=' Z+R]N&%P+S$N,"\ /#]X M<&%C:V5T(&)E9VEN/2?ON[\G(&ED/2=7-4TP37!#96AI2'IR95-Z3E1C>FMC M.60G/SX-"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B/CQR M9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO&UL;G,Z&UP;65T83X-"B @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @ M(" @(" @(" @/#]X<&%C:V5T(&5N9#TG=R<_/O_; $, !P4%!@4$!P8%!@@' M!P@*$0L*"0D*%0\0#!$8%1H9&!48%QL>)R$;'24=%Q@B+B(E*"DK+"L:("\S M+RHR)RHK*O_; $,!!P@("@D*% L+%"H<&!PJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*O_ !$( ", Z0,!(@ " M$0$#$0'_Q ? !!0$! 0$! 0 0(#! 4&!P@)"@O_Q "U$ " M 0,# @0#!04$! 7T! @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1 M\"0S8G*""0H6%Q@9&B4F)R@I*C0U-CH.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:W MN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q ? M 0 # 0$! 0$! 0$! 0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$ M! ! G< 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3% MQL?(RKR\_3U]O?X^?K_V@ , P$ A$#$0 _ M /?]2\0:;I$RQ:A.T3N RXA=@:(S(IC924!VD M\CCD].M5O$,4DUC;K#&TA%Y Q"KG $BDGZ 55O[&ZN?%\#V\\]HBV+@SQ1JP MSO7Y1[Z+RKB]WW$-KYC_,XP2NTCYOI]*Z2^+7? M@^\$/VB=WM)%7S82DCG:1]S Y)]J8$VG^(=,U28PV5SOD"[]K1LA*^HW 9'T MHMO$&EWETMO;W:O(^0GRL%DQUVL1AOP)K-BT"]N;>.>]OEDFCLGAMT6#R_++ MJ 2W))/ ]*IQ+/>:?H&FI8W4-Q8SPO<-+"RI&(QAB&Z'/;!.!SQZ5R%SH M]_)M<.L!E\D,8) 2^,XQMST[XJWIVJ6>JPM+83 M"54;:WRE2I]"" 16!J276H:=I@LI[N2:/44)N+BS*L@VM\Q3:ORC(YZ>]6_# M-MM("[)XATJ&\-M)>*)%?8QVMM5O[ MI;&T'V)IEQXETJUOWLIKAQ<1D!D6"1L$@$']2T4Z=(M3F2ZDMX/.B)0P@B8"-;>9_+1EC9B6YXP!D'@] M16=XFCF_MO1YXVNXHXA/OFM8#*R950.-K=>G2LF.WNX]'LV:*\@V:K))YZ6Q M:9T*O^\9,'!)..GI0!U=OKFGW4<+PS,5FF\F/=$Z[GV[L8('8=>E+#KFG3V' MVV&Y#V_FB$L%/#E@H!&,CDC\\]*S9#)=_P!CM&UW<^3?$R2SVYC;'EOR1M7 MY SBN;@T;4K'3;*2U@F,5[!9GVM<2>7&,$[FP3CVX!KDKB74](?5X[.&X% MU-=FYAE2T:9)D*@!,C[I!'?I6WKZRK_9MU'!),EM=K)*L2[F"E&7( Y."PZ4 M@+%SKFG69NOM-SY?V0H)\HWR;_N]N<^U23ZK96TSQ33;72W:Z8!2<1#@MD#] M.M6,NJ_VQ.;2X^S7MS9QHKQLCNJ, YVGD#GK[5672]3M-0U*SFBEG@@T> M>"TG"$^8I(*KG^\.1CVI@=58>(M+U.4QV=UOD"[]K1LA*^H# 9_"FV/B;2M2 MG6*RN'D9@2O[B100!D\E0*Q[?S=0N]#$-E)](U*Y2"SN]TD@)16B=- M^.N"P&:=;>(M*O+X6=M="28DJ-J-M8CDX;&#T/>NPU2*;0%U-I9+..(O& MB6^TP2A+:07,C3LP4(;>0:0'1W>OZ98W36]U=!)%QO 5F$>>FX@87\<4V_P#$>EZ9<+!> M7)21HQ* L3N-I)&TFL?#=K!^O[;3;-[J^E$4"8W.03C)P.!SU M-2&XB6ZCMRW[V1&D5<'E5(!.?^!#\ZR]8BNKR^M;:"UCGA0/+*)G*(>-JKD* MV3\S'&.PJG8O/ M[#=R03K'_:,LI A8LJ&.502H&1G([=Q231RW;W5W%!,L4MY9A \;*S!)5+/M M(R!]>RYZ4 :AUJS6^^QG[3YY. OV27!YQG.W&,D-NV///&T^] &\VIVB1R. MTN!%*(7&TY#D@ 8QDYR,>NW=86CV- MNDX(\X#OMW8''(W$=JW9O^/FW_WC_P"@F@".ZU.ULYEAF=S*R[A'%$TC;>F2 M%!('O23:M:0; [R%G0.$CA=V"GN54$@?6JC3?V?KUU-<0SM%<0Q^7)%"T@RN M[*G:"1U!YZYIJW(M-8N+J:&X,-U!$8W2W=C\N[*D 94\@X('7ZT :']HV>ZU M N$/VO/D$,_I6+'H[W=G9 M0W,;PL6N)T8#YK=F?>A]B,C\B*9:))+;7DNLPW-K<"_#1O;1.Y#K"B;UPI^4 MX;J".<&@#?BU"WEC1U,BAY/+421,AW8SC# &EDO[:*62.23#Q*C.-IX#DJOY MD&LA9[R2S6>X2>>.VO5*.;YDU&\B@G\DI;1K MNA8,Q21F8A2,D88=O6@#7OM4M=-V&[,RAR "D#R#)( &5!P22 !WI)-5M(H? M,ED>-?(>X(>)E(1,;B01D8R..M5-0N5U#3PMK'.Q2ZMF(:!TX\Y"3\P&< $G MTJ#Q#;S3-/Y43R9TJ[0;5)RQ\O"_4X/'M0!L)=P2"$I(&$Z[HBO(88SG/TJ" M'5K.YN!% \DA)(#K"YC)'7Y\;>WK69#97%CK4-G#$QL=LDD$@'$)(P8SZ#)R M/KCM1IMW<06NEV$<$TBB@ HHHH *,444 %%%% !1110 4444 ?%%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$! end XML 37 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Cover Page - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2022
Feb. 24, 2023
Jun. 30, 2022
Document Information [Line Items]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2022    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Entity Registrant Name SLR INVESTMENT CORP.    
Securities Act File Number 814-00754    
Entity Tax Identification Number 26-1381340    
Trading Symbol SLRC    
Entity Central Index Key 0001418076    
Current Fiscal Year End Date --12-31    
Document Annual Report true    
Document Transition Report false    
Entity Current Reporting Status Yes    
Entity Filer Category Large Accelerated Filer    
Entity Interactive Data Current Yes    
City Area Code 212    
Local Phone Number 993-1670    
Entity Small Business false    
Entity Emerging Growth Company false    
Entity Address, Address Line One 500 Park Avenue    
Entity Shell Company false    
Title of 12(b) Security Common Stock, par value $0.01 per share    
Security Exchange Name NASDAQ    
Entity Address, State or Province NY    
Entity Address, City or Town New York    
Entity Address, Postal Zip Code 10022    
Entity Incorporation, State or Country Code MD    
Entity Common Stock, Shares Outstanding   54,554,634  
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
ICFR Auditor Attestation Flag true    
Entity Public Float     $ 741.8
Auditor Name KPMG LLP    
Auditor Location New York    
Auditor Firm ID 185    
XML 38 R2.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Assets And Liabilities - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Investments at fair value:    
Cash $ 10,743 $ 2,935
Cash equivalents (cost: $417,590 and $320,000, respectively) 417,590 320,000
Dividends receivable 11,192 9,028
Interest receivable 9,706 6,521
Receivable for investments sold 1,124 1,378
Prepaid expenses and other assets 664 567
Total assets 2,537,695 2,011,011
Liabilities    
Debt ($1,093,200 and $818,500 face amounts, respectively, reported net of unamortized debt issuance costs of $7,202 and $6,462, respectively. See notes 6 and 7) 1,085,998 812,038
Payable for investments and cash equivalents purchased 417,611 320,041
Distributions payable 7,481 17,327
Management fee payable (see note 3) 7,964 7,435
Performance-based incentive fee payable (see note 3) 5,422 1,864
Interest payable (see note 7) 7,943 4,492
Administrative services payable (see note 3) 1,488 2,689
Other liabilities and accrued expenses 4,057 2,844
Total liabilities 1,537,964 1,168,730
Commitments and contingencies (see note 11)
Net Assets    
Common stock, par value $0.01 per share, 200,000,000 and 200,000,000 common shares authorized, respectively, and 54,555,380 and 42,260,826 shares issued and outstanding, respectively 546 423
Paid-in capital in excess of par (see note 2f) 1,162,569 936,999
Accumulated distributable net loss (see note 2f) (163,384) (95,141)
Total net assets $ 999,731 $ 842,281
Net Asset Value Per Share $ 18.33 $ 19.93
Companies less than 5% owned [Member]    
Investments at fair value:    
Investment Owned, at Fair Value $ 1,289,082 $ 964,379
Companies more than 25% owned [Member]    
Investments at fair value:    
Investment Owned, at Fair Value $ 797,594 $ 706,203
XML 39 R3.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Assets And Liabilities (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Investment owned, at cost $ 2,552,177 $ 2,016,953
Cash equivalents at cost 417,590 320,000
Debt instrument, face amount 1,093,200 818,500
Debt issuance costs $ 7,202 $ 6,462
Common stock, par or stated value per share $ 0.01 $ 0.01
Common Stock, shares authorized 200,000,000 200,000,000
Common stock, shares, issued 54,555,380 42,260,826
Common stock, shares, outstanding 54,555,380 42,260,826
Companies less than 5% owned [Member]    
Investment owned, at cost $ 1,312,701 $ 985,088
Companies more than 25% owned [Member]    
Investment owned, at cost $ 821,886 $ 711,865
XML 40 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
INVESTMENT INCOME:      
Total investment income $ 177,505 $ 139,354 $ 121,745
EXPENSES:      
Management fees (see note 3) 29,982 28,277 24,951
Performance-based incentive fees (see note 3) 15,097 10,309 2,272
Interest and other credit facility expenses (see note 7) 46,087 29,876 27,156
Administrative services expense (see note 3) 5,401 5,575 5,215
Other general and administrative expenses 6,099 4,390 2,936
Total expenses 102,666 78,427 62,530
Performance-based incentive fees waived (see note 3) (1,527) 0 0
Net expenses 101,139 78,427 62,530
Net investment income 76,366 60,927 59,215
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND CASH EQUIVALENTS:      
Net realized gain (loss) on investments and cash equivalents (companies less than 5% owned) (36,485) 26 (26,638)
Net change in unrealized gain (loss) on investments and cash equivalents:      
Net change in unrealized gain (loss) on investments and cash equivalents (21,539) (1,387) (17,126)
Net realized and unrealized gain (loss) on investments and cash equivalents (58,024) (1,361) (43,764)
Net increase in net assets resulting from operations $ 18,342 $ 59,566 $ 15,451
Earnings Per Share, Basic $ 0.35 $ 1.41 $ 0.37
Earnings Per Share, Diluted $ 0.35 $ 1.41 $ 0.37
Companies less than 5% owned [Member]      
INVESTMENT INCOME:      
Interest $ 121,491 $ 86,122 $ 84,143
Dividends 0 133 50
Other income 2,116 4,157 1,885
Net change in unrealized gain (loss) on investments and cash equivalents:      
Net change in unrealized gain (loss) on investments and cash equivalents (2,909) (10,500) 8,970
Companies more than 25% owned [Member]      
INVESTMENT INCOME:      
Interest 9,515 11,354 8,861
Dividends 44,383 37,564 26,794
Other income 0 24 12
Net change in unrealized gain (loss) on investments and cash equivalents:      
Net change in unrealized gain (loss) on investments and cash equivalents $ (18,630) $ 9,113 $ (26,096)
XML 41 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Changes In Net Assets - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Increase (decrease) in net assets resulting from operations:      
Net investment income $ 76,366 $ 60,927 $ 59,215
Net realized gain (loss) (36,485) 26 (26,638)
Net change in unrealized gain (loss) (21,539) (1,387) (17,126)
Net increase in net assets resulting from operations 18,342 59,566 15,451
Distributions to stockholders (see note 8a):      
From distributable earnings (57,594) (41,221) (48,795)
From return of capital (27,099) (28,087) (20,513)
Net distributions to stockholders (84,693) (69,308) (69,308)
Capital transactions (see note 13):      
Issuance of common stock 226,839 0 0
Repurchases of common stock (3,038) 0 0
Net increase in net assets resulting from capital transactions 223,801 0 0
Total increase (decrease) in net assets 157,450 (9,742) (53,857)
Net assets at beginning of period 842,281 852,023 905,880
Net assets at end of period $ 999,731 $ 842,281 $ 852,023
Capital share activity (see note 13):      
Issuance of common stock 12,511,825 0 0
Repurchases of common stock (217,271) 0 0
Net increase from capital share activity 12,294,554 0 0
XML 42 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash Flows from Operating Activities      
Net increase in net assets resulting from operations $ 18,342 $ 59,566 $ 15,451
Adjustments to reconcile net increase in net assets resulting from operations to net cash provided by (used in) operating activities:      
Net realized (gain) loss on investments and cash equivalents 36,485 (26) 26,638
Net change in unrealized loss on investments 21,539 1,387 17,126
(Increase) decrease in operating assets:      
Purchase of investments (609,645) (596,256) (426,897)
Proceeds from disposition of investments 531,389 468,532 357,632
Net accretion of discount on investments (9,850) (6,087) (7,581)
Capitalization of payment-in-kind income (4,282) (7,592) (5,384)
Collections of payment-in-kind income 1,286 1,411 1,339
Receivable for investments sold 254 (1,123) 1,952
Interest receivable (3,185) (43) (1,077)
Dividends receivable (2,164) (1,101) 2,561
Prepaid expenses and other assets (97) 4 44
Cash and other net assets acquired in merger 3,640 0 0
Increase (decrease) in operating liabilities:      
Payable for investments and cash equivalents purchased 97,570 (59,997) (39,624)
Management fee payable 529 900 (212)
Performance-based incentive fee payable 3,558 1,072 (3,489)
Administrative services expense payable (1,201) 743 (811)
Interest payable 3,451 1,076 (262)
Other liabilities and accrued expenses 1,213 414 (10)
Deferred financing costs/market discount 2,227 2,019 1,234
Net Cash Provided by (Used in) Operating Activities 91,059 (135,101) (61,370)
Cash Flows from Financing Activities:      
Cash distributions paid (94,539) (69,308) (69,308)
Proceeds from unsecured borrowings 134,914 49,936 0
Repayment of unsecured borrowings (171,000) 0 0
Proceeds from secured borrowings 844,002 812,132 337,000
Repayments of secured borrowings (696,000) (723,500) (253,900)
Repurchase of common stock (3,038) 0 0
Net Cash Provided by Financing Activities 14,339 69,260 13,792
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 105,398 (65,841) (47,578)
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR 322,935 388,776 436,354
CASH AND CASH EQUIVALENTS AT END OF YEAR 428,333 322,935 388,776
Supplemental disclosure of cash flow information:      
Cash paid for interest 42,636 28,800 27,418
Issuance of shares in connection with the Mergers [1] $ 226,839 $ 0 $ 0
[1] On April 1, 2022, in connection with the Mergers (as defined in Note 1 “Organization”), the Company acquired net assets of $244,691 for the total stock consideration of $226,839. For further details, refer to Note 17 “Merger with SUNS”.
XML 43 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows (Parenthetical)
$ in Thousands
Apr. 01, 2022
USD ($)
Statement of Cash Flows [Abstract]  
Noncash or part noncash acquisition, value of assets acquired $ 244,691
Stock issued $ 226,839
XML 44 R8.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Schedule of Investments - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Schedule of Investments [Line Items]    
Cost $ 2,552,177 $ 2,016,953
Total Investments & Cash Equivalents 2,504,266 1,990,582
Liabilities in Excess of Other Assets (1,504,535) (1,148,301)
Total net assets $ 999,731 $ 842,281
Percentage of Total Investments (at fair value) 100.00% 100.00%
Senior Secured Loans  0 124.6%    
Schedule of Investments [Line Items]    
Cost $ 1,272,952  
Fair Value 1,245,414  
Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Cost 912,558  
Fair Value 886,513  
Senior Secured Loans  0 124.6% | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Cost 319,205  
Fair Value 322,455  
Total Investments [Member]    
Schedule of Investments [Line Items]    
Cost 2,134,587 $ 1,696,953
Fair Value $ 2,086,676 1,670,582
Senior Secured Loans  0 111.5% [Member]    
Schedule of Investments [Line Items]    
Cost   959,162
Fair Value   939,690
Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Cost   579,211
Fair Value   559,571
Senior Secured Loans  0 111.5% [Member] | Second Lien Asset-Based Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Cost   58,795
Fair Value   58,889
Senior Secured Loans  0 111.5% [Member] | Second Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Cost   49,576
Fair Value   48,703
Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Cost   271,580
Fair Value   272,527
Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Cost   292,365
Fair Value   273,795
Preferred Equity  2 0.7% [Member]    
Schedule of Investments [Line Items]    
Cost   6,049
Fair Value   5,630
Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Cost   439,377
Fair Value   $ 451,467
Cash Equivalents  0 38.0% [Member] | U.S. Treasury Bill [Member]    
Schedule of Investments [Line Items]    
Industry Government  
Acquisition Date   Dec. 31, 2021
Maturity Date   Jan. 25, 2022
Par Amount   $ 320,000
Cost   320,000
Fair Value   $ 320,000
Multi-Sector Holdings (includes Kingsbridge Holdings, LLC, SLR Equipment Finance, Equipment Operating Leases, LLC and Loyer Capital LLC) [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 17.50% 24.80%
Diversified Financial Services (includes SLR Credit Solutions) [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 22.10% 20.70%
Health Care Providers & Services [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 7.70% 9.60%
Pharmaceuticals [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 5.50% 7.80%
Health Care Equipment & Supplies [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 6.60% 5.00%
Software [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 4.30% 5.00%
Biotechnology [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 3.90% 2.40%
Wireless Telecommunication Services [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.10% 2.20%
Capital Markets [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.70% 1.60%
Personal Products [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.70% 2.00%
Road & Rail [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.70% 1.90%
IT Services [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.60% 1.90%
Insurance [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 4.20% 1.60%
Diversified Consumer Services [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 2.70% 1.80%
Commercial Services & Supplies [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.10% 1.60%
Auto Parts & Equipment [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.20% 1.50%
Internet & Catalog Retail [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.10% 1.50%
Packaged Foods & Meats [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.20% 1.10%
Life Sciences Tools & Services [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.30% 1.00%
Communications Equipment [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.70% 0.90%
Specialty Retail [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.50% 0.70%
Auto Components [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.40% 0.60%
Airlines [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.30% 0.60%
Health Care Technology [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.80% 0.50%
Transportation Infrastructure [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.70%  
Machinery [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.30% 0.30%
Metals & Mining [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.20% 0.30%
Aerospace & Defense [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.30% 0.30%
Consumer Finance [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.10% 0.10%
Air Freight & Logistics [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value)   0.10%
Construction & Engineering [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.00% 0.10%
Hotels, Restaurants & Leisure [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.30% 0.30%
Oil, Gas & Consumable Fuels [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.30% 0.10%
Containers & Packaging [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.00% 0.00%
Energy Equipment & Services [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.00% 0.10%
Building Products [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.90%  
Internet Software Services [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.00%  
Trading Companies and Distributors [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.90%  
Leisure Equipment and Products [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.50%  
Footwear [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.30%  
Water Utilities [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.10%  
Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Cost $ 291,445  
Fair Value $ 265,952  
Equipment Financing  0 26.6% | Minimum [Member]    
Schedule of Investments [Line Items]    
Maturity Date [1] Oct. 04, 2023  
Common Equity/Equity Interests/Warrants 057.1%    
Schedule of Investments [Line Items]    
Cost $ 565,263  
Fair Value $ 571,509  
Cash Equivalents  0 41.8% | U.S. Treasury Bill [Member]    
Schedule of Investments [Line Items]    
Industry Government  
Acquisition Date Dec. 30, 2022  
Maturity Date Feb. 23, 2023  
Par Amount $ 420,000  
Cost 417,590  
Fair Value $ 417,590  
Thrifts Mortgage Finance [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.30%  
Media [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.90%  
Food Products [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.40%  
Food and Staples Retailing [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.10%  
Asset Management [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.50%  
Aegis Toxicology Sciences Corporation [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Health Care Providers & Services  
Spread Above Index [2],[3] L+550  
Floor [2] 1.00%  
Interest Rate [2],[4] 10.09%  
Acquisition Date [2] May 07, 2018  
Maturity Date [2] May 09, 2025  
Par Amount [2] $ 17,103  
Cost [2] 16,793  
Fair Value [2] $ 17,103  
Aegis Toxicology Sciences Corporation [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Providers & Services
Spread Above Index [5]   L+550
Floor   1.00%
Interest Rate [6]   6.50%
Acquisition Date   May 07, 2018
Maturity Date   May 09, 2025
Par Amount   $ 12,402
Cost   12,283
Fair Value   $ 12,402
All State Ag Parts, LLC [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Trading Companies & Distributors  
Spread Above Index [2],[3] S+575  
Floor [2] 1.00%  
Interest Rate [2],[4] 10.19%  
Acquisition Date [2] Apr. 01, 2022  
Maturity Date [2] Sep. 01, 2026  
Par Amount [2] $ 4,197  
Cost [2] 4,081  
Fair Value [2] $ 4,197  
Alteon Health, LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Providers & Services
Spread Above Index [5]   L+650
Floor   1.00%
Interest Rate [6]   7.50%
Acquisition Date   Sep. 14, 2018
Maturity Date   Sep. 01, 2023
Par Amount   $ 14,117
Cost   14,079
Fair Value   $ 14,117
American Teleconferencing Services, Ltd. [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [7] Communications Equipment  
Spread Above Index [3],[7] L+650  
Floor [7] 1.00%  
Interest Rate [4],[7] 0.00%  
Acquisition Date [7] May 05, 2016  
Maturity Date [7] Sep. 09, 2021  
Par Amount [7] $ 36,135  
Cost [7] 25,926  
Fair Value [7] $ 0  
American Teleconferencing Services, Ltd. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [7]   Communications Equipment
Spread Above Index [5],[7]   L+650
Floor [7]   1.00%
Interest Rate [6],[7]   7.50%
Acquisition Date [7]   May 05, 2016
Maturity Date [7]   Sep. 09, 2021
Par Amount [7]   $ 24,822
Cost [7]   24,453
Fair Value [7]   $ 3,345
American Teleconferencing Services, Ltd. [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [7] Communications Equipment  
Spread Above Index [3],[7] L+650  
Floor [7] 1.00%  
Interest Rate [4],[7] 0.00%  
Acquisition Date [7] Sep. 17, 2021  
Maturity Date [7] Jan. 31, 2023  
Par Amount [7] $ 6,405  
Cost [7] 6,254  
Fair Value [7] $ 224  
American Teleconferencing Services, Ltd. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [7]   Communications Equipment
Spread Above Index [5],[7]   L+650
Floor [7]   1.00%
Interest Rate [6],[7]   7.50%
Acquisition Date [7]   Sep. 17, 2021
Maturity Date [7]   Mar. 31, 2022
Par Amount [7]   $ 4,576
Cost [7]   4,508
Fair Value [7]   $ 4,576
AmeriMark Intermediate Holdings, LLC [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [8] Internet & Catalog Retail  
Spread Above Index [3],[8] L+800  
Floor [8] 1.00%  
Interest Rate [4],[8] 14.77%  
Acquisition Date [8] Jul. 28, 2021  
Maturity Date [8] Oct. 15, 2026  
Par Amount [8] $ 24,087  
Cost [8] 23,711  
Fair Value [8] $ 22,882  
AmeriMark Intermediate Holdings, LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [9]   Internet & Catalog Retail
Spread Above Index [5],[9]   L+600
Floor [9]   1.00%
Interest Rate [6],[9]   7.00%
Acquisition Date [9]   Jul. 28, 2021
Maturity Date [9]   Oct. 15, 2026
Par Amount [9]   $ 25,226
Cost [9]   24,739
Fair Value [9]   $ 24,721
Atria Wealth Solutions, Inc. [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2],[3] Diversified Financial Services  
Spread Above Index [2],[3] S+600  
Floor [2] 1.00%  
Interest Rate [2],[4] 10.84%  
Acquisition Date [2] Sep. 14, 2018  
Maturity Date [2] Feb. 29, 2024  
Par Amount [2] $ 8,149  
Cost [2] 8,107  
Fair Value [2] $ 8,149  
Atria Wealth Solutions, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Diversified Financial Services
Spread Above Index [5]   L+600
Floor   1.00%
Interest Rate [6]   7.00%
Acquisition Date   Sep. 14, 2018
Maturity Date   Nov. 30, 2022
Par Amount   $ 6,345
Cost   6,329
Fair Value   $ 6,345
Basic Fun, Inc. [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Specialty Retail  
Spread Above Index [2],[3] L+550  
Floor [2] 1.00%  
Interest Rate [2],[4] 10.27%  
Acquisition Date [2] Oct. 30, 2020  
Maturity Date [2] Oct. 30, 2023  
Par Amount [2] $ 2,162  
Cost [2] 2,152  
Fair Value [2] $ 2,162  
Basic Fun, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Specialty Retail
Spread Above Index [5]   L+550
Floor   1.00%
Interest Rate [6]   6.50%
Acquisition Date   Oct. 30, 2020
Maturity Date   Oct. 30, 2023
Par Amount   $ 2,902
Cost   2,871
Fair Value   $ 2,902
BayMark Health Services Inc [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Health Care Providers & Services  
Spread Above Index [2],[3] L+500  
Floor [2] 1.00%  
Interest Rate [2],[4] 9.73%  
Acquisition Date [2] Apr. 01, 2022  
Maturity Date [2] Jun. 11, 2027  
Par Amount [2] $ 9,432  
Cost [2] 9,078  
Fair Value [2] $ 9,432  
CC SAG Holdings Corp. (Spectrum Automotive) [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Diversified Consumer Services  
Spread Above Index [2],[3] L+575  
Floor [2] 0.75%  
Interest Rate [2],[4] 10.48%  
Acquisition Date [2] Jun. 29, 2021  
Maturity Date [2] Jun. 29, 2028  
Par Amount [2] $ 20,427  
Cost [2] 20,057  
Fair Value [2] $ 20,427  
CC SAG Holdings Corp. (Spectrum Automotive) [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Diversified Consumer Services
Spread Above Index [5]   L+575
Floor   0.75%
Interest Rate [6]   6.50%
Acquisition Date   Jun. 29, 2021
Maturity Date   Jun. 29, 2028
Par Amount   $ 12,168
Cost   11,995
Fair Value   $ 12,168
Community Brands ParentCo, LLC (fka Ministry Brands) [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Software
Spread Above Index [5]   L+400
Floor   1.00%
Interest Rate [6]   5.00%
Acquisition Date   Jul. 30, 2021
Maturity Date   Dec. 02, 2022
Par Amount   $ 34,901
Cost   34,538
Fair Value   $ 34,901
Enhanced Permanent Capital, LLC [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [10] Capital Markets  
Spread Above Index [3],[10] L+700  
Floor [10] 1.00%  
Interest Rate [4],[10] 10.13%  
Acquisition Date [10] Dec. 29, 2020  
Maturity Date [10] Dec. 29, 2025  
Par Amount [10] $ 35,205  
Cost [10] 34,496  
Fair Value [10],[11] $ 35,205  
Enhanced Permanent Capital, LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [10]   Capital Markets
Spread Above Index [5],[10]   L+700
Floor [10]   1.00%
Interest Rate [6],[10]   8.00%
Acquisition Date [10]   Dec. 29, 2020
Maturity Date [10]   Dec. 29, 2025
Par Amount [10]   $ 26,061
Cost [10]   25,418
Fair Value [10]   $ 26,061
Foundation Consumer Brands, LLC [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Personal Products  
Spread Above Index [2],[3] L+550  
Floor [2] 1.00%  
Interest Rate [2],[4] 10.15%  
Acquisition Date [2] Feb. 12, 2021  
Maturity Date [2] Feb. 12, 2027  
Par Amount [2] $ 35,273  
Cost [2] 34,421  
Fair Value [2] $ 35,273  
Foundation Consumer Brands, LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Personal Products
Spread Above Index [5]   L+638
Floor   1.00%
Interest Rate [6]   7.38%
Acquisition Date   Feb. 12, 2021
Maturity Date   Feb. 12, 2027
Par Amount   $ 33,367
Cost   32,633
Fair Value   $ 33,367
iCIMS, Inc. [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Software  
Spread Above Index [3] S+725  
Floor [2] 0.75%  
Interest Rate [4] 11.52%  
Acquisition Date Aug. 18, 2022  
Maturity Date Aug. 18, 2028  
Par Amount $ 32,084  
Cost 31,548  
Fair Value $ 31,522  
iCIMS, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Software
Spread Above Index [5]   L+650
Floor   1.00%
Interest Rate [6]   7.50%
Acquisition Date   Sep. 07, 2018
Maturity Date   Sep. 12, 2024
Par Amount   $ 19,341
Cost   19,120
Fair Value   $ 19,341
Inszone Mid, LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Insurance
Spread Above Index [5]   L+575
Floor   1.00%
Interest Rate [6]   6.75%
Acquisition Date   Sep. 28, 2021
Maturity Date   Jun. 30, 2026
Par Amount   $ 11,141
Cost   11,035
Fair Value   $ 11,086
Ivy Fertility Services, LLC [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Providers & Services  
Spread Above Index [3] L+625  
Floor [2] 1.00%  
Interest Rate [4] 10.39%  
Acquisition Date Dec. 22, 2021  
Maturity Date Feb. 25, 2026  
Par Amount $ 30,092  
Cost 29,415  
Fair Value $ 30,393  
Ivy Fertility Services, LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Providers & Services
Spread Above Index [5]   L+625
Floor   1.00%
Interest Rate [6]   7.25%
Acquisition Date   Dec. 22, 2021
Maturity Date   Feb. 25, 2026
Par Amount   $ 21,677
Cost   21,299
Fair Value   $ 21,298
Kid Distro Holdings, LLC (Distro Kid) [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Software  
Spread Above Index [2],[3] L+575  
Floor [2] 1.00%  
Interest Rate [2],[4] 10.48%  
Acquisition Date [2] Sep. 24, 2021  
Maturity Date [2] Oct. 01, 2027  
Par Amount [2] $ 26,452  
Cost [2] 26,015  
Fair Value [2] $ 26,452  
Kid Distro Holdings, LLC (Distro Kid) [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Software
Spread Above Index [5]   L+600
Floor   1.00%
Interest Rate [6]   7.00%
Acquisition Date   Sep. 24, 2021
Maturity Date   Oct. 01, 2027
Par Amount   $ 29,743
Cost   29,168
Fair Value   $ 29,148
Kingsbridge Holdings, LLC [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [12] Multi-Sector Holdings  
Spread Above Index [3],[12] L+700  
Floor [2] 1.00%  
Interest Rate [2],[4],[12] 10.75%  
Acquisition Date [12] Dec. 21, 2018  
Maturity Date [12] Dec. 21, 2024  
Par Amount [12] $ 80,000  
Cost [12] 79,800  
Fair Value [12] $ 80,000  
Kingsbridge Holdings, LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [13]   Multi-Sector Holdings
Spread Above Index [5],[13]   L+700
Floor [13]   1.00%
Interest Rate [6],[13]   8.00%
Acquisition Date [13]   Dec. 21, 2018
Maturity Date [13]   Dec. 21, 2024
Par Amount [13]   $ 80,000
Cost [13]   79,713
Fair Value [13]   $ 80,000
KORE Wireless Group, Inc. [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Wireless Telecommunication Services  
Spread Above Index [2],[3] S+550  
Floor [2] 0.00%  
Interest Rate [2],[4] 10.08%  
Acquisition Date [2] Dec. 21, 2018  
Maturity Date [2] Dec. 21, 2024  
Par Amount [2] $ 23,588  
Cost [2] 23,123  
Fair Value [2] $ 23,588  
KORE Wireless Group, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [10]   Wireless Telecommunication Services
Spread Above Index [5],[10]   L+550
Floor [10]   0.00%
Interest Rate [6],[10]   5.72%
Acquisition Date [10]   Dec. 21, 2018
Maturity Date [10]   Dec. 21, 2024
Par Amount [10]   $ 36,470
Cost [10]   36,062
Fair Value [10]   $ 36,470
Logix Holding Company, LLC [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Communications Equipment  
Spread Above Index [2],[3] L+575  
Floor [2] 1.00%  
Interest Rate [2],[4] 10.13%  
Acquisition Date [2] Sep. 14, 2018  
Maturity Date [2] Dec. 22, 2024  
Par Amount [2] $ 14,009  
Cost [2] 13,246  
Fair Value [2] $ 13,449  
Logix Holding Company, LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Communications Equipment
Spread Above Index [5]   L+575
Floor   1.00%
Interest Rate [6]   6.75%
Acquisition Date   Sep. 14, 2018
Maturity Date   Dec. 22, 2024
Par Amount   $ 7,400
Cost   7,359
Fair Value   $ 7,178
Maurices, Incorporated [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Specialty Retail  
Spread Above Index [2],[3] S+675  
Floor [2] 1.00%  
Interest Rate [2],[4] 8.74%  
Acquisition Date [2] Aug. 27, 2021  
Maturity Date [2] Jun. 01, 2024  
Par Amount [2] $ 7,808  
Cost [2] 7,678  
Fair Value [2] $ 7,808  
Maurices, Incorporated [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Specialty Retail
Spread Above Index [5]   L+675
Floor   1.00%
Interest Rate [6]   7.75%
Acquisition Date   Aug. 27, 2021
Maturity Date   Jun. 01, 2024
Par Amount   $ 5,135
Cost   5,044
Fair Value   $ 5,135
MMIT Holdings, LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   IT Services
Spread Above Index [5]   L+625
Floor   1.00%
Interest Rate [6]   7.25%
Acquisition Date   Sep. 21, 2021
Maturity Date   Sep. 15, 2027
Par Amount   $ 31,026
Cost   30,541
Fair Value   $ 31,026
NAC Holdings Corporation (Jaguar) [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Insurance  
Spread Above Index [2],[3] S+525  
Floor [2] 1.00%  
Interest Rate [2],[4] 9.45%  
Acquisition Date [2] Jul. 30, 2021  
Maturity Date [2] Sep. 28, 2024  
Par Amount [2] $ 28,603  
Cost [2] 28,214  
Fair Value [2] $ 28,603  
NAC Holdings Corporation (Jaguar) [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Insurance
Spread Above Index [5]   L+525
Floor   1.00%
Interest Rate [6]   6.25%
Acquisition Date   Jul. 30, 2021
Maturity Date   Sep. 28, 2024
Par Amount   $ 15,924
Cost   15,730
Fair Value   $ 15,844
One Touch Direct, LLC [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Commercial Services & Supplies  
Spread Above Index [3] P+75  
Floor [2] 0.00%  
Interest Rate [4] 8.25%  
Acquisition Date Apr. 03, 2020  
Maturity Date Mar. 30, 2024  
Par Amount $ 4,431  
Cost 4,431  
Fair Value $ 4,431  
One Touch Direct, LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Commercial Services & Supplies
Spread Above Index [5]   P+75
Floor   0.00%
Interest Rate [6]   4.00%
Acquisition Date   Apr. 03, 2020
Maturity Date   Sep. 30, 2022
Par Amount   $ 274
Cost   274
Fair Value   $ 274
PhyNet Dermatology LLC [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Providers & Services  
Spread Above Index [3],[14] S+625  
Floor [2] 1.00%  
Interest Rate [4] 9.81%  
Acquisition Date Sep. 05, 2018  
Maturity Date Aug. 16, 2024  
Par Amount $ 14,458  
Cost 14,420  
Fair Value $ 14,458  
PhyNet Dermatology LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Providers & Services
Spread Above Index [5],[15]   L+600
Floor   1.00%
Interest Rate [6]   7.00%
Acquisition Date   Sep. 05, 2018
Maturity Date   Aug. 16, 2024
Par Amount   $ 14,589
Cost   14,529
Fair Value   $ 14,589
Pinnacle Treatment Centers, Inc. [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Health Care Providers & Services  
Spread Above Index [2],[3] S+650  
Floor [2] 1.00%  
Interest Rate [2],[4] 10.57%  
Acquisition Date [2] Jan. 22, 2020  
Maturity Date [2] Jan. 02, 2026  
Par Amount [2] $ 27,997  
Cost [2] 27,528  
Fair Value [2] $ 27,367  
Pinnacle Treatment Centers, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Providers & Services
Spread Above Index [5]   L+575
Floor   1.00%
Interest Rate [6]   6.75%
Acquisition Date   Jan. 22, 2020
Maturity Date   Dec. 31, 2022
Par Amount   $ 11,996
Cost   11,953
Fair Value   $ 11,996
PPT Management Holdings, LLC [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Health Care Providers & Services  
Spread Above Index [2],[3] L+850  
Floor [2] 1.00%  
Interest Rate [2],[4] 12.83%  
Acquisition Date [2] Sep. 14, 2018  
Maturity Date [2] Jan. 30, 2023  
Par Amount [2] $ 32,163  
Cost [2] 31,987  
Fair Value [2] $ 25,827  
PPT Management Holdings, LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Providers & Services
Spread Above Index [5],[16]   L+800
Floor   1.00%
Interest Rate [6]   9.00%
Acquisition Date   Sep. 14, 2018
Maturity Date   Dec. 16, 2022
Par Amount   $ 21,120
Cost   21,086
Fair Value   $ 18,374
RQM+ Corp. [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Life Sciences Tools & Services  
Spread Above Index [2],[3] S+575  
Floor [2] 1.00%  
Interest Rate [2],[4] 10.97%  
Acquisition Date [2] Aug. 20, 2021  
Maturity Date [2] Aug. 12, 2026  
Par Amount [2] $ 26,823  
Cost [2] 26,455  
Fair Value [2] $ 26,823  
RQM+ Corp. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Life Sciences Tools & Services
Spread Above Index [5]   L+575
Floor   1.00%
Interest Rate [6]   6.75%
Acquisition Date   Aug. 20, 2021
Maturity Date   Aug. 12, 2026
Par Amount   $ 16,504
Cost   16,349
Fair Value   $ 16,462
Stryten Energy LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Auto Parts & Equipment
Spread Above Index [5]   L+800
Floor   1.00%
Interest Rate [6]   9.00%
Acquisition Date   Aug. 11, 2021
Maturity Date   Oct. 12, 2026
Par Amount   $ 26,184
Cost   25,676
Fair Value   $ 25,923
SunMed Group Holdings, LLC [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Health Care Equipment & Supplies  
Spread Above Index [2],[3] L+575  
Floor [2] 0.75%  
Interest Rate [2],[4] 10.48%  
Acquisition Date [2] Jun. 16, 2021  
Maturity Date [2] Jun. 16, 2028  
Par Amount [2] $ 24,953  
Cost [2] 24,446  
Fair Value [2] $ 24,953  
SunMed Group Holdings, LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Equipment & Supplies
Spread Above Index [5]   L+575
Floor   0.75%
Interest Rate [6]   6.50%
Acquisition Date   Jun. 16, 2021
Maturity Date   Jun. 16, 2028
Par Amount   $ 18,536
Cost   18,232
Fair Value   $ 18,351
Ultimate Baked Goods Midco LLC (Rise Baking) [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Packaged Foods & Meats  
Spread Above Index [2],[3] L+650  
Floor [2] 1.00%  
Interest Rate [2],[4] 10.88%  
Acquisition Date [2] Aug. 12, 2021  
Maturity Date [2] Aug. 13, 2027  
Par Amount [2] $ 24,789  
Cost [2] 24,038  
Fair Value [2] $ 24,789  
Ultimate Baked Goods Midco LLC (Rise Baking) [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Packaged Foods & Meats
Spread Above Index [5]   L+625
Floor   1.00%
Interest Rate [6]   7.25%
Acquisition Date   Aug. 12, 2021
Maturity Date   Aug. 13, 2027
Par Amount   $ 19,381
Cost   18,920
Fair Value   $ 18,896
USR Parent, Inc. (Staples) [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Specialty Retail
Spread Above Index [5]   L+884
Floor   1.00%
Interest Rate [6]   9.84%
Acquisition Date   Jun. 03, 2020
Maturity Date   Sep. 12, 2022
Par Amount   $ 3,275
Cost   3,275
Fair Value   $ 3,275
ACRES Commercial Mortgage, LLC [Member] | Senior Secured Loans  0 124.6% | Second Lien Asset-Based Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Diversified Financial Services  
Spread Above Index [3] S+705  
Floor 1.00%  
Interest Rate [4] 11.38%  
Acquisition Date Dec. 24, 2021  
Maturity Date Aug. 21, 2028  
Par Amount $ 29,925  
Cost 29,398  
Fair Value $ 29,925  
ACRES Commercial Mortgage, LLC [Member] | Senior Secured Loans  0 111.5% [Member] | Second Lien Asset-Based Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Diversified Financial Services
Spread Above Index [5]   S+705
Floor   1.00%
Interest Rate [6]   8.05%
Acquisition Date   Dec. 24, 2021
Maturity Date   Aug. 21, 2028
Par Amount   $ 29,925
Cost   29,328
Fair Value   $ 29,326
Varilease Finance, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | Second Lien Asset-Based Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Multi-Sector Holdings
Spread Above Index [5]   L+750
Floor   1.00%
Interest Rate [6]   8.50%
Acquisition Date   Aug. 22, 2014
Maturity Date   Nov. 15, 2025
Par Amount   $ 29,563
Cost   29,467
Fair Value   $ 29,563
PhyMed Management LLC [Member] | Senior Secured Loans  0 111.5% [Member] | Second Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Providers & Services
Spread Above Index [5],[17]   L+1500
Floor   1.00%
Interest Rate [6]   16.00%
Acquisition Date   Dec. 18, 2015
Maturity Date   Sep. 30, 2022
Par Amount   $ 37,819
Cost   37,757
Fair Value   $ 36,874
Rug Doctor LLC [Member] | Senior Secured Loans  0 111.5% [Member] | Second Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [13]   Diversified Consumer Services
Spread Above Index [5],[13],[18]   L+975
Floor [13]   1.50%
Interest Rate [6],[13]   11.25%
Acquisition Date [13]   Dec. 23, 2013
Maturity Date [13]   May 16, 2023
Par Amount [13]   $ 11,828
Cost [13]   11,819
Fair Value [13]   $ 11,829
Alimera Sciences, Inc. [Member] | Senior Secured Loans  0 124.6% | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Pharmaceuticals  
Spread Above Index [2],[3] L+765  
Floor [2] 1.78%  
Interest Rate [2],[4] 11.82%  
Acquisition Date [2] Dec. 31, 2019  
Maturity Date [2] Jul. 01, 2024  
Par Amount [2] $ 23,159  
Cost [2] 23,894  
Fair Value [2] $ 24,433  
Alimera Sciences, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Pharmaceuticals
Spread Above Index [5]   L+765
Floor   1.78%
Interest Rate [6]   9.43%
Acquisition Date   Dec. 31, 2019
Maturity Date   Jul. 01, 2024
Par Amount   $ 20,074
Cost   20,512
Fair Value   $ 20,475
Arcutis Biotherapeutics, Inc. [Member] | Senior Secured Loans  0 124.6% | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [11] Pharamceuticals  
Spread Above Index [3],[11] L+745  
Floor [11] 0.10%  
Interest Rate [4],[11] 11.62%  
Acquisition Date [11] Dec. 22, 2021  
Maturity Date [11] Jan. 01, 2027  
Par Amount [11] $ 66,849  
Cost [11] 67,077  
Fair Value [11] $ 67,685  
Arcutis Biotherapeutics, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [10]   Pharamceuticals
Spread Above Index [5],[10]   L+745
Floor [10]   0.10%
Interest Rate [6],[10]   7.55%
Acquisition Date [10]   Dec. 22, 2021
Maturity Date [10]   Jan. 01, 2027
Par Amount [10]   $ 21,735
Cost [10]   21,645
Fair Value [10]   $ 21,637
Ardelyx, Inc. [Member] | Senior Secured Loans  0 124.6% | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [11] Pharmaceuticals  
Spread Above Index [3],[11] L+795  
Floor [11] 0.10%  
Interest Rate [4],[11] 12.12%  
Acquisition Date [11] Feb. 23, 2022  
Maturity Date [11] Mar. 01, 2027  
Par Amount [11] $ 9,475  
Cost [11] 9,437  
Fair Value [11] $ 9,499  
Ardelyx, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Pharmaceuticals
Spread Above Index [5]   L+745
Floor   0.25%
Interest Rate [6]   7.70%
Acquisition Date   May 10, 2018
Maturity Date   Nov. 01, 2022
Par Amount   $ 14,972
Cost   16,198
Fair Value   $ 16,170
Axcella Health Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Pharmaceuticals
Spread Above Index [5]   L+860
Floor   0.10%
Interest Rate [6]   8.70%
Acquisition Date   Sep. 02, 2021
Maturity Date   Sep. 01, 2026
Par Amount   $ 9,278
Cost   9,318
Fair Value   $ 9,302
BridgeBio Pharma, Inc. [Member] | Senior Secured Loans  0 124.6% | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [11] Biotechnology  
Spread Above Index [3],[11] 0  
Floor [11] 0.00%  
Interest Rate [4],[11],[19] 9.00%  
Acquisition Date [11] Nov. 17, 2021  
Maturity Date [11] Nov. 17, 2026  
Par Amount [11] $ 39,839  
Cost [11] 39,340  
Fair Value [11] $ 39,839  
BridgeBio Pharma, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [10]   Biotechnology
Spread Above Index [5],[10]   0
Floor [10]   0.00%
Interest Rate [6],[10]   9.00%
Acquisition Date [10]   Nov. 17, 2021
Maturity Date [10]   Nov. 17, 2026
Par Amount [10]   $ 34,574
Cost [10]   34,082
Fair Value [10]   $ 34,055
Centrexion Therapeutics, Inc. [Member] | Senior Secured Loans  0 124.6% | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Pharmaceuticals  
Spread Above Index [3] L+725  
Floor 2.45%  
Interest Rate [4] 11.42%  
Acquisition Date Jun. 28, 2019  
Maturity Date Jan. 01, 2024  
Par Amount $ 11,844  
Cost 12,372  
Fair Value $ 12,555  
Centrexion Therapeutics, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Pharmaceuticals
Spread Above Index [5]   L+725
Floor   2.45%
Interest Rate [6]   9.70%
Acquisition Date   Jun. 28, 2019
Maturity Date   Jan. 01, 2024
Par Amount   $ 16,400
Cost   16,693
Fair Value   $ 16,728
Cerapedics, Inc. [Member] | Senior Secured Loans  0 124.6% | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Biotechnology  
Spread Above Index [3] S+620  
Floor 2.75%  
Interest Rate [4] 10.52%  
Acquisition Date Dec. 27, 2022  
Maturity Date Jan. 01, 2028  
Par Amount $ 26,939  
Cost 26,874  
Fair Value $ 26,872  
Cerapedics, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Equipment & Supplies
Spread Above Index [5]   L+695
Floor   2.50%
Interest Rate [6]   9.45%
Acquisition Date   Mar. 22, 2019
Maturity Date   Mar. 01, 2025
Par Amount   $ 26,861
Cost   27,518
Fair Value   $ 27,465
Delphinus Medical Technologies, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Equipment & Supplies
Spread Above Index [5]   L+850
Floor   1.00%
Interest Rate [6]   9.50%
Acquisition Date   Aug. 18, 2017
Maturity Date   Jun. 01, 2022
Par Amount   $ 1,089
Cost   1,414
Fair Value   $ 1,405
Glooko, Inc. [Member] | Senior Secured Loans  0 124.6% | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Health Care Technology  
Spread Above Index [2],[3] L+790  
Floor [2] 0.10%  
Interest Rate [2],[4] 12.07%  
Acquisition Date [2] Sep. 30, 2021  
Maturity Date [2] Oct. 01, 2026  
Par Amount [2] $ 15,883  
Cost [2] 15,867  
Fair Value [2] $ 15,922  
Glooko, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Technology
Spread Above Index [5]   L+790
Floor   0.10%
Interest Rate [6]   8.00%
Acquisition Date   Sep. 30, 2021
Maturity Date   Oct. 01, 2026
Par Amount   $ 8,364
Cost   8,339
Fair Value   $ 8,322
Neuronetics, Inc. [Member] | Senior Secured Loans  0 124.6% | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Health Care Equipment & Supplies  
Spread Above Index [2],[3] L+765  
Floor [2] 1.66%  
Interest Rate [2],[4] 11.82%  
Acquisition Date [2] Mar. 02, 2020  
Maturity Date [2] Feb. 28, 2025  
Par Amount [2] $ 18,012  
Cost [2] 18,450  
Fair Value [2] $ 19,003  
Neuronetics, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Equipment & Supplies
Spread Above Index [5]   L+765
Floor   1.66%
Interest Rate [6]   9.31%
Acquisition Date   Mar. 02, 2020
Maturity Date   Feb. 28, 2025
Par Amount   $ 15,613
Cost   15,874
Fair Value   $ 15,878
OmniGuide Holdings, Inc. [Member] | Senior Secured Loans  0 124.6% | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [20] Health Care Equipment & Supplies  
Spread Above Index [3],[20] L+1405  
Floor [20] 0.10%  
Interest Rate [4],[20],[21] 18.22%  
Acquisition Date [20] Jul. 30, 2018  
Maturity Date [20] Jul. 01, 2023  
Par Amount [20] $ 19,201  
Cost [20] 19,380  
Fair Value [20] $ 19,777  
OmniGuide Holdings, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [20]   Health Care Equipment & Supplies
Spread Above Index [5],[20]   L+1405
Floor [20]   0.10%
Interest Rate [6],[20]   14.15%
Acquisition Date [20]   Jul. 30, 2018
Maturity Date [20]   Jul. 01, 2023
Par Amount [20]   $ 18,879
Cost [20]   17,845
Fair Value [20]   $ 18,958
Rezolute, Inc [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Biotechnology
Spread Above Index [5]   L+875
Floor   0.12%
Interest Rate [6]   8.87%
Acquisition Date   Apr. 14, 2021
Maturity Date   Apr. 01, 2026
Par Amount   $ 5,675
Cost   5,663
Fair Value   $ 5,661
Rubius Therapeutics, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [10]   Pharmaceuticals
Spread Above Index [5],[10]   L+550
Floor [10]   2.10%
Interest Rate [6],[10]   7.60%
Acquisition Date [10]   Dec. 21, 2018
Maturity Date [10]   Jun. 01, 2026
Par Amount [10]   $ 40,291
Cost [10]   41,103
Fair Value [10]   $ 41,097
scPharmaceuticals, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Pharmaceuticals
Spread Above Index [5]   L+795
Floor   2.23%
Interest Rate [6]   10.18%
Acquisition Date   Sep. 17, 2019
Maturity Date   Sep. 17, 2023
Par Amount   $ 4,098
Cost   4,165
Fair Value   $ 4,160
SOC Telemed, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Providers & Services
Spread Above Index [5]   L+747
Floor   0.13%
Interest Rate [6]   7.60%
Acquisition Date   Mar. 26, 2021
Maturity Date   Apr. 01, 2026
Par Amount   $ 31,137
Cost   31,211
Fair Value   $ 31,214
Vapotherm, Inc. [Member] | Senior Secured Loans  0 124.6% | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Equipment & Supplies  
Spread Above Index [3] S+830  
Floor 1.00%  
Interest Rate [4],[22] 12.58%  
Acquisition Date Feb. 18, 2022  
Maturity Date Feb. 01, 2027  
Par Amount $ 34,455  
Cost 34,270  
Fair Value 34,628  
Aero Operating LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Commercial Services & Supplies
Acquisition Date [1]   Feb. 12, 2021
Par Amount [1] 3,103  
Cost [1] 3,100  
Fair Value [1] $ 3,100  
Aero Operating LLC [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   8.47%
Maturity Date [1]   Mar. 01, 2025
Aero Operating LLC [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   9.64%
Maturity Date [1]   Dec. 01, 2026
Aero Operating LLC [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Commercial Services & Supplies  
Acquisition Date [1] Feb. 12, 2021  
Par Amount [1] $ 2,264  
Cost [1] 2,262  
Fair Value [1] $ 2,262  
Aero Operating LLC [Member] | Equipment Financing  0 26.6% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 8.47%  
Maturity Date [1] Mar. 01, 2025  
Aero Operating LLC [Member] | Equipment Financing  0 26.6% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 9.64%  
Maturity Date [1] Dec. 01, 2026  
Air Methods Corporation [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Airlines
Acquisition Date [1]   Nov. 03, 2021
Par Amount [1] $ 4,063  
Cost [1] 4,145  
Fair Value [1] $ 4,063  
Air Methods Corporation [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   7.08%
Maturity Date [1]   Nov. 03, 2026
Air Methods Corporation [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   7.13%
Maturity Date [1]   Nov. 23, 2026
Air Methods Corporation [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Airlines  
Acquisition Date [1] Nov. 03, 2021  
Par Amount [1] $ 3,600  
Cost [1] 3,660  
Fair Value [1] $ 3,600  
Air Methods Corporation [Member] | Equipment Financing  0 26.6% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 7.08%  
Maturity Date [1] Nov. 03, 2026  
Air Methods Corporation [Member] | Equipment Financing  0 26.6% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 7.13%  
Maturity Date [1] Nov. 23, 2026  
AmeraMex International, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Commercial Services & Supplies
Interest Rate [1],[6]   10.00%
Acquisition Date [1]   Mar. 29, 2019
Maturity Date [1]   Mar. 28, 2022
Par Amount [1] $ 3,149  
Cost [1] 3,148  
Fair Value [1] $ 3,180  
AmeraMex International, Inc. [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Commercial Services & Supplies  
Interest Rate [1],[4] 10.00%  
Acquisition Date [1] Mar. 29, 2019  
Maturity Date [1] Sep. 15, 2024  
Par Amount [1] $ 1,059  
Cost [1] 1,059  
Fair Value [1] 1,069  
Blackhawk Mining, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Oil, Gas & Consumable Fuels
Acquisition Date [1]   Feb. 16, 2018
Par Amount [1] 1,642  
Cost [1] 1,615  
Fair Value [1] 1,636  
Blackhawk Mining, LLC [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   10.97%
Maturity Date [1]   Mar. 01, 2022
Blackhawk Mining, LLC [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   11.16%
Maturity Date [1]   Nov. 01, 2022
Boart Longyear Company [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Metals & Mining
Acquisition Date [1]   May 28, 2020
Par Amount [1] 5,374  
Cost [1] 5,374  
Fair Value [1] $ 5,374  
Boart Longyear Company [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   9.06%
Maturity Date [1]   Jul. 01, 2024
Boart Longyear Company [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   10.44%
Maturity Date [1]   Jan. 01, 2026
Boart Longyear Company [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Metals & Mining  
Acquisition Date [1] May 28, 2020  
Par Amount [1] $ 4,568  
Cost [1] 4,568  
Fair Value [1] $ 4,568  
Boart Longyear Company [Member] | Equipment Financing  0 26.6% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 8.31%  
Maturity Date [1] Jul. 01, 2024  
Boart Longyear Company [Member] | Equipment Financing  0 26.6% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 10.44%  
Maturity Date [1] Oct. 07, 2026  
Capital City Jet Center, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Airlines
Interest Rate [1],[6]   10.00%
Acquisition Date [1]   Apr. 04, 2018
Par Amount [1] $ 3,102  
Cost [1] 3,102  
Fair Value [1] $ 3,053  
Capital City Jet Center, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Maturity Date [1]   Oct. 04, 2023
Capital City Jet Center, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Maturity Date [1]   Jun. 22, 2026
Capital City Jet Center, Inc. [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Airlines  
Interest Rate [1],[4] 10.00%  
Acquisition Date [1] Apr. 04, 2018  
Par Amount [1] $ 2,241  
Cost [1] 2,241  
Fair Value [1] $ 2,214  
Capital City Jet Center, Inc. [Member] | Equipment Financing  0 26.6% | Maximum [Member]    
Schedule of Investments [Line Items]    
Maturity Date [1] Jun. 22, 2026  
Champion Air, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Airlines
Interest Rate [1],[6]   10.00%
Acquisition Date [1]   Mar. 19, 2018
Maturity Date [1]   Jan. 01, 2023
Par Amount [1] $ 1,685  
Cost [1] 1,685  
Fair Value [1] $ 1,685  
Champion Air, LLC [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Airlines  
Interest Rate [1],[4] 10.00%  
Acquisition Date [1] Mar. 19, 2018  
Maturity Date [1] Jan. 01, 2023  
Par Amount [1] $ 1,055  
Cost [1] 1,055  
Fair Value [1] 1,055  
Clubcorp Holdings, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Hotels, Restaurants & Leisure
Acquisition Date [1]   May 27, 2021
Par Amount [1] 4,326  
Cost [1] 4,326  
Fair Value [1] $ 4,326  
Clubcorp Holdings, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   8.87%
Maturity Date [1]   Jun. 01, 2025
Clubcorp Holdings, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   9.41%
Maturity Date [1]   Jan. 01, 2027
Clubcorp Holdings, Inc. [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Hotels, Restaurants & Leisure  
Acquisition Date [1] May 27, 2021  
Par Amount [1] $ 6,539  
Cost [1] 6,539  
Fair Value [1] $ 6,539  
Clubcorp Holdings, Inc. [Member] | Equipment Financing  0 26.6% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 9.36%  
Maturity Date [1] Apr. 01, 2025  
Clubcorp Holdings, Inc. [Member] | Equipment Financing  0 26.6% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 13.01%  
Maturity Date [1] Jan. 01, 2028  
Dongwon Autopart Technology Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Auto Components
Interest Rate [1],[6]   7.96%
Acquisition Date [1]   Feb. 02, 2021
Maturity Date [1]   Jan. 01, 2026
Par Amount [1] $ 2,347  
Cost [1] 2,382  
Fair Value [1] $ 2,347  
Dongwon Autopart Technology Inc. [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Auto Components  
Interest Rate [1],[4] 7.96%  
Acquisition Date [1] Feb. 02, 2021  
Maturity Date [1] Jan. 01, 2026  
Par Amount [1] $ 1,828  
Cost [1] 1,849  
Fair Value [1] 1,828  
EasyPak, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Containers & Packaging
Interest Rate [1],[6]   9.01%
Acquisition Date [1]   Jan. 06, 2021
Maturity Date [1]   Jan. 01, 2024
Par Amount [1] 616  
Cost [1] 616  
Fair Value [1] $ 616  
EasyPak, LLC [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Containers & Packaging  
Interest Rate [1],[4] 9.01%  
Acquisition Date [1] Jan. 06, 2021  
Maturity Date [1] Jan. 01, 2024  
Par Amount [1] $ 276  
Cost [1] 276  
Fair Value [1] 276  
Environmental Protection & Improvement Company, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Road & Rail
Interest Rate [1],[6]   8.25%
Acquisition Date [1]   Sep. 30, 2020
Maturity Date [1]   Oct. 01, 2027
Par Amount [1] 5,921  
Cost [1] 5,959  
Fair Value [1] $ 5,921  
Environmental Protection & Improvement Company, LLC [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Road & Rail  
Interest Rate [1],[4] 8.25%  
Acquisition Date [1] Sep. 30, 2020  
Maturity Date [1] Oct. 01, 2027  
Par Amount [1] $ 5,270  
Cost [1] 5,300  
Fair Value [1] 5,270  
Equipment Operating Leases, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [13],[23]   Multi-Sector Holdings
Acquisition Date [13],[23]   Apr. 27, 2018
Par Amount [13],[23] 19,671  
Cost [13],[23] 19,671  
Fair Value [13],[23] $ 18,939  
Equipment Operating Leases, LLC [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[13],[23]   7.53%
Maturity Date [13],[23]   Aug. 01, 2022
Equipment Operating Leases, LLC [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[13],[23]   8.37%
Maturity Date [13],[23]   Apr. 27, 2025
Equipment Operating Leases, LLC [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [12],[23] Multi-Sector Holdings  
Interest Rate [4],[12],[23] 8.37%  
Acquisition Date [12],[23] Apr. 27, 2018  
Maturity Date [12],[23] Apr. 27, 2025  
Par Amount [12],[23] $ 3,837  
Cost [12],[23] 3,837  
Fair Value [12],[23] 3,741  
First American Commercial Bancorp, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Diversified Financial Services
Interest Rate [1],[6]   7.50%
Acquisition Date [1]   Oct. 28, 2021
Maturity Date [1]   Nov. 01, 2026
Par Amount [1] 2,487  
Cost [1] 2,492  
Fair Value [1] $ 2,487  
First American Commercial Bancorp, Inc. [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Diversified Financial Services  
Acquisition Date [1] Oct. 28, 2021  
Par Amount [1] $ 2,938  
Cost [1] 2,941  
Fair Value [1] $ 2,938  
First American Commercial Bancorp, Inc. [Member] | Equipment Financing  0 26.6% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 7.50%  
Maturity Date [1] Oct. 01, 2026  
First American Commercial Bancorp, Inc. [Member] | Equipment Financing  0 26.6% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 9.02%  
Maturity Date [1] Mar. 01, 2027  
First National Capital, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Diversified Financial Services
Interest Rate [1],[6]   9.00%
Acquisition Date [1]   Nov. 05, 2021
Maturity Date [1]   Aug. 01, 2026
Par Amount [1] $ 8,681  
Cost [1] 8,681  
Fair Value [1] $ 8,681  
First National Capital, LLC [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Diversified Financial Services  
Interest Rate [1],[4] 9.00%  
Acquisition Date [1] Nov. 05, 2021  
Maturity Date [1] Aug. 01, 2026  
Par Amount [1] $ 7,116  
Cost [1] 7,116  
Fair Value [1] 7,116  
Freightsol LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Road & Rail
Acquisition Date [1]   Apr. 09, 2019
Maturity Date [1]   Nov. 01, 2023
Par Amount [1] 1,364  
Cost [1] 1,381  
Fair Value [1] $ 1,364  
Freightsol LLC [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   12.51%
Freightsol LLC [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   12.89%
Freightsol LLC [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Road & Rail  
Acquisition Date [1] Apr. 09, 2019  
Maturity Date [1] Nov. 01, 2023  
Par Amount [1] $ 779  
Cost [1] 784  
Fair Value [1] $ 779  
Freightsol LLC [Member] | Equipment Financing  0 26.6% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 12.51%  
Freightsol LLC [Member] | Equipment Financing  0 26.6% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 12.89%  
Garda CL Technical Services, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Commercial Services & Supplies
Acquisition Date [1]   Mar. 22, 2018
Par Amount [1] $ 1,245  
Cost [1] 1,245  
Fair Value [1] $ 1,242  
Garda CL Technical Services, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   8.30%
Maturity Date [1]   Jun. 05, 2023
Garda CL Technical Services, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   8.77%
Maturity Date [1]   Oct. 05, 2023
Garda CL Technical Services, Inc. [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Commercial Services & Supplies  
Acquisition Date [1] Mar. 22, 2018  
Par Amount [1] $ 469  
Cost [1] 469  
Fair Value [1] $ 468  
Garda CL Technical Services, Inc. [Member] | Equipment Financing  0 26.6% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 8.30%  
Maturity Date [1] Jun. 05, 2023  
Garda CL Technical Services, Inc. [Member] | Equipment Financing  0 26.6% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 8.77%  
Maturity Date [1] Oct. 05, 2023  
Georgia Jet, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Airlines
Interest Rate [1],[6]   8.00%
Acquisition Date [1]   Dec. 04, 2017
Maturity Date [1]   Jan. 04, 2024
Par Amount [1] $ 795  
Cost [1] 795  
Fair Value [1] $ 795  
Georgia Jet, Inc. [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Airlines  
Interest Rate [1],[4] 8.00%  
Acquisition Date [1] Dec. 04, 2017  
Maturity Date [1] Jan. 04, 2024  
Par Amount [1] $ 425  
Cost [1] 425  
Fair Value [1] 425  
GMT Corporation [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Machinery
Interest Rate [1],[6]   10.71%
Acquisition Date [1]   Oct. 23, 2018
Maturity Date [1]   Oct. 01, 2025
Par Amount [1] 5,476  
Cost [1] 5,484  
Fair Value [1] $ 5,476  
GMT Corporation [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Machinery  
Interest Rate [1],[4] 10.71%  
Acquisition Date [1] Oct. 23, 2018  
Maturity Date [1] Jan. 01, 2026  
Par Amount [1] $ 4,801  
Cost [1] 4,806  
Fair Value [1] 4,801  
Haljoe Coaches USA, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Road & Rail
Interest Rate [1],[6]   8.53%
Acquisition Date [1]   Jul. 31, 2017
Maturity Date [1]   Jul. 01, 2024
Par Amount [1] 1,061  
Cost [1] 1,061  
Fair Value [1] 915  
Hawkeye Contracting Company, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Construction & Engineering
Interest Rate [1],[6]   10.50%
Acquisition Date [1]   Oct. 08, 2021
Maturity Date [1]   Nov. 01, 2025
Par Amount [1] 1,252  
Cost [1] 1,252  
Fair Value [1] $ 1,252  
Hawkeye Contracting Company, LLC [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Construction & Engineering  
Interest Rate [1],[4] 10.50%  
Acquisition Date [1] Oct. 08, 2021  
Maturity Date [1] Nov. 01, 2025  
Par Amount [1] $ 997  
Cost [1] 997  
Fair Value [1] 997  
HTI Logistics Corporation [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Commercial Services & Supplies
Acquisition Date [1]   Nov. 15, 2018
Par Amount [1] 414  
Cost [1] 414  
Fair Value [1] $ 404  
HTI Logistics Corporation [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   9.69%
Maturity Date [1]   May 01, 2024
HTI Logistics Corporation [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   9.94%
Maturity Date [1]   Sep. 01, 2025
HTI Logistics Corporation [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Commercial Services & Supplies  
Acquisition Date [1] Nov. 15, 2018  
Par Amount [1] $ 290  
Cost [1] 290  
Fair Value [1] $ 283  
HTI Logistics Corporation [Member] | Equipment Financing  0 26.6% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 9.69%  
Maturity Date [1] May 01, 2024  
HTI Logistics Corporation [Member] | Equipment Financing  0 26.6% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 9.94%  
Maturity Date [1] Sep. 01, 2025  
International Automotive Components Group, North America, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Auto Components
Interest Rate [1],[6]   7.95%
Acquisition Date [1]   Jun. 23, 2021
Maturity Date [1]   Jun. 23, 2025
Par Amount [1] $ 8,184  
Cost [1] 8,250  
Fair Value [1] $ 8,184  
International Automotive Components Group, North America, Inc. [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Auto Components  
Interest Rate [1],[4] 7.95%  
Acquisition Date [1] Jun. 23, 2021  
Maturity Date [1] Jun. 23, 2025  
Par Amount [1] $ 6,072  
Cost [1] 6,109  
Fair Value [1] 5,951  
Kool Pak, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Road & Rail
Interest Rate [1],[6]   8.58%
Acquisition Date [1]   Feb. 05, 2018
Maturity Date [1]   Mar. 01, 2024
Par Amount [1] 345  
Cost [1] 345  
Fair Value [1] $ 345  
Kool Pak, LLC [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Road & Rail  
Interest Rate [1],[4] 8.58%  
Acquisition Date [1] Feb. 05, 2018  
Maturity Date [1] Mar. 01, 2024  
Par Amount [1] $ 194  
Cost [1] 194  
Fair Value [1] 194  
Loyer Capital LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [13],[23]   Multi-Sector Holdings
Acquisition Date [13],[23]   May 16, 2019
Par Amount [13],[23] 11,000  
Cost [13],[23] 11,000  
Fair Value [13],[23] $ 10,725  
Loyer Capital LLC [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[13],[23]   8.73%
Maturity Date [13],[23]   May 16, 2024
Loyer Capital LLC [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[13],[23]   11.52%
Maturity Date [13],[23]   Sep. 25, 2024
Loyer Capital LLC [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [12],[23] Multi-Sector Holdings  
Acquisition Date [12],[23] May 16, 2019  
Par Amount [12],[23] $ 7,500  
Cost [12],[23] 7,500  
Fair Value [12],[23] $ 7,361  
Loyer Capital LLC [Member] | Equipment Financing  0 26.6% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [4],[12],[23] 8.73%  
Maturity Date [12],[23] May 16, 2024  
Loyer Capital LLC [Member] | Equipment Financing  0 26.6% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [4],[12],[23] 11.52%  
Maturity Date [12],[23] Sep. 25, 2024  
Lux Credit Consultants, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Road & Rail
Acquisition Date [1]   Jun. 17, 2021
Par Amount [1] $ 9,343  
Cost [1] 9,343  
Fair Value [1] $ 9,343  
Lux Credit Consultants, LLC [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   8.28%
Maturity Date [1]   Dec. 01, 2024
Lux Credit Consultants, LLC [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   9.65%
Maturity Date [1]   Dec. 01, 2025
Lux Credit Consultants, LLC [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Road & Rail  
Acquisition Date [1] Jun. 17, 2021  
Par Amount [1] $ 16,411  
Cost [1] 16,411  
Fair Value [1] $ 16,411  
Lux Credit Consultants, LLC [Member] | Equipment Financing  0 26.6% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 8.28%  
Maturity Date [1] Dec. 01, 2024  
Lux Credit Consultants, LLC [Member] | Equipment Financing  0 26.6% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 12.09%  
Maturity Date [1] Dec. 01, 2026  
Lux Vending, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Consumer Finance
Acquisition Date [1]   Aug. 20, 2021
Par Amount [1] $ 2,526  
Cost [1] 2,583  
Fair Value [1] $ 2,526  
Lux Vending, LLC [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   12.46%
Maturity Date [1]   Aug. 20, 2024
Lux Vending, LLC [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   13.26%
Maturity Date [1]   Oct. 01, 2024
Lux Vending, LLC [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Consumer Finance  
Acquisition Date [1] Aug. 20, 2021  
Par Amount [1] $ 1,638  
Cost [1] 1,663  
Fair Value [1] $ 1,638  
Lux Vending, LLC [Member] | Equipment Financing  0 26.6% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 12.46%  
Maturity Date [1] Aug. 20, 2024  
Lux Vending, LLC [Member] | Equipment Financing  0 26.6% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 13.26%  
Maturity Date [1] Oct. 01, 2024  
Mountain Air Helicopters, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Commercial Services & Supplies
Interest Rate [1],[6]   10.00%
Acquisition Date [1]   Jul. 31, 2017
Maturity Date [1]   Feb. 28, 2025
Par Amount [1] $ 479  
Cost [1] 476  
Fair Value [1] $ 479  
Mountain Air Helicopters, Inc. [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Commercial Services & Supplies  
Interest Rate [1],[4] 10.00%  
Acquisition Date [1] Jul. 31, 2017  
Maturity Date [1] Feb. 28, 2025  
Par Amount [1] $ 369  
Cost [1] 368  
Fair Value [1] 369  
Rane Light Metal Castings Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Machinery
Interest Rate [1],[6]   10.00%
Acquisition Date [1]   Jun. 01, 2020
Maturity Date [1]   Jul. 01, 2024
Par Amount [1] 253  
Cost [1] 253  
Fair Value [1] $ 253  
Rane Light Metal Castings Inc. [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Machinery  
Interest Rate [1],[4] 10.00%  
Acquisition Date [1] Jun. 01, 2020  
Maturity Date [1] Jun. 01, 2024  
Par Amount [1] $ 159  
Cost [1] 159  
Fair Value [1] 159  
Rango, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Commercial Services & Supplies
Acquisition Date [1]   Sep. 24, 2019
Par Amount [1] 3,615  
Cost [1] 3,656  
Fair Value [1] $ 3,547  
Rango, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   9.33%
Maturity Date [1]   Apr. 01, 2023
Rango, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   9.79%
Maturity Date [1]   Nov. 01, 2024
Rango, Inc. [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Commercial Services & Supplies  
Acquisition Date [1] Sep. 24, 2019  
Par Amount [1] $ 1,940  
Cost [1] 1,960  
Fair Value [1] $ 1,904  
Rango, Inc. [Member] | Equipment Financing  0 26.6% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 9.33%  
Maturity Date [1] Apr. 01, 2023  
Rango, Inc. [Member] | Equipment Financing  0 26.6% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 9.79%  
Maturity Date [1] Nov. 01, 2024  
Rossco Crane & Rigging, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Commercial Services & Supplies
Interest Rate [1],[6]   11.53%
Acquisition Date [1]   Aug. 25, 2017
Maturity Date [1]   Sep. 01, 2022
Par Amount [1] $ 126  
Cost [1] 126  
Fair Value [1] 126  
Royal Coach Lines, Inc.[Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Road & Rail
Interest Rate [1],[6]   9.56%
Acquisition Date [1]   Nov. 21, 2019
Maturity Date [1]   Aug. 01, 2025
Par Amount [1] 1,041  
Cost [1] 1,041  
Fair Value [1] $ 950  
Royal Coach Lines, Inc.[Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Road & Rail  
Interest Rate [1],[4] 9.56%  
Acquisition Date [1] Nov. 21, 2019  
Maturity Date [1] Aug. 01, 2025  
Par Amount [1] $ 849  
Cost [1] 849  
Fair Value [1] 775  
Royal Express Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Road & Rail
Interest Rate [1],[6]   9.53%
Acquisition Date [1]   Jan. 17, 2019
Maturity Date [1]   Feb. 01, 2024
Par Amount [1] 683  
Cost [1] 690  
Fair Value [1] $ 683  
Royal Express Inc. [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Road & Rail  
Interest Rate [1],[4] 9.53%  
Acquisition Date [1] Jan. 17, 2019  
Maturity Date [1] Feb. 01, 2024  
Par Amount [1] $ 428  
Cost [1] 431  
Fair Value [1] 428  
Sidelines Tree Service LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Diversified Consumer Services
Interest Rate [1],[6]   10.25%
Acquisition Date [1]   Jul. 31, 2017
Maturity Date [1]   Oct. 01, 2022
Par Amount [1] 46  
Cost [1] 46  
Fair Value [1] $ 45  
SLR Equipment Finance [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [12] Multi-Sector Holdings  
Interest Rate [4],[12] 8.50%  
Acquisition Date [12] Jan. 24, 2022  
Maturity Date [12] Jan. 24, 2023  
Par Amount [12] $ 5,000  
Cost [12] 5,000  
Fair Value [12] 5,000  
South Texas Oilfield Solutions, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Energy Equipment & Services
Acquisition Date [1]   Mar. 29, 2018
Par Amount [1] 1,363  
Cost [1] 1,363  
Fair Value [1] 1,338  
South Texas Oilfield Solutions, LLC [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   12.52%
Maturity Date [1]   Sep. 01, 2022
South Texas Oilfield Solutions, LLC [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   13.76%
Maturity Date [1]   Jul. 01, 2023
ST Coaches, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Road & Rail
Acquisition Date [1]   Jul. 31, 2017
Par Amount [1] 1,951  
Cost [1] 1,951  
Fair Value [1] $ 1,839  
ST Coaches, LLC [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   8.22%
Maturity Date [1]   Oct. 01, 2022
ST Coaches, LLC [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   8.58%
Maturity Date [1]   Jan. 25, 2025
ST Coaches, LLC [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Road & Rail  
Acquisition Date [1] Jul. 31, 2017  
Par Amount [1] $ 1,521  
Cost [1] 1,521  
Fair Value [1] $ 1,459  
ST Coaches, LLC [Member] | Equipment Financing  0 26.6% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 8.47%  
Maturity Date [1] Jul. 01, 2023  
ST Coaches, LLC [Member] | Equipment Financing  0 26.6% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 8.58%  
Maturity Date [1] Jan. 25, 2025  
Stafford Logistics, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Commercial Services & Supplies
Interest Rate [1],[6]   12.62%
Acquisition Date [1]   Sep. 11, 2019
Maturity Date [1]   Feb. 15, 2026
Par Amount [1] $ 7,094  
Cost [1] 7,094  
Fair Value [1] 7,094  
Star Coaches Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Road & Rail
Interest Rate [1],[6]   8.42%
Acquisition Date [1]   Mar. 09, 2018
Maturity Date [1]   Apr. 01, 2025
Par Amount [1] 3,401  
Cost [1] 3,401  
Fair Value [1] $ 2,916  
Star Coaches Inc. [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Road & Rail  
Interest Rate [1],[4] 8.42%  
Acquisition Date [1] Mar. 09, 2018  
Maturity Date [1] Apr. 01, 2025  
Par Amount [1] $ 2,887  
Cost [1] 2,887  
Fair Value [1] 2,591  
Sturgeon Services International Inc.[Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Energy Equipment & Services
Interest Rate [1],[6]   18.38%
Acquisition Date [1]   Jul. 31, 2017
Maturity Date [1]   Feb. 28, 2022
Par Amount [1] 132  
Cost [1] 132  
Fair Value [1] 125  
Superior Transportation, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Road & Rail
Acquisition Date [1]   Jul. 31, 2017
Maturity Date [1]   Jan. 01, 2026
Par Amount [1] 4,578  
Cost [1] 4,578  
Fair Value [1] $ 4,578  
Superior Transportation, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   10.22%
Superior Transportation, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   10.62%
Superior Transportation, Inc. [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Road & Rail  
Acquisition Date [1] Jul. 31, 2017  
Maturity Date [1] Jan. 01, 2026  
Par Amount [1] $ 3,369  
Cost [1] 3,369  
Fair Value [1] $ 3,369  
Superior Transportation, Inc. [Member] | Equipment Financing  0 26.6% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 10.22%  
Superior Transportation, Inc. [Member] | Equipment Financing  0 26.6% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 10.63%  
Tailwinds, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Air Freight & Logistics
Acquisition Date [1]   Jul. 26, 2019
Par Amount [1] $ 2,267  
Cost [1] 2,267  
Fair Value [1] 2,267  
Tailwinds, LLC [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   8.50%
Maturity Date [1]   Aug. 01, 2024
Tailwinds, LLC [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   9.00%
Maturity Date [1]   Oct. 16, 2025
The Smedley Company & Smedley Services, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Commercial Services & Supplies
Acquisition Date [1]   Jul. 31, 2017
Par Amount [1] 3,798  
Cost [1] 3,800  
Fair Value [1] $ 3,536  
The Smedley Company & Smedley Services, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   10.21%
Maturity Date [1]   Oct. 29, 2023
The Smedley Company & Smedley Services, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   15.36%
Maturity Date [1]   Feb. 10, 2024
The Smedley Company & Smedley Services, Inc. [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Commercial Services & Supplies  
Interest Rate [1],[4] 4.07%  
Acquisition Date [1] Jul. 31, 2017  
Maturity Date [1] Jan. 15, 2028  
Par Amount [1] $ 1,706  
Cost [1] 1,706  
Fair Value [1] 1,706  
Trinity Equipment Rentals, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Commercial Services & Supplies
Acquisition Date [1]   Oct. 08, 2021
Par Amount [1] 777  
Cost [1] 777  
Fair Value [1] $ 777  
Trinity Equipment Rentals, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   7.94%
Maturity Date [1]   Nov. 01, 2024
Trinity Equipment Rentals, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   8.75%
Maturity Date [1]   Dec. 01, 2026
Trinity Equipment Rentals, Inc. [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Commercial Services & Supplies  
Acquisition Date [1] Oct. 08, 2021  
Par Amount [1] $ 577  
Cost [1] 577  
Fair Value [1] $ 577  
Trinity Equipment Rentals, Inc. [Member] | Equipment Financing  0 26.6% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 7.94%  
Maturity Date [1] Nov. 01, 2024  
Trinity Equipment Rentals, Inc. [Member] | Equipment Financing  0 26.6% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 8.75%  
Maturity Date [1] Dec. 01, 2026  
Trolleys, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Road & Rail
Interest Rate [1],[6]   9.99%
Acquisition Date [1]   Jul. 18, 2018
Maturity Date [1]   Aug. 01, 2022
Par Amount [1] $ 1,573  
Cost [1] 1,573  
Fair Value [1] 1,540  
Up Trucking Services, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Road & Rail
Interest Rate [1],[6]   11.21%
Acquisition Date [1]   Mar. 23, 2018
Maturity Date [1]   Aug. 01, 2024
Par Amount [1] 696  
Cost [1] 705  
Fair Value [1] $ 696  
Up Trucking Services, LLC [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Road & Rail  
Interest Rate [1],[4] 11.21%  
Acquisition Date [1] Mar. 23, 2018  
Maturity Date [1] Aug. 01, 2024  
Par Amount [1] $ 469  
Cost [1] 473  
Fair Value [1] 469  
Warrior Crane Services, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Commercial Services & Supplies
Interest Rate [1],[6]   8.95%
Acquisition Date [1]   Jul. 11, 2019
Par Amount [1] 2,567  
Cost [1] 2,567  
Fair Value [1] 2,518  
Warrior Crane Services, LLC [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Maturity Date [1]   Aug. 01, 2024
Warrior Crane Services, LLC [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Maturity Date [1]   Aug. 01, 2026
Wind River Environmental, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Diversified Consumer Services
Acquisition Date [1]   Jul. 31, 2019
Par Amount [1] 870  
Cost [1] 873  
Fair Value [1] $ 870  
Wind River Environmental, LLC [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   8.43%
Maturity Date [1]   Aug. 01, 2024
Wind River Environmental, LLC [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[6]   10.00%
Maturity Date [1]   Oct. 05, 2025
Wind River Environmental, LLC [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Diversified Consumer Services  
Acquisition Date [1] Jul. 31, 2019  
Par Amount [1] $ 604  
Cost [1] 605  
Fair Value [1] $ 604  
Wind River Environmental, LLC [Member] | Equipment Financing  0 26.6% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 8.43%  
Maturity Date [1] Aug. 01, 2024  
Wind River Environmental, LLC [Member] | Equipment Financing  0 26.6% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 10.00%  
Maturity Date [1] Oct. 05, 2025  
Womble Company, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [1]   Energy Equipment & Services
Interest Rate [1],[6]   9.11%
Acquisition Date [1]   Dec. 27, 2019
Maturity Date [1]   Jan. 01, 2025
Par Amount [1] $ 547  
Cost [1] 547  
Fair Value [1] $ 537  
Womble Company, Inc. [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Energy Equipment & Services  
Interest Rate [1],[4] 9.11%  
Acquisition Date [1] Dec. 27, 2019  
Maturity Date [1] Jan. 01, 2025  
Par Amount [1] $ 386  
Cost [1] 386  
Fair Value [1] $ 371  
SLR Equipment Finance Equity Interests [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [13],[24],[25]   Multi-Sector Holdings
Acquisition Date [13],[24],[25]   Jul. 31, 2017
Shares/Units [13],[24],[25]   200
Cost [13],[24],[25]   $ 145,000
Fair Value [13],[24],[25]   $ 129,102
SLR Equipment Finance Equity Interests [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [12],[26] Multi-Sector Holdings  
Acquisition Date [12],[26] Jul. 31, 2017  
Shares/Units [12],[26] 200  
Cost [12],[26] $ 145,000  
Fair Value [12],[26] $ 120,820  
SOINT, LLC [Member] | Preferred Equity  2 0.4% [Member]    
Schedule of Investments [Line Items]    
Industry [11],[12],[27] Aerospace & Defense  
Interest Rate [4],[11],[12],[18],[27] 5.00%  
Acquisition Date [11],[12],[27] Jun. 08, 2012  
Maturity Date [11],[12],[27] Jun. 30, 2023  
Shares/Units [11],[12],[27] 49,273  
Cost [11],[12],[27] $ 4,927  
Fair Value [11],[12],[27] $ 3,801  
SOINT, LLC [Member] | Preferred Equity  2 0.7% [Member]    
Schedule of Investments [Line Items]    
Industry [10],[13],[28]   Aerospace & Defense
Interest Rate [11],[12],[27]   8.00%
Acquisition Date [10],[13],[28]   Jun. 08, 2012
Maturity Date [10],[13],[28]   Jun. 30, 2023
Shares/Units [10],[13],[28]   56,030
Cost [10],[13],[28]   $ 5,603
Fair Value [10],[13],[28]   $ 4,509
SOAGG LLC [Member] | Preferred Equity  2 0.7% [Member]    
Schedule of Investments [Line Items]    
Industry [10],[13],[28]   Aerospace & Defense
Interest Rate [11],[12],[27]   5.00%
Acquisition Date [10],[13],[28]   Dec. 14, 2010
Maturity Date [10],[13],[28]   Jun. 30, 2023
Shares/Units [10],[13],[28]   446
Cost [10],[13],[28]   $ 446
Fair Value [10],[13],[28]   $ 1,121
aTyr Pharma, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Industry [24]   Pharmaceuticals
Acquisition Date [24]   Nov. 18, 2016
Shares/Units [24]   6,347
Cost [24]   $ 106
Fair Value [24]   $ 0
aTyr Pharma, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants 057.1%    
Schedule of Investments [Line Items]    
Industry [24] Pharmaceuticals  
Acquisition Date [24] Nov. 18, 2016  
Shares/Units [24] 6,347  
Cost [24] $ 106  
Fair Value [24] $ 0  
CardioFocus, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Industry [24]   Health Care Equipment & Supplies
Acquisition Date [24]   Mar. 31, 2017
Shares/Units [24]   90
Cost [24]   $ 51
Fair Value [24]   $ 0
CardioFocus, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants 057.1%    
Schedule of Investments [Line Items]    
Industry [24] Health Care Equipment & Supplies  
Acquisition Date [24] Mar. 31, 2017  
Shares/Units [24] 90  
Cost [24] $ 51  
Fair Value [24] $ 0  
Centrexion Therapeutics, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Industry [24]   Pharmaceuticals
Acquisition Date [24]   Jun. 28, 2019
Shares/Units [24]   289,102
Cost [24]   $ 136
Fair Value [24]   $ 65
Centrexion Therapeutics, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants 057.1%    
Schedule of Investments [Line Items]    
Industry [24] Pharmaceuticals  
Acquisition Date [24] Jun. 28, 2019  
Shares/Units [24] 289,102  
Cost [24] $ 136  
Fair Value [24] $ 82  
Conventus Orthopaedics, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Industry [24]   Health Care Equipment & Supplies
Acquisition Date [24]   Jun. 15, 2016
Shares/Units [24]   157,500
Cost [24]   $ 65
Fair Value [24]   $ 0
Conventus Orthopaedics, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants 057.1%    
Schedule of Investments [Line Items]    
Industry [24] Health Care Equipment & Supplies  
Acquisition Date [24] Jun. 15, 2016  
Shares/Units [24] 157,500  
Cost [24] $ 65  
Fair Value [24] $ 0  
Delphinus Medical Technologies, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Industry [24]   Health Care Equipment & Supplies
Acquisition Date [24]   Aug. 18, 2017
Shares/Units [24]   444,388
Cost [24]   $ 74
Fair Value [24]   $ 80
Delphinus Medical Technologies, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants 057.1%    
Schedule of Investments [Line Items]    
Industry [24] Health Care Equipment & Supplies  
Acquisition Date [24] Aug. 18, 2017  
Shares/Units [24] 444,388  
Cost [24] $ 74  
Fair Value [24] $ 103  
Essence Group Holdings Corporation (Lumeris) Warrants [Member] | Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Industry [24]   Health Care Technology
Acquisition Date [24]   Mar. 22, 2017
Shares/Units [24]   208,000
Cost [24]   $ 63
Fair Value [24]   $ 258
Essence Group Holdings Corporation (Lumeris) Warrants [Member] | Common Equity/Equity Interests/Warrants 057.1%    
Schedule of Investments [Line Items]    
Industry [24] Health Care Technology  
Acquisition Date [24] Mar. 22, 2017  
Shares/Units [24] 260,000  
Cost [24] $ 129  
Fair Value [24] $ 366  
KBH Topco LLC (Kingsbridge) [Member] | Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Industry [13],[29]   Multi-Sector Holdings
Acquisition Date [13],[29]   Nov. 03, 2020
Shares/Units [13],[29]   73,500,000
Cost [13],[29]   $ 136,596
Fair Value [13],[29]   $ 145,996
KBH Topco LLC (Kingsbridge) [Member] | Common Equity/Equity Interests/Warrants 057.1%    
Schedule of Investments [Line Items]    
Industry [12],[29],[30] Multi-Sector Holdings  
Acquisition Date [12],[29],[30] Nov. 03, 2020  
Shares/Units [12],[29],[30] 73,500,000  
Cost [12],[29],[30] $ 136,596  
Fair Value [12],[29],[30] $ 148,444  
RD Holdco Inc. (Rug Doctor) [Member] | Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Industry [13],[24]   Diversified Consumer Services
Acquisition Date [13],[24]   Dec. 23, 2013
Shares/Units [13],[24]   231,177
Cost [13],[24]   $ 15,683
Fair Value [13],[24]   $ 0
RD Holdco Inc. (Rug Doctor) [Member] | Common Equity/Equity Interests/Warrants 057.1%    
Schedule of Investments [Line Items]    
Industry [12],[24] Diversified Consumer Services  
Acquisition Date [12],[24] Dec. 23, 2013  
Shares/Units [12],[24] 231,177  
Cost [12],[24] $ 15,683  
Fair Value [12],[24] $ 0  
RD Holdco Inc. (Rug Doctor, class B) [Member] | Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Industry [13],[24]   Diversified Consumer Services
Acquisition Date [13],[24]   Dec. 23, 2013
Shares/Units [13],[24]   522
Cost [13],[24]   $ 5,216
Fair Value [13],[24]   $ 5,216
RD Holdco Inc. (Rug Doctor, class B) [Member] | Common Equity/Equity Interests/Warrants 057.1%    
Schedule of Investments [Line Items]    
Industry [12],[24] Diversified Consumer Services  
Acquisition Date [12],[24] Dec. 23, 2013  
Shares/Units [12],[24] 522  
Cost [12],[24] $ 5,216  
Fair Value [12],[24] $ 0  
RD Holdco Inc. (Rug Doctor, Warrants) [Member] | Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Industry [13],[24]   Diversified Consumer Services
Acquisition Date [13],[24]   Dec. 23, 2013
Shares/Units [13],[24]   30,370
Cost [13],[24]   $ 381
Fair Value [13],[24]   $ 0
RD Holdco Inc. (Rug Doctor, Warrants) [Member] | Common Equity/Equity Interests/Warrants 057.1%    
Schedule of Investments [Line Items]    
Industry [12],[24] Diversified Consumer Services  
Acquisition Date [12],[24] Dec. 23, 2013  
Shares/Units [12],[24] 30,370  
Cost [12],[24] $ 381  
Fair Value [12],[24] $ 0  
Senseonics Holdings, Inc. [Member] | Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Industry [10],[24],[31]   Health Care Equipment & Supplies
Acquisition Date [10],[24],[31]   Jul. 25, 2019
Shares/Units [10],[24],[31]   406,923
Cost [10],[24],[31]   $ 117
Fair Value [10],[24],[31]   $ 1,086
Senseonics Holdings, Inc. [Member] | Common Equity/Equity Interests/Warrants 057.1%    
Schedule of Investments [Line Items]    
Industry [11],[24],[31] Health Care Equipment & Supplies  
Acquisition Date [11],[24],[31] Jul. 25, 2019  
Shares/Units [11],[24],[31] 469,353  
Cost [11],[24],[31] $ 235  
Fair Value [11],[24],[31] $ 483  
SLR Business Credit [Member] | Common Equity/Equity Interests/Warrants 057.1%    
Schedule of Investments [Line Items]    
Industry [11],[12],[32] Diversified Financial Services  
Acquisition Date [11],[12],[32] Apr. 01, 2022  
Shares/Units [11],[12],[32] 100  
Cost [11],[12],[32] $ 81,583  
Fair Value [11],[12],[32] $ 89,370  
SLR Credit Solutions [Member] | Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Industry [10],[13]   Diversified Financial Services
Acquisition Date [10],[13]   Dec. 28, 2012
Shares/Units [10],[13]   280,303
Cost [10],[13]   $ 280,737
Fair Value [10],[13]   $ 298,766
SLR Credit Solutions [Member] | Common Equity/Equity Interests/Warrants 057.1%    
Schedule of Investments [Line Items]    
Industry [11],[12],[33] Diversified Financial Services  
Acquisition Date [11],[12],[33] Dec. 28, 2012  
Shares/Units [11],[12],[33] 280,303  
Cost [11],[12],[33] $ 280,737  
Fair Value [11],[12],[33] $ 288,760  
SLR Healthcare ABL [Member] | Common Equity/Equity Interests/Warrants 057.1%    
Schedule of Investments [Line Items]    
Industry [11],[12],[34] Diversified Financial Services  
Acquisition Date [11],[12],[34] Apr. 01, 2022  
Shares/Units [11],[12],[34] 32,839  
Cost [11],[12],[34] $ 34,335  
Fair Value [11],[12],[34] $ 34,350  
Spectrum Pharmaceuticals, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants 057.1%    
Schedule of Investments [Line Items]    
Industry [24] Biotechnology  
Acquisition Date [24] Sep. 21, 2022  
Shares/Units [24] 159,470  
Cost [24] $ 51  
Fair Value [24] $ 15  
Vapotherm, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants 057.1%    
Schedule of Investments [Line Items]    
Industry [24] Health Care Equipment & Supplies  
Acquisition Date [24] Feb. 18, 2022  
Shares/Units [24] 36,996  
Cost [24] $ 210  
Fair Value [24] $ 87  
Venus Concept Ltd. Warrants (f/k/a Restoration Robotics) [Member] | Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Industry [24]   Health Care Equipment & Supplies
Acquisition Date [24]   May 10, 2018
Shares/Units [24]   27,352
Cost [24]   $ 152
Fair Value [24]   $ 0
Venus Concept Ltd. Warrants (f/k/a Restoration Robotics) [Member] | Common Equity/Equity Interests/Warrants 057.1%    
Schedule of Investments [Line Items]    
Industry [24] Health Care Equipment & Supplies  
Acquisition Date [24] May 10, 2018  
Shares/Units [24] 33,430  
Cost [24] $ 152  
Fair Value [24] $ 0  
ENS Holdings III Corp. & ES Opco USA LLC (Bluefin) [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Trading Companies & Distributors  
Spread Above Index [2],[3] S+475  
Floor [2] 1.00%  
Interest Rate [2],[4] 9.43%  
Acquisition Date [2] Apr. 01, 2022  
Maturity Date [2] Dec. 31, 2025  
Par Amount [2] $ 4,978  
Cost [2] 4,804  
Fair Value [2] $ 4,978  
Enverus Holdings, Inc. (fka Drilling Info Holdings) [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] IT Services  
Spread Above Index [2],[3] L+450  
Floor [2] 0.00%  
Interest Rate [2],[4] 8.88%  
Acquisition Date [2] Apr. 01, 2022  
Maturity Date [2] Jul. 30, 2025  
Par Amount [2] $ 11,598  
Cost [2] 11,129  
Fair Value [2] $ 11,598  
Erie Construction Mid-west, LLC [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Building Products  
Spread Above Index [2],[3] S+475  
Floor [2] 1.00%  
Interest Rate [2],[4] 9.79%  
Acquisition Date [2] Apr. 01, 2022  
Maturity Date [2] Jul. 30, 2027  
Par Amount [2] $ 8,915  
Cost [2] 8,580  
Fair Value [2] $ 8,915  
GSM Acquisition Corp [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Leisure Equipment & Products  
Spread Above Index [2],[3] S+500  
Floor [2] 1.00%  
Interest Rate [2],[4] 9.03%  
Acquisition Date [2] Apr. 01, 2022  
Maturity Date [2] Nov. 16, 2026  
Par Amount [2] $ 11,022  
Cost [2] 10,562  
Fair Value [2] $ 10,912  
Higginbotham Insurance Agency, Inc [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Insurance  
Spread Above Index [2],[3] L+525  
Floor [2] 0.75%  
Interest Rate [2],[4] 9.63%  
Acquisition Date [2] Apr. 01, 2022  
Maturity Date [2] Nov. 25, 2026  
Par Amount [2] $ 6,223  
Cost [2] 5,994  
Fair Value [2] $ 6,223  
High Street Buyer, Inc [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Insurance  
Spread Above Index [2],[3] L+600  
Floor [2] 0.75%  
Interest Rate [2],[4] 10.73%  
Acquisition Date [2] Apr. 01, 2022  
Maturity Date [2] Apr. 16, 2028  
Par Amount [2] $ 5,188  
Cost [2] 4,900  
Fair Value [2] $ 5,188  
Human Interest Inc [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Internet Software & Services  
Spread Above Index [3] S+785  
Floor [2] 1.00%  
Interest Rate [4] 11.97%  
Acquisition Date Jun. 30, 2022  
Maturity Date Jul. 01, 2027  
Par Amount $ 20,104  
Cost 19,783  
Fair Value $ 20,104  
Kaseya, Inc [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Software  
Spread Above Index [2],[3] S+575  
Floor [2] 0.75%  
Interest Rate [2],[4] 10.33%  
Acquisition Date [2] Jun. 22, 2022  
Maturity Date [2] Jun. 23, 2029  
Par Amount [2] $ 32,426  
Cost [2] 31,966  
Fair Value [2] $ 32,426  
National Spine and Pain Centers, LLC [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Providers & Services  
Spread Above Index [3] L+500  
Floor [2] 1.00%  
Interest Rate [4] 7.31%  
Acquisition Date Apr. 01, 2022  
Maturity Date Jun. 02, 2024  
Par Amount $ 2,681  
Cost 2,564  
Fair Value $ 2,547  
Peter C. Foy & Associates Insurance Services, LLC [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Insurance  
Spread Above Index [3] S+600  
Floor [2] 0.75%  
Interest Rate [4] 10.44%  
Acquisition Date Apr. 01, 2022  
Maturity Date Nov. 01, 2028  
Par Amount $ 10,854  
Cost 10,699  
Fair Value $ 10,854  
Plastics Management, LLC [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Health Care Providers & Services  
Spread Above Index [2],[3] S+500  
Floor [2] 1.00%  
Interest Rate [2],[4] 9.89%  
Acquisition Date [2] Apr. 01, 2022  
Maturity Date [2] Aug. 18, 2027  
Par Amount [2] $ 9,491  
Cost [2] 9,161  
Fair Value [2] $ 9,491  
RSC Acquisition, Inc [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Insurance  
Spread Above Index [2],[3] S+550  
Floor [2] 0.75%  
Interest Rate [2],[4] 9.26%  
Acquisition Date [2] Apr. 01, 2022  
Maturity Date [2] Nov. 01, 2026  
Par Amount [2] $ 6,985  
Cost [2] 6,813  
Fair Value [2] $ 6,985  
RxSense Holdings LLC [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Diversified Consumer Services  
Spread Above Index [2],[3] L+500  
Floor [2] 1.00%  
Interest Rate [2],[4] 9.41%  
Acquisition Date [2] Apr. 01, 2022  
Maturity Date [2] Mar. 13, 2026  
Par Amount [2] $ 11,775  
Cost [2] 11,357  
Fair Value [2] $ 11,775  
SHO Holding I Corporation (Shoes for Crews) [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Footwear  
Spread Above Index [2],[3] L+523  
Floor [2] 1.00%  
Interest Rate [2],[4] 9.66%  
Acquisition Date [2] Apr. 01, 2022  
Maturity Date [2] Apr. 27, 2024  
Par Amount [2] $ 5,704  
Cost [2] 5,361  
Fair Value [2] $ 5,419  
Southern Orthodontic Partners Management, LLC [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Health Care Providers & Services  
Spread Above Index [2],[3] S+600  
Floor [2] 1.00%  
Interest Rate [2],[4] 10.77%  
Acquisition Date [2] Jun. 03, 2022  
Maturity Date [2] Jan. 27, 2026  
Par Amount [2] $ 1,399  
Cost [2] 1,387  
Fair Value [2] $ 1,399  
TAUC Management, LLC [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Health Care Providers & Services  
Spread Above Index [2],[3] L+525  
Floor [2] 1.00%  
Interest Rate [2],[4] 9.98%  
Acquisition Date [2] Apr. 01, 2022  
Maturity Date [2] Feb. 12, 2027  
Par Amount [2] $ 6,899  
Cost [2] 6,585  
Fair Value [2] $ 6,864  
Tilley Distribution, Inc [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Trading Companies & Distributors  
Spread Above Index [2],[3] S+550  
Floor [2] 1.00%  
Interest Rate [2],[4] 10.14%  
Acquisition Date [2] Apr. 01, 2022  
Maturity Date [2] Dec. 31, 2026  
Par Amount [2] $ 9,996  
Cost [2] 9,527  
Fair Value [2] $ 9,996  
Vessco Midco Holdings, LLC [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Water Utilities  
Spread Above Index [2],[3] L+450  
Floor [2] 1.00%  
Interest Rate [2],[4] 7.87%  
Acquisition Date [2] Apr. 01, 2022  
Maturity Date [2] Nov. 02, 2026  
Par Amount [2] $ 1,728  
Cost [2] 1,668  
Fair Value [2] $ 1,728  
World Insurance Associates, LLC [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Insurance  
Spread Above Index [2],[3] S+575  
Floor [2] 1.00%  
Interest Rate [2],[4] 9.31%  
Acquisition Date [2] Apr. 01, 2022  
Maturity Date [2] Apr. 01, 2026  
Par Amount [2] $ 31,624  
Cost [2] 30,785  
Fair Value [2] $ 30,359  
Apeel Technology, Inc [Member] | Senior Secured Loans  0 124.6% | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Biotechnology  
Spread Above Index [3] S+625  
Floor 1.00%  
Interest Rate [4] 8.75%  
Acquisition Date Jun. 29, 2022  
Maturity Date Jun. 01, 2027  
Par Amount $ 3,643  
Cost 3,620  
Fair Value $ 3,643  
Smiley Lifting Solutions, LLC [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Commercial Services & Supplies  
Acquisition Date [1] Jun. 30, 2022  
Par Amount [1] $ 4,139  
Cost [1] 4,139  
Fair Value [1] $ 4,139  
Smiley Lifting Solutions, LLC [Member] | Equipment Financing  0 26.6% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 7.82%  
Maturity Date [1] Sep. 15, 2026  
Smiley Lifting Solutions, LLC [Member] | Equipment Financing  0 26.6% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 8.28%  
Maturity Date [1] Dec. 29, 2029  
Apex Services Partners, LLC [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Diversified Consumer Services  
Spread Above Index [2],[3] S+525  
Floor [2] 1.00%  
Interest Rate [2],[4] 9.80%  
Acquisition Date [2] Aug. 31, 2022  
Maturity Date [2] Jul. 31, 2025  
Par Amount [2] $ 14,021  
Cost [2] 13,644  
Fair Value [2] $ 14,021  
Composite Technology Acquisition Corp. [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Building Products  
Spread Above Index [2],[3] L+475  
Floor [2] 1.00%  
Interest Rate [2],[4] 9.73%  
Acquisition Date [2] Apr. 01, 2022  
Maturity Date [2] Feb. 01, 2025  
Par Amount [2] $ 10,386  
Cost [2] 9,983  
Fair Value [2] $ 10,386  
Copper River Seafoods, Inc. [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Food Products  
Spread Above Index [3] P+275  
Floor [2] 0.00%  
Interest Rate [4] 10.25%  
Acquisition Date Aug. 31, 2022  
Maturity Date Apr. 23, 2025  
Par Amount $ 8,405  
Cost 8,405  
Fair Value $ 8,405  
Luxury Asset Capital, LLC [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Thrifts & Mortgage Finance  
Spread Above Index [2],[3] S+675  
Floor [2] 1.00%  
Interest Rate [2],[4] 10.99%  
Acquisition Date [2] Jul. 15, 2022  
Maturity Date [2] Jul. 15, 2027  
Par Amount [2] $ 27,500  
Cost [2] 26,991  
Fair Value [2] $ 27,500  
Montefiore Nyack Hospital [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Providers & Services  
Spread Above Index [3] L+495  
Floor [2] 0.00%  
Interest Rate [4] 9.72%  
Acquisition Date Aug. 09, 2022  
Maturity Date Nov. 15, 2024  
Par Amount $ 3,966  
Cost 3,966  
Fair Value $ 3,966  
Orthopedic Care Partners Management, LLC [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Providers & Services  
Spread Above Index [3] S+650  
Floor [2] 1.00%  
Interest Rate [4] 10.91%  
Acquisition Date Aug. 17, 2022  
Maturity Date May 16, 2024  
Par Amount $ 3,111  
Cost 3,092  
Fair Value $ 3,111  
Pediatric Home Respiratory Services, LLC [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Providers & Services  
Spread Above Index [3] S+625  
Floor [2] 1.00%  
Interest Rate [4] 10.67%  
Acquisition Date Aug. 19, 2022  
Maturity Date Dec. 04, 2024  
Par Amount $ 1,327  
Cost 1,309  
Fair Value $ 1,313  
SPAR Marketing Force, Inc. [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Media  
Spread Above Index [3] P+95  
Floor 0.00%  
Interest Rate [4] 8.45%  
Acquisition Date Jul. 18, 2022  
Maturity Date Oct. 10, 2024  
Par Amount $ 9,162  
Cost 9,162  
Fair Value $ 9,162  
Stryten Resources LLC [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Auto Parts & Equipment  
Spread Above Index [3] S+800  
Floor 1.00%  
Interest Rate [4] 12.44%  
Acquisition Date Aug. 11, 2021  
Maturity Date Oct. 12, 2026  
Par Amount $ 25,922  
Cost 25,506  
Fair Value $ 25,922  
BDG Media, Inc. [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Media  
Spread Above Index [3] L+900  
Floor [2] 0.25%  
Interest Rate [4] 13.17%  
Acquisition Date Jul. 18, 2022  
Maturity Date Apr. 27, 2023  
Par Amount $ 14,454  
Cost 14,454  
Fair Value $ 14,454  
RD Holdco, Inc. [Member] | Senior Secured Loans  0 124.6% | Second Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [7],[13] Diversified Consumer Services  
Spread Above Index [3],[7],[13],[18] S+975  
Floor [7],[13] 1.00%  
Interest Rate [4],[7],[13] 0.00%  
Acquisition Date [7],[13] Dec. 23, 2013  
Maturity Date [7],[13] Oct. 12, 2026  
Par Amount [7],[13] $ 13,043  
Cost [7],[13] 11,791  
Fair Value [7],[13] $ 6,521  
Spectrum Pharmaceuticals, Inc. [Member] | Senior Secured Loans  0 124.6% | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [2] Biotechnology  
Spread Above Index [2],[3] S+570  
Floor [2] 2.30%  
Interest Rate [2],[4] 9.88%  
Acquisition Date [2] Sep. 21, 2022  
Maturity Date [2] Sep. 01, 2027  
Par Amount [2] $ 10,525  
Cost [2] 10,406  
Fair Value [2] $ 10,420  
AFG Dallas III, LLC [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Diversified Consumer Services  
Interest Rate [1],[4] 10.00%  
Acquisition Date [1] Aug. 11, 2022  
Par Amount [1] $ 1,036  
Cost [1] 1,036  
Fair Value [1] $ 1,036  
AFG Dallas III, LLC [Member] | Equipment Financing  0 26.6% | Minimum [Member]    
Schedule of Investments [Line Items]    
Maturity Date [1] Aug. 11, 2026  
AFG Dallas III, LLC [Member] | Equipment Financing  0 26.6% | Maximum [Member]    
Schedule of Investments [Line Items]    
Maturity Date [1] Aug. 29, 2026  
Bowman Energy Solutions, LLC [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Commercial Services & Supplies  
Interest Rate [1],[4] 7.42%  
Acquisition Date [1] Jul. 01, 2022  
Maturity Date [1] Aug. 01, 2026  
Par Amount [1] $ 153  
Cost [1] 153  
Fair Value [1] $ 153  
Energy Drilling Services, LLC [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Diversified Consumer Services  
Acquisition Date [1] Aug. 26, 2022  
Par Amount [1] $ 1,321  
Cost [1] 1,321  
Fair Value [1] $ 1,295  
Energy Drilling Services, LLC [Member] | Equipment Financing  0 26.6% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 6.58%  
Maturity Date [1] Dec. 09, 2025  
Energy Drilling Services, LLC [Member] | Equipment Financing  0 26.6% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 9.16%  
Maturity Date [1] Sep. 01, 2027  
CKD Holdings, Inc. [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Road & Rail  
Acquisition Date [1] Sep. 22, 2022  
Par Amount [1] $ 3,690  
Cost [1] 3,690  
Fair Value [1] $ 3,690  
CKD Holdings, Inc. [Member] | Equipment Financing  0 26.6% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 8.10%  
Maturity Date [1] Mar. 22, 2026  
CKD Holdings, Inc. [Member] | Equipment Financing  0 26.6% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 8.60%  
Maturity Date [1] Sep. 22, 2027  
Worldwide Flight Services, Inc. [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Transportation Infrastructure  
Acquisition Date [1] Sep. 23, 2022  
Par Amount [1] $ 304  
Cost [1] 308  
Fair Value [1] $ 304  
Worldwide Flight Services, Inc. [Member] | Equipment Financing  0 26.6% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 8.32%  
Maturity Date [1] Sep. 23, 2027  
Worldwide Flight Services, Inc. [Member] | Equipment Financing  0 26.6% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1],[4] 9.36%  
Maturity Date [1] Oct. 28, 2027  
DeepIntent, Inc. [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Media  
Spread Above Index [3] P+175  
Floor [2] 0.00%  
Interest Rate [4] 9.25%  
Acquisition Date Oct. 12, 2022  
Maturity Date Mar. 25, 2025  
Par Amount $ 16,951  
Cost 16,951  
Fair Value $ 16,951  
SCP Eye Care, LLC [Member] | Senior Secured Loans  0 124.6% | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Providers & Services  
Spread Above Index [3] S+575  
Floor [2] 1.00%  
Interest Rate [4] 9.46%  
Acquisition Date Oct. 06, 2022  
Maturity Date Oct. 05, 2029  
Par Amount $ 8,314  
Cost 8,050  
Fair Value $ 8,044  
Meditrina, Inc. [Member] | Senior Secured Loans  0 124.6% | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Equipment & Supplies  
Spread Above Index [3] S+550  
Floor 3.45%  
Interest Rate [4] 9.82%  
Acquisition Date Dec. 20, 2022  
Maturity Date Dec. 01, 2027  
Par Amount $ 3,367  
Cost 3,338  
Fair Value $ 3,359  
Outset Medical, Inc. [Member] | Senior Secured Loans  0 124.6% | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [11] Health Care Equipment & Supplies  
Spread Above Index [3],[11] S+515  
Floor [11] 2.75%  
Interest Rate [4],[11] 9.33%  
Acquisition Date [11] Nov. 03, 2022  
Maturity Date [11] Nov. 01, 2027  
Par Amount [11] $ 35,084  
Cost [11] 34,880  
Fair Value [11] $ 34,820  
Bazzini, LLC [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Food & Staples Retailing  
Interest Rate [1],[4] 10.46%  
Acquisition Date [1] Dec. 23, 2022  
Maturity Date [1] Jan. 01, 2028  
Par Amount [1] $ 2,365  
Cost [1] 2,440  
Fair Value [1] $ 2,365  
C-Port/Stone LLC | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Oil, Gas & Consumable Fuels  
Interest Rate [1],[4] 8.54%  
Acquisition Date [1] Oct. 07, 2022  
Maturity Date [1] Nov. 01, 2027  
Par Amount [1] $ 6,708  
Cost [1] 6,514  
Fair Value [1] $ 6,507  
Drillers Choice, Inc [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Commercial Services & Supplies  
Interest Rate [1],[4] 8.00%  
Acquisition Date [1] Oct. 31, 2022  
Maturity Date [1] Nov. 01, 2027  
Par Amount [1] $ 1,589  
Cost [1] 1,589  
Fair Value [1] $ 1,589  
Loc Performance Products, LLC [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Machinery  
Interest Rate [1],[4] 10.50%  
Acquisition Date [1] Dec. 29, 2022  
Maturity Date [1] Jun. 01, 2027  
Par Amount [1] $ 767  
Cost [1] 767  
Fair Value [1] $ 767  
Ozzies, Inc. [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Commercial Services & Supplies  
Interest Rate [1],[4] 10.72%  
Acquisition Date [1] Dec. 23, 2022  
Maturity Date [1] Jan. 01, 2027  
Par Amount [1] $ 2,005  
Cost [1] 2,072  
Fair Value [1] $ 2,005  
PCX Aerostructures LLC [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Aerospace & Defense  
Interest Rate [1],[4] 9.32%  
Acquisition Date [1] Nov. 23, 2022  
Maturity Date [1] Dec. 01, 2028  
Par Amount [1] $ 2,658  
Cost [1] 2,658  
Fair Value [1] $ 2,658  
Rotten Rock Hardscaping & Tree Service | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Diversified Consumer Services  
Interest Rate [1],[4] 8.21%  
Acquisition Date [1] Dec. 06, 2022  
Maturity Date [1] Dec. 06, 2027  
Par Amount [1] $ 245  
Cost [1] 245  
Fair Value [1] $ 245  
Signet Marine Corporation [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Transportation Infrastructure  
Interest Rate [1],[4] 8.50%  
Acquisition Date [1] Oct. 31, 2022  
Maturity Date [1] Jul. 01, 2029  
Par Amount [1] $ 14,102  
Cost [1] 14,152  
Fair Value [1] $ 14,102  
U.S. Crane & Rigging, LLC | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Commercial Services & Supplies  
Interest Rate [1],[4] 10.92%  
Acquisition Date [1] Dec. 23, 2022  
Maturity Date [1] Mar. 01, 2027  
Par Amount [1] $ 2,005  
Cost [1] 2,005  
Fair Value [1] $ 2,005  
Zamborelli Enterprises Pacific Souther Foundation [Member] | Equipment Financing  0 26.6%    
Schedule of Investments [Line Items]    
Industry [1] Diversified Consumer Services  
Interest Rate [1],[4] 8.91%  
Acquisition Date [1] Dec. 07, 2022  
Maturity Date [1] Jan. 01, 2027  
Par Amount [1] $ 707  
Cost [1] 714  
Fair Value [1] 707  
SLR Senior Lending Program LLC [Member]    
Schedule of Investments [Line Items]    
Cost 18,032  
Fair Value 18,062  
Total Investments & Cash Equivalents $ 1,043  
SLR Senior Lending Program LLC [Member] | Common Equity/Equity Interests/Warrants 057.1%    
Schedule of Investments [Line Items]    
Industry [11],[12],[35] Asset Management  
Acquisition Date [11],[12],[35] Dec. 01, 2022  
Shares/Units [11],[12],[35] 0  
Cost [11],[12],[35] $ 9,500  
Fair Value [11],[12],[35] $ 9,426  
Meditrina, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants 057.1%    
Schedule of Investments [Line Items]    
Industry [24] Health Care Equipment & Supplies  
Acquisition Date [24] Dec. 20, 2022  
Shares/Units [24] 29,366  
Cost [24] $ 23  
Fair Value [24] $ 23  
[1] Indicates an investment that is wholly held by the Company through NEFPASS LLC.
[2] Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SUNS SPV LLC (the “SUNS SPV”). Such investments are pledged as collateral under the Senior Secured Revolving SPV Credit Facility (the “SPV Credit Facility”) (see Note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company.
[3] Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR, SOFR or PRIME rate. These instruments are often subject to a LIBOR, SOFR or PRIME rate floor.
[4] Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR” or “L”), the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of December 31, 2022.
[5] Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or PRIME rate. These instruments are often subject to a LIBOR or PRIME rate floor.
[6] Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of December 31, 2021.
[7] Investment is on non-accrual status.
[8] AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers. Amerimark may elect to defer up to 8.00% of the coupon as PIK.
[9] AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers.
[10] Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2021, on a fair value basis, non-qualifying assets in the portfolio represented 23.1% of the total assets of the Company.
[11] Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2022, on a fair value basis, non-qualifying assets in the portfolio represented 24.2% of the total assets of the Company.
[12] Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2022 in these controlled investments are as follows:
[13] Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2021 in these controlled investments are as follows:
[14] Spread is 5.75% Cash / 0.50% PIK.
[15] Spread is 5.50% Cash / 0.50% PIK.
[16] Spread is 6.00% Cash / 2.00% PIK.
[17] Spread is 2.50% Cash / 12.50% PIK.
[18] Interest is paid in kind (“PIK”).
[19] BridgeBio Pharma, Inc. may elect to defer up to 3.00% of the coupon as PIK.
[20] OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are co-borrowers.
[21] OmniGuide Holdings, Inc. may elect to defer up to 10.00% of the coupon as PIK.
[22] Vapotherm, Inc. may elect to defer up to 8.00% of the coupon as PIK.
[23] Denotes a subsidiary of SLR Equipment Finance.
[24] Non-income producing security.
[25] SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary and NEFPASS LLC, a wholly-owned consolidated subsidiary.
[26] See note 12 to the consolidated financial statements.
[27] The Company’s investment in SOINT, LLC includes a one dollar investment in common shares.
[28] The Company’s investments in SOAGG, LLC and SOINT, LLC include a two and one dollar investment in common shares, respectively.
[29] Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation.
[30] See note 14 to the consolidated financial statements.
[31] Denotes a Level 1 investment.
[32] See note 16 to the consolidated financial statements.
[33] See note 10 to the consolidated financial statements.
[34] See note 15 to the consolidated financial statements.
[35] See note 19 to the consolidated financial statements.
XML 45 R9.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Schedule of Investments (Parenthetical) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Percentage representing senior secured loans in investments owned 124.60% 111.50%
Percentage representing equipment financing in investments owned 26.60% 32.50%
Percentage representing preferred equity in investments owned 0.40% 0.70%
Percentage representing common equity or equity interests or warrants owned   53.60%
Percentage representing total investments in investments owned 208.70% 198.30%
Percentage representing cash equivalents in investments owned 41.80% 38.00%
Percentage representing total investments and cash equivalents in investments owned 250.50% 236.30%
Percentage representing liabilities in excess of other assets in investments owned (150.50%) (136.30%)
Percentage representing net assets in investments owned 100.00% 100.00%
Percentage of outstanding voting securities of the investment 25.00% 25.00%
Percentage of non-qualifying assets in the portfolio of total assets 24.20% 23.10%
Tax Basis of Investments, Unrealized Appreciation (Depreciation), Net $ 17,187 $ 19,495
Tax Basis of Investments, Gross, Unrealized Appreciation 161,053 82,598
Tax Basis of Investments, Gross, Unrealized Depreciation 143,866 63,103
Investment Owned tax costs $ 2,069,489 $ 1,651,087
Spread One [Member]    
Percentage spread as cash 5.75% 6.00%
Percentage spread as paid in kind 0.50% 2.00%
Spread Two [Member]    
Percentage spread as cash   2.50%
Percentage spread as paid in kind   12.50%
Spread Three [Member]    
Percentage spread as cash   5.50%
Percentage spread as paid in kind   0.50%
Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance $ 706,203 $ 709,653
Gross Additions 131,369 1,541
Gross Reductions 20,722 14,189
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) (18,630) 9,113
Interest/Dividend Income 53,898 48,942
Ending balance 797,594 706,203
AviatorCap SII LLC [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 0 2,941
Gross Additions   0
Gross Reductions   2,941
Net realized gain (loss)   0
Net change in unrealized gain (loss)   0
Interest/Dividend Income   92
Ending balance   0
Equipment Operating Leases LLC [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 18,939 25,540
Gross Additions 0 0
Gross Reductions 15,833 6,667
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 635 66
Interest/Dividend Income 749 1,950
Ending balance 3,741 18,939
Kingsbridge Holdings, LLC [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 80,000 80,000
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) (87) (79)
Interest/Dividend Income 7,402 6,568
Ending balance 80,000 80,000
KBH Topco LLC (Kingsbridge) [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 145,996 136,596
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 2,448 9,400
Interest/Dividend Income 15,225 13,250
Ending balance 148,444 145,996
Loyer Capital LLC [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 10,725 14,456
Gross Additions 0 0
Gross Reductions 3,500 3,731
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 136 0
Interest/Dividend Income 1,003 1,426
Ending balance 7,361 10,725
RD Holdco Inc Common Equity [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 0 1,226
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 0 (1,226)
Interest/Dividend Income 0 0
Ending balance 0 0
RD Holdco Inc Class B [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 5,216 5,216
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) (5,216) 0
Interest/Dividend Income 0 0
Ending balance 0 5,216
RD Holdco Inc Warrants [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 0 0
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 0 0
Interest/Dividend Income 0 0
Ending balance 0 0
RD Holdco Inc Debt [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 11,829  
Gross Additions 685  
Gross Reductions 0  
Net realized gain (loss) 0  
Net change in unrealized gain (loss) (5,280)  
Interest/Dividend Income (18)  
Ending balance 6,521 11,829
Rug Doctor LLC [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 11,829 10,559
Gross Additions   1,270
Gross Reductions   0
Net realized gain (loss)   0
Net change in unrealized gain (loss)   (6)
Interest/Dividend Income   1,300
Ending balance   11,829
SLR Business Credit [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 0  
Gross Additions 81,583  
Gross Reductions 0  
Net realized gain (loss) 0  
Net change in unrealized gain (loss) 7,787  
Interest/Dividend Income 5,150  
Ending balance 89,370 0
SLR Credit Solutions [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 298,766 296,766
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) (10,006) 2,000
Interest/Dividend Income 20,500 22,500
Ending balance 288,760 298,766
SLR Equipment Finance Equity [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 129,102 129,102
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) (8,282) 0
Interest/Dividend Income 0 0
Ending balance 120,820 129,102
SLR Equipment Finance Debt [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 0 850
Gross Additions 5,000 0
Gross Reductions 0 850
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 0 0
Interest/Dividend Income 379 42
Ending balance 5,000 0
SLR Healthcare ABL [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 0  
Gross Additions 34,335  
Gross Reductions 0  
Net realized gain (loss) 0  
Net change in unrealized gain (loss) 15  
Interest/Dividend Income 2,595  
Ending balance 34,350 0
SLR Senior Lending Program LLC [Member]    
Investment Company Change in Net Assets    
Ending balance 18,062  
SLR Senior Lending Program LLC [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 0  
Gross Additions 9,500  
Gross Reductions 0  
Net realized gain (loss) 0  
Net change in unrealized gain (loss) (74)  
Interest/Dividend Income 0  
Ending balance 9,426 0
SOAGG LLC [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 1,121 2,300
Gross Additions 0 0
Gross Reductions 447 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) (674) (1,179)
Interest/Dividend Income 647 1,543
Ending balance 0 1,121
SOINT LLC [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 4,509 4,101
Gross Additions 266 271
Gross Reductions 942 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) (32) 137
Interest/Dividend Income 266 271
Ending balance $ 3,801 $ 4,509
Amerimark [Member]    
Investment interest rate, Paid in kind 8.00%  
Bridge Bio Pharma, Inc [Member]    
Investment interest rate, Paid in kind 3.00%  
Omni Guide Holdings, Inc [Member]    
Investment interest rate, Paid in kind 10.00%  
Vapotherm, Inc. [Member]    
Investment interest rate, Paid in kind 8.00%  
iCIMS, Inc. [Member]    
Investment interest rate, Paid in kind 3.875%  
XML 46 R10.htm IDEA: XBRL DOCUMENT v3.22.4
N-2 - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Cover [Abstract]                                    
Entity Central Index Key                 0001418076                  
Amendment Flag                 false                  
Securities Act File Number                 814-00754                  
Document Type                 10-K                  
Entity Registrant Name                 SLR INVESTMENT CORP.                  
Entity Address, Address Line One                 500 Park Avenue                  
Entity Address, City or Town                 New York                  
Entity Address, State or Province                 NY                  
Entity Address, Postal Zip Code                 10022                  
City Area Code                 212                  
Local Phone Number                 993-1670                  
Entity Well-known Seasoned Issuer                 Yes                  
Entity Emerging Growth Company                 false                  
Fee Table [Abstract]                                    
Shareholder Transaction Expenses [Table Text Block]                
 
Stockholder transaction expenses:
        
Sales load (as a percentage of offering price)
     —   %
(1)
 
Offering expenses (as a percentage of offering price)
     —   %
(2)
 
Dividend reinvestment plan expenses
     —   %
(3)
 
Total stockholder transaction expenses (as a percentage of offering price)
     —   %
(2)
 
Annual expenses (as a percentage of net assets attributable to common stock)
(4)
:
        
Base management fee
     3.00 %
(5)
 
Incentive fees payable under our Investment Advisory and Management Agreement (up to 20%)
     1.51 %
(6)
 
Interest payments on borrowed funds
     4.61 %
(7)
 
Acquired fund fees and expenses
     0.02 %
(8)
 
Other expenses (estimated)
     1.15 %
(9)
 
Total annual expenses
     10.29
 
(1)
 
In the event that the shares of common stock are sold to or through underwriters, a corresponding prospectus supplement will disclose the applicable sales load and the “Example” will be updated accordingly.
(2)
 
The prospectus supplement corresponding to each offering will disclose the applicable offering expenses and total stockholder transaction expenses.
(3)
 
The expenses of the dividend reinvestment plan are included in “other expenses.”
(4)
Annual Expenses are presented in this manner because common shareholders will bear all costs of running the Company.
(5)
 
Our 1.50% base management fee under the Investment Advisory and Management Agreement (giving effect to the Letter Agreement) is based on our gross assets, which is defined as all the assets of SLRC, excluding temporary assets, including those acquired using borrowings for investment purposes, and assumes our gross assets remain consistent with gross assets for the fiscal year ended December 31, 2022. The base management fee is reduced to 1.00% on gross assets that exceed 200% of total net assets as of the immediately preceding quarter.
(6)
Assumes that annual incentive fees earned by our investment adviser, SLR Capital Partners, remain consistent with the incentive fees earned by SLR Capital Partners for the fiscal year ended December 31, 2022. The incentive fee consists of two parts:
 
The first part, which is payable quarterly in arrears, equals 20% of the excess, if any, of our
“Pre-Incentive
Fee Net Investment Income” that exceeds a 1.75% quarterly (7.00% annualized) hurdle rate, which we refer to as the Hurdle, subject to a
“catch-up”
provision measured at the end of each calendar quarter. The first part of the incentive fee is computed and paid on income that may include interest that is accrued but not yet received in cash. The operation of the first part of the incentive fee for each quarter is as follows:
 
 
no incentive fee is payable to our investment adviser in any calendar quarter in which our
Pre-Incentive
Fee Net Investment Income does not exceed the Hurdle of 1.75%;
 
 
100% of our
Pre-Incentive
Fee Net Investment Income with respect to that portion of such
Pre-Incentive
Fee Net Investment Income, if any, that exceeds the Hurdle but is less than 2.1875% in any calendar quarter (8.75% annualized) is payable to our investment adviser. We refer to this portion of our
Pre-Incentive
Fee Net Investment Income (which exceeds the Hurdle but is less than 2.1875%) as the
“catch-up.”
The
“catch-up”
is meant to provide our investment adviser with 20% of our
Pre-Incentive
Fee Net Investment Income, as if a Hurdle did not apply when our
Pre-Incentive
Fee Net Investment Income exceeds 2.1875% in any calendar quarter; and
 
 
20% of the amount of our
Pre-Incentive
Fee Net Investment Income, if any, that exceeds 2.1875% in any calendar quarter (8.75% annualized) is payable to our investment adviser (once the Hurdle is reached and the
catch-up
is achieved, 20% of all
Pre-Incentive
Fee Investment Income thereafter is allocated to our investment adviser).
The second part of the incentive fee equals 20% of our “Incentive Fee Capital Gains,” if any, which equals our realized capital gains on a cumulative basis from inception through the end of each calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees. The second part of the incentive fee is payable, in arrears, at the end of each calendar year (or upon termination of the Investment Advisory and Management Agreement, as of the termination date).
 
(7)
 
We have historically and will in the future borrow funds from time to time to make investments to the extent we determine that the economic situation is conducive to doing so. The costs associated with our outstanding borrowings are indirectly borne by our investors. For purposes of this section, we have computed interest expense using the average consolidated balance outstanding for borrowings during the fiscal year ended December 31, 2022. We used the Secured Overnight Financing Rate (“SOFR”) or similar base rate on December 31, 2022 and the interest rate on the Credit Facility, the SPV Credit Facility, the 2027 Series F Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes, the 2024 Unsecured Notes and the 2023 Unsecured Notes on December 31, 2022. We have also included, as applicable, the estimated market discount or amortization of fees incurred in establishing the Credit Facility, the SPV Credit Facility, the 2027 Series F Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes, the 2024 Unsecured Notes and the 2023 Unsecured Notes as of December 31, 2022. Additionally, we included the estimated cost of commitment fees for unused balances on the Credit Facility and the SPV Credit Facility. As of December 31, 2022, we had $393.0 million outstanding under the Credit Facility, $155.2 million outstanding under the SPV Credit Facility and $135 million, $50 million, $75 million, $125 million, $85 million, and $75 million outstanding under the 2027 Series F Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes, the 2024 Unsecured Notes and the 2023 Unsecured Notes, respectively. We may also issue preferred stock, subject to our compliance with applicable requirements under the 1940 Act, although we have no immediate intention to do so.
(8)
 
The holders of shares of our common stock indirectly bear the expenses of our investment in SLR Senior Lending Program LLC (“SSLP”). No management fee is charged on our investments in SSLP in connection with the administrative services provided to SSLP. Future expenses for SSLP may be substantially higher or lower because certain expenses may fluctuate over time.
(9)
 
“Other expenses” are based on estimated amounts for the current fiscal year, which considers the amounts incurred for the fiscal year ended December 31, 2022 and include our overhead expenses, including payments under our Administration Agreement based on our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement.
                 
Sales Load [Percent] [1]                 0.00%                  
Dividend Reinvestment and Cash Purchase Fees [2]                 $ 0                  
Other Transaction Expenses [Abstract]                                    
Other Transaction Expense 1 [Percent] [3]                 0.00%                  
Other Transaction Expenses [Percent] [3]                 0.00%                  
Management Fees [Percent] [4]                 3.00%                  
Interest Expenses on Borrowings [Percent] [5]                 4.61%                  
Incentive Fees [Percent] [6]                 1.51%                  
Acquired Fund Fees and Expenses [Percent] [7]                 0.02%                  
Other Annual Expenses [Abstract]                                    
Other Annual Expenses [Percent] [8]                 1.15%                  
Total Annual Expenses [Percent]                 10.29%                  
Expense Example [Table Text Block]                
The following example demonstrates the projected dollar amount of total cumulative expenses that would be incurred over various periods with respect to a hypothetical investment in our common stock. In calculating the following expense amounts, we have assumed that our annual operating expenses would remain at the levels set forth in the table above and have excluded performance-based incentive fees. As such, the below example is based on an annual expense ratio of 8.78%. See Note 7 above for additional information regarding certain assumptions regarding our level of leverage. In the event that shares are sold to or through underwriters, a corresponding prospectus supplement will restate this example to reflect the applicable sales load.
 
    
1 Year
    
3 Years
    
5 Years
    
10 Years
 
You would pay the following expenses on a $1,000 investment, assuming a 5% annual return
   $ 88      $ 253      $ 407      $ 743  
 
    
1 Year
    
3 Years
    
5 Years
    
10 Years
 
You would pay the following expenses on a $1,000 investment, assuming a 5% annual return
   $ 98      $ 279      $ 444      $ 792  
                 
Expense Example, Year 01                 $ 88                  
Expense Example, Years 1 to 3                 253                  
Expense Example, Years 1 to 5                 407                  
Expense Example, Years 1 to 10                 $ 743                  
Financial Highlights [Abstract]                                    
Senior Securities [Table Text Block]                
Information about our senior securities is shown in the following table (in thousands) as of each year ended December 31 for the past ten years, unless otherwise noted. The “—” indicates information which the SEC expressly does not require to be disclosed for certain types of senior securities.
 
Class and Year
  
Total Amount
Outstanding(1)
 
  
Asset
Coverage
Per Unit(2)
 
  
Involuntary
Liquidating
Preference
Per Unit(3)
 
  
Average
Market Value
Per Unit(4)
 
Credit Facility
  
  
  
  
Fiscal 2022
   $ 293,000      $ 513        —          N/A  
Fiscal 2021
     222,500        552        —          N/A  
Fiscal 2020
     126,000        421        —          N/A  
Fiscal 2019
     42,900        182        —          N/A  
Fiscal 2018
     96,400        593        —          N/A  
Fiscal 2017
     245,600        1,225        —          N/A  
Fiscal 2016
     115,200        990        —          N/A  
Fiscal 2015
     207,900        1,459        —          N/A  
Fiscal 2014
     —          —          —          N/A  
Fiscal 2013
     —          —          —          N/A  
SPV Credit Facility
                                   
Fiscal 2022
     155,200        272        —          N/A  
2022 Unsecured Notes
                                   
Fiscal 2022
     —          —          —          N/A  
Fiscal 2021
     150,000        372        —          N/A  
Fiscal 2020
     150,000        501        —          N/A  
Fiscal 2019
     150,000        638        —          N/A  
Fiscal 2018
     150,000        923        —          N/A  
Fiscal 2017
     150,000        748        —          N/A  
Fiscal 2016
     50,000        430        —          N/A  
2022 Tranche C Notes
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Class and Year
  
Total Amount
Outstanding(1)
 
  
Asset
Coverage
Per Unit(2)
 
  
Involuntary
Liquidating
Preference
Per Unit(3)
 
  
Average
Market Value
Per Unit(4)
 
Fiscal 2022
     —          —          —          N/A  
Fiscal 2021
     21,000        52        —          N/A  
Fiscal 2020
     21,000        70        —          N/A  
Fiscal 2019
     21,000        89        —          N/A  
Fiscal 2018
     21,000        129        —          N/A  
Fiscal 2017
     21,000        105        —          N/A  
2023 Unsecured Notes
                                   
Fiscal 2022
     75,000        131        —          N/A  
Fiscal 2021
     75,000        186        —          N/A  
Fiscal 2020
     75,000        250        —          N/A  
Fiscal 2019
     75,000        319        —          N/A  
Fiscal 2018
     75,000        461        —          N/A  
Fiscal 2017
     75,000        374        —          N/A  
2024 Unsecured Notes
                                   
Fiscal 2022
     125,000        219        —          N/A  
Fiscal 2021
     125,000        309        —          N/A  
Fiscal 2020
     125,000        417        —          N/A  
Fiscal 2019
     125,000        531        —          N/A  
2025 Unsecured Notes
                                   
Fiscal 2022
     85,000        149        —          N/A  
2026 Unsecured Notes
                                   
Fiscal 2022
     75,000        131        —          N/A  
Fiscal 2021
     75,000        186        —          N/A  
Fiscal 2020
     75,000        250        —          N/A  
Fiscal 2019
     75,000        319        —          N/A  
2027 Unsecured Notes
                                   
Fiscal 2022
     50,000        88        —          N/A  
Fiscal 2021
     50,000        124        —          N/A  
2027 Series F Unsecured Notes
                                   
Fiscal 2022
     135,000        237        —          N/A  
2042 Unsecured Notes
                                   
Fiscal 2017
     —          —          —          N/A  
Fiscal 2016
     100,000        859        —        $ 1,002  
Fiscal 2015
     100,000        702        —          982  
Fiscal 2014
     100,000        2,294        —          943  
Fiscal 2013
     100,000        2,411        —          934  
Senior Secured Notes
                                   
Fiscal 2017
     —          —          —          N/A  
Fiscal 2016
     75,000        645        —          N/A  
Fiscal 2015
     75,000        527        —          N/A  
Fiscal 2014
     75,000        1,721        —          N/A  
Fiscal 2013
     75,000        1,808        —          N/A  
Term Loans
                                   
Fiscal 2022
     100,000        175        —          N/A  
Fiscal 2021
     100,000        248        —          N/A  
Fiscal 2020
     75,000        250        —          N/A  
Fiscal 2019
     75,000        319        —          N/A  
Fiscal 2018
     50,000        308        —          N/A  
Fiscal 2017
     50,000        250        —          N/A  
Fiscal 2016
     50,000        430        —          N/A  
Fiscal 2015
     50,000        351        —          N/A  
Fiscal 2014
     50,000        1,147        —          N/A  
Fiscal 2013
     50,000        1,206        —          N/A  
 
NEFPASS Facility
  
  
  
  
Fiscal 2021
     —          —          —          N/A  
Fiscal 2020
     30,000        100        —          N/A  
Fiscal 2019
     30,000        128        —          N/A  
Fiscal 2018
     30,000        185        —          N/A  
SSLP Facility
                                   
Fiscal 2019
     —          —          —          N/A  
Fiscal 2018
     53,785        331        —          N/A  
Total Senior Securities
                                   
Fiscal 2022
   $ 1,093,200      $ 1,915        —          N/A  
Fiscal 2021
     818,500        2,029        —          N/A  
Fiscal 2020
     677,000        2,259        —          N/A  
Fiscal 2019
     593,900        2,525        —          N/A  
Fiscal 2018
     476,185        2,930        —          N/A  
Fiscal 2017
     541,600        2,702        —          N/A  
Fiscal 2016
     390,200        3,354        —          N/A  
Fiscal 2015
     432,900        3,039        —          N/A  
Fiscal 2014
     225,000        5,162        —          N/A  
Fiscal 2013
     225,000        5,425        —          N/A  
 

(1)
Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented.
(2)
The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of December 31, 2022, asset coverage was 1
91
.
5
%.
(3)
The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it.
(4)
Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014 and 2013 periods was $100,175, $98,196, $94,301 and $93,392, respectively.
                 
Senior Securities Amount [9]                 $ 1,093,200 $ 818,500 $ 677,000 $ 593,900 $ 476,185 $ 541,600 $ 390,200 $ 432,900 $ 225,000 $ 225,000
Senior Securities Coverage per Unit [10]                 $ 1,915 $ 2,029 $ 2,259 $ 2,525 $ 2,930 $ 2,702 $ 3,354 $ 3,039 $ 5,162 $ 5,425
Senior Securities Involuntary Liquidating Preference per Unit [11]                 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0
Senior Securities, Note [Text Block]                
Senior Securities
Information about our senior securities is shown in the following table (in thousands) as of each year ended December 31 for the past ten years, unless otherwise noted. The “—” indicates information which the SEC expressly does not require to be disclosed for certain types of senior securities.
 
Class and Year
  
Total Amount
Outstanding(1)
 
  
Asset
Coverage
Per Unit(2)
 
  
Involuntary
Liquidating
Preference
Per Unit(3)
 
  
Average
Market Value
Per Unit(4)
 
Credit Facility
  
  
  
  
Fiscal 2022
   $ 293,000      $ 513        —          N/A  
Fiscal 2021
     222,500        552        —          N/A  
Fiscal 2020
     126,000        421        —          N/A  
Fiscal 2019
     42,900        182        —          N/A  
Fiscal 2018
     96,400        593        —          N/A  
Fiscal 2017
     245,600        1,225        —          N/A  
Fiscal 2016
     115,200        990        —          N/A  
Fiscal 2015
     207,900        1,459        —          N/A  
Fiscal 2014
     —          —          —          N/A  
Fiscal 2013
     —          —          —          N/A  
SPV Credit Facility
                                   
Fiscal 2022
     155,200        272        —          N/A  
2022 Unsecured Notes
                                   
Fiscal 2022
     —          —          —          N/A  
Fiscal 2021
     150,000        372        —          N/A  
Fiscal 2020
     150,000        501        —          N/A  
Fiscal 2019
     150,000        638        —          N/A  
Fiscal 2018
     150,000        923        —          N/A  
Fiscal 2017
     150,000        748        —          N/A  
Fiscal 2016
     50,000        430        —          N/A  
2022 Tranche C Notes
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Class and Year
  
Total Amount
Outstanding(1)
 
  
Asset
Coverage
Per Unit(2)
 
  
Involuntary
Liquidating
Preference
Per Unit(3)
 
  
Average
Market Value
Per Unit(4)
 
Fiscal 2022
     —          —          —          N/A  
Fiscal 2021
     21,000        52        —          N/A  
Fiscal 2020
     21,000        70        —          N/A  
Fiscal 2019
     21,000        89        —          N/A  
Fiscal 2018
     21,000        129        —          N/A  
Fiscal 2017
     21,000        105        —          N/A  
2023 Unsecured Notes
                                   
Fiscal 2022
     75,000        131        —          N/A  
Fiscal 2021
     75,000        186        —          N/A  
Fiscal 2020
     75,000        250        —          N/A  
Fiscal 2019
     75,000        319        —          N/A  
Fiscal 2018
     75,000        461        —          N/A  
Fiscal 2017
     75,000        374        —          N/A  
2024 Unsecured Notes
                                   
Fiscal 2022
     125,000        219        —          N/A  
Fiscal 2021
     125,000        309        —          N/A  
Fiscal 2020
     125,000        417        —          N/A  
Fiscal 2019
     125,000        531        —          N/A  
2025 Unsecured Notes
                                   
Fiscal 2022
     85,000        149        —          N/A  
2026 Unsecured Notes
                                   
Fiscal 2022
     75,000        131        —          N/A  
Fiscal 2021
     75,000        186        —          N/A  
Fiscal 2020
     75,000        250        —          N/A  
Fiscal 2019
     75,000        319        —          N/A  
2027 Unsecured Notes
                                   
Fiscal 2022
     50,000        88        —          N/A  
Fiscal 2021
     50,000        124        —          N/A  
2027 Series F Unsecured Notes
                                   
Fiscal 2022
     135,000        237        —          N/A  
2042 Unsecured Notes
                                   
Fiscal 2017
     —          —          —          N/A  
Fiscal 2016
     100,000        859        —        $ 1,002  
Fiscal 2015
     100,000        702        —          982  
Fiscal 2014
     100,000        2,294        —          943  
Fiscal 2013
     100,000        2,411        —          934  
Senior Secured Notes
                                   
Fiscal 2017
     —          —          —          N/A  
Fiscal 2016
     75,000        645        —          N/A  
Fiscal 2015
     75,000        527        —          N/A  
Fiscal 2014
     75,000        1,721        —          N/A  
Fiscal 2013
     75,000        1,808        —          N/A  
Term Loans
                                   
Fiscal 2022
     100,000        175        —          N/A  
Fiscal 2021
     100,000        248        —          N/A  
Fiscal 2020
     75,000        250        —          N/A  
Fiscal 2019
     75,000        319        —          N/A  
Fiscal 2018
     50,000        308        —          N/A  
Fiscal 2017
     50,000        250        —          N/A  
Fiscal 2016
     50,000        430        —          N/A  
Fiscal 2015
     50,000        351        —          N/A  
Fiscal 2014
     50,000        1,147        —          N/A  
Fiscal 2013
     50,000        1,206        —          N/A  
 
NEFPASS Facility
  
  
  
  
Fiscal 2021
     —          —          —          N/A  
Fiscal 2020
     30,000        100        —          N/A  
Fiscal 2019
     30,000        128        —          N/A  
Fiscal 2018
     30,000        185        —          N/A  
SSLP Facility
                                   
Fiscal 2019
     —          —          —          N/A  
Fiscal 2018
     53,785        331        —          N/A  
Total Senior Securities
                                   
Fiscal 2022
   $ 1,093,200      $ 1,915        —          N/A  
Fiscal 2021
     818,500        2,029        —          N/A  
Fiscal 2020
     677,000        2,259        —          N/A  
Fiscal 2019
     593,900        2,525        —          N/A  
Fiscal 2018
     476,185        2,930        —          N/A  
Fiscal 2017
     541,600        2,702        —          N/A  
Fiscal 2016
     390,200        3,354        —          N/A  
Fiscal 2015
     432,900        3,039        —          N/A  
Fiscal 2014
     225,000        5,162        —          N/A  
Fiscal 2013
     225,000        5,425        —          N/A  
 

(1)
Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented.
(2)
The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of December 31, 2022, asset coverage was 1
91
.
5
%.
(3)
The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it.
(4)
Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014 and 2013 periods was $100,175, $98,196, $94,301 and $93,392, respectively.
                 
General Description of Registrant [Abstract]                                    
Investment Objectives and Practices [Text Block]                
Portfolio and Investment Activity
During the year ended December 31, 2022, exclusive of the assets acquired through the Mergers, we invested approximately $610 million across 77 portfolio companies. This compares to investing approximately $596 million across 52 portfolio companies for the year ended December 31, 2021. Investments sold, prepaid or repaid during the year ended December 31, 2022 totaled approximately $532 million versus approximately $468 million for the year ended December 31, 2021.
At December 31, 2022, our portfolio consisted of 139 portfolio companies and was invested 30.8% in cash flow senior secured loans, 30.0% in asset-based senior secured loans / SLR Credit Solutions (“SLR Credit”) / SLR Healthcare ABL / SLR Business Credit, 23.7% in equipment senior secured financings / SLR Equipment Finance (“SLR Equipment”) / Kingsbridge Holdings, LLC (“KBH”) and 15.5% in life science senior secured loans, in each case, measured at fair value, versus 106 portfolio companies invested 26.7% in cash flow senior secured loans, 27.0% in asset-based senior secured loans / SLR Credit, 29.9% in equipment senior secured financings / SLR Equipment / KBH, and 16.4% in life science senior secured loans, in each case, measured at fair value, at December 31, 2021.
At December 31, 2022, 77.7% or $1.61 billion of our income producing investment portfolio
*
is floating rate and 22.3% or $464.5 million is fixed rate, measured at fair value. At December 31, 2021, 79.4% or $1.20 billion of our income producing investment portfolio
*
is floating rate and 20.6% or $313.4 million is fixed rate, measured at fair value. As of December 31, 2022 and 2021, we had two and one issuers on
non-accrual
status, respectively.
 
*
We have included SLR Credit Solutions, SLR Equipment Finance, SLR Healthcare ABL, SLR Business Credit and Kingsbridge Holdings, LLC within our income producing investment portfolio.
                 
Risk Factors [Table Text Block]                
RISK FACTORS
Risks Relating to Our Investments
We operate in a highly competitive market for investment opportunities.
A number of entities compete with us to make the types of investments that we target in leveraged companies. We compete with other BDCs, public and private funds, commercial and investment banks, commercial financing companies and, to the extent they provide an alternative form of financing, private equity funds. Many of our competitors are substantially larger and have considerably greater financial, technical and marketing resources than we do. For example, some competitors may have a lower cost of funds and access to funding sources that are not available to us. In addition, some of our competitors may have higher risk tolerances or different risk assessments than we have, which could allow them to consider a wider variety of investments and establish more relationships and offer better pricing and a more flexible structure than we are able to do. Furthermore, many of our potential competitors are not subject to the regulatory restrictions that the 1940 Act imposes on us as a BDC. If we are unable to source attractive investments, we may hold a greater percentage of our assets in cash and cash equivalents than anticipated, which could impact potential returns on our portfolio. We cannot assure you that the competitive pressures we face will not have a material adverse effect on our business, financial condition and results of operations. Also, as a result of this competition, we may not be able to take advantage of attractive investment opportunities from time to time, and we can offer no assurance that we will be able to identify and make investments that are consistent with our investment objective.
Participants in our industry compete on several factors, including price, flexibility in transaction structure, customer service, reputation, market knowledge and speed in decision-making. We do not seek to compete primarily based on the interest rates we will offer, and we believe that some of our competitors may make loans with interest rates that will be comparable to or lower than the rates we offer. We may lose investment opportunities if we do not match our competitors’ pricing, terms and structure. However, if we match our competitors’ pricing, terms and structure, we may experience decreased net interest income and increased risk of credit loss.
Our investments are very risky and highly speculative.
We invest primarily in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities.
Senior Secured Loans.
 When we make a senior secured term loan investment in a portfolio company, we generally take a security interest in the available assets of the portfolio company, including the equity interests of its subsidiaries, which we expect to help mitigate the risk that we will not be repaid. However, there is a risk that the collateral securing our loans may decrease in value over time, may be difficult to sell in a timely manner, may be difficult to appraise and may fluctuate in value based upon the success of the business and market conditions, including as a result of the inability of the portfolio company to raise additional capital, and, in some circumstances, our lien could be subordinated to claims of other creditors. In addition, deterioration in a portfolio company’s financial condition and prospects, including its inability to raise additional capital, may be accompanied by deterioration in the value of the collateral for the loan. Consequently, the fact that a loan is secured does not guarantee that we will receive principal and interest payments according to the loan’s terms, or at all, or that we will be able to collect on the loan should we be forced to enforce our remedies.
Unsecured Loans and Preferred Securities.
 Our unsecured and preferred investments are generally subordinated to senior loans and are generally unsecured. As such, other creditors may rank senior to us in the event of an insolvency. This may result in an above average amount of risk and loss of principal.
Equity Investments.
 When we invest in senior secured loans, unitranche loans, unsecured loans or preferred securities, we may acquire common equity securities as well. In certain other unique circumstances we may also make equity investments in businesses that make senior loans and/or leases, such as our investments in Kingsbridge Holdings, LLC, SLR Credit Solutions, SLR Equipment
 
Finance, SLR Business Credit and SLR Healthcare ABL. In addition, we may invest directly in the equity securities of portfolio companies without limitation as to market capitalization. For instance, we may invest in thinly traded companies, the prices of which may be subject to erratic market movement. Our goal is ultimately to exit such equity interests and realize gains upon our disposition of such interests. However, the equity interests we receive may not appreciate in value and, in fact, may decline in value. Accordingly, we may not be able to realize gains from our equity interests, and any gains that we do realize on the disposition of any equity interests may not be sufficient to offset any other losses we experience.
In addition, investing in middle-market companies involves a number of significant risks, including:
 
   
these companies may have limited financial resources and may be unable to meet their obligations under their debt securities that we hold, which may be accompanied by a deterioration in the value of any collateral and a reduction in the likelihood of us realizing any guarantees we may have obtained in connection with our investment;
 
   
they typically have shorter operating histories, narrower product lines and smaller market shares than larger businesses, which tend to render them more vulnerable to competitors’ actions and market conditions, as well as general economic downturns;
 
   
they are more likely to depend on the management talents and efforts of a small group of persons; therefore, the death, disability, resignation or termination of one or more of these persons could have a material adverse impact on our portfolio company and, in turn, on us;
 
   
they generally have less predictable operating results, may from time to time be parties to litigation, may be engaged in rapidly changing businesses with products subject to a substantial risk of obsolescence, and may require substantial additional capital to support their operations, finance expansion or maintain their competitive position. In addition, our executive officers, directors and our Investment Adviser may, in the ordinary course of business, be named as defendants in litigation arising from our investments in the portfolio companies; and
 
   
they may have difficulty accessing the capital markets to meet future capital needs, which may limit their ability to grow or to repay their outstanding indebtedness upon maturity.
The lack of liquidity in our investments may make it difficult for us to dispose of our investments at a favorable price, which may adversely affect our ability to meet our investment objectives.
We generally make investments in private companies. We invest and expect to continue investing in companies whose securities have no established trading market and whose securities are and will be subject to legal and other restrictions on resale or whose securities are and will be less liquid than are publicly-traded securities. Investments purchased by us that are liquid at the time of purchase may subsequently become illiquid due to events relating to the issuer of the investments, market events, economic conditions or investor perceptions. The illiquidity of our investments may make it difficult for us to sell such investments if the need arises. In addition, if we are required to liquidate all or a portion of our portfolio quickly, we may realize significantly less than the value at which we have previously recorded our investments. As a result, we do not expect to achieve liquidity in our investments in the near-term. However, to maintain our qualification as a BDC and as a RIC, we may have to dispose of investments if we do not satisfy one or more of the applicable criteria under the respective regulatory frameworks. Domestic and foreign markets are complex and interrelated, so that events in one sector of the world markets or economy, or in one geographical region, can reverberate and have materially negative consequences for other markets, economic or regional sectors in a manner that may not be foreseen and which may negatively impact the liquidity of our investments and materially harm our business. In addition, we may face other restrictions on our ability to liquidate an investment in a portfolio company to the extent that we
have material non-public information regarding
such portfolio company.
Our portfolio may be concentrated in a limited number of portfolio companies and industries, which will subject us to a risk of significant loss if any of these companies performs poorly or defaults on its obligations under any of its debt instruments or if there is a downturn in a particular industry.
Our portfolio may be concentrated in a limited number of portfolio companies and industries. For example, as of December 31, 2022, our investments in SLR Credit Solutions, Kingsbridge Holdings, LLC and SLR Equipment Finance comprised 11.4%, 9.0% and 5.0%, respectively, of our total assets and our investments in diversified financial services and multi-sector holdings industries comprised 18.2% and 14.4%, respectively, of our total assets. Beyond the asset diversification requirements associated with our qualification as a RIC under Subchapter M of the Code, we do not have fixed guidelines for diversification, and while we are not targeting any specific industries, our investments may be concentrated in relatively few industries or portfolio companies. As a result, the aggregate returns we realize may be significantly adversely affected if a small number of investments perform poorly or if we need to write down the value of any one investment. Additionally, a downturn in any particular industry in which we are invested could also significantly impact the aggregate returns we realize.
 
Our investments in securities rated below investment grade are speculative in nature and are subject to additional risk factors such as the increased possibility of default, illiquidity of the security, and changes in value based on changes in interest rates.
The securities that we invest in are typically rated below investment grade. Securities rated below investment grade are speculative and are often referred to as “leveraged loans,” “high yield” or “junk” securities, and may be considered “high risk” compared to debt instruments that are rated investment grade. High yield securities are regarded as having predominantly speculative characteristics with respect to the issuer’s capacity to pay interest and repay principal in accordance with the terms of the obligations and involve major risk exposure to adverse conditions. In addition, high yield securities generally offer a higher current yield than that available from higher grade issues, but typically involve greater risk. These securities are especially sensitive to adverse changes in general economic conditions, to changes in the financial condition of their issuers and to price fluctuation in response to changes in interest rates. During periods of economic downturn or rising interest rates, such as the current economic period, issuers of below investment grade instruments may experience financial stress that could adversely affect their ability to make payments of principal and interest and increase the possibility of default. The secondary market for high yield securities may not be as liquid as the secondary market for more highly rated securities. In addition, many of our debt investments will not fully amortize during their lifetime, which means that a borrower may be unable to payoff its debt due to bankruptcy or other reasons and therefore
we may write-off such debt
investment prior to its scheduled maturity. Upon such an occurrence, we may realize a loss or a substantial amount of unpaid principal and interest due upon maturity.
Price declines and illiquidity in the corporate debt markets have adversely affected, and may continue to adversely affect, the fair value of our portfolio investments, reducing our net asset value through increased net unrealized depreciation. Any unrealized depreciation that we experience on our loan portfolio may be an indication of future realized losses, which could reduce our income available for distribution and could adversely affect our ability to service our outstanding borrowings.
As a BDC, we are required to carry our investments at market value or, if no market value is ascertainable, at fair value as determined in good faith by or under the direction of our board of directors. Decreases in the market values or fair values of our investments are recorded as unrealized depreciation. Any unrealized depreciation in our loan portfolio could be an indication of a portfolio company’s inability to meet its repayment obligations to us with respect to the affected loans. This could result in realized losses in the future and ultimately in reductions of our income available for distribution in future periods and could materially adversely affect our ability to service our outstanding borrowings. Depending on market conditions, we could incur substantial losses in future periods, which could further reduce our net asset value and have a material adverse impact on our business, financial condition and results of operations.
Economic sanction laws in the United States and other jurisdictions may prohibit us and our affiliates from transacting with certain countries, individuals and companies.
Economic sanction laws in the United States and other jurisdictions may prohibit us or our affiliates from transacting with certain countries, individuals and companies. In the United States, the U.S. Department of the Treasury’s Office of Foreign Assets Control administers and enforces laws, executive orders and regulations establishing U.S. economic and trade sanctions, which prohibit, among other things, transactions with, and the provision of
services to, certain non-U.S. countries, territories, entities
and individuals. These types of sanctions may significantly restrict or completely prohibit investment activities in certain jurisdictions, and if we, our portfolio companies or other issuers in which we invest were to violate any such laws or regulations, we may face significant legal and monetary penalties.
The Foreign Corrupt Practices Act, or FCPA, and other anti-corruption laws and regulations, as well as anti-boycott regulations, may also apply to and restrict our activities, our portfolio companies and other issuers of our investments. If an issuer or we were to violate any such laws or regulations, such issuer or we may face significant legal and monetary penalties. The U.S. government has indicated that it is particularly focused on FCPA enforcement, which may increase the risk that an issuer or us becomes the subject of such actual or threatened enforcement. In addition, certain commentators have suggested that private investment firms and the funds that they manage may face increased scrutiny and/or liability with respect to the activities of their underlying portfolio companies. As such, a violation of the FCPA or other applicable regulations by us or an issuer of our portfolio investments could have a material adverse effect on us. We are committed to complying with the FCPA and other anti-corruption laws and regulations, as well as anti-boycott regulations, to which it is subject. As a result, we may be adversely affected because of our unwillingness to enter into transactions that violate any such laws or regulations.
 
If we cannot obtain additional capital because of either regulatory or market price constraints, we could be forced to curtail or cease our new lending and investment activities, our net asset value could decrease and our level of distributions and liquidity could be affected adversely.
Our ability to secure additional financing and satisfy our financial obligations under indebtedness outstanding from time to time will depend upon our future operating performance, which is subject to the prevailing general economic and credit market conditions, including interest rate levels and the availability of credit generally, and financial, business and other factors, many of which are beyond our control. The worsening of current economic and capital market conditions could have a material adverse effect on our ability to secure financing on favorable terms, if at all.
If we are unable to obtain debt capital, then our equity investors will not benefit from the potential for increased returns on equity resulting from leverage to the extent that our investment strategy is successful and we may be limited in our ability to make new commitments or fundings to our portfolio companies.
We may suffer a loss if a portfolio company defaults on a loan and the underlying collateral is not sufficient.
In the event of a default by a portfolio company on a secured loan, we will only have recourse to the assets collateralizing the loan. If the underlying collateral value is less than the loan amount, we will suffer a loss. In addition, we sometimes make loans that are unsecured, which are subject to the risk that other lenders may be directly secured by the assets of the portfolio company. In the event of a default, those collateralized lenders would have priority over us with respect to the proceeds of a sale of the underlying assets. In cases described above, we may lack control over the underlying asset collateralizing our loan or the underlying assets of the portfolio company prior to a default, and as a result the value of the collateral may be reduced by acts or omissions by owners or managers of the assets.
In the event of bankruptcy of a portfolio company, we may not have full recourse to its assets in order to satisfy our loan, or our loan may be subject to equitable subordination. In addition, certain of our loans are subordinate to other debt of the portfolio company. If a portfolio company defaults on our loan or on debt senior to our loan, or in the event of a portfolio company bankruptcy, our loan will be satisfied only after the senior debt receives payment. Where debt senior to our loan exists, the presence of inter-creditor arrangements may limit our ability to amend our loan documents, assign our loans, accept prepayments, exercise our remedies (through “standstill” periods) and control decisions made in bankruptcy proceedings relating to the portfolio company. Bankruptcy and portfolio company litigation can significantly increase collection losses and the time needed for us to acquire the underlying collateral in the event of a default, during which time the collateral may decline in value, causing us to suffer further losses.
If the value of the collateral underlying our loan declines or interest rates increase during the term of our loan, a portfolio company may not be able to obtain the necessary funds to repay our loan at maturity through refinancing. Decreasing collateral value and/or periods of increasing interest rates, such as the current economic period, may hinder a portfolio company’s ability to refinance our loan because the underlying collateral cannot satisfy the debt service coverage requirements necessary to obtain new financing. If a borrower is unable to repay our loan at maturity, we could suffer a loss which may adversely impact our financial performance.
The business, financial condition and results of operations of our portfolio companies could be adversely affected by worldwide economic conditions, as well as political and economic conditions in the countries in which they conduct business.
The business and operating results of our portfolio companies may be impacted by worldwide economic conditions, such as the economic impact that
the COVID-19 pandemic
and the Russian invasion of Ukraine have imposed, and may continue to impose, on the U.S. and worldwide economy. Any deterioration of general economic conditions may lead to significant declines in corporate earnings or loan performance, and the ability of corporate borrowers to service their debt, any of which could trigger a period of global economic slowdown, and have an adverse impact on our performance and financial results, and the value and the liquidity of our investments. In an economic downturn, we could
have non-performing assets
or an increase
in non-performing assets,
and we would anticipate that the value of our portfolio would decrease during these periods. For instance, concerns of economic slowdown in China and other emerging markets and signs of deteriorating sovereign debt conditions in Europe could lead to disruption and instability in the global financial markets. The significant debt in the United States and European countries is expected to hinder growth in those countries for the foreseeable future. In the future, the U.S. government may not be able to meet its debt payments unless the federal debt ceiling is raised. If legislation increasing the debt ceiling is not enacted, as needed, and the debt ceiling is reached, the U.S. federal government may stop or delay making payments on its obligations. Any default by the U.S. government on its obligations or any prolonged U.S. government shutdown could negatively impact the U.S. economy and our portfolio companies. Multiple factors relating to the international operations of some of our portfolio companies and to particular countries in which they operate could negatively impact their business, financial condition and results of operations.
Some of the products of our portfolio companies are developed, manufactured, assembled, tested or marketed outside the United States. Any conflict or uncertainty in these countries, including due to natural disasters, public health concerns (including
the global COVID-19 pandemic), political
unrest or safety concerns, could harm their business, financial condition and results of operations. In addition, if the government of any country in which their products are developed, manufactured or sold sets technical or regulatory standards for products developed or manufactured in or imported into their country that are not widely shared, it may lead some of their customers to suspend imports of their products into that country, require manufacturers or developers in that country to manufacture or develop products with different technical or regulatory standards and disrupt cross-border manufacturing, marketing or business relationships which, in each case, could harm their businesses.
 
Our failure
to make follow-on investments in
our portfolio companies could impair the value of our portfolio.
Following an initial investment in a portfolio company, we may make additional investments in that portfolio
company as “follow-on” investments, in
order to: (i) increase or maintain in whole or in part our ownership percentage; (ii) exercise warrants, options or convertible securities that were acquired in the original or subsequent financing; or (iii) attempt to preserve or enhance the value of our investment. We may elect not
to make follow-on investments or
otherwise lack sufficient funds to make those investments. We will have the discretion to
make any follow-on investments, subject
to the availability of capital resources. The failure
to make follow-on investments may,
in some circumstances, jeopardize the continued viability of a portfolio company and our initial investment, or may result in a missed opportunity for us to increase our participation in a successful operation. Even if we have sufficient capital to make
a desired follow-on investment, we
may elect not to
make a follow-on investment because
we may not want to increase our concentration of risk, either because we prefer other opportunities or because we are subject to BDC requirements that would
prevent such follow-on investments or
the desire to maintain our RIC tax treatment.
Where we do not hold controlling equity interests in our portfolio companies, we may not be in a position to exercise control over our portfolio companies or to prevent decisions by management of our portfolio companies that could decrease the value of our investments.
Although we hold controlling equity positions in some of our portfolio companies, we do not currently hold controlling equity positions in the majority of our portfolio companies. As a result, we are subject to the risk that a portfolio company in which we do not have a controlling interest may make business decisions with which we disagree, and that the management and/or stockholders of such portfolio company may take risks or otherwise act in ways that are adverse to our interests. Due to the lack of liquidity of the debt and equity investments that we typically hold in our portfolio companies, we may not be able to dispose of our investments in the event we disagree with the actions of a portfolio company and may therefore suffer a decrease in the value of our investments.
Prepayments of our debt investments by our portfolio companies could adversely impact our results of operations and reduce our return on equity.
We are subject to the risk that the investments we make in our portfolio companies may be prepaid prior to maturity. When this occurs, we may reduce our borrowings outstanding or reinvest these proceeds in temporary investments, pending their future investment in new portfolio companies. These temporary investments, if any, will typically have substantially lower yields than the debt investment being prepaid and we could experience significant delays in reinvesting these amounts. Any future investment in a new portfolio company may also be at lower yields than the debt investment that was prepaid. As a result, our results of operations could be materially adversely affected if one or more of our portfolio companies elect to prepay amounts owed to us. Additionally, prepayments could negatively impact our return on equity, which could result in a decline in the market price of our common stock.
We may choose to waive or defer enforcement of covenants in the debt securities held in our portfolio, which may cause us to lose all or part of our investment in these companies.
We structure the debt investments in our portfolio companies to include business and financial covenants placing affirmative and negative obligations on the operation of the company’s business and its financial condition. However, from time to time we may elect to waive breaches of these covenants, including our right to payment, or waive or defer enforcement of remedies, such as acceleration of obligations or foreclosure on collateral, depending upon the financial condition and prospects of the particular portfolio company. These actions may reduce the likelihood of our receiving the full amount of future payments of interest or principal and be accompanied by a deterioration in the value of the underlying collateral as many of these companies may have limited financial resources, may be unable to meet future obligations and may go bankrupt. This could negatively impact our ability to pay distributions, could adversely affect our results of operation and financial condition and cause the loss of all or part of your investment.
In addition, some of the loans in which we may invest may be “covenant-lite” loans. We use the term “covenant-lite” loans to refer generally to loans that do not have a complete set of financial maintenance covenants.
Generally, “covenant-lite” loans provide borrower companies more freedom to negatively impact lenders because their covenants are incurrence-based, which means they are only tested and can only be breached following an affirmative action of the borrower, rather than by a deterioration in the borrower’s financial condition. Accordingly, to the extent we invest in “covenant-lite” loans, we may have fewer rights against a borrower and may have a greater risk of loss on such investments as compared to investments in or exposure to loans with financial maintenance covenants.
 
Our loans could be subject to equitable subordination by a court which would increase our risk of loss with respect to such loans.
Courts may apply the doctrine of equitable subordination to subordinate the claim or lien of a lender against a borrower to claims or liens of other creditors of the borrower, when the lender or its affiliates is found to have engaged in unfair, inequitable or fraudulent conduct. The courts have also applied the doctrine of equitable subordination when a lender or its affiliates is found to have exerted inappropriate control over a client, including control resulting from the ownership of equity interests in a client. We have made direct equity investments or received warrants in connection with loans. Payments on one or more of our loans, particularly a loan to a client in which we may also hold an equity interest, may be subject to claims of equitable subordination. If we were deemed to have the ability to control or otherwise exercise influence over the business and affairs of one or more of our portfolio companies resulting in economic hardship to other creditors of that company, this control or influence may constitute grounds for equitable subordination and a court may treat one or more of our loans as if it were unsecured or common equity in the portfolio company. In that case, if the portfolio company were to liquidate, we would be entitled to repayment of our loan
on a pro-rata basis with
other unsecured debt or, if the effect of subordination was to place us at the level of common equity, then on an equal basis with other holders of the portfolio company’s common equity only after all of its obligations relating to its debt and preferred securities had been satisfied.
An investment strategy focused primarily on privately held companies presents certain challenges, including the lack of available information about these companies, a dependence on the talents and efforts of only a few key portfolio company personnel and a greater vulnerability to economic downturns.
We invest primarily in privately held companies. Generally, little public information exists about these companies, and we are required to rely on the ability of SLR Capital Partners’ investment professionals to obtain adequate information to evaluate the potential returns from investing in these companies. If we are unable to uncover all material information about these companies, we may not make a fully informed investment decision, and we may lose money on our investments. Also, smaller privately held companies frequently have less diverse product lines and smaller market presence than larger competitors. These factors could adversely affect our investment returns as compared to companies investing primarily in the securities of public companies.
Our portfolio companies may incur debt that ranks equally with, or senior to, our investments in such companies.
We invest primarily in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. Our portfolio companies typically have, or may be permitted to incur, other debt that ranks equally with, or senior to, the debt securities in which we invest. By their terms, such debt instruments may provide that the holders are entitled to receive payment of interest or principal on or before the dates on which we are entitled to receive payments in respect of the debt securities in which we invest. Also, in the event of insolvency, liquidation, dissolution, reorganization or bankruptcy of a portfolio company, holders of debt instruments ranking senior to our investment in that portfolio company would typically be entitled to receive payment in full before we receive any distribution in respect of our investment. After repaying such senior creditors, such portfolio company may not have any remaining assets to use for repaying its obligation to us. In the case of debt ranking equally with debt securities in which we invest, we would have to share on an equal basis any distributions with other creditors holding such debt in the event of an insolvency, liquidation, dissolution, reorganization or bankruptcy of the relevant portfolio company. Any such limitations on the ability of our portfolio companies to make principal or interest payments to us, if at all, may reduce our net asset value and have a negative material adverse impact to our business, financial condition and results of operation.
Our investments in foreign securities may involve significant risks in addition to the risks inherent in U.S. investments.
Our investment strategy contemplates potential investments in debt securities of foreign companies, including emerging market companies. Investing in foreign companies may expose us to additional risks not typically associated with investing in U.S. companies. These risks include changes in exchange control regulations, political and social instability, expropriation, imposition of foreign taxes, less liquid markets and less available information than is generally the case in the United States, higher transaction costs, less government supervision of exchanges, brokers and issuers, less developed bankruptcy laws, difficulty in enforcing contractual obligations, lack of uniform accounting and auditing standards and greater price volatility. These risks may be more pronounced for portfolio companies located or operating primarily in emerging markets, whose economies, markets and legal systems may be less developed.
Although most of our investments will be U.S. dollar-denominated, any investments denominated in a foreign currency will be subject to the risk that the value of a particular currency will change in relation to one or more other currencies. Among the factors that may affect currency values are trade balances, the level of short-term interest rates, differences in relative values of similar assets in different currencies, long-term opportunities for investment and capital appreciation, and political developments. We may employ hedging techniques to minimize these risks, but we can offer no assurance that we will, in fact, hedge currency risk, or that if we do, such strategies will be effective.
 
We may expose ourselves to risks if we engage in hedging transactions.
If we engage in hedging transactions, we may expose ourselves to risks associated with such transactions. We may utilize instruments such as forward contracts, currency options and interest rate swaps, caps, collars and floors to seek to hedge against fluctuations in the relative values of our portfolio positions from changes in currency exchange rates and market interest rates. Hedging against a decline in the values of our portfolio positions does not eliminate the possibility of fluctuations in the values of such positions or prevent losses if the values of such positions decline. However, such hedging can establish other positions designed to gain from those same developments, thereby offsetting the decline in the value of such portfolio positions. Such hedging transactions may also limit the opportunity for gain if the values of the underlying portfolio positions should increase. It may not be possible to hedge against an exchange rate or interest rate fluctuation that is so generally anticipated that we are not able to enter into a hedging transaction at an acceptable price.
The success of our hedging transactions will depend on our ability to correctly predict movements in currencies and interest rates. Therefore, while we may enter into such transactions to seek to reduce currency exchange rate and interest rate risks, unanticipated changes in currency exchange rates or interest rates may result in poorer overall investment performance than if we had not engaged in any such hedging transactions. In addition, the degree of correlation between price movements of the instruments used in a hedging strategy and price movements in the portfolio positions being hedged may vary. Moreover, for a variety of reasons, we may not seek to establish a perfect correlation between such hedging instruments and the portfolio holdings being hedged. Any such imperfect correlation may prevent us from achieving the intended hedge and expose us to risk of loss. In addition, it may not be possible to hedge fully or perfectly against currency fluctuations affecting the value of securities
denominated in non-U.S. currencies because
the value of those securities is likely to fluctuate as a result of factors not related to currency fluctuations. To the extent we engage in hedging transactions, we also face the risk that counterparties to the derivative instruments we hold may default, which may expose us to unexpected losses from positions where we believed that our risk had been appropriately hedged.
Our Investment Adviser may not be able to achieve the same or similar returns as those achieved for other funds it currently manages or by our senior investment professionals while they were employed at prior positions.
Our Investment Adviser manages other funds, including other BDCs, and may manage other entities in the future. The track record and achievements of these other entities are not necessarily indicative of future results that will be achieved by our Investment Adviser because these other entities may have investment objectives and strategies that differ from ours. Additionally, although in the past our senior investment professionals held senior positions at a number of investment firms, their track record and achievements are not necessarily indicative of future results that will be achieved by our Investment Adviser. In their roles at such other firms, our senior investment professionals were part of investment teams, and they were not solely responsible for generating investment ideas. In addition, such investment teams arrived at investment decisions by consensus.
We may be exposed to higher risks with respect to our investments that include original issue discount or PIK interest.
Zero-coupon bonds pay interest only at maturity rather than at intervals during the life of the security. Deferred interest rate bonds generally provide for a period of delay before the regular payment of interest begins. PIK securities are debt obligations that pay “interest” in the form of other debt obligations, instead of in cash. Each of these instruments
 is normally issued and traded at a deep discount from face value. Zero-coupon bonds, deferred interest rate bonds and PIKs allow an issuer to avoid or delay the need to generate cash to meet current interest payments and, as a result, may involve greater credit risk than bonds that pay interest currently or in cash. In addition, such investments experience greater volatility in market value due to changes in interest rates than debt obligations that provide for regular payments of interest.
To the extent we invest in original issue discount instruments, including PIK, zero coupon bonds, and debt securities with attached warrants, investors will be exposed to the risks associated with the inclusion of
such non-cash income
in taxable and accounting income prior to receipt of cash, including the following:
 
 
The interest payments deferred on a PIK loan are subject to the risk that the borrower may default when the deferred payments are due in cash at the maturity of the loan;
 
 
The interest rates on PIK loans are higher to reflect the time-value of money on deferred interest payments and the higher credit risk of borrowers who may need to defer interest payments;
 
 
PIK instruments may have unreliable valuations because the accruals require judgments about ultimate collectability of the deferred payments and the value of the associated collateral;
 
 
An election to defer PIK income payments by adding them to principal increases our gross assets and, thus, increases future base fees to the Investment Adviser and, because income payments will then be payable on a larger principal amount, the PIK election also increases the Investment Adviser’s future income incentive fees at a compounding rate;
 
 
Market prices of original issue discount instruments are more volatile because they are affected to a greater extent by interest rate changes than instruments that pay interest periodically in cash;
 
The deferral of interest on a PIK loan increases
its loan-to-value ratio,
which is a measure of the riskiness of a loan; and
 
 
Original issue discount creates the risk
of non-refundable cash
payments to the Investment Adviser based
on non-cash accruals
that may never be realized.
Risks Relating to an Investment in Our Securities
Our shares may trade at a substantial discount from net asset value and may continue to do so over the long term.
Shares of BDCs may trade at a market price that is less than the net asset value that is attributable to those shares. The possibility that our shares of common stock will trade at a substantial discount from net asset value over the long term is separate and distinct from the risk that our net asset value will decrease. We cannot predict whether shares of our common stock will trade above, at or below our net asset value in the future. If our common stock trades below its net asset value, we will generally not be able to issue additional shares or sell our common stock at its market price without first obtaining the approval for such issuance from our stockholders and our independent directors. If additional funds are not available to us, we could be forced to curtail or cease our new lending and investment activities, and our net asset value could decrease and our level of distributions could be impacted.
Our common stock price may be volatile and may decrease substantially.
The trading price of our common stock may fluctuate substantially. The price of our common stock that will prevail in the market may be higher or lower than the price you pay, depending on many factors, some of which are beyond our control and may not be directly related to our operating performance. These factors include, but are not limited to, the following:
 
 
price and volume fluctuations in the overall stock market from time to time;
 
 
investor demand for our shares;
 
 
significant volatility in the market price and trading volume of securities of BDCs or other companies in our sector, which are not necessarily related to the operating performance of these companies;
 
 
exclusion of our common stock from certain market indices, such as the Russell 2000 Financial Services Index, which could reduce the ability of certain investment funds to own our common stock and put short-term selling pressure on our common stock;
 
 
changes in regulatory policies or tax guidelines with respect to RICs or BDCs;
 
 
failure to qualify as a RIC, or the loss of RIC tax treatment;
 
 
any shortfall in revenue or net income or any increase in losses from levels expected by investors or securities analysts;
 
 
changes, or perceived changes, in the value of our portfolio investments;
 
 
departures of SLR Capital Partners’ key personnel;
 
 
operating performance of companies comparable to us;
 
 
changes in the prevailing interest rates;
 
 
loss of a major funding source; or
 
 
general economic conditions and trends and other external factors.
Our businesses may be adversely affected by litigation and regulatory proceedings.
From time to time, we may be subject to legal actions as well as various regulatory, governmental and law enforcement inquiries, investigations and subpoenas. In any such claims or actions, demands for substantial monetary damages may be asserted against us and may result in financial liability or an adverse effect on our reputation among investors. In connection with acquisitions of, and investments in, businesses complementary to our business, we have been and may be in the future subject to securities litigation or shareholder activism in connection with such acquisitions or investments. Securities litigation and shareholder activism, including potential proxy contests, could result in substantial costs and divert management’s and our board of directors’ attention and resources from our business. We may be unable to accurately estimate our exposure to litigation risk when we record balance sheet reserves for probable loss contingencies. As a result, any reserves we establish to cover any settlements or judgments may not be sufficient to cover our actual financial exposure, which may have a material impact on our results of operations or financial condition. In regulatory enforcement matters, claims for disgorgement, the imposition of penalties and the imposition of other remedial sanctions are possible.
 
If the current period of capital market disruption and instability continues for an extended period of time, there is a risk that investors in our equity securities may not receive distributions consistent with historical levels or at all or that our distributions may not grow over time and a portion of our distributions may be a return of capital.
We intend to make distributions on a monthly basis to our stockholders out of assets legally available for distribution. We cannot assure you that we will achieve investment results that will allow us to make a specified level of cash distributions. Our ability to pay distributions might be adversely affected by the impact of one or more of the risk factors described in this annual report. If we violate certain covenants under our existing or future credit facilities or other leverage, we may be limited in our ability to make distributions. If we declare a distribution and if more stockholders opt to receive cash distributions rather than participate in our dividend reinvestment plan, we may be forced to sell some of our investments in order to make cash distribution payments. To the extent we make distributions to stockholders that include a return of capital, such portion of the distribution essentially constitutes a return of the stockholder’s investment. Although such return of capital may not be taxable, such distributions would generally decrease a stockholder’s basis in our common stock and may therefore increase such stockholder’s tax liability for capital gains upon the future sale of such stock. A return of capital distribution may cause a stockholder to recognize a capital gain from the sale of our common stock even if the stockholder sells its shares for less than the original purchase price.
As a RIC, if we do not distribute a certain percentage of our income annually, we may suffer adverse tax consequences,
including
possibly losing the U.S. federal income tax benefits allowable to RICs. We cannot assure you that you will receive distributions at a particular level or at all.
In certain cases, we may recognize income before or without receiving the accompanying cash. Depending on the amount of noncash income, this could result in difficulty satisfying the annual distribution requirement applicable to RICs. Accordingly, we may have to sell some portfolio investments at times it would not consider advantageous, raise additional debt or equity capital or reduce new investments to meet these distribution requirements.
Due to disruptions in the economy, we may reduce or defer our dividends and choose to incur U.S. federal excise tax in order to preserve cash and maintain flexibility.
In order to maintain our tax treatment as a RIC, we must distribute to shareholders for each taxable year at least 90% of our investment company taxable income (i.e., net ordinary income plus realized net short-term capital gains in excess of realized net long-term capital losses). If we qualify for taxation as a RIC, we generally will not be subject to corporate-level US federal income tax on our investment company taxable income and net capital gains (i.e., realized net long-term capital gains in excess of realized net short-term capital losses) that we timely distribute to shareholders. We will be subject to a 4% U.S. federal excise tax on undistributed earnings of a RIC unless we distribute each calendar year at least the sum of (i) 98.0% of our ordinary income for the calendar year, (ii) 98.2% of our capital gains in excess of
capital losses for the one-year period ending on October 31
of the calendar year, and (iii) any ordinary income and net capital gains that were recognized for preceding years, but were not distributed during such years and on which we paid no U.S. federal income tax. Any net operating losses that we incur in periods during which we qualify as a RIC will not offset net capital gains (i.e., net realized long-term capital gains in excess of net realized short-term capital losses) that we are otherwise required to distribute, and we cannot pass such net operating losses through to our stockholders. In addition, net operating losses that we carry over to a taxable year in which we qualify as a RIC normally cannot offset ordinary income or capital gains.
Under the Code, we may satisfy certain of our RIC distributions with dividends paid after the end of the current year. In particular, if we pay a distribution in January of the following year that was declared in October, November, or December of the current year and is payable to shareholders of record in the current year, the dividend will be treated for all US federal income tax purposes as if it were paid on December 31 of the current year. In addition, under the Code, we may pay dividends, referred to as “spillover dividends,” that are paid during the following taxable year that will allow us to maintain our qualification for taxation as a RIC and eliminate our liability for corporate-level U.S. federal income tax. Under these spillover dividend procedures, we may defer distribution of income earned during the current year until December of the following year. For example, we may defer distributions of income earned during 2023 until as late as December 31, 2024. If we choose to pay a spillover dividend, we will incur the 4% U.S. federal excise tax on some or all of the distribution.
Due to events such as
the COVID-19 pandemic,
the Russian invasion of Ukraine or other disruptions in the economy, such as the current inflationary environment, we may take certain actions with respect to the timing and amounts of our distributions in order to preserve cash and maintain flexibility. For example, we may reduce our dividends and/or defer dividends to the following taxable year. If we defer our dividends, we may choose to utilize the spillover dividend rules discussed above and incur the 4% U.S. federal excise tax on such amounts. To further preserve cash, we may combine these reductions or deferrals of dividends with one or more distributions that are payable partially in our stock as discussed below under “
We may choose to pay
 distributions in our own stock, in which case our stockholders may be required to pay U.S. federal income taxes in excess of the cash distributions they receive.”
 
We may choose to pay distributions in our own common stock, in which case our stockholders may be required to pay U.S. federal income taxes in excess of the cash distributions they receive.
We may distribute taxable distributions that are payable in part in shares of our common stock. Under certain applicable provisions of the Code and the published guidance, distributions of a publicly offered RIC that are in cash or in shares of stock at the election of stockholders may be treated as taxable distributions. The Internal Revenue Service has issued a revenue procedure indicating that this rule will apply if the total amount of cash to be distributed is not less than 20% of the total distribution. Under this revenue procedure, if too many stockholders elect to receive their distributions in cash, the cash available for distribution must be allocated among the stockholders electing to receive cash (with the balance of distributions paid in stock). In no event will any stockholder electing to receive cash, receive less than the lesser of (a) the portion of the distribution such stockholder has elected to receive in cash or (b) an amount equal to his or her entire distribution times the percentage limitation on cash available for distribution. If we decide to make any distributions consistent with this revenue procedure that are payable in part in our stock, taxable stockholders receiving such distributions will be required to include the full amount of the distribution (whether received in cash, our stock, or a combination thereof) as ordinary income (or as long-term capital gain to the extent such distribution is properly reported as a capital gain distribution) to the extent of our current and accumulated earnings and profits for U.S. federal income tax purposes. As a result, a U.S. stockholder may be required to pay tax with respect to such distributions in excess of any cash received. If a U.S. stockholder sells the stock it receives as a distribution in order to pay this tax, the sales proceeds may be less than the amount included in income with respect to the distribution, depending on the market price of our stock at the time of the sale. Furthermore, with respect to
non-U.S.
stockholders, we may be required to withhold U.S. tax with respect to such distributions, including in respect of all or a portion of such distribution that is payable in stock. If a significant number of our stockholders determine to sell shares of our stock in order to pay taxes owed on distributions, it may put downward pressure on the trading price of our stock.
Sales of substantial amounts of our common stock in the public market may have an adverse effect on the market price of our common stock.
The shares of our common stock beneficially owned by each of Messrs. Gross and Spohler immediately prior to completion of our initial public offering, including any shares that are attributable to such shares issued pursuant to our dividend reinvestment plan, are no longer
subject to lock-up restrictions that
each of Messrs. Gross and Spohler agreed to in connection with our initial public offering, and are generally available for resale without restriction, subject to the provisions of Rule 144 promulgated under the Securities Act. In addition, on November 30, 2010, Messrs. Gross and Spohler jointly acquired 115,000 shares of our common stock in a private placement transaction conducted in accordance with Regulation D under the Securities Act. Such shares are generally available for resale without restriction, subject to the provisions of Rule 144 promulgated under the Securities Act. Sales of substantial amounts of our common stock, or the availability of such common stock for sale, could adversely affect the prevailing market prices for our common stock. If this occurs and continues, it could impair our ability to raise additional capital through the sale of securities should we desire to do so.
We may be unable to invest the net proceeds raised from any offerings on acceptable terms or allocate net proceeds from any offering of our securities in ways with which you may not agree.
We cannot assure you that we will be able to find enough appropriate investments that meet our investment criteria or that any investment we complete using the proceeds from any securities offering will produce a sufficient return. Until we identify new investment opportunities, we intend to either invest the net proceeds of future offerings in cash equivalents, U.S. government securities and other high-quality debt investments that mature in one year or less or use the net proceeds from such offerings to reduce then-outstanding obligations.
We have significant flexibility in investing the net proceeds of any offering of our securities and may use the net proceeds from an offering in ways with which you may not agree or for purposes other than those contemplated at the time of the offering.
The net asset value per share of our common stock may be diluted if we issue or sell shares of our common stock at prices below the then current net asset value per share of our common stock or securities to subscribe for or convertible into shares of our common stock.
We will generally not be able to issue additional shares or sell our common stock at its market price without first obtaining the approval for such issuance from our stockholders and our independent directors. Any offering of our common stock that requires stockholder approval must occur, if at all, within one year after receiving such stockholder approval. At our 2011 Annual Stockholders Meeting, our stockholders authorized us to sell or otherwise issue warrants or securities to subscribe for or convertible into shares of our common stock subject to certain limitations (including, without limitation, that the number of shares issuable does not exceed 25% of our then outstanding common stock and that the exercise or conversion price thereof is not, at the date of issuance, less than the market value per share of our common stock). Such authorization has no expiration.
 
We may also use newly issued shares to implement our dividend reinvestment plan, whether our shares are trading at a premium or at a discount to our then current net asset value per share. Any decision to issue or sell shares of our common stock below our then current net asset value per share or securities to subscribe for or convertible into shares of our common stock would be subject to the determination by our board of directors that such issuance or sale is in our and our stockholders’ best interests.
If we were to issue or sell shares of our common stock below our then current net asset value per share, such issuances or sales would result in an immediate dilution to the net asset value per share of our common stock.
This dilution would occur as a result of the issuance or sale of shares at a price below the then current net asset value per share of our common stock and a proportionately greater decrease in the stockholders’ interest in our earnings and assets and their voting interest in us than the increase in our assets resulting from such issuance or sale. Because the number of shares of common stock that could be so issued and the timing of any issuance is not currently known, the actual dilutive effect cannot be predicted.
In addition, if we issue warrants or securities to subscribe for or convertible into shares of our common stock, subject to certain limitations, the exercise or conversion price per share could be less than net asset value per share at the time of exercise or conversion (including through the operation of anti-dilution protections).
Because we would incur expenses in connection with any issuance of such securities, such issuance could result in a dilution of the net asset value per share at the time of exercise or conversion. This dilution would include reduction in net asset value per share as a result of the proportionately greater decrease in the stockholders’ interest in our earnings and assets and their voting interest than the increase in our assets resulting from such issuance.
Further, if our current stockholders do not purchase any shares to maintain their percentage interest, regardless of whether such offering is above or below the then current net asset value per share, their voting power will be diluted. For example, if we sell an additional 10% of our common stock at a 5% discount from net asset value, a stockholder who does not participate in that offering for its proportionate interest will suffer net asset value dilution of up to 0.5% or $5 per $1,000 of net asset value.
Similarly, all distributions declared in cash payable to stockholders that are participants in our dividend reinvestment plan are automatically reinvested in shares of our common stock. As a result, stockholders that opt out of the dividend reinvestment plan may experience dilution over time. Stockholders who do not elect to receive distributions in shares of common stock may experience accretion to the net asset value of their shares if our shares are trading at a premium and dilution if our shares are trading at a discount. The level of accretion or discount would depend on various factors, including the proportion of our stockholders who participate in the plan, the level of premium or discount at which our shares are trading and the amount of the distribution payable to a stockholder.
If we issue preferred stock, the net asset value and market value of our common stock may become more volatile.
We cannot assure you that the issuance of preferred stock would result in a higher yield or return to the holders of the common stock. The issuance of preferred stock would likely cause the net asset value and market value of the common stock to become more volatile. If the distribution rate on the preferred stock were to approach the net rate of return on our investment portfolio, the benefit of leverage to the holders of the common stock would be reduced. If the distribution rate on the preferred stock were to exceed the net rate of return on our portfolio, the leverage would result in a lower rate of return to the holders of common stock than if we had not issued preferred stock. Any decline in the net asset value of our investments would be borne entirely by the holders of common stock. Therefore, if the market value of our portfolio were to decline, the leverage would result in a greater decrease in net asset value to the holders of common stock than if we were not leveraged through the issuance of preferred stock. This greater net asset value decrease would also tend to cause a greater decline in the market price for the common stock. We might be in danger of failing to maintain the required asset coverage of the preferred stock or of losing our ratings on the preferred stock or, in an extreme case, our current investment income might not be sufficient to meet the distribution requirements on the preferred stock. In order to counteract such an event, we might need to liquidate investments in order to fund a redemption of some or all of the preferred stock. In addition, we would pay (and the holders of common stock would bear) all costs and expenses relating to the issuance and ongoing maintenance of the preferred stock, including higher advisory fees if our total return exceeds the distribution rate on the preferred stock. Holders of preferred stock may have different interests than holders of common stock and may at times have disproportionate influence over our affairs.
Our board of directors is authorized to reclassify any unissued shares of common stock into one or more classes of preferred stock, which could convey special rights and privileges to its owners.
Under Maryland General Corporation Law and our charter, our board of directors is authorized to classify and reclassify any authorized but unissued shares of stock into one or more classes of stock, including preferred stock. Prior to issuance of shares of each class or series, the board of directors is required by Maryland law and our charter to set the preferences, conversion or other rights,
 
voting powers, restrictions, limitations as to other distributions, qualifications and terms or conditions of redemption for each class or series. Thus, the board of directors could authorize the issuance of shares of preferred stock with terms and conditions which could have the effect of delaying, deferring or preventing a transaction or a change in control that might involve a premium price for holders of our common stock or otherwise be in their best interest. The cost of any such reclassification would be borne by our existing common stockholders. The issuance of shares of preferred stock convertible into shares of common stock might also reduce the net income and net asset value per share of our common stock upon conversion, provided, that we will only be permitted to issue such convertible preferred stock to the extent we comply with the requirements of Section 61 of the 1940 Act, including obtaining common stockholder approval. These effects, among others, could have an adverse effect on your investment in our common stock.
Certain matters under the 1940 Act require the separate vote of the holders of any issued and outstanding preferred stock. For example, holders of preferred stock would vote separately from the holders of common stock on a proposal to cease operations as a BDC. In addition, the 1940 Act provides that holders of preferred stock are entitled to vote separately from holders of common stock to elect two preferred stock directors. In the event distributions become two full years in arrears, holders of any preferred stock would have the right to elect a majority of the directors until such arrearage is completely eliminated. Preferred stockholders also have class voting rights on certain matters, including changes in fundamental investment restrictions and
conversion to open-end status, and
accordingly can veto any such changes. Restrictions imposed on the declarations and payment of distributions to the holders of our common stock and preferred stock, both by the 1940 Act and by requirements imposed by rating agencies or the terms of our credit facilities, might impair our ability to maintain our qualification for tax treatment as a RIC for U.S. federal income tax purposes. While we would intend to redeem our preferred stock to the extent necessary to enable us to distribute our income as required to maintain our qualification as a RIC, there can be no assurance that such actions could be effected in time to meet the tax requirements.
To the extent we use debt or preferred stock to finance our investments, changes in interest rates will affect our cost of capital and net investment income.
To the extent we borrow money, or issue preferred stock, to make investments, our net investment income will depend, in part, upon the difference between the rate at which we borrow funds or pay distributions on preferred stock and the rate at which we invest those funds. In addition, many of our debt investments and borrowings have floating interest rates that reset on a periodic basis, and many of our investments are subject to interest rate floors. As a result, we can offer no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income in the event we use debt to finance our investments. In periods of rising interest rates, such as the current economic period, our cost of funds have increased, and could continue to increase, because the interest rates on the amounts borrowed under our credit facilities or certain other financing arrangements are typically floating, except to the extent we issue fixed rate debt or preferred stock, which could reduce our net investment income, and the interest rate on investments with an interest rate floor (such as a SOFR floor) above current levels will not increase until interest rates exceed the applicable floor. We expect that our long-term fixed-rate investments will generally be financed with equity and long-term debt.
We may use interest rate risk management techniques in an effort to limit our exposure to interest rate fluctuations. Such techniques may include various interest rate hedging activities to the extent permitted by the 1940 Act. These activities could limit our ability to participate in the benefits of lower interest rates with respect to the hedged borrowings. Adverse developments resulting from changes in interest rates or hedging transactions could have a material adverse effect on our business, financial condition and results of operations.
You should also be aware that the rise in the general level of interest rates can be expected to lead to higher interest rates applicable to our debt investments. Accordingly, such increase in interest rates makes it easier for us to meet or exceed the incentive fee hurdle rate and may result in a substantial increase of the amount of incentive fees payable to our Investment Adviser with respect to our
pre-incentive
fee net investment income. Also, an increase in interest rates available to investors could make an investment in our common stock less attractive if we are not able to increase our distribution rate, which could reduce the value of our common stock.
We may in the future determine to fund a portion of our investments with preferred stock, which would magnify the potential for loss and the risks of investing in us in a similar way as our borrowings.
Preferred stock, which is another form of leverage, has the same risks to our common stockholders as borrowings because the distributions on any preferred stock we issue must be cumulative. Payment of such distributions and repayment of the liquidation preference of such preferred stock must take preference over any distributions or other payments to our common stockholders, and preferred stockholders are not subject to any of our expenses or losses and are not entitled to participate in any income or appreciation in excess of their stated preference.
 
Risks Relating to Our Business and Structure
We are dependent upon SLR Capital Partners’ key personnel for our future success.
We depend on the diligence, skill and network of business contacts of Messrs. Gross and Spohler, who serve as the managing partners of SLR Capital Partners and who lead SLR Capital Partners’ investment team. Messrs. Gross and Spohler, together with the other dedicated investment professionals available to SLR Capital Partners, evaluate, negotiate, structure, close and monitor our investments. Our future success will depend on the diligence, skill, network of business contacts and continued service of Messrs. Gross and Spohler and the other investment professionals available to SLR Capital Partners. We cannot assure you that unforeseen business, medical, personal or other circumstances would not lead any such individual to terminate his relationship with us. The loss of Mr. Gross or Mr. Spohler, or any of the other senior investment professionals who serve on SLR Capital Partners’ investment team, could have a material adverse effect on our ability to achieve our investment objective as well as on our financial condition and results of operations. In addition, we can offer no assurance that SLR Capital Partners will remain our Investment Adviser.
The senior investment professionals of SLR Capital Partners are and may in the future become affiliated with entities engaged in business activities similar to those intended to be conducted by us, and may have conflicts of interest in allocating their time. We expect that Messrs. Gross and Spohler will dedicate a significant portion of their time to the activities of SLR Investment Corp.; however, they may be engaged in other business activities which could divert their time and attention in the future. Specifically, Mr. Gross
serves as Co-Chief Executive Officer
and President of SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC. In addition, Mr. Spohler
serves as Co-Chief Executive Officer
and Chief Operating Officer of SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC.
Our business model depends to a significant extent upon strong referral relationships with financial sponsors, and the inability of the senior investment professionals of our Investment Adviser to maintain or develop these relationships, or the failure of these relationships to generate investment opportunities, could adversely affect our business.
We expect that the principals of our Investment Adviser will maintain and develop their relationships with financial sponsors, and we will rely to a significant extent upon these relationships to provide us with potential investment opportunities. If the senior investment professionals of our Investment Adviser fail to maintain their existing relationships or develop new relationships with other sponsors or sources of investment opportunities, we will not be able to grow our investment portfolio. In addition, individuals with whom the senior investment professionals of our Investment Adviser have relationships are not obligated to provide us with investment opportunities, and, therefore, there is no assurance that such relationships will generate investment opportunities for us. If our Investment Adviser is unable to source investment opportunities, we may hold a greater percentage of our assets in cash and cash equivalents than anticipated, which could impact potential returns on our portfolio.
A disruption in the capital markets and the credit markets could negatively affect our business.
As a BDC, we must maintain our ability to raise additional capital for investment purposes. Without sufficient access to the capital markets or credit markets, we may be forced to curtail our business operations or we may not be able to pursue new business opportunities. Disruptive conditions in the financial industry and the impact of new legislation in response to those conditions could restrict our business operations and could adversely impact our results of operations and financial condition.
If the fair value of our assets declines substantially, we may fail to maintain the asset coverage ratios imposed upon us by the 1940 Act and our existing credit facilities. Any such failure could result in an event of default and all of our debt being declared immediately due and payable and would affect our ability to issue senior securities, including borrowings, and pay distributions, which could materially impair our business operations. Our liquidity could be impaired further by an inability to access the capital markets or to draw on our credit facilities. For example, we cannot be certain that we will be able to renew our existing credit facilities as they mature or to consummate new borrowing facilities to provide capital for normal operations, including new originations. Reflecting concern about the stability of the financial markets, many lenders and institutional investors have reduced or ceased providing funding to borrowers. This market turmoil and tightening of credit have led to increased market volatility and widespread reduction of business activity generally.
If we are unable to renew or replace our existing credit facilities and consummate new facilities on commercially reasonable terms, our liquidity will be reduced significantly. If we consummate new facilities but are then unable to repay amounts outstanding under such facilities and are declared in default or are unable to renew or refinance these facilities, we would not be able to initiate significant originations or to operate our business in the normal course. These situations may arise due to circumstances that we may be unable to control, such as inaccessibility to the credit markets, a severe decline in the value of the U.S. dollar, a further economic downturn or an operational problem that affects third parties or us, and could materially damage our business. Moreover, we are unable to predict when economic and market conditions may become more favorable. Even if such conditions improve broadly and significantly over the long term, adverse conditions in particular sectors of the financial markets could adversely impact our business.
 
Our financial condition and results of operations will depend on SLR Capital Partners’ ability to manage our future growth effectively by identifying, investing in and monitoring companies that meet our investment criteria.
Our ability to achieve our investment objective and to grow depends on SLR Capital Partners’ ability to identify, invest in and monitor companies that meet our investment criteria. Accomplishing this result on a cost-effective basis is largely a function of SLR Capital Partners’ structuring of the investment process, its ability to provide competent, attentive and efficient services to us and its ability to access financing for us on acceptable terms. The investment team of SLR Capital Partners has substantial responsibilities under the Advisory Agreement, and they may also be called upon to provide managerial assistance to our portfolio companies as the principals of our administrator. In addition, the members of SLR Capital Partners’ investment team have similar responsibilities with respect to the management of other investment portfolios, including the investment portfolios of SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC. Such demands on their time may distract them or slow our rate of investment. In order to grow, we and SLR Capital Partners will need to retain, train, supervise and manage new investment professionals. However, we can offer no assurance that any such investment professionals will contribute effectively to the work of the Investment Adviser. Any failure to manage our future growth effectively could have a material adverse effect on our business, financial condition and results of operations.
We may need to raise additional capital to grow because we must distribute most of our income.
We may need additional capital to fund growth in our investments. We expect to issue equity securities and expect to borrow from financial institutions in the future. A reduction in the availability of new capital could limit our ability to grow. We must distribute at least 90% of our investment company taxable income to our stockholders to maintain our tax treatment as a RIC. As a result, any such cash earnings may not be available to fund investment originations. We expect to borrow from financial institutions and issue additional debt and equity securities. If we fail to obtain funds from such sources or from other sources to fund our investments, it could limit our ability to grow, which may have an adverse effect on the value of our securities. In addition, as a BDC, our ability to borrow or issue additional preferred stock may be restricted if our total assets are less than 150% of our total borrowings and preferred stock.
Any failure on our part to maintain our status as a BDC would reduce our operating flexibility and we may be limited in our investment choices as a BDC.
The 1940 Act imposes numerous constraints on the operations of BDCs. For example, BDCs are required to invest at least 70% of their total assets in specified types of securities, primarily in private companies or thinly-traded U.S. public companies, cash, cash equivalents, U.S. government securities and other high quality debt investments that mature in one year or less. Furthermore, any failure to comply with the requirements imposed on BDCs by the 1940 Act could cause the SEC to bring an enforcement action against us and/or expose us to claims of private litigants. In addition, upon approval of a majority of our stockholders, we may elect to withdraw our status as a BDC. If we decide to withdraw our election, or if we otherwise fail to qualify, or maintain our qualification, as a BDC, we may be subject to the substantially greater regulation under the 1940 Act
as a closed-end investment company.
Compliance with such regulations would significantly decrease our operating flexibility, and could have a material adverse effect on our business, financial condition and results of operations.
Regulations governing our operation as a BDC affect our ability to, and the way in which we will, raise additional capital. As a BDC, the necessity of raising additional capital may expose us to risks, including the typical risks associated with leverage.
In order to satisfy the tax requirements applicable to a RIC, to avoid payment of excise taxes and to minimize or avoid payment of income taxes, we intend to distribute to our stockholders substantially all of our ordinary income and realized net capital gains except for certain realized net long-term capital gains, which we may retain, pay applicable income taxes with respect thereto and elect to treat as deemed distributions to our stockholders. We may issue debt securities or preferred stock and/or borrow money from banks or other financial institutions, which we refer to collectively as “senior securities,” up to the maximum amount permitted by the 1940 Act. Under the provisions of the 1940 Act, we had been permitted, as a BDC, to issue senior securities in amounts such that our asset coverage ratio, as defined in the 1940 Act, equals at least 200% of gross assets less all liabilities and indebtedness not represented by senior securities, after each issuance of senior securities. However, our stockholders have approved a resolution permitting us to be subject to a 150% asset coverage ratio effective as of October 12, 2018. If the value of our assets declines, we may be unable to satisfy the asset coverage test. If that happens, we may be required to sell a portion of our investments and, depending on the nature of our leverage, repay a portion of our indebtedness at a time when such sales may be disadvantageous. Also, any amounts that we use to service our indebtedness would not be available for distributions to our common stockholders. Furthermore, as a result of issuing senior securities, we would also be exposed to typical risks associated with leverage, including an increased risk of loss. In addition, because our management fee is calculated as a percentage of our gross assets, which includes any borrowings for investment purposes, the management fee expenses will increase if we incur additional indebtedness.
 
As of December 31, 2022, we had $393.0 million outstanding under the Credit Facility, composed of $293.0 million of revolving credit and $100.0 million outstanding of term loans, and $155.2 million outstanding under our SPV Credit Facility. We also had $135.0 million outstanding of the Series F 2027 Unsecured Notes, $50.0 million outstanding of the 2027 Unsecured Notes, $75.0 million outstanding of the 2026 Unsecured Notes, $85.0 million outstanding of the 2025 Unsecured Notes, $125.0 million outstanding of the 2024 Unsecured Notes, and $75.0 million outstanding of the 2023 Unsecured Notes. If we issue preferred stock, the preferred stock would rank “senior” to common stock in our capital structure, preferred stockholders would generally vote together with common stockholders but would have separate voting rights on certain matters and might have other rights, preferences, or privileges more favorable than those of our common stockholders, and the issuance of preferred stock could have the effect of delaying, deferring or preventing a transaction or a change of control that might involve a premium price for holders of our common stock or otherwise be in your best interest.
We are not generally able to issue and sell our common stock at a price below net asset value per share. We may, however, sell our common stock, or warrants, options or rights to acquire our common stock, at a price below the then-current net asset value per share of our common stock if our board of directors determines that such sale is in the best interests of SLR Investment Corp. and its stockholders, and our stockholders approve such sale. In any such case, the price at which our securities are to be issued and sold may not be less than a price that, in the determination of our board of directors, closely approximates the market value of such securities (less any distributing commission or discount). If we raise additional funds by issuing more common stock or senior securities convertible into, or exchangeable for, our common stock, then the percentage ownership of our stockholders at that time will decrease, and you might experience dilution. This dilution would occur as a result of a proportionately greater decrease in a stockholder’s interest in our earnings and assets and voting interest in us than the increase in our assets resulting from such issuance. Because the number of future shares of common stock that may be issued below our net asset value per share and the price and timing of such issuances are not currently known, we cannot predict the actual dilutive effect of any such issuance. We cannot determine the resulting reduction in our net asset value per share of any such issuance. We also cannot predict whether shares of our common stock will trade above, at or below our net asset value.
Our credit ratings may not reflect all risks of an investment in our debt securities.
Our credit ratings are an assessment by third parties of our ability to pay our obligations. Consequently, real or anticipated changes in our credit ratings will generally affect the market value of our publicly issued debt securities. Our credit ratings, however, may not reflect the potential impact of risks related to market conditions generally or other factors discussed above on the market value of, or trading market for, any publicly issued debt securities.
Our stockholders may experience dilution in their ownership percentage if they opt out of our dividend reinvestment plan.
All distributions declared in cash payable to stockholders that are participants in our dividend reinvestment plan are automatically reinvested in shares of our common stock. In the event we issue new shares in connection with our dividend reinvestment plan, our stockholders that do not elect to receive distributions in shares of common stock may experience dilution in their ownership percentage over time as a result of such issuance.
We have and will continue to borrow money, which would magnify the potential for loss on amounts invested and may increase the risk of investing in us.
We borrow money as part of our business plan. Borrowings, also known as leverage, magnify the potential for loss on amounts invested and, therefore, increase the risks associated with investing in our securities. As of December 31, 2022, we had $393.0 million outstanding under the Credit Facility, composed of $293.0 million of revolving credit and $100.0 million outstanding of term loans, and $155.2 million outstanding under our SPV Credit Facility. We also had $135.0 million outstanding of the Series F 2027 Unsecured Notes, $50.0 million outstanding of the 2027 Unsecured Notes, $75.0 million outstanding of the 2026 Unsecured Notes, $85.0 million outstanding of the 2025 Unsecured Notes, $125.0 million outstanding of the 2024 Unsecured Notes, and $75.0 million outstanding of the 2023 Unsecured Notes. We may borrow from and issue senior debt securities to banks, insurance companies and other lenders in the future. Lenders of these senior securities, including the Credit Facility, the SPV Credit Facility, the Series F 2027 Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes, the 2024 Unsecured Notes, and the 2023 Unsecured Notes, will have fixed dollar claims on our assets that are superior to the claims of our common stockholders, and we would expect such lenders to seek recovery against our assets in the event of a default. If the value of our assets increases, then leveraging would cause the net asset value attributable to our common stock to increase more sharply than it would have had we not leveraged. Conversely, if the value of our assets decreases, leveraging would cause net asset value to decline more sharply than it otherwise would have had we not leveraged. Similarly, any decrease in our income would cause net income to decline more sharply than it would have had we not borrowed. Also, any increase in our income in excess of interest payable on the borrowed funds would cause our net investment income to increase more than it would without the leverage, while any decrease in our income would cause net investment income to decline more sharply than it would have had we not borrowed. Such a decline could also negatively affect
 
our ability to make distribution payments on our common stock, scheduled debt payments or other payments related to our securities. Leverage is generally considered a speculative investment technique. Our ability to service any debt that we incur will depend largely on our financial performance and will be subject to prevailing economic conditions and competitive pressures. Moreover, as the management fee payable to our Investment Adviser, SLR Capital Partners, will be payable based on our gross assets, including those assets acquired through the use of leverage, SLR Capital Partners will have a financial incentive to incur leverage which may not be consistent with our stockholders’ interests. In addition, our common stockholders will bear the burden of any increase in our expenses as a result of leverage, including any increase in the management fee payable to SLR Capital Partners.
As a BDC, we had generally been required to meet a coverage ratio of total assets to total borrowings and other senior securities, which include all of our borrowings and any preferred stock that we may issue in the future, of at least 200%. However, our stockholders have approved a resolution permitting us to be subject to a 150% asset coverage ratio effective as of October 12, 2018. Even though we are subject to a 150% asset coverage ratio effective as of October 12, 2018, contractual leverage limitations under our existing credit facilities or future borrowings may limit our ability to incur additional indebtedness. On August 28, 2019, we entered into the Credit Agreement, which was amended on December 28, 2021, which permits 150% asset coverage. Some of our wholly and/or substantially owned portfolio companies, including Kingsbridge Holdings, LLC, SLR Credit Solutions, SLR Equipment Finance, SLR Business Credit and SLR Healthcare ABL, may incur significantly more leverage than we can but we do not consolidate Kingsbridge Holdings, LLC, SLR Credit Solutions, SLR Equipment Finance, SLR Business Credit and SLR Healthcare ABL and their
leverage is non-recourse to us.
Additionally, the Credit Facility and the SPV Credit Facility require us to comply with certain financial and other restrictive covenants including maintaining an asset coverage ratio of not less than 150% at any time. Failure to maintain compliance with these covenants could result in an event of default and all of our debt being declared immediately due and payable. If this ratio declines below 150%, we may not be able to incur additional debt and could be required by law to sell a portion of our investments to repay some debt when it is disadvantageous to do so, which could have a material adverse effect on our operations, and we may not be able to make distributions. The amount of leverage that we employ will depend on our Investment Adviser’s and our board of directors’ assessment of the market and other factors at the time of any proposed borrowing. We cannot assure you that we will be able to obtain credit at all or on terms acceptable to us.
In addition, our credit facilities impose, and any other debt facility into which we may enter would likely impose, financial and operating covenants that restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain RIC tax treatment under Subchapter M of the Code.
The debt securities that we may issue will be governed by an indenture or other instrument containing covenants restricting our operating flexibility. We, and indirectly our stockholders, bear the cost of issuing and servicing such debt securities. Any convertible or exchangeable securities that we issue in the future may have rights, preferences and privileges more favorable than those of our common stock.
Illustration.
 The following table illustrates the effect of leverage on returns from an investment in our common stock assuming various annual returns on our portfolio, net of interest expense. The calculations in the table below are hypothetical and actual returns may be higher or lower than those appearing in the table below.
 
    
Assumed total return
(net of interest expense)
 
    
(10)%
   
(5)%
   
0%
   
5%
   
10%
 
Corresponding return to stockholder(1)
     (29.9 )%      (17.2 )%      (4.5 )%      8.2     20.9
 
(1)
Assumes $2.5 billion in total assets and $1.1 billion in total debt outstanding, which reflects our total assets and total debt outstanding as of December 31, 2022, and a cost of funds of
4.09%. Excludes non-leverage related expenses.
In
 
order for us to cover our annual interest payments on our outstanding indebtedness at December 31, 2022, we must achieve annual returns on our December 31, 2022 total assets of at least 1.8%.
It is likely that the terms of any current or future long-term or revolving credit or warehouse facility we may enter into in the future could constrain our ability to grow our business.
Our current lenders have, and any future lender or lenders may have, fixed dollar claims on our assets that are senior to the claims of our stockholders and, thus, will have a preference over our stockholders with respect to our assets in the collateral pool. Our current credit facilities and borrowings also subject us to various financial and operating covenants, including, but not limited to, maintaining certain financial ratios and minimum tangible net worth amounts. Future credit facilities and borrowings will likely subject us to similar or additional covenants. In addition, we may grant a security interest in our assets in connection with any such credit facilities and borrowings.
 
Our credit facilities generally contain customary default provisions such as a minimum net worth amount, a profitability test, and a restriction on changing our business and loan quality standards. In addition, our credit facilities require or are expected to require the repayment of all outstanding debt on the maturity, which may disrupt our business and potentially the business of our portfolio companies that are financed through our credit facilities. An event of default under our credit facilities would likely result, among other things, in termination of the availability of further funds under our credit facilities and accelerated maturity dates for all amounts outstanding under our credit facilities, which would likely disrupt our business and, potentially, the business of the portfolio companies whose loans we finance through our credit facilities. This could reduce our revenues and, by delaying any cash payment allowed to us under our credit facilities until the lender has been paid in full, reduce our liquidity and cash flow and impair our ability to grow our business and maintain RIC tax treatment.
The terms of future available financing may place limits on our financial and operational flexibility. If we are unable to obtain sufficient capital in the future, we may be forced to reduce or discontinue our operations, not be able to make new investments, or otherwise respond to changing business conditions or competitive pressures.
Our quarterly and annual operating results are subject to fluctuation as a result of the nature of our business, and if we fail to achieve our investment objective, the net asset value of our common stock may decline.
We could experience fluctuations in our quarterly and annual operating results due to a number of factors, some of which are beyond our control, including, but not limited to, the interest rate payable on the debt securities that we acquire, the default rate on such securities, the level of our expenses, variations in and the timing of the recognition of realized and unrealized gains or losses, changes in our portfolio composition, the degree to which we encounter competition in our markets, market volatility in our publicly traded securities and the securities of our portfolio companies, and general economic conditions. As a result of these factors, results for any period should not be relied upon as being indicative of performance in future periods. In addition, any of these factors could negatively impact our ability to achieve our investment objectives, which may cause our net asset value of our common stock to decline.
Our investments may be in portfolio companies that may have limited operating histories and financial resources.
We expect that our portfolio will continue to consist of investments that may have relatively limited operating histories. These companies may be particularly vulnerable to U.S. and foreign economic downturns such as the U.S. recession that
began in mid-2007, the European
financial crisis,
and the COVID-19 related economic
downturn, may have more limited access to capital and higher funding costs, may have a weaker financial position and may need more capital to expand or compete. These businesses also may experience substantial variations in operating results. They may face intense competition, including from companies with greater financial, technical and marketing resources. Furthermore, some of these companies do business in regulated industries and could be affected by changes in government regulation. Accordingly, these factors could impair their cash flow or result in other events, such as bankruptcy, which could limit their ability to repay their obligations to us, and may adversely affect the return on, or the recovery of, our investment in these companies. We cannot assure you that any of our investments in our portfolio companies will be successful. Our portfolio companies compete with larger, more established companies with greater access to, and resources for, further development in these new technologies. Therefore, we may lose our entire investment in any or all of our portfolio companies.
There will be uncertainty as to the value of our portfolio investments, which may impact our net asset value.
A large percentage of our portfolio investments are in the form of securities that are not publicly traded. The fair value of securities and other investments that are not publicly traded may not be readily determinable. We value these securities on a quarterly basis in accordance with our valuation policy, which is at all times consistent with GAAP. Our board of directors will (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services; (5) oversee the reporting required by Rule
2a-5
under the 1940 Act; and (6) maintain recordkeeping requirements under Rule
2a-5.
Our board of directors utilizes the services of third-party valuation firms to aid it in determining the fair value of material assets. The board of directors discusses valuations and determines the fair value in good faith based on the input of our Investment Adviser and, when utilized, the respective third-party valuation firms. The factors that may be considered in fair value pricing our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments and its earnings, the markets in which the portfolio company does business, comparisons to publicly traded companies, discounted cash flow and other relevant factors. Because such valuations, and particularly valuations of private securities and private companies, are inherently uncertain, may fluctuate over short periods of time and may be based on estimates, our determinations of fair value may differ materially from the values that would have been used if a ready market for these securities existed. Our net asset value could be adversely affected if our determinations regarding the fair value of our investments were materially higher than the values that we ultimately realize upon the disposal of such securities.
 
Our equity ownership in a portfolio company may represent a control investment. Our ability to exit an investment in a timely manner because we are in a control position or have access to inside information in the portfolio company could result in a realized loss on the investment.
If we obtain a control investment in a portfolio company our ability to divest ourselves from a debt or equity investment could be restricted due to illiquidity in a private stock, limited trading volume on a public company’s stock, inside information on a company’s performance, insider blackout periods, or other factors that could prohibit us from disposing of the investment as we would if it were not a control investment. Additionally, we may choose not to take certain actions to protect a debt investment in a control investment portfolio company. As a result, we could experience a decrease in the value of our portfolio company holdings and potentially incur a realized loss on the investment.
There are significant potential conflicts of interest, including SLR Capital Partners’ management of other investment funds such as SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC, which could impact our investment returns, and an investment in SLR Investment Corp. is not an investment in SCP Private Credit Income BDC LLC, SLR HC BDC LLC, or SLR Private Credit BDC II LLC.
Our executive officers and directors, as well as the current and future partners of our Investment Adviser, SLR Capital Partners, may serve as officers, directors or principals of entities that operate in the same or a related line of business as we do. For example, SLR Capital Partners presently serves as the Investment Adviser to (i) SCP Private Credit Income BDC LLC, an unlisted BDC that focuses on investing primarily in senior secured
loans, including non-traditional asset-based loans
and first lien loans, (ii) SLR HC BDC LLC, an unlisted BDC whose principal focus is to invest directly and indirectly in senior secured loans and other debt instruments typically to middle market companies within the healthcare industry, and (iii) SLR Private Credit BDC II LLC, an unlisted BDC whose principal focus is to invest in first lien senior secured floating rate loans primarily to upper middle market leveraged companies with EBITDA between approximately $25 million and $250 million that have significant free cash flow and are in
non-cyclical
industries in which the Investment Adviser has significant experience. In addition, Michael S. Gross,
our Chairman, Co-Chief Executive Officer
and President, Bruce
Spohler, our Co-Chief Executive Officer
and Chief Operating Officer and board member, and Richard L. Peteka, our Chief Financial Officer, serve in similar capacities for SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC. Accordingly, they may have obligations to investors in those entities, the fulfillment of which obligations might not be in the best interests of us or our stockholders. In addition, we note that any affiliated investment vehicle formed in the future and managed by our Investment Adviser or its affiliates may, notwithstanding different stated investment objectives, have overlapping investment objectives with our own and, accordingly, may invest in asset classes similar to those targeted by us. As a result, SLR Capital Partners may face conflicts in allocating investment opportunities between us and such other entities. Although SLR Capital Partners will endeavor to allocate investment opportunities in a fair and equitable manner, it is possible that, in the future, we may not be given the opportunity to participate in investments made by investment funds managed by our Investment Adviser or an investment manager affiliated with our Investment Adviser. In any such case, when SLR Capital Partners identifies an investment, it will be forced to choose which investment fund should make the investment.
As a BDC, we were substantially limited in our
ability to co-invest in privately
negotiated transactions with affiliated funds until we obtained an exemptive order from the SEC. The most recent exemptive order, received on June 13, 2017 (the “Exemptive Order”), permits us to participate
in negotiated co-investment transactions with
certain affiliates, each of whose investment adviser is an investment adviser that controls, is controlled by or is under common control with SLR Capital Partners and is registered as an Investment Adviser under the Advisers Act, in a manner consistent with our investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, and pursuant to the conditions to the Exemptive Order. If we are unable to rely on the Exemptive Order for a particular opportunity, such opportunity will be allocated first to the entity whose investment strategy is the most consistent with the opportunity being allocated, and second, if the terms of the opportunity are consistent with more than one entity’s investment strategy, on an alternating basis. Although our investment professionals will endeavor to allocate investment opportunities in a fair and equitable manner, we and our common stockholders could be adversely affected to the extent investment opportunities are allocated among us and other investment vehicles managed or sponsored by, or affiliated with, our executive officers, directors and members of our Investment Adviser.
SLR Capital Partners and certain investment advisory affiliates may determine that an investment is appropriate for us and for one or more of those other funds. In such event, depending on the availability of such investment and other appropriate factors, SLR Capital Partners or its affiliates may determine that we
should invest side-by-side with one
or more other funds. Any such investments will be made only to the extent permitted by applicable law and interpretive positions of the SEC and its staff, and consistent with SLR Capital Partners’ allocation procedures. Related party transactions may occur among SLR Investment Corp., SLR Credit Solutions, Equipment Operating Leases LLC, Loyer Capital LLC, SLR Equipment Finance, SLR Business Credit, SLR Healthcare ABL, SLR Senior Lending Program LLC and SLR Senior Lending Program SPV LLC. These transactions may occur in the normal course of business. No administrative or other fees are paid to SLR Capital Partners by SLR Credit Solutions, Equipment Operating Leases LLC, Loyer Capital LLC, SLR Equipment Finance, SLR Business Credit, SLR Healthcare ABL, SLR Senior Lending Program LLC and SLR Senior Lending Program SPV LLC.
 
In the ordinary course of our investing activities, we pay management and incentive fees to SLR Capital Partners and reimburse SLR Capital Partners for certain expenses it incurs. As a result, investors in our common stock will invest on a “gross” basis and receive distributions on a “net” basis after expenses, resulting in a lower rate of return than an investor might achieve through direct investments. Accordingly, there may be times when the management team of SLR Capital Partners has interests that differ from those of our stockholders, giving rise to a conflict.
We entered into an amended and restated royalty-free license agreement on February 25, 2021 with our Investment Adviser, pursuant to which our Investment Adviser has granted
us a non-exclusive license to
use the marks “SOLAR” and “SLR.” Under the license agreement, we have the right to use the “SLR Investment” name for so long as SLR Capital Partners or one of its affiliates remains our Investment Adviser. In addition, we pay SLR Capital Management, an affiliate of SLR Capital Partners, our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions, and our allocable portion of the compensation of our chief compliance officer and our chief financial officer and their respective staffs. These arrangements create conflicts of interest that our board of directors must monitor.
Our ability to enter into transactions involving derivatives and financial commitment transactions may be limited.
Through comprehensive new global regulatory regimes impacting derivatives (
e.g.
, the Dodd-Frank Act, European Market Infrastructure Regulation (“EMIR”), Markets in Financial Investments Regulation (“MIFIR”)/Markets in Financial Instruments Directive (“MIFID II”)), certain
over-the-counter
derivatives transactions in which we may engage are either now or will soon be subject to various requirements, such as mandatory central clearing of transactions which include additional margin requirements and in certain cases trading on electronic platforms,
pre-and
post-trade transparency reporting requirements and mandatory
bi-lateral
exchange of initial margin for
non-cleared
swaps. The Dodd-Frank Act also created new categories of regulated market participants, such as “swap dealers,” “security-based swap dealers,” “major swap participants,” and “major security-based swap participants” who are subject to significant new capital, registration, recordkeeping, reporting, disclosure, business conduct and other regulatory requirements. The EU and some other jurisdictions are implementing similar requirements. Because these requirements are new and evolving (and some of the rules are not yet final), their ultimate impact remains unclear. However, even if we are not located in a particular jurisdiction or directly subject to the jurisdiction’s derivatives regulations, we may still be impacted to the extent we enter into a derivatives transaction with a regulated market participant or counterparty that is organized in that jurisdiction or otherwise subject to that jurisdiction’s derivatives regulations.
Based on information available as of the date of this annual report
on Form 10-K, the effect
of such requirements will be likely to (directly or indirectly) increase our overall costs of entering into derivatives transactions. In particular, new margin requirements, position limits and significantly higher capital charges resulting from new global capital regulations, even if not directly applicable to us, may cause an increase in the pricing of derivatives transactions entered into by market participants to whom such requirements apply or affect our overall ability to enter into derivatives transactions with certain counterparties. Such new global capital regulations and the need to satisfy the various requirements by counterparties are resulting in increased funding costs, increased overall transaction costs, and significantly affecting balance sheets, thereby resulting in changes to financing terms and potentially impacting our ability to obtain financing. Administrative costs, due to new requirements such as registration, recordkeeping, reporting, and compliance, even if not directly applicable to us, may also be reflected in our derivatives transactions. New requirements to trade certain derivatives transactions on electronic trading platforms and trade reporting requirements may lead to (among other things) fragmentation of the markets, higher transaction costs or reduced availability of derivatives, and/or a reduced ability to hedge, all of which could adversely affect the performance of certain of our trading strategies. In addition, changes to derivatives regulations may impact the tax and/or accounting treatment of certain derivatives, which could adversely impact us.
In November 2020, the SEC adopted new rules regarding the ability of a BDC (or a registered investment company) to use derivatives and other transactions that create future payment or delivery obligations. BDCs that use derivatives would be subject
to a value-at-risk leverage limit,
certain other derivatives risk management program and testing requirements and requirements related to board reporting. These new requirements would apply unless the BDC qualified as a “limited derivatives user,” as defined in the SEC’s adopted rules. A BDC that enters into reverse repurchase agreements or similar financing transactions would need to aggregate the amount of indebtedness associated with the reverse repurchase agreements or similar financing transactions could either (i) comply with the asset coverage requirements of the Section 18 of the 1940 Act when engaging in reverse repurchase agreements or (ii) choose to treat such agreements as derivative transactions under the adopted rule. Under the adopted rule, a BDC may enter into an unfunded commitment agreement that is not a derivatives transaction, such as an agreement to provide financing to a portfolio company, if the BDC has a reasonable belief, at the time it enters into such an agreement, that it will have sufficient cash and cash equivalents to meet its obligations with respect to all of its unfunded commitment agreements, in each case as it becomes due. If the BDC cannot meet this test, it is required to treat unfunded commitments as a derivatives transaction subject to the requirements of the rule. Collectively, these requirements may limit our ability to use derivatives and/or enter into certain other financial contracts.
 
We may be obligated to pay our Investment Adviser incentive compensation even if we incur a loss.
Our Investment Adviser will be entitled to incentive compensation for each fiscal quarter in an amount equal to a percentage of the excess
of our pre-incentive fee net
investment income for that quarter (before deducting incentive compensation) above a performance threshold for that quarter. Accordingly, since the performance threshold is based on a percentage of our net asset value, decreases in our net asset value make it easier to achieve the performance
threshold. Our pre-incentive fee net
investment income for incentive compensation purposes excludes realized and unrealized capital losses or depreciation that we may incur in the fiscal quarter, even if such capital losses or depreciation result in a net loss on our statement of operations for that quarter.
Thus, we may be required to pay SLR Capital Partners incentive compensation for a fiscal quarter even if there is a decline in the value of our portfolio or we incur a net loss for that quarter.
Our incentive fee may induce SLR Capital Partners to pursue speculative investments.
The incentive fee payable by us to SLR Capital Partners may create an incentive for SLR Capital Partners to pursue investments on our behalf that are riskier or more speculative than would be the case in the absence of such compensation arrangement. The incentive fee payable to our Investment Adviser is calculated based on a percentage of our return on invested capital. This may encourage our Investment Adviser to use leverage to increase the return on our investments. Under certain circumstances, the use of leverage may increase the likelihood of default, which would impair the value of our common stock. In addition, our Investment Adviser receives the incentive fee based, in part, upon net capital gains realized on our investments. Unlike that portion of the incentive fee based on income, there is no hurdle rate applicable to the portion of the incentive fee based on net capital gains. As a result, our Investment Adviser may have a tendency to invest more capital in investments that are likely to result in capital gains as compared to income producing securities. Such a practice could result in our investing in more speculative securities than would otherwise be the case, which could result in higher investment losses, particularly during economic downturns.
The incentive fee payable by us to our Investment Adviser also may induce SLR Capital Partners to invest on our behalf in instruments that have a deferred interest feature, even if such deferred payments would not provide the cash necessary to enable us to pay current distributions to our stockholders. Under these investments, we would accrue interest over the life of the investment but would not receive the cash income from the investment until the end of the term. Our net investment income used to calculate the income portion of our investment fee, however, includes accrued interest. Thus, a portion of this incentive fee would be based on income that we have not received in cash. In
addition, the “catch-up” portion of
the incentive fee may encourage SLR Capital Partners to accelerate or defer interest payable by portfolio companies from one calendar quarter to another, potentially resulting in fluctuations in timing and distribution amounts.
We may invest, to the extent permitted by law, in the securities and instruments of other investment companies, including private funds, and, to the extent we so invest, will bear our ratable share of any such investment company’s expenses, including management and performance fees. We will also remain obligated to pay management and incentive fees to SLR Capital Partners with respect to the assets invested in the securities and instruments of other investment companies. With respect to each of these investments, each of our stockholders will bear his or her share of the management and incentive fee of SLR Capital Partners as well as indirectly bearing the management and performance fees and other expenses of any investment companies in which we invest.
We may become subject to corporate-level U.S. federal income tax if we are unable to qualify and maintain our qualification for tax treatment as a regulated investment company under Subchapter M of the Code.
Although we have elected to be treated as a RIC under Subchapter M of the Code, no assurance can be given that we will continue to be able to qualify for and maintain RIC tax treatment. To maintain RIC tax treatment under the Code, we must meet the following annual distribution, income source and asset diversification requirements on an ongoing basis.
 
 
The Annual Distribution Requirement for a RIC will be satisfied if we distribute to our stockholders on an annual basis at least 90% of our net ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any. Because we may use debt financing, we are subject to certain asset coverage ratio requirements under the 1940 Act and financial covenants under loan and credit agreements that could, under certain circumstances, restrict us from making distributions necessary to satisfy the Annual Distribution Requirement. If we are unable to obtain cash from other sources, we could fail to qualify for RIC tax treatment and become subject to corporate-level U.S federal income tax.
 
 
The income source requirement will be satisfied if we obtain at least 90% of our income for each year from certain passive investments, including interest, dividends, gains from the sale of stock or securities, or similar sources.
 
 
The asset diversification requirement will be satisfied if we meet certain asset diversification requirements at the end of each quarter of our taxable year. Failure to meet those requirements may result in our having to dispose of certain investments quickly in order to prevent the loss of RIC tax treatment. Because most of our investments will be relatively illiquid, any such dispositions could be made at disadvantageous prices and could result in substantial losses.
If we fail to qualify for RIC tax treatment for any reason and become subject to corporate income tax, the resulting corporate taxes could substantially reduce our net assets, the amount of income available for distribution and the amount of our distributions. Such a failure could have a material adverse effect on us, the net asset value of our common stock and the total return, if any, obtainable from your investment in our common stock.
We may have difficulty satisfying the Annual Distribution Requirement in order to qualify and maintain RIC tax treatment if we recognize income before or without receiving cash representing such income.
In accordance with GAAP and tax requirements, we include in income certain amounts that we have not yet received in cash, such as contractual PIK interest, which represents contractual interest added to a loan balance and due at the end of such loan’s term. In addition to the cash yields received on our loans, in some instances, certain loans may also include any of
the following: end-of-term payments, exit
fees, balloon payment fees or prepayment fees. The increases in loan balances as a result of contractual PIK arrangements are included in income for the period in which such PIK interest was accrued, which is often in advance of receiving a cash payment, and are separately identified on our statements of cash flows. We also may be required to include in income certain other amounts prior to receiving the related cash.
Any warrants that we receive in connection with our debt investments will generally be valued as part of the negotiation process with the particular portfolio company. As a result, a portion of the aggregate purchase price for the debt investments and warrants will be allocated to the warrants that we receive. This will generally result in “original issue discount” for U.S. federal income tax purposes, which we must recognize as ordinary income, increasing the amount that we are required to distribute to qualify for the U.S. federal income tax benefits applicable to RICs. Because these warrants generally will not produce distributable cash for us at the same time as we are required to make distributions in respect of the related original issue discount, we would need to obtain cash from other sources or to pay a portion of our distributions using shares of newly issued common stock, consistent with Internal Revenue Service requirements, to satisfy the Annual Distribution and Excise Tax Avoidance requirements.
Other features of the debt instruments that we hold may also cause such instruments to generate original issue discount, resulting in a distribution requirement in excess of current cash interest received. Since in certain cases we may recognize income before or without receiving cash representing such income, we may have difficulty meeting the RIC tax requirement to distribute at least 90% of our net ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any. Under such circumstances, we may have to sell some of our investments at times we would not consider advantageous, raise additional debt or equity capital or reduce new investment originations to meet these distribution requirements. If we are unable to obtain cash from other sources and are otherwise unable to satisfy such distribution requirements, we may fail to qualify for the U.S. federal income tax benefits allowable to RICs and, thus, become subject to a corporate-level U.S. federal income tax on all our income.
Provisions of the Maryland General Corporation Law and of our charter and bylaws could deter takeover attempts and have an adverse impact on the price of our common stock.
The Maryland General Corporation Law and our charter and bylaws contain provisions that may discourage, delay or make more difficult a change in control of SLR Investment Corp. or the removal of our directors. We are subject to the Maryland Business Combination Act, subject to any applicable requirements of the 1940 Act. Our board of directors has adopted a resolution exempting from the Maryland Business Combination Act any business combination between us and any other person, subject to prior approval of such business combination by our board of directors, including approval by a majority of our disinterested directors. If the resolution exempting business combinations is repealed or our board of directors does not approve a business combination, the Maryland Business Combination Act may discourage third parties from trying to acquire control of us and increase the difficulty of consummating such an offer. Our bylaws exempt from the Maryland Control Share Acquisition Act (the “Control Share Act”) acquisitions of our stock by any person. If we amend our bylaws to repeal the exemption from the Control Share Act, the Control Share Act also may make it more difficult for a third party to obtain control of us and increase the difficulty of consummating such a transaction. The SEC staff has rescinded its position that, under the 1940 Act, an investment company may not avail itself of the Control Share Act. As a result, we will amend our bylaws to be subject to the Control Share Act only if our board of directors determines that it would be in our best interests.
 
We have also adopted measures that may make it difficult for a third party to obtain control of us, including provisions of our charter classifying our board of directors in three classes serving staggered three-year terms, and authorizing our board of directors to classify or reclassify shares of our stock in one or more classes or series, to cause the issuance of additional shares of our stock and to amend our charter without stockholder approval to increase or decrease the number of shares of stock that we have authority to issue. These provisions, as well as other provisions of our charter and bylaws, may delay, defer or prevent a transaction or a change in control that might otherwise be in the best interests of our stockholders.
The foregoing provisions are expected to discourage certain coercive takeover practices and inadequate takeover bids and to encourage persons seeking to acquire control of us to negotiate first with our board of directors. However, these provisions may deprive a stockholder of the opportunity to sell such stockholder’s shares at a premium to a potential acquirer. We believe that the benefits of these provisions outweigh the potential disadvantages of discouraging any such acquisition proposals because, among other things, the negotiation of such proposals may improve their terms. Our board of directors has considered both the positive and negative effects of the foregoing provisions and determined that they are in the best interest of our stockholders.
Our bylaws designate the Circuit Court for Baltimore City, Maryland as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders and provide that claims relating to causes of action under the Securities Act may only be brought in federal district courts, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers or agents, if any, and could discourage lawsuits against us and our directors, officers and agents, if any.
Our bylaws provide that, unless we consent in writing to the selection of an alternative forum, the Circuit Court for Baltimore City, Maryland, or, if that court does not have jurisdiction, the United States District Court for the District of Maryland, Northern Division, will be the sole and exclusive forum for (a) any Internal Corporate Claim, as such term is defined in the MGCL, (b) any derivative action or proceeding brought on our behalf (other than actions arising under federal securities laws), (c) any action asserting a claim of breach of any duty owed by any of our directors, officers or other agents to us or to our stockholders, (d) any action asserting a claim against us or any of our directors, officers or other agents arising pursuant to any provision of the MGCL or our charter or bylaws or (e) any other action asserting a claim against us or any of our directors, officers or other employees that is governed by the internal affairs doctrine. With respect to any proceeding described in the foregoing sentence that is in the Circuit Court for Baltimore City, Maryland, our stockholders consent to the assignment of the proceeding to the Business and Technology Case Management Program pursuant to Maryland
Rule 16-308 or
any successor thereof. None of the foregoing actions, claims or proceedings may be brought in any court sitting outside the State of Maryland unless we consent in writing to such court. Our bylaws do not apply to lawsuits asserting claims brought to enforce a duty or liability arising exclusively under the Securities Act, the 1934 Act, or the 1940 Act, or any other claim for which the federal courts have exclusive jurisdiction.
Unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States of America shall, to the fullest extent permitted by law, be the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. This paragraph does not apply to claims arising exclusively under the 1934 Act or the 1940 Act, or any other claim for which the federal courts have exclusive jurisdiction. These exclusive forum provisions may limit the ability of our stockholders to bring a claim in a judicial forum that such stockholders find favorable for disputes with us or our directors, officers, or agents, if any, which may discourage such lawsuits against us and our directors, officers, and agents, if any. Alternatively, if a court were to find the choice of forum provisions contained in our bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could materially adversely affect our business, financial condition, and operating results. For example, under the Securities Act, federal courts have concurrent jurisdiction over all suits brought to enforce any duty or liability created by the Securities Act, and investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder.
The failure in cyber security systems, as well as the occurrence of events unanticipated in our disaster recovery systems and management continuity planning could impair our ability to conduct business effectively.
The occurrence of a disaster, such as a cyber-attack against us or against a third party that has access to our data or networks, a natural catastrophe, an industrial accident, failure of our disaster recovery systems, or consequential employee error, could have an adverse effect on our ability to communicate or conduct business, negatively impacting our operations and financial condition. This adverse effect can become particularly acute if those events affect our electronic data processing, transmission, storage, and retrieval systems, or impact the availability, integrity, or confidentiality of our data.
We depend heavily upon computer systems to perform necessary business functions. Despite our implementation of a variety of security measures, our computer systems, networks, and data, like those of other companies, could be subject to cyber-attacks and unauthorized access, use, alteration, or destruction, such as from physical
and electronic break-ins or unauthorized
tampering. If one or more of these events occurs, it could potentially jeopardize the confidential, proprietary, and other information processed, stored in,
 
and transmitted through our computer systems and networks. Such an attack could cause interruptions or malfunctions in our operations, which could result in financial losses, litigation, regulatory penalties, client dissatisfaction or loss, reputational damage, and increased costs associated with mitigation of damages and remediation. If unauthorized parties gain access to such information and technology systems, they may be able to steal, publish, delete or modify private and sensitive information, including nonpublic personal information related to stockholders (and their beneficial owners) and material nonpublic information. The systems we have implemented to manage risks relating to these types of events could prove to be inadequate and, if compromised, could become inoperable for extended periods of time, cease to function properly or fail to adequately secure private information. Breaches such as those involving covertly introduced malware, impersonation of authorized users and industrial or other espionage may not be identified even with sophisticated prevention and detection systems, potentially resulting in further harm and preventing them from being addressed appropriately. The failure of these systems or of disaster recovery plans for any reason could cause significant interruptions in our and our Investment Adviser’s operations and result in a failure to maintain the security, confidentiality or privacy of sensitive data, including personal information relating to stockholders, material nonpublic information and other sensitive information in our possession.
A disaster or a disruption in the infrastructure that supports our business, including a disruption involving electronic communications or other services used by us or third parties with whom we conduct business, or directly affecting our headquarters, could have a material adverse impact on our ability to continue to operate our business without interruption. Our disaster recovery programs may not be sufficient to mitigate the harm that may result from such a disaster or disruption. In addition, insurance and other safeguards might only partially reimburse us for our losses, if at all.
Third parties with which we do business may also be sources of cybersecurity or other technological risk. We outsource certain functions and these relationships allow for the storage and processing of our information, as well as client, counterparty, employee, and borrower information. While we engage in actions to reduce our exposure resulting from outsourcing, ongoing threats may result in unauthorized access, loss, exposure, destruction, or other cybersecurity incident that affects our data, resulting in increased costs and other consequences as described above.
In addition, cybersecurity has become a top priority for global lawmakers and regulators around the world, and some jurisdictions have proposed or enacted laws requiring companies to notify regulators and individuals of data security breaches involving certain types of personal data. In particular, state and federal laws and regulations related to cybersecurity compliance continue to evolve and change, which may require substantial investments in new technology, software and personnel, which could affect the Company’s profitability. These changes may also result in enhanced and unforeseen consequences for cyber-related breaches and incidents, which may further adversely affect the Company’s profitability. If we fail to comply with the relevant and increasing laws and regulations, we could suffer financial losses, a disruption of our businesses, liability to investors, regulatory intervention or reputational damage.
We and our service providers may be impacted by quarantines and similar measures being enacted by governments in response to
the global COVID-19 pandemic, which
are obstructing the regular functioning of business workforces (including requiring employees to work from external locations and their homes). Policies of remote working, whether by us or by our service providers, could strain technology resources, introduce operational risks and otherwise heighten the risks described above. Remote working environments may be less secure and more susceptible to hacking attacks, including phishing and social engineering attempts.
We, our Investment Adviser and our portfolio companies are subject to risks associated with “phishing” and other cyber-attacks.
Our business and the business of our portfolio companies rely upon secure information technology systems for data processing, storage and reporting. Despite careful security and controls design, implementation and updating, ours and our portfolio companies’ information technology systems could become subject to cyber-attacks. Cyber-attacks include, but are not limited to, gaining unauthorized access to digital systems (e.g., through “hacking”, malicious software coding, social engineering or “phishing” attempts) for purposes of misappropriating assets or sensitive information, corrupting data, or causing operational disruption. The risk of a security breach or disruption, particularly through cyber-attacks or cyber intrusions, including by computer hackers, nation-state affiliated actors, and cyber terrorists, has generally increased as the number, intensity and sophistication of attempted attacks and intrusions from around the world have increased. Cyber-attacks may also be carried out in a manner that does not require gaining unauthorized access, such
as causing denial-of service attacks
on websites (i.e., efforts to make network services unavailable to intended users). Our Investment Adviser’s employees have been and expect to continue to be the target of fraudulent calls, emails and other forms of potentially malicious or otherwise negatively impacting activities and attempts to gain unauthorized access to confidential, personal or other sensitive information. The result of these incidents may include disrupted operations, misstated or unreliable financial data, liability for stolen information, investigations, misappropriation of assets, increased cybersecurity protection and insurance costs, litigation and damage to our business relationships, regulatory fines or penalties, or other adverse effects on our business, financial condition or results of operations. In addition, we may be required to expend significant additional resources to modify our protective measures and to investigate and remediate vulnerabilities or other exposures arising from operational and security risks related to cyber-attacks.
 
Our Investment Adviser’s and other service providers’ increased use of mobile and cloud technologies could heighten the risk of a cyber-attack as well as other operational risks, as certain aspects of the security of such technologies may be complex, unpredictable or beyond their control. Our Investment Adviser’s and other service providers’ reliance on mobile or cloud technology or any failure by mobile technology and cloud service providers to adequately safeguard their systems and prevent cyber-attacks could disrupt their operations and result in misappropriation, corruption or loss of personal, confidential or proprietary information. In addition, there is a risk that encryption and other protective measures against cyber-attacks may be circumvented, particularly to the extent that new computing technologies increase the speed and computing power available. Even the most well-protected information, networks, systems and facilities remain potentially vulnerable because the techniques used in such attempted security breaches evolve and generally are not recognized until launched against a target, and in some cases are designed not to be detected and, in fact, may not be detected. Accordingly, we and our service providers may be unable to anticipate these techniques or to implement adequate security barriers or other preventative measures, and thus it is impossible for us and our service providers to entirely mitigate this risk. Cybersecurity risks require continuous and increasing attention and other resources from us to, among other actions, identify and quantify these risks, upgrade and expand our technologies, systems and processes to adequately address such risks. Such attention diverts time and other resources from other activities and there is no assurance that our efforts will be effective.
Cybersecurity incidents may adversely impact us and our stockholders. There is no guarantee that we, the Investment Adviser, and/or their respective service providers will be successful in protecting against cybersecurity incidents.
We can be highly dependent on information systems and systems failures could significantly disrupt our business, which may, in turn, negatively affect the market price of our common stock and our ability to pay distributions.
Our business is highly dependent upon our and third parties’ communications and information systems. Any failure or interruption of those systems, including as a result of the termination of an agreement with any third-party service providers, could cause delays or other problems in our activities. Our financial, accounting, data processing, backup or other operating systems and facilities may fail to operate properly or become disabled or damaged as a result of a number of factors including events that are wholly or partially beyond our control and adversely affect our business. There could be:
 
 
sudden electrical or telecommunications outages;
 
 
natural disasters such as earthquakes, tornadoes and hurricanes;
 
 
events arising from local or larger scale political or social matters, including terrorist acts; and
 
 
cyber-attacks.
These events, in turn, could have a material adverse effect on our operating results and negatively affect the market price of our common stock and our ability to pay distributions to our stockholders.
Communications with shareholders may be delivered electronically and there may be certain costs and possible risks associated with such electronic delivery. Moreover, the Investment Adviser cannot provide any assurance that these communication methods are secure and will not be responsible for any computer viruses, problems or malfunctions resulting from the use of such communication methods.
Our board of directors may change our investment objective, operating policies and strategies without prior notice or stockholder approval.
Our board of directors has the authority to modify or waive certain of our operating policies and strategies without prior notice (except as required by the 1940 Act) and without stockholder approval. However, absent stockholder approval, we may not change the nature of our business so as to cease to be, or withdraw our election as a BDC. We cannot predict the effect any changes to our current operating policies and strategies would have on our business, operating results and the value of our stock. Nevertheless, the effects may adversely affect our business and impact our ability to make distributions.
Our business is subject to increasingly complex corporate governance, public disclosure and accounting requirements that could adversely affect our business and financial results.
We are subject to changing rules and regulations of federal and state government as well as the stock exchange on which our common stock is listed. These entities, including the Public Company Accounting Oversight Board, the SEC and the NASDAQ Stock Market, have issued a significant number of new and increasingly complex requirements and regulations over the course of the last several years and continue to develop additional regulations and requirements in response to laws enacted by Congress. Our efforts to comply with these existing requirements, or any revised or amended requirements, have resulted in, and are likely to continue to result in, an increase in expenses and a diversion of management’s time from other business activities.
 
Changes in laws or regulations governing our operations may adversely affect our business.
Changes in the laws or regulations, or the interpretations of the laws and regulations, which govern BDCs,
RICs or non-depository commercial lenders
could significantly affect our operations and our cost of doing business. We are subject to federal, state and local laws and regulations and are subject to judicial and administrative decisions that affect our operations, including our loan originations, maximum interest rates, fees and other charges, disclosures to portfolio companies, the terms of secured transactions, collection and foreclosure procedures, and other trade practices. If these laws, regulations or decisions change, or if we expand our business into jurisdictions that have adopted more stringent requirements than those in which we currently conduct business, then we may have to incur significant expenses in order to comply or we may have to restrict our operations. In addition, if we do not comply with applicable laws, regulations and decisions, then we may lose licenses needed for the conduct of our business and be subject to civil fines and criminal penalties, any of which could have a material adverse effect upon our business results of operations or financial condition.
Changes to United States tariff and import/export regulations may have a negative effect on our portfolio companies and, in turn, harm us.
There has been ongoing discussion and commentary regarding potential significant changes to United States trade policies, treaties and tariffs. The current administration, along with Congress, has created significant uncertainty about the future relationship between the United States and other countries with respect to the trade policies, treaties and tariffs. These developments, or the perception that any of them could occur, may have a material adverse effect on global economic conditions and the stability of global financial markets, and may significantly reduce global trade and, in particular, trade between the impacted nations and the United States. Any of these factors could depress economic activity and restrict our portfolio companies’ access to suppliers or customers and have a material adverse effect on their business, financial condition and results of operations, which in turn would negatively impact us.
Our Investment Adviser can resign on 60 days’ notice, and we may not be able to find a suitable replacement within that time, resulting in a disruption in our operations that could adversely affect our financial condition, business and results of operations.
Our Investment Adviser has the right, under the Advisory Agreement, to resign at any time upon 60 days written notice, whether we have found a replacement or not. If our Investment Adviser resigns, we may not be able to find a new investment adviser or hire internal management with similar experience and ability to provide the same or equivalent services on acceptable terms within 60 days, or at all. If we are unable to do so quickly, our operations are likely to experience a disruption, our financial condition, business and results of operations as well as our ability to pay distributions are likely to be adversely affected and the market price of our shares may decline. In addition, the coordination of our internal management and investment activities is likely to suffer if we are unable to identify and reach an agreement with a single institution or group of executives having the experience possessed by our Investment Adviser and its affiliates. Even if we are able to retain comparable management, whether internal or external, the integration of such management and their lack of familiarity with our investment objective may result in additional costs and time delays that may adversely affect our financial condition, business and results of operations.
General Risk Factors
Volatility or a prolonged disruption in the credit markets could materially damage our business.
We are required to record our assets at fair value, as determined in good faith by our board of directors, in accordance with our valuation policy. As a result, volatility in the capital markets may have a material adverse effect on our valuations and our net asset value, even if we hold investments to maturity. Volatility or dislocation in the capital markets may depress our stock price below our net asset value per share and create a challenging environment in which to raise equity and debt capital. These conditions could continue for a prolonged period of time or worsen in the future. While these conditions persist, we and other companies in the financial services sector may have to access, if available, alternative markets for debt and equity capital. Equity capital may be difficult to raise because, subject to some limited exceptions which apply to us, as a BDC we are generally not able to issue additional shares of our common stock at a price less than net asset value without first obtaining approval for such issuance from our stockholders and our independent directors. Any offering of our common stock that requires stockholder approval must occur, if at all, within one year after receiving such stockholder approval. In addition, our ability to incur indebtedness (including by issuing preferred stock) is limited by applicable regulations such that our asset coverage, as defined in the 1940 Act, must equal at least 150% immediately after each time we incur indebtedness. The debt capital that will be available, if at all, may be at a higher cost and on less favorable terms and conditions in the future. Any inability to raise capital could have a negative effect on our business, financial condition and results of operations.
 
Additionally, our ability to incur indebtedness is limited by the asset coverage ratio for a BDC, as defined under the 1940 Act. Declining portfolio values negatively impact our ability to borrow additional funds because our net asset value is reduced for purposes of the asset coverage ratio. If the fair value of our assets declines substantially, we may fail to maintain the asset coverage ratio stipulated by the 1940 Act, which could, in turn, cause us to lose our status as a BDC and materially impair our business operations. A lengthy disruption in the credit markets could also materially decrease demand for our investments.
The significant disruption in the capital markets experienced in the past, including the disruption caused
by the COVID-19 pandemic
and the Russian invasion of Ukraine, have had, and may in the future have, a negative effect on the valuations of our investments and on the potential for liquidity events involving our investments. The debt capital that may be available to us in the future may be at a higher cost and have less favorable terms and conditions than those currently in effect. If our financing costs increase and we have no increase in interest income, then our net investment income will decrease. A prolonged inability to raise capital may require us to reduce the volume of investments we originate and could have a material adverse impact on our business, financial condition and results of operations. This may also increase the probability that other structural risks will negatively impact us. These situations may arise due to circumstances that we may be unable to control, such as a lengthy disruption in the credit markets, a severe decline in the value of the U.S. dollar, a sharp economic downturn or recession or an operational problem that affects third parties or us, and could materially damage our business, financial condition and results of operations.
Global economic, regulatory and market conditions may adversely affect our business, results of operations and financial condition, including our revenue growth and profitability.
We and our portfolio companies are subject to regulation by laws at the U.S. federal, state and local levels. These laws and regulations, as well as their interpretation, could change from time to time, including as the result of interpretive guidance or other directives from the U.S. President and others in the executive branch, and new laws, regulations and interpretations could also come into effect. Any such new or changed laws or regulations could have a material adverse effect on our business, and political uncertainty could increase regulatory uncertainty in the near term.
The effects of legislative and regulatory proposals directed at the financial services industry or affecting taxation, could negatively impact the operations, cash flows or financial condition of us and our portfolio companies, impose additional costs on us or our portfolio companies, intensify the regulatory supervision of us or our portfolio companies or otherwise adversely affect our business or the business of our portfolio companies. In addition, if we do not comply with applicable laws and regulations, we could lose any licenses that we then hold for the conduct of business and could be subject to civil fines and criminal penalties.
Over the last several years, there also has been an increase in regulatory attention to the extension of credit outside of the traditional banking sector, raising the possibility that some portion
of the non-bank financial sector
will be subject to new regulation. While it cannot be known at this time whether any regulation will be implemented or what form it will take, increased
regulation of non-bank credit extension
could negatively impact our operations, cash flows or financial condition, impose additional costs on us, intensify the regulatory supervision of us or otherwise adversely affect our business, financial condition and results of operations.
Although we cannot predict the impact, if any, of these changes to our business, they could adversely affect our business, financial condition, operating results and cash flows. Until we know what policy changes are made and how those changes impact business and the business of our competitors over the long term, we will not know if, overall, it will benefit from them or be negatively affected by them.
Deterioration in the economic conditions in the Eurozone and other regions or countries globally and the resulting instability in global financial markets may pose a risk to our business. Financial markets have been affected at times by a number of global macroeconomic events, including the following: large sovereign debts and fiscal deficits of several countries in Europe and in emerging markets jurisdictions, levels of
non-performing
loans on the balance sheets of European banks, the effect of the United Kingdom leaving the European Union, instability in the Chinese capital markets and the
COVID-19
pandemic.
Various social and political circumstances in the U.S. and around the world (including wars and other forms of conflict, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics), may also contribute to increased market volatility and economic uncertainties or deterioration in the U.S. and worldwide. Such events, including rising trade tensions between the United States and China, other uncertainties regarding actual and potential shifts in U.S. and foreign, trade, economic and other policies with other countries, the large-scale invasion of Ukraine by Russia that began in February 2022 and resulting sanctions or other restrictive actions that the United States and other countries have imposed against Russia, and
the COVID-19 pandemic,
could adversely affect our business, financial condition or results of operations. These market and economic disruptions could negatively impact the operating results of our portfolio companies.
 
In addition, Russia’s invasion of Ukraine and corresponding events have had, and could continue to have, severe adverse effects on regional and global economic markets. Following Russia’s actions, various governments, including the United States, have issued broad-ranging economic sanctions against Russia, including, among other actions, a prohibition on doing business with certain Russian companies, large financial institutions, officials and oligarchs; a commitment by certain countries and the European Union to remove selected Russian banks from the Society for Worldwide Interbank Financial Telecommunications, the electronic banking network that connects banks globally; and restrictive measures to prevent the Russian Central Bank from undermining the impact of the sanctions. The duration of hostilities and the vast array of sanctions and related events (including cyberattacks and espionage) cannot be predicted. Furthermore, the conflict between the two nations and the varying involvement of the United States and other NATO countries could preclude prediction as to their ultimate adverse impact on global economic and market conditions, and, as a result, presents material uncertainty and risk with respect to markets globally, which pose potential adverse risks to us and the performance of our investments and operations, and our ability to achieve our investment objectives. Additionally, to the extent that third parties, investors, or related customer bases have material operations or assets in Russia or Ukraine, they may have adverse consequences related to the ongoing conflict. Any such market disruptions could affect our portfolio companies’ operations and, as a result, could have a material adverse effect on our business, financial condition and results of operations.
Additionally, the Federal Reserve raised the Federal Funds Rate in 2022 and in 2023, and may raise or announce its intention to raise the Federal Funds Rate further. These developments, along with the United States government’s credit and deficit concerns, global economic uncertainties and market volatility and the impacts
of COVID-19, could
cause interest rates to be volatile, which may negatively impact our ability to access the debt markets and capital markets on favorable terms.
Events outside of our control, including
the COVID-19 public
health crises, could negatively affect our portfolio companies and our results of our operations.
Periods of market volatility have occurred and could continue to occur in response to pandemics or other events outside of our control. These types of events have adversely affected and could continue to adversely affect operating results for us and for our portfolio companies. For example, the
COVID-19
pandemic has adversely impacted global commercial activity and contributed to significant volatility in the equity and debt markets. The
COVID-19
pandemic and restrictive measures taken to contain or mitigate its spread have caused, and may continue to cause, business shutdowns, or the
re-introduction
of business shutdowns, cancellations of events and restrictions on travel, significant reductions in demand for certain goods and services, reductions in business activity and financial transactions, supply chain interruptions, labor shortages, increased inflationary pressure and overall economic and financial market instability both globally and in the United States. Many states, including those in which we and portfolio companies in which we invest may operate, have previously issued orders requiring the closure of, or certain restrictions on the operation of, certain businesses. The ultimate duration and severity of the
COVID-19
pandemic, including
COVID-19
variants, remain uncertain. While several countries, as well as certain states, counties and cities in the United States, relaxed the public health restrictions throughout 2021 partly as a result of the introduction of vaccines, recurring
COVID-19
outbreaks caused by different virus variants continue to lead to the
re-introduction
of certain restrictions in certain states in the United States and globally. Even after the
COVID-19
pandemic subsides, the U.S. economy and most other major global economies may continue to experience a recession, and our business and operations, as well as the business and operations of the portfolio companies in which we invest, could be materially adversely affected by a prolonged recession in the U.S. and other major markets.
Despite actions of the U.S. federal government and foreign governments, the uncertainty surrounding the
COVID-19
pandemic, including uncertainty regarding existing or future variants and other factors, has contributed to significant volatility in the global public equity markets and global debt capital markets.
The continued uncertainty related to the sustainability and pace of economic recovery in the U.S. and globally could have a negative impact on our business.
Our business is directly influenced by the economic cycle, and could be negatively impacted by a downturn in economic activity in the U.S. as well as globally. Fiscal and monetary actions taken by
U.S. and non-U.S. government and
regulatory authorities could have a material adverse impact on our business. To the extent uncertainty regarding the U.S. or global economy, including as a result of
the global COVID-19 pandemic, negatively
impacts consumer confidence and consumer credit factors, our business, financial condition and results of operations could be adversely affected. Moreover, Federal Reserve policy, including with respect to certain interest rates and the decision to end its quantitative easing policy, along with the general policies of the current Presidential administration, may also adversely affect the value, volatility and liquidity of dividend- and interest-paying securities. Market volatility, periods of rising interest rates, such as the current economic period, and/or a return to unfavorable economic conditions could adversely affect our business.
 
There is uncertainty surrounding potential legal, regulatory and policy changes by new presidential administrations in the United States that may directly affect financial institutions and the global economy.
The current administration has called for significant changes to U.S. trade, healthcare, immigration, foreign and government regulatory policy. In this regard, there is significant uncertainty with respect to legislation, regulation and government policy at the federal level, as well as the state and local levels. Recent events have created a climate of heightened uncertainty and introduced new and
difficult-to-quantify
macroeconomic and political risks with potentially
far-reaching
implications. There has been a corresponding meaningful increase in the uncertainty surrounding interest rates, inflation, foreign exchange rates, trade volumes and fiscal and monetary policy. To the extent the U.S. Congress or the current administration implements changes to U.S. policy, those changes may impact, among other things, the U.S. and global economy, international trade and relations, unemployment, immigration, corporate taxes, healthcare, the U.S. regulatory environment, inflation and other areas. Although we cannot predict the impact, if any, of these changes to our business, they could adversely affect our business, financial condition, operating results and cash flows. Until we know what policy changes are made and how those changes impact our business and the business of our competitors over the long term, we will not know if, overall, we will benefit from them or be negatively affected by them.
We are exposed to risks associated with changes in interest rates, including the transition away from LIBOR and the adoption of alternative reference rates.
Although we no longer intend to lend at rates based on the London Interbank Offered Rate (“LIBOR”), we may acquire loans that continue to use LIBOR. While many LIBOR rates were phased out at the end of 2021, a selection of widely used U.S.-dollar LIBOR rates will continue to be published until June 2023. On July 29, 2021, the U.S. Federal Reserve System, in conjunction with the Alternative Reference Rates Committee, a steering committee comprised of large U.S. financial institutions, formally recommended replacing U.S.-dollar LIBOR with the Secured Overnight Financing Rate (“SOFR”), a new index calculated by short-term repurchase agreements, backed by Treasury securities. Further, on March 15, 2022, the Consolidation Appropriations Act of 2022, which includes the Adjustable Interest Rate (LIBOR) Act (“LIBOR Act”), was signed into law in the U.S. This legislation establishes a uniform benchmark replacement process for financial contracts that mature after June 30, 2023 which do not contain clearly defined or practicable fallback provisions. The legislation also creates a safe harbor that shields lenders from litigation if they choose to utilize a replacement rate recommended by the Board of Governors of the Federal Reserve. Although the transition process away from LIBOR has become increasingly well-defined (e.g. the LIBOR Act now provides a uniform benchmark replacement for LIBOR-based instruments in the U.S.), the transition process may involve, among other things, increased volatility or illiquidity in markets for instruments that currently rely on LIBOR and may result in a reduction in the value of certain instruments that we may acquire. Further, disruptions related to loans in the marketplace could have a material adverse effect on the ability of the Investment Adviser or its affiliates to enter into loans in the future in accordance with our investment strategy and have a material adverse effect on us.
Inflation and a rising interest rate environment may adversely affect the business, results of operations and financial condition of us and our portfolio companies.
The current macroeconomic environment is characterized by record-high inflation, supply chain challenges, labor shortages, high interest rates, foreign currency exchange volatility, volatility in global capital markets and growing recession risk. The risks associated with the Company’s and our portfolio companies’ businesses are more severe during periods of economic slowdown or recession.
Any disruptions in the capital markets, as a result of inflation and a rising interest environment or otherwise, may increase the spread between the yields realized on risk-free and higher risk securities and can result in illiquidity in parts of the capital markets, significant write-offs in the financial sector and
re-pricing
of credit risk in the broadly syndicated market. These and any other unfavorable economic conditions could increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us.
In addition, market conditions (including inflation, supply chain issues and decreased consumer demand) have adversely impacted, and could in the future further impact, the operations of certain of our portfolio companies. If the financial results of middle-market companies, like those in which we invest, experience deterioration, it could ultimately lead to difficulty in meeting debt service requirements and an increase in defaults, and further deterioration in market conditions will further depress the outlook for those companies. Further, adverse economic conditions decreased and may in the future decrease the value of collateral securing some of our loans and the value of our equity investments. Such conditions have required and may in the future require us to modify the payment terms of our investments, including changes in PIK interest provisions and/or cash interest rates. The performance of certain of our portfolio companies has been, and in the future may be, negatively impacted by these economic or other conditions, which can result in our receipt of reduced interest income from our portfolio companies and/or realized and unrealized losses related to our investments, and, in turn, may adversely affect distributable income and have a material adverse effect on our results of operations.
Inflation may cause the real value of our investments to decline.
Inflation risk results from the variation in the value of cash flows from a security due to inflation, as measured in terms of purchasing power. We are exposed to inflation risk with respect to any fixed rate investments that we make, if any, because the interest rate the issuer has to pay us is fixed for the life of the security. To the extent that interest rates reflect the expected inflation rate, floating rate loans have a lower level of inflation risk.
 
Technological innovations and industry disruptions may negatively impact us.
Technological innovations have disrupted traditional approaches in multiple industries and can permit younger companies to achieve success and in the process disrupt markets and market practices. We can provide no assurance that new businesses and approaches will not be created that would compete with us and/or our portfolio companies or alter the market practices in which SLR Capital Partners and its affiliates and us have been designed to function within and on which we depend on for our investment return. New approaches could damage our investments, disrupt the market in which we operate and subject us to increased competition, which could materially and adversely affect our business, financial condition and results of investments.
We are subject to risks related to corporate social responsibility.
Our business (including that of our portfolio companies) faces increasing public scrutiny related to environmental, social and governance (“ESG”) activities, which are increasingly considered to contribute to reducing a company’s operational risk, market risk and reputational risk, which may in turn impact the long-term sustainability of a company’s performance. A variety of organizations measure the performance of companies on ESG topics, and the results of these assessments are widely publicized. In addition, investment in funds that specialize in companies that perform well in such assessments are increasingly popular, and major institutional investors have publicly emphasized the importance of such ESG measures to their investment decisions. We risk damage to our brand and reputation if we fail to act responsibly in a number of areas, including, but not limited to, diversity, equity and inclusion, human rights, climate change, environmental stewardship, corporate governance and considering ESG factors in our investment processes. Adverse incidents with respect to ESG activities could impact the value of our brand, our relationship with existing and future portfolio companies, the cost of our operations and relationships with investors, all of which could adversely affect our business and results of operations.
However, regional and investor specific sentiment may differ in what constitutes a material positive or negative ESG corporate practice. There is no guarantee that the Company’s corporate social responsibility practices will uniformly fit every investor’s definition of best practices for all environmental, social and governance considerations across geographies and investor types.
There is also a growing regulatory interest across jurisdictions in improving transparency regarding the definition, measurement and disclosure of ESG factors in order to allow investors to validate and better understand sustainability claims. For example, the SEC has proposed, or has announced that it is working on proposals for, rules that, among other matters, would establish a framework for reporting of climate-related risks, corporate and fund carbon emissions, broad diversity and capital management. At this time, there is uncertainty regarding the scope of such proposals or when they would become effective (if at all). In addition, in 2021 the SEC established an enforcement task force to look into ESG practices and disclosures by public companies and investment managers and has started to bring enforcement actions based on ESG disclosures not matching actual investment processes. We and our portfolio companies are subject to the risk that similar measures might be introduced in other jurisdictions in the future. Additionally, compliance with any new laws or regulations increases our regulatory burden and could make compliance more difficult and expensive, affect the manner in which we or our portfolio companies conduct our businesses and adversely affect our profitability.
The effect of global climate change may impact the operations of our portfolio companies.
There may be evidence of global climate change. Climate change creates physical and financial risk and some of our portfolio companies may be adversely affected by climate change. For example, the needs of customers of energy companies vary with weather conditions, primarily temperature and humidity. To the extent weather conditions are affected by climate change, energy use could increase or decrease depending on the duration and magnitude of any changes. Increases in the cost of energy could adversely affect the cost of operations of our portfolio companies if the use of energy products or services is material to their business. A decrease in energy use due to weather changes may affect some of our portfolio companies’ financial condition, through decreased revenues. Extreme weather conditions in general require more system backup, adding to costs, and can contribute to increased system stresses, including service interruptions. Energy companies could also be affected by the potential for lawsuits against or taxes or other regulatory costs imposed on greenhouse gas emitters, based on links drawn between greenhouse gas emissions and climate change.
In December 2015, the United Nations, of which the U.S. is a member, adopted a climate accord with the long-term goal of limiting global warming and the short-term goal of significantly reducing greenhouse gas emissions. As a result, some of our portfolio companies may become subject to new or strengthened regulations or legislation, which could increase their operating costs and/or decrease their revenues.
 
We cannot predict how changes in tax law will affect us, our investments, or our stockholders, and any such legislation could adversely affect our business.
Legislative or other actions relating to taxes could have a negative effect on us. The rules dealing with U.S. federal income taxation are constantly under review by persons involved in the legislative process and by the Internal Revenue Service and the U.S. Treasury Department. New legislation and any other tax law developments, including new or revised U.S. Treasury regulations, administrative interpretations or court decisions, could negatively and perhaps retroactively affect our ability to qualify for tax treatment as a RIC or the U.S. federal income tax consequences to us and our shareholders, or could have other adverse consequences. Investors are urged to consult with their tax advisor regarding tax legislative, regulatory, or administrative developments and proposals and their potential effect on an investment in our common stock.
Uncertainty about U.S. government initiatives could negatively impact our business, financial condition and results of operations.
The U.S. government has recently called for significant changes to U.S. trade, healthcare, immigration, foreign and government regulatory policy. In this regard, there is significant uncertainty with respect to legislation, regulation and government policy at the federal level, as well as the state and local levels. Recent events have created a climate of heightened uncertainty and introduced
new and difficult-to-quantify macroeconomic and
political risks
with potentially far-reaching implications. There
has been a corresponding meaningful increase in the uncertainty surrounding interest rates, inflation, foreign exchange rates, trade volumes and fiscal and monetary policy. To the extent the U.S. Congress or the current administration implements changes to U.S. policy, those changes may impact, among other things, the U.S. and global economy, international trade and relations, unemployment, immigration, corporate taxes, healthcare, the U.S. regulatory environment, inflation and other areas.
A particular area identified as subject to potential change, amendment or repeal includes the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the “Dodd-Frank Act,” including the Volcker Rule and various swaps and derivatives regulations, credit risk retention requirements and the authorities of the Federal Reserve, the Financial Stability Oversight Council and the SEC. Given the uncertainty associated with the manner in which and whether the provisions of the Dodd-Frank Act will be implemented, repealed, amended, or replaced, the full impact such requirements will have on our business, results of operations or financial condition is unclear. The changes resulting from the Dodd-Frank Act or any changes to the regulations already implemented thereunder may require us to invest significant management attention and resources to evaluate and make necessary changes in order to comply with new statutory and regulatory requirements. Failure to comply with any such laws, regulations or principles, or changes thereto, may negatively impact our business, results of operations or financial condition. While we cannot predict what effect any changes in the laws or regulations or their interpretations would have on us as a result of recent financial reform legislation, these changes could be materially adverse to us and our stockholders.
                 
Risk [Text Block]                
General Risk Factors
Volatility or a prolonged disruption in the credit markets could materially damage our business.
We are required to record our assets at fair value, as determined in good faith by our board of directors, in accordance with our valuation policy. As a result, volatility in the capital markets may have a material adverse effect on our valuations and our net asset value, even if we hold investments to maturity. Volatility or dislocation in the capital markets may depress our stock price below our net asset value per share and create a challenging environment in which to raise equity and debt capital. These conditions could continue for a prolonged period of time or worsen in the future. While these conditions persist, we and other companies in the financial services sector may have to access, if available, alternative markets for debt and equity capital. Equity capital may be difficult to raise because, subject to some limited exceptions which apply to us, as a BDC we are generally not able to issue additional shares of our common stock at a price less than net asset value without first obtaining approval for such issuance from our stockholders and our independent directors. Any offering of our common stock that requires stockholder approval must occur, if at all, within one year after receiving such stockholder approval. In addition, our ability to incur indebtedness (including by issuing preferred stock) is limited by applicable regulations such that our asset coverage, as defined in the 1940 Act, must equal at least 150% immediately after each time we incur indebtedness. The debt capital that will be available, if at all, may be at a higher cost and on less favorable terms and conditions in the future. Any inability to raise capital could have a negative effect on our business, financial condition and results of operations.
 
Additionally, our ability to incur indebtedness is limited by the asset coverage ratio for a BDC, as defined under the 1940 Act. Declining portfolio values negatively impact our ability to borrow additional funds because our net asset value is reduced for purposes of the asset coverage ratio. If the fair value of our assets declines substantially, we may fail to maintain the asset coverage ratio stipulated by the 1940 Act, which could, in turn, cause us to lose our status as a BDC and materially impair our business operations. A lengthy disruption in the credit markets could also materially decrease demand for our investments.
The significant disruption in the capital markets experienced in the past, including the disruption caused
by the COVID-19 pandemic
and the Russian invasion of Ukraine, have had, and may in the future have, a negative effect on the valuations of our investments and on the potential for liquidity events involving our investments. The debt capital that may be available to us in the future may be at a higher cost and have less favorable terms and conditions than those currently in effect. If our financing costs increase and we have no increase in interest income, then our net investment income will decrease. A prolonged inability to raise capital may require us to reduce the volume of investments we originate and could have a material adverse impact on our business, financial condition and results of operations. This may also increase the probability that other structural risks will negatively impact us. These situations may arise due to circumstances that we may be unable to control, such as a lengthy disruption in the credit markets, a severe decline in the value of the U.S. dollar, a sharp economic downturn or recession or an operational problem that affects third parties or us, and could materially damage our business, financial condition and results of operations.
Global economic, regulatory and market conditions may adversely affect our business, results of operations and financial condition, including our revenue growth and profitability.
We and our portfolio companies are subject to regulation by laws at the U.S. federal, state and local levels. These laws and regulations, as well as their interpretation, could change from time to time, including as the result of interpretive guidance or other directives from the U.S. President and others in the executive branch, and new laws, regulations and interpretations could also come into effect. Any such new or changed laws or regulations could have a material adverse effect on our business, and political uncertainty could increase regulatory uncertainty in the near term.
The effects of legislative and regulatory proposals directed at the financial services industry or affecting taxation, could negatively impact the operations, cash flows or financial condition of us and our portfolio companies, impose additional costs on us or our portfolio companies, intensify the regulatory supervision of us or our portfolio companies or otherwise adversely affect our business or the business of our portfolio companies. In addition, if we do not comply with applicable laws and regulations, we could lose any licenses that we then hold for the conduct of business and could be subject to civil fines and criminal penalties.
Over the last several years, there also has been an increase in regulatory attention to the extension of credit outside of the traditional banking sector, raising the possibility that some portion
of the non-bank financial sector
will be subject to new regulation. While it cannot be known at this time whether any regulation will be implemented or what form it will take, increased
regulation of non-bank credit extension
could negatively impact our operations, cash flows or financial condition, impose additional costs on us, intensify the regulatory supervision of us or otherwise adversely affect our business, financial condition and results of operations.
Although we cannot predict the impact, if any, of these changes to our business, they could adversely affect our business, financial condition, operating results and cash flows. Until we know what policy changes are made and how those changes impact business and the business of our competitors over the long term, we will not know if, overall, it will benefit from them or be negatively affected by them.
Deterioration in the economic conditions in the Eurozone and other regions or countries globally and the resulting instability in global financial markets may pose a risk to our business. Financial markets have been affected at times by a number of global macroeconomic events, including the following: large sovereign debts and fiscal deficits of several countries in Europe and in emerging markets jurisdictions, levels of
non-performing
loans on the balance sheets of European banks, the effect of the United Kingdom leaving the European Union, instability in the Chinese capital markets and the
COVID-19
pandemic.
Various social and political circumstances in the U.S. and around the world (including wars and other forms of conflict, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics), may also contribute to increased market volatility and economic uncertainties or deterioration in the U.S. and worldwide. Such events, including rising trade tensions between the United States and China, other uncertainties regarding actual and potential shifts in U.S. and foreign, trade, economic and other policies with other countries, the large-scale invasion of Ukraine by Russia that began in February 2022 and resulting sanctions or other restrictive actions that the United States and other countries have imposed against Russia, and
the COVID-19 pandemic,
could adversely affect our business, financial condition or results of operations. These market and economic disruptions could negatively impact the operating results of our portfolio companies.
 
In addition, Russia’s invasion of Ukraine and corresponding events have had, and could continue to have, severe adverse effects on regional and global economic markets. Following Russia’s actions, various governments, including the United States, have issued broad-ranging economic sanctions against Russia, including, among other actions, a prohibition on doing business with certain Russian companies, large financial institutions, officials and oligarchs; a commitment by certain countries and the European Union to remove selected Russian banks from the Society for Worldwide Interbank Financial Telecommunications, the electronic banking network that connects banks globally; and restrictive measures to prevent the Russian Central Bank from undermining the impact of the sanctions. The duration of hostilities and the vast array of sanctions and related events (including cyberattacks and espionage) cannot be predicted. Furthermore, the conflict between the two nations and the varying involvement of the United States and other NATO countries could preclude prediction as to their ultimate adverse impact on global economic and market conditions, and, as a result, presents material uncertainty and risk with respect to markets globally, which pose potential adverse risks to us and the performance of our investments and operations, and our ability to achieve our investment objectives. Additionally, to the extent that third parties, investors, or related customer bases have material operations or assets in Russia or Ukraine, they may have adverse consequences related to the ongoing conflict. Any such market disruptions could affect our portfolio companies’ operations and, as a result, could have a material adverse effect on our business, financial condition and results of operations.
Additionally, the Federal Reserve raised the Federal Funds Rate in 2022 and in 2023, and may raise or announce its intention to raise the Federal Funds Rate further. These developments, along with the United States government’s credit and deficit concerns, global economic uncertainties and market volatility and the impacts
of COVID-19, could
cause interest rates to be volatile, which may negatively impact our ability to access the debt markets and capital markets on favorable terms.
Events outside of our control, including
the COVID-19 public
health crises, could negatively affect our portfolio companies and our results of our operations.
Periods of market volatility have occurred and could continue to occur in response to pandemics or other events outside of our control. These types of events have adversely affected and could continue to adversely affect operating results for us and for our portfolio companies. For example, the
COVID-19
pandemic has adversely impacted global commercial activity and contributed to significant volatility in the equity and debt markets. The
COVID-19
pandemic and restrictive measures taken to contain or mitigate its spread have caused, and may continue to cause, business shutdowns, or the
re-introduction
of business shutdowns, cancellations of events and restrictions on travel, significant reductions in demand for certain goods and services, reductions in business activity and financial transactions, supply chain interruptions, labor shortages, increased inflationary pressure and overall economic and financial market instability both globally and in the United States. Many states, including those in which we and portfolio companies in which we invest may operate, have previously issued orders requiring the closure of, or certain restrictions on the operation of, certain businesses. The ultimate duration and severity of the
COVID-19
pandemic, including
COVID-19
variants, remain uncertain. While several countries, as well as certain states, counties and cities in the United States, relaxed the public health restrictions throughout 2021 partly as a result of the introduction of vaccines, recurring
COVID-19
outbreaks caused by different virus variants continue to lead to the
re-introduction
of certain restrictions in certain states in the United States and globally. Even after the
COVID-19
pandemic subsides, the U.S. economy and most other major global economies may continue to experience a recession, and our business and operations, as well as the business and operations of the portfolio companies in which we invest, could be materially adversely affected by a prolonged recession in the U.S. and other major markets.
Despite actions of the U.S. federal government and foreign governments, the uncertainty surrounding the
COVID-19
pandemic, including uncertainty regarding existing or future variants and other factors, has contributed to significant volatility in the global public equity markets and global debt capital markets.
The continued uncertainty related to the sustainability and pace of economic recovery in the U.S. and globally could have a negative impact on our business.
Our business is directly influenced by the economic cycle, and could be negatively impacted by a downturn in economic activity in the U.S. as well as globally. Fiscal and monetary actions taken by
U.S. and non-U.S. government and
regulatory authorities could have a material adverse impact on our business. To the extent uncertainty regarding the U.S. or global economy, including as a result of
the global COVID-19 pandemic, negatively
impacts consumer confidence and consumer credit factors, our business, financial condition and results of operations could be adversely affected. Moreover, Federal Reserve policy, including with respect to certain interest rates and the decision to end its quantitative easing policy, along with the general policies of the current Presidential administration, may also adversely affect the value, volatility and liquidity of dividend- and interest-paying securities. Market volatility, periods of rising interest rates, such as the current economic period, and/or a return to unfavorable economic conditions could adversely affect our business.
 
There is uncertainty surrounding potential legal, regulatory and policy changes by new presidential administrations in the United States that may directly affect financial institutions and the global economy.
The current administration has called for significant changes to U.S. trade, healthcare, immigration, foreign and government regulatory policy. In this regard, there is significant uncertainty with respect to legislation, regulation and government policy at the federal level, as well as the state and local levels. Recent events have created a climate of heightened uncertainty and introduced new and
difficult-to-quantify
macroeconomic and political risks with potentially
far-reaching
implications. There has been a corresponding meaningful increase in the uncertainty surrounding interest rates, inflation, foreign exchange rates, trade volumes and fiscal and monetary policy. To the extent the U.S. Congress or the current administration implements changes to U.S. policy, those changes may impact, among other things, the U.S. and global economy, international trade and relations, unemployment, immigration, corporate taxes, healthcare, the U.S. regulatory environment, inflation and other areas. Although we cannot predict the impact, if any, of these changes to our business, they could adversely affect our business, financial condition, operating results and cash flows. Until we know what policy changes are made and how those changes impact our business and the business of our competitors over the long term, we will not know if, overall, we will benefit from them or be negatively affected by them.
We are exposed to risks associated with changes in interest rates, including the transition away from LIBOR and the adoption of alternative reference rates.
Although we no longer intend to lend at rates based on the London Interbank Offered Rate (“LIBOR”), we may acquire loans that continue to use LIBOR. While many LIBOR rates were phased out at the end of 2021, a selection of widely used U.S.-dollar LIBOR rates will continue to be published until June 2023. On July 29, 2021, the U.S. Federal Reserve System, in conjunction with the Alternative Reference Rates Committee, a steering committee comprised of large U.S. financial institutions, formally recommended replacing U.S.-dollar LIBOR with the Secured Overnight Financing Rate (“SOFR”), a new index calculated by short-term repurchase agreements, backed by Treasury securities. Further, on March 15, 2022, the Consolidation Appropriations Act of 2022, which includes the Adjustable Interest Rate (LIBOR) Act (“LIBOR Act”), was signed into law in the U.S. This legislation establishes a uniform benchmark replacement process for financial contracts that mature after June 30, 2023 which do not contain clearly defined or practicable fallback provisions. The legislation also creates a safe harbor that shields lenders from litigation if they choose to utilize a replacement rate recommended by the Board of Governors of the Federal Reserve. Although the transition process away from LIBOR has become increasingly well-defined (e.g. the LIBOR Act now provides a uniform benchmark replacement for LIBOR-based instruments in the U.S.), the transition process may involve, among other things, increased volatility or illiquidity in markets for instruments that currently rely on LIBOR and may result in a reduction in the value of certain instruments that we may acquire. Further, disruptions related to loans in the marketplace could have a material adverse effect on the ability of the Investment Adviser or its affiliates to enter into loans in the future in accordance with our investment strategy and have a material adverse effect on us.
Inflation and a rising interest rate environment may adversely affect the business, results of operations and financial condition of us and our portfolio companies.
The current macroeconomic environment is characterized by record-high inflation, supply chain challenges, labor shortages, high interest rates, foreign currency exchange volatility, volatility in global capital markets and growing recession risk. The risks associated with the Company’s and our portfolio companies’ businesses are more severe during periods of economic slowdown or recession.
Any disruptions in the capital markets, as a result of inflation and a rising interest environment or otherwise, may increase the spread between the yields realized on risk-free and higher risk securities and can result in illiquidity in parts of the capital markets, significant write-offs in the financial sector and
re-pricing
of credit risk in the broadly syndicated market. These and any other unfavorable economic conditions could increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us.
In addition, market conditions (including inflation, supply chain issues and decreased consumer demand) have adversely impacted, and could in the future further impact, the operations of certain of our portfolio companies. If the financial results of middle-market companies, like those in which we invest, experience deterioration, it could ultimately lead to difficulty in meeting debt service requirements and an increase in defaults, and further deterioration in market conditions will further depress the outlook for those companies. Further, adverse economic conditions decreased and may in the future decrease the value of collateral securing some of our loans and the value of our equity investments. Such conditions have required and may in the future require us to modify the payment terms of our investments, including changes in PIK interest provisions and/or cash interest rates. The performance of certain of our portfolio companies has been, and in the future may be, negatively impacted by these economic or other conditions, which can result in our receipt of reduced interest income from our portfolio companies and/or realized and unrealized losses related to our investments, and, in turn, may adversely affect distributable income and have a material adverse effect on our results of operations.
Inflation may cause the real value of our investments to decline.
Inflation risk results from the variation in the value of cash flows from a security due to inflation, as measured in terms of purchasing power. We are exposed to inflation risk with respect to any fixed rate investments that we make, if any, because the interest rate the issuer has to pay us is fixed for the life of the security. To the extent that interest rates reflect the expected inflation rate, floating rate loans have a lower level of inflation risk.
 
Technological innovations and industry disruptions may negatively impact us.
Technological innovations have disrupted traditional approaches in multiple industries and can permit younger companies to achieve success and in the process disrupt markets and market practices. We can provide no assurance that new businesses and approaches will not be created that would compete with us and/or our portfolio companies or alter the market practices in which SLR Capital Partners and its affiliates and us have been designed to function within and on which we depend on for our investment return. New approaches could damage our investments, disrupt the market in which we operate and subject us to increased competition, which could materially and adversely affect our business, financial condition and results of investments.
We are subject to risks related to corporate social responsibility.
Our business (including that of our portfolio companies) faces increasing public scrutiny related to environmental, social and governance (“ESG”) activities, which are increasingly considered to contribute to reducing a company’s operational risk, market risk and reputational risk, which may in turn impact the long-term sustainability of a company’s performance. A variety of organizations measure the performance of companies on ESG topics, and the results of these assessments are widely publicized. In addition, investment in funds that specialize in companies that perform well in such assessments are increasingly popular, and major institutional investors have publicly emphasized the importance of such ESG measures to their investment decisions. We risk damage to our brand and reputation if we fail to act responsibly in a number of areas, including, but not limited to, diversity, equity and inclusion, human rights, climate change, environmental stewardship, corporate governance and considering ESG factors in our investment processes. Adverse incidents with respect to ESG activities could impact the value of our brand, our relationship with existing and future portfolio companies, the cost of our operations and relationships with investors, all of which could adversely affect our business and results of operations.
However, regional and investor specific sentiment may differ in what constitutes a material positive or negative ESG corporate practice. There is no guarantee that the Company’s corporate social responsibility practices will uniformly fit every investor’s definition of best practices for all environmental, social and governance considerations across geographies and investor types.
There is also a growing regulatory interest across jurisdictions in improving transparency regarding the definition, measurement and disclosure of ESG factors in order to allow investors to validate and better understand sustainability claims. For example, the SEC has proposed, or has announced that it is working on proposals for, rules that, among other matters, would establish a framework for reporting of climate-related risks, corporate and fund carbon emissions, broad diversity and capital management. At this time, there is uncertainty regarding the scope of such proposals or when they would become effective (if at all). In addition, in 2021 the SEC established an enforcement task force to look into ESG practices and disclosures by public companies and investment managers and has started to bring enforcement actions based on ESG disclosures not matching actual investment processes. We and our portfolio companies are subject to the risk that similar measures might be introduced in other jurisdictions in the future. Additionally, compliance with any new laws or regulations increases our regulatory burden and could make compliance more difficult and expensive, affect the manner in which we or our portfolio companies conduct our businesses and adversely affect our profitability.
The effect of global climate change may impact the operations of our portfolio companies.
There may be evidence of global climate change. Climate change creates physical and financial risk and some of our portfolio companies may be adversely affected by climate change. For example, the needs of customers of energy companies vary with weather conditions, primarily temperature and humidity. To the extent weather conditions are affected by climate change, energy use could increase or decrease depending on the duration and magnitude of any changes. Increases in the cost of energy could adversely affect the cost of operations of our portfolio companies if the use of energy products or services is material to their business. A decrease in energy use due to weather changes may affect some of our portfolio companies’ financial condition, through decreased revenues. Extreme weather conditions in general require more system backup, adding to costs, and can contribute to increased system stresses, including service interruptions. Energy companies could also be affected by the potential for lawsuits against or taxes or other regulatory costs imposed on greenhouse gas emitters, based on links drawn between greenhouse gas emissions and climate change.
In December 2015, the United Nations, of which the U.S. is a member, adopted a climate accord with the long-term goal of limiting global warming and the short-term goal of significantly reducing greenhouse gas emissions. As a result, some of our portfolio companies may become subject to new or strengthened regulations or legislation, which could increase their operating costs and/or decrease their revenues.
 
We cannot predict how changes in tax law will affect us, our investments, or our stockholders, and any such legislation could adversely affect our business.
Legislative or other actions relating to taxes could have a negative effect on us. The rules dealing with U.S. federal income taxation are constantly under review by persons involved in the legislative process and by the Internal Revenue Service and the U.S. Treasury Department. New legislation and any other tax law developments, including new or revised U.S. Treasury regulations, administrative interpretations or court decisions, could negatively and perhaps retroactively affect our ability to qualify for tax treatment as a RIC or the U.S. federal income tax consequences to us and our shareholders, or could have other adverse consequences. Investors are urged to consult with their tax advisor regarding tax legislative, regulatory, or administrative developments and proposals and their potential effect on an investment in our common stock.
Uncertainty about U.S. government initiatives could negatively impact our business, financial condition and results of operations.
The U.S. government has recently called for significant changes to U.S. trade, healthcare, immigration, foreign and government regulatory policy. In this regard, there is significant uncertainty with respect to legislation, regulation and government policy at the federal level, as well as the state and local levels. Recent events have created a climate of heightened uncertainty and introduced
new and difficult-to-quantify macroeconomic and
political risks
with potentially far-reaching implications. There
has been a corresponding meaningful increase in the uncertainty surrounding interest rates, inflation, foreign exchange rates, trade volumes and fiscal and monetary policy. To the extent the U.S. Congress or the current administration implements changes to U.S. policy, those changes may impact, among other things, the U.S. and global economy, international trade and relations, unemployment, immigration, corporate taxes, healthcare, the U.S. regulatory environment, inflation and other areas.
A particular area identified as subject to potential change, amendment or repeal includes the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the “Dodd-Frank Act,” including the Volcker Rule and various swaps and derivatives regulations, credit risk retention requirements and the authorities of the Federal Reserve, the Financial Stability Oversight Council and the SEC. Given the uncertainty associated with the manner in which and whether the provisions of the Dodd-Frank Act will be implemented, repealed, amended, or replaced, the full impact such requirements will have on our business, results of operations or financial condition is unclear. The changes resulting from the Dodd-Frank Act or any changes to the regulations already implemented thereunder may require us to invest significant management attention and resources to evaluate and make necessary changes in order to comply with new statutory and regulatory requirements. Failure to comply with any such laws, regulations or principles, or changes thereto, may negatively impact our business, results of operations or financial condition. While we cannot predict what effect any changes in the laws or regulations or their interpretations would have on us as a result of recent financial reform legislation, these changes could be materially adverse to us and our stockholders.
                 
Effects of Leverage [Table Text Block]                 The calculations in the table below are hypothetical and actual returns may be higher or lower than those appearing in the table below.
 
    
Assumed total return
(net of interest expense)
 
    
(10)%
   
(5)%
   
0%
   
5%
   
10%
 
Corresponding return to stockholder(1)
     (29.9 )%      (17.2 )%      (4.5 )%      8.2     20.9
 
(1)
Assumes $2.5 billion in total assets and $1.1 billion in total debt outstanding, which reflects our total assets and total debt outstanding as of December 31, 2022, and a cost of funds of
4.09%. Excludes non-leverage related expenses.
In
 
order for us to cover our annual interest payments on our outstanding indebtedness at December 31, 2022, we must achieve annual returns on our December 31, 2022 total assets of at least 1.8%.
                 
Return at Minus Ten [Percent]                 (29.90%)                  
Return at Minus Five [Percent]                 (17.20%)                  
Return at Zero [Percent]                 (4.50%)                  
Return at Plus Five [Percent]                 8.20%                  
Return at Plus Ten [Percent]                 20.90%                  
Share Price [Table Text Block]                 The following table sets forth, for each fiscal quarter during the last two fiscal years, the net asset value (“NAV”) per share of our common stock, the high and low closing sales prices for our common stock, such sales prices as a percentage of NAV per share and distributions per share.
 
 
  
NAV
(1)
 
  
Price Range
 
  
Premium or

(Discount)

of High Closing

Price to NAV
(2)
 
 
Premium or

(Discount)

of

Low Closing

Price to

NAV
(2)
 
 
Declared

Distributions
 (3)
 
 
  
High
 
  
Low
 
Fiscal 2022
                                                   
Fourth Quarter
   $ 18.33      $ 15.03      $ 12.50        (18.0 )%      (31.8 )%    $ 0.41  
Third Quarter
     18.37        15.76        12.32        (14.2     (32.9     0.41  
Second Quarter
     18.53        18.19        14.17        (1.8     (23.5     0.41  
First Quarter
     19.56        19.26        17.68        (1.5     (9.6     0.41  
Fiscal 2021
                                                   
Fourth Quarter
   $ 19.93      $ 19.90      $ 17.55        (0.2 )%      (11.9 )%    $ 0.41  
Third Quarter
     20.20        19.75        18.42        (2.2     (8.8     0.41  
Second Quarter
     20.29        19.58        17.88        (3.5     (11.9     0.41  
First Quarter
     20.26        19.35        17.35        (4.5     (14.4     0.41  
 
(1)
 
NAV per share is determined as of the last day in the relevant quarter and therefore may not reflect the NAV per share on the date of the high and low sales prices. The net asset values shown are based on outstanding shares at the end of each period.
(2)
 
Calculated as of the respective high or low closing price divided by NAV and subtracting 1.
(3)
 
Represents the cash distribution for the specified quarter.
                 
Lowest Price or Bid $ 12.5 $ 12.32 $ 14.17 $ 17.68 $ 17.55 $ 18.42 $ 17.88 $ 17.35                    
Highest Price or Bid $ 15.03 $ 15.76 $ 18.19 $ 19.26 $ 19.9 $ 19.75 $ 19.58 $ 19.35                    
Highest Price or Bid, Premium (Discount) to NAV [Percent] [12] (18.00%) (14.20%) (1.80%) (1.50%) (0.20%) (2.20%) (3.50%) (4.50%)                    
Lowest Price or Bid, Premium (Discount) to NAV [Percent] [12] (31.80%) (32.90%) (23.50%) (9.60%) (11.90%) (8.80%) (11.90%) (14.40%)                    
Latest NAV [13] $ 18.33 $ 18.37 $ 18.53 $ 19.56 $ 19.93 $ 20.2 $ 20.29 $ 20.26                    
Risks Relating to Our Investments [Member]                                    
General Description of Registrant [Abstract]                                    
Risk [Text Block]                
Risks Relating to Our Investments
We operate in a highly competitive market for investment opportunities.
A number of entities compete with us to make the types of investments that we target in leveraged companies. We compete with other BDCs, public and private funds, commercial and investment banks, commercial financing companies and, to the extent they provide an alternative form of financing, private equity funds. Many of our competitors are substantially larger and have considerably greater financial, technical and marketing resources than we do. For example, some competitors may have a lower cost of funds and access to funding sources that are not available to us. In addition, some of our competitors may have higher risk tolerances or different risk assessments than we have, which could allow them to consider a wider variety of investments and establish more relationships and offer better pricing and a more flexible structure than we are able to do. Furthermore, many of our potential competitors are not subject to the regulatory restrictions that the 1940 Act imposes on us as a BDC. If we are unable to source attractive investments, we may hold a greater percentage of our assets in cash and cash equivalents than anticipated, which could impact potential returns on our portfolio. We cannot assure you that the competitive pressures we face will not have a material adverse effect on our business, financial condition and results of operations. Also, as a result of this competition, we may not be able to take advantage of attractive investment opportunities from time to time, and we can offer no assurance that we will be able to identify and make investments that are consistent with our investment objective.
Participants in our industry compete on several factors, including price, flexibility in transaction structure, customer service, reputation, market knowledge and speed in decision-making. We do not seek to compete primarily based on the interest rates we will offer, and we believe that some of our competitors may make loans with interest rates that will be comparable to or lower than the rates we offer. We may lose investment opportunities if we do not match our competitors’ pricing, terms and structure. However, if we match our competitors’ pricing, terms and structure, we may experience decreased net interest income and increased risk of credit loss.
Our investments are very risky and highly speculative.
We invest primarily in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities.
Senior Secured Loans.
 When we make a senior secured term loan investment in a portfolio company, we generally take a security interest in the available assets of the portfolio company, including the equity interests of its subsidiaries, which we expect to help mitigate the risk that we will not be repaid. However, there is a risk that the collateral securing our loans may decrease in value over time, may be difficult to sell in a timely manner, may be difficult to appraise and may fluctuate in value based upon the success of the business and market conditions, including as a result of the inability of the portfolio company to raise additional capital, and, in some circumstances, our lien could be subordinated to claims of other creditors. In addition, deterioration in a portfolio company’s financial condition and prospects, including its inability to raise additional capital, may be accompanied by deterioration in the value of the collateral for the loan. Consequently, the fact that a loan is secured does not guarantee that we will receive principal and interest payments according to the loan’s terms, or at all, or that we will be able to collect on the loan should we be forced to enforce our remedies.
Unsecured Loans and Preferred Securities.
 Our unsecured and preferred investments are generally subordinated to senior loans and are generally unsecured. As such, other creditors may rank senior to us in the event of an insolvency. This may result in an above average amount of risk and loss of principal.
Equity Investments.
 When we invest in senior secured loans, unitranche loans, unsecured loans or preferred securities, we may acquire common equity securities as well. In certain other unique circumstances we may also make equity investments in businesses that make senior loans and/or leases, such as our investments in Kingsbridge Holdings, LLC, SLR Credit Solutions, SLR Equipment
 
Finance, SLR Business Credit and SLR Healthcare ABL. In addition, we may invest directly in the equity securities of portfolio companies without limitation as to market capitalization. For instance, we may invest in thinly traded companies, the prices of which may be subject to erratic market movement. Our goal is ultimately to exit such equity interests and realize gains upon our disposition of such interests. However, the equity interests we receive may not appreciate in value and, in fact, may decline in value. Accordingly, we may not be able to realize gains from our equity interests, and any gains that we do realize on the disposition of any equity interests may not be sufficient to offset any other losses we experience.
In addition, investing in middle-market companies involves a number of significant risks, including:
 
   
these companies may have limited financial resources and may be unable to meet their obligations under their debt securities that we hold, which may be accompanied by a deterioration in the value of any collateral and a reduction in the likelihood of us realizing any guarantees we may have obtained in connection with our investment;
 
   
they typically have shorter operating histories, narrower product lines and smaller market shares than larger businesses, which tend to render them more vulnerable to competitors’ actions and market conditions, as well as general economic downturns;
 
   
they are more likely to depend on the management talents and efforts of a small group of persons; therefore, the death, disability, resignation or termination of one or more of these persons could have a material adverse impact on our portfolio company and, in turn, on us;
 
   
they generally have less predictable operating results, may from time to time be parties to litigation, may be engaged in rapidly changing businesses with products subject to a substantial risk of obsolescence, and may require substantial additional capital to support their operations, finance expansion or maintain their competitive position. In addition, our executive officers, directors and our Investment Adviser may, in the ordinary course of business, be named as defendants in litigation arising from our investments in the portfolio companies; and
 
   
they may have difficulty accessing the capital markets to meet future capital needs, which may limit their ability to grow or to repay their outstanding indebtedness upon maturity.
The lack of liquidity in our investments may make it difficult for us to dispose of our investments at a favorable price, which may adversely affect our ability to meet our investment objectives.
We generally make investments in private companies. We invest and expect to continue investing in companies whose securities have no established trading market and whose securities are and will be subject to legal and other restrictions on resale or whose securities are and will be less liquid than are publicly-traded securities. Investments purchased by us that are liquid at the time of purchase may subsequently become illiquid due to events relating to the issuer of the investments, market events, economic conditions or investor perceptions. The illiquidity of our investments may make it difficult for us to sell such investments if the need arises. In addition, if we are required to liquidate all or a portion of our portfolio quickly, we may realize significantly less than the value at which we have previously recorded our investments. As a result, we do not expect to achieve liquidity in our investments in the near-term. However, to maintain our qualification as a BDC and as a RIC, we may have to dispose of investments if we do not satisfy one or more of the applicable criteria under the respective regulatory frameworks. Domestic and foreign markets are complex and interrelated, so that events in one sector of the world markets or economy, or in one geographical region, can reverberate and have materially negative consequences for other markets, economic or regional sectors in a manner that may not be foreseen and which may negatively impact the liquidity of our investments and materially harm our business. In addition, we may face other restrictions on our ability to liquidate an investment in a portfolio company to the extent that we
have material non-public information regarding
such portfolio company.
Our portfolio may be concentrated in a limited number of portfolio companies and industries, which will subject us to a risk of significant loss if any of these companies performs poorly or defaults on its obligations under any of its debt instruments or if there is a downturn in a particular industry.
Our portfolio may be concentrated in a limited number of portfolio companies and industries. For example, as of December 31, 2022, our investments in SLR Credit Solutions, Kingsbridge Holdings, LLC and SLR Equipment Finance comprised 11.4%, 9.0% and 5.0%, respectively, of our total assets and our investments in diversified financial services and multi-sector holdings industries comprised 18.2% and 14.4%, respectively, of our total assets. Beyond the asset diversification requirements associated with our qualification as a RIC under Subchapter M of the Code, we do not have fixed guidelines for diversification, and while we are not targeting any specific industries, our investments may be concentrated in relatively few industries or portfolio companies. As a result, the aggregate returns we realize may be significantly adversely affected if a small number of investments perform poorly or if we need to write down the value of any one investment. Additionally, a downturn in any particular industry in which we are invested could also significantly impact the aggregate returns we realize.
 
Our investments in securities rated below investment grade are speculative in nature and are subject to additional risk factors such as the increased possibility of default, illiquidity of the security, and changes in value based on changes in interest rates.
The securities that we invest in are typically rated below investment grade. Securities rated below investment grade are speculative and are often referred to as “leveraged loans,” “high yield” or “junk” securities, and may be considered “high risk” compared to debt instruments that are rated investment grade. High yield securities are regarded as having predominantly speculative characteristics with respect to the issuer’s capacity to pay interest and repay principal in accordance with the terms of the obligations and involve major risk exposure to adverse conditions. In addition, high yield securities generally offer a higher current yield than that available from higher grade issues, but typically involve greater risk. These securities are especially sensitive to adverse changes in general economic conditions, to changes in the financial condition of their issuers and to price fluctuation in response to changes in interest rates. During periods of economic downturn or rising interest rates, such as the current economic period, issuers of below investment grade instruments may experience financial stress that could adversely affect their ability to make payments of principal and interest and increase the possibility of default. The secondary market for high yield securities may not be as liquid as the secondary market for more highly rated securities. In addition, many of our debt investments will not fully amortize during their lifetime, which means that a borrower may be unable to payoff its debt due to bankruptcy or other reasons and therefore
we may write-off such debt
investment prior to its scheduled maturity. Upon such an occurrence, we may realize a loss or a substantial amount of unpaid principal and interest due upon maturity.
Price declines and illiquidity in the corporate debt markets have adversely affected, and may continue to adversely affect, the fair value of our portfolio investments, reducing our net asset value through increased net unrealized depreciation. Any unrealized depreciation that we experience on our loan portfolio may be an indication of future realized losses, which could reduce our income available for distribution and could adversely affect our ability to service our outstanding borrowings.
As a BDC, we are required to carry our investments at market value or, if no market value is ascertainable, at fair value as determined in good faith by or under the direction of our board of directors. Decreases in the market values or fair values of our investments are recorded as unrealized depreciation. Any unrealized depreciation in our loan portfolio could be an indication of a portfolio company’s inability to meet its repayment obligations to us with respect to the affected loans. This could result in realized losses in the future and ultimately in reductions of our income available for distribution in future periods and could materially adversely affect our ability to service our outstanding borrowings. Depending on market conditions, we could incur substantial losses in future periods, which could further reduce our net asset value and have a material adverse impact on our business, financial condition and results of operations.
Economic sanction laws in the United States and other jurisdictions may prohibit us and our affiliates from transacting with certain countries, individuals and companies.
Economic sanction laws in the United States and other jurisdictions may prohibit us or our affiliates from transacting with certain countries, individuals and companies. In the United States, the U.S. Department of the Treasury’s Office of Foreign Assets Control administers and enforces laws, executive orders and regulations establishing U.S. economic and trade sanctions, which prohibit, among other things, transactions with, and the provision of
services to, certain non-U.S. countries, territories, entities
and individuals. These types of sanctions may significantly restrict or completely prohibit investment activities in certain jurisdictions, and if we, our portfolio companies or other issuers in which we invest were to violate any such laws or regulations, we may face significant legal and monetary penalties.
The Foreign Corrupt Practices Act, or FCPA, and other anti-corruption laws and regulations, as well as anti-boycott regulations, may also apply to and restrict our activities, our portfolio companies and other issuers of our investments. If an issuer or we were to violate any such laws or regulations, such issuer or we may face significant legal and monetary penalties. The U.S. government has indicated that it is particularly focused on FCPA enforcement, which may increase the risk that an issuer or us becomes the subject of such actual or threatened enforcement. In addition, certain commentators have suggested that private investment firms and the funds that they manage may face increased scrutiny and/or liability with respect to the activities of their underlying portfolio companies. As such, a violation of the FCPA or other applicable regulations by us or an issuer of our portfolio investments could have a material adverse effect on us. We are committed to complying with the FCPA and other anti-corruption laws and regulations, as well as anti-boycott regulations, to which it is subject. As a result, we may be adversely affected because of our unwillingness to enter into transactions that violate any such laws or regulations.
 
If we cannot obtain additional capital because of either regulatory or market price constraints, we could be forced to curtail or cease our new lending and investment activities, our net asset value could decrease and our level of distributions and liquidity could be affected adversely.
Our ability to secure additional financing and satisfy our financial obligations under indebtedness outstanding from time to time will depend upon our future operating performance, which is subject to the prevailing general economic and credit market conditions, including interest rate levels and the availability of credit generally, and financial, business and other factors, many of which are beyond our control. The worsening of current economic and capital market conditions could have a material adverse effect on our ability to secure financing on favorable terms, if at all.
If we are unable to obtain debt capital, then our equity investors will not benefit from the potential for increased returns on equity resulting from leverage to the extent that our investment strategy is successful and we may be limited in our ability to make new commitments or fundings to our portfolio companies.
We may suffer a loss if a portfolio company defaults on a loan and the underlying collateral is not sufficient.
In the event of a default by a portfolio company on a secured loan, we will only have recourse to the assets collateralizing the loan. If the underlying collateral value is less than the loan amount, we will suffer a loss. In addition, we sometimes make loans that are unsecured, which are subject to the risk that other lenders may be directly secured by the assets of the portfolio company. In the event of a default, those collateralized lenders would have priority over us with respect to the proceeds of a sale of the underlying assets. In cases described above, we may lack control over the underlying asset collateralizing our loan or the underlying assets of the portfolio company prior to a default, and as a result the value of the collateral may be reduced by acts or omissions by owners or managers of the assets.
In the event of bankruptcy of a portfolio company, we may not have full recourse to its assets in order to satisfy our loan, or our loan may be subject to equitable subordination. In addition, certain of our loans are subordinate to other debt of the portfolio company. If a portfolio company defaults on our loan or on debt senior to our loan, or in the event of a portfolio company bankruptcy, our loan will be satisfied only after the senior debt receives payment. Where debt senior to our loan exists, the presence of inter-creditor arrangements may limit our ability to amend our loan documents, assign our loans, accept prepayments, exercise our remedies (through “standstill” periods) and control decisions made in bankruptcy proceedings relating to the portfolio company. Bankruptcy and portfolio company litigation can significantly increase collection losses and the time needed for us to acquire the underlying collateral in the event of a default, during which time the collateral may decline in value, causing us to suffer further losses.
If the value of the collateral underlying our loan declines or interest rates increase during the term of our loan, a portfolio company may not be able to obtain the necessary funds to repay our loan at maturity through refinancing. Decreasing collateral value and/or periods of increasing interest rates, such as the current economic period, may hinder a portfolio company’s ability to refinance our loan because the underlying collateral cannot satisfy the debt service coverage requirements necessary to obtain new financing. If a borrower is unable to repay our loan at maturity, we could suffer a loss which may adversely impact our financial performance.
The business, financial condition and results of operations of our portfolio companies could be adversely affected by worldwide economic conditions, as well as political and economic conditions in the countries in which they conduct business.
The business and operating results of our portfolio companies may be impacted by worldwide economic conditions, such as the economic impact that
the COVID-19 pandemic
and the Russian invasion of Ukraine have imposed, and may continue to impose, on the U.S. and worldwide economy. Any deterioration of general economic conditions may lead to significant declines in corporate earnings or loan performance, and the ability of corporate borrowers to service their debt, any of which could trigger a period of global economic slowdown, and have an adverse impact on our performance and financial results, and the value and the liquidity of our investments. In an economic downturn, we could
have non-performing assets
or an increase
in non-performing assets,
and we would anticipate that the value of our portfolio would decrease during these periods. For instance, concerns of economic slowdown in China and other emerging markets and signs of deteriorating sovereign debt conditions in Europe could lead to disruption and instability in the global financial markets. The significant debt in the United States and European countries is expected to hinder growth in those countries for the foreseeable future. In the future, the U.S. government may not be able to meet its debt payments unless the federal debt ceiling is raised. If legislation increasing the debt ceiling is not enacted, as needed, and the debt ceiling is reached, the U.S. federal government may stop or delay making payments on its obligations. Any default by the U.S. government on its obligations or any prolonged U.S. government shutdown could negatively impact the U.S. economy and our portfolio companies. Multiple factors relating to the international operations of some of our portfolio companies and to particular countries in which they operate could negatively impact their business, financial condition and results of operations.
Some of the products of our portfolio companies are developed, manufactured, assembled, tested or marketed outside the United States. Any conflict or uncertainty in these countries, including due to natural disasters, public health concerns (including
the global COVID-19 pandemic), political
unrest or safety concerns, could harm their business, financial condition and results of operations. In addition, if the government of any country in which their products are developed, manufactured or sold sets technical or regulatory standards for products developed or manufactured in or imported into their country that are not widely shared, it may lead some of their customers to suspend imports of their products into that country, require manufacturers or developers in that country to manufacture or develop products with different technical or regulatory standards and disrupt cross-border manufacturing, marketing or business relationships which, in each case, could harm their businesses.
 
Our failure
to make follow-on investments in
our portfolio companies could impair the value of our portfolio.
Following an initial investment in a portfolio company, we may make additional investments in that portfolio
company as “follow-on” investments, in
order to: (i) increase or maintain in whole or in part our ownership percentage; (ii) exercise warrants, options or convertible securities that were acquired in the original or subsequent financing; or (iii) attempt to preserve or enhance the value of our investment. We may elect not
to make follow-on investments or
otherwise lack sufficient funds to make those investments. We will have the discretion to
make any follow-on investments, subject
to the availability of capital resources. The failure
to make follow-on investments may,
in some circumstances, jeopardize the continued viability of a portfolio company and our initial investment, or may result in a missed opportunity for us to increase our participation in a successful operation. Even if we have sufficient capital to make
a desired follow-on investment, we
may elect not to
make a follow-on investment because
we may not want to increase our concentration of risk, either because we prefer other opportunities or because we are subject to BDC requirements that would
prevent such follow-on investments or
the desire to maintain our RIC tax treatment.
Where we do not hold controlling equity interests in our portfolio companies, we may not be in a position to exercise control over our portfolio companies or to prevent decisions by management of our portfolio companies that could decrease the value of our investments.
Although we hold controlling equity positions in some of our portfolio companies, we do not currently hold controlling equity positions in the majority of our portfolio companies. As a result, we are subject to the risk that a portfolio company in which we do not have a controlling interest may make business decisions with which we disagree, and that the management and/or stockholders of such portfolio company may take risks or otherwise act in ways that are adverse to our interests. Due to the lack of liquidity of the debt and equity investments that we typically hold in our portfolio companies, we may not be able to dispose of our investments in the event we disagree with the actions of a portfolio company and may therefore suffer a decrease in the value of our investments.
Prepayments of our debt investments by our portfolio companies could adversely impact our results of operations and reduce our return on equity.
We are subject to the risk that the investments we make in our portfolio companies may be prepaid prior to maturity. When this occurs, we may reduce our borrowings outstanding or reinvest these proceeds in temporary investments, pending their future investment in new portfolio companies. These temporary investments, if any, will typically have substantially lower yields than the debt investment being prepaid and we could experience significant delays in reinvesting these amounts. Any future investment in a new portfolio company may also be at lower yields than the debt investment that was prepaid. As a result, our results of operations could be materially adversely affected if one or more of our portfolio companies elect to prepay amounts owed to us. Additionally, prepayments could negatively impact our return on equity, which could result in a decline in the market price of our common stock.
We may choose to waive or defer enforcement of covenants in the debt securities held in our portfolio, which may cause us to lose all or part of our investment in these companies.
We structure the debt investments in our portfolio companies to include business and financial covenants placing affirmative and negative obligations on the operation of the company’s business and its financial condition. However, from time to time we may elect to waive breaches of these covenants, including our right to payment, or waive or defer enforcement of remedies, such as acceleration of obligations or foreclosure on collateral, depending upon the financial condition and prospects of the particular portfolio company. These actions may reduce the likelihood of our receiving the full amount of future payments of interest or principal and be accompanied by a deterioration in the value of the underlying collateral as many of these companies may have limited financial resources, may be unable to meet future obligations and may go bankrupt. This could negatively impact our ability to pay distributions, could adversely affect our results of operation and financial condition and cause the loss of all or part of your investment.
In addition, some of the loans in which we may invest may be “covenant-lite” loans. We use the term “covenant-lite” loans to refer generally to loans that do not have a complete set of financial maintenance covenants.
Generally, “covenant-lite” loans provide borrower companies more freedom to negatively impact lenders because their covenants are incurrence-based, which means they are only tested and can only be breached following an affirmative action of the borrower, rather than by a deterioration in the borrower’s financial condition. Accordingly, to the extent we invest in “covenant-lite” loans, we may have fewer rights against a borrower and may have a greater risk of loss on such investments as compared to investments in or exposure to loans with financial maintenance covenants.
 
Our loans could be subject to equitable subordination by a court which would increase our risk of loss with respect to such loans.
Courts may apply the doctrine of equitable subordination to subordinate the claim or lien of a lender against a borrower to claims or liens of other creditors of the borrower, when the lender or its affiliates is found to have engaged in unfair, inequitable or fraudulent conduct. The courts have also applied the doctrine of equitable subordination when a lender or its affiliates is found to have exerted inappropriate control over a client, including control resulting from the ownership of equity interests in a client. We have made direct equity investments or received warrants in connection with loans. Payments on one or more of our loans, particularly a loan to a client in which we may also hold an equity interest, may be subject to claims of equitable subordination. If we were deemed to have the ability to control or otherwise exercise influence over the business and affairs of one or more of our portfolio companies resulting in economic hardship to other creditors of that company, this control or influence may constitute grounds for equitable subordination and a court may treat one or more of our loans as if it were unsecured or common equity in the portfolio company. In that case, if the portfolio company were to liquidate, we would be entitled to repayment of our loan
on a pro-rata basis with
other unsecured debt or, if the effect of subordination was to place us at the level of common equity, then on an equal basis with other holders of the portfolio company’s common equity only after all of its obligations relating to its debt and preferred securities had been satisfied.
An investment strategy focused primarily on privately held companies presents certain challenges, including the lack of available information about these companies, a dependence on the talents and efforts of only a few key portfolio company personnel and a greater vulnerability to economic downturns.
We invest primarily in privately held companies. Generally, little public information exists about these companies, and we are required to rely on the ability of SLR Capital Partners’ investment professionals to obtain adequate information to evaluate the potential returns from investing in these companies. If we are unable to uncover all material information about these companies, we may not make a fully informed investment decision, and we may lose money on our investments. Also, smaller privately held companies frequently have less diverse product lines and smaller market presence than larger competitors. These factors could adversely affect our investment returns as compared to companies investing primarily in the securities of public companies.
Our portfolio companies may incur debt that ranks equally with, or senior to, our investments in such companies.
We invest primarily in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. Our portfolio companies typically have, or may be permitted to incur, other debt that ranks equally with, or senior to, the debt securities in which we invest. By their terms, such debt instruments may provide that the holders are entitled to receive payment of interest or principal on or before the dates on which we are entitled to receive payments in respect of the debt securities in which we invest. Also, in the event of insolvency, liquidation, dissolution, reorganization or bankruptcy of a portfolio company, holders of debt instruments ranking senior to our investment in that portfolio company would typically be entitled to receive payment in full before we receive any distribution in respect of our investment. After repaying such senior creditors, such portfolio company may not have any remaining assets to use for repaying its obligation to us. In the case of debt ranking equally with debt securities in which we invest, we would have to share on an equal basis any distributions with other creditors holding such debt in the event of an insolvency, liquidation, dissolution, reorganization or bankruptcy of the relevant portfolio company. Any such limitations on the ability of our portfolio companies to make principal or interest payments to us, if at all, may reduce our net asset value and have a negative material adverse impact to our business, financial condition and results of operation.
Our investments in foreign securities may involve significant risks in addition to the risks inherent in U.S. investments.
Our investment strategy contemplates potential investments in debt securities of foreign companies, including emerging market companies. Investing in foreign companies may expose us to additional risks not typically associated with investing in U.S. companies. These risks include changes in exchange control regulations, political and social instability, expropriation, imposition of foreign taxes, less liquid markets and less available information than is generally the case in the United States, higher transaction costs, less government supervision of exchanges, brokers and issuers, less developed bankruptcy laws, difficulty in enforcing contractual obligations, lack of uniform accounting and auditing standards and greater price volatility. These risks may be more pronounced for portfolio companies located or operating primarily in emerging markets, whose economies, markets and legal systems may be less developed.
Although most of our investments will be U.S. dollar-denominated, any investments denominated in a foreign currency will be subject to the risk that the value of a particular currency will change in relation to one or more other currencies. Among the factors that may affect currency values are trade balances, the level of short-term interest rates, differences in relative values of similar assets in different currencies, long-term opportunities for investment and capital appreciation, and political developments. We may employ hedging techniques to minimize these risks, but we can offer no assurance that we will, in fact, hedge currency risk, or that if we do, such strategies will be effective.
 
We may expose ourselves to risks if we engage in hedging transactions.
If we engage in hedging transactions, we may expose ourselves to risks associated with such transactions. We may utilize instruments such as forward contracts, currency options and interest rate swaps, caps, collars and floors to seek to hedge against fluctuations in the relative values of our portfolio positions from changes in currency exchange rates and market interest rates. Hedging against a decline in the values of our portfolio positions does not eliminate the possibility of fluctuations in the values of such positions or prevent losses if the values of such positions decline. However, such hedging can establish other positions designed to gain from those same developments, thereby offsetting the decline in the value of such portfolio positions. Such hedging transactions may also limit the opportunity for gain if the values of the underlying portfolio positions should increase. It may not be possible to hedge against an exchange rate or interest rate fluctuation that is so generally anticipated that we are not able to enter into a hedging transaction at an acceptable price.
The success of our hedging transactions will depend on our ability to correctly predict movements in currencies and interest rates. Therefore, while we may enter into such transactions to seek to reduce currency exchange rate and interest rate risks, unanticipated changes in currency exchange rates or interest rates may result in poorer overall investment performance than if we had not engaged in any such hedging transactions. In addition, the degree of correlation between price movements of the instruments used in a hedging strategy and price movements in the portfolio positions being hedged may vary. Moreover, for a variety of reasons, we may not seek to establish a perfect correlation between such hedging instruments and the portfolio holdings being hedged. Any such imperfect correlation may prevent us from achieving the intended hedge and expose us to risk of loss. In addition, it may not be possible to hedge fully or perfectly against currency fluctuations affecting the value of securities
denominated in non-U.S. currencies because
the value of those securities is likely to fluctuate as a result of factors not related to currency fluctuations. To the extent we engage in hedging transactions, we also face the risk that counterparties to the derivative instruments we hold may default, which may expose us to unexpected losses from positions where we believed that our risk had been appropriately hedged.
Our Investment Adviser may not be able to achieve the same or similar returns as those achieved for other funds it currently manages or by our senior investment professionals while they were employed at prior positions.
Our Investment Adviser manages other funds, including other BDCs, and may manage other entities in the future. The track record and achievements of these other entities are not necessarily indicative of future results that will be achieved by our Investment Adviser because these other entities may have investment objectives and strategies that differ from ours. Additionally, although in the past our senior investment professionals held senior positions at a number of investment firms, their track record and achievements are not necessarily indicative of future results that will be achieved by our Investment Adviser. In their roles at such other firms, our senior investment professionals were part of investment teams, and they were not solely responsible for generating investment ideas. In addition, such investment teams arrived at investment decisions by consensus.
We may be exposed to higher risks with respect to our investments that include original issue discount or PIK interest.
Zero-coupon bonds pay interest only at maturity rather than at intervals during the life of the security. Deferred interest rate bonds generally provide for a period of delay before the regular payment of interest begins. PIK securities are debt obligations that pay “interest” in the form of other debt obligations, instead of in cash. Each of these instruments
 is normally issued and traded at a deep discount from face value. Zero-coupon bonds, deferred interest rate bonds and PIKs allow an issuer to avoid or delay the need to generate cash to meet current interest payments and, as a result, may involve greater credit risk than bonds that pay interest currently or in cash. In addition, such investments experience greater volatility in market value due to changes in interest rates than debt obligations that provide for regular payments of interest.
To the extent we invest in original issue discount instruments, including PIK, zero coupon bonds, and debt securities with attached warrants, investors will be exposed to the risks associated with the inclusion of
such non-cash income
in taxable and accounting income prior to receipt of cash, including the following:
 
 
The interest payments deferred on a PIK loan are subject to the risk that the borrower may default when the deferred payments are due in cash at the maturity of the loan;
 
 
The interest rates on PIK loans are higher to reflect the time-value of money on deferred interest payments and the higher credit risk of borrowers who may need to defer interest payments;
 
 
PIK instruments may have unreliable valuations because the accruals require judgments about ultimate collectability of the deferred payments and the value of the associated collateral;
 
 
An election to defer PIK income payments by adding them to principal increases our gross assets and, thus, increases future base fees to the Investment Adviser and, because income payments will then be payable on a larger principal amount, the PIK election also increases the Investment Adviser’s future income incentive fees at a compounding rate;
 
 
Market prices of original issue discount instruments are more volatile because they are affected to a greater extent by interest rate changes than instruments that pay interest periodically in cash;
 
The deferral of interest on a PIK loan increases
its loan-to-value ratio,
which is a measure of the riskiness of a loan; and
 
 
Original issue discount creates the risk
of non-refundable cash
payments to the Investment Adviser based
on non-cash accruals
that may never be realized.
                 
Risks Relating to an Investment in Our Securities [Member]                                    
General Description of Registrant [Abstract]                                    
Risk [Text Block]                
Risks Relating to an Investment in Our Securities
Our shares may trade at a substantial discount from net asset value and may continue to do so over the long term.
Shares of BDCs may trade at a market price that is less than the net asset value that is attributable to those shares. The possibility that our shares of common stock will trade at a substantial discount from net asset value over the long term is separate and distinct from the risk that our net asset value will decrease. We cannot predict whether shares of our common stock will trade above, at or below our net asset value in the future. If our common stock trades below its net asset value, we will generally not be able to issue additional shares or sell our common stock at its market price without first obtaining the approval for such issuance from our stockholders and our independent directors. If additional funds are not available to us, we could be forced to curtail or cease our new lending and investment activities, and our net asset value could decrease and our level of distributions could be impacted.
Our common stock price may be volatile and may decrease substantially.
The trading price of our common stock may fluctuate substantially. The price of our common stock that will prevail in the market may be higher or lower than the price you pay, depending on many factors, some of which are beyond our control and may not be directly related to our operating performance. These factors include, but are not limited to, the following:
 
 
price and volume fluctuations in the overall stock market from time to time;
 
 
investor demand for our shares;
 
 
significant volatility in the market price and trading volume of securities of BDCs or other companies in our sector, which are not necessarily related to the operating performance of these companies;
 
 
exclusion of our common stock from certain market indices, such as the Russell 2000 Financial Services Index, which could reduce the ability of certain investment funds to own our common stock and put short-term selling pressure on our common stock;
 
 
changes in regulatory policies or tax guidelines with respect to RICs or BDCs;
 
 
failure to qualify as a RIC, or the loss of RIC tax treatment;
 
 
any shortfall in revenue or net income or any increase in losses from levels expected by investors or securities analysts;
 
 
changes, or perceived changes, in the value of our portfolio investments;
 
 
departures of SLR Capital Partners’ key personnel;
 
 
operating performance of companies comparable to us;
 
 
changes in the prevailing interest rates;
 
 
loss of a major funding source; or
 
 
general economic conditions and trends and other external factors.
Our businesses may be adversely affected by litigation and regulatory proceedings.
From time to time, we may be subject to legal actions as well as various regulatory, governmental and law enforcement inquiries, investigations and subpoenas. In any such claims or actions, demands for substantial monetary damages may be asserted against us and may result in financial liability or an adverse effect on our reputation among investors. In connection with acquisitions of, and investments in, businesses complementary to our business, we have been and may be in the future subject to securities litigation or shareholder activism in connection with such acquisitions or investments. Securities litigation and shareholder activism, including potential proxy contests, could result in substantial costs and divert management’s and our board of directors’ attention and resources from our business. We may be unable to accurately estimate our exposure to litigation risk when we record balance sheet reserves for probable loss contingencies. As a result, any reserves we establish to cover any settlements or judgments may not be sufficient to cover our actual financial exposure, which may have a material impact on our results of operations or financial condition. In regulatory enforcement matters, claims for disgorgement, the imposition of penalties and the imposition of other remedial sanctions are possible.
 
If the current period of capital market disruption and instability continues for an extended period of time, there is a risk that investors in our equity securities may not receive distributions consistent with historical levels or at all or that our distributions may not grow over time and a portion of our distributions may be a return of capital.
We intend to make distributions on a monthly basis to our stockholders out of assets legally available for distribution. We cannot assure you that we will achieve investment results that will allow us to make a specified level of cash distributions. Our ability to pay distributions might be adversely affected by the impact of one or more of the risk factors described in this annual report. If we violate certain covenants under our existing or future credit facilities or other leverage, we may be limited in our ability to make distributions. If we declare a distribution and if more stockholders opt to receive cash distributions rather than participate in our dividend reinvestment plan, we may be forced to sell some of our investments in order to make cash distribution payments. To the extent we make distributions to stockholders that include a return of capital, such portion of the distribution essentially constitutes a return of the stockholder’s investment. Although such return of capital may not be taxable, such distributions would generally decrease a stockholder’s basis in our common stock and may therefore increase such stockholder’s tax liability for capital gains upon the future sale of such stock. A return of capital distribution may cause a stockholder to recognize a capital gain from the sale of our common stock even if the stockholder sells its shares for less than the original purchase price.
As a RIC, if we do not distribute a certain percentage of our income annually, we may suffer adverse tax consequences,
including
possibly losing the U.S. federal income tax benefits allowable to RICs. We cannot assure you that you will receive distributions at a particular level or at all.
In certain cases, we may recognize income before or without receiving the accompanying cash. Depending on the amount of noncash income, this could result in difficulty satisfying the annual distribution requirement applicable to RICs. Accordingly, we may have to sell some portfolio investments at times it would not consider advantageous, raise additional debt or equity capital or reduce new investments to meet these distribution requirements.
Due to disruptions in the economy, we may reduce or defer our dividends and choose to incur U.S. federal excise tax in order to preserve cash and maintain flexibility.
In order to maintain our tax treatment as a RIC, we must distribute to shareholders for each taxable year at least 90% of our investment company taxable income (i.e., net ordinary income plus realized net short-term capital gains in excess of realized net long-term capital losses). If we qualify for taxation as a RIC, we generally will not be subject to corporate-level US federal income tax on our investment company taxable income and net capital gains (i.e., realized net long-term capital gains in excess of realized net short-term capital losses) that we timely distribute to shareholders. We will be subject to a 4% U.S. federal excise tax on undistributed earnings of a RIC unless we distribute each calendar year at least the sum of (i) 98.0% of our ordinary income for the calendar year, (ii) 98.2% of our capital gains in excess of
capital losses for the one-year period ending on October 31
of the calendar year, and (iii) any ordinary income and net capital gains that were recognized for preceding years, but were not distributed during such years and on which we paid no U.S. federal income tax. Any net operating losses that we incur in periods during which we qualify as a RIC will not offset net capital gains (i.e., net realized long-term capital gains in excess of net realized short-term capital losses) that we are otherwise required to distribute, and we cannot pass such net operating losses through to our stockholders. In addition, net operating losses that we carry over to a taxable year in which we qualify as a RIC normally cannot offset ordinary income or capital gains.
Under the Code, we may satisfy certain of our RIC distributions with dividends paid after the end of the current year. In particular, if we pay a distribution in January of the following year that was declared in October, November, or December of the current year and is payable to shareholders of record in the current year, the dividend will be treated for all US federal income tax purposes as if it were paid on December 31 of the current year. In addition, under the Code, we may pay dividends, referred to as “spillover dividends,” that are paid during the following taxable year that will allow us to maintain our qualification for taxation as a RIC and eliminate our liability for corporate-level U.S. federal income tax. Under these spillover dividend procedures, we may defer distribution of income earned during the current year until December of the following year. For example, we may defer distributions of income earned during 2023 until as late as December 31, 2024. If we choose to pay a spillover dividend, we will incur the 4% U.S. federal excise tax on some or all of the distribution.
Due to events such as
the COVID-19 pandemic,
the Russian invasion of Ukraine or other disruptions in the economy, such as the current inflationary environment, we may take certain actions with respect to the timing and amounts of our distributions in order to preserve cash and maintain flexibility. For example, we may reduce our dividends and/or defer dividends to the following taxable year. If we defer our dividends, we may choose to utilize the spillover dividend rules discussed above and incur the 4% U.S. federal excise tax on such amounts. To further preserve cash, we may combine these reductions or deferrals of dividends with one or more distributions that are payable partially in our stock as discussed below under “
We may choose to pay
 distributions in our own stock, in which case our stockholders may be required to pay U.S. federal income taxes in excess of the cash distributions they receive.”
 
We may choose to pay distributions in our own common stock, in which case our stockholders may be required to pay U.S. federal income taxes in excess of the cash distributions they receive.
We may distribute taxable distributions that are payable in part in shares of our common stock. Under certain applicable provisions of the Code and the published guidance, distributions of a publicly offered RIC that are in cash or in shares of stock at the election of stockholders may be treated as taxable distributions. The Internal Revenue Service has issued a revenue procedure indicating that this rule will apply if the total amount of cash to be distributed is not less than 20% of the total distribution. Under this revenue procedure, if too many stockholders elect to receive their distributions in cash, the cash available for distribution must be allocated among the stockholders electing to receive cash (with the balance of distributions paid in stock). In no event will any stockholder electing to receive cash, receive less than the lesser of (a) the portion of the distribution such stockholder has elected to receive in cash or (b) an amount equal to his or her entire distribution times the percentage limitation on cash available for distribution. If we decide to make any distributions consistent with this revenue procedure that are payable in part in our stock, taxable stockholders receiving such distributions will be required to include the full amount of the distribution (whether received in cash, our stock, or a combination thereof) as ordinary income (or as long-term capital gain to the extent such distribution is properly reported as a capital gain distribution) to the extent of our current and accumulated earnings and profits for U.S. federal income tax purposes. As a result, a U.S. stockholder may be required to pay tax with respect to such distributions in excess of any cash received. If a U.S. stockholder sells the stock it receives as a distribution in order to pay this tax, the sales proceeds may be less than the amount included in income with respect to the distribution, depending on the market price of our stock at the time of the sale. Furthermore, with respect to
non-U.S.
stockholders, we may be required to withhold U.S. tax with respect to such distributions, including in respect of all or a portion of such distribution that is payable in stock. If a significant number of our stockholders determine to sell shares of our stock in order to pay taxes owed on distributions, it may put downward pressure on the trading price of our stock.
Sales of substantial amounts of our common stock in the public market may have an adverse effect on the market price of our common stock.
The shares of our common stock beneficially owned by each of Messrs. Gross and Spohler immediately prior to completion of our initial public offering, including any shares that are attributable to such shares issued pursuant to our dividend reinvestment plan, are no longer
subject to lock-up restrictions that
each of Messrs. Gross and Spohler agreed to in connection with our initial public offering, and are generally available for resale without restriction, subject to the provisions of Rule 144 promulgated under the Securities Act. In addition, on November 30, 2010, Messrs. Gross and Spohler jointly acquired 115,000 shares of our common stock in a private placement transaction conducted in accordance with Regulation D under the Securities Act. Such shares are generally available for resale without restriction, subject to the provisions of Rule 144 promulgated under the Securities Act. Sales of substantial amounts of our common stock, or the availability of such common stock for sale, could adversely affect the prevailing market prices for our common stock. If this occurs and continues, it could impair our ability to raise additional capital through the sale of securities should we desire to do so.
We may be unable to invest the net proceeds raised from any offerings on acceptable terms or allocate net proceeds from any offering of our securities in ways with which you may not agree.
We cannot assure you that we will be able to find enough appropriate investments that meet our investment criteria or that any investment we complete using the proceeds from any securities offering will produce a sufficient return. Until we identify new investment opportunities, we intend to either invest the net proceeds of future offerings in cash equivalents, U.S. government securities and other high-quality debt investments that mature in one year or less or use the net proceeds from such offerings to reduce then-outstanding obligations.
We have significant flexibility in investing the net proceeds of any offering of our securities and may use the net proceeds from an offering in ways with which you may not agree or for purposes other than those contemplated at the time of the offering.
The net asset value per share of our common stock may be diluted if we issue or sell shares of our common stock at prices below the then current net asset value per share of our common stock or securities to subscribe for or convertible into shares of our common stock.
We will generally not be able to issue additional shares or sell our common stock at its market price without first obtaining the approval for such issuance from our stockholders and our independent directors. Any offering of our common stock that requires stockholder approval must occur, if at all, within one year after receiving such stockholder approval. At our 2011 Annual Stockholders Meeting, our stockholders authorized us to sell or otherwise issue warrants or securities to subscribe for or convertible into shares of our common stock subject to certain limitations (including, without limitation, that the number of shares issuable does not exceed 25% of our then outstanding common stock and that the exercise or conversion price thereof is not, at the date of issuance, less than the market value per share of our common stock). Such authorization has no expiration.
 
We may also use newly issued shares to implement our dividend reinvestment plan, whether our shares are trading at a premium or at a discount to our then current net asset value per share. Any decision to issue or sell shares of our common stock below our then current net asset value per share or securities to subscribe for or convertible into shares of our common stock would be subject to the determination by our board of directors that such issuance or sale is in our and our stockholders’ best interests.
If we were to issue or sell shares of our common stock below our then current net asset value per share, such issuances or sales would result in an immediate dilution to the net asset value per share of our common stock.
This dilution would occur as a result of the issuance or sale of shares at a price below the then current net asset value per share of our common stock and a proportionately greater decrease in the stockholders’ interest in our earnings and assets and their voting interest in us than the increase in our assets resulting from such issuance or sale. Because the number of shares of common stock that could be so issued and the timing of any issuance is not currently known, the actual dilutive effect cannot be predicted.
In addition, if we issue warrants or securities to subscribe for or convertible into shares of our common stock, subject to certain limitations, the exercise or conversion price per share could be less than net asset value per share at the time of exercise or conversion (including through the operation of anti-dilution protections).
Because we would incur expenses in connection with any issuance of such securities, such issuance could result in a dilution of the net asset value per share at the time of exercise or conversion. This dilution would include reduction in net asset value per share as a result of the proportionately greater decrease in the stockholders’ interest in our earnings and assets and their voting interest than the increase in our assets resulting from such issuance.
Further, if our current stockholders do not purchase any shares to maintain their percentage interest, regardless of whether such offering is above or below the then current net asset value per share, their voting power will be diluted. For example, if we sell an additional 10% of our common stock at a 5% discount from net asset value, a stockholder who does not participate in that offering for its proportionate interest will suffer net asset value dilution of up to 0.5% or $5 per $1,000 of net asset value.
Similarly, all distributions declared in cash payable to stockholders that are participants in our dividend reinvestment plan are automatically reinvested in shares of our common stock. As a result, stockholders that opt out of the dividend reinvestment plan may experience dilution over time. Stockholders who do not elect to receive distributions in shares of common stock may experience accretion to the net asset value of their shares if our shares are trading at a premium and dilution if our shares are trading at a discount. The level of accretion or discount would depend on various factors, including the proportion of our stockholders who participate in the plan, the level of premium or discount at which our shares are trading and the amount of the distribution payable to a stockholder.
If we issue preferred stock, the net asset value and market value of our common stock may become more volatile.
We cannot assure you that the issuance of preferred stock would result in a higher yield or return to the holders of the common stock. The issuance of preferred stock would likely cause the net asset value and market value of the common stock to become more volatile. If the distribution rate on the preferred stock were to approach the net rate of return on our investment portfolio, the benefit of leverage to the holders of the common stock would be reduced. If the distribution rate on the preferred stock were to exceed the net rate of return on our portfolio, the leverage would result in a lower rate of return to the holders of common stock than if we had not issued preferred stock. Any decline in the net asset value of our investments would be borne entirely by the holders of common stock. Therefore, if the market value of our portfolio were to decline, the leverage would result in a greater decrease in net asset value to the holders of common stock than if we were not leveraged through the issuance of preferred stock. This greater net asset value decrease would also tend to cause a greater decline in the market price for the common stock. We might be in danger of failing to maintain the required asset coverage of the preferred stock or of losing our ratings on the preferred stock or, in an extreme case, our current investment income might not be sufficient to meet the distribution requirements on the preferred stock. In order to counteract such an event, we might need to liquidate investments in order to fund a redemption of some or all of the preferred stock. In addition, we would pay (and the holders of common stock would bear) all costs and expenses relating to the issuance and ongoing maintenance of the preferred stock, including higher advisory fees if our total return exceeds the distribution rate on the preferred stock. Holders of preferred stock may have different interests than holders of common stock and may at times have disproportionate influence over our affairs.
Our board of directors is authorized to reclassify any unissued shares of common stock into one or more classes of preferred stock, which could convey special rights and privileges to its owners.
Under Maryland General Corporation Law and our charter, our board of directors is authorized to classify and reclassify any authorized but unissued shares of stock into one or more classes of stock, including preferred stock. Prior to issuance of shares of each class or series, the board of directors is required by Maryland law and our charter to set the preferences, conversion or other rights,
 
voting powers, restrictions, limitations as to other distributions, qualifications and terms or conditions of redemption for each class or series. Thus, the board of directors could authorize the issuance of shares of preferred stock with terms and conditions which could have the effect of delaying, deferring or preventing a transaction or a change in control that might involve a premium price for holders of our common stock or otherwise be in their best interest. The cost of any such reclassification would be borne by our existing common stockholders. The issuance of shares of preferred stock convertible into shares of common stock might also reduce the net income and net asset value per share of our common stock upon conversion, provided, that we will only be permitted to issue such convertible preferred stock to the extent we comply with the requirements of Section 61 of the 1940 Act, including obtaining common stockholder approval. These effects, among others, could have an adverse effect on your investment in our common stock.
Certain matters under the 1940 Act require the separate vote of the holders of any issued and outstanding preferred stock. For example, holders of preferred stock would vote separately from the holders of common stock on a proposal to cease operations as a BDC. In addition, the 1940 Act provides that holders of preferred stock are entitled to vote separately from holders of common stock to elect two preferred stock directors. In the event distributions become two full years in arrears, holders of any preferred stock would have the right to elect a majority of the directors until such arrearage is completely eliminated. Preferred stockholders also have class voting rights on certain matters, including changes in fundamental investment restrictions and
conversion to open-end status, and
accordingly can veto any such changes. Restrictions imposed on the declarations and payment of distributions to the holders of our common stock and preferred stock, both by the 1940 Act and by requirements imposed by rating agencies or the terms of our credit facilities, might impair our ability to maintain our qualification for tax treatment as a RIC for U.S. federal income tax purposes. While we would intend to redeem our preferred stock to the extent necessary to enable us to distribute our income as required to maintain our qualification as a RIC, there can be no assurance that such actions could be effected in time to meet the tax requirements.
To the extent we use debt or preferred stock to finance our investments, changes in interest rates will affect our cost of capital and net investment income.
To the extent we borrow money, or issue preferred stock, to make investments, our net investment income will depend, in part, upon the difference between the rate at which we borrow funds or pay distributions on preferred stock and the rate at which we invest those funds. In addition, many of our debt investments and borrowings have floating interest rates that reset on a periodic basis, and many of our investments are subject to interest rate floors. As a result, we can offer no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income in the event we use debt to finance our investments. In periods of rising interest rates, such as the current economic period, our cost of funds have increased, and could continue to increase, because the interest rates on the amounts borrowed under our credit facilities or certain other financing arrangements are typically floating, except to the extent we issue fixed rate debt or preferred stock, which could reduce our net investment income, and the interest rate on investments with an interest rate floor (such as a SOFR floor) above current levels will not increase until interest rates exceed the applicable floor. We expect that our long-term fixed-rate investments will generally be financed with equity and long-term debt.
We may use interest rate risk management techniques in an effort to limit our exposure to interest rate fluctuations. Such techniques may include various interest rate hedging activities to the extent permitted by the 1940 Act. These activities could limit our ability to participate in the benefits of lower interest rates with respect to the hedged borrowings. Adverse developments resulting from changes in interest rates or hedging transactions could have a material adverse effect on our business, financial condition and results of operations.
You should also be aware that the rise in the general level of interest rates can be expected to lead to higher interest rates applicable to our debt investments. Accordingly, such increase in interest rates makes it easier for us to meet or exceed the incentive fee hurdle rate and may result in a substantial increase of the amount of incentive fees payable to our Investment Adviser with respect to our
pre-incentive
fee net investment income. Also, an increase in interest rates available to investors could make an investment in our common stock less attractive if we are not able to increase our distribution rate, which could reduce the value of our common stock.
We may in the future determine to fund a portion of our investments with preferred stock, which would magnify the potential for loss and the risks of investing in us in a similar way as our borrowings.
Preferred stock, which is another form of leverage, has the same risks to our common stockholders as borrowings because the distributions on any preferred stock we issue must be cumulative. Payment of such distributions and repayment of the liquidation preference of such preferred stock must take preference over any distributions or other payments to our common stockholders, and preferred stockholders are not subject to any of our expenses or losses and are not entitled to participate in any income or appreciation in excess of their stated preference.
                 
Risks Relating to Our Business and Structure [Member]                                    
General Description of Registrant [Abstract]                                    
Risk [Text Block]                
Risks Relating to Our Business and Structure
We are dependent upon SLR Capital Partners’ key personnel for our future success.
We depend on the diligence, skill and network of business contacts of Messrs. Gross and Spohler, who serve as the managing partners of SLR Capital Partners and who lead SLR Capital Partners’ investment team. Messrs. Gross and Spohler, together with the other dedicated investment professionals available to SLR Capital Partners, evaluate, negotiate, structure, close and monitor our investments. Our future success will depend on the diligence, skill, network of business contacts and continued service of Messrs. Gross and Spohler and the other investment professionals available to SLR Capital Partners. We cannot assure you that unforeseen business, medical, personal or other circumstances would not lead any such individual to terminate his relationship with us. The loss of Mr. Gross or Mr. Spohler, or any of the other senior investment professionals who serve on SLR Capital Partners’ investment team, could have a material adverse effect on our ability to achieve our investment objective as well as on our financial condition and results of operations. In addition, we can offer no assurance that SLR Capital Partners will remain our Investment Adviser.
The senior investment professionals of SLR Capital Partners are and may in the future become affiliated with entities engaged in business activities similar to those intended to be conducted by us, and may have conflicts of interest in allocating their time. We expect that Messrs. Gross and Spohler will dedicate a significant portion of their time to the activities of SLR Investment Corp.; however, they may be engaged in other business activities which could divert their time and attention in the future. Specifically, Mr. Gross
serves as Co-Chief Executive Officer
and President of SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC. In addition, Mr. Spohler
serves as Co-Chief Executive Officer
and Chief Operating Officer of SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC.
Our business model depends to a significant extent upon strong referral relationships with financial sponsors, and the inability of the senior investment professionals of our Investment Adviser to maintain or develop these relationships, or the failure of these relationships to generate investment opportunities, could adversely affect our business.
We expect that the principals of our Investment Adviser will maintain and develop their relationships with financial sponsors, and we will rely to a significant extent upon these relationships to provide us with potential investment opportunities. If the senior investment professionals of our Investment Adviser fail to maintain their existing relationships or develop new relationships with other sponsors or sources of investment opportunities, we will not be able to grow our investment portfolio. In addition, individuals with whom the senior investment professionals of our Investment Adviser have relationships are not obligated to provide us with investment opportunities, and, therefore, there is no assurance that such relationships will generate investment opportunities for us. If our Investment Adviser is unable to source investment opportunities, we may hold a greater percentage of our assets in cash and cash equivalents than anticipated, which could impact potential returns on our portfolio.
A disruption in the capital markets and the credit markets could negatively affect our business.
As a BDC, we must maintain our ability to raise additional capital for investment purposes. Without sufficient access to the capital markets or credit markets, we may be forced to curtail our business operations or we may not be able to pursue new business opportunities. Disruptive conditions in the financial industry and the impact of new legislation in response to those conditions could restrict our business operations and could adversely impact our results of operations and financial condition.
If the fair value of our assets declines substantially, we may fail to maintain the asset coverage ratios imposed upon us by the 1940 Act and our existing credit facilities. Any such failure could result in an event of default and all of our debt being declared immediately due and payable and would affect our ability to issue senior securities, including borrowings, and pay distributions, which could materially impair our business operations. Our liquidity could be impaired further by an inability to access the capital markets or to draw on our credit facilities. For example, we cannot be certain that we will be able to renew our existing credit facilities as they mature or to consummate new borrowing facilities to provide capital for normal operations, including new originations. Reflecting concern about the stability of the financial markets, many lenders and institutional investors have reduced or ceased providing funding to borrowers. This market turmoil and tightening of credit have led to increased market volatility and widespread reduction of business activity generally.
If we are unable to renew or replace our existing credit facilities and consummate new facilities on commercially reasonable terms, our liquidity will be reduced significantly. If we consummate new facilities but are then unable to repay amounts outstanding under such facilities and are declared in default or are unable to renew or refinance these facilities, we would not be able to initiate significant originations or to operate our business in the normal course. These situations may arise due to circumstances that we may be unable to control, such as inaccessibility to the credit markets, a severe decline in the value of the U.S. dollar, a further economic downturn or an operational problem that affects third parties or us, and could materially damage our business. Moreover, we are unable to predict when economic and market conditions may become more favorable. Even if such conditions improve broadly and significantly over the long term, adverse conditions in particular sectors of the financial markets could adversely impact our business.
 
Our financial condition and results of operations will depend on SLR Capital Partners’ ability to manage our future growth effectively by identifying, investing in and monitoring companies that meet our investment criteria.
Our ability to achieve our investment objective and to grow depends on SLR Capital Partners’ ability to identify, invest in and monitor companies that meet our investment criteria. Accomplishing this result on a cost-effective basis is largely a function of SLR Capital Partners’ structuring of the investment process, its ability to provide competent, attentive and efficient services to us and its ability to access financing for us on acceptable terms. The investment team of SLR Capital Partners has substantial responsibilities under the Advisory Agreement, and they may also be called upon to provide managerial assistance to our portfolio companies as the principals of our administrator. In addition, the members of SLR Capital Partners’ investment team have similar responsibilities with respect to the management of other investment portfolios, including the investment portfolios of SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC. Such demands on their time may distract them or slow our rate of investment. In order to grow, we and SLR Capital Partners will need to retain, train, supervise and manage new investment professionals. However, we can offer no assurance that any such investment professionals will contribute effectively to the work of the Investment Adviser. Any failure to manage our future growth effectively could have a material adverse effect on our business, financial condition and results of operations.
We may need to raise additional capital to grow because we must distribute most of our income.
We may need additional capital to fund growth in our investments. We expect to issue equity securities and expect to borrow from financial institutions in the future. A reduction in the availability of new capital could limit our ability to grow. We must distribute at least 90% of our investment company taxable income to our stockholders to maintain our tax treatment as a RIC. As a result, any such cash earnings may not be available to fund investment originations. We expect to borrow from financial institutions and issue additional debt and equity securities. If we fail to obtain funds from such sources or from other sources to fund our investments, it could limit our ability to grow, which may have an adverse effect on the value of our securities. In addition, as a BDC, our ability to borrow or issue additional preferred stock may be restricted if our total assets are less than 150% of our total borrowings and preferred stock.
Any failure on our part to maintain our status as a BDC would reduce our operating flexibility and we may be limited in our investment choices as a BDC.
The 1940 Act imposes numerous constraints on the operations of BDCs. For example, BDCs are required to invest at least 70% of their total assets in specified types of securities, primarily in private companies or thinly-traded U.S. public companies, cash, cash equivalents, U.S. government securities and other high quality debt investments that mature in one year or less. Furthermore, any failure to comply with the requirements imposed on BDCs by the 1940 Act could cause the SEC to bring an enforcement action against us and/or expose us to claims of private litigants. In addition, upon approval of a majority of our stockholders, we may elect to withdraw our status as a BDC. If we decide to withdraw our election, or if we otherwise fail to qualify, or maintain our qualification, as a BDC, we may be subject to the substantially greater regulation under the 1940 Act
as a closed-end investment company.
Compliance with such regulations would significantly decrease our operating flexibility, and could have a material adverse effect on our business, financial condition and results of operations.
Regulations governing our operation as a BDC affect our ability to, and the way in which we will, raise additional capital. As a BDC, the necessity of raising additional capital may expose us to risks, including the typical risks associated with leverage.
In order to satisfy the tax requirements applicable to a RIC, to avoid payment of excise taxes and to minimize or avoid payment of income taxes, we intend to distribute to our stockholders substantially all of our ordinary income and realized net capital gains except for certain realized net long-term capital gains, which we may retain, pay applicable income taxes with respect thereto and elect to treat as deemed distributions to our stockholders. We may issue debt securities or preferred stock and/or borrow money from banks or other financial institutions, which we refer to collectively as “senior securities,” up to the maximum amount permitted by the 1940 Act. Under the provisions of the 1940 Act, we had been permitted, as a BDC, to issue senior securities in amounts such that our asset coverage ratio, as defined in the 1940 Act, equals at least 200% of gross assets less all liabilities and indebtedness not represented by senior securities, after each issuance of senior securities. However, our stockholders have approved a resolution permitting us to be subject to a 150% asset coverage ratio effective as of October 12, 2018. If the value of our assets declines, we may be unable to satisfy the asset coverage test. If that happens, we may be required to sell a portion of our investments and, depending on the nature of our leverage, repay a portion of our indebtedness at a time when such sales may be disadvantageous. Also, any amounts that we use to service our indebtedness would not be available for distributions to our common stockholders. Furthermore, as a result of issuing senior securities, we would also be exposed to typical risks associated with leverage, including an increased risk of loss. In addition, because our management fee is calculated as a percentage of our gross assets, which includes any borrowings for investment purposes, the management fee expenses will increase if we incur additional indebtedness.
 
As of December 31, 2022, we had $393.0 million outstanding under the Credit Facility, composed of $293.0 million of revolving credit and $100.0 million outstanding of term loans, and $155.2 million outstanding under our SPV Credit Facility. We also had $135.0 million outstanding of the Series F 2027 Unsecured Notes, $50.0 million outstanding of the 2027 Unsecured Notes, $75.0 million outstanding of the 2026 Unsecured Notes, $85.0 million outstanding of the 2025 Unsecured Notes, $125.0 million outstanding of the 2024 Unsecured Notes, and $75.0 million outstanding of the 2023 Unsecured Notes. If we issue preferred stock, the preferred stock would rank “senior” to common stock in our capital structure, preferred stockholders would generally vote together with common stockholders but would have separate voting rights on certain matters and might have other rights, preferences, or privileges more favorable than those of our common stockholders, and the issuance of preferred stock could have the effect of delaying, deferring or preventing a transaction or a change of control that might involve a premium price for holders of our common stock or otherwise be in your best interest.
We are not generally able to issue and sell our common stock at a price below net asset value per share. We may, however, sell our common stock, or warrants, options or rights to acquire our common stock, at a price below the then-current net asset value per share of our common stock if our board of directors determines that such sale is in the best interests of SLR Investment Corp. and its stockholders, and our stockholders approve such sale. In any such case, the price at which our securities are to be issued and sold may not be less than a price that, in the determination of our board of directors, closely approximates the market value of such securities (less any distributing commission or discount). If we raise additional funds by issuing more common stock or senior securities convertible into, or exchangeable for, our common stock, then the percentage ownership of our stockholders at that time will decrease, and you might experience dilution. This dilution would occur as a result of a proportionately greater decrease in a stockholder’s interest in our earnings and assets and voting interest in us than the increase in our assets resulting from such issuance. Because the number of future shares of common stock that may be issued below our net asset value per share and the price and timing of such issuances are not currently known, we cannot predict the actual dilutive effect of any such issuance. We cannot determine the resulting reduction in our net asset value per share of any such issuance. We also cannot predict whether shares of our common stock will trade above, at or below our net asset value.
Our credit ratings may not reflect all risks of an investment in our debt securities.
Our credit ratings are an assessment by third parties of our ability to pay our obligations. Consequently, real or anticipated changes in our credit ratings will generally affect the market value of our publicly issued debt securities. Our credit ratings, however, may not reflect the potential impact of risks related to market conditions generally or other factors discussed above on the market value of, or trading market for, any publicly issued debt securities.
Our stockholders may experience dilution in their ownership percentage if they opt out of our dividend reinvestment plan.
All distributions declared in cash payable to stockholders that are participants in our dividend reinvestment plan are automatically reinvested in shares of our common stock. In the event we issue new shares in connection with our dividend reinvestment plan, our stockholders that do not elect to receive distributions in shares of common stock may experience dilution in their ownership percentage over time as a result of such issuance.
We have and will continue to borrow money, which would magnify the potential for loss on amounts invested and may increase the risk of investing in us.
We borrow money as part of our business plan. Borrowings, also known as leverage, magnify the potential for loss on amounts invested and, therefore, increase the risks associated with investing in our securities. As of December 31, 2022, we had $393.0 million outstanding under the Credit Facility, composed of $293.0 million of revolving credit and $100.0 million outstanding of term loans, and $155.2 million outstanding under our SPV Credit Facility. We also had $135.0 million outstanding of the Series F 2027 Unsecured Notes, $50.0 million outstanding of the 2027 Unsecured Notes, $75.0 million outstanding of the 2026 Unsecured Notes, $85.0 million outstanding of the 2025 Unsecured Notes, $125.0 million outstanding of the 2024 Unsecured Notes, and $75.0 million outstanding of the 2023 Unsecured Notes. We may borrow from and issue senior debt securities to banks, insurance companies and other lenders in the future. Lenders of these senior securities, including the Credit Facility, the SPV Credit Facility, the Series F 2027 Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes, the 2024 Unsecured Notes, and the 2023 Unsecured Notes, will have fixed dollar claims on our assets that are superior to the claims of our common stockholders, and we would expect such lenders to seek recovery against our assets in the event of a default. If the value of our assets increases, then leveraging would cause the net asset value attributable to our common stock to increase more sharply than it would have had we not leveraged. Conversely, if the value of our assets decreases, leveraging would cause net asset value to decline more sharply than it otherwise would have had we not leveraged. Similarly, any decrease in our income would cause net income to decline more sharply than it would have had we not borrowed. Also, any increase in our income in excess of interest payable on the borrowed funds would cause our net investment income to increase more than it would without the leverage, while any decrease in our income would cause net investment income to decline more sharply than it would have had we not borrowed. Such a decline could also negatively affect
 
our ability to make distribution payments on our common stock, scheduled debt payments or other payments related to our securities. Leverage is generally considered a speculative investment technique. Our ability to service any debt that we incur will depend largely on our financial performance and will be subject to prevailing economic conditions and competitive pressures. Moreover, as the management fee payable to our Investment Adviser, SLR Capital Partners, will be payable based on our gross assets, including those assets acquired through the use of leverage, SLR Capital Partners will have a financial incentive to incur leverage which may not be consistent with our stockholders’ interests. In addition, our common stockholders will bear the burden of any increase in our expenses as a result of leverage, including any increase in the management fee payable to SLR Capital Partners.
As a BDC, we had generally been required to meet a coverage ratio of total assets to total borrowings and other senior securities, which include all of our borrowings and any preferred stock that we may issue in the future, of at least 200%. However, our stockholders have approved a resolution permitting us to be subject to a 150% asset coverage ratio effective as of October 12, 2018. Even though we are subject to a 150% asset coverage ratio effective as of October 12, 2018, contractual leverage limitations under our existing credit facilities or future borrowings may limit our ability to incur additional indebtedness. On August 28, 2019, we entered into the Credit Agreement, which was amended on December 28, 2021, which permits 150% asset coverage. Some of our wholly and/or substantially owned portfolio companies, including Kingsbridge Holdings, LLC, SLR Credit Solutions, SLR Equipment Finance, SLR Business Credit and SLR Healthcare ABL, may incur significantly more leverage than we can but we do not consolidate Kingsbridge Holdings, LLC, SLR Credit Solutions, SLR Equipment Finance, SLR Business Credit and SLR Healthcare ABL and their
leverage is non-recourse to us.
Additionally, the Credit Facility and the SPV Credit Facility require us to comply with certain financial and other restrictive covenants including maintaining an asset coverage ratio of not less than 150% at any time. Failure to maintain compliance with these covenants could result in an event of default and all of our debt being declared immediately due and payable. If this ratio declines below 150%, we may not be able to incur additional debt and could be required by law to sell a portion of our investments to repay some debt when it is disadvantageous to do so, which could have a material adverse effect on our operations, and we may not be able to make distributions. The amount of leverage that we employ will depend on our Investment Adviser’s and our board of directors’ assessment of the market and other factors at the time of any proposed borrowing. We cannot assure you that we will be able to obtain credit at all or on terms acceptable to us.
In addition, our credit facilities impose, and any other debt facility into which we may enter would likely impose, financial and operating covenants that restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain RIC tax treatment under Subchapter M of the Code.
The debt securities that we may issue will be governed by an indenture or other instrument containing covenants restricting our operating flexibility. We, and indirectly our stockholders, bear the cost of issuing and servicing such debt securities. Any convertible or exchangeable securities that we issue in the future may have rights, preferences and privileges more favorable than those of our common stock.
Illustration.
 The following table illustrates the effect of leverage on returns from an investment in our common stock assuming various annual returns on our portfolio, net of interest expense. The calculations in the table below are hypothetical and actual returns may be higher or lower than those appearing in the table below.
 
    
Assumed total return
(net of interest expense)
 
    
(10)%
   
(5)%
   
0%
   
5%
   
10%
 
Corresponding return to stockholder(1)
     (29.9 )%      (17.2 )%      (4.5 )%      8.2     20.9
 
(1)
Assumes $2.5 billion in total assets and $1.1 billion in total debt outstanding, which reflects our total assets and total debt outstanding as of December 31, 2022, and a cost of funds of
4.09%. Excludes non-leverage related expenses.
In
 
order for us to cover our annual interest payments on our outstanding indebtedness at December 31, 2022, we must achieve annual returns on our December 31, 2022 total assets of at least 1.8%.
It is likely that the terms of any current or future long-term or revolving credit or warehouse facility we may enter into in the future could constrain our ability to grow our business.
Our current lenders have, and any future lender or lenders may have, fixed dollar claims on our assets that are senior to the claims of our stockholders and, thus, will have a preference over our stockholders with respect to our assets in the collateral pool. Our current credit facilities and borrowings also subject us to various financial and operating covenants, including, but not limited to, maintaining certain financial ratios and minimum tangible net worth amounts. Future credit facilities and borrowings will likely subject us to similar or additional covenants. In addition, we may grant a security interest in our assets in connection with any such credit facilities and borrowings.
 
Our credit facilities generally contain customary default provisions such as a minimum net worth amount, a profitability test, and a restriction on changing our business and loan quality standards. In addition, our credit facilities require or are expected to require the repayment of all outstanding debt on the maturity, which may disrupt our business and potentially the business of our portfolio companies that are financed through our credit facilities. An event of default under our credit facilities would likely result, among other things, in termination of the availability of further funds under our credit facilities and accelerated maturity dates for all amounts outstanding under our credit facilities, which would likely disrupt our business and, potentially, the business of the portfolio companies whose loans we finance through our credit facilities. This could reduce our revenues and, by delaying any cash payment allowed to us under our credit facilities until the lender has been paid in full, reduce our liquidity and cash flow and impair our ability to grow our business and maintain RIC tax treatment.
The terms of future available financing may place limits on our financial and operational flexibility. If we are unable to obtain sufficient capital in the future, we may be forced to reduce or discontinue our operations, not be able to make new investments, or otherwise respond to changing business conditions or competitive pressures.
Our quarterly and annual operating results are subject to fluctuation as a result of the nature of our business, and if we fail to achieve our investment objective, the net asset value of our common stock may decline.
We could experience fluctuations in our quarterly and annual operating results due to a number of factors, some of which are beyond our control, including, but not limited to, the interest rate payable on the debt securities that we acquire, the default rate on such securities, the level of our expenses, variations in and the timing of the recognition of realized and unrealized gains or losses, changes in our portfolio composition, the degree to which we encounter competition in our markets, market volatility in our publicly traded securities and the securities of our portfolio companies, and general economic conditions. As a result of these factors, results for any period should not be relied upon as being indicative of performance in future periods. In addition, any of these factors could negatively impact our ability to achieve our investment objectives, which may cause our net asset value of our common stock to decline.
Our investments may be in portfolio companies that may have limited operating histories and financial resources.
We expect that our portfolio will continue to consist of investments that may have relatively limited operating histories. These companies may be particularly vulnerable to U.S. and foreign economic downturns such as the U.S. recession that
began in mid-2007, the European
financial crisis,
and the COVID-19 related economic
downturn, may have more limited access to capital and higher funding costs, may have a weaker financial position and may need more capital to expand or compete. These businesses also may experience substantial variations in operating results. They may face intense competition, including from companies with greater financial, technical and marketing resources. Furthermore, some of these companies do business in regulated industries and could be affected by changes in government regulation. Accordingly, these factors could impair their cash flow or result in other events, such as bankruptcy, which could limit their ability to repay their obligations to us, and may adversely affect the return on, or the recovery of, our investment in these companies. We cannot assure you that any of our investments in our portfolio companies will be successful. Our portfolio companies compete with larger, more established companies with greater access to, and resources for, further development in these new technologies. Therefore, we may lose our entire investment in any or all of our portfolio companies.
There will be uncertainty as to the value of our portfolio investments, which may impact our net asset value.
A large percentage of our portfolio investments are in the form of securities that are not publicly traded. The fair value of securities and other investments that are not publicly traded may not be readily determinable. We value these securities on a quarterly basis in accordance with our valuation policy, which is at all times consistent with GAAP. Our board of directors will (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services; (5) oversee the reporting required by Rule
2a-5
under the 1940 Act; and (6) maintain recordkeeping requirements under Rule
2a-5.
Our board of directors utilizes the services of third-party valuation firms to aid it in determining the fair value of material assets. The board of directors discusses valuations and determines the fair value in good faith based on the input of our Investment Adviser and, when utilized, the respective third-party valuation firms. The factors that may be considered in fair value pricing our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments and its earnings, the markets in which the portfolio company does business, comparisons to publicly traded companies, discounted cash flow and other relevant factors. Because such valuations, and particularly valuations of private securities and private companies, are inherently uncertain, may fluctuate over short periods of time and may be based on estimates, our determinations of fair value may differ materially from the values that would have been used if a ready market for these securities existed. Our net asset value could be adversely affected if our determinations regarding the fair value of our investments were materially higher than the values that we ultimately realize upon the disposal of such securities.
 
Our equity ownership in a portfolio company may represent a control investment. Our ability to exit an investment in a timely manner because we are in a control position or have access to inside information in the portfolio company could result in a realized loss on the investment.
If we obtain a control investment in a portfolio company our ability to divest ourselves from a debt or equity investment could be restricted due to illiquidity in a private stock, limited trading volume on a public company’s stock, inside information on a company’s performance, insider blackout periods, or other factors that could prohibit us from disposing of the investment as we would if it were not a control investment. Additionally, we may choose not to take certain actions to protect a debt investment in a control investment portfolio company. As a result, we could experience a decrease in the value of our portfolio company holdings and potentially incur a realized loss on the investment.
There are significant potential conflicts of interest, including SLR Capital Partners’ management of other investment funds such as SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC, which could impact our investment returns, and an investment in SLR Investment Corp. is not an investment in SCP Private Credit Income BDC LLC, SLR HC BDC LLC, or SLR Private Credit BDC II LLC.
Our executive officers and directors, as well as the current and future partners of our Investment Adviser, SLR Capital Partners, may serve as officers, directors or principals of entities that operate in the same or a related line of business as we do. For example, SLR Capital Partners presently serves as the Investment Adviser to (i) SCP Private Credit Income BDC LLC, an unlisted BDC that focuses on investing primarily in senior secured
loans, including non-traditional asset-based loans
and first lien loans, (ii) SLR HC BDC LLC, an unlisted BDC whose principal focus is to invest directly and indirectly in senior secured loans and other debt instruments typically to middle market companies within the healthcare industry, and (iii) SLR Private Credit BDC II LLC, an unlisted BDC whose principal focus is to invest in first lien senior secured floating rate loans primarily to upper middle market leveraged companies with EBITDA between approximately $25 million and $250 million that have significant free cash flow and are in
non-cyclical
industries in which the Investment Adviser has significant experience. In addition, Michael S. Gross,
our Chairman, Co-Chief Executive Officer
and President, Bruce
Spohler, our Co-Chief Executive Officer
and Chief Operating Officer and board member, and Richard L. Peteka, our Chief Financial Officer, serve in similar capacities for SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC. Accordingly, they may have obligations to investors in those entities, the fulfillment of which obligations might not be in the best interests of us or our stockholders. In addition, we note that any affiliated investment vehicle formed in the future and managed by our Investment Adviser or its affiliates may, notwithstanding different stated investment objectives, have overlapping investment objectives with our own and, accordingly, may invest in asset classes similar to those targeted by us. As a result, SLR Capital Partners may face conflicts in allocating investment opportunities between us and such other entities. Although SLR Capital Partners will endeavor to allocate investment opportunities in a fair and equitable manner, it is possible that, in the future, we may not be given the opportunity to participate in investments made by investment funds managed by our Investment Adviser or an investment manager affiliated with our Investment Adviser. In any such case, when SLR Capital Partners identifies an investment, it will be forced to choose which investment fund should make the investment.
As a BDC, we were substantially limited in our
ability to co-invest in privately
negotiated transactions with affiliated funds until we obtained an exemptive order from the SEC. The most recent exemptive order, received on June 13, 2017 (the “Exemptive Order”), permits us to participate
in negotiated co-investment transactions with
certain affiliates, each of whose investment adviser is an investment adviser that controls, is controlled by or is under common control with SLR Capital Partners and is registered as an Investment Adviser under the Advisers Act, in a manner consistent with our investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, and pursuant to the conditions to the Exemptive Order. If we are unable to rely on the Exemptive Order for a particular opportunity, such opportunity will be allocated first to the entity whose investment strategy is the most consistent with the opportunity being allocated, and second, if the terms of the opportunity are consistent with more than one entity’s investment strategy, on an alternating basis. Although our investment professionals will endeavor to allocate investment opportunities in a fair and equitable manner, we and our common stockholders could be adversely affected to the extent investment opportunities are allocated among us and other investment vehicles managed or sponsored by, or affiliated with, our executive officers, directors and members of our Investment Adviser.
SLR Capital Partners and certain investment advisory affiliates may determine that an investment is appropriate for us and for one or more of those other funds. In such event, depending on the availability of such investment and other appropriate factors, SLR Capital Partners or its affiliates may determine that we
should invest side-by-side with one
or more other funds. Any such investments will be made only to the extent permitted by applicable law and interpretive positions of the SEC and its staff, and consistent with SLR Capital Partners’ allocation procedures. Related party transactions may occur among SLR Investment Corp., SLR Credit Solutions, Equipment Operating Leases LLC, Loyer Capital LLC, SLR Equipment Finance, SLR Business Credit, SLR Healthcare ABL, SLR Senior Lending Program LLC and SLR Senior Lending Program SPV LLC. These transactions may occur in the normal course of business. No administrative or other fees are paid to SLR Capital Partners by SLR Credit Solutions, Equipment Operating Leases LLC, Loyer Capital LLC, SLR Equipment Finance, SLR Business Credit, SLR Healthcare ABL, SLR Senior Lending Program LLC and SLR Senior Lending Program SPV LLC.
 
In the ordinary course of our investing activities, we pay management and incentive fees to SLR Capital Partners and reimburse SLR Capital Partners for certain expenses it incurs. As a result, investors in our common stock will invest on a “gross” basis and receive distributions on a “net” basis after expenses, resulting in a lower rate of return than an investor might achieve through direct investments. Accordingly, there may be times when the management team of SLR Capital Partners has interests that differ from those of our stockholders, giving rise to a conflict.
We entered into an amended and restated royalty-free license agreement on February 25, 2021 with our Investment Adviser, pursuant to which our Investment Adviser has granted
us a non-exclusive license to
use the marks “SOLAR” and “SLR.” Under the license agreement, we have the right to use the “SLR Investment” name for so long as SLR Capital Partners or one of its affiliates remains our Investment Adviser. In addition, we pay SLR Capital Management, an affiliate of SLR Capital Partners, our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions, and our allocable portion of the compensation of our chief compliance officer and our chief financial officer and their respective staffs. These arrangements create conflicts of interest that our board of directors must monitor.
Our ability to enter into transactions involving derivatives and financial commitment transactions may be limited.
Through comprehensive new global regulatory regimes impacting derivatives (
e.g.
, the Dodd-Frank Act, European Market Infrastructure Regulation (“EMIR”), Markets in Financial Investments Regulation (“MIFIR”)/Markets in Financial Instruments Directive (“MIFID II”)), certain
over-the-counter
derivatives transactions in which we may engage are either now or will soon be subject to various requirements, such as mandatory central clearing of transactions which include additional margin requirements and in certain cases trading on electronic platforms,
pre-and
post-trade transparency reporting requirements and mandatory
bi-lateral
exchange of initial margin for
non-cleared
swaps. The Dodd-Frank Act also created new categories of regulated market participants, such as “swap dealers,” “security-based swap dealers,” “major swap participants,” and “major security-based swap participants” who are subject to significant new capital, registration, recordkeeping, reporting, disclosure, business conduct and other regulatory requirements. The EU and some other jurisdictions are implementing similar requirements. Because these requirements are new and evolving (and some of the rules are not yet final), their ultimate impact remains unclear. However, even if we are not located in a particular jurisdiction or directly subject to the jurisdiction’s derivatives regulations, we may still be impacted to the extent we enter into a derivatives transaction with a regulated market participant or counterparty that is organized in that jurisdiction or otherwise subject to that jurisdiction’s derivatives regulations.
Based on information available as of the date of this annual report
on Form 10-K, the effect
of such requirements will be likely to (directly or indirectly) increase our overall costs of entering into derivatives transactions. In particular, new margin requirements, position limits and significantly higher capital charges resulting from new global capital regulations, even if not directly applicable to us, may cause an increase in the pricing of derivatives transactions entered into by market participants to whom such requirements apply or affect our overall ability to enter into derivatives transactions with certain counterparties. Such new global capital regulations and the need to satisfy the various requirements by counterparties are resulting in increased funding costs, increased overall transaction costs, and significantly affecting balance sheets, thereby resulting in changes to financing terms and potentially impacting our ability to obtain financing. Administrative costs, due to new requirements such as registration, recordkeeping, reporting, and compliance, even if not directly applicable to us, may also be reflected in our derivatives transactions. New requirements to trade certain derivatives transactions on electronic trading platforms and trade reporting requirements may lead to (among other things) fragmentation of the markets, higher transaction costs or reduced availability of derivatives, and/or a reduced ability to hedge, all of which could adversely affect the performance of certain of our trading strategies. In addition, changes to derivatives regulations may impact the tax and/or accounting treatment of certain derivatives, which could adversely impact us.
In November 2020, the SEC adopted new rules regarding the ability of a BDC (or a registered investment company) to use derivatives and other transactions that create future payment or delivery obligations. BDCs that use derivatives would be subject
to a value-at-risk leverage limit,
certain other derivatives risk management program and testing requirements and requirements related to board reporting. These new requirements would apply unless the BDC qualified as a “limited derivatives user,” as defined in the SEC’s adopted rules. A BDC that enters into reverse repurchase agreements or similar financing transactions would need to aggregate the amount of indebtedness associated with the reverse repurchase agreements or similar financing transactions could either (i) comply with the asset coverage requirements of the Section 18 of the 1940 Act when engaging in reverse repurchase agreements or (ii) choose to treat such agreements as derivative transactions under the adopted rule. Under the adopted rule, a BDC may enter into an unfunded commitment agreement that is not a derivatives transaction, such as an agreement to provide financing to a portfolio company, if the BDC has a reasonable belief, at the time it enters into such an agreement, that it will have sufficient cash and cash equivalents to meet its obligations with respect to all of its unfunded commitment agreements, in each case as it becomes due. If the BDC cannot meet this test, it is required to treat unfunded commitments as a derivatives transaction subject to the requirements of the rule. Collectively, these requirements may limit our ability to use derivatives and/or enter into certain other financial contracts.
 
We may be obligated to pay our Investment Adviser incentive compensation even if we incur a loss.
Our Investment Adviser will be entitled to incentive compensation for each fiscal quarter in an amount equal to a percentage of the excess
of our pre-incentive fee net
investment income for that quarter (before deducting incentive compensation) above a performance threshold for that quarter. Accordingly, since the performance threshold is based on a percentage of our net asset value, decreases in our net asset value make it easier to achieve the performance
threshold. Our pre-incentive fee net
investment income for incentive compensation purposes excludes realized and unrealized capital losses or depreciation that we may incur in the fiscal quarter, even if such capital losses or depreciation result in a net loss on our statement of operations for that quarter.
Thus, we may be required to pay SLR Capital Partners incentive compensation for a fiscal quarter even if there is a decline in the value of our portfolio or we incur a net loss for that quarter.
Our incentive fee may induce SLR Capital Partners to pursue speculative investments.
The incentive fee payable by us to SLR Capital Partners may create an incentive for SLR Capital Partners to pursue investments on our behalf that are riskier or more speculative than would be the case in the absence of such compensation arrangement. The incentive fee payable to our Investment Adviser is calculated based on a percentage of our return on invested capital. This may encourage our Investment Adviser to use leverage to increase the return on our investments. Under certain circumstances, the use of leverage may increase the likelihood of default, which would impair the value of our common stock. In addition, our Investment Adviser receives the incentive fee based, in part, upon net capital gains realized on our investments. Unlike that portion of the incentive fee based on income, there is no hurdle rate applicable to the portion of the incentive fee based on net capital gains. As a result, our Investment Adviser may have a tendency to invest more capital in investments that are likely to result in capital gains as compared to income producing securities. Such a practice could result in our investing in more speculative securities than would otherwise be the case, which could result in higher investment losses, particularly during economic downturns.
The incentive fee payable by us to our Investment Adviser also may induce SLR Capital Partners to invest on our behalf in instruments that have a deferred interest feature, even if such deferred payments would not provide the cash necessary to enable us to pay current distributions to our stockholders. Under these investments, we would accrue interest over the life of the investment but would not receive the cash income from the investment until the end of the term. Our net investment income used to calculate the income portion of our investment fee, however, includes accrued interest. Thus, a portion of this incentive fee would be based on income that we have not received in cash. In
addition, the “catch-up” portion of
the incentive fee may encourage SLR Capital Partners to accelerate or defer interest payable by portfolio companies from one calendar quarter to another, potentially resulting in fluctuations in timing and distribution amounts.
We may invest, to the extent permitted by law, in the securities and instruments of other investment companies, including private funds, and, to the extent we so invest, will bear our ratable share of any such investment company’s expenses, including management and performance fees. We will also remain obligated to pay management and incentive fees to SLR Capital Partners with respect to the assets invested in the securities and instruments of other investment companies. With respect to each of these investments, each of our stockholders will bear his or her share of the management and incentive fee of SLR Capital Partners as well as indirectly bearing the management and performance fees and other expenses of any investment companies in which we invest.
We may become subject to corporate-level U.S. federal income tax if we are unable to qualify and maintain our qualification for tax treatment as a regulated investment company under Subchapter M of the Code.
Although we have elected to be treated as a RIC under Subchapter M of the Code, no assurance can be given that we will continue to be able to qualify for and maintain RIC tax treatment. To maintain RIC tax treatment under the Code, we must meet the following annual distribution, income source and asset diversification requirements on an ongoing basis.
 
 
The Annual Distribution Requirement for a RIC will be satisfied if we distribute to our stockholders on an annual basis at least 90% of our net ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any. Because we may use debt financing, we are subject to certain asset coverage ratio requirements under the 1940 Act and financial covenants under loan and credit agreements that could, under certain circumstances, restrict us from making distributions necessary to satisfy the Annual Distribution Requirement. If we are unable to obtain cash from other sources, we could fail to qualify for RIC tax treatment and become subject to corporate-level U.S federal income tax.
 
 
The income source requirement will be satisfied if we obtain at least 90% of our income for each year from certain passive investments, including interest, dividends, gains from the sale of stock or securities, or similar sources.
 
 
The asset diversification requirement will be satisfied if we meet certain asset diversification requirements at the end of each quarter of our taxable year. Failure to meet those requirements may result in our having to dispose of certain investments quickly in order to prevent the loss of RIC tax treatment. Because most of our investments will be relatively illiquid, any such dispositions could be made at disadvantageous prices and could result in substantial losses.
If we fail to qualify for RIC tax treatment for any reason and become subject to corporate income tax, the resulting corporate taxes could substantially reduce our net assets, the amount of income available for distribution and the amount of our distributions. Such a failure could have a material adverse effect on us, the net asset value of our common stock and the total return, if any, obtainable from your investment in our common stock.
We may have difficulty satisfying the Annual Distribution Requirement in order to qualify and maintain RIC tax treatment if we recognize income before or without receiving cash representing such income.
In accordance with GAAP and tax requirements, we include in income certain amounts that we have not yet received in cash, such as contractual PIK interest, which represents contractual interest added to a loan balance and due at the end of such loan’s term. In addition to the cash yields received on our loans, in some instances, certain loans may also include any of
the following: end-of-term payments, exit
fees, balloon payment fees or prepayment fees. The increases in loan balances as a result of contractual PIK arrangements are included in income for the period in which such PIK interest was accrued, which is often in advance of receiving a cash payment, and are separately identified on our statements of cash flows. We also may be required to include in income certain other amounts prior to receiving the related cash.
Any warrants that we receive in connection with our debt investments will generally be valued as part of the negotiation process with the particular portfolio company. As a result, a portion of the aggregate purchase price for the debt investments and warrants will be allocated to the warrants that we receive. This will generally result in “original issue discount” for U.S. federal income tax purposes, which we must recognize as ordinary income, increasing the amount that we are required to distribute to qualify for the U.S. federal income tax benefits applicable to RICs. Because these warrants generally will not produce distributable cash for us at the same time as we are required to make distributions in respect of the related original issue discount, we would need to obtain cash from other sources or to pay a portion of our distributions using shares of newly issued common stock, consistent with Internal Revenue Service requirements, to satisfy the Annual Distribution and Excise Tax Avoidance requirements.
Other features of the debt instruments that we hold may also cause such instruments to generate original issue discount, resulting in a distribution requirement in excess of current cash interest received. Since in certain cases we may recognize income before or without receiving cash representing such income, we may have difficulty meeting the RIC tax requirement to distribute at least 90% of our net ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any. Under such circumstances, we may have to sell some of our investments at times we would not consider advantageous, raise additional debt or equity capital or reduce new investment originations to meet these distribution requirements. If we are unable to obtain cash from other sources and are otherwise unable to satisfy such distribution requirements, we may fail to qualify for the U.S. federal income tax benefits allowable to RICs and, thus, become subject to a corporate-level U.S. federal income tax on all our income.
Provisions of the Maryland General Corporation Law and of our charter and bylaws could deter takeover attempts and have an adverse impact on the price of our common stock.
The Maryland General Corporation Law and our charter and bylaws contain provisions that may discourage, delay or make more difficult a change in control of SLR Investment Corp. or the removal of our directors. We are subject to the Maryland Business Combination Act, subject to any applicable requirements of the 1940 Act. Our board of directors has adopted a resolution exempting from the Maryland Business Combination Act any business combination between us and any other person, subject to prior approval of such business combination by our board of directors, including approval by a majority of our disinterested directors. If the resolution exempting business combinations is repealed or our board of directors does not approve a business combination, the Maryland Business Combination Act may discourage third parties from trying to acquire control of us and increase the difficulty of consummating such an offer. Our bylaws exempt from the Maryland Control Share Acquisition Act (the “Control Share Act”) acquisitions of our stock by any person. If we amend our bylaws to repeal the exemption from the Control Share Act, the Control Share Act also may make it more difficult for a third party to obtain control of us and increase the difficulty of consummating such a transaction. The SEC staff has rescinded its position that, under the 1940 Act, an investment company may not avail itself of the Control Share Act. As a result, we will amend our bylaws to be subject to the Control Share Act only if our board of directors determines that it would be in our best interests.
 
We have also adopted measures that may make it difficult for a third party to obtain control of us, including provisions of our charter classifying our board of directors in three classes serving staggered three-year terms, and authorizing our board of directors to classify or reclassify shares of our stock in one or more classes or series, to cause the issuance of additional shares of our stock and to amend our charter without stockholder approval to increase or decrease the number of shares of stock that we have authority to issue. These provisions, as well as other provisions of our charter and bylaws, may delay, defer or prevent a transaction or a change in control that might otherwise be in the best interests of our stockholders.
The foregoing provisions are expected to discourage certain coercive takeover practices and inadequate takeover bids and to encourage persons seeking to acquire control of us to negotiate first with our board of directors. However, these provisions may deprive a stockholder of the opportunity to sell such stockholder’s shares at a premium to a potential acquirer. We believe that the benefits of these provisions outweigh the potential disadvantages of discouraging any such acquisition proposals because, among other things, the negotiation of such proposals may improve their terms. Our board of directors has considered both the positive and negative effects of the foregoing provisions and determined that they are in the best interest of our stockholders.
Our bylaws designate the Circuit Court for Baltimore City, Maryland as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders and provide that claims relating to causes of action under the Securities Act may only be brought in federal district courts, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers or agents, if any, and could discourage lawsuits against us and our directors, officers and agents, if any.
Our bylaws provide that, unless we consent in writing to the selection of an alternative forum, the Circuit Court for Baltimore City, Maryland, or, if that court does not have jurisdiction, the United States District Court for the District of Maryland, Northern Division, will be the sole and exclusive forum for (a) any Internal Corporate Claim, as such term is defined in the MGCL, (b) any derivative action or proceeding brought on our behalf (other than actions arising under federal securities laws), (c) any action asserting a claim of breach of any duty owed by any of our directors, officers or other agents to us or to our stockholders, (d) any action asserting a claim against us or any of our directors, officers or other agents arising pursuant to any provision of the MGCL or our charter or bylaws or (e) any other action asserting a claim against us or any of our directors, officers or other employees that is governed by the internal affairs doctrine. With respect to any proceeding described in the foregoing sentence that is in the Circuit Court for Baltimore City, Maryland, our stockholders consent to the assignment of the proceeding to the Business and Technology Case Management Program pursuant to Maryland
Rule 16-308 or
any successor thereof. None of the foregoing actions, claims or proceedings may be brought in any court sitting outside the State of Maryland unless we consent in writing to such court. Our bylaws do not apply to lawsuits asserting claims brought to enforce a duty or liability arising exclusively under the Securities Act, the 1934 Act, or the 1940 Act, or any other claim for which the federal courts have exclusive jurisdiction.
Unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States of America shall, to the fullest extent permitted by law, be the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. This paragraph does not apply to claims arising exclusively under the 1934 Act or the 1940 Act, or any other claim for which the federal courts have exclusive jurisdiction. These exclusive forum provisions may limit the ability of our stockholders to bring a claim in a judicial forum that such stockholders find favorable for disputes with us or our directors, officers, or agents, if any, which may discourage such lawsuits against us and our directors, officers, and agents, if any. Alternatively, if a court were to find the choice of forum provisions contained in our bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could materially adversely affect our business, financial condition, and operating results. For example, under the Securities Act, federal courts have concurrent jurisdiction over all suits brought to enforce any duty or liability created by the Securities Act, and investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder.
The failure in cyber security systems, as well as the occurrence of events unanticipated in our disaster recovery systems and management continuity planning could impair our ability to conduct business effectively.
The occurrence of a disaster, such as a cyber-attack against us or against a third party that has access to our data or networks, a natural catastrophe, an industrial accident, failure of our disaster recovery systems, or consequential employee error, could have an adverse effect on our ability to communicate or conduct business, negatively impacting our operations and financial condition. This adverse effect can become particularly acute if those events affect our electronic data processing, transmission, storage, and retrieval systems, or impact the availability, integrity, or confidentiality of our data.
We depend heavily upon computer systems to perform necessary business functions. Despite our implementation of a variety of security measures, our computer systems, networks, and data, like those of other companies, could be subject to cyber-attacks and unauthorized access, use, alteration, or destruction, such as from physical
and electronic break-ins or unauthorized
tampering. If one or more of these events occurs, it could potentially jeopardize the confidential, proprietary, and other information processed, stored in,
 
and transmitted through our computer systems and networks. Such an attack could cause interruptions or malfunctions in our operations, which could result in financial losses, litigation, regulatory penalties, client dissatisfaction or loss, reputational damage, and increased costs associated with mitigation of damages and remediation. If unauthorized parties gain access to such information and technology systems, they may be able to steal, publish, delete or modify private and sensitive information, including nonpublic personal information related to stockholders (and their beneficial owners) and material nonpublic information. The systems we have implemented to manage risks relating to these types of events could prove to be inadequate and, if compromised, could become inoperable for extended periods of time, cease to function properly or fail to adequately secure private information. Breaches such as those involving covertly introduced malware, impersonation of authorized users and industrial or other espionage may not be identified even with sophisticated prevention and detection systems, potentially resulting in further harm and preventing them from being addressed appropriately. The failure of these systems or of disaster recovery plans for any reason could cause significant interruptions in our and our Investment Adviser’s operations and result in a failure to maintain the security, confidentiality or privacy of sensitive data, including personal information relating to stockholders, material nonpublic information and other sensitive information in our possession.
A disaster or a disruption in the infrastructure that supports our business, including a disruption involving electronic communications or other services used by us or third parties with whom we conduct business, or directly affecting our headquarters, could have a material adverse impact on our ability to continue to operate our business without interruption. Our disaster recovery programs may not be sufficient to mitigate the harm that may result from such a disaster or disruption. In addition, insurance and other safeguards might only partially reimburse us for our losses, if at all.
Third parties with which we do business may also be sources of cybersecurity or other technological risk. We outsource certain functions and these relationships allow for the storage and processing of our information, as well as client, counterparty, employee, and borrower information. While we engage in actions to reduce our exposure resulting from outsourcing, ongoing threats may result in unauthorized access, loss, exposure, destruction, or other cybersecurity incident that affects our data, resulting in increased costs and other consequences as described above.
In addition, cybersecurity has become a top priority for global lawmakers and regulators around the world, and some jurisdictions have proposed or enacted laws requiring companies to notify regulators and individuals of data security breaches involving certain types of personal data. In particular, state and federal laws and regulations related to cybersecurity compliance continue to evolve and change, which may require substantial investments in new technology, software and personnel, which could affect the Company’s profitability. These changes may also result in enhanced and unforeseen consequences for cyber-related breaches and incidents, which may further adversely affect the Company’s profitability. If we fail to comply with the relevant and increasing laws and regulations, we could suffer financial losses, a disruption of our businesses, liability to investors, regulatory intervention or reputational damage.
We and our service providers may be impacted by quarantines and similar measures being enacted by governments in response to
the global COVID-19 pandemic, which
are obstructing the regular functioning of business workforces (including requiring employees to work from external locations and their homes). Policies of remote working, whether by us or by our service providers, could strain technology resources, introduce operational risks and otherwise heighten the risks described above. Remote working environments may be less secure and more susceptible to hacking attacks, including phishing and social engineering attempts.
We, our Investment Adviser and our portfolio companies are subject to risks associated with “phishing” and other cyber-attacks.
Our business and the business of our portfolio companies rely upon secure information technology systems for data processing, storage and reporting. Despite careful security and controls design, implementation and updating, ours and our portfolio companies’ information technology systems could become subject to cyber-attacks. Cyber-attacks include, but are not limited to, gaining unauthorized access to digital systems (e.g., through “hacking”, malicious software coding, social engineering or “phishing” attempts) for purposes of misappropriating assets or sensitive information, corrupting data, or causing operational disruption. The risk of a security breach or disruption, particularly through cyber-attacks or cyber intrusions, including by computer hackers, nation-state affiliated actors, and cyber terrorists, has generally increased as the number, intensity and sophistication of attempted attacks and intrusions from around the world have increased. Cyber-attacks may also be carried out in a manner that does not require gaining unauthorized access, such
as causing denial-of service attacks
on websites (i.e., efforts to make network services unavailable to intended users). Our Investment Adviser’s employees have been and expect to continue to be the target of fraudulent calls, emails and other forms of potentially malicious or otherwise negatively impacting activities and attempts to gain unauthorized access to confidential, personal or other sensitive information. The result of these incidents may include disrupted operations, misstated or unreliable financial data, liability for stolen information, investigations, misappropriation of assets, increased cybersecurity protection and insurance costs, litigation and damage to our business relationships, regulatory fines or penalties, or other adverse effects on our business, financial condition or results of operations. In addition, we may be required to expend significant additional resources to modify our protective measures and to investigate and remediate vulnerabilities or other exposures arising from operational and security risks related to cyber-attacks.
 
Our Investment Adviser’s and other service providers’ increased use of mobile and cloud technologies could heighten the risk of a cyber-attack as well as other operational risks, as certain aspects of the security of such technologies may be complex, unpredictable or beyond their control. Our Investment Adviser’s and other service providers’ reliance on mobile or cloud technology or any failure by mobile technology and cloud service providers to adequately safeguard their systems and prevent cyber-attacks could disrupt their operations and result in misappropriation, corruption or loss of personal, confidential or proprietary information. In addition, there is a risk that encryption and other protective measures against cyber-attacks may be circumvented, particularly to the extent that new computing technologies increase the speed and computing power available. Even the most well-protected information, networks, systems and facilities remain potentially vulnerable because the techniques used in such attempted security breaches evolve and generally are not recognized until launched against a target, and in some cases are designed not to be detected and, in fact, may not be detected. Accordingly, we and our service providers may be unable to anticipate these techniques or to implement adequate security barriers or other preventative measures, and thus it is impossible for us and our service providers to entirely mitigate this risk. Cybersecurity risks require continuous and increasing attention and other resources from us to, among other actions, identify and quantify these risks, upgrade and expand our technologies, systems and processes to adequately address such risks. Such attention diverts time and other resources from other activities and there is no assurance that our efforts will be effective.
Cybersecurity incidents may adversely impact us and our stockholders. There is no guarantee that we, the Investment Adviser, and/or their respective service providers will be successful in protecting against cybersecurity incidents.
We can be highly dependent on information systems and systems failures could significantly disrupt our business, which may, in turn, negatively affect the market price of our common stock and our ability to pay distributions.
Our business is highly dependent upon our and third parties’ communications and information systems. Any failure or interruption of those systems, including as a result of the termination of an agreement with any third-party service providers, could cause delays or other problems in our activities. Our financial, accounting, data processing, backup or other operating systems and facilities may fail to operate properly or become disabled or damaged as a result of a number of factors including events that are wholly or partially beyond our control and adversely affect our business. There could be:
 
 
sudden electrical or telecommunications outages;
 
 
natural disasters such as earthquakes, tornadoes and hurricanes;
 
 
events arising from local or larger scale political or social matters, including terrorist acts; and
 
 
cyber-attacks.
These events, in turn, could have a material adverse effect on our operating results and negatively affect the market price of our common stock and our ability to pay distributions to our stockholders.
Communications with shareholders may be delivered electronically and there may be certain costs and possible risks associated with such electronic delivery. Moreover, the Investment Adviser cannot provide any assurance that these communication methods are secure and will not be responsible for any computer viruses, problems or malfunctions resulting from the use of such communication methods.
Our board of directors may change our investment objective, operating policies and strategies without prior notice or stockholder approval.
Our board of directors has the authority to modify or waive certain of our operating policies and strategies without prior notice (except as required by the 1940 Act) and without stockholder approval. However, absent stockholder approval, we may not change the nature of our business so as to cease to be, or withdraw our election as a BDC. We cannot predict the effect any changes to our current operating policies and strategies would have on our business, operating results and the value of our stock. Nevertheless, the effects may adversely affect our business and impact our ability to make distributions.
Our business is subject to increasingly complex corporate governance, public disclosure and accounting requirements that could adversely affect our business and financial results.
We are subject to changing rules and regulations of federal and state government as well as the stock exchange on which our common stock is listed. These entities, including the Public Company Accounting Oversight Board, the SEC and the NASDAQ Stock Market, have issued a significant number of new and increasingly complex requirements and regulations over the course of the last several years and continue to develop additional regulations and requirements in response to laws enacted by Congress. Our efforts to comply with these existing requirements, or any revised or amended requirements, have resulted in, and are likely to continue to result in, an increase in expenses and a diversion of management’s time from other business activities.
 
Changes in laws or regulations governing our operations may adversely affect our business.
Changes in the laws or regulations, or the interpretations of the laws and regulations, which govern BDCs,
RICs or non-depository commercial lenders
could significantly affect our operations and our cost of doing business. We are subject to federal, state and local laws and regulations and are subject to judicial and administrative decisions that affect our operations, including our loan originations, maximum interest rates, fees and other charges, disclosures to portfolio companies, the terms of secured transactions, collection and foreclosure procedures, and other trade practices. If these laws, regulations or decisions change, or if we expand our business into jurisdictions that have adopted more stringent requirements than those in which we currently conduct business, then we may have to incur significant expenses in order to comply or we may have to restrict our operations. In addition, if we do not comply with applicable laws, regulations and decisions, then we may lose licenses needed for the conduct of our business and be subject to civil fines and criminal penalties, any of which could have a material adverse effect upon our business results of operations or financial condition.
Changes to United States tariff and import/export regulations may have a negative effect on our portfolio companies and, in turn, harm us.
There has been ongoing discussion and commentary regarding potential significant changes to United States trade policies, treaties and tariffs. The current administration, along with Congress, has created significant uncertainty about the future relationship between the United States and other countries with respect to the trade policies, treaties and tariffs. These developments, or the perception that any of them could occur, may have a material adverse effect on global economic conditions and the stability of global financial markets, and may significantly reduce global trade and, in particular, trade between the impacted nations and the United States. Any of these factors could depress economic activity and restrict our portfolio companies’ access to suppliers or customers and have a material adverse effect on their business, financial condition and results of operations, which in turn would negatively impact us.
Our Investment Adviser can resign on 60 days’ notice, and we may not be able to find a suitable replacement within that time, resulting in a disruption in our operations that could adversely affect our financial condition, business and results of operations.
Our Investment Adviser has the right, under the Advisory Agreement, to resign at any time upon 60 days written notice, whether we have found a replacement or not. If our Investment Adviser resigns, we may not be able to find a new investment adviser or hire internal management with similar experience and ability to provide the same or equivalent services on acceptable terms within 60 days, or at all. If we are unable to do so quickly, our operations are likely to experience a disruption, our financial condition, business and results of operations as well as our ability to pay distributions are likely to be adversely affected and the market price of our shares may decline. In addition, the coordination of our internal management and investment activities is likely to suffer if we are unable to identify and reach an agreement with a single institution or group of executives having the experience possessed by our Investment Adviser and its affiliates. Even if we are able to retain comparable management, whether internal or external, the integration of such management and their lack of familiarity with our investment objective may result in additional costs and time delays that may adversely affect our financial condition, business and results of operations.
                 
Credit Facility                                    
Financial Highlights [Abstract]                                    
Senior Securities Amount [9]                 $ 293,000 $ 222,500 $ 126,000 $ 42,900 $ 96,400 $ 245,600 $ 115,200 $ 207,900 $ 0 $ 0
Senior Securities Coverage per Unit [10]                 $ 513 $ 552 $ 421 $ 182 $ 593 $ 1,225 $ 990 $ 1,459 $ 0 $ 0
Senior Securities Involuntary Liquidating Preference per Unit [11]                 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0
SPV Credit Facility                                    
Financial Highlights [Abstract]                                    
Senior Securities Amount [9]                 $ 155,200                  
Senior Securities Coverage per Unit [10]                 $ 272                  
Senior Securities Involuntary Liquidating Preference per Unit [11]                 $ 0                  
2022 Unsecured Notes                                    
Financial Highlights [Abstract]                                    
Senior Securities Amount [9]                 $ 0 $ 150,000 $ 150,000 $ 150,000 $ 150,000 $ 150,000 $ 50,000      
Senior Securities Coverage per Unit [10]                 $ 0 $ 372 $ 501 $ 638 $ 923 $ 748 $ 430      
Senior Securities Involuntary Liquidating Preference per Unit [11]                 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0      
2022 Tranche C Notes                                    
Financial Highlights [Abstract]                                    
Senior Securities Amount [9]                 $ 0 $ 21,000 $ 21,000 $ 21,000 $ 21,000 $ 21,000        
Senior Securities Coverage per Unit [10]                 $ 0 $ 52 $ 70 $ 89 $ 129 $ 105        
Senior Securities Involuntary Liquidating Preference per Unit [11]                 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0        
2023 Unsecured Notes                                    
Financial Highlights [Abstract]                                    
Senior Securities Amount [9]                 $ 75,000 $ 75,000 $ 75,000 $ 75,000 $ 75,000 $ 75,000        
Senior Securities Coverage per Unit [10]                 $ 131 $ 186 $ 250 $ 319 $ 461 $ 374        
Senior Securities Involuntary Liquidating Preference per Unit [11]                 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0        
2024 Unsecured Notes                                    
Financial Highlights [Abstract]                                    
Senior Securities Amount [9]                 $ 125,000 $ 125,000 $ 125,000 $ 125,000            
Senior Securities Coverage per Unit [10]                 $ 219 $ 309 $ 417 $ 531            
Senior Securities Involuntary Liquidating Preference per Unit [11]                 $ 0 $ 0 $ 0 $ 0            
2025 Unsecured Notes                                    
Financial Highlights [Abstract]                                    
Senior Securities Amount [9]                 $ 85,000                  
Senior Securities Coverage per Unit [10]                 $ 149                  
Senior Securities Involuntary Liquidating Preference per Unit [11]                 $ 0                  
2026 Unsecured Notes                                    
Financial Highlights [Abstract]                                    
Senior Securities Amount [9]                 $ 75,000 $ 75,000 $ 75,000 $ 75,000            
Senior Securities Coverage per Unit [10]                 $ 131 $ 186 $ 250 $ 319            
Senior Securities Involuntary Liquidating Preference per Unit [11]                 $ 0 $ 0 $ 0 $ 0            
2027 Unsecured Notes                                    
Financial Highlights [Abstract]                                    
Senior Securities Amount [9]                 $ 50,000 $ 50,000                
Senior Securities Coverage per Unit [10]                 $ 88 $ 124                
Senior Securities Involuntary Liquidating Preference per Unit [11]                 $ 0 $ 0                
2027 Series F Unsecured Notes                                    
Financial Highlights [Abstract]                                    
Senior Securities Amount [9]                 $ 135,000                  
Senior Securities Coverage per Unit [10]                 $ 237                  
Senior Securities Involuntary Liquidating Preference per Unit [11]                 $ 0                  
2042 Unsecured Notes                                    
Financial Highlights [Abstract]                                    
Senior Securities Amount [9]                           $ 0 $ 100,000 $ 100,000 $ 100,000 $ 100,000
Senior Securities Coverage per Unit [10]                           $ 0 $ 859 $ 702 $ 2,294 $ 2,411
Senior Securities Involuntary Liquidating Preference per Unit [11]                           $ 0 0 0 0 0
Senior Securities Average Market Value per Unit [14]                             $ 1,002 $ 982 $ 943 $ 934
Senior Secured Notes                                    
Financial Highlights [Abstract]                                    
Senior Securities Amount [9]                           $ 0 $ 75,000 $ 75,000 $ 75,000 $ 75,000
Senior Securities Coverage per Unit [10]                           $ 0 $ 645 $ 527 $ 1,721 $ 1,808
Senior Securities Involuntary Liquidating Preference per Unit [11]                           $ 0 $ 0 $ 0 $ 0 $ 0
Term Loans                                    
Financial Highlights [Abstract]                                    
Senior Securities Amount [9]                 $ 100,000 $ 100,000 $ 75,000 $ 75,000 $ 50,000 $ 50,000 $ 50,000 $ 50,000 $ 50,000 $ 50,000
Senior Securities Coverage per Unit [10]                 $ 175 $ 248 $ 250 $ 319 $ 308 $ 250 $ 430 $ 351 $ 1,147 $ 1,206
Senior Securities Involuntary Liquidating Preference per Unit [11]                 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0
NEFPASS Facility                                    
Financial Highlights [Abstract]                                    
Senior Securities Amount [9]                   $ 0 $ 30,000 $ 30,000 $ 30,000          
Senior Securities Coverage per Unit [10]                   $ 0 $ 100 $ 128 $ 185          
Senior Securities Involuntary Liquidating Preference per Unit [11]                   $ 0 $ 0 $ 0 $ 0          
SSLP Facility                                    
Financial Highlights [Abstract]                                    
Senior Securities Amount [9]                       $ 0 $ 53,785          
Senior Securities Coverage per Unit [10]                       $ 0 $ 331          
Senior Securities Involuntary Liquidating Preference per Unit [11]                       $ 0 $ 0          
On a $1,000 investment                                    
Other Annual Expenses [Abstract]                                    
Expense Example, Year 01                 $ 98                  
Expense Example, Years 1 to 3                 279                  
Expense Example, Years 1 to 5                 444                  
Expense Example, Years 1 to 10                 $ 792                  
[1] In the event that the shares of common stock are sold to or through underwriters, a corresponding prospectus supplement will disclose the applicable sales load and the “Example” will be updated accordingly.
[2] The expenses of the dividend reinvestment plan are included in “other expenses.”
[3] The prospectus supplement corresponding to each offering will disclose the applicable offering expenses and total stockholder transaction expenses.
[4] Our 1.50% base management fee under the Investment Advisory and Management Agreement (giving effect to the Letter Agreement) is based on our gross assets, which is defined as all the assets of SLRC, excluding temporary assets, including those acquired using borrowings for investment purposes, and assumes our gross assets remain consistent with gross assets for the fiscal year ended December 31, 2022. The base management fee is reduced to 1.00% on gross assets that exceed 200% of total net assets as of the immediately preceding quarter.
[5] We have historically and will in the future borrow funds from time to time to make investments to the extent we determine that the economic situation is conducive to doing so. The costs associated with our outstanding borrowings are indirectly borne by our investors. For purposes of this section, we have computed interest expense using the average consolidated balance outstanding for borrowings during the fiscal year ended December 31, 2022. We used the Secured Overnight Financing Rate (“SOFR”) or similar base rate on December 31, 2022 and the interest rate on the Credit Facility, the SPV Credit Facility, the 2027 Series F Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes, the 2024 Unsecured Notes and the 2023 Unsecured Notes on December 31, 2022. We have also included, as applicable, the estimated market discount or amortization of fees incurred in establishing the Credit Facility, the SPV Credit Facility, the 2027 Series F Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes, the 2024 Unsecured Notes and the 2023 Unsecured Notes as of December 31, 2022. Additionally, we included the estimated cost of commitment fees for unused balances on the Credit Facility and the SPV Credit Facility. As of December 31, 2022, we had $393.0 million outstanding under the Credit Facility, $155.2 million outstanding under the SPV Credit Facility and $135 million, $50 million, $75 million, $125 million, $85 million, and $75 million outstanding under the 2027 Series F Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes, the 2024 Unsecured Notes and the 2023 Unsecured Notes, respectively. We may also issue preferred stock, subject to our compliance with applicable requirements under the 1940 Act, although we have no immediate intention to do so.
[6] Assumes that annual incentive fees earned by our investment adviser, SLR Capital Partners, remain consistent with the incentive fees earned by SLR Capital Partners for the fiscal year ended December 31, 2022.
[7] The holders of shares of our common stock indirectly bear the expenses of our investment in SLR Senior Lending Program LLC (“SSLP”). No management fee is charged on our investments in SSLP in connection with the administrative services provided to SSLP. Future expenses for SSLP may be substantially higher or lower because certain expenses may fluctuate over time.
[8] “Other expenses” are based on estimated amounts for the current fiscal year, which considers the amounts incurred for the fiscal year ended December 31, 2022 and include our overhead expenses, including payments under our Administration Agreement based on our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement.
[9] Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented.
[10] The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of December 31, 2022, asset coverage was 191.5%.
[11] The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it.
[12] Calculated as of the respective high or low closing price divided by NAV and subtracting 1.
[13] NAV per share is determined as of the last day in the relevant quarter and therefore may not reflect the NAV per share on the date of the high and low sales prices. The net asset values shown are based on outstanding shares at the end of each period.
[14] Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014 and 2013 periods was $100,175, $98,196, $94,301 and $93,392, respectively.
XML 47 R11.htm IDEA: XBRL DOCUMENT v3.22.4
Organization
12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization
Note 1. Organization
Solar Capital LLC, a Maryland limited liability company, was formed in February 2007 and commenced operations on March 13, 2007 with initial capital of $1,200,000 of which 47.04% was funded by affiliated parties.
Immediately prior to our initial public offering, through a series of transactions, SLR Investment Corp. (the “Company”, “we”, “us” or “our”), merged with Solar Capital LLC, leaving SLR Investment Corp. as the surviving entity (the
“Pre-IPO
Merger”). SLR Investment Corp. issued an aggregate of approximately 26.65 million shares of common stock and $125,000 in senior unsecured notes to the existing Solar Capital LLC unit holders in connection with the
Pre-IPO
Merger. SLR Investment Corp. had no assets or operations prior to completion of the
Pre-IPO
Merger and as a result, the historical books and records of Solar Capital LLC have become the books and records of the surviving entity. The number of shares used to calculate weighted average shares for use in computations on a per share basis have been decreased retroactively by a factor of approximately 0.4022 for all periods prior to February 9, 2010. This factor represents the effective impact of the reduction in shares resulting from the
Pre-IPO
Merger.
SLR Investment Corp., a Maryland corporation formed in November 2007, is a
closed-end,
externally managed,
non-diversified
management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Furthermore, as the Company is an investment company, it continues to apply the guidance in FASB Accounting Standards Codification (“ASC”) Topic 946. In addition, for U.S. federal income tax purposes, the Company has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).
On February 9, 2010, the Company priced its initial public offering, selling 5.68 million shares of common stock, including the underwriters’ over-allotment, at a price of $18.50 per share. Concurrent with this offering, the Company’s senior management purchased an additional 600,000 shares through a private placement, also at $18.50 per share.
The Company’s investment objective is to maximize both current income and capital appreciation through debt and equity investments. The Company directly and indirectly invests primarily in leveraged middle market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. From time to time, we may also invest in public companies that are thinly traded.
On April 1, 2022, we acquired SLR Senior Investment Corp., a Maryland corporation (“SUNS”) pursuant to that certain Agreement and Plan of Merger (the “Merger Agreement”), dated as of December 1, 2021, by and among us, SUNS, Solstice Merger Sub, Inc., a Maryland corporation and our wholly-owned subsidiary (“Merger Sub”), and, solely for the limited purposes set forth therein, SLR Capital Partners, LLC (the “Investment Adviser”). Pursuant to the Merger Agreement, Merger Sub merged with and into SUNS, with SUNS continuing as the surviving company and as SUNS’s wholly-owned subsidiary (the “Merger,”) and, immediately thereafter, SUNS merged with and into us, with us continuing as the surviving company (together with the Merger, the “Mergers”). . In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each outstanding share of SUNS’s common stock was converted into the right to receive 0.7796 shares of our common stock (with SUNS’s stockholders receiving cash in lieu of fractional shares of our common stock). As a result of the Mergers, we issued an aggregate of 12,511,825 shares of our common stock to former SUNS stockholders. See Note 17 for additional information.
XML 48 R12.htm IDEA: XBRL DOCUMENT v3.22.4
Significant Accounting Policies
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Significant Accounting Policies
Note 2. Significant Accounting Policies
The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“GAAP”), and include the accounts of the Company and certain wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications which, in the opinion of management, are necessary for the fair presentation of the results of the operations and financial condition for the periods presented. All significant intercompany balances and transactions have been eliminated. Certain prior period amounts may have been reclassified to conform to the current period presentation.
The preparation of consolidated financial statements in conformity with GAAP and pursuant to the requirements for reporting on Form
10-K
and Regulation
S-X,
as appropriate, also requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reported periods. Changes in the economic environment, financial markets and any other parameters used in determining these estimates could cause actual results to differ materially.
 
 

 
In the opinion of management, all adjustments, which are of a normal recurring nature and considered necessary for the fair presentation of financial statements, have been included.
The significant accounting policies consistently followed by the Company are:
 
  (a)
Investment transactions are accounted for on the trade date;
 
  (b)
Under procedures established by the board of directors (the “Board”), we value investments, including certain senior secured debt, subordinated debt and other debt securities with maturities greater than 60 days, for which market quotations are readily available and deemed to represent fair value under U.S. GAAP, at such market quotations (unless they are deemed not to represent fair value). A market quotation is readily available for a security only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. If the Company anticipates using a market quotation for a security, it will also monitor for circumstances that may necessitate the use of fair value, such as significant events that may cause concern over the reliability of a market quotation. We attempt to obtain market quotations from at least two brokers or dealers (if available, otherwise from a principal market maker or a primary market dealer or other independent pricing service). We utilize
mid-market
pricing as a practical expedient for fair value unless a different point within the range is more representative. If and when market quotations are deemed not to represent fair value, we may utilize independent third-party valuation firms to assist us in determining the fair value of material assets. Accordingly, such investments go through our multi-step valuation process as described below. In each such case, independent valuation firms, that may from time to time be engaged by the Board, consider observable market inputs together with significant unobservable inputs in arriving at their valuation recommendations. Debt investments with maturities of 60 days or less shall each be valued at cost plus accreted discount, or minus amortized premium, which is expected to approximate fair value, unless such valuation, in the judgment of the Investment Adviser, does not represent fair value, in which case such investments shall be valued at fair value as determined in good faith by or under the direction of the Board. Investments that are not publicly traded or whose market quotations are not readily available are valued at fair value as determined in good faith by or under the direction of the Board. Such determination of fair values involves subjective judgments and estimates.
With respect to investments for which market quotations are not readily available or when such market quotations are deemed not to represent fair value under U.S. GAAP, the Board has approved a multi-step valuation process each quarter, as described below:
 
 
(1)
our quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of the Investment Adviser responsible for the portfolio investment;
 
 
(2)
preliminary valuation conclusions are then documented and discussed with senior management of the Investment Adviser;
 
 
(3)
independent valuation firms engaged by the Board conduct independent appraisals and review the Investment Adviser’s preliminary valuations and make their own independent assessment for all material assets;
 
 
(4)
the audit committee of the Board reviews the preliminary valuation of the Investment Adviser and that of the independent valuation firm and responds to the valuation recommendation of the independent valuation firm, if any, to reflect any comments; and
 
 
(5)
the Board discusses valuations and determines the fair value of each investment in our portfolio in good faith based on the input of the Investment Adviser, the respective independent valuation firm, if any, and the audit committee.
 
103
The valuation principles set forth above may be modified from time to time, in whole or in part, as determined by the Board in its sole discretion. The Board will also (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services, as applicable; (5) oversee the reporting required by Rule
2a-5
under the 1940 Act; and (6) maintain recordkeeping requirements under Rule
2a-5.
Investments in all asset classes are valued utilizing a market approach, an income approach, or both approaches, as appropriate. However, in accordance with ASC
820-10,
certain investments that qualify as investment companies in accordance with ASC 946, may be valued using net asset value as a practical expedient for fair value. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities (including a business). The income approach uses valuation approaches to convert future amounts (for example, cash flows or earnings) to a single present amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. In following these approaches, the types of factors that we may take into account in fair value pricing our investments include, as relevant: available current market data, including relevant and applicable market trading and transaction comparables, applicable market yields and multiples, security covenants, call protection provisions, the nature and realizable value of any collateral, the portfolio company’s ability to make payments, its earnings and discounted cash flows, the markets in which the portfolio company does business, comparisons of financial ratios of peer companies that are public, M&A comparables, our principal market (as the reporting entity) and enterprise values, among other factors. When available, broker quotations and/or quotations provided by pricing services are considered as an input in the valuation process. For the fiscal year ended December 31, 2022, there has been no change to the Company’s valuation approaches or techniques and the nature of the related inputs considered in the valuation process.
ASC Topic 820 classifies the inputs used to measure these fair values into the following hierarchy:
Level
 1
: Unadjusted quoted prices in active markets for identical assets or liabilities, accessible by the Company at the measurement date.
Level
 2
: Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices.
Level
 3
: Unobservable inputs for the asset or liability.
In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The exercise of judgment is based in part on our knowledge of the asset class and our prior experience.
 
  (c)
Gains or losses on investments are calculated by using the specific identification method.
 
  (d)
The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Loan origination fees, original issue discount, and market discounts are capitalized and we amortize such amounts into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record call premiums received on loans repaid as interest income when we receive such amounts. Capital structuring fees, amendment fees, consent fees, and any other
non-recurring
fee income as well as a management fee and other fee income for services rendered, if any, are recorded as other income when earned.
 
  (e)
The Company intends to comply with the applicable provisions of the Code pertaining to regulated investment companies to make distributions of taxable income sufficient to relieve it of substantially all U.S. federal income taxes. The Company, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4% excise tax on this income. The Company will accrue excise tax on such estimated excess taxable income as appropriate.
 
104
SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2022
(in thousands, except share amounts)
 
  (f)
Book and tax basis differences relating to stockholder distributions and other permanent book and tax differences are typically reclassified among the Company’s capital accounts. In addition, the character of income and gains to be distributed is determined in accordance with income tax regulations that may differ from GAAP; accordingly at December 31, 2022, $28,991 was reclassified on our balance sheet between accumulated distributable net loss and
paid-in
capital in excess of par. Total earnings and net asset value are not affected.
 
  (g)
Distributions to common stockholders are recorded as of the record date. The amount to be paid out as a distribution is determined by the Board. Net realized capital gains, if any, are generally distributed or deemed distributed at least annually.
 
  (h)
In accordance with Regulation
S-X
and ASC Topic 810—
Consolidation
, the Company consolidates its interest in controlled investment company subsidiaries, financing subsidiaries and certain wholly-owned holding companies that serve to facilitate investment in portfolio companies. In addition, the Company may also consolidate any controlled operating companies substantially all of whose business consists of providing services to the Company.
 
  (i)
The accounting records of the Company are maintained in U.S. dollars. Any assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the rate of exchange of such currencies against U.S. dollars on the date of valuation. The Company will not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Such fluctuations would be included with the net unrealized gain or loss from investments. The Company’s investments in foreign securities, if any, may involve certain risks, including without limitation: foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments in terms of U.S. dollars and therefore the earnings of the Company.
 
  (j)
In accordance with ASC
835-30,
the Company reports origination and other expenses related to certain debt issuances as a direct deduction from the carrying amount of the debt liability. Applicable expenses are deferred and amortized using either the effective interest method or the straight-line method over the stated life. The straight-line method may be used on revolving facilities and/or when it approximates the effective yield method.
 
  (k)
The Company may enter into forward exchange contracts in order to hedge against foreign currency risk. These contracts are
marked-to-market
by recognizing the difference between the contract exchange rate and the current market rate as unrealized appreciation or depreciation. Realized gains or losses are recognized when contracts are settled.
 
  (l)
The Company records expenses related to shelf registration statements and applicable equity offering costs as prepaid assets. These expenses are typically charged as a reduction of capital upon the sale of shares or expensed, in accordance with ASC
946-20-25.

  (m)
Investments that are expected to pay regularly scheduled interest in cash are generally placed on
non-accrual
status when principal or interest cash payments are past due 30 days or more (90 days or more for equipment financing) and/or when it is no longer probable that principal or interest cash payments will be collected. Such
non-accrual
investments are restored to accrual status if past due principal and interest are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining principal and interest obligations. Cash interest payments received on such investments may be recognized as income or applied to principal depending on management’s judgment.
 
  (n)
The Company defines cash equivalents as securities that are readily convertible into known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only securities with a maturity of three months or less would qualify, with limited exceptions. The Company believes that certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities would qualify as cash equivalents.
 
 
Recent Accounting Pronouncements
In March 2020, the FASB issued Accounting Standards Update
No. 2020-04,
“Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The guidance provides optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships and other transactions, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued because of the reference rate reform. ASU
2020-04
is effective for all entities as of March 12, 2020 through December 31, 2022. The Company has determined that the adoption of this guidance has not had a material impact on the Company’s consolidated financial statements and disclosures.
XML 49 R13.htm IDEA: XBRL DOCUMENT v3.22.4
Agreements
12 Months Ended
Dec. 31, 2022
Agreements [Abstract]  
Agreements
Note 3. Agreements
The Company has an investment advisory and management agreement (the “Advisory Agreement”) with the Investment Adviser, under which the Investment Adviser manages the
day-to-day
operations of, and provides investment advisory services to the Company. For providing these services, the Investment Adviser receives a fee from the Company, consisting of two components—a base management fee and a performance-based incentive fee. The base management fee is determined by taking the average value of the Company’s gross assets at the end of the two most recently completed calendar quarters calculated at an annual rate of 1.50% on gross assets up to 200% of the Company’s total net assets as of the immediately preceding quarter end and 1.00% on gross assets that exceed 200% of the Company’s total net assets as of the immediately preceding quarter end. For purposes of computing the base management fee, gross assets exclude temporary assets acquired at the end of each fiscal quarter for purposes of preserving investment flexibility in the next fiscal quarter. Temporary assets include, but are not limited to, U.S. treasury bills, other short-term U.S. government or government agency securities, repurchase agreements or cash borrowings.
The performance-based incentive fee has two parts, as follows: one part is calculated and payable quarterly in arrears based on the Company’s
pre-incentive
fee net investment income for the immediately preceding calendar quarter. For this purpose,
pre-incentive
fee net investment income means interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that we receive from portfolio companies) accrued during the calendar quarter, minus the Company’s operating expenses for the quarter (including the base management fee, any expenses payable under the Administration Agreement, and any interest expense and distributions paid on any issued and outstanding preferred stock, but excluding the performance-based incentive fee).
Pre-incentive
fee net investment income does not include any realized capital gains or losses, or unrealized capital appreciation or depreciation.
Pre-incentive
fee net investment income, expressed as a rate of return on the value of the Company’s net assets at the end of the immediately preceding calendar quarter, is compared to the hurdle rate of 1.75% per quarter (7% annualized). The Company pays the Investment Adviser a performance-based incentive fee with respect to the Company’s
pre-incentive
fee net investment income in each calendar quarter as follows: (1) no performance-based incentive fee in any calendar quarter in which the Company’s
pre-incentive
fee net investment income does not exceed the hurdle rate; (2) 100% of the Company’s
pre-incentive
fee net investment income with respect to that portion of such
pre-incentive
fee net investment income, if any, that exceeds the hurdle rate but is less than 2.1875% in any calendar quarter; and (3) 20% of the amount of the Company’s
pre-incentive
fee net investment income, if any, that exceeds 2.1875% in any calendar quarter. These calculations are appropriately
pro-rated
for any period of less than three months.
The second part of the performance-based incentive fee is determined and payable in arrears as of the end of each calendar year (or upon termination of the Advisory Agreement, as of the termination date), and will equal 20% of the Company’s cumulative realized capital gains less cumulative realized capital losses, unrealized capital depreciation (unrealized depreciation on a gross
investment-by-investment
basis at the end of each calendar year) and all net capital gains upon which prior performance-based capital gains incentive fee payments were previously made to the Investment Adviser. For financial statement purposes, the second part of the performance-based incentive fee is accrued based upon 20% of cumulative net realized gains and net unrealized capital appreciation. No accrual was required for the fiscal years ended December 31, 2022, 2021 and 2020.
For the fiscal years ended December 31, 2022, 2021 and 2020, the Company recognized $29,982, $28,277 and $24,951, respectively, in base management fees and $15,097, $10,309 and $2,272, respectively, in performance-based incentive fees. For the fiscal years ended December 31, 2022, 2021 and 2020, $1,527, $0 and $0, respectively, of such performance-based incentive fees were waived. The Investment Adviser has agreed to waive incentive fees resulting from income earned due to the accretion of purchase discount allocated to investments acquired as a result of the Mergers. Fees waived pursuant to the above are not subject to recoupment by the Investment Adviser.
 
 
The
Company has also entered into an Administration Agreement with SLR Capital Management, LLC (the “Administrator”) under which the Administrator provides administrative services to the Company. For providing these services, facilities and personnel, the Company reimburses the Administrator for the Company’s allocable portion of overhead and other expenses incurred by the Administrator in performing its obligations under the Administration Agreement, including rent. The Administrator will also provide, on the Company’s behalf, managerial assistance to those portfolio companies to which the Company is required to provide such assistance. The Company typically reimburses the Administrator on a quarterly basis.
For the fiscal years ended December 31, 2022, 2021 and 2020, the Company recognized expenses under the Administration Agreement of $5,401, $5,575 and $5,215, respectively. No managerial assistance fees were accrued or collected for the fiscal years ended December 31, 2022, 2021 and 2020.
XML 50 R14.htm IDEA: XBRL DOCUMENT v3.22.4
Net Asset Value Per Share
12 Months Ended
Dec. 31, 2022
Net Asset Value Per Share [Abstract]  
Net Asset Value Per Share
Note 4. Net Asset Value Per Share
At December 31, 2022, the Company’s total net assets and net asset value per share were $999,731 and $18.33, respectively. This compares to total net assets and net asset value per share at December 31, 2021 of $842,281 and $19.93, respectively.
XML 51 R15.htm IDEA: XBRL DOCUMENT v3.22.4
Earnings Per Share
12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Earnings Per Share
Note 5. Earnings Per Share
The following table sets forth the computation of basic and diluted net increase in net assets per share resulting from operations, pursuant to ASC
260-10,
for the years ended December 31, 2022, 2021 and 2020:
 
    
Year ended
December 31, 2022
    
Year ended
December 31, 2021
    
Year ended
December 31, 2020
 
Earnings per share (basic & diluted)
 
 
 
 
 
 
 
 
 
 
 
 
Numerator - net increase in net assets resulting from operations:

   $ 18,342      $ 59,566      $ 15,451  
Denominator - weighted average shares:

     51,680,522        42,260,826        42,260,826  
Earnings per share:
   $ 0.35      $ 1.41      $ 0.37  
XML 52 R16.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value
12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Fair Value
Note 6. Fair Value
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The hierarchy prioritizes the inputs to valuations used to measure fair value into three levels. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows:
Level
 1.
 Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access.
Level
 2.
 Financial assets and liabilities whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following:
 
  a)
Quoted prices for similar assets or liabilities in active markets;
 
  b)
Quoted prices for identical or similar assets or liabilities in
non-active
markets;
 
  c)
Pricing models whose inputs are observable for substantially the full term of the asset or liability; and
 
  d)
Pricing models whose inputs are derived principally from or corroborated by observable market data through correlation or other means for substantially the full term of the asset or liability.
Level
 3.
Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumptions about the assumptions a market participant would use in pricing the asset or liability.
 
When the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3).
Gains and losses for assets and liabilities categorized within the Level 3 table below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).
A review of fair value hierarchy classifications is conducted on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. Such reclassifications involving Level 3 assets and liabilities are reported as transfers in/out of Level 3 as of the end of the quarter in which the reclassifications occur. Within the fair value hierarchy tables below, cash and cash equivalents are excluded but could be classified as Level 1.
The following tables present the balances of assets and liabilities measured at fair value on a recurring basis, as of December 31, 2022 and December 31, 2021:
Fair Value Measurements
As of December 31, 2022
 
    
Level 1
    
Level 2
    
Level 3
    
Measured at
Net Asset Value*
    
Total
 
Assets:
                                            
Senior Secured Loans
   $ —        $ —        $ 1,245,414      $ —        $ 1,245,414  
Equipment Financing
     —          —          265,952        —          265,952  
Preferred Equity
     —          —          3,801        —          3,801  
Common Equity/Equity Interests/Warrants
     483        —          561,600        9,426        571,509  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
   $ 483      $ —        $ 2,076,767      $ 9,426      $ 2,086,676  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
*
In accordance with ASC
820-10,
certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP. See Note 19 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members.
Fair Value Measurements
As of December 31, 2021
 
    
Level 1
    
Level 2
    
Level 3
    
Total
 
Assets:
                                   
Senior Secured Loans
   $      $
     $ 939,690      $ 939,690  
Equipment Financing
                   273,795        273,795  
Preferred Equity
                   5,630        5,630  
Common Equity/Equity Interests/Warrants
     1,086               450,381        451,467  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
   $ 1,086           $ 1,669,496      $ 1,670,582  
    
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities:
                                   
2022 Unsecured Notes
   $     
     $ 150,000      $ 150,000  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2022, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2022:
Fair Value Measurements Using Level 3 Inputs
 
    
Senior Secured
Loans
   
Equipment

Financing
   
Preferred Equity
   
Common Equity/
Equity
Interests/
Warrants
   
Total
 
Fair value, December
 31, 2021
   $ 939,690     $ 273,795     $ 5,630     $ 450,381     $ 1,669,496  
Total gains or losses included in earnings:
                                        
Net realized gain (loss)
     (36,244     —         —         6       (36,238
Net change in unrealized loss
     (8,065     (6,924     (706     (5,048     (20,743
Purchase of investment securities(1)
     796,389       84,168       266       116,272       997,095  
Proceeds from dispositions of investment securities
     (446,356     (85,087     (1,389     (11     (532,843
Transfers in/out of Level 3
     —         —         —         —         —    
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Fair value, December
 31, 2022
   $ 1,245,414     $ 265,952     $ 3,801     $ 561,600     $ 2,076,767  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
                                        
Net change in unrealized loss
   $ (8,920   $ (6,924   $ (706   $ (5,048   $ (21,598
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
Includes positions acquired from SUNS as a result of the Mergers.
The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the year ended December 31, 2022:
 
2022 Unsecured Notes
  
For the year ended
December 31, 2022
 
Beginning fair value
   $ 150,000  
Net realized (gain) loss
     —    
Net change in unrealized (gain) loss
     —    
Borrowings
     —    
Repayments
     (150,000
Transfers in/out of Level 3
     —    
    
 
 
 
Ending fair value
   $ —    
    
 
 
 
The Company made an election to apply the fair value option of accounting to the 2022 Unsecured Notes, in accordance with ASC
825-10.
On May 8, 2022, the borrowings were repaid in full. While the Company has not made an election to apply the fair value option of accounting to any of its other debt obligations, if the Company’s debt obligations were carried at fair value at December 31, 2022, the fair value of the Credit Facility, SPV Credit Facility, 2023 Unsecured Notes, 2024 Unsecured Notes, 2025 Unsecured Notes, 2026 Unsecured Notes, 2027 Unsecured Notes and 2027 Series F Unsecured Notes would be $393,000, $155,200, $75,000, $118,750, $79,688, $68,250, $42,875 and $118,125, respectively.
 
The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2021, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2021:
Fair Value Measurements Using Level 3 Inputs
 

 
  
Senior Secured
Loans
 
 
Equipment

Financing
 
 
Preferred Equity
 
 
Common Equity/
Equity
Interests/
Warrants
 
 
Total
 
Fair value, December
 31, 2020
   $ 798,052     $ 284,846     $ 6,401     $ 440,971     $ 1,530,270  
Total gains or losses included in earnings:
                                        
Net realized gain (loss)
     —         (8     —         345       337  
Net change in unrealized gain (loss)
     (13,567     1,394       (1,042     9,857       (3,358
Purchase of investment securities
     533,614       76,700       271       —         610,585  
Proceeds from dispositions of investment securities
     (378,409     (89,137     —         (675     (468,221
Transfers in/out of Level 3
(1)
     —         —         —         (117     (117
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Fair value, December
 31, 2021
   $ 939,690     $ 273,795     $ 5,630     $ 450,381     $ 1,669,496  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Unrealized gains (losses) for the period relating to those Level 3
assets that were still held by the Company at the end of the
period:
                                        
Net change in unrealized gain (loss)
   $ (12,837   $ 1,394     $ (1,042   $ 9,597     $ (2,888
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
On February 17, 2021, the Company exercised its warrants in Senseonics Holdings, Inc., receiving shares in the common stock of Senseonics Holdings, Inc. The common stock of Senseonics Holdings, Inc. is publicly traded, so this position is considered to be a Level 1 asset.
The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the year ended December 31, 2021:
 
2022 Unsecured Notes
  
For the year ended
December 31, 2021
 
Beginning fair value
   $ 150,000  
Net realized (gain) loss
     —    
Net change in unrealized (gain) loss
     —    
Borrowings
     —    
Repayments
     —    
Transfers in/out of Level 3
     —    
    
 
 
 
Ending fair value
   $ 150,000  
    
 
 
 
The Company made elections to apply the fair value option of accounting to the 2022 Unsecured Notes, in accordance with ASC
825-10.
On December 31, 2021, there were borrowings of $150,000 on the 2022 Unsecured Notes.
 
 
Quantitative Information about Level 3 Fair Value Measurements
The Company typically determines the fair value of its performing debt investments utilizing a yield analysis. In a yield analysis, a price is ascribed for each investment based upon an assessment of current and expected market yields for similar investments and risk profiles. Additional consideration is given to current contractual interest rates, relative maturities and other key terms and risks associated with an investment. Among other factors, a significant determinant of risk is the amount of leverage used by the portfolio company relative to the total enterprise value of the company, and the rights and remedies of our investment within each portfolio company.
Significant unobservable quantitative inputs typically used in the fair value measurement of the Company’s Level 3 assets and liabilities primarily reflect current market yields, including indices, and readily available quotes from brokers, dealers, and pricing services as indicated by comparable assets and liabilities, as well as enterprise values, returns on equity and earnings before income taxes, depreciation and amortization (“EBITDA”) multiples of similar companies, and comparable market transactions for equity securities.
Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2022 is summarized in the table below:
 
    
Asset or
Liability
  
Fair Value at

December 31, 2022
    
Principal Valuation

Technique/Methodology
 
Unobservable Input
  
Range (Weighted

Average)
Senior Secured Loans
   Asset    $
$
1,212,842
32,572
 
 
   Income Approach
Market Multiple
(1)
  Market Yield
Comparable Multiple
  
9.4%
 
 
18.2% (12.0%)
0.1x-21.4x
 
(12.4x)
Equipment Financing
   Asset    $
$
145,132
120,820
 
 
   Income Approach
Market Multiple
(2)
  Market Yield
Comparable Multiple
   8.5% –9.7% (9.7%)
1.1x-1.4x
(1.2x)
Preferred Equity
   Asset    $ 3,801      Income Approach   Market Yield    5.0% –
 
5.0% (5.0%)
Common Equity/Equity Interests/Warrants
   Asset    $
$
149,120
412,480
 
 
   Market Multiple
(3)
Market Approach
  Comparable Multiple
Return on Equity
   7.8x –
 
9.8x (8.8x)
6.6% –
 
35.2% (9.2%)
 
(1)
Investments are valued using a
sum-of-the
parts analysis, using expected revenue multiples for certain segments of the businesses and expected EBITDA multiples for certain segments of the businesses.
(2)
Includes $120,820 of investments valued using
an implied
multiple.
(3)
Includes $676 of investments valued using a Black-Scholes model and $148,444 of investments valued using an EBITDA multiple.
Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2021 is summarized in the table below
:
 

 
  
Asset or
Liability
  
Fair Value at
December 31, 2021
 
  
Principal Valuation
Technique/Methodology
 
Unobservable Input
  
Range (Weighted
Average)
Senior Secured Loans
   Asset    $
$
931,769
7,921
 
 
   Income Approach
Market Multiple
(1)
  Market Yield
Comparable Multiple
   4.0% –
 
19.6% (8.7%)
2.0x-3.0x(2.5x)/2.0x-
3.0x(2.5x)
Equipment Financing
   Asset    $
$
144,693
129,102
 
 
   Income Approach
Market Approach
  Market Yield
Return on Equity
   7.1% –
 
20.3% (9.8%)
4.6%-4.6%
(4.6%)
Preferred Equity
   Asset    $ 5,630      Income Approach   Market Yield    3.5% –
 
8.0% (4.4%)
Common Equity/Equity Interests/Warrants
   Asset    $
$
151,615
298,766
 
 
   Market Multiple
(2)
Market Approach
  Comparable Multiple
Return on Equity
   5.8x –
 
10.5x (9.5x)
6.1% –
 
18.5% (8.6%)
2022 Unsecured Notes
   Liability    $ 150,000      Income Approach   Market Yield    2.2% –
 
4.6% (4.5%)
 
(1)
Investments are valued using a
sum-of-the
parts analysis, using expected EBITDA multiples
(2x-3x)
for certain segments of the business and expected revenue multiples
(2x-3x)
for certain segments of the business.
(2)
Includes $403 of investments valued using a Black-Scholes model and $151,212 of investments valued using an EBITDA multiple.
 
Significant increases or decreases in any of the above unobservable inputs in isolation, including unobservable inputs used in deriving
bid-ask
spreads, if applicable, could result in significantly lower or higher fair value measurements for such assets and liabilities. Generally, an increase in market yields or decrease in EBITDA multiples may result in a decrease in the fair value of certain of the Company’s investments.
XML 53 R17.htm IDEA: XBRL DOCUMENT v3.22.4
Debt
12 Months Ended
Dec. 31, 2022
Debt Instruments [Abstract]  
Debt
Note 7. Debt
Our debt obligations consisted of the following as of December 31, 2022 and December 31, 2021:
 
    
December 31, 2022
   
December 31, 2021
 
Facility
  
Face Amount
    
Carrying Value
   
Face Amount
    
Carrying Value
 
Credit Facility
   $ 393,000      $ 388,254
(1)
 
  $ 322,500      $ 318,015
(1)
 
SPV Credit Facility
     155,200        154,302
(2)
 
    —          —    
2022 Unsecured Notes
     —          —         150,000        150,000  
2022 Tranche C Notes
     —          —         21,000        20,964
(3)
 
2023 Unsecured Notes
     75,000        74,979
(4)
 
    75,000        74,592
(4)
 
2024 Unsecured Notes
     125,000        124,421
(5)
 
    125,000        124,143
(5)
 
2025 Unsecured Notes
     85,000        84,613
(6)
 
    —          —    
2026 Unsecured Notes
     75,000        74,498
(7)
 
    75,000        74,384
(7)
 
2027 Unsecured Notes
     50,000        49,953
(8)
 
    50,000        49,940
(8)
 
2027 Series F Unsecured Notes
     135,000        134,978
(9)
 
    —          —    
    
 
 
    
 
 
   
 
 
    
 
 
 
     $ 1,093,200      $ 1,085,998     $ 818,500      $ 812,038  
    
 
 
    
 
 
   
 
 
    
 
 
 
 
(1)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $
4,746
and $
4,485
as of December 31, 2022 and December 31, 2021, respectively.
(2)
Carrying Value equals the Face Amount net of unamortized market discount of $898 as of December 31, 2022.
(3)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $36 as of December 31, 2021.
(4)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $21 and $408 as of December 31, 2022 and December 31, 2021, respectively.
(5)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $579 and $857 as of December 31, 2022 and December 31, 2021, respectively.
(6)
Carrying Value equals the Face Amount net of unamortized market discount of $387 as of December 31, 2022.
(7)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $502 and $616 as of December 31, 2022 and December 31, 2021, respectively.
(8)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $47 and $60 as of December 31, 2022 and December 31, 2021, respectively.
(9)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $22 as of December 31, 2022.
Unsecured Notes
On April 1, 2022, the Company entered into an assumption agreement (the “Note Assumption Agreement”), effective as of the closing of the Mergers. The Note Assumption Agreement relates to the Company’s assumption of $85,000 in aggregate principal amount of five-year, 3.90% senior unsecured notes, due March 31, 2025 (the “2025 Unsecured Notes”) and other obligations of SUNS under the Note Purchase Agreement, dated as of March 31, 2020 (the “Note Purchase Agreement”), among SUNS and certain institutional investors. Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30. Pursuant to the Note Assumption Agreement, the Company expressly assumed on behalf of SUNS the due and punctual payment of the principal of (and premium, if any) and interest on all the 2025 Unsecured Notes outstanding, and the due and punctual performance and observance of every covenant and every condition of the Note Purchase Agreement, to be performed or observed by SUNS.
 
On January 6, 2022, the Company closed a private offering of $135,000 of the 2027 Series F Unsecured Notes with a fixed interest rate of 3.33% and a maturity date of January 6, 2027. Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6. The 2027 Series F Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On September 14, 2021, the Company closed a private offering of $50,000 of the 2027 Unsecured Notes with a fixed interest rate of 2.95% and a maturity date of March 14, 2027. Interest on the 2027 Unsecured Notes is due semi-annually on March 14 and September 14. The 2027 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $125,000 of the 2024 Unsecured Notes with a fixed interest rate of 4.20% and a maturity date of December 15, 2024. Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15. The 2024 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $75,000 of the 2026 Unsecured Notes with a fixed interest rate of 4.375% and a maturity date of December 15, 2026. Interest on the 2026 Unsecured Notes is due semi-annually on June 15 and December 15. The 2026 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 28, 2017, the Company closed a private offering of $21,000 of the 2022 Tranche C Notes with a fixed interest rate of 4.50% and a maturity date of December 28, 2022. Interest on the 2022 Tranche C Notes is due semi-annually on June 28 and December 28. The 2022 Tranche C Notes were issued in a private placement only to qualified institutional buyers. The 2022 Tranche C Notes were repaid in full at maturity.
On November 22, 2017, we issued $75,000 in aggregate principal amount of publicly registered 2023 Unsecured Notes for net proceeds of $73,846. Interest on the 2023 Unsecured Notes is paid semi-annually on January 20 and July 20, at a fixed rate of 4.50% per year, commencing on January 20, 2018. The 2023 Unsecured Notes mature on January 20, 2023.
On February 15, 2017, the Company closed a private offering of $100,000 of the 2022 Unsecured Notes with a fixed interest rate of 4.60% and a maturity date of May 8, 2022. Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional
buyers. The 2022 Unsecured Notes were repaid in full at maturity.
On November 8, 2016, the Company closed a private offering of $50,000 of the 2022 Unsecured Notes with a fixed interest rate of 4.40% and a maturity date of May 8, 2022. Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional buyers. The 2022 Unsecured Notes were repaid in full at maturity.
Revolving and Term Loan Facilities
On April 1, 2022, the Company entered into an assumption agreement (the “CF Assumption Agreement”), effective as of the closing of the Mergers. The CF Assumption Agreement relates to the Company’s assumption of the Revolving Credit Facility, originally entered into on August 26, 2011 (as amended from time to time, the “SPV Credit Facility”), by and among SUNS SPV LLC (the “SUNS SPV”), a wholly-owned subsidiary of SUNS, acting as borrower, Citibank, N.A., acting as administrative agent and collateral agent, and the other parties thereto. Currently, the commitment under the SPV Credit Facility is $225,000; however, the commitment can also be expanded up to $600,000. The stated interest rate on the SPV Credit Facility is LIBOR plus
2.00%-2.50%
with no LIBOR floor requirement and the current final maturity date is June 1, 2026. The SPV Credit Facility is secured by all of the assets held by SUNS SPV. Under the terms of the SPV Credit Facility and related transaction documents, the Company as successor to SUNS, and SUNS SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SPV Credit Facility also includes usual and customary events of default for credit facilities of this nature. At December 31, 2022, outstanding USD equivalent borrowings under the SPV Credit Facility totaled $155,200.
 
On December 28, 2021, the Company closed on Amendment No. 1 to its August 28, 2019 senior secured credit agreement (the “Credit Facility”). Following the amendment and a November 2022 upsizing, the Credit Facility is composed of $625,000 of revolving credit and $100,000 of term loans. Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of
1.75%-2.00%
or the alternate base rate plus
0.75%-1.00%.
The Credit Facility has a 0% floor and matures in December 2026 and includes ratable amortization in the final year. The Credit Facility may be increased up to $800,000 with additional new lenders or an increase in commitments from current lenders. The Credit Facility contains certain customary affirmative and negative covenants and events of default. In addition, the Credit Facility contains certain financial covenants that among other things, requires the Company to maintain a minimum shareholder’s equity and a minimum asset coverage ratio. At December 31, 2022, outstanding USD equivalent borrowings under the Credit Facility totaled $393,000, composed of $293,000 of revolving credit and $100,000 of term loans.
Certain covenants on our issued debt may restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a RIC under Subchapter M of the Code.
The average annualized interest cost for all borrowings for the year ended December 31, 2022 and the year ended December 31, 2021 was 4.09% and 3.64%, respectively. These costs are exclusive of other credit facility expenses such as unused fees, agency fees and other prepaid expenses related to establishing and/or amending the Credit Facility, the SPV Credit Facility, the 2022 Unsecured Notes, the 2022 Tranche C Notes, the 2023 Unsecured Notes, the 2024 Unsecured Notes, the 2025 Unsecured Notes, the 2026 Unsecured Notes, the 2027 Unsecured Notes and the 2027 Series F Unsecured Notes (collectively the “Debt Instruments”), if any. The maximum amounts borrowed on the Debt Instruments during the year ended December 31, 2022 and the year ended December 31, 2021 were $1,164,200 and $902,550, respectively.
XML 54 R18.htm IDEA: XBRL DOCUMENT v3.22.4
Income Tax Information and Distributions to Stockholders and Other Tax Information
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Income Tax Information and Distributions to Stockholders and Other Tax Information
Note 8(a). Income Tax Information and Distributions to Stockholders
The tax character of distributions for the fiscal years ended December 31, 2022, 2021 and 2020 were as follows (1):
 
    
2022
   
2021
   
2020
 
Ordinary income
   $ 50,113        59.2   $ 41,221        59.5   $ 48,795        70.4
Capital gains
     —          0.0     —          0.0     —          0.0
Return of capital
     27,099        32.0     28,087        40.5     20,513        29.6
Distribution recognized in subsequent year
     7,481        8.8     —          0.0     —          0.0
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
Total distributions
   $ 84,693        100.0   $ 69,308        100.0   $ 69,308        100.0
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
As of December 31, 2022, 2021 and 2020 the total accumulated earnings (loss) on a tax basis were as follows (1):
 
    
2022
 
2021
    
2020
 
Undistributed ordinary income
   $ —    
$ —        $ —    
Undistributed long-term net capital gains
     —    
  —          —    
    
 
 
 
 
 
    
 
 
 
Total undistributed net earnings
     —    
  —          —    
Post-October capital losses
     —    
  —          —    
Capital loss carryforward
     (127,348 )
(2)

  (68,857      (69,384
Other book/tax temporary differences
     (53,223
  2,332        2,168  
Net unrealized appreciation
     17,187  
  19,495        4,446  
    
 
 
 
 
 
    
 
 
 
Total tax accumulated loss
   $ (163,384
$ (47,030    $ (62,770
    
 
 
 
 
 
    
 
 
 
 
(1)
Tax information for the fiscal years ended December 31, 2022, 2021 and 2020 are/were estimates and are not final until the Company files its tax returns, typically in September or October each year.
(2)
Includes capital loss carryforward acquired from the Mergers which is subject to limitations under IRC Sections 381-384.
 
 
The Company recognizes in its consolidated financial statements the tax effect of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. To the best of our knowledge, we did
not
have any uncertain tax positions that met the recognition or measurement criteria of ASC
740-10-25
nor
did we have any unrecognized tax benefits as of the periods presented herein. Although we file federal and state tax returns, our major tax jurisdiction is federal. Our tax returns for each of our federal tax years since 2019 remain subject to examination by the Internal Revenue Service and the state department of revenue. The capital loss carryforwards shown above do not expire.
Note 8(b). Other Tax Information (unaudited)
For the fiscal years ended December 31, 2022, 2021 and 2020, 0.00%, 0.32% and 0.10%, respectively, of the dividends paid during the year were eligible for qualified dividend income treatment and the dividends received deduction for corporate stockholders. For the fiscal years ended December 31, 2022, 2021, and 2020, 88.05%, 93.05% and 92.05%, respectively, of each of the distributions paid during the year represent interest-related dividends. For the fiscal years ended December 31, 2022, 2021 and 2020, none of the distributions represent short-term capital gains dividends.
XML 55 R19.htm IDEA: XBRL DOCUMENT v3.22.4
Financial Highlights
12 Months Ended
Dec. 31, 2022
Investment Company, Financial Highlights [Abstract]  
Financial Highlights
Note 9. Financial Highlights
The following is a schedule of financial highlights for the respective years:
 
    
Year ended
December 31,
2022
   
Year ended
December 31,
2021
   
Year ended
December 31,
2020
   
Year ended
December 31,
2019
   
Year ended
December 31,
2018
 
Per Share Data: (a)
                                        
Net asset value, beginning of year
   $ 19.93     $ 20.16     $ 21.44     $ 21.75     $ 21.81  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Net investment income
     1.48       1.44       1.40       1.71       1.77  
Net realized and unrealized loss
     (1.13 )*      (0.03     (1.04     (0.38     (0.19
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Net increase in net assets resulting from operations
     0.35       1.41       0.36       1.33       1.58  
Issuance of common stock in connection with the Mergers
     (0.33     —         —         —         —    
Anti-dilution
     0.02       —         —         —         —    
Distributions to stockholders (see note 8a):
                                        
From distributable earnings
     (1.12     (0.98     (1.15     (1.55     (1.64
From return of capital
     (0.52     (0.66     (0.49     (0.09     —    
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Net asset value, end of year
   $ 18.33     $ 19.93     $ 20.16     $ 21.44     $ 21.75  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Per share market value, end of year
   $ 13.91     $ 18.43     $ 17.51     $ 20.62     $ 19.19  
Total Return(b)
     (16.09 %)      14.66     (5.72 %)      16.22     2.77
Net assets, end of year
   $ 999,731     $ 842,281     $ 852,023     $ 905,880     $ 919,171  
Shares outstanding, end of year
     54,555,380       42,260,826       42,260,826       42,260,826       42,260,826  
Ratios to average net assets:
                                        
Net investment income
     7.76     7.13     6.93     7.83     8.10
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Operating expenses
     5.60 %**      5.68     4.14     5.76     5.83
Interest and other credit facility expenses
     4.68     3.50     3.18     3.13     2.67
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total expenses
     10.28 %**      9.18     7.32     8.89     8.50
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Average debt outstanding
   $ 994,578     $ 703,670     $ 556,104     $ 561,249     $ 508,445  
Portfolio turnover ratio
     27.4     29.9     26.0     24.1     39.3
 
 
(a)
Calculated using the average shares outstanding method, except for the issuance of common stock in connection with the Mergers, which reflects the actual amount per share for the applicable period.
(b)
Total return is based on the change in market price per share during the year and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. Total return does not include a sales load.
*
The amount shown may not correspond with the aggregate amount for the period as it includes the effect of the timing of the Mergers.
**
The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of the performance-based incentive fee waiver (see note 3). For the year ended December 31, 2022, the ratios of operating expenses to average net assets and total expenses to average net assets would be 5.75% and 10.43%, respectively, without the performance-based incentive fee waiver.
XML 56 R20.htm IDEA: XBRL DOCUMENT v3.22.4
SLR Credit Solutions
12 Months Ended
Dec. 31, 2022
Line of Credit Facility [Abstract]  
SLR Credit Solution
Note 10. SLR Credit Solutions
On December 28, 2012, we acquired an equity interest in Crystal Capital Financial Holdings LLC (“Crystal Financial”) for $275,000 in cash. Crystal Financial owned approximately 98% of the outstanding ownership interest in SLR Credit Solutions (“SLR Credit”), f/k/a Crystal Financial LLC. The remaining financial interest was held by various employees of SLR Credit, through their investment in Crystal Management LP. SLR Credit had a diversified portfolio of 23 loans having a total par value of approximately $400,000 at November 30, 2012 and a $275,000 committed revolving credit facility. On July 28, 2016, the Company purchased Crystal Management LP’s approximately 2% equity interest in SLR Credit for approximately $5,737. Upon the closing of this transaction, the Company holds 100% of the equity interest in SLR Credit. On September 30, 2016, Crystal Capital Financial Holdings LLC was dissolved. As of December 31, 2022, total commitments to the revolving credit facility are $285,000.
As of December 31, 2022 SLR Credit had 29 funded commitments to 25 different issuers with total funded loans of approximately $439,484 on total assets of $460,683. As of December 31, 2021 SLR Credit had 22 funded commitments to 19 different issuers with total funded loans of approximately $287,375 on total assets of $347,821. As of December 31, 2022 and December 31, 2021, the largest loan outstanding totaled $33,420 and $35,000, respectively. For the same periods, the average exposure per issuer was $17,579 and $15,125, respectively. SLR Credit’s credit facility, which is
non-recourse
to the Company, had approximately $224,325 and $100,742 of borrowings outstanding at December 31, 2022 and December 31, 2021, respectively. For the years ended December 31, 2022, 2021 and 2020 SLR Credit had net income of $7,521, $14,164 and $23,293, respectively, on gross income of $30,324, $33,993 and $45,315, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. SLR Credit’s consolidated financial statements for the fiscal years ended December 31, 2022 and December 31, 2021 are attached as an exhibit to this annual report on Form
10
-K.
 
XML 57 R21.htm IDEA: XBRL DOCUMENT v3.22.4
Commitments and Contingencies
12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
Note 11. Commitments and Contingencies
Off-Balance
Sheet Arrangements
The Company had unfunded debt and equity commitments to various revolving and delayed-draw term loans as well as to SLR Credit and SLR Healthcare. The total amount of these unfunded commitments as of December 31, 2022 and December 31, 2021 is $323,663 and $226,733, respectively, comprised of the following:
 
    
December 31,
2022
    
December 31,
2021
 
SLR Credit Solutions*
   $ 44,263      $ 44,263  
Outset Medical, Inc
     35,084        —    
Apeel Technology, Inc
     32,786        —    
CC SAG Holdings Corp. (Spectrum Automotive)
     20,670        18,827  
Human Interest, Inc
     20,104        —    
Glooko, Inc
     17,868        25,091  
World Insurance Associates, LLC
     17,117        —    
iCIMS, Inc
     11,435        —    
Spectrum Pharmaceuticals, Inc
     8,771        —    
Arcutis Biotherapeutics, Inc
     8,356        43,470  
Atria Wealth Solutions, Inc
     8,215        3,746  
Ardelyx, Inc
     7,752        —    
Luxury Asset Capital, LLC
     7,500        —    
RSC Acquisition, Inc
     7,498        —    
Cerapedics, Inc
     6,735        —    
Maurices, Incorporated
     4,314        5,649  
Kaseya, Inc
     3,936        —    
Vessco Midco Holdings, LLC
     3,892        —    
Copper River Seafoods, Inc
     3,595        —    
BDG Media, Inc
     3,546        —    
Meditrina, Inc
     3,367        —    
One Touch Direct, LLC
     3,069        7,226  
DeepIntent, Inc
     3,049        —    
Foundation Consumer Brands, LLC
     3,009        2,269  
SCP Eye Care, LLC
     2,771        —    
Basic Fun, Inc
     2,675        1,935  
Kid Distro Holdings, LLC
     2,650        2,650  
Plastics Management, LLC
     2,424        —    
Southern Orthodontic Partners Management, LLC
     1,918        —    
Pediatric Home Respiratory Services, LLC
     1,805        —    
Pinnacle Treatment Centers, Inc
     1,745        1,414  
Ultimate Baked Goods Midco LLC
     1,636        801  
Orthopedic Care Partners Management, LLC
     1,620        —    
Ivy Fertility Services, LLC
     1,571        4,532  
Composite Technology Acquisition Corp
     1,537        —    
NAC Holdings Corporation
     1,479        4,765  
SLR Healthcare ABL*
     1,400        —    
SPAR Marketing Force, Inc
     1,338        —    
RxSense Holdings LLC
     1,250        —    
Erie Construction
Mid-west,
LLC
     1,248        —    
Peter C. Foy & Associates Insurance Services, LLC
     1,094        —    
American Teleconferencing Services, Ltd
     1,090        573  
Montefiore Nyack Hospital
     1,034        —    
Enverus Holdings, Inc
     1,004        —    
SLR Equipment Finance
     1,000        5,000  
SunMed Group Holdings, LLC
     843        828  
GSM Acquisition Corp
     784        —    
Tilley Distribution, Inc
     525        —    
BayMark Health Services, Inc
     391        —    
High Street Buyer, Inc
     327        —    
TAUC Management, LLC
     294        —    
ENS Holdings III Corp, LLC
     144        —    
All State Ag Parts, LLC
     135        —    
BridgeBio Pharma, Inc
     —          23,049  
Inszone Mid, LLC
     —          12,465  
Rezolute, Inc
     —          5,675  
SOC Telemed, Inc
     —          4,448  
RQM+ Corp
     —          3,818  
MMIT Holdings, LLC
     —          2,009  
Neuronetics, Inc
     —          2,230  
    
 
 
    
 
 
 
Total Commitments
   $ 323,663      $ 226,733  
    
 
 
    
 
 
 
 
*
The Company controls the funding of the SLR Credit Solutions and SLR Healthcare ABL commitments and may cancel them at its discretion.
 
 
In addition to the above, please see SLR Senior Lending Program LLC herein where the Company has a remaining equity commitment of $40,500 in which the Company also controls such funding. The credit agreements of the above loan commitments contain customary lending provisions and/or are subject to the portfolio company’s achievement of certain milestones that allow relief to the Company from funding obligations for previously made commitments in instances where the underlying company experiences materially adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. As of December 31, 2022 and December 31, 2021, the Company had sufficient cash available and/or liquid securities available to fund its commitments and had reviewed them for any
appropriate
fair value adjustment.
XML 58 R22.htm IDEA: XBRL DOCUMENT v3.22.4
SLR Equipment Finance
12 Months Ended
Dec. 31, 2022
Schedule of Equity Method Investments [Line Items]  
SLR Equipment Finance
Note 14. Kingsbridge Holdings, LLC
On November 3, 2020, the Company acquired 87.5% of the equity securities of Kingsbridge Holdings, LLC (“KBH”) through KBH Topco LLC (“KBHT”), a Delaware corporation. KBH is a residual focused independent
mid-ticket
lessor of equipment primarily to U.S. investment grade companies. The Company invested $216,596 to effect the transaction, of which $136,596 was invested to acquire 87.5% of KBHT’s equity and $80,000 in KBH’s debt. The existing management team of KBH committed to continuing to lead KBH after the transaction. Following the transaction, the Company owns 87.5% of KBHT equity and the KBH management team owns the remaining 12.5% of KBHT’s equity.
As of December 31, 2022 and December 31, 2021, KBHT had total assets of $777,151 and $738,425, respectively. For the same periods, debt recourse to KBHT totaled $222,094 and $216,881, respectively, and
non-recourse
debt totaled $353,128 and $323,844, respectively. None of the debt is recourse to the Company. For the years ended December 31, 2022, December 31, 2021 and for the period November 3, 2020 through December 31, 2020, KBHT had net income of $13,287, $12,151 and $2,170, respectively, on gross income of $298,760, $245,889 and $43,618, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us. KBHT’s consolidated financial statements for the fiscal years ended December 31, 2022 and December 31, 2021 are attached as an exhibit to this annual
report
on Form
10
-
K.
SLR Equipment Finance [Member]  
Schedule of Equity Method Investments [Line Items]  
SLR Equipment Finance
Note 12. SLR Equipment Finance
On July 31, 2017, we acquired a 100% equity interest in NEF Holdings, LLC, which conducts its business through its wholly-owned subsidiary Nations Equipment Finance, LLC. Effective February 25, 2021, Nations Equipment Finance, LLC and its related companies are doing business as SLR Equipment Finance (“SLR Equipment”). SLR Equipment is an independent equipment finance company that provides senior secured loans and leases primarily to U.S. based companies. We invested $209,866 in cash to effect the transaction, of which $145,000 was invested in the equity of SLR Equipment through our wholly-owned consolidated taxable subsidiary NEFCORP LLC and our wholly-owned consolidated subsidiary NEFPASS LLC and $64,866 was used to purchase certain leases and loans held by SLR Equipment through NEFPASS LLC. Concurrent with the transaction, SLR Equipment refinanced its existing senior secured credit facility into a $150,000
non-recourse
facility with an accordion feature to expand up to $250,000. In September 2019, SLR Equipment amended the facility, increasing commitments to $213,957 with an accordion feature to expand up to $313,957 and extended the maturity date of the facility to July 31, 2023.
As of December 31, 2022, SLR Equipment had 131 funded equipment-backed leases and loans to 59 different customers with a total net investment in leases and loans of approximately $190,830 on total assets of $241,813. As of December 31, 2021, SLR Equipment had 135 funded equipment-backed leases and loans to 61 different customers with a total net investment in leases and loans of approximately $210,986 on total assets of $264,007. As of December 31, 2022 and December 31, 2021, the largest position outstanding totaled $19,259 and $19,207, respectively. For the same periods, the average exposure per customer was $3,234 and $3,459, respectively. SLR Equipment’s credit facility, which is
non-recourse
to the Company, had approximately $114,977 and $118,002 of borrowings outstanding at December 31, 2022 and December 31, 2021, respectively. For the years ended December 31, 2022, 2021 and 2020, SLR Equipment had net losses of $2,867, $9,729 and $8,883, respectively on gross income of $20,380, $22,931 and $24,512, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. SLR Equipment’s consolidated financial statements for the fiscal years ended December 31, 2022 and
December 
31, 2021
are
attached as an exhibit to this annual report on Form
10-K.
XML 59 R23.htm IDEA: XBRL DOCUMENT v3.22.4
Capital Share Transactions
12 Months Ended
Dec. 31, 2022
Stockholders' Equity Note [Abstract]  
Capital Share Transactions
Note 13. Capital Share Transactions
As of December 31, 2022 and December 31, 2021, 200,000,000 shares of $0.01 par value capital stock were
authorized
.
Transactions in capital stock were as follows:
 
    
Shares
    
Amount
 
    
For the year ended
December 31, 2022
    
For the year ended
December 31, 2021
    
For the year ended
December 31, 2022
    
For the year ended
December 31, 2021
 
Shares issued in connection with the Mergers
     12,511,825        —        $ 226,839      $ —    
Shares repurchased
     (217,271      —          (3,038      —    
    
 
 
    
 
 
    
 
 
    
 
 
 
Net increase
     12,294,554        —        $ 223,801      $ —    
    
 
 
    
 
 
    
 
 
    
 
 
 
XML 60 R24.htm IDEA: XBRL DOCUMENT v3.22.4
Kingsbridge Holdings, LLC
12 Months Ended
Dec. 31, 2022
Equity Method Investments and Joint Ventures [Abstract]  
Kingsbridge Holdings, LLC
Note 14. Kingsbridge Holdings, LLC
On November 3, 2020, the Company acquired 87.5% of the equity securities of Kingsbridge Holdings, LLC (“KBH”) through KBH Topco LLC (“KBHT”), a Delaware corporation. KBH is a residual focused independent
mid-ticket
lessor of equipment primarily to U.S. investment grade companies. The Company invested $216,596 to effect the transaction, of which $136,596 was invested to acquire 87.5% of KBHT’s equity and $80,000 in KBH’s debt. The existing management team of KBH committed to continuing to lead KBH after the transaction. Following the transaction, the Company owns 87.5% of KBHT equity and the KBH management team owns the remaining 12.5% of KBHT’s equity.
As of December 31, 2022 and December 31, 2021, KBHT had total assets of $777,151 and $738,425, respectively. For the same periods, debt recourse to KBHT totaled $222,094 and $216,881, respectively, and
non-recourse
debt totaled $353,128 and $323,844, respectively. None of the debt is recourse to the Company. For the years ended December 31, 2022, December 31, 2021 and for the period November 3, 2020 through December 31, 2020, KBHT had net income of $13,287, $12,151 and $2,170, respectively, on gross income of $298,760, $245,889 and $43,618, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us. KBHT’s consolidated financial statements for the fiscal years ended December 31, 2022 and December 31, 2021 are attached as an exhibit to this annual
report
on Form
10
-
K.
XML 61 R25.htm IDEA: XBRL DOCUMENT v3.22.4
SLR Healthcare ABL
12 Months Ended
Dec. 31, 2022
Equity Method Investments and Joint Ventures [Abstract]  
SLR Healthcare ABL
Note 15. SLR Healthcare ABL
SUNS acquired an equity interest in SLR Healthcare ABL, f/k/a Gemino Healthcare Finance, LLC (“SLR Healthcare”) on September 30, 2013. SLR Healthcare is a commercial finance company that originates, underwrites, and manages primarily secured, asset-based loans for small and
mid-sized
companies operating in the healthcare industry. SUNS initial investment in SLR Healthcare ABL was $32,839. The management team of SLR Healthcare
co-invested
in the transaction and continues to lead SLR Healthcare. As of September 30, 2022, SLR Healthcare’s management team and the Company own approximately 7% and 93% of the equity in SLR Healthcare, respectively. SLRC acquired SLR Healthcare in connection with the Mergers on April 1, 2022.
Concurrent with the closing of the transaction, SLR Healthcare entered into a new, four-year,
non-recourse,
$100,000 credit facility with
non-affiliates,
which was expandable to $150,000 under its accordion feature. Effective March 31, 2014, the credit facility was expanded to $105,000 and again on June 27, 2014 to $110,000. On May 27, 2016, SLR Healthcare entered into a new $125,000 credit facility which replaced the previously existing facility. The new facility has similar terms as compared to the previous facility and includes an accordion feature increase to $200,000 and had a maturity date of May 27, 2020. On June 28, 2019, this $125,000 facility was amended, extending the maturity date to June 28, 2023.
SLR Healthcare currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of December 31, 2022, the portfolio totaled approximately $242,106 of commitments with a total net investment in loans of $92,383 on total assets of $108,705. As of December 31, 2021, the portfolio totaled approximately $183,501 of commitments with a total net investment in loans of $81,604 on total assets of $91,275. At December 31, 2022, the portfolio consisted of 41 issuers with an average balance of approximately $2,253 versus 36 issuers with an average balance of approximately $2,267 at December 31, 2021. All of the commitments in SLR Healthcare’s portfolio are floating-rate, senior-secured,
cash-pay
loans. SLR Healthcare’s credit facility, which is
non-recourse
to us, had approximately $77,000 and $60,000 of borrowings outstanding at December 31, 2022 and December 31, 2021, respectively. For the years ended December 31, 2022, 2021 and 2020, SLR Healthcare had net income of $3,475, $662 and $4,289, respectively, on gross income of $11,593, $10,052 and $10,367, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. SLR Healthcare’s consolidated financial statements for the fiscal years ended December 31, 2022 and December 31, 2021 are attached as an exhibit to this annual report on Form
10-K.
XML 62 R26.htm IDEA: XBRL DOCUMENT v3.22.4
SLR Business Credit
12 Months Ended
Dec. 31, 2022
Equity Method Investments and Joint Ventures [Abstract]  
SLR Business Credit
Note 16. SLR Business Credit
SUNS acquired 100% of the equity interests of North Mill Capital LLC (“NMC”) on October 20, 2017. NMC is a leading asset-backed lending commercial finance company that provides senior secured asset-backed financings to U.S. based
small-to-medium-sized
businesses primarily in the manufacturing, services and distribution industries. SUNS invested approximately $51,000 to effect the transaction. Subsequently, SUNS contributed 1% of its equity interest in NMC to ESP SSC Corporation. Immediately thereafter, SUNS and ESP SSC Corporation contributed their equity interests to NorthMill LLC (“North Mill”). On May 1, 2018, North Mill merged with and into NMC, with NMC being the surviving company. SUNS and ESP SSC Corporation then owned 99% and 1% of the equity interests of NMC, respectively. The management team of NMC continues to lead NMC. On June 28, 2019, North Mill Holdco LLC (“NM Holdco”), a newly formed entity and ESP SSC Corporation acquired 100% of Summit Financial Resources, a Salt Lake City-based provider of asset-backed financing to small and
medium-sized
businesses. As part of this transaction, SUNS 99% interest in the equity of NMC was contributed to NM Holdco. This approximately $15,500 transaction was financed with borrowings on NMC’s credit facility. Effective February 25, 2021, NMC and its related companies are doing business as SLR Business Credit. On June 3, 2021, NMC acquired 100% of Fast Pay Partners LLC, a Los Angeles-based provider of asset-backed financing to digital media companies. The transaction purchase price of $66,671 was financed with equity from SUNS of $19,000 and borrowings on NMC’s credit facility of $47,671. SLRC acquired SLR Business Credit in connection with the Mergers on April 1, 2022.
SLR Business Credit currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of December 31, 2022, the portfolio totaled approximately $603,432 of commitments, of which $286,006 were funded, on total assets of $332,247. As of December 31, 2021, the portfolio totaled approximately $513,869 of commitments, of which $248,652 were funded, on total assets of $290,794. At December 31, 2022, the portfolio consisted of 108 issuers with an average balance of approximately $2,648 versus 125 issuers with an average balance of approximately $1,989 at December 31, 2021. NMC has a senior credit facility with a bank lending group for $285,307
 
which expires on
 
November 13, 2025
. Borrowings are secured by substantially all of NMC’s assets. NMC’s credit facility, which is
non-recourse
to us, had
 
approximately $
214,425
and $
183,252
of borrowings outstanding at December 31, 2022 and December 31, 2021, respectively. For the years ended December 31, 2022, 2021 and 2020, SLR Business Credit had net income of $
3,941
, $
7,295
and $
4,512
, respectively, on gross income of $
29,433
, $
24,021
and $
19,715
, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Business Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Business Credit will be able to maintain consistent dividend payments to us. SLR Business Credit’s consolidated financial statements for the fiscal years ended December 31, 2022 and December 31, 2021 are attached as an exhibit to this annual
report
on Form
10-K.
XML 63 R27.htm IDEA: XBRL DOCUMENT v3.22.4
Merger with SUNS
12 Months Ended
Dec. 31, 2022
Business Combinations [Abstract]  
Merger with SUNS
Note 17. Merger with SUNS
On April 1, 2022, the Company completed its previously announced acquisition of SUNS. Pursuant to the Merger Agreement, Merger Sub was first merged with and into SUNS, with SUNS as the surviving corporation, and, immediately following the Merger, SUNS was then merged with and into the Company, with the Company as the surviving company. In accordance with the terms of the Merger Agreement, at the effective time of the Mergers, each outstanding share of SUNS’s common stock was converted into the right to receive 0.7796 shares of the Company’s common stock (with SUNS’s stockholders receiving cash in lieu of fractional shares of the Company’s common stock). As a result of the Mergers, the Company issued an aggregate of 12,511,825 shares of its common stock to former SUNS stockholders.
The Mergers are accounted for as an asset acquisition of SUNS by the Company in accordance with the asset acquisition method of accounting as detailed in ASC
805-50,
Business Combinations – Related Issues, with the fair value of total consideration paid in conjunction with the Mergers allocated to the assets acquired and liabilities assumed based on their relative fair values as of the date of the Mergers. Generally, under asset acquisition accounting, acquiring assets in groups not only requires ascertaining the cost of the asset (or net assets), but also allocating that cost to the individual assets (or individual assets and liabilities) that make up the group. The cost of the group of assets acquired in an asset acquisition is allocated to the individual assets acquired or liabilities assumed based on their relative fair values of net identifiable assets acquired other than certain
“non-qualifying”
assets (for example cash) and does not give rise to goodwill. The Company is the accounting survivor of the Mergers. The Mergers were considered a
tax-free
reorganization and the historical cost basis of the acquired SUNS investments are carried forward for tax purposes. Prior to the Mergers, SUNS was also managed by the Investment Adviser.
 
 
The following table summarizes the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Mergers:
 
Common stock issued by the Company
(1)
   $ 227,602  
    
 
 
 
Assets acquired:
        
Investments, at fair value
   $ 400,105  
Cash
     2,313  
Other assets
     4,662  
    
 
 
 
Total assets acquired
   $ 407,080  
    
 
 
 
Liabilities assumed:
        
Debt, at fair value
   $ 159,816  
Other liabilities
     2,573  
    
 
 
 
Total liabilities assumed
   $ 162,389  
    
 
 
 
Net assets acquired
   $ 244,691  
    
 
 
 
Total purchase discount
   $ (17,089
    
 
 
 
 
(1)
Based on the market price at closing of $18.13, adjusted for transaction costs.
Letter Agreement
On April 1, 2022, in connection with the consummation of the Mergers, the Company entered into a letter agreement (the “Letter Agreement”) pursuant to which the Investment Adviser voluntarily agreed to a permanent 25 basis point reduction of the annual base management fee rate payable by the Company to the Investment Adviser pursuant to the Advisory Agreement, resulting in an annual base management fee rate payable by the Company to the Investment Adviser of 1.50% on gross assets up to 200% of the Company’s total net assets. The Company retained the annual base management fee rate payable by the Company to the Investment Adviser of 1.00% on gross assets that exceed 200% of the Company’s total net assets.
XML 64 R28.htm IDEA: XBRL DOCUMENT v3.22.4
Stock Repurchase Program
12 Months Ended
Dec. 31, 2022
Stockholders' Equity Note [Abstract]  
Stock Repurchase Program
Note 18. Stock Repurchase Program
On May 3, 2022, our Board authorized a program for the purpose of repurchasing up to $50,000 of our outstanding shares of common stock. Under the repurchase program, we may, but are not obligated to, repurchase shares of our outstanding common stock in the open market from time to time provided that we comply with our code of ethics and the guidelines specified in Rule
10b-18
of the 1934 Act, including certain price, market volume and timing constraints. In addition, any repurchases will be conducted in accordance with the 1940 Act. Unless amended or extended by our Board, we expect the repurchase program to be in place until the earlier of May 1, 2023 or until $50,000 of our outstanding shares of common stock have been repurchased. The timing and number of shares to be repurchased will depend on a number of factors, including market conditions. There are no assurances that we will engage in any repurchases beyond what is reported herein. During the fiscal year ended December 31, 2022, the Company repurchased 217,271 shares at an average price of approximately $13.98 per share, inclusive of commissions. The total dollar amount of shares repurchased was $3,038.
XML 65 R29.htm IDEA: XBRL DOCUMENT v3.22.4
SLR Senior Lending Program LLC
12 Months Ended
Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]  
SLR Senior Lending Program LLC
Note 19. SLR Senior Lending Program LLC
On October 12, 2022, the Company entered into an amended and restated limited liability company agreement with Sunstone Senior Credit L.P. (the “Investor”) to create a joint venture vehicle, SLR Senior Lending Program LLC (“SSLP”). SSLP is expected to invest primarily in senior secured cash flow loans. The Company and the Investor each have made initial equity commitments of $50,000, resulting in a total equity commitment of $100,000. Investment decisions and all material decisions in respect of SSLP must be approved by representatives of the Company and the Investor.
On December 1, 2022, SSLP commenced operations. On December 12, 2022, SSLP as servicer and SLR Senior Lending Program SPV LLC (“SSLP SPV”), a newly formed wholly owned subsidiary of SSLP, as borrower entered into a $100,000 senior secured revolving credit facility (the “SSLP Facility”) with Goldman Sachs Bank USA acting as administrative agent. The SSLP Facility is scheduled to mature on December 12, 2027. The SSLP Facility generally bears interest at a rate of SOFR plus 3.25%. SSLP and SSLP SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SSLP Facility also includes usual and customary events of default for credit facilities of this nature. There were no borrowings during the period December 12, 2022 to December 31, 2022. As of December 31, 2022 the Company and the Investor had contributed combined equity capital in the amount of $19,000. As of December 31, 2022, the Company and the Investors’ remaining commitments to SSLP totaled $40,500 and $40,500, respectively. The Company, along with the Investor, controls the funding of SSLP and SSLP may not call the unfunded commitments of the Company or the Investor without the approval of both the Company and the Investor.
As of December 31, 2022, SSLP had total assets of $19,105. SSLP’s portfolio consisted of floating rate senior secured loans to seven (7) different borrowers. For the period December 1, 2022 (commencement of operations) through December 31, 2022, SSLP invested $18,100 in seven (7) portfolio companies. Investments prepaid totaled $68 for the same period.
 
 
SSLP Portfolio as of December 31, 2022 
 
Description
  
Industry
    
Spread
Above
Index
(1)
    
Floor
   
Interest
Rate
(2)
   
Maturity
Date
    
Par
Amount
    
Cost
    
Fair
Value
(3)
 
Atria Wealth Solutions, Inc.
(4)
     Diversified Financial
Services
 
 
     S+600        1.00     10.84     2/29/24      $ 2,494      $ 2,494      $ 2,494  
BayMark Health Services, Inc.
(4)
     Health Care Providers &
Services
 
 
     L+500        1.00     9.73     6/11/27        2,992        2,992        2,992  
ENS Holdings III Corp. & ES Opco USA LLC
(4)
     Trading Companies &
Distributors
 
 
     L+475        1.00     9.43     12/31/25        1,097        1,097        1,097  
Foundation Consumer Brands, LLC
(4)
     Personal Products        L+550        1.00     10.15     2/12/27        2,963        2,963        2,963  
High Street Buyer, Inc.
(4)
     Insurance        L+600        0.75     10.73     4/16/28        2,494        2,494        2,494  
Ivy Fertility Services, LLC
(4)
     Health Care Providers &
Services
 
 
     L+625        1.00     10.39     2/25/26        3,000        3,000        3,030  
Kid Distro Holdings, LLC
(4)
     Software        L+575        1.00     10.48     10/1/27        2,992        2,992        2,992  
                                                        
 
 
    
 
 
 
                                                         $  18,032      $  18,062  
                                                        
 
 
    
 
 
 
 
(1)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or SOFR. These instruments are typically subject to a LIBOR or SOFR floor.
(2)
Floating rate debt investments typically bear interest at a rate determined by reference to either the LIBOR (“L”) or SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022.
(3)
Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
(4)
The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
Below is certain summarized financial information for SSLP as of December 31, 2022 and for the period December 1, 2022 (commencement of operations) through December 31, 2022:
 
    
December 31,
2022
 
Selected Balance Sheet Information for SSLP:
        
Investments at fair value (cost $18,032)
   $ 18,062  
Cash and other assets
     1,043  
    
 
 
 
Total assets
   $ 19,105  
    
 
 
 
Debt outstanding
   $ —    
Interest payable and other credit facility related expenses
     165  
Accrued expenses and other payables
     89  
    
 
 
 
Total liabilities
   $ 254  
    
 
 
 
Members’ equity
   $ 18,851  
    
 
 
 
Total liabilities and members’ equity
   $ 19,105  
    
 
 
 
 
 
    
For the Period
December 1, 2022
(commencement of
operations) through
December 31, 2022
 
Selected Income Statement Information for SSLP:
        
Interest income
   $ 152  
    
 
 
 
Service fees*
   $ 4  
Interest and other credit facility expenses
     166  
Organizational costs
     73  
Other general and administrative expenses
     88  
    
 
 
 
Total expenses
     331  
    
 
 
 
Net investment loss
   $ (179
    
 
 
 
Realized gain on investments
     —    
Net change in unrealized gain on investments
     30  
    
 
 
 
Net realized and unrealized gain on investments
     30  
    
 
 
 
Net loss
   $ (149
    
 
 
 
 
*
Service fees are included within the Company’s Consolidated Statements of Operations as other income.
XML 66 R30.htm IDEA: XBRL DOCUMENT v3.22.4
Subsequent Events
12 Months Ended
Dec. 31, 2022
Subsequent Events [Abstract]  
Subsequent Events
Note 20. Subsequent Events
The Company has evaluated the need for disclosures and/or adjustments resulting from subsequent events through the date the consolidated financial statements were issued.
On January 10, 2023, the Board declared
a monthly distribution
of $0.136667 per share payable on February 2, 2023 to holders of record as of January 26, 2023.
On February 2, 2023, the Board declared
a monthly distribution of
$0.136667 per share payable on March 1, 2023 to holders of record as of February 16, 2023.
On February 28, 2023, the Board declared
a monthly distribution
of $0.136667 per share payable on April 4, 2023 to holders of record as of March 23, 2023.
XML 67 R31.htm IDEA: XBRL DOCUMENT v3.22.4
Significant Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Recent Accounting Pronouncements
 
Recent Accounting Pronouncements
In March 2020, the FASB issued Accounting Standards Update
No. 2020-04,
“Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The guidance provides optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships and other transactions, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued because of the reference rate reform. ASU
2020-04
is effective for all entities as of March 12, 2020 through December 31, 2022. The Company has determined that the adoption of this guidance has not had a material impact on the Company’s consolidated financial statements and disclosures.
XML 68 R32.htm IDEA: XBRL DOCUMENT v3.22.4
Earnings Per Share (Tables)
12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Summary of Computation of Basic And Diluted Net
The following table sets forth the computation of basic and diluted net increase in net assets per share resulting from operations, pursuant to ASC
260-10,
for the years ended December 31, 2022, 2021 and 2020:
 
    
Year ended
December 31, 2022
    
Year ended
December 31, 2021
    
Year ended
December 31, 2020
 
Earnings per share (basic & diluted)
 
 
 
 
 
 
 
 
 
 
 
 
Numerator - net increase in net assets resulting from operations:

   $ 18,342      $ 59,566      $ 15,451  
Denominator - weighted average shares:

     51,680,522        42,260,826        42,260,826  
Earnings per share:
   $ 0.35      $ 1.41      $ 0.37  
XML 69 R33.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value (Tables)
12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following tables present the balances of assets and liabilities measured at fair value on a recurring basis, as of December 31, 2022 and December 31, 2021:
Fair Value Measurements
As of December 31, 2022
 
    
Level 1
    
Level 2
    
Level 3
    
Measured at
Net Asset Value*
    
Total
 
Assets:
                                            
Senior Secured Loans
   $ —        $ —        $ 1,245,414      $ —        $ 1,245,414  
Equipment Financing
     —          —          265,952        —          265,952  
Preferred Equity
     —          —          3,801        —          3,801  
Common Equity/Equity Interests/Warrants
     483        —          561,600        9,426        571,509  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
   $ 483      $ —        $ 2,076,767      $ 9,426      $ 2,086,676  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
*
In accordance with ASC
820-10,
certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP. See Note 19 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members.
Fair Value Measurements
As of December 31, 2021
 
    
Level 1
    
Level 2
    
Level 3
    
Total
 
Assets:
                                   
Senior Secured Loans
   $      $
     $ 939,690      $ 939,690  
Equipment Financing
                   273,795        273,795  
Preferred Equity
                   5,630        5,630  
Common Equity/Equity Interests/Warrants
     1,086               450,381        451,467  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
   $ 1,086           $ 1,669,496      $ 1,670,582  
    
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities:
                                   
2022 Unsecured Notes
   $     
     $ 150,000      $ 150,000  
    
 
 
    
 
 
    
 
 
    
 
 
 
Summary of Changes in Fair Value of Level 3 Assets and Liabilities
The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2022, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2022:
Fair Value Measurements Using Level 3 Inputs
 
    
Senior Secured
Loans
   
Equipment

Financing
   
Preferred Equity
   
Common Equity/
Equity
Interests/
Warrants
   
Total
 
Fair value, December
 31, 2021
   $ 939,690     $ 273,795     $ 5,630     $ 450,381     $ 1,669,496  
Total gains or losses included in earnings:
                                        
Net realized gain (loss)
     (36,244     —         —         6       (36,238
Net change in unrealized loss
     (8,065     (6,924     (706     (5,048     (20,743
Purchase of investment securities(1)
     796,389       84,168       266       116,272       997,095  
Proceeds from dispositions of investment securities
     (446,356     (85,087     (1,389     (11     (532,843
Transfers in/out of Level 3
     —         —         —         —         —    
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Fair value, December
 31, 2022
   $ 1,245,414     $ 265,952     $ 3,801     $ 561,600     $ 2,076,767  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
                                        
Net change in unrealized loss
   $ (8,920   $ (6,924   $ (706   $ (5,048   $ (21,598
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
Includes positions acquired from SUNS as a result of the Mergers.
The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the year ended December 31, 2022:
 
2022 Unsecured Notes
  
For the year ended
December 31, 2022
 
Beginning fair value
   $ 150,000  
Net realized (gain) loss
     —    
Net change in unrealized (gain) loss
     —    
Borrowings
     —    
Repayments
     (150,000
Transfers in/out of Level 3
     —    
    
 
 
 
Ending fair value
   $ —    
    
 
 
 
The Company made an election to apply the fair value option of accounting to the 2022 Unsecured Notes, in accordance with ASC
825-10.
On May 8, 2022, the borrowings were repaid in full. While the Company has not made an election to apply the fair value option of accounting to any of its other debt obligations, if the Company’s debt obligations were carried at fair value at December 31, 2022, the fair value of the Credit Facility, SPV Credit Facility, 2023 Unsecured Notes, 2024 Unsecured Notes, 2025 Unsecured Notes, 2026 Unsecured Notes, 2027 Unsecured Notes and 2027 Series F Unsecured Notes would be $393,000, $155,200, $75,000, $118,750, $79,688, $68,250, $42,875 and $118,125, respectively.
 
The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2021, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2021:
Fair Value Measurements Using Level 3 Inputs
 

 
  
Senior Secured
Loans
 
 
Equipment

Financing
 
 
Preferred Equity
 
 
Common Equity/
Equity
Interests/
Warrants
 
 
Total
 
Fair value, December
 31, 2020
   $ 798,052     $ 284,846     $ 6,401     $ 440,971     $ 1,530,270  
Total gains or losses included in earnings:
                                        
Net realized gain (loss)
     —         (8     —         345       337  
Net change in unrealized gain (loss)
     (13,567     1,394       (1,042     9,857       (3,358
Purchase of investment securities
     533,614       76,700       271       —         610,585  
Proceeds from dispositions of investment securities
     (378,409     (89,137     —         (675     (468,221
Transfers in/out of Level 3
(1)
     —         —         —         (117     (117
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Fair value, December
 31, 2021
   $ 939,690     $ 273,795     $ 5,630     $ 450,381     $ 1,669,496  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Unrealized gains (losses) for the period relating to those Level 3
assets that were still held by the Company at the end of the
period:
                                        
Net change in unrealized gain (loss)
   $ (12,837   $ 1,394     $ (1,042   $ 9,597     $ (2,888
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
On February 17, 2021, the Company exercised its warrants in Senseonics Holdings, Inc., receiving shares in the common stock of Senseonics Holdings, Inc. The common stock of Senseonics Holdings, Inc. is publicly traded, so this position is considered to be a Level 1 asset.
Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3)
The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the year ended December 31, 2021:
 
2022 Unsecured Notes
  
For the year ended
December 31, 2021
 
Beginning fair value
   $ 150,000  
Net realized (gain) loss
     —    
Net change in unrealized (gain) loss
     —    
Borrowings
     —    
Repayments
     —    
Transfers in/out of Level 3
     —    
    
 
 
 
Ending fair value
   $ 150,000  
    
 
 
 
Summary of Quantitative Information about the Company's Level 3 Asset and Liability
Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2022 is summarized in the table below:
 
    
Asset or
Liability
  
Fair Value at

December 31, 2022
    
Principal Valuation

Technique/Methodology
 
Unobservable Input
  
Range (Weighted

Average)
Senior Secured Loans
   Asset    $
$
1,212,842
32,572
 
 
   Income Approach
Market Multiple
(1)
  Market Yield
Comparable Multiple
  
9.4%
 
 
18.2% (12.0%)
0.1x-21.4x
 
(12.4x)
Equipment Financing
   Asset    $
$
145,132
120,820
 
 
   Income Approach
Market Multiple
(2)
  Market Yield
Comparable Multiple
   8.5% –9.7% (9.7%)
1.1x-1.4x
(1.2x)
Preferred Equity
   Asset    $ 3,801      Income Approach   Market Yield    5.0% –
 
5.0% (5.0%)
Common Equity/Equity Interests/Warrants
   Asset    $
$
149,120
412,480
 
 
   Market Multiple
(3)
Market Approach
  Comparable Multiple
Return on Equity
   7.8x –
 
9.8x (8.8x)
6.6% –
 
35.2% (9.2%)
 
(1)
Investments are valued using a
sum-of-the
parts analysis, using expected revenue multiples for certain segments of the businesses and expected EBITDA multiples for certain segments of the businesses.
(2)
Includes $120,820 of investments valued using
an implied
multiple.
(3)
Includes $676 of investments valued using a Black-Scholes model and $148,444 of investments valued using an EBITDA multiple.
Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2021 is summarized in the table below
:
 

 
  
Asset or
Liability
  
Fair Value at
December 31, 2021
 
  
Principal Valuation
Technique/Methodology
 
Unobservable Input
  
Range (Weighted
Average)
Senior Secured Loans
   Asset    $
$
931,769
7,921
 
 
   Income Approach
Market Multiple
(1)
  Market Yield
Comparable Multiple
   4.0% –
 
19.6% (8.7%)
2.0x-3.0x(2.5x)/2.0x-
3.0x(2.5x)
Equipment Financing
   Asset    $
$
144,693
129,102
 
 
   Income Approach
Market Approach
  Market Yield
Return on Equity
   7.1% –
 
20.3% (9.8%)
4.6%-4.6%
(4.6%)
Preferred Equity
   Asset    $ 5,630      Income Approach   Market Yield    3.5% –
 
8.0% (4.4%)
Common Equity/Equity Interests/Warrants
   Asset    $
$
151,615
298,766
 
 
   Market Multiple
(2)
Market Approach
  Comparable Multiple
Return on Equity
   5.8x –
 
10.5x (9.5x)
6.1% –
 
18.5% (8.6%)
2022 Unsecured Notes
   Liability    $ 150,000      Income Approach   Market Yield    2.2% –
 
4.6% (4.5%)
 
(1)
Investments are valued using a
sum-of-the
parts analysis, using expected EBITDA multiples
(2x-3x)
for certain segments of the business and expected revenue multiples
(2x-3x)
for certain segments of the business.
(2)
Includes $403 of investments valued using a Black-Scholes model and $151,212 of investments valued using an EBITDA multiple.
XML 70 R34.htm IDEA: XBRL DOCUMENT v3.22.4
Debt (Tables)
12 Months Ended
Dec. 31, 2022
Debt Instruments [Abstract]  
Schedule of Long-term Debt Instruments
Our debt obligations consisted of the following as of December 31, 2022 and December 31, 2021:
 
    
December 31, 2022
   
December 31, 2021
 
Facility
  
Face Amount
    
Carrying Value
   
Face Amount
    
Carrying Value
 
Credit Facility
   $ 393,000      $ 388,254
(1)
 
  $ 322,500      $ 318,015
(1)
 
SPV Credit Facility
     155,200        154,302
(2)
 
    —          —    
2022 Unsecured Notes
     —          —         150,000        150,000  
2022 Tranche C Notes
     —          —         21,000        20,964
(3)
 
2023 Unsecured Notes
     75,000        74,979
(4)
 
    75,000        74,592
(4)
 
2024 Unsecured Notes
     125,000        124,421
(5)
 
    125,000        124,143
(5)
 
2025 Unsecured Notes
     85,000        84,613
(6)
 
    —          —    
2026 Unsecured Notes
     75,000        74,498
(7)
 
    75,000        74,384
(7)
 
2027 Unsecured Notes
     50,000        49,953
(8)
 
    50,000        49,940
(8)
 
2027 Series F Unsecured Notes
     135,000        134,978
(9)
 
    —          —    
    
 
 
    
 
 
   
 
 
    
 
 
 
     $ 1,093,200      $ 1,085,998     $ 818,500      $ 812,038  
    
 
 
    
 
 
   
 
 
    
 
 
 
 
(1)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $
4,746
and $
4,485
as of December 31, 2022 and December 31, 2021, respectively.
(2)
Carrying Value equals the Face Amount net of unamortized market discount of $898 as of December 31, 2022.
(3)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $36 as of December 31, 2021.
(4)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $21 and $408 as of December 31, 2022 and December 31, 2021, respectively.
(5)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $579 and $857 as of December 31, 2022 and December 31, 2021, respectively.
(6)
Carrying Value equals the Face Amount net of unamortized market discount of $387 as of December 31, 2022.
(7)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $502 and $616 as of December 31, 2022 and December 31, 2021, respectively.
(8)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $47 and $60 as of December 31, 2022 and December 31, 2021, respectively.
(9)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $22 as of December 31, 2022.
XML 71 R35.htm IDEA: XBRL DOCUMENT v3.22.4
Income Tax Information and Distributions to Stockholders and Other Tax Information (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Investment Company, Distribution To Shareholders
The tax character of distributions for the fiscal years ended December 31, 2022, 2021 and 2020 were as follows (1):
 
    
2022
   
2021
   
2020
 
Ordinary income
   $ 50,113        59.2   $ 41,221        59.5   $ 48,795        70.4
Capital gains
     —          0.0     —          0.0     —          0.0
Return of capital
     27,099        32.0     28,087        40.5     20,513        29.6
Distribution recognized in subsequent year
     7,481        8.8     —          0.0     —          0.0
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
Total distributions
   $ 84,693        100.0   $ 69,308        100.0   $ 69,308        100.0
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
Summary of total accumulated earnings
As of December 31, 2022, 2021 and 2020 the total accumulated earnings (loss) on a tax basis were as follows (1):
 
    
2022
 
2021
    
2020
 
Undistributed ordinary income
   $ —    
$ —        $ —    
Undistributed long-term net capital gains
     —    
  —          —    
    
 
 
 
 
 
    
 
 
 
Total undistributed net earnings
     —    
  —          —    
Post-October capital losses
     —    
  —          —    
Capital loss carryforward
     (127,348 )
(2)

  (68,857      (69,384
Other book/tax temporary differences
     (53,223
  2,332        2,168  
Net unrealized appreciation
     17,187  
  19,495        4,446  
    
 
 
 
 
 
    
 
 
 
Total tax accumulated loss
   $ (163,384
$ (47,030    $ (62,770
    
 
 
 
 
 
    
 
 
 
 
(1)
Tax information for the fiscal years ended December 31, 2022, 2021 and 2020 are/were estimates and are not final until the Company files its tax returns, typically in September or October each year.
(2)
Includes capital loss carryforward acquired from the Mergers which is subject to limitations under IRC Sections 381-384.
XML 72 R36.htm IDEA: XBRL DOCUMENT v3.22.4
Financial Highlights (Tables)
12 Months Ended
Dec. 31, 2022
Investment Company, Financial Highlights [Abstract]  
Schedule of financial highlights
The following is a schedule of financial highlights for the respective years:
 
    
Year ended
December 31,
2022
   
Year ended
December 31,
2021
   
Year ended
December 31,
2020
   
Year ended
December 31,
2019
   
Year ended
December 31,
2018
 
Per Share Data: (a)
                                        
Net asset value, beginning of year
   $ 19.93     $ 20.16     $ 21.44     $ 21.75     $ 21.81  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Net investment income
     1.48       1.44       1.40       1.71       1.77  
Net realized and unrealized loss
     (1.13 )*      (0.03     (1.04     (0.38     (0.19
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Net increase in net assets resulting from operations
     0.35       1.41       0.36       1.33       1.58  
Issuance of common stock in connection with the Mergers
     (0.33     —         —         —         —    
Anti-dilution
     0.02       —         —         —         —    
Distributions to stockholders (see note 8a):
                                        
From distributable earnings
     (1.12     (0.98     (1.15     (1.55     (1.64
From return of capital
     (0.52     (0.66     (0.49     (0.09     —    
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Net asset value, end of year
   $ 18.33     $ 19.93     $ 20.16     $ 21.44     $ 21.75  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Per share market value, end of year
   $ 13.91     $ 18.43     $ 17.51     $ 20.62     $ 19.19  
Total Return(b)
     (16.09 %)      14.66     (5.72 %)      16.22     2.77
Net assets, end of year
   $ 999,731     $ 842,281     $ 852,023     $ 905,880     $ 919,171  
Shares outstanding, end of year
     54,555,380       42,260,826       42,260,826       42,260,826       42,260,826  
Ratios to average net assets:
                                        
Net investment income
     7.76     7.13     6.93     7.83     8.10
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Operating expenses
     5.60 %**      5.68     4.14     5.76     5.83
Interest and other credit facility expenses
     4.68     3.50     3.18     3.13     2.67
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total expenses
     10.28 %**      9.18     7.32     8.89     8.50
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Average debt outstanding
   $ 994,578     $ 703,670     $ 556,104     $ 561,249     $ 508,445  
Portfolio turnover ratio
     27.4     29.9     26.0     24.1     39.3
 
 
(a)
Calculated using the average shares outstanding method, except for the issuance of common stock in connection with the Mergers, which reflects the actual amount per share for the applicable period.
(b)
Total return is based on the change in market price per share during the year and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. Total return does not include a sales load.
*
The amount shown may not correspond with the aggregate amount for the period as it includes the effect of the timing of the Mergers.
**
The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of the performance-based incentive fee waiver (see note 3). For the year ended December 31, 2022, the ratios of operating expenses to average net assets and total expenses to average net assets would be 5.75% and 10.43%, respectively, without the performance-based incentive fee waiver.
XML 73 R37.htm IDEA: XBRL DOCUMENT v3.22.4
Commitments and Contingencies (Tables)
12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Summary of unfunded debt and equity commitments The total amount of these unfunded commitments as of December 31, 2022 and December 31, 2021 is $323,663 and $226,733, respectively, comprised of the following:
 
    
December 31,
2022
    
December 31,
2021
 
SLR Credit Solutions*
   $ 44,263      $ 44,263  
Outset Medical, Inc
     35,084        —    
Apeel Technology, Inc
     32,786        —    
CC SAG Holdings Corp. (Spectrum Automotive)
     20,670        18,827  
Human Interest, Inc
     20,104        —    
Glooko, Inc
     17,868        25,091  
World Insurance Associates, LLC
     17,117        —    
iCIMS, Inc
     11,435        —    
Spectrum Pharmaceuticals, Inc
     8,771        —    
Arcutis Biotherapeutics, Inc
     8,356        43,470  
Atria Wealth Solutions, Inc
     8,215        3,746  
Ardelyx, Inc
     7,752        —    
Luxury Asset Capital, LLC
     7,500        —    
RSC Acquisition, Inc
     7,498        —    
Cerapedics, Inc
     6,735        —    
Maurices, Incorporated
     4,314        5,649  
Kaseya, Inc
     3,936        —    
Vessco Midco Holdings, LLC
     3,892        —    
Copper River Seafoods, Inc
     3,595        —    
BDG Media, Inc
     3,546        —    
Meditrina, Inc
     3,367        —    
One Touch Direct, LLC
     3,069        7,226  
DeepIntent, Inc
     3,049        —    
Foundation Consumer Brands, LLC
     3,009        2,269  
SCP Eye Care, LLC
     2,771        —    
Basic Fun, Inc
     2,675        1,935  
Kid Distro Holdings, LLC
     2,650        2,650  
Plastics Management, LLC
     2,424        —    
Southern Orthodontic Partners Management, LLC
     1,918        —    
Pediatric Home Respiratory Services, LLC
     1,805        —    
Pinnacle Treatment Centers, Inc
     1,745        1,414  
Ultimate Baked Goods Midco LLC
     1,636        801  
Orthopedic Care Partners Management, LLC
     1,620        —    
Ivy Fertility Services, LLC
     1,571        4,532  
Composite Technology Acquisition Corp
     1,537        —    
NAC Holdings Corporation
     1,479        4,765  
SLR Healthcare ABL*
     1,400        —    
SPAR Marketing Force, Inc
     1,338        —    
RxSense Holdings LLC
     1,250        —    
Erie Construction
Mid-west,
LLC
     1,248        —    
Peter C. Foy & Associates Insurance Services, LLC
     1,094        —    
American Teleconferencing Services, Ltd
     1,090        573  
Montefiore Nyack Hospital
     1,034        —    
Enverus Holdings, Inc
     1,004        —    
SLR Equipment Finance
     1,000        5,000  
SunMed Group Holdings, LLC
     843        828  
GSM Acquisition Corp
     784        —    
Tilley Distribution, Inc
     525        —    
BayMark Health Services, Inc
     391        —    
High Street Buyer, Inc
     327        —    
TAUC Management, LLC
     294        —    
ENS Holdings III Corp, LLC
     144        —    
All State Ag Parts, LLC
     135        —    
BridgeBio Pharma, Inc
     —          23,049  
Inszone Mid, LLC
     —          12,465  
Rezolute, Inc
     —          5,675  
SOC Telemed, Inc
     —          4,448  
RQM+ Corp
     —          3,818  
MMIT Holdings, LLC
     —          2,009  
Neuronetics, Inc
     —          2,230  
    
 
 
    
 
 
 
Total Commitments
   $ 323,663      $ 226,733  
    
 
 
    
 
 
 
 
*
The Company controls the funding of the SLR Credit Solutions and SLR Healthcare ABL commitments and may cancel them at its discretion.
XML 74 R38.htm IDEA: XBRL DOCUMENT v3.22.4
Capital Share Transactions (Tables)
12 Months Ended
Dec. 31, 2022
Stockholders' Equity Note [Abstract]  
Schedule of Stockholders Equity
Transactions in capital stock were as follows:
 
    
Shares
    
Amount
 
    
For the year ended
December 31, 2022
    
For the year ended
December 31, 2021
    
For the year ended
December 31, 2022
    
For the year ended
December 31, 2021
 
Shares issued in connection with the Mergers
     12,511,825        —        $ 226,839      $ —    
Shares repurchased
     (217,271      —          (3,038      —    
    
 
 
    
 
 
    
 
 
    
 
 
 
Net increase
     12,294,554        —        $ 223,801      $ —    
    
 
 
    
 
 
    
 
 
    
 
 
 
XML 75 R39.htm IDEA: XBRL DOCUMENT v3.22.4
Merger with SUNS (Tables)
12 Months Ended
Dec. 31, 2022
Business Combinations [Abstract]  
Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger The following table summarizes the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Mergers:
 
Common stock issued by the Company
(1)
   $ 227,602  
    
 
 
 
Assets acquired:
        
Investments, at fair value
   $ 400,105  
Cash
     2,313  
Other assets
     4,662  
    
 
 
 
Total assets acquired
   $ 407,080  
    
 
 
 
Liabilities assumed:
        
Debt, at fair value
   $ 159,816  
Other liabilities
     2,573  
    
 
 
 
Total liabilities assumed
   $ 162,389  
    
 
 
 
Net assets acquired
   $ 244,691  
    
 
 
 
Total purchase discount
   $ (17,089
    
 
 
 
 
(1)
Based on the market price at closing of $18.13, adjusted for transaction costs.
XML 76 R40.htm IDEA: XBRL DOCUMENT v3.22.4
SLR Senior Lending Program LLC (Tables)
12 Months Ended
Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]  
SSLP Portfolio
As of December 31, 2022, SSLP had total assets of $19,105. SSLP’s portfolio consisted of floating rate senior secured loans to seven (7) different borrowers. For the period December 1, 2022 (commencement of operations) through December 31, 2022, SSLP invested $18,100 in seven (7) portfolio companies. Investments prepaid totaled $68 for the same period.
 
 
SSLP Portfolio as of December 31, 2022 
 
Description
  
Industry
    
Spread
Above
Index
(1)
    
Floor
   
Interest
Rate
(2)
   
Maturity
Date
    
Par
Amount
    
Cost
    
Fair
Value
(3)
 
Atria Wealth Solutions, Inc.
(4)
     Diversified Financial
Services
 
 
     S+600        1.00     10.84     2/29/24      $ 2,494      $ 2,494      $ 2,494  
BayMark Health Services, Inc.
(4)
     Health Care Providers &
Services
 
 
     L+500        1.00     9.73     6/11/27        2,992        2,992        2,992  
ENS Holdings III Corp. & ES Opco USA LLC
(4)
     Trading Companies &
Distributors
 
 
     L+475        1.00     9.43     12/31/25        1,097        1,097        1,097  
Foundation Consumer Brands, LLC
(4)
     Personal Products        L+550        1.00     10.15     2/12/27        2,963        2,963        2,963  
High Street Buyer, Inc.
(4)
     Insurance        L+600        0.75     10.73     4/16/28        2,494        2,494        2,494  
Ivy Fertility Services, LLC
(4)
     Health Care Providers &
Services
 
 
     L+625        1.00     10.39     2/25/26        3,000        3,000        3,030  
Kid Distro Holdings, LLC
(4)
     Software        L+575        1.00     10.48     10/1/27        2,992        2,992        2,992  
                                                        
 
 
    
 
 
 
                                                         $  18,032      $  18,062  
                                                        
 
 
    
 
 
 
 
(1)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or SOFR. These instruments are typically subject to a LIBOR or SOFR floor.
(2)
Floating rate debt investments typically bear interest at a rate determined by reference to either the LIBOR (“L”) or SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022.
(3)
Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
(4)
The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
Summary financial information for SSLP
Below is certain summarized financial information for SSLP as of December 31, 2022 and for the period December 1, 2022 (commencement of operations) through December 31, 2022:
 
    
December 31,
2022
 
Selected Balance Sheet Information for SSLP:
        
Investments at fair value (cost $18,032)
   $ 18,062  
Cash and other assets
     1,043  
    
 
 
 
Total assets
   $ 19,105  
    
 
 
 
Debt outstanding
   $ —    
Interest payable and other credit facility related expenses
     165  
Accrued expenses and other payables
     89  
    
 
 
 
Total liabilities
   $ 254  
    
 
 
 
Members’ equity
   $ 18,851  
    
 
 
 
Total liabilities and members’ equity
   $ 19,105  
    
 
 
 
 
 
    
For the Period
December 1, 2022
(commencement of
operations) through
December 31, 2022
 
Selected Income Statement Information for SSLP:
        
Interest income
   $ 152  
    
 
 
 
Service fees*
   $ 4  
Interest and other credit facility expenses
     166  
Organizational costs
     73  
Other general and administrative expenses
     88  
    
 
 
 
Total expenses
     331  
    
 
 
 
Net investment loss
   $ (179
    
 
 
 
Realized gain on investments
     —    
Net change in unrealized gain on investments
     30  
    
 
 
 
Net realized and unrealized gain on investments
     30  
    
 
 
 
Net loss
   $ (149
    
 
 
 
 
*
Service fees are included within the Company’s Consolidated Statements of Operations as other income.
XML 77 R41.htm IDEA: XBRL DOCUMENT v3.22.4
Organization - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2022
Apr. 01, 2022
Feb. 10, 2010
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Date of commencement of business Mar. 13, 2007          
Initial capital of business $ 1,200,000          
Percentage of initial capital funded by affiliated parties 47.04%          
Stock issued during period, shares       12,511,825 0 0
Stock issued during period, values       $ 226,839 $ 0 $ 0
Shares issued, price per share $ 13.98     $ 13.98    
Stock issued during period, shares, acquisitions       12,294,554 0  
IPO [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Stock issued during period, shares     5,680,000      
Over-Allotment Option [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Share price     $ 18.5      
Private Placement [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Stock issued during period, shares     600,000      
Share price     $ 18.5      
Common Stock [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Stock issued during period, shares 26,650,000          
Stock issued during period, values $ 125,000          
Common Stock [Member] | SUNS Company Merger [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Shares issued, price per share   $ 0.7796        
Stock issued during period, shares, acquisitions   12,511,825        
XML 78 R42.htm IDEA: XBRL DOCUMENT v3.22.4
Significant Accounting Policies - Additional Information (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2022
USD ($)
Property, Plant and Equipment [Line Items]  
Percentage of excise tax 4.00%
Reclassification between accumulated distributable net loss and paid in capital in excess of Par $ 28,991
Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Debt instrument term 60 days
Restricted investment term 90 days
Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Debt instrument term 60 days
Restricted investment term 30 days
XML 79 R43.htm IDEA: XBRL DOCUMENT v3.22.4
Agreements - Additional Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Apr. 01, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Agreement [Line Items]        
Management fees   $ 29,982 $ 28,277 $ 24,951
Administrative fees expense   5,401 5,575 5,215
Performance Based Incentive Fees Waiver   $ 1,527 0 0
Advisory Agreement [Member]        
Agreement [Line Items]        
Pre-incentive fee net investment income Quarter hurdle rate   1.75%    
Pre-incentive fee net investment income Annual hurdle rate   7.00%    
Percentage of cumulative realized capital gain loss   20.00%    
Percentage of cumulative net realized gain and unrealized capital appreciation   20.00%    
Management fees   $ 29,982 28,277 24,951
Performance based incentive fees   15,097 10,309 2,272
Administrative fees expense   $ 5,401 $ 5,575 $ 5,215
Advisory Agreement [Member] | Minimum [Member]        
Agreement [Line Items]        
Percentage of gross assets 1.00% 1.00%    
Percentage of total net assets 200.00% 200.00%    
Percentage of pre-incentive fee net investment income   100.00%    
Advisory Agreement [Member] | Maximum [Member]        
Agreement [Line Items]        
Percentage of gross assets 1.50% 1.50%    
Percentage of total net assets 200.00% 200.00%    
Percentage of pre-incentive fee net investment income   20.00%    
XML 80 R44.htm IDEA: XBRL DOCUMENT v3.22.4
Net Asset Value Per Share - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Net Asset Value Per Share [Abstract]            
Net assets $ 999,731 $ 842,281 $ 852,023 $ 905,880 $ 919,171  
Net asset value per share $ 18.33 $ 19.93 $ 20.16 $ 21.44 $ 21.75 $ 21.81
XML 81 R45.htm IDEA: XBRL DOCUMENT v3.22.4
Earnings Per Share - Summary of Computation of Basic and Diluted Net (Detail) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Earnings per share (basic & diluted)      
Numerator 0net increase in net assets resulting from operations $ 18,342 $ 59,566 $ 15,451
Denominator 0weighted average shares, Basic 51,680,522 42,260,826 42,260,826
Denominator 0weighted average shares, Diluted 51,680,522 42,260,826 42,260,826
Earnings per share, Basic $ 0.35 $ 1.41 $ 0.37
Earnings per share, Diluted $ 0.35 $ 1.41 $ 0.37
XML 82 R46.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Level 3 | 2022 Unsecured Notes    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities   $ 150,000
Recurring Fair Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets $ 2,086,676 1,670,582
Recurring Fair Value | Measured at Net Asset Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets [1] 9,426  
Recurring Fair Value | 2022 Unsecured Notes    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities   150,000
Recurring Fair Value | Senior Secured Loans    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 1,245,414 939,690
Recurring Fair Value | Senior Secured Loans | Measured at Net Asset Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets [1] 0  
Recurring Fair Value | Equipment Financing    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 265,952 273,795
Recurring Fair Value | Equipment Financing | Measured at Net Asset Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets [1] 0  
Recurring Fair Value | Preferred Equity    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 3,801 5,630
Recurring Fair Value | Common Equity/Equity Interests/Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 571,509 451,467
Recurring Fair Value | Common Equity/Equity Interests/Warrants | Measured at Net Asset Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets [1] 9,426  
Recurring Fair Value | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 483 1,086
Recurring Fair Value | Level 1 | 2022 Unsecured Notes    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities   0
Recurring Fair Value | Level 1 | Senior Secured Loans    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Recurring Fair Value | Level 1 | Equipment Financing    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Recurring Fair Value | Level 1 | Preferred Equity    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Recurring Fair Value | Level 1 | Common Equity/Equity Interests/Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 483 1,086
Recurring Fair Value | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Recurring Fair Value | Level 2 | 2022 Unsecured Notes    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities   0
Recurring Fair Value | Level 2 | Senior Secured Loans    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Recurring Fair Value | Level 2 | Equipment Financing    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Recurring Fair Value | Level 2 | Preferred Equity    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Recurring Fair Value | Level 2 | Common Equity/Equity Interests/Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Recurring Fair Value | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 2,076,767 1,669,496
Recurring Fair Value | Level 3 | 2022 Unsecured Notes    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities   150,000
Recurring Fair Value | Level 3 | Senior Secured Loans    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 1,245,414 939,690
Recurring Fair Value | Level 3 | Equipment Financing    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 265,952 273,795
Recurring Fair Value | Level 3 | Preferred Equity    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 3,801 5,630
Recurring Fair Value | Level 3 | Common Equity/Equity Interests/Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets $ 561,600 $ 450,381
[1] In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP. See Note 19 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members.
XML 83 R47.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value - Summary of Changes in Fair Value of Level 3 Assets and Liabilities (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Opening balance $ 1,669,496 $ 1,530,270
Net realized gain (loss) (36,238) 337
Net change in unrealized gain (loss) $ (20,743) (3,358)
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Unrealized Gain (Loss) on Investments  
Purchase of investment securities $ 997,095 610,585
Proceeds from dispositions of investment securities (532,843) (468,221)
Transfers in/out of Level 3 0 (117)
Closing balance 2,076,767 1,669,496
Net change in unrealized gain (loss) $ (21,598) (2,888)
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Unrealized Gain (Loss) on Investments  
Senior Secured Loans    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Opening balance $ 939,690 798,052
Net realized gain (loss) (36,244) 0
Net change in unrealized gain (loss) (8,065) (13,567)
Purchase of investment securities 796,389 533,614
Proceeds from dispositions of investment securities (446,356) (378,409)
Transfers in/out of Level 3 0 0
Closing balance 1,245,414 939,690
Net change in unrealized gain (loss) (8,920) (12,837)
Equipment Financing    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Opening balance 273,795 284,846
Net realized gain (loss) 0 (8)
Net change in unrealized gain (loss) (6,924) 1,394
Purchase of investment securities 84,168 76,700
Proceeds from dispositions of investment securities (85,087) (89,137)
Transfers in/out of Level 3 0 0
Closing balance 265,952 273,795
Net change in unrealized gain (loss) (6,924) 1,394
Preferred Equity    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Opening balance 5,630 6,401
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) (706) (1,042)
Purchase of investment securities 266 271
Proceeds from dispositions of investment securities (1,389) 0
Transfers in/out of Level 3 0 0
Closing balance 3,801 5,630
Net change in unrealized gain (loss) (706) (1,042)
Common Equity/Equity Interests/Warrants    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Opening balance 450,381 440,971
Net realized gain (loss) 6 345
Net change in unrealized gain (loss) (5,048) 9,857
Purchase of investment securities 116,272 0
Proceeds from dispositions of investment securities (11) (675)
Transfers in/out of Level 3 0 (117)
Closing balance 561,600 450,381
Net change in unrealized gain (loss) $ (5,048) $ 9,597
XML 84 R48.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Details) - 2022 Unsecured Notes - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Beginning fair value $ 150,000 $ 150,000
Net realized (gain) loss 0 0
Net change in unrealized (gain) loss 0 0
Borrowings 0 0
Repayments (150,000) 0
Transfers in/out of Level 3 0 0
Ending fair value $ 0 $ 150,000
XML 85 R49.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Parenthetical) (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
SLRCTerm Loan And Credit Facility Member    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Debt Instrument, Fair Value Disclosure $ 393,000  
SPV Credit Facility    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Debt Instrument, Fair Value Disclosure 155,200  
2023 Unsecured Notes    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Debt Instrument, Fair Value Disclosure 75,000  
2024 Unsecured Notes    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Debt Instrument, Fair Value Disclosure 118,750  
2025 Unsecured Notes    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Debt Instrument, Fair Value Disclosure 79,688  
2026 Unsecured Notes    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Debt Instrument, Fair Value Disclosure 68,250  
2027 Unsecured Notes    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Debt Instrument, Fair Value Disclosure 42,875  
2027 Series F Unsecured Notes    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Debt Instrument, Fair Value Disclosure $ 118,125  
Level 3 | 2022 Unsecured Notes    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Notes payable fair value disclosure   $ 150,000
XML 86 R50.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Details) - Level 3 - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Senior Secured Loans | Income Approach | Market Yield      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Assets   $ 1,212,842 $ 931,769
Principal Valuation Technique/Methodology   Income Approach Income Approach
Unobservable Input   Market Yield Market Yield
Senior Secured Loans | Market Multiple | Comparable Multiple      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Assets   $ 32,572 $ 7,921
Principal Valuation Technique/Methodology   Market Multiple Market Multiple
Unobservable Input   Comparable Multiple Comparable Multiple
Equipment Financing | Income Approach | Market Yield      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Assets   $ 145,132 $ 144,693
Principal Valuation Technique/Methodology   Income Approach Income Approach
Unobservable Input   Market Yield Market Yield
Equipment Financing | Market Multiple | Comparable Multiple      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Assets   $ 120,820  
Principal Valuation Technique/Methodology   Market Multiple  
Unobservable Input   Comparable Multiple  
Equipment Financing | Market Approach | Return on Equity      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Assets     $ 129,102
Principal Valuation Technique/Methodology     Market Approach
Unobservable Input     Return on Equity
Preferred Equity | Income Approach | Market Yield      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Assets   $ 3,801 $ 5,630
Principal Valuation Technique/Methodology   Income Approach Income Approach
Unobservable Input Market Yield Market Yield  
Common Equity/Equity Interests/Warrants | Market Multiple | Comparable Multiple      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Assets   $ 149,120 $ 151,615
Principal Valuation Technique/Methodology   Market Multiple Market Multiple
Unobservable Input   Comparable Multiple Comparable Multiple
Common Equity/Equity Interests/Warrants | Market Approach | Return on Equity      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Assets   $ 412,480 $ 298,766
Principal Valuation Technique/Methodology   Market Approach Market Approach
Unobservable Input   Return on Equity Return on Equity
2022 Unsecured Notes | Income Approach | Market Yield      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Assets     $ 150,000
Principal Valuation Technique/Methodology     Income Approach
Unobservable Input Market Yield    
XML 87 R51.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Parenthetical) (Details)
$ in Thousands
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Measurement Input, EBITDA Multiple [Member] | Level 3    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 148,444 $ 151,212
Black Scholes Pricing Model [Member] | Level 3    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value 676 403
Senior Secured Loans | Income Approach | Market Yield | Level 3    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 1,212,842 $ 931,769
Senior Secured Loans | Income Approach | Market Yield | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 9.4 4
Senior Secured Loans | Income Approach | Market Yield | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 18.2 19.6
Senior Secured Loans | Income Approach | Market Yield | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 12 8.7
Senior Secured Loans | Market Multiple | Comparable Multiple | Level 3    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 32,572 $ 7,921
Senior Secured Loans | Market Multiple | Comparable Multiple | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 0.1  
Senior Secured Loans | Market Multiple | Comparable Multiple | Minimum [Member] | Measurement Input, EBITDA Multiple [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input   2
Senior Secured Loans | Market Multiple | Comparable Multiple | Minimum [Member] | Black Scholes Pricing Model [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input   2
Senior Secured Loans | Market Multiple | Comparable Multiple | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 21.4  
Senior Secured Loans | Market Multiple | Comparable Multiple | Maximum [Member] | Measurement Input, EBITDA Multiple [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input   3
Senior Secured Loans | Market Multiple | Comparable Multiple | Maximum [Member] | Black Scholes Pricing Model [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input   3
Senior Secured Loans | Market Multiple | Comparable Multiple | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 12.4  
Senior Secured Loans | Market Multiple | Comparable Multiple | Weighted Average [Member] | Measurement Input, EBITDA Multiple [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input   2.5
Senior Secured Loans | Market Multiple | Comparable Multiple | Weighted Average [Member] | Black Scholes Pricing Model [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input   2.5
Equipment Financing | Income Approach | Market Yield | Level 3    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 145,132 $ 144,693
Equipment Financing | Income Approach | Market Yield | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 8.5 7.1
Equipment Financing | Income Approach | Market Yield | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 9.7 20.3
Equipment Financing | Income Approach | Market Yield | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 9.7 9.8
Equipment Financing | Market Multiple | Comparable Multiple | Level 3    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 120,820  
Equipment Financing | Market Multiple | Comparable Multiple | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 1.1  
Equipment Financing | Market Multiple | Comparable Multiple | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 1.4  
Equipment Financing | Market Multiple | Comparable Multiple | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 1.2  
Equipment Financing | Market Approach | Return on Equity | Level 3    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value   $ 129,102
Equipment Financing | Market Approach | Return on Equity | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input   4.6
Equipment Financing | Market Approach | Return on Equity | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input   4.6
Equipment Financing | Market Approach | Return on Equity | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input   4.6
Preferred Equity | Income Approach | Market Yield | Level 3    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 3,801 $ 5,630
Preferred Equity | Income Approach | Market Yield | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 5 3.5
Preferred Equity | Income Approach | Market Yield | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 5 8
Preferred Equity | Income Approach | Market Yield | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 5 4.4
2022 Unsecured Notes | Income Approach | Market Yield | Level 3    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value   $ 150,000
2022 Unsecured Notes | Income Approach | Market Yield | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long-term Debt, Measurement Input   2.2
2022 Unsecured Notes | Income Approach | Market Yield | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long-term Debt, Measurement Input   4.6
2022 Unsecured Notes | Income Approach | Market Yield | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long-term Debt, Measurement Input   4.5
Common Equity/Equity Interests/Warrants | Market Multiple | Comparable Multiple | Level 3    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 149,120 $ 151,615
Common Equity/Equity Interests/Warrants | Market Multiple | Comparable Multiple | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 7.8 5.8
Common Equity/Equity Interests/Warrants | Market Multiple | Comparable Multiple | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 9.8 10.5
Common Equity/Equity Interests/Warrants | Market Multiple | Comparable Multiple | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 8.8 9.5
Common Equity/Equity Interests/Warrants | Market Approach | Return on Equity | Level 3    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 412,480 $ 298,766
Common Equity/Equity Interests/Warrants | Market Approach | Return on Equity | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 6.6 6.1
Common Equity/Equity Interests/Warrants | Market Approach | Return on Equity | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 35.2 18.5
Common Equity/Equity Interests/Warrants | Market Approach | Return on Equity | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 9.2 8.6
XML 88 R52.htm IDEA: XBRL DOCUMENT v3.22.4
Debt - Schedule of Long-term Debt Instruments (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Debt Instrument [Line Items]    
Face Amount $ 1,093,200 $ 818,500
Total 1,085,998 812,038
Credit Facility    
Debt Instrument [Line Items]    
Face Amount 393,000 322,500
Credit Facility, Carrying Value 388,254 318,015
SPV Credit Facility    
Debt Instrument [Line Items]    
Face Amount 155,200 0
SPV Credit Facility, Carrying Value 154,302 0
2022 Unsecured Notes    
Debt Instrument [Line Items]    
Face Amount 0 150,000
Unsecured Debt 0 150,000
2022 Tranche C Notes    
Debt Instrument [Line Items]    
Face Amount 0 21,000
Unsecured Debt 0 20,964
2023 Unsecured Notes    
Debt Instrument [Line Items]    
Face Amount 75,000 75,000
Unsecured Debt 74,979 74,592
2024 Unsecured Notes    
Debt Instrument [Line Items]    
Face Amount 125,000 125,000
Unsecured Debt 124,421 124,143
2025 Unsecured Notes    
Debt Instrument [Line Items]    
Face Amount 85,000 0
Unsecured Debt 84,613 0
2026 Unsecured Notes    
Debt Instrument [Line Items]    
Face Amount 75,000 75,000
Unsecured Debt 74,498 74,384
2027 Unsecured Notes    
Debt Instrument [Line Items]    
Face Amount 50,000 50,000
Unsecured Debt 49,953 49,940
2027 Series F Unsecured Notes    
Debt Instrument [Line Items]    
Face Amount 135,000 0
Unsecured Debt $ 134,978 $ 0
XML 89 R53.htm IDEA: XBRL DOCUMENT v3.22.4
Debt - Schedule of Long-term Debt Instruments (Parenthetical) (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Credit Facility    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs $ 4,746 $ 4,485
SPV Credit Facility    
Debt Instrument [Line Items]    
Debt Instrument, Unamortized Discount 898  
2022 Tranche C Notes    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs   36
2023 Unsecured Notes    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs 21 408
2024 Unsecured Notes    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs 579 857
2025 Unsecured Notes    
Debt Instrument [Line Items]    
Debt Instrument, Unamortized Discount 387  
2026 Unsecured Notes    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs 502 616
2027 Unsecured Notes    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs 47 $ 60
2027 Series F Unsecured Notes    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs $ 22  
XML 90 R54.htm IDEA: XBRL DOCUMENT v3.22.4
Debt - Additional Information (Details) - USD ($)
4 Months Ended 11 Months Ended 12 Months Ended 14 Months Ended 49 Months Ended
Dec. 31, 2021
Dec. 31, 2019
Dec. 31, 2011
Dec. 31, 2017
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2017
Dec. 31, 2021
Jun. 30, 2022
Apr. 01, 2022
Jan. 06, 2022
Dec. 28, 2021
Sep. 14, 2021
Dec. 18, 2019
Dec. 28, 2017
Nov. 22, 2017
Feb. 15, 2017
Nov. 08, 2016
Aug. 26, 2011
Debt Instrument [Line Items]                                      
Debt instrument face value $ 818,500,000       $ 1,093,200,000 $ 818,500,000   $ 818,500,000                      
Debt instrument payment terms Interest on the 2022 Tranche C Notes is due semi-annually on June 28 and December 28                                    
Long term debt weighted average interest over a period of time         4.09% 3.64%                          
Long term debt maximum amount borrowed during the period         $ 1,164,200,000 $ 902,550,000                          
Credit Facility One [Member]                                      
Debt Instrument [Line Items]                                      
Debt instrument face value         $ 85,000,000         $ 85,000,000                  
Long term debt term         5 years                            
Debt instrument maturity date         Mar. 31, 2025                            
Debt instrument payment terms         Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30                            
Debt instrument stated interest rate percentage         3.90%                            
Line of credit $ 0       $ 154,302,000 0   0                      
Two Thousand And Twenty Seven Series F Unsecured Notes [Member]                                      
Debt Instrument [Line Items]                                      
Debt instrument face value         $ 135,000,000           $ 135,000,000                
Debt instrument maturity date         Jan. 06, 2027                            
Debt instrument payment terms         Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6                            
Debt instrument stated interest rate percentage         3.33%                            
Two Thousand And Twenty Four Unsecured Notes [Member]                                      
Debt Instrument [Line Items]                                      
Debt instrument face value 125,000,000       $ 125,000,000 125,000,000   125,000,000           $ 125,000,000          
Debt instrument maturity date   Dec. 15, 2024                                  
Debt instrument payment terms         Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15                            
Debt instrument stated interest rate percentage         4.20%                            
Two Thousand And Twenty Six Unsecured Notes [Member]                                      
Debt Instrument [Line Items]                                      
Debt instrument face value $ 75,000,000       $ 75,000,000 $ 75,000,000   $ 75,000,000           $ 75,000,000          
Debt instrument stated interest rate percentage 4.375%       4.375% 4.375%   4.375%                      
Two Thousand And Twenty Two Tranche C Notes [Member]                                      
Debt Instrument [Line Items]                                      
Debt instrument face value $ 21,000,000       $ 21,000,000 $ 21,000,000   $ 21,000,000             $ 21,000,000        
Debt instrument maturity date   Dec. 15, 2026                                  
Debt instrument stated interest rate percentage 4.50%       4.50% 4.50%   4.50%                      
Two Thousand And Twenty Two Tranche C Notes [Member] | Tranche One [Member]                                      
Debt Instrument [Line Items]                                      
Debt instrument face value $ 100,000,000       $ 100,000,000 $ 100,000,000   $ 100,000,000                 $ 100,000,000    
Debt instrument maturity date       May 08, 2022                              
Debt instrument payment terms       Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8                              
Debt instrument stated interest rate percentage 4.60%         4.60%   4.60% 4.60%                    
Two Thousand And Twenty Two Tranche C Notes [Member] | Tranche Two [Member]                                      
Debt Instrument [Line Items]                                      
Debt instrument face value $ 50,000,000       50,000,000 $ 50,000,000   $ 50,000,000                   $ 50,000,000  
Debt instrument payment terms             Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8                        
Debt instrument stated interest rate percentage 4.40%         4.40%   4.40% 4.40%                    
Two Thousand And Twenty Three Unsecured Notes [Member]                                      
Debt Instrument [Line Items]                                      
Debt instrument face value $ 75,000,000       $ 75,000,000 $ 75,000,000   $ 75,000,000               $ 75,000,000      
Debt instrument maturity date               Jan. 20, 2023                      
Debt instrument payment terms               semi-annually on January 20 and July 20                      
Debt instrument stated interest rate percentage 4.50%       4.50% 4.50%   4.50%                      
Proceeds from net debt               $ 73,846,000                      
Term Loan And Credit Facility [Member]                                      
Debt Instrument [Line Items]                                      
Line of credit and term loan outstanding $ 318,015,000       $ 388,254,000 $ 318,015,000   $ 318,015,000                      
Term Loan And Credit Facility [Member] | SPV LLC [Member] | Citi Bank NA [Member]                                      
Debt Instrument [Line Items]                                      
Debt instrument maturity date         Jun. 01, 2026                            
Line of credit and term loan outstanding         $ 155,200,000                            
Line of credit maximum borrowing capacity and debt instrument face value                       $ 800,000,000              
Term Loan And Credit Facility [Member] | SPV LLC [Member] | Citi Bank NA [Member] | Line of Credit [Member]                                      
Debt Instrument [Line Items]                                      
Line of credit facility, maximum borrowing capacity                       625,000,000              
Other long term debt         293,000,000                            
Term Loan And Credit Facility [Member] | SPV LLC [Member] | Citi Bank NA [Member] | Term Loan [Member]                                      
Debt Instrument [Line Items]                                      
Debt instrument face value                       $ 100,000,000              
Line of credit         100,000,000                            
Term Loan And Credit Facility [Member] | Credit Facility [Member] | Citi Bank NA [Member]                                      
Debt Instrument [Line Items]                                      
Line of credit and term loan outstanding         $ 393,000,000                            
Term Loan And Credit Facility [Member] | Maximum [Member] | SPV LLC [Member] | Citi Bank NA [Member]                                      
Debt Instrument [Line Items]                                      
Line of credit facility, maximum borrowing capacity                                     $ 600,000,000
Debt instrument variable interest rate spread (1.00%)       (2.00%)                            
Term Loan And Credit Facility [Member] | Maximum [Member] | London Interbank Offered Rate (LIBOR) [Member] | Citi Bank NA [Member]                                      
Debt Instrument [Line Items]                                      
Debt instrument variable interest rate spread     (2.50%)                                
Term Loan And Credit Facility [Member] | Minimum [Member] | SPV LLC [Member] | Citi Bank NA [Member]                                      
Debt Instrument [Line Items]                                      
Line of credit facility, maximum borrowing capacity                                     $ 225,000,000
Debt instrument variable interest rate spread 0.75%       1.75%                            
Term Loan And Credit Facility [Member] | Minimum [Member] | London Interbank Offered Rate (LIBOR) [Member] | Citi Bank NA [Member]                                      
Debt Instrument [Line Items]                                      
Debt instrument variable interest rate spread     2.00%                                
Two Thousand And Twenty Seven Unsecured Notes [Member]                                      
Debt Instrument [Line Items]                                      
Debt instrument face value         $ 50,000,000               $ 50,000,000            
Debt instrument stated interest rate percentage 2.95%       2.95% 2.95%   2.95%                      
XML 91 R55.htm IDEA: XBRL DOCUMENT v3.22.4
Income Tax Information and Distributions to Stockholders and Other Tax Information - Summary of distributions to shareholders (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Schedule of Investments [Line Items]      
Ordinary income $ 50,113 $ 41,221 $ 48,795
Capital gains 0 0 0
Return of capital 27,099 28,087 20,513
Distribution recognized in subsequent year 7,481 0 0
Total distributions $ 84,693 $ 69,308 $ 69,308
Ordinary income percent 59.20% 59.50% 70.40%
Capital gains percent 0.00% 0.00% 0.00%
Return of capital percent 32.00% 40.50% 29.60%
Distribution recognized in subsequent year percent 8.80% 0.00% 0.00%
Total distributions percent 100.00% 100.00% 100.00%
XML 92 R56.htm IDEA: XBRL DOCUMENT v3.22.4
Income Tax Information and Distributions to Stockholders and Other Tax Information - Summary of total accumulated earnings (loss) on a tax basis (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Investments, Owned, Federal Income Tax Note [Line Items]      
Undistributed ordinary income $ 0 $ 0 $ 0
Undistributed long-term net capital gains 0 0 0
Total undistributed net earnings 0 0 0
Post-October capital losses 0 0 0
Capital loss carryforward (127,348) (68,857) (69,384)
Other book/tax temporary differences (53,223) 2,332 2,168
Net unrealized appreciation 17,187 19,495 4,446
Total tax accumulated loss $ (163,384) $ (47,030) $ (62,770)
XML 93 R57.htm IDEA: XBRL DOCUMENT v3.22.4
Income Tax Information and Distributions to Stockholders and Other Tax Information - Additional information (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2022
USD ($)
Dec. 31, 2021
Dec. 31, 2020
Schedule of Investments [Line Items]      
uncertain tax positions $ 0    
Unrecognized Tax Benefits $ 0    
Operating Loss Carryforwards, Limitations on Use The capital loss carryforwards shown above do not expire    
Investment Company,Dividend Distribution, eligible for qualified dividend income treatment or the dividends received deduction for corporate stockholders Percent 0 0.32 0.1
Investment Company,Dividend Distribution, interest-related dividends Percent 88.05 93.05 92.05
Investment Company, Dividend Distribution, short-term capital gains, Percent 0 0 0
XML 94 R58.htm IDEA: XBRL DOCUMENT v3.22.4
Financial Highlights - Schedule of Financial Highlights (Details)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2022
USD ($)
shares
$ / shares
Dec. 31, 2021
USD ($)
shares
$ / shares
Dec. 31, 2020
USD ($)
shares
$ / shares
Dec. 31, 2019
USD ($)
shares
$ / shares
Dec. 31, 2018
USD ($)
shares
$ / shares
Per Share Data:          
Net asset value, beginning of year $ 19.93 $ 20.16 $ 21.44 $ 21.75 $ 21.81
Net asset value, end of period 13.91 18.43 17.51 20.62 19.19
Net investment income 1.48 1.44 1.4 1.71 1.77
Net realized and unrealized loss (1.13) (0.03) (1.04) (0.38) (0.19)
Net increase in net assets resulting from operations 0.35 1.41 0.36 1.33 1.58
Issuance of common stock in connection with the Mergers $ (0.33) $ 0 $ 0 $ 0 $ 0
Anti-dilution | shares 0.02 0 0 0 0
From distributable earnings $ (1.12) $ (0.98) $ (1.15) $ (1.55) $ (1.64)
From return of capital (0.52) (0.66) (0.49) (0.09) 0
Net asset value, end of period $ 18.33 $ 19.93 $ 20.16 $ 21.44 $ 21.75
Total Return(b) (16.09%) 14.66% (5.72%) 16.22% 2.77%
Net assets, end of period | $ $ 999,731 $ 842,281 $ 852,023 $ 905,880 $ 919,171
Shares outstanding, end of period | shares 54,555,380 42,260,826 42,260,826 42,260,826 42,260,826
Ratios to average net assets:          
Net investment income 7.76% 7.13% 6.93% 7.83% 8.10%
Operating expenses 5.60% 5.68% 4.14% 5.76% 5.83%
Interest and other credit facility expenses 4.68% 3.50% 3.18% 3.13% 2.67%
Total expenses 10.28% 9.18% 7.32% 8.89% 8.50%
Average debt outstanding | $ $ 994,578 $ 703,670 $ 556,104 $ 561,249 $ 508,445
Portfolio turnover ratio 27.40% 29.90% 26.00% 24.10% 39.30%
XML 95 R59.htm IDEA: XBRL DOCUMENT v3.22.4
Financial Highlights - Schedule of Financial Highlights (Parentheticals) (Details)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Investment Company, Financial Highlights [Abstract]    
Investment company, expense ratio excluding incentive fee 5.75% 10.43%
XML 96 R60.htm IDEA: XBRL DOCUMENT v3.22.4
SLR Credit Solutions - Additional Information (Details)
$ in Thousands
12 Months Ended
Jul. 28, 2016
USD ($)
Dec. 28, 2012
USD ($)
Nov. 30, 2012
USD ($)
loans
Dec. 31, 2022
USD ($)
fund
issuers
Dec. 31, 2021
USD ($)
issuers
fund
Dec. 31, 2020
USD ($)
Number of issuers in business credit | issuers       108 125  
Assets       $ 2,537,695 $ 2,011,011  
Non-recourse debt       1,085,998 812,038  
Revolving Credit Facility [Member]            
Line of credit facility, maximum borrowing capacity   $ 275,000        
Crystal Financial [Member]            
Line of credit facility, maximum borrowing capacity     $ 400,000      
SLR Business Credit Facility [Member]            
Line of credit facility, maximum borrowing capacity       $ 33,420 $ 35,000  
Business combination, consideration transferred $ 5,737          
Number of funded commitments | fund       29 22  
Number of issuers in business credit | issuers       25 19  
Long-term line of credit       $ 439,484 $ 287,375  
Assets       460,683 347,821  
Line of credit facility average outstanding amount       17,579 15,125  
Net income (loss)        7,521 14,164 $ 23,293
Gross income       30,324 33,993 $ 45,315
Non-recourse debt       224,325 $ 100,742  
SLR Business Credit Facility [Member] | Revolving Credit Facility [Member]            
Line of credit facility commitments amount       $ 285,000    
SLR Business Credit Facility [Member] | Crystal Financial [Member]            
Payment to acquire business   $ 275,000        
Equity method investment, ownership percentage 2.00% 98.00%        
Number of loans in business credit | loans     23      
SLR Business Credit Facility [Member] | Crystal Capital Financial Holdings LLC [Member]            
Equity method investment, ownership percentage 100.00%          
XML 97 R61.htm IDEA: XBRL DOCUMENT v3.22.4
Commitments and Contingencies - Additional Information (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Oct. 12, 2022
Dec. 31, 2021
Other Commitments [Line Items]      
Other Commitment $ 323,663   $ 226,733
Unfunded Debt and Equity Commitments [Member]      
Other Commitments [Line Items]      
Other Commitment 323,663   $ 226,733
Unfunded Debt and Equity Commitments [Member] | SLR Senior Lending Program LLC [Member]      
Other Commitments [Line Items]      
Other Commitment $ 40,500 $ 100,000  
XML 98 R62.htm IDEA: XBRL DOCUMENT v3.22.4
Commitments and Contingencies - Summary of Unfunded Debt and Equity Commitments (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Other Commitments [Line Items]    
Other Commitment $ 323,663 $ 226,733
Unfunded Debt and Equity Commitments [Member]    
Other Commitments [Line Items]    
Other Commitment 323,663 226,733
Unfunded Debt and Equity Commitments [Member] | SLR Credit Solutions [Member]    
Other Commitments [Line Items]    
Other Commitment [1] 44,263 44,263
Unfunded Debt and Equity Commitments [Member] | Outset Medical, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 35,084 0
Unfunded Debt and Equity Commitments [Member] | Apeel Technology, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 32,786 0
Unfunded Debt and Equity Commitments [Member] | CC SAG Holdings Corp. (Spectrum Automotive) [Member]    
Other Commitments [Line Items]    
Other Commitment 20,670 18,827
Unfunded Debt and Equity Commitments [Member] | Human Interest, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 20,104 0
Unfunded Debt and Equity Commitments [Member] | Glooko, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 17,868 25,091
Unfunded Debt and Equity Commitments [Member] | World Insurance Associates, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 17,117 0
Unfunded Debt and Equity Commitments [Member] | iCIMS, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 11,435 0
Unfunded Debt and Equity Commitments [Member] | Spectrum Pharmaceuticals, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 8,771 0
Unfunded Debt and Equity Commitments [Member] | Arcutis Biotherapeutics, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 8,356 43,470
Unfunded Debt and Equity Commitments [Member] | Atria Wealth Solutions, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 8,215 3,746
Unfunded Debt and Equity Commitments [Member] | Ardelyx, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 7,752 0
Unfunded Debt and Equity Commitments [Member] | Luxury Asset Capital, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 7,500 0
Unfunded Debt and Equity Commitments [Member] | RSC Acquisition, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 7,498 0
Unfunded Debt and Equity Commitments [Member] | Cerapedics, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 6,735 0
Unfunded Debt and Equity Commitments [Member] | Maurices, Incorporated [Member]    
Other Commitments [Line Items]    
Other Commitment 4,314 5,649
Unfunded Debt and Equity Commitments [Member] | Kaseya, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 3,936 0
Unfunded Debt and Equity Commitments [Member] | Vessco Midco Holdings, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 3,892 0
Unfunded Debt and Equity Commitments [Member] | Copper River Seafoods, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 3,595 0
Unfunded Debt and Equity Commitments [Member] | BDG Media, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 3,546 0
Unfunded Debt and Equity Commitments [Member] | Meditrina, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 3,367 0
Unfunded Debt and Equity Commitments [Member] | One Touch Direct, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 3,069 7,226
Unfunded Debt and Equity Commitments [Member] | DeepIntent, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 3,049 0
Unfunded Debt and Equity Commitments [Member] | Foundation Consumer Brands, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 3,009 2,269
Unfunded Debt and Equity Commitments [Member] | SCP Eye Care, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 2,771 0
Unfunded Debt and Equity Commitments [Member] | Basic Fun, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 2,675 1,935
Unfunded Debt and Equity Commitments [Member] | Kid Distro Holdings, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 2,650 2,650
Unfunded Debt and Equity Commitments [Member] | Plastics Management, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 2,424 0
Unfunded Debt and Equity Commitments [Member] | Southern Orthodontic Partners Management, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 1,918 0
Unfunded Debt and Equity Commitments [Member] | Pediatric Home Respiratory Services, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 1,805 0
Unfunded Debt and Equity Commitments [Member] | Pinnacle Treatment Centers, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 1,745 1,414
Unfunded Debt and Equity Commitments [Member] | Ultimate Baked Goods Midco LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 1,636 801
Unfunded Debt and Equity Commitments [Member] | Orthopedic Care Partners Management, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 1,620 0
Unfunded Debt and Equity Commitments [Member] | Ivy Fertility Services, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 1,571 4,532
Unfunded Debt and Equity Commitments [Member] | Composite Technology Acquisition Corp [Member]    
Other Commitments [Line Items]    
Other Commitment 1,537 0
Unfunded Debt and Equity Commitments [Member] | NAC Holdings Corporation [Member]    
Other Commitments [Line Items]    
Other Commitment 1,479 4,765
Unfunded Debt and Equity Commitments [Member] | SLR Healthcare ABL [Member]    
Other Commitments [Line Items]    
Other Commitment [1] 1,400 0
Unfunded Debt and Equity Commitments [Member] | SPAR Marketing Force, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 1,338 0
Unfunded Debt and Equity Commitments [Member] | RxSense Holdings LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 1,250 0
Unfunded Debt and Equity Commitments [Member] | Erie Construction Mid-west, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 1,248 0
Unfunded Debt and Equity Commitments [Member] | Peter C. Foy & Associates Insurance Services, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 1,094 0
Unfunded Debt and Equity Commitments [Member] | American Teleconferencing Services, Ltd. [Member]    
Other Commitments [Line Items]    
Other Commitment 1,090 573
Unfunded Debt and Equity Commitments [Member] | Montefiore Nyack Hospital [Member]    
Other Commitments [Line Items]    
Other Commitment 1,034 0
Unfunded Debt and Equity Commitments [Member] | Enverus Holdings, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 1,004 0
Unfunded Debt and Equity Commitments [Member] | SLR Equipment Finance [Member]    
Other Commitments [Line Items]    
Other Commitment 1,000 5,000
Unfunded Debt and Equity Commitments [Member] | GSM Acquisition Corp [Member]    
Other Commitments [Line Items]    
Other Commitment 784 0
Unfunded Debt and Equity Commitments [Member] | SunMed Group Holdings, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 843 828
Unfunded Debt and Equity Commitments [Member] | Tilley Distribution, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 525 0
Unfunded Debt and Equity Commitments [Member] | BayMark Health Services, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 391 0
Unfunded Debt and Equity Commitments [Member] | High Street Buyer, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 327 0
Unfunded Debt and Equity Commitments [Member] | ENS Holdings III Corp, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 144 0
Unfunded Debt and Equity Commitments [Member] | All State Ag Parts, LLC    
Other Commitments [Line Items]    
Other Commitment 135 0
Unfunded Debt and Equity Commitments [Member] | BridgeBio Pharma, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 0 23,049
Unfunded Debt and Equity Commitments [Member] | Inszone Mid, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 0 12,465
Unfunded Debt and Equity Commitments [Member] | Rezolute, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 0 5,675
Unfunded Debt and Equity Commitments [Member] | SOC Telemed, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 0 4,448
Unfunded Debt and Equity Commitments [Member] | RQM+ Corp. [Member]    
Other Commitments [Line Items]    
Other Commitment 0 3,818
Unfunded Debt and Equity Commitments [Member] | MMIT Holdings, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 0 2,009
Unfunded Debt and Equity Commitments [Member] | Neuronetics, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 0 2,230
Unfunded Debt and Equity Commitments [Member] | TAUC Management, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment $ 294 $ 0
[1] The Company controls the funding of the SLR Credit Solutions and SLR Healthcare ABL commitments and may cancel them at its discretion.
XML 99 R63.htm IDEA: XBRL DOCUMENT v3.22.4
SLR Equipment Finance - Additional Information (Details)
$ in Thousands
12 Months Ended
Sep. 30, 2019
USD ($)
Dec. 31, 2022
USD ($)
Customers
Dec. 31, 2021
USD ($)
Customers
Dec. 31, 2020
USD ($)
Jul. 31, 2017
USD ($)
Schedule of Equity Method Investments [Line Items]          
Non-recourse debt   $ 1,085,998 $ 812,038    
SLR Equipment Finance [Member]          
Schedule of Equity Method Investments [Line Items]          
Equity method investment, ownership percentage         100.00%
Equity method investment, aggregate cost         $ 209,866
Equity method investment aggregate equity investment         145,000
Equity method investment aggregate investment in investee leases and loans held         64,866
Line of credit facility, maximum borrowing capacity $ 213,957       150,000
Line of credit facility maximum borrowing capacity with accordion feature $ 313,957       $ 250,000
Number of funded equipment-backed leases and loans   131 135    
Number of Customers | Customers   59 61    
Net investment in lease   $ 190,830 $ 210,986    
Assets under lease   241,813 264,007    
Equipment backed leases and loans largest position outstanding   19,259 19,207    
Equipment backed leases and loans average exposure per customer   3,234 3,459    
Non-recourse debt   114,977 118,002    
Net income   2,867 9,729 $ 8,883  
Gross income   $ 20,380 $ 22,931 $ 24,512  
Line of credit facility, expiration date Jul. 31, 2023        
XML 100 R64.htm IDEA: XBRL DOCUMENT v3.22.4
Capital Share Transactions - Additional Information (Details) - $ / shares
Dec. 31, 2022
Dec. 31, 2021
Stockholders' Equity Note [Abstract]    
Shares authorized 200,000,000 200,000,000
Par value $ 0.01 $ 0.01
XML 101 R65.htm IDEA: XBRL DOCUMENT v3.22.4
Capital Share Transactions - Summary of Transactions In Capital Stock (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Shares   12,294,554 0  
Amount   $ 223,801 $ 0  
Shares repurchased, Shares   (217,271) 0 0
Shares repurchased, Value $ (3,038) $ (3,038) $ 0 $ 0
Shares issued in connection with the Mergers [Member]        
Shares   12,511,825 0  
Amount   $ 226,839 $ 0  
XML 102 R66.htm IDEA: XBRL DOCUMENT v3.22.4
Kingsbridge Holdings, LLC - Additional Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Nov. 03, 2020
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Proceeds from unsecured borrowings   $ 134,914 $ 49,936 $ 0
Total assets   2,537,695 2,011,011  
Non-recourse debt   1,085,998 812,038  
KBHT [Member]        
Total assets   777,151 738,425  
Kingsbridge Holdings, LLC [Member]        
Equity method investments $ 216,596      
Payments to acquire investments 136,596      
Proceeds from unsecured borrowings $ 80,000      
Recourse debt   222,094 216,881  
Non-recourse debt   353,128 323,844  
Net income (loss)    13,287 12,151 2,170
Gross income   $ 298,760 $ 245,889 $ 43,618
Maximum [Member] | Kingsbridge Holdings, LLC [Member]        
Equity method investment, ownership percentage 87.50%      
Minimum [Member] | Kingsbridge Holdings, LLC [Member]        
Equity method investment, ownership percentage 12.50%      
XML 103 R67.htm IDEA: XBRL DOCUMENT v3.22.4
SLR Healthcare ABL - Additional Information (Details)
$ in Thousands
12 Months Ended
Jun. 28, 2019
USD ($)
May 27, 2016
USD ($)
Sep. 30, 2013
USD ($)
Dec. 31, 2022
USD ($)
issuers
Dec. 31, 2021
USD ($)
issuers
Dec. 31, 2020
USD ($)
Sep. 30, 2022
Jun. 27, 2014
USD ($)
Mar. 31, 2014
USD ($)
Commitments and contingencies              
Total assets       $ 2,537,695 $ 2,011,011        
Number of issuers in business credit | issuers       108 125        
SLR Healthcare ABL Credit [Member]                  
Line of credit facility, maximum borrowing capacity $ 125,000     $ 77,000 $ 60,000        
Debt instrument term     4 years            
Line of credit facility, expiration date Jun. 28, 2023 May 27, 2020              
Total assets       $ 108,705 $ 91,275        
Number of issuers in business credit | issuers       41 36        
Long-term line of credit       $ 2,253 $ 2,267        
Net income (loss)        3,475 662 $ 4,289      
Gross income       11,593 10,052 $ 10,367      
Senior Secured Commitments [Member]                  
Commitments and contingencies       242,106 183,501        
Senior Secured Commitments [Member] | SLR Healthcare ABL Credit [Member]                  
Commitment funded amount       $ 92,383 $ 81,604        
Maximum [Member]                  
Debt instrument term       60 days          
Maximum [Member] | SLR Healthcare ABL Credit [Member]                  
Line of credit facility, maximum borrowing capacity   $ 200,000 $ 150,000         $ 110,000  
Minimum [Member]                  
Debt instrument term       60 days          
Minimum [Member] | SLR Healthcare ABL Credit [Member]                  
Line of credit facility, maximum borrowing capacity   $ 125,000 100,000           $ 105,000
SLR Healthcare ABL [Member]                  
Equity method investments     $ 32,839            
SLR Healthcare ABL [Member] | Maximum [Member]                  
Equity method investment, ownership percentage             93.00%    
SLR Healthcare ABL [Member] | Minimum [Member]                  
Equity method investment, ownership percentage             7.00%    
XML 104 R68.htm IDEA: XBRL DOCUMENT v3.22.4
SLR Business Credit - Additional Information (Details)
$ in Thousands
12 Months Ended
Jun. 03, 2021
USD ($)
Dec. 31, 2022
USD ($)
issuers
Dec. 31, 2021
USD ($)
issuers
Dec. 31, 2020
USD ($)
Jun. 28, 2019
USD ($)
May 01, 2018
Oct. 20, 2017
USD ($)
SLR Business Credit [Line Items]              
Commitments and contingencies          
Assets   $ 2,537,695 $ 2,011,011        
Number of issuers in business credit | issuers   108 125        
SLR Business Credit [Member]              
SLR Business Credit [Line Items]              
Long-term line of credit   $ 2,648 $ 1,989        
Net income   3,941 7,295 $ 4,512      
Gross income   29,433 24,021 $ 19,715      
Senior Secured Commitments [Member]              
SLR Business Credit [Line Items]              
Commitments and contingencies   242,106 183,501        
Senior Secured Commitments [Member] | SLR Business Credit [Member]              
SLR Business Credit [Line Items]              
Commitments and contingencies   603,432 513,869        
Commitment funded amount   286,006 248,652        
Assets   332,247 290,794        
Fast Pay Partners LLC [Member]              
SLR Business Credit [Line Items]              
Percentage of voting interests acquired 100.00%            
Business combination, consideration transferred $ 66,671            
NMCs Credit Facility [Member]              
SLR Business Credit [Line Items]              
Line of credit facility, maximum borrowing capacity 47,671       $ 15,500    
SUNS [Member]              
SLR Business Credit [Line Items]              
Line of credit facility, maximum borrowing capacity $ 19,000            
NMC Senior Credit Facility [Member]              
SLR Business Credit [Line Items]              
Line of credit facility, maximum borrowing capacity   285,307          
Long-term line of credit   $ 214,425 $ 183,252        
Line of credit facility, expiration date   Nov. 13, 2025          
NM Holdco [Member]              
SLR Business Credit [Line Items]              
Percentage of equity interest contributed to another entity         99.00%    
North Mill Capital LLC [Member]              
SLR Business Credit [Line Items]              
Equity method investment, ownership percentage           99.00% 100.00%
Equity method investments             $ 51,000
ESP SSC Corporation [Member]              
SLR Business Credit [Line Items]              
Equity method investment, ownership percentage           1.00% 1.00%
Summit Financial Resources [Member]              
SLR Business Credit [Line Items]              
Equity method investment, ownership percentage         100.00%    
XML 105 R69.htm IDEA: XBRL DOCUMENT v3.22.4
Merger with SUNS - Additional Information (Details)
12 Months Ended
Apr. 01, 2022
basispoints
$ / shares
shares
Dec. 31, 2022
$ / shares
shares
Dec. 31, 2021
shares
Merger With Suns [Line Items]      
Shares issued, price per share | $ / shares   $ 13.98  
Stock issued during period, shares, acquisitions | shares   12,294,554 0
Number of basis points | basispoints 25    
Minimum [Member] | Advisory Agreement [Member]      
Merger With Suns [Line Items]      
Percentage of gross assets 1.00% 1.00%  
Percentage of total net assets 200.00% 200.00%  
Maximum [Member] | Advisory Agreement [Member]      
Merger With Suns [Line Items]      
Percentage of gross assets 1.50% 1.50%  
Percentage of total net assets 200.00% 200.00%  
Common Stock [Member] | SUNS Company Merger [Member]      
Merger With Suns [Line Items]      
Shares issued, price per share | $ / shares $ 0.7796    
Stock issued during period, shares, acquisitions | shares 12,511,825    
XML 106 R70.htm IDEA: XBRL DOCUMENT v3.22.4
Merger with SUNS - Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger (Detail) - SUNS Company Merger [Member]
$ in Thousands
Dec. 31, 2022
USD ($)
Business Acquisition [Line Items]  
Common stock issued by the Company $ 227,602 [1]
Assets acquired:  
Investments, at fair value 400,105
Cash 2,313
Other assets 4,662
Total assets acquired 407,080
Liabilities assumed:  
Debt, at fair value 159,816
Other liabilities 2,573
Total liabilities assumed 162,389
Net assets acquired 244,691
Total purchase discount $ (17,089)
[1] Based on the market price at closing of $18.13, adjusted for transaction costs.
XML 107 R71.htm IDEA: XBRL DOCUMENT v3.22.4
Merger with SUNS - Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger (Parenthetical) (Detail)
Dec. 31, 2022
$ / shares
SUNS Company Merger [Member]  
Business Acquisition [Line Items]  
Business acquisition, share price $ 18.13
XML 108 R72.htm IDEA: XBRL DOCUMENT v3.22.4
Stock Repurchase Program - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2022
May 23, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
May 03, 2022
Stockholders' Equity Note [Abstract]            
Stock repurchase program, authorized amount           $ 50,000
Stock repurchase program expiration date   May 01, 2023        
Stock Repurchased During Period, Shares     217,271 0 0  
Shares Issued, Price Per Share $ 13.98   $ 13.98      
Stock Repurchased During Period, Value $ 3,038   $ 3,038 $ 0 $ 0  
XML 109 R73.htm IDEA: XBRL DOCUMENT v3.22.4
SLR Senior Lending Program LLC - Summary of SSLP's portfolio (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Summary of Investment Holdings [Line Items]    
Cost $ 2,552,177 $ 2,016,953
SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Cost 18,032  
Fair Value $ 18,062  
Diversified Financial Services | Atria Wealth Solutions, Inc [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index S+600  
Floor 1.00%  
Interest Rate 10.84%  
Maturity Date Feb. 29, 2024  
Par Amount $ 2,494  
Cost 2,494  
Fair Value $ 2,494  
Health Care Providers & Services | BayMark Health Services Inc [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index L+500  
Floor 1.00%  
Interest Rate 9.73%  
Maturity Date Jun. 11, 2027  
Par Amount $ 2,992  
Cost 2,992  
Fair Value $ 2,992  
Health Care Providers & Services | Ivy Fertility Services, LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index L+625  
Floor 1.00%  
Interest Rate 10.39%  
Maturity Date Feb. 25, 2026  
Par Amount $ 3,000  
Cost 3,000  
Fair Value $ 3,030  
Trading Companies & Distributors | ENS Holdings III Corp. ES Opco USA LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index L+475  
Floor 1.00%  
Interest Rate 9.43%  
Maturity Date Dec. 31, 2025  
Par Amount $ 1,097  
Cost 1,097  
Fair Value $ 1,097  
Personal Products | Foundation Consumer Brands, LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index L+550  
Floor 1.00%  
Interest Rate 10.15%  
Maturity Date Feb. 12, 2027  
Par Amount $ 2,963  
Cost 2,963  
Fair Value $ 2,963  
Insurance | High Street Buyer Inc [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index L+600  
Floor 0.75%  
Interest Rate 10.73%  
Maturity Date Apr. 16, 2028  
Par Amount $ 2,494  
Cost 2,494  
Fair Value $ 2,494  
Software | Kid Distro Holdings, LLC (Distro Kid) [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index L+575  
Floor 1.00%  
Interest Rate 10.48%  
Maturity Date Oct. 01, 2027  
Par Amount $ 2,992  
Cost 2,992  
Fair Value $ 2,992  
XML 110 R74.htm IDEA: XBRL DOCUMENT v3.22.4
SLR Senior Lending Program LLC - Summary financial information for SSLP (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Dec. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Condensed Financial Statements, Captions [Line Items]        
Cash and other assets $ 2,504,266 $ 2,504,266 $ 1,990,582  
Total assets 2,537,695 2,537,695 2,011,011  
Debt outstanding 1,085,998 1,085,998 812,038  
Total liabilities 1,537,964 1,537,964 1,168,730  
Organizational costs   5,401 5,575 $ 5,215
Other general and administrative expenses   6,099 4,390 2,936
Total expenses   102,666 78,427 62,530
Net investment loss   76,366 60,927 59,215
Realized gain on investments   (36,485) 26 (26,638)
Net change in unrealized gain on investments   (21,539) (1,387) (17,126)
Net realized and unrealized gain on investments   (58,024) (1,361) (43,764)
Net loss   18,342 $ 59,566 $ 15,451
SLR Senior Lending Program LLC [Member]        
Condensed Financial Statements, Captions [Line Items]        
Investments at fair value (cost $18,032) 18,062 18,062    
Cash and other assets 1,043 1,043    
Total assets 19,105 19,105    
Debt outstanding 0 0    
Interest payable and other credit facility related expenses 165 165    
Accrued expenses and other payables 89 89    
Total liabilities 254 254    
Members' equity 18,851 18,851    
Total liabilities and members' equity 19,105 $ 19,105    
Interest income 152      
Service fees [1] 4      
Interest and other credit facility expenses 166      
Organizational costs 73      
Other general and administrative expenses 88      
Total expenses 331      
Net investment loss (179)      
Realized gain on investments 0      
Net change in unrealized gain on investments 30      
Net realized and unrealized gain on investments 30      
Net loss $ (149)      
[1] Service fees are included within the Company’s Consolidated Statements of Operations as other income.
XML 111 R75.htm IDEA: XBRL DOCUMENT v3.22.4
SLR Senior Lending Program LLC - Additional Information (Details) - USD ($)
$ in Thousands
1 Months Ended
Dec. 12, 2022
Dec. 31, 2022
Dec. 31, 2022
Oct. 12, 2022
Dec. 31, 2021
Summary of Investment Holdings [Line Items]          
Other Commitment   $ 323,663 $ 323,663   $ 226,733
total assets   2,537,695 2,537,695   2,011,011
Unfunded Debt and Equity Commitments [Member]          
Summary of Investment Holdings [Line Items]          
Other Commitment   323,663 323,663   $ 226,733
SLR Senior Lending Program LLC [Member]          
Summary of Investment Holdings [Line Items]          
Other Ownership Interests, Contributed Capital   19,000 19,000    
total assets   19,105 19,105    
Payments to Acquire Investments   18,100      
Prepaid Expense   68 68    
SLR Senior Lending Program LLC [Member] | Unfunded Debt and Equity Commitments [Member]          
Summary of Investment Holdings [Line Items]          
Other Commitment   40,500 40,500 $ 100,000  
SLR Senior Lending Program LLC [Member] | Senior Secured Revolving Credit Facility [Member] | SLR Senior Lending Program SPV LLC [Member]          
Summary of Investment Holdings [Line Items]          
Long-term Line of Credit $ 100,000        
Debt Instrument, Maturity Date Dec. 12, 2027        
Proceeds from Lines of Credit     0    
SLR Senior Lending Program LLC [Member] | Senior Secured Revolving Credit Facility [Member] | SLR Senior Lending Program SPV LLC [Member] | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]          
Summary of Investment Holdings [Line Items]          
Line of Credit Facility, Interest Rate During Period 3.25%        
SLR Senior Lending Program LLC [Member] | Investor | Unfunded Debt and Equity Commitments [Member]          
Summary of Investment Holdings [Line Items]          
Other Commitment   40,500 40,500 50,000  
SLR Senior Lending Program LLC [Member] | Management | Unfunded Debt and Equity Commitments [Member]          
Summary of Investment Holdings [Line Items]          
Other Commitment   $ 40,500 $ 40,500 $ 50,000  
XML 112 R76.htm IDEA: XBRL DOCUMENT v3.22.4
Subsequent Events - Additional Information (Details) - $ / shares
Feb. 28, 2023
Feb. 02, 2023
Jan. 10, 2023
Subsequent Event [Member] | Board [Member]      
Subsequent Event [Line Items]      
Dividends payable, amount per share $ 0.136667 $ 0.136667 $ 0.136667
XML 113 d437884d10k_htm.xml IDEA: XBRL DOCUMENT 0001418076 2022-01-01 2022-12-31 0001418076 2021-01-01 2021-12-31 0001418076 2020-01-01 2020-12-31 0001418076 2021-12-31 0001418076 2022-12-31 0001418076 2023-02-24 0001418076 2022-06-30 0001418076 2022-12-31 2022-12-31 0001418076 2022-04-01 2022-04-01 0001418076 2022-05-03 0001418076 2022-05-23 2022-05-23 0001418076 2020-12-31 0001418076 2019-12-31 0001418076 2018-12-31 0001418076 2018-01-01 2018-12-31 0001418076 2019-01-01 2019-12-31 0001418076 2021-12-28 2021-12-31 0001418076 2022-10-01 2022-12-31 0001418076 2021-01-01 2021-03-31 0001418076 2021-04-01 2021-06-30 0001418076 2021-10-01 2021-12-31 0001418076 2021-07-01 2021-09-30 0001418076 2022-07-01 2022-09-30 0001418076 2022-04-01 2022-06-30 0001418076 2022-01-01 2022-03-31 0001418076 2016-01-01 2016-12-31 0001418076 2015-01-01 2015-12-31 0001418076 2017-01-01 2017-12-31 0001418076 2013-01-01 2013-12-31 0001418076 2014-01-01 2014-12-31 0001418076 2017-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:RdHoldcoIncClassBMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SlrBusinessCreditMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SlrCreditSolutionsMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SlrHealthcareAblMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SpectrumPharmaceuticalsInc.WarrantsMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:VapothermIncMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:VenusConceptLtdMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:RdHoldcoIncWarrantsMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SenseonicsHoldingsIncMember 2022-12-31 0001418076 slrc:PreferredEquityzeroPointFourPercentMember slrc:SointLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SlrEquipmentFinanceEquityInterestsMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:CardioFocusIncMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:AtyrPharmaIncMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:CentrexionTherapeuticsIncMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:EssenceGroupHoldingsCorporationLumerisMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:DelphinusMedicalTechnologiesIncMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:ConventusOrthopaedicsIncMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:KbhTopcoLlcKingsbridgeMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:MeditrinaIncWarrantsMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:RdHoldcoIncMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:LuxuryAssetCapitalLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:MauricesIncorporatedMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:MontefioreNyackHospitalMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:NacHoldingsCorporationJaguarMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:NationalSpineAndPainCentersLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:OneTouchDirectLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ShoHoldingICorporationShoesForCrewsMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SouthernOrthodonticPartnersManagementLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SparMarketingForceInc.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:StrytenResourcesLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:OrthopedicCarePartnersManagementLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:PediatricHomeRespiratoryServicesLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SunmedGroupHoldingsLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AmericanTeleconferencingServicesLtd.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AmericanTeleconferencingServicesLtdOneMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AmerimarkIntermediateHoldingsLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:TaucManagementLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:TilleyDistributionIncMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:UltimateBakedGoodsMidcoLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:VesscoMidcoHoldingsLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:WorldInsuranceAssociatesLlcMember 2022-12-31 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AcresCommercialMortgageLlcMember 2022-12-31 0001418076 slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:RdHoldcoInc.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:KoreWirelessGroupInc.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:LogixHoldingCompanyLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:PptManagementHoldingsLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:RqmCorp.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:RscAcquisitionIncMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:RxsenseHoldingsLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcBluefinMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:EnverusHoldingsIncFkaDrillingInfoHoldingsMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ErieConstructionMidwestLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FoundationConsumerBrandsLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:GsmAcquisitionCorpMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:HigginbothamInsuranceAgencyIncMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:HighStreetBuyerIncMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:HumanInterestIncMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:IcimsInc.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:IvyFertilityServicesLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:KaseyaIncMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:KidDistroHoldingsLlcDistroKidMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:KingsbridgeHoldingsLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:PeterCFoyandAssociatesInsuranceServicesLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:PhynetDermatologyLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:PinnacleTreatmentCentersInc.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:PlasticsManagementLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AegisToxicologySciencesCorporationMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AllStateAgPartsLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:EnhancedPermanentCapitalLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:CopperRiverSeafoodsInc.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:CompositeTechnologyAcquisitionCorp.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:BdgMediaInc.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:BaymarkHealthServicesIncMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:BasicFunInc.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AtriaWealthSolutionsIncMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ApexServicesPartnersLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AeroOperatingLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AfgDallasIiiLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AirMethodsCorporationMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:ClubcorpHoldingsIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:BoartLongyearCompanyMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:BowmanEnergySolutionsLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:CapitalCityJetCenterIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:ChampionAirLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:CkdHoldingsInc.Member 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AmeraMexInternationalIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:HawkeyeContractingCompanyLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:HtiLogisticsCorporationMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:InternationalAutomotiveComponentsGroupNorthAmericaIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:KoolPakLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:GmtCorporationMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:FreightsolLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:GardaClTechnicalServicesIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:GeorgiaJetIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EasyPakLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EnergyDrillingServicesLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EnvironmentalProtectionImprovementCompanyLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EquipmentOperatingLeasesLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:FirstAmericanCommercialBancorpIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:FirstNationalCapitalLlcMember 2022-12-31 0001418076 slrc:U.s.TreasuryBillMember slrc:CashEquivalentsAtFortyOnePointEightMember 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SpectrumPharmaceuticalsInc.Member 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:VapothermInc.Member 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:GlookoInc.Member 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:NeuroneticsInc.Member 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:OmniguideHoldingsInc.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:DeepintentInc.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ScpEyeCareLlcMember 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:CerapedicsInc.Member 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:InternationalAutomotiveComponentsGroupNorthAmericaIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:KoolPakLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:DongwonAutopartTechnologyIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LuxVendingLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:MountainAirHelicoptersIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SuperiorTransportationIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:StarCoachesIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:StCoachesLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SmileyLiftingSolutionsLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SlrEquipmentFinanceMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:TrinityEquipmentRentalsIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:TheSmedleyCompanySmedleyServicesIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WombleCompanyIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WindRiverEnvironmentalLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:UpTruckingServicesLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WorldwideFlightServicesInc.Member 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RaneLightMetalCastingsIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RangoIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RoyalCoachLinesIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RoyalExpressIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LoyerCapitalLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LuxCreditConsultantsLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LoyerCapitalLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LuxCreditConsultantsLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LuxVendingLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:MountainAirHelicoptersIncMember 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:BridgebioPharmaInc.Member 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:CentrexionTherapeuticsInc.Member 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ArdelyxInc.Member 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ArcutisBiotherapeuticsInc.Member 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AlimeraSciencesInc.Member 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ApeelTechnologyIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:GmtCorporationMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:HaljoeCoachesUsaLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:HtiLogisticsCorporationMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:HawkeyeContractingCompanyLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:ZamborelliEnterprisesPacificSoutherFoundationMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:U.s.CraneAndRiggingLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SignetMarineCorporationMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RottenRockHardscapingAndTreeServiceMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:PcxAerostructuresLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:OzziesIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:GardaClTechnicalServicesIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:FreightsolLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:FirstNationalCapitalLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:FirstAmericanCommercialBancorpIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:EquipmentOperatingLeasesLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:EnvironmentalProtectionImprovementCompanyLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:EasyPakLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:DongwonAutopartTechnologyIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:ClubcorpHoldingsIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:ChampionAirLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SturgeonServicesInternationalIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SuperiorTransportationIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TailwindsLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TheSmedleyCompanySmedleyServicesIncMember 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:OutsetMedicalInc.Member 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:MeditrinaInc.Member 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TrinityEquipmentRentalsIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:GeorgiaJetIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LocPerformanceProductsLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:DrillersChoiceIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:CPortStoneLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:BazziniLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TrolleysIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:UpTruckingServicesLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:StCoachesLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:StaffordLogisticsIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:StarCoachesIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:CapitalCityJetCenterIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:BoartLongyearCompanyMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:BlackhawkMiningLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AmeraMexInternationalIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AirMethodsCorporationMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AeroOperatingLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:WarriorCraneServicesLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:WombleCompanyIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:WindRiverEnvironmentalLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RaneLightMetalCastingsIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RangoIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RosscoCraneRiggingIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RoyalCoachLinesIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RoyalExpressIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SouthTexasOilfieldSolutionsLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SidelinesTreeServiceLlcMember 2022-12-31 0001418076 slrc:TotalInvestmentMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2022-12-31 0001418076 srt:MinimumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 srt:MaximumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 srt:WeightedAverageMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 srt:MinimumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:MaximumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:WeightedAverageMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 srt:WeightedAverageMember slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:WeightedAverageMember slrc:EquipmentFinancingMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:MinimumMember slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 srt:MaximumMember slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 srt:WeightedAverageMember slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 srt:MinimumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:MaximumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:WeightedAverageMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:MinimumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2022-12-31 0001418076 srt:MaximumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2022-12-31 0001418076 srt:WeightedAverageMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member slrc:BlackScholesPricingModelMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember 2022-12-31 0001418076 slrc:CreditFacilityOneMember 2022-12-31 0001418076 slrc:NmcSeniorCreditFacilityMember 2022-12-31 0001418076 slrc:SlrBusinessCreditMember slrc:SeniorSecuredCommitmentsMember 2022-12-31 0001418076 slrc:SlrBusinessCreditMember 2022-12-31 0001418076 slrc:KbhtMember 2022-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheOneMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheTwoMember 2022-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2022-12-31 0001418076 slrc:SeniorSecuredCommitmentsMember 2022-12-31 0001418076 slrc:SlrHealthcareAblCreditMember slrc:SeniorSecuredCommitmentsMember 2022-12-31 0001418076 slrc:AmerimarkMember 2022-12-31 0001418076 slrc:BridgeBioPharmaIncMember 2022-12-31 0001418076 slrc:OmniGuideHoldingsIncMember 2022-12-31 0001418076 slrc:VapothermInc.Member 2022-12-31 0001418076 slrc:IcimsInc.Member 2022-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:CreditFacilityMember slrc:CitiBankNaMember 2022-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2022-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember us-gaap:LineOfCreditMember 2022-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember slrc:TermLoanMember 2022-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-12-31 0001418076 slrc:SlrEquipmentFinanceMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:EnsHoldingsIiiCorpLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MontefioreNyackHospitalMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ScpEyeCareLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:DeepintentInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MeditrinaInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CerapedicsInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OutsetMedicalInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:RqmCorp.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:EnverusHoldingsIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrEquipmentFinanceMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ErieConstructionMidwestLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PeterC.FoyAssociatesInsuranceServicesLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AmericanTeleconferencingServicesLtd.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SunmedGroupHoldingsLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:GsmAcquisitionCorpMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:TilleyDistributionIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BaymarkHealthServicesIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:HighStreetBuyerIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AllStateAgPartsLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BridgebioPharmaInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:TaucManagementLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:RezoluteIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SocTelemedInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:InszoneMidLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MmitHoldingsLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:NeuroneticsInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrCreditSolutionsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:LuxuryAssetCapitalLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:RscAcquisitionIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ArdelyxIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:KaseyaIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:VesscoMidcoHoldingsLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MauricesIncorporatedMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BdgMediaInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OneTouchDirectLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CopperRiverSeafoodsInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BasicFunInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:KidDistroHoldingsLlcDistroKidMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:FoundationConsumerBrandsLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SouthernOrthodonticPartnersManagementLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PediatricHomeRespiratoryServicesLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PlasticsManagementLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UltimateBakedGoodsMidcoLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OrthopedicCarePartnersManagementLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:IvyFertilityServicesLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PinnacleTreatmentCentersInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CompositeTechnologyAcquisitionCorpMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:NacHoldingsCorporationMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrHealthcareAblMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SparMarketingForceInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:RxsenseHoldingsLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ApeelTechnologyIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:HumanInterestIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:GlookoInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:WorldInsuranceAssociatesLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:IcimsInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SpectrumPharmaceuticalsInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ArcutisBiotherapeuticsInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AtriaWealthSolutionsIncMember 2022-12-31 0001418076 slrc:MultiSectorHoldingsMember 2022-12-31 0001418076 slrc:HealthCareProvidersAndServicesMember 2022-12-31 0001418076 slrc:FootwearMember 2022-12-31 0001418076 slrc:HotelsRestaurantsAndLeisureMember 2022-12-31 0001418076 slrc:ContainersAndPackagingMember 2022-12-31 0001418076 slrc:OilGasAndConsumableFuelsMember 2022-12-31 0001418076 slrc:EnergyEquipmentAndServicesMember 2022-12-31 0001418076 slrc:TransportationInfrastructureMember 2022-12-31 0001418076 slrc:FoodProductsMember 2022-12-31 0001418076 slrc:HealthCareEquipmentAndSuppliesMember 2022-12-31 0001418076 slrc:PharmaceuticalsMember 2022-12-31 0001418076 slrc:SoftwareMember 2022-12-31 0001418076 slrc:InsuranceMember 2022-12-31 0001418076 slrc:BiotechnologyMember 2022-12-31 0001418076 slrc:DiversifiedConsumerServicesMember 2022-12-31 0001418076 slrc:MediaMember 2022-12-31 0001418076 slrc:RoadAndRailMember 2022-12-31 0001418076 slrc:PersonalProductsMember 2022-12-31 0001418076 slrc:CapitalMarketsMember 2022-12-31 0001418076 slrc:ThriftsMortgageFinanceMember 2022-12-31 0001418076 slrc:LifeSciencesToolsAndServicesMember 2022-12-31 0001418076 slrc:AutoPartsAndEquipmentMember 2022-12-31 0001418076 slrc:PackagedFoodsAndMeatsMember 2022-12-31 0001418076 slrc:WirelessTelecommunicationServicesMember 2022-12-31 0001418076 slrc:BuildingProductsMember 2022-12-31 0001418076 slrc:InternetAndCatalogRetailMember 2022-12-31 0001418076 slrc:ItServicesMember 2022-12-31 0001418076 slrc:AirlinesMember 2022-12-31 0001418076 slrc:AutoComponentsMember 2022-12-31 0001418076 slrc:LeisureEquipmentAndProductsMember 2022-12-31 0001418076 slrc:SpecialtyRetailMember 2022-12-31 0001418076 slrc:CommunicationsEquipmentMember 2022-12-31 0001418076 slrc:HealthCareTechnologyMember 2022-12-31 0001418076 slrc:CommercialServicesAndSuppliesMember 2022-12-31 0001418076 slrc:InternetSoftwareServicesMember 2022-12-31 0001418076 slrc:TradingCompaniesAndDistributorsMember 2022-12-31 0001418076 slrc:ConstructionAndEngineeringMember 2022-12-31 0001418076 slrc:WaterUtilitiesMember 2022-12-31 0001418076 slrc:ConsumerFinanceMember 2022-12-31 0001418076 slrc:DiversifiedFinancialServicesMember 2022-12-31 0001418076 slrc:AerospaceAndDefenseMember 2022-12-31 0001418076 slrc:MetalsAndMiningMember 2022-12-31 0001418076 slrc:MachineryMember 2022-12-31 0001418076 us-gaap:AssetManagement1Member 2022-12-31 0001418076 slrc:FoodAndStaplesRetailingMember 2022-12-31 0001418076 slrc:SunsCompanyMergerMember 2022-12-31 0001418076 slrc:KidDistroHoldingsLlcDistroKidMember us-gaap:TechnologySectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:PersonalProductsMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:HighStreetBuyerIncMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:IvyFertilityServicesLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:BaymarkHealthServicesIncMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:AtriaWealthSolutionsIncMember us-gaap:FinancialServicesSectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcMember slrc:TradingCompaniesDistributorsMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember srt:ManagementMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember us-gaap:InvestorMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:CardioFocusIncMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:AtyrPharmaIncMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:KbhTopcoLlcKingsbridgeMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:RdHoldcoIncClassBMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:RdHoldcoIncMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:RdHoldcoIncWarrantsMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:EssenceGroupHoldingsCorporationLumerisMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:DelphinusMedicalTechnologiesIncMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:VenusConceptLtdMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:SenseonicsHoldingsIncMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:SlrCreditSolutionsMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:CentrexionTherapeuticsIncMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:ConventusOrthopaedicsIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SlrEquipmentFinanceEquityInterestsMember 2021-12-31 0001418076 slrc:PreferredEquityZeroPointSevenPercentMember slrc:SoaggLlcMember 2021-12-31 0001418076 slrc:PreferredEquityZeroPointSevenPercentMember slrc:SointLlcMember 2021-12-31 0001418076 slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:PhymedManagementLlcMember 2021-12-31 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:VarileaseFinanceInc.Member 2021-12-31 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AcresCommercialMortgageLlcMember 2021-12-31 0001418076 slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:RugDoctorLlcMember 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:BridgebioPharmaInc.Member 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AxcellaHealthIncMember 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:ArdelyxInc.Member 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:ArcutisBiotherapeuticsInc.Member 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AlimeraSciencesInc.Member 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:OmniguideHoldingsInc.Member 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:CentrexionTherapeuticsInc.Member 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:NeuroneticsInc.Member 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:GlookoInc.Member 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:DelphinusMedicalTechnologiesInc.Member 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:CerapedicsInc.Member 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:RezoluteIncMember 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:SocTelemedInc.Member 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:ScpharmaceuticalsInc.Member 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:RubiusTherapeuticsInc.Member 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:UltimateBakedGoodsMidcoLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:UsrParentInc.StaplesMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:RqmCorp.Member 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:StrytenEnergyLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:SunmedGroupHoldingsLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:PptManagementHoldingsLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:MmitHoldingsLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:NacHoldingsCorporationJaguarMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:OneTouchDirectLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:PhynetDermatologyLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:PinnacleTreatmentCentersInc.Member 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:MauricesIncorporatedMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:KidDistroHoldingsLlcDistroKidMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:KingsbridgeHoldingsLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:KoreWirelessGroupInc.Member 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:LogixHoldingCompanyLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AmericanTeleconferencingServicesLtdOneMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AmerimarkIntermediateHoldingsLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AtriaWealthSolutionsIncMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AmericanTeleconferencingServicesLtd.Member 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AlteonHealthLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AegisToxicologySciencesCorporationMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:EnhancedPermanentCapitalLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FoundationConsumerBrandsLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:IcimsInc.Member 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:InszoneMidLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:IvyFertilityServicesLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:CommunityBrandsParentcoLlcFkaMinistryBrandsMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:BasicFunInc.Member 2021-12-31 0001418076 slrc:U.s.TreasuryBillMember slrc:CashEquivalentsAtThirtyEightPointZeroMember 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-12-31 0001418076 slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-12-31 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-12-31 0001418076 slrc:TotalInvestmentMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember 2021-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-12-31 0001418076 slrc:PreferredEquityZeroPointSevenPercentMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel2Member slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel1Member slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel3Member slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel3Member slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2021-12-31 0001418076 srt:MinimumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 srt:MaximumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 srt:WeightedAverageMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 srt:MinimumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember us-gaap:MeasurementInputEbitdaMultipleMember 2021-12-31 0001418076 srt:MaximumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember us-gaap:MeasurementInputEbitdaMultipleMember 2021-12-31 0001418076 srt:WeightedAverageMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember us-gaap:MeasurementInputEbitdaMultipleMember 2021-12-31 0001418076 srt:MinimumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember slrc:BlackScholesPricingModelMember 2021-12-31 0001418076 srt:MaximumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember slrc:BlackScholesPricingModelMember 2021-12-31 0001418076 srt:WeightedAverageMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember slrc:BlackScholesPricingModelMember 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 srt:WeightedAverageMember slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2021-12-31 0001418076 srt:WeightedAverageMember slrc:EquipmentFinancingMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2021-12-31 0001418076 srt:MinimumMember slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 srt:MaximumMember slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 srt:WeightedAverageMember slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 srt:MinimumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2021-12-31 0001418076 srt:MaximumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2021-12-31 0001418076 srt:WeightedAverageMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2021-12-31 0001418076 srt:MinimumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2021-12-31 0001418076 srt:MaximumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2021-12-31 0001418076 srt:WeightedAverageMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2021-12-31 0001418076 srt:MinimumMember slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 srt:MaximumMember slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 srt:WeightedAverageMember slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel3Member slrc:BlackScholesPricingModelMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2021-12-31 0001418076 slrc:CreditFacilityOneMember 2021-12-31 0001418076 slrc:SlrBusinessCreditMember slrc:SeniorSecuredCommitmentsMember 2021-12-31 0001418076 slrc:SlrBusinessCreditMember 2021-12-31 0001418076 slrc:NmcSeniorCreditFacilityMember 2021-12-31 0001418076 slrc:KbhtMember 2021-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheOneMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheTwoMember 2021-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2021-12-31 0001418076 slrc:SeniorSecuredCommitmentsMember 2021-12-31 0001418076 slrc:SlrHealthcareAblCreditMember slrc:SeniorSecuredCommitmentsMember 2021-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember 2021-12-31 0001418076 slrc:SlrEquipmentFinanceMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:NeuroneticsInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:EnsHoldingsIiiCorpLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MontefioreNyackHospitalMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ScpEyeCareLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:DeepintentInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MeditrinaInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CerapedicsInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OutsetMedicalInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AmericanTeleconferencingServicesLtd.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ErieConstructionMidwestLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:RxsenseHoldingsLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrHealthcareAblMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PeterC.FoyAssociatesInsuranceServicesLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrEquipmentFinanceMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SunmedGroupHoldingsLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:EnverusHoldingsIncMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:TilleyDistributionIncMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BaymarkHealthServicesIncMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:GsmAcquisitionCorpMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:HighStreetBuyerIncMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:TaucManagementLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AllStateAgPartsLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BridgebioPharmaInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:InszoneMidLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:RezoluteIncMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SocTelemedInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:RqmCorp.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MmitHoldingsLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrCreditSolutionsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ArdelyxIncMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:LuxuryAssetCapitalLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:RscAcquisitionIncMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MauricesIncorporatedMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:KaseyaIncMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:VesscoMidcoHoldingsLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CopperRiverSeafoodsInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BdgMediaInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OneTouchDirectLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:FoundationConsumerBrandsLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BasicFunInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:KidDistroHoldingsLlcDistroKidMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PlasticsManagementLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SouthernOrthodonticPartnersManagementLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PediatricHomeRespiratoryServicesLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PinnacleTreatmentCentersInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UltimateBakedGoodsMidcoLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OrthopedicCarePartnersManagementLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CompositeTechnologyAcquisitionCorpMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:NacHoldingsCorporationMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:IvyFertilityServicesLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SparMarketingForceInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ApeelTechnologyIncMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:GlookoInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:WorldInsuranceAssociatesLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:HumanInterestIncMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SpectrumPharmaceuticalsInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ArcutisBiotherapeuticsInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:IcimsInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AtriaWealthSolutionsIncMember 2021-12-31 0001418076 slrc:CapitalMarketsMember 2021-12-31 0001418076 slrc:AutoPartsAndEquipmentMember 2021-12-31 0001418076 slrc:InternetAndCatalogRetailMember 2021-12-31 0001418076 slrc:PackagedFoodsAndMeatsMember 2021-12-31 0001418076 slrc:LifeSciencesToolsAndServicesMember 2021-12-31 0001418076 slrc:CommunicationsEquipmentMember 2021-12-31 0001418076 slrc:SpecialtyRetailMember 2021-12-31 0001418076 slrc:AutoComponentsMember 2021-12-31 0001418076 slrc:AirlinesMember 2021-12-31 0001418076 slrc:MultiSectorHoldingsMember 2021-12-31 0001418076 slrc:DiversifiedFinancialServicesMember 2021-12-31 0001418076 slrc:HealthCareProvidersAndServicesMember 2021-12-31 0001418076 slrc:PharmaceuticalsMember 2021-12-31 0001418076 slrc:SoftwareMember 2021-12-31 0001418076 slrc:HealthCareEquipmentAndSuppliesMember 2021-12-31 0001418076 slrc:BiotechnologyMember 2021-12-31 0001418076 slrc:WirelessTelecommunicationServicesMember 2021-12-31 0001418076 slrc:PersonalProductsMember 2021-12-31 0001418076 slrc:RoadAndRailMember 2021-12-31 0001418076 slrc:ItServicesMember 2021-12-31 0001418076 slrc:DiversifiedConsumerServicesMember 2021-12-31 0001418076 slrc:InsuranceMember 2021-12-31 0001418076 slrc:CommercialServicesAndSuppliesMember 2021-12-31 0001418076 slrc:HealthCareTechnologyMember 2021-12-31 0001418076 slrc:MachineryMember 2021-12-31 0001418076 slrc:AerospaceAndDefenseMember 2021-12-31 0001418076 slrc:MetalsAndMiningMember 2021-12-31 0001418076 slrc:HotelsRestaurantsAndLeisureMember 2021-12-31 0001418076 slrc:ConsumerFinanceMember 2021-12-31 0001418076 slrc:AirFreightAndLogisticsMember 2021-12-31 0001418076 slrc:EnergyEquipmentAndServicesMember 2021-12-31 0001418076 slrc:OilGasAndConsumableFuelsMember 2021-12-31 0001418076 slrc:ConstructionAndEngineeringMember 2021-12-31 0001418076 slrc:ContainersAndPackagingMember 2021-12-31 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2020-01-01 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2020-01-01 2020-12-31 0001418076 slrc:AdvisoryAgreementMember 2020-01-01 2020-12-31 0001418076 slrc:SlrBusinessCreditMember 2020-01-01 2020-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember 2020-01-01 2020-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2020-01-01 2020-12-31 0001418076 slrc:SlrEquipmentFinanceMember 2020-01-01 2020-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember 2020-01-01 2020-12-31 0001418076 slrc:CreditFacilityMember 2020-01-01 2020-12-31 0001418076 slrc:NefpassFacilityMember 2020-01-01 2020-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2020-01-01 2020-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2020-01-01 2020-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2020-01-01 2020-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2020-01-01 2020-12-31 0001418076 slrc:TermLoansMember 2020-01-01 2020-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2020-01-01 2020-12-31 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:RubiusTherapeuticsInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:ScpharmaceuticalsInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:RezoluteIncMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AxcellaHealthIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SlrEquipmentFinanceEquityInterestsMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:InszoneMidLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:IcimsInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FoundationConsumerBrandsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:EnhancedPermanentCapitalLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:BasicFunInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:CommunityBrandsParentcoLlcFkaMinistryBrandsMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AmerimarkIntermediateHoldingsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:ArcutisBiotherapeuticsInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AlimeraSciencesInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:CentrexionTherapeuticsInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:BridgebioPharmaInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:ArdelyxInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AmericanTeleconferencingServicesLtdOneMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:KidDistroHoldingsLlcDistroKidMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:NacHoldingsCorporationJaguarMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:MmitHoldingsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:MauricesIncorporatedMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:UsrParentInc.StaplesMember 2021-01-01 2021-12-31 0001418076 slrc:PreferredEquityZeroPointSevenPercentMember slrc:SointLlcMember 2021-01-01 2021-12-31 0001418076 slrc:PreferredEquityZeroPointSevenPercentMember slrc:SoaggLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AegisToxicologySciencesCorporationMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AlteonHealthLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AmericanTeleconferencingServicesLtd.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AtriaWealthSolutionsIncMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:IvyFertilityServicesLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:KingsbridgeHoldingsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:KoreWirelessGroupInc.Member 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:EasyPakLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:LogixHoldingCompanyLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:OneTouchDirectLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:PhynetDermatologyLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:PinnacleTreatmentCentersInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:PptManagementHoldingsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:RqmCorp.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:StrytenEnergyLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:SunmedGroupHoldingsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:UltimateBakedGoodsMidcoLlcMember 2021-01-01 2021-12-31 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AcresCommercialMortgageLlcMember 2021-01-01 2021-12-31 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:VarileaseFinanceInc.Member 2021-01-01 2021-12-31 0001418076 slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:PhymedManagementLlcMember 2021-01-01 2021-12-31 0001418076 slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:RugDoctorLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:CerapedicsInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:DelphinusMedicalTechnologiesInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:GlookoInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:NeuroneticsInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:OmniguideHoldingsInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:SocTelemedInc.Member 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:VenusConceptLtdMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:SlrCreditSolutionsMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:SenseonicsHoldingsIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:WombleCompanyIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:WindRiverEnvironmentalLlcMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:RdHoldcoIncWarrantsMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:RdHoldcoIncClassBMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:RdHoldcoIncMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:KbhTopcoLlcKingsbridgeMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:EssenceGroupHoldingsCorporationLumerisMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:DelphinusMedicalTechnologiesIncMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:ConventusOrthopaedicsIncMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:CentrexionTherapeuticsIncMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:CardioFocusIncMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:AtyrPharmaIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:WarriorCraneServicesLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:UpTruckingServicesLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TrolleysIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TrinityEquipmentRentalsIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TheSmedleyCompanySmedleyServicesIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TailwindsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SuperiorTransportationIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SturgeonServicesInternationalIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:StarCoachesIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:StaffordLogisticsIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:StCoachesLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SouthTexasOilfieldSolutionsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SidelinesTreeServiceLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RoyalExpressIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RoyalCoachLinesIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RosscoCraneRiggingIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RangoIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RaneLightMetalCastingsIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:MountainAirHelicoptersIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LuxVendingLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LuxCreditConsultantsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LoyerCapitalLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:KoolPakLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:InternationalAutomotiveComponentsGroupNorthAmericaIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:HtiLogisticsCorporationMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:HawkeyeContractingCompanyLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:HaljoeCoachesUsaLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:GmtCorporationMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:GeorgiaJetIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:GardaClTechnicalServicesIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:FreightsolLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:FirstNationalCapitalLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:FirstAmericanCommercialBancorpIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:EquipmentOperatingLeasesLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:EnvironmentalProtectionImprovementCompanyLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:DongwonAutopartTechnologyIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:ClubcorpHoldingsIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:ChampionAirLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:CapitalCityJetCenterIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:BoartLongyearCompanyMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:BlackhawkMiningLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AmeraMexInternationalIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AirMethodsCorporationMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AeroOperatingLlcMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TrinityEquipmentRentalsIncMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TrinityEquipmentRentalsIncMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TheSmedleyCompanySmedleyServicesIncMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TheSmedleyCompanySmedleyServicesIncMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TailwindsLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TailwindsLlcMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SuperiorTransportationIncMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SuperiorTransportationIncMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:StCoachesLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:StCoachesLlcMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SouthTexasOilfieldSolutionsLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SouthTexasOilfieldSolutionsLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RangoIncMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AirMethodsCorporationMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AirMethodsCorporationMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AeroOperatingLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AeroOperatingLlcMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:BoartLongyearCompanyMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:BoartLongyearCompanyMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:BlackhawkMiningLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:BlackhawkMiningLlcMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RangoIncMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:WindRiverEnvironmentalLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:WindRiverEnvironmentalLlcMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LuxVendingLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LuxVendingLlcMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LuxCreditConsultantsLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LuxCreditConsultantsLlcMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LoyerCapitalLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LoyerCapitalLlcMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:HtiLogisticsCorporationMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:HtiLogisticsCorporationMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:GardaClTechnicalServicesIncMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:GardaClTechnicalServicesIncMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:FreightsolLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:FreightsolLlcMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:EquipmentOperatingLeasesLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:EquipmentOperatingLeasesLlcMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:ClubcorpHoldingsIncMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:ClubcorpHoldingsIncMember 2021-01-01 2021-12-31 0001418076 slrc:U.s.TreasuryBillMember slrc:CashEquivalentsAtThirtyEightPointZeroMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:CapitalCityJetCenterIncMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:CapitalCityJetCenterIncMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:WarriorCraneServicesLlcMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:WarriorCraneServicesLlcMember 2021-01-01 2021-12-31 0001418076 slrc:AdvisoryAgreementMember 2021-01-01 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingMember 2021-01-01 2021-12-31 0001418076 slrc:PreferredEquityMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-01-01 2021-12-31 0001418076 slrc:SpreadThreeMember 2021-01-01 2021-12-31 0001418076 slrc:SpreadOneMember 2021-01-01 2021-12-31 0001418076 slrc:SpreadTwoMember 2021-01-01 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-01-01 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2021-01-01 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2021-01-01 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-01-01 2021-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-01-01 2021-12-31 0001418076 slrc:SlrBusinessCreditMember 2021-01-01 2021-12-31 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2021-01-01 2021-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RugDoctorLlcMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:AviatorcapSiiLlcMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2021-01-01 2021-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember 2021-01-01 2021-12-31 0001418076 slrc:SlrEquipmentFinanceMember 2021-01-01 2021-12-31 0001418076 slrc:CreditFacilityMember 2021-01-01 2021-12-31 0001418076 slrc:NefpassFacilityMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-01-01 2021-12-31 0001418076 slrc:TermLoansMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AllStateAgPartsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AegisToxicologySciencesCorporationMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:IcimsInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:IvyFertilityServicesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:KoreWirelessGroupInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:KaseyaIncMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:KidDistroHoldingsLlcDistroKidMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:KingsbridgeHoldingsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:RdHoldcoInc.Member 2022-01-01 2022-12-31 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AcresCommercialMortgageLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AmericanTeleconferencingServicesLtd.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AmericanTeleconferencingServicesLtdOneMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AmerimarkIntermediateHoldingsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ApexServicesPartnersLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AtriaWealthSolutionsIncMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:BasicFunInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:BaymarkHealthServicesIncMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:BdgMediaInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:CompositeTechnologyAcquisitionCorp.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:CopperRiverSeafoodsInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:EnhancedPermanentCapitalLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcBluefinMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:EnverusHoldingsIncFkaDrillingInfoHoldingsMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ErieConstructionMidwestLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FoundationConsumerBrandsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:GsmAcquisitionCorpMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:HigginbothamInsuranceAgencyIncMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:HighStreetBuyerIncMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:HumanInterestIncMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:LogixHoldingCompanyLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:LuxuryAssetCapitalLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:MauricesIncorporatedMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:MontefioreNyackHospitalMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:NacHoldingsCorporationJaguarMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:NationalSpineAndPainCentersLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:OneTouchDirectLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:OrthopedicCarePartnersManagementLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:PediatricHomeRespiratoryServicesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:PeterCFoyandAssociatesInsuranceServicesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:PhynetDermatologyLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:PinnacleTreatmentCentersInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:PlasticsManagementLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:PptManagementHoldingsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:RqmCorp.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:RscAcquisitionIncMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:WorldInsuranceAssociatesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:RxsenseHoldingsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ShoHoldingICorporationShoesForCrewsMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SouthernOrthodonticPartnersManagementLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SparMarketingForceInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:StrytenResourcesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SunmedGroupHoldingsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:TaucManagementLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:TilleyDistributionIncMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:UltimateBakedGoodsMidcoLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:VesscoMidcoHoldingsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RaneLightMetalCastingsIncMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:CerapedicsInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:GlookoInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:MeditrinaInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ScpEyeCareLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:DeepintentInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:NeuroneticsInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:OmniguideHoldingsInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:OutsetMedicalInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:VapothermInc.Member 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LoyerCapitalLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LuxCreditConsultantsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LuxVendingLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:MountainAirHelicoptersIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RangoIncMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AlimeraSciencesInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ArdelyxInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:CentrexionTherapeuticsInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:BridgebioPharmaInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ArcutisBiotherapeuticsInc.Member 2022-01-01 2022-12-31 0001418076 slrc:U.s.TreasuryBillMember slrc:CashEquivalentsAtFortyOnePointEightMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ApeelTechnologyIncMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SpectrumPharmaceuticalsInc.Member 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:ChampionAirLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:CapitalCityJetCenterIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AirMethodsCorporationMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:BazziniLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:CPortStoneLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:DrillersChoiceIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:GmtCorporationMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:GeorgiaJetIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LocPerformanceProductsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:OzziesIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:PcxAerostructuresLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RottenRockHardscapingAndTreeServiceMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SignetMarineCorporationMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:U.s.CraneAndRiggingLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:ZamborelliEnterprisesPacificSoutherFoundationMember 2022-01-01 2022-12-31 0001418076 slrc:PreferredEquityzeroPointFourPercentMember slrc:SointLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AeroOperatingLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AfgDallasIiiLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AmeraMexInternationalIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:BoartLongyearCompanyMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:BowmanEnergySolutionsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:CkdHoldingsInc.Member 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:ClubcorpHoldingsIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:DongwonAutopartTechnologyIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EasyPakLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EnergyDrillingServicesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EnvironmentalProtectionImprovementCompanyLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EquipmentOperatingLeasesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:FirstAmericanCommercialBancorpIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:FirstNationalCapitalLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:FreightsolLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:GardaClTechnicalServicesIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:HawkeyeContractingCompanyLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:HtiLogisticsCorporationMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:InternationalAutomotiveComponentsGroupNorthAmericaIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:KoolPakLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:AtyrPharmaIncMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:CardioFocusIncMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:CentrexionTherapeuticsIncMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:ConventusOrthopaedicsIncMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:DelphinusMedicalTechnologiesIncMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:EssenceGroupHoldingsCorporationLumerisMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:KbhTopcoLlcKingsbridgeMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:MeditrinaIncWarrantsMember 2022-01-01 2022-12-31 0001418076 slrc:U.s.TreasuryBillMember slrc:CashEquivalentsAtThirtyEightPointZeroMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:VenusConceptLtdMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:VapothermIncMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SpectrumPharmaceuticalsInc.WarrantsMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SlrHealthcareAblMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SlrCreditSolutionsMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SlrBusinessCreditMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SenseonicsHoldingsIncMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:RdHoldcoIncWarrantsMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:RdHoldcoIncClassBMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:RdHoldcoIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SlrEquipmentFinanceEquityInterestsMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WorldwideFlightServicesInc.Member 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WombleCompanyIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WindRiverEnvironmentalLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:UpTruckingServicesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:TrinityEquipmentRentalsIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:TheSmedleyCompanySmedleyServicesIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SuperiorTransportationIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:StarCoachesIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:StCoachesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SmileyLiftingSolutionsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SlrEquipmentFinanceMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RoyalExpressIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RoyalCoachLinesIncMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:ClubcorpHoldingsIncMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:CkdHoldingsInc.Member 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:CkdHoldingsInc.Member 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:BoartLongyearCompanyMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:BoartLongyearCompanyMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AirMethodsCorporationMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AirMethodsCorporationMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AeroOperatingLlcMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AeroOperatingLlcMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:ClubcorpHoldingsIncMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EnergyDrillingServicesLlcMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EnergyDrillingServicesLlcMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:FirstAmericanCommercialBancorpIncMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:FirstAmericanCommercialBancorpIncMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:GardaClTechnicalServicesIncMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:GardaClTechnicalServicesIncMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:HtiLogisticsCorporationMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:HtiLogisticsCorporationMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:FreightsolLlcMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:FreightsolLlcMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LoyerCapitalLlcMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LoyerCapitalLlcMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LuxCreditConsultantsLlcMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LuxCreditConsultantsLlcMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LuxVendingLlcMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LuxVendingLlcMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RangoIncMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RangoIncMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SmileyLiftingSolutionsLlcMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SmileyLiftingSolutionsLlcMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:StCoachesLlcMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WorldwideFlightServicesInc.Member 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WorldwideFlightServicesInc.Member 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:StCoachesLlcMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SuperiorTransportationIncMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SuperiorTransportationIncMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:TrinityEquipmentRentalsIncMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:TrinityEquipmentRentalsIncMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WindRiverEnvironmentalLlcMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WindRiverEnvironmentalLlcMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:CapitalCityJetCenterIncMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AfgDallasIiiLlcMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AfgDallasIiiLlcMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:AdvisoryAgreementMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:AdvisoryAgreementMember 2022-01-01 2022-12-31 0001418076 slrc:AdvisoryAgreementMember 2022-01-01 2022-12-31 0001418076 slrc:PreferredEquityMember 2022-01-01 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingMember 2022-01-01 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-01-01 2022-12-31 0001418076 slrc:SpreadOneMember 2022-01-01 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-01-01 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-01-01 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-01-01 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2022-01-01 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-01-01 2022-12-31 0001418076 slrc:NmcSeniorCreditFacilityMember 2022-01-01 2022-12-31 0001418076 slrc:SlrBusinessCreditMember 2022-01-01 2022-12-31 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2022-01-01 2022-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CreditFacilityOneMember 2022-01-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-01-01 2022-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2022-01-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2022-01-01 2022-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrHealthcareAblMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrBusinessCreditMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncDebtMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2022-01-01 2022-12-31 0001418076 slrc:SlrEquipmentFinanceMember 2022-01-01 2022-12-31 0001418076 us-gaap:RevolvingCreditFacilityMember slrc:SlrBusinessCreditFacilityMember 2022-01-01 2022-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-01-01 2022-12-31 0001418076 slrc:RisksRelatingToOurInvestmentsMember 2022-01-01 2022-12-31 0001418076 slrc:RisksRelatingToAnInvestmentInOurSecuritiesMember 2022-01-01 2022-12-31 0001418076 slrc:RisksRelatingToOurBusinessAndStructureMember 2022-01-01 2022-12-31 0001418076 slrc:CreditFacilityMember 2022-01-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2022-01-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2022-01-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2022-01-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2022-01-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-01-01 2022-12-31 0001418076 slrc:CreditFacilityOneMember 2022-01-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-01-01 2022-12-31 0001418076 slrc:TermLoansMember 2022-01-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2022-01-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2022-01-01 2022-12-31 0001418076 slrc:OnAOneThousandInvestmentMember 2022-01-01 2022-12-31 0001418076 slrc:AtriaWealthSolutionsIncMember us-gaap:FinancialServicesSectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcMember slrc:TradingCompaniesDistributorsMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:BaymarkHealthServicesIncMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:IvyFertilityServicesLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:HighStreetBuyerIncMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:PersonalProductsMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:KidDistroHoldingsLlcDistroKidMember us-gaap:TechnologySectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 us-gaap:CommonStockMember 2022-12-31 2022-12-31 0001418076 us-gaap:PrivatePlacementMember 2010-02-10 2010-02-10 0001418076 us-gaap:IPOMember 2010-02-10 2010-02-10 0001418076 us-gaap:OverAllotmentOptionMember 2010-02-10 0001418076 us-gaap:PrivatePlacementMember 2010-02-10 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-01-01 2022-09-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-01-01 2022-09-30 0001418076 slrc:SunsCompanyMergerMember us-gaap:CommonStockMember 2022-04-01 0001418076 slrc:CreditFacilityOneMember 2022-04-01 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-01-06 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2021-09-14 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2019-12-18 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2019-12-18 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheTwoMember 2016-11-08 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheTwoMember 2016-11-08 2017-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheOneMember 2022-06-30 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheTwoMember 2022-06-30 0001418076 srt:MaximumMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2011-08-26 0001418076 srt:MinimumMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2011-08-26 0001418076 srt:MaximumMember slrc:TermLoanAndCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember slrc:CitiBankNaMember 2011-08-26 2011-12-31 0001418076 srt:MinimumMember slrc:TermLoanAndCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember slrc:CitiBankNaMember 2011-08-26 2011-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember slrc:TermLoanMember 2021-12-28 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember us-gaap:LineOfCreditMember 2021-12-28 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2021-12-28 0001418076 srt:MinimumMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2021-12-28 2021-12-31 0001418076 srt:MaximumMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2021-12-28 2021-12-31 0001418076 srt:MaximumMember slrc:SlrHealthcareAblMember 2022-09-30 0001418076 srt:MinimumMember slrc:SlrHealthcareAblMember 2022-09-30 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheOneMember 2017-02-15 0001418076 slrc:CreditFacilityMember 2019-01-01 2019-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2019-01-01 2019-12-31 0001418076 slrc:SslpFacilityMember 2019-01-01 2019-12-31 0001418076 slrc:NefpassFacilityMember 2019-01-01 2019-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2019-01-01 2019-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2019-01-01 2019-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2019-01-01 2019-12-31 0001418076 slrc:TermLoansMember 2019-01-01 2019-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2019-01-01 2019-12-31 0001418076 slrc:CreditFacilityMember 2018-01-01 2018-12-31 0001418076 slrc:NefpassFacilityMember 2018-01-01 2018-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2018-01-01 2018-12-31 0001418076 slrc:SslpFacilityMember 2018-01-01 2018-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2018-01-01 2018-12-31 0001418076 slrc:TermLoansMember 2018-01-01 2018-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2018-01-01 2018-12-31 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2012-11-30 2012-11-30 0001418076 slrc:CrystalFinancialMember 2012-11-30 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2012-12-28 2012-12-28 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2012-12-28 0001418076 us-gaap:RevolvingCreditFacilityMember 2012-12-28 0001418076 slrc:SlrBusinessCreditFacilityMember 2016-07-28 2016-07-28 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2016-07-28 0001418076 slrc:CrystalCapitalFinancialHoldingsLlcMember slrc:SlrBusinessCreditFacilityMember 2016-07-28 0001418076 slrc:SlrEquipmentFinanceMember 2017-07-31 0001418076 slrc:SlrEquipmentFinanceMember 2019-09-30 2019-09-30 0001418076 slrc:SlrEquipmentFinanceMember 2019-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2020-11-03 2020-11-03 0001418076 srt:MinimumMember slrc:KingsbridgeHoldingsLlcMember 2020-11-03 0001418076 srt:MaximumMember slrc:KingsbridgeHoldingsLlcMember 2020-11-03 0001418076 slrc:KingsbridgeHoldingsLlcMember 2020-11-03 0001418076 slrc:SlrHealthcareAblMember 2013-09-30 0001418076 srt:MaximumMember slrc:SlrHealthcareAblCreditMember 2013-09-30 0001418076 srt:MinimumMember slrc:SlrHealthcareAblCreditMember 2013-09-30 0001418076 srt:MinimumMember slrc:SlrHealthcareAblCreditMember 2014-03-31 0001418076 slrc:SlrHealthcareAblCreditMember 2016-05-27 2016-05-27 0001418076 srt:MinimumMember slrc:SlrHealthcareAblCreditMember 2016-05-27 0001418076 srt:MaximumMember slrc:SlrHealthcareAblCreditMember 2016-05-27 0001418076 slrc:SlrHealthcareAblCreditMember 2019-06-28 2019-06-28 0001418076 slrc:SummitFinancialResourcesMember 2019-06-28 0001418076 slrc:NmHoldcoMember 2019-06-28 0001418076 slrc:NmcsCreditFacilityMember 2019-06-28 0001418076 slrc:SlrHealthcareAblCreditMember 2019-06-28 0001418076 slrc:EspSscCorporationMember 2017-10-20 0001418076 slrc:NorthMillCapitalLlcMember 2017-10-20 0001418076 slrc:NorthMillCapitalLlcMember 2018-05-01 0001418076 slrc:EspSscCorporationMember 2018-05-01 0001418076 slrc:FastPayPartnersLlcMember 2021-06-03 2021-06-03 0001418076 slrc:NmcsCreditFacilityMember 2021-06-03 0001418076 slrc:SunsMember 2021-06-03 0001418076 slrc:FastPayPartnersLlcMember 2021-06-03 0001418076 slrc:SunsCompanyMergerMember us-gaap:CommonStockMember 2022-04-01 2022-04-01 0001418076 srt:MinimumMember slrc:AdvisoryAgreementMember 2022-04-01 2022-04-01 0001418076 srt:MaximumMember slrc:AdvisoryAgreementMember 2022-04-01 2022-04-01 0001418076 slrc:BoardMember us-gaap:SubsequentEventMember 2023-01-10 0001418076 slrc:BoardMember us-gaap:SubsequentEventMember 2023-02-02 0001418076 slrc:BoardMember us-gaap:SubsequentEventMember 2023-02-28 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2019-12-18 2019-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2019-12-18 2019-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2017-12-28 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2017-11-22 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2017-11-22 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheOneMember 2017-02-15 2017-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2013-09-30 2013-09-30 0001418076 srt:MaximumMember slrc:SlrHealthcareAblCreditMember 2014-06-27 0001418076 slrc:CreditFacilityMember 2017-01-01 2017-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2017-01-01 2017-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2017-01-01 2017-12-31 0001418076 slrc:TermLoansMember 2017-01-01 2017-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2017-01-01 2017-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2017-01-01 2017-12-31 0001418076 slrc:SeniorSecuredNotesMember 2017-01-01 2017-12-31 0001418076 slrc:CreditFacilityMember 2016-01-01 2016-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2016-01-01 2016-12-31 0001418076 slrc:TermLoansMember 2016-01-01 2016-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2016-01-01 2016-12-31 0001418076 slrc:SeniorSecuredNotesMember 2016-01-01 2016-12-31 0001418076 slrc:CreditFacilityMember 2015-01-01 2015-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2015-01-01 2015-12-31 0001418076 slrc:TermLoansMember 2015-01-01 2015-12-31 0001418076 slrc:SeniorSecuredNotesMember 2015-01-01 2015-12-31 0001418076 slrc:CreditFacilityMember 2014-01-01 2014-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2014-01-01 2014-12-31 0001418076 slrc:SeniorSecuredNotesMember 2014-01-01 2014-12-31 0001418076 slrc:TermLoansMember 2014-01-01 2014-12-31 0001418076 slrc:CreditFacilityMember 2013-01-01 2013-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2013-01-01 2013-12-31 0001418076 slrc:SeniorSecuredNotesMember 2013-01-01 2013-12-31 0001418076 slrc:TermLoansMember 2013-01-01 2013-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2022-12-01 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrSeniorLendingProgramLlcMember 2022-10-12 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember srt:ManagementMember slrc:SlrSeniorLendingProgramLlcMember 2022-10-12 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember us-gaap:InvestorMember slrc:SlrSeniorLendingProgramLlcMember 2022-10-12 0001418076 slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramSpvLlcMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-12 0001418076 slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramSpvLlcMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-12 2022-12-12 0001418076 slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramSpvLlcMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-12 2022-12-12 0001418076 slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramSpvLlcMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-12 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember 2020-12-31 0001418076 slrc:PreferredEquityMember 2020-12-31 0001418076 slrc:EquipmentFinancingMember 2020-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:AviatorcapSiiLlcMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RugDoctorLlcMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RugDoctorLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:AviatorcapSiiLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember 2021-12-31 0001418076 slrc:PreferredEquityMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrSeniorLendingProgramLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrBusinessCreditMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncDebtMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrHealthcareAblMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrHealthcareAblMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrBusinessCreditMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncDebtMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 slrc:PreferredEquityMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2022-12-31 iso4217:USD shares pure utr:Day utr:Year iso4217:USD shares slrc:basispoints slrc:issuers slrc:loans slrc:fund slrc:Customers false FY 0001418076 NY http://fasb.org/us-gaap/2022#UnrealizedGainLossOnInvestments http://fasb.org/us-gaap/2022#UnrealizedGainLossOnInvestments 10-K true 2022-12-31 --12-31 2022 false 814-00754 SLR INVESTMENT CORP. MD 26-1381340 500 Park Avenue New York 10022 212 993-1670 Common Stock, par value $0.01 per share SLRC NASDAQ Yes No Yes Yes Large Accelerated Filer false false true false 741800000 54554634 185 KPMG LLP New York <div style="margin-top: 24pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">RISK FACTORS </div></div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Risks Relating to Our Investments </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We operate in a highly competitive market for investment opportunities. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A number of entities compete with us to make the types of investments that we target in leveraged companies. We compete with other BDCs, public and private funds, commercial and investment banks, commercial financing companies and, to the extent they provide an alternative form of financing, private equity funds. Many of our competitors are substantially larger and have considerably greater financial, technical and marketing resources than we do. For example, some competitors may have a lower cost of funds and access to funding sources that are not available to us. In addition, some of our competitors may have higher risk tolerances or different risk assessments than we have, which could allow them to consider a wider variety of investments and establish more relationships and offer better pricing and a more flexible structure than we are able to do. Furthermore, many of our potential competitors are not subject to the regulatory restrictions that the 1940 Act imposes on us as a BDC. If we are unable to source attractive investments, we may hold a greater percentage of our assets in cash and cash equivalents than anticipated, which could impact potential returns on our portfolio. We cannot assure you that the competitive pressures we face will not have a material adverse effect on our business, financial condition and results of operations. Also, as a result of this competition, we may not be able to take advantage of attractive investment opportunities from time to time, and we can offer no assurance that we will be able to identify and make investments that are consistent with our investment objective. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Participants in our industry compete on several factors, including price, flexibility in transaction structure, customer service, reputation, market knowledge and speed in decision-making. We do not seek to compete primarily based on the interest rates we will offer, and we believe that some of our competitors may make loans with interest rates that will be comparable to or lower than the rates we offer. We may lose investment opportunities if we do not match our competitors’ pricing, terms and structure. However, if we match our competitors’ pricing, terms and structure, we may experience decreased net interest income and increased risk of credit loss. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our investments are very risky and highly speculative. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We invest primarily in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Senior Secured Loans.</div></div></div></div> When we make a senior secured term loan investment in a portfolio company, we generally take a security interest in the available assets of the portfolio company, including the equity interests of its subsidiaries, which we expect to help mitigate the risk that we will not be repaid. However, there is a risk that the collateral securing our loans may decrease in value over time, may be difficult to sell in a timely manner, may be difficult to appraise and may fluctuate in value based upon the success of the business and market conditions, including as a result of the inability of the portfolio company to raise additional capital, and, in some circumstances, our lien could be subordinated to claims of other creditors. In addition, deterioration in a portfolio company’s financial condition and prospects, including its inability to raise additional capital, may be accompanied by deterioration in the value of the collateral for the loan. Consequently, the fact that a loan is secured does not guarantee that we will receive principal and interest payments according to the loan’s terms, or at all, or that we will be able to collect on the loan should we be forced to enforce our remedies. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Unsecured Loans and Preferred Securities.</div></div></div></div> Our unsecured and preferred investments are generally subordinated to senior loans and are generally unsecured. As such, other creditors may rank senior to us in the event of an insolvency. This may result in an above average amount of risk and loss of principal. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Equity Investments.</div></div></div></div> When we invest in senior secured loans, unitranche loans, unsecured loans or preferred securities, we may acquire common equity securities as well. In certain other unique circumstances we may also make equity investments in businesses that make senior loans and/or leases, such as our investments in Kingsbridge Holdings, LLC, SLR Credit Solutions, SLR Equipment </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Finance, SLR Business Credit and SLR Healthcare ABL. In addition, we may invest directly in the equity securities of portfolio companies without limitation as to market capitalization. For instance, we may invest in thinly traded companies, the prices of which may be subject to erratic market movement. Our goal is ultimately to exit such equity interests and realize gains upon our disposition of such interests. However, the equity interests we receive may not appreciate in value and, in fact, may decline in value. Accordingly, we may not be able to realize gains from our equity interests, and any gains that we do realize on the disposition of any equity interests may not be sufficient to offset any other losses we experience. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, investing in middle-market companies involves a number of significant risks, including: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">these companies may have limited financial resources and may be unable to meet their obligations under their debt securities that we hold, which may be accompanied by a deterioration in the value of any collateral and a reduction in the likelihood of us realizing any guarantees we may have obtained in connection with our investment; </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">they typically have shorter operating histories, narrower product lines and smaller market shares than larger businesses, which tend to render them more vulnerable to competitors’ actions and market conditions, as well as general economic downturns; </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">they are more likely to depend on the management talents and efforts of a small group of persons; therefore, the death, disability, resignation or termination of one or more of these persons could have a material adverse impact on our portfolio company and, in turn, on us; </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">they generally have less predictable operating results, may from time to time be parties to litigation, may be engaged in rapidly changing businesses with products subject to a substantial risk of obsolescence, and may require substantial additional capital to support their operations, finance expansion or maintain their competitive position. In addition, our executive officers, directors and our Investment Adviser may, in the ordinary course of business, be named as defendants in litigation arising from our investments in the portfolio companies; and </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">they may have difficulty accessing the capital markets to meet future capital needs, which may limit their ability to grow or to repay their outstanding indebtedness upon maturity. </div> </td> </tr> </table> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">The lack of liquidity in our investments may make it difficult for us to dispose of our investments at a favorable price, which may adversely affect our ability to meet our investment objectives. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We generally make investments in private companies. We invest and expect to continue investing in companies whose securities have no established trading market and whose securities are and will be subject to legal and other restrictions on resale or whose securities are and will be less liquid than are publicly-traded securities. Investments purchased by us that are liquid at the time of purchase may subsequently become illiquid due to events relating to the issuer of the investments, market events, economic conditions or investor perceptions. The illiquidity of our investments may make it difficult for us to sell such investments if the need arises. In addition, if we are required to liquidate all or a portion of our portfolio quickly, we may realize significantly less than the value at which we have previously recorded our investments. As a result, we do not expect to achieve liquidity in our investments in the near-term. However, to maintain our qualification as a BDC and as a RIC, we may have to dispose of investments if we do not satisfy one or more of the applicable criteria under the respective regulatory frameworks. Domestic and foreign markets are complex and interrelated, so that events in one sector of the world markets or economy, or in one geographical region, can reverberate and have materially negative consequences for other markets, economic or regional sectors in a manner that may not be foreseen and which may negatively impact the liquidity of our investments and materially harm our business. In addition, we may face other restrictions on our ability to liquidate an investment in a portfolio company to the extent that we <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">have material non-public information regarding</div> such portfolio company. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our portfolio may be concentrated in a limited number of portfolio companies and industries, which will subject us to a risk of significant loss if any of these companies performs poorly or defaults on its obligations under any of its debt instruments or if there is a downturn in a particular industry. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our portfolio may be concentrated in a limited number of portfolio companies and industries. For example, as of December 31, 2022, our investments in SLR Credit Solutions, Kingsbridge Holdings, LLC and SLR Equipment Finance comprised 11.4%, 9.0% and 5.0%, respectively, of our total assets and our investments in diversified financial services and multi-sector holdings industries comprised 18.2% and 14.4%, respectively, of our total assets. Beyond the asset diversification requirements associated with our qualification as a RIC under Subchapter M of the Code, we do not have fixed guidelines for diversification, and while we are not targeting any specific industries, our investments may be concentrated in relatively few industries or portfolio companies. As a result, the aggregate returns we realize may be significantly adversely affected if a small number of investments perform poorly or if we need to write down the value of any one investment. Additionally, a downturn in any particular industry in which we are invested could also significantly impact the aggregate returns we realize. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our investments in securities rated below investment grade are speculative in nature and are subject to additional risk factors such as the increased possibility of default, illiquidity of the security, and changes in value based on changes in interest rates. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The securities that we invest in are typically rated below investment grade. Securities rated below investment grade are speculative and are often referred to as “leveraged loans,” “high yield” or “junk” securities, and may be considered “high risk” compared to debt instruments that are rated investment grade. High yield securities are regarded as having predominantly speculative characteristics with respect to the issuer’s capacity to pay interest and repay principal in accordance with the terms of the obligations and involve major risk exposure to adverse conditions. In addition, high yield securities generally offer a higher current yield than that available from higher grade issues, but typically involve greater risk. These securities are especially sensitive to adverse changes in general economic conditions, to changes in the financial condition of their issuers and to price fluctuation in response to changes in interest rates. During periods of economic downturn or rising interest rates, such as the current economic period, issuers of below investment grade instruments may experience financial stress that could adversely affect their ability to make payments of principal and interest and increase the possibility of default. The secondary market for high yield securities may not be as liquid as the secondary market for more highly rated securities. In addition, many of our debt investments will not fully amortize during their lifetime, which means that a borrower may be unable to payoff its debt due to bankruptcy or other reasons and therefore <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">we may write-off such debt</div> investment prior to its scheduled maturity. Upon such an occurrence, we may realize a loss or a substantial amount of unpaid principal and interest due upon maturity. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Price declines and illiquidity in the corporate debt markets have adversely affected, and may continue to adversely affect, the fair value of our portfolio investments, reducing our net asset value through increased net unrealized depreciation. Any unrealized depreciation that we experience on our loan portfolio may be an indication of future realized losses, which could reduce our income available for distribution and could adversely affect our ability to service our outstanding borrowings. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a BDC, we are required to carry our investments at market value or, if no market value is ascertainable, at fair value as determined in good faith by or under the direction of our board of directors. Decreases in the market values or fair values of our investments are recorded as unrealized depreciation. Any unrealized depreciation in our loan portfolio could be an indication of a portfolio company’s inability to meet its repayment obligations to us with respect to the affected loans. This could result in realized losses in the future and ultimately in reductions of our income available for distribution in future periods and could materially adversely affect our ability to service our outstanding borrowings. Depending on market conditions, we could incur substantial losses in future periods, which could further reduce our net asset value and have a material adverse impact on our business, financial condition and results of operations. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Economic sanction laws in the United States and other jurisdictions may prohibit us and our affiliates from transacting with certain countries, individuals and companies. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Economic sanction laws in the United States and other jurisdictions may prohibit us or our affiliates from transacting with certain countries, individuals and companies. In the United States, the U.S. Department of the Treasury’s Office of Foreign Assets Control administers and enforces laws, executive orders and regulations establishing U.S. economic and trade sanctions, which prohibit, among other things, transactions with, and the provision of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">services to, certain non-U.S. countries, territories, entities</div> and individuals. These types of sanctions may significantly restrict or completely prohibit investment activities in certain jurisdictions, and if we, our portfolio companies or other issuers in which we invest were to violate any such laws or regulations, we may face significant legal and monetary penalties. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Foreign Corrupt Practices Act, or FCPA, and other anti-corruption laws and regulations, as well as anti-boycott regulations, may also apply to and restrict our activities, our portfolio companies and other issuers of our investments. If an issuer or we were to violate any such laws or regulations, such issuer or we may face significant legal and monetary penalties. The U.S. government has indicated that it is particularly focused on FCPA enforcement, which may increase the risk that an issuer or us becomes the subject of such actual or threatened enforcement. In addition, certain commentators have suggested that private investment firms and the funds that they manage may face increased scrutiny and/or liability with respect to the activities of their underlying portfolio companies. As such, a violation of the FCPA or other applicable regulations by us or an issuer of our portfolio investments could have a material adverse effect on us. We are committed to complying with the FCPA and other anti-corruption laws and regulations, as well as anti-boycott regulations, to which it is subject. As a result, we may be adversely affected because of our unwillingness to enter into transactions that violate any such laws or regulations. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div/> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">If we cannot obtain additional capital because of either regulatory or market price constraints, we could be forced to curtail or cease our new lending and investment activities, our net asset value could decrease and our level of distributions and liquidity could be affected adversely. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our ability to secure additional financing and satisfy our financial obligations under indebtedness outstanding from time to time will depend upon our future operating performance, which is subject to the prevailing general economic and credit market conditions, including interest rate levels and the availability of credit generally, and financial, business and other factors, many of which are beyond our control. The worsening of current economic and capital market conditions could have a material adverse effect on our ability to secure financing on favorable terms, if at all. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we are unable to obtain debt capital, then our equity investors will not benefit from the potential for increased returns on equity resulting from leverage to the extent that our investment strategy is successful and we may be limited in our ability to make new commitments or fundings to our portfolio companies. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may suffer a loss if a portfolio company defaults on a loan and the underlying collateral is not sufficient. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of a default by a portfolio company on a secured loan, we will only have recourse to the assets collateralizing the loan. If the underlying collateral value is less than the loan amount, we will suffer a loss. In addition, we sometimes make loans that are unsecured, which are subject to the risk that other lenders may be directly secured by the assets of the portfolio company. In the event of a default, those collateralized lenders would have priority over us with respect to the proceeds of a sale of the underlying assets. In cases described above, we may lack control over the underlying asset collateralizing our loan or the underlying assets of the portfolio company prior to a default, and as a result the value of the collateral may be reduced by acts or omissions by owners or managers of the assets. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of bankruptcy of a portfolio company, we may not have full recourse to its assets in order to satisfy our loan, or our loan may be subject to equitable subordination. In addition, certain of our loans are subordinate to other debt of the portfolio company. If a portfolio company defaults on our loan or on debt senior to our loan, or in the event of a portfolio company bankruptcy, our loan will be satisfied only after the senior debt receives payment. Where debt senior to our loan exists, the presence of inter-creditor arrangements may limit our ability to amend our loan documents, assign our loans, accept prepayments, exercise our remedies (through “standstill” periods) and control decisions made in bankruptcy proceedings relating to the portfolio company. Bankruptcy and portfolio company litigation can significantly increase collection losses and the time needed for us to acquire the underlying collateral in the event of a default, during which time the collateral may decline in value, causing us to suffer further losses. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the value of the collateral underlying our loan declines or interest rates increase during the term of our loan, a portfolio company may not be able to obtain the necessary funds to repay our loan at maturity through refinancing. Decreasing collateral value and/or periods of increasing interest rates, such as the current economic period, may hinder a portfolio company’s ability to refinance our loan because the underlying collateral cannot satisfy the debt service coverage requirements necessary to obtain new financing. If a borrower is unable to repay our loan at maturity, we could suffer a loss which may adversely impact our financial performance. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">The business, financial condition and results of operations of our portfolio companies could be adversely affected by worldwide economic conditions, as well as political and economic conditions in the countries in which they conduct business. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The business and operating results of our portfolio companies may be impacted by worldwide economic conditions, such as the economic impact that <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the COVID-19 pandemic</div> and the Russian invasion of Ukraine have imposed, and may continue to impose, on the U.S. and worldwide economy. Any deterioration of general economic conditions may lead to significant declines in corporate earnings or loan performance, and the ability of corporate borrowers to service their debt, any of which could trigger a period of global economic slowdown, and have an adverse impact on our performance and financial results, and the value and the liquidity of our investments. In an economic downturn, we could <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">have non-performing assets</div> or an increase <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">in non-performing assets,</div> and we would anticipate that the value of our portfolio would decrease during these periods. For instance, concerns of economic slowdown in China and other emerging markets and signs of deteriorating sovereign debt conditions in Europe could lead to disruption and instability in the global financial markets. The significant debt in the United States and European countries is expected to hinder growth in those countries for the foreseeable future. In the future, the U.S. government may not be able to meet its debt payments unless the federal debt ceiling is raised. If legislation increasing the debt ceiling is not enacted, as needed, and the debt ceiling is reached, the U.S. federal government may stop or delay making payments on its obligations. Any default by the U.S. government on its obligations or any prolonged U.S. government shutdown could negatively impact the U.S. economy and our portfolio companies. Multiple factors relating to the international operations of some of our portfolio companies and to particular countries in which they operate could negatively impact their business, financial condition and results of operations. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Some of the products of our portfolio companies are developed, manufactured, assembled, tested or marketed outside the United States. Any conflict or uncertainty in these countries, including due to natural disasters, public health concerns (including <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the global COVID-19 pandemic), political</div> unrest or safety concerns, could harm their business, financial condition and results of operations. In addition, if the government of any country in which their products are developed, manufactured or sold sets technical or regulatory standards for products developed or manufactured in or imported into their country that are not widely shared, it may lead some of their customers to suspend imports of their products into that country, require manufacturers or developers in that country to manufacture or develop products with different technical or regulatory standards and disrupt cross-border manufacturing, marketing or business relationships which, in each case, could harm their businesses. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our failure <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">to make follow-on investments in</div> our portfolio companies could impair the value of our portfolio. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">Following an initial investment in a portfolio company, we may make additional investments in that portfolio <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">company as “follow-on” investments, in</div> order to: (i) increase or maintain in whole or in part our ownership percentage; (ii) exercise warrants, options or convertible securities that were acquired in the original or subsequent financing; or (iii) attempt to preserve or enhance the value of our investment. We may elect not <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">to make follow-on investments or</div> otherwise lack sufficient funds to make those investments. We will have the discretion to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">make any follow-on investments, subject</div> to the availability of capital resources. The failure <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">to make follow-on investments may,</div> in some circumstances, jeopardize the continued viability of a portfolio company and our initial investment, or may result in a missed opportunity for us to increase our participation in a successful operation. Even if we have sufficient capital to make <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">a desired follow-on investment, we</div> may elect not to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">make a follow-on investment because</div> we may not want to increase our concentration of risk, either because we prefer other opportunities or because we are subject to BDC requirements that would <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">prevent such follow-on investments or</div> the desire to maintain our RIC tax treatment. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Where we do not hold controlling equity interests in our portfolio companies, we may not be in a position to exercise control over our portfolio companies or to prevent decisions by management of our portfolio companies that could decrease the value of our investments. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Although we hold controlling equity positions in some of our portfolio companies, we do not currently hold controlling equity positions in the majority of our portfolio companies. As a result, we are subject to the risk that a portfolio company in which we do not have a controlling interest may make business decisions with which we disagree, and that the management and/or stockholders of such portfolio company may take risks or otherwise act in ways that are adverse to our interests. Due to the lack of liquidity of the debt and equity investments that we typically hold in our portfolio companies, we may not be able to dispose of our investments in the event we disagree with the actions of a portfolio company and may therefore suffer a decrease in the value of our investments. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Prepayments of our debt investments by our portfolio companies could adversely impact our results of operations and reduce our return on equity. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We are subject to the risk that the investments we make in our portfolio companies may be prepaid prior to maturity. When this occurs, we may reduce our borrowings outstanding or reinvest these proceeds in temporary investments, pending their future investment in new portfolio companies. These temporary investments, if any, will typically have substantially lower yields than the debt investment being prepaid and we could experience significant delays in reinvesting these amounts. Any future investment in a new portfolio company may also be at lower yields than the debt investment that was prepaid. As a result, our results of operations could be materially adversely affected if one or more of our portfolio companies elect to prepay amounts owed to us. Additionally, prepayments could negatively impact our return on equity, which could result in a decline in the market price of our common stock. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may choose to waive or defer enforcement of covenants in the debt securities held in our portfolio, which may cause us to lose all or part of our investment in these companies. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We structure the debt investments in our portfolio companies to include business and financial covenants placing affirmative and negative obligations on the operation of the company’s business and its financial condition. However, from time to time we may elect to waive breaches of these covenants, including our right to payment, or waive or defer enforcement of remedies, such as acceleration of obligations or foreclosure on collateral, depending upon the financial condition and prospects of the particular portfolio company. These actions may reduce the likelihood of our receiving the full amount of future payments of interest or principal and be accompanied by a deterioration in the value of the underlying collateral as many of these companies may have limited financial resources, may be unable to meet future obligations and may go bankrupt. This could negatively impact our ability to pay distributions, could adversely affect our results of operation and financial condition and cause the loss of all or part of your investment. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, some of the loans in which we may invest may be “covenant-lite” loans. We use the term “covenant-lite” loans to refer generally to loans that do not have a complete set of financial maintenance covenants. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Generally, “covenant-lite” loans provide borrower companies more freedom to negatively impact lenders because their covenants are incurrence-based, which means they are only tested and can only be breached following an affirmative action of the borrower, rather than by a deterioration in the borrower’s financial condition. Accordingly, to the extent we invest in “covenant-lite” loans, we may have fewer rights against a borrower and may have a greater risk of loss on such investments as compared to investments in or exposure to loans with financial maintenance covenants. </div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our loans could be subject to equitable subordination by a court which would increase our risk of loss with respect to such loans. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Courts may apply the doctrine of equitable subordination to subordinate the claim or lien of a lender against a borrower to claims or liens of other creditors of the borrower, when the lender or its affiliates is found to have engaged in unfair, inequitable or fraudulent conduct. The courts have also applied the doctrine of equitable subordination when a lender or its affiliates is found to have exerted inappropriate control over a client, including control resulting from the ownership of equity interests in a client. We have made direct equity investments or received warrants in connection with loans. Payments on one or more of our loans, particularly a loan to a client in which we may also hold an equity interest, may be subject to claims of equitable subordination. If we were deemed to have the ability to control or otherwise exercise influence over the business and affairs of one or more of our portfolio companies resulting in economic hardship to other creditors of that company, this control or influence may constitute grounds for equitable subordination and a court may treat one or more of our loans as if it were unsecured or common equity in the portfolio company. In that case, if the portfolio company were to liquidate, we would be entitled to repayment of our loan <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">on a pro-rata basis with</div> other unsecured debt or, if the effect of subordination was to place us at the level of common equity, then on an equal basis with other holders of the portfolio company’s common equity only after all of its obligations relating to its debt and preferred securities had been satisfied. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">An investment strategy focused primarily on privately held companies presents certain challenges, including the lack of available information about these companies, a dependence on the talents and efforts of only a few key portfolio company personnel and a greater vulnerability to economic downturns. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We invest primarily in privately held companies. Generally, little public information exists about these companies, and we are required to rely on the ability of SLR Capital Partners’ investment professionals to obtain adequate information to evaluate the potential returns from investing in these companies. If we are unable to uncover all material information about these companies, we may not make a fully informed investment decision, and we may lose money on our investments. Also, smaller privately held companies frequently have less diverse product lines and smaller market presence than larger competitors. These factors could adversely affect our investment returns as compared to companies investing primarily in the securities of public companies. </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our portfolio companies may incur debt that ranks equally with, or senior to, our investments in such companies. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We invest primarily in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. Our portfolio companies typically have, or may be permitted to incur, other debt that ranks equally with, or senior to, the debt securities in which we invest. By their terms, such debt instruments may provide that the holders are entitled to receive payment of interest or principal on or before the dates on which we are entitled to receive payments in respect of the debt securities in which we invest. Also, in the event of insolvency, liquidation, dissolution, reorganization or bankruptcy of a portfolio company, holders of debt instruments ranking senior to our investment in that portfolio company would typically be entitled to receive payment in full before we receive any distribution in respect of our investment. After repaying such senior creditors, such portfolio company may not have any remaining assets to use for repaying its obligation to us. In the case of debt ranking equally with debt securities in which we invest, we would have to share on an equal basis any distributions with other creditors holding such debt in the event of an insolvency, liquidation, dissolution, reorganization or bankruptcy of the relevant portfolio company. Any such limitations on the ability of our portfolio companies to make principal or interest payments to us, if at all, may reduce our net asset value and have a negative material adverse impact to our business, financial condition and results of operation. </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our investments in foreign securities may involve significant risks in addition to the risks inherent in U.S. investments. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our investment strategy contemplates potential investments in debt securities of foreign companies, including emerging market companies. Investing in foreign companies may expose us to additional risks not typically associated with investing in U.S. companies. These risks include changes in exchange control regulations, political and social instability, expropriation, imposition of foreign taxes, less liquid markets and less available information than is generally the case in the United States, higher transaction costs, less government supervision of exchanges, brokers and issuers, less developed bankruptcy laws, difficulty in enforcing contractual obligations, lack of uniform accounting and auditing standards and greater price volatility. These risks may be more pronounced for portfolio companies located or operating primarily in emerging markets, whose economies, markets and legal systems may be less developed. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Although most of our investments will be U.S. dollar-denominated, any investments denominated in a foreign currency will be subject to the risk that the value of a particular currency will change in relation to one or more other currencies. Among the factors that may affect currency values are trade balances, the level of short-term interest rates, differences in relative values of similar assets in different currencies, long-term opportunities for investment and capital appreciation, and political developments. We may employ hedging techniques to minimize these risks, but we can offer no assurance that we will, in fact, hedge currency risk, or that if we do, such strategies will be effective. </div></div></div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may expose ourselves to risks if we engage in hedging transactions. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If we engage in hedging transactions, we may expose ourselves to risks associated with such transactions. We may utilize instruments such as forward contracts, currency options and interest rate swaps, caps, collars and floors to seek to hedge against fluctuations in the relative values of our portfolio positions from changes in currency exchange rates and market interest rates. Hedging against a decline in the values of our portfolio positions does not eliminate the possibility of fluctuations in the values of such positions or prevent losses if the values of such positions decline. However, such hedging can establish other positions designed to gain from those same developments, thereby offsetting the decline in the value of such portfolio positions. Such hedging transactions may also limit the opportunity for gain if the values of the underlying portfolio positions should increase. It may not be possible to hedge against an exchange rate or interest rate fluctuation that is so generally anticipated that we are not able to enter into a hedging transaction at an acceptable price. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The success of our hedging transactions will depend on our ability to correctly predict movements in currencies and interest rates. Therefore, while we may enter into such transactions to seek to reduce currency exchange rate and interest rate risks, unanticipated changes in currency exchange rates or interest rates may result in poorer overall investment performance than if we had not engaged in any such hedging transactions. In addition, the degree of correlation between price movements of the instruments used in a hedging strategy and price movements in the portfolio positions being hedged may vary. Moreover, for a variety of reasons, we may not seek to establish a perfect correlation between such hedging instruments and the portfolio holdings being hedged. Any such imperfect correlation may prevent us from achieving the intended hedge and expose us to risk of loss. In addition, it may not be possible to hedge fully or perfectly against currency fluctuations affecting the value of securities <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">denominated in non-U.S. currencies because</div> the value of those securities is likely to fluctuate as a result of factors not related to currency fluctuations. To the extent we engage in hedging transactions, we also face the risk that counterparties to the derivative instruments we hold may default, which may expose us to unexpected losses from positions where we believed that our risk had been appropriately hedged. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our Investment Adviser may not be able to achieve the same or similar returns as those achieved for other funds it currently manages or by our senior investment professionals while they were employed at prior positions. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our Investment Adviser manages other funds, including other BDCs, and may manage other entities in the future. The track record and achievements of these other entities are not necessarily indicative of future results that will be achieved by our Investment Adviser because these other entities may have investment objectives and strategies that differ from ours. Additionally, although in the past our senior investment professionals held senior positions at a number of investment firms, their track record and achievements are not necessarily indicative of future results that will be achieved by our Investment Adviser. In their roles at such other firms, our senior investment professionals were part of investment teams, and they were not solely responsible for generating investment ideas. In addition, such investment teams arrived at investment decisions by consensus. </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may be exposed to higher risks with respect to our investments that include original issue discount or PIK interest. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Zero-coupon bonds pay interest only at maturity rather than at intervals during the life of the security. Deferred interest rate bonds generally provide for a period of delay before the regular payment of interest begins. PIK securities are debt obligations that pay “interest” in the form of other debt obligations, instead of in cash. Each of these instruments<div style="letter-spacing: 0px; top: 0px;;display:inline;"/> is normally issued and traded at a deep discount from face value. Zero-coupon bonds, deferred interest rate bonds and PIKs allow an issuer to avoid or delay the need to generate cash to meet current interest payments and, as a result, may involve greater credit risk than bonds that pay interest currently or in cash. In addition, such investments experience greater volatility in market value due to changes in interest rates than debt obligations that provide for regular payments of interest. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">To the extent we invest in original issue discount instruments, including PIK, zero coupon bonds, and debt securities with attached warrants, investors will be exposed to the risks associated with the inclusion of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">such non-cash income</div> in taxable and accounting income prior to receipt of cash, including the following: </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The interest payments deferred on a PIK loan are subject to the risk that the borrower may default when the deferred payments are due in cash at the maturity of the loan; </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The interest rates on PIK loans are higher to reflect the time-value of money on deferred interest payments and the higher credit risk of borrowers who may need to defer interest payments; </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">PIK instruments may have unreliable valuations because the accruals require judgments about ultimate collectability of the deferred payments and the value of the associated collateral; </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">An election to defer PIK income payments by adding them to principal increases our gross assets and, thus, increases future base fees to the Investment Adviser and, because income payments will then be payable on a larger principal amount, the PIK election also increases the Investment Adviser’s future income incentive fees at a compounding rate; </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Market prices of original issue discount instruments are more volatile because they are affected to a greater extent by interest rate changes than instruments that pay interest periodically in cash; </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"/></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;">The deferral of interest on a PIK loan increases <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">its loan-to-value ratio,</div></div> which is a measure of the riskiness of a loan; and </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;">Original issue discount creates the risk <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of non-refundable cash</div> payments to the Investment Adviser based <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">on non-cash accruals</div> that may never be realized. </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risks Relating to an Investment in Our Securities </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our shares may trade at a substantial discount from net asset value and may continue to do so over the long term. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Shares of BDCs may trade at a market price that is less than the net asset value that is attributable to those shares. The possibility that our shares of common stock will trade at a substantial discount from net asset value over the long term is separate and distinct from the risk that our net asset value will decrease. We cannot predict whether shares of our common stock will trade above, at or below our net asset value in the future. If our common stock trades below its net asset value, we will generally not be able to issue additional shares or sell our common stock at its market price without first obtaining the approval for such issuance from our stockholders and our independent directors. If additional funds are not available to us, we could be forced to curtail or cease our new lending and investment activities, and our net asset value could decrease and our level of distributions could be impacted. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our common stock price may be volatile and may decrease substantially. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The trading price of our common stock may fluctuate substantially. The price of our common stock that will prevail in the market may be higher or lower than the price you pay, depending on many factors, some of which are beyond our control and may not be directly related to our operating performance. These factors include, but are not limited to, the following: </div></div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">price and volume fluctuations in the overall stock market from time to time; </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">investor demand for our shares; </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">significant volatility in the market price and trading volume of securities of BDCs or other companies in our sector, which are not necessarily related to the operating performance of these companies; </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">exclusion of our common stock from certain market indices, such as the Russell 2000 Financial Services Index, which could reduce the ability of certain investment funds to own our common stock and put short-term selling pressure on our common stock; </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">changes in regulatory policies or tax guidelines with respect to RICs or BDCs; </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">failure to qualify as a RIC, or the loss of RIC tax treatment; </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">any shortfall in revenue or net income or any increase in losses from levels expected by investors or securities analysts; </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">changes, or perceived changes, in the value of our portfolio investments; </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">departures of SLR Capital Partners’ key personnel; </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">operating performance of companies comparable to us; </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">changes in the prevailing interest rates; </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">loss of a major funding source; or </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">general economic conditions and trends and other external factors. </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our businesses may be adversely affected by litigation and regulatory proceedings. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">From time to time, we may be subject to legal actions as well as various regulatory, governmental and law enforcement inquiries, investigations and subpoenas. In any such claims or actions, demands for substantial monetary damages may be asserted against us and may result in financial liability or an adverse effect on our reputation among investors. In connection with acquisitions of, and investments in, businesses complementary to our business, we have been and may be in the future subject to securities litigation or shareholder activism in connection with such acquisitions or investments. Securities litigation and shareholder activism, including potential proxy contests, could result in substantial costs and divert management’s and our board of directors’ attention and resources from our business. We may be unable to accurately estimate our exposure to litigation risk when we record balance sheet reserves for probable loss contingencies. As a result, any reserves we establish to cover any settlements or judgments may not be sufficient to cover our actual financial exposure, which may have a material impact on our results of operations or financial condition. In regulatory enforcement matters, claims for disgorgement, the imposition of penalties and the imposition of other remedial sanctions are possible. </div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">If the current period of capital market disruption and instability continues for an extended period of time, there is a risk that investors in our equity securities may not receive distributions consistent with historical levels or at all or that our distributions may not grow over time and a portion of our distributions may be a return of capital. </div></div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to make distributions on a monthly basis to our stockholders out of assets legally available for distribution. We cannot assure you that we will achieve investment results that will allow us to make a specified level of cash distributions. Our ability to pay distributions might be adversely affected by the impact of one or more of the risk factors described in this annual report. If we violate certain covenants under our existing or future credit facilities or other leverage, we may be limited in our ability to make distributions. If we declare a distribution and if more stockholders opt to receive cash distributions rather than participate in our dividend reinvestment plan, we may be forced to sell some of our investments in order to make cash distribution payments. To the extent we make distributions to stockholders that include a return of capital, such portion of the distribution essentially constitutes a return of the stockholder’s investment. Although such return of capital may not be taxable, such distributions would generally decrease a stockholder’s basis in our common stock and may therefore increase such stockholder’s tax liability for capital gains upon the future sale of such stock. A return of capital distribution may cause a stockholder to recognize a capital gain from the sale of our common stock even if the stockholder sells its shares for less than the original purchase price. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As a RIC, if we do not distribute a certain percentage of our income annually, we may suffer adverse tax consequences, <div style="display:inline;">including </div>possibly losing the U.S. federal income tax benefits allowable to RICs. We cannot assure you that you will receive distributions at a particular level or at all. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In certain cases, we may recognize income before or without receiving the accompanying cash. Depending on the amount of noncash income, this could result in difficulty satisfying the annual distribution requirement applicable to RICs. Accordingly, we may have to sell some portfolio investments at times it would not consider advantageous, raise additional debt or equity capital or reduce new investments to meet these distribution requirements. </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Due to disruptions in the economy, we may reduce or defer our dividends and choose to incur U.S. federal excise tax in order to preserve cash and maintain flexibility. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">In order to maintain our tax treatment as a RIC, we must distribute to shareholders for each taxable year at least 90% of our investment company taxable income (i.e., net ordinary income plus realized net short-term capital gains in excess of realized net long-term capital losses). If we qualify for taxation as a RIC, we generally will not be subject to corporate-level US federal income tax on our investment company taxable income and net capital gains (i.e., realized net long-term capital gains in excess of realized net short-term capital losses) that we timely distribute to shareholders. We will be subject to a 4% U.S. federal excise tax on undistributed earnings of a RIC unless we distribute each calendar year at least the sum of (i) 98.0% of our ordinary income for the calendar year, (ii) 98.2% of our capital gains in excess of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">capital losses for the one-year period ending on October 31</div> of the calendar year, and (iii) any ordinary income and net capital gains that were recognized for preceding years, but were not distributed during such years and on which we paid no U.S. federal income tax. Any net operating losses that we incur in periods during which we qualify as a RIC will not offset net capital gains (i.e., net realized long-term capital gains in excess of net realized short-term capital losses) that we are otherwise required to distribute, and we cannot pass such net operating losses through to our stockholders. In addition, net operating losses that we carry over to a taxable year in which we qualify as a RIC normally cannot offset ordinary income or capital gains. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Under the Code, we may satisfy certain of our RIC distributions with dividends paid after the end of the current year. In particular, if we pay a distribution in January of the following year that was declared in October, November, or December of the current year and is payable to shareholders of record in the current year, the dividend will be treated for all US federal income tax purposes as if it were paid on December 31 of the current year. In addition, under the Code, we may pay dividends, referred to as “spillover dividends,” that are paid during the following taxable year that will allow us to maintain our qualification for taxation as a RIC and eliminate our liability for corporate-level U.S. federal income tax. Under these spillover dividend procedures, we may defer distribution of income earned during the current year until December of the following year. For example, we may defer distributions of income earned during 2023 until as late as December 31, 2024. If we choose to pay a spillover dividend, we will incur the 4% U.S. federal excise tax on some or all of the distribution. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">Due to events such as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the COVID-19 pandemic,</div> the Russian invasion of Ukraine or other disruptions in the economy, such as the current inflationary environment, we may take certain actions with respect to the timing and amounts of our distributions in order to preserve cash and maintain flexibility. For example, we may reduce our dividends and/or defer dividends to the following taxable year. If we defer our dividends, we may choose to utilize the spillover dividend rules discussed above and incur the 4% U.S. federal excise tax on such amounts. To further preserve cash, we may combine these reductions or deferrals of dividends with one or more distributions that are payable partially in our stock as discussed below under “<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may choose to pay</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> distributions in our own stock, in which case our stockholders may be required to pay U.S. federal income taxes in excess of the cash distributions they receive.”</div></div></div></div> </div></div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may choose to pay distributions in our own common stock, in which case our stockholders may be required to pay U.S. federal income taxes in excess of the cash distributions they receive. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">We may distribute taxable distributions that are payable in part in shares of our common stock. Under certain applicable provisions of the Code and the published guidance, distributions of a publicly offered RIC that are in cash or in shares of stock at the election of stockholders may be treated as taxable distributions. The Internal Revenue Service has issued a revenue procedure indicating that this rule will apply if the total amount of cash to be distributed is not less than 20% of the total distribution. Under this revenue procedure, if too many stockholders elect to receive their distributions in cash, the cash available for distribution must be allocated among the stockholders electing to receive cash (with the balance of distributions paid in stock). In no event will any stockholder electing to receive cash, receive less than the lesser of (a) the portion of the distribution such stockholder has elected to receive in cash or (b) an amount equal to his or her entire distribution times the percentage limitation on cash available for distribution. If we decide to make any distributions consistent with this revenue procedure that are payable in part in our stock, taxable stockholders receiving such distributions will be required to include the full amount of the distribution (whether received in cash, our stock, or a combination thereof) as ordinary income (or as long-term capital gain to the extent such distribution is properly reported as a capital gain distribution) to the extent of our current and accumulated earnings and profits for U.S. federal income tax purposes. As a result, a U.S. stockholder may be required to pay tax with respect to such distributions in excess of any cash received. If a U.S. stockholder sells the stock it receives as a distribution in order to pay this tax, the sales proceeds may be less than the amount included in income with respect to the distribution, depending on the market price of our stock at the time of the sale. Furthermore, with respect to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-U.S.</div> stockholders, we may be required to withhold U.S. tax with respect to such distributions, including in respect of all or a portion of such distribution that is payable in stock. If a significant number of our stockholders determine to sell shares of our stock in order to pay taxes owed on distributions, it may put downward pressure on the trading price of our stock. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Sales of substantial amounts of our common stock in the public market may have an adverse effect on the market price of our common stock. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">The shares of our common stock beneficially owned by each of Messrs. Gross and Spohler immediately prior to completion of our initial public offering, including any shares that are attributable to such shares issued pursuant to our dividend reinvestment plan, are no longer <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">subject to lock-up restrictions that</div> each of Messrs. Gross and Spohler agreed to in connection with our initial public offering, and are generally available for resale without restriction, subject to the provisions of Rule 144 promulgated under the Securities Act. In addition, on November 30, 2010, Messrs. Gross and Spohler jointly acquired 115,000 shares of our common stock in a private placement transaction conducted in accordance with Regulation D under the Securities Act. Such shares are generally available for resale without restriction, subject to the provisions of Rule 144 promulgated under the Securities Act. Sales of substantial amounts of our common stock, or the availability of such common stock for sale, could adversely affect the prevailing market prices for our common stock. If this occurs and continues, it could impair our ability to raise additional capital through the sale of securities should we desire to do so. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may be unable to invest the net proceeds raised from any offerings on acceptable terms or allocate net proceeds from any offering of our securities in ways with which you may not agree. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We cannot assure you that we will be able to find enough appropriate investments that meet our investment criteria or that any investment we complete using the proceeds from any securities offering will produce a sufficient return. Until we identify new investment opportunities, we intend to either invest the net proceeds of future offerings in cash equivalents, U.S. government securities and other high-quality debt investments that mature in one year or less or use the net proceeds from such offerings to reduce then-outstanding obligations. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We have significant flexibility in investing the net proceeds of any offering of our securities and may use the net proceeds from an offering in ways with which you may not agree or for purposes other than those contemplated at the time of the offering. </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">The net asset value per share of our common stock may be diluted if we issue or sell shares of our common stock at prices below the then current net asset value per share of our common stock or securities to subscribe for or convertible into shares of our common stock. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We will generally not be able to issue additional shares or sell our common stock at its market price without first obtaining the approval for such issuance from our stockholders and our independent directors. Any offering of our common stock that requires stockholder approval must occur, if at all, within one year after receiving such stockholder approval. At our 2011 Annual Stockholders Meeting, our stockholders authorized us to sell or otherwise issue warrants or securities to subscribe for or convertible into shares of our common stock subject to certain limitations (including, without limitation, that the number of shares issuable does not exceed 25% of our then outstanding common stock and that the exercise or conversion price thereof is not, at the date of issuance, less than the market value per share of our common stock). Such authorization has no expiration. </div></div></div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We may also use newly issued shares to implement our dividend reinvestment plan, whether our shares are trading at a premium or at a discount to our then current net asset value per share. Any decision to issue or sell shares of our common stock below our then current net asset value per share or securities to subscribe for or convertible into shares of our common stock would be subject to the determination by our board of directors that such issuance or sale is in our and our stockholders’ best interests. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If we were to issue or sell shares of our common stock below our then current net asset value per share, such issuances or sales would result in an immediate dilution to the net asset value per share of our common stock. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">This dilution would occur as a result of the issuance or sale of shares at a price below the then current net asset value per share of our common stock and a proportionately greater decrease in the stockholders’ interest in our earnings and assets and their voting interest in us than the increase in our assets resulting from such issuance or sale. Because the number of shares of common stock that could be so issued and the timing of any issuance is not currently known, the actual dilutive effect cannot be predicted. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, if we issue warrants or securities to subscribe for or convertible into shares of our common stock, subject to certain limitations, the exercise or conversion price per share could be less than net asset value per share at the time of exercise or conversion (including through the operation of anti-dilution protections). </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Because we would incur expenses in connection with any issuance of such securities, such issuance could result in a dilution of the net asset value per share at the time of exercise or conversion. This dilution would include reduction in net asset value per share as a result of the proportionately greater decrease in the stockholders’ interest in our earnings and assets and their voting interest than the increase in our assets resulting from such issuance. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Further, if our current stockholders do not purchase any shares to maintain their percentage interest, regardless of whether such offering is above or below the then current net asset value per share, their voting power will be diluted. For example, if we sell an additional 10% of our common stock at a 5% discount from net asset value, a stockholder who does not participate in that offering for its proportionate interest will suffer net asset value dilution of up to 0.5% or $5 per $1,000 of net asset value. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Similarly, all distributions declared in cash payable to stockholders that are participants in our dividend reinvestment plan are automatically reinvested in shares of our common stock. As a result, stockholders that opt out of the dividend reinvestment plan may experience dilution over time. Stockholders who do not elect to receive distributions in shares of common stock may experience accretion to the net asset value of their shares if our shares are trading at a premium and dilution if our shares are trading at a discount. The level of accretion or discount would depend on various factors, including the proportion of our stockholders who participate in the plan, the level of premium or discount at which our shares are trading and the amount of the distribution payable to a stockholder. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">If we issue preferred stock, the net asset value and market value of our common stock may become more volatile. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We cannot assure you that the issuance of preferred stock would result in a higher yield or return to the holders of the common stock. The issuance of preferred stock would likely cause the net asset value and market value of the common stock to become more volatile. If the distribution rate on the preferred stock were to approach the net rate of return on our investment portfolio, the benefit of leverage to the holders of the common stock would be reduced. If the distribution rate on the preferred stock were to exceed the net rate of return on our portfolio, the leverage would result in a lower rate of return to the holders of common stock than if we had not issued preferred stock. Any decline in the net asset value of our investments would be borne entirely by the holders of common stock. Therefore, if the market value of our portfolio were to decline, the leverage would result in a greater decrease in net asset value to the holders of common stock than if we were not leveraged through the issuance of preferred stock. This greater net asset value decrease would also tend to cause a greater decline in the market price for the common stock. We might be in danger of failing to maintain the required asset coverage of the preferred stock or of losing our ratings on the preferred stock or, in an extreme case, our current investment income might not be sufficient to meet the distribution requirements on the preferred stock. In order to counteract such an event, we might need to liquidate investments in order to fund a redemption of some or all of the preferred stock. In addition, we would pay (and the holders of common stock would bear) all costs and expenses relating to the issuance and ongoing maintenance of the preferred stock, including higher advisory fees if our total return exceeds the distribution rate on the preferred stock. Holders of preferred stock may have different interests than holders of common stock and may at times have disproportionate influence over our affairs. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our board of directors is authorized to reclassify any unissued shares of common stock into one or more classes of preferred stock, which could convey special rights and privileges to its owners. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Under Maryland General Corporation Law and our charter, our board of directors is authorized to classify and reclassify any authorized but unissued shares of stock into one or more classes of stock, including preferred stock. Prior to issuance of shares of each class or series, the board of directors is required by Maryland law and our charter to set the preferences, conversion or other rights, </div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">voting powers, restrictions, limitations as to other distributions, qualifications and terms or conditions of redemption for each class or series. Thus, the board of directors could authorize the issuance of shares of preferred stock with terms and conditions which could have the effect of delaying, deferring or preventing a transaction or a change in control that might involve a premium price for holders of our common stock or otherwise be in their best interest. The cost of any such reclassification would be borne by our existing common stockholders. The issuance of shares of preferred stock convertible into shares of common stock might also reduce the net income and net asset value per share of our common stock upon conversion, provided, that we will only be permitted to issue such convertible preferred stock to the extent we comply with the requirements of Section 61 of the 1940 Act, including obtaining common stockholder approval. These effects, among others, could have an adverse effect on your investment in our common stock. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">Certain matters under the 1940 Act require the separate vote of the holders of any issued and outstanding preferred stock. For example, holders of preferred stock would vote separately from the holders of common stock on a proposal to cease operations as a BDC. In addition, the 1940 Act provides that holders of preferred stock are entitled to vote separately from holders of common stock to elect two preferred stock directors. In the event distributions become two full years in arrears, holders of any preferred stock would have the right to elect a majority of the directors until such arrearage is completely eliminated. Preferred stockholders also have class voting rights on certain matters, including changes in fundamental investment restrictions and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">conversion to open-end status, and</div> accordingly can veto any such changes. Restrictions imposed on the declarations and payment of distributions to the holders of our common stock and preferred stock, both by the 1940 Act and by requirements imposed by rating agencies or the terms of our credit facilities, might impair our ability to maintain our qualification for tax treatment as a RIC for U.S. federal income tax purposes. While we would intend to redeem our preferred stock to the extent necessary to enable us to distribute our income as required to maintain our qualification as a RIC, there can be no assurance that such actions could be effected in time to meet the tax requirements. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">To the extent we use debt or preferred stock to finance our investments, changes in interest rates will affect our cost of capital and net investment income. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">To the extent we borrow money, or issue preferred stock, to make investments, our net investment income will depend, in part, upon the difference between the rate at which we borrow funds or pay distributions on preferred stock and the rate at which we invest those funds. In addition, many of our debt investments and borrowings have floating interest rates that reset on a periodic basis, and many of our investments are subject to interest rate floors. As a result, we can offer no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income in the event we use debt to finance our investments. In periods of rising interest rates, such as the current economic period, our cost of funds have increased, and could continue to increase, because the interest rates on the amounts borrowed under our credit facilities or certain other financing arrangements are typically floating, except to the extent we issue fixed rate debt or preferred stock, which could reduce our net investment income, and the interest rate on investments with an interest rate floor (such as a SOFR floor) above current levels will not increase until interest rates exceed the applicable floor. We expect that our long-term fixed-rate investments will generally be financed with equity and long-term debt. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We may use interest rate risk management techniques in an effort to limit our exposure to interest rate fluctuations. Such techniques may include various interest rate hedging activities to the extent permitted by the 1940 Act. These activities could limit our ability to participate in the benefits of lower interest rates with respect to the hedged borrowings. Adverse developments resulting from changes in interest rates or hedging transactions could have a material adverse effect on our business, financial condition and results of operations. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">You should also be aware that the rise in the general level of interest rates can be expected to lead to higher interest rates applicable to our debt investments. Accordingly, such increase in interest rates makes it easier for us to meet or exceed the incentive fee hurdle rate and may result in a substantial increase of the amount of incentive fees payable to our Investment Adviser with respect to our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income. Also, an increase in interest rates available to investors could make an investment in our common stock less attractive if we are not able to increase our distribution rate, which could reduce the value of our common stock. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may in the future determine to fund a portion of our investments with preferred stock, which would magnify the potential for loss and the risks of investing in us in a similar way as our borrowings. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Preferred stock, which is another form of leverage, has the same risks to our common stockholders as borrowings because the distributions on any preferred stock we issue must be cumulative. Payment of such distributions and repayment of the liquidation preference of such preferred stock must take preference over any distributions or other payments to our common stockholders, and preferred stockholders are not subject to any of our expenses or losses and are not entitled to participate in any income or appreciation in excess of their stated preference. </div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risks Relating to Our Business and Structure </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We are dependent upon SLR Capital Partners’ key personnel for our future success. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We depend on the diligence, skill and network of business contacts of Messrs. Gross and Spohler, who serve as the managing partners of SLR Capital Partners and who lead SLR Capital Partners’ investment team. Messrs. Gross and Spohler, together with the other dedicated investment professionals available to SLR Capital Partners, evaluate, negotiate, structure, close and monitor our investments. Our future success will depend on the diligence, skill, network of business contacts and continued service of Messrs. Gross and Spohler and the other investment professionals available to SLR Capital Partners. We cannot assure you that unforeseen business, medical, personal or other circumstances would not lead any such individual to terminate his relationship with us. The loss of Mr. Gross or Mr. Spohler, or any of the other senior investment professionals who serve on SLR Capital Partners’ investment team, could have a material adverse effect on our ability to achieve our investment objective as well as on our financial condition and results of operations. In addition, we can offer no assurance that SLR Capital Partners will remain our Investment Adviser. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">The senior investment professionals of SLR Capital Partners are and may in the future become affiliated with entities engaged in business activities similar to those intended to be conducted by us, and may have conflicts of interest in allocating their time. We expect that Messrs. Gross and Spohler will dedicate a significant portion of their time to the activities of SLR Investment Corp.; however, they may be engaged in other business activities which could divert their time and attention in the future. Specifically, Mr. Gross <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">serves as Co-Chief Executive Officer</div> and President of SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC. In addition, Mr. Spohler <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">serves as Co-Chief Executive Officer</div> and Chief Operating Officer of SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our business model depends to a significant extent upon strong referral relationships with financial sponsors, and the inability of the senior investment professionals of our Investment Adviser to maintain or develop these relationships, or the failure of these relationships to generate investment opportunities, could adversely affect our business. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We expect that the principals of our Investment Adviser will maintain and develop their relationships with financial sponsors, and we will rely to a significant extent upon these relationships to provide us with potential investment opportunities. If the senior investment professionals of our Investment Adviser fail to maintain their existing relationships or develop new relationships with other sponsors or sources of investment opportunities, we will not be able to grow our investment portfolio. In addition, individuals with whom the senior investment professionals of our Investment Adviser have relationships are not obligated to provide us with investment opportunities, and, therefore, there is no assurance that such relationships will generate investment opportunities for us. If our Investment Adviser is unable to source investment opportunities, we may hold a greater percentage of our assets in cash and cash equivalents than anticipated, which could impact potential returns on our portfolio. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">A disruption in the capital markets and the credit markets could negatively affect our business. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As a BDC, we must maintain our ability to raise additional capital for investment purposes. Without sufficient access to the capital markets or credit markets, we may be forced to curtail our business operations or we may not be able to pursue new business opportunities. Disruptive conditions in the financial industry and the impact of new legislation in response to those conditions could restrict our business operations and could adversely impact our results of operations and financial condition. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If the fair value of our assets declines substantially, we may fail to maintain the asset coverage ratios imposed upon us by the 1940 Act and our existing credit facilities. Any such failure could result in an event of default and all of our debt being declared immediately due and payable and would affect our ability to issue senior securities, including borrowings, and pay distributions, which could materially impair our business operations. Our liquidity could be impaired further by an inability to access the capital markets or to draw on our credit facilities. For example, we cannot be certain that we will be able to renew our existing credit facilities as they mature or to consummate new borrowing facilities to provide capital for normal operations, including new originations. Reflecting concern about the stability of the financial markets, many lenders and institutional investors have reduced or ceased providing funding to borrowers. This market turmoil and tightening of credit have led to increased market volatility and widespread reduction of business activity generally. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If we are unable to renew or replace our existing credit facilities and consummate new facilities on commercially reasonable terms, our liquidity will be reduced significantly. If we consummate new facilities but are then unable to repay amounts outstanding under such facilities and are declared in default or are unable to renew or refinance these facilities, we would not be able to initiate significant originations or to operate our business in the normal course. These situations may arise due to circumstances that we may be unable to control, such as inaccessibility to the credit markets, a severe decline in the value of the U.S. dollar, a further economic downturn or an operational problem that affects third parties or us, and could materially damage our business. Moreover, we are unable to predict when economic and market conditions may become more favorable. Even if such conditions improve broadly and significantly over the long term, adverse conditions in particular sectors of the financial markets could adversely impact our business. </div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our financial condition and results of operations will depend on SLR Capital Partners’ ability to manage our future growth effectively by identifying, investing in and monitoring companies that meet our investment criteria. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our ability to achieve our investment objective and to grow depends on SLR Capital Partners’ ability to identify, invest in and monitor companies that meet our investment criteria. Accomplishing this result on a cost-effective basis is largely a function of SLR Capital Partners’ structuring of the investment process, its ability to provide competent, attentive and efficient services to us and its ability to access financing for us on acceptable terms. The investment team of SLR Capital Partners has substantial responsibilities under the Advisory Agreement, and they may also be called upon to provide managerial assistance to our portfolio companies as the principals of our administrator. In addition, the members of SLR Capital Partners’ investment team have similar responsibilities with respect to the management of other investment portfolios, including the investment portfolios of SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC. Such demands on their time may distract them or slow our rate of investment. In order to grow, we and SLR Capital Partners will need to retain, train, supervise and manage new investment professionals. However, we can offer no assurance that any such investment professionals will contribute effectively to the work of the Investment Adviser. Any failure to manage our future growth effectively could have a material adverse effect on our business, financial condition and results of operations. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may need to raise additional capital to grow because we must distribute most of our income. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We may need additional capital to fund growth in our investments. We expect to issue equity securities and expect to borrow from financial institutions in the future. A reduction in the availability of new capital could limit our ability to grow. We must distribute at least 90% of our investment company taxable income to our stockholders to maintain our tax treatment as a RIC. As a result, any such cash earnings may not be available to fund investment originations. We expect to borrow from financial institutions and issue additional debt and equity securities. If we fail to obtain funds from such sources or from other sources to fund our investments, it could limit our ability to grow, which may have an adverse effect on the value of our securities. In addition, as a BDC, our ability to borrow or issue additional preferred stock may be restricted if our total assets are less than 150% of our total borrowings and preferred stock. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Any failure on our part to maintain our status as a BDC would reduce our operating flexibility and we may be limited in our investment choices as a BDC. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">The 1940 Act imposes numerous constraints on the operations of BDCs. For example, BDCs are required to invest at least 70% of their total assets in specified types of securities, primarily in private companies or thinly-traded U.S. public companies, cash, cash equivalents, U.S. government securities and other high quality debt investments that mature in one year or less. Furthermore, any failure to comply with the requirements imposed on BDCs by the 1940 Act could cause the SEC to bring an enforcement action against us and/or expose us to claims of private litigants. In addition, upon approval of a majority of our stockholders, we may elect to withdraw our status as a BDC. If we decide to withdraw our election, or if we otherwise fail to qualify, or maintain our qualification, as a BDC, we may be subject to the substantially greater regulation under the 1940 Act <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as a closed-end investment company.</div> Compliance with such regulations would significantly decrease our operating flexibility, and could have a material adverse effect on our business, financial condition and results of operations. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Regulations governing our operation as a BDC affect our ability to, and the way in which we will, raise additional capital. As a BDC, the necessity of raising additional capital may expose us to risks, including the typical risks associated with leverage. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In order to satisfy the tax requirements applicable to a RIC, to avoid payment of excise taxes and to minimize or avoid payment of income taxes, we intend to distribute to our stockholders substantially all of our ordinary income and realized net capital gains except for certain realized net long-term capital gains, which we may retain, pay applicable income taxes with respect thereto and elect to treat as deemed distributions to our stockholders. We may issue debt securities or preferred stock and/or borrow money from banks or other financial institutions, which we refer to collectively as “senior securities,” up to the maximum amount permitted by the 1940 Act. Under the provisions of the 1940 Act, we had been permitted, as a BDC, to issue senior securities in amounts such that our asset coverage ratio, as defined in the 1940 Act, equals at least 200% of gross assets less all liabilities and indebtedness not represented by senior securities, after each issuance of senior securities. However, our stockholders have approved a resolution permitting us to be subject to a 150% asset coverage ratio effective as of October 12, 2018. If the value of our assets declines, we may be unable to satisfy the asset coverage test. If that happens, we may be required to sell a portion of our investments and, depending on the nature of our leverage, repay a portion of our indebtedness at a time when such sales may be disadvantageous. Also, any amounts that we use to service our indebtedness would not be available for distributions to our common stockholders. Furthermore, as a result of issuing senior securities, we would also be exposed to typical risks associated with leverage, including an increased risk of loss. In addition, because our management fee is calculated as a percentage of our gross assets, which includes any borrowings for investment purposes, the management fee expenses will increase if we incur additional indebtedness. </div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2022, we had $393.0 million outstanding under the Credit Facility, composed of $293.0 million of revolving credit and $100.0 million outstanding of term loans, and $155.2 million outstanding under our SPV Credit Facility. We also had $135.0 million outstanding of the Series F 2027 Unsecured Notes, $50.0 million outstanding of the 2027 Unsecured Notes, $75.0 million outstanding of the 2026 Unsecured Notes, $85.0 million outstanding of the 2025 Unsecured Notes, $125.0 million outstanding of the 2024 Unsecured Notes, and $75.0 million outstanding of the 2023 Unsecured Notes. If we issue preferred stock, the preferred stock would rank “senior” to common stock in our capital structure, preferred stockholders would generally vote together with common stockholders but would have separate voting rights on certain matters and might have other rights, preferences, or privileges more favorable than those of our common stockholders, and the issuance of preferred stock could have the effect of delaying, deferring or preventing a transaction or a change of control that might involve a premium price for holders of our common stock or otherwise be in your best interest. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We are not generally able to issue and sell our common stock at a price below net asset value per share. We may, however, sell our common stock, or warrants, options or rights to acquire our common stock, at a price below the then-current net asset value per share of our common stock if our board of directors determines that such sale is in the best interests of SLR Investment Corp. and its stockholders, and our stockholders approve such sale. In any such case, the price at which our securities are to be issued and sold may not be less than a price that, in the determination of our board of directors, closely approximates the market value of such securities (less any distributing commission or discount). If we raise additional funds by issuing more common stock or senior securities convertible into, or exchangeable for, our common stock, then the percentage ownership of our stockholders at that time will decrease, and you might experience dilution. This dilution would occur as a result of a proportionately greater decrease in a stockholder’s interest in our earnings and assets and voting interest in us than the increase in our assets resulting from such issuance. Because the number of future shares of common stock that may be issued below our net asset value per share and the price and timing of such issuances are not currently known, we cannot predict the actual dilutive effect of any such issuance. We cannot determine the resulting reduction in our net asset value per share of any such issuance. We also cannot predict whether shares of our common stock will trade above, at or below our net asset value. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our credit ratings may not reflect all risks of an investment in our debt securities. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our credit ratings are an assessment by third parties of our ability to pay our obligations. Consequently, real or anticipated changes in our credit ratings will generally affect the market value of our publicly issued debt securities. Our credit ratings, however, may not reflect the potential impact of risks related to market conditions generally or other factors discussed above on the market value of, or trading market for, any publicly issued debt securities. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our stockholders may experience dilution in their ownership percentage if they opt out of our dividend reinvestment plan. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">All distributions declared in cash payable to stockholders that are participants in our dividend reinvestment plan are automatically reinvested in shares of our common stock. In the event we issue new shares in connection with our dividend reinvestment plan, our stockholders that do not elect to receive distributions in shares of common stock may experience dilution in their ownership percentage over time as a result of such issuance. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We have and will continue to borrow money, which would magnify the potential for loss on amounts invested and may increase the risk of investing in us. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We borrow money as part of our business plan. Borrowings, also known as leverage, magnify the potential for loss on amounts invested and, therefore, increase the risks associated with investing in our securities. As of December 31, 2022, we had $393.0 million outstanding under the Credit Facility, composed of $293.0 million of revolving credit and $100.0 million outstanding of term loans, and $155.2 million outstanding under our SPV Credit Facility. We also had $135.0 million outstanding of the Series F 2027 Unsecured Notes, $50.0 million outstanding of the 2027 Unsecured Notes, $75.0 million outstanding of the 2026 Unsecured Notes, $85.0 million outstanding of the 2025 Unsecured Notes, $125.0 million outstanding of the 2024 Unsecured Notes, and $75.0 million outstanding of the 2023 Unsecured Notes. We may borrow from and issue senior debt securities to banks, insurance companies and other lenders in the future. Lenders of these senior securities, including the Credit Facility, the SPV Credit Facility, the Series F 2027 Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes, the 2024 Unsecured Notes, and the 2023 Unsecured Notes, will have fixed dollar claims on our assets that are superior to the claims of our common stockholders, and we would expect such lenders to seek recovery against our assets in the event of a default. If the value of our assets increases, then leveraging would cause the net asset value attributable to our common stock to increase more sharply than it would have had we not leveraged. Conversely, if the value of our assets decreases, leveraging would cause net asset value to decline more sharply than it otherwise would have had we not leveraged. Similarly, any decrease in our income would cause net income to decline more sharply than it would have had we not borrowed. Also, any increase in our income in excess of interest payable on the borrowed funds would cause our net investment income to increase more than it would without the leverage, while any decrease in our income would cause net investment income to decline more sharply than it would have had we not borrowed. Such a decline could also negatively affect </div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div/><div> <div style="background-color:white;display: inline;"> </div> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">our ability to make distribution payments on our common stock, scheduled debt payments or other payments related to our securities. Leverage is generally considered a speculative investment technique. Our ability to service any debt that we incur will depend largely on our financial performance and will be subject to prevailing economic conditions and competitive pressures. Moreover, as the management fee payable to our Investment Adviser, SLR Capital Partners, will be payable based on our gross assets, including those assets acquired through the use of leverage, SLR Capital Partners will have a financial incentive to incur leverage which may not be consistent with our stockholders’ interests. In addition, our common stockholders will bear the burden of any increase in our expenses as a result of leverage, including any increase in the management fee payable to SLR Capital Partners. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a BDC, we had generally been required to meet a coverage ratio of total assets to total borrowings and other senior securities, which include all of our borrowings and any preferred stock that we may issue in the future, of at least 200%. However, our stockholders have approved a resolution permitting us to be subject to a 150% asset coverage ratio effective as of October 12, 2018. Even though we are subject to a 150% asset coverage ratio effective as of October 12, 2018, contractual leverage limitations under our existing credit facilities or future borrowings may limit our ability to incur additional indebtedness. On August 28, 2019, we entered into the Credit Agreement, which was amended on December 28, 2021, which permits 150% asset coverage. Some of our wholly and/or substantially owned portfolio companies, including Kingsbridge Holdings, LLC, SLR Credit Solutions, SLR Equipment Finance, SLR Business Credit and SLR Healthcare ABL, may incur significantly more leverage than we can but we do not consolidate Kingsbridge Holdings, LLC, SLR Credit Solutions, SLR Equipment Finance, SLR Business Credit and SLR Healthcare ABL and their <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">leverage is non-recourse to us.</div> Additionally, the Credit Facility and the SPV Credit Facility require us to comply with certain financial and other restrictive covenants including maintaining an asset coverage ratio of not less than 150% at any time. Failure to maintain compliance with these covenants could result in an event of default and all of our debt being declared immediately due and payable. If this ratio declines below 150%, we may not be able to incur additional debt and could be required by law to sell a portion of our investments to repay some debt when it is disadvantageous to do so, which could have a material adverse effect on our operations, and we may not be able to make distributions. The amount of leverage that we employ will depend on our Investment Adviser’s and our board of directors’ assessment of the market and other factors at the time of any proposed borrowing. We cannot assure you that we will be able to obtain credit at all or on terms acceptable to us. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, our credit facilities impose, and any other debt facility into which we may enter would likely impose, financial and operating covenants that restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain RIC tax treatment under Subchapter M of the Code. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The debt securities that we may issue will be governed by an indenture or other instrument containing covenants restricting our operating flexibility. We, and indirectly our stockholders, bear the cost of issuing and servicing such debt securities. Any convertible or exchangeable securities that we issue in the future may have rights, preferences and privileges more favorable than those of our common stock. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Illustration.</div></div> The following table illustrates the effect of leverage on returns from an investment in our common stock assuming various annual returns on our portfolio, net of interest expense. The calculations in the table below are hypothetical and actual returns may be higher or lower than those appearing in the table below. </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:82%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="18" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Assumed total return<br/>(net of interest expense)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(10)%</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(5)%</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">0%</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5%</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">10%</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corresponding return to stockholder(1)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(29.9</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(17.2</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4.5</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8.2</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20.9</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table><div style="font-size: 10pt;;display:inline;"/> <div style="width: 11%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;;text-indent: 0px;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="display:inline;">(1)</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;">Assumes $2.5 billion in total assets and $1.1 billion in total debt outstanding, which reflects our total assets and total debt outstanding as of December 31, 2022, and a cost of funds of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">4.09%. Excludes non-leverage related expenses.</div> </div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In<div style="display:inline;"> </div></div></div><div style="font-size: 10pt;;display:inline;">order for us to cover our annual interest payments on our outstanding indebtedness at December 31, 2022, we must achieve annual returns on our December 31, 2022 total assets of at least 1.8%.</div></div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">It is likely that the terms of any current or future long-term or revolving credit or warehouse facility we may enter into in the future could constrain our ability to grow our business. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our current lenders have, and any future lender or lenders may have, fixed dollar claims on our assets that are senior to the claims of our stockholders and, thus, will have a preference over our stockholders with respect to our assets in the collateral pool. Our current credit facilities and borrowings also subject us to various financial and operating covenants, including, but not limited to, maintaining certain financial ratios and minimum tangible net worth amounts. Future credit facilities and borrowings will likely subject us to similar or additional covenants. In addition, we may grant a security interest in our assets in connection with any such credit facilities and borrowings. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our credit facilities generally contain customary default provisions such as a minimum net worth amount, a profitability test, and a restriction on changing our business and loan quality standards. In addition, our credit facilities require or are expected to require the repayment of all outstanding debt on the maturity, which may disrupt our business and potentially the business of our portfolio companies that are financed through our credit facilities. An event of default under our credit facilities would likely result, among other things, in termination of the availability of further funds under our credit facilities and accelerated maturity dates for all amounts outstanding under our credit facilities, which would likely disrupt our business and, potentially, the business of the portfolio companies whose loans we finance through our credit facilities. This could reduce our revenues and, by delaying any cash payment allowed to us under our credit facilities until the lender has been paid in full, reduce our liquidity and cash flow and impair our ability to grow our business and maintain RIC tax treatment. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The terms of future available financing may place limits on our financial and operational flexibility. If we are unable to obtain sufficient capital in the future, we may be forced to reduce or discontinue our operations, not be able to make new investments, or otherwise respond to changing business conditions or competitive pressures. </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our quarterly and annual operating results are subject to fluctuation as a result of the nature of our business, and if we fail to achieve our investment objective, the net asset value of our common stock may decline. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We could experience fluctuations in our quarterly and annual operating results due to a number of factors, some of which are beyond our control, including, but not limited to, the interest rate payable on the debt securities that we acquire, the default rate on such securities, the level of our expenses, variations in and the timing of the recognition of realized and unrealized gains or losses, changes in our portfolio composition, the degree to which we encounter competition in our markets, market volatility in our publicly traded securities and the securities of our portfolio companies, and general economic conditions. As a result of these factors, results for any period should not be relied upon as being indicative of performance in future periods. In addition, any of these factors could negatively impact our ability to achieve our investment objectives, which may cause our net asset value of our common stock to decline. </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our investments may be in portfolio companies that may have limited operating histories and financial resources. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;">We expect that our portfolio will continue to consist of investments that may have relatively limited operating histories. These companies may be particularly vulnerable to U.S. and foreign economic downturns such as the U.S. recession that <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">began in mid-2007, the European</div> financial crisis, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">and the COVID-19 related economic</div> downturn, may have more limited access to capital and higher funding costs, may have a weaker financial position and may need more capital to expand or compete. These businesses also may experience substantial variations in operating results. They may face intense competition, including from companies with greater financial, technical and marketing resources. Furthermore, some of these companies do business in regulated industries and could be affected by changes in government regulation. Accordingly, these factors could impair their cash flow or result in other events, such as bankruptcy, which could limit their ability to repay their obligations to us, and may adversely affect the return on, or the recovery of, our investment in these companies. We cannot assure you that any of our investments in our portfolio companies will be successful. Our portfolio companies compete with larger, more established companies with greater access to, and resources for, further development in these new technologies. Therefore, we may lose our entire investment in any or all of our portfolio companies. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">There will be uncertainty as to the value of our portfolio investments, which may impact our net asset value. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;">A large percentage of our portfolio investments are in the form of securities that are not publicly traded. The fair value of securities and other investments that are not publicly traded may not be readily determinable. We value these securities on a quarterly basis in accordance with our valuation policy, which is at all times consistent with GAAP. Our board of directors will (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services; (5) oversee the reporting required by Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-5</div> under the 1940 Act; and (6) maintain recordkeeping requirements under Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-5.</div> Our board of directors utilizes the services of third-party valuation firms to aid it in determining the fair value of material assets. The board of directors discusses valuations and determines the fair value in good faith based on the input of our Investment Adviser and, when utilized, the respective third-party valuation firms. The factors that may be considered in fair value pricing our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments and its earnings, the markets in which the portfolio company does business, comparisons to publicly traded companies, discounted cash flow and other relevant factors. Because such valuations, and particularly valuations of private securities and private companies, are inherently uncertain, may fluctuate over short periods of time and may be based on estimates, our determinations of fair value may differ materially from the values that would have been used if a ready market for these securities existed. Our net asset value could be adversely affected if our determinations regarding the fair value of our investments were materially higher than the values that we ultimately realize upon the disposal of such securities. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our equity ownership in a portfolio company may represent a control investment. Our ability to exit an investment in a timely manner because we are in a control position or have access to inside information in the portfolio company could result in a realized loss on the investment. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If we obtain a control investment in a portfolio company our ability to divest ourselves from a debt or equity investment could be restricted due to illiquidity in a private stock, limited trading volume on a public company’s stock, inside information on a company’s performance, insider blackout periods, or other factors that could prohibit us from disposing of the investment as we would if it were not a control investment. Additionally, we may choose not to take certain actions to protect a debt investment in a control investment portfolio company. As a result, we could experience a decrease in the value of our portfolio company holdings and potentially incur a realized loss on the investment. </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">There are significant potential conflicts of interest, including SLR Capital Partners’ management of other investment funds such as SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC, which could impact our investment returns, and an investment in SLR Investment Corp. is not an investment in SCP Private Credit Income BDC LLC, SLR HC BDC LLC, or SLR Private Credit BDC II LLC. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;">Our executive officers and directors, as well as the current and future partners of our Investment Adviser, SLR Capital Partners, may serve as officers, directors or principals of entities that operate in the same or a related line of business as we do. For example, SLR Capital Partners presently serves as the Investment Adviser to (i) SCP Private Credit Income BDC LLC, an unlisted BDC that focuses on investing primarily in senior secured <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">loans, including non-traditional asset-based loans</div> and first lien loans, (ii) SLR HC BDC LLC, an unlisted BDC whose principal focus is to invest directly and indirectly in senior secured loans and other debt instruments typically to middle market companies within the healthcare industry, and (iii) SLR Private Credit BDC II LLC, an unlisted BDC whose principal focus is to invest in first lien senior secured floating rate loans primarily to upper middle market leveraged companies with EBITDA between approximately $25 million and $250 million that have significant free cash flow and are in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cyclical</div> industries in which the Investment Adviser has significant experience. In addition, Michael S. Gross, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">our Chairman, Co-Chief Executive Officer</div> and President, Bruce <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Spohler, our Co-Chief Executive Officer</div> and Chief Operating Officer and board member, and Richard L. Peteka, our Chief Financial Officer, serve in similar capacities for SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC. Accordingly, they may have obligations to investors in those entities, the fulfillment of which obligations might not be in the best interests of us or our stockholders. In addition, we note that any affiliated investment vehicle formed in the future and managed by our Investment Adviser or its affiliates may, notwithstanding different stated investment objectives, have overlapping investment objectives with our own and, accordingly, may invest in asset classes similar to those targeted by us. As a result, SLR Capital Partners may face conflicts in allocating investment opportunities between us and such other entities. Although SLR Capital Partners will endeavor to allocate investment opportunities in a fair and equitable manner, it is possible that, in the future, we may not be given the opportunity to participate in investments made by investment funds managed by our Investment Adviser or an investment manager affiliated with our Investment Adviser. In any such case, when SLR Capital Partners identifies an investment, it will be forced to choose which investment fund should make the investment. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;">As a BDC, we were substantially limited in our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ability to co-invest in privately</div> negotiated transactions with affiliated funds until we obtained an exemptive order from the SEC. The most recent exemptive order, received on June 13, 2017 (the “Exemptive Order”), permits us to participate <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">in negotiated co-investment transactions with</div> certain affiliates, each of whose investment adviser is an investment adviser that controls, is controlled by or is under common control with SLR Capital Partners and is registered as an Investment Adviser under the Advisers Act, in a manner consistent with our investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, and pursuant to the conditions to the Exemptive Order. If we are unable to rely on the Exemptive Order for a particular opportunity, such opportunity will be allocated first to the entity whose investment strategy is the most consistent with the opportunity being allocated, and second, if the terms of the opportunity are consistent with more than one entity’s investment strategy, on an alternating basis. Although our investment professionals will endeavor to allocate investment opportunities in a fair and equitable manner, we and our common stockholders could be adversely affected to the extent investment opportunities are allocated among us and other investment vehicles managed or sponsored by, or affiliated with, our executive officers, directors and members of our Investment Adviser. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;">SLR Capital Partners and certain investment advisory affiliates may determine that an investment is appropriate for us and for one or more of those other funds. In such event, depending on the availability of such investment and other appropriate factors, SLR Capital Partners or its affiliates may determine that we <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">should invest side-by-side with one</div></div> or more other funds. Any such investments will be made only to the extent permitted by applicable law and interpretive positions of the SEC and its staff, and consistent with SLR Capital Partners’ allocation procedures. Related party transactions may occur among SLR Investment Corp., SLR Credit Solutions, Equipment Operating Leases LLC, Loyer Capital LLC, SLR Equipment Finance, SLR Business Credit, SLR Healthcare ABL, SLR Senior Lending Program LLC and SLR Senior Lending Program SPV LLC. These transactions may occur in the normal course of business. No administrative or other fees are paid to SLR Capital Partners by SLR Credit Solutions, Equipment Operating Leases LLC, Loyer Capital LLC, SLR Equipment Finance, SLR Business Credit, SLR Healthcare ABL, SLR Senior Lending Program LLC and SLR Senior Lending Program SPV LLC. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In the ordinary course of our investing activities, we pay management and incentive fees to SLR Capital Partners and reimburse SLR Capital Partners for certain expenses it incurs. As a result, investors in our common stock will invest on a “gross” basis and receive distributions on a “net” basis after expenses, resulting in a lower rate of return than an investor might achieve through direct investments. Accordingly, there may be times when the management team of SLR Capital Partners has interests that differ from those of our stockholders, giving rise to a conflict. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;">We entered into an amended and restated royalty-free license agreement on February 25, 2021 with our Investment Adviser, pursuant to which our Investment Adviser has granted <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">us a non-exclusive license to</div> use the marks “SOLAR” and “SLR.” Under the license agreement, we have the right to use the “SLR Investment” name for so long as SLR Capital Partners or one of its affiliates remains our Investment Adviser. In addition, we pay SLR Capital Management, an affiliate of SLR Capital Partners, our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions, and our allocable portion of the compensation of our chief compliance officer and our chief financial officer and their respective staffs. These arrangements create conflicts of interest that our board of directors must monitor. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our ability to enter into transactions involving derivatives and financial commitment transactions may be limited. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;">Through comprehensive new global regulatory regimes impacting derivatives (<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">e.g.</div></div>, the Dodd-Frank Act, European Market Infrastructure Regulation (“EMIR”), Markets in Financial Investments Regulation (“MIFIR”)/Markets in Financial Instruments Directive (“MIFID II”)), certain <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">over-the-counter</div></div> derivatives transactions in which we may engage are either now or will soon be subject to various requirements, such as mandatory central clearing of transactions which include additional margin requirements and in certain cases trading on electronic platforms, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-and</div> post-trade transparency reporting requirements and mandatory <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">bi-lateral</div> exchange of initial margin for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cleared</div> swaps. The Dodd-Frank Act also created new categories of regulated market participants, such as “swap dealers,” “security-based swap dealers,” “major swap participants,” and “major security-based swap participants” who are subject to significant new capital, registration, recordkeeping, reporting, disclosure, business conduct and other regulatory requirements. The EU and some other jurisdictions are implementing similar requirements. Because these requirements are new and evolving (and some of the rules are not yet final), their ultimate impact remains unclear. However, even if we are not located in a particular jurisdiction or directly subject to the jurisdiction’s derivatives regulations, we may still be impacted to the extent we enter into a derivatives transaction with a regulated market participant or counterparty that is organized in that jurisdiction or otherwise subject to that jurisdiction’s derivatives regulations. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;">Based on information available as of the date of this annual report <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">on Form 10-K, the effect</div> of such requirements will be likely to (directly or indirectly) increase our overall costs of entering into derivatives transactions. In particular, new margin requirements, position limits and significantly higher capital charges resulting from new global capital regulations, even if not directly applicable to us, may cause an increase in the pricing of derivatives transactions entered into by market participants to whom such requirements apply or affect our overall ability to enter into derivatives transactions with certain counterparties. Such new global capital regulations and the need to satisfy the various requirements by counterparties are resulting in increased funding costs, increased overall transaction costs, and significantly affecting balance sheets, thereby resulting in changes to financing terms and potentially impacting our ability to obtain financing. Administrative costs, due to new requirements such as registration, recordkeeping, reporting, and compliance, even if not directly applicable to us, may also be reflected in our derivatives transactions. New requirements to trade certain derivatives transactions on electronic trading platforms and trade reporting requirements may lead to (among other things) fragmentation of the markets, higher transaction costs or reduced availability of derivatives, and/or a reduced ability to hedge, all of which could adversely affect the performance of certain of our trading strategies. In addition, changes to derivatives regulations may impact the tax and/or accounting treatment of certain derivatives, which could adversely impact us. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;">In November 2020, the SEC adopted new rules regarding the ability of a BDC (or a registered investment company) to use derivatives and other transactions that create future payment or delivery obligations. BDCs that use derivatives would be subject <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">to a value-at-risk leverage limit,</div></div> certain other derivatives risk management program and testing requirements and requirements related to board reporting. These new requirements would apply unless the BDC qualified as a “limited derivatives user,” as defined in the SEC’s adopted rules. A BDC that enters into reverse repurchase agreements or similar financing transactions would need to aggregate the amount of indebtedness associated with the reverse repurchase agreements or similar financing transactions could either (i) comply with the asset coverage requirements of the Section 18 of the 1940 Act when engaging in reverse repurchase agreements or (ii) choose to treat such agreements as derivative transactions under the adopted rule. Under the adopted rule, a BDC may enter into an unfunded commitment agreement that is not a derivatives transaction, such as an agreement to provide financing to a portfolio company, if the BDC has a reasonable belief, at the time it enters into such an agreement, that it will have sufficient cash and cash equivalents to meet its obligations with respect to all of its unfunded commitment agreements, in each case as it becomes due. If the BDC cannot meet this test, it is required to treat unfunded commitments as a derivatives transaction subject to the requirements of the rule. Collectively, these requirements may limit our ability to use derivatives and/or enter into certain other financial contracts. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may be obligated to pay our Investment Adviser incentive compensation even if we incur a loss. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;">Our Investment Adviser will be entitled to incentive compensation for each fiscal quarter in an amount equal to a percentage of the excess <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of our pre-incentive fee net</div> investment income for that quarter (before deducting incentive compensation) above a performance threshold for that quarter. Accordingly, since the performance threshold is based on a percentage of our net asset value, decreases in our net asset value make it easier to achieve the performance <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">threshold. Our pre-incentive fee net</div> investment income for incentive compensation purposes excludes realized and unrealized capital losses or depreciation that we may incur in the fiscal quarter, even if such capital losses or depreciation result in a net loss on our statement of operations for that quarter. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Thus, we may be required to pay SLR Capital Partners incentive compensation for a fiscal quarter even if there is a decline in the value of our portfolio or we incur a net loss for that quarter. </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our incentive fee may induce SLR Capital Partners to pursue speculative investments. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The incentive fee payable by us to SLR Capital Partners may create an incentive for SLR Capital Partners to pursue investments on our behalf that are riskier or more speculative than would be the case in the absence of such compensation arrangement. The incentive fee payable to our Investment Adviser is calculated based on a percentage of our return on invested capital. This may encourage our Investment Adviser to use leverage to increase the return on our investments. Under certain circumstances, the use of leverage may increase the likelihood of default, which would impair the value of our common stock. In addition, our Investment Adviser receives the incentive fee based, in part, upon net capital gains realized on our investments. Unlike that portion of the incentive fee based on income, there is no hurdle rate applicable to the portion of the incentive fee based on net capital gains. As a result, our Investment Adviser may have a tendency to invest more capital in investments that are likely to result in capital gains as compared to income producing securities. Such a practice could result in our investing in more speculative securities than would otherwise be the case, which could result in higher investment losses, particularly during economic downturns. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;">The incentive fee payable by us to our Investment Adviser also may induce SLR Capital Partners to invest on our behalf in instruments that have a deferred interest feature, even if such deferred payments would not provide the cash necessary to enable us to pay current distributions to our stockholders. Under these investments, we would accrue interest over the life of the investment but would not receive the cash income from the investment until the end of the term. Our net investment income used to calculate the income portion of our investment fee, however, includes accrued interest. Thus, a portion of this incentive fee would be based on income that we have not received in cash. In <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">addition, the “catch-up” portion of</div> the incentive fee may encourage SLR Capital Partners to accelerate or defer interest payable by portfolio companies from one calendar quarter to another, potentially resulting in fluctuations in timing and distribution amounts. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We may invest, to the extent permitted by law, in the securities and instruments of other investment companies, including private funds, and, to the extent we so invest, will bear our ratable share of any such investment company’s expenses, including management and performance fees. We will also remain obligated to pay management and incentive fees to SLR Capital Partners with respect to the assets invested in the securities and instruments of other investment companies. With respect to each of these investments, each of our stockholders will bear his or her share of the management and incentive fee of SLR Capital Partners as well as indirectly bearing the management and performance fees and other expenses of any investment companies in which we invest. </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may become subject to corporate-level U.S. federal income tax if we are unable to qualify and maintain our qualification for tax treatment as a regulated investment company under Subchapter M of the Code. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Although we have elected to be treated as a RIC under Subchapter M of the Code, no assurance can be given that we will continue to be able to qualify for and maintain RIC tax treatment. To maintain RIC tax treatment under the Code, we must meet the following annual distribution, income source and asset diversification requirements on an ongoing basis. </div></div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Annual Distribution Requirement for a RIC will be satisfied if we distribute to our stockholders on an annual basis at least 90% of our net ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any. Because we may use debt financing, we are subject to certain asset coverage ratio requirements under the 1940 Act and financial covenants under loan and credit agreements that could, under certain circumstances, restrict us from making distributions necessary to satisfy the Annual Distribution Requirement. If we are unable to obtain cash from other sources, we could fail to qualify for RIC tax treatment and become subject to corporate-level U.S federal income tax. </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The income source requirement will be satisfied if we obtain at least 90% of our income for each year from certain passive investments, including interest, dividends, gains from the sale of stock or securities, or similar sources. </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The asset diversification requirement will be satisfied if we meet certain asset diversification requirements at the end of each quarter of our taxable year. Failure to meet those requirements may result in our having to dispose of certain investments quickly in order to prevent the loss of RIC tax treatment. Because most of our investments will be relatively illiquid, any such dispositions could be made at disadvantageous prices and could result in substantial losses. </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If we fail to qualify for RIC tax treatment for any reason and become subject to corporate income tax, the resulting corporate taxes could substantially reduce our net assets, the amount of income available for distribution and the amount of our distributions. Such a failure could have a material adverse effect on us, the net asset value of our common stock and the total return, if any, obtainable from your investment in our common stock. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may have difficulty satisfying the Annual Distribution Requirement in order to qualify and maintain RIC tax treatment if we recognize income before or without receiving cash representing such income. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">In accordance with GAAP and tax requirements, we include in income certain amounts that we have not yet received in cash, such as contractual PIK interest, which represents contractual interest added to a loan balance and due at the end of such loan’s term. In addition to the cash yields received on our loans, in some instances, certain loans may also include any of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the following: end-of-term payments, exit</div></div> fees, balloon payment fees or prepayment fees. The increases in loan balances as a result of contractual PIK arrangements are included in income for the period in which such PIK interest was accrued, which is often in advance of receiving a cash payment, and are separately identified on our statements of cash flows. We also may be required to include in income certain other amounts prior to receiving the related cash. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Any warrants that we receive in connection with our debt investments will generally be valued as part of the negotiation process with the particular portfolio company. As a result, a portion of the aggregate purchase price for the debt investments and warrants will be allocated to the warrants that we receive. This will generally result in “original issue discount” for U.S. federal income tax purposes, which we must recognize as ordinary income, increasing the amount that we are required to distribute to qualify for the U.S. federal income tax benefits applicable to RICs. Because these warrants generally will not produce distributable cash for us at the same time as we are required to make distributions in respect of the related original issue discount, we would need to obtain cash from other sources or to pay a portion of our distributions using shares of newly issued common stock, consistent with Internal Revenue Service requirements, to satisfy the Annual Distribution and Excise Tax Avoidance requirements. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other features of the debt instruments that we hold may also cause such instruments to generate original issue discount, resulting in a distribution requirement in excess of current cash interest received. Since in certain cases we may recognize income before or without receiving cash representing such income, we may have difficulty meeting the RIC tax requirement to distribute at least 90% of our net ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any. Under such circumstances, we may have to sell some of our investments at times we would not consider advantageous, raise additional debt or equity capital or reduce new investment originations to meet these distribution requirements. If we are unable to obtain cash from other sources and are otherwise unable to satisfy such distribution requirements, we may fail to qualify for the U.S. federal income tax benefits allowable to RICs and, thus, become subject to a corporate-level U.S. federal income tax on all our income. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Provisions of the Maryland General Corporation Law and of our charter and bylaws could deter takeover attempts and have an adverse impact on the price of our common stock. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Maryland General Corporation Law and our charter and bylaws contain provisions that may discourage, delay or make more difficult a change in control of SLR Investment Corp. or the removal of our directors. We are subject to the Maryland Business Combination Act, subject to any applicable requirements of the 1940 Act. Our board of directors has adopted a resolution exempting from the Maryland Business Combination Act any business combination between us and any other person, subject to prior approval of such business combination by our board of directors, including approval by a majority of our disinterested directors. If the resolution exempting business combinations is repealed or our board of directors does not approve a business combination, the Maryland Business Combination Act may discourage third parties from trying to acquire control of us and increase the difficulty of consummating such an offer. Our bylaws exempt from the Maryland Control Share Acquisition Act (the “Control Share Act”) acquisitions of our stock by any person. If we amend our bylaws to repeal the exemption from the Control Share Act, the Control Share Act also may make it more difficult for a third party to obtain control of us and increase the difficulty of consummating such a transaction. The SEC staff has rescinded its position that, under the 1940 Act, an investment company may not avail itself of the Control Share Act. As a result, we will amend our bylaws to be subject to the Control Share Act only if our board of directors determines that it would be in our best interests. </div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We have also adopted measures that may make it difficult for a third party to obtain control of us, including provisions of our charter classifying our board of directors in three classes serving staggered three-year terms, and authorizing our board of directors to classify or reclassify shares of our stock in one or more classes or series, to cause the issuance of additional shares of our stock and to amend our charter without stockholder approval to increase or decrease the number of shares of stock that we have authority to issue. These provisions, as well as other provisions of our charter and bylaws, may delay, defer or prevent a transaction or a change in control that might otherwise be in the best interests of our stockholders. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The foregoing provisions are expected to discourage certain coercive takeover practices and inadequate takeover bids and to encourage persons seeking to acquire control of us to negotiate first with our board of directors. However, these provisions may deprive a stockholder of the opportunity to sell such stockholder’s shares at a premium to a potential acquirer. We believe that the benefits of these provisions outweigh the potential disadvantages of discouraging any such acquisition proposals because, among other things, the negotiation of such proposals may improve their terms. Our board of directors has considered both the positive and negative effects of the foregoing provisions and determined that they are in the best interest of our stockholders. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our bylaws designate the Circuit Court for Baltimore City, Maryland as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders and provide that claims relating to causes of action under the Securities Act may only be brought in federal district courts, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers or agents, if any, and could discourage lawsuits against us and our directors, officers and agents, if any. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Our bylaws provide that, unless we consent in writing to the selection of an alternative forum, the Circuit Court for Baltimore City, Maryland, or, if that court does not have jurisdiction, the United States District Court for the District of Maryland, Northern Division, will be the sole and exclusive forum for (a) any Internal Corporate Claim, as such term is defined in the MGCL, (b) any derivative action or proceeding brought on our behalf (other than actions arising under federal securities laws), (c) any action asserting a claim of breach of any duty owed by any of our directors, officers or other agents to us or to our stockholders, (d) any action asserting a claim against us or any of our directors, officers or other agents arising pursuant to any provision of the MGCL or our charter or bylaws or (e) any other action asserting a claim against us or any of our directors, officers or other employees that is governed by the internal affairs doctrine. With respect to any proceeding described in the foregoing sentence that is in the Circuit Court for Baltimore City, Maryland, our stockholders consent to the assignment of the proceeding to the Business and Technology Case Management Program pursuant to Maryland <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Rule 16-308 or</div> any successor thereof. None of the foregoing actions, claims or proceedings may be brought in any court sitting outside the State of Maryland unless we consent in writing to such court. Our bylaws do not apply to lawsuits asserting claims brought to enforce a duty or liability arising exclusively under the Securities Act, the 1934 Act, or the 1940 Act, or any other claim for which the federal courts have exclusive jurisdiction. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States of America shall, to the fullest extent permitted by law, be the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. This paragraph does not apply to claims arising exclusively under the 1934 Act or the 1940 Act, or any other claim for which the federal courts have exclusive jurisdiction. These exclusive forum provisions may limit the ability of our stockholders to bring a claim in a judicial forum that such stockholders find favorable for disputes with us or our directors, officers, or agents, if any, which may discourage such lawsuits against us and our directors, officers, and agents, if any. Alternatively, if a court were to find the choice of forum provisions contained in our bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could materially adversely affect our business, financial condition, and operating results. For example, under the Securities Act, federal courts have concurrent jurisdiction over all suits brought to enforce any duty or liability created by the Securities Act, and investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">The failure in cyber security systems, as well as the occurrence of events unanticipated in our disaster recovery systems and management continuity planning could impair our ability to conduct business effectively. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The occurrence of a disaster, such as a cyber-attack against us or against a third party that has access to our data or networks, a natural catastrophe, an industrial accident, failure of our disaster recovery systems, or consequential employee error, could have an adverse effect on our ability to communicate or conduct business, negatively impacting our operations and financial condition. This adverse effect can become particularly acute if those events affect our electronic data processing, transmission, storage, and retrieval systems, or impact the availability, integrity, or confidentiality of our data. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">We depend heavily upon computer systems to perform necessary business functions. Despite our implementation of a variety of security measures, our computer systems, networks, and data, like those of other companies, could be subject to cyber-attacks and unauthorized access, use, alteration, or destruction, such as from physical <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">and electronic break-ins or unauthorized</div> tampering. If one or more of these events occurs, it could potentially jeopardize the confidential, proprietary, and other information processed, stored in, </div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">and transmitted through our computer systems and networks. Such an attack could cause interruptions or malfunctions in our operations, which could result in financial losses, litigation, regulatory penalties, client dissatisfaction or loss, reputational damage, and increased costs associated with mitigation of damages and remediation. If unauthorized parties gain access to such information and technology systems, they may be able to steal, publish, delete or modify private and sensitive information, including nonpublic personal information related to stockholders (and their beneficial owners) and material nonpublic information. The systems we have implemented to manage risks relating to these types of events could prove to be inadequate and, if compromised, could become inoperable for extended periods of time, cease to function properly or fail to adequately secure private information. Breaches such as those involving covertly introduced malware, impersonation of authorized users and industrial or other espionage may not be identified even with sophisticated prevention and detection systems, potentially resulting in further harm and preventing them from being addressed appropriately. The failure of these systems or of disaster recovery plans for any reason could cause significant interruptions in our and our Investment Adviser’s operations and result in a failure to maintain the security, confidentiality or privacy of sensitive data, including personal information relating to stockholders, material nonpublic information and other sensitive information in our possession. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A disaster or a disruption in the infrastructure that supports our business, including a disruption involving electronic communications or other services used by us or third parties with whom we conduct business, or directly affecting our headquarters, could have a material adverse impact on our ability to continue to operate our business without interruption. Our disaster recovery programs may not be sufficient to mitigate the harm that may result from such a disaster or disruption. In addition, insurance and other safeguards might only partially reimburse us for our losses, if at all. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Third parties with which we do business may also be sources of cybersecurity or other technological risk. We outsource certain functions and these relationships allow for the storage and processing of our information, as well as client, counterparty, employee, and borrower information. While we engage in actions to reduce our exposure resulting from outsourcing, ongoing threats may result in unauthorized access, loss, exposure, destruction, or other cybersecurity incident that affects our data, resulting in increased costs and other consequences as described above. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, cybersecurity has become a top priority for global lawmakers and regulators around the world, and some jurisdictions have proposed or enacted laws requiring companies to notify regulators and individuals of data security breaches involving certain types of personal data. In particular, state and federal laws and regulations related to cybersecurity compliance continue to evolve and change, which may require substantial investments in new technology, software and personnel, which could affect the Company’s profitability. These changes may also result in enhanced and unforeseen consequences for cyber-related breaches and incidents, which may further adversely affect the Company’s profitability. If we fail to comply with the relevant and increasing laws and regulations, we could suffer financial losses, a disruption of our businesses, liability to investors, regulatory intervention or reputational damage. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">We and our service providers may be impacted by quarantines and similar measures being enacted by governments in response to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the global COVID-19 pandemic, which</div> are obstructing the regular functioning of business workforces (including requiring employees to work from external locations and their homes). Policies of remote working, whether by us or by our service providers, could strain technology resources, introduce operational risks and otherwise heighten the risks described above. Remote working environments may be less secure and more susceptible to hacking attacks, including phishing and social engineering attempts.</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We, our Investment Adviser and our portfolio companies are subject to risks associated with “phishing” and other cyber-attacks. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Our business and the business of our portfolio companies rely upon secure information technology systems for data processing, storage and reporting. Despite careful security and controls design, implementation and updating, ours and our portfolio companies’ information technology systems could become subject to cyber-attacks. Cyber-attacks include, but are not limited to, gaining unauthorized access to digital systems (e.g., through “hacking”, malicious software coding, social engineering or “phishing” attempts) for purposes of misappropriating assets or sensitive information, corrupting data, or causing operational disruption. The risk of a security breach or disruption, particularly through cyber-attacks or cyber intrusions, including by computer hackers, nation-state affiliated actors, and cyber terrorists, has generally increased as the number, intensity and sophistication of attempted attacks and intrusions from around the world have increased. Cyber-attacks may also be carried out in a manner that does not require gaining unauthorized access, such <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as causing denial-of service attacks</div> on websites (i.e., efforts to make network services unavailable to intended users). Our Investment Adviser’s employees have been and expect to continue to be the target of fraudulent calls, emails and other forms of potentially malicious or otherwise negatively impacting activities and attempts to gain unauthorized access to confidential, personal or other sensitive information. The result of these incidents may include disrupted operations, misstated or unreliable financial data, liability for stolen information, investigations, misappropriation of assets, increased cybersecurity protection and insurance costs, litigation and damage to our business relationships, regulatory fines or penalties, or other adverse effects on our business, financial condition or results of operations. In addition, we may be required to expend significant additional resources to modify our protective measures and to investigate and remediate vulnerabilities or other exposures arising from operational and security risks related to cyber-attacks. </div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our Investment Adviser’s and other service providers’ increased use of mobile and cloud technologies could heighten the risk of a cyber-attack as well as other operational risks, as certain aspects of the security of such technologies may be complex, unpredictable or beyond their control. Our Investment Adviser’s and other service providers’ reliance on mobile or cloud technology or any failure by mobile technology and cloud service providers to adequately safeguard their systems and prevent cyber-attacks could disrupt their operations and result in misappropriation, corruption or loss of personal, confidential or proprietary information. In addition, there is a risk that encryption and other protective measures against cyber-attacks may be circumvented, particularly to the extent that new computing technologies increase the speed and computing power available. Even the most well-protected information, networks, systems and facilities remain potentially vulnerable because the techniques used in such attempted security breaches evolve and generally are not recognized until launched against a target, and in some cases are designed not to be detected and, in fact, may not be detected. Accordingly, we and our service providers may be unable to anticipate these techniques or to implement adequate security barriers or other preventative measures, and thus it is impossible for us and our service providers to entirely mitigate this risk. Cybersecurity risks require continuous and increasing attention and other resources from us to, among other actions, identify and quantify these risks, upgrade and expand our technologies, systems and processes to adequately address such risks. Such attention diverts time and other resources from other activities and there is no assurance that our efforts will be effective. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cybersecurity incidents may adversely impact us and our stockholders. There is no guarantee that we, the Investment Adviser, and/or their respective service providers will be successful in protecting against cybersecurity incidents. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We can be highly dependent on information systems and systems failures could significantly disrupt our business, which may, in turn, negatively affect the market price of our common stock and our ability to pay distributions. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our business is highly dependent upon our and third parties’ communications and information systems. Any failure or interruption of those systems, including as a result of the termination of an agreement with any third-party service providers, could cause delays or other problems in our activities. Our financial, accounting, data processing, backup or other operating systems and facilities may fail to operate properly or become disabled or damaged as a result of a number of factors including events that are wholly or partially beyond our control and adversely affect our business. There could be: </div></div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">sudden electrical or telecommunications outages; </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">natural disasters such as earthquakes, tornadoes and hurricanes; </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">events arising from local or larger scale political or social matters, including terrorist acts; and </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">cyber-attacks. </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">These events, in turn, could have a material adverse effect on our operating results and negatively affect the market price of our common stock and our ability to pay distributions to our stockholders. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Communications with shareholders may be delivered electronically and there may be certain costs and possible risks associated with such electronic delivery. Moreover, the Investment Adviser cannot provide any assurance that these communication methods are secure and will not be responsible for any computer viruses, problems or malfunctions resulting from the use of such communication methods. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our board of directors may change our investment objective, operating policies and strategies without prior notice or stockholder approval. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our board of directors has the authority to modify or waive certain of our operating policies and strategies without prior notice (except as required by the 1940 Act) and without stockholder approval. However, absent stockholder approval, we may not change the nature of our business so as to cease to be, or withdraw our election as a BDC. We cannot predict the effect any changes to our current operating policies and strategies would have on our business, operating results and the value of our stock. Nevertheless, the effects may adversely affect our business and impact our ability to make distributions. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our business is subject to increasingly complex corporate governance, public disclosure and accounting requirements that could adversely affect our business and financial results. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We are subject to changing rules and regulations of federal and state government as well as the stock exchange on which our common stock is listed. These entities, including the Public Company Accounting Oversight Board, the SEC and the NASDAQ Stock Market, have issued a significant number of new and increasingly complex requirements and regulations over the course of the last several years and continue to develop additional regulations and requirements in response to laws enacted by Congress. Our efforts to comply with these existing requirements, or any revised or amended requirements, have resulted in, and are likely to continue to result in, an increase in expenses and a diversion of management’s time from other business activities. </div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Changes in laws or regulations governing our operations may adversely affect our business. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Changes in the laws or regulations, or the interpretations of the laws and regulations, which govern BDCs, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">RICs or non-depository commercial lenders</div> could significantly affect our operations and our cost of doing business. We are subject to federal, state and local laws and regulations and are subject to judicial and administrative decisions that affect our operations, including our loan originations, maximum interest rates, fees and other charges, disclosures to portfolio companies, the terms of secured transactions, collection and foreclosure procedures, and other trade practices. If these laws, regulations or decisions change, or if we expand our business into jurisdictions that have adopted more stringent requirements than those in which we currently conduct business, then we may have to incur significant expenses in order to comply or we may have to restrict our operations. In addition, if we do not comply with applicable laws, regulations and decisions, then we may lose licenses needed for the conduct of our business and be subject to civil fines and criminal penalties, any of which could have a material adverse effect upon our business results of operations or financial condition. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Changes to United States tariff and import/export regulations may have a negative effect on our portfolio companies and, in turn, harm us. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There has been ongoing discussion and commentary regarding potential significant changes to United States trade policies, treaties and tariffs. The current administration, along with Congress, has created significant uncertainty about the future relationship between the United States and other countries with respect to the trade policies, treaties and tariffs. These developments, or the perception that any of them could occur, may have a material adverse effect on global economic conditions and the stability of global financial markets, and may significantly reduce global trade and, in particular, trade between the impacted nations and the United States. Any of these factors could depress economic activity and restrict our portfolio companies’ access to suppliers or customers and have a material adverse effect on their business, financial condition and results of operations, which in turn would negatively impact us. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our Investment Adviser can resign on 60 days’ notice, and we may not be able to find a suitable replacement within that time, resulting in a disruption in our operations that could adversely affect our financial condition, business and results of operations. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Investment Adviser has the right, under the Advisory Agreement, to resign at any time upon 60 days written notice, whether we have found a replacement or not. If our Investment Adviser resigns, we may not be able to find a new investment adviser or hire internal management with similar experience and ability to provide the same or equivalent services on acceptable terms within 60 days, or at all. If we are unable to do so quickly, our operations are likely to experience a disruption, our financial condition, business and results of operations as well as our ability to pay distributions are likely to be adversely affected and the market price of our shares may decline. In addition, the coordination of our internal management and investment activities is likely to suffer if we are unable to identify and reach an agreement with a single institution or group of executives having the experience possessed by our Investment Adviser and its affiliates. Even if we are able to retain comparable management, whether internal or external, the integration of such management and their lack of familiarity with our investment objective may result in additional costs and time delays that may adversely affect our financial condition, business and results of operations. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">General Risk Factors </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Volatility or a prolonged disruption in the credit markets could materially damage our business. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are required to record our assets at fair value, as determined in good faith by our board of directors, in accordance with our valuation policy. As a result, volatility in the capital markets may have a material adverse effect on our valuations and our net asset value, even if we hold investments to maturity. Volatility or dislocation in the capital markets may depress our stock price below our net asset value per share and create a challenging environment in which to raise equity and debt capital. These conditions could continue for a prolonged period of time or worsen in the future. While these conditions persist, we and other companies in the financial services sector may have to access, if available, alternative markets for debt and equity capital. Equity capital may be difficult to raise because, subject to some limited exceptions which apply to us, as a BDC we are generally not able to issue additional shares of our common stock at a price less than net asset value without first obtaining approval for such issuance from our stockholders and our independent directors. Any offering of our common stock that requires stockholder approval must occur, if at all, within one year after receiving such stockholder approval. In addition, our ability to incur indebtedness (including by issuing preferred stock) is limited by applicable regulations such that our asset coverage, as defined in the 1940 Act, must equal at least 150% immediately after each time we incur indebtedness. The debt capital that will be available, if at all, may be at a higher cost and on less favorable terms and conditions in the future. Any inability to raise capital could have a negative effect on our business, financial condition and results of operations. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, our ability to incur indebtedness is limited by the asset coverage ratio for a BDC, as defined under the 1940 Act. Declining portfolio values negatively impact our ability to borrow additional funds because our net asset value is reduced for purposes of the asset coverage ratio. If the fair value of our assets declines substantially, we may fail to maintain the asset coverage ratio stipulated by the 1940 Act, which could, in turn, cause us to lose our status as a BDC and materially impair our business operations. A lengthy disruption in the credit markets could also materially decrease demand for our investments. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The significant disruption in the capital markets experienced in the past, including the disruption caused <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">by the COVID-19 pandemic</div> and the Russian invasion of Ukraine, have had, and may in the future have, a negative effect on the valuations of our investments and on the potential for liquidity events involving our investments. The debt capital that may be available to us in the future may be at a higher cost and have less favorable terms and conditions than those currently in effect. If our financing costs increase and we have no increase in interest income, then our net investment income will decrease. A prolonged inability to raise capital may require us to reduce the volume of investments we originate and could have a material adverse impact on our business, financial condition and results of operations. This may also increase the probability that other structural risks will negatively impact us. These situations may arise due to circumstances that we may be unable to control, such as a lengthy disruption in the credit markets, a severe decline in the value of the U.S. dollar, a sharp economic downturn or recession or an operational problem that affects third parties or us, and could materially damage our business, financial condition and results of operations. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Global economic, regulatory and market conditions may adversely affect our business, results of operations and financial condition, including our revenue growth and profitability. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We and our portfolio companies are subject to regulation by laws at the U.S. federal, state and local levels. These laws and regulations, as well as their interpretation, could change from time to time, including as the result of interpretive guidance or other directives from the U.S. President and others in the executive branch, and new laws, regulations and interpretations could also come into effect. Any such new or changed laws or regulations could have a material adverse effect on our business, and political uncertainty could increase regulatory uncertainty in the near term. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The effects of legislative and regulatory proposals directed at the financial services industry or affecting taxation, could negatively impact the operations, cash flows or financial condition of us and our portfolio companies, impose additional costs on us or our portfolio companies, intensify the regulatory supervision of us or our portfolio companies or otherwise adversely affect our business or the business of our portfolio companies. In addition, if we do not comply with applicable laws and regulations, we could lose any licenses that we then hold for the conduct of business and could be subject to civil fines and criminal penalties. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Over the last several years, there also has been an increase in regulatory attention to the extension of credit outside of the traditional banking sector, raising the possibility that some portion <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of the non-bank financial sector</div> will be subject to new regulation. While it cannot be known at this time whether any regulation will be implemented or what form it will take, increased <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">regulation of non-bank credit extension</div> could negatively impact our operations, cash flows or financial condition, impose additional costs on us, intensify the regulatory supervision of us or otherwise adversely affect our business, financial condition and results of operations. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although we cannot predict the impact, if any, of these changes to our business, they could adversely affect our business, financial condition, operating results and cash flows. Until we know what policy changes are made and how those changes impact business and the business of our competitors over the long term, we will not know if, overall, it will benefit from them or be negatively affected by them. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deterioration in the economic conditions in the Eurozone and other regions or countries globally and the resulting instability in global financial markets may pose a risk to our business. Financial markets have been affected at times by a number of global macroeconomic events, including the following: large sovereign debts and fiscal deficits of several countries in Europe and in emerging markets jurisdictions, levels of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-performing</div> loans on the balance sheets of European banks, the effect of the United Kingdom leaving the European Union, instability in the Chinese capital markets and the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Various social and political circumstances in the U.S. and around the world (including wars and other forms of conflict, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics), may also contribute to increased market volatility and economic uncertainties or deterioration in the U.S. and worldwide. Such events, including rising trade tensions between the United States and China, other uncertainties regarding actual and potential shifts in U.S. and foreign, trade, economic and other policies with other countries, the large-scale invasion of Ukraine by Russia that began in February 2022 and resulting sanctions or other restrictive actions that the United States and other countries have imposed against Russia, and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the COVID-19 pandemic,</div> could adversely affect our business, financial condition or results of operations. These market and economic disruptions could negatively impact the operating results of our portfolio companies. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, Russia’s invasion of Ukraine and corresponding events have had, and could continue to have, severe adverse effects on regional and global economic markets. Following Russia’s actions, various governments, including the United States, have issued broad-ranging economic sanctions against Russia, including, among other actions, a prohibition on doing business with certain Russian companies, large financial institutions, officials and oligarchs; a commitment by certain countries and the European Union to remove selected Russian banks from the Society for Worldwide Interbank Financial Telecommunications, the electronic banking network that connects banks globally; and restrictive measures to prevent the Russian Central Bank from undermining the impact of the sanctions. The duration of hostilities and the vast array of sanctions and related events (including cyberattacks and espionage) cannot be predicted. Furthermore, the conflict between the two nations and the varying involvement of the United States and other NATO countries could preclude prediction as to their ultimate adverse impact on global economic and market conditions, and, as a result, presents material uncertainty and risk with respect to markets globally, which pose potential adverse risks to us and the performance of our investments and operations, and our ability to achieve our investment objectives. Additionally, to the extent that third parties, investors, or related customer bases have material operations or assets in Russia or Ukraine, they may have adverse consequences related to the ongoing conflict. Any such market disruptions could affect our portfolio companies’ operations and, as a result, could have a material adverse effect on our business, financial condition and results of operations. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, the Federal Reserve raised the Federal Funds Rate in 2022 and in 2023, and may raise or announce its intention to raise the Federal Funds Rate further. These developments, along with the United States government’s credit and deficit concerns, global economic uncertainties and market volatility and the impacts <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of COVID-19, could</div> cause interest rates to be volatile, which may negatively impact our ability to access the debt markets and capital markets on favorable terms. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Events outside of our control, including <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the COVID-19 public</div> health crises, could negatively affect our portfolio companies and our results of our operations. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Periods of market volatility have occurred and could continue to occur in response to pandemics or other events outside of our control. These types of events have adversely affected and could continue to adversely affect operating results for us and for our portfolio companies. For example, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic has adversely impacted global commercial activity and contributed to significant volatility in the equity and debt markets. The <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic and restrictive measures taken to contain or mitigate its spread have caused, and may continue to cause, business shutdowns, or the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-introduction</div> of business shutdowns, cancellations of events and restrictions on travel, significant reductions in demand for certain goods and services, reductions in business activity and financial transactions, supply chain interruptions, labor shortages, increased inflationary pressure and overall economic and financial market instability both globally and in the United States. Many states, including those in which we and portfolio companies in which we invest may operate, have previously issued orders requiring the closure of, or certain restrictions on the operation of, certain businesses. The ultimate duration and severity of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic, including <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> variants, remain uncertain. While several countries, as well as certain states, counties and cities in the United States, relaxed the public health restrictions throughout 2021 partly as a result of the introduction of vaccines, recurring <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> outbreaks caused by different virus variants continue to lead to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-introduction</div> of certain restrictions in certain states in the United States and globally. Even after the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic subsides, the U.S. economy and most other major global economies may continue to experience a recession, and our business and operations, as well as the business and operations of the portfolio companies in which we invest, could be materially adversely affected by a prolonged recession in the U.S. and other major markets. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Despite actions of the U.S. federal government and foreign governments, the uncertainty surrounding the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic, including uncertainty regarding existing or future variants and other factors, has contributed to significant volatility in the global public equity markets and global debt capital markets. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">The continued uncertainty related to the sustainability and pace of economic recovery in the U.S. and globally could have a negative impact on our business. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our business is directly influenced by the economic cycle, and could be negatively impacted by a downturn in economic activity in the U.S. as well as globally. Fiscal and monetary actions taken by <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">U.S. and non-U.S. government and</div> regulatory authorities could have a material adverse impact on our business. To the extent uncertainty regarding the U.S. or global economy, including as a result of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the global COVID-19 pandemic, negatively</div> impacts consumer confidence and consumer credit factors, our business, financial condition and results of operations could be adversely affected. Moreover, Federal Reserve policy, including with respect to certain interest rates and the decision to end its quantitative easing policy, along with the general policies of the current Presidential administration, may also adversely affect the value, volatility and liquidity of dividend- and interest-paying securities. Market volatility, periods of rising interest rates, such as the current economic period, and/or a return to unfavorable economic conditions could adversely affect our business. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">There is uncertainty surrounding potential legal, regulatory and policy changes by new presidential administrations in the United States that may directly affect financial institutions and the global economy. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The current administration has called for significant changes to U.S. trade, healthcare, immigration, foreign and government regulatory policy. In this regard, there is significant uncertainty with respect to legislation, regulation and government policy at the federal level, as well as the state and local levels. Recent events have created a climate of heightened uncertainty and introduced new and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">difficult-to-quantify</div></div> macroeconomic and political risks with potentially <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">far-reaching</div> implications. There has been a corresponding meaningful increase in the uncertainty surrounding interest rates, inflation, foreign exchange rates, trade volumes and fiscal and monetary policy. To the extent the U.S. Congress or the current administration implements changes to U.S. policy, those changes may impact, among other things, the U.S. and global economy, international trade and relations, unemployment, immigration, corporate taxes, healthcare, the U.S. regulatory environment, inflation and other areas. Although we cannot predict the impact, if any, of these changes to our business, they could adversely affect our business, financial condition, operating results and cash flows. Until we know what policy changes are made and how those changes impact our business and the business of our competitors over the long term, we will not know if, overall, we will benefit from them or be negatively affected by them. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We are exposed to risks associated with changes in interest rates, including the transition away from LIBOR and the adoption of alternative reference rates. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although we no longer intend to lend at rates based on the London Interbank Offered Rate (“LIBOR”), we may acquire loans that continue to use LIBOR. While many LIBOR rates were phased out at the end of 2021, a selection of widely used U.S.-dollar LIBOR rates will continue to be published until June 2023. On July 29, 2021, the U.S. Federal Reserve System, in conjunction with the Alternative Reference Rates Committee, a steering committee comprised of large U.S. financial institutions, formally recommended replacing U.S.-dollar LIBOR with the Secured Overnight Financing Rate (“SOFR”), a new index calculated by short-term repurchase agreements, backed by Treasury securities. Further, on March 15, 2022, the Consolidation Appropriations Act of 2022, which includes the Adjustable Interest Rate (LIBOR) Act (“LIBOR Act”), was signed into law in the U.S. This legislation establishes a uniform benchmark replacement process for financial contracts that mature after June 30, 2023 which do not contain clearly defined or practicable fallback provisions. The legislation also creates a safe harbor that shields lenders from litigation if they choose to utilize a replacement rate recommended by the Board of Governors of the Federal Reserve. Although the transition process away from LIBOR has become increasingly well-defined (e.g. the LIBOR Act now provides a uniform benchmark replacement for LIBOR-based instruments in the U.S.), the transition process may involve, among other things, increased volatility or illiquidity in markets for instruments that currently rely on LIBOR and may result in a reduction in the value of certain instruments that we may acquire. Further, disruptions related to loans in the marketplace could have a material adverse effect on the ability of the Investment Adviser or its affiliates to enter into loans in the future in accordance with our investment strategy and have a material adverse effect on us. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Inflation and a rising interest rate environment may adversely affect the business, results of operations and financial condition of us and our portfolio companies. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The current macroeconomic environment is characterized by record-high inflation, supply chain challenges, labor shortages, high interest rates, foreign currency exchange volatility, volatility in global capital markets and growing recession risk. The risks associated with the Company’s and our portfolio companies’ businesses are more severe during periods of economic slowdown or recession. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any disruptions in the capital markets, as a result of inflation and a rising interest environment or otherwise, may increase the spread between the yields realized on risk-free and higher risk securities and can result in illiquidity in parts of the capital markets, significant write-offs in the financial sector and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-pricing</div> of credit risk in the broadly syndicated market. These and any other unfavorable economic conditions could increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, market conditions (including inflation, supply chain issues and decreased consumer demand) have adversely impacted, and could in the future further impact, the operations of certain of our portfolio companies. If the financial results of middle-market companies, like those in which we invest, experience deterioration, it could ultimately lead to difficulty in meeting debt service requirements and an increase in defaults, and further deterioration in market conditions will further depress the outlook for those companies. Further, adverse economic conditions decreased and may in the future decrease the value of collateral securing some of our loans and the value of our equity investments. Such conditions have required and may in the future require us to modify the payment terms of our investments, including changes in PIK interest provisions and/or cash interest rates. The performance of certain of our portfolio companies has been, and in the future may be, negatively impacted by these economic or other conditions, which can result in our receipt of reduced interest income from our portfolio companies and/or realized and unrealized losses related to our investments, and, in turn, may adversely affect distributable income and have a material adverse effect on our results of operations. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Inflation may cause the real value of our investments to decline. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Inflation risk results from the variation in the value of cash flows from a security due to inflation, as measured in terms of purchasing power. We are exposed to inflation risk with respect to any fixed rate investments that we make, if any, because the interest rate the issuer has to pay us is fixed for the life of the security. To the extent that interest rates reflect the expected inflation rate, floating rate loans have a lower level of inflation risk. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div/> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Technological innovations and industry disruptions may negatively impact us. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Technological innovations have disrupted traditional approaches in multiple industries and can permit younger companies to achieve success and in the process disrupt markets and market practices. We can provide no assurance that new businesses and approaches will not be created that would compete with us and/or our portfolio companies or alter the market practices in which SLR Capital Partners and its affiliates and us have been designed to function within and on which we depend on for our investment return. New approaches could damage our investments, disrupt the market in which we operate and subject us to increased competition, which could materially and adversely affect our business, financial condition and results of investments. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We are subject to risks related to corporate social responsibility. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our business (including that of our portfolio companies) faces increasing public scrutiny related to environmental, social and governance (“ESG”) activities, which are increasingly considered to contribute to reducing a company’s operational risk, market risk and reputational risk, which may in turn impact the long-term sustainability of a company’s performance. A variety of organizations measure the performance of companies on ESG topics, and the results of these assessments are widely publicized. In addition, investment in funds that specialize in companies that perform well in such assessments are increasingly popular, and major institutional investors have publicly emphasized the importance of such ESG measures to their investment decisions. We risk damage to our brand and reputation if we fail to act responsibly in a number of areas, including, but not limited to, diversity, equity and inclusion, human rights, climate change, environmental stewardship, corporate governance and considering ESG factors in our investment processes. Adverse incidents with respect to ESG activities could impact the value of our brand, our relationship with existing and future portfolio companies, the cost of our operations and relationships with investors, all of which could adversely affect our business and results of operations. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">However, regional and investor specific sentiment may differ in what constitutes a material positive or negative ESG corporate practice. There is no guarantee that the Company’s corporate social responsibility practices will uniformly fit every investor’s definition of best practices for all environmental, social and governance considerations across geographies and investor types. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is also a growing regulatory interest across jurisdictions in improving transparency regarding the definition, measurement and disclosure of ESG factors in order to allow investors to validate and better understand sustainability claims. For example, the SEC has proposed, or has announced that it is working on proposals for, rules that, among other matters, would establish a framework for reporting of climate-related risks, corporate and fund carbon emissions, broad diversity and capital management. At this time, there is uncertainty regarding the scope of such proposals or when they would become effective (if at all). In addition, in 2021 the SEC established an enforcement task force to look into ESG practices and disclosures by public companies and investment managers and has started to bring enforcement actions based on ESG disclosures not matching actual investment processes. We and our portfolio companies are subject to the risk that similar measures might be introduced in other jurisdictions in the future. Additionally, compliance with any new laws or regulations increases our regulatory burden and could make compliance more difficult and expensive, affect the manner in which we or our portfolio companies conduct our businesses and adversely affect our profitability. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">The effect of global climate change may impact the operations of our portfolio companies. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There may be evidence of global climate change. Climate change creates physical and financial risk and some of our portfolio companies may be adversely affected by climate change. For example, the needs of customers of energy companies vary with weather conditions, primarily temperature and humidity. To the extent weather conditions are affected by climate change, energy use could increase or decrease depending on the duration and magnitude of any changes. Increases in the cost of energy could adversely affect the cost of operations of our portfolio companies if the use of energy products or services is material to their business. A decrease in energy use due to weather changes may affect some of our portfolio companies’ financial condition, through decreased revenues. Extreme weather conditions in general require more system backup, adding to costs, and can contribute to increased system stresses, including service interruptions. Energy companies could also be affected by the potential for lawsuits against or taxes or other regulatory costs imposed on greenhouse gas emitters, based on links drawn between greenhouse gas emissions and climate change. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2015, the United Nations, of which the U.S. is a member, adopted a climate accord with the long-term goal of limiting global warming and the short-term goal of significantly reducing greenhouse gas emissions. As a result, some of our portfolio companies may become subject to new or strengthened regulations or legislation, which could increase their operating costs and/or decrease their revenues. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We cannot predict how changes in tax law will affect us, our investments, or our stockholders, and any such legislation could adversely affect our business. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Legislative or other actions relating to taxes could have a negative effect on us. The rules dealing with U.S. federal income taxation are constantly under review by persons involved in the legislative process and by the Internal Revenue Service and the U.S. Treasury Department. New legislation and any other tax law developments, including new or revised U.S. Treasury regulations, administrative interpretations or court decisions, could negatively and perhaps retroactively affect our ability to qualify for tax treatment as a RIC or the U.S. federal income tax consequences to us and our shareholders, or could have other adverse consequences. Investors are urged to consult with their tax advisor regarding tax legislative, regulatory, or administrative developments and proposals and their potential effect on an investment in our common stock. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Uncertainty about U.S. government initiatives could negatively impact our business, financial condition and results of operations. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">The U.S. government has recently called for significant changes to U.S. trade, healthcare, immigration, foreign and government regulatory policy. In this regard, there is significant uncertainty with respect to legislation, regulation and government policy at the federal level, as well as the state and local levels. Recent events have created a climate of heightened uncertainty and introduced <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">new and difficult-to-quantify macroeconomic and</div></div> political risks <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">with potentially far-reaching implications. There</div> has been a corresponding meaningful increase in the uncertainty surrounding interest rates, inflation, foreign exchange rates, trade volumes and fiscal and monetary policy. To the extent the U.S. Congress or the current administration implements changes to U.S. policy, those changes may impact, among other things, the U.S. and global economy, international trade and relations, unemployment, immigration, corporate taxes, healthcare, the U.S. regulatory environment, inflation and other areas. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A particular area identified as subject to potential change, amendment or repeal includes the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the “Dodd-Frank Act,” including the Volcker Rule and various swaps and derivatives regulations, credit risk retention requirements and the authorities of the Federal Reserve, the Financial Stability Oversight Council and the SEC. Given the uncertainty associated with the manner in which and whether the provisions of the Dodd-Frank Act will be implemented, repealed, amended, or replaced, the full impact such requirements will have on our business, results of operations or financial condition is unclear. The changes resulting from the Dodd-Frank Act or any changes to the regulations already implemented thereunder may require us to invest significant management attention and resources to evaluate and make necessary changes in order to comply with new statutory and regulatory requirements. Failure to comply with any such laws, regulations or principles, or changes thereto, may negatively impact our business, results of operations or financial condition. While we cannot predict what effect any changes in the laws or regulations or their interpretations would have on us as a result of recent financial reform legislation, these changes could be materially adverse to us and our stockholders. </div></div></div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Risks Relating to Our Investments </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We operate in a highly competitive market for investment opportunities. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A number of entities compete with us to make the types of investments that we target in leveraged companies. We compete with other BDCs, public and private funds, commercial and investment banks, commercial financing companies and, to the extent they provide an alternative form of financing, private equity funds. Many of our competitors are substantially larger and have considerably greater financial, technical and marketing resources than we do. For example, some competitors may have a lower cost of funds and access to funding sources that are not available to us. In addition, some of our competitors may have higher risk tolerances or different risk assessments than we have, which could allow them to consider a wider variety of investments and establish more relationships and offer better pricing and a more flexible structure than we are able to do. Furthermore, many of our potential competitors are not subject to the regulatory restrictions that the 1940 Act imposes on us as a BDC. If we are unable to source attractive investments, we may hold a greater percentage of our assets in cash and cash equivalents than anticipated, which could impact potential returns on our portfolio. We cannot assure you that the competitive pressures we face will not have a material adverse effect on our business, financial condition and results of operations. Also, as a result of this competition, we may not be able to take advantage of attractive investment opportunities from time to time, and we can offer no assurance that we will be able to identify and make investments that are consistent with our investment objective. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Participants in our industry compete on several factors, including price, flexibility in transaction structure, customer service, reputation, market knowledge and speed in decision-making. We do not seek to compete primarily based on the interest rates we will offer, and we believe that some of our competitors may make loans with interest rates that will be comparable to or lower than the rates we offer. We may lose investment opportunities if we do not match our competitors’ pricing, terms and structure. However, if we match our competitors’ pricing, terms and structure, we may experience decreased net interest income and increased risk of credit loss. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our investments are very risky and highly speculative. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We invest primarily in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Senior Secured Loans.</div></div></div></div> When we make a senior secured term loan investment in a portfolio company, we generally take a security interest in the available assets of the portfolio company, including the equity interests of its subsidiaries, which we expect to help mitigate the risk that we will not be repaid. However, there is a risk that the collateral securing our loans may decrease in value over time, may be difficult to sell in a timely manner, may be difficult to appraise and may fluctuate in value based upon the success of the business and market conditions, including as a result of the inability of the portfolio company to raise additional capital, and, in some circumstances, our lien could be subordinated to claims of other creditors. In addition, deterioration in a portfolio company’s financial condition and prospects, including its inability to raise additional capital, may be accompanied by deterioration in the value of the collateral for the loan. Consequently, the fact that a loan is secured does not guarantee that we will receive principal and interest payments according to the loan’s terms, or at all, or that we will be able to collect on the loan should we be forced to enforce our remedies. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Unsecured Loans and Preferred Securities.</div></div></div></div> Our unsecured and preferred investments are generally subordinated to senior loans and are generally unsecured. As such, other creditors may rank senior to us in the event of an insolvency. This may result in an above average amount of risk and loss of principal. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Equity Investments.</div></div></div></div> When we invest in senior secured loans, unitranche loans, unsecured loans or preferred securities, we may acquire common equity securities as well. In certain other unique circumstances we may also make equity investments in businesses that make senior loans and/or leases, such as our investments in Kingsbridge Holdings, LLC, SLR Credit Solutions, SLR Equipment </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Finance, SLR Business Credit and SLR Healthcare ABL. In addition, we may invest directly in the equity securities of portfolio companies without limitation as to market capitalization. For instance, we may invest in thinly traded companies, the prices of which may be subject to erratic market movement. Our goal is ultimately to exit such equity interests and realize gains upon our disposition of such interests. However, the equity interests we receive may not appreciate in value and, in fact, may decline in value. Accordingly, we may not be able to realize gains from our equity interests, and any gains that we do realize on the disposition of any equity interests may not be sufficient to offset any other losses we experience. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, investing in middle-market companies involves a number of significant risks, including: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">these companies may have limited financial resources and may be unable to meet their obligations under their debt securities that we hold, which may be accompanied by a deterioration in the value of any collateral and a reduction in the likelihood of us realizing any guarantees we may have obtained in connection with our investment; </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">they typically have shorter operating histories, narrower product lines and smaller market shares than larger businesses, which tend to render them more vulnerable to competitors’ actions and market conditions, as well as general economic downturns; </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">they are more likely to depend on the management talents and efforts of a small group of persons; therefore, the death, disability, resignation or termination of one or more of these persons could have a material adverse impact on our portfolio company and, in turn, on us; </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">they generally have less predictable operating results, may from time to time be parties to litigation, may be engaged in rapidly changing businesses with products subject to a substantial risk of obsolescence, and may require substantial additional capital to support their operations, finance expansion or maintain their competitive position. In addition, our executive officers, directors and our Investment Adviser may, in the ordinary course of business, be named as defendants in litigation arising from our investments in the portfolio companies; and </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">they may have difficulty accessing the capital markets to meet future capital needs, which may limit their ability to grow or to repay their outstanding indebtedness upon maturity. </div> </td> </tr> </table> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">The lack of liquidity in our investments may make it difficult for us to dispose of our investments at a favorable price, which may adversely affect our ability to meet our investment objectives. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We generally make investments in private companies. We invest and expect to continue investing in companies whose securities have no established trading market and whose securities are and will be subject to legal and other restrictions on resale or whose securities are and will be less liquid than are publicly-traded securities. Investments purchased by us that are liquid at the time of purchase may subsequently become illiquid due to events relating to the issuer of the investments, market events, economic conditions or investor perceptions. The illiquidity of our investments may make it difficult for us to sell such investments if the need arises. In addition, if we are required to liquidate all or a portion of our portfolio quickly, we may realize significantly less than the value at which we have previously recorded our investments. As a result, we do not expect to achieve liquidity in our investments in the near-term. However, to maintain our qualification as a BDC and as a RIC, we may have to dispose of investments if we do not satisfy one or more of the applicable criteria under the respective regulatory frameworks. Domestic and foreign markets are complex and interrelated, so that events in one sector of the world markets or economy, or in one geographical region, can reverberate and have materially negative consequences for other markets, economic or regional sectors in a manner that may not be foreseen and which may negatively impact the liquidity of our investments and materially harm our business. In addition, we may face other restrictions on our ability to liquidate an investment in a portfolio company to the extent that we <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">have material non-public information regarding</div> such portfolio company. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our portfolio may be concentrated in a limited number of portfolio companies and industries, which will subject us to a risk of significant loss if any of these companies performs poorly or defaults on its obligations under any of its debt instruments or if there is a downturn in a particular industry. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our portfolio may be concentrated in a limited number of portfolio companies and industries. For example, as of December 31, 2022, our investments in SLR Credit Solutions, Kingsbridge Holdings, LLC and SLR Equipment Finance comprised 11.4%, 9.0% and 5.0%, respectively, of our total assets and our investments in diversified financial services and multi-sector holdings industries comprised 18.2% and 14.4%, respectively, of our total assets. Beyond the asset diversification requirements associated with our qualification as a RIC under Subchapter M of the Code, we do not have fixed guidelines for diversification, and while we are not targeting any specific industries, our investments may be concentrated in relatively few industries or portfolio companies. As a result, the aggregate returns we realize may be significantly adversely affected if a small number of investments perform poorly or if we need to write down the value of any one investment. Additionally, a downturn in any particular industry in which we are invested could also significantly impact the aggregate returns we realize. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our investments in securities rated below investment grade are speculative in nature and are subject to additional risk factors such as the increased possibility of default, illiquidity of the security, and changes in value based on changes in interest rates. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The securities that we invest in are typically rated below investment grade. Securities rated below investment grade are speculative and are often referred to as “leveraged loans,” “high yield” or “junk” securities, and may be considered “high risk” compared to debt instruments that are rated investment grade. High yield securities are regarded as having predominantly speculative characteristics with respect to the issuer’s capacity to pay interest and repay principal in accordance with the terms of the obligations and involve major risk exposure to adverse conditions. In addition, high yield securities generally offer a higher current yield than that available from higher grade issues, but typically involve greater risk. These securities are especially sensitive to adverse changes in general economic conditions, to changes in the financial condition of their issuers and to price fluctuation in response to changes in interest rates. During periods of economic downturn or rising interest rates, such as the current economic period, issuers of below investment grade instruments may experience financial stress that could adversely affect their ability to make payments of principal and interest and increase the possibility of default. The secondary market for high yield securities may not be as liquid as the secondary market for more highly rated securities. In addition, many of our debt investments will not fully amortize during their lifetime, which means that a borrower may be unable to payoff its debt due to bankruptcy or other reasons and therefore <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">we may write-off such debt</div> investment prior to its scheduled maturity. Upon such an occurrence, we may realize a loss or a substantial amount of unpaid principal and interest due upon maturity. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Price declines and illiquidity in the corporate debt markets have adversely affected, and may continue to adversely affect, the fair value of our portfolio investments, reducing our net asset value through increased net unrealized depreciation. Any unrealized depreciation that we experience on our loan portfolio may be an indication of future realized losses, which could reduce our income available for distribution and could adversely affect our ability to service our outstanding borrowings. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a BDC, we are required to carry our investments at market value or, if no market value is ascertainable, at fair value as determined in good faith by or under the direction of our board of directors. Decreases in the market values or fair values of our investments are recorded as unrealized depreciation. Any unrealized depreciation in our loan portfolio could be an indication of a portfolio company’s inability to meet its repayment obligations to us with respect to the affected loans. This could result in realized losses in the future and ultimately in reductions of our income available for distribution in future periods and could materially adversely affect our ability to service our outstanding borrowings. Depending on market conditions, we could incur substantial losses in future periods, which could further reduce our net asset value and have a material adverse impact on our business, financial condition and results of operations. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Economic sanction laws in the United States and other jurisdictions may prohibit us and our affiliates from transacting with certain countries, individuals and companies. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Economic sanction laws in the United States and other jurisdictions may prohibit us or our affiliates from transacting with certain countries, individuals and companies. In the United States, the U.S. Department of the Treasury’s Office of Foreign Assets Control administers and enforces laws, executive orders and regulations establishing U.S. economic and trade sanctions, which prohibit, among other things, transactions with, and the provision of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">services to, certain non-U.S. countries, territories, entities</div> and individuals. These types of sanctions may significantly restrict or completely prohibit investment activities in certain jurisdictions, and if we, our portfolio companies or other issuers in which we invest were to violate any such laws or regulations, we may face significant legal and monetary penalties. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Foreign Corrupt Practices Act, or FCPA, and other anti-corruption laws and regulations, as well as anti-boycott regulations, may also apply to and restrict our activities, our portfolio companies and other issuers of our investments. If an issuer or we were to violate any such laws or regulations, such issuer or we may face significant legal and monetary penalties. The U.S. government has indicated that it is particularly focused on FCPA enforcement, which may increase the risk that an issuer or us becomes the subject of such actual or threatened enforcement. In addition, certain commentators have suggested that private investment firms and the funds that they manage may face increased scrutiny and/or liability with respect to the activities of their underlying portfolio companies. As such, a violation of the FCPA or other applicable regulations by us or an issuer of our portfolio investments could have a material adverse effect on us. We are committed to complying with the FCPA and other anti-corruption laws and regulations, as well as anti-boycott regulations, to which it is subject. As a result, we may be adversely affected because of our unwillingness to enter into transactions that violate any such laws or regulations. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div/> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">If we cannot obtain additional capital because of either regulatory or market price constraints, we could be forced to curtail or cease our new lending and investment activities, our net asset value could decrease and our level of distributions and liquidity could be affected adversely. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our ability to secure additional financing and satisfy our financial obligations under indebtedness outstanding from time to time will depend upon our future operating performance, which is subject to the prevailing general economic and credit market conditions, including interest rate levels and the availability of credit generally, and financial, business and other factors, many of which are beyond our control. The worsening of current economic and capital market conditions could have a material adverse effect on our ability to secure financing on favorable terms, if at all. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we are unable to obtain debt capital, then our equity investors will not benefit from the potential for increased returns on equity resulting from leverage to the extent that our investment strategy is successful and we may be limited in our ability to make new commitments or fundings to our portfolio companies. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may suffer a loss if a portfolio company defaults on a loan and the underlying collateral is not sufficient. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of a default by a portfolio company on a secured loan, we will only have recourse to the assets collateralizing the loan. If the underlying collateral value is less than the loan amount, we will suffer a loss. In addition, we sometimes make loans that are unsecured, which are subject to the risk that other lenders may be directly secured by the assets of the portfolio company. In the event of a default, those collateralized lenders would have priority over us with respect to the proceeds of a sale of the underlying assets. In cases described above, we may lack control over the underlying asset collateralizing our loan or the underlying assets of the portfolio company prior to a default, and as a result the value of the collateral may be reduced by acts or omissions by owners or managers of the assets. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of bankruptcy of a portfolio company, we may not have full recourse to its assets in order to satisfy our loan, or our loan may be subject to equitable subordination. In addition, certain of our loans are subordinate to other debt of the portfolio company. If a portfolio company defaults on our loan or on debt senior to our loan, or in the event of a portfolio company bankruptcy, our loan will be satisfied only after the senior debt receives payment. Where debt senior to our loan exists, the presence of inter-creditor arrangements may limit our ability to amend our loan documents, assign our loans, accept prepayments, exercise our remedies (through “standstill” periods) and control decisions made in bankruptcy proceedings relating to the portfolio company. Bankruptcy and portfolio company litigation can significantly increase collection losses and the time needed for us to acquire the underlying collateral in the event of a default, during which time the collateral may decline in value, causing us to suffer further losses. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the value of the collateral underlying our loan declines or interest rates increase during the term of our loan, a portfolio company may not be able to obtain the necessary funds to repay our loan at maturity through refinancing. Decreasing collateral value and/or periods of increasing interest rates, such as the current economic period, may hinder a portfolio company’s ability to refinance our loan because the underlying collateral cannot satisfy the debt service coverage requirements necessary to obtain new financing. If a borrower is unable to repay our loan at maturity, we could suffer a loss which may adversely impact our financial performance. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">The business, financial condition and results of operations of our portfolio companies could be adversely affected by worldwide economic conditions, as well as political and economic conditions in the countries in which they conduct business. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The business and operating results of our portfolio companies may be impacted by worldwide economic conditions, such as the economic impact that <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the COVID-19 pandemic</div> and the Russian invasion of Ukraine have imposed, and may continue to impose, on the U.S. and worldwide economy. Any deterioration of general economic conditions may lead to significant declines in corporate earnings or loan performance, and the ability of corporate borrowers to service their debt, any of which could trigger a period of global economic slowdown, and have an adverse impact on our performance and financial results, and the value and the liquidity of our investments. In an economic downturn, we could <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">have non-performing assets</div> or an increase <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">in non-performing assets,</div> and we would anticipate that the value of our portfolio would decrease during these periods. For instance, concerns of economic slowdown in China and other emerging markets and signs of deteriorating sovereign debt conditions in Europe could lead to disruption and instability in the global financial markets. The significant debt in the United States and European countries is expected to hinder growth in those countries for the foreseeable future. In the future, the U.S. government may not be able to meet its debt payments unless the federal debt ceiling is raised. If legislation increasing the debt ceiling is not enacted, as needed, and the debt ceiling is reached, the U.S. federal government may stop or delay making payments on its obligations. Any default by the U.S. government on its obligations or any prolonged U.S. government shutdown could negatively impact the U.S. economy and our portfolio companies. Multiple factors relating to the international operations of some of our portfolio companies and to particular countries in which they operate could negatively impact their business, financial condition and results of operations. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Some of the products of our portfolio companies are developed, manufactured, assembled, tested or marketed outside the United States. Any conflict or uncertainty in these countries, including due to natural disasters, public health concerns (including <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the global COVID-19 pandemic), political</div> unrest or safety concerns, could harm their business, financial condition and results of operations. In addition, if the government of any country in which their products are developed, manufactured or sold sets technical or regulatory standards for products developed or manufactured in or imported into their country that are not widely shared, it may lead some of their customers to suspend imports of their products into that country, require manufacturers or developers in that country to manufacture or develop products with different technical or regulatory standards and disrupt cross-border manufacturing, marketing or business relationships which, in each case, could harm their businesses. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our failure <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">to make follow-on investments in</div> our portfolio companies could impair the value of our portfolio. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">Following an initial investment in a portfolio company, we may make additional investments in that portfolio <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">company as “follow-on” investments, in</div> order to: (i) increase or maintain in whole or in part our ownership percentage; (ii) exercise warrants, options or convertible securities that were acquired in the original or subsequent financing; or (iii) attempt to preserve or enhance the value of our investment. We may elect not <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">to make follow-on investments or</div> otherwise lack sufficient funds to make those investments. We will have the discretion to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">make any follow-on investments, subject</div> to the availability of capital resources. The failure <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">to make follow-on investments may,</div> in some circumstances, jeopardize the continued viability of a portfolio company and our initial investment, or may result in a missed opportunity for us to increase our participation in a successful operation. Even if we have sufficient capital to make <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">a desired follow-on investment, we</div> may elect not to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">make a follow-on investment because</div> we may not want to increase our concentration of risk, either because we prefer other opportunities or because we are subject to BDC requirements that would <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">prevent such follow-on investments or</div> the desire to maintain our RIC tax treatment. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Where we do not hold controlling equity interests in our portfolio companies, we may not be in a position to exercise control over our portfolio companies or to prevent decisions by management of our portfolio companies that could decrease the value of our investments. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Although we hold controlling equity positions in some of our portfolio companies, we do not currently hold controlling equity positions in the majority of our portfolio companies. As a result, we are subject to the risk that a portfolio company in which we do not have a controlling interest may make business decisions with which we disagree, and that the management and/or stockholders of such portfolio company may take risks or otherwise act in ways that are adverse to our interests. Due to the lack of liquidity of the debt and equity investments that we typically hold in our portfolio companies, we may not be able to dispose of our investments in the event we disagree with the actions of a portfolio company and may therefore suffer a decrease in the value of our investments. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Prepayments of our debt investments by our portfolio companies could adversely impact our results of operations and reduce our return on equity. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We are subject to the risk that the investments we make in our portfolio companies may be prepaid prior to maturity. When this occurs, we may reduce our borrowings outstanding or reinvest these proceeds in temporary investments, pending their future investment in new portfolio companies. These temporary investments, if any, will typically have substantially lower yields than the debt investment being prepaid and we could experience significant delays in reinvesting these amounts. Any future investment in a new portfolio company may also be at lower yields than the debt investment that was prepaid. As a result, our results of operations could be materially adversely affected if one or more of our portfolio companies elect to prepay amounts owed to us. Additionally, prepayments could negatively impact our return on equity, which could result in a decline in the market price of our common stock. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may choose to waive or defer enforcement of covenants in the debt securities held in our portfolio, which may cause us to lose all or part of our investment in these companies. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We structure the debt investments in our portfolio companies to include business and financial covenants placing affirmative and negative obligations on the operation of the company’s business and its financial condition. However, from time to time we may elect to waive breaches of these covenants, including our right to payment, or waive or defer enforcement of remedies, such as acceleration of obligations or foreclosure on collateral, depending upon the financial condition and prospects of the particular portfolio company. These actions may reduce the likelihood of our receiving the full amount of future payments of interest or principal and be accompanied by a deterioration in the value of the underlying collateral as many of these companies may have limited financial resources, may be unable to meet future obligations and may go bankrupt. This could negatively impact our ability to pay distributions, could adversely affect our results of operation and financial condition and cause the loss of all or part of your investment. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, some of the loans in which we may invest may be “covenant-lite” loans. We use the term “covenant-lite” loans to refer generally to loans that do not have a complete set of financial maintenance covenants. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Generally, “covenant-lite” loans provide borrower companies more freedom to negatively impact lenders because their covenants are incurrence-based, which means they are only tested and can only be breached following an affirmative action of the borrower, rather than by a deterioration in the borrower’s financial condition. Accordingly, to the extent we invest in “covenant-lite” loans, we may have fewer rights against a borrower and may have a greater risk of loss on such investments as compared to investments in or exposure to loans with financial maintenance covenants. </div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our loans could be subject to equitable subordination by a court which would increase our risk of loss with respect to such loans. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Courts may apply the doctrine of equitable subordination to subordinate the claim or lien of a lender against a borrower to claims or liens of other creditors of the borrower, when the lender or its affiliates is found to have engaged in unfair, inequitable or fraudulent conduct. The courts have also applied the doctrine of equitable subordination when a lender or its affiliates is found to have exerted inappropriate control over a client, including control resulting from the ownership of equity interests in a client. We have made direct equity investments or received warrants in connection with loans. Payments on one or more of our loans, particularly a loan to a client in which we may also hold an equity interest, may be subject to claims of equitable subordination. If we were deemed to have the ability to control or otherwise exercise influence over the business and affairs of one or more of our portfolio companies resulting in economic hardship to other creditors of that company, this control or influence may constitute grounds for equitable subordination and a court may treat one or more of our loans as if it were unsecured or common equity in the portfolio company. In that case, if the portfolio company were to liquidate, we would be entitled to repayment of our loan <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">on a pro-rata basis with</div> other unsecured debt or, if the effect of subordination was to place us at the level of common equity, then on an equal basis with other holders of the portfolio company’s common equity only after all of its obligations relating to its debt and preferred securities had been satisfied. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">An investment strategy focused primarily on privately held companies presents certain challenges, including the lack of available information about these companies, a dependence on the talents and efforts of only a few key portfolio company personnel and a greater vulnerability to economic downturns. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We invest primarily in privately held companies. Generally, little public information exists about these companies, and we are required to rely on the ability of SLR Capital Partners’ investment professionals to obtain adequate information to evaluate the potential returns from investing in these companies. If we are unable to uncover all material information about these companies, we may not make a fully informed investment decision, and we may lose money on our investments. Also, smaller privately held companies frequently have less diverse product lines and smaller market presence than larger competitors. These factors could adversely affect our investment returns as compared to companies investing primarily in the securities of public companies. </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our portfolio companies may incur debt that ranks equally with, or senior to, our investments in such companies. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We invest primarily in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. Our portfolio companies typically have, or may be permitted to incur, other debt that ranks equally with, or senior to, the debt securities in which we invest. By their terms, such debt instruments may provide that the holders are entitled to receive payment of interest or principal on or before the dates on which we are entitled to receive payments in respect of the debt securities in which we invest. Also, in the event of insolvency, liquidation, dissolution, reorganization or bankruptcy of a portfolio company, holders of debt instruments ranking senior to our investment in that portfolio company would typically be entitled to receive payment in full before we receive any distribution in respect of our investment. After repaying such senior creditors, such portfolio company may not have any remaining assets to use for repaying its obligation to us. In the case of debt ranking equally with debt securities in which we invest, we would have to share on an equal basis any distributions with other creditors holding such debt in the event of an insolvency, liquidation, dissolution, reorganization or bankruptcy of the relevant portfolio company. Any such limitations on the ability of our portfolio companies to make principal or interest payments to us, if at all, may reduce our net asset value and have a negative material adverse impact to our business, financial condition and results of operation. </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our investments in foreign securities may involve significant risks in addition to the risks inherent in U.S. investments. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our investment strategy contemplates potential investments in debt securities of foreign companies, including emerging market companies. Investing in foreign companies may expose us to additional risks not typically associated with investing in U.S. companies. These risks include changes in exchange control regulations, political and social instability, expropriation, imposition of foreign taxes, less liquid markets and less available information than is generally the case in the United States, higher transaction costs, less government supervision of exchanges, brokers and issuers, less developed bankruptcy laws, difficulty in enforcing contractual obligations, lack of uniform accounting and auditing standards and greater price volatility. These risks may be more pronounced for portfolio companies located or operating primarily in emerging markets, whose economies, markets and legal systems may be less developed. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Although most of our investments will be U.S. dollar-denominated, any investments denominated in a foreign currency will be subject to the risk that the value of a particular currency will change in relation to one or more other currencies. Among the factors that may affect currency values are trade balances, the level of short-term interest rates, differences in relative values of similar assets in different currencies, long-term opportunities for investment and capital appreciation, and political developments. We may employ hedging techniques to minimize these risks, but we can offer no assurance that we will, in fact, hedge currency risk, or that if we do, such strategies will be effective. </div></div></div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may expose ourselves to risks if we engage in hedging transactions. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If we engage in hedging transactions, we may expose ourselves to risks associated with such transactions. We may utilize instruments such as forward contracts, currency options and interest rate swaps, caps, collars and floors to seek to hedge against fluctuations in the relative values of our portfolio positions from changes in currency exchange rates and market interest rates. Hedging against a decline in the values of our portfolio positions does not eliminate the possibility of fluctuations in the values of such positions or prevent losses if the values of such positions decline. However, such hedging can establish other positions designed to gain from those same developments, thereby offsetting the decline in the value of such portfolio positions. Such hedging transactions may also limit the opportunity for gain if the values of the underlying portfolio positions should increase. It may not be possible to hedge against an exchange rate or interest rate fluctuation that is so generally anticipated that we are not able to enter into a hedging transaction at an acceptable price. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The success of our hedging transactions will depend on our ability to correctly predict movements in currencies and interest rates. Therefore, while we may enter into such transactions to seek to reduce currency exchange rate and interest rate risks, unanticipated changes in currency exchange rates or interest rates may result in poorer overall investment performance than if we had not engaged in any such hedging transactions. In addition, the degree of correlation between price movements of the instruments used in a hedging strategy and price movements in the portfolio positions being hedged may vary. Moreover, for a variety of reasons, we may not seek to establish a perfect correlation between such hedging instruments and the portfolio holdings being hedged. Any such imperfect correlation may prevent us from achieving the intended hedge and expose us to risk of loss. In addition, it may not be possible to hedge fully or perfectly against currency fluctuations affecting the value of securities <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">denominated in non-U.S. currencies because</div> the value of those securities is likely to fluctuate as a result of factors not related to currency fluctuations. To the extent we engage in hedging transactions, we also face the risk that counterparties to the derivative instruments we hold may default, which may expose us to unexpected losses from positions where we believed that our risk had been appropriately hedged. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our Investment Adviser may not be able to achieve the same or similar returns as those achieved for other funds it currently manages or by our senior investment professionals while they were employed at prior positions. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our Investment Adviser manages other funds, including other BDCs, and may manage other entities in the future. The track record and achievements of these other entities are not necessarily indicative of future results that will be achieved by our Investment Adviser because these other entities may have investment objectives and strategies that differ from ours. Additionally, although in the past our senior investment professionals held senior positions at a number of investment firms, their track record and achievements are not necessarily indicative of future results that will be achieved by our Investment Adviser. In their roles at such other firms, our senior investment professionals were part of investment teams, and they were not solely responsible for generating investment ideas. In addition, such investment teams arrived at investment decisions by consensus. </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may be exposed to higher risks with respect to our investments that include original issue discount or PIK interest. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Zero-coupon bonds pay interest only at maturity rather than at intervals during the life of the security. Deferred interest rate bonds generally provide for a period of delay before the regular payment of interest begins. PIK securities are debt obligations that pay “interest” in the form of other debt obligations, instead of in cash. Each of these instruments<div style="letter-spacing: 0px; top: 0px;;display:inline;"/> is normally issued and traded at a deep discount from face value. Zero-coupon bonds, deferred interest rate bonds and PIKs allow an issuer to avoid or delay the need to generate cash to meet current interest payments and, as a result, may involve greater credit risk than bonds that pay interest currently or in cash. In addition, such investments experience greater volatility in market value due to changes in interest rates than debt obligations that provide for regular payments of interest. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">To the extent we invest in original issue discount instruments, including PIK, zero coupon bonds, and debt securities with attached warrants, investors will be exposed to the risks associated with the inclusion of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">such non-cash income</div> in taxable and accounting income prior to receipt of cash, including the following: </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The interest payments deferred on a PIK loan are subject to the risk that the borrower may default when the deferred payments are due in cash at the maturity of the loan; </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The interest rates on PIK loans are higher to reflect the time-value of money on deferred interest payments and the higher credit risk of borrowers who may need to defer interest payments; </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">PIK instruments may have unreliable valuations because the accruals require judgments about ultimate collectability of the deferred payments and the value of the associated collateral; </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">An election to defer PIK income payments by adding them to principal increases our gross assets and, thus, increases future base fees to the Investment Adviser and, because income payments will then be payable on a larger principal amount, the PIK election also increases the Investment Adviser’s future income incentive fees at a compounding rate; </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Market prices of original issue discount instruments are more volatile because they are affected to a greater extent by interest rate changes than instruments that pay interest periodically in cash; </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"/></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;">The deferral of interest on a PIK loan increases <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">its loan-to-value ratio,</div></div> which is a measure of the riskiness of a loan; and </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;">Original issue discount creates the risk <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of non-refundable cash</div> payments to the Investment Adviser based <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">on non-cash accruals</div> that may never be realized. </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risks Relating to an Investment in Our Securities </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our shares may trade at a substantial discount from net asset value and may continue to do so over the long term. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Shares of BDCs may trade at a market price that is less than the net asset value that is attributable to those shares. The possibility that our shares of common stock will trade at a substantial discount from net asset value over the long term is separate and distinct from the risk that our net asset value will decrease. We cannot predict whether shares of our common stock will trade above, at or below our net asset value in the future. If our common stock trades below its net asset value, we will generally not be able to issue additional shares or sell our common stock at its market price without first obtaining the approval for such issuance from our stockholders and our independent directors. If additional funds are not available to us, we could be forced to curtail or cease our new lending and investment activities, and our net asset value could decrease and our level of distributions could be impacted. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our common stock price may be volatile and may decrease substantially. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The trading price of our common stock may fluctuate substantially. The price of our common stock that will prevail in the market may be higher or lower than the price you pay, depending on many factors, some of which are beyond our control and may not be directly related to our operating performance. These factors include, but are not limited to, the following: </div></div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">price and volume fluctuations in the overall stock market from time to time; </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">investor demand for our shares; </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">significant volatility in the market price and trading volume of securities of BDCs or other companies in our sector, which are not necessarily related to the operating performance of these companies; </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">exclusion of our common stock from certain market indices, such as the Russell 2000 Financial Services Index, which could reduce the ability of certain investment funds to own our common stock and put short-term selling pressure on our common stock; </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">changes in regulatory policies or tax guidelines with respect to RICs or BDCs; </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">failure to qualify as a RIC, or the loss of RIC tax treatment; </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">any shortfall in revenue or net income or any increase in losses from levels expected by investors or securities analysts; </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">changes, or perceived changes, in the value of our portfolio investments; </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">departures of SLR Capital Partners’ key personnel; </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">operating performance of companies comparable to us; </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">changes in the prevailing interest rates; </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">loss of a major funding source; or </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">general economic conditions and trends and other external factors. </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our businesses may be adversely affected by litigation and regulatory proceedings. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">From time to time, we may be subject to legal actions as well as various regulatory, governmental and law enforcement inquiries, investigations and subpoenas. In any such claims or actions, demands for substantial monetary damages may be asserted against us and may result in financial liability or an adverse effect on our reputation among investors. In connection with acquisitions of, and investments in, businesses complementary to our business, we have been and may be in the future subject to securities litigation or shareholder activism in connection with such acquisitions or investments. Securities litigation and shareholder activism, including potential proxy contests, could result in substantial costs and divert management’s and our board of directors’ attention and resources from our business. We may be unable to accurately estimate our exposure to litigation risk when we record balance sheet reserves for probable loss contingencies. As a result, any reserves we establish to cover any settlements or judgments may not be sufficient to cover our actual financial exposure, which may have a material impact on our results of operations or financial condition. In regulatory enforcement matters, claims for disgorgement, the imposition of penalties and the imposition of other remedial sanctions are possible. </div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">If the current period of capital market disruption and instability continues for an extended period of time, there is a risk that investors in our equity securities may not receive distributions consistent with historical levels or at all or that our distributions may not grow over time and a portion of our distributions may be a return of capital. </div></div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to make distributions on a monthly basis to our stockholders out of assets legally available for distribution. We cannot assure you that we will achieve investment results that will allow us to make a specified level of cash distributions. Our ability to pay distributions might be adversely affected by the impact of one or more of the risk factors described in this annual report. If we violate certain covenants under our existing or future credit facilities or other leverage, we may be limited in our ability to make distributions. If we declare a distribution and if more stockholders opt to receive cash distributions rather than participate in our dividend reinvestment plan, we may be forced to sell some of our investments in order to make cash distribution payments. To the extent we make distributions to stockholders that include a return of capital, such portion of the distribution essentially constitutes a return of the stockholder’s investment. Although such return of capital may not be taxable, such distributions would generally decrease a stockholder’s basis in our common stock and may therefore increase such stockholder’s tax liability for capital gains upon the future sale of such stock. A return of capital distribution may cause a stockholder to recognize a capital gain from the sale of our common stock even if the stockholder sells its shares for less than the original purchase price. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As a RIC, if we do not distribute a certain percentage of our income annually, we may suffer adverse tax consequences, <div style="display:inline;">including </div>possibly losing the U.S. federal income tax benefits allowable to RICs. We cannot assure you that you will receive distributions at a particular level or at all. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In certain cases, we may recognize income before or without receiving the accompanying cash. Depending on the amount of noncash income, this could result in difficulty satisfying the annual distribution requirement applicable to RICs. Accordingly, we may have to sell some portfolio investments at times it would not consider advantageous, raise additional debt or equity capital or reduce new investments to meet these distribution requirements. </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Due to disruptions in the economy, we may reduce or defer our dividends and choose to incur U.S. federal excise tax in order to preserve cash and maintain flexibility. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">In order to maintain our tax treatment as a RIC, we must distribute to shareholders for each taxable year at least 90% of our investment company taxable income (i.e., net ordinary income plus realized net short-term capital gains in excess of realized net long-term capital losses). If we qualify for taxation as a RIC, we generally will not be subject to corporate-level US federal income tax on our investment company taxable income and net capital gains (i.e., realized net long-term capital gains in excess of realized net short-term capital losses) that we timely distribute to shareholders. We will be subject to a 4% U.S. federal excise tax on undistributed earnings of a RIC unless we distribute each calendar year at least the sum of (i) 98.0% of our ordinary income for the calendar year, (ii) 98.2% of our capital gains in excess of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">capital losses for the one-year period ending on October 31</div> of the calendar year, and (iii) any ordinary income and net capital gains that were recognized for preceding years, but were not distributed during such years and on which we paid no U.S. federal income tax. Any net operating losses that we incur in periods during which we qualify as a RIC will not offset net capital gains (i.e., net realized long-term capital gains in excess of net realized short-term capital losses) that we are otherwise required to distribute, and we cannot pass such net operating losses through to our stockholders. In addition, net operating losses that we carry over to a taxable year in which we qualify as a RIC normally cannot offset ordinary income or capital gains. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Under the Code, we may satisfy certain of our RIC distributions with dividends paid after the end of the current year. In particular, if we pay a distribution in January of the following year that was declared in October, November, or December of the current year and is payable to shareholders of record in the current year, the dividend will be treated for all US federal income tax purposes as if it were paid on December 31 of the current year. In addition, under the Code, we may pay dividends, referred to as “spillover dividends,” that are paid during the following taxable year that will allow us to maintain our qualification for taxation as a RIC and eliminate our liability for corporate-level U.S. federal income tax. Under these spillover dividend procedures, we may defer distribution of income earned during the current year until December of the following year. For example, we may defer distributions of income earned during 2023 until as late as December 31, 2024. If we choose to pay a spillover dividend, we will incur the 4% U.S. federal excise tax on some or all of the distribution. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">Due to events such as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the COVID-19 pandemic,</div> the Russian invasion of Ukraine or other disruptions in the economy, such as the current inflationary environment, we may take certain actions with respect to the timing and amounts of our distributions in order to preserve cash and maintain flexibility. For example, we may reduce our dividends and/or defer dividends to the following taxable year. If we defer our dividends, we may choose to utilize the spillover dividend rules discussed above and incur the 4% U.S. federal excise tax on such amounts. To further preserve cash, we may combine these reductions or deferrals of dividends with one or more distributions that are payable partially in our stock as discussed below under “<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may choose to pay</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> distributions in our own stock, in which case our stockholders may be required to pay U.S. federal income taxes in excess of the cash distributions they receive.”</div></div></div></div> </div></div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may choose to pay distributions in our own common stock, in which case our stockholders may be required to pay U.S. federal income taxes in excess of the cash distributions they receive. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">We may distribute taxable distributions that are payable in part in shares of our common stock. Under certain applicable provisions of the Code and the published guidance, distributions of a publicly offered RIC that are in cash or in shares of stock at the election of stockholders may be treated as taxable distributions. The Internal Revenue Service has issued a revenue procedure indicating that this rule will apply if the total amount of cash to be distributed is not less than 20% of the total distribution. Under this revenue procedure, if too many stockholders elect to receive their distributions in cash, the cash available for distribution must be allocated among the stockholders electing to receive cash (with the balance of distributions paid in stock). In no event will any stockholder electing to receive cash, receive less than the lesser of (a) the portion of the distribution such stockholder has elected to receive in cash or (b) an amount equal to his or her entire distribution times the percentage limitation on cash available for distribution. If we decide to make any distributions consistent with this revenue procedure that are payable in part in our stock, taxable stockholders receiving such distributions will be required to include the full amount of the distribution (whether received in cash, our stock, or a combination thereof) as ordinary income (or as long-term capital gain to the extent such distribution is properly reported as a capital gain distribution) to the extent of our current and accumulated earnings and profits for U.S. federal income tax purposes. As a result, a U.S. stockholder may be required to pay tax with respect to such distributions in excess of any cash received. If a U.S. stockholder sells the stock it receives as a distribution in order to pay this tax, the sales proceeds may be less than the amount included in income with respect to the distribution, depending on the market price of our stock at the time of the sale. Furthermore, with respect to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-U.S.</div> stockholders, we may be required to withhold U.S. tax with respect to such distributions, including in respect of all or a portion of such distribution that is payable in stock. If a significant number of our stockholders determine to sell shares of our stock in order to pay taxes owed on distributions, it may put downward pressure on the trading price of our stock. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Sales of substantial amounts of our common stock in the public market may have an adverse effect on the market price of our common stock. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">The shares of our common stock beneficially owned by each of Messrs. Gross and Spohler immediately prior to completion of our initial public offering, including any shares that are attributable to such shares issued pursuant to our dividend reinvestment plan, are no longer <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">subject to lock-up restrictions that</div> each of Messrs. Gross and Spohler agreed to in connection with our initial public offering, and are generally available for resale without restriction, subject to the provisions of Rule 144 promulgated under the Securities Act. In addition, on November 30, 2010, Messrs. Gross and Spohler jointly acquired 115,000 shares of our common stock in a private placement transaction conducted in accordance with Regulation D under the Securities Act. Such shares are generally available for resale without restriction, subject to the provisions of Rule 144 promulgated under the Securities Act. Sales of substantial amounts of our common stock, or the availability of such common stock for sale, could adversely affect the prevailing market prices for our common stock. If this occurs and continues, it could impair our ability to raise additional capital through the sale of securities should we desire to do so. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may be unable to invest the net proceeds raised from any offerings on acceptable terms or allocate net proceeds from any offering of our securities in ways with which you may not agree. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We cannot assure you that we will be able to find enough appropriate investments that meet our investment criteria or that any investment we complete using the proceeds from any securities offering will produce a sufficient return. Until we identify new investment opportunities, we intend to either invest the net proceeds of future offerings in cash equivalents, U.S. government securities and other high-quality debt investments that mature in one year or less or use the net proceeds from such offerings to reduce then-outstanding obligations. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We have significant flexibility in investing the net proceeds of any offering of our securities and may use the net proceeds from an offering in ways with which you may not agree or for purposes other than those contemplated at the time of the offering. </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">The net asset value per share of our common stock may be diluted if we issue or sell shares of our common stock at prices below the then current net asset value per share of our common stock or securities to subscribe for or convertible into shares of our common stock. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We will generally not be able to issue additional shares or sell our common stock at its market price without first obtaining the approval for such issuance from our stockholders and our independent directors. Any offering of our common stock that requires stockholder approval must occur, if at all, within one year after receiving such stockholder approval. At our 2011 Annual Stockholders Meeting, our stockholders authorized us to sell or otherwise issue warrants or securities to subscribe for or convertible into shares of our common stock subject to certain limitations (including, without limitation, that the number of shares issuable does not exceed 25% of our then outstanding common stock and that the exercise or conversion price thereof is not, at the date of issuance, less than the market value per share of our common stock). Such authorization has no expiration. </div></div></div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We may also use newly issued shares to implement our dividend reinvestment plan, whether our shares are trading at a premium or at a discount to our then current net asset value per share. Any decision to issue or sell shares of our common stock below our then current net asset value per share or securities to subscribe for or convertible into shares of our common stock would be subject to the determination by our board of directors that such issuance or sale is in our and our stockholders’ best interests. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If we were to issue or sell shares of our common stock below our then current net asset value per share, such issuances or sales would result in an immediate dilution to the net asset value per share of our common stock. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">This dilution would occur as a result of the issuance or sale of shares at a price below the then current net asset value per share of our common stock and a proportionately greater decrease in the stockholders’ interest in our earnings and assets and their voting interest in us than the increase in our assets resulting from such issuance or sale. Because the number of shares of common stock that could be so issued and the timing of any issuance is not currently known, the actual dilutive effect cannot be predicted. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, if we issue warrants or securities to subscribe for or convertible into shares of our common stock, subject to certain limitations, the exercise or conversion price per share could be less than net asset value per share at the time of exercise or conversion (including through the operation of anti-dilution protections). </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Because we would incur expenses in connection with any issuance of such securities, such issuance could result in a dilution of the net asset value per share at the time of exercise or conversion. This dilution would include reduction in net asset value per share as a result of the proportionately greater decrease in the stockholders’ interest in our earnings and assets and their voting interest than the increase in our assets resulting from such issuance. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Further, if our current stockholders do not purchase any shares to maintain their percentage interest, regardless of whether such offering is above or below the then current net asset value per share, their voting power will be diluted. For example, if we sell an additional 10% of our common stock at a 5% discount from net asset value, a stockholder who does not participate in that offering for its proportionate interest will suffer net asset value dilution of up to 0.5% or $5 per $1,000 of net asset value. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Similarly, all distributions declared in cash payable to stockholders that are participants in our dividend reinvestment plan are automatically reinvested in shares of our common stock. As a result, stockholders that opt out of the dividend reinvestment plan may experience dilution over time. Stockholders who do not elect to receive distributions in shares of common stock may experience accretion to the net asset value of their shares if our shares are trading at a premium and dilution if our shares are trading at a discount. The level of accretion or discount would depend on various factors, including the proportion of our stockholders who participate in the plan, the level of premium or discount at which our shares are trading and the amount of the distribution payable to a stockholder. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">If we issue preferred stock, the net asset value and market value of our common stock may become more volatile. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We cannot assure you that the issuance of preferred stock would result in a higher yield or return to the holders of the common stock. The issuance of preferred stock would likely cause the net asset value and market value of the common stock to become more volatile. If the distribution rate on the preferred stock were to approach the net rate of return on our investment portfolio, the benefit of leverage to the holders of the common stock would be reduced. If the distribution rate on the preferred stock were to exceed the net rate of return on our portfolio, the leverage would result in a lower rate of return to the holders of common stock than if we had not issued preferred stock. Any decline in the net asset value of our investments would be borne entirely by the holders of common stock. Therefore, if the market value of our portfolio were to decline, the leverage would result in a greater decrease in net asset value to the holders of common stock than if we were not leveraged through the issuance of preferred stock. This greater net asset value decrease would also tend to cause a greater decline in the market price for the common stock. We might be in danger of failing to maintain the required asset coverage of the preferred stock or of losing our ratings on the preferred stock or, in an extreme case, our current investment income might not be sufficient to meet the distribution requirements on the preferred stock. In order to counteract such an event, we might need to liquidate investments in order to fund a redemption of some or all of the preferred stock. In addition, we would pay (and the holders of common stock would bear) all costs and expenses relating to the issuance and ongoing maintenance of the preferred stock, including higher advisory fees if our total return exceeds the distribution rate on the preferred stock. Holders of preferred stock may have different interests than holders of common stock and may at times have disproportionate influence over our affairs. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our board of directors is authorized to reclassify any unissued shares of common stock into one or more classes of preferred stock, which could convey special rights and privileges to its owners. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Under Maryland General Corporation Law and our charter, our board of directors is authorized to classify and reclassify any authorized but unissued shares of stock into one or more classes of stock, including preferred stock. Prior to issuance of shares of each class or series, the board of directors is required by Maryland law and our charter to set the preferences, conversion or other rights, </div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">voting powers, restrictions, limitations as to other distributions, qualifications and terms or conditions of redemption for each class or series. Thus, the board of directors could authorize the issuance of shares of preferred stock with terms and conditions which could have the effect of delaying, deferring or preventing a transaction or a change in control that might involve a premium price for holders of our common stock or otherwise be in their best interest. The cost of any such reclassification would be borne by our existing common stockholders. The issuance of shares of preferred stock convertible into shares of common stock might also reduce the net income and net asset value per share of our common stock upon conversion, provided, that we will only be permitted to issue such convertible preferred stock to the extent we comply with the requirements of Section 61 of the 1940 Act, including obtaining common stockholder approval. These effects, among others, could have an adverse effect on your investment in our common stock. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">Certain matters under the 1940 Act require the separate vote of the holders of any issued and outstanding preferred stock. For example, holders of preferred stock would vote separately from the holders of common stock on a proposal to cease operations as a BDC. In addition, the 1940 Act provides that holders of preferred stock are entitled to vote separately from holders of common stock to elect two preferred stock directors. In the event distributions become two full years in arrears, holders of any preferred stock would have the right to elect a majority of the directors until such arrearage is completely eliminated. Preferred stockholders also have class voting rights on certain matters, including changes in fundamental investment restrictions and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">conversion to open-end status, and</div> accordingly can veto any such changes. Restrictions imposed on the declarations and payment of distributions to the holders of our common stock and preferred stock, both by the 1940 Act and by requirements imposed by rating agencies or the terms of our credit facilities, might impair our ability to maintain our qualification for tax treatment as a RIC for U.S. federal income tax purposes. While we would intend to redeem our preferred stock to the extent necessary to enable us to distribute our income as required to maintain our qualification as a RIC, there can be no assurance that such actions could be effected in time to meet the tax requirements. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">To the extent we use debt or preferred stock to finance our investments, changes in interest rates will affect our cost of capital and net investment income. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">To the extent we borrow money, or issue preferred stock, to make investments, our net investment income will depend, in part, upon the difference between the rate at which we borrow funds or pay distributions on preferred stock and the rate at which we invest those funds. In addition, many of our debt investments and borrowings have floating interest rates that reset on a periodic basis, and many of our investments are subject to interest rate floors. As a result, we can offer no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income in the event we use debt to finance our investments. In periods of rising interest rates, such as the current economic period, our cost of funds have increased, and could continue to increase, because the interest rates on the amounts borrowed under our credit facilities or certain other financing arrangements are typically floating, except to the extent we issue fixed rate debt or preferred stock, which could reduce our net investment income, and the interest rate on investments with an interest rate floor (such as a SOFR floor) above current levels will not increase until interest rates exceed the applicable floor. We expect that our long-term fixed-rate investments will generally be financed with equity and long-term debt. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We may use interest rate risk management techniques in an effort to limit our exposure to interest rate fluctuations. Such techniques may include various interest rate hedging activities to the extent permitted by the 1940 Act. These activities could limit our ability to participate in the benefits of lower interest rates with respect to the hedged borrowings. Adverse developments resulting from changes in interest rates or hedging transactions could have a material adverse effect on our business, financial condition and results of operations. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">You should also be aware that the rise in the general level of interest rates can be expected to lead to higher interest rates applicable to our debt investments. Accordingly, such increase in interest rates makes it easier for us to meet or exceed the incentive fee hurdle rate and may result in a substantial increase of the amount of incentive fees payable to our Investment Adviser with respect to our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income. Also, an increase in interest rates available to investors could make an investment in our common stock less attractive if we are not able to increase our distribution rate, which could reduce the value of our common stock. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may in the future determine to fund a portion of our investments with preferred stock, which would magnify the potential for loss and the risks of investing in us in a similar way as our borrowings. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Preferred stock, which is another form of leverage, has the same risks to our common stockholders as borrowings because the distributions on any preferred stock we issue must be cumulative. Payment of such distributions and repayment of the liquidation preference of such preferred stock must take preference over any distributions or other payments to our common stockholders, and preferred stockholders are not subject to any of our expenses or losses and are not entitled to participate in any income or appreciation in excess of their stated preference. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risks Relating to Our Business and Structure </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We are dependent upon SLR Capital Partners’ key personnel for our future success. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We depend on the diligence, skill and network of business contacts of Messrs. Gross and Spohler, who serve as the managing partners of SLR Capital Partners and who lead SLR Capital Partners’ investment team. Messrs. Gross and Spohler, together with the other dedicated investment professionals available to SLR Capital Partners, evaluate, negotiate, structure, close and monitor our investments. Our future success will depend on the diligence, skill, network of business contacts and continued service of Messrs. Gross and Spohler and the other investment professionals available to SLR Capital Partners. We cannot assure you that unforeseen business, medical, personal or other circumstances would not lead any such individual to terminate his relationship with us. The loss of Mr. Gross or Mr. Spohler, or any of the other senior investment professionals who serve on SLR Capital Partners’ investment team, could have a material adverse effect on our ability to achieve our investment objective as well as on our financial condition and results of operations. In addition, we can offer no assurance that SLR Capital Partners will remain our Investment Adviser. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">The senior investment professionals of SLR Capital Partners are and may in the future become affiliated with entities engaged in business activities similar to those intended to be conducted by us, and may have conflicts of interest in allocating their time. We expect that Messrs. Gross and Spohler will dedicate a significant portion of their time to the activities of SLR Investment Corp.; however, they may be engaged in other business activities which could divert their time and attention in the future. Specifically, Mr. Gross <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">serves as Co-Chief Executive Officer</div> and President of SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC. In addition, Mr. Spohler <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">serves as Co-Chief Executive Officer</div> and Chief Operating Officer of SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our business model depends to a significant extent upon strong referral relationships with financial sponsors, and the inability of the senior investment professionals of our Investment Adviser to maintain or develop these relationships, or the failure of these relationships to generate investment opportunities, could adversely affect our business. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We expect that the principals of our Investment Adviser will maintain and develop their relationships with financial sponsors, and we will rely to a significant extent upon these relationships to provide us with potential investment opportunities. If the senior investment professionals of our Investment Adviser fail to maintain their existing relationships or develop new relationships with other sponsors or sources of investment opportunities, we will not be able to grow our investment portfolio. In addition, individuals with whom the senior investment professionals of our Investment Adviser have relationships are not obligated to provide us with investment opportunities, and, therefore, there is no assurance that such relationships will generate investment opportunities for us. If our Investment Adviser is unable to source investment opportunities, we may hold a greater percentage of our assets in cash and cash equivalents than anticipated, which could impact potential returns on our portfolio. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">A disruption in the capital markets and the credit markets could negatively affect our business. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As a BDC, we must maintain our ability to raise additional capital for investment purposes. Without sufficient access to the capital markets or credit markets, we may be forced to curtail our business operations or we may not be able to pursue new business opportunities. Disruptive conditions in the financial industry and the impact of new legislation in response to those conditions could restrict our business operations and could adversely impact our results of operations and financial condition. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If the fair value of our assets declines substantially, we may fail to maintain the asset coverage ratios imposed upon us by the 1940 Act and our existing credit facilities. Any such failure could result in an event of default and all of our debt being declared immediately due and payable and would affect our ability to issue senior securities, including borrowings, and pay distributions, which could materially impair our business operations. Our liquidity could be impaired further by an inability to access the capital markets or to draw on our credit facilities. For example, we cannot be certain that we will be able to renew our existing credit facilities as they mature or to consummate new borrowing facilities to provide capital for normal operations, including new originations. Reflecting concern about the stability of the financial markets, many lenders and institutional investors have reduced or ceased providing funding to borrowers. This market turmoil and tightening of credit have led to increased market volatility and widespread reduction of business activity generally. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If we are unable to renew or replace our existing credit facilities and consummate new facilities on commercially reasonable terms, our liquidity will be reduced significantly. If we consummate new facilities but are then unable to repay amounts outstanding under such facilities and are declared in default or are unable to renew or refinance these facilities, we would not be able to initiate significant originations or to operate our business in the normal course. These situations may arise due to circumstances that we may be unable to control, such as inaccessibility to the credit markets, a severe decline in the value of the U.S. dollar, a further economic downturn or an operational problem that affects third parties or us, and could materially damage our business. Moreover, we are unable to predict when economic and market conditions may become more favorable. Even if such conditions improve broadly and significantly over the long term, adverse conditions in particular sectors of the financial markets could adversely impact our business. </div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our financial condition and results of operations will depend on SLR Capital Partners’ ability to manage our future growth effectively by identifying, investing in and monitoring companies that meet our investment criteria. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our ability to achieve our investment objective and to grow depends on SLR Capital Partners’ ability to identify, invest in and monitor companies that meet our investment criteria. Accomplishing this result on a cost-effective basis is largely a function of SLR Capital Partners’ structuring of the investment process, its ability to provide competent, attentive and efficient services to us and its ability to access financing for us on acceptable terms. The investment team of SLR Capital Partners has substantial responsibilities under the Advisory Agreement, and they may also be called upon to provide managerial assistance to our portfolio companies as the principals of our administrator. In addition, the members of SLR Capital Partners’ investment team have similar responsibilities with respect to the management of other investment portfolios, including the investment portfolios of SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC. Such demands on their time may distract them or slow our rate of investment. In order to grow, we and SLR Capital Partners will need to retain, train, supervise and manage new investment professionals. However, we can offer no assurance that any such investment professionals will contribute effectively to the work of the Investment Adviser. Any failure to manage our future growth effectively could have a material adverse effect on our business, financial condition and results of operations. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may need to raise additional capital to grow because we must distribute most of our income. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We may need additional capital to fund growth in our investments. We expect to issue equity securities and expect to borrow from financial institutions in the future. A reduction in the availability of new capital could limit our ability to grow. We must distribute at least 90% of our investment company taxable income to our stockholders to maintain our tax treatment as a RIC. As a result, any such cash earnings may not be available to fund investment originations. We expect to borrow from financial institutions and issue additional debt and equity securities. If we fail to obtain funds from such sources or from other sources to fund our investments, it could limit our ability to grow, which may have an adverse effect on the value of our securities. In addition, as a BDC, our ability to borrow or issue additional preferred stock may be restricted if our total assets are less than 150% of our total borrowings and preferred stock. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Any failure on our part to maintain our status as a BDC would reduce our operating flexibility and we may be limited in our investment choices as a BDC. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">The 1940 Act imposes numerous constraints on the operations of BDCs. For example, BDCs are required to invest at least 70% of their total assets in specified types of securities, primarily in private companies or thinly-traded U.S. public companies, cash, cash equivalents, U.S. government securities and other high quality debt investments that mature in one year or less. Furthermore, any failure to comply with the requirements imposed on BDCs by the 1940 Act could cause the SEC to bring an enforcement action against us and/or expose us to claims of private litigants. In addition, upon approval of a majority of our stockholders, we may elect to withdraw our status as a BDC. If we decide to withdraw our election, or if we otherwise fail to qualify, or maintain our qualification, as a BDC, we may be subject to the substantially greater regulation under the 1940 Act <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as a closed-end investment company.</div> Compliance with such regulations would significantly decrease our operating flexibility, and could have a material adverse effect on our business, financial condition and results of operations. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Regulations governing our operation as a BDC affect our ability to, and the way in which we will, raise additional capital. As a BDC, the necessity of raising additional capital may expose us to risks, including the typical risks associated with leverage. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In order to satisfy the tax requirements applicable to a RIC, to avoid payment of excise taxes and to minimize or avoid payment of income taxes, we intend to distribute to our stockholders substantially all of our ordinary income and realized net capital gains except for certain realized net long-term capital gains, which we may retain, pay applicable income taxes with respect thereto and elect to treat as deemed distributions to our stockholders. We may issue debt securities or preferred stock and/or borrow money from banks or other financial institutions, which we refer to collectively as “senior securities,” up to the maximum amount permitted by the 1940 Act. Under the provisions of the 1940 Act, we had been permitted, as a BDC, to issue senior securities in amounts such that our asset coverage ratio, as defined in the 1940 Act, equals at least 200% of gross assets less all liabilities and indebtedness not represented by senior securities, after each issuance of senior securities. However, our stockholders have approved a resolution permitting us to be subject to a 150% asset coverage ratio effective as of October 12, 2018. If the value of our assets declines, we may be unable to satisfy the asset coverage test. If that happens, we may be required to sell a portion of our investments and, depending on the nature of our leverage, repay a portion of our indebtedness at a time when such sales may be disadvantageous. Also, any amounts that we use to service our indebtedness would not be available for distributions to our common stockholders. Furthermore, as a result of issuing senior securities, we would also be exposed to typical risks associated with leverage, including an increased risk of loss. In addition, because our management fee is calculated as a percentage of our gross assets, which includes any borrowings for investment purposes, the management fee expenses will increase if we incur additional indebtedness. </div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2022, we had $393.0 million outstanding under the Credit Facility, composed of $293.0 million of revolving credit and $100.0 million outstanding of term loans, and $155.2 million outstanding under our SPV Credit Facility. We also had $135.0 million outstanding of the Series F 2027 Unsecured Notes, $50.0 million outstanding of the 2027 Unsecured Notes, $75.0 million outstanding of the 2026 Unsecured Notes, $85.0 million outstanding of the 2025 Unsecured Notes, $125.0 million outstanding of the 2024 Unsecured Notes, and $75.0 million outstanding of the 2023 Unsecured Notes. If we issue preferred stock, the preferred stock would rank “senior” to common stock in our capital structure, preferred stockholders would generally vote together with common stockholders but would have separate voting rights on certain matters and might have other rights, preferences, or privileges more favorable than those of our common stockholders, and the issuance of preferred stock could have the effect of delaying, deferring or preventing a transaction or a change of control that might involve a premium price for holders of our common stock or otherwise be in your best interest. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We are not generally able to issue and sell our common stock at a price below net asset value per share. We may, however, sell our common stock, or warrants, options or rights to acquire our common stock, at a price below the then-current net asset value per share of our common stock if our board of directors determines that such sale is in the best interests of SLR Investment Corp. and its stockholders, and our stockholders approve such sale. In any such case, the price at which our securities are to be issued and sold may not be less than a price that, in the determination of our board of directors, closely approximates the market value of such securities (less any distributing commission or discount). If we raise additional funds by issuing more common stock or senior securities convertible into, or exchangeable for, our common stock, then the percentage ownership of our stockholders at that time will decrease, and you might experience dilution. This dilution would occur as a result of a proportionately greater decrease in a stockholder’s interest in our earnings and assets and voting interest in us than the increase in our assets resulting from such issuance. Because the number of future shares of common stock that may be issued below our net asset value per share and the price and timing of such issuances are not currently known, we cannot predict the actual dilutive effect of any such issuance. We cannot determine the resulting reduction in our net asset value per share of any such issuance. We also cannot predict whether shares of our common stock will trade above, at or below our net asset value. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our credit ratings may not reflect all risks of an investment in our debt securities. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our credit ratings are an assessment by third parties of our ability to pay our obligations. Consequently, real or anticipated changes in our credit ratings will generally affect the market value of our publicly issued debt securities. Our credit ratings, however, may not reflect the potential impact of risks related to market conditions generally or other factors discussed above on the market value of, or trading market for, any publicly issued debt securities. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our stockholders may experience dilution in their ownership percentage if they opt out of our dividend reinvestment plan. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">All distributions declared in cash payable to stockholders that are participants in our dividend reinvestment plan are automatically reinvested in shares of our common stock. In the event we issue new shares in connection with our dividend reinvestment plan, our stockholders that do not elect to receive distributions in shares of common stock may experience dilution in their ownership percentage over time as a result of such issuance. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We have and will continue to borrow money, which would magnify the potential for loss on amounts invested and may increase the risk of investing in us. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We borrow money as part of our business plan. Borrowings, also known as leverage, magnify the potential for loss on amounts invested and, therefore, increase the risks associated with investing in our securities. As of December 31, 2022, we had $393.0 million outstanding under the Credit Facility, composed of $293.0 million of revolving credit and $100.0 million outstanding of term loans, and $155.2 million outstanding under our SPV Credit Facility. We also had $135.0 million outstanding of the Series F 2027 Unsecured Notes, $50.0 million outstanding of the 2027 Unsecured Notes, $75.0 million outstanding of the 2026 Unsecured Notes, $85.0 million outstanding of the 2025 Unsecured Notes, $125.0 million outstanding of the 2024 Unsecured Notes, and $75.0 million outstanding of the 2023 Unsecured Notes. We may borrow from and issue senior debt securities to banks, insurance companies and other lenders in the future. Lenders of these senior securities, including the Credit Facility, the SPV Credit Facility, the Series F 2027 Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes, the 2024 Unsecured Notes, and the 2023 Unsecured Notes, will have fixed dollar claims on our assets that are superior to the claims of our common stockholders, and we would expect such lenders to seek recovery against our assets in the event of a default. If the value of our assets increases, then leveraging would cause the net asset value attributable to our common stock to increase more sharply than it would have had we not leveraged. Conversely, if the value of our assets decreases, leveraging would cause net asset value to decline more sharply than it otherwise would have had we not leveraged. Similarly, any decrease in our income would cause net income to decline more sharply than it would have had we not borrowed. Also, any increase in our income in excess of interest payable on the borrowed funds would cause our net investment income to increase more than it would without the leverage, while any decrease in our income would cause net investment income to decline more sharply than it would have had we not borrowed. Such a decline could also negatively affect </div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div/><div> <div style="background-color:white;display: inline;"> </div> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">our ability to make distribution payments on our common stock, scheduled debt payments or other payments related to our securities. Leverage is generally considered a speculative investment technique. Our ability to service any debt that we incur will depend largely on our financial performance and will be subject to prevailing economic conditions and competitive pressures. Moreover, as the management fee payable to our Investment Adviser, SLR Capital Partners, will be payable based on our gross assets, including those assets acquired through the use of leverage, SLR Capital Partners will have a financial incentive to incur leverage which may not be consistent with our stockholders’ interests. In addition, our common stockholders will bear the burden of any increase in our expenses as a result of leverage, including any increase in the management fee payable to SLR Capital Partners. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a BDC, we had generally been required to meet a coverage ratio of total assets to total borrowings and other senior securities, which include all of our borrowings and any preferred stock that we may issue in the future, of at least 200%. However, our stockholders have approved a resolution permitting us to be subject to a 150% asset coverage ratio effective as of October 12, 2018. Even though we are subject to a 150% asset coverage ratio effective as of October 12, 2018, contractual leverage limitations under our existing credit facilities or future borrowings may limit our ability to incur additional indebtedness. On August 28, 2019, we entered into the Credit Agreement, which was amended on December 28, 2021, which permits 150% asset coverage. Some of our wholly and/or substantially owned portfolio companies, including Kingsbridge Holdings, LLC, SLR Credit Solutions, SLR Equipment Finance, SLR Business Credit and SLR Healthcare ABL, may incur significantly more leverage than we can but we do not consolidate Kingsbridge Holdings, LLC, SLR Credit Solutions, SLR Equipment Finance, SLR Business Credit and SLR Healthcare ABL and their <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">leverage is non-recourse to us.</div> Additionally, the Credit Facility and the SPV Credit Facility require us to comply with certain financial and other restrictive covenants including maintaining an asset coverage ratio of not less than 150% at any time. Failure to maintain compliance with these covenants could result in an event of default and all of our debt being declared immediately due and payable. If this ratio declines below 150%, we may not be able to incur additional debt and could be required by law to sell a portion of our investments to repay some debt when it is disadvantageous to do so, which could have a material adverse effect on our operations, and we may not be able to make distributions. The amount of leverage that we employ will depend on our Investment Adviser’s and our board of directors’ assessment of the market and other factors at the time of any proposed borrowing. We cannot assure you that we will be able to obtain credit at all or on terms acceptable to us. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, our credit facilities impose, and any other debt facility into which we may enter would likely impose, financial and operating covenants that restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain RIC tax treatment under Subchapter M of the Code. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The debt securities that we may issue will be governed by an indenture or other instrument containing covenants restricting our operating flexibility. We, and indirectly our stockholders, bear the cost of issuing and servicing such debt securities. Any convertible or exchangeable securities that we issue in the future may have rights, preferences and privileges more favorable than those of our common stock. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Illustration.</div></div> The following table illustrates the effect of leverage on returns from an investment in our common stock assuming various annual returns on our portfolio, net of interest expense. The calculations in the table below are hypothetical and actual returns may be higher or lower than those appearing in the table below. </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:82%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="18" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Assumed total return<br/>(net of interest expense)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(10)%</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(5)%</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">0%</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5%</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">10%</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corresponding return to stockholder(1)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(29.9</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(17.2</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4.5</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8.2</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20.9</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table><div style="font-size: 10pt;;display:inline;"/> <div style="width: 11%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;;text-indent: 0px;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="display:inline;">(1)</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;">Assumes $2.5 billion in total assets and $1.1 billion in total debt outstanding, which reflects our total assets and total debt outstanding as of December 31, 2022, and a cost of funds of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">4.09%. Excludes non-leverage related expenses.</div> </div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In<div style="display:inline;"> </div></div></div><div style="font-size: 10pt;;display:inline;">order for us to cover our annual interest payments on our outstanding indebtedness at December 31, 2022, we must achieve annual returns on our December 31, 2022 total assets of at least 1.8%.</div></div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">It is likely that the terms of any current or future long-term or revolving credit or warehouse facility we may enter into in the future could constrain our ability to grow our business. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our current lenders have, and any future lender or lenders may have, fixed dollar claims on our assets that are senior to the claims of our stockholders and, thus, will have a preference over our stockholders with respect to our assets in the collateral pool. Our current credit facilities and borrowings also subject us to various financial and operating covenants, including, but not limited to, maintaining certain financial ratios and minimum tangible net worth amounts. Future credit facilities and borrowings will likely subject us to similar or additional covenants. In addition, we may grant a security interest in our assets in connection with any such credit facilities and borrowings. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our credit facilities generally contain customary default provisions such as a minimum net worth amount, a profitability test, and a restriction on changing our business and loan quality standards. In addition, our credit facilities require or are expected to require the repayment of all outstanding debt on the maturity, which may disrupt our business and potentially the business of our portfolio companies that are financed through our credit facilities. An event of default under our credit facilities would likely result, among other things, in termination of the availability of further funds under our credit facilities and accelerated maturity dates for all amounts outstanding under our credit facilities, which would likely disrupt our business and, potentially, the business of the portfolio companies whose loans we finance through our credit facilities. This could reduce our revenues and, by delaying any cash payment allowed to us under our credit facilities until the lender has been paid in full, reduce our liquidity and cash flow and impair our ability to grow our business and maintain RIC tax treatment. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The terms of future available financing may place limits on our financial and operational flexibility. If we are unable to obtain sufficient capital in the future, we may be forced to reduce or discontinue our operations, not be able to make new investments, or otherwise respond to changing business conditions or competitive pressures. </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our quarterly and annual operating results are subject to fluctuation as a result of the nature of our business, and if we fail to achieve our investment objective, the net asset value of our common stock may decline. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We could experience fluctuations in our quarterly and annual operating results due to a number of factors, some of which are beyond our control, including, but not limited to, the interest rate payable on the debt securities that we acquire, the default rate on such securities, the level of our expenses, variations in and the timing of the recognition of realized and unrealized gains or losses, changes in our portfolio composition, the degree to which we encounter competition in our markets, market volatility in our publicly traded securities and the securities of our portfolio companies, and general economic conditions. As a result of these factors, results for any period should not be relied upon as being indicative of performance in future periods. In addition, any of these factors could negatively impact our ability to achieve our investment objectives, which may cause our net asset value of our common stock to decline. </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our investments may be in portfolio companies that may have limited operating histories and financial resources. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;">We expect that our portfolio will continue to consist of investments that may have relatively limited operating histories. These companies may be particularly vulnerable to U.S. and foreign economic downturns such as the U.S. recession that <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">began in mid-2007, the European</div> financial crisis, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">and the COVID-19 related economic</div> downturn, may have more limited access to capital and higher funding costs, may have a weaker financial position and may need more capital to expand or compete. These businesses also may experience substantial variations in operating results. They may face intense competition, including from companies with greater financial, technical and marketing resources. Furthermore, some of these companies do business in regulated industries and could be affected by changes in government regulation. Accordingly, these factors could impair their cash flow or result in other events, such as bankruptcy, which could limit their ability to repay their obligations to us, and may adversely affect the return on, or the recovery of, our investment in these companies. We cannot assure you that any of our investments in our portfolio companies will be successful. Our portfolio companies compete with larger, more established companies with greater access to, and resources for, further development in these new technologies. Therefore, we may lose our entire investment in any or all of our portfolio companies. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">There will be uncertainty as to the value of our portfolio investments, which may impact our net asset value. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;">A large percentage of our portfolio investments are in the form of securities that are not publicly traded. The fair value of securities and other investments that are not publicly traded may not be readily determinable. We value these securities on a quarterly basis in accordance with our valuation policy, which is at all times consistent with GAAP. Our board of directors will (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services; (5) oversee the reporting required by Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-5</div> under the 1940 Act; and (6) maintain recordkeeping requirements under Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-5.</div> Our board of directors utilizes the services of third-party valuation firms to aid it in determining the fair value of material assets. The board of directors discusses valuations and determines the fair value in good faith based on the input of our Investment Adviser and, when utilized, the respective third-party valuation firms. The factors that may be considered in fair value pricing our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments and its earnings, the markets in which the portfolio company does business, comparisons to publicly traded companies, discounted cash flow and other relevant factors. Because such valuations, and particularly valuations of private securities and private companies, are inherently uncertain, may fluctuate over short periods of time and may be based on estimates, our determinations of fair value may differ materially from the values that would have been used if a ready market for these securities existed. Our net asset value could be adversely affected if our determinations regarding the fair value of our investments were materially higher than the values that we ultimately realize upon the disposal of such securities. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our equity ownership in a portfolio company may represent a control investment. Our ability to exit an investment in a timely manner because we are in a control position or have access to inside information in the portfolio company could result in a realized loss on the investment. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If we obtain a control investment in a portfolio company our ability to divest ourselves from a debt or equity investment could be restricted due to illiquidity in a private stock, limited trading volume on a public company’s stock, inside information on a company’s performance, insider blackout periods, or other factors that could prohibit us from disposing of the investment as we would if it were not a control investment. Additionally, we may choose not to take certain actions to protect a debt investment in a control investment portfolio company. As a result, we could experience a decrease in the value of our portfolio company holdings and potentially incur a realized loss on the investment. </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">There are significant potential conflicts of interest, including SLR Capital Partners’ management of other investment funds such as SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC, which could impact our investment returns, and an investment in SLR Investment Corp. is not an investment in SCP Private Credit Income BDC LLC, SLR HC BDC LLC, or SLR Private Credit BDC II LLC. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;">Our executive officers and directors, as well as the current and future partners of our Investment Adviser, SLR Capital Partners, may serve as officers, directors or principals of entities that operate in the same or a related line of business as we do. For example, SLR Capital Partners presently serves as the Investment Adviser to (i) SCP Private Credit Income BDC LLC, an unlisted BDC that focuses on investing primarily in senior secured <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">loans, including non-traditional asset-based loans</div> and first lien loans, (ii) SLR HC BDC LLC, an unlisted BDC whose principal focus is to invest directly and indirectly in senior secured loans and other debt instruments typically to middle market companies within the healthcare industry, and (iii) SLR Private Credit BDC II LLC, an unlisted BDC whose principal focus is to invest in first lien senior secured floating rate loans primarily to upper middle market leveraged companies with EBITDA between approximately $25 million and $250 million that have significant free cash flow and are in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cyclical</div> industries in which the Investment Adviser has significant experience. In addition, Michael S. Gross, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">our Chairman, Co-Chief Executive Officer</div> and President, Bruce <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Spohler, our Co-Chief Executive Officer</div> and Chief Operating Officer and board member, and Richard L. Peteka, our Chief Financial Officer, serve in similar capacities for SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC. Accordingly, they may have obligations to investors in those entities, the fulfillment of which obligations might not be in the best interests of us or our stockholders. In addition, we note that any affiliated investment vehicle formed in the future and managed by our Investment Adviser or its affiliates may, notwithstanding different stated investment objectives, have overlapping investment objectives with our own and, accordingly, may invest in asset classes similar to those targeted by us. As a result, SLR Capital Partners may face conflicts in allocating investment opportunities between us and such other entities. Although SLR Capital Partners will endeavor to allocate investment opportunities in a fair and equitable manner, it is possible that, in the future, we may not be given the opportunity to participate in investments made by investment funds managed by our Investment Adviser or an investment manager affiliated with our Investment Adviser. In any such case, when SLR Capital Partners identifies an investment, it will be forced to choose which investment fund should make the investment. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;">As a BDC, we were substantially limited in our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ability to co-invest in privately</div> negotiated transactions with affiliated funds until we obtained an exemptive order from the SEC. The most recent exemptive order, received on June 13, 2017 (the “Exemptive Order”), permits us to participate <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">in negotiated co-investment transactions with</div> certain affiliates, each of whose investment adviser is an investment adviser that controls, is controlled by or is under common control with SLR Capital Partners and is registered as an Investment Adviser under the Advisers Act, in a manner consistent with our investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, and pursuant to the conditions to the Exemptive Order. If we are unable to rely on the Exemptive Order for a particular opportunity, such opportunity will be allocated first to the entity whose investment strategy is the most consistent with the opportunity being allocated, and second, if the terms of the opportunity are consistent with more than one entity’s investment strategy, on an alternating basis. Although our investment professionals will endeavor to allocate investment opportunities in a fair and equitable manner, we and our common stockholders could be adversely affected to the extent investment opportunities are allocated among us and other investment vehicles managed or sponsored by, or affiliated with, our executive officers, directors and members of our Investment Adviser. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;">SLR Capital Partners and certain investment advisory affiliates may determine that an investment is appropriate for us and for one or more of those other funds. In such event, depending on the availability of such investment and other appropriate factors, SLR Capital Partners or its affiliates may determine that we <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">should invest side-by-side with one</div></div> or more other funds. Any such investments will be made only to the extent permitted by applicable law and interpretive positions of the SEC and its staff, and consistent with SLR Capital Partners’ allocation procedures. Related party transactions may occur among SLR Investment Corp., SLR Credit Solutions, Equipment Operating Leases LLC, Loyer Capital LLC, SLR Equipment Finance, SLR Business Credit, SLR Healthcare ABL, SLR Senior Lending Program LLC and SLR Senior Lending Program SPV LLC. These transactions may occur in the normal course of business. No administrative or other fees are paid to SLR Capital Partners by SLR Credit Solutions, Equipment Operating Leases LLC, Loyer Capital LLC, SLR Equipment Finance, SLR Business Credit, SLR Healthcare ABL, SLR Senior Lending Program LLC and SLR Senior Lending Program SPV LLC. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In the ordinary course of our investing activities, we pay management and incentive fees to SLR Capital Partners and reimburse SLR Capital Partners for certain expenses it incurs. As a result, investors in our common stock will invest on a “gross” basis and receive distributions on a “net” basis after expenses, resulting in a lower rate of return than an investor might achieve through direct investments. Accordingly, there may be times when the management team of SLR Capital Partners has interests that differ from those of our stockholders, giving rise to a conflict. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;">We entered into an amended and restated royalty-free license agreement on February 25, 2021 with our Investment Adviser, pursuant to which our Investment Adviser has granted <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">us a non-exclusive license to</div> use the marks “SOLAR” and “SLR.” Under the license agreement, we have the right to use the “SLR Investment” name for so long as SLR Capital Partners or one of its affiliates remains our Investment Adviser. In addition, we pay SLR Capital Management, an affiliate of SLR Capital Partners, our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions, and our allocable portion of the compensation of our chief compliance officer and our chief financial officer and their respective staffs. These arrangements create conflicts of interest that our board of directors must monitor. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our ability to enter into transactions involving derivatives and financial commitment transactions may be limited. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;">Through comprehensive new global regulatory regimes impacting derivatives (<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">e.g.</div></div>, the Dodd-Frank Act, European Market Infrastructure Regulation (“EMIR”), Markets in Financial Investments Regulation (“MIFIR”)/Markets in Financial Instruments Directive (“MIFID II”)), certain <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">over-the-counter</div></div> derivatives transactions in which we may engage are either now or will soon be subject to various requirements, such as mandatory central clearing of transactions which include additional margin requirements and in certain cases trading on electronic platforms, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-and</div> post-trade transparency reporting requirements and mandatory <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">bi-lateral</div> exchange of initial margin for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cleared</div> swaps. The Dodd-Frank Act also created new categories of regulated market participants, such as “swap dealers,” “security-based swap dealers,” “major swap participants,” and “major security-based swap participants” who are subject to significant new capital, registration, recordkeeping, reporting, disclosure, business conduct and other regulatory requirements. The EU and some other jurisdictions are implementing similar requirements. Because these requirements are new and evolving (and some of the rules are not yet final), their ultimate impact remains unclear. However, even if we are not located in a particular jurisdiction or directly subject to the jurisdiction’s derivatives regulations, we may still be impacted to the extent we enter into a derivatives transaction with a regulated market participant or counterparty that is organized in that jurisdiction or otherwise subject to that jurisdiction’s derivatives regulations. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;">Based on information available as of the date of this annual report <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">on Form 10-K, the effect</div> of such requirements will be likely to (directly or indirectly) increase our overall costs of entering into derivatives transactions. In particular, new margin requirements, position limits and significantly higher capital charges resulting from new global capital regulations, even if not directly applicable to us, may cause an increase in the pricing of derivatives transactions entered into by market participants to whom such requirements apply or affect our overall ability to enter into derivatives transactions with certain counterparties. Such new global capital regulations and the need to satisfy the various requirements by counterparties are resulting in increased funding costs, increased overall transaction costs, and significantly affecting balance sheets, thereby resulting in changes to financing terms and potentially impacting our ability to obtain financing. Administrative costs, due to new requirements such as registration, recordkeeping, reporting, and compliance, even if not directly applicable to us, may also be reflected in our derivatives transactions. New requirements to trade certain derivatives transactions on electronic trading platforms and trade reporting requirements may lead to (among other things) fragmentation of the markets, higher transaction costs or reduced availability of derivatives, and/or a reduced ability to hedge, all of which could adversely affect the performance of certain of our trading strategies. In addition, changes to derivatives regulations may impact the tax and/or accounting treatment of certain derivatives, which could adversely impact us. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;">In November 2020, the SEC adopted new rules regarding the ability of a BDC (or a registered investment company) to use derivatives and other transactions that create future payment or delivery obligations. BDCs that use derivatives would be subject <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">to a value-at-risk leverage limit,</div></div> certain other derivatives risk management program and testing requirements and requirements related to board reporting. These new requirements would apply unless the BDC qualified as a “limited derivatives user,” as defined in the SEC’s adopted rules. A BDC that enters into reverse repurchase agreements or similar financing transactions would need to aggregate the amount of indebtedness associated with the reverse repurchase agreements or similar financing transactions could either (i) comply with the asset coverage requirements of the Section 18 of the 1940 Act when engaging in reverse repurchase agreements or (ii) choose to treat such agreements as derivative transactions under the adopted rule. Under the adopted rule, a BDC may enter into an unfunded commitment agreement that is not a derivatives transaction, such as an agreement to provide financing to a portfolio company, if the BDC has a reasonable belief, at the time it enters into such an agreement, that it will have sufficient cash and cash equivalents to meet its obligations with respect to all of its unfunded commitment agreements, in each case as it becomes due. If the BDC cannot meet this test, it is required to treat unfunded commitments as a derivatives transaction subject to the requirements of the rule. Collectively, these requirements may limit our ability to use derivatives and/or enter into certain other financial contracts. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may be obligated to pay our Investment Adviser incentive compensation even if we incur a loss. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;">Our Investment Adviser will be entitled to incentive compensation for each fiscal quarter in an amount equal to a percentage of the excess <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of our pre-incentive fee net</div> investment income for that quarter (before deducting incentive compensation) above a performance threshold for that quarter. Accordingly, since the performance threshold is based on a percentage of our net asset value, decreases in our net asset value make it easier to achieve the performance <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">threshold. Our pre-incentive fee net</div> investment income for incentive compensation purposes excludes realized and unrealized capital losses or depreciation that we may incur in the fiscal quarter, even if such capital losses or depreciation result in a net loss on our statement of operations for that quarter. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Thus, we may be required to pay SLR Capital Partners incentive compensation for a fiscal quarter even if there is a decline in the value of our portfolio or we incur a net loss for that quarter. </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our incentive fee may induce SLR Capital Partners to pursue speculative investments. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The incentive fee payable by us to SLR Capital Partners may create an incentive for SLR Capital Partners to pursue investments on our behalf that are riskier or more speculative than would be the case in the absence of such compensation arrangement. The incentive fee payable to our Investment Adviser is calculated based on a percentage of our return on invested capital. This may encourage our Investment Adviser to use leverage to increase the return on our investments. Under certain circumstances, the use of leverage may increase the likelihood of default, which would impair the value of our common stock. In addition, our Investment Adviser receives the incentive fee based, in part, upon net capital gains realized on our investments. Unlike that portion of the incentive fee based on income, there is no hurdle rate applicable to the portion of the incentive fee based on net capital gains. As a result, our Investment Adviser may have a tendency to invest more capital in investments that are likely to result in capital gains as compared to income producing securities. Such a practice could result in our investing in more speculative securities than would otherwise be the case, which could result in higher investment losses, particularly during economic downturns. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;">The incentive fee payable by us to our Investment Adviser also may induce SLR Capital Partners to invest on our behalf in instruments that have a deferred interest feature, even if such deferred payments would not provide the cash necessary to enable us to pay current distributions to our stockholders. Under these investments, we would accrue interest over the life of the investment but would not receive the cash income from the investment until the end of the term. Our net investment income used to calculate the income portion of our investment fee, however, includes accrued interest. Thus, a portion of this incentive fee would be based on income that we have not received in cash. In <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">addition, the “catch-up” portion of</div> the incentive fee may encourage SLR Capital Partners to accelerate or defer interest payable by portfolio companies from one calendar quarter to another, potentially resulting in fluctuations in timing and distribution amounts. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We may invest, to the extent permitted by law, in the securities and instruments of other investment companies, including private funds, and, to the extent we so invest, will bear our ratable share of any such investment company’s expenses, including management and performance fees. We will also remain obligated to pay management and incentive fees to SLR Capital Partners with respect to the assets invested in the securities and instruments of other investment companies. With respect to each of these investments, each of our stockholders will bear his or her share of the management and incentive fee of SLR Capital Partners as well as indirectly bearing the management and performance fees and other expenses of any investment companies in which we invest. </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may become subject to corporate-level U.S. federal income tax if we are unable to qualify and maintain our qualification for tax treatment as a regulated investment company under Subchapter M of the Code. </div></div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Although we have elected to be treated as a RIC under Subchapter M of the Code, no assurance can be given that we will continue to be able to qualify for and maintain RIC tax treatment. To maintain RIC tax treatment under the Code, we must meet the following annual distribution, income source and asset diversification requirements on an ongoing basis. </div></div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Annual Distribution Requirement for a RIC will be satisfied if we distribute to our stockholders on an annual basis at least 90% of our net ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any. Because we may use debt financing, we are subject to certain asset coverage ratio requirements under the 1940 Act and financial covenants under loan and credit agreements that could, under certain circumstances, restrict us from making distributions necessary to satisfy the Annual Distribution Requirement. If we are unable to obtain cash from other sources, we could fail to qualify for RIC tax treatment and become subject to corporate-level U.S federal income tax. </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The income source requirement will be satisfied if we obtain at least 90% of our income for each year from certain passive investments, including interest, dividends, gains from the sale of stock or securities, or similar sources. </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The asset diversification requirement will be satisfied if we meet certain asset diversification requirements at the end of each quarter of our taxable year. Failure to meet those requirements may result in our having to dispose of certain investments quickly in order to prevent the loss of RIC tax treatment. Because most of our investments will be relatively illiquid, any such dispositions could be made at disadvantageous prices and could result in substantial losses. </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If we fail to qualify for RIC tax treatment for any reason and become subject to corporate income tax, the resulting corporate taxes could substantially reduce our net assets, the amount of income available for distribution and the amount of our distributions. Such a failure could have a material adverse effect on us, the net asset value of our common stock and the total return, if any, obtainable from your investment in our common stock. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may have difficulty satisfying the Annual Distribution Requirement in order to qualify and maintain RIC tax treatment if we recognize income before or without receiving cash representing such income. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">In accordance with GAAP and tax requirements, we include in income certain amounts that we have not yet received in cash, such as contractual PIK interest, which represents contractual interest added to a loan balance and due at the end of such loan’s term. In addition to the cash yields received on our loans, in some instances, certain loans may also include any of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the following: end-of-term payments, exit</div></div> fees, balloon payment fees or prepayment fees. The increases in loan balances as a result of contractual PIK arrangements are included in income for the period in which such PIK interest was accrued, which is often in advance of receiving a cash payment, and are separately identified on our statements of cash flows. We also may be required to include in income certain other amounts prior to receiving the related cash. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Any warrants that we receive in connection with our debt investments will generally be valued as part of the negotiation process with the particular portfolio company. As a result, a portion of the aggregate purchase price for the debt investments and warrants will be allocated to the warrants that we receive. This will generally result in “original issue discount” for U.S. federal income tax purposes, which we must recognize as ordinary income, increasing the amount that we are required to distribute to qualify for the U.S. federal income tax benefits applicable to RICs. Because these warrants generally will not produce distributable cash for us at the same time as we are required to make distributions in respect of the related original issue discount, we would need to obtain cash from other sources or to pay a portion of our distributions using shares of newly issued common stock, consistent with Internal Revenue Service requirements, to satisfy the Annual Distribution and Excise Tax Avoidance requirements. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other features of the debt instruments that we hold may also cause such instruments to generate original issue discount, resulting in a distribution requirement in excess of current cash interest received. Since in certain cases we may recognize income before or without receiving cash representing such income, we may have difficulty meeting the RIC tax requirement to distribute at least 90% of our net ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any. Under such circumstances, we may have to sell some of our investments at times we would not consider advantageous, raise additional debt or equity capital or reduce new investment originations to meet these distribution requirements. If we are unable to obtain cash from other sources and are otherwise unable to satisfy such distribution requirements, we may fail to qualify for the U.S. federal income tax benefits allowable to RICs and, thus, become subject to a corporate-level U.S. federal income tax on all our income. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Provisions of the Maryland General Corporation Law and of our charter and bylaws could deter takeover attempts and have an adverse impact on the price of our common stock. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Maryland General Corporation Law and our charter and bylaws contain provisions that may discourage, delay or make more difficult a change in control of SLR Investment Corp. or the removal of our directors. We are subject to the Maryland Business Combination Act, subject to any applicable requirements of the 1940 Act. Our board of directors has adopted a resolution exempting from the Maryland Business Combination Act any business combination between us and any other person, subject to prior approval of such business combination by our board of directors, including approval by a majority of our disinterested directors. If the resolution exempting business combinations is repealed or our board of directors does not approve a business combination, the Maryland Business Combination Act may discourage third parties from trying to acquire control of us and increase the difficulty of consummating such an offer. Our bylaws exempt from the Maryland Control Share Acquisition Act (the “Control Share Act”) acquisitions of our stock by any person. If we amend our bylaws to repeal the exemption from the Control Share Act, the Control Share Act also may make it more difficult for a third party to obtain control of us and increase the difficulty of consummating such a transaction. The SEC staff has rescinded its position that, under the 1940 Act, an investment company may not avail itself of the Control Share Act. As a result, we will amend our bylaws to be subject to the Control Share Act only if our board of directors determines that it would be in our best interests. </div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We have also adopted measures that may make it difficult for a third party to obtain control of us, including provisions of our charter classifying our board of directors in three classes serving staggered three-year terms, and authorizing our board of directors to classify or reclassify shares of our stock in one or more classes or series, to cause the issuance of additional shares of our stock and to amend our charter without stockholder approval to increase or decrease the number of shares of stock that we have authority to issue. These provisions, as well as other provisions of our charter and bylaws, may delay, defer or prevent a transaction or a change in control that might otherwise be in the best interests of our stockholders. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The foregoing provisions are expected to discourage certain coercive takeover practices and inadequate takeover bids and to encourage persons seeking to acquire control of us to negotiate first with our board of directors. However, these provisions may deprive a stockholder of the opportunity to sell such stockholder’s shares at a premium to a potential acquirer. We believe that the benefits of these provisions outweigh the potential disadvantages of discouraging any such acquisition proposals because, among other things, the negotiation of such proposals may improve their terms. Our board of directors has considered both the positive and negative effects of the foregoing provisions and determined that they are in the best interest of our stockholders. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our bylaws designate the Circuit Court for Baltimore City, Maryland as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders and provide that claims relating to causes of action under the Securities Act may only be brought in federal district courts, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers or agents, if any, and could discourage lawsuits against us and our directors, officers and agents, if any. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Our bylaws provide that, unless we consent in writing to the selection of an alternative forum, the Circuit Court for Baltimore City, Maryland, or, if that court does not have jurisdiction, the United States District Court for the District of Maryland, Northern Division, will be the sole and exclusive forum for (a) any Internal Corporate Claim, as such term is defined in the MGCL, (b) any derivative action or proceeding brought on our behalf (other than actions arising under federal securities laws), (c) any action asserting a claim of breach of any duty owed by any of our directors, officers or other agents to us or to our stockholders, (d) any action asserting a claim against us or any of our directors, officers or other agents arising pursuant to any provision of the MGCL or our charter or bylaws or (e) any other action asserting a claim against us or any of our directors, officers or other employees that is governed by the internal affairs doctrine. With respect to any proceeding described in the foregoing sentence that is in the Circuit Court for Baltimore City, Maryland, our stockholders consent to the assignment of the proceeding to the Business and Technology Case Management Program pursuant to Maryland <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Rule 16-308 or</div> any successor thereof. None of the foregoing actions, claims or proceedings may be brought in any court sitting outside the State of Maryland unless we consent in writing to such court. Our bylaws do not apply to lawsuits asserting claims brought to enforce a duty or liability arising exclusively under the Securities Act, the 1934 Act, or the 1940 Act, or any other claim for which the federal courts have exclusive jurisdiction. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States of America shall, to the fullest extent permitted by law, be the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. This paragraph does not apply to claims arising exclusively under the 1934 Act or the 1940 Act, or any other claim for which the federal courts have exclusive jurisdiction. These exclusive forum provisions may limit the ability of our stockholders to bring a claim in a judicial forum that such stockholders find favorable for disputes with us or our directors, officers, or agents, if any, which may discourage such lawsuits against us and our directors, officers, and agents, if any. Alternatively, if a court were to find the choice of forum provisions contained in our bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could materially adversely affect our business, financial condition, and operating results. For example, under the Securities Act, federal courts have concurrent jurisdiction over all suits brought to enforce any duty or liability created by the Securities Act, and investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">The failure in cyber security systems, as well as the occurrence of events unanticipated in our disaster recovery systems and management continuity planning could impair our ability to conduct business effectively. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The occurrence of a disaster, such as a cyber-attack against us or against a third party that has access to our data or networks, a natural catastrophe, an industrial accident, failure of our disaster recovery systems, or consequential employee error, could have an adverse effect on our ability to communicate or conduct business, negatively impacting our operations and financial condition. This adverse effect can become particularly acute if those events affect our electronic data processing, transmission, storage, and retrieval systems, or impact the availability, integrity, or confidentiality of our data. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">We depend heavily upon computer systems to perform necessary business functions. Despite our implementation of a variety of security measures, our computer systems, networks, and data, like those of other companies, could be subject to cyber-attacks and unauthorized access, use, alteration, or destruction, such as from physical <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">and electronic break-ins or unauthorized</div> tampering. If one or more of these events occurs, it could potentially jeopardize the confidential, proprietary, and other information processed, stored in, </div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">and transmitted through our computer systems and networks. Such an attack could cause interruptions or malfunctions in our operations, which could result in financial losses, litigation, regulatory penalties, client dissatisfaction or loss, reputational damage, and increased costs associated with mitigation of damages and remediation. If unauthorized parties gain access to such information and technology systems, they may be able to steal, publish, delete or modify private and sensitive information, including nonpublic personal information related to stockholders (and their beneficial owners) and material nonpublic information. The systems we have implemented to manage risks relating to these types of events could prove to be inadequate and, if compromised, could become inoperable for extended periods of time, cease to function properly or fail to adequately secure private information. Breaches such as those involving covertly introduced malware, impersonation of authorized users and industrial or other espionage may not be identified even with sophisticated prevention and detection systems, potentially resulting in further harm and preventing them from being addressed appropriately. The failure of these systems or of disaster recovery plans for any reason could cause significant interruptions in our and our Investment Adviser’s operations and result in a failure to maintain the security, confidentiality or privacy of sensitive data, including personal information relating to stockholders, material nonpublic information and other sensitive information in our possession. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A disaster or a disruption in the infrastructure that supports our business, including a disruption involving electronic communications or other services used by us or third parties with whom we conduct business, or directly affecting our headquarters, could have a material adverse impact on our ability to continue to operate our business without interruption. Our disaster recovery programs may not be sufficient to mitigate the harm that may result from such a disaster or disruption. In addition, insurance and other safeguards might only partially reimburse us for our losses, if at all. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Third parties with which we do business may also be sources of cybersecurity or other technological risk. We outsource certain functions and these relationships allow for the storage and processing of our information, as well as client, counterparty, employee, and borrower information. While we engage in actions to reduce our exposure resulting from outsourcing, ongoing threats may result in unauthorized access, loss, exposure, destruction, or other cybersecurity incident that affects our data, resulting in increased costs and other consequences as described above. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, cybersecurity has become a top priority for global lawmakers and regulators around the world, and some jurisdictions have proposed or enacted laws requiring companies to notify regulators and individuals of data security breaches involving certain types of personal data. In particular, state and federal laws and regulations related to cybersecurity compliance continue to evolve and change, which may require substantial investments in new technology, software and personnel, which could affect the Company’s profitability. These changes may also result in enhanced and unforeseen consequences for cyber-related breaches and incidents, which may further adversely affect the Company’s profitability. If we fail to comply with the relevant and increasing laws and regulations, we could suffer financial losses, a disruption of our businesses, liability to investors, regulatory intervention or reputational damage. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">We and our service providers may be impacted by quarantines and similar measures being enacted by governments in response to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the global COVID-19 pandemic, which</div> are obstructing the regular functioning of business workforces (including requiring employees to work from external locations and their homes). Policies of remote working, whether by us or by our service providers, could strain technology resources, introduce operational risks and otherwise heighten the risks described above. Remote working environments may be less secure and more susceptible to hacking attacks, including phishing and social engineering attempts.</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We, our Investment Adviser and our portfolio companies are subject to risks associated with “phishing” and other cyber-attacks. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Our business and the business of our portfolio companies rely upon secure information technology systems for data processing, storage and reporting. Despite careful security and controls design, implementation and updating, ours and our portfolio companies’ information technology systems could become subject to cyber-attacks. Cyber-attacks include, but are not limited to, gaining unauthorized access to digital systems (e.g., through “hacking”, malicious software coding, social engineering or “phishing” attempts) for purposes of misappropriating assets or sensitive information, corrupting data, or causing operational disruption. The risk of a security breach or disruption, particularly through cyber-attacks or cyber intrusions, including by computer hackers, nation-state affiliated actors, and cyber terrorists, has generally increased as the number, intensity and sophistication of attempted attacks and intrusions from around the world have increased. Cyber-attacks may also be carried out in a manner that does not require gaining unauthorized access, such <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as causing denial-of service attacks</div> on websites (i.e., efforts to make network services unavailable to intended users). Our Investment Adviser’s employees have been and expect to continue to be the target of fraudulent calls, emails and other forms of potentially malicious or otherwise negatively impacting activities and attempts to gain unauthorized access to confidential, personal or other sensitive information. The result of these incidents may include disrupted operations, misstated or unreliable financial data, liability for stolen information, investigations, misappropriation of assets, increased cybersecurity protection and insurance costs, litigation and damage to our business relationships, regulatory fines or penalties, or other adverse effects on our business, financial condition or results of operations. In addition, we may be required to expend significant additional resources to modify our protective measures and to investigate and remediate vulnerabilities or other exposures arising from operational and security risks related to cyber-attacks. </div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our Investment Adviser’s and other service providers’ increased use of mobile and cloud technologies could heighten the risk of a cyber-attack as well as other operational risks, as certain aspects of the security of such technologies may be complex, unpredictable or beyond their control. Our Investment Adviser’s and other service providers’ reliance on mobile or cloud technology or any failure by mobile technology and cloud service providers to adequately safeguard their systems and prevent cyber-attacks could disrupt their operations and result in misappropriation, corruption or loss of personal, confidential or proprietary information. In addition, there is a risk that encryption and other protective measures against cyber-attacks may be circumvented, particularly to the extent that new computing technologies increase the speed and computing power available. Even the most well-protected information, networks, systems and facilities remain potentially vulnerable because the techniques used in such attempted security breaches evolve and generally are not recognized until launched against a target, and in some cases are designed not to be detected and, in fact, may not be detected. Accordingly, we and our service providers may be unable to anticipate these techniques or to implement adequate security barriers or other preventative measures, and thus it is impossible for us and our service providers to entirely mitigate this risk. Cybersecurity risks require continuous and increasing attention and other resources from us to, among other actions, identify and quantify these risks, upgrade and expand our technologies, systems and processes to adequately address such risks. Such attention diverts time and other resources from other activities and there is no assurance that our efforts will be effective. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cybersecurity incidents may adversely impact us and our stockholders. There is no guarantee that we, the Investment Adviser, and/or their respective service providers will be successful in protecting against cybersecurity incidents. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We can be highly dependent on information systems and systems failures could significantly disrupt our business, which may, in turn, negatively affect the market price of our common stock and our ability to pay distributions. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our business is highly dependent upon our and third parties’ communications and information systems. Any failure or interruption of those systems, including as a result of the termination of an agreement with any third-party service providers, could cause delays or other problems in our activities. Our financial, accounting, data processing, backup or other operating systems and facilities may fail to operate properly or become disabled or damaged as a result of a number of factors including events that are wholly or partially beyond our control and adversely affect our business. There could be: </div></div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">sudden electrical or telecommunications outages; </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">natural disasters such as earthquakes, tornadoes and hurricanes; </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">events arising from local or larger scale political or social matters, including terrorist acts; and </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">cyber-attacks. </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">These events, in turn, could have a material adverse effect on our operating results and negatively affect the market price of our common stock and our ability to pay distributions to our stockholders. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Communications with shareholders may be delivered electronically and there may be certain costs and possible risks associated with such electronic delivery. Moreover, the Investment Adviser cannot provide any assurance that these communication methods are secure and will not be responsible for any computer viruses, problems or malfunctions resulting from the use of such communication methods. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our board of directors may change our investment objective, operating policies and strategies without prior notice or stockholder approval. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our board of directors has the authority to modify or waive certain of our operating policies and strategies without prior notice (except as required by the 1940 Act) and without stockholder approval. However, absent stockholder approval, we may not change the nature of our business so as to cease to be, or withdraw our election as a BDC. We cannot predict the effect any changes to our current operating policies and strategies would have on our business, operating results and the value of our stock. Nevertheless, the effects may adversely affect our business and impact our ability to make distributions. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our business is subject to increasingly complex corporate governance, public disclosure and accounting requirements that could adversely affect our business and financial results. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We are subject to changing rules and regulations of federal and state government as well as the stock exchange on which our common stock is listed. These entities, including the Public Company Accounting Oversight Board, the SEC and the NASDAQ Stock Market, have issued a significant number of new and increasingly complex requirements and regulations over the course of the last several years and continue to develop additional regulations and requirements in response to laws enacted by Congress. Our efforts to comply with these existing requirements, or any revised or amended requirements, have resulted in, and are likely to continue to result in, an increase in expenses and a diversion of management’s time from other business activities. </div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Changes in laws or regulations governing our operations may adversely affect our business. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Changes in the laws or regulations, or the interpretations of the laws and regulations, which govern BDCs, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">RICs or non-depository commercial lenders</div> could significantly affect our operations and our cost of doing business. We are subject to federal, state and local laws and regulations and are subject to judicial and administrative decisions that affect our operations, including our loan originations, maximum interest rates, fees and other charges, disclosures to portfolio companies, the terms of secured transactions, collection and foreclosure procedures, and other trade practices. If these laws, regulations or decisions change, or if we expand our business into jurisdictions that have adopted more stringent requirements than those in which we currently conduct business, then we may have to incur significant expenses in order to comply or we may have to restrict our operations. In addition, if we do not comply with applicable laws, regulations and decisions, then we may lose licenses needed for the conduct of our business and be subject to civil fines and criminal penalties, any of which could have a material adverse effect upon our business results of operations or financial condition. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Changes to United States tariff and import/export regulations may have a negative effect on our portfolio companies and, in turn, harm us. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There has been ongoing discussion and commentary regarding potential significant changes to United States trade policies, treaties and tariffs. The current administration, along with Congress, has created significant uncertainty about the future relationship between the United States and other countries with respect to the trade policies, treaties and tariffs. These developments, or the perception that any of them could occur, may have a material adverse effect on global economic conditions and the stability of global financial markets, and may significantly reduce global trade and, in particular, trade between the impacted nations and the United States. Any of these factors could depress economic activity and restrict our portfolio companies’ access to suppliers or customers and have a material adverse effect on their business, financial condition and results of operations, which in turn would negatively impact us. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our Investment Adviser can resign on 60 days’ notice, and we may not be able to find a suitable replacement within that time, resulting in a disruption in our operations that could adversely affect our financial condition, business and results of operations. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Investment Adviser has the right, under the Advisory Agreement, to resign at any time upon 60 days written notice, whether we have found a replacement or not. If our Investment Adviser resigns, we may not be able to find a new investment adviser or hire internal management with similar experience and ability to provide the same or equivalent services on acceptable terms within 60 days, or at all. If we are unable to do so quickly, our operations are likely to experience a disruption, our financial condition, business and results of operations as well as our ability to pay distributions are likely to be adversely affected and the market price of our shares may decline. In addition, the coordination of our internal management and investment activities is likely to suffer if we are unable to identify and reach an agreement with a single institution or group of executives having the experience possessed by our Investment Adviser and its affiliates. Even if we are able to retain comparable management, whether internal or external, the integration of such management and their lack of familiarity with our investment objective may result in additional costs and time delays that may adversely affect our financial condition, business and results of operations. </div> The calculations in the table below are hypothetical and actual returns may be higher or lower than those appearing in the table below. <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:82%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="18" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Assumed total return<br/>(net of interest expense)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(10)%</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(5)%</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">0%</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5%</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">10%</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corresponding return to stockholder(1)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(29.9</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(17.2</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4.5</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8.2</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20.9</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table><div style="font-size: 10pt;;display:inline;"/> <div style="width: 11%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;;text-indent: 0px;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="display:inline;">(1)</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;">Assumes $2.5 billion in total assets and $1.1 billion in total debt outstanding, which reflects our total assets and total debt outstanding as of December 31, 2022, and a cost of funds of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">4.09%. Excludes non-leverage related expenses.</div> </div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In<div style="display:inline;"> </div></div></div><div style="font-size: 10pt;;display:inline;">order for us to cover our annual interest payments on our outstanding indebtedness at December 31, 2022, we must achieve annual returns on our December 31, 2022 total assets of at least 1.8%.</div> -0.299 -0.172 -0.045 0.082 0.209 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">General Risk Factors </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Volatility or a prolonged disruption in the credit markets could materially damage our business. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are required to record our assets at fair value, as determined in good faith by our board of directors, in accordance with our valuation policy. As a result, volatility in the capital markets may have a material adverse effect on our valuations and our net asset value, even if we hold investments to maturity. Volatility or dislocation in the capital markets may depress our stock price below our net asset value per share and create a challenging environment in which to raise equity and debt capital. These conditions could continue for a prolonged period of time or worsen in the future. While these conditions persist, we and other companies in the financial services sector may have to access, if available, alternative markets for debt and equity capital. Equity capital may be difficult to raise because, subject to some limited exceptions which apply to us, as a BDC we are generally not able to issue additional shares of our common stock at a price less than net asset value without first obtaining approval for such issuance from our stockholders and our independent directors. Any offering of our common stock that requires stockholder approval must occur, if at all, within one year after receiving such stockholder approval. In addition, our ability to incur indebtedness (including by issuing preferred stock) is limited by applicable regulations such that our asset coverage, as defined in the 1940 Act, must equal at least 150% immediately after each time we incur indebtedness. The debt capital that will be available, if at all, may be at a higher cost and on less favorable terms and conditions in the future. Any inability to raise capital could have a negative effect on our business, financial condition and results of operations. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, our ability to incur indebtedness is limited by the asset coverage ratio for a BDC, as defined under the 1940 Act. Declining portfolio values negatively impact our ability to borrow additional funds because our net asset value is reduced for purposes of the asset coverage ratio. If the fair value of our assets declines substantially, we may fail to maintain the asset coverage ratio stipulated by the 1940 Act, which could, in turn, cause us to lose our status as a BDC and materially impair our business operations. A lengthy disruption in the credit markets could also materially decrease demand for our investments. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The significant disruption in the capital markets experienced in the past, including the disruption caused <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">by the COVID-19 pandemic</div> and the Russian invasion of Ukraine, have had, and may in the future have, a negative effect on the valuations of our investments and on the potential for liquidity events involving our investments. The debt capital that may be available to us in the future may be at a higher cost and have less favorable terms and conditions than those currently in effect. If our financing costs increase and we have no increase in interest income, then our net investment income will decrease. A prolonged inability to raise capital may require us to reduce the volume of investments we originate and could have a material adverse impact on our business, financial condition and results of operations. This may also increase the probability that other structural risks will negatively impact us. These situations may arise due to circumstances that we may be unable to control, such as a lengthy disruption in the credit markets, a severe decline in the value of the U.S. dollar, a sharp economic downturn or recession or an operational problem that affects third parties or us, and could materially damage our business, financial condition and results of operations. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Global economic, regulatory and market conditions may adversely affect our business, results of operations and financial condition, including our revenue growth and profitability. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We and our portfolio companies are subject to regulation by laws at the U.S. federal, state and local levels. These laws and regulations, as well as their interpretation, could change from time to time, including as the result of interpretive guidance or other directives from the U.S. President and others in the executive branch, and new laws, regulations and interpretations could also come into effect. Any such new or changed laws or regulations could have a material adverse effect on our business, and political uncertainty could increase regulatory uncertainty in the near term. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The effects of legislative and regulatory proposals directed at the financial services industry or affecting taxation, could negatively impact the operations, cash flows or financial condition of us and our portfolio companies, impose additional costs on us or our portfolio companies, intensify the regulatory supervision of us or our portfolio companies or otherwise adversely affect our business or the business of our portfolio companies. In addition, if we do not comply with applicable laws and regulations, we could lose any licenses that we then hold for the conduct of business and could be subject to civil fines and criminal penalties. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Over the last several years, there also has been an increase in regulatory attention to the extension of credit outside of the traditional banking sector, raising the possibility that some portion <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of the non-bank financial sector</div> will be subject to new regulation. While it cannot be known at this time whether any regulation will be implemented or what form it will take, increased <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">regulation of non-bank credit extension</div> could negatively impact our operations, cash flows or financial condition, impose additional costs on us, intensify the regulatory supervision of us or otherwise adversely affect our business, financial condition and results of operations. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although we cannot predict the impact, if any, of these changes to our business, they could adversely affect our business, financial condition, operating results and cash flows. Until we know what policy changes are made and how those changes impact business and the business of our competitors over the long term, we will not know if, overall, it will benefit from them or be negatively affected by them. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deterioration in the economic conditions in the Eurozone and other regions or countries globally and the resulting instability in global financial markets may pose a risk to our business. Financial markets have been affected at times by a number of global macroeconomic events, including the following: large sovereign debts and fiscal deficits of several countries in Europe and in emerging markets jurisdictions, levels of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-performing</div> loans on the balance sheets of European banks, the effect of the United Kingdom leaving the European Union, instability in the Chinese capital markets and the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Various social and political circumstances in the U.S. and around the world (including wars and other forms of conflict, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics), may also contribute to increased market volatility and economic uncertainties or deterioration in the U.S. and worldwide. Such events, including rising trade tensions between the United States and China, other uncertainties regarding actual and potential shifts in U.S. and foreign, trade, economic and other policies with other countries, the large-scale invasion of Ukraine by Russia that began in February 2022 and resulting sanctions or other restrictive actions that the United States and other countries have imposed against Russia, and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the COVID-19 pandemic,</div> could adversely affect our business, financial condition or results of operations. These market and economic disruptions could negatively impact the operating results of our portfolio companies. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, Russia’s invasion of Ukraine and corresponding events have had, and could continue to have, severe adverse effects on regional and global economic markets. Following Russia’s actions, various governments, including the United States, have issued broad-ranging economic sanctions against Russia, including, among other actions, a prohibition on doing business with certain Russian companies, large financial institutions, officials and oligarchs; a commitment by certain countries and the European Union to remove selected Russian banks from the Society for Worldwide Interbank Financial Telecommunications, the electronic banking network that connects banks globally; and restrictive measures to prevent the Russian Central Bank from undermining the impact of the sanctions. The duration of hostilities and the vast array of sanctions and related events (including cyberattacks and espionage) cannot be predicted. Furthermore, the conflict between the two nations and the varying involvement of the United States and other NATO countries could preclude prediction as to their ultimate adverse impact on global economic and market conditions, and, as a result, presents material uncertainty and risk with respect to markets globally, which pose potential adverse risks to us and the performance of our investments and operations, and our ability to achieve our investment objectives. Additionally, to the extent that third parties, investors, or related customer bases have material operations or assets in Russia or Ukraine, they may have adverse consequences related to the ongoing conflict. Any such market disruptions could affect our portfolio companies’ operations and, as a result, could have a material adverse effect on our business, financial condition and results of operations. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, the Federal Reserve raised the Federal Funds Rate in 2022 and in 2023, and may raise or announce its intention to raise the Federal Funds Rate further. These developments, along with the United States government’s credit and deficit concerns, global economic uncertainties and market volatility and the impacts <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of COVID-19, could</div> cause interest rates to be volatile, which may negatively impact our ability to access the debt markets and capital markets on favorable terms. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Events outside of our control, including <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the COVID-19 public</div> health crises, could negatively affect our portfolio companies and our results of our operations. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Periods of market volatility have occurred and could continue to occur in response to pandemics or other events outside of our control. These types of events have adversely affected and could continue to adversely affect operating results for us and for our portfolio companies. For example, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic has adversely impacted global commercial activity and contributed to significant volatility in the equity and debt markets. The <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic and restrictive measures taken to contain or mitigate its spread have caused, and may continue to cause, business shutdowns, or the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-introduction</div> of business shutdowns, cancellations of events and restrictions on travel, significant reductions in demand for certain goods and services, reductions in business activity and financial transactions, supply chain interruptions, labor shortages, increased inflationary pressure and overall economic and financial market instability both globally and in the United States. Many states, including those in which we and portfolio companies in which we invest may operate, have previously issued orders requiring the closure of, or certain restrictions on the operation of, certain businesses. The ultimate duration and severity of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic, including <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> variants, remain uncertain. While several countries, as well as certain states, counties and cities in the United States, relaxed the public health restrictions throughout 2021 partly as a result of the introduction of vaccines, recurring <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> outbreaks caused by different virus variants continue to lead to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-introduction</div> of certain restrictions in certain states in the United States and globally. Even after the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic subsides, the U.S. economy and most other major global economies may continue to experience a recession, and our business and operations, as well as the business and operations of the portfolio companies in which we invest, could be materially adversely affected by a prolonged recession in the U.S. and other major markets. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Despite actions of the U.S. federal government and foreign governments, the uncertainty surrounding the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic, including uncertainty regarding existing or future variants and other factors, has contributed to significant volatility in the global public equity markets and global debt capital markets. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">The continued uncertainty related to the sustainability and pace of economic recovery in the U.S. and globally could have a negative impact on our business. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our business is directly influenced by the economic cycle, and could be negatively impacted by a downturn in economic activity in the U.S. as well as globally. Fiscal and monetary actions taken by <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">U.S. and non-U.S. government and</div> regulatory authorities could have a material adverse impact on our business. To the extent uncertainty regarding the U.S. or global economy, including as a result of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the global COVID-19 pandemic, negatively</div> impacts consumer confidence and consumer credit factors, our business, financial condition and results of operations could be adversely affected. Moreover, Federal Reserve policy, including with respect to certain interest rates and the decision to end its quantitative easing policy, along with the general policies of the current Presidential administration, may also adversely affect the value, volatility and liquidity of dividend- and interest-paying securities. Market volatility, periods of rising interest rates, such as the current economic period, and/or a return to unfavorable economic conditions could adversely affect our business. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">There is uncertainty surrounding potential legal, regulatory and policy changes by new presidential administrations in the United States that may directly affect financial institutions and the global economy. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The current administration has called for significant changes to U.S. trade, healthcare, immigration, foreign and government regulatory policy. In this regard, there is significant uncertainty with respect to legislation, regulation and government policy at the federal level, as well as the state and local levels. Recent events have created a climate of heightened uncertainty and introduced new and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">difficult-to-quantify</div></div> macroeconomic and political risks with potentially <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">far-reaching</div> implications. There has been a corresponding meaningful increase in the uncertainty surrounding interest rates, inflation, foreign exchange rates, trade volumes and fiscal and monetary policy. To the extent the U.S. Congress or the current administration implements changes to U.S. policy, those changes may impact, among other things, the U.S. and global economy, international trade and relations, unemployment, immigration, corporate taxes, healthcare, the U.S. regulatory environment, inflation and other areas. Although we cannot predict the impact, if any, of these changes to our business, they could adversely affect our business, financial condition, operating results and cash flows. Until we know what policy changes are made and how those changes impact our business and the business of our competitors over the long term, we will not know if, overall, we will benefit from them or be negatively affected by them. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We are exposed to risks associated with changes in interest rates, including the transition away from LIBOR and the adoption of alternative reference rates. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although we no longer intend to lend at rates based on the London Interbank Offered Rate (“LIBOR”), we may acquire loans that continue to use LIBOR. While many LIBOR rates were phased out at the end of 2021, a selection of widely used U.S.-dollar LIBOR rates will continue to be published until June 2023. On July 29, 2021, the U.S. Federal Reserve System, in conjunction with the Alternative Reference Rates Committee, a steering committee comprised of large U.S. financial institutions, formally recommended replacing U.S.-dollar LIBOR with the Secured Overnight Financing Rate (“SOFR”), a new index calculated by short-term repurchase agreements, backed by Treasury securities. Further, on March 15, 2022, the Consolidation Appropriations Act of 2022, which includes the Adjustable Interest Rate (LIBOR) Act (“LIBOR Act”), was signed into law in the U.S. This legislation establishes a uniform benchmark replacement process for financial contracts that mature after June 30, 2023 which do not contain clearly defined or practicable fallback provisions. The legislation also creates a safe harbor that shields lenders from litigation if they choose to utilize a replacement rate recommended by the Board of Governors of the Federal Reserve. Although the transition process away from LIBOR has become increasingly well-defined (e.g. the LIBOR Act now provides a uniform benchmark replacement for LIBOR-based instruments in the U.S.), the transition process may involve, among other things, increased volatility or illiquidity in markets for instruments that currently rely on LIBOR and may result in a reduction in the value of certain instruments that we may acquire. Further, disruptions related to loans in the marketplace could have a material adverse effect on the ability of the Investment Adviser or its affiliates to enter into loans in the future in accordance with our investment strategy and have a material adverse effect on us. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Inflation and a rising interest rate environment may adversely affect the business, results of operations and financial condition of us and our portfolio companies. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The current macroeconomic environment is characterized by record-high inflation, supply chain challenges, labor shortages, high interest rates, foreign currency exchange volatility, volatility in global capital markets and growing recession risk. The risks associated with the Company’s and our portfolio companies’ businesses are more severe during periods of economic slowdown or recession. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any disruptions in the capital markets, as a result of inflation and a rising interest environment or otherwise, may increase the spread between the yields realized on risk-free and higher risk securities and can result in illiquidity in parts of the capital markets, significant write-offs in the financial sector and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-pricing</div> of credit risk in the broadly syndicated market. These and any other unfavorable economic conditions could increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, market conditions (including inflation, supply chain issues and decreased consumer demand) have adversely impacted, and could in the future further impact, the operations of certain of our portfolio companies. If the financial results of middle-market companies, like those in which we invest, experience deterioration, it could ultimately lead to difficulty in meeting debt service requirements and an increase in defaults, and further deterioration in market conditions will further depress the outlook for those companies. Further, adverse economic conditions decreased and may in the future decrease the value of collateral securing some of our loans and the value of our equity investments. Such conditions have required and may in the future require us to modify the payment terms of our investments, including changes in PIK interest provisions and/or cash interest rates. The performance of certain of our portfolio companies has been, and in the future may be, negatively impacted by these economic or other conditions, which can result in our receipt of reduced interest income from our portfolio companies and/or realized and unrealized losses related to our investments, and, in turn, may adversely affect distributable income and have a material adverse effect on our results of operations. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Inflation may cause the real value of our investments to decline. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Inflation risk results from the variation in the value of cash flows from a security due to inflation, as measured in terms of purchasing power. We are exposed to inflation risk with respect to any fixed rate investments that we make, if any, because the interest rate the issuer has to pay us is fixed for the life of the security. To the extent that interest rates reflect the expected inflation rate, floating rate loans have a lower level of inflation risk. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div/> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Technological innovations and industry disruptions may negatively impact us. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Technological innovations have disrupted traditional approaches in multiple industries and can permit younger companies to achieve success and in the process disrupt markets and market practices. We can provide no assurance that new businesses and approaches will not be created that would compete with us and/or our portfolio companies or alter the market practices in which SLR Capital Partners and its affiliates and us have been designed to function within and on which we depend on for our investment return. New approaches could damage our investments, disrupt the market in which we operate and subject us to increased competition, which could materially and adversely affect our business, financial condition and results of investments. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We are subject to risks related to corporate social responsibility. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our business (including that of our portfolio companies) faces increasing public scrutiny related to environmental, social and governance (“ESG”) activities, which are increasingly considered to contribute to reducing a company’s operational risk, market risk and reputational risk, which may in turn impact the long-term sustainability of a company’s performance. A variety of organizations measure the performance of companies on ESG topics, and the results of these assessments are widely publicized. In addition, investment in funds that specialize in companies that perform well in such assessments are increasingly popular, and major institutional investors have publicly emphasized the importance of such ESG measures to their investment decisions. We risk damage to our brand and reputation if we fail to act responsibly in a number of areas, including, but not limited to, diversity, equity and inclusion, human rights, climate change, environmental stewardship, corporate governance and considering ESG factors in our investment processes. Adverse incidents with respect to ESG activities could impact the value of our brand, our relationship with existing and future portfolio companies, the cost of our operations and relationships with investors, all of which could adversely affect our business and results of operations. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">However, regional and investor specific sentiment may differ in what constitutes a material positive or negative ESG corporate practice. There is no guarantee that the Company’s corporate social responsibility practices will uniformly fit every investor’s definition of best practices for all environmental, social and governance considerations across geographies and investor types. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is also a growing regulatory interest across jurisdictions in improving transparency regarding the definition, measurement and disclosure of ESG factors in order to allow investors to validate and better understand sustainability claims. For example, the SEC has proposed, or has announced that it is working on proposals for, rules that, among other matters, would establish a framework for reporting of climate-related risks, corporate and fund carbon emissions, broad diversity and capital management. At this time, there is uncertainty regarding the scope of such proposals or when they would become effective (if at all). In addition, in 2021 the SEC established an enforcement task force to look into ESG practices and disclosures by public companies and investment managers and has started to bring enforcement actions based on ESG disclosures not matching actual investment processes. We and our portfolio companies are subject to the risk that similar measures might be introduced in other jurisdictions in the future. Additionally, compliance with any new laws or regulations increases our regulatory burden and could make compliance more difficult and expensive, affect the manner in which we or our portfolio companies conduct our businesses and adversely affect our profitability. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">The effect of global climate change may impact the operations of our portfolio companies. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There may be evidence of global climate change. Climate change creates physical and financial risk and some of our portfolio companies may be adversely affected by climate change. For example, the needs of customers of energy companies vary with weather conditions, primarily temperature and humidity. To the extent weather conditions are affected by climate change, energy use could increase or decrease depending on the duration and magnitude of any changes. Increases in the cost of energy could adversely affect the cost of operations of our portfolio companies if the use of energy products or services is material to their business. A decrease in energy use due to weather changes may affect some of our portfolio companies’ financial condition, through decreased revenues. Extreme weather conditions in general require more system backup, adding to costs, and can contribute to increased system stresses, including service interruptions. Energy companies could also be affected by the potential for lawsuits against or taxes or other regulatory costs imposed on greenhouse gas emitters, based on links drawn between greenhouse gas emissions and climate change. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2015, the United Nations, of which the U.S. is a member, adopted a climate accord with the long-term goal of limiting global warming and the short-term goal of significantly reducing greenhouse gas emissions. As a result, some of our portfolio companies may become subject to new or strengthened regulations or legislation, which could increase their operating costs and/or decrease their revenues. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We cannot predict how changes in tax law will affect us, our investments, or our stockholders, and any such legislation could adversely affect our business. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Legislative or other actions relating to taxes could have a negative effect on us. The rules dealing with U.S. federal income taxation are constantly under review by persons involved in the legislative process and by the Internal Revenue Service and the U.S. Treasury Department. New legislation and any other tax law developments, including new or revised U.S. Treasury regulations, administrative interpretations or court decisions, could negatively and perhaps retroactively affect our ability to qualify for tax treatment as a RIC or the U.S. federal income tax consequences to us and our shareholders, or could have other adverse consequences. Investors are urged to consult with their tax advisor regarding tax legislative, regulatory, or administrative developments and proposals and their potential effect on an investment in our common stock. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Uncertainty about U.S. government initiatives could negatively impact our business, financial condition and results of operations. </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">The U.S. government has recently called for significant changes to U.S. trade, healthcare, immigration, foreign and government regulatory policy. In this regard, there is significant uncertainty with respect to legislation, regulation and government policy at the federal level, as well as the state and local levels. Recent events have created a climate of heightened uncertainty and introduced <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">new and difficult-to-quantify macroeconomic and</div></div> political risks <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">with potentially far-reaching implications. There</div> has been a corresponding meaningful increase in the uncertainty surrounding interest rates, inflation, foreign exchange rates, trade volumes and fiscal and monetary policy. To the extent the U.S. Congress or the current administration implements changes to U.S. policy, those changes may impact, among other things, the U.S. and global economy, international trade and relations, unemployment, immigration, corporate taxes, healthcare, the U.S. regulatory environment, inflation and other areas. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A particular area identified as subject to potential change, amendment or repeal includes the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the “Dodd-Frank Act,” including the Volcker Rule and various swaps and derivatives regulations, credit risk retention requirements and the authorities of the Federal Reserve, the Financial Stability Oversight Council and the SEC. Given the uncertainty associated with the manner in which and whether the provisions of the Dodd-Frank Act will be implemented, repealed, amended, or replaced, the full impact such requirements will have on our business, results of operations or financial condition is unclear. The changes resulting from the Dodd-Frank Act or any changes to the regulations already implemented thereunder may require us to invest significant management attention and resources to evaluate and make necessary changes in order to comply with new statutory and regulatory requirements. Failure to comply with any such laws, regulations or principles, or changes thereto, may negatively impact our business, results of operations or financial condition. While we cannot predict what effect any changes in the laws or regulations or their interpretations would have on us as a result of recent financial reform legislation, these changes could be materially adverse to us and our stockholders. </div></div></div> The following table sets forth, for each fiscal quarter during the last two fiscal years, the net asset value (“NAV”) per share of our common stock, the high and low closing sales prices for our common stock, such sales prices as a percentage of NAV per share and distributions per share. <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> <br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 55%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NAV<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:6.6px">(1) </div></div></div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Price Range</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Premium or</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Discount)</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">of High Closing</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Price to NAV<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:6.6px"> (2)</div></div></div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Premium or</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Discount)</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">of</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Low Closing</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Price to</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NAV<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:6.6px"> (2) </div></div></div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Declared</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Distributions<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:6.6px"> (3)</div></div></div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">High</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Low</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2022</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fourth Quarter</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.33</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15.03</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12.50</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(18.0</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(31.8</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.41</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Third Quarter</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.37</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15.76</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12.32</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(14.2</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(32.9</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.41</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Second Quarter</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.53</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.19</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14.17</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.8</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(23.5</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.41</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">First Quarter</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19.56</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19.26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17.68</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.5</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(9.6</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.41</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2021</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fourth Quarter</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19.93</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19.90</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17.55</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.2</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(11.9</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.41</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Third Quarter</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20.20</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19.75</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.42</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2.2</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8.8</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.41</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Second Quarter</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20.29</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19.58</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17.88</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3.5</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(11.9</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.41</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">First Quarter</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20.26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19.35</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17.35</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4.5</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(14.4</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.41</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table><div style="width: 11%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">NAV per share is determined as of the last day in the relevant quarter and therefore may not reflect the NAV per share on the date of the high and low sales prices. The net asset values shown are based on outstanding shares at the end of each period. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Calculated as of the respective high or low closing price divided by NAV and subtracting 1. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)</div> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Represents the cash distribution for the specified quarter. </div></td></tr></table> 18.33 15.03 12.5 -0.18 -0.318 18.37 15.76 12.32 -0.142 -0.329 18.53 18.19 14.17 -0.018 -0.235 19.56 19.26 17.68 -0.015 -0.096 19.93 19.9 17.55 -0.002 -0.119 20.2 19.75 18.42 -0.022 -0.088 20.29 19.58 17.88 -0.035 -0.119 20.26 19.35 17.35 -0.045 -0.144 <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:91%"/> <td style="vertical-align:bottom;width:6%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Stockholder transaction expenses:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales load (as a percentage of offering price)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom">%<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Offering expenses (as a percentage of offering price)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom">%<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Dividend reinvestment plan expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom">%<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total stockholder transaction expenses (as a percentage of offering price)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom">%<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Annual expenses (as a percentage of net assets attributable to common stock)<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div>:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Base management fee</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.00</td> <td style="white-space:nowrap;vertical-align:bottom">%<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Incentive fees payable under our Investment Advisory and Management Agreement (up to 20%)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.51</td> <td style="white-space:nowrap;vertical-align:bottom">%<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(6)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest payments on borrowed funds</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.61</td> <td style="white-space:nowrap;vertical-align:bottom">%<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(7)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Acquired fund fees and expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.02</td> <td style="white-space:nowrap;vertical-align:bottom">%<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(8)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other expenses (estimated)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.15</td> <td style="white-space:nowrap;vertical-align:bottom">%<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(9)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total annual expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.29</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table><div style="width: 11%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(1)</div> </div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In the event that the shares of common stock are sold to or through underwriters, a corresponding prospectus supplement will disclose the applicable sales load and the “Example” will be updated accordingly. </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(2)</div> </div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The prospectus supplement corresponding to each offering will disclose the applicable offering expenses and total stockholder transaction expenses. </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(3)</div> </div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The expenses of the dividend reinvestment plan are included in “other expenses.” </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Annual Expenses are presented in this manner because common shareholders will bear all costs of running the Company. </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(5)</div> </div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our 1.50% base management fee under the Investment Advisory and Management Agreement (giving effect to the Letter Agreement) is based on our gross assets, which is defined as all the assets of SLRC, excluding temporary assets, including those acquired using borrowings for investment purposes, and assumes our gross assets remain consistent with gross assets for the fiscal year ended December 31, 2022. The base management fee is reduced to 1.00% on gross assets that exceed 200% of total net assets as of the immediately preceding quarter. </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(6)</div></div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assumes that annual incentive fees earned by our investment adviser, SLR Capital Partners, remain consistent with the incentive fees earned by SLR Capital Partners for the fiscal year ended December 31, 2022. The incentive fee consists of two parts: </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The first part, which is payable quarterly in arrears, equals 20% of the excess, if any, of our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">“Pre-Incentive</div> Fee Net Investment Income” that exceeds a 1.75% quarterly (7.00% annualized) hurdle rate, which we refer to as the Hurdle, subject to a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">“catch-up”</div> provision measured at the end of each calendar quarter. The first part of the incentive fee is computed and paid on income that may include interest that is accrued but not yet received in cash. The operation of the first part of the incentive fee for each quarter is as follows: </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">no incentive fee is payable to our investment adviser in any calendar quarter in which our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-Incentive</div> Fee Net Investment Income does not exceed the Hurdle of 1.75%; </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">100% of our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-Incentive</div> Fee Net Investment Income with respect to that portion of such <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-Incentive</div> Fee Net Investment Income, if any, that exceeds the Hurdle but is less than 2.1875% in any calendar quarter (8.75% annualized) is payable to our investment adviser. We refer to this portion of our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-Incentive</div> Fee Net Investment Income (which exceeds the Hurdle but is less than 2.1875%) as the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">“catch-up.”</div> The <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">“catch-up”</div> is meant to provide our investment adviser with 20% of our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-Incentive</div> Fee Net Investment Income, as if a Hurdle did not apply when our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-Incentive</div> Fee Net Investment Income exceeds 2.1875% in any calendar quarter; and </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">20% of the amount of our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-Incentive</div> Fee Net Investment Income, if any, that exceeds 2.1875% in any calendar quarter (8.75% annualized) is payable to our investment adviser (once the Hurdle is reached and the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">catch-up</div> is achieved, 20% of all <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-Incentive</div> Fee Investment Income thereafter is allocated to our investment adviser). </div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The second part of the incentive fee equals 20% of our “Incentive Fee Capital Gains,” if any, which equals our realized capital gains on a cumulative basis from inception through the end of each calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees. The second part of the incentive fee is payable, in arrears, at the end of each calendar year (or upon termination of the Investment Advisory and Management Agreement, as of the termination date). </div></div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(7)</div> </div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We have historically and will in the future borrow funds from time to time to make investments to the extent we determine that the economic situation is conducive to doing so. The costs associated with our outstanding borrowings are indirectly borne by our investors. For purposes of this section, we have computed interest expense using the average consolidated balance outstanding for borrowings during the fiscal year ended December 31, 2022. We used the Secured Overnight Financing Rate (“SOFR”) or similar base rate on December 31, 2022 and the interest rate on the Credit Facility, the SPV Credit Facility, the 2027 Series F Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes, the 2024 Unsecured Notes and the 2023 Unsecured Notes on December 31, 2022. We have also included, as applicable, the estimated market discount or amortization of fees incurred in establishing the Credit Facility, the SPV Credit Facility, the 2027 Series F Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes, the 2024 Unsecured Notes and the 2023 Unsecured Notes as of December 31, 2022. Additionally, we included the estimated cost of commitment fees for unused balances on the Credit Facility and the SPV Credit Facility. As of December 31, 2022, we had $393.0 million outstanding under the Credit Facility, $155.2 million outstanding under the SPV Credit Facility and $135 million, $50 million, $75 million, $125 million, $85 million, and $75 million outstanding under the 2027 Series F Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes, the 2024 Unsecured Notes and the 2023 Unsecured Notes, respectively. We may also issue preferred stock, subject to our compliance with applicable requirements under the 1940 Act, although we have no immediate intention to do so. </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(8)</div> </div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The holders of shares of our common stock indirectly bear the expenses of our investment in SLR Senior Lending Program LLC (“SSLP”). No management fee is charged on our investments in SSLP in connection with the administrative services provided to SSLP. Future expenses for SSLP may be substantially higher or lower because certain expenses may fluctuate over time. </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(9)</div> </div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">“Other expenses” are based on estimated amounts for the current fiscal year, which considers the amounts incurred for the fiscal year ended December 31, 2022 and include our overhead expenses, including payments under our Administration Agreement based on our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement. </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/> 0 0 0 0 0.03 0.0151 0.0461 0.0002 0.0115 0.1029 <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following example demonstrates the projected dollar amount of total cumulative expenses that would be incurred over various periods with respect to a hypothetical investment in our common stock. In calculating the following expense amounts, we have assumed that our annual operating expenses would remain at the levels set forth in the table above and have excluded performance-based incentive fees. As such, the below example is based on an annual expense ratio of 8.78%. See Note 7 above for additional information regarding certain assumptions regarding our level of leverage. In the event that shares are sold to or through underwriters, a corresponding prospectus supplement will restate this example to reflect the applicable sales load. </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:73%"/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1 Year</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3 Years</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5 Years</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">10 Years</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">You would pay the following expenses on a $1,000 investment, assuming a 5% annual return</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">88</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">253</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">407</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">743</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:73%"/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1 Year</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3 Years</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5 Years</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">10 Years</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">You would pay the following expenses on a $1,000 investment, assuming a 5% annual return</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">98</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">279</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">444</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">792</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> 88000 253000 407000 743000 98000 279000 444000 792000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Portfolio and Investment Activity </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">During the year ended December 31, 2022, exclusive of the assets acquired through the Mergers, we invested approximately $610 million across 77 portfolio companies. This compares to investing approximately $596 million across 52 portfolio companies for the year ended December 31, 2021. Investments sold, prepaid or repaid during the year ended December 31, 2022 totaled approximately $532 million versus approximately $468 million for the year ended December 31, 2021. </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">At December 31, 2022, our portfolio consisted of 139 portfolio companies and was invested 30.8% in cash flow senior secured loans, 30.0% in asset-based senior secured loans / SLR Credit Solutions (“SLR Credit”) / SLR Healthcare ABL / SLR Business Credit, 23.7% in equipment senior secured financings / SLR Equipment Finance (“SLR Equipment”) / Kingsbridge Holdings, LLC (“KBH”) and 15.5% in life science senior secured loans, in each case, measured at fair value, versus 106 portfolio companies invested 26.7% in cash flow senior secured loans, 27.0% in asset-based senior secured loans / SLR Credit, 29.9% in equipment senior secured financings / SLR Equipment / KBH, and 16.4% in life science senior secured loans, in each case, measured at fair value, at December 31, 2021. </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">At December 31, 2022, 77.7% or $1.61 billion of our income producing investment portfolio<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">*</div> is floating rate and 22.3% or $464.5 million is fixed rate, measured at fair value. At December 31, 2021, 79.4% or $1.20 billion of our income producing investment portfolio<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">*</div> is floating rate and 20.6% or $313.4 million is fixed rate, measured at fair value. As of December 31, 2022 and 2021, we had two and one issuers on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-accrual</div> status, respectively. </div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top: 1em; margin-bottom: 1em"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">*</div> We have included SLR Credit Solutions, SLR Equipment Finance, SLR Healthcare ABL, SLR Business Credit and Kingsbridge Holdings, LLC within our income producing investment portfolio. </div></div></div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 2%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Senior Securities</div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Information about our senior securities is shown in the following table (in thousands) as of each year ended December 31 for the past ten years, unless otherwise noted. The “—” indicates information which the SEC expressly does not require to be disclosed for certain types of senior securities.</div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 55%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Class and Year</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Amount<br/>Outstanding(1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset<br/>Coverage<br/>Per Unit(2)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Involuntary<br/>Liquidating<br/>Preference<br/>Per Unit(3)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Market Value<br/>Per Unit(4)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Credit Facility</div></div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">293,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">513</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">222,500</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">552</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">126,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">421</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">42,900</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">182</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">96,400</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">593</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">245,600</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">1,225</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">115,200</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">990</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">207,900</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">1,459</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">SPV Credit Facility</div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">155,200</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">272</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2022 Unsecured Notes</div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">150,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">372</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">150,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">501</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">150,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">638</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">150,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">923</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">150,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">748</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">50,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">430</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">2022 Tranche C Notes</div></div> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> </tr> </table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"/> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 55%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Class and Year</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Amount<br/>Outstanding(1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset<br/>Coverage<br/>Per Unit(2)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Involuntary<br/>Liquidating<br/>Preference<br/>Per Unit(3)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Market Value<br/>Per Unit(4)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">21,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">52</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">21,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">70</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">21,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">89</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">21,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">129</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">21,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">105</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2023 Unsecured Notes</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">131</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">186</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">250</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">319</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">461</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">374</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2024 Unsecured Notes</div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">125,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">219</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">125,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">309</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">125,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">417</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">125,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">531</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2025 Unsecured Notes</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">85,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">149</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2026 Unsecured Notes</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">131</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">186</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">250</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">319</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2027 Unsecured Notes</div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">50,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">88</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">50,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">124</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2027 Series F Unsecured Notes</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">135,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">237</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2042 Unsecured Notes</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">100,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">859</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">1,002</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">100,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">702</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">982</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">100,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">2,294</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">943</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">100,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">2,411</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">934</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Senior Secured Notes</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">645</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">527</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">1,721</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">1,808</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Term Loans</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">100,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">175</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">100,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">248</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">250</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">319</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">50,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">308</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">50,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">250</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">50,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">430</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">50,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">351</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">50,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">1,147</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">50,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">1,206</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> </table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"/> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 76%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NEFPASS Facility</div></div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">128</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">185</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">SSLP Facility</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">53,785</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">331</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Senior Securities</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,093,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,915</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">818,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,029</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">677,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,259</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">593,900</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,525</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">476,185</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,930</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">541,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,702</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">390,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,354</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">432,900</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,039</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">225,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,162</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">225,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,425</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="width: 11%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><br/></div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of December 31, 2022, asset coverage was 1<div style="display:inline;">91</div>.<div style="display:inline;">5</div>%. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(4)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014 and 2013 periods was $100,175, $98,196, $94,301 and $93,392, respectively.</div> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Information about our senior securities is shown in the following table (in thousands) as of each year ended December 31 for the past ten years, unless otherwise noted. The “—” indicates information which the SEC expressly does not require to be disclosed for certain types of senior securities.</div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 55%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Class and Year</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Amount<br/>Outstanding(1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset<br/>Coverage<br/>Per Unit(2)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Involuntary<br/>Liquidating<br/>Preference<br/>Per Unit(3)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Market Value<br/>Per Unit(4)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Credit Facility</div></div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">293,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">513</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">222,500</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">552</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">126,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">421</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">42,900</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">182</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">96,400</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">593</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">245,600</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">1,225</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">115,200</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">990</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">207,900</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">1,459</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">SPV Credit Facility</div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">155,200</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">272</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2022 Unsecured Notes</div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">150,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">372</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">150,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">501</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">150,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">638</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">150,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">923</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">150,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">748</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">50,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">430</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">2022 Tranche C Notes</div></div> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> </tr> </table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"/> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 55%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Class and Year</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Amount<br/>Outstanding(1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset<br/>Coverage<br/>Per Unit(2)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Involuntary<br/>Liquidating<br/>Preference<br/>Per Unit(3)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Market Value<br/>Per Unit(4)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">21,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">52</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">21,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">70</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">21,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">89</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">21,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">129</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">21,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">105</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2023 Unsecured Notes</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">131</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">186</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">250</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">319</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">461</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">374</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2024 Unsecured Notes</div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">125,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">219</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">125,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">309</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">125,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">417</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">125,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">531</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2025 Unsecured Notes</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">85,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">149</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2026 Unsecured Notes</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">131</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">186</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">250</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">319</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2027 Unsecured Notes</div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">50,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">88</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">50,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">124</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2027 Series F Unsecured Notes</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">135,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">237</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2042 Unsecured Notes</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">100,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">859</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">1,002</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">100,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">702</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">982</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">100,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">2,294</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">943</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">100,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">2,411</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">934</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Senior Secured Notes</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">645</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">527</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">1,721</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">1,808</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Term Loans</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">100,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">175</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">100,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">248</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">250</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">75,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">319</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">50,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">308</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">50,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">250</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">50,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">430</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">50,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">351</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">50,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">1,147</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">50,000</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">1,206</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">N/A</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> </table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"/> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 76%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NEFPASS Facility</div></div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">128</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">185</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">SSLP Facility</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">53,785</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">331</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Senior Securities</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,093,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,915</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">818,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,029</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">677,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,259</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">593,900</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,525</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">476,185</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,930</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">541,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,702</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">390,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,354</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">432,900</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,039</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">225,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,162</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">225,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,425</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="width: 11%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><br/></div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of December 31, 2022, asset coverage was 1<div style="display:inline;">91</div>.<div style="display:inline;">5</div>%. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(4)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014 and 2013 periods was $100,175, $98,196, $94,301 and $93,392, respectively.</div> </td> </tr> </table> 293000000 513 0 222500000 552 0 126000000 421 0 42900000 182 0 96400000 593 0 245600000 1225 0 115200000 990 0 207900000 1459 0 0 0 0 0 0 0 155200000 272 0 0 0 0 150000000 372 0 150000000 501 0 150000000 638 0 150000000 923 0 150000000 748 0 50000000 430 0 0 0 0 21000000 52 0 21000000 70 0 21000000 89 0 21000000 129 0 21000000 105 0 75000000 131 0 75000000 186 0 75000000 250 0 75000000 319 0 75000000 461 0 75000000 374 0 125000000 219 0 125000000 309 0 125000000 417 0 125000000 531 0 85000000 149 0 75000000 131 0 75000000 186 0 75000000 250 0 75000000 319 0 50000000 88 0 50000000 124 0 135000000 237 0 0 0 0 100000000 859 0 1002 100000000 702 0 982 100000000 2294 0 943 100000000 2411 0 934 0 0 0 75000000 645 0 75000000 527 0 75000000 1721 0 75000000 1808 0 100000000 175 0 100000000 248 0 75000000 250 0 75000000 319 0 50000000 308 0 50000000 250 0 50000000 430 0 50000000 351 0 50000000 1147 0 50000000 1206 0 0 0 0 30000000 100 0 30000000 128 0 30000000 185 0 0 0 0 53785000 331 0 1093200000 1915 0 818500000 2029 0 677000000 2259 0 593900000 2525 0 476185000 2930 0 541600000 2702 0 390200000 3354 0 432900000 3039 0 225000000 5162 0 225000000 5425 0 1312701000 985088000 1289082000 964379000 821886000 711865000 797594000 706203000 10743000 2935000 417590000 320000000 417590000 320000000 11192000 9028000 9706000 6521000 1124000 1378000 664000 567000 2537695000 2011011000 1093200000 818500000 7202000 6462000 1085998000 812038000 417611000 320041000 7481000 17327000 7964000 7435000 5422000 1864000 7943000 4492000 1488000 2689000 4057000 2844000 1537964000 1168730000 0.01 0.01 200000000 200000000 54555380 54555380 42260826 42260826 546000 423000 1162569000 936999000 -163384000 -95141000 999731000 842281000 18.33 19.93 121491000 86122000 84143000 9515000 11354000 8861000 0 133000 50000 44383000 37564000 26794000 2116000 4157000 1885000 0 24000 12000 177505000 139354000 121745000 29982000 28277000 24951000 15097000 10309000 2272000 46087000 29876000 27156000 5401000 5575000 5215000 6099000 4390000 2936000 102666000 78427000 62530000 -1527000 0 0 101139000 78427000 62530000 76366000 60927000 59215000 -36485000 26000 -26638000 -2909000 -10500000 8970000 -18630000 9113000 -26096000 -21539000 -1387000 -17126000 -58024000 -1361000 -43764000 18342000 59566000 15451000 0.35 0.35 1.41 1.41 0.37 0.37 76366000 60927000 59215000 -36485000 26000 -26638000 -21539000 -1387000 -17126000 18342000 59566000 15451000 57594000 41221000 48795000 27099000 28087000 20513000 84693000 69308000 69308000 226839000 0 0 3038000 0 0 223801000 0 0 157450000 -9742000 -53857000 842281000 852023000 905880000 999731000 842281000 852023000 12511825 0 0 217271 0 0 12294554 0 0 -18342000 -59566000 -15451000 -36485000 26000 -26638000 -21539000 -1387000 -17126000 -609645000 -596256000 -426897000 531389000 468532000 357632000 -9850000 -6087000 -7581000 -4282000 -7592000 -5384000 1286000 1411000 1339000 254000 -1123000 1952000 3185000 43000 1077000 2164000 1101000 -2561000 97000 -4000 -44000 3640000 0 0 97570000 -59997000 -39624000 529000 900000 -212000 3558000 1072000 -3489000 -1201000 743000 -811000 3451000 1076000 -262000 1213000 414000 -10000 2227000 2019000 1234000 91059000 -135101000 -61370000 94539000 69308000 69308000 134914000 49936000 0 171000000 0 0 844002000 812132000 337000000 696000000 723500000 253900000 3038000 0 0 14339000 69260000 13792000 105398000 -65841000 -47578000 322935000 388776000 436354000 428333000 322935000 388776000 42636000 28800000 27418000 226839000 0 0 244691000 226839000 1.246 Health Care Providers & Services L+550 0.01 0.1009 2018-05-07 2025-05-09 17103000 16793000 17103000 Trading Companies & Distributors S+575 0.01 0.1019 2022-04-01 2026-09-01 4197000 4081000 4197000 Communications Equipment L+650 0.01 0 2016-05-05 2021-09-09 36135000 25926000 0 Communications Equipment L+650 0.01 0 2021-09-17 2023-01-31 6405000 6254000 224000 Internet & Catalog Retail L+800 0.01 0.1477 2021-07-28 2026-10-15 24087000 23711000 22882000 Diversified Consumer Services S+525 0.01 0.098 2022-08-31 2025-07-31 14021000 13644000 14021000 Diversified Financial Services S+600 0.01 0.1084 2018-09-14 2024-02-29 8149000 8107000 8149000 Specialty Retail L+550 0.01 0.1027 2020-10-30 2023-10-30 2162000 2152000 2162000 Health Care Providers & Services L+500 0.01 0.0973 2022-04-01 2027-06-11 9432000 9078000 9432000 Media L+900 0.0025 0.1317 2022-07-18 2023-04-27 14454000 14454000 14454000 Diversified Consumer Services L+575 0.0075 0.1048 2021-06-29 2028-06-29 20427000 20057000 20427000 Building Products L+475 0.01 0.0973 2022-04-01 2025-02-01 10386000 9983000 10386000 Food Products P+275 0 0.1025 2022-08-31 2025-04-23 8405000 8405000 8405000 Media P+175 0 0.0925 2022-10-12 2025-03-25 16951000 16951000 16951000 Capital Markets L+700 0.01 0.1013 2020-12-29 2025-12-29 35205000 34496000 35205000 Trading Companies & Distributors S+475 0.01 0.0943 2022-04-01 2025-12-31 4978000 4804000 4978000 IT Services L+450 0 0.0888 2022-04-01 2025-07-30 11598000 11129000 11598000 Building Products S+475 0.01 0.0979 2022-04-01 2027-07-30 8915000 8580000 8915000 Personal Products L+550 0.01 0.1015 2021-02-12 2027-02-12 35273000 34421000 35273000 Leisure Equipment & Products S+500 0.01 0.0903 2022-04-01 2026-11-16 11022000 10562000 10912000 Insurance L+525 0.0075 0.0963 2022-04-01 2026-11-25 6223000 5994000 6223000 Insurance L+600 0.0075 0.1073 2022-04-01 2028-04-16 5188000 4900000 5188000 Internet Software & Services S+785 0.01 0.1197 2022-06-30 2027-07-01 20104000 19783000 20104000 Software S+725 0.0075 0.1152 2022-08-18 2028-08-18 32084000 31548000 31522000 Health Care Providers & Services L+625 0.01 0.1039 2021-12-22 2026-02-25 30092000 29415000 30393000 Software S+575 0.0075 0.1033 2022-06-22 2029-06-23 32426000 31966000 32426000 Software L+575 0.01 0.1048 2021-09-24 2027-10-01 26452000 26015000 26452000 Multi-Sector Holdings L+700 0.01 0.1075 2018-12-21 2024-12-21 80000000 79800000 80000000 Wireless Telecommunication Services S+550 0 0.1008 2018-12-21 2024-12-21 23588000 23123000 23588000 Communications Equipment L+575 0.01 0.1013 2018-09-14 2024-12-22 14009000 13246000 13449000 Thrifts & Mortgage Finance S+675 0.01 0.1099 2022-07-15 2027-07-15 27500000 26991000 27500000 Specialty Retail S+675 0.01 0.0874 2021-08-27 2024-06-01 7808000 7678000 7808000 Health Care Providers & Services L+495 0 0.0972 2022-08-09 2024-11-15 3966000 3966000 3966000 Insurance S+525 0.01 0.0945 2021-07-30 2024-09-28 28603000 28214000 28603000 Health Care Providers & Services L+500 0.01 0.0731 2022-04-01 2024-06-02 2681000 2564000 2547000 Commercial Services & Supplies P+75 0 0.0825 2020-04-03 2024-03-30 4431000 4431000 4431000 Health Care Providers & Services S+650 0.01 0.1091 2022-08-17 2024-05-16 3111000 3092000 3111000 Health Care Providers & Services S+625 0.01 0.1067 2022-08-19 2024-12-04 1327000 1309000 1313000 Insurance S+600 0.0075 0.1044 2022-04-01 2028-11-01 10854000 10699000 10854000 Health Care Providers & Services S+625 0.01 0.0981 2018-09-05 2024-08-16 14458000 14420000 14458000 Health Care Providers & Services S+650 0.01 0.1057 2020-01-22 2026-01-02 27997000 27528000 27367000 Health Care Providers & Services S+500 0.01 0.0989 2022-04-01 2027-08-18 9491000 9161000 9491000 Health Care Providers & Services L+850 0.01 0.1283 2018-09-14 2023-01-30 32163000 31987000 25827000 Life Sciences Tools & Services S+575 0.01 0.1097 2021-08-20 2026-08-12 26823000 26455000 26823000 Insurance S+550 0.0075 0.0926 2022-04-01 2026-11-01 6985000 6813000 6985000 Diversified Consumer Services L+500 0.01 0.0941 2022-04-01 2026-03-13 11775000 11357000 11775000 Health Care Providers & Services S+575 0.01 0.0946 2022-10-06 2029-10-05 8314000 8050000 8044000 Footwear L+523 0.01 0.0966 2022-04-01 2024-04-27 5704000 5361000 5419000 Health Care Providers & Services S+600 0.01 0.1077 2022-06-03 2026-01-27 1399000 1387000 1399000 Media P+95 0 0.0845 2022-07-18 2024-10-10 9162000 9162000 9162000 Auto Parts & Equipment S+800 0.01 0.1244 2021-08-11 2026-10-12 25922000 25506000 25922000 Health Care Equipment & Supplies L+575 0.0075 0.1048 2021-06-16 2028-06-16 24953000 24446000 24953000 Health Care Providers & Services L+525 0.01 0.0998 2022-04-01 2027-02-12 6899000 6585000 6864000 Trading Companies & Distributors S+550 0.01 0.1014 2022-04-01 2026-12-31 9996000 9527000 9996000 Packaged Foods & Meats L+650 0.01 0.1088 2021-08-12 2027-08-13 24789000 24038000 24789000 Water Utilities L+450 0.01 0.0787 2022-04-01 2026-11-02 1728000 1668000 1728000 Insurance S+575 0.01 0.0931 2022-04-01 2026-04-01 31624000 30785000 30359000 912558000 886513000 Diversified Financial Services S+705 0.01 0.1138 2021-12-24 2028-08-21 29925000 29398000 29925000 Diversified Consumer Services S+975 0.01 0 2013-12-23 2026-10-12 13043000 11791000 6521000 Pharmaceuticals L+765 0.0178 0.1182 2019-12-31 2024-07-01 23159000 23894000 24433000 Biotechnology S+625 0.01 0.0875 2022-06-29 2027-06-01 3643000 3620000 3643000 Pharamceuticals L+745 0.001 0.1162 2021-12-22 2027-01-01 66849000 67077000 67685000 Pharmaceuticals L+795 0.001 0.1212 2022-02-23 2027-03-01 9475000 9437000 9499000 Biotechnology 0 0 0.09 2021-11-17 2026-11-17 39839000 39340000 39839000 Pharmaceuticals L+725 0.0245 0.1142 2019-06-28 2024-01-01 11844000 12372000 12555000 Biotechnology S+620 0.0275 0.1052 2022-12-27 2028-01-01 26939000 26874000 26872000 Health Care Technology L+790 0.001 0.1207 2021-09-30 2026-10-01 15883000 15867000 15922000 Health Care Equipment & Supplies S+550 0.0345 0.0982 2022-12-20 2027-12-01 3367000 3338000 3359000 Health Care Equipment & Supplies L+765 0.0166 0.1182 2020-03-02 2025-02-28 18012000 18450000 19003000 Health Care Equipment & Supplies L+1405 0.001 0.1822 2018-07-30 2023-07-01 19201000 19380000 19777000 Health Care Equipment & Supplies S+515 0.0275 0.0933 2022-11-03 2027-11-01 35084000 34880000 34820000 Biotechnology S+570 0.023 0.0988 2022-09-21 2027-09-01 10525000 10406000 10420000 Health Care Equipment & Supplies S+830 0.01 0.1258 2022-02-18 2027-02-01 34455000 34270000 34628000 319205000 322455000 1272952000 1245414000 0.266 Commercial Services & Supplies 0.0847 0.0964 2021-02-12 2025-03-01 2026-12-01 2264000 2262000 2262000 Diversified Consumer Services 0.10 2022-08-11 2026-08-11 2026-08-29 1036000 1036000 1036000 Airlines 0.0708 0.0713 2021-11-03 2026-11-03 2026-11-23 3600000 3660000 3600000 Commercial Services & Supplies 0.10 2019-03-29 2024-09-15 1059000 1059000 1069000 Food & Staples Retailing 0.1046 2022-12-23 2028-01-01 2365000 2440000 2365000 Metals & Mining 0.0831 0.1044 2020-05-28 2024-07-01 2026-10-07 4568000 4568000 4568000 Commercial Services & Supplies 0.0742 2022-07-01 2026-08-01 153000 153000 153000 Oil, Gas & Consumable Fuels 0.0854 2022-10-07 2027-11-01 6708000 6514000 6507000 Airlines 0.10 2018-04-04 2023-10-04 2026-06-22 2241000 2241000 2214000 Airlines 0.10 2018-03-19 2023-01-01 1055000 1055000 1055000 Road & Rail 0.081 0.086 2022-09-22 2026-03-22 2027-09-22 3690000 3690000 3690000 Hotels, Restaurants & Leisure 0.0936 0.1301 2021-05-27 2025-04-01 2028-01-01 6539000 6539000 6539000 Auto Components 0.0796 2021-02-02 2026-01-01 1828000 1849000 1828000 Commercial Services & Supplies 0.08 2022-10-31 2027-11-01 1589000 1589000 1589000 Containers & Packaging 0.0901 2021-01-06 2024-01-01 276000 276000 276000 Diversified Consumer Services 0.0658 0.0916 2022-08-26 2025-12-09 2027-09-01 1321000 1321000 1295000 Road & Rail 0.0825 2020-09-30 2027-10-01 5270000 5300000 5270000 Multi-Sector Holdings 0.0837 2018-04-27 2025-04-27 3837000 3837000 3741000 Diversified Financial Services 0.075 0.0902 2021-10-28 2026-10-01 2027-03-01 2938000 2941000 2938000 Diversified Financial Services 0.09 2021-11-05 2026-08-01 7116000 7116000 7116000 Road & Rail 0.1251 0.1289 2019-04-09 2023-11-01 779000 784000 779000 Commercial Services & Supplies 0.083 0.0877 2018-03-22 2023-06-05 2023-10-05 469000 469000 468000 Airlines 0.08 2017-12-04 2024-01-04 425000 425000 425000 Machinery 0.1071 2018-10-23 2026-01-01 4801000 4806000 4801000 Construction & Engineering 0.105 2021-10-08 2025-11-01 997000 997000 997000 Commercial Services & Supplies 0.0969 0.0994 2018-11-15 2024-05-01 2025-09-01 290000 290000 283000 Auto Components 0.0795 2021-06-23 2025-06-23 6072000 6109000 5951000 Road & Rail 0.0858 2018-02-05 2024-03-01 194000 194000 194000 Machinery 0.105 2022-12-29 2027-06-01 767000 767000 767000 Multi-Sector Holdings 0.0873 0.1152 2019-05-16 2024-05-16 2024-09-25 7500000 7500000 7361000 Road & Rail 0.0828 0.1209 2021-06-17 2024-12-01 2026-12-01 16411000 16411000 16411000 Consumer Finance 0.1246 0.1326 2021-08-20 2024-08-20 2024-10-01 1638000 1663000 1638000 Commercial Services & Supplies 0.10 2017-07-31 2025-02-28 369000 368000 369000 Commercial Services & Supplies 0.1072 2022-12-23 2027-01-01 2005000 2072000 2005000 Aerospace & Defense 0.0932 2022-11-23 2028-12-01 2658000 2658000 2658000 Machinery 0.10 2020-06-01 2024-06-01 159000 159000 159000 Commercial Services & Supplies 0.0933 0.0979 2019-09-24 2023-04-01 2024-11-01 1940000 1960000 1904000 Road & Rail 0.0956 2019-11-21 2025-08-01 849000 849000 775000 Road & Rail 0.0953 2019-01-17 2024-02-01 428000 431000 428000 Diversified Consumer Services 0.0821 2022-12-06 2027-12-06 245000 245000 245000 Transportation Infrastructure 0.085 2022-10-31 2029-07-01 14102000 14152000 14102000 Multi-Sector Holdings 0.085 2022-01-24 2023-01-24 5000000 5000000 5000000 Commercial Services & Supplies 0.0782 0.0828 2022-06-30 2026-09-15 2029-12-29 4139000 4139000 4139000 Road & Rail 0.0847 0.0858 2017-07-31 2023-07-01 2025-01-25 1521000 1521000 1459000 Road & Rail 0.0842 2018-03-09 2025-04-01 2887000 2887000 2591000 Road & Rail 0.1022 0.1063 2017-07-31 2026-01-01 3369000 3369000 3369000 Commercial Services & Supplies 0.0407 2017-07-31 2028-01-15 1706000 1706000 1706000 Commercial Services & Supplies 0.0794 0.0875 2021-10-08 2024-11-01 2026-12-01 577000 577000 577000 Commercial Services & Supplies 0.1092 2022-12-23 2027-03-01 2005000 2005000 2005000 Road & Rail 0.1121 2018-03-23 2024-08-01 469000 473000 469000 Diversified Consumer Services 0.0843 0.10 2019-07-31 2024-08-01 2025-10-05 604000 605000 604000 Energy Equipment & Services 0.0911 2019-12-27 2025-01-01 386000 386000 371000 Transportation Infrastructure 0.0832 0.0936 2022-09-23 2027-09-23 2027-10-28 304000 308000 304000 Diversified Consumer Services 0.0891 2022-12-07 2027-01-01 707000 714000 707000 Multi-Sector Holdings 2017-07-31 200 145000000 120820000 291445000 265952000 0.004 Aerospace & Defense 0.05 2012-06-08 2023-06-30 49273 4927000 3801000 Pharmaceuticals 2016-11-18 6347 106000 0 Health Care Equipment & Supplies 2017-03-31 90 51000 0 Pharmaceuticals 2019-06-28 289102 136000 82000 Health Care Equipment & Supplies 2016-06-15 157500 65000 0 Health Care Equipment & Supplies 2017-08-18 444388 74000 103000 Health Care Technology 2017-03-22 260000 129000 366000 Multi-Sector Holdings 2020-11-03 73500000 136596000 148444000 Health Care Equipment & Supplies 2022-12-20 29366 23000 23000 Diversified Consumer Services 2013-12-23 231177 15683000 0 Diversified Consumer Services 2013-12-23 522 5216000 0 Diversified Consumer Services 2013-12-23 30370 381000 0 Health Care Equipment & Supplies 2019-07-25 469353 235000 483000 Diversified Financial Services 2022-04-01 100 81583000 89370000 Diversified Financial Services 2012-12-28 280303 280737000 288760000 Diversified Financial Services 2022-04-01 32839 34335000 34350000 Asset Management 2022-12-01 0 9500000 9426000 Biotechnology 2022-09-21 159470 51000 15000 Health Care Equipment & Supplies 2022-02-18 36996 210000 87000 Health Care Equipment & Supplies 2018-05-10 33430 152000 0 565263000 571509000 2.087 2134587000 2086676000 0.418 Government 2022-12-30 2023-02-23 420000000 417590000 417590000 2.505 2552177000 2504266000 -1.505 1504535000 1 999731000 0.25 18939000 0 -15833000 0 -635000 -749000 3741000 80000000 0 0 0 87000 -7402000 80000000 145996000 0 0 0 -2448000 -15225000 148444000 10725000 0 -3500000 0 -136000 -1003000 7361000 0 0 0 0 0 0 0 5216000 0 0 0 5216000 0 0 0 0 0 0 0 0 0 11829000 685000 0 0 5280000 18000 6521000 0 81583000 0 0 -7787000 -5150000 89370000 298766000 0 0 0 10006000 -20500000 288760000 129102000 0 0 0 8282000 0 120820000 0 5000000 0 0 0 -379000 5000000 0 34335000 0 0 -15000 -2595000 34350000 0 9500000 0 0 74000 0 9426000 1121000 0 -447000 0 674000 -647000 0 4509000 266000 -942000 0 32000 -266000 3801000 706203000 131369000 -20722000 0 18630000 -53898000 797594000 0.242 17187000 161053000 143866000 2069489000 0.08 0.0575 0.005 0.03 0.10 0.08 0.03875 0.221 0.175 0.077 0.066 0.055 0.043 0.042 0.039 0.027 0.019 0.017 0.017 0.017 0.013 0.013 0.012 0.012 0.011 0.011 0.011 0.01 0.009 0.009 0.008 0.007 0.007 0.006 0.005 0.005 0.005 0.004 0.004 0.003 0.003 0.003 0.003 0.003 0.003 0.002 0.001 0.001 0.001 0 0 0 1 1.115 Health Care Providers & Services L+550 0.01 0.065 2018-05-07 2025-05-09 12402000 12283000 12402000 Health Care Providers & Services L+650 0.01 0.075 2018-09-14 2023-09-01 14117000 14079000 14117000 Communications Equipment L+650 0.01 0.075 2016-05-05 2021-09-09 24822000 24453000 3345000 Communications Equipment L+650 0.01 0.075 2021-09-17 2022-03-31 4576000 4508000 4576000 Internet & Catalog Retail L+600 0.01 0.07 2021-07-28 2026-10-15 25226000 24739000 24721000 Diversified Financial Services L+600 0.01 0.07 2018-09-14 2022-11-30 6345000 6329000 6345000 Specialty Retail L+550 0.01 0.065 2020-10-30 2023-10-30 2902000 2871000 2902000 Diversified Consumer Services L+575 0.0075 0.065 2021-06-29 2028-06-29 12168000 11995000 12168000 Software L+400 0.01 0.05 2021-07-30 2022-12-02 34901000 34538000 34901000 Capital Markets L+700 0.01 0.08 2020-12-29 2025-12-29 26061000 25418000 26061000 Personal Products L+638 0.01 0.0738 2021-02-12 2027-02-12 33367000 32633000 33367000 Software L+650 0.01 0.075 2018-09-07 2024-09-12 19341000 19120000 19341000 Insurance L+575 0.01 0.0675 2021-09-28 2026-06-30 11141000 11035000 11086000 Health Care Providers & Services L+625 0.01 0.0725 2021-12-22 2026-02-25 21677000 21299000 21298000 Software L+600 0.01 0.07 2021-09-24 2027-10-01 29743000 29168000 29148000 Multi-Sector Holdings L+700 0.01 0.08 2018-12-21 2024-12-21 80000000 79713000 80000000 Wireless Telecommunication Services L+550 0 0.0572 2018-12-21 2024-12-21 36470000 36062000 36470000 Communications Equipment L+575 0.01 0.0675 2018-09-14 2024-12-22 7400000 7359000 7178000 Specialty Retail L+675 0.01 0.0775 2021-08-27 2024-06-01 5135000 5044000 5135000 IT Services L+625 0.01 0.0725 2021-09-21 2027-09-15 31026000 30541000 31026000 Insurance L+525 0.01 0.0625 2021-07-30 2024-09-28 15924000 15730000 15844000 Commercial Services & Supplies P+75 0 0.04 2020-04-03 2022-09-30 274000 274000 274000 Health Care Providers & Services L+600 0.01 0.07 2018-09-05 2024-08-16 14589000 14529000 14589000 Health Care Providers & Services L+575 0.01 0.0675 2020-01-22 2022-12-31 11996000 11953000 11996000 Health Care Providers & Services L+800 0.01 0.09 2018-09-14 2022-12-16 21120000 21086000 18374000 Life Sciences Tools & Services L+575 0.01 0.0675 2021-08-20 2026-08-12 16504000 16349000 16462000 Auto Parts & Equipment L+800 0.01 0.09 2021-08-11 2026-10-12 26184000 25676000 25923000 Health Care Equipment & Supplies L+575 0.0075 0.065 2021-06-16 2028-06-16 18536000 18232000 18351000 Packaged Foods & Meats L+625 0.01 0.0725 2021-08-12 2027-08-13 19381000 18920000 18896000 Specialty Retail L+884 0.01 0.0984 2020-06-03 2022-09-12 3275000 3275000 3275000 579211000 559571000 Diversified Financial Services S+705 0.01 0.0805 2021-12-24 2028-08-21 29925000 29328000 29326000 Multi-Sector Holdings L+750 0.01 0.085 2014-08-22 2025-11-15 29563000 29467000 29563000 58795000 58889000 Health Care Providers & Services L+1500 0.01 0.16 2015-12-18 2022-09-30 37819000 37757000 36874000 Diversified Consumer Services L+975 0.015 0.1125 2013-12-23 2023-05-16 11828000 11819000 11829000 49576000 48703000 Pharmaceuticals L+765 0.0178 0.0943 2019-12-31 2024-07-01 20074000 20512000 20475000 Pharamceuticals L+745 0.001 0.0755 2021-12-22 2027-01-01 21735000 21645000 21637000 Pharmaceuticals L+745 0.0025 0.077 2018-05-10 2022-11-01 14972000 16198000 16170000 Pharmaceuticals L+860 0.001 0.087 2021-09-02 2026-09-01 9278000 9318000 9302000 Biotechnology 0 0 0.09 2021-11-17 2026-11-17 34574000 34082000 34055000 Pharmaceuticals L+725 0.0245 0.097 2019-06-28 2024-01-01 16400000 16693000 16728000 Health Care Equipment & Supplies L+695 0.025 0.0945 2019-03-22 2025-03-01 26861000 27518000 27465000 Health Care Equipment & Supplies L+850 0.01 0.095 2017-08-18 2022-06-01 1089000 1414000 1405000 Health Care Technology L+790 0.001 0.08 2021-09-30 2026-10-01 8364000 8339000 8322000 Health Care Equipment & Supplies L+765 0.0166 0.0931 2020-03-02 2025-02-28 15613000 15874000 15878000 Health Care Equipment & Supplies L+1405 0.001 0.1415 2018-07-30 2023-07-01 18879000 17845000 18958000 Biotechnology L+875 0.0012 0.0887 2021-04-14 2026-04-01 5675000 5663000 5661000 Pharmaceuticals L+550 0.021 0.076 2018-12-21 2026-06-01 40291000 41103000 41097000 Pharmaceuticals L+795 0.0223 0.1018 2019-09-17 2023-09-17 4098000 4165000 4160000 Health Care Providers & Services L+747 0.0013 0.076 2021-03-26 2026-04-01 31137000 31211000 31214000 271580000 272527000 959162000 939690000 0.325 Commercial Services & Supplies 0.0847 0.0964 2021-02-12 2025-03-01 2026-12-01 3103000 3100000 3100000 Airlines 0.0708 0.0713 2021-11-03 2026-11-03 2026-11-23 4063000 4145000 4063000 Commercial Services & Supplies 0.10 2019-03-29 2022-03-28 3149000 3148000 3180000 Oil, Gas & Consumable Fuels 0.1097 0.1116 2018-02-16 2022-03-01 2022-11-01 1642000 1615000 1636000 Metals & Mining 0.0906 0.1044 2020-05-28 2024-07-01 2026-01-01 5374000 5374000 5374000 Airlines 0.10 2018-04-04 2023-10-04 2026-06-22 3102000 3102000 3053000 Airlines 0.10 2018-03-19 2023-01-01 1685000 1685000 1685000 Hotels, Restaurants & Leisure 0.0887 0.0941 2021-05-27 2025-06-01 2027-01-01 4326000 4326000 4326000 Auto Components 0.0796 2021-02-02 2026-01-01 2347000 2382000 2347000 Containers & Packaging 0.0901 2021-01-06 2024-01-01 616000 616000 616000 Road & Rail 0.0825 2020-09-30 2027-10-01 5921000 5959000 5921000 Multi-Sector Holdings 0.0753 0.0837 2018-04-27 2022-08-01 2025-04-27 19671000 19671000 18939000 Diversified Financial Services 0.075 2021-10-28 2026-11-01 2487000 2492000 2487000 Diversified Financial Services 0.09 2021-11-05 2026-08-01 8681000 8681000 8681000 Road & Rail 0.1251 0.1289 2019-04-09 2023-11-01 1364000 1381000 1364000 Commercial Services & Supplies 0.083 0.0877 2018-03-22 2023-06-05 2023-10-05 1245000 1245000 1242000 Airlines 0.08 2017-12-04 2024-01-04 795000 795000 795000 Machinery 0.1071 2018-10-23 2025-10-01 5476000 5484000 5476000 Road & Rail 0.0853 2017-07-31 2024-07-01 1061000 1061000 915000 Construction & Engineering 0.105 2021-10-08 2025-11-01 1252000 1252000 1252000 Commercial Services & Supplies 0.0969 0.0994 2018-11-15 2024-05-01 2025-09-01 414000 414000 404000 Auto Components 0.0795 2021-06-23 2025-06-23 8184000 8250000 8184000 Road & Rail 0.0858 2018-02-05 2024-03-01 345000 345000 345000 Multi-Sector Holdings 0.0873 0.1152 2019-05-16 2024-05-16 2024-09-25 11000000 11000000 10725000 Road & Rail 0.0828 0.0965 2021-06-17 2024-12-01 2025-12-01 9343000 9343000 9343000 Consumer Finance 0.1246 0.1326 2021-08-20 2024-08-20 2024-10-01 2526000 2583000 2526000 Commercial Services & Supplies 0.10 2017-07-31 2025-02-28 479000 476000 479000 Machinery 0.10 2020-06-01 2024-07-01 253000 253000 253000 Commercial Services & Supplies 0.0933 0.0979 2019-09-24 2023-04-01 2024-11-01 3615000 3656000 3547000 Commercial Services & Supplies 0.1153 2017-08-25 2022-09-01 126000 126000 126000 Road & Rail 0.0956 2019-11-21 2025-08-01 1041000 1041000 950000 Road & Rail 0.0953 2019-01-17 2024-02-01 683000 690000 683000 Diversified Consumer Services 0.1025 2017-07-31 2022-10-01 46000 46000 45000 Energy Equipment & Services 0.1252 0.1376 2018-03-29 2022-09-01 2023-07-01 1363000 1363000 1338000 Road & Rail 0.0822 0.0858 2017-07-31 2022-10-01 2025-01-25 1951000 1951000 1839000 Commercial Services & Supplies 0.1262 2019-09-11 2026-02-15 7094000 7094000 7094000 Road & Rail 0.0842 2018-03-09 2025-04-01 3401000 3401000 2916000 Energy Equipment & Services 0.1838 2017-07-31 2022-02-28 132000 132000 125000 Road & Rail 0.1022 0.1062 2017-07-31 2026-01-01 4578000 4578000 4578000 Air Freight & Logistics 0.085 0.09 2019-07-26 2024-08-01 2025-10-16 2267000 2267000 2267000 Commercial Services & Supplies 0.1021 0.1536 2017-07-31 2023-10-29 2024-02-10 3798000 3800000 3536000 Commercial Services & Supplies 0.0794 0.0875 2021-10-08 2024-11-01 2026-12-01 777000 777000 777000 Road & Rail 0.0999 2018-07-18 2022-08-01 1573000 1573000 1540000 Road & Rail 0.1121 2018-03-23 2024-08-01 696000 705000 696000 Commercial Services & Supplies 0.0895 2019-07-11 2024-08-01 2026-08-01 2567000 2567000 2518000 Diversified Consumer Services 0.0843 0.10 2019-07-31 2024-08-01 2025-10-05 870000 873000 870000 Energy Equipment & Services 0.0911 2019-12-27 2025-01-01 547000 547000 537000 Multi-Sector Holdings 2017-07-31 200 145000000 129102000 292365000 273795000 0.007 Aerospace & Defense 0.08 2010-12-14 2023-06-30 446 446000 1121000 Aerospace & Defense 0.05 2012-06-08 2023-06-30 56030 5603000 4509000 6049000 5630000 0.536 Pharmaceuticals 2016-11-18 6347 106000 0 Health Care Equipment & Supplies 2017-03-31 90 51000 0 Pharmaceuticals 2019-06-28 289102 136000 65000 Health Care Equipment & Supplies 2016-06-15 157500 65000 0 Health Care Equipment & Supplies 2017-08-18 444388 74000 80000 Health Care Technology 2017-03-22 208000 63000 258000 Multi-Sector Holdings 2020-11-03 73500000 136596000 145996000 Diversified Consumer Services 2013-12-23 231177 15683000 0 Diversified Consumer Services 2013-12-23 522 5216000 5216000 Diversified Consumer Services 2013-12-23 30370 381000 0 Health Care Equipment & Supplies 2019-07-25 406923 117000 1086000 Diversified Financial Services 2012-12-28 280303 280737000 298766000 Health Care Equipment & Supplies 2018-05-10 27352 152000 0 439377000 451467000 1.983 1696953000 1670582000 0.38 Government 2021-12-31 2022-01-25 320000000 320000000 320000000 2.363 2016953000 1990582000 -1.363 1148301000 1 842281000 0.25 2941000 0 -2941000 0 0 -92000 0 25540000 0 -6667000 0 -66000 -1950000 18939000 80000000 0 0 0 79000 -6568000 80000000 136596000 0 0 0 -9400000 -13250000 145996000 14456000 0 -3731000 0 0 -1426000 10725000 1226000 0 0 0 1226000 0 0 5216000 0 0 0 0 0 5216000 0 0 0 0 0 0 0 10559000 1270000 0 0 6000 -1300000 11829000 296766000 0 0 0 -2000000 -22500000 298766000 129102000 0 0 0 0 0 129102000 850000 0 -850000 0 0 -42000 0 2300000 0 0 0 1179000 -1543000 1121000 4101000 271000 0 0 -137000 -271000 4509000 709653000 1541000 -14189000 0 -9113000 -48942000 706203000 0.231 19495000 82598000 63103000 1651087000 0.06 0.02 0.025 0.125 0.055 0.005 0.248 0.207 0.096 0.078 0.05 0.05 0.024 0.022 0.02 0.019 0.019 0.018 0.016 0.016 0.016 0.015 0.015 0.011 0.01 0.009 0.007 0.006 0.006 0.005 0.003 0.003 0.003 0.003 0.001 0.001 0.001 0.001 0.001 0 1 <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 1. Organization </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Solar Capital LLC, a Maryland limited liability company, was formed in February 2007 and commenced operations on March 13, 2007 with initial capital of $1,200,000 of which 47.04% was funded by affiliated parties. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Immediately prior to our initial public offering, through a series of transactions, SLR Investment Corp. (the “Company”, “we”, “us” or “our”), merged with Solar Capital LLC, leaving SLR Investment Corp. as the surviving entity (the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">“Pre-IPO</div> Merger”). SLR Investment Corp. issued an aggregate of approximately 26.65 million shares of common stock and $125,000 in senior unsecured notes to the existing Solar Capital LLC unit holders in connection with the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-IPO</div> Merger. SLR Investment Corp. had no assets or operations prior to completion of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-IPO</div> Merger and as a result, the historical books and records of Solar Capital LLC have become the books and records of the surviving entity. The number of shares used to calculate weighted average shares for use in computations on a per share basis have been decreased retroactively by a factor of approximately 0.4022 for all periods prior to February 9, 2010. This factor represents the effective impact of the reduction in shares resulting from the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-IPO</div> Merger. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SLR Investment Corp., a Maryland corporation formed in November 2007, is a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">closed-end,</div> externally managed, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-diversified</div> management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Furthermore, as the Company is an investment company, it continues to apply the guidance in FASB Accounting Standards Codification (“ASC”) Topic 946. In addition, for U.S. federal income tax purposes, the Company has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February 9, 2010, the Company priced its initial public offering, selling 5.68 million shares of common stock, including the underwriters’ over-allotment, at a price of $18.50 per share. Concurrent with this offering, the Company’s senior management purchased an additional 600,000 shares through a private placement, also at $18.50 per share. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company’s investment objective is to maximize both current income and capital appreciation through debt and equity investments. The Company directly and indirectly invests primarily in leveraged middle market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. From time to time, we may also invest in public companies that are thinly traded. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On April 1, 2022, we acquired SLR Senior Investment Corp., a Maryland corporation (“SUNS”) pursuant to that certain Agreement and Plan of Merger (the “Merger Agreement”), dated as of December 1, 2021, by and among us, SUNS, Solstice Merger Sub, Inc., a Maryland corporation and our wholly-owned subsidiary (“Merger Sub”), and, solely for the limited purposes set forth therein, SLR Capital Partners, LLC (the “Investment Adviser”). Pursuant to the Merger Agreement, Merger Sub merged with and into SUNS, with SUNS continuing as the surviving company and as SUNS’s wholly-owned subsidiary (the “Merger,”) and, immediately thereafter, SUNS merged with and into us, with us continuing as the surviving company (together with the Merger, the “Mergers”). . In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each outstanding share of SUNS’s common stock was converted into the right to receive 0.7796 shares of our common stock (with SUNS’s stockholders receiving cash in lieu of fractional shares of our common stock). As a result of the Mergers, we issued an aggregate of 12,511,825 shares of our common stock to former SUNS stockholders. See Note 17 for additional information. </div> 2007-03-13 1200000000 0.4704 26650000 125000000 5680000 18.5 600000 18.5 0.7796 12511825 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 2. Significant Accounting Policies </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“GAAP”), and include the accounts of the Company and certain wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications which, in the opinion of management, are necessary for the fair presentation of the results of the operations and financial condition for the periods presented. All significant intercompany balances and transactions have been eliminated. Certain prior period amounts may have been reclassified to conform to the current period presentation. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The preparation of consolidated financial statements in conformity with GAAP and pursuant to the requirements for reporting on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K</div> and Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X,</div> as appropriate, also requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reported periods. Changes in the economic environment, financial markets and any other parameters used in determining these estimates could cause actual results to differ materially.</div><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><br/></div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"/><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 1.5pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: 1.5pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"/><div style="font-size: 1.5pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In the opinion of management, all adjustments, which are of a normal recurring nature and considered necessary for the fair presentation of financial statements, have been included. </div></div></div><div style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">The significant accounting policies consistently followed by the Company are: </div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(a)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Investment transactions are accounted for on the trade date; </div></td></tr></table><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(b)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Under procedures established by the board of directors (the “Board”), we value investments, including certain senior secured debt, subordinated debt and other debt securities with maturities greater than 60 days, for which market quotations are readily available and deemed to represent fair value under U.S. GAAP, at such market quotations (unless they are deemed not to represent fair value). A market quotation is readily available for a security only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. If the Company anticipates using a market quotation for a security, it will also monitor for circumstances that may necessitate the use of fair value, such as significant events that may cause concern over the reliability of a market quotation. We attempt to obtain market quotations from at least two brokers or dealers (if available, otherwise from a principal market maker or a primary market dealer or other independent pricing service). We utilize <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">mid-market</div> pricing as a practical expedient for fair value unless a different point within the range is more representative. If and when market quotations are deemed not to represent fair value, we may utilize independent third-party valuation firms to assist us in determining the fair value of material assets. Accordingly, such investments go through our multi-step valuation process as described below. In each such case, independent valuation firms, that may from time to time be engaged by the Board, consider observable market inputs together with significant unobservable inputs in arriving at their valuation recommendations. Debt investments with maturities of 60 days or less shall each be valued at cost plus accreted discount, or minus amortized premium, which is expected to approximate fair value, unless such valuation, in the judgment of the Investment Adviser, does not represent fair value, in which case such investments shall be valued at fair value as determined in good faith by or under the direction of the Board. Investments that are not publicly traded or whose market quotations are not readily available are valued at fair value as determined in good faith by or under the direction of the Board. Such determination of fair values involves subjective judgments and estimates. </div></td></tr></table><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 9%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">With respect to investments for which market quotations are not readily available or when such market quotations are deemed not to represent fair value under U.S. GAAP, the Board has approved a multi-step valuation process each quarter, as described below: </div></div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 13%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(1)</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">our quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of the Investment Adviser responsible for the portfolio investment; </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 13%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(2)</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">preliminary valuation conclusions are then documented and discussed with senior management of the Investment Adviser; </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 13%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(3)</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">independent valuation firms engaged by the Board conduct independent appraisals and review the Investment Adviser’s preliminary valuations and make their own independent assessment for all material assets; </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 13%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(4)</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the audit committee of the Board reviews the preliminary valuation of the Investment Adviser and that of the independent valuation firm and responds to the valuation recommendation of the independent valuation firm, if any, to reflect any comments; and </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 13%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(5)</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the Board discusses valuations and determines the fair value of each investment in our portfolio in good faith based on the input of the Investment Adviser, the respective independent valuation firm, if any, and the audit committee. </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">103</div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The valuation principles set forth above may be modified from time to time, in whole or in part, as determined by the Board in its sole discretion. The Board will also (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services, as applicable; (5) oversee the reporting required by Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-5</div> under the 1940 Act; and (6) maintain recordkeeping requirements under Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-5.</div> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 9%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Investments in all asset classes are valued utilizing a market approach, an income approach, or both approaches, as appropriate. However, in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">820-10,</div> certain investments that qualify as investment companies in accordance with ASC 946, may be valued using net asset value as a practical expedient for fair value. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities (including a business). The income approach uses valuation approaches to convert future amounts (for example, cash flows or earnings) to a single present amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. In following these approaches, the types of factors that we may take into account in fair value pricing our investments include, as relevant: available current market data, including relevant and applicable market trading and transaction comparables, applicable market yields and multiples, security covenants, call protection provisions, the nature and realizable value of any collateral, the portfolio company’s ability to make payments, its earnings and discounted cash flows, the markets in which the portfolio company does business, comparisons of financial ratios of peer companies that are public, M&amp;A comparables, our principal market (as the reporting entity) and enterprise values, among other factors. When available, broker quotations and/or quotations provided by pricing services are considered as an input in the valuation process. For the fiscal year ended December 31, 2022, there has been no change to the Company’s valuation approaches or techniques and the nature of the related inputs considered in the valuation process. </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ASC Topic 820 classifies the inputs used to measure these fair values into the following hierarchy: </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Level</div><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"/><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"> 1</div>: Unadjusted quoted prices in active markets for identical assets or liabilities, accessible by the Company at the measurement date. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Level</div><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"/><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"> 2</div>: Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Level</div><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"/><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"> 3</div>: Unobservable inputs for the asset or liability. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The exercise of judgment is based in part on our knowledge of the asset class and our prior experience. </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%;text-indent: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(c)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Gains or losses on investments are calculated by using the specific identification method. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%;text-indent: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(d)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Loan origination fees, original issue discount, and market discounts are capitalized and we amortize such amounts into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record call premiums received on loans repaid as interest income when we receive such amounts. Capital structuring fees, amendment fees, consent fees, and any other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recurring</div> fee income as well as a management fee and other fee income for services rendered, if any, are recorded as other income when earned. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%;text-indent: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(e)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company intends to comply with the applicable provisions of the Code pertaining to regulated investment companies to make distributions of taxable income sufficient to relieve it of substantially all U.S. federal income taxes. The Company, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4% excise tax on this income. The Company will accrue excise tax on such estimated excess taxable income as appropriate. </div> </td> </tr> </table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;"> </div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">104 </div></div></div> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Content<span style="letter-spacing: 0px; top: 0px;;display:inline;">s</span></a></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SLR INVESTMENT CORP. </div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued) </div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">December 31, 2022 </div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(in thousands, except share amounts) </div></div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(f)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Book and tax basis differences relating to stockholder distributions and other permanent book and tax differences are typically reclassified among the Company’s capital accounts. In addition, the character of income and gains to be distributed is determined in accordance with income tax regulations that may differ from GAAP; accordingly at December 31, 2022, $28,991 was reclassified on our balance sheet between accumulated distributable net loss and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital in excess of par. Total earnings and net asset value are not affected. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(g)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Distributions to common stockholders are recorded as of the record date. The amount to be paid out as a distribution is determined by the Board. Net realized capital gains, if any, are generally distributed or deemed distributed at least annually. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(h)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">In accordance with Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X</div> and ASC Topic 810—<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Consolidation</div></div>, the Company consolidates its interest in controlled investment company subsidiaries, financing subsidiaries and certain wholly-owned holding companies that serve to facilitate investment in portfolio companies. In addition, the Company may also consolidate any controlled operating companies substantially all of whose business consists of providing services to the Company. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(i)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The accounting records of the Company are maintained in U.S. dollars. Any assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the rate of exchange of such currencies against U.S. dollars on the date of valuation. The Company will not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Such fluctuations would be included with the net unrealized gain or loss from investments. The Company’s investments in foreign securities, if any, may involve certain risks, including without limitation: foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments in terms of U.S. dollars and therefore the earnings of the Company. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(j)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">In accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">835-30,</div> the Company reports origination and other expenses related to certain debt issuances as a direct deduction from the carrying amount of the debt liability. Applicable expenses are deferred and amortized using either the effective interest method or the straight-line method over the stated life. The straight-line method may be used on revolving facilities and/or when it approximates the effective yield method. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(k)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company may enter into forward exchange contracts in order to hedge against foreign currency risk. These contracts are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">marked-to-market</div></div> by recognizing the difference between the contract exchange rate and the current market rate as unrealized appreciation or depreciation. Realized gains or losses are recognized when contracts are settled. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(l)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company records expenses related to shelf registration statements and applicable equity offering costs as prepaid assets. These expenses are typically charged as a reduction of capital upon the sale of shares or expensed, in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">946-20-25.</div></div> </div> </td> </tr> </table> <div style="margin-top: 0px; margin-bottom: 0px;"><br/></div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(m)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Investments that are expected to pay regularly scheduled interest in cash are generally placed on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-accrual</div> status when principal or interest cash payments are past due 30 days or more (90 days or more for equipment financing) and/or when it is no longer probable that principal or interest cash payments will be collected. Such <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-accrual</div> investments are restored to accrual status if past due principal and interest are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining principal and interest obligations. Cash interest payments received on such investments may be recognized as income or applied to principal depending on management’s judgment. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(n)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company defines cash equivalents as securities that are readily convertible into known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only securities with a maturity of three months or less would qualify, with limited exceptions. The Company believes that certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities would qualify as cash equivalents. </div> </td> </tr> </table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recent Accounting Pronouncements </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In March 2020, the FASB issued Accounting Standards Update <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2020-04,</div> “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The guidance provides optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships and other transactions, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued because of the reference rate reform. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-04</div> is effective for all entities as of March 12, 2020 through December 31, 2022. The Company has determined that the adoption of this guidance has not had a material impact on the Company’s consolidated financial statements and disclosures. </div> P60D P60D 0.04 28991000 P30D P90D <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recent Accounting Pronouncements </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In March 2020, the FASB issued Accounting Standards Update <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2020-04,</div> “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The guidance provides optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships and other transactions, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued because of the reference rate reform. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-04</div> is effective for all entities as of March 12, 2020 through December 31, 2022. The Company has determined that the adoption of this guidance has not had a material impact on the Company’s consolidated financial statements and disclosures. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 3. Agreements </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has an investment advisory and management agreement (the “Advisory Agreement”) with the Investment Adviser, under which the Investment Adviser manages the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">day-to-day</div></div> operations of, and provides investment advisory services to the Company. For providing these services, the Investment Adviser receives a fee from the Company, consisting of two components—a base management fee and a performance-based incentive fee. The base management fee is determined by taking the average value of the Company’s gross assets at the end of the two most recently completed calendar quarters calculated at an annual rate of 1.50% on gross assets up to 200% of the Company’s total net assets as of the immediately preceding quarter end and 1.00% on gross assets that exceed 200% of the Company’s total net assets as of the immediately preceding quarter end. For purposes of computing the base management fee, gross assets exclude temporary assets acquired at the end of each fiscal quarter for purposes of preserving investment flexibility in the next fiscal quarter. Temporary assets include, but are not limited to, U.S. treasury bills, other short-term U.S. government or government agency securities, repurchase agreements or cash borrowings. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The performance-based incentive fee has two parts, as follows: one part is calculated and payable quarterly in arrears based on the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income for the immediately preceding calendar quarter. For this purpose, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income means interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that we receive from portfolio companies) accrued during the calendar quarter, minus the Company’s operating expenses for the quarter (including the base management fee, any expenses payable under the Administration Agreement, and any interest expense and distributions paid on any issued and outstanding preferred stock, but excluding the performance-based incentive fee). <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-incentive</div> fee net investment income does not include any realized capital gains or losses, or unrealized capital appreciation or depreciation. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-incentive</div> fee net investment income, expressed as a rate of return on the value of the Company’s net assets at the end of the immediately preceding calendar quarter, is compared to the hurdle rate of 1.75% per quarter (7% annualized). The Company pays the Investment Adviser a performance-based incentive fee with respect to the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income in each calendar quarter as follows: (1) no performance-based incentive fee in any calendar quarter in which the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income does not exceed the hurdle rate; (2) 100% of the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income with respect to that portion of such <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income, if any, that exceeds the hurdle rate but is less than 2.1875% in any calendar quarter; and (3) 20% of the amount of the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income, if any, that exceeds 2.1875% in any calendar quarter. These calculations are appropriately <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pro-rated</div> for any period of less than three months. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The second part of the performance-based incentive fee is determined and payable in arrears as of the end of each calendar year (or upon termination of the Advisory Agreement, as of the termination date), and will equal 20% of the Company’s cumulative realized capital gains less cumulative realized capital losses, unrealized capital depreciation (unrealized depreciation on a gross <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">investment-by-investment</div></div> basis at the end of each calendar year) and all net capital gains upon which prior performance-based capital gains incentive fee payments were previously made to the Investment Adviser. For financial statement purposes, the second part of the performance-based incentive fee is accrued based upon 20% of cumulative net realized gains and net unrealized capital appreciation. No accrual was required for the fiscal years ended December 31, 2022, 2021 and 2020. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the fiscal years ended December 31, 2022, 2021 and 2020, the Company recognized $29,982, $28,277 and $24,951, respectively, in base management fees and $15,097, $10,309 and $2,272, respectively, in performance-based incentive fees. For the fiscal years ended December 31, 2022, 2021 and 2020, $1,527, $0 and $0, respectively, of such performance-based incentive fees were waived. The Investment Adviser has agreed to waive incentive fees resulting from income earned due to the accretion of purchase discount allocated to investments acquired as a result of the Mergers. Fees waived pursuant to the above are not subject to recoupment by the Investment Adviser. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"/> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The </div></div> Company has also entered into an Administration Agreement with SLR Capital Management, LLC (the “Administrator”) under which the Administrator provides administrative services to the Company. For providing these services, facilities and personnel, the Company reimburses the Administrator for the Company’s allocable portion of overhead and other expenses incurred by the Administrator in performing its obligations under the Administration Agreement, including rent. The Administrator will also provide, on the Company’s behalf, managerial assistance to those portfolio companies to which the Company is required to provide such assistance. The Company typically reimburses the Administrator on a quarterly basis. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the fiscal years ended December 31, 2022, 2021 and 2020, the Company recognized expenses under the Administration Agreement of $5,401, $5,575 and $5,215, respectively. No managerial assistance fees were accrued or collected for the fiscal years ended December 31, 2022, 2021 and 2020. </div> 0.015 2 0.01 2 0.0175 0.07 1 0.20 0.20 0.20 29982000 28277000 24951000 15097000 10309000 2272000 1527000 0 0 5401000 5575000 5215000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 4. Net Asset Value Per Share </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At December 31, 2022, the Company’s total net assets and net asset value per share were $999,731 and $18.33, respectively. This compares to total net assets and net asset value per share at December 31, 2021 of $842,281 and $19.93, respectively. </div> 999731000 18.33 842281000 19.93 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 5. Earnings Per Share </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the computation of basic and diluted net increase in net assets per share resulting from operations, pursuant to ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">260-10,</div> for the years ended December 31, 2022, 2021 and 2020: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:52%"/> <td style="vertical-align:bottom;width:10%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:10%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:10%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended<br/> December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended<br/> December 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended<br/> December 31, 2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Earnings per share (basic &amp; diluted)</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Numerator - net increase in net assets resulting from operations:</div><br/></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">18,342</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">59,566</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">15,451</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Denominator - weighted average shares:</div><br/></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">51,680,522</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">42,260,826</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">42,260,826</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Earnings per share:</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">0.35</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">1.41</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">0.37</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the computation of basic and diluted net increase in net assets per share resulting from operations, pursuant to ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">260-10,</div> for the years ended December 31, 2022, 2021 and 2020: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:52%"/> <td style="vertical-align:bottom;width:10%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:10%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:10%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended<br/> December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended<br/> December 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended<br/> December 31, 2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Earnings per share (basic &amp; diluted)</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Numerator - net increase in net assets resulting from operations:</div><br/></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">18,342</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">59,566</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">15,451</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Denominator - weighted average shares:</div><br/></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">51,680,522</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">42,260,826</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">42,260,826</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Earnings per share:</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">0.35</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">1.41</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">0.37</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> </tr> </table> 18342000 59566000 15451000 51680522 51680522 42260826 42260826 42260826 42260826 0.35 0.35 1.41 1.41 0.37 0.37 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 6. Fair Value </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The hierarchy prioritizes the inputs to valuations used to measure fair value into three levels. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows: </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 1.</div></div> Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 2.</div></div> Financial assets and liabilities whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">a)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Quoted prices for similar assets or liabilities in active markets; </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">b)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Quoted prices for identical or similar assets or liabilities in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-active</div> markets; </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">c)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Pricing models whose inputs are observable for substantially the full term of the asset or liability; and </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">d)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Pricing models whose inputs are derived principally from or corroborated by observable market data through correlation or other means for substantially the full term of the asset or liability. </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 3. </div></div>Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumptions about the assumptions a market participant would use in pricing the asset or liability. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">When the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3). </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Gains and losses for assets and liabilities categorized within the Level 3 table below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3). </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A review of fair value hierarchy classifications is conducted on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. Such reclassifications involving Level 3 assets and liabilities are reported as transfers in/out of Level 3 as of the end of the quarter in which the reclassifications occur. Within the fair value hierarchy tables below, cash and cash equivalents are excluded but could be classified as Level 1. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables present the balances of assets and liabilities measured at fair value on a recurring basis, as of December 31, 2022 and December 31, 2021: </div> <div style="margin-top: 24pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Fair Value Measurements </div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2022 </div></div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:61%"/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Measured at<br/> Net Asset Value*</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets:</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,245,414</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,245,414</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment Financing</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,952</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,952</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Equity</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Equity/Equity Interests/Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">483</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">561,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">9,426</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">571,509</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Investments</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">483</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,076,767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,426</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,086,676</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">*</div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">820-10,</div> certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP. See Note 19 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members. </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"/> <div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="margin-top: 24pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Fair Value Measurements </div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2021 </div></div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 92%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:66%"/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets:</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space: nowrap; vertical-align: bottom; width: 4%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$<br/></td> <td style="white-space: nowrap; vertical-align: bottom; width: 3%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">939,690</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">939,690</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment Financing</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; width: 4%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; width: 3%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">273,795</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">273,795</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Equity</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; width: 4%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; width: 3%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,630</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,630</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Equity/Equity Interests/Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">1,086</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; width: 3%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">450,381</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">451,467</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Investments</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,086</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ </td> <td style="white-space: nowrap; vertical-align: bottom; width: 3%; padding: 0pt 5pt 0pt 0pt;">—</td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,669,496</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,670,582</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Liabilities:</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022 Unsecured Notes</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space: nowrap; vertical-align: bottom; width: 4%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ </td> <td style="white-space: nowrap; vertical-align: bottom; text-align: right; width: 2%; padding: 0pt 5pt 0pt 0pt;">—<br/></td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2022, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2022: </div> <div style="margin-top: 24pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Fair Value Measurements Using Level 3 Inputs </div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:52%"/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Senior Secured<br/> Loans</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equipment</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financing</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preferred Equity</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common Equity/<br/> Equity<br/> Interests/<br/> Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, December</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2021</div></div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">939,690</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">273,795</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,630</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">450,381</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,669,496</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total gains or losses included in earnings:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized gain (loss)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(36,244</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(36,238</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><span style="-sec-ix-hidden:hidden67612324">Net</span> change in unrealized loss</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8,065</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,924</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(706</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,048</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(20,743</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Purchase of investment securities(1)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">796,389</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">84,168</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">266</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">116,272</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">997,095</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from dispositions of investment securities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(446,356</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(85,087</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,389</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(11</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(532,843</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfers in/out of Level 3</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, December</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2022</div></div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,245,414</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,952</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">561,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,076,767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><span style="-sec-ix-hidden:hidden67612326">Net</span> change in unrealized loss</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">(8,920</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">(6,924</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">(706</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,048</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(21,598</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes positions acquired from SUNS as a result of the Mergers. </div> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the year ended December 31, 2022: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 80%;"/> <td style="width: 12%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">2022 Unsecured Notes</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the year ended<br/>December 31, 2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Beginning fair value</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized (gain) loss</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized (gain) loss</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Borrowings</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Repayments</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(150,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfers in/out of Level 3</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ending fair value</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company made an election to apply the fair value option of accounting to the 2022 Unsecured Notes, in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">825-10.</div> On May 8, 2022, the borrowings were repaid in full. While the Company has not made an election to apply the fair value option of accounting to any of its other debt obligations, if the Company’s debt obligations were carried at fair value at December 31, 2022, the fair value of the Credit Facility, SPV Credit Facility, 2023 Unsecured Notes, 2024 Unsecured Notes, 2025 Unsecured Notes, 2026 Unsecured Notes, 2027 Unsecured Notes and 2027 Series F Unsecured Notes would be $393,000, $155,200, $75,000, $118,750, $79,688, $68,250, $42,875 and $118,125, respectively. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div/><div> <div style="background-color:white;display: inline;"> </div> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2021, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2021: </div> <div style="margin-top: 24pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Fair Value Measurements Using Level 3 Inputs </div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 53%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Senior Secured<br/>Loans</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equipment</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financing</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preferred Equity</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common Equity/<br/>Equity<br/>Interests/<br/>Warrants</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 0px;"> <td style="width:48%"/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, December</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2020</div></div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">798,052</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">284,846</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,401</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">440,971</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,530,270</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total gains or losses included in earnings:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized gain (loss)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">345</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">337</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized gain (loss)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(13,567</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,394</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,042</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,857</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,358</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Purchase of investment securities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">533,614</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">76,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">271</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">610,585</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from dispositions of investment securities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(378,409</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(89,137</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(675</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(468,221</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfers in/out of Level 3<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(117</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(117</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, December</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2021</div></div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">939,690</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">273,795</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,630</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">450,381</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,669,496</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; white-space: nowrap;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal; white-space: nowrap;">Unrealized gains (losses) for the period relating to those Level 3 <br/>assets that were still held by the Company at the end of the <br/>period:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized gain (loss)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(12,837</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,394</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,042</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,597</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,888</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">On February 17, 2021, the Company exercised its warrants in Senseonics Holdings, Inc., receiving shares in the common stock of Senseonics Holdings, Inc. The common stock of Senseonics Holdings, Inc. is publicly traded, so this position is considered to be a Level 1 asset. </div> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the year ended December 31, 2021: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 80%;"/> <td style="width: 12%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">2022 Unsecured Notes</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the year ended<br/>December 31, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Beginning fair value</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized (gain) loss</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized (gain) loss</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Borrowings</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Repayments</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfers in/out of Level 3</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ending fair value</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company made elections to apply the fair value option of accounting to the 2022 Unsecured Notes, in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">825-10.</div> On December 31, 2021, there were borrowings of $150,000 on the 2022 Unsecured Notes. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Quantitative Information about Level 3 Fair Value Measurements </div></div></div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company typically determines the fair value of its performing debt investments utilizing a yield analysis. In a yield analysis, a price is ascribed for each investment based upon an assessment of current and expected market yields for similar investments and risk profiles. Additional consideration is given to current contractual interest rates, relative maturities and other key terms and risks associated with an investment. Among other factors, a significant determinant of risk is the amount of leverage used by the portfolio company relative to the total enterprise value of the company, and the rights and remedies of our investment within each portfolio company. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Significant unobservable quantitative inputs typically used in the fair value measurement of the Company’s Level 3 assets and liabilities primarily reflect current market yields, including indices, and readily available quotes from brokers, dealers, and pricing services as indicated by comparable assets and liabilities, as well as enterprise values, returns on equity and earnings before income taxes, depreciation and amortization (“EBITDA”) multiples of similar companies, and comparable market transactions for equity securities. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2022 is summarized in the table below: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 39%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="1" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset or<br/> Liability</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value at</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Principal Valuation</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Technique/Methodology</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unobservable Input</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Range (Weighted</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average)</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Asset</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,212,842 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">32,572</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Income Approach<br/> Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Comparable Multiple</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align: bottom; white-space: nowrap; text-indent: 0px;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">9.4%<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;">–<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">18.2% (12.0%)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;;text-indent: 0px;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">0.1x-21.4x<div style="display:inline;"> </div>(12.4x)</div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment Financing</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Asset</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">145,132 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">120,820</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Income Approach<br/> Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Comparable Multiple</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">8.5% –9.7% (9.7%) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1.1x-1.4x</div> (1.2x)</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Equity</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Asset</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Income Approach</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">5.0% –<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>5.0% (5.0%)</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Equity/Equity Interests/Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Asset</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">149,120 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">412,480</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Approach</div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Comparable Multiple <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Return on Equity</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">7.8x –<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>9.8x (8.8x) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">6.6% –<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>35.2% (9.2%)</div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Investments are valued using a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">sum-of-the</div></div> parts analysis, using expected revenue multiples for certain segments of the businesses and expected EBITDA multiples for certain segments of the businesses. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $120,820 of investments valued using <div style="display:inline;">an implied</div> multiple. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $676 of investments valued using a Black-Scholes model and $148,444 of investments valued using an EBITDA multiple. </div> </td> </tr> </table> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2021 is summarized in the table below</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 38%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset or<br/>Liability</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value at<br/>December 31, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Principal Valuation<br/>Technique/Methodology</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unobservable Input</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Range (Weighted<br/>Average)</div></div></div></td> </tr> <tr style="font-size: 0px;"> <td style="width: 38%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; padding: 0pt;;width:38%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div> </td> <td style="vertical-align: bottom; padding: 0pt;;width:4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Asset</td> <td style="vertical-align: bottom; padding: 0pt;;width:4%;">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0pt;">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0pt;;text-align:right;;width:4%;">931,769 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">7,921</div> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0pt;">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; padding: 0pt;;width:4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; padding: 0pt;;text-align:center;">Income Approach <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div> </td> <td style="vertical-align: bottom; padding: 0pt;;width:4%;"> </td> <td style="vertical-align: bottom; white-space: nowrap; padding: 0pt;;text-align:center;">Market Yield <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Comparable Multiple</div> </td> <td style="vertical-align: bottom; padding: 0pt;;width:4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; padding: 0pt;;text-align:center;">4.0% –<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>19.6% (8.7%) <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal; white-space: nowrap;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2.0x-3.0x(2.5x)/2.0x-</div></div>3.0x(2.5x)</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top;;width:38%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment Financing</div> </td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Asset</td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:4%;">144,693 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">129,102</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Income Approach <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Approach</div> </td> <td style="vertical-align: bottom;;width:4%;"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Return on Equity</div> </td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">7.1% –<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>20.3% (9.8%) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">4.6%-4.6%</div> (4.6%)</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top;;width:38%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Equity</div> </td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Asset</td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:4%;">5,630</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Income Approach</td> <td style="vertical-align: bottom;;width:4%;"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield</td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">3.5% –<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>8.0% (4.4%)</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top;;width:38%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Equity/Equity Interests/Warrants</div> </td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Asset</td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:4%;">151,615 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">298,766</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Approach</div> </td> <td style="vertical-align: bottom;;width:4%;"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Comparable Multiple <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Return on Equity</div> </td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">5.8x –<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>10.5x (9.5x) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">6.1% –<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>18.5% (8.6%)</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top;;width:38%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022 Unsecured Notes</div> </td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Liability</td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:4%;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Income Approach</td> <td style="vertical-align: bottom;;width:4%;"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield</td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">2.2% –<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>4.6% (4.5%)</td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Investments are valued using a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">sum-of-the</div></div> parts analysis, using expected EBITDA multiples <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(2x-3x)</div> for certain segments of the business and expected revenue multiples <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(2x-3x)</div> for certain segments of the business. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $403 of investments valued using a Black-Scholes model and $151,212 of investments valued using an EBITDA multiple. </div> </td> </tr> </table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Significant increases or decreases in any of the above unobservable inputs in isolation, including unobservable inputs used in deriving <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">bid-ask</div> spreads, if applicable, could result in significantly lower or higher fair value measurements for such assets and liabilities. Generally, an increase in market yields or decrease in EBITDA multiples may result in a decrease in the fair value of certain of the Company’s investments. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables present the balances of assets and liabilities measured at fair value on a recurring basis, as of December 31, 2022 and December 31, 2021: </div> <div style="margin-top: 24pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Fair Value Measurements </div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2022 </div></div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:61%"/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Measured at<br/> Net Asset Value*</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets:</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,245,414</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,245,414</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment Financing</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,952</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,952</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Equity</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Equity/Equity Interests/Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">483</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">561,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">9,426</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">571,509</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Investments</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">483</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,076,767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,426</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,086,676</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">*</div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">820-10,</div> certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP. See Note 19 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members. </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"/> <div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="margin-top: 24pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Fair Value Measurements </div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2021 </div></div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 92%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:66%"/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets:</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space: nowrap; vertical-align: bottom; width: 4%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$<br/></td> <td style="white-space: nowrap; vertical-align: bottom; width: 3%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">939,690</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">939,690</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment Financing</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; width: 4%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; width: 3%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">273,795</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">273,795</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Equity</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; width: 4%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; width: 3%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,630</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,630</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Equity/Equity Interests/Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">1,086</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; width: 3%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">450,381</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">451,467</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Investments</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,086</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ </td> <td style="white-space: nowrap; vertical-align: bottom; width: 3%; padding: 0pt 5pt 0pt 0pt;">—</td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,669,496</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,670,582</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Liabilities:</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022 Unsecured Notes</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space: nowrap; vertical-align: bottom; width: 4%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ </td> <td style="white-space: nowrap; vertical-align: bottom; text-align: right; width: 2%; padding: 0pt 5pt 0pt 0pt;">—<br/></td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 0 0 1245414000 0 1245414000 0 0 265952000 0 265952000 0 0 3801000 0 3801000 483000 0 561600000 9426000 571509000 483000 0 2076767000 9426000 2086676000 0 0 939690000 939690000 0 0 273795000 273795000 0 0 5630000 5630000 1086000 0 450381000 451467000 1086000 0 1669496000 1670582000 0 0 150000000 150000000 <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2022, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2022: </div> <div style="margin-top: 24pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Fair Value Measurements Using Level 3 Inputs </div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:52%"/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Senior Secured<br/> Loans</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equipment</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financing</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preferred Equity</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common Equity/<br/> Equity<br/> Interests/<br/> Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, December</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2021</div></div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">939,690</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">273,795</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,630</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">450,381</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,669,496</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total gains or losses included in earnings:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized gain (loss)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(36,244</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(36,238</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><span style="-sec-ix-hidden:hidden67612324">Net</span> change in unrealized loss</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8,065</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,924</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(706</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,048</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(20,743</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Purchase of investment securities(1)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">796,389</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">84,168</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">266</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">116,272</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">997,095</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from dispositions of investment securities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(446,356</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(85,087</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,389</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(11</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(532,843</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfers in/out of Level 3</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, December</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2022</div></div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,245,414</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,952</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">561,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,076,767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><span style="-sec-ix-hidden:hidden67612326">Net</span> change in unrealized loss</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">(8,920</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">(6,924</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">(706</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,048</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(21,598</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes positions acquired from SUNS as a result of the Mergers. </div> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the year ended December 31, 2022: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 80%;"/> <td style="width: 12%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">2022 Unsecured Notes</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the year ended<br/>December 31, 2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Beginning fair value</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized (gain) loss</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized (gain) loss</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Borrowings</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Repayments</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(150,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfers in/out of Level 3</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ending fair value</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company made an election to apply the fair value option of accounting to the 2022 Unsecured Notes, in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">825-10.</div> On May 8, 2022, the borrowings were repaid in full. While the Company has not made an election to apply the fair value option of accounting to any of its other debt obligations, if the Company’s debt obligations were carried at fair value at December 31, 2022, the fair value of the Credit Facility, SPV Credit Facility, 2023 Unsecured Notes, 2024 Unsecured Notes, 2025 Unsecured Notes, 2026 Unsecured Notes, 2027 Unsecured Notes and 2027 Series F Unsecured Notes would be $393,000, $155,200, $75,000, $118,750, $79,688, $68,250, $42,875 and $118,125, respectively. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div/><div> <div style="background-color:white;display: inline;"> </div> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2021, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2021: </div> <div style="margin-top: 24pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Fair Value Measurements Using Level 3 Inputs </div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 53%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Senior Secured<br/>Loans</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equipment</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financing</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preferred Equity</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common Equity/<br/>Equity<br/>Interests/<br/>Warrants</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 0px;"> <td style="width:48%"/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, December</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2020</div></div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">798,052</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">284,846</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,401</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">440,971</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,530,270</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total gains or losses included in earnings:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized gain (loss)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">345</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">337</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized gain (loss)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(13,567</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,394</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,042</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,857</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,358</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Purchase of investment securities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">533,614</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">76,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">271</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">610,585</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from dispositions of investment securities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(378,409</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(89,137</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(675</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(468,221</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfers in/out of Level 3<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(117</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(117</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, December</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2021</div></div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">939,690</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">273,795</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,630</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">450,381</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,669,496</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; white-space: nowrap;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal; white-space: nowrap;">Unrealized gains (losses) for the period relating to those Level 3 <br/>assets that were still held by the Company at the end of the <br/>period:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized gain (loss)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(12,837</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,394</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,042</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,597</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,888</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">On February 17, 2021, the Company exercised its warrants in Senseonics Holdings, Inc., receiving shares in the common stock of Senseonics Holdings, Inc. The common stock of Senseonics Holdings, Inc. is publicly traded, so this position is considered to be a Level 1 asset. </div> </td> </tr> </table> 939690000 273795000 5630000 450381000 1669496000 -36244000 0 0 6000 -36238000 -8065000 -6924000 -706000 -5048000 -20743000 796389000 84168000 266000 116272000 997095000 -446356000 -85087000 -1389000 -11000 -532843000 0 0 0 0 0 1245414000 265952000 3801000 561600000 2076767000 -8920000 -6924000 -706000 -5048000 -21598000 150000000 0 0 0 -150000000 0 0 393000000 155200000 75000000 118750000 79688000 68250000 42875000 118125000 798052000 284846000 6401000 440971000 1530270000 0 -8000 0 345000 337000 -13567000 1394000 -1042000 9857000 -3358000 533614000 76700000 271000 0 610585000 -378409000 -89137000 0 -675000 -468221000 0 0 0 -117000 -117000 939690000 273795000 5630000 450381000 1669496000 -12837000 1394000 -1042000 9597000 -2888000 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the year ended December 31, 2021: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 80%;"/> <td style="width: 12%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">2022 Unsecured Notes</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the year ended<br/>December 31, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Beginning fair value</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized (gain) loss</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized (gain) loss</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Borrowings</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Repayments</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfers in/out of Level 3</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ending fair value</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> 150000000 0 0 0 0 0 150000000 150000000 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2022 is summarized in the table below: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 39%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="1" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset or<br/> Liability</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value at</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Principal Valuation</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Technique/Methodology</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unobservable Input</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Range (Weighted</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average)</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Asset</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,212,842 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">32,572</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Income Approach<br/> Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Comparable Multiple</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align: bottom; white-space: nowrap; text-indent: 0px;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">9.4%<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;">–<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">18.2% (12.0%)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;;text-indent: 0px;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">0.1x-21.4x<div style="display:inline;"> </div>(12.4x)</div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment Financing</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Asset</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">145,132 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">120,820</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Income Approach<br/> Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Comparable Multiple</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">8.5% –9.7% (9.7%) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1.1x-1.4x</div> (1.2x)</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Equity</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Asset</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Income Approach</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">5.0% –<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>5.0% (5.0%)</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Equity/Equity Interests/Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Asset</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">149,120 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">412,480</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Approach</div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Comparable Multiple <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Return on Equity</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">7.8x –<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>9.8x (8.8x) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">6.6% –<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>35.2% (9.2%)</div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Investments are valued using a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">sum-of-the</div></div> parts analysis, using expected revenue multiples for certain segments of the businesses and expected EBITDA multiples for certain segments of the businesses. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $120,820 of investments valued using <div style="display:inline;">an implied</div> multiple. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $676 of investments valued using a Black-Scholes model and $148,444 of investments valued using an EBITDA multiple. </div> </td> </tr> </table> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2021 is summarized in the table below</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 38%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset or<br/>Liability</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value at<br/>December 31, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Principal Valuation<br/>Technique/Methodology</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unobservable Input</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Range (Weighted<br/>Average)</div></div></div></td> </tr> <tr style="font-size: 0px;"> <td style="width: 38%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; padding: 0pt;;width:38%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div> </td> <td style="vertical-align: bottom; padding: 0pt;;width:4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Asset</td> <td style="vertical-align: bottom; padding: 0pt;;width:4%;">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0pt;">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0pt;;text-align:right;;width:4%;">931,769 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">7,921</div> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0pt;">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; padding: 0pt;;width:4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; padding: 0pt;;text-align:center;">Income Approach <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div> </td> <td style="vertical-align: bottom; padding: 0pt;;width:4%;"> </td> <td style="vertical-align: bottom; white-space: nowrap; padding: 0pt;;text-align:center;">Market Yield <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Comparable Multiple</div> </td> <td style="vertical-align: bottom; padding: 0pt;;width:4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; padding: 0pt;;text-align:center;">4.0% –<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>19.6% (8.7%) <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal; white-space: nowrap;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2.0x-3.0x(2.5x)/2.0x-</div></div>3.0x(2.5x)</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top;;width:38%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment Financing</div> </td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Asset</td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:4%;">144,693 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">129,102</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Income Approach <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Approach</div> </td> <td style="vertical-align: bottom;;width:4%;"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Return on Equity</div> </td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">7.1% –<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>20.3% (9.8%) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">4.6%-4.6%</div> (4.6%)</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top;;width:38%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Equity</div> </td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Asset</td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:4%;">5,630</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Income Approach</td> <td style="vertical-align: bottom;;width:4%;"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield</td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">3.5% –<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>8.0% (4.4%)</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top;;width:38%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Equity/Equity Interests/Warrants</div> </td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Asset</td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:4%;">151,615 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">298,766</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Approach</div> </td> <td style="vertical-align: bottom;;width:4%;"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Comparable Multiple <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Return on Equity</div> </td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">5.8x –<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>10.5x (9.5x) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">6.1% –<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>18.5% (8.6%)</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top;;width:38%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022 Unsecured Notes</div> </td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Liability</td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:4%;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Income Approach</td> <td style="vertical-align: bottom;;width:4%;"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield</td> <td style="vertical-align: bottom;;width:4%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">2.2% –<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>4.6% (4.5%)</td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Investments are valued using a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">sum-of-the</div></div> parts analysis, using expected EBITDA multiples <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(2x-3x)</div> for certain segments of the business and expected revenue multiples <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(2x-3x)</div> for certain segments of the business. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $403 of investments valued using a Black-Scholes model and $151,212 of investments valued using an EBITDA multiple. </div> </td> </tr> </table> 1212842000 32572000 Income Approach Market Multiple Market Yield Comparable Multiple 9.4 18.2 12 0.1 21.4 12.4 145132000 120820000 Income Approach Market Multiple Market Yield Comparable Multiple 8.5 9.7 9.7 1.1 1.4 1.2 3801000 Income Approach Market Yield 5 5 5 149120000 412480000 Market Multiple Market Approach Comparable Multiple Return on Equity 7.8 9.8 8.8 6.6 35.2 9.2 120820000 676000 148444000 931769000 7921000 Income Approach Market Multiple Market Yield Comparable Multiple 4 19.6 8.7 2 3 2.5 2 3 2.5 144693000 129102000 Income Approach Market Approach Market Yield Return on Equity 7.1 20.3 9.8 4.6 4.6 4.6 5630000 Income Approach Market Yield 3.5 8 4.4 151615000 298766000 Market Multiple Market Approach Comparable Multiple Return on Equity 5.8 10.5 9.5 6.1 18.5 8.6 150000000 Income Approach Market Yield 2.2 4.6 4.5 403000 151212000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 7. Debt </div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Our debt obligations consisted of the following as of December 31, 2022 and December 31, 2021: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:54%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Facility</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Face Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Face Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Credit Facility</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">393,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">388,254</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">322,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">318,015</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SPV Credit Facility</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">155,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">154,302</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022 Unsecured Notes</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022 Tranche C Notes</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,964</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023 Unsecured Notes</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,979</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,592</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024 Unsecured Notes</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">124,421</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">124,143</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025 Unsecured Notes</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">85,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">84,613</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(6)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026 Unsecured Notes</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,498</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(7)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,384</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(7)</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027 Unsecured Notes</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">49,953</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(8)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">49,940</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(8)</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027 Series F Unsecured Notes</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">135,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">134,978</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(9)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,093,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,085,998</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">818,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">812,038</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $<div style="letter-spacing: 0px; top: 0px;;display:inline;">4,746</div> and $<div style="letter-spacing: 0px; top: 0px;;display:inline;">4,485</div> as of December 31, 2022 and December 31, 2021, respectively. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized market discount of $898 as of December 31, 2022. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $36 as of December 31, 2021. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(4)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $21 and $408 as of December 31, 2022 and December 31, 2021, respectively. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(5)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $579 and $857 as of December 31, 2022 and December 31, 2021, respectively. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(6)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized market discount of $387 as of December 31, 2022. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(7)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $502 and $616 as of December 31, 2022 and December 31, 2021, respectively. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(8)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $47 and $60 as of December 31, 2022 and December 31, 2021, respectively. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(9)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $22 as of December 31, 2022. </div> </td> </tr> </table> <div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Unsecured Notes </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On April 1, 2022, the Company entered into an assumption agreement (the “Note Assumption Agreement”), effective as of the closing of the Mergers. The Note Assumption Agreement relates to the Company’s assumption of $85,000 in aggregate principal amount of five-year, 3.90% senior unsecured notes, due March 31, 2025 (the “2025 Unsecured Notes”) and other obligations of SUNS under the Note Purchase Agreement, dated as of March 31, 2020 (the “Note Purchase Agreement”), among SUNS and certain institutional investors. Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30. Pursuant to the Note Assumption Agreement, the Company expressly assumed on behalf of SUNS the due and punctual payment of the principal of (and premium, if any) and interest on all the 2025 Unsecured Notes outstanding, and the due and punctual performance and observance of every covenant and every condition of the Note Purchase Agreement, to be performed or observed by SUNS. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"/> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January 6, 2022, the Company closed a private offering of $135,000 of the 2027 Series F Unsecured Notes with a fixed interest rate of 3.33% and a maturity date of January 6, 2027. Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6. The 2027 Series F Unsecured Notes were issued in a private placement only to qualified institutional buyers. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September 14, 2021, the Company closed a private offering of $50,000 of the 2027 Unsecured Notes with a fixed interest rate of 2.95% and a maturity date of March 14, 2027. Interest on the 2027 Unsecured Notes is due semi-annually on March 14 and September 14. The 2027 Unsecured Notes were issued in a private placement only to qualified institutional buyers. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December 18, 2019, the Company closed a private offering of $125,000 of the 2024 Unsecured Notes with a fixed interest rate of 4.20% and a maturity date of December 15, 2024. Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15. The 2024 Unsecured Notes were issued in a private placement only to qualified institutional buyers. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December 18, 2019, the Company closed a private offering of $75,000 of the 2026 Unsecured Notes with a fixed interest rate of 4.375% and a maturity date of December 15, 2026. Interest on the 2026 Unsecured Notes is due semi-annually on June 15 and December 15. The 2026 Unsecured Notes were issued in a private placement only to qualified institutional buyers. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December 28, 2017, the Company closed a private offering of $21,000 of the 2022 Tranche C Notes with a fixed interest rate of 4.50% and a maturity date of December 28, 2022. Interest on the 2022 Tranche C Notes is due semi-annually on June 28 and December 28. The 2022 Tranche C Notes were issued in a private placement only to qualified institutional buyers. The 2022 Tranche C Notes were repaid in full at maturity. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November 22, 2017, we issued $75,000 in aggregate principal amount of publicly registered 2023 Unsecured Notes for net proceeds of $73,846. Interest on the 2023 Unsecured Notes is paid semi-annually on January 20 and July 20, at a fixed rate of 4.50% per year, commencing on January 20, 2018. The 2023 Unsecured Notes mature on January 20, 2023. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February 15, 2017, the Company closed a private offering of $100,000 of the 2022 Unsecured Notes with a fixed interest rate of 4.60% and a maturity date of May 8, 2022. Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional <div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">buyers. The 2022 Unsecured Notes were repaid in full at maturity. </div></div></div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November 8, 2016, the Company closed a private offering of $50,000 of the 2022 Unsecured Notes with a fixed interest rate of 4.40% and a maturity date of May 8, 2022. Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional buyers. The 2022 Unsecured Notes were repaid in full at maturity. </div> <div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Revolving and Term Loan Facilities </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On April 1, 2022, the Company entered into an assumption agreement (the “CF Assumption Agreement”), effective as of the closing of the Mergers. The CF Assumption Agreement relates to the Company’s assumption of the Revolving Credit Facility, originally entered into on August 26, 2011 (as amended from time to time, the “SPV Credit Facility”), by and among SUNS SPV LLC (the “SUNS SPV”), a wholly-owned subsidiary of SUNS, acting as borrower, Citibank, N.A., acting as administrative agent and collateral agent, and the other parties thereto. Currently, the commitment under the SPV Credit Facility is $225,000; however, the commitment can also be expanded up to $600,000. The stated interest rate on the SPV Credit Facility is LIBOR plus <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2.00%-2.50%</div> with no LIBOR floor requirement and the current final maturity date is June 1, 2026. The SPV Credit Facility is secured by all of the assets held by SUNS SPV. Under the terms of the SPV Credit Facility and related transaction documents, the Company as successor to SUNS, and SUNS SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SPV Credit Facility also includes usual and customary events of default for credit facilities of this nature. At December 31, 2022, outstanding USD equivalent borrowings under the SPV Credit Facility totaled $155,200. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December 28, 2021, the Company closed on Amendment No. 1 to its August 28, 2019 senior secured credit agreement (the “Credit Facility”). Following the amendment and a November 2022 upsizing, the Credit Facility is composed of $625,000 of revolving credit and $100,000 of term loans. Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1.75%-2.00%</div> or the alternate base rate plus <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">0.75%-1.00%.</div> The Credit Facility has a 0% floor and matures in December 2026 and includes ratable amortization in the final year. The Credit Facility may be increased up to $800,000 with additional new lenders or an increase in commitments from current lenders. The Credit Facility contains certain customary affirmative and negative covenants and events of default. In addition, the Credit Facility contains certain financial covenants that among other things, requires the Company to maintain a minimum shareholder’s equity and a minimum asset coverage ratio. At December 31, 2022, outstanding USD equivalent borrowings under the Credit Facility totaled $393,000, composed of $293,000 of revolving credit and $100,000 of term loans. </div> <div style="margin-top: 6pt; margin-bottom: 0pt; text-indent: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Certain covenants on our issued debt may restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a RIC under Subchapter M of the Code. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The average annualized interest cost for all borrowings for the year ended December 31, 2022 and the year ended December 31, 2021 was 4.09% and 3.64%, respectively. These costs are exclusive of other credit facility expenses such as unused fees, agency fees and other prepaid expenses related to establishing and/or amending the Credit Facility, the SPV Credit Facility, the 2022 Unsecured Notes, the 2022 Tranche C Notes, the 2023 Unsecured Notes, the 2024 Unsecured Notes, the 2025 Unsecured Notes, the 2026 Unsecured Notes, the 2027 Unsecured Notes and the 2027 Series F Unsecured Notes (collectively the “Debt Instruments”), if any. The maximum amounts borrowed on the Debt Instruments during the year ended December 31, 2022 and the year ended December 31, 2021 were $1,164,200 and $902,550, respectively. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Our debt obligations consisted of the following as of December 31, 2022 and December 31, 2021: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:54%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Facility</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Face Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Face Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Credit Facility</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">393,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">388,254</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">322,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">318,015</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SPV Credit Facility</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">155,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">154,302</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022 Unsecured Notes</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022 Tranche C Notes</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,964</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023 Unsecured Notes</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,979</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,592</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024 Unsecured Notes</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">124,421</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">124,143</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025 Unsecured Notes</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">85,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">84,613</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(6)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026 Unsecured Notes</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,498</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(7)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,384</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(7)</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027 Unsecured Notes</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">49,953</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(8)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">49,940</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(8)</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027 Series F Unsecured Notes</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">135,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">134,978</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(9)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,093,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,085,998</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">818,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">812,038</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $<div style="letter-spacing: 0px; top: 0px;;display:inline;">4,746</div> and $<div style="letter-spacing: 0px; top: 0px;;display:inline;">4,485</div> as of December 31, 2022 and December 31, 2021, respectively. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized market discount of $898 as of December 31, 2022. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $36 as of December 31, 2021. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(4)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $21 and $408 as of December 31, 2022 and December 31, 2021, respectively. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(5)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $579 and $857 as of December 31, 2022 and December 31, 2021, respectively. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(6)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized market discount of $387 as of December 31, 2022. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(7)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $502 and $616 as of December 31, 2022 and December 31, 2021, respectively. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(8)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $47 and $60 as of December 31, 2022 and December 31, 2021, respectively. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(9)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $22 as of December 31, 2022. </div> </td> </tr> </table> 393000000 388254000 322500000 318015000 155200000 154302000 0 0 0 0 150000000 150000000 0 0 21000000 20964000 75000000 74979000 75000000 74592000 125000000 124421000 125000000 124143000 85000000 84613000 0 0 75000000 74498000 75000000 74384000 50000000 49953000 50000000 49940000 135000000 134978000 0 0 1093200000 1085998000 818500000 812038000 4746000 4485000 898000 36000 21000 408000 579000 857000 387000 502000 616000 47000 60000 22000 85000000 85000000 P5Y 0.039 2025-03-31 Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30 135000000 135000000 0.0333 2027-01-06 Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6 50000000 50000000 0.0295 0.0295 125000000 125000000 125000000 0.042 2024-12-15 Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15 75000000 75000000 75000000 0.04375 0.04375 2026-12-15 21000000 21000000 21000000 0.045 0.045 Interest on the 2022 Tranche C Notes is due semi-annually on June 28 and December 28 75000000 75000000 75000000 73846000 semi-annually on January 20 and July 20 0.045 0.045 2023-01-20 100000000 100000000 100000000 0.046 0.046 2022-05-08 Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8 50000000 50000000 50000000 0.044 0.044 Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8 225000000 600000000 0.02 -0.025 2026-06-01 155200000 625000000 100000000 0.0175 -0.02 0.0075 -0.01 800000000 393000000 293000000 100000000 0.0409 0.0364 1164200000 902550000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 8(a). Income Tax Information and Distributions to Stockholders </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The tax character of distributions for the fiscal years ended December 31, 2022, 2021 and 2020 were as follows (1): </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:67%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ordinary income</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,113</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">59.2</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">41,221</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">59.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">48,795</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">70.4</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Capital gains</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Return of capital</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27,099</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,087</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">40.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,513</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Distribution recognized in subsequent year</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,481</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8.8</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total distributions</div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">84,693</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">100.0</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">% </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">69,308</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">100.0</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">% </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">69,308</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">100.0</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December 31, 2022, 2021 and 2020 the total accumulated earnings (loss) on a tax basis were as follows (1): </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 84%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:71%"/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><br/></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Undistributed ordinary income</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><br/></td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Undistributed long-term net capital gains</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><br/></td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td><br/></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total undistributed net earnings</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><br/></td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Post-October capital losses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><br/></td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Capital loss carryforward</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(127,348</td> <td style="vertical-align: bottom; white-space: nowrap;">)<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(2)</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><br/></td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(68,857</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(69,384</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other book/tax temporary differences</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(53,223</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="white-space:nowrap;vertical-align:bottom"><br/></td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,332</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,168</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net unrealized appreciation</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,187</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><br/></td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,495</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,446</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td><br/></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total tax accumulated loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(163,384</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="white-space:nowrap;vertical-align:bottom"><br/></td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(47,030</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(62,770</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td><br/></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="line-height: 8pt; margin-top: 0px; margin-bottom: 0px; border-bottom: 1px solid rgb(0, 0, 0); width: 11%;"> </div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(1)</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Tax information for the fiscal years ended December 31, 2022, 2021 and 2020 are/were estimates and are not final until the Company files its tax returns, typically in September or October each year. </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(2)</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Includes capital loss carryforward acquired from the Mergers which is subject to limitations under IRC Sections 381-384. </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div/> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company recognizes in its consolidated financial statements the tax effect of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. To the best of our knowledge, we did <div style="letter-spacing: 0px; top: 0px;;display:inline;">not</div> have any uncertain tax positions that met the recognition or measurement criteria of ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">740-10-25</div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;">nor</div> did we have any unrecognized tax benefits as of the periods presented herein. Although we file federal and state tax returns, our major tax jurisdiction is federal. Our tax returns for each of our federal tax years since 2019 remain subject to examination by the Internal Revenue Service and the state department of revenue. The capital loss carryforwards shown above do not expire. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 8(b). Other Tax Information (unaudited) </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the fiscal years ended December 31, 2022, 2021 and 2020, 0.00%, 0.32% and 0.10%, respectively, of the dividends paid during the year were eligible for qualified dividend income treatment and the dividends received deduction for corporate stockholders. For the fiscal years ended December 31, 2022, 2021, and 2020, 88.05%, 93.05% and 92.05%, respectively, of each of the distributions paid during the year represent interest-related dividends. For the fiscal years ended December 31, 2022, 2021 and 2020, none of the distributions represent short-term capital gains dividends. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The tax character of distributions for the fiscal years ended December 31, 2022, 2021 and 2020 were as follows (1): </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:67%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ordinary income</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,113</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">59.2</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">41,221</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">59.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">48,795</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">70.4</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Capital gains</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Return of capital</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27,099</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,087</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">40.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,513</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Distribution recognized in subsequent year</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,481</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8.8</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total distributions</div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">84,693</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">100.0</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">% </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">69,308</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">100.0</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">% </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">69,308</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">100.0</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td></tr></table> 50113000 0.592 41221000 0.595 48795000 0.704 0 0 0 0 0 0 27099000 0.32 28087000 0.405 20513000 0.296 7481000 0.088 0 0 0 0 84693000 1 69308000 1 69308000 1 <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December 31, 2022, 2021 and 2020 the total accumulated earnings (loss) on a tax basis were as follows (1): </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 84%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:71%"/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><br/></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Undistributed ordinary income</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><br/></td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Undistributed long-term net capital gains</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><br/></td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td><br/></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total undistributed net earnings</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><br/></td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Post-October capital losses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><br/></td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Capital loss carryforward</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(127,348</td> <td style="vertical-align: bottom; white-space: nowrap;">)<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(2)</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><br/></td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(68,857</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(69,384</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other book/tax temporary differences</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(53,223</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="white-space:nowrap;vertical-align:bottom"><br/></td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,332</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,168</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net unrealized appreciation</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,187</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><br/></td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,495</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,446</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td><br/></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total tax accumulated loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(163,384</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="white-space:nowrap;vertical-align:bottom"><br/></td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(47,030</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(62,770</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td><br/></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="line-height: 8pt; margin-top: 0px; margin-bottom: 0px; border-bottom: 1px solid rgb(0, 0, 0); width: 11%;"> </div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(1)</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Tax information for the fiscal years ended December 31, 2022, 2021 and 2020 are/were estimates and are not final until the Company files its tax returns, typically in September or October each year. </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(2)</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Includes capital loss carryforward acquired from the Mergers which is subject to limitations under IRC Sections 381-384. </div></div></div></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> 0 0 0 0 0 0 0 0 0 0 0 0 -127348000 -68857000 -69384000 53223000 -2332000 -2168000 17187000 19495000 4446000 -163384000 -47030000 -62770000 0 0 The capital loss carryforwards shown above do not expire 0 0.32 0.1 88.05 93.05 92.05 0 0 0 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 9. Financial Highlights </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a schedule of financial highlights for the respective years: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:53%"/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended<br/> December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended<br/> December 31,<br/> 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended<br/> December 31,<br/> 2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended<br/> December 31,<br/> 2019</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended<br/> December 31,<br/> 2018</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Per Share Data: (a)</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net asset value, beginning of year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19.93</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20.16</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21.44</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21.75</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21.81</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment income</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.48</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.44</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.40</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.71</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.77</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized and unrealized loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.13</td> <td style="white-space:nowrap;vertical-align:bottom">)* </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.03</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.04</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.38</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.19</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net increase in net assets resulting from operations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.35</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.41</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.36</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.33</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.58</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of common stock in connection with the Mergers</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.33</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Anti-dilution</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.02</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Distributions to stockholders (see note 8a):</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">From distributable earnings</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.12</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.98</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.15</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.55</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.64</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">From return of capital</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.52</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.66</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.49</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.09</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net asset value, end of year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.33</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19.93</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20.16</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21.44</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21.75</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Per share market value, end of year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13.91</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.43</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17.51</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20.62</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19.19</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Return(b)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(16.09</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14.66</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5.72</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16.22</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.77</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net assets, end of year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">999,731</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">842,281</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">852,023</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">905,880</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">919,171</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares outstanding, end of year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,555,380</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,260,826</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,260,826</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,260,826</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,260,826</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ratios to average net assets:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment income</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.76</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.13</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.93</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.83</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8.10</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.60</td> <td style="white-space:nowrap;vertical-align:bottom">%** </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.68</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.14</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.76</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.83</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest and other credit facility expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.68</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.50</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.18</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.13</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.67</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.28</td> <td style="white-space:nowrap;vertical-align:bottom">%** </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.18</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.32</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8.89</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8.50</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Average debt outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">994,578</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">703,670</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">556,104</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">561,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">508,445</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Portfolio turnover ratio</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27.4</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29.9</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">39.3</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="width: 11%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(a)</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Calculated using the average shares outstanding method, except for the issuance of common stock in connection with the Mergers, which reflects the actual amount per share for the applicable period. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(b)</div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Total return is based on the change in market price per share during the year and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. Total return does not include a sales load. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">*</div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The amount shown may not correspond with the aggregate amount for the period as it includes the effect of the timing of the Mergers. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">**</div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of the performance-based incentive fee waiver (see note 3). For the year ended December 31, 2022, the ratios of operating expenses to average net assets and total expenses to average net assets would be 5.75% and 10.43%, respectively, without the performance-based incentive fee waiver. </div></td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a schedule of financial highlights for the respective years: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:53%"/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended<br/> December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended<br/> December 31,<br/> 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended<br/> December 31,<br/> 2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended<br/> December 31,<br/> 2019</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended<br/> December 31,<br/> 2018</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Per Share Data: (a)</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net asset value, beginning of year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19.93</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20.16</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21.44</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21.75</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21.81</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment income</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.48</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.44</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.40</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.71</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.77</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized and unrealized loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.13</td> <td style="white-space:nowrap;vertical-align:bottom">)* </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.03</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.04</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.38</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.19</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net increase in net assets resulting from operations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.35</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.41</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.36</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.33</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.58</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of common stock in connection with the Mergers</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.33</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Anti-dilution</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.02</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Distributions to stockholders (see note 8a):</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">From distributable earnings</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.12</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.98</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.15</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.55</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.64</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">From return of capital</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.52</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.66</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.49</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.09</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net asset value, end of year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.33</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19.93</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20.16</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21.44</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21.75</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Per share market value, end of year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13.91</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.43</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17.51</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20.62</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19.19</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Return(b)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(16.09</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14.66</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5.72</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16.22</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.77</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net assets, end of year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">999,731</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">842,281</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">852,023</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">905,880</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">919,171</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares outstanding, end of year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,555,380</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,260,826</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,260,826</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,260,826</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,260,826</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ratios to average net assets:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment income</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.76</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.13</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.93</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.83</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8.10</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.60</td> <td style="white-space:nowrap;vertical-align:bottom">%** </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.68</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.14</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.76</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.83</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest and other credit facility expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.68</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.50</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.18</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.13</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.67</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.28</td> <td style="white-space:nowrap;vertical-align:bottom">%** </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.18</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.32</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8.89</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8.50</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Average debt outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">994,578</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">703,670</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">556,104</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">561,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">508,445</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Portfolio turnover ratio</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27.4</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29.9</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">39.3</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="width: 11%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(a)</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Calculated using the average shares outstanding method, except for the issuance of common stock in connection with the Mergers, which reflects the actual amount per share for the applicable period. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(b)</div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Total return is based on the change in market price per share during the year and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. Total return does not include a sales load. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">*</div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The amount shown may not correspond with the aggregate amount for the period as it includes the effect of the timing of the Mergers. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">**</div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of the performance-based incentive fee waiver (see note 3). For the year ended December 31, 2022, the ratios of operating expenses to average net assets and total expenses to average net assets would be 5.75% and 10.43%, respectively, without the performance-based incentive fee waiver. </div></td></tr></table> 19.93 20.16 21.44 21.75 21.81 1.48 1.44 1.4 1.71 1.77 -1.13 -0.03 -1.04 -0.38 -0.19 0.35 1.41 0.36 1.33 1.58 -0.33 0 0 0 0 0.02 0 0 0 0 1.12 0.98 1.15 1.55 1.64 -0.52 -0.66 -0.49 -0.09 0 18.33 19.93 20.16 21.44 21.75 13.91 18.43 17.51 20.62 19.19 -0.1609 0.1466 -0.0572 0.1622 0.0277 999731000 842281000 852023000 905880000 919171000 54555380 42260826 42260826 42260826 42260826 0.0776 0.0713 0.0693 0.0783 0.081 0.056 0.0568 0.0414 0.0576 0.0583 0.0468 0.035 0.0318 0.0313 0.0267 0.1028 0.0918 0.0732 0.0889 0.085 994578000 703670000 556104000 561249000 508445000 0.274 0.299 0.26 0.241 0.393 0.0575 0.1043 <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 10. SLR Credit Solutions </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December 28, 2012, we acquired an equity interest in Crystal Capital Financial Holdings LLC (“Crystal Financial”) for $275,000 in cash. Crystal Financial owned approximately 98% of the outstanding ownership interest in SLR Credit Solutions (“SLR Credit”), f/k/a Crystal Financial LLC. The remaining financial interest was held by various employees of SLR Credit, through their investment in Crystal Management LP. SLR Credit had a diversified portfolio of 23 loans having a total par value of approximately $400,000 at November 30, 2012 and a $275,000 committed revolving credit facility. On July 28, 2016, the Company purchased Crystal Management LP’s approximately 2% equity interest in SLR Credit for approximately $5,737. Upon the closing of this transaction, the Company holds 100% of the equity interest in SLR Credit. On September 30, 2016, Crystal Capital Financial Holdings LLC was dissolved. As of December 31, 2022, total commitments to the revolving credit facility are $285,000. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December 31, 2022 SLR Credit had 29 funded commitments to 25 different issuers with total funded loans of approximately $439,484 on total assets of $460,683. As of December 31, 2021 SLR Credit had 22 funded commitments to 19 different issuers with total funded loans of approximately $287,375 on total assets of $347,821. As of December 31, 2022 and December 31, 2021, the largest loan outstanding totaled $33,420 and $35,000, respectively. For the same periods, the average exposure per issuer was $17,579 and $15,125, respectively. SLR Credit’s credit facility, which is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse</div> to the Company, had approximately $224,325 and $100,742 of borrowings outstanding at December 31, 2022 and December 31, 2021, respectively. For the years ended December 31, 2022, 2021 and 2020 SLR Credit had net income of $7,521, $14,164 and $23,293, respectively, on gross income of $30,324, $33,993 and $45,315, respectively. Due to timing and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> items, there may be material differences between GAAP net income and cash available for distributions. SLR Credit’s consolidated financial statements for the fiscal years ended December 31, 2022 and December 31, 2021 are attached as an exhibit to this annual report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">10</div>-K.</div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> 275000000 0.98 23 400000000 275000000 0.02 5737000 1 285000000 29 25 439484000 460683000 22 19 287375000 347821000 33420000 35000000 17579000 15125000 224325000 100742000 7521000 14164000 23293000 30324000 33993000 45315000 <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 11. Commitments and Contingencies </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Off-Balance</div> Sheet Arrangements </div></div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; text-indent: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">The Company had unfunded debt and equity commitments to various revolving and delayed-draw term loans as well as to SLR Credit and SLR Healthcare. The total amount of these unfunded commitments as of December 31, 2022 and December 31, 2021 is $323,663 and $226,733, respectively, comprised of the following: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:74%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SLR Credit Solutions*</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">44,263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">44,263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outset Medical, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">35,084</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apeel Technology, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32,786</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">CC SAG Holdings Corp. (Spectrum Automotive)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,670</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,827</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Human Interest, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,104</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Glooko, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,868</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25,091</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">World Insurance Associates, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,117</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">iCIMS, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,435</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Spectrum Pharmaceuticals, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,771</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Arcutis Biotherapeutics, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,356</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43,470</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Atria Wealth Solutions, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,215</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,746</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ardelyx, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,752</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Luxury Asset Capital, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">RSC Acquisition, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,498</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cerapedics, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,735</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Maurices, Incorporated</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,649</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Kaseya, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,936</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vessco Midco Holdings, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,892</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Copper River Seafoods, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,595</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">BDG Media, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,546</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Meditrina, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,367</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">One Touch Direct, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,069</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,226</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">DeepIntent, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,049</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foundation Consumer Brands, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,009</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SCP Eye Care, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,771</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic Fun, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,675</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,935</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Kid Distro Holdings, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,650</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,650</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Plastics Management, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,424</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Southern Orthodontic Partners Management, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,918</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Pediatric Home Respiratory Services, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,805</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Pinnacle Treatment Centers, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,745</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,414</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ultimate Baked Goods Midco LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,636</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Orthopedic Care Partners Management, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,620</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ivy Fertility Services, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,571</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,532</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Composite Technology Acquisition Corp</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,537</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NAC Holdings Corporation</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,479</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,765</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SLR Healthcare ABL*</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,400</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SPAR Marketing Force, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,338</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">RxSense Holdings LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Erie Construction <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Mid-west,</div> LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,248</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Peter C. Foy &amp; Associates Insurance Services, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,094</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">American Teleconferencing Services, Ltd</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,090</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">573</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Montefiore Nyack Hospital</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,034</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Enverus Holdings, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,004</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SLR Equipment Finance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SunMed Group Holdings, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">843</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">828</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">GSM Acquisition Corp</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">784</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Tilley Distribution, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">525</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">BayMark Health Services, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">391</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">High Street Buyer, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">327</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TAUC Management, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">294</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ENS Holdings III Corp, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">144</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">All State Ag Parts, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">135</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">BridgeBio Pharma, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,049</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inszone Mid, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,465</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Rezolute, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,675</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SOC Telemed, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,448</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">RQM+ Corp</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,818</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">MMIT Holdings, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,009</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Neuronetics, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,230</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Commitments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">323,663</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">226,733</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width: 4%; vertical-align: top;;text-align:left;">*</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company controls the funding of the SLR Credit Solutions and SLR Healthcare ABL commitments and may cancel them at its discretion.</div></td></tr></table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div/><div><div style="background-color:white;display: inline;"/></div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the above, please see SLR Senior Lending Program LLC herein where the Company has a remaining equity commitment of $40,500 in which the Company also controls such funding. The credit agreements of the above loan commitments contain customary lending provisions and/or are subject to the portfolio company’s achievement of certain milestones that allow relief to the Company from funding obligations for previously made commitments in instances where the underlying company experiences materially adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. As of December 31, 2022 and December 31, 2021, the Company had sufficient cash available and/or liquid securities available to fund its commitments and had reviewed them for any <div style="letter-spacing: 0px; top: 0px;;display:inline;">appropriate</div> fair value adjustment. </div> The total amount of these unfunded commitments as of December 31, 2022 and December 31, 2021 is $323,663 and $226,733, respectively, comprised of the following: <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:74%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SLR Credit Solutions*</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">44,263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">44,263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outset Medical, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">35,084</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apeel Technology, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32,786</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">CC SAG Holdings Corp. (Spectrum Automotive)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,670</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,827</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Human Interest, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,104</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Glooko, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,868</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25,091</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">World Insurance Associates, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,117</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">iCIMS, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,435</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Spectrum Pharmaceuticals, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,771</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Arcutis Biotherapeutics, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,356</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43,470</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Atria Wealth Solutions, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,215</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,746</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ardelyx, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,752</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Luxury Asset Capital, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">RSC Acquisition, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,498</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cerapedics, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,735</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Maurices, Incorporated</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,649</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Kaseya, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,936</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vessco Midco Holdings, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,892</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Copper River Seafoods, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,595</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">BDG Media, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,546</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Meditrina, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,367</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">One Touch Direct, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,069</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,226</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">DeepIntent, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,049</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foundation Consumer Brands, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,009</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SCP Eye Care, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,771</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic Fun, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,675</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,935</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Kid Distro Holdings, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,650</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,650</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Plastics Management, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,424</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Southern Orthodontic Partners Management, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,918</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Pediatric Home Respiratory Services, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,805</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Pinnacle Treatment Centers, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,745</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,414</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ultimate Baked Goods Midco LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,636</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Orthopedic Care Partners Management, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,620</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ivy Fertility Services, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,571</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,532</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Composite Technology Acquisition Corp</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,537</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NAC Holdings Corporation</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,479</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,765</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SLR Healthcare ABL*</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,400</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SPAR Marketing Force, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,338</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">RxSense Holdings LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Erie Construction <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Mid-west,</div> LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,248</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Peter C. Foy &amp; Associates Insurance Services, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,094</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">American Teleconferencing Services, Ltd</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,090</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">573</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Montefiore Nyack Hospital</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,034</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Enverus Holdings, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,004</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SLR Equipment Finance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SunMed Group Holdings, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">843</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">828</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">GSM Acquisition Corp</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">784</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Tilley Distribution, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">525</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">BayMark Health Services, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">391</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">High Street Buyer, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">327</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TAUC Management, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">294</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ENS Holdings III Corp, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">144</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">All State Ag Parts, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">135</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">BridgeBio Pharma, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,049</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inszone Mid, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,465</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Rezolute, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,675</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SOC Telemed, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,448</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">RQM+ Corp</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,818</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">MMIT Holdings, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,009</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Neuronetics, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,230</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Commitments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">323,663</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">226,733</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width: 4%; vertical-align: top;;text-align:left;">*</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company controls the funding of the SLR Credit Solutions and SLR Healthcare ABL commitments and may cancel them at its discretion.</div></td></tr></table> 323663000 226733000 44263000 44263000 35084000 0 32786000 0 20670000 18827000 20104000 0 17868000 25091000 17117000 0 11435000 0 8771000 0 8356000 43470000 8215000 3746000 7752000 0 7500000 0 7498000 0 6735000 0 4314000 5649000 3936000 0 3892000 0 3595000 0 3546000 0 3367000 0 3069000 7226000 3049000 0 3009000 2269000 2771000 0 2675000 1935000 2650000 2650000 2424000 0 1918000 0 1805000 0 1745000 1414000 1636000 801000 1620000 0 1571000 4532000 1537000 0 1479000 4765000 1400000 0 1338000 0 1250000 0 1248000 0 1094000 0 1090000 573000 1034000 0 1004000 0 1000000 5000000 843000 828000 784000 0 525000 0 391000 0 327000 0 294000 0 144000 0 135000 0 0 23049000 0 12465000 0 5675000 0 4448000 0 3818000 0 2009000 0 2230000 323663000 226733000 40500000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 12. SLR Equipment Finance </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July 31, 2017, we acquired a 100% equity interest in NEF Holdings, LLC, which conducts its business through its wholly-owned subsidiary Nations Equipment Finance, LLC. Effective February 25, 2021, Nations Equipment Finance, LLC and its related companies are doing business as SLR Equipment Finance (“SLR Equipment”). SLR Equipment is an independent equipment finance company that provides senior secured loans and leases primarily to U.S. based companies. We invested $209,866 in cash to effect the transaction, of which $145,000 was invested in the equity of SLR Equipment through our wholly-owned consolidated taxable subsidiary NEFCORP LLC and our wholly-owned consolidated subsidiary NEFPASS LLC and $64,866 was used to purchase certain leases and loans held by SLR Equipment through NEFPASS LLC. Concurrent with the transaction, SLR Equipment refinanced its existing senior secured credit facility into a $150,000 <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse</div> facility with an accordion feature to expand up to $250,000. In September 2019, SLR Equipment amended the facility, increasing commitments to $213,957 with an accordion feature to expand up to $313,957 and extended the maturity date of the facility to July 31, 2023. </div> <div style="margin-top: 6pt; margin-bottom: 0pt; text-indent: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">As of December 31, 2022, SLR Equipment had 131 funded equipment-backed leases and loans to 59 different customers with a total net investment in leases and loans of approximately $190,830 on total assets of $241,813. As of December 31, 2021, SLR Equipment had 135 funded equipment-backed leases and loans to 61 different customers with a total net investment in leases and loans of approximately $210,986 on total assets of $264,007. As of December 31, 2022 and December 31, 2021, the largest position outstanding totaled $19,259 and $19,207, respectively. For the same periods, the average exposure per customer was $3,234 and $3,459, respectively. SLR Equipment’s credit facility, which is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse</div> to the Company, had approximately $114,977 and $118,002 of borrowings outstanding at December 31, 2022 and December 31, 2021, respectively. For the years ended December 31, 2022, 2021 and 2020, SLR Equipment had net losses of $2,867, $9,729 and $8,883, respectively on gross income of $20,380, $22,931 and $24,512, respectively. Due to timing and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> items, there may be material differences between GAAP net income and cash available for distributions. SLR Equipment’s consolidated financial statements for the fiscal years ended December 31, 2022 and <div style="letter-spacing: 0px; top: 0px;;display:inline;">December </div>31, 2021 <div style="letter-spacing: 0px; top: 0px;;display:inline;">are </div>attached as an exhibit to this annual report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K.</div> </div> 1 209866000 145000000 64866000 150000000 250000000 213957000 313957000 2023-07-31 131 59 190830000 241813000 135 61 210986000 264007000 19259000 19207000 3234000 3459000 114977000 118002000 2867000 9729000 8883000 20380000 22931000 24512000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 13. Capital Share Transactions </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December 31, 2022 and December 31, 2021, 200,000,000 shares of $0.01 par value capital stock were <div style="letter-spacing: 0px; top: 0px;;display:inline;">authorized</div>. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Transactions in capital stock were as follows:</div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:40%"/> <td style="vertical-align:bottom;width:10%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:9%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:10%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:9%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the year ended<br/> December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the year ended<br/> December 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the year ended<br/> December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the year ended<br/> December 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares issued in connection with the Mergers</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,511,825</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">226,839</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares repurchased</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(217,271</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,038</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net increase</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,294,554</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">223,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 200000000 200000000 0.01 0.01 <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Transactions in capital stock were as follows:</div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:40%"/> <td style="vertical-align:bottom;width:10%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:9%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:10%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:9%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the year ended<br/> December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the year ended<br/> December 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the year ended<br/> December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the year ended<br/> December 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares issued in connection with the Mergers</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,511,825</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">226,839</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares repurchased</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(217,271</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,038</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net increase</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,294,554</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">223,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 12511825 0 226839000 0 217271 0 3038000 0 12294554 0 223801000 0 <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 14. Kingsbridge Holdings, LLC </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November 3, 2020, the Company acquired 87.5% of the equity securities of Kingsbridge Holdings, LLC (“KBH”) through KBH Topco LLC (“KBHT”), a Delaware corporation. KBH is a residual focused independent <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">mid-ticket</div> lessor of equipment primarily to U.S. investment grade companies. The Company invested $216,596 to effect the transaction, of which $136,596 was invested to acquire 87.5% of KBHT’s equity and $80,000 in KBH’s debt. The existing management team of KBH committed to continuing to lead KBH after the transaction. Following the transaction, the Company owns 87.5% of KBHT equity and the KBH management team owns the remaining 12.5% of KBHT’s equity. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December 31, 2022 and December 31, 2021, KBHT had total assets of $777,151 and $738,425, respectively. For the same periods, debt recourse to KBHT totaled $222,094 and $216,881, respectively, and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse</div> debt totaled $353,128 and $323,844, respectively. None of the debt is recourse to the Company. For the years ended December 31, 2022, December 31, 2021 and for the period November 3, 2020 through December 31, 2020, KBHT had net income of $13,287, $12,151 and $2,170, respectively, on gross income of $298,760, $245,889 and $43,618, respectively. Due to timing and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us. KBHT’s consolidated financial statements for the fiscal years ended December 31, 2022 and December 31, 2021 are attached as an exhibit to this annual <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">report </div></div>on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10<div style="letter-spacing: 0px; top: 0px;;display:inline;">-</div>K.</div> </div> 0.875 216596000 136596000 0.875 80000000 0.875 0.125 777151000 738425000 222094000 216881000 353128000 323844000 13287000 12151000 2170000 298760000 245889000 43618000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 15. SLR Healthcare ABL </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SUNS acquired an equity interest in SLR Healthcare ABL, f/k/a Gemino Healthcare Finance, LLC (“SLR Healthcare”) on September 30, 2013. SLR Healthcare is a commercial finance company that originates, underwrites, and manages primarily secured, asset-based loans for small and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">mid-sized</div> companies operating in the healthcare industry. SUNS initial investment in SLR Healthcare ABL was $32,839. The management team of SLR Healthcare <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">co-invested</div> in the transaction and continues to lead SLR Healthcare. As of September 30, 2022, SLR Healthcare’s management team and the Company own approximately 7% and 93% of the equity in SLR Healthcare, respectively. SLRC acquired SLR Healthcare in connection with the Mergers on April 1, 2022. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Concurrent with the closing of the transaction, SLR Healthcare entered into a new, four-year, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse,</div> $100,000 credit facility with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-affiliates,</div> which was expandable to $150,000 under its accordion feature. Effective March 31, 2014, the credit facility was expanded to $105,000 and again on June 27, 2014 to $110,000. On May 27, 2016, SLR Healthcare entered into a new $125,000 credit facility which replaced the previously existing facility. The new facility has similar terms as compared to the previous facility and includes an accordion feature increase to $200,000 and had a maturity date of May 27, 2020. On June 28, 2019, this $125,000 facility was amended, extending the maturity date to June 28, 2023. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SLR Healthcare currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of December 31, 2022, the portfolio totaled approximately $242,106 of commitments with a total net investment in loans of $92,383 on total assets of $108,705. As of December 31, 2021, the portfolio totaled approximately $183,501 of commitments with a total net investment in loans of $81,604 on total assets of $91,275. At December 31, 2022, the portfolio consisted of 41 issuers with an average balance of approximately $2,253 versus 36 issuers with an average balance of approximately $2,267 at December 31, 2021. All of the commitments in SLR Healthcare’s portfolio are floating-rate, senior-secured, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">cash-pay</div> loans. SLR Healthcare’s credit facility, which is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse</div> to us, had approximately $77,000 and $60,000 of borrowings outstanding at December 31, 2022 and December 31, 2021, respectively. For the years ended December 31, 2022, 2021 and 2020, SLR Healthcare had net income of $3,475, $662 and $4,289, respectively, on gross income of $11,593, $10,052 and $10,367, respectively. Due to timing and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> items, there may be material differences between GAAP net income and cash available for distributions. SLR Healthcare’s consolidated financial statements for the fiscal years ended December 31, 2022 and December 31, 2021 are attached as an exhibit to this annual report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K.</div> </div> 32839000 0.07 0.93 P4Y 100000000 150000000 105000000 110000000 125000000 200000000 2020-05-27 125000000 2023-06-28 242106000 92383000 108705000 183501000 81604000 91275000 41 2253000 36 2267000 77000000 60000000 3475000 662000 4289000 11593000 10052000 10367000 <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 16. SLR Business Credit </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SUNS acquired 100% of the equity interests of North Mill Capital LLC (“NMC”) on October 20, 2017. NMC is a leading asset-backed lending commercial finance company that provides senior secured asset-backed financings to U.S. based <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">small-to-medium-sized</div></div></div> businesses primarily in the manufacturing, services and distribution industries. SUNS invested approximately $51,000 to effect the transaction. Subsequently, SUNS contributed 1% of its equity interest in NMC to ESP SSC Corporation. Immediately thereafter, SUNS and ESP SSC Corporation contributed their equity interests to NorthMill LLC (“North Mill”). On May 1, 2018, North Mill merged with and into NMC, with NMC being the surviving company. SUNS and ESP SSC Corporation then owned 99% and 1% of the equity interests of NMC, respectively. The management team of NMC continues to lead NMC. On June 28, 2019, North Mill Holdco LLC (“NM Holdco”), a newly formed entity and ESP SSC Corporation acquired 100% of Summit Financial Resources, a Salt Lake City-based provider of asset-backed financing to small and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">medium-sized</div> businesses. As part of this transaction, SUNS 99% interest in the equity of NMC was contributed to NM Holdco. This approximately $15,500 transaction was financed with borrowings on NMC’s credit facility. Effective February 25, 2021, NMC and its related companies are doing business as SLR Business Credit. On June 3, 2021, NMC acquired 100% of Fast Pay Partners LLC, a Los Angeles-based provider of asset-backed financing to digital media companies. The transaction purchase price of $66,671 was financed with equity from SUNS of $19,000 and borrowings on NMC’s credit facility of $47,671. SLRC acquired SLR Business Credit in connection with the Mergers on April 1, 2022. </div> <div style="margin-top: 6pt; margin-bottom: 0pt; text-indent: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">SLR Business Credit currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of December 31, 2022, the portfolio totaled approximately $603,432 of commitments, of which $286,006 were funded, on total assets of $332,247. As of December 31, 2021, the portfolio totaled approximately $513,869 of commitments, of which $248,652 were funded, on total assets of $290,794. At December 31, 2022, the portfolio consisted of 108 issuers with an average balance of approximately $2,648 versus 125 issuers with an average balance of approximately $1,989 at December 31, 2021. NMC has a senior credit facility with a bank lending group for $285,307<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">which expires on</div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div>November 13, 2025<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">. Borrowings are secured by substantially all of NMC’s assets. NMC’s credit facility, which is </div><div style="font-size: 10pt; white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse</div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> to us, had</div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">approximately $</div>214,425 <div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">and $</div>183,252 <div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">of borrowings outstanding at December 31, 2022 and December 31, 2021, respectively. For the years ended December 31, 2022, 2021 and 2020, SLR Business Credit had net income of $</div>3,941<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">, $</div>7,295 <div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">and $</div>4,512<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">, respectively, on gross income of $</div>29,433<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">, $</div>24,021 <div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">and $</div>19,715<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">, respectively. Due to timing and </div><div style="font-size: 10pt; white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Business Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Business Credit will be able to maintain consistent dividend payments to us. SLR Business Credit’s consolidated financial statements for the fiscal years ended December 31, 2022 and December 31, 2021 are attached as an exhibit to this annual </div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">report </div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">on Form </div><div style="font-size: 10pt; white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K.</div></div> 1 51000000 0.01 0.99 0.01 1 0.99 15500000 1 66671000 19000000 47671000 603432000 286006000 332247000 513869000 248652000 290794000 108 2648000 125 1989000 285307000 2025-11-13 214425000 183252000 3941000 7295000 4512000 29433000 24021000 19715000 <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 17. Merger with SUNS </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On April 1, 2022, the Company completed its previously announced acquisition of SUNS. Pursuant to the Merger Agreement, Merger Sub was first merged with and into SUNS, with SUNS as the surviving corporation, and, immediately following the Merger, SUNS was then merged with and into the Company, with the Company as the surviving company. In accordance with the terms of the Merger Agreement, at the effective time of the Mergers, each outstanding share of SUNS’s common stock was converted into the right to receive 0.7796 shares of the Company’s common stock (with SUNS’s stockholders receiving cash in lieu of fractional shares of the Company’s common stock). As a result of the Mergers, the Company issued an aggregate of 12,511,825 shares of its common stock to former SUNS stockholders. </div> <div style="margin-top: 6pt; margin-bottom: 0pt; text-indent: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">The Mergers are accounted for as an asset acquisition of SUNS by the Company in accordance with the asset acquisition method of accounting as detailed in ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">805-50,</div> Business Combinations – Related Issues, with the fair value of total consideration paid in conjunction with the Mergers allocated to the assets acquired and liabilities assumed based on their relative fair values as of the date of the Mergers. Generally, under asset acquisition accounting, acquiring assets in groups not only requires ascertaining the cost of the asset (or net assets), but also allocating that cost to the individual assets (or individual assets and liabilities) that make up the group. The cost of the group of assets acquired in an asset acquisition is allocated to the individual assets acquired or liabilities assumed based on their relative fair values of net identifiable assets acquired other than certain <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">“non-qualifying”</div> assets (for example cash) and does not give rise to goodwill. The Company is the accounting survivor of the Mergers. The Mergers were considered a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">tax-free</div> reorganization and the historical cost basis of the acquired SUNS investments are carried forward for tax purposes. Prior to the Mergers, SUNS was also managed by the Investment Adviser. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Mergers:</div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:87%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common stock issued by the Company<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">227,602</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Assets acquired:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investments, at fair value</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">400,105</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,313</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other assets</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,662</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total assets acquired</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">407,080</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Liabilities assumed:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Debt, at fair value</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">159,816</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other liabilities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,573</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total liabilities assumed</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">162,389</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net assets acquired</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">244,691</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total purchase discount</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(17,089</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Based on the market price at closing of $18.13, adjusted for transaction costs. </div> </td> </tr> </table> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Letter Agreement </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On April 1, 2022, in connection with the consummation of the Mergers, the Company entered into a letter agreement (the “Letter Agreement”) pursuant to which the Investment Adviser voluntarily agreed to a permanent 25 basis point reduction of the annual base management fee rate payable by the Company to the Investment Adviser pursuant to the Advisory Agreement, resulting in an annual base management fee rate payable by the Company to the Investment Adviser of 1.50% on gross assets up to 200% of the Company’s total net assets. The Company retained the annual base management fee rate payable by the Company to the Investment Adviser of 1.00% on gross assets that exceed 200% of the Company’s total net assets. </div> 0.7796 12511825 The following table summarizes the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Mergers:<div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:87%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common stock issued by the Company<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">227,602</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Assets acquired:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investments, at fair value</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">400,105</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,313</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other assets</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,662</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total assets acquired</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">407,080</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Liabilities assumed:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Debt, at fair value</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">159,816</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other liabilities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,573</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total liabilities assumed</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">162,389</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net assets acquired</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">244,691</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total purchase discount</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(17,089</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Based on the market price at closing of $18.13, adjusted for transaction costs. </div> </td> </tr> </table> 227602000 400105000 2313000 4662000 407080000 159816000 2573000 162389000 244691000 -17089000 18.13 25 0.015 2 0.01 2 <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 18. Stock Repurchase Program</div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May 3, 2022, our Board authorized a program for the purpose of repurchasing up to $50,000 of our outstanding shares of common stock. Under the repurchase program, we may, but are not obligated to, repurchase shares of our outstanding common stock in the open market from time to time provided that we comply with our code of ethics and the guidelines specified in Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10b-18</div> of the 1934 Act, including certain price, market volume and timing constraints. In addition, any repurchases will be conducted in accordance with the 1940 Act. Unless amended or extended by our Board, we expect the repurchase program to be in place until the earlier of May 1, 2023 or until $50,000 of our outstanding shares of common stock have been repurchased. The timing and number of shares to be repurchased will depend on a number of factors, including market conditions. There are no assurances that we will engage in any repurchases beyond what is reported herein. During the fiscal year ended December 31, 2022, the Company repurchased 217,271 shares at an average price of approximately $13.98 per share, inclusive of commissions. The total dollar amount of shares repurchased was $3,038. </div> 50000000 2023-05-01 217271 13.98 3038000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 19. SLR Senior Lending Program LLC </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October 12, 2022, the Company entered into an amended and restated limited liability company agreement with Sunstone Senior Credit L.P. (the “Investor”) to create a joint venture vehicle, SLR Senior Lending Program LLC (“SSLP”). SSLP is expected to invest primarily in senior secured cash flow loans. The Company and the Investor each have made initial equity commitments of $50,000, resulting in a total equity commitment of $100,000. Investment decisions and all material decisions in respect of SSLP must be approved by representatives of the Company and the Investor. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December 1, 2022, SSLP commenced operations. On December 12, 2022, SSLP as servicer and SLR Senior Lending Program SPV LLC (“SSLP SPV”), a newly formed wholly owned subsidiary of SSLP, as borrower entered into a $100,000 senior secured revolving credit facility (the “SSLP Facility”) with Goldman Sachs Bank USA acting as administrative agent. The SSLP Facility is scheduled to mature on December 12, 2027. The SSLP Facility generally bears interest at a rate of SOFR plus 3.25%. SSLP and SSLP SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SSLP Facility also includes usual and customary events of default for credit facilities of this nature. There were no borrowings during the period December 12, 2022 to December 31, 2022. As of December 31, 2022 the Company and the Investor had contributed combined equity capital in the amount of $19,000. As of December 31, 2022, the Company and the Investors’ remaining commitments to SSLP totaled $40,500 and $40,500, respectively. The Company, along with the Investor, controls the funding of SSLP and SSLP may not call the unfunded commitments of the Company or the Investor without the approval of both the Company and the Investor. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December 31, 2022, SSLP had total assets of $19,105. SSLP’s portfolio consisted of floating rate senior secured loans to seven (7) different borrowers. For the period December 1, 2022 (commencement of operations) through December 31, 2022, SSLP invested $18,100 in seven (7) portfolio companies. Investments prepaid totaled $68 for the same period.</div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"><div style="display:inline;">SSLP Portfolio as of December 31, 2022 </div> </div></div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:39%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Description</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Industry</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Spread<br/> Above<br/> Index<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Floor</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Interest<br/> Rate<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(2)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Maturity<br/> Date</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Par<br/> Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair<br/> Value<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(3)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Atria Wealth Solutions, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">Diversified Financial<br/> Services</td> <td style="white-space:nowrap;vertical-align:bottom"> <br/>  </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.84</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2/29/24</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">BayMark Health Services, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">Health Care Providers &amp;<br/> Services</td> <td style="white-space:nowrap;vertical-align:bottom"> <br/>  </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.73</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6/11/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ENS Holdings III Corp. &amp; ES Opco USA LLC <div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">Trading Companies &amp;<br/> Distributors</td> <td style="white-space:nowrap;vertical-align:bottom"> <br/>  </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+475</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.43</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12/31/25</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,097</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,097</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,097</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foundation Consumer Brands, LLC <div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">Personal Products</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+550</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.15</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2/12/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,963</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,963</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,963</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">High Street Buyer, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">Insurance</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.73</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4/16/28</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ivy Fertility Services, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">Health Care Providers &amp;<br/> Services</td> <td style="white-space:nowrap;vertical-align:bottom"> <br/>  </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.39</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2/25/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,030</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Kid Distro Holdings, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">Software</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+575</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.48</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10/1/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 18,032</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 18,062</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or SOFR. These instruments are typically subject to a LIBOR or SOFR floor. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Floating rate debt investments typically bear interest at a rate determined by reference to either the LIBOR (“L”) or SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(4)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company also holds this security on its Consolidated Statements of Assets and Liabilities. </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Below is certain summarized financial information for SSLP as of December 31, 2022 and for the period December 1, 2022 (commencement of operations) through December 31, 2022: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:85%"/> <td style="vertical-align:bottom;width:8%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Selected Balance Sheet Information for SSLP:</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investments at fair value (cost $18,032)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,062</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash and other assets</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,043</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total assets</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,105</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Debt outstanding</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest payable and other credit facility related expenses</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">165</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued expenses and other payables</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">89</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total liabilities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">254</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Members’ equity</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,851</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total liabilities and members’ equity</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,105</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:79%"/> <td style="vertical-align:bottom;width:16%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Period<br/>December 1, 2022<br/>(commencement of<br/>operations) through<br/>December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Selected Income Statement Information for SSLP:</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest income</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service fees*</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest and other credit facility expenses</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">166</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Organizational costs</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">73</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other general and administrative expenses</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">88</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total expenses</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">331</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment loss</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(179</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Realized gain on investments</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized gain on investments</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized and unrealized gain on investments</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(149</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%;text-indent: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">*</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Service fees are included within the Company’s Consolidated Statements of Operations as other income. </div> </td> </tr> </table> 50000000 50000000 100000000 100000000 2027-12-12 0.0325 0 19000000 40500000 40500000 <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December 31, 2022, SSLP had total assets of $19,105. SSLP’s portfolio consisted of floating rate senior secured loans to seven (7) different borrowers. For the period December 1, 2022 (commencement of operations) through December 31, 2022, SSLP invested $18,100 in seven (7) portfolio companies. Investments prepaid totaled $68 for the same period.</div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"><div style="display:inline;">SSLP Portfolio as of December 31, 2022 </div> </div></div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:39%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Description</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Industry</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Spread<br/> Above<br/> Index<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Floor</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Interest<br/> Rate<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(2)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Maturity<br/> Date</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Par<br/> Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair<br/> Value<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(3)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Atria Wealth Solutions, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">Diversified Financial<br/> Services</td> <td style="white-space:nowrap;vertical-align:bottom"> <br/>  </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.84</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2/29/24</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">BayMark Health Services, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">Health Care Providers &amp;<br/> Services</td> <td style="white-space:nowrap;vertical-align:bottom"> <br/>  </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.73</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6/11/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ENS Holdings III Corp. &amp; ES Opco USA LLC <div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">Trading Companies &amp;<br/> Distributors</td> <td style="white-space:nowrap;vertical-align:bottom"> <br/>  </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+475</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.43</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12/31/25</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,097</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,097</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,097</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foundation Consumer Brands, LLC <div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">Personal Products</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+550</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.15</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2/12/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,963</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,963</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,963</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">High Street Buyer, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">Insurance</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.73</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4/16/28</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ivy Fertility Services, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">Health Care Providers &amp;<br/> Services</td> <td style="white-space:nowrap;vertical-align:bottom"> <br/>  </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.39</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2/25/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,030</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Kid Distro Holdings, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">Software</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+575</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.48</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10/1/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 18,032</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 18,062</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or SOFR. These instruments are typically subject to a LIBOR or SOFR floor. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Floating rate debt investments typically bear interest at a rate determined by reference to either the LIBOR (“L”) or SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(4)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company also holds this security on its Consolidated Statements of Assets and Liabilities. </div> </td> </tr> </table> 19105000 18100000 68000 S+600 0.01 0.1084 2024-02-29 2494000 2494000 2494000 L+500 0.01 0.0973 2027-06-11 2992000 2992000 2992000 L+475 0.01 0.0943 2025-12-31 1097000 1097000 1097000 L+550 0.01 0.1015 2027-02-12 2963000 2963000 2963000 L+600 0.0075 0.1073 2028-04-16 2494000 2494000 2494000 L+625 0.01 0.1039 2026-02-25 3000000 3000000 3030000 L+575 0.01 0.1048 2027-10-01 2992000 2992000 2992000 18032000 18062000 <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Below is certain summarized financial information for SSLP as of December 31, 2022 and for the period December 1, 2022 (commencement of operations) through December 31, 2022: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:85%"/> <td style="vertical-align:bottom;width:8%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Selected Balance Sheet Information for SSLP:</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investments at fair value (cost $18,032)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,062</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash and other assets</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,043</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total assets</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,105</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Debt outstanding</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest payable and other credit facility related expenses</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">165</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued expenses and other payables</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">89</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total liabilities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">254</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Members’ equity</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,851</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total liabilities and members’ equity</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,105</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:79%"/> <td style="vertical-align:bottom;width:16%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Period<br/>December 1, 2022<br/>(commencement of<br/>operations) through<br/>December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Selected Income Statement Information for SSLP:</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest income</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service fees*</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest and other credit facility expenses</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">166</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Organizational costs</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">73</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other general and administrative expenses</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">88</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total expenses</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">331</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment loss</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(179</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Realized gain on investments</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized gain on investments</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized and unrealized gain on investments</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(149</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%;text-indent: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">*</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Service fees are included within the Company’s Consolidated Statements of Operations as other income. </div> </td> </tr> </table> 18062000 1043000 19105000 0 165000 89000 254000 18851000 19105000 152000 4000 166000 73000 88000 331000 -179000 0 30000 30000 -149000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">Note 20. Subsequent Events </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has evaluated the need for disclosures and/or adjustments resulting from subsequent events through the date the consolidated financial statements were issued. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January 10, 2023, the Board declared <div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 4%; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; top: 0px;;display:inline;">a monthly distribution</div> <div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 4%; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; top: 0px; display: inline !important;;display:inline;"/> of $0.136667 per share payable on February 2, 2023 to holders of record as of January 26, 2023. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February 2, 2023, the Board declared <div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 4%; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; top: 0px;;display:inline;">a monthly distribution of</div> $0.136667 per share payable on March 1, 2023 to holders of record as of February 16, 2023. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February 28, 2023, the Board declared <div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 4%; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; top: 0px;;display:inline;">a monthly distribution</div> of $0.136667 per share payable on April 4, 2023 to holders of record as of March 23, 2023. </div> 0.136667 0.136667 0.136667 Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SUNS SPV LLC (the “SUNS SPV”). Such investments are pledged as collateral under the Senior Secured Revolving SPV Credit Facility (the “SPV Credit Facility”) (see Note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company. Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR, SOFR or PRIME rate. These instruments are often subject to a LIBOR, SOFR or PRIME rate floor. Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2021, on a fair value basis, non-qualifying assets in the portfolio represented 23.1% of the total assets of the Company. Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2022 in these controlled investments are as follows: AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers. Amerimark may elect to defer up to 8.00% of the coupon as PIK. Investment is on non-accrual status. Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2021 in these controlled investments are as follows: Interest is paid in kind (“PIK”). Spread is 5.75% Cash / 0.50% PIK. Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR” or “L”), the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of December 31, 2022. Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of December 31, 2021. OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are co-borrowers. Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or PRIME rate. These instruments are often subject to a LIBOR or PRIME rate floor. SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary and NEFPASS LLC, a wholly-owned consolidated subsidiary. Non-income producing security. AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers. Indicates an investment that is wholly held by the Company through NEFPASS LLC. Denotes a subsidiary of SLR Equipment Finance. Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2022, on a fair value basis, non-qualifying assets in the portfolio represented 24.2% of the total assets of the Company. BridgeBio Pharma, Inc. may elect to defer up to 3.00% of the coupon as PIK. Vapotherm, Inc. may elect to defer up to 8.00% of the coupon as PIK. OmniGuide Holdings, Inc. may elect to defer up to 10.00% of the coupon as PIK. The Company’s investment in SOINT, LLC includes a one dollar investment in common shares. The Company’s investments in SOAGG, LLC and SOINT, LLC include a two and one dollar investment in common shares, respectively. Denotes a Level 1 investment. Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation. Spread is 2.50% Cash / 12.50% PIK. Spread is 5.50% Cash / 0.50% PIK. Spread is 6.00% Cash / 2.00% PIK. See note 12 to the consolidated financial statements. See note 19 to the consolidated financial statements. See note 15 to the consolidated financial statements. See note 10 to the consolidated financial statements. See note 16 to the consolidated financial statements. See note 14 to the consolidated financial statements. The Company controls the funding of the SLR Credit Solutions and SLR Healthcare ABL commitments and may cancel them at its discretion. In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP. See Note 19 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members. On April 1, 2022, in connection with the Mergers (as defined in Note 1 “Organization”), the Company acquired net assets of $244,691 for the total stock consideration of $226,839. For further details, refer to Note 17 “Merger with SUNS”. Based on the market price at closing of $18.13, adjusted for transaction costs. The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of December 31, 2022, asset coverage was 191.5%. The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it. Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented. NAV per share is determined as of the last day in the relevant quarter and therefore may not reflect the NAV per share on the date of the high and low sales prices. The net asset values shown are based on outstanding shares at the end of each period. Calculated as of the respective high or low closing price divided by NAV and subtracting 1. Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014 and 2013 periods was $100,175, $98,196, $94,301 and $93,392, respectively. Service fees are included within the Company’s Consolidated Statements of Operations as other income. In the event that the shares of common stock are sold to or through underwriters, a corresponding prospectus supplement will disclose the applicable sales load and the “Example” will be updated accordingly. The prospectus supplement corresponding to each offering will disclose the applicable offering expenses and total stockholder transaction expenses. The expenses of the dividend reinvestment plan are included in “other expenses.” Our 1.50% base management fee under the Investment Advisory and Management Agreement (giving effect to the Letter Agreement) is based on our gross assets, which is defined as all the assets of SLRC, excluding temporary assets, including those acquired using borrowings for investment purposes, and assumes our gross assets remain consistent with gross assets for the fiscal year ended December 31, 2022. The base management fee is reduced to 1.00% on gross assets that exceed 200% of total net assets as of the immediately preceding quarter. Assumes that annual incentive fees earned by our investment adviser, SLR Capital Partners, remain consistent with the incentive fees earned by SLR Capital Partners for the fiscal year ended December 31, 2022. We have historically and will in the future borrow funds from time to time to make investments to the extent we determine that the economic situation is conducive to doing so. The costs associated with our outstanding borrowings are indirectly borne by our investors. For purposes of this section, we have computed interest expense using the average consolidated balance outstanding for borrowings during the fiscal year ended December 31, 2022. We used the Secured Overnight Financing Rate (“SOFR”) or similar base rate on December 31, 2022 and the interest rate on the Credit Facility, the SPV Credit Facility, the 2027 Series F Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes, the 2024 Unsecured Notes and the 2023 Unsecured Notes on December 31, 2022. We have also included, as applicable, the estimated market discount or amortization of fees incurred in establishing the Credit Facility, the SPV Credit Facility, the 2027 Series F Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes, the 2024 Unsecured Notes and the 2023 Unsecured Notes as of December 31, 2022. Additionally, we included the estimated cost of commitment fees for unused balances on the Credit Facility and the SPV Credit Facility. As of December 31, 2022, we had $393.0 million outstanding under the Credit Facility, $155.2 million outstanding under the SPV Credit Facility and $135 million, $50 million, $75 million, $125 million, $85 million, and $75 million outstanding under the 2027 Series F Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes, the 2024 Unsecured Notes and the 2023 Unsecured Notes, respectively. We may also issue preferred stock, subject to our compliance with applicable requirements under the 1940 Act, although we have no immediate intention to do so. The holders of shares of our common stock indirectly bear the expenses of our investment in SLR Senior Lending Program LLC (“SSLP”). No management fee is charged on our investments in SSLP in connection with the administrative services provided to SSLP. Future expenses for SSLP may be substantially higher or lower because certain expenses may fluctuate over time. “Other expenses” are based on estimated amounts for the current fiscal year, which considers the amounts incurred for the fiscal year ended December 31, 2022 and include our overhead expenses, including payments under our Administration Agreement based on our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement. EXCEL 114 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 115 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 116 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 117 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 1371 389 1 true 361 0 false 11 false false R1.htm 1001 - Document - Cover Page Sheet http://www.slrinvestments.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - Consolidated Statements of Assets And Liabilities Sheet http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities Consolidated Statements of Assets And Liabilities Statements 2 false false R3.htm 1003 - Statement - Consolidated Statements of Assets And Liabilities (Parenthetical) Sheet http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical Consolidated Statements of Assets And Liabilities (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - Consolidated Statements of Operations Sheet http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 1005 - Statement - Consolidated Statements of Changes In Net Assets Sheet http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets Consolidated Statements of Changes In Net Assets Statements 5 false false R6.htm 1006 - Statement - Consolidated Statements of Cash Flows Sheet http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 1007 - Statement - Consolidated Statements of Cash Flows (Parenthetical) Sheet http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlowsParenthetical Consolidated Statements of Cash Flows (Parenthetical) Statements 7 false false R8.htm 1008 - Statement - Consolidated Schedule of Investments Sheet http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments Consolidated Schedule of Investments Statements 8 false false R9.htm 1009 - Statement - Consolidated Schedule of Investments (Parenthetical) Sheet http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical Consolidated Schedule of Investments (Parenthetical) Statements 9 false false R10.htm 995470 - Disclosure - N-2 Sheet http://xbrl.sec.gov/cef/role/N2 N-2 Notes 10 false false R11.htm 999001 - Disclosure - Organization Sheet http://www.slrinvestments.com/role/Organization Organization Notes 11 false false R12.htm 999002 - Disclosure - Significant Accounting Policies Sheet http://www.slrinvestments.com/role/SignificantAccountingPolicies Significant Accounting Policies Notes 12 false false R13.htm 999003 - Disclosure - Agreements Sheet http://www.slrinvestments.com/role/Agreements Agreements Notes 13 false false R14.htm 999004 - Disclosure - Net Asset Value Per Share Sheet http://www.slrinvestments.com/role/NetAssetValuePerShare Net Asset Value Per Share Notes 14 false false R15.htm 999005 - Disclosure - Earnings Per Share Sheet http://www.slrinvestments.com/role/EarningsPerShare Earnings Per Share Notes 15 false false R16.htm 999006 - Disclosure - Fair Value Sheet http://www.slrinvestments.com/role/FairValue Fair Value Notes 16 false false R17.htm 999007 - Disclosure - Debt Sheet http://www.slrinvestments.com/role/Debt Debt Notes 17 false false R18.htm 999008 - Disclosure - Income Tax Information and Distributions to Stockholders and Other Tax Information Sheet http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformation Income Tax Information and Distributions to Stockholders and Other Tax Information Notes 18 false false R19.htm 999009 - Disclosure - Financial Highlights Sheet http://www.slrinvestments.com/role/FinancialHighlights Financial Highlights Notes 19 false false R20.htm 999010 - Disclosure - SLR Credit Solutions Sheet http://www.slrinvestments.com/role/SlrCreditSolutions SLR Credit Solutions Notes 20 false false R21.htm 999011 - Disclosure - Commitments and Contingencies Sheet http://www.slrinvestments.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 21 false false R22.htm 999012 - Disclosure - SLR Equipment Finance Sheet http://www.slrinvestments.com/role/SlrEquipmentFinance SLR Equipment Finance Notes 22 false false R23.htm 999013 - Disclosure - Capital Share Transactions Sheet http://www.slrinvestments.com/role/CapitalShareTransactions Capital Share Transactions Notes 23 false false R24.htm 999014 - Disclosure - Kingsbridge Holdings, LLC Sheet http://www.slrinvestments.com/role/KingsbridgeHoldingsLlc Kingsbridge Holdings, LLC Notes 24 false false R25.htm 999015 - Disclosure - SLR Healthcare ABL Sheet http://www.slrinvestments.com/role/SlrHealthcareAbl SLR Healthcare ABL Notes 25 false false R26.htm 999016 - Disclosure - SLR Business Credit Sheet http://www.slrinvestments.com/role/SlrBusinessCredit SLR Business Credit Notes 26 false false R27.htm 999017 - Disclosure - Merger with SUNS Sheet http://www.slrinvestments.com/role/MergerWithSuns Merger with SUNS Notes 27 false false R28.htm 999018 - Disclosure - Stock Repurchase Program Sheet http://www.slrinvestments.com/role/StockRepurchaseProgram Stock Repurchase Program Notes 28 false false R29.htm 999019 - Disclosure - SLR Senior Lending Program LLC Sheet http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlc SLR Senior Lending Program LLC Notes 29 false false R30.htm 999020 - Disclosure - Subsequent Events Sheet http://www.slrinvestments.com/role/SubsequentEvents Subsequent Events Notes 30 false false R31.htm 999021 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.slrinvestments.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://www.slrinvestments.com/role/SignificantAccountingPolicies 31 false false R32.htm 999022 - Disclosure - Earnings Per Share (Tables) Sheet http://www.slrinvestments.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.slrinvestments.com/role/EarningsPerShare 32 false false R33.htm 999023 - Disclosure - Fair Value (Tables) Sheet http://www.slrinvestments.com/role/FairValueTables Fair Value (Tables) Tables http://www.slrinvestments.com/role/FairValue 33 false false R34.htm 999024 - Disclosure - Debt (Tables) Sheet http://www.slrinvestments.com/role/DebtTables Debt (Tables) Tables http://www.slrinvestments.com/role/Debt 34 false false R35.htm 999025 - Disclosure - Income Tax Information and Distributions to Stockholders and Other Tax Information (Tables) Sheet http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationTables Income Tax Information and Distributions to Stockholders and Other Tax Information (Tables) Tables http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformation 35 false false R36.htm 999026 - Disclosure - Financial Highlights (Tables) Sheet http://www.slrinvestments.com/role/FinancialHighlightsTables Financial Highlights (Tables) Tables http://www.slrinvestments.com/role/FinancialHighlights 36 false false R37.htm 999027 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.slrinvestments.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.slrinvestments.com/role/CommitmentsAndContingencies 37 false false R38.htm 999028 - Disclosure - Capital Share Transactions (Tables) Sheet http://www.slrinvestments.com/role/CapitalShareTransactionsTables Capital Share Transactions (Tables) Tables http://www.slrinvestments.com/role/CapitalShareTransactions 38 false false R39.htm 999029 - Disclosure - Merger with SUNS (Tables) Sheet http://www.slrinvestments.com/role/MergerWithSunsTables Merger with SUNS (Tables) Tables http://www.slrinvestments.com/role/MergerWithSuns 39 false false R40.htm 999030 - Disclosure - SLR Senior Lending Program LLC (Tables) Sheet http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcTables SLR Senior Lending Program LLC (Tables) Tables http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlc 40 false false R41.htm 999031 - Disclosure - Organization - Additional Information (Details) Sheet http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails Organization - Additional Information (Details) Details 41 false false R42.htm 999032 - Disclosure - Significant Accounting Policies - Additional Information (Details) Sheet http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails Significant Accounting Policies - Additional Information (Details) Details 42 false false R43.htm 999033 - Disclosure - Agreements - Additional Information (Details) Sheet http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails Agreements - Additional Information (Details) Details 43 false false R44.htm 999034 - Disclosure - Net Asset Value Per Share - Additional Information (Details) Sheet http://www.slrinvestments.com/role/NetAssetValuePerShareAdditionalInformationDetails Net Asset Value Per Share - Additional Information (Details) Details 44 false false R45.htm 999035 - Disclosure - Earnings Per Share - Summary of Computation of Basic and Diluted Net (Detail) Sheet http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetail Earnings Per Share - Summary of Computation of Basic and Diluted Net (Detail) Details 45 false false R46.htm 999036 - Disclosure - Fair Value - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails Fair Value - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Details 46 false false R47.htm 999037 - Disclosure - Fair Value - Summary of Changes in Fair Value of Level 3 Assets and Liabilities (Details) Sheet http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails Fair Value - Summary of Changes in Fair Value of Level 3 Assets and Liabilities (Details) Details 47 false false R48.htm 999038 - Disclosure - Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Details) Sheet http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Details) Details 48 false false R49.htm 999039 - Disclosure - Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Parenthetical) (Details) Sheet http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Parenthetical) (Details) Details 49 false false R50.htm 999040 - Disclosure - Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Details) Sheet http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Details) Details 50 false false R51.htm 999041 - Disclosure - Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Parenthetical) (Details) Sheet http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Parenthetical) (Details) Details 51 false false R52.htm 999042 - Disclosure - Debt - Schedule of Long-term Debt Instruments (Details) Sheet http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails Debt - Schedule of Long-term Debt Instruments (Details) Details 52 false false R53.htm 999043 - Disclosure - Debt - Schedule of Long-term Debt Instruments (Parenthetical) (Details) Sheet http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails Debt - Schedule of Long-term Debt Instruments (Parenthetical) (Details) Details 53 false false R54.htm 999044 - Disclosure - Debt - Additional Information (Details) Sheet http://www.slrinvestments.com/role/DebtAdditionalInformationDetails Debt - Additional Information (Details) Details 54 false false R55.htm 999045 - Disclosure - Income Tax Information and Distributions to Stockholders and Other Tax Information - Summary of distributions to shareholders (Details) Sheet http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfDistributionsToShareholdersDetails Income Tax Information and Distributions to Stockholders and Other Tax Information - Summary of distributions to shareholders (Details) Details 55 false false R56.htm 999046 - Disclosure - Income Tax Information and Distributions to Stockholders and Other Tax Information - Summary of total accumulated earnings (loss) on a tax basis (Details) Sheet http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfTotalAccumulatedEarningsLossOnATaxBasisDetails Income Tax Information and Distributions to Stockholders and Other Tax Information - Summary of total accumulated earnings (loss) on a tax basis (Details) Details 56 false false R57.htm 999047 - Disclosure - Income Tax Information and Distributions to Stockholders and Other Tax Information - Additional information (Details) Sheet http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationAdditionalInformationDetails Income Tax Information and Distributions to Stockholders and Other Tax Information - Additional information (Details) Details 57 false false R58.htm 999048 - Disclosure - Financial Highlights - Schedule of Financial Highlights (Details) Sheet http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails Financial Highlights - Schedule of Financial Highlights (Details) Details 58 false false R59.htm 999049 - Disclosure - Financial Highlights - Schedule of Financial Highlights (Parentheticals) (Details) Sheet http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsParentheticalsDetails Financial Highlights - Schedule of Financial Highlights (Parentheticals) (Details) Details 59 false false R60.htm 999050 - Disclosure - SLR Credit Solutions - Additional Information (Details) Sheet http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails SLR Credit Solutions - Additional Information (Details) Details 60 false false R61.htm 999051 - Disclosure - Commitments and Contingencies - Additional Information (Details) Sheet http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails Commitments and Contingencies - Additional Information (Details) Details 61 false false R62.htm 999052 - Disclosure - Commitments and Contingencies - Summary of Unfunded Debt and Equity Commitments (Details) Sheet http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails Commitments and Contingencies - Summary of Unfunded Debt and Equity Commitments (Details) Details 62 false false R63.htm 999053 - Disclosure - SLR Equipment Finance - Additional Information (Details) Sheet http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails SLR Equipment Finance - Additional Information (Details) Details 63 false false R64.htm 999054 - Disclosure - Capital Share Transactions - Additional Information (Details) Sheet http://www.slrinvestments.com/role/CapitalShareTransactionsAdditionalInformationDetails Capital Share Transactions - Additional Information (Details) Details 64 false false R65.htm 999055 - Disclosure - Capital Share Transactions - Summary of Transactions In Capital Stock (Details) Sheet http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails Capital Share Transactions - Summary of Transactions In Capital Stock (Details) Details 65 false false R66.htm 999056 - Disclosure - Kingsbridge Holdings, LLC - Additional Information (Details) Sheet http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails Kingsbridge Holdings, LLC - Additional Information (Details) Details 66 false false R67.htm 999057 - Disclosure - SLR Healthcare ABL - Additional Information (Details) Sheet http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails SLR Healthcare ABL - Additional Information (Details) Details 67 false false R68.htm 999058 - Disclosure - SLR Business Credit - Additional Information (Details) Sheet http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails SLR Business Credit - Additional Information (Details) Details 68 false false R69.htm 999059 - Disclosure - Merger with SUNS - Additional Information (Details) Sheet http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails Merger with SUNS - Additional Information (Details) Details 69 false false R70.htm 999060 - Disclosure - Merger with SUNS - Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger (Detail) Sheet http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail Merger with SUNS - Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger (Detail) Details 70 false false R71.htm 999061 - Disclosure - Merger with SUNS - Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger (Parenthetical) (Detail) Sheet http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerParentheticalDetail Merger with SUNS - Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger (Parenthetical) (Detail) Details 71 false false R72.htm 999062 - Disclosure - Stock Repurchase Program - Additional Information (Details) Sheet http://www.slrinvestments.com/role/StockRepurchaseProgramAdditionalInformationDetails Stock Repurchase Program - Additional Information (Details) Details 72 false false R73.htm 999063 - Disclosure - SLR Senior Lending Program LLC - Summary of SSLP's portfolio (Details) Sheet http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails SLR Senior Lending Program LLC - Summary of SSLP's portfolio (Details) Details 73 false false R74.htm 999064 - Disclosure - SLR Senior Lending Program LLC - Summary financial information for SSLP (Details) Sheet http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails SLR Senior Lending Program LLC - Summary financial information for SSLP (Details) Details 74 false false R75.htm 999065 - Disclosure - SLR Senior Lending Program LLC - Additional Information (Details) Sheet http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails SLR Senior Lending Program LLC - Additional Information (Details) Details 75 false false R76.htm 999066 - Disclosure - Subsequent Events - Additional Information (Details) Sheet http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails Subsequent Events - Additional Information (Details) Details 76 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityAddressStateOrProvince - d437884d10k.htm 7 d437884d10k.htm d437884dex141.htm d437884dex211.htm d437884dex231.htm d437884dex232.htm d437884dex233.htm d437884dex234.htm d437884dex235.htm d437884dex236.htm d437884dex311.htm d437884dex312.htm d437884dex313.htm d437884dex321.htm d437884dex322.htm d437884dex323.htm d437884dex991.htm d437884dex992.htm d437884dex993.htm d437884dex994.htm d437884dex995.htm d437884dex996.htm slrc-20221231.xsd slrc-20221231_cal.xml slrc-20221231_def.xml slrc-20221231_lab.xml slrc-20221231_pre.xml g437884g08d23.jpg g437884page61.jpg http://fasb.org/srt/2022 http://fasb.org/us-gaap-sup/2022q3 http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/cef/2022 http://xbrl.sec.gov/dei/2022 true true JSON 120 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d437884d10k.htm": { "axisCustom": 7, "axisStandard": 26, "baseTaxonomies": { "http://fasb.org/srt/2022": 1, "http://fasb.org/us-gaap-sup/2022q3": 14, "http://fasb.org/us-gaap/2022": 2225, "http://xbrl.sec.gov/cef/2022": 313, "http://xbrl.sec.gov/dei/2022": 36 }, "contextCount": 1371, "dts": { "calculationLink": { "local": [ "slrc-20221231_cal.xml" ] }, "definitionLink": { "local": [ "slrc-20221231_def.xml" ] }, "inline": { "local": [ "d437884d10k.htm" ] }, "labelLink": { "local": [ "slrc-20221231_lab.xml" ] }, "presentationLink": { "local": [ "slrc-20221231_pre.xml" ] }, "schema": { "local": [ "slrc-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/2006/xbrldi-2006.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/cef/2022/cef-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022_lab.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 1015, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 2, "http://xbrl.sec.gov/dei/2022": 4, "total": 6 }, "keyCustom": 118, "keyStandard": 271, "memberCustom": 311, "memberStandard": 26, "nsprefix": "slrc", "nsuri": "http://www.slrinvestments.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "1001 - Document - Cover Page", "menuCat": "Cover", "order": "1", "role": "http://www.slrinvestments.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "lang": "en-US", "name": "dei:DocumentPeriodEndDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityFileNumber", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "995470 - Disclosure - N-2", "menuCat": "Notes", "order": "10", "role": "http://xbrl.sec.gov/cef/role/N2", "shortName": "N-2", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "lang": "en-US", "name": "cef:ShareholderTransactionExpensesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999001 - Disclosure - Organization", "menuCat": "Notes", "order": "11", "role": "http://www.slrinvestments.com/role/Organization", "shortName": "Organization", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999002 - Disclosure - Significant Accounting Policies", "menuCat": "Notes", "order": "12", "role": "http://www.slrinvestments.com/role/SignificantAccountingPolicies", "shortName": "Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:AgreementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999003 - Disclosure - Agreements", "menuCat": "Notes", "order": "13", "role": "http://www.slrinvestments.com/role/Agreements", "shortName": "Agreements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:AgreementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:NetAssetValuePerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999004 - Disclosure - Net Asset Value Per Share", "menuCat": "Notes", "order": "14", "role": "http://www.slrinvestments.com/role/NetAssetValuePerShare", "shortName": "Net Asset Value Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:NetAssetValuePerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999005 - Disclosure - Earnings Per Share", "menuCat": "Notes", "order": "15", "role": "http://www.slrinvestments.com/role/EarningsPerShare", "shortName": "Earnings Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999006 - Disclosure - Fair Value", "menuCat": "Notes", "order": "16", "role": "http://www.slrinvestments.com/role/FairValue", "shortName": "Fair Value", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999007 - Disclosure - Debt", "menuCat": "Notes", "order": "17", "role": "http://www.slrinvestments.com/role/Debt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999008 - Disclosure - Income Tax Information and Distributions to Stockholders and Other Tax Information", "menuCat": "Notes", "order": "18", "role": "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformation", "shortName": "Income Tax Information and Distributions to Stockholders and Other Tax Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999009 - Disclosure - Financial Highlights", "menuCat": "Notes", "order": "19", "role": "http://www.slrinvestments.com/role/FinancialHighlights", "shortName": "Financial Highlights", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002 - Statement - Consolidated Statements of Assets And Liabilities", "menuCat": "Statements", "order": "2", "role": "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "shortName": "Consolidated Statements of Assets And Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:SlrCreditSolutionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999010 - Disclosure - SLR Credit Solutions", "menuCat": "Notes", "order": "20", "role": "http://www.slrinvestments.com/role/SlrCreditSolutions", "shortName": "SLR Credit Solutions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:SlrCreditSolutionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999011 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "21", "role": "http://www.slrinvestments.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999012 - Disclosure - SLR Equipment Finance", "menuCat": "Notes", "order": "22", "role": "http://www.slrinvestments.com/role/SlrEquipmentFinance", "shortName": "SLR Equipment Finance", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022_SlrEquipmentFinanceMembersrtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "decimals": null, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:CapitalShareTransactionsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999013 - Disclosure - Capital Share Transactions", "menuCat": "Notes", "order": "23", "role": "http://www.slrinvestments.com/role/CapitalShareTransactions", "shortName": "Capital Share Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:CapitalShareTransactionsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999014 - Disclosure - Kingsbridge Holdings, LLC", "menuCat": "Notes", "order": "24", "role": "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlc", "shortName": "Kingsbridge Holdings, LLC", "subGroupType": "", "uniqueAnchor": null }, "R25": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:SlrHealthcareAblTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999015 - Disclosure - SLR Healthcare ABL", "menuCat": "Notes", "order": "25", "role": "http://www.slrinvestments.com/role/SlrHealthcareAbl", "shortName": "SLR Healthcare ABL", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:SlrHealthcareAblTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:SlrBusinessCreditDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999016 - Disclosure - SLR Business Credit", "menuCat": "Notes", "order": "26", "role": "http://www.slrinvestments.com/role/SlrBusinessCredit", "shortName": "SLR Business Credit", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:SlrBusinessCreditDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:BusinessMergerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999017 - Disclosure - Merger with SUNS", "menuCat": "Notes", "order": "27", "role": "http://www.slrinvestments.com/role/MergerWithSuns", "shortName": "Merger with SUNS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:BusinessMergerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999018 - Disclosure - Stock Repurchase Program", "menuCat": "Notes", "order": "28", "role": "http://www.slrinvestments.com/role/StockRepurchaseProgram", "shortName": "Stock Repurchase Program", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999019 - Disclosure - SLR Senior Lending Program LLC", "menuCat": "Notes", "order": "29", "role": "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlc", "shortName": "SLR Senior Lending Program LLC", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtCost", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003 - Statement - Consolidated Statements of Assets And Liabilities (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "shortName": "Consolidated Statements of Assets And Liabilities (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-3", "lang": null, "name": "slrc:CashEquivalentsAtCost", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999020 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "30", "role": "http://www.slrinvestments.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999021 - Disclosure - Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "31", "role": "http://www.slrinvestments.com/role/SignificantAccountingPoliciesPolicies", "shortName": "Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999022 - Disclosure - Earnings Per Share (Tables)", "menuCat": "Tables", "order": "32", "role": "http://www.slrinvestments.com/role/EarningsPerShareTables", "shortName": "Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999023 - Disclosure - Fair Value (Tables)", "menuCat": "Tables", "order": "33", "role": "http://www.slrinvestments.com/role/FairValueTables", "shortName": "Fair Value (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999024 - Disclosure - Debt (Tables)", "menuCat": "Tables", "order": "34", "role": "http://www.slrinvestments.com/role/DebtTables", "shortName": "Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:InvestmentCompanyDistributionToShareholdersTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999025 - Disclosure - Income Tax Information and Distributions to Stockholders and Other Tax Information (Tables)", "menuCat": "Tables", "order": "35", "role": "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationTables", "shortName": "Income Tax Information and Distributions to Stockholders and Other Tax Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:InvestmentCompanyDistributionToShareholdersTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999026 - Disclosure - Financial Highlights (Tables)", "menuCat": "Tables", "order": "36", "role": "http://www.slrinvestments.com/role/FinancialHighlightsTables", "shortName": "Financial Highlights (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCommitmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999027 - Disclosure - Commitments and Contingencies (Tables)", "menuCat": "Tables", "order": "37", "role": "http://www.slrinvestments.com/role/CommitmentsAndContingenciesTables", "shortName": "Commitments and Contingencies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCommitmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "slrc:CapitalShareTransactionsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999028 - Disclosure - Capital Share Transactions (Tables)", "menuCat": "Tables", "order": "38", "role": "http://www.slrinvestments.com/role/CapitalShareTransactionsTables", "shortName": "Capital Share Transactions (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "slrc:CapitalShareTransactionsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999029 - Disclosure - Merger with SUNS (Tables)", "menuCat": "Tables", "order": "39", "role": "http://www.slrinvestments.com/role/MergerWithSunsTables", "shortName": "Merger with SUNS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GrossInvestmentIncomeOperating", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004 - Statement - Consolidated Statements of Operations", "menuCat": "Statements", "order": "4", "role": "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GrossInvestmentIncomeOperating", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999030 - Disclosure - SLR Senior Lending Program LLC (Tables)", "menuCat": "Tables", "order": "40", "role": "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcTables", "shortName": "SLR Senior Lending Program LLC (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P12_31_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:DateOfCommencementOfBusiness", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999031 - Disclosure - Organization - Additional Information (Details)", "menuCat": "Details", "order": "41", "role": "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails", "shortName": "Organization - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P12_31_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:DateOfCommencementOfBusiness", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "2", "first": true, "lang": null, "name": "slrc:PercentageOfExciseTax", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999032 - Disclosure - Significant Accounting Policies - Additional Information (Details)", "menuCat": "Details", "order": "42", "role": "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "shortName": "Significant Accounting Policies - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "2", "first": true, "lang": null, "name": "slrc:PercentageOfExciseTax", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ManagementFeeExpense", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999033 - Disclosure - Agreements - Additional Information (Details)", "menuCat": "Details", "order": "43", "role": "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "shortName": "Agreements - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "slrc:AgreementsTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-3", "lang": null, "name": "slrc:PerformanceBasedIncentiveFeesWaiver", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AssetsNet", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999034 - Disclosure - Net Asset Value Per Share - Additional Information (Details)", "menuCat": "Details", "order": "44", "role": "http://www.slrinvestments.com/role/NetAssetValuePerShareAdditionalInformationDetails", "shortName": "Net Asset Value Per Share - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R45": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "slrc:IncreaseDecreaseInNetAssetsFromOperation", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999035 - Disclosure - Earnings Per Share - Summary of Computation of Basic and Diluted Net (Detail)", "menuCat": "Details", "order": "45", "role": "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetail", "shortName": "Earnings Per Share - Summary of Computation of Basic and Diluted Net (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "slrc:IncreaseDecreaseInNetAssetsFromOperation", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_TwoThousandAndTwentyTwoUnsecuredNotesMemberusgaapFairValueByLiabilityClassAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NotesPayableFairValueDisclosure", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999036 - Disclosure - Fair Value - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "menuCat": "Details", "order": "46", "role": "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "shortName": "Fair Value - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis", "decimals": "-3", "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999037 - Disclosure - Fair Value - Summary of Changes in Fair Value of Level 3 Assets and Liabilities (Details)", "menuCat": "Details", "order": "47", "role": "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "shortName": "Fair Value - Summary of Changes in Fair Value of Level 3 Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2020", "decimals": "-3", "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2021_TwoThousandAndTwentyTwoUnsecuredNotesMemberusgaapFairValueByLiabilityClassAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999038 - Disclosure - Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Details)", "menuCat": "Details", "order": "48", "role": "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details", "shortName": "Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2020_TwoThousandAndTwentyTwoUnsecuredNotesMemberusgaapFairValueByLiabilityClassAxis", "decimals": "-3", "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022_TermLoanAndCreditFacilityMemberusgaapLongtermDebtTypeAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFairValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999039 - Disclosure - Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Parenthetical) (Details)", "menuCat": "Details", "order": "49", "role": "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "shortName": "Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Parenthetical) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022_TermLoanAndCreditFacilityMemberusgaapLongtermDebtTypeAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFairValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentIncomeNet", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005 - Statement - Consolidated Statements of Changes In Net Assets", "menuCat": "Statements", "order": "5", "role": "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "shortName": "Consolidated Statements of Changes In Net Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentIncomeNet", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_IncomeApproachValuationTechniqueMemberusgaapValuationTechniqueAxis_InvestmentInSeniorSecuredLoansMemberusgaapFairValueByAssetClassAxis_MeasurementInputMarketYieldMemberusgaapMeasurementInputTypeAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999040 - Disclosure - Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Details)", "menuCat": "Details", "order": "50", "role": "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "shortName": "Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_IncomeApproachValuationTechniqueMemberusgaapValuationTechniqueAxis_InvestmentInSeniorSecuredLoansMemberusgaapFairValueByAssetClassAxis_MeasurementInputMarketYieldMemberusgaapMeasurementInputTypeAxis", "decimals": null, "lang": "en-US", "name": "slrc:DescriptionOfFairValueMeasurementValuationProcess", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputEbitdaMultipleMemberSLRCMeasurementInputTypeOneAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999041 - Disclosure - Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Parenthetical) (Details)", "menuCat": "Details", "order": "51", "role": "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails", "shortName": "Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Parenthetical) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputEbitdaMultipleMemberSLRCMeasurementInputTypeOneAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999042 - Disclosure - Debt - Schedule of Long-term Debt Instruments (Details)", "menuCat": "Details", "order": "52", "role": "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "shortName": "Debt - Schedule of Long-term Debt Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022_TermLoanAndCreditFacilityMemberusgaapLongtermDebtTypeAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredFinanceCostsNet", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999043 - Disclosure - Debt - Schedule of Long-term Debt Instruments (Parenthetical) (Details)", "menuCat": "Details", "order": "53", "role": "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "shortName": "Debt - Schedule of Long-term Debt Instruments (Parenthetical) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022_TermLoanAndCreditFacilityMemberusgaapLongtermDebtTypeAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredFinanceCostsNet", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999044 - Disclosure - Debt - Additional Information (Details)", "menuCat": "Details", "order": "54", "role": "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "shortName": "Debt - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P12_28_2021To12_31_2021", "decimals": null, "lang": "en-US", "name": "us-gaap:DebtInstrumentPaymentTerms", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "slrc:InvestmentCompanyDistributionToShareholdersTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap-supplement:InvestmentCompanyDistributionOrdinaryIncome", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999045 - Disclosure - Income Tax Information and Distributions to Stockholders and Other Tax Information - Summary of distributions to shareholders (Details)", "menuCat": "Details", "order": "55", "role": "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfDistributionsToShareholdersDetails", "shortName": "Income Tax Information and Distributions to Stockholders and Other Tax Information - Summary of distributions to shareholders (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "slrc:InvestmentCompanyDistributionToShareholdersTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap-supplement:InvestmentCompanyDistributionOrdinaryIncome", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FederalIncomeTaxNoteTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999046 - Disclosure - Income Tax Information and Distributions to Stockholders and Other Tax Information - Summary of total accumulated earnings (loss) on a tax basis (Details)", "menuCat": "Details", "order": "56", "role": "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfTotalAccumulatedEarningsLossOnATaxBasisDetails", "shortName": "Income Tax Information and Distributions to Stockholders and Other Tax Information - Summary of total accumulated earnings (loss) on a tax basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FederalIncomeTaxNoteTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999047 - Disclosure - Income Tax Information and Distributions to Stockholders and Other Tax Information - Additional information (Details)", "menuCat": "Details", "order": "57", "role": "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationAdditionalInformationDetails", "shortName": "Income Tax Information and Distributions to Stockholders and Other Tax Information - Additional information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "div", "slrc:NetAssetValuePerShareTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NetAssetValuePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999048 - Disclosure - Financial Highlights - Schedule of Financial Highlights (Details)", "menuCat": "Details", "order": "58", "role": "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails", "shortName": "Financial Highlights - Schedule of Financial Highlights (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock", "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "2", "lang": null, "name": "slrc:FairValueOfCommonStockPerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock", "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:InvestmentCompanyExpenseRatioExcludingIncentiveFee", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999049 - Disclosure - Financial Highlights - Schedule of Financial Highlights (Parentheticals) (Details)", "menuCat": "Details", "order": "59", "role": "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsParentheticalsDetails", "shortName": "Financial Highlights - Schedule of Financial Highlights (Parentheticals) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock", "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:InvestmentCompanyExpenseRatioExcludingIncentiveFee", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "slrc:NetIncreaseInNetAssetsResultingFromoperations", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "6", "role": "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "slrc:NetIncreaseInNetAssetsResultingFromoperations", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "div", "slrc:SlrBusinessCreditDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "slrc:NumberOfIssuerInBusinessCredit", "reportCount": 1, "unitRef": "Unit_issuers", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999050 - Disclosure - SLR Credit Solutions - Additional Information (Details)", "menuCat": "Details", "order": "60", "role": "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "shortName": "SLR Credit Solutions - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "slrc:SlrCreditSolutionTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_28_2012_RevolvingCreditFacilityMemberusgaapCreditFacilityAxis", "decimals": "-3", "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "us-gaap:OtherCommitmentsTableTextBlock", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OtherCommitment", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999051 - Disclosure - Commitments and Contingencies - Additional Information (Details)", "menuCat": "Details", "order": "61", "role": "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "shortName": "Commitments and Contingencies - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R62": { "firstAnchor": { "ancestors": [ "us-gaap:OtherCommitmentsTableTextBlock", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OtherCommitment", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999052 - Disclosure - Commitments and Contingencies - Summary of Unfunded Debt and Equity Commitments (Details)", "menuCat": "Details", "order": "62", "role": "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "shortName": "Commitments and Contingencies - Summary of Unfunded Debt and Equity Commitments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022_SlrCreditSolutionsMemberdeiLegalEntityAxis_UnfundedDebtAndEquityCommitmentsMemberusgaapOtherCommitmentsAxis", "decimals": "-3", "lang": null, "name": "us-gaap:OtherCommitment", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebt", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999053 - Disclosure - SLR Equipment Finance - Additional Information (Details)", "menuCat": "Details", "order": "63", "role": "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "shortName": "SLR Equipment Finance - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn07_31_2017_SlrEquipmentFinanceMembersrtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "decimals": "2", "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999054 - Disclosure - Capital Share Transactions - Additional Information (Details)", "menuCat": "Details", "order": "64", "role": "http://www.slrinvestments.com/role/CapitalShareTransactionsAdditionalInformationDetails", "shortName": "Capital Share Transactions - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R65": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "slrc:CapitalShareTransactionsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999055 - Disclosure - Capital Share Transactions - Summary of Transactions In Capital Stock (Details)", "menuCat": "Details", "order": "65", "role": "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "shortName": "Capital Share Transactions - Summary of Transactions In Capital Stock (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "slrc:CapitalShareTransactionsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-3", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueAcquisitions", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfUnsecuredDebt", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999056 - Disclosure - Kingsbridge Holdings, LLC - Additional Information (Details)", "menuCat": "Details", "order": "66", "role": "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "shortName": "Kingsbridge Holdings, LLC - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022_KbhtMemberdeiLegalEntityAxis", "decimals": "-3", "lang": null, "name": "us-gaap:Assets", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": null, "first": true, "lang": null, "name": "us-gaap:CommitmentsAndContingencies", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "true" }, "groupType": "disclosure", "isDefault": "false", "longName": "999057 - Disclosure - SLR Healthcare ABL - Additional Information (Details)", "menuCat": "Details", "order": "67", "role": "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "shortName": "SLR Healthcare ABL - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "slrc:SlrHealthcareAblTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn06_28_2019_SlrHealthcareAblCreditMemberusgaapLineOfCreditFacilityAxis", "decimals": "-3", "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": null, "first": true, "lang": null, "name": "us-gaap:CommitmentsAndContingencies", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "true" }, "groupType": "disclosure", "isDefault": "false", "longName": "999058 - Disclosure - SLR Business Credit - Additional Information (Details)", "menuCat": "Details", "order": "68", "role": "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "shortName": "SLR Business Credit - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "slrc:SlrBusinessCreditDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022_SlrBusinessCreditMemberusgaapLineOfCreditFacilityAxis", "decimals": "-3", "lang": null, "name": "us-gaap:LineOfCredit", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SharesIssuedPricePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999059 - Disclosure - Merger with SUNS - Additional Information (Details)", "menuCat": "Details", "order": "69", "role": "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails", "shortName": "Merger with SUNS - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P04_01_2022To04_01_2022", "decimals": "0", "lang": null, "name": "slrc:NumberOfBasisPoints", "reportCount": 1, "unique": true, "unitRef": "Unit_basispoints", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P04_01_2022To04_01_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1007 - Statement - Consolidated Statements of Cash Flows (Parenthetical)", "menuCat": "Statements", "order": "7", "role": "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlowsParenthetical", "shortName": "Consolidated Statements of Cash Flows (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P04_01_2022To04_01_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022_SunsCompanyMergerMemberusgaapBusinessAcquisitionAxis", "decimals": "-3", "first": true, "lang": null, "name": "slrc:BusinessCombinationCommonStockIssuedByTheCompany", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999060 - Disclosure - Merger with SUNS - Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger (Detail)", "menuCat": "Details", "order": "70", "role": "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail", "shortName": "Merger with SUNS - Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022_SunsCompanyMergerMemberusgaapBusinessAcquisitionAxis", "decimals": "-3", "first": true, "lang": null, "name": "slrc:BusinessCombinationCommonStockIssuedByTheCompany", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022_SunsCompanyMergerMemberusgaapBusinessAcquisitionAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionSharePrice", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999061 - Disclosure - Merger with SUNS - Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger (Parenthetical) (Detail)", "menuCat": "Details", "order": "71", "role": "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerParentheticalDetail", "shortName": "Merger with SUNS - Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022_SunsCompanyMergerMemberusgaapBusinessAcquisitionAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionSharePrice", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn05_03_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999062 - Disclosure - Stock Repurchase Program - Additional Information (Details)", "menuCat": "Details", "order": "72", "role": "http://www.slrinvestments.com/role/StockRepurchaseProgramAdditionalInformationDetails", "shortName": "Stock Repurchase Program - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn05_03_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtCost", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999063 - Disclosure - SLR Senior Lending Program LLC - Summary of SSLP's portfolio (Details)", "menuCat": "Details", "order": "73", "role": "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails", "shortName": "SLR Senior Lending Program LLC - Summary of SSLP's portfolio (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022_AtriaWealthSolutionsIncMembersrtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_FinancialServicesSectorMemberusgaapEquitySecuritiesByIndustryAxis_SlrSeniorLendingProgramLlcMemberdeiLegalEntityAxis", "decimals": null, "lang": "en-US", "name": "slrc:InvestmentsOwnedSpreadAboveIndexRate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999064 - Disclosure - SLR Senior Lending Program LLC - Summary financial information for SSLP (Details)", "menuCat": "Details", "order": "74", "role": "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails", "shortName": "SLR Senior Lending Program LLC - Summary financial information for SSLP (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P12_01_2022To12_31_2022_SlrSeniorLendingProgramLlcMemberdeiLegalEntityAxis", "decimals": "-3", "lang": null, "name": "us-gaap:InvestmentIncomeInterest", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "us-gaap:OtherCommitmentsTableTextBlock", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OtherCommitment", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999065 - Disclosure - SLR Senior Lending Program LLC - Additional Information (Details)", "menuCat": "Details", "order": "75", "role": "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails", "shortName": "SLR Senior Lending Program LLC - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P12_01_2022To12_31_2022_SlrSeniorLendingProgramLlcMemberdeiLegalEntityAxis", "decimals": "-3", "lang": null, "name": "us-gaap:PaymentsToAcquireInvestments", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "div", "us-gaap:SubsequentEventsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn02_28_2023_BoardMembersrtTitleOfIndividualAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis", "decimals": "6", "first": true, "lang": null, "name": "us-gaap:DividendsPayableAmountPerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999066 - Disclosure - Subsequent Events - Additional Information (Details)", "menuCat": "Details", "order": "76", "role": "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails", "shortName": "Subsequent Events - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:SubsequentEventsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn02_28_2023_BoardMembersrtTitleOfIndividualAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis", "decimals": "6", "first": true, "lang": null, "name": "us-gaap:DividendsPayableAmountPerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtCost", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1008 - Statement - Consolidated Schedule of Investments", "menuCat": "Statements", "order": "8", "role": "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "shortName": "Consolidated Schedule of Investments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-3", "lang": null, "name": "slrc:LiabilitiesInExcessOfOtherAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "3", "first": true, "lang": null, "name": "slrc:PercentageRepresentingSeniorSecuredLoansInInvestmentsOwned", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1009 - Statement - Consolidated Schedule of Investments (Parenthetical)", "menuCat": "Statements", "order": "9", "role": "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "shortName": "Consolidated Schedule of Investments (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d437884d10k.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "3", "first": true, "lang": null, "name": "slrc:PercentageRepresentingSeniorSecuredLoansInInvestmentsOwned", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } } }, "segmentCount": 361, "tag": { "cef_AcquiredFundFeesAndExpensesNoteTextBlock": { "auth_ref": [ "r502" ], "lang": { "en-us": { "role": { "label": "Acquired Fund Fees and Expenses, Note [Text Block]" } } }, "localname": "AcquiredFundFeesAndExpensesNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_AcquiredFundFeesAndExpensesPercent": { "auth_ref": [ "r503" ], "lang": { "en-us": { "role": { "label": "Acquired Fund Fees and Expenses [Percent]" } } }, "localname": "AcquiredFundFeesAndExpensesPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_AcquiredFundFeesEstimatedNoteTextBlock": { "auth_ref": [ "r504" ], "lang": { "en-us": { "role": { "label": "Acquired Fund Fees Estimated, Note [Text Block]" } } }, "localname": "AcquiredFundFeesEstimatedNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_AcquiredFundIncentiveAllocationNoteTextBlock": { "auth_ref": [ "r505" ], "lang": { "en-us": { "role": { "label": "Acquired Fund Incentive Allocation, Note [Text Block]" } } }, "localname": "AcquiredFundIncentiveAllocationNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": { "auth_ref": [ "r506" ], "lang": { "en-us": { "role": { "label": "Acquired Fund Total Annual Expenses, Note [Text Block]" } } }, "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_AllRisksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "All Risks:" } } }, "localname": "AllRisksMember", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "cef_AllSecuritiesMember": { "auth_ref": [ "r475" ], "lang": { "en-us": { "role": { "label": "All Securities:" } } }, "localname": "AllSecuritiesMember", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "cef_AnnualCoverageReturnRatePercent": { "auth_ref": [ "r532" ], "lang": { "en-us": { "role": { "label": "Annual Coverage Return Rate [Percent]" } } }, "localname": "AnnualCoverageReturnRatePercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_AnnualDividendPayment": { "auth_ref": [ "r531" ], "lang": { "en-us": { "role": { "label": "Annual Dividend Payment" } } }, "localname": "AnnualDividendPayment", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_AnnualDividendPaymentCurrent": { "auth_ref": [ "r531" ], "lang": { "en-us": { "role": { "label": "Annual Dividend Payment, Current" } } }, "localname": "AnnualDividendPaymentCurrent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_AnnualDividendPaymentInitial": { "auth_ref": [ "r531" ], "lang": { "en-us": { "role": { "label": "Annual Dividend Payment, Initial" } } }, "localname": "AnnualDividendPaymentInitial", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_AnnualExpensesTableTextBlock": { "auth_ref": [ "r510" ], "lang": { "en-us": { "role": { "label": "Annual Expenses [Table Text Block]" } } }, "localname": "AnnualExpensesTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_AnnualInterestRateCurrentPercent": { "auth_ref": [ "r531" ], "lang": { "en-us": { "role": { "label": "Annual Interest Rate, Current [Percent]" } } }, "localname": "AnnualInterestRateCurrentPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_AnnualInterestRateInitialPercent": { "auth_ref": [ "r531" ], "lang": { "en-us": { "role": { "label": "Annual Interest Rate, Initial [Percent]" } } }, "localname": "AnnualInterestRateInitialPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_AnnualInterestRatePercent": { "auth_ref": [ "r531" ], "lang": { "en-us": { "role": { "label": "Annual Interest Rate [Percent]" } } }, "localname": "AnnualInterestRatePercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_BasisOfTransactionFeesNoteTextBlock": { "auth_ref": [ "r508" ], "lang": { "en-us": { "role": { "label": "Basis of Transaction Fees, Note [Text Block]" } } }, "localname": "BasisOfTransactionFeesNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_BdcFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BDC File Number" } } }, "localname": "BdcFileNumber", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "fileNumberItemType" }, "cef_BusinessDevelopmentCompanyFlag": { "auth_ref": [ "r475" ], "lang": { "en-us": { "role": { "label": "Business Development Company [Flag]" } } }, "localname": "BusinessDevelopmentCompanyFlag", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": { "auth_ref": [ "r476" ], "lang": { "en-us": { "role": { "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]" } } }, "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_CapitalStockTableTextBlock": { "auth_ref": [ "r477" ], "lang": { "en-us": { "role": { "label": "Capital Stock [Table Text Block]" } } }, "localname": "CapitalStockTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_DistributionServicingFeesPercent": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "label": "Distribution/Servicing Fees [Percent]" } } }, "localname": "DistributionServicingFeesPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_DistributionsMayReducePrincipalTextBlock": { "auth_ref": [ "r484" ], "lang": { "en-us": { "role": { "label": "Distributions May Reduce Principal [Text Block]" } } }, "localname": "DistributionsMayReducePrincipalTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_DividendAndInterestExpensesOnShortSalesPercent": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "label": "Dividend and Interest Expenses on Short Sales [Percent]" } } }, "localname": "DividendAndInterestExpensesOnShortSalesPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_DividendExpenseOnPreferredSharesPercent": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "label": "Dividend Expenses on Preferred Shares [Percent]" } } }, "localname": "DividendExpenseOnPreferredSharesPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_DividendReinvestmentAndCashPurchaseFees": { "auth_ref": [ "r500" ], "lang": { "en-us": { "role": { "label": "Dividend Reinvestment and Cash Purchase Fees" } } }, "localname": "DividendReinvestmentAndCashPurchaseFees", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_EffectsOfLeveragePurposeTextBlock": { "auth_ref": [ "r533" ], "lang": { "en-us": { "role": { "label": "Effects of Leverage, Purpose [Text Block]" } } }, "localname": "EffectsOfLeveragePurposeTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_EffectsOfLeverageTableTextBlock": { "auth_ref": [ "r533" ], "lang": { "en-us": { "role": { "label": "Effects of Leverage [Table Text Block]" } } }, "localname": "EffectsOfLeverageTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_EffectsOfLeverageTextBlock": { "auth_ref": [ "r530" ], "lang": { "en-us": { "role": { "label": "Effects of Leverage [Text Block]" } } }, "localname": "EffectsOfLeverageTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_ExpenseExampleTableTextBlock": { "auth_ref": [ "r500" ], "lang": { "en-us": { "role": { "label": "Expense Example [Table Text Block]" } } }, "localname": "ExpenseExampleTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_ExpenseExampleYear01": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "label": "Expense Example, Year 01" } } }, "localname": "ExpenseExampleYear01", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_ExpenseExampleYears1to10": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "label": "Expense Example, Years 1 to 10" } } }, "localname": "ExpenseExampleYears1to10", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_ExpenseExampleYears1to3": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "label": "Expense Example, Years 1 to 3" } } }, "localname": "ExpenseExampleYears1to3", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_ExpenseExampleYears1to5": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "label": "Expense Example, Years 1 to 5" } } }, "localname": "ExpenseExampleYears1to5", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_FeeTableAbstract": { "auth_ref": [ "r500" ], "lang": { "en-us": { "role": { "label": "Fee Table [Abstract]" } } }, "localname": "FeeTableAbstract", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_FinancialHighlightsAbstract": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "label": "Financial Highlights [Abstract]" } } }, "localname": "FinancialHighlightsAbstract", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_GeneralDescriptionOfRegistrantAbstract": { "auth_ref": [ "r527" ], "lang": { "en-us": { "role": { "label": "General Description of Registrant [Abstract]" } } }, "localname": "GeneralDescriptionOfRegistrantAbstract", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_HighestPriceOrBid": { "auth_ref": [ "r534" ], "lang": { "en-us": { "role": { "label": "Highest Price or Bid" } } }, "localname": "HighestPriceOrBid", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_HighestPriceOrBidNav": { "auth_ref": [ "r538" ], "lang": { "en-us": { "role": { "label": "Highest Price or Bid, NAV" } } }, "localname": "HighestPriceOrBidNav", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_HighestPriceOrBidPremiumDiscountToNavPercent": { "auth_ref": [ "r539" ], "lang": { "en-us": { "role": { "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]" } } }, "localname": "HighestPriceOrBidPremiumDiscountToNavPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_IncentiveAllocationMaximumPercent": { "auth_ref": [ "r505" ], "lang": { "en-us": { "role": { "label": "Incentive Allocation Maximum [Percent]" } } }, "localname": "IncentiveAllocationMaximumPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_IncentiveAllocationMinimumPercent": { "auth_ref": [ "r505" ], "lang": { "en-us": { "role": { "label": "Incentive Allocation Minimum [Percent]" } } }, "localname": "IncentiveAllocationMinimumPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_IncentiveAllocationPercent": { "auth_ref": [ "r505" ], "lang": { "en-us": { "role": { "label": "Incentive Allocation [Percent]" } } }, "localname": "IncentiveAllocationPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_IncentiveFeesPercent": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "label": "Incentive Fees [Percent]" } } }, "localname": "IncentiveFeesPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_InterestExpensesOnBorrowingsPercent": { "auth_ref": [ "r513" ], "lang": { "en-us": { "role": { "label": "Interest Expenses on Borrowings [Percent]" } } }, "localname": "InterestExpensesOnBorrowingsPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_IntervalFundFlag": { "auth_ref": [ "r475" ], "lang": { "en-us": { "role": { "label": "Interval Fund [Flag]" } } }, "localname": "IntervalFundFlag", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "cef_InvestmentObjectivesAndPracticesTextBlock": { "auth_ref": [ "r528" ], "lang": { "en-us": { "role": { "label": "Investment Objectives and Practices [Text Block]" } } }, "localname": "InvestmentObjectivesAndPracticesTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LatestNav": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "label": "Latest NAV" } } }, "localname": "LatestNav", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_LatestPremiumDiscountToNavPercent": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "label": "Latest Premium (Discount) to NAV [Percent]" } } }, "localname": "LatestPremiumDiscountToNavPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_LatestSharePrice": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "label": "Latest Share Price" } } }, "localname": "LatestSharePrice", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_LoanServicingFeesPercent": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "label": "Loan Servicing Fees [Percent]" } } }, "localname": "LoanServicingFeesPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_LongTermDebtDividendsAndCovenantsTextBlock": { "auth_ref": [ "r491" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Dividends and Covenants [Text Block]" } } }, "localname": "LongTermDebtDividendsAndCovenantsTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": { "auth_ref": [ "r492" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Issuance and Substitution [Text Block]" } } }, "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LongTermDebtPrincipal": { "auth_ref": [ "r489" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Principal" } } }, "localname": "LongTermDebtPrincipal", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": { "auth_ref": [ "r493" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]" } } }, "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LongTermDebtStructuringTextBlock": { "auth_ref": [ "r490" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Structuring [Text Block]" } } }, "localname": "LongTermDebtStructuringTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LongTermDebtTableTextBlock": { "auth_ref": [ "r489" ], "lang": { "en-us": { "role": { "label": "Long Term Debt [Table Text Block]" } } }, "localname": "LongTermDebtTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LongTermDebtTitleTextBlock": { "auth_ref": [ "r489" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Title [Text Block]" } } }, "localname": "LongTermDebtTitleTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LowestPriceOrBid": { "auth_ref": [ "r534" ], "lang": { "en-us": { "role": { "label": "Lowest Price or Bid" } } }, "localname": "LowestPriceOrBid", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_LowestPriceOrBidNav": { "auth_ref": [ "r538" ], "lang": { "en-us": { "role": { "label": "Lowest Price or Bid, NAV" } } }, "localname": "LowestPriceOrBidNav", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_LowestPriceOrBidPremiumDiscountToNavPercent": { "auth_ref": [ "r539" ], "lang": { "en-us": { "role": { "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]" } } }, "localname": "LowestPriceOrBidPremiumDiscountToNavPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": { "auth_ref": [ "r512" ], "lang": { "en-us": { "role": { "label": "Management Fee not based on Net Assets, Note [Text Block]" } } }, "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_ManagementFeesPercent": { "auth_ref": [ "r511" ], "lang": { "en-us": { "role": { "label": "Management Fees [Percent]" } } }, "localname": "ManagementFeesPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_NetExpenseOverAssetsPercent": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "label": "Net Expense over Assets [Percent]" } } }, "localname": "NetExpenseOverAssetsPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_NewCefOrBdcRegistrantFlag": { "auth_ref": [ "r475" ], "lang": { "en-us": { "role": { "label": "New CEF or BDC Registrant [Flag]" } } }, "localname": "NewCefOrBdcRegistrantFlag", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "cef_NoPublicTradingTextBlock": { "auth_ref": [ "r537" ], "lang": { "en-us": { "role": { "label": "No Public Trading [Text Block]" } } }, "localname": "NoPublicTradingTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_NoTradingHistoryTextBlock": { "auth_ref": [ "r541" ], "lang": { "en-us": { "role": { "label": "No Trading History [Text Block]" } } }, "localname": "NoTradingHistoryTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OtherAnnualExpense1Percent": { "auth_ref": [ "r514" ], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Ae": { "order": 1.0, "parentTag": "cef_OtherAnnualExpensesPercent", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Other Annual Expense 1 [Percent]" } } }, "localname": "OtherAnnualExpense1Percent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherAnnualExpense2Percent": { "auth_ref": [ "r514" ], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Ae": { "order": 2.0, "parentTag": "cef_OtherAnnualExpensesPercent", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Other Annual Expense 2 [Percent]" } } }, "localname": "OtherAnnualExpense2Percent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherAnnualExpense3Percent": { "auth_ref": [ "r514" ], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Ae": { "order": 3.0, "parentTag": "cef_OtherAnnualExpensesPercent", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Other Annual Expense 3 [Percent]" } } }, "localname": "OtherAnnualExpense3Percent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherAnnualExpensesAbstract": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "label": "Other Annual Expenses [Abstract]" } } }, "localname": "OtherAnnualExpensesAbstract", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_OtherAnnualExpensesPercent": { "auth_ref": [ "r514" ], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Ae": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "label": "Other Annual Expenses [Percent]" } } }, "localname": "OtherAnnualExpensesPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherExpensesNoteTextBlock": { "auth_ref": [ "r510" ], "lang": { "en-us": { "role": { "label": "Other Expenses, Note [Text Block]" } } }, "localname": "OtherExpensesNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OtherFeederFundExpensesPercent": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "label": "Other Feeder Fund Expenses [Percent]" } } }, "localname": "OtherFeederFundExpensesPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherMasterFundExpensesPercent": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "label": "Other Master Fund Expenses [Percent]" } } }, "localname": "OtherMasterFundExpensesPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherSecuritiesTableTextBlock": { "auth_ref": [ "r494" ], "lang": { "en-us": { "role": { "label": "Other Securities [Table Text Block]" } } }, "localname": "OtherSecuritiesTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OtherSecurityDescriptionTextBlock": { "auth_ref": [ "r494" ], "lang": { "en-us": { "role": { "label": "Other Security, Description [Text Block]" } } }, "localname": "OtherSecurityDescriptionTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OtherSecurityTitleTextBlock": { "auth_ref": [ "r494" ], "lang": { "en-us": { "role": { "label": "Other Security, Title [Text Block]" } } }, "localname": "OtherSecurityTitleTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OtherTransactionExpense1Percent": { "auth_ref": [ "r509" ], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Te": { "order": 1.0, "parentTag": "cef_OtherTransactionExpensesPercent", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Other Transaction Expense 1 [Percent]" } } }, "localname": "OtherTransactionExpense1Percent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherTransactionExpense2Percent": { "auth_ref": [ "r509" ], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Te": { "order": 2.0, "parentTag": "cef_OtherTransactionExpensesPercent", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Other Transaction Expense 2 [Percent]" } } }, "localname": "OtherTransactionExpense2Percent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherTransactionExpense3Percent": { "auth_ref": [ "r509" ], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Te": { "order": 3.0, "parentTag": "cef_OtherTransactionExpensesPercent", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Other Transaction Expense 3 [Percent]" } } }, "localname": "OtherTransactionExpense3Percent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherTransactionExpensesAbstract": { "auth_ref": [ "r509" ], "lang": { "en-us": { "role": { "label": "Other Transaction Expenses [Abstract]" } } }, "localname": "OtherTransactionExpensesAbstract", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_OtherTransactionExpensesPercent": { "auth_ref": [ "r509" ], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Te": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "label": "Other Transaction Expenses [Percent]" } } }, "localname": "OtherTransactionExpensesPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherTransactionFeesBasisMaximum": { "auth_ref": [ "r509" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fees Basis, Maximum" } } }, "localname": "OtherTransactionFeesBasisMaximum", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_OtherTransactionFeesBasisMaximumPercent": { "auth_ref": [ "r509" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fees Basis, Maximum [Percent]" } } }, "localname": "OtherTransactionFeesBasisMaximumPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherTransactionFeesBasisNoteTextBlock": { "auth_ref": [ "r509" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fees Basis, Note [Text Block]" } } }, "localname": "OtherTransactionFeesBasisNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OtherTransactionFeesNoteTextBlock": { "auth_ref": [ "r509" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fees, Note [Text Block]" } } }, "localname": "OtherTransactionFeesNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OutstandingSecuritiesTableTextBlock": { "auth_ref": [ "r495" ], "lang": { "en-us": { "role": { "label": "Outstanding Securities [Table Text Block]" } } }, "localname": "OutstandingSecuritiesTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OutstandingSecurityAuthorizedShares": { "auth_ref": [ "r497" ], "lang": { "en-us": { "role": { "label": "Outstanding Security, Authorized [Shares]" } } }, "localname": "OutstandingSecurityAuthorizedShares", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "sharesItemType" }, "cef_OutstandingSecurityHeldShares": { "auth_ref": [ "r498" ], "lang": { "en-us": { "role": { "label": "Outstanding Security, Held [Shares]" } } }, "localname": "OutstandingSecurityHeldShares", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "sharesItemType" }, "cef_OutstandingSecurityNotHeldShares": { "auth_ref": [ "r499" ], "lang": { "en-us": { "role": { "label": "Outstanding Security, Not Held [Shares]" } } }, "localname": "OutstandingSecurityNotHeldShares", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "sharesItemType" }, "cef_OutstandingSecurityTitleTextBlock": { "auth_ref": [ "r496" ], "lang": { "en-us": { "role": { "label": "Outstanding Security, Title [Text Block]" } } }, "localname": "OutstandingSecurityTitleTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_PreferredStockRestrictionsArrearageTextBlock": { "auth_ref": [ "r485" ], "lang": { "en-us": { "role": { "label": "Preferred Stock Restrictions, Arrearage [Text Block]" } } }, "localname": "PreferredStockRestrictionsArrearageTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_PreferredStockRestrictionsOtherTextBlock": { "auth_ref": [ "r486" ], "lang": { "en-us": { "role": { "label": "Preferred Stock Restrictions, Other [Text Block]" } } }, "localname": "PreferredStockRestrictionsOtherTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_PrimaryShelfFlag": { "auth_ref": [ "r475" ], "lang": { "en-us": { "role": { "label": "Primary Shelf [Flag]" } } }, "localname": "PrimaryShelfFlag", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "cef_PrimaryShelfQualifiedFlag": { "auth_ref": [ "r475" ], "lang": { "en-us": { "role": { "label": "Primary Shelf Qualified [Flag]" } } }, "localname": "PrimaryShelfQualifiedFlag", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "cef_ProspectusLineItems": { "auth_ref": [ "r475" ], "lang": { "en-us": { "role": { "label": "Prospectus [Line Items]" } } }, "localname": "ProspectusLineItems", "nsuri": "http://xbrl.sec.gov/cef/2022", "xbrltype": "stringItemType" }, "cef_ProspectusTable": { "auth_ref": [ "r475" ], "lang": { "en-us": { "role": { "label": "Prospectus:" } } }, "localname": "ProspectusTable", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_PurposeOfFeeTableNoteTextBlock": { "auth_ref": [ "r501" ], "lang": { "en-us": { "role": { "label": "Purpose of Fee Table , Note [Text Block]" } } }, "localname": "PurposeOfFeeTableNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_RegisteredClosedEndFundFlag": { "auth_ref": [ "r475" ], "lang": { "en-us": { "role": { "label": "Registered Closed-End Fund [Flag]" } } }, "localname": "RegisteredClosedEndFundFlag", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "cef_ReturnAtMinusFivePercent": { "auth_ref": [ "r533" ], "lang": { "en-us": { "role": { "label": "Return at Minus Five [Percent]" } } }, "localname": "ReturnAtMinusFivePercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_ReturnAtMinusTenPercent": { "auth_ref": [ "r533" ], "lang": { "en-us": { "role": { "label": "Return at Minus Ten [Percent]" } } }, "localname": "ReturnAtMinusTenPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_ReturnAtPlusFivePercent": { "auth_ref": [ "r533" ], "lang": { "en-us": { "role": { "label": "Return at Plus Five [Percent]" } } }, "localname": "ReturnAtPlusFivePercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_ReturnAtPlusTenPercent": { "auth_ref": [ "r533" ], "lang": { "en-us": { "role": { "label": "Return at Plus Ten [Percent]" } } }, "localname": "ReturnAtPlusTenPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_ReturnAtZeroPercent": { "auth_ref": [ "r533" ], "lang": { "en-us": { "role": { "label": "Return at Zero [Percent]" } } }, "localname": "ReturnAtZeroPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_RightsLimitedByOtherSecuritiesTextBlock": { "auth_ref": [ "r488" ], "lang": { "en-us": { "role": { "label": "Rights Limited by Other Securities [Text Block]" } } }, "localname": "RightsLimitedByOtherSecuritiesTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": { "auth_ref": [ "r487" ], "lang": { "en-us": { "role": { "label": "Rights Subject to Other than Majority Vote [Text Block]" } } }, "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_RiskAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risk [Axis]" } } }, "localname": "RiskAxis", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_RiskFactorsTableTextBlock": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "label": "Risk Factors [Table Text Block]" } } }, "localname": "RiskFactorsTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_RiskTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risk [Text Block]" } } }, "localname": "RiskTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SalesLoadPercent": { "auth_ref": [ "r500" ], "lang": { "en-us": { "role": { "label": "Sales Load [Percent]" } } }, "localname": "SalesLoadPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_SecurityAxis": { "auth_ref": [ "r475" ], "lang": { "en-us": { "role": { "label": "Security [Axis]" } } }, "localname": "SecurityAxis", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_SecurityDividendsTextBlock": { "auth_ref": [ "r478" ], "lang": { "en-us": { "role": { "label": "Security Dividends [Text Block]" } } }, "localname": "SecurityDividendsTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SecurityLiabilitiesTextBlock": { "auth_ref": [ "r481" ], "lang": { "en-us": { "role": { "label": "Security Liabilities [Text Block]" } } }, "localname": "SecurityLiabilitiesTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SecurityLiquidationRightsTextBlock": { "auth_ref": [ "r480" ], "lang": { "en-us": { "role": { "label": "Security Liquidation Rights [Text Block]" } } }, "localname": "SecurityLiquidationRightsTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SecurityObligationsOfOwnershipTextBlock": { "auth_ref": [ "r483" ], "lang": { "en-us": { "role": { "label": "Security Obligations of Ownership [Text Block]" } } }, "localname": "SecurityObligationsOfOwnershipTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SecurityPreemptiveAndOtherRightsTextBlock": { "auth_ref": [ "r482" ], "lang": { "en-us": { "role": { "label": "Security Preemptive and Other Rights [Text Block]" } } }, "localname": "SecurityPreemptiveAndOtherRightsTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SecurityTitleTextBlock": { "auth_ref": [ "r477" ], "lang": { "en-us": { "role": { "label": "Security Title [Text Block]" } } }, "localname": "SecurityTitleTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SecurityVotingRightsTextBlock": { "auth_ref": [ "r479" ], "lang": { "en-us": { "role": { "label": "Security Voting Rights [Text Block]" } } }, "localname": "SecurityVotingRightsTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SeniorSecuritiesAmount": { "auth_ref": [ "r520" ], "lang": { "en-us": { "role": { "label": "Senior Securities Amount" } } }, "localname": "SeniorSecuritiesAmount", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_SeniorSecuritiesAverageMarketValuePerUnit": { "auth_ref": [ "r523" ], "lang": { "en-us": { "role": { "label": "Senior Securities Average Market Value per Unit" } } }, "localname": "SeniorSecuritiesAverageMarketValuePerUnit", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "label": "Senior Securities Averaging Method, Note [Text Block]" } } }, "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SeniorSecuritiesCoveragePerUnit": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "label": "Senior Securities Coverage per Unit" } } }, "localname": "SeniorSecuritiesCoveragePerUnit", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_SeniorSecuritiesHeadingsNoteTextBlock": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "label": "Senior Securities Headings, Note [Text Block]" } } }, "localname": "SeniorSecuritiesHeadingsNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": { "auth_ref": [ "r517", "r524" ], "lang": { "en-us": { "role": { "label": "Senior Securities Highlights Annualized, Note [Text Block]" } } }, "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": { "auth_ref": [ "r518", "r524" ], "lang": { "en-us": { "role": { "label": "Senior Securities Highlights Audited, Note [Text Block]" } } }, "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit": { "auth_ref": [ "r522" ], "lang": { "en-us": { "role": { "label": "Senior Securities Involuntary Liquidating Preference per Unit" } } }, "localname": "SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_SeniorSecuritiesNoteTextBlock": { "auth_ref": [ "r516", "r524" ], "lang": { "en-us": { "role": { "label": "Senior Securities, Note [Text Block]" } } }, "localname": "SeniorSecuritiesNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SeniorSecuritiesTableTextBlock": { "auth_ref": [ "r519" ], "lang": { "en-us": { "role": { "label": "Senior Securities [Table Text Block]" } } }, "localname": "SeniorSecuritiesTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SharePriceTableTextBlock": { "auth_ref": [ "r535" ], "lang": { "en-us": { "role": { "label": "Share Price [Table Text Block]" } } }, "localname": "SharePriceTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SharePricesNotActualTransactionsTextBlock": { "auth_ref": [ "r536" ], "lang": { "en-us": { "role": { "label": "Share Prices Not Actual Transactions [Text Block]" } } }, "localname": "SharePricesNotActualTransactionsTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_ShareholderTransactionExpensesTableTextBlock": { "auth_ref": [ "r500" ], "lang": { "en-us": { "role": { "label": "Shareholder Transaction Expenses [Table Text Block]" } } }, "localname": "ShareholderTransactionExpensesTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_TotalAnnualExpensesPercent": { "auth_ref": [ "r513" ], "lang": { "en-us": { "role": { "label": "Total Annual Expenses [Percent]" } } }, "localname": "TotalAnnualExpensesPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_UnderwritersCompensationPercent": { "auth_ref": [ "r509" ], "lang": { "en-us": { "role": { "label": "Underwriters Compensation [Percent]" } } }, "localname": "UnderwritersCompensationPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_WaiversAndReimbursementsOfFeesPercent": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "label": "Waivers and Reimbursements of Fees [Percent]" } } }, "localname": "WaiversAndReimbursementsOfFeesPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_WarrantsOrRightsCalledAmount": { "auth_ref": [ "r494" ], "lang": { "en-us": { "role": { "label": "Warrants or Rights, Called Amount" } } }, "localname": "WarrantsOrRightsCalledAmount", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_WarrantsOrRightsCalledPeriodDate": { "auth_ref": [ "r494" ], "lang": { "en-us": { "role": { "label": "Warrants or Rights, Called Period [Date]" } } }, "localname": "WarrantsOrRightsCalledPeriodDate", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "dateItemType" }, "cef_WarrantsOrRightsCalledTitleTextBlock": { "auth_ref": [ "r494" ], "lang": { "en-us": { "role": { "label": "Warrants or Rights, Called Title" } } }, "localname": "WarrantsOrRightsCalledTitleTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_WarrantsOrRightsExercisePrice": { "auth_ref": [ "r494" ], "lang": { "en-us": { "role": { "label": "Warrants or Rights, Exercise Price" } } }, "localname": "WarrantsOrRightsExercisePrice", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "dei_AdditionalSecurities462b": { "auth_ref": [ "r552" ], "lang": { "en-us": { "role": { "label": "Additional Securities. 462(b)" } } }, "localname": "AdditionalSecurities462b", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_AdditionalSecurities462bFileNumber": { "auth_ref": [ "r552" ], "lang": { "en-us": { "role": { "label": "Additional Securities, 462(b), File Number" } } }, "localname": "AdditionalSecurities462bFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "fileNumberItemType" }, "dei_AdditionalSecuritiesEffective413b": { "auth_ref": [ "r551" ], "lang": { "en-us": { "role": { "label": "Additional Securities Effective, 413(b)" } } }, "localname": "AdditionalSecuritiesEffective413b", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_AddressTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.", "label": "Address Type [Domain]" } } }, "localname": "AddressTypeDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings.", "label": "Approximate Date of Commencement of Proposed Sale to Public" } } }, "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "dateOrAsapItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r471", "r472", "r473" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r471", "r472", "r473" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r471", "r472", "r473" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "internationalNameItemType" }, "dei_BusinessContactMember": { "auth_ref": [ "r472", "r473" ], "lang": { "en-us": { "role": { "documentation": "Business contact for the entity", "label": "Business Contact [Member]" } } }, "localname": "BusinessContactMember", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_ContactPersonnelName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of contact personnel", "label": "Contact Personnel Name" } } }, "localname": "ContactPersonnelName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DelayedOrContinuousOffering": { "auth_ref": [ "r474", "r475", "r545" ], "lang": { "en-us": { "role": { "label": "Delayed or Continuous Offering" } } }, "localname": "DelayedOrContinuousOffering", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_DividendOrInterestReinvestmentPlanOnly": { "auth_ref": [ "r474", "r475", "r545" ], "lang": { "en-us": { "role": { "label": "Dividend or Interest Reinvestment Plan Only" } } }, "localname": "DividendOrInterestReinvestmentPlanOnly", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r471", "r472", "r473" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r546" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "submissionTypeItemType" }, "dei_EffectiveAfter60Days486a": { "auth_ref": [ "r556" ], "lang": { "en-us": { "role": { "label": "Effective after 60 Days, 486(a)" } } }, "localname": "EffectiveAfter60Days486a", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EffectiveOnDate486a": { "auth_ref": [ "r556" ], "lang": { "en-us": { "role": { "label": "Effective on Date, 486(a)" } } }, "localname": "EffectiveOnDate486a", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "dateItemType" }, "dei_EffectiveOnDate486b": { "auth_ref": [ "r557" ], "lang": { "en-us": { "role": { "label": "Effective on Date, 486(b)" } } }, "localname": "EffectiveOnDate486b", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "dateItemType" }, "dei_EffectiveOnSetDate486a": { "auth_ref": [ "r556" ], "lang": { "en-us": { "role": { "label": "Effective on Set Date, 486(a)" } } }, "localname": "EffectiveOnSetDate486a", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EffectiveOnSetDate486b": { "auth_ref": [ "r557" ], "lang": { "en-us": { "role": { "label": "Effective on Set Date, 486(b)" } } }, "localname": "EffectiveOnSetDate486b", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EffectiveUponFiling462e": { "auth_ref": [ "r555" ], "lang": { "en-us": { "role": { "label": "Effective Upon Filing, 462(e)" } } }, "localname": "EffectiveUponFiling462e", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EffectiveUponFiling486b": { "auth_ref": [ "r557" ], "lang": { "en-us": { "role": { "label": "Effective upon Filing, 486(b)" } } }, "localname": "EffectiveUponFiling486b", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EffectiveWhenDeclaredSection8c": { "auth_ref": [ "r559" ], "lang": { "en-us": { "role": { "label": "Effective when Declared, Section 8(c)" } } }, "localname": "EffectiveWhenDeclaredSection8c", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityAddressesAddressTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Entity Addresses, Address Type [Axis]" } } }, "localname": "EntityAddressesAddressTypeAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r469" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r469" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r558" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Securities Act File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r469" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r549" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityInvCompanyType": { "auth_ref": [ "r548" ], "lang": { "en-us": { "role": { "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product).", "label": "Entity Inv Company Type" } } }, "localname": "EntityInvCompanyType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "invCompanyType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r469" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r469" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r469" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r469" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r550" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "yesNoItemType" }, "dei_ExhibitsOnly462d": { "auth_ref": [ "r554" ], "lang": { "en-us": { "role": { "label": "Exhibits Only, 462(d)" } } }, "localname": "ExhibitsOnly462d", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_ExhibitsOnly462dFileNumber": { "auth_ref": [ "r554" ], "lang": { "en-us": { "role": { "label": "Exhibits Only, 462(d), File Number" } } }, "localname": "ExhibitsOnly462dFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "fileNumberItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r471", "r472", "r473" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_InvestmentCompanyActFileNumber": { "auth_ref": [ "r475", "r542", "r543", "r544" ], "lang": { "en-us": { "role": { "label": "Investment Company Act File Number" } } }, "localname": "InvestmentCompanyActFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "fileNumberItemType" }, "dei_InvestmentCompanyActRegistration": { "auth_ref": [ "r547" ], "lang": { "en-us": { "role": { "label": "Investment Company Act Registration" } } }, "localname": "InvestmentCompanyActRegistration", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_InvestmentCompanyRegistrationAmendment": { "auth_ref": [ "r547" ], "lang": { "en-us": { "role": { "label": "Investment Company Registration Amendment" } } }, "localname": "InvestmentCompanyRegistrationAmendment", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_InvestmentCompanyRegistrationAmendmentNumber": { "auth_ref": [ "r547" ], "lang": { "en-us": { "role": { "label": "Investment Company Registration Amendment Number" } } }, "localname": "InvestmentCompanyRegistrationAmendmentNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "sequenceNumberItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_NewEffectiveDateForPreviousFiling": { "auth_ref": [ "r475", "r542", "r543", "r544" ], "lang": { "en-us": { "role": { "label": "New Effective Date for Previous Filing" } } }, "localname": "NewEffectiveDateForPreviousFiling", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_NoSubstantiveChanges462c": { "auth_ref": [ "r553" ], "lang": { "en-us": { "role": { "label": "No Substantive Changes, 462(c)" } } }, "localname": "NoSubstantiveChanges462c", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_NoSubstantiveChanges462cFileNumber": { "auth_ref": [ "r553" ], "lang": { "en-us": { "role": { "label": "No Substantive Changes, 462(c), File Number" } } }, "localname": "NoSubstantiveChanges462cFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "fileNumberItemType" }, "dei_PostEffectiveAmendment": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "label": "Post-Effective Amendment" } } }, "localname": "PostEffectiveAmendment", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_PostEffectiveAmendmentNumber": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective.", "label": "Post-Effective Amendment Number" } } }, "localname": "PostEffectiveAmendmentNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "sequenceNumberItemType" }, "dei_PreEffectiveAmendment": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "label": "Pre-Effective Amendment" } } }, "localname": "PreEffectiveAmendment", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_PreEffectiveAmendmentNumber": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective.", "label": "Pre-Effective Amendment Number" } } }, "localname": "PreEffectiveAmendmentNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "sequenceNumberItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r468" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r470" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "slrc_AcresCommercialMortgageLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ACRES Commercial Mortgage, LLC.", "label": "ACRES Commercial Mortgage, LLC [Member]", "terseLabel": "ACRES Commercial Mortgage, LLC [Member]" } } }, "localname": "AcresCommercialMortgageLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AdministrativeServicesPayable": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 16.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Administrative services payable.", "label": "Administrative Services Payable", "terseLabel": "Administrative services payable (see note 3)" } } }, "localname": "AdministrativeServicesPayable", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "slrc_AdvisoryAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Advisory Agreement (Member)", "label": "Advisory Agreement [Member]", "terseLabel": "Advisory Agreement [Member]" } } }, "localname": "AdvisoryAgreementMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_AegisToxicologySciencesCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aegis toxicology sciences corporation.", "label": "Aegis Toxicology Sciences Corporation [Member]", "terseLabel": "Aegis Toxicology Sciences Corporation [Member]" } } }, "localname": "AegisToxicologySciencesCorporationMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AeroOperatingLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aero operating llc.", "label": "Aero Operating LLC [Member]", "terseLabel": "Aero Operating LLC [Member]" } } }, "localname": "AeroOperatingLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AerospaceAndDefenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aerospace and defense member.", "label": "Aerospace and Defense [Member]", "terseLabel": "Aerospace & Defense [Member]" } } }, "localname": "AerospaceAndDefenseMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AfgDallasIiiLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "AFG dallas III, LLC.", "label": "AFG Dallas III, LLC [Member]" } } }, "localname": "AfgDallasIiiLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AgreementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement Axis", "label": "Agreement [Axis]" } } }, "localname": "AgreementAxis", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_AgreementDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement Domain", "label": "Agreement [Domain]" } } }, "localname": "AgreementDomain", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_AgreementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement [Line item]", "label": "Agreement [Line Items]" } } }, "localname": "AgreementLineItems", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_AgreementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreements Abstract", "label": "Agreements [Abstract]" } } }, "localname": "AgreementsAbstract", "nsuri": "http://www.slrinvestments.com/20221231", "xbrltype": "stringItemType" }, "slrc_AgreementsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreements [Table]", "label": "Agreements [Table]" } } }, "localname": "AgreementsTable", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_AgreementsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of Agreements.", "label": "Agreements [Text Block]", "terseLabel": "Agreements" } } }, "localname": "AgreementsTextBlock", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/Agreements" ], "xbrltype": "textBlockItemType" }, "slrc_AirFreightAndLogisticsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Air freight and logistics member.", "label": "Air Freight and Logistics [Member]", "verboseLabel": "Air Freight & Logistics [Member]" } } }, "localname": "AirFreightAndLogisticsMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AirMethodsCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Air methods corporation.", "label": "Air Methods Corporation [Member]", "terseLabel": "Air Methods Corporation [Member]" } } }, "localname": "AirMethodsCorporationMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AirlinesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Airlines member.", "label": "Airlines [Member]" } } }, "localname": "AirlinesMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AlimeraSciencesInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Alimera sciences, inc.", "label": "Alimera Sciences, Inc. [Member]", "terseLabel": "Alimera Sciences, Inc. [Member]" } } }, "localname": "AlimeraSciencesInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AllStateAgPartsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All State Ag Parts, LLC.", "label": "All State Ag Parts LLC [Member]", "terseLabel": "All State Ag Parts, LLC", "verboseLabel": "All State Ag Parts, LLC [Member]" } } }, "localname": "AllStateAgPartsLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AlteonHealthLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Alteon Health, LLC", "label": "Alteon Health, LLC [Member]", "terseLabel": "Alteon Health, LLC [Member]" } } }, "localname": "AlteonHealthLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AmeraMexInternationalIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amera mex international inc.", "label": "Amera Mex International Inc [Member]", "terseLabel": "AmeraMex International, Inc. [Member]" } } }, "localname": "AmeraMexInternationalIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AmericanTeleconferencingServicesLtd.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "American teleconferencing services, ltd.", "label": "American Teleconferencing Services, Ltd. [Member]", "terseLabel": "American Teleconferencing Services, Ltd. [Member]" } } }, "localname": "AmericanTeleconferencingServicesLtd.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AmericanTeleconferencingServicesLtdOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "American Teleconferencing Services, Ltd One [Member]", "terseLabel": "American Teleconferencing Services, Ltd. [Member]" } } }, "localname": "AmericanTeleconferencingServicesLtdOneMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AmerimarkIntermediateHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ameri mark intermediate holdings, llc", "label": "AmeriMark Intermediate Holdings, LLC [Member]", "terseLabel": "AmeriMark Intermediate Holdings, LLC [Member]" } } }, "localname": "AmerimarkIntermediateHoldingsLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AmerimarkMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amerimark member.", "label": "Amerimark [Member]", "terseLabel": "Amerimark [Member]" } } }, "localname": "AmerimarkMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_ApeelTechnologyIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Apeel technology Inc.", "label": "Apeel Technology Inc [Member]", "terseLabel": "Apeel Technology, Inc [Member]" } } }, "localname": "ApeelTechnologyIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ApexServicesPartnersLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Apex services partners, LLC.", "label": "Apex Services Partners, LLC [Member]" } } }, "localname": "ApexServicesPartnersLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ArcutisBiotherapeuticsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arcutis Biotherapeutics, Inc.", "label": "Arcutis Biotherapeutics, Inc. [Member]", "terseLabel": "Arcutis Biotherapeutics, Inc. [Member]" } } }, "localname": "ArcutisBiotherapeuticsInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ArdelyxInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ardelyx, Inc.", "label": "Ardelyx, Inc. [Member]", "terseLabel": "Ardelyx, Inc. [Member]" } } }, "localname": "ArdelyxInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ArdelyxIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ardelyx Inc.", "label": "Ardelyx Inc [Member]", "terseLabel": "Ardelyx, Inc [Member]" } } }, "localname": "ArdelyxIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "xbrltype": "domainItemType" }, "slrc_AtriaWealthSolutionsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Atria wealth solutions, inc.", "label": "Atria Wealth Solutions, Inc [Member]", "terseLabel": "Atria Wealth Solutions, Inc. [Member]", "verboseLabel": "Atria Wealth Solutions, Inc [Member]" } } }, "localname": "AtriaWealthSolutionsIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_AtyrPharmaIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Atyr pharma inc.", "label": "ATyr Pharma Inc [Member]", "terseLabel": "aTyr Pharma, Inc. Warrants [Member]" } } }, "localname": "AtyrPharmaIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AutoComponentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Auto components member.", "label": "Auto Components [Member]" } } }, "localname": "AutoComponentsMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AutoPartsAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Auto parts and equipment member.", "label": "Auto Parts and Equipment [Member]", "verboseLabel": "Auto Parts & Equipment [Member]" } } }, "localname": "AutoPartsAndEquipmentMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AviatorcapSiiLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aviatorcap sii, llc.", "label": "AviatorCap SII LLC [Member]" } } }, "localname": "AviatorcapSiiLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_AxcellaHealthIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Axcella health inc.", "label": "Axcella Health Inc [Member]", "terseLabel": "Axcella Health Inc. [Member]" } } }, "localname": "AxcellaHealthIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BasicAndDilutedEarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basic And Diluted Earnings Per Share.", "label": "Basic And Diluted Earnings Per Share [Abstract]", "terseLabel": "Earnings per share (basic\u00a0& diluted)" } } }, "localname": "BasicAndDilutedEarningsPerShareAbstract", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetail" ], "xbrltype": "stringItemType" }, "slrc_BasicFunInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basic fun, Inc.", "label": "Basic Fun, Inc. [Member]", "terseLabel": "Basic Fun, Inc. [Member]" } } }, "localname": "BasicFunInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BaymarkHealthServicesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "BayMark health services, Inc.", "label": "BayMark Health Services Inc [Member]", "terseLabel": "BayMark Health Services, Inc [Member]", "verboseLabel": "BayMark Health Services Inc [Member]" } } }, "localname": "BaymarkHealthServicesIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_BazziniLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bazzini, LLC.", "label": "Bazzini, LLC [Member]" } } }, "localname": "BazziniLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BdgMediaInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "BDG media, Inc.", "label": "BDG Media, Inc. [Member]" } } }, "localname": "BdgMediaInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BiotechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Biotechnology member.", "label": "Biotechnology [Member]" } } }, "localname": "BiotechnologyMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BlackScholesPricingModelMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Black scholes pricing model.", "label": "Black Scholes Pricing Model [Member]" } } }, "localname": "BlackScholesPricingModelMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_BlackhawkMiningLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Blackhawk mining llc.", "label": "Blackhawk Mining LLC [Member]", "terseLabel": "Blackhawk Mining, LLC [Member]" } } }, "localname": "BlackhawkMiningLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BoardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Board [Member].", "label": "Board [Member]", "terseLabel": "Board [Member]" } } }, "localname": "BoardMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_BoartLongyearCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boart longyear company.", "label": "Boart Longyear Company [Member]", "terseLabel": "Boart Longyear Company [Member]" } } }, "localname": "BoartLongyearCompanyMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BowmanEnergySolutionsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bowman energy solutions, LLC.", "label": "Bowman Energy Solutions, LLC [Member]" } } }, "localname": "BowmanEnergySolutionsLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BridgeBioPharmaIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bridge Bio Pharma, Inc member.", "label": "Bridge Bio Pharma, Inc [Member]" } } }, "localname": "BridgeBioPharmaIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_BridgebioPharmaInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bridgebio pharma, inc.", "label": "BridgeBio Pharma, Inc. [Member]", "terseLabel": "BridgeBio Pharma, Inc. [Member]" } } }, "localname": "BridgebioPharmaInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BuildingProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Building Products Member.", "label": "Building Products [Member]" } } }, "localname": "BuildingProductsMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BusinessCombinationCommonStockIssuedByTheCompany": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail": { "order": 9.0, "parentTag": "slrc_BusinessCombinationPurchaseDiscount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common stock issued by the company.", "label": "Business Combination Common stock issued by the Company", "verboseLabel": "Common stock issued by the Company" } } }, "localname": "BusinessCombinationCommonStockIssuedByTheCompany", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail" ], "xbrltype": "monetaryItemType" }, "slrc_BusinessCombinationPurchaseDiscount": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business combination purchase discount.", "label": "Business Combination Purchase Discount", "totalLabel": "Total purchase discount" } } }, "localname": "BusinessCombinationPurchaseDiscount", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail" ], "xbrltype": "monetaryItemType" }, "slrc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsAtFairValue": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed investments at fair value.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Investments at Fair value", "terseLabel": "Investments, at fair value" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsAtFairValue", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail" ], "xbrltype": "monetaryItemType" }, "slrc_BusinessMergerTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business merger [Text block].", "label": "Business Merger [Text Block]", "terseLabel": "Merger with SUNS" } } }, "localname": "BusinessMergerTextBlock", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSuns" ], "xbrltype": "textBlockItemType" }, "slrc_CPortStoneLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "C Port Stone LLC.", "label": "C Port Stone LLC [Member]", "terseLabel": "C-Port/Stone LLC" } } }, "localname": "CPortStoneLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CapitalCityJetCenterIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capital city jet center inc.", "label": "Capital City Jet Center Inc [Member]", "terseLabel": "Capital City Jet Center, Inc. [Member]" } } }, "localname": "CapitalCityJetCenterIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CapitalMarketsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capital markets member.", "label": "Capital Markets [Member]" } } }, "localname": "CapitalMarketsMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CapitalShareTransactionsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capital share transactions.", "label": "Capital Share Transactions [Text Block]", "verboseLabel": "Capital Share Transactions" } } }, "localname": "CapitalShareTransactionsTextBlock", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactions" ], "xbrltype": "textBlockItemType" }, "slrc_CapitalizationOfPaymentInKindIncome": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Capitalization of\u00a0payment-in-kind\u00a0income.", "label": "Capitalization Of Payment In Kind Income", "terseLabel": "Capitalization of payment-in-kind income" } } }, "localname": "CapitalizationOfPaymentInKindIncome", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_CardioFocusIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cardio focus inc.", "label": "Cardio Focus Inc [Member]", "terseLabel": "CardioFocus, Inc. Warrants [Member]" } } }, "localname": "CardioFocusIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CashAndOtherAssetsAcquiredInMerger": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash and other assets acquired In merger.", "label": "Cash And Other Assets Acquired In Merger", "terseLabel": "Cash and other net assets acquired in merger" } } }, "localname": "CashAndOtherAssetsAcquiredInMerger", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_CashEquivalentsAtCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash equivalents at cost.", "label": "Cash Equivalents At Cost", "terseLabel": "Cash equivalents at cost" } } }, "localname": "CashEquivalentsAtCost", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "monetaryItemType" }, "slrc_CashEquivalentsAtFortyOnePointEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash Equivalents at Forty One Point Eight.", "label": "Cash Equivalents at Forty One Point Eight [Member]", "terseLabel": "Cash Equivalents \u00a00 41.8%" } } }, "localname": "CashEquivalentsAtFortyOnePointEightMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CashEquivalentsAtThirtyEightPointZeroMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash equivalents at thirty eight point zero.", "label": "Cash Equivalents at Thirty Eight Point Zero [Member]", "terseLabel": "Cash Equivalents \u00a00 38.0% [Member]" } } }, "localname": "CashEquivalentsAtThirtyEightPointZeroMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CcSagHoldingsCorp.SpectrumAutomotiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cc sag holdings corp. (spectrum automotive).", "label": "CC SAG Holdings Corp. (Spectrum Automotive) [Member]", "terseLabel": "CC SAG Holdings Corp. (Spectrum Automotive) [Member]" } } }, "localname": "CcSagHoldingsCorp.SpectrumAutomotiveMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CentrexionTherapeuticsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Centrexion therapeutics, inc.", "label": "Centrexion Therapeutics, Inc. [Member]", "terseLabel": "Centrexion Therapeutics, Inc. [Member]" } } }, "localname": "CentrexionTherapeuticsInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CentrexionTherapeuticsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Centrexion therapeutics inc.", "label": "Centrexion Therapeutics Inc [Member]", "terseLabel": "Centrexion Therapeutics, Inc. Warrants [Member]" } } }, "localname": "CentrexionTherapeuticsIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CerapedicsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cerapedics, inc.", "label": "Cerapedics, Inc. [Member]", "terseLabel": "Cerapedics, Inc. [Member]" } } }, "localname": "CerapedicsInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ChampionAirLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Champion air llc.", "label": "Champion Air LLC [Member]", "terseLabel": "Champion Air, LLC [Member]" } } }, "localname": "ChampionAirLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ChangeInUnrealizedGainLossOnInvestmentsAndCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Change in unrealized gain loss on investments and cash equivalents.", "label": "Change In Unrealized Gain Loss On Investments And Cash Equivalents [Abstract]", "terseLabel": "Net change in unrealized gain (loss) on investments and cash equivalents:" } } }, "localname": "ChangeInUnrealizedGainLossOnInvestmentsAndCashEquivalentsAbstract", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "slrc_CitiBankNaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Citi Bank NA.", "label": "Citi Bank NA [Member]" } } }, "localname": "CitiBankNaMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_CkdHoldingsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CKD holdings, Inc.", "label": "CKD Holdings, Inc. [Member]" } } }, "localname": "CkdHoldingsInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ClubcorpHoldingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Clubcorp holdings inc.", "label": "Clubcorp Holdings Inc [Member]", "terseLabel": "Clubcorp Holdings, Inc. [Member]" } } }, "localname": "ClubcorpHoldingsIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CollateralAgentAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collateral agent.", "label": "Collateral Agent [Axis]" } } }, "localname": "CollateralAgentAxis", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_CollateralAgentDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collateral agent.", "label": "Collateral Agent [Domain]" } } }, "localname": "CollateralAgentDomain", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_CollectionsOfPaymentInKindIncome": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Collections of\u00a0payment-in-kind\u00a0income.", "label": "Collections Of Payment In Kind Income", "terseLabel": "Collections of payment-in-kind income" } } }, "localname": "CollectionsOfPaymentInKindIncome", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_CommercialServicesAndSuppliesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commercial services and supplies member.", "label": "Commercial Services and Supplies [Member]", "verboseLabel": "Commercial Services & Supplies [Member]" } } }, "localname": "CommercialServicesAndSuppliesMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CommitmentFundedAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Commitment funded amount.", "label": "Commitment Funded Amount", "terseLabel": "Commitment funded amount" } } }, "localname": "CommitmentFundedAmount", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common equity or equity interests or warrants at fifty seven point one.", "label": "Common Equity Or Equity Interests Or Warrants At Fifty Seven Point one [Member]", "terseLabel": "Common Equity/Equity Interests/Warrants\u00a0057.1%" } } }, "localname": "CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common equity or equity interests or warrants at fifty three point six.", "label": "Common Equity Or Equity Interests Or Warrants At Fifty Three Point Six [Member]", "terseLabel": "Common Equity/Equity Interests/Warrants \u00a00 53.6% [Member]" } } }, "localname": "CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CommunicationsEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Communications equipment member.", "label": "Communications Equipment [Member]" } } }, "localname": "CommunicationsEquipmentMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CommunityBrandsParentcoLlcFkaMinistryBrandsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Community brands parentCo, LLC (f/k/a ministry brands).", "label": "Community Brands ParentCo, LLC (fka Ministry Brands) [Member]", "terseLabel": "Community Brands ParentCo, LLC (fka Ministry Brands) [Member]" } } }, "localname": "CommunityBrandsParentcoLlcFkaMinistryBrandsMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CompaniesLessThanFivePercentageOwnedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Companies less than five percentage owned.", "label": "Companies Less Than Five Percentage Owned [Member]", "terseLabel": "Companies less than 5% owned [Member]" } } }, "localname": "CompaniesLessThanFivePercentageOwnedMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "slrc_CompaniesMoreThanTwentyFivePercentageOwnedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Companies more than twenty five percentage owned.", "label": "Companies More Than Twenty Five Percentage Owned [Member]", "terseLabel": "Companies more than 25% owned [Member]" } } }, "localname": "CompaniesMoreThanTwentyFivePercentageOwnedMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "slrc_CompositeTechnologyAcquisitionCorp.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Composite technology acquisition corp.", "label": "Composite Technology Acquisition Corp. [Member]" } } }, "localname": "CompositeTechnologyAcquisitionCorp.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CompositeTechnologyAcquisitionCorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Composite technology acquisition corp.", "label": "Composite Technology Acquisition Corp [Member]", "terseLabel": "Composite Technology Acquisition Corp [Member]" } } }, "localname": "CompositeTechnologyAcquisitionCorpMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "xbrltype": "domainItemType" }, "slrc_ConstructionAndEngineeringMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Construction and engineering member.", "label": "Construction and Engineering [Member]", "verboseLabel": "Construction & Engineering [Member]" } } }, "localname": "ConstructionAndEngineeringMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ConsumerFinanceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consumer finance member.", "label": "Consumer Finance [Member]" } } }, "localname": "ConsumerFinanceMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ContainersAndPackagingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Containers and packaging member.", "label": "Containers and Packaging [Member]", "verboseLabel": "Containers & Packaging [Member]" } } }, "localname": "ContainersAndPackagingMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ConventusOrthopaedicsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conventus orthopaedics inc.", "label": "Conventus Orthopaedics Inc [Member]", "terseLabel": "Conventus Orthopaedics, Inc. Warrants [Member]" } } }, "localname": "ConventusOrthopaedicsIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CopperRiverSeafoodsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Copper river seafoods, Inc.", "label": "Copper River Seafoods, Inc. [Member]" } } }, "localname": "CopperRiverSeafoodsInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Credit Facility.", "label": "Credit Facility [Member]", "terseLabel": "Credit Facility" } } }, "localname": "CreditFacilityMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_CreditFacilityOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Credit facility one.", "label": "Credit Facility One [Member]", "terseLabel": "SPV\u00a0Credit Facility", "verboseLabel": "SPV Credit Facility" } } }, "localname": "CreditFacilityOneMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_CrystalCapitalFinancialHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Crystal capital financial holdings LLC.", "label": "Crystal Capital Financial Holdings LLC [Member]" } } }, "localname": "CrystalCapitalFinancialHoldingsLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_CrystalFinancialMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Crystal Financial(Member)", "label": "Crystal Financial [Member]", "terseLabel": "Crystal Financial [Member]" } } }, "localname": "CrystalFinancialMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_DateOfCommencementOfBusiness": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date of commencement of business.", "label": "Date of Commencement of Business", "terseLabel": "Date of commencement of business" } } }, "localname": "DateOfCommencementOfBusiness", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "slrc_DeepintentInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DeepIntent, inc.", "label": "DeepIntent, Inc. [Member]" } } }, "localname": "DeepintentInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_DelphinusMedicalTechnologiesInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Delphinus medical technologies, inc.", "label": "Delphinus Medical Technologies, Inc. [Member]", "terseLabel": "Delphinus Medical Technologies, Inc. [Member]" } } }, "localname": "DelphinusMedicalTechnologiesInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_DelphinusMedicalTechnologiesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Delphinus medical technologies inc.", "label": "Delphinus Medical Technologies Inc [Member]", "terseLabel": "Delphinus Medical Technologies, Inc. Warrants [Member]" } } }, "localname": "DelphinusMedicalTechnologiesIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_DescriptionOfFairValueMeasurementValuationProcess": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of fair value measurement valuation process.", "label": "Description Of Fair Value Measurement Valuation Process", "terseLabel": "Principal Valuation Technique/Methodology" } } }, "localname": "DescriptionOfFairValueMeasurementValuationProcess", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails" ], "xbrltype": "stringItemType" }, "slrc_DescriptionOfSignificantUnobservableInputUsed": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of significant unobservable input used.", "label": "Description of Significant Unobservable Input Used", "terseLabel": "Unobservable Input" } } }, "localname": "DescriptionOfSignificantUnobservableInputUsed", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails" ], "xbrltype": "stringItemType" }, "slrc_DiversifiedConsumerServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Diversified consumer services member.", "label": "Diversified Consumer Services [Member]" } } }, "localname": "DiversifiedConsumerServicesMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_DiversifiedFinancialServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Diversified financial services member", "label": "Diversified Financial Services [Member]", "verboseLabel": "Diversified Financial Services (includes SLR Credit Solutions) [Member]" } } }, "localname": "DiversifiedFinancialServicesMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_DongwonAutopartTechnologyIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dongwon autopart technology inc.", "label": "Dongwon Autopart Technology Inc [Member]", "terseLabel": "Dongwon Autopart Technology Inc. [Member]" } } }, "localname": "DongwonAutopartTechnologyIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_DrillersChoiceIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Drillers Choice, Inc", "label": "Drillers Choice, Inc [Member]" } } }, "localname": "DrillersChoiceIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EasyPakLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Easy pak llc.", "label": "Easy pak LLC [Member]", "terseLabel": "EasyPak, LLC [Member]" } } }, "localname": "EasyPakLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EnergyDrillingServicesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Energy drilling services, LLC.", "label": "Energy Drilling Services, LLC [Member]" } } }, "localname": "EnergyDrillingServicesLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EnergyEquipmentAndServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Energy equipment and services member.", "label": "Energy Equipment and Services [Member]", "verboseLabel": "Energy Equipment & Services [Member]" } } }, "localname": "EnergyEquipmentAndServicesMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EnhancedPermanentCapitalLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Enhanced permanent capital, llc.", "label": "Enhanced Permanent Capital, LLC [Member]", "terseLabel": "Enhanced Permanent Capital, LLC [Member]" } } }, "localname": "EnhancedPermanentCapitalLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EnsHoldingsIiiCorp.EsOpcoUsaLlcBluefinMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ENC holdings III corp. ES opco USALLC (Bluefin).", "label": "ENS Holdings III Corp. ES Opco USA LLC (Bluefin) [Member]", "terseLabel": "ENS Holdings III Corp. & ES Opco USA LLC (Bluefin) [Member]" } } }, "localname": "EnsHoldingsIiiCorp.EsOpcoUsaLlcBluefinMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EnsHoldingsIiiCorp.EsOpcoUsaLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ENS holdings III corp. & ES Opco USA LLC member.", "label": "ENS Holdings III Corp. ES Opco USA LLC [Member]", "terseLabel": "ENS Holdings III Corp. ES Opco USA LLC [Member]" } } }, "localname": "EnsHoldingsIiiCorp.EsOpcoUsaLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_EnsHoldingsIiiCorpLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ENS holdings III corp, LLC.", "label": "ENS Holdings III Corp, LLC [Member]" } } }, "localname": "EnsHoldingsIiiCorpLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "xbrltype": "domainItemType" }, "slrc_EnverusHoldingsIncFkaDrillingInfoHoldingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Enverus Holdings Inc fka Drilling Info Holdings Member.", "label": "Enverus Holdings Inc fka Drilling Info Holdings [Member]", "terseLabel": "Enverus Holdings, Inc. (fka Drilling Info Holdings) [Member]" } } }, "localname": "EnverusHoldingsIncFkaDrillingInfoHoldingsMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EnverusHoldingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Enverus holdings Inc.", "label": "Enverus Holdings Inc [Member]", "terseLabel": "Enverus Holdings, Inc [Member]" } } }, "localname": "EnverusHoldingsIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "xbrltype": "domainItemType" }, "slrc_EnvironmentalProtectionImprovementCompanyLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Environmental protection\u00a0& improvement company llc.", "label": "Environmental Protection Improvement Company LLC [Member]", "terseLabel": "Environmental Protection & Improvement Company, LLC [Member]" } } }, "localname": "EnvironmentalProtectionImprovementCompanyLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EquipmentBackedLeasesAndLoansLargestPositionOutstanding": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equipment backed leases and loans largest position outstanding.", "label": "Equipment Backed Leases And Loans Largest Position Outstanding", "terseLabel": "Equipment backed leases and loans largest position outstanding" } } }, "localname": "EquipmentBackedLeasesAndLoansLargestPositionOutstanding", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_EquipmentBackedLeasesAndLoansaverageExposurePerCustomer": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equipment backed leases and loans average exposure per customer.", "label": "Equipment Backed Leases and LoansAverage Exposure Per Customer", "terseLabel": "Equipment backed leases and loans average exposure per customer" } } }, "localname": "EquipmentBackedLeasesAndLoansaverageExposurePerCustomer", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_EquipmentFinancingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment financing.", "label": "Equipment Financing [Member]", "terseLabel": "Equipment Financing" } } }, "localname": "EquipmentFinancingMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_EquipmentFinancingThirtyTwoPointFivePercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment financing thirty two point five percent.", "label": "Equipment Financing Thirty Two Point Five Percent [Member]", "terseLabel": "Equipment Financing \u00a00 32.5% [Member]" } } }, "localname": "EquipmentFinancingThirtyTwoPointFivePercentMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EquipmentFinancingTwentySixPointSixPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment financing twenty six point six percent.", "label": "Equipment Financing Twenty Six Point Six Percent [Member]", "terseLabel": "Equipment Financing \u00a00 26.6%" } } }, "localname": "EquipmentFinancingTwentySixPointSixPercentMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EquipmentOperatingLeasesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment operating leases llc,", "label": "Equipment Operating Leases LLC [Member]", "terseLabel": "Equipment Operating Leases, LLC [Member]" } } }, "localname": "EquipmentOperatingLeasesLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_EquityMethodInvestmentAggregateEquityInvestment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity method investment aggregate equity investment.", "label": "Equity Method Investment Aggregate Equity Investment", "terseLabel": "Equity method investment aggregate equity investment" } } }, "localname": "EquityMethodInvestmentAggregateEquityInvestment", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_EquityMethodInvestmentAggregateInvestmentInInvesteeLeasesAndLoansHeld": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity method investment aggregate investment in investee leases and loans held.", "label": "Equity Method Investment Aggregate Investment In Investee Leases and Loans held", "terseLabel": "Equity method investment aggregate investment in investee leases and loans held" } } }, "localname": "EquityMethodInvestmentAggregateInvestmentInInvesteeLeasesAndLoansHeld", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_ErieConstructionMidwestLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Erie Construction mid-west LLC.", "label": "Erie Construction Midwest LLC [Member]", "terseLabel": "Erie Construction Mid-west, LLC [Member]" } } }, "localname": "ErieConstructionMidwestLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EspSscCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ESP SSC Corporation Member", "label": "ESP SSC Corporation [Member]", "terseLabel": "ESP SSC Corporation [Member]" } } }, "localname": "EspSscCorporationMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_EssenceGroupHoldingsCorporationLumerisMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Essence group holdings corporation (lumeris).", "label": "Essence Group Holdings Corporation (Lumeris) [Member]", "terseLabel": "Essence Group Holdings Corporation (Lumeris) Warrants [Member]" } } }, "localname": "EssenceGroupHoldingsCorporationLumerisMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expenses.", "label": "Expenses [Abstract]", "terseLabel": "EXPENSES:" } } }, "localname": "ExpensesAbstract", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "slrc_FairValueMeasurementWithUnobservableInputsReconciliationBasisRealizedGainLossIncludedInEarnings": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value measurement with unobservable inputs reconciliation basis realized gain loss included in earnings.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Basis Realized Gain Loss Included In Earnings", "terseLabel": "Net realized gain (loss)" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationBasisRealizedGainLossIncludedInEarnings", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "slrc_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value measurement with unobservable inputs reconciliation recurring basis liability realized gain loss included in earnings.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Realized Gain Loss Included In Earnings", "terseLabel": "Net realized (gain) loss" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details" ], "xbrltype": "monetaryItemType" }, "slrc_FairValueOfCommonStockPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value of common stock per share.", "label": "Fair Value Of Common Stock Per Share", "terseLabel": "Net asset value, end of period" } } }, "localname": "FairValueOfCommonStockPerShare", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "perShareItemType" }, "slrc_FastPayPartnersLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fast Pay Partners LLC [Member].", "label": "Fast Pay Partners LLC [Member]", "terseLabel": "Fast Pay Partners LLC [Member]" } } }, "localname": "FastPayPartnersLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_FirstAmericanCommercialBancorpIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First american commercial bancorp inc.", "label": "First American Commercial Bancorp Inc [Member]", "terseLabel": "First American Commercial Bancorp, Inc. [Member]" } } }, "localname": "FirstAmericanCommercialBancorpIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_FirstLienBankDebtOrSeniorSecuredLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First lien bank debt or senior secured loans.", "label": "First Lien Bank Debt Or Senior Secured Loans [Member]", "terseLabel": "First Lien Bank Debt/Senior Secured Loans [Member]" } } }, "localname": "FirstLienBankDebtOrSeniorSecuredLoansMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_FirstLienLifeScienceSeniorSecuredLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First lien life science senior secured loans.", "label": "First Lien Life Science Senior Secured Loans [Member]", "terseLabel": "First Lien Life Science Senior Secured Loans [Member]" } } }, "localname": "FirstLienLifeScienceSeniorSecuredLoansMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_FirstNationalCapitalLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First national capital llc.", "label": "First National Capital LLC [Member]", "terseLabel": "First National Capital, LLC [Member]" } } }, "localname": "FirstNationalCapitalLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_FoodAndStaplesRetailingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Food and staples retailing.", "label": "Food and Staples Retailing [Member]" } } }, "localname": "FoodAndStaplesRetailingMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_FoodProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Food products.", "label": "Food Products [Member]", "terseLabel": "Food Products [Member]" } } }, "localname": "FoodProductsMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_FootwearMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Footwear Member.", "label": "Footwear [Member]" } } }, "localname": "FootwearMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_FoundationConsumerBrandsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foundation consumer brands, llc", "label": "Foundation Consumer Brands, LLC [Member]", "terseLabel": "Foundation Consumer Brands, LLC [Member]", "verboseLabel": "Foundation Consumer Brands, LLC [Member]" } } }, "localname": "FoundationConsumerBrandsLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_FreightsolLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Freightsol llc.", "label": "Freightsol LLC [Member]", "terseLabel": "Freightsol LLC [Member]" } } }, "localname": "FreightsolLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_GardaClTechnicalServicesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Garda cl technical services inc.", "label": "Garda CL Technical Services Inc [Member]", "terseLabel": "Garda CL Technical Services, Inc. [Member]" } } }, "localname": "GardaClTechnicalServicesIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_GeorgiaJetIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Georgia Jet Inc.", "label": "Georgia Jet Inc [Member]", "terseLabel": "Georgia Jet, Inc. [Member]" } } }, "localname": "GeorgiaJetIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_GlookoInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Glooko, inc.", "label": "Glooko, Inc. [Member]", "terseLabel": "Glooko, Inc. [Member]" } } }, "localname": "GlookoInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_GmtCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "GMT corporation.", "label": "GMT Corporation [Member]", "terseLabel": "GMT Corporation [Member]" } } }, "localname": "GmtCorporationMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_GrossIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gross income.", "label": "Gross Income", "terseLabel": "Gross income" } } }, "localname": "GrossIncome", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_GsmAcquisitionCorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "GSM acquisition corp.", "label": "GSM Acquisition Corp [Member]", "terseLabel": "GSM Acquisition Corp [Member]" } } }, "localname": "GsmAcquisitionCorpMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_HaljoeCoachesUsaLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Haljoe coaches usa llc.", "label": "Haljoe Coaches USA LLC [Member]", "terseLabel": "Haljoe Coaches USA, LLC [Member]" } } }, "localname": "HaljoeCoachesUsaLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_HawkeyeContractingCompanyLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hawkeye contracting company llc.", "label": "Hawkeye Contracting Company LLC [Member]", "terseLabel": "Hawkeye Contracting Company, LLC [Member]" } } }, "localname": "HawkeyeContractingCompanyLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_HealthCareEquipmentAndSuppliesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Health care equipment and supplies member.", "label": "Health Care Equipment and Supplies [Member]", "verboseLabel": "Health Care Equipment & Supplies [Member]" } } }, "localname": "HealthCareEquipmentAndSuppliesMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_HealthCareProvidersAndServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Health care providers and services.", "label": "Health Care Providers and Services [Member]", "verboseLabel": "Health Care Providers & Services [Member]" } } }, "localname": "HealthCareProvidersAndServicesMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_HealthCareTechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Health care technology member.", "label": "Health Care Technology [Member]" } } }, "localname": "HealthCareTechnologyMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_HigginbothamInsuranceAgencyIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Higginbotham Insurance Agency Inc Member.", "label": "Higginbotham Insurance Agency Inc [Member]", "terseLabel": "Higginbotham Insurance Agency, Inc [Member]" } } }, "localname": "HigginbothamInsuranceAgencyIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_HighStreetBuyerIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "High street buyer, Inc.", "label": "High Street Buyer Inc [Member]", "terseLabel": "High Street Buyer, Inc [Member]", "verboseLabel": "High Street Buyer Inc [Member]" } } }, "localname": "HighStreetBuyerIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_HotelsRestaurantsAndLeisureMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hotels, restaurants and leisure member.", "label": "Hotels, Restaurants and Leisure [Member]", "verboseLabel": "Hotels, Restaurants & Leisure [Member]" } } }, "localname": "HotelsRestaurantsAndLeisureMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_HtiLogisticsCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "HTI logistics corporation.", "label": "HTI Logistics Corporation [Member]", "terseLabel": "HTI Logistics Corporation [Member]" } } }, "localname": "HtiLogisticsCorporationMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_HumanInterestIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Human interest Inc.", "label": "Human Interest Inc [Member]", "terseLabel": "Human Interest, Inc [Member]" } } }, "localname": "HumanInterestIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_IcimsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "iCIMS, Inc.", "label": "iCIMS, Inc. [Member]", "terseLabel": "iCIMS, Inc. [Member]" } } }, "localname": "IcimsInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_IncreaseDecreaseInAdministrativeServicesExpensePayable": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in administrative services expense payable.", "label": "Increase Decrease In Administrative Services Expense Payable", "terseLabel": "Administrative services expense payable" } } }, "localname": "IncreaseDecreaseInAdministrativeServicesExpensePayable", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_IncreaseDecreaseInDeferredFinancingCosts": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in deferred financing costs.", "label": "Increase Decrease In Deferred Financing Costs", "terseLabel": "Deferred financing costs/market discount" } } }, "localname": "IncreaseDecreaseInDeferredFinancingCosts", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_IncreaseDecreaseInInvestmentIncomeAmortizationOfDiscount": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in investment income amortization of discount.", "label": "Increase Decrease In Investment Income Amortization Of Discount", "terseLabel": "Net accretion of discount on investments" } } }, "localname": "IncreaseDecreaseInInvestmentIncomeAmortizationOfDiscount", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_IncreaseDecreaseInNetAssetsFromOperation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in net assets from operation.", "label": "Increase Decrease In Net Assets From Operation", "terseLabel": "Numerator\u00a00net increase in net assets resulting from operations" } } }, "localname": "IncreaseDecreaseInNetAssetsFromOperation", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetail" ], "xbrltype": "monetaryItemType" }, "slrc_IncreaseDecreaseInPayableForInvestmentsAndCashEquivalentsPurchased": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in payable for investments and cash equivalents purchased.", "label": "Increase Decrease In Payable For Investments And Cash Equivalents Purchased", "terseLabel": "Payable for investments and cash equivalents purchased" } } }, "localname": "IncreaseDecreaseInPayableForInvestmentsAndCashEquivalentsPurchased", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_IncreaseDecreaseInPaymentsToAcquireInvestments": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in payments to acquire investments.", "label": "Increase Decrease In Payments To Acquire Investments", "terseLabel": "Purchase of investments" } } }, "localname": "IncreaseDecreaseInPaymentsToAcquireInvestments", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_IncreaseDecreaseInPerformanceBasedIncentiveFeePayable": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease In performance-based incentive fee payable.", "label": "Increase Decrease In Performance Based Incentive Fee Payable", "terseLabel": "Performance-based incentive fee payable" } } }, "localname": "IncreaseDecreaseInPerformanceBasedIncentiveFeePayable", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_IncreaseDecreaseInProceedsFromSaleMaturityAndCollectionsOfInvestments": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in proceeds from sale maturity and collections of investments.", "label": "Increase Decrease IN Proceeds From Sale Maturity And Collections Of Investments", "terseLabel": "Proceeds from disposition of investments" } } }, "localname": "IncreaseDecreaseInProceedsFromSaleMaturityAndCollectionsOfInvestments", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_IncreaseDecreaseReceivableForInvestmentsSold": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 25.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease receivable for investments sold.", "label": "Increase Decrease Receivable For Investments Sold", "terseLabel": "Receivable for investments sold" } } }, "localname": "IncreaseDecreaseReceivableForInvestmentsSold", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_InitialCapitalOfBusiness": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Initial capital of business.", "label": "Initial Capital Of Business", "terseLabel": "Initial capital of business" } } }, "localname": "InitialCapitalOfBusiness", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_InsuranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Insurance member.", "label": "Insurance [Member]", "terseLabel": "Insurance" } } }, "localname": "InsuranceMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_InszoneMidLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Inszone mid, llc.", "label": "Inszone Mid, LLC [Member]", "terseLabel": "Inszone Mid, LLC [Member]" } } }, "localname": "InszoneMidLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_InterestAndOtherCreditFacilityExpenses": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest and other credit facility expenses.", "label": "Interest And Other Credit Facility Expenses", "terseLabel": "Interest and other credit facility expenses (see note 7)" } } }, "localname": "InterestAndOtherCreditFacilityExpenses", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "slrc_InterestPayableAndOtherCreditFacilityRelatedExpenses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest payable and other credit facility related expenses.", "label": "Interest payable and other credit facility related expenses", "terseLabel": "Interest payable and other credit facility related expenses" } } }, "localname": "InterestPayableAndOtherCreditFacilityRelatedExpenses", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "slrc_InternationalAutomotiveComponentsGroupNorthAmericaIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "International automotive components group north america inc", "label": "International Automotive Components Group North America Inc [Member]", "terseLabel": "International Automotive Components Group, North America, Inc. [Member]" } } }, "localname": "InternationalAutomotiveComponentsGroupNorthAmericaIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_InternetAndCatalogRetailMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Internet and catalog retail member.", "label": "Internet and Catalog Retail [Member]", "verboseLabel": "Internet & Catalog Retail [Member]" } } }, "localname": "InternetAndCatalogRetailMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_InternetSoftwareServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Internet Software & Services Member.", "label": "Internet Software Services [Member]" } } }, "localname": "InternetSoftwareServicesMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_InvestmentCompanyAntidilutionPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment company, anti-dilution, per share.", "label": "Investment Company, Antidilution, Per Share", "terseLabel": "Anti-dilution" } } }, "localname": "InvestmentCompanyAntidilutionPerShare", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "decimalItemType" }, "slrc_InvestmentCompanyDistributableEarningsLossOtherBookTaxTemporaryDifferences": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfTotalAccumulatedEarningsLossOnATaxBasisDetails": { "order": 6.0, "parentTag": "slrc_InvestmentCompanyTaxAccumulatedLoss", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Investment company, distributable earnings (Loss),other book/tax temporary differences.", "label": "Investment Company Distributable Earnings Loss Other book tax temporary differences", "negatedLabel": "Other book/tax temporary differences" } } }, "localname": "InvestmentCompanyDistributableEarningsLossOtherBookTaxTemporaryDifferences", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfTotalAccumulatedEarningsLossOnATaxBasisDetails" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentCompanyDistributableEarningsLossPostOctoberCapitalLosses": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfTotalAccumulatedEarningsLossOnATaxBasisDetails": { "order": 4.0, "parentTag": "slrc_InvestmentCompanyTaxAccumulatedLoss", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Investment company, distributable earnings (loss),post-october capital losses.", "label": "Investment Company Distributable Earnings Loss Post October capital losses", "terseLabel": "Post-October capital losses" } } }, "localname": "InvestmentCompanyDistributableEarningsLossPostOctoberCapitalLosses", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfTotalAccumulatedEarningsLossOnATaxBasisDetails" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentCompanyDistributionLongTermCapitalGainPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment company distribution long term capital gain percent.", "label": "Investment Company Distribution Long Term Capital Gain Percent", "terseLabel": "Capital gains percent" } } }, "localname": "InvestmentCompanyDistributionLongTermCapitalGainPercent", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfDistributionsToShareholdersDetails" ], "xbrltype": "percentItemType" }, "slrc_InvestmentCompanyDistributionOrdinaryIncomePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment company distribution ordinary income percent.", "label": "Investment Company Distribution Ordinary Income Percent", "terseLabel": "Ordinary income percent" } } }, "localname": "InvestmentCompanyDistributionOrdinaryIncomePercent", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfDistributionsToShareholdersDetails" ], "xbrltype": "percentItemType" }, "slrc_InvestmentCompanyDistributionRecognizedInSubsequentYear": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investment company distribution recognized in subsequent year.", "label": "Investment Company Distribution recognized in subsequent year", "terseLabel": "Distribution recognized in subsequent year" } } }, "localname": "InvestmentCompanyDistributionRecognizedInSubsequentYear", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfDistributionsToShareholdersDetails" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentCompanyDistributionRecognizedInSubsequentYearPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment company Distribution recognized in subsequent year Percent.", "label": "Investment Company Distribution Recognized in Subsequent Year Percent", "terseLabel": "Distribution recognized in subsequent year percent" } } }, "localname": "InvestmentCompanyDistributionRecognizedInSubsequentYearPercent", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfDistributionsToShareholdersDetails" ], "xbrltype": "percentItemType" }, "slrc_InvestmentCompanyDistributionToShareholdersTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment company, distribution to shareholders.", "label": "Investment Company, Distribution To Shareholders [Table Text Block]", "terseLabel": "Investment Company, Distribution To Shareholders" } } }, "localname": "InvestmentCompanyDistributionToShareholdersTableTextBlock", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationTables" ], "xbrltype": "textBlockItemType" }, "slrc_InvestmentCompanyDividendDistributionEligibleForQualifiedDividendIncomeTreatmentOrTheDividendsReceivedDeductionForCorporateStockholdersPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment company, Dividend distribution, eligible for qualified dividend income treatment or the dividends received deduction for corporate stockholders percent.", "label": "Investment Company Dividend Distribution eligible for qualified dividend income treatment or the dividends received deduction for corporate stockholders Percent", "terseLabel": "Investment Company,Dividend Distribution, eligible for qualified dividend income treatment or the dividends received deduction for corporate stockholders Percent" } } }, "localname": "InvestmentCompanyDividendDistributionEligibleForQualifiedDividendIncomeTreatmentOrTheDividendsReceivedDeductionForCorporateStockholdersPercent", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationAdditionalInformationDetails" ], "xbrltype": "pureItemType" }, "slrc_InvestmentCompanyDividendDistributionInterestRelatedDividendsPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment company, Dividend distribution, interest-related dividends percent.", "label": "Investment Company Dividend Distribution Interest related dividends Percent", "terseLabel": "Investment Company,Dividend Distribution, interest-related dividends Percent" } } }, "localname": "InvestmentCompanyDividendDistributionInterestRelatedDividendsPercent", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationAdditionalInformationDetails" ], "xbrltype": "pureItemType" }, "slrc_InvestmentCompanyDividendDistributionPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment company dividend distribution percent.", "label": "Investment Company Dividend Distribution Percent", "terseLabel": "Total distributions percent" } } }, "localname": "InvestmentCompanyDividendDistributionPercent", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfDistributionsToShareholdersDetails" ], "xbrltype": "percentItemType" }, "slrc_InvestmentCompanyDividendDistributionShortTermCapitalGainsPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment company, Dividend distribution, short-term capital gains, percent.", "label": "Investment Company Dividend Distribution short term capital gains Percent", "terseLabel": "Investment Company, Dividend Distribution, short-term capital gains, Percent" } } }, "localname": "InvestmentCompanyDividendDistributionShortTermCapitalGainsPercent", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationAdditionalInformationDetails" ], "xbrltype": "pureItemType" }, "slrc_InvestmentCompanyEarningsDistribution": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": 7.0, "parentTag": "us-gaap_InvestmentCompanyDividendDistribution", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investment company earnings distribution.", "label": "Investment Company Earnings Distribution", "negatedLabel": "From distributable earnings" } } }, "localname": "InvestmentCompanyEarningsDistribution", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentCompanyIncreaseDecreaseInNetAssets": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase (decrease) in net assets.", "label": "Investment Company Increase Decrease In Net Assets", "totalLabel": "Total increase (decrease) in net assets" } } }, "localname": "InvestmentCompanyIncreaseDecreaseInNetAssets", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentCompanyInterestAndOtherCreditFacilityExpensesRatioAfterIncentiveAllocation": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails": { "order": 2.0, "parentTag": "us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Investment company interest and other credit facility expenses ratio after incentive allocation.", "label": "Investment Company Interest And Other Credit Facility Expenses Ratio After Incentive Allocation", "terseLabel": "Interest and other credit facility expenses" } } }, "localname": "InvestmentCompanyInterestAndOtherCreditFacilityExpensesRatioAfterIncentiveAllocation", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "percentItemType" }, "slrc_InvestmentCompanyNetAssetsFromOperationIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment Company Net Assets From Operation Increase Decrease", "label": "Investment Company Net Assets From Operation Increase Decrease [Abstract]", "verboseLabel": "Investment Company Change in Net Assets" } } }, "localname": "InvestmentCompanyNetAssetsFromOperationIncreaseDecreaseAbstract", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "stringItemType" }, "slrc_InvestmentCompanyNetIncreaseInNetAssetsResultingFromCapitalTransactions": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": 8.0, "parentTag": "slrc_InvestmentCompanyIncreaseDecreaseInNetAssets", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net increase in net assets resulting from capital transactions.", "label": "Investment Company Net Increase In Net Assets Resulting From Capital Transactions", "totalLabel": "Net increase in net assets resulting from capital transactions" } } }, "localname": "InvestmentCompanyNetIncreaseInNetAssetsResultingFromCapitalTransactions", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentCompanyOperatingExpensesRatioAfterIncentiveAllocation": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails": { "order": 1.0, "parentTag": "us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Investment company operating expenses ratio after incentive allocation.", "label": "Investment Company Operating Expenses Ratio After Incentive Allocation", "terseLabel": "Operating expenses" } } }, "localname": "InvestmentCompanyOperatingExpensesRatioAfterIncentiveAllocation", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "percentItemType" }, "slrc_InvestmentCompanyPerformanceBasedIncentiveFeesWaived": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Investment company performance based incentive fees waived.", "label": "Investment Company Performance Based Incentive Fees Waived", "terseLabel": "Performance-based incentive fees waived (see note 3)" } } }, "localname": "InvestmentCompanyPerformanceBasedIncentiveFeesWaived", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentCompanyReturnOfCapitalDistribution": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": 6.0, "parentTag": "us-gaap_InvestmentCompanyDividendDistribution", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of distributions to stockholders return of capital.", "label": "Investment Company Return Of Capital Distribution", "negatedLabel": "From return of capital", "terseLabel": "Return of capital" } } }, "localname": "InvestmentCompanyReturnOfCapitalDistribution", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfDistributionsToShareholdersDetails" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentCompanyTaxAccumulatedLoss": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfTotalAccumulatedEarningsLossOnATaxBasisDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investment company tax accumulated loss.", "label": "Investment Company Tax Accumulated Loss", "totalLabel": "Total tax accumulated loss" } } }, "localname": "InvestmentCompanyTaxAccumulatedLoss", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfTotalAccumulatedEarningsLossOnATaxBasisDetails" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentCompanyTaxReturnOfCapitalDistributionPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment company tax return of capital distribution percent.", "label": "Investment Company Tax Return Of Capital Distribution Percent", "terseLabel": "Return of capital percent" } } }, "localname": "InvestmentCompanyTaxReturnOfCapitalDistributionPercent", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfDistributionsToShareholdersDetails" ], "xbrltype": "percentItemType" }, "slrc_InvestmentHoldingsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment Holdings.", "label": "Investment Holdings [Axis]" } } }, "localname": "InvestmentHoldingsAxis", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "slrc_InvestmentHoldingsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment Holdings.", "label": "Investment Holdings [Domain]" } } }, "localname": "InvestmentHoldingsDomain", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "slrc_InvestmentInSeniorSecuredLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment in senior secured loans.", "label": "Investment in Senior Secured Loans [Member]", "terseLabel": "Senior Secured Loans" } } }, "localname": "InvestmentInSeniorSecuredLoansMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_InvestmentIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment income.", "label": "Investment Income [Abstract]", "terseLabel": "INVESTMENT INCOME:" } } }, "localname": "InvestmentIncomeAbstract", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "slrc_InvestmentIncomeInvestmentExpensesNet": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 14.0, "parentTag": "us-gaap_NetInvestmentIncome", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investment income investment expenses net.", "label": "Investment Income Investment Expenses Net", "terseLabel": "Net expenses" } } }, "localname": "InvestmentIncomeInvestmentExpensesNet", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentOwnedAcquisitionDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment owned acquisition date.", "label": "Investment Owned Acquisition Date", "terseLabel": "Acquisition Date" } } }, "localname": "InvestmentOwnedAcquisitionDate", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "dateItemType" }, "slrc_InvestmentOwnedAtFairValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment owned at fair value.", "label": "Investment Owned At Fair Value [Abstract]", "terseLabel": "Investments at fair value:" } } }, "localname": "InvestmentOwnedAtFairValueAbstract", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "stringItemType" }, "slrc_InvestmentOwnedInterestAndDividendIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Investment owned, interest and dividend income.", "label": "Investment Owned, Interest And Dividend Income", "negatedLabel": "Interest/Dividend Income" } } }, "localname": "InvestmentOwnedInterestAndDividendIncome", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentOwnedUnrecognizedRealizedGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Investment owned, unrecognized realized gain loss.", "label": "Investment Owned, Unrecognized Realized Gain Loss", "negatedLabel": "Net realized gain (loss)" } } }, "localname": "InvestmentOwnedUnrecognizedRealizedGainLoss", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentOwnedUnrecognizedUnrealizedAdditions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investment owned, unrecognized unrealized additions.", "label": "Investment Owned, Unrecognized Unrealized Additions", "terseLabel": "Gross Additions" } } }, "localname": "InvestmentOwnedUnrecognizedUnrealizedAdditions", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentOwnedUnrecognizedUnrealizedGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Investment owned, unrecognized unrealized gain loss.", "label": "Investment Owned, Unrecognized Unrealized Gain Loss", "negatedLabel": "Net change in unrealized gain (loss)" } } }, "localname": "InvestmentOwnedUnrecognizedUnrealizedGainLoss", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentOwnedUnrecognizedUnrealizedReductions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Investment owned, unrecognized unrealized reductions.", "label": "Investment Owned, Unrecognized Unrealized Reductions", "negatedLabel": "Gross Reductions" } } }, "localname": "InvestmentOwnedUnrecognizedUnrealizedReductions", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentsOwnedFloorRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments owned floor rate .", "label": "Investments Owned Floor Rate", "terseLabel": "Floor" } } }, "localname": "InvestmentsOwnedFloorRate", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "percentItemType" }, "slrc_InvestmentsOwnedIndustryName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments owned industry name.", "label": "Investments Owned Industry Name", "terseLabel": "Industry" } } }, "localname": "InvestmentsOwnedIndustryName", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "stringItemType" }, "slrc_InvestmentsOwnedInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments owned interest rate.", "label": "Investments Owned Interest Rate", "terseLabel": "Interest Rate" } } }, "localname": "InvestmentsOwnedInterestRate", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "percentItemType" }, "slrc_InvestmentsOwnedSpreadAboveIndexRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments owned Spread above index rate.", "label": "Investments Owned Spread Above Index Rate", "terseLabel": "Spread Above Index", "verboseLabel": "Spread Above Index" } } }, "localname": "InvestmentsOwnedSpreadAboveIndexRate", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "stringItemType" }, "slrc_IssuanceOfCommonStockInConnectionWithTheMerger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of common stock in connection with the merger.", "label": "Issuance of Common Stock in Connection With the Merger", "terseLabel": "Issuance of common stock in connection with the Mergers" } } }, "localname": "IssuanceOfCommonStockInConnectionWithTheMerger", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "perShareItemType" }, "slrc_ItServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "IT services member.", "label": "IT Services [Member]" } } }, "localname": "ItServicesMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_IvyFertilityServicesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ivy fertility services, llc.", "label": "Ivy Fertility Services, LLC [Member]", "terseLabel": "Ivy Fertility Services, LLC [Member]", "verboseLabel": "Ivy Fertility Services, LLC [Member]" } } }, "localname": "IvyFertilityServicesLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_KaseyaIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kaseya Inc.", "label": "Kaseya Inc [Member]", "terseLabel": "Kaseya, Inc [Member]" } } }, "localname": "KaseyaIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_KbhTopcoLlcKingsbridgeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kbh topco llc (kingsbridge).", "label": "KBH Topco LLC (Kingsbridge) [Member]", "terseLabel": "KBH Topco LLC (Kingsbridge) [Member]" } } }, "localname": "KbhTopcoLlcKingsbridgeMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_KbhtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "KBHT", "label": "KBHT [Member]" } } }, "localname": "KbhtMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_KidDistroHoldingsLlcDistroKidMember": { "auth_ref": [], "lang": { "en-us": { "role": { "definitionGuidance": "Kid Distro Holdings, LLC (Distro Kid) [Member]", "documentation": "Kid distro holdings, llc (distro kid).", "label": "Kid Distro Holdings, LLC (Distro Kid) [Member]", "terseLabel": "Kid Distro Holdings, LLC (Distro Kid) [Member]", "verboseLabel": "Kid Distro Holdings, LLC [Member]" } } }, "localname": "KidDistroHoldingsLlcDistroKidMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_KingsbridgeHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kingsbridge Holdings, LLC.", "label": "Kingsbridge Holdings, LLC [Member]", "terseLabel": "Kingsbridge Holdings, LLC [Member]" } } }, "localname": "KingsbridgeHoldingsLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_KoolPakLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kool pak llc.", "label": "Kool Pak LLC [Member]", "terseLabel": "Kool Pak, LLC [Member]" } } }, "localname": "KoolPakLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_KoreWirelessGroupInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kore wireless group, inc..", "label": "KORE Wireless Group, Inc. [Member]", "terseLabel": "KORE Wireless Group, Inc. [Member]" } } }, "localname": "KoreWirelessGroupInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_LeisureEquipmentAndProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Leisure Equipment & Products member.", "label": "Leisure Equipment and Products [Member]" } } }, "localname": "LeisureEquipmentAndProductsMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_LiabilitiesInExcessOfOtherAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Liabilities in excess of other assets.", "label": "Liabilities in Excess of Other Assets", "negatedLabel": "Liabilities in Excess of Other Assets" } } }, "localname": "LiabilitiesInExcessOfOtherAssets", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "monetaryItemType" }, "slrc_LifeSciencesToolsAndServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Life sciences tools and services member.", "label": "Life Sciences Tools and Services [Member]", "verboseLabel": "Life Sciences Tools & Services [Member]" } } }, "localname": "LifeSciencesToolsAndServicesMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_LineOfCreditAndTermLoanOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of credit and term loan outstanding.", "label": "Line Of Credit And Term Loan Outstanding", "terseLabel": "Credit Facility, Carrying Value", "verboseLabel": "Line of credit and term loan outstanding" } } }, "localname": "LineOfCreditAndTermLoanOutstanding", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "slrc_LineOfCreditFacilityCommitmentsAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Line Of Credit Facility Commitments Amount", "label": "Line Of Credit Facility Commitments Amount", "terseLabel": "Line of credit facility commitments amount" } } }, "localname": "LineOfCreditFacilityCommitmentsAmount", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_LineOfCreditFacilityMaximumBorrowingCapacityWithAccordionFeature": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of credit facility maximum borrowing capacity with accordion feature.", "label": "Line Of Credit Facility Maximum Borrowing Capacity with Accordion Feature", "terseLabel": "Line of credit facility maximum borrowing capacity with accordion feature" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacityWithAccordionFeature", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_LineOfCreditMaximumBorrowingCapacityAndDebtInstrumentFaceValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of credit maximum borrowing capacity and debt instrument face value.", "label": "Line Of Credit Maximum Borrowing Capacity And Debt Instrument Face Value", "terseLabel": "Line of credit maximum borrowing capacity and debt instrument face value" } } }, "localname": "LineOfCreditMaximumBorrowingCapacityAndDebtInstrumentFaceValue", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_LocPerformanceProductsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loc Performance Products, LLC.", "label": "Loc Performance Products, LLC [Member]" } } }, "localname": "LocPerformanceProductsLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_LogixHoldingCompanyLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Logix holding company, llc.", "label": "Logix Holding Company, LLC [Member]", "terseLabel": "Logix Holding Company, LLC [Member]" } } }, "localname": "LogixHoldingCompanyLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_LongTermDebtMaximumAmountBorrowedDuringThePeriod": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long term debt maximum amount borrowed during the period.", "label": "Long Term Debt Maximum Amount Borrowed During The Period", "terseLabel": "Long term debt maximum amount borrowed during the period" } } }, "localname": "LongTermDebtMaximumAmountBorrowedDuringThePeriod", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_LongTermDebtOneAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long term debt one.", "label": "Long Term Debt One [Axis]" } } }, "localname": "LongTermDebtOneAxis", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_LongTermDebtOneDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long term debt one.", "label": "Long Term Debt One [Domain]" } } }, "localname": "LongTermDebtOneDomain", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_LongTermInvestmentsMeasurementInput": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long term investments measurement input.", "label": "Long Term Investments Measurement Input" } } }, "localname": "LongTermInvestmentsMeasurementInput", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "pureItemType" }, "slrc_LoyerCapitalLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loyer capital llc.", "label": "Loyer Capital LLC [Member]", "terseLabel": "Loyer Capital LLC [Member]" } } }, "localname": "LoyerCapitalLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_LuxCreditConsultantsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lux credit consultants llc.", "label": "Lux Credit Consultants LLC [Member]", "terseLabel": "Lux Credit Consultants, LLC [Member]" } } }, "localname": "LuxCreditConsultantsLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_LuxVendingLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lux vending llc.", "label": "Lux Vending LLC [Member]", "terseLabel": "Lux Vending, LLC [Member]" } } }, "localname": "LuxVendingLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_LuxuryAssetCapitalLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Luxury asset capital, LLC.", "label": "Luxury Asset Capital, LLC [Member]" } } }, "localname": "LuxuryAssetCapitalLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MachineryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Machinery member.", "label": "Machinery [Member]" } } }, "localname": "MachineryMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MauricesIncorporatedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maurices, incorporated.", "label": "Maurices, Incorporated [Member]", "terseLabel": "Maurices, Incorporated [Member]" } } }, "localname": "MauricesIncorporatedMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MeasuredAtNetAssetValueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measured at net asset value.", "label": "Measured at Net Asset Value" } } }, "localname": "MeasuredAtNetAssetValueMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "domainItemType" }, "slrc_MeasurementInputComparableMultipleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input comparable multiple.", "label": "Measurement Input Comparable Multiple [Member]", "terseLabel": "Comparable Multiple" } } }, "localname": "MeasurementInputComparableMultipleMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_MeasurementInputMarketYieldMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input market yield.", "label": "Measurement Input Market Yield [Member]", "terseLabel": "Market Yield" } } }, "localname": "MeasurementInputMarketYieldMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_MeasurementInputReturnOnEquityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input return on equity.", "label": "Measurement Input Return on Equity [Member]", "terseLabel": "Return on Equity" } } }, "localname": "MeasurementInputReturnOnEquityMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_MeasurementInputTypeOneAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input type one.", "label": "Measurement Input Type One [Axis]" } } }, "localname": "MeasurementInputTypeOneAxis", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "stringItemType" }, "slrc_MeasurementInputTypeOneDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input type one.", "label": "Measurement Input Type One [Domain]" } } }, "localname": "MeasurementInputTypeOneDomain", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_MediaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Media", "label": "Media [Member]", "terseLabel": "Media [Member]" } } }, "localname": "MediaMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MeditrinaInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Meditrina, inc.", "label": "Meditrina, Inc. [Member]" } } }, "localname": "MeditrinaInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MeditrinaIncWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Meditrina, Inc warrants.", "label": "Meditrina, Inc Warrants [Member]", "terseLabel": "Meditrina, Inc. Warrants [Member]" } } }, "localname": "MeditrinaIncWarrantsMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MergerWithSunsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Merger With Suns", "label": "Merger With Suns [Line Items]" } } }, "localname": "MergerWithSunsLineItems", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_MergerWithSunsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Merger with SUNS Table", "label": "Merger with SUNS [Table]" } } }, "localname": "MergerWithSunsTable", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_MetalsAndMiningMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Metals and mining member.", "label": "Metals and Mining [Member]", "terseLabel": "Metals & Mining [Member]" } } }, "localname": "MetalsAndMiningMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MmitHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "MMIT Holdings, LLC.", "label": "MMIT Holdings, LLC [Member]", "terseLabel": "MMIT Holdings, LLC [Member]" } } }, "localname": "MmitHoldingsLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MontefioreNyackHospitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Montefiore nyack Hospital.", "label": "Montefiore Nyack Hospital [Member]" } } }, "localname": "MontefioreNyackHospitalMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MountainAirHelicoptersIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mountain air helicopters inc.", "label": "Mountain Air Helicopters Inc [Member]", "terseLabel": "Mountain Air Helicopters, Inc. [Member]" } } }, "localname": "MountainAirHelicoptersIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MultiSectorHoldingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Multi-sector holdings member.", "label": "Multi Sector Holdings [Member]", "verboseLabel": "Multi-Sector Holdings (includes Kingsbridge Holdings, LLC, SLR Equipment Finance, Equipment Operating Leases, LLC and Loyer Capital LLC) [Member]" } } }, "localname": "MultiSectorHoldingsMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_NacHoldingsCorporationJaguarMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nac holdings corporation (jaguar).", "label": "NAC Holdings Corporation (Jaguar) [Member]", "terseLabel": "NAC Holdings Corporation (Jaguar) [Member]" } } }, "localname": "NacHoldingsCorporationJaguarMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_NacHoldingsCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NAC Holdings Corporation", "label": "NAC Holdings Corporation [Member]", "terseLabel": "NAC Holdings Corporation [Member]" } } }, "localname": "NacHoldingsCorporationMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "xbrltype": "domainItemType" }, "slrc_NationalSpineAndPainCentersLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "National Spine and Pain Centers LLC Member.", "label": "National Spine and Pain Centers LLC [Member]", "terseLabel": "National Spine and Pain Centers, LLC [Member]" } } }, "localname": "NationalSpineAndPainCentersLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_NefpassFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NEFPASS Facility [Member]", "verboseLabel": "NEFPASS Facility" } } }, "localname": "NefpassFacilityMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_NetAssetValuePerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net asset value per share.", "label": "Net Asset Value Per Share [Abstract]", "terseLabel": "Net Asset Value Per Share [Abstract]" } } }, "localname": "NetAssetValuePerShareAbstract", "nsuri": "http://www.slrinvestments.com/20221231", "xbrltype": "stringItemType" }, "slrc_NetAssetValuePerShareTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net asset value per share.", "label": "Net Asset Value Per Share [Text Block]", "terseLabel": "Net Asset Value Per Share" } } }, "localname": "NetAssetValuePerShareTextBlock", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/NetAssetValuePerShare" ], "xbrltype": "textBlockItemType" }, "slrc_NetChangeInUnrealizedGainLossOnInvestments": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 28.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net change in unrealized gain loss on investments.", "label": "Net Change In Unrealized Gain Loss On Investments", "negatedLabel": "Net change in unrealized loss on investments" } } }, "localname": "NetChangeInUnrealizedGainLossOnInvestments", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_NetIncreaseInNetAssetsResultingFromoperations": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 26.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net increase in net assets resulting from\u00a0operations.", "label": "Net Increase In Net Assets Resulting From Operations", "negatedLabel": "Net increase in net assets resulting from operations" } } }, "localname": "NetIncreaseInNetAssetsResultingFromoperations", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_NetRealizedGainLossOnInvestmentsAndCashEquivalents": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 27.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net realized (gain) loss on investments and cash equivalents.", "label": "Net Realized Gain Loss On Investments And Cash Equivalents", "negatedLabel": "Net realized (gain) loss on investments and cash equivalents" } } }, "localname": "NetRealizedGainLossOnInvestmentsAndCashEquivalents", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_NeuroneticsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Neuronetics, inc.", "label": "Neuronetics, Inc. [Member]", "terseLabel": "Neuronetics, Inc. [Member]" } } }, "localname": "NeuroneticsInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_NmHoldcoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NM Holdco [Member].", "label": "NM Holdco [Member]", "terseLabel": "NM Holdco [Member]" } } }, "localname": "NmHoldcoMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_NmcSeniorCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NMC senior credit facility.", "label": "NMC Senior Credit Facility [Member]", "terseLabel": "NMC Senior Credit Facility [Member]" } } }, "localname": "NmcSeniorCreditFacilityMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_NmcsCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NMC's credit facility [Member].", "label": "NMCs Credit Facility [Member]", "terseLabel": "NMCs Credit Facility [Member]" } } }, "localname": "NmcsCreditFacilityMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_NorthMillCapitalLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "North Mill Capital LLC Member", "label": "North Mill Capital LLC [Member]", "terseLabel": "North Mill Capital LLC [Member]" } } }, "localname": "NorthMillCapitalLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_NumberOfBasisPoints": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of basis points.", "label": "Number of Basis Points", "terseLabel": "Number of basis points" } } }, "localname": "NumberOfBasisPoints", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "slrc_NumberOfCustomers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Customers.", "label": "Number Of Customers", "terseLabel": "Number of Customers" } } }, "localname": "NumberOfCustomers", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "slrc_NumberOfFundedCommitment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of funded commitment.", "label": "Number Of Funded Commitment", "terseLabel": "Number of funded commitments" } } }, "localname": "NumberOfFundedCommitment", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "slrc_NumberOfIssuerInBusinessCredit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of issuer in business credit.", "label": "Number Of Issuer In Business Credit", "terseLabel": "Number of issuers in business credit" } } }, "localname": "NumberOfIssuerInBusinessCredit", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "slrc_NumberOfLoanInBusinessCredit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Loan in business credit.", "label": "Number Of Loan In Business Credit", "terseLabel": "Number of loans in business credit" } } }, "localname": "NumberOfLoanInBusinessCredit", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "slrc_OilGasAndConsumableFuelsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Oil, gas and consumable fuels member.", "label": "Oil, Gas and Consumable Fuels [Member]", "verboseLabel": "Oil, Gas & Consumable Fuels [Member]" } } }, "localname": "OilGasAndConsumableFuelsMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_OmniGuideHoldingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Omni Guide Holdings, Inc member.", "label": "Omni Guide Holdings, Inc [Member]" } } }, "localname": "OmniGuideHoldingsIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_OmniguideHoldingsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "OmniGuide holdings, inc.", "label": "OmniGuide Holdings, Inc. [Member]", "terseLabel": "OmniGuide Holdings, Inc. [Member]" } } }, "localname": "OmniguideHoldingsInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_OnAOneThousandInvestmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "On a one thousand investment.", "label": "On A One Thousand Investment [Member]", "terseLabel": "On a $1,000 investment" } } }, "localname": "OnAOneThousandInvestmentMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_OneTouchDirectLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "One touch direct, llc.", "label": "One Touch Direct, LLC [Member]", "terseLabel": "One Touch Direct, LLC [Member]" } } }, "localname": "OneTouchDirectLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_OrthopedicCarePartnersManagementLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Orthopedic care partners management, LLC.", "label": "Orthopedic Care Partners Management, LLC [Member]" } } }, "localname": "OrthopedicCarePartnersManagementLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_OutsetMedicalInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Outset medical, inc.", "label": "Outset Medical, Inc. [Member]" } } }, "localname": "OutsetMedicalInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_OzziesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ozzies, Inc", "label": "Ozzies, Inc [Member]", "terseLabel": "Ozzies, Inc. [Member]" } } }, "localname": "OzziesIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PackagedFoodsAndMeatsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Packaged foods and meats member.", "label": "Packaged Foods and Meats [Member]", "verboseLabel": "Packaged Foods & Meats [Member]" } } }, "localname": "PackagedFoodsAndMeatsMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PayableForInvestmentsAndCashEquivalentsPurchased": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 11.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payable for investments and cash equivalents purchased.", "label": "Payable For Investments And Cash Equivalents Purchased", "terseLabel": "Payable for investments and cash equivalents purchased" } } }, "localname": "PayableForInvestmentsAndCashEquivalentsPurchased", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "slrc_PcxAerostructuresLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PCX Aerostructures LLC.", "label": "PCX Aerostructures LLC [Member]" } } }, "localname": "PcxAerostructuresLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PediatricHomeRespiratoryServicesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pediatric home respiratory services, LLC.", "label": "Pediatric Home Respiratory Services, LLC [Member]" } } }, "localname": "PediatricHomeRespiratoryServicesLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PerShareDataAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share data.", "label": "Per Share Data [Abstract]", "terseLabel": "Per Share Data:" } } }, "localname": "PerShareDataAbstract", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "stringItemType" }, "slrc_PercentageOfCumulativeNetRealizedGainAndUnrealizedCapitalAppreciation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage Of Cumulative Net Realized Gain And Unrealized Capital Appreciation", "label": "Percentage Of Cumulative Net Realized Gain And Unrealized Capital Appreciation", "terseLabel": "Percentage of cumulative net realized gain and unrealized capital appreciation" } } }, "localname": "PercentageOfCumulativeNetRealizedGainAndUnrealizedCapitalAppreciation", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PercentageOfCumulativeRealizedCapitalGainLoss": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage Of Cumulative Realized Capital Gain Loss", "label": "Percentage of Cumulative Realized Capital Gain Loss", "terseLabel": "Percentage of cumulative realized capital gain loss" } } }, "localname": "PercentageOfCumulativeRealizedCapitalGainLoss", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PercentageOfEquityInterestContributedToAnotherEntity": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of equity interest contributed to another entity.", "label": "Percentage Of Equity Interest Contributed To Another Entity", "terseLabel": "Percentage of equity interest contributed to another entity" } } }, "localname": "PercentageOfEquityInterestContributedToAnotherEntity", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PercentageOfExciseTax": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of excise tax.", "label": "Percentage Of Excise Tax", "terseLabel": "Percentage of excise tax" } } }, "localname": "PercentageOfExciseTax", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PercentageOfGrossAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of gross assets.", "label": "Percentage Of Gross Assets", "terseLabel": "Percentage of gross assets" } } }, "localname": "PercentageOfGrossAssets", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PercentageOfInitialCapitalFundedByAffiliatedParties": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of initial capital funded by affiliated parties.", "label": "Percentage Of Initial Capital Funded By Affiliated Parties", "terseLabel": "Percentage of initial capital funded by affiliated parties" } } }, "localname": "PercentageOfInitialCapitalFundedByAffiliatedParties", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PercentageOfNonQualifyingAssetsInThePortfolioOfTotalAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of non qualifying\u00a0assets in the portfolio of total assets.", "label": "Percentage of Non Qualifying Assets in the Portfolio of Total Assets", "terseLabel": "Percentage of non-qualifying\u00a0assets in the portfolio of total assets" } } }, "localname": "PercentageOfNonQualifyingAssetsInThePortfolioOfTotalAssets", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageOfOutstandingVotingSecuritiesOfTheInvestment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of outstanding voting securities of the investment.", "label": "Percentage of Outstanding Voting Securities of the Investment", "terseLabel": "Percentage of outstanding voting securities of the investment" } } }, "localname": "PercentageOfOutstandingVotingSecuritiesOfTheInvestment", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageOfPreIncentiveFeeNetInvestmentIncome": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of pre-incentive fee net investment income.", "label": "Percentage of Pre Incentive Fee Net Investment Income", "terseLabel": "Percentage of pre-incentive fee net investment income" } } }, "localname": "PercentageOfPreIncentiveFeeNetInvestmentIncome", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PercentageOfTotalNetAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of total net assets.", "label": "Percentage Of Total Net Assets", "terseLabel": "Percentage of total net assets" } } }, "localname": "PercentageOfTotalNetAssets", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PercentageRepresentingCashEquivalentsInInvestmentsOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage representing cash equivalents in investments owned.", "label": "Percentage Representing Cash Equivalents in Investments Owned", "terseLabel": "Percentage representing cash equivalents in investments owned" } } }, "localname": "PercentageRepresentingCashEquivalentsInInvestmentsOwned", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageRepresentingCommonEquityOrEquityInterestsOrWarrantsOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage representing common equity or equity interests or warrants owned.", "label": "Percentage Representing Common Equity Or Equity Interests Or Warrants Owned", "terseLabel": "Percentage representing common equity or equity interests or warrants owned" } } }, "localname": "PercentageRepresentingCommonEquityOrEquityInterestsOrWarrantsOwned", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageRepresentingEquipmentFinancingInInvestmentsOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage representing equipment financing in investments owned.", "label": "Percentage Representing Equipment Financing in Investments Owned", "terseLabel": "Percentage representing equipment financing in investments owned" } } }, "localname": "PercentageRepresentingEquipmentFinancingInInvestmentsOwned", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageRepresentingLiabilitiesInExcessOfOtherAssetsInInvestmentsOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage representing liabilities in excess of other assets in investments owned.", "label": "Percentage Representing Liabilities in Excess of Other Assets in Investments Owned", "terseLabel": "Percentage representing liabilities in excess of other assets in investments owned" } } }, "localname": "PercentageRepresentingLiabilitiesInExcessOfOtherAssetsInInvestmentsOwned", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageRepresentingNetAssetsInInvestmentsOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage representing net assets in investments owned.", "label": "Percentage Representing Net Assets in Investments Owned", "terseLabel": "Percentage representing net assets in investments owned" } } }, "localname": "PercentageRepresentingNetAssetsInInvestmentsOwned", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageRepresentingPreferredEquityInInvestmentsOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage representing preferred equity in investments owned.", "label": "Percentage Representing Preferred Equity in Investments Owned", "terseLabel": "Percentage representing preferred equity in investments owned" } } }, "localname": "PercentageRepresentingPreferredEquityInInvestmentsOwned", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageRepresentingSeniorSecuredLoansInInvestmentsOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage representing senior secured loans in investments owned.", "label": "Percentage Representing Senior Secured Loans In Investments Owned", "terseLabel": "Percentage representing senior secured loans in investments owned" } } }, "localname": "PercentageRepresentingSeniorSecuredLoansInInvestmentsOwned", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageRepresentingTotalInvestmentsAndCashEquivalentsInInvestmentsOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage representing total investments and cash equivalents in investments owned.", "label": "Percentage Representing Total Investments and Cash Equivalents in Investments Owned", "terseLabel": "Percentage representing total investments and cash equivalents in investments owned" } } }, "localname": "PercentageRepresentingTotalInvestmentsAndCashEquivalentsInInvestmentsOwned", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageRepresentingTotalInvestmentsInInvestmentsOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage representing total investments in investments owned.", "label": "Percentage Representing Total Investments in Investments Owned", "terseLabel": "Percentage representing total investments in investments owned" } } }, "localname": "PercentageRepresentingTotalInvestmentsInInvestmentsOwned", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageSpreadAsCash": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage spread as cash.", "label": "Percentage Spread as Cash", "terseLabel": "Percentage spread as cash" } } }, "localname": "PercentageSpreadAsCash", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageSpreadAsPaidInKind": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage spread as paid in kind .", "label": "Percentage Spread as Paid in Kind", "terseLabel": "Percentage spread as paid in kind" } } }, "localname": "PercentageSpreadAsPaidInKind", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PerformanceBasedIncentiveFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Performance Based Incentive Fees", "label": "Performance Based Incentive Fees", "terseLabel": "Performance based incentive fees" } } }, "localname": "PerformanceBasedIncentiveFees", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_PerformanceBasedIncentiveFeesWaiver": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Performance based incentive fees waiver.", "label": "Performance Based Incentive Fees Waiver" } } }, "localname": "PerformanceBasedIncentiveFeesWaiver", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_PersonalProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Personal products member.", "label": "Personal Products [Member]", "terseLabel": "Personal Products" } } }, "localname": "PersonalProductsMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_PeterC.FoyAssociatesInsuranceServicesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Peter C. Foy Associates Insurance Services LLC.", "label": "Peter C. Foy Associates Insurance Services LLC [Member]", "terseLabel": "Peter C. Foy & Associates Insurance Services, LLC [Member]" } } }, "localname": "PeterC.FoyAssociatesInsuranceServicesLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "xbrltype": "domainItemType" }, "slrc_PeterCFoyandAssociatesInsuranceServicesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Peter C Foy\u00a0And Associates Insurance Services LLC Member.", "label": "Peter C FoyAnd Associates Insurance Services LLC [Member]", "terseLabel": "Peter C. Foy & Associates Insurance Services, LLC [Member]" } } }, "localname": "PeterCFoyandAssociatesInsuranceServicesLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PharmaceuticalsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pharmaceuticals member.", "label": "Pharmaceuticals [Member]" } } }, "localname": "PharmaceuticalsMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PhymedManagementLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PhyMed Management LLC.", "label": "PhyMed Management LLC [Member]", "terseLabel": "PhyMed Management LLC [Member]" } } }, "localname": "PhymedManagementLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PhynetDermatologyLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Phynet dermatology llc.", "label": "PhyNet Dermatology LLC [Member]", "terseLabel": "PhyNet Dermatology LLC [Member]" } } }, "localname": "PhynetDermatologyLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PinnacleTreatmentCentersInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pinnacle treatment centers, inc.", "label": "Pinnacle Treatment Centers, Inc. [Member]", "terseLabel": "Pinnacle Treatment Centers, Inc. [Member]" } } }, "localname": "PinnacleTreatmentCentersInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PlasticsManagementLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plastics Management LLC.", "label": "Plastics Management LLC [Member]", "terseLabel": "Plastics Management, LLC [Member]" } } }, "localname": "PlasticsManagementLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PortfolioTurnoverRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Portfolio turnover ratio.", "label": "Portfolio Turnover Ratio", "terseLabel": "Portfolio turnover ratio" } } }, "localname": "PortfolioTurnoverRatio", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "percentItemType" }, "slrc_PptManagementHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ppt management holdings, llc.", "label": "PPT Management Holdings, LLC [Member]", "terseLabel": "PPT Management Holdings, LLC [Member]" } } }, "localname": "PptManagementHoldingsLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PreIncentiveFeeNetInvestmentIncomeAnnualHurdleRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pre-incentive fee net investment income annual hurdle rate.", "label": "Pre Incentive Fee Net Investment Income Annual Hurdle Rate", "terseLabel": "Pre-incentive fee net investment income Annual hurdle rate" } } }, "localname": "PreIncentiveFeeNetInvestmentIncomeAnnualHurdleRate", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PreIncentiveFeeNetInvestmentIncomeQuarterHurdleRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pre-incentive fee net investment income Quarter hurdle rate.", "label": "Pre Incentive Fee Net Investment Income Quarter Hurdle Rate", "terseLabel": "Pre-incentive fee net investment income Quarter hurdle rate" } } }, "localname": "PreIncentiveFeeNetInvestmentIncomeQuarterHurdleRate", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PreferredEquityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred equity.", "label": "Preferred Equity [Member]", "terseLabel": "Preferred Equity" } } }, "localname": "PreferredEquityMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_PreferredEquityZeroPointSevenPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred equity zero point seven percent.", "label": "Preferred Equity Zero Point Seven Percent [Member]", "terseLabel": "Preferred Equity \u00a02 0.7% [Member]" } } }, "localname": "PreferredEquityZeroPointSevenPercentMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PreferredEquityzeroPointFourPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred EquityZero Point Four Percent Member.", "label": "Preferred EquityZero Point Four Percent [Member]", "terseLabel": "Preferred Equity \u00a02 0.4% [Member]" } } }, "localname": "PreferredEquityzeroPointFourPercentMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RaneLightMetalCastingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rane light metal castings inc.", "label": "Rane Light Metal Castings Inc [Member]", "terseLabel": "Rane Light Metal Castings Inc. [Member]" } } }, "localname": "RaneLightMetalCastingsIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RangoIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rango inc.", "label": "Rango Inc [Member]", "terseLabel": "Rango, Inc. [Member]" } } }, "localname": "RangoIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RdHoldcoInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RD holdco, Inc.", "label": "RD Holdco, Inc. [Member]" } } }, "localname": "RdHoldcoInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RdHoldcoIncClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RD Holdco Inc Class B.", "label": "RD Holdco Inc Class B [Member]", "terseLabel": "RD Holdco Inc. (Rug Doctor, class B) [Member]" } } }, "localname": "RdHoldcoIncClassBMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_RdHoldcoIncCommonEquityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RD Holdco Inc Common Equity.", "label": "RD Holdco Inc Common Equity [Member]" } } }, "localname": "RdHoldcoIncCommonEquityMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_RdHoldcoIncDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RD Holdco Inc Debt [Member]" } } }, "localname": "RdHoldcoIncDebtMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_RdHoldcoIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rd holdco inc.", "label": "RD Holdco Inc [Member]", "terseLabel": "RD Holdco Inc. (Rug Doctor) [Member]" } } }, "localname": "RdHoldcoIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RdHoldcoIncWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RD Holdco Inc Warrants [Member]", "terseLabel": "RD Holdco Inc. (Rug Doctor, Warrants) [Member]" } } }, "localname": "RdHoldcoIncWarrantsMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_ReceivableForInvestmentsSold": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Receivable for investments sold.", "label": "Receivable for Investments Sold", "terseLabel": "Receivable for investments sold" } } }, "localname": "ReceivableForInvestmentsSold", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "slrc_ReclassificationBetweenAccumulatedDistributableNetLossAndpaidIncapitalInExcessOfPar": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Reclassification between accumulated distributable net loss and paid in capital in excess of par.", "label": "Reclassification Between Accumulated Distributable Net Loss andPaid inCapital in Excess of Par", "terseLabel": "Reclassification between accumulated distributable net loss and\u00a0paid in\u00a0capital in excess of Par" } } }, "localname": "ReclassificationBetweenAccumulatedDistributableNetLossAndpaidIncapitalInExcessOfPar", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_RecourseDebt": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Recourse debt.", "label": "Recourse Debt", "terseLabel": "Recourse debt" } } }, "localname": "RecourseDebt", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_RestrictedInvestmentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted investment term.", "label": "Restricted Investment Term", "terseLabel": "Restricted investment term" } } }, "localname": "RestrictedInvestmentTerm", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "slrc_RezoluteIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rezolute, inc.", "label": "Rezolute, Inc [Member]", "terseLabel": "Rezolute, Inc [Member]" } } }, "localname": "RezoluteIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RisksRelatingToAnInvestmentInOurSecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Risks relating to an investment in our securities.", "label": "Risks Relating To An Investment In Our Securities [Member]", "terseLabel": "Risks Relating to an Investment in Our Securities [Member]" } } }, "localname": "RisksRelatingToAnInvestmentInOurSecuritiesMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_RisksRelatingToOurBusinessAndStructureMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Risks relating to our business and structure.", "label": "Risks Relating To Our Business And Structure [Member]", "terseLabel": "Risks Relating to Our Business and Structure [Member]" } } }, "localname": "RisksRelatingToOurBusinessAndStructureMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_RisksRelatingToOurInvestmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Risks relating to our investment.", "label": "Risks Relating To Our Investments [Member]", "terseLabel": "Risks Relating to Our Investments [Member]" } } }, "localname": "RisksRelatingToOurInvestmentsMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_RoadAndRailMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Road and rail member.", "label": "Road and Rail [Member]", "verboseLabel": "Road & Rail [Member]" } } }, "localname": "RoadAndRailMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RosscoCraneRiggingIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rossco crane\u00a0& rigging inc.", "label": "Rossco Crane Rigging Inc [Member]", "terseLabel": "Rossco Crane & Rigging, Inc. [Member]" } } }, "localname": "RosscoCraneRiggingIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RottenRockHardscapingAndTreeServiceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rotten Rock Hardscaping and Tree Service", "label": "Rotten Rock Hardscaping and Tree Service [Member]", "terseLabel": "Rotten Rock Hardscaping & Tree Service" } } }, "localname": "RottenRockHardscapingAndTreeServiceMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RoyalCoachLinesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Royal coach lines inc.", "label": "Royal Coach Lines Inc [Member]", "terseLabel": "Royal Coach Lines, Inc.[Member]" } } }, "localname": "RoyalCoachLinesIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RoyalExpressIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Royal express inc.", "label": "Royal Express Inc [Member]", "terseLabel": "Royal Express Inc. [Member]" } } }, "localname": "RoyalExpressIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RqmCorp.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RQM Corp.", "label": "RQM Corp. [Member]", "terseLabel": "RQM+ Corp. [Member]" } } }, "localname": "RqmCorp.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RscAcquisitionIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RSC acquisition Inc.", "label": "RSC Acquisition Inc [Member]", "terseLabel": "RSC Acquisition, Inc [Member]" } } }, "localname": "RscAcquisitionIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RubiusTherapeuticsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rubius therapeutics, inc.", "label": "Rubius Therapeutics, Inc. [Member]", "terseLabel": "Rubius Therapeutics, Inc. [Member]" } } }, "localname": "RubiusTherapeuticsInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RugDoctorLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rug Doctor LLC.", "label": "Rug Doctor LLC [Member]", "terseLabel": "Rug Doctor LLC [Member]" } } }, "localname": "RugDoctorLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_RxsenseHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RxSense holdings LLC.", "label": "RxSense Holdings LLC [Member]", "terseLabel": "RxSense Holdings LLC [Member]" } } }, "localname": "RxsenseHoldingsLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ScpEyeCareLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SCP eye care, LLC.", "label": "SCP Eye Care, LLC [Member]" } } }, "localname": "ScpEyeCareLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ScpharmaceuticalsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "scPharmaceuticals, inc.", "label": "scPharmaceuticals, Inc. [Member]", "terseLabel": "scPharmaceuticals, Inc. [Member]" } } }, "localname": "ScpharmaceuticalsInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SecondLienAssetbasedSeniorSecuredLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second lien asset based senior secured loans.", "label": "Second Lien AssetBased Senior Secured Loans [Member]", "terseLabel": "Second Lien Asset-Based Senior Secured Loans [Member]" } } }, "localname": "SecondLienAssetbasedSeniorSecuredLoansMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SecondLienBankDebtOrSeniorSecuredLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second lien bank debt or senior secured loans.", "label": "Second Lien Bank Debt or Senior Secured Loans [Member]", "terseLabel": "Second Lien Bank Debt/Senior Secured Loans [Member]" } } }, "localname": "SecondLienBankDebtOrSeniorSecuredLoansMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SeniorSecuredCommitmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior-secured commitments [Member].", "label": "Senior Secured Commitments [Member]", "terseLabel": "Senior Secured Commitments [Member]" } } }, "localname": "SeniorSecuredCommitmentsMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior secured loans at one hundred and eleven point five percent.", "label": "Senior Secured Loans At One Hundred And Eleven Point Five Percent [Member]", "terseLabel": "Senior Secured Loans \u00a00 111.5% [Member]" } } }, "localname": "SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Secured Loans at One hundred and Twenty Four Point Six Percent.", "label": "Senior Secured Loans at One hundred and Twenty Four Point Six Percent [Member]", "terseLabel": "Senior Secured Loans \u00a00 124.6%" } } }, "localname": "SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SeniorSecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Senior Secured Notes [Member]", "verboseLabel": "Senior Secured Notes" } } }, "localname": "SeniorSecuredNotesMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_SeniorSecuredRevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "senior secured revolving credit facility member.", "label": "Senior Secured Revolving Credit Facility [Member]", "verboseLabel": "Senior Secured Revolving Credit Facility [Member]" } } }, "localname": "SeniorSecuredRevolvingCreditFacilityMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SenseonicsHoldingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senseonics holdings inc.", "label": "Senseonics Holdings Inc [Member]", "terseLabel": "Senseonics Holdings, Inc. [Member]" } } }, "localname": "SenseonicsHoldingsIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SharesIssuedInConnectionWithTheMergersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued in connection with the mergers.", "label": "Shares Issued In Connection With The Mergers [Member]", "terseLabel": "Shares issued in connection with the Mergers [Member]" } } }, "localname": "SharesIssuedInConnectionWithTheMergersMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails" ], "xbrltype": "domainItemType" }, "slrc_ShoHoldingICorporationShoesForCrewsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SHO Holding I Corporation Shoes for Crews Member.", "label": "SHO Holding I Corporation Shoes for Crews [Member]", "terseLabel": "SHO Holding I Corporation (Shoes for Crews) [Member]" } } }, "localname": "ShoHoldingICorporationShoesForCrewsMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SidelinesTreeServiceLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sidelines tree service llc.", "label": "Sidelines Tree Service LLC [Member]", "terseLabel": "Sidelines Tree Service LLC [Member]" } } }, "localname": "SidelinesTreeServiceLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SignetMarineCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Signet marine corporation.", "label": "Signet Marine Corporation [Member]" } } }, "localname": "SignetMarineCorporationMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SlrBusinessCreditDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Business Credit Disclosure TextBlock", "label": "SLR Business Credit Disclosure [Text Block]", "terseLabel": "SLR Business Credit" } } }, "localname": "SlrBusinessCreditDisclosureTextBlock", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCredit" ], "xbrltype": "textBlockItemType" }, "slrc_SlrBusinessCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Business Credit Facility", "label": "SLR Business Credit Facility [Member]", "terseLabel": "SLR Business Credit Facility [Member]" } } }, "localname": "SlrBusinessCreditFacilityMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SlrBusinessCreditLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Business Credit [Line Item]", "label": "SLR Business Credit [Line Items]" } } }, "localname": "SlrBusinessCreditLineItems", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_SlrBusinessCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Business Credit [Member].", "label": "SLR Business Credit [Member]", "terseLabel": "SLR Business Credit [Member]" } } }, "localname": "SlrBusinessCreditMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SlrBusinessCreditTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Business Credit Table", "label": "SLR Business Credit [Table]" } } }, "localname": "SlrBusinessCreditTable", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_SlrCreditSolutionTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Credit Solution Text Block", "label": "SLR Credit Solution [Text Block]", "terseLabel": "SLR Credit Solution" } } }, "localname": "SlrCreditSolutionTextBlock", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutions" ], "xbrltype": "textBlockItemType" }, "slrc_SlrCreditSolutionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Slr credit solutions.", "label": "SLR Credit Solutions [Member]", "terseLabel": "SLR Credit Solutions [Member]" } } }, "localname": "SlrCreditSolutionsMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_SlrEquipmentFinanceDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Equipment Finance Debt.", "label": "SLR Equipment Finance Debt [Member]" } } }, "localname": "SlrEquipmentFinanceDebtMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_SlrEquipmentFinanceEquityInterestsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Slr equipment finance equity interests.", "label": "SLR Equipment Finance Equity Interests [Member]", "terseLabel": "SLR Equipment Finance Equity Interests [Member]" } } }, "localname": "SlrEquipmentFinanceEquityInterestsMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SlrEquipmentFinanceEquityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Equipment Finance Equity.", "label": "SLR Equipment Finance Equity [Member]" } } }, "localname": "SlrEquipmentFinanceEquityMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_SlrEquipmentFinanceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR equipment finance.", "label": "SLR Equipment Finance [Member]", "terseLabel": "SLR Equipment Finance [Member]", "verboseLabel": "SLR Equipment Finance [Member]" } } }, "localname": "SlrEquipmentFinanceMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrEquipmentFinance", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SlrHealthcareAblCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Healthcare ABL Credit.", "label": "SLR Healthcare ABL Credit [Member]", "terseLabel": "SLR Healthcare ABL Credit [Member]" } } }, "localname": "SlrHealthcareAblCreditMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SlrHealthcareAblMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR healthcare ABL.", "label": "SLR Healthcare ABL [Member]", "terseLabel": "SLR Healthcare ABL [Member]", "verboseLabel": "SLR Healthcare ABL [Member]" } } }, "localname": "SlrHealthcareAblMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SlrHealthcareAblTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR healthcare ABL.", "label": "SLR Healthcare ABL [Text Block]", "verboseLabel": "SLR Healthcare ABL" } } }, "localname": "SlrHealthcareAblTextBlock", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrHealthcareAbl" ], "xbrltype": "textBlockItemType" }, "slrc_SlrSeniorLendingProgramLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Senior Lending Program LLC", "label": "SLR Senior Lending Program LLC [Member]", "verboseLabel": "SLR Senior Lending Program LLC [Member]" } } }, "localname": "SlrSeniorLendingProgramLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_SlrSeniorLendingProgramSpvLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Senior Lending Program SPV LLC member.", "label": "SLR Senior Lending Program SPV LLC [Member]", "terseLabel": "SLR Senior Lending Program SPV LLC [Member]" } } }, "localname": "SlrSeniorLendingProgramSpvLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SmileyLiftingSolutionsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Smiley Lifting Solutions LLC Member.", "label": "Smiley Lifting Solutions LLC [Member]", "terseLabel": "Smiley Lifting Solutions, LLC [Member]" } } }, "localname": "SmileyLiftingSolutionsLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SoaggLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Soagg llc.", "label": "SOAGG LLC [Member]" } } }, "localname": "SoaggLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_SocTelemedInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SOC telemed, inc.", "label": "SOC Telemed, Inc. [Member]", "terseLabel": "SOC Telemed, Inc. [Member]" } } }, "localname": "SocTelemedInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Software member.", "label": "Software [Member]" } } }, "localname": "SoftwareMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SointLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Soint llc.", "label": "SOINT LLC [Member]", "terseLabel": "SOINT, LLC [Member]" } } }, "localname": "SointLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_SouthTexasOilfieldSolutionsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "South texas oilfield solutions llc.", "label": "South Texas Oilfield Solutions LLC [Member]", "terseLabel": "South Texas Oilfield Solutions, LLC [Member]" } } }, "localname": "SouthTexasOilfieldSolutionsLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SouthernOrthodonticPartnersManagementLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Southern Orthodontic Partners Management LLC.", "label": "Southern Orthodontic Partners Management LLC [Member]", "terseLabel": "Southern Orthodontic Partners Management, LLC [Member]" } } }, "localname": "SouthernOrthodonticPartnersManagementLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SparMarketingForceInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SPAR marketing force, Inc.", "label": "SPAR Marketing Force, Inc. [Member]" } } }, "localname": "SparMarketingForceInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SpecialtyRetailMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Specialty retail member.", "label": "Specialty Retail [Member]" } } }, "localname": "SpecialtyRetailMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SpectrumPharmaceuticalsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Spectrum pharmaceuticals, Inc.", "label": "Spectrum Pharmaceuticals, Inc. [Member]" } } }, "localname": "SpectrumPharmaceuticalsInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SpectrumPharmaceuticalsInc.WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Spectrum Pharmaceuticals, Inc. Warrants", "label": "Spectrum Pharmaceuticals, Inc. Warrants [Member]" } } }, "localname": "SpectrumPharmaceuticalsInc.WarrantsMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SpreadAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Spread [Axis]" } } }, "localname": "SpreadAxis", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "stringItemType" }, "slrc_SpreadDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Spread [Domain]" } } }, "localname": "SpreadDomain", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_SpreadOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Spread One [Member]" } } }, "localname": "SpreadOneMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_SpreadThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Spread Three [Member]" } } }, "localname": "SpreadThreeMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_SpreadTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Spread Two [Member]" } } }, "localname": "SpreadTwoMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_SslpFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SSLP Facility [Member]", "verboseLabel": "SSLP Facility" } } }, "localname": "SslpFacilityMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_StCoachesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "St coaches llc.", "label": "ST Coaches LLC [Member]", "terseLabel": "ST Coaches, LLC [Member]" } } }, "localname": "StCoachesLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_StaffordLogisticsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stafford logistics inc.", "label": "Stafford Logistics Inc [Member]", "terseLabel": "Stafford Logistics, Inc. [Member]" } } }, "localname": "StaffordLogisticsIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_StarCoachesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Star coaches inc.", "label": "Star Coaches Inc [Member]", "terseLabel": "Star Coaches Inc. [Member]" } } }, "localname": "StarCoachesIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_StrytenEnergyLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stryten energy llc.", "label": "Stryten Energy LLC [Member]", "terseLabel": "Stryten Energy LLC [Member]" } } }, "localname": "StrytenEnergyLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_StrytenResourcesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stryten resources LLC.", "label": "Stryten Resources LLC [Member]" } } }, "localname": "StrytenResourcesLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SturgeonServicesInternationalIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sturgeon services international inc.", "label": "Sturgeon Services International Inc [Member]", "terseLabel": "Sturgeon Services International Inc.[Member]" } } }, "localname": "SturgeonServicesInternationalIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SummitFinancialResourcesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summit Financial Resources [Member].", "label": "Summit Financial Resources [Member]", "terseLabel": "Summit Financial Resources [Member]" } } }, "localname": "SummitFinancialResourcesMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SunmedGroupHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sunmed group holdings, llc.", "label": "SunMed Group Holdings, LLC [Member]", "terseLabel": "SunMed Group Holdings, LLC [Member]" } } }, "localname": "SunmedGroupHoldingsLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SunsCompanyMergerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUNS Company Merger [Member]" } } }, "localname": "SunsCompanyMergerMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails", "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail", "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerParentheticalDetail", "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SunsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SUNS [Member].", "label": "SUNS [Member]", "terseLabel": "SUNS [Member]" } } }, "localname": "SunsMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SunsSpvLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Suns SPV LLC.", "label": "SPV LLC [Member]" } } }, "localname": "SunsSpvLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SuperiorTransportationIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Superior transportation inc.", "label": "Superior Transportation Inc [Member]", "terseLabel": "Superior Transportation, Inc. [Member]" } } }, "localname": "SuperiorTransportationIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TailwindsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tailwinds llc.", "label": "Tailwinds LLC [Member]", "terseLabel": "Tailwinds, LLC [Member]" } } }, "localname": "TailwindsLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TaucManagementLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "TAUC management, LLC.", "label": "TAUC Management LLC [Member]", "terseLabel": "TAUC Management, LLC [Member]" } } }, "localname": "TaucManagementLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TermLoanAndCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term loan and credit facility.", "label": "Term Loan And Credit Facility [Member]", "terseLabel": "Credit Facility", "verboseLabel": "SLRCTerm Loan And Credit Facility Member" } } }, "localname": "TermLoanAndCreditFacilityMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_TermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term loan.", "label": "Term Loan [Member]" } } }, "localname": "TermLoanMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_TermLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Term Loans [Member]", "verboseLabel": "Term Loans" } } }, "localname": "TermLoansMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_TheSmedleyCompanySmedleyServicesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The smedley company\u00a0& smedley services inc.", "label": "The Smedley Company Smedley Services Inc [Member]", "terseLabel": "The Smedley Company & Smedley Services, Inc. [Member]" } } }, "localname": "TheSmedleyCompanySmedleyServicesIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ThriftsMortgageFinanceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Thrifts & mortgage finance.", "label": "Thrifts Mortgage Finance [Member]", "terseLabel": "Thrifts Mortgage Finance [Member]" } } }, "localname": "ThriftsMortgageFinanceMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TilleyDistributionIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tilley Distribution, Inc.", "label": "Tilley Distribution Inc [Member]", "terseLabel": "Tilley Distribution, Inc [Member]" } } }, "localname": "TilleyDistributionIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TotalInvestmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Total Investment [Member]", "terseLabel": "Total Investments [Member]" } } }, "localname": "TotalInvestmentMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TradingCompaniesAndDistributorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading Companies & Distributors member.", "label": "Trading Companies and Distributors [Member]" } } }, "localname": "TradingCompaniesAndDistributorsMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TradingCompaniesDistributorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading companies &\ndistributors member.", "label": "Trading Companies Distributors [Member]", "terseLabel": "Trading Companies & Distributors" } } }, "localname": "TradingCompaniesDistributorsMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_TrancheAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche.", "label": "Tranche [Axis]" } } }, "localname": "TrancheAxis", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_TrancheDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche.", "label": "Tranche [Domain]" } } }, "localname": "TrancheDomain", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_TrancheOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche one.", "label": "Tranche One [Member]" } } }, "localname": "TrancheOneMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_TrancheTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche two.", "label": "Tranche Two [Member]" } } }, "localname": "TrancheTwoMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_TransportationInfrastructureMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transportation Infrastructure [Member]", "label": "Transportation Infrastructure [Member]" } } }, "localname": "TransportationInfrastructureMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TrinityEquipmentRentalsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trinity equipment rentals inc.", "label": "Trinity Equipment Rentals Inc [Member]", "terseLabel": "Trinity Equipment Rentals, Inc. [Member]" } } }, "localname": "TrinityEquipmentRentalsIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TrolleysIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trolleys inc.", "label": "Trolleys Inc [Member]", "terseLabel": "Trolleys, Inc. [Member]" } } }, "localname": "TrolleysIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TwoThousandAndFortyTwoUnsecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Two Thousand And Forty Two Unsecured Notes [Member]", "verboseLabel": "2042 Unsecured Notes" } } }, "localname": "TwoThousandAndFortyTwoUnsecuredNotesMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_TwoThousandAndTwentyFiveUnsecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty five unsecured notes.", "label": "Two Thousand And Twenty Five Unsecured Notes [Member]", "terseLabel": "2025 Unsecured Notes", "verboseLabel": "2025 Unsecured Notes" } } }, "localname": "TwoThousandAndTwentyFiveUnsecuredNotesMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_TwoThousandAndTwentyFourUnsecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty four unsecured notes.", "label": "Two Thousand And Twenty Four Unsecured Notes [Member]", "terseLabel": "2024 Unsecured Notes", "verboseLabel": "2024 Unsecured Notes" } } }, "localname": "TwoThousandAndTwentyFourUnsecuredNotesMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty seven series F unsecured notes.", "label": "Two Thousand And Twenty Seven Series F Unsecured Notes [Member]", "terseLabel": "2027 Series F Unsecured Notes", "verboseLabel": "2027 Series F Unsecured Notes" } } }, "localname": "TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_TwoThousandAndTwentySevenUnsecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty seven unsecured notes.", "label": "Two Thousand And Twenty Seven Unsecured Notes [Member]", "terseLabel": "2027 Unsecured Notes", "verboseLabel": "2027 Unsecured Notes" } } }, "localname": "TwoThousandAndTwentySevenUnsecuredNotesMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_TwoThousandAndTwentySixUnsecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty six unsecured notes.", "label": "Two Thousand And Twenty Six Unsecured Notes [Member]", "terseLabel": "2026 Unsecured Notes", "verboseLabel": "2026 Unsecured Notes" } } }, "localname": "TwoThousandAndTwentySixUnsecuredNotesMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_TwoThousandAndTwentyThreeUnsecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty three unsecured notes.", "label": "Two Thousand And Twenty Three Unsecured Notes [Member]", "terseLabel": "2023 Unsecured Notes", "verboseLabel": "2023 Unsecured Notes" } } }, "localname": "TwoThousandAndTwentyThreeUnsecuredNotesMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_TwoThousandAndTwentyTwoTrancheCNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty two tranche C notes.", "label": "Two Thousand And Twenty Two Tranche C Notes [Member]", "terseLabel": "2022 Tranche C Notes", "verboseLabel": "2022 Tranche C Notes" } } }, "localname": "TwoThousandAndTwentyTwoTrancheCNotesMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_TwoThousandAndTwentyTwoUnsecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty two unsecured notes.", "label": "Two Thousand and Twenty Two Unsecured Notes [Member]", "terseLabel": "2022 Unsecured Notes", "verboseLabel": "2022 Unsecured Notes" } } }, "localname": "TwoThousandAndTwentyTwoUnsecuredNotesMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_U.s.CraneAndRiggingLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "U.S. Crane and Rigging, LLC", "label": "U.S. Crane and Rigging, LLC [Member]", "terseLabel": "U.S. Crane & Rigging, LLC" } } }, "localname": "U.s.CraneAndRiggingLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_U.s.TreasuryBillMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "U.S. treasury bill.", "label": "U.S. Treasury Bill [Member]", "terseLabel": "U.S. Treasury Bill [Member]" } } }, "localname": "U.s.TreasuryBillMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_UltimateBakedGoodsMidcoLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ultimate baked goods midco llc.", "label": "Ultimate Baked Goods Midco LLC [Member]", "terseLabel": "Ultimate Baked Goods Midco LLC (Rise Baking) [Member]", "verboseLabel": "Ultimate Baked Goods Midco LLC [Member]" } } }, "localname": "UltimateBakedGoodsMidcoLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_UnfundedDebtAndEquityCommitmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Unfunded Debt and Equity Commitments [Member]", "label": "Unfunded Debt and Equity Commitments [Member]", "terseLabel": "Unfunded Debt and Equity Commitments [Member]", "verboseLabel": "Unfunded Debt and Equity Commitments [Member]" } } }, "localname": "UnfundedDebtAndEquityCommitmentsMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_UpTruckingServicesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Up trucking services llc.", "label": "Up Trucking Services LLC [Member]", "terseLabel": "Up Trucking Services, LLC [Member]" } } }, "localname": "UpTruckingServicesLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_UsrParentInc.StaplesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "USR Parent, Inc. (Staples)", "label": "USR Parent, Inc. (Staples) [Member]" } } }, "localname": "UsrParentInc.StaplesMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ValuationApproachMarketMultipleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Valuation approach market multiple.", "label": "Valuation Approach Market Multiple [Member]", "terseLabel": "Market Multiple" } } }, "localname": "ValuationApproachMarketMultipleMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_VapothermInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vapotherm, inc.", "label": "Vapotherm, Inc. [Member]", "terseLabel": "Vapotherm, Inc. [Member]" } } }, "localname": "VapothermInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_VapothermIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vapotherm inc.", "label": "Vapotherm Inc [Member]", "terseLabel": "Vapotherm, Inc. Warrants [Member]" } } }, "localname": "VapothermIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_VarileaseFinanceInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Varilease Finance, Inc.", "label": "Varilease Finance, Inc. [Member]", "terseLabel": "Varilease Finance, Inc. [Member]" } } }, "localname": "VarileaseFinanceInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_VenusConceptLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Venus concept ltd.", "label": "Venus Concept Ltd [Member]", "terseLabel": "Venus Concept Ltd. Warrants (f/k/a Restoration Robotics) [Member]" } } }, "localname": "VenusConceptLtdMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_VesscoMidcoHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vessco midco holdings LLC.", "label": "Vessco Midco Holdings LLC [Member]", "terseLabel": "Vessco Midco Holdings, LLC [Member]" } } }, "localname": "VesscoMidcoHoldingsLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_WarriorCraneServicesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrior crane services llc.", "label": "Warrior Crane Services LLC [Member]", "terseLabel": "Warrior Crane Services, LLC [Member]" } } }, "localname": "WarriorCraneServicesLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_WaterUtilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Water Utilities Member.", "label": "Water Utilities [Member]" } } }, "localname": "WaterUtilitiesMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_WindRiverEnvironmentalLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Wind river environmental llc.", "label": "Wind River Environmental LLC [Member]", "terseLabel": "Wind River Environmental, LLC [Member]" } } }, "localname": "WindRiverEnvironmentalLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_WirelessTelecommunicationServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Wireless telecommunication services member.", "label": "Wireless Telecommunication Services [Member]" } } }, "localname": "WirelessTelecommunicationServicesMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_WombleCompanyIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Womble company inc.", "label": "Womble Company Inc [Member]", "terseLabel": "Womble Company, Inc. [Member]" } } }, "localname": "WombleCompanyIncMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_WorldInsuranceAssociatesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "World Insurance associates LLC.", "label": "World Insurance Associates LLC [Member]", "terseLabel": "World Insurance Associates, LLC [Member]" } } }, "localname": "WorldInsuranceAssociatesLlcMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_WorldwideFlightServicesInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Worldwide flight services, Inc.", "label": "Worldwide Flight Services, Inc. [Member]" } } }, "localname": "WorldwideFlightServicesInc.Member", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ZamborelliEnterprisesPacificSoutherFoundationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Zamborelli Enterprises Pacific Souther Foundation.", "label": "Zamborelli Enterprises Pacific Souther Foundation [Member]" } } }, "localname": "ZamborelliEnterprisesPacificSoutherFoundationMember", "nsuri": "http://www.slrinvestments.com/20221231", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "srt_CondensedFinancialStatementsCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Condensed Financial Statements, Captions [Line Items]" } } }, "localname": "CondensedFinancialStatementsCaptionsLineItems", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "stringItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of investment including named security. Excludes entity that is consolidated.", "label": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinance", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails", "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ManagementMember": { "auth_ref": [ "r576", "r602" ], "lang": { "en-us": { "role": { "documentation": "Person or persons designated as part of management.", "label": "Management [Member]", "terseLabel": "Management" } } }, "localname": "ManagementMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r228", "r229", "r230", "r231", "r294", "r382", "r399", "r436", "r437", "r455", "r461", "r463", "r589", "r606", "r607", "r608", "r609", "r610", "r611" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r228", "r229", "r230", "r231", "r294", "r382", "r399", "r436", "r437", "r455", "r461", "r463", "r589", "r606", "r607", "r608", "r609", "r610", "r611" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r228", "r229", "r230", "r231", "r286", "r294", "r295", "r296", "r297", "r358", "r382", "r399", "r436", "r437", "r455", "r461", "r463", "r585", "r589", "r607", "r608", "r609", "r610", "r611" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r228", "r229", "r230", "r231", "r286", "r294", "r295", "r296", "r297", "r358", "r382", "r399", "r436", "r437", "r455", "r461", "r463", "r585", "r589", "r607", "r608", "r609", "r610", "r611" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfCondensedFinancialStatementsTable": { "auth_ref": [ "r170", "r441", "r442", "r443", "r444", "r561" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows.", "label": "Condensed Financial Statements [Table]" } } }, "localname": "ScheduleOfCondensedFinancialStatementsTable", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "stringItemType" }, "srt_ScheduleOfCondensedFinancialStatementsTableTextBlock": { "auth_ref": [ "r571", "r621" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows.", "label": "Condensed Financial Statements [Table Text Block]", "terseLabel": "Summary financial information for SSLP" } } }, "localname": "ScheduleOfCondensedFinancialStatementsTableTextBlock", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcTables" ], "xbrltype": "textBlockItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r214" ], "lang": { "en-us": { "role": { "documentation": "Information by name of investment including named security. Excludes entity that is consolidated.", "label": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinance", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails", "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r576", "r602" ], "lang": { "en-us": { "role": { "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Title of individual, or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_WeightedAverageMember": { "auth_ref": [ "r436", "r437", "r606", "r608", "r611" ], "lang": { "en-us": { "role": { "documentation": "Average of a range of values, calculated with consideration of proportional relevance.", "label": "Weighted Average [Member]" } } }, "localname": "WeightedAverageMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r94", "r113" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.", "label": "Accounts Payable and Accrued Liabilities", "terseLabel": "Accrued expenses and other payables" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesAndOtherLiabilities": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 17.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.", "label": "Accrued Liabilities and Other Liabilities", "terseLabel": "Other liabilities and accrued expenses" } } }, "localname": "AccruedLiabilitiesAndOtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r7" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Paid-in capital in excess of par (see note 2f)" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Adjustments to reconcile net increase in net assets resulting from operations to net cash provided by (used in) operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdministrativeFeesExpense": { "auth_ref": [ "r87" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Organizational costs", "documentation": "Amount of expense for administrative services provided to the limited liability company (LLC) or limited partnership (LP) by the managing member or general partner, affiliate of managing member or general partner, or affiliate of LLC or LP, for example, but not limited to, salaries, rent, or overhead costs.", "label": "Administrative Fees Expense", "terseLabel": "Administrative services expense (see note 3)", "verboseLabel": "Administrative fees expense" } } }, "localname": "AdministrativeFeesExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetManagement1Member": { "auth_ref": [ "r591" ], "lang": { "en-us": { "role": { "documentation": "Management of investment fund portfolio. Excludes investment advisory, distribution and servicing, and performance fee.", "label": "Asset Management [Member]", "terseLabel": "Asset Management [Member]" } } }, "localname": "AssetManagement1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r89", "r105", "r150", "r168", "r204", "r207", "r209", "r215", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r315", "r317", "r335", "r462", "r587", "r588", "r604" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 1.0, "parentTag": "us-gaap_AssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "disclosureGuidance": "total assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "terseLabel": "Assets", "totalLabel": "Total assets", "verboseLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNet": { "auth_ref": [ "r0", "r122", "r138", "r141", "r142" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net assets (liabilities).", "label": "Net Assets", "periodEndLabel": "Net assets at end of period", "periodStartLabel": "Net assets at beginning of period", "terseLabel": "Net assets", "totalLabel": "Total net assets", "verboseLabel": "Net assets, end of period" } } }, "localname": "AssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails", "http://www.slrinvestments.com/role/NetAssetValuePerShareAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Assets [Abstract]", "terseLabel": "Net Assets" } } }, "localname": "AssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r313", "r459", "r460" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails", "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail", "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerParentheticalDetail", "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r60", "r61", "r313", "r459", "r460" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails", "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail", "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerParentheticalDetail", "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail", "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r59" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "terseLabel": "Percentage of voting interests acquired" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessAcquisitionSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.", "label": "Business Acquisition, Share Price", "terseLabel": "Business acquisition, share price" } } }, "localname": "BusinessAcquisitionSharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerParentheticalDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r64", "r65", "r66" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Business combination, consideration transferred" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r63" ], "calculation": { "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "totalLabel": "Total assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]", "terseLabel": "Assets acquired:" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r63" ], "calculation": { "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "terseLabel": "Cash" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt": { "auth_ref": [ "r63" ], "calculation": { "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail": { "order": 7.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt", "verboseLabel": "Debt, at fair value" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r63" ], "calculation": { "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "totalLabel": "Total liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]", "terseLabel": "Liabilities assumed:" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r62", "r63" ], "calculation": { "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail": { "order": 1.0, "parentTag": "slrc_BusinessCombinationPurchaseDiscount", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "totalLabel": "Net assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": { "auth_ref": [ "r63" ], "calculation": { "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail": { "order": 8.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other", "terseLabel": "Other liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": { "auth_ref": [ "r63" ], "calculation": { "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets", "terseLabel": "Other assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_Cash": { "auth_ref": [ "r409", "r410", "r462", "r562" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "terseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsAndShortTermInvestments": { "auth_ref": [ "r565" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.", "label": "Cash, Cash Equivalents, and Short-term Investments", "terseLabel": "Total Investments\u00a0& Cash Equivalents", "verboseLabel": "Cash and other assets" } } }, "localname": "CashCashEquivalentsAndShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r31", "r36", "r41" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "CASH AND CASH EQUIVALENTS AT END OF YEAR", "periodStartLabel": "CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r31", "r82" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r562" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash Equivalents, at Carrying Value", "verboseLabel": "Cash equivalents (cost: $417,590 and $320,000, respectively)" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r151", "r152", "r153", "r168", "r186", "r187", "r189", "r191", "r200", "r201", "r215", "r232", "r234", "r235", "r236", "r239", "r240", "r270", "r271", "r273", "r277", "r284", "r335", "r438", "r560", "r568", "r574" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/CoverPage", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r17", "r96", "r110" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies", "verboseLabel": "Commitments and contingencies (see note 11)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r48", "r226", "r227", "r435", "r586" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r572", "r573", "r595" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails", "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par or stated value per share", "verboseLabel": "Par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common Stock, shares authorized", "verboseLabel": "Shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares, issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r6", "r51" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares, outstanding", "verboseLabel": "Shares outstanding, end of period" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r6", "r462" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "verboseLabel": "Common stock, par value $0.01 per share, 200,000,000 and 200,000,000 common shares authorized, respectively, and 54,555,380 and 42,260,826 shares issued and outstanding, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r50", "r166", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r257", "r264", "r265", "r267" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Debt instrument variable interest rate spread" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r3", "r91", "r103", "r268" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-term Debt, Gross", "terseLabel": "Face Amount" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r84", "r86", "r241", "r344", "r451", "r452" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt instrument, face amount", "verboseLabel": "Debt instrument face value" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r255", "r334", "r451", "r452" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "verboseLabel": "Debt Instrument, Fair Value Disclosure" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r14", "r242" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "verboseLabel": "Debt instrument stated interest rate percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r155", "r450", "r597" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Debt Instrument, Maturity Date", "terseLabel": "Debt Instrument, Maturity Date", "verboseLabel": "Debt instrument maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentPaymentTerms": { "auth_ref": [ "r15", "r101" ], "lang": { "en-us": { "role": { "documentation": "Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment.", "label": "Debt Instrument, Payment Terms", "verboseLabel": "Debt instrument payment terms" } } }, "localname": "DebtInstrumentPaymentTerms", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r16", "r52", "r53", "r54", "r55", "r83", "r84", "r86", "r102", "r170", "r241", "r242", "r243", "r244", "r245", "r247", "r253", "r254", "r255", "r256", "r258", "r259", "r260", "r261", "r262", "r263", "r266", "r344", "r450", "r451", "r452", "r453", "r454", "r569" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Debt instrument term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r83", "r86", "r590" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "terseLabel": "Debt Instrument, Unamortized Discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instruments [Abstract]" } } }, "localname": "DebtInstrumentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtLongtermAndShorttermCombinedAmount": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 10.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt.", "label": "Debt, Long-term and Short-term, Combined Amount", "terseLabel": "Debt outstanding", "verboseLabel": "Debt ($1,093,200 and $818,500 face amounts, respectively, reported net of unamortized debt issuance costs of $7,202 and $6,462, respectively. See notes 6 and 7)" } } }, "localname": "DebtLongtermAndShorttermCombinedAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsGross": { "auth_ref": [ "r85" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Gross", "terseLabel": "Debt issuance costs" } } }, "localname": "DeferredFinanceCostsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r85", "r590" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "terseLabel": "Long term debt unamortized debt issuance costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFloorInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Floor rate on an interest rate derivative such as an interest rate floor or collar. If market rates falls below the floor rate, a payment or receipt is triggered on the contract.", "label": "Derivative, Floor Interest Rate", "terseLabel": "Floor" } } }, "localname": "DerivativeFloorInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeMaturityDates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date the derivative contract matures, in YYYY-MM-DD format.", "label": "Derivative, Maturity Date", "terseLabel": "Maturity Date", "verboseLabel": "Maturity Date" } } }, "localname": "DerivativeMaturityDates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DividendsPayableAmountPerShare": { "auth_ref": [ "r38" ], "lang": { "en-us": { "role": { "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.", "label": "Dividends Payable, Amount Per Share", "terseLabel": "Dividends payable, amount per share" } } }, "localname": "DividendsPayableAmountPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DividendsPayableCurrentAndNoncurrent": { "auth_ref": [ "r2", "r4", "r90", "r106" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 12.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.", "label": "Dividends Payable", "terseLabel": "Distributions payable" } } }, "localname": "DividendsPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsReceivable": { "auth_ref": [ "r564" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of dividends declared but not received.", "label": "Dividends Receivable", "terseLabel": "Dividends receivable" } } }, "localname": "DividendsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r162", "r176", "r177", "r178", "r179", "r180", "r184", "r186", "r189", "r190", "r191", "r195", "r322", "r323", "r396", "r398", "r445" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Earnings per share, Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r162", "r176", "r177", "r178", "r179", "r180", "r186", "r189", "r190", "r191", "r195", "r322", "r323", "r396", "r398", "r445" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Earnings per share, Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r192", "r193", "r194", "r196" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r95", "r112" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 14.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Employee-related Liabilities", "terseLabel": "Performance-based incentive fee payable (see note 3)" } } }, "localname": "EmployeeRelatedLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r51", "r148", "r158", "r159", "r160", "r171", "r172", "r173", "r175", "r181", "r183", "r197", "r217", "r285", "r298", "r299", "r300", "r306", "r307", "r321", "r336", "r337", "r338", "r339", "r340", "r341", "r346", "r400", "r401", "r402" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails", "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentAggregateCost": { "auth_ref": [ "r10" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the aggregate cost of investments accounted for under the equity method of accounting.", "label": "Equity Method Investment, Aggregate Cost", "terseLabel": "Equity method investment, aggregate cost" } } }, "localname": "EquityMethodInvestmentAggregateCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": { "auth_ref": [ "r149", "r168", "r215", "r335" ], "lang": { "en-us": { "role": { "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity.", "label": "Equity Method Investment, Nonconsolidated Investee [Axis]" } } }, "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": { "auth_ref": [ "r149", "r168", "r215", "r335" ], "lang": { "en-us": { "role": { "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity.", "label": "Equity Method Investment, Nonconsolidated Investee [Domain]" } } }, "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r45" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Equity method investment, ownership percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r44", "r205", "r563" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Equity method investments" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investments and Joint Ventures [Abstract]" } } }, "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": { "auth_ref": [ "r216" ], "lang": { "en-us": { "role": { "definitionGuidance": "Kingsbridge Holdings, LLC", "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.", "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]", "terseLabel": "SLR Equipment Finance" } } }, "localname": "EquityMethodInvestmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlc", "http://www.slrinvestments.com/role/SlrEquipmentFinance" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquitySecuritiesByIndustryAxis": { "auth_ref": [ "r448" ], "lang": { "en-us": { "role": { "documentation": "Information by industry sector, examples include but are not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate.", "label": "Industry Sector [Axis]" } } }, "localname": "EquitySecuritiesByIndustryAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquitySecuritiesIndustryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Industry sector consisting of government, private and corporate entities engaged in business activities, including but not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate.", "label": "Industry Sector [Domain]" } } }, "localname": "EquitySecuritiesIndustryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquitySecuritiesMember": { "auth_ref": [ "r43", "r104", "r464", "r465", "r466" ], "lang": { "en-us": { "role": { "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.", "label": "Equity Securities [Member]", "terseLabel": "Common Equity/Equity Interests/Warrants" } } }, "localname": "EquitySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement in which net income is reported that includes unrealized gain (loss) from asset measured at fair value using unobservable input (level 3) and still held.", "label": "Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]" } } }, "localname": "FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r324", "r325", "r332" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "auth_ref": [ "r72", "r73", "r74", "r79", "r80" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]", "terseLabel": "Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "auth_ref": [ "r75" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r75" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "terseLabel": "Summary of Quantitative Information about the Company's Level 3 Asset and Liability" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss": { "auth_ref": [ "r330" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3) and still held.", "label": "Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss)", "terseLabel": "Net change in unrealized gain (loss)" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r76" ], "lang": { "en-us": { "role": { "documentation": "Class of asset.", "label": "Asset Class [Domain]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r76", "r80" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r76", "r80" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Summary of Changes in Fair Value of Level 3 Assets and Liabilities" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r72", "r80" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Asset Class [Axis]" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r255", "r287", "r288", "r289", "r290", "r291", "r292", "r325", "r355", "r356", "r357", "r451", "r452", "r456", "r457", "r458" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r78", "r80" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r324", "r325", "r327", "r328", "r333" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r331" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValue" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r255", "r287", "r292", "r325", "r355", "r456", "r457", "r458" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r255", "r287", "r292", "r325", "r356", "r451", "r452", "r456", "r457", "r458" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r255", "r287", "r288", "r289", "r290", "r291", "r292", "r325", "r357", "r451", "r452", "r456", "r457", "r458" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r76" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r76", "r80" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r76", "r80" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3)" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": { "auth_ref": [ "r329" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings", "terseLabel": "Net change in unrealized gain (loss)" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases": { "auth_ref": [ "r77" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases", "terseLabel": "Purchase of investment securities" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales": { "auth_ref": [ "r77" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales", "terseLabel": "Proceeds from dispositions of investment securities" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net", "terseLabel": "Transfers in/out of Level\u00a03" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": { "auth_ref": [ "r76" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value", "periodEndLabel": "Closing balance", "periodStartLabel": "Opening balance" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [ "r329" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "terseLabel": "Net change in unrealized (gain) loss" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": { "auth_ref": [ "r77" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances", "terseLabel": "Borrowings" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": { "auth_ref": [ "r77" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements", "terseLabel": "Repayments" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net", "terseLabel": "Transfers in/out of Level\u00a03" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r76" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Ending fair value", "periodStartLabel": "Beginning fair value" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r255", "r287", "r288", "r289", "r290", "r291", "r292", "r355", "r356", "r357", "r451", "r452", "r456", "r457", "r458" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r331", "r333" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Recurring Fair Value" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleList": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement in which net income is reported that includes gain (loss) from asset measured at fair value using unobservable input (level 3).", "label": "Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]" } } }, "localname": "FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_FederalIncomeTaxNoteTable": { "auth_ref": [ "r612" ], "lang": { "en-us": { "role": { "documentation": "Table of federal income tax note for schedule of investments. The federal income tax note may be qualified for security investments, non-security investments and/or for the combination of security and non-security investments.", "label": "Federal Income Tax Note [Table]" } } }, "localname": "FederalIncomeTaxNoteTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfTotalAccumulatedEarningsLossOnATaxBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FederalIncomeTaxNoteTextBlock": { "auth_ref": [ "r612" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the federal tax basis of investment holdings. This item captures the aggregate cost of securities, aggregate gross unrealized appreciation for all securities in which there is an excess of value over tax cost, aggregate gross unrealized depreciation for all securities in which there is an excess of tax cost over value, net unrealized appreciation (depreciation), and an explanation of the differences between tax and book.", "label": "Federal Income Tax Note [Table Text Block]", "terseLabel": "Summary of total accumulated earnings" } } }, "localname": "FederalIncomeTaxNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r212", "r213", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r266", "r282", "r319", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r449", "r579", "r580", "r581", "r614", "r615", "r616", "r617", "r618", "r619", "r620" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialServicesSectorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sector of the economy consisting of companies engaged in financial services.", "label": "Financial Services Sector [Member]", "terseLabel": "Diversified Financial Services" } } }, "localname": "FinancialServicesSectorMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GrossInvestmentIncomeOperating": { "auth_ref": [ "r115" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 10.0, "parentTag": "us-gaap_NetInvestmentIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.", "label": "Gross Investment Income, Operating", "totalLabel": "Total investment income" } } }, "localname": "GrossInvestmentIncomeOperating", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_HealthcareSectorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sector of the economy consisting of companies engaged in healthcare-related business activities.", "label": "Healthcare Sector [Member]", "terseLabel": "Health Care Providers & Services" } } }, "localname": "HealthcareSectorMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]", "terseLabel": "IPO [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeApproachValuationTechniqueMember": { "auth_ref": [ "r75" ], "lang": { "en-us": { "role": { "documentation": "Valuation approach converting future amounts to single current discounted amount.", "label": "Valuation, Income Approach [Member]", "terseLabel": "Income Approach" } } }, "localname": "IncomeApproachValuationTechniqueMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r169", "r302", "r304", "r305", "r308", "r309", "r310", "r311", "r312" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Tax Information and Distributions to Stockholders and Other Tax Information" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r37" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Cash paid for interest" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet": { "auth_ref": [ "r33" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 22.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount due from borrowers for interest payments.", "label": "Increase (Decrease) in Accrued Interest Receivable, Net", "negatedLabel": "Interest receivable" } } }, "localname": "IncreaseDecreaseInAccruedInterestReceivableNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": { "auth_ref": [ "r567" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.", "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities", "terseLabel": "Other liabilities and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDividendsReceivable": { "auth_ref": [ "r33" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 23.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in cash disbursements due from investments, representing the shareholders' portion of profits.", "label": "Increase (Decrease) in Dividends Receivable", "negatedLabel": "Dividends receivable" } } }, "localname": "IncreaseDecreaseInDividendsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInterestPayableNet": { "auth_ref": [ "r33" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.", "label": "Increase (Decrease) in Interest Payable, Net", "terseLabel": "Interest payable" } } }, "localname": "IncreaseDecreaseInInterestPayableNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInManagementFeePayable": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Management Fee Payable", "terseLabel": "Management fee payable" } } }, "localname": "IncreaseDecreaseInManagementFeePayable", "nsuri": "http://fasb.org/us-gaap-sup/2022q3", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Assets [Abstract]", "terseLabel": "(Increase) decrease in operating assets:" } } }, "localname": "IncreaseDecreaseInOperatingAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Liabilities [Abstract]", "terseLabel": "Increase (decrease) in operating liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r33" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 24.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r85", "r99", "r161", "r203", "r343" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "terseLabel": "Interest and other credit facility expenses" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrentAndNoncurrent": { "auth_ref": [ "r95", "r112" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 15.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.", "label": "Interest Payable", "terseLabel": "Interest payable (see note 7)" } } }, "localname": "InterestPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestReceivable": { "auth_ref": [ "r564" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.", "label": "Interest Receivable", "terseLabel": "Interest receivable" } } }, "localname": "InterestReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyCapitalShareTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Capital Share Transactions [Abstract]", "terseLabel": "Capital transactions (see note 13):" } } }, "localname": "InvestmentCompanyCapitalShareTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyCapitalShareTransactionsStockIssuedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Capital Share Transactions, Stock Issued [Abstract]", "terseLabel": "Capital share activity (see note 13):" } } }, "localname": "InvestmentCompanyCapitalShareTransactionsStockIssuedAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyDistributableEarnings": { "auth_ref": [ "r117", "r118" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed tax basis earnings (deficit).", "label": "Investment Company, Distributable Earnings", "verboseLabel": "Accumulated distributable net loss (see note 2f)" } } }, "localname": "InvestmentCompanyDistributableEarnings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward": { "auth_ref": [ "r118" ], "calculation": { "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfTotalAccumulatedEarningsLossOnATaxBasisDetails": { "order": 5.0, "parentTag": "slrc_InvestmentCompanyTaxAccumulatedLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed deficit from capital loss carryforward of investment company.", "label": "Investment Company, Distributable Earnings (Loss), Accumulated Capital Loss Carryforward", "terseLabel": "Capital loss carryforward" } } }, "localname": "InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfTotalAccumulatedEarningsLossOnATaxBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss": { "auth_ref": [ "r117", "r118" ], "calculation": { "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfTotalAccumulatedEarningsLossOnATaxBasisDetails": { "order": 2.0, "parentTag": "slrc_InvestmentCompanyTaxAccumulatedLoss", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit) from long-term capital gain (loss) of investment company.", "label": "Investment Company, Distributable Earnings (Loss), Accumulated Long-Term Capital Gain (Loss)", "terseLabel": "Undistributed long-term net capital gains" } } }, "localname": "InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfTotalAccumulatedEarningsLossOnATaxBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss": { "auth_ref": [ "r117", "r118" ], "calculation": { "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfTotalAccumulatedEarningsLossOnATaxBasisDetails": { "order": 1.0, "parentTag": "slrc_InvestmentCompanyTaxAccumulatedLoss", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit) from ordinary income (loss) of investment company.", "label": "Investment Company, Distributable Earnings (Loss), Accumulated Ordinary Income (Loss)", "terseLabel": "Undistributed ordinary income" } } }, "localname": "InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfTotalAccumulatedEarningsLossOnATaxBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyDistributionLongTermCapitalGain": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Investment Company, Distribution, Long-Term Capital Gain", "terseLabel": "Capital gains" } } }, "localname": "InvestmentCompanyDistributionLongTermCapitalGain", "nsuri": "http://fasb.org/us-gaap-sup/2022q3", "presentation": [ "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfDistributionsToShareholdersDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyDistributionOrdinaryIncome": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Investment Company, Distribution, Ordinary Income", "terseLabel": "Ordinary income" } } }, "localname": "InvestmentCompanyDistributionOrdinaryIncome", "nsuri": "http://fasb.org/us-gaap-sup/2022q3", "presentation": [ "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfDistributionsToShareholdersDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyDistributionToShareholdersAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Distribution to Shareholders [Abstract]", "terseLabel": "Distributions to stockholders (see note 8a):" } } }, "localname": "InvestmentCompanyDistributionToShareholdersAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyDistributionToShareholdersPerShare": { "auth_ref": [ "r133" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit amount of distribution to shareholders. Includes, but is not limited to, dividend and capital gain. Excludes distribution for tax return of capital.", "label": "Investment Company, Distribution to Shareholders, Per Share", "negatedLabel": "From distributable earnings" } } }, "localname": "InvestmentCompanyDistributionToShareholdersPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_InvestmentCompanyDividendDistribution": { "auth_ref": [ "r119", "r121" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": 5.0, "parentTag": "slrc_InvestmentCompanyIncreaseDecreaseInNetAssets", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of dividend distribution from ordinary income and capital gain. Excludes distribution for tax return of capital.", "label": "Investment Company, Dividend Distribution", "negatedTotalLabel": "Net distributions to stockholders", "verboseLabel": "Total distributions" } } }, "localname": "InvestmentCompanyDividendDistribution", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfDistributionsToShareholdersDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation": { "auth_ref": [ "r125" ], "calculation": { "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Percentage of expense, after incentive allocation, to average net assets.", "label": "Investment Company, Expense Ratio after Incentive Allocation", "totalLabel": "Total expenses" } } }, "localname": "InvestmentCompanyExpenseRatioAfterIncentiveAllocation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentCompanyExpenseRatioExcludingIncentiveFee": { "auth_ref": [ "r125" ], "lang": { "en-us": { "role": { "documentation": "Percentage, after deduction of fee waiver and before deduction of incentive fee, of expense to average net assets.", "label": "Investment Company, Expense Ratio Excluding Incentive Fee", "terseLabel": "Investment company, expense ratio excluding incentive fee" } } }, "localname": "InvestmentCompanyExpenseRatioExcludingIncentiveFee", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsParentheticalsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentCompanyFinancialHighlightsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Financial Highlights [Abstract]" } } }, "localname": "InvestmentCompanyFinancialHighlightsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyFinancialHighlightsTableTextBlock": { "auth_ref": [ "r123" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial highlights. Includes, but is not limited to, per share information, income and expense ratios, total return, capital commitment and fee waiver.", "label": "Investment Company, Financial Highlights [Table Text Block]", "terseLabel": "Schedule of financial highlights" } } }, "localname": "InvestmentCompanyFinancialHighlightsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentCompanyFinancialHighlightsTextBlock": { "auth_ref": [ "r135", "r411" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of financial highlights reported by investment company.", "label": "Investment Company, Financial Highlights [Text Block]", "terseLabel": "Financial Highlights" } } }, "localname": "InvestmentCompanyFinancialHighlightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlights" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentCompanyFinancialRatiosAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Financial Ratios [Abstract]", "verboseLabel": "Ratios to average net assets:" } } }, "localname": "InvestmentCompanyFinancialRatiosAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare": { "auth_ref": [ "r131" ], "calculation": { "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails": { "order": 4.0, "parentTag": "us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Per share or unit amount of realized and unrealized gain (loss) on investment.", "label": "Investment Company, Gain (Loss) on Investment, Per Share", "terseLabel": "Net realized and unrealized loss" } } }, "localname": "InvestmentCompanyGainLossOnInvestmentPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare": { "auth_ref": [ "r132" ], "calculation": { "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Per share or unit amount of investment income (loss) and realized and unrealized gain (loss) on investment.", "label": "Investment Company, Investment Income (Loss) from Operations, Per Share", "totalLabel": "Net increase in net assets resulting from operations" } } }, "localname": "InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare": { "auth_ref": [ "r130" ], "calculation": { "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails": { "order": 3.0, "parentTag": "us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Per share or unit amount, after investment expense, of dividend and interest investment income (loss).", "label": "Investment Company, Investment Income (Loss), Per Share", "terseLabel": "Net investment income" } } }, "localname": "InvestmentCompanyInvestmentIncomeLossPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_InvestmentCompanyInvestmentIncomeLossRatio": { "auth_ref": [ "r124" ], "lang": { "en-us": { "role": { "documentation": "Percentage of investment income (loss) to average net assets.", "label": "Investment Company, Investment Income (Loss) Ratio", "terseLabel": "Net investment income" } } }, "localname": "InvestmentCompanyInvestmentIncomeLossRatio", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease": { "auth_ref": [ "r120", "r140" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": 1.0, "parentTag": "slrc_InvestmentCompanyIncreaseDecreaseInNetAssets", "weight": 1.0 }, "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in net assets from operations of investment company.", "label": "Investment Company, Net Assets from Operations, Increase (Decrease)", "terseLabel": "Net loss", "totalLabel": "Net increase in net assets resulting from operations" } } }, "localname": "InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Net Assets from Operations, Increase (Decrease) [Abstract]", "terseLabel": "Increase (decrease) in net assets resulting from operations:" } } }, "localname": "InvestmentCompanyNetAssetsFromOperationsIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency": { "auth_ref": [ "r139" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized and unrealized gain (loss) on investment, foreign currency translation and foreign currency denominated asset and liability.", "label": "Investment Company, Realized and Unrealized Gain (Loss) on Investment and Foreign Currency", "terseLabel": "Net realized and unrealized gain on investments", "totalLabel": "Net realized and unrealized gain (loss) on investments and cash equivalents" } } }, "localname": "InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrencyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Realized and Unrealized Gain (Loss) on Investment and Foreign Currency [Abstract]", "terseLabel": "REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND CASH EQUIVALENTS:" } } }, "localname": "InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrencyAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyTaxReturnOfCapitalDistributionPerShare": { "auth_ref": [ "r133" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit amount of capital distribution in excess of tax basis earnings.", "label": "Investment Company, Tax Return of Capital Distribution, Per Share", "terseLabel": "From return of capital" } } }, "localname": "InvestmentCompanyTaxReturnOfCapitalDistributionPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_InvestmentCompanyTotalReturn": { "auth_ref": [ "r126", "r127", "r128" ], "lang": { "en-us": { "role": { "documentation": "Percentage increase (decrease) in fund net asset value, assuming reinvestment of dividends and capital gain distributions.", "label": "Investment Company, Total Return", "terseLabel": "Total Return(b)" } } }, "localname": "InvestmentCompanyTotalReturn", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.", "label": "Investment Holdings, Schedule of Investments [Table Text Block]", "verboseLabel": "SSLP Portfolio" } } }, "localname": "InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentHoldingsTable": { "auth_ref": [ "r143", "r145", "r427", "r613" ], "lang": { "en-us": { "role": { "documentation": "The investment holdings table is used for any listing of investments. The \"Investment [Axis]\" identifies the investment for which the line items apply. The other axes are used for categorizing the investments and creating useful subtotals. These axes cover different categorizations. The appropriate axes are expected to be used. Additional axes can be added for alternative categorizations.", "label": "Investment Holdings [Table]" } } }, "localname": "InvestmentHoldingsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentIncomeDividend": { "auth_ref": [ "r21" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 12.0, "parentTag": "us-gaap_GrossInvestmentIncomeOperating", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of dividend income on nonoperating securities.", "label": "Investment Income, Dividend", "terseLabel": "Dividends" } } }, "localname": "InvestmentIncomeDividend", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r23", "r202" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 11.0, "parentTag": "us-gaap_GrossInvestmentIncomeOperating", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Interest income", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "verboseLabel": "Interest" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInvestmentExpense": { "auth_ref": [ "r25", "r115" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses related to the generation of investment income.", "label": "Investment Income, Investment Expense", "totalLabel": "Total expenses" } } }, "localname": "InvestmentIncomeInvestmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeNet": { "auth_ref": [ "r22", "r24" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": 2.0, "parentTag": "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.", "label": "Investment Income, Net", "terseLabel": "Net investment income" } } }, "localname": "InvestmentIncomeNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentInterestRate": { "auth_ref": [ "r577", "r578" ], "lang": { "en-us": { "role": { "documentation": "Rate of interest on investment.", "label": "Investment Interest Rate", "terseLabel": "Interest Rate" } } }, "localname": "InvestmentInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentInterestRatePaidInKind": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment, Interest Rate, Paid in Kind", "terseLabel": "Investment interest rate, Paid in kind" } } }, "localname": "InvestmentInterestRatePaidInKind", "nsuri": "http://fasb.org/us-gaap-sup/2022q3", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentOwnedAtCost": { "auth_ref": [ "r136" ], "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Cost", "documentation": "Cost of the investment.", "label": "Investment Owned, at Cost", "terseLabel": "Cost", "verboseLabel": "Investment owned, at cost" } } }, "localname": "InvestmentOwnedAtCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedAtFairValue": { "auth_ref": [ "r136", "r421", "r430" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Investments at fair value (cost $18,032)", "documentation": "Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.", "label": "Investment Owned, at Fair Value", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "terseLabel": "Fair Value", "verboseLabel": "Fair Value" } } }, "localname": "InvestmentOwnedAtFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedBalanceShares": { "auth_ref": [ "r137", "r416" ], "lang": { "en-us": { "role": { "documentation": "Balance held at close of period in number of shares.", "label": "Investment Owned, Balance, Shares", "terseLabel": "Shares/Units" } } }, "localname": "InvestmentOwnedBalanceShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "sharesItemType" }, "us-gaap_InvestmentOwnedPercentOfNetAssets": { "auth_ref": [ "r136", "r426" ], "lang": { "en-us": { "role": { "documentation": "Percent of net assets at close of period. For schedules of investments that are categorized, each category has a percent of net assets for the aggregated value of the Investments in the category.", "label": "Investment Owned, Percent of Net Assets", "terseLabel": "Percentage of Total Investments (at fair value)" } } }, "localname": "InvestmentOwnedPercentOfNetAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentOwnedUnderlyingFaceAmountAtMarketValue": { "auth_ref": [ "r68", "r69" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Nominal or face amount on the investment owned.", "label": "Investment Owned, Face Amount", "terseLabel": "Par Amount", "verboseLabel": "Par Amount" } } }, "localname": "InvestmentOwnedUnderlyingFaceAmountAtMarketValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentSecondaryCategorizationAxis": { "auth_ref": [ "r413", "r418", "r423" ], "lang": { "en-us": { "role": { "documentation": "Information by second categorization of investments, which may include, but is not limited to industry.", "label": "Investment Secondary Categorization [Axis]", "terseLabel": "Investment Secondary Categorization [Axis]" } } }, "localname": "InvestmentSecondaryCategorizationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r412", "r414", "r415", "r417", "r419", "r420", "r422", "r424", "r425", "r428", "r429", "r431", "r432", "r433", "r434" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]", "terseLabel": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r412", "r414", "r415", "r417", "r419", "r420", "r422", "r424", "r425", "r428", "r429", "r431", "r432", "r433", "r434" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]", "terseLabel": "Investments [Domain]" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentsBySecondaryCategorizationDomain": { "auth_ref": [ "r144", "r413", "r418", "r423" ], "lang": { "en-us": { "role": { "documentation": "Investments in the \"Investment Holdings [Table]\" and the \"Summary of Investment Holdings [Table]\" are often categorized at two levels. The first categorization is the investment type. The second categorization can vary. The usual secondary categorizations are industry, country or geography.", "label": "Investments by Secondary Categorization [Domain]", "terseLabel": "Investments by Secondary Categorization [Domain]" } } }, "localname": "InvestmentsBySecondaryCategorizationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, Debt and Equity Securities [Abstract]" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r324" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments, Fair Value Disclosure", "terseLabel": "Assets", "verboseLabel": "Investments at fair value" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "auth_ref": [ "r43", "r88", "r100", "r146", "r440" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investments in certain debt and equity securities.", "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]", "terseLabel": "SLR Senior Lending Program LLC" } } }, "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlc" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Investments, Owned, Federal Income Tax Note [Line Items]" } } }, "localname": "InvestmentsOwnedFederalIncomeTaxNoteLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfTotalAccumulatedEarningsLossOnATaxBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestorMember": { "auth_ref": [ "r600", "r601" ], "lang": { "en-us": { "role": { "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value.", "label": "Investor [Member]", "terseLabel": "Investor" } } }, "localname": "InvestorMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LaborAndRelatedExpense": { "auth_ref": [ "r566" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.", "label": "Labor and Related Expense", "terseLabel": "Performance-based incentive fees (see note 3)" } } }, "localname": "LaborAndRelatedExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r13", "r168", "r215", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r316", "r317", "r318", "r335", "r446", "r587", "r604", "r605" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 9.0, "parentTag": "us-gaap_AssetsNet", "weight": -1.0 }, "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r9", "r92", "r109", "r462", "r570", "r582", "r598" ], "calculation": { "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and members' equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r3", "r91", "r103" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-term Line of Credit", "presentationGuidance": "Line of credit", "terseLabel": "SPV Credit Facility, Carrying Value", "verboseLabel": "Long-term line of credit" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Line of Credit Facility [Abstract]" } } }, "localname": "LineOfCreditFacilityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityAverageOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Average amount borrowed under the credit facility during the period.", "label": "Line of Credit Facility, Average Outstanding Amount", "terseLabel": "Line of credit facility average outstanding amount" } } }, "localname": "LineOfCreditFacilityAverageOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityAxis": { "auth_ref": [ "r11", "r569" ], "lang": { "en-us": { "role": { "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.", "label": "Lender Name [Axis]" } } }, "localname": "LineOfCreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityExpirationDate1": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Date the credit facility terminates, in YYYY-MM-DD format.", "label": "Line of Credit Facility, Expiration Date", "terseLabel": "Line of credit facility, expiration date" } } }, "localname": "LineOfCreditFacilityExpirationDate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The effective interest rate during the reporting period.", "label": "Line of Credit Facility, Interest Rate During Period", "terseLabel": "Line of Credit Facility, Interest Rate During Period" } } }, "localname": "LineOfCreditFacilityInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityLenderDomain": { "auth_ref": [ "r11", "r569" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.", "label": "Line of Credit Facility, Lender [Domain]" } } }, "localname": "LineOfCreditFacilityLenderDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r11" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Line of credit facility, maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate (LIBOR) [Member]" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r3", "r91", "r107", "r254", "r269", "r451", "r452" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Long-Term Debt", "presentationGuidance": "Non-recourse debt", "terseLabel": "Total" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAverageAmountOutstanding": { "auth_ref": [ "r438", "r439" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Average amount outstanding of long-term debt.", "label": "Long-Term Debt, Average Amount Outstanding", "terseLabel": "Average debt outstanding" } } }, "localname": "LongTermDebtAverageAmountOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMeasurementInput": { "auth_ref": [ "r328" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure long-term debt.", "label": "Long-term Debt, Measurement Input" } } }, "localname": "LongTermDebtMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_LongTermDebtTerm": { "auth_ref": [ "r597" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Long-term Debt, Term", "verboseLabel": "Long term debt term" } } }, "localname": "LongTermDebtTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LongTermDebtWeightedAverageInterestRateOverTime": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of long-term debt outstanding calculated over time.", "label": "Long-term Debt, Weighted Average Interest Rate, over Time", "terseLabel": "Long term debt weighted average interest over a period of time" } } }, "localname": "LongTermDebtWeightedAverageInterestRateOverTime", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r16", "r49" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ManagementFeeExpense": { "auth_ref": [ "r87" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses related to the managing member or general partner for management of the day-to-day business functions of the limited liability company (LLC) or limited partnership (LP).", "label": "Management Fee Expense", "terseLabel": "Management fees (see note 3)", "verboseLabel": "Management fees" } } }, "localname": "ManagementFeeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ManagementFeePayable": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 13.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of the unpaid portion of the fee payable to the managing member or general partner for management of the fund or trust.", "label": "Management Fee Payable", "terseLabel": "Management fee payable (see note 3)" } } }, "localname": "ManagementFeePayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketApproachValuationTechniqueMember": { "auth_ref": [ "r75" ], "lang": { "en-us": { "role": { "documentation": "Valuation approach using price and other relevant information generated by market transaction involving identical or comparable asset, liability, or group of assets and liabilities.", "label": "Valuation, Market Approach [Member]", "terseLabel": "Market Approach" } } }, "localname": "MarketApproachValuationTechniqueMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputEbitdaMultipleMember": { "auth_ref": [ "r596" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using earnings before interest, tax, depreciation and amortization (EBITDA) multiple.", "label": "Measurement Input, EBITDA Multiple [Member]" } } }, "localname": "MeasurementInputEbitdaMultipleMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r326" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MembersEquity": { "auth_ref": [ "r56", "r198", "r199", "r200", "r201" ], "calculation": { "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of ownership interest in limited liability company (LLC), attributable to the parent entity.", "label": "Members' Equity", "terseLabel": "Members' equity" } } }, "localname": "MembersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetAssetValuePerShare": { "auth_ref": [ "r70", "r71", "r81", "r129", "r134" ], "lang": { "en-us": { "role": { "documentation": "Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure.", "label": "Net Asset Value Per Share", "periodEndLabel": "Net asset value, end of period", "periodStartLabel": "Net asset value, beginning of year", "terseLabel": "Net asset value per share", "verboseLabel": "Net Asset Value Per Share" } } }, "localname": "NetAssetValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails", "http://www.slrinvestments.com/role/NetAssetValuePerShareAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r164" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net Cash Provided by Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash Flows from Financing Activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r31", "r32", "r35" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net Cash Provided by (Used in) Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows from Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r19", "r35", "r97", "r114", "r149", "r156", "r157", "r160", "r168", "r174", "r176", "r177", "r178", "r179", "r182", "r183", "r188", "r204", "r206", "r208", "r210", "r215", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r323", "r335", "r447", "r587" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income (loss)", "verboseLabel": "Net income" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentInLease": { "auth_ref": [ "r211", "r220", "r345", "r583" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of net investment in sales-type and direct financing leases.", "label": "Net Investment in Lease, before Allowance for Credit Loss", "terseLabel": "Net investment in lease" } } }, "localname": "NetInvestmentInLease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentIncome": { "auth_ref": [ "r397" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 9.0, "parentTag": "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.", "label": "Net Investment Income", "terseLabel": "Net investment loss", "totalLabel": "Net investment income" } } }, "localname": "NetInvestmentIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1": { "auth_ref": [ "r38", "r39", "r40" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value of an asset or business acquired in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Noncash or Part Noncash Acquisition, Value of Assets Acquired", "terseLabel": "Noncash or part noncash acquisition, value of assets acquired" } } }, "localname": "NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoninterestIncome": { "auth_ref": [ "r98" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 13.0, "parentTag": "us-gaap_GrossInvestmentIncomeOperating", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of noninterest income which may be derived from: (1) fees and commissions; (2) premiums earned; (3) insurance policy charges; (4) the sale or disposal of assets; and (5) other sources not otherwise specified.", "label": "Noninterest Income", "terseLabel": "Other income", "verboseLabel": "Service fees" } } }, "localname": "NoninterestIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableFairValueDisclosure": { "auth_ref": [ "r12" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of notes payable.", "label": "Notes Payable, Fair Value Disclosure", "terseLabel": "Liabilities", "verboseLabel": "Notes payable fair value disclosure" } } }, "localname": "NotesPayableFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLimitationsOnUse": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.", "label": "Operating Loss Carryforwards, Limitations on Use", "terseLabel": "Operating Loss Carryforwards, Limitations on Use" } } }, "localname": "OperatingLossCarryforwardsLimitationsOnUse", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r1", "r67" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Organization" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/Organization" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherCommitment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.", "label": "Other Commitment", "terseLabel": "Other Commitment", "verboseLabel": "Other Commitment" } } }, "localname": "OtherCommitment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of other commitment.", "label": "Other Commitments [Axis]" } } }, "localname": "OtherCommitmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other future obligation.", "label": "Other Commitments [Domain]" } } }, "localname": "OtherCommitmentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherCommitmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Other Commitments [Line Items]" } } }, "localname": "OtherCommitmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about obligations resulting from other commitments.", "label": "Other Commitments [Table]" } } }, "localname": "OtherCommitmentsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information about obligations resulting from other commitments.", "label": "Other Commitments [Table Text Block]", "terseLabel": "Summary of unfunded debt and equity commitments" } } }, "localname": "OtherCommitmentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherGeneralAndAdministrativeExpense": { "auth_ref": [ "r20" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of general and administrative expense classified as other.", "label": "Other General and Administrative Expense", "terseLabel": "Other general and administrative expenses", "verboseLabel": "Other general and administrative expenses" } } }, "localname": "OtherGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLongTermDebt": { "auth_ref": [ "r3", "r91", "r107" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt classified as other.", "label": "Other Long-term Debt", "terseLabel": "Other long term debt" } } }, "localname": "OtherLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOwnershipInterestsValue": { "auth_ref": [ "r57" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of capital contributed by other unit holders.", "label": "Other Ownership Interests, Contributed Capital", "terseLabel": "Other Ownership Interests, Contributed Capital" } } }, "localname": "OtherOwnershipInterestsValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]", "terseLabel": "Over-Allotment Option [Member]" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r29" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Repurchase of common stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDistributionsToAffiliates": { "auth_ref": [ "r29" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The distributions of earnings to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.", "label": "Payments of Distributions to Affiliates", "negatedLabel": "Cash distributions paid" } } }, "localname": "PaymentsOfDistributionsToAffiliates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r26", "r314" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Payment to acquire business" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInvestments": { "auth_ref": [ "r27" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.", "label": "Payments to Acquire Investments", "terseLabel": "Payments to acquire investments", "verboseLabel": "Payments to Acquire Investments" } } }, "localname": "PaymentsToAcquireInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssets": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.", "label": "Prepaid Expense and Other Assets", "terseLabel": "Prepaid expenses and other assets" } } }, "localname": "PrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrentAndNoncurrent": { "auth_ref": [ "r93", "r111", "r154" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs.", "label": "Prepaid Expense", "terseLabel": "Prepaid Expense" } } }, "localname": "PrepaidExpenseCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]", "terseLabel": "Private Placement [Member]" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": { "auth_ref": [ "r163" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.", "label": "Proceeds from Debt, Net of Issuance Costs", "verboseLabel": "Proceeds from net debt" } } }, "localname": "ProceedsFromDebtNetOfIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfSecuredDebt": { "auth_ref": [ "r28" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.", "label": "Proceeds from Issuance of Secured Debt", "terseLabel": "Proceeds from secured borrowings" } } }, "localname": "ProceedsFromIssuanceOfSecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfUnsecuredDebt": { "auth_ref": [ "r28" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of long-term debt that is not secured by collateral. Excludes proceeds from tax exempt unsecured debt.", "label": "Proceeds from Issuance of Unsecured Debt", "terseLabel": "Proceeds from unsecured borrowings" } } }, "localname": "ProceedsFromIssuanceOfUnsecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLinesOfCredit": { "auth_ref": [ "r28", "r569" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Proceeds from Lines of Credit", "terseLabel": "Proceeds from Lines of Credit" } } }, "localname": "ProceedsFromLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet": { "auth_ref": [ "r147", "r584", "r599" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated depreciation, of lessor's underlying asset for which right to use has been conveyed to lessee under operating lease.", "label": "Property, Plant, and Equipment, Lessor Asset under Operating Lease, after Accumulated Depreciation", "terseLabel": "Assets under lease" } } }, "localname": "PropertySubjectToOrAvailableForOperatingLeaseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits": { "auth_ref": [ "r584", "r599" ], "lang": { "en-us": { "role": { "documentation": "The number of units (items of property) under operating lease arrangements.", "label": "Property Subject to or Available for Operating Lease, Number of Units", "terseLabel": "Number of funded equipment-backed leases and loans" } } }, "localname": "PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_RealizedInvestmentGainsLosses": { "auth_ref": [ "r116" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": 3.0, "parentTag": "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease", "weight": 1.0 }, "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 7.0, "parentTag": "us-gaap_InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "disclosureGuidance": "Realized gain on investments", "documentation": "Amount of realized gain (loss) on investment.", "label": "Realized Investment Gains (Losses)", "terseLabel": "Net realized gain (loss)", "verboseLabel": "Net realized gain (loss) on investments and cash equivalents (companies less than 5% owned)" } } }, "localname": "RealizedInvestmentGainsLosses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r293", "r347", "r348" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r293", "r347", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r603" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfSecuredDebt": { "auth_ref": [ "r30" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.", "label": "Repayments of Secured Debt", "negatedLabel": "Repayments of secured borrowings" } } }, "localname": "RepaymentsOfSecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfUnsecuredDebt": { "auth_ref": [ "r30" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to repay long-term debt that is not secured by collateral. Excludes repayments of tax exempt unsecured debt.", "label": "Repayments of Unsecured Debt", "negatedLabel": "Repayment of unsecured borrowings" } } }, "localname": "RepaymentsOfUnsecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r8", "r56", "r108", "r403", "r404", "r462" ], "calculation": { "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfTotalAccumulatedEarningsLossOnATaxBasisDetails": { "order": 3.0, "parentTag": "slrc_InvestmentCompanyTaxAccumulatedLoss", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Total undistributed net earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfTotalAccumulatedEarningsLossOnATaxBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility [Member]" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r60", "r61", "r313" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail", "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "auth_ref": [ "r60", "r61" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.", "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]", "terseLabel": "Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r593" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r16", "r52", "r53", "r54", "r55", "r83", "r84", "r86", "r102", "r451", "r453", "r571" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "terseLabel": "Schedule of Long-term Debt Instruments" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r575" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Summary of Computation of Basic And Diluted Net" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Equity Method Investments [Line Items]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinance", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "auth_ref": [ "r46", "r149", "r168", "r215", "r335" ], "lang": { "en-us": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.", "label": "Schedule of Equity Method Investments [Table]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinance", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Investments [Abstract]", "terseLabel": "Schedule of Investments [Abstract]" } } }, "localname": "ScheduleOfInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInvestmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Investments [Line Items]", "terseLabel": "Schedule of Investments [Line Items]" } } }, "localname": "ScheduleOfInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationAdditionalInformationDetails", "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfDistributionsToShareholdersDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInvestmentsTable": { "auth_ref": [ "r143" ], "lang": { "en-us": { "role": { "documentation": "A container table for all schedule of investment items. It ties in the \"Legal Entity [Axis]\" to all of its contained line items.", "label": "Schedule of Investments [Table]", "terseLabel": "Schedule of Investments [Table]" } } }, "localname": "ScheduleOfInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationAdditionalInformationDetails", "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfDistributionsToShareholdersDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r47" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.", "label": "Schedule of Stockholders Equity [Table Text Block]", "terseLabel": "Schedule of Stockholders Equity" } } }, "localname": "ScheduleOfStockholdersEquityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": { "auth_ref": [ "r594" ], "lang": { "en-us": { "role": { "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg.", "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]", "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]" } } }, "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share", "terseLabel": "Shares issued, price per share", "verboseLabel": "Shares Issued, Price Per Share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails", "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails", "http://www.slrinvestments.com/role/StockRepurchaseProgramAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r42", "r165" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r151", "r152", "r153", "r168", "r186", "r187", "r189", "r191", "r200", "r201", "r215", "r232", "r234", "r235", "r236", "r239", "r240", "r270", "r271", "r273", "r277", "r284", "r335", "r438", "r560", "r568", "r574" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/CoverPage", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r18", "r51", "r148", "r158", "r159", "r160", "r171", "r172", "r173", "r175", "r181", "r183", "r197", "r217", "r285", "r298", "r299", "r300", "r306", "r307", "r321", "r336", "r337", "r338", "r339", "r340", "r341", "r346", "r400", "r401", "r402" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails", "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r171", "r172", "r173", "r197", "r383" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r38", "r39", "r40" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Stock Issued", "terseLabel": "Stock issued", "verboseLabel": "Issuance of shares in connection with the Mergers" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r5", "r6", "r56" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock Issued During Period, Shares, Acquisitions", "terseLabel": "Stock issued during period, shares, acquisitions", "verboseLabel": "Shares" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails", "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r5", "r6", "r51", "r56" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuance of common stock", "verboseLabel": "Stock issued during period, shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the number of shares issued.", "label": "Stock Issued During Period, Shares, Period Increase (Decrease)", "terseLabel": "Net increase from capital share activity" } } }, "localname": "StockIssuedDuringPeriodSharesPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r18", "r51", "r56" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock Issued During Period, Value, Acquisitions", "verboseLabel": "Amount" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r5", "r6", "r51", "r56" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": 10.0, "parentTag": "slrc_InvestmentCompanyNetIncreaseInNetAssetsResultingFromCapitalTransactions", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of common stock", "verboseLabel": "Stock issued during period, values" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Stock repurchase program, authorized amount" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/StockRepurchaseProgramAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramExpirationDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expiration date for the purchase of an entity's own shares under a stock repurchase plan, in the YYYY-MM-DD format.", "label": "Stock Repurchase Program Expiration Date", "terseLabel": "Stock repurchase program expiration date" } } }, "localname": "StockRepurchaseProgramExpirationDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/StockRepurchaseProgramAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r5", "r6", "r51", "r56" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "negatedLabel": "Shares repurchased, Shares", "negatedTerseLabel": "Repurchases of common stock", "verboseLabel": "Stock Repurchased During Period, Shares" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/StockRepurchaseProgramAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r5", "r6", "r51", "r56" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": 9.0, "parentTag": "slrc_InvestmentCompanyNetIncreaseInNetAssetsResultingFromCapitalTransactions", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "negatedLabel": "Repurchases of common stock", "negatedTerseLabel": "Shares repurchased, Value", "verboseLabel": "Stock Repurchased During Period, Value" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/StockRepurchaseProgramAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r58", "r167", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r283", "r285", "r320" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Stock Repurchase Program" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/StockRepurchaseProgram" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r342", "r350" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r342", "r350" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r342", "r350" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r342", "r350" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r349", "r351" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SummaryOfInvestmentHoldingsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Summary of Investment Holdings [Line Items]" } } }, "localname": "SummaryOfInvestmentHoldingsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosure of cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TaxBasisOfInvestmentsCostForIncomeTaxPurposes": { "auth_ref": [ "r408" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of investments for Federal income tax purposes.", "label": "Tax Basis of Investments, Cost for Income Tax Purposes", "terseLabel": "Investment Owned tax costs" } } }, "localname": "TaxBasisOfInvestmentsCostForIncomeTaxPurposes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxBasisOfInvestmentsGrossUnrealizedAppreciation": { "auth_ref": [ "r405" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate gross unrealized appreciation for all Investments in which there is an excess of value over tax cost.", "label": "Tax Basis of Investments, Gross, Unrealized Appreciation", "terseLabel": "Tax Basis of Investments, Gross, Unrealized Appreciation" } } }, "localname": "TaxBasisOfInvestmentsGrossUnrealizedAppreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxBasisOfInvestmentsGrossUnrealizedDepreciation": { "auth_ref": [ "r406" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate gross unrealized depreciation for all Investments in which there is an excess of tax cost over value.", "label": "Tax Basis of Investments, Gross, Unrealized Depreciation", "terseLabel": "Tax Basis of Investments, Gross, Unrealized Depreciation" } } }, "localname": "TaxBasisOfInvestmentsGrossUnrealizedDepreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet": { "auth_ref": [ "r407" ], "calculation": { "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfTotalAccumulatedEarningsLossOnATaxBasisDetails": { "order": 7.0, "parentTag": "slrc_InvestmentCompanyTaxAccumulatedLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net unrealized appreciation or depreciation.", "label": "Tax Basis of Investments, Unrealized Appreciation (Depreciation), Net", "terseLabel": "Tax Basis of Investments, Unrealized Appreciation (Depreciation), Net", "verboseLabel": "Net unrealized appreciation" } } }, "localname": "TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationSummaryOfTotalAccumulatedEarningsLossOnATaxBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TechnologySectorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sector of the economy consisting of companies engaged in technology-related business activities.", "label": "Technology Sector [Member]", "terseLabel": "Software" } } }, "localname": "TechnologySectorMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r212", "r213", "r266", "r282", "r319", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r579", "r580", "r581", "r614", "r615", "r616", "r617", "r618", "r619", "r620" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrealizedGainLossOnInvestments": { "auth_ref": [ "r34" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": 4.0, "parentTag": "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease", "weight": 1.0 }, "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 8.0, "parentTag": "us-gaap_InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment.", "label": "Unrealized Gain (Loss) on Investments", "presentationGuidance": "Net change in unrealized gain (loss) on investments and cash equivalents", "terseLabel": "Net change in unrealized gain (loss)", "verboseLabel": "Net change in unrealized gain on investments" } } }, "localname": "UnrealizedGainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r301", "r303" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "terseLabel": "Unrecognized Tax Benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": { "auth_ref": [ "r592" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.", "label": "Unrecognized Tax Benefits, Period Increase (Decrease)", "terseLabel": "uncertain tax positions" } } }, "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/IncomeTaxInformationAndDistributionsToStockholdersAndOtherTaxInformationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnsecuredDebt": { "auth_ref": [ "r3", "r91", "r107" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).", "label": "Unsecured Debt", "terseLabel": "Unsecured Debt" } } }, "localname": "UnsecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationTechniqueAxis": { "auth_ref": [ "r75" ], "lang": { "en-us": { "role": { "documentation": "Information by valuation approach and technique.", "label": "Valuation Approach and Technique [Axis]" } } }, "localname": "ValuationTechniqueAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ValuationTechniqueDomain": { "auth_ref": [ "r75" ], "lang": { "en-us": { "role": { "documentation": "Valuation approach and technique.", "label": "Valuation Approach and Technique [Domain]" } } }, "localname": "ValuationTechniqueDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r185", "r191" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Denominator\u00a00weighted average shares, Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r184", "r191" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Denominator\u00a00weighted average shares, Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetail" ], "xbrltype": "sharesItemType" } }, "unitCount": 11 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=77885760&loc=SL35686385-199418", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org/subtopic&trid=2209399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(c)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(b))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(5))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.10)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.3(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=66023616&loc=d3e9120-115832", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=66023616&loc=d3e9145-115832", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=66023616&loc=d3e9079-115832", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20,22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10177-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10328-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10342-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10396-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10403-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10411-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(h)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/subtopic&trid=2324234", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604008-122996", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874225-224268", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874234-224268", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12.2(ii))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611322-123010", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "946", "URI": "https://asc.fasb.org/subtopic&trid=2324412", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123405975&loc=d3e41551-112718", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70258-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "https://asc.fasb.org/topic&trid=2196965", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123420820&loc=SL77919306-209978", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(h)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=126898976&loc=d3e600178-122990", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(h)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=126898976&loc=d3e600178-122990", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(h)(2)(iii))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=126898976&loc=d3e600178-122990", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(h)(2)(iv))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=126898976&loc=d3e600178-122990", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=124439613&loc=SL124453110-224270", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org/topic&trid=2196928", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1403", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "a", "Publisher": "SEC", "Section": "12", "Subsection": "04", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "c", "Publisher": "SEC", "Section": "5", "Subparagraph": "Schedule I", "Subsection": "04", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "c", "Publisher": "SEC", "Section": "7", "Subparagraph": "Schedule II", "Subsection": "05", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "9", "Subsection": "06", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(b)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r467": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r468": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r469": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r471": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r472": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r473": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r474": { "Name": "Form F-3", "Publisher": "SEC", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r475": { "Name": "Form N-2", "Publisher": "SEC", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r476": { "Name": "Form N-2", "Publisher": "SEC", "Section": "Item 10", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r477": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 10", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r478": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 10", "Subparagraph": "1", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r479": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 10", "Subparagraph": "2", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r48": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 10", "Subparagraph": "3", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r481": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 10", "Subparagraph": "4", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r482": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 10", "Subparagraph": "5", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r483": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 10", "Subparagraph": "6", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r484": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 10", "Subparagraph": "Instruction 2", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r485": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 10", "Subparagraph": "1", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r486": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 10", "Subparagraph": "2", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r487": { "Name": "Form N-2", "Paragraph": "c", "Publisher": "SEC", "Section": "Item 10", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r488": { "Name": "Form N-2", "Paragraph": "d", "Publisher": "SEC", "Section": "Item 10", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r489": { "Name": "Form N-2", "Publisher": "SEC", "Section": "Item 10", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 10", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r491": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 10", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r492": { "Name": "Form N-2", "Paragraph": "c", "Publisher": "SEC", "Section": "Item 10", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r493": { "Name": "Form N-2", "Paragraph": "e", "Publisher": "SEC", "Section": "Item 10", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r494": { "Name": "Form N-2", "Publisher": "SEC", "Section": "Item 10", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r495": { "Name": "Form N-2", "Publisher": "SEC", "Section": "Item 10", "Subsection": "5", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r496": { "Name": "Form N-2", "Paragraph": "1", "Publisher": "SEC", "Section": "Item 10", "Subsection": "5", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r497": { "Name": "Form N-2", "Paragraph": "2", "Publisher": "SEC", "Section": "Item 10", "Subsection": "5", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r498": { "Name": "Form N-2", "Paragraph": "3", "Publisher": "SEC", "Section": "Item 10", "Subsection": "5", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r499": { "Name": "Form N-2", "Paragraph": "4", "Publisher": "SEC", "Section": "Item 10", "Subsection": "5", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Form N-2", "Publisher": "SEC", "Section": "Item 3", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r501": { "Name": "Form N-2", "Paragraph": "Instruction 1", "Publisher": "SEC", "Section": "Item 3", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r502": { "Name": "Form N-2", "Paragraph": "Instruction 10", "Publisher": "SEC", "Section": "Item 3", "Subparagraph": "a", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r503": { "Name": "Form N-2", "Paragraph": "Instruction 10", "Publisher": "SEC", "Section": "Item 3", "Subparagraph": "a, g, h", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r504": { "Name": "Form N-2", "Paragraph": "Instruction 10", "Publisher": "SEC", "Section": "Item 3", "Subparagraph": "f", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r505": { "Name": "Form N-2", "Paragraph": "Instruction 10", "Publisher": "SEC", "Section": "Item 3", "Subparagraph": "g", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r506": { "Name": "Form N-2", "Paragraph": "Instruction 10", "Publisher": "SEC", "Section": "Item 3", "Subparagraph": "i", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r507": { "Name": "Form N-2", "Paragraph": "Instruction 11", "Publisher": "SEC", "Section": "Item 3", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r508": { "Name": "Form N-2", "Paragraph": "Instruction 4", "Publisher": "SEC", "Section": "Item 3", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r509": { "Name": "Form N-2", "Paragraph": "Instruction 5", "Publisher": "SEC", "Section": "Item 3", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Form N-2", "Paragraph": "Instruction 6", "Publisher": "SEC", "Section": "Item 3", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r511": { "Name": "Form N-2", "Paragraph": "Instruction 7", "Publisher": "SEC", "Section": "Item 3", "Subparagraph": "a", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r512": { "Name": "Form N-2", "Paragraph": "Instruction 7", "Publisher": "SEC", "Section": "Item 3", "Subparagraph": "b", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r513": { "Name": "Form N-2", "Paragraph": "Instruction 8", "Publisher": "SEC", "Section": "Item 3", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r514": { "Name": "Form N-2", "Paragraph": "Instruction 9", "Publisher": "SEC", "Section": "Item 3", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r515": { "Name": "Form N-2", "Publisher": "SEC", "Section": "Item 4", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r516": { "Name": "Form N-2", "Paragraph": "Instruction 2", "Publisher": "SEC", "Section": "Item 4", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r517": { "Name": "Form N-2", "Paragraph": "Instruction 3", "Publisher": "SEC", "Section": "Item 4", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r518": { "Name": "Form N-2", "Paragraph": "Instruction 8", "Publisher": "SEC", "Section": "Item 4", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r519": { "Name": "Form N-2", "Publisher": "SEC", "Section": "Item 4", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Form N-2", "Paragraph": "2", "Publisher": "SEC", "Section": "Item 4", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r521": { "Name": "Form N-2", "Paragraph": "3", "Publisher": "SEC", "Section": "Item 4", "Subparagraph": "Instruction 2", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r522": { "Name": "Form N-2", "Paragraph": "4", "Publisher": "SEC", "Section": "Item 4", "Subparagraph": "Instruction 3", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r523": { "Name": "Form N-2", "Paragraph": "5", "Publisher": "SEC", "Section": "Item 4", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r524": { "Name": "Form N-2", "Paragraph": "Instruction 1", "Publisher": "SEC", "Section": "Item 4", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r525": { "Name": "Form N-2", "Paragraph": "Instruction 4", "Publisher": "SEC", "Section": "Item 4", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r526": { "Name": "Form N-2", "Paragraph": "Instruction 5", "Publisher": "SEC", "Section": "Item 4", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r527": { "Name": "Form N-2", "Publisher": "SEC", "Section": "Item 8", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r528": { "Name": "Form N-2", "Paragraph": "b, d", "Publisher": "SEC", "Section": "Item 8", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r529": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 8", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r531": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subparagraph": "1", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r532": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subparagraph": "2", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r533": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subparagraph": "3", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r534": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subsection": "5", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r535": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subparagraph": "4", "Subsection": "5", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r536": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subparagraph": "Instruction 2", "Subsection": "5", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r537": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subparagraph": "Instruction 3", "Subsection": "5", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r538": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subparagraph": "Instruction 4", "Subsection": "5", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r539": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subparagraph": "Instructions 4, 5", "Subsection": "5", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Form N-2", "Paragraph": "c", "Publisher": "SEC", "Section": "Item 8", "Subsection": "5", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r541": { "Name": "Form N-2", "Paragraph": "e", "Publisher": "SEC", "Section": "Item 8", "Subsection": "5", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r542": { "Name": "Form N-3", "Publisher": "SEC", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r543": { "Name": "Form N-4", "Publisher": "SEC", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r544": { "Name": "Form N-6", "Publisher": "SEC", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r545": { "Name": "Form S-3", "Publisher": "SEC", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r546": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r547": { "Name": "Investment Company Act", "Number": "270", "Publisher": "SEC", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r548": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "313", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r549": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r551": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "413", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r552": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "462", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r553": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "462", "Subsection": "c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r554": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "462", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r555": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "462", "Subsection": "e", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r556": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "486", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r557": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "486", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r558": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r559": { "Name": "Securities Act", "Publisher": "SEC", "Section": "8", "Subsection": "c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=d3e5283-111683", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 4.F)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r58": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r586": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919398-209981", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(h)(2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=126898976&loc=d3e600178-122990", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r614": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r615": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r616": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r617": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r618": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r619": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r621": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "12", "Subsection": "04", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "10", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=6431724&loc=d3e32938-113948", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "10", "SubTopic": "20", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=6438156&loc=d3e57880-113973", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "54B", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126972413&loc=SL7495116-110257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "59", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126972413&loc=SL6740821-110257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL7498348-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "940", "URI": "https://asc.fasb.org/subtopic&trid=2176304", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(1),(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.13)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 121 0001193125-23-053980-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-053980-xbrl.zip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end

%B#?UE))@@ V5@CRTQL^W+9# MC8["6H#YC\-(RL9XBU'X1C5-Z3YJL)8T:F2N'% M]V-7BK#%?T_V"NIYU+G5PPT$V!;SI0(CJ#\($]]W/9CZ4IHBY"7[@HWC1A5A M[!:^4BA)QY%3@#'U%[@GIGV)".7BD9\P*V5( *#1&AI]3??P$QJ0P'9]"2*. M%0%TC+\YZ Q0!(G IC_0S<02L]-'03P\CDC%7FF"$,/ 8BC'E8A +L(EE/C M:IQL@IG%4]8@1GQ;>G]4V=.8'O)Q7]8"&1N. 6WM"'XT\LK3U7KAYG N%U@\ MNJ$>PD\78!A?P8A.[M?S?<^U\>9V=3+WH(GCH>\TUZ#K::!:+G"JQ9[2:TI, M>MLU>C6>QM>+!3TP1 T0%@*)_9*3G(A!F;15C7ZQ%FV7NPH/=)E-F_APR^@08,2:^^%>!@)T*1VZ!?DU= J?SLM#@#9E MGV,5CPP#L/4QVMW%A,_19.:=*M%6LOES3W$((%B[?'M.#0&PI/Y-Y=]4_DWE M?Q$5%)\K:26\E@-NO\SS7[_*\GCYR>J ;OQ@DEX!J5?%$29\LL^^WF][0)7L M#[V&O^SLBT$CHR-<@F%_KML_Y;-.G0T!9@9\M@O*R&OP9U/JDOW_Y3LE"%N/ M_I";\*)P?\H"DA Q!(AQ> D!*LPAP!F&ZNLU(X\45:B_HUEARI]U^+KE\N6_ MLK"F@6+A9/9YUR\P09IU%@9UE;':^@<.9-U#R'XQ]N]PB;Y?@.%F]ZH6ERD; MPPP'-A'F72GB>=Y&/@:W!!EDH:2;@LT(Q*Z!'5#&)CS=_,9G#_' ]#$TQ0QV M=V]JB0J;/&ZTP6O '\USJX 0!7C;12>/)!M,LXNG4 5&7E2/4)!X;$4B!!A3 MT)(RY:SA9!.4,"7I?8P(C!^CZL<' (\HVQ*^\MF&J MTW%,% ]*<21,5-06=33$&+GP?Z$?Y#7?2 B,&(B@IP>BJW/:"]'H;B#&X8XO[9&OUD@ MC72#BDIG@0,.PM]Y#0%O)?#%GTK@MI,%*FW# J:6NQ5%YOU?,"X2OS^N)^I? M%I.P:<"#:\']"3TK_"P8 F300@#/4$!H"/[N6.%V71%T82Z\%>JS3.:+5B,* M 01>/UQC EXI:->KF9>]8.C]49\1S,<@0@(@_I4.#7#+07S:)7P4(_)O@G\N MP16GYB8!A1)BU&T_Y46T&Y/Q2.!A6WB+^KC<36;HY,6Y^>M(?**E\GN,487O M!_C6&(YMU<5D3-B*<#]\6C,V:QU7U_KMI7#4. 7SACU>3I8+T'JG,']0,JXU M"K,:;S$:S3R-RC/#XQ'2)'0R[WA&;"7E77B8N+08S]:%!Q\M0C CNO&6^;^Y MO\A3YD PF4T*GWR"YQ[U\-(_K8?_CUS2O]"PH')WX1],+>Y>V8KS5^2O6J@< M(UUN53WH:77;6Y](.8RWCX8;'>R]K3_EKD5!FNFX,=321F[0I"!/LGVMCD!# M3Q[;ZJ:>R1$A6P.5490W9X7-;.:!'DMU-WD3\&VRGTYV<#Q!4SF) Z];TQ)G M"?:S/+N::>/8.D_#I^Z7WCUWPG1=W#)SVD3Q.QUXQ!8*,DY2'@0A#%84-H2X M)IJO1+%&W>0Y]GL42?ZU!B] %0=>(<;:1&.3 M"LWXJ)1C.4%.$ 15WTZ+#+ M>WA\_*YQ.(U('E_"[GDKF_@8\N^)H$PXR05/?U/@?Z+._M997ZF]\F"**SS2 M?136(T+W@N;I!I-&'^M'D_#O'\3JH4'ST#/EYD#BPP8GBF2OY5/&UEPX#M$S&5[?2E\.5K:2?1V^?30YRA+!#Z5^^XV\W9;$;0Y! &$MAYN, &W M&I^1IL=9' C\N]J?7PTTY)K3.?'M[?C9MMSNC!Z#)0(_Z('\7IBO/_<@>^&P M?24> KB]EL[V07;UO/(>"FLW_9RYF6'X)5$H8"Z=QYZ9C54C25?+ JN:NV6V M;6L! BR+U?)"#Z4^>(W M(U/1>6A]Y#UE$S$V;VBB=!3AOE(3;]GY_]6$CQ^5B\&[%E>:G'7N.P$7!'?O.@4M0^ MUSK09?AHAEP4I',*RUZA_YI3HD\UMV7,;6@,,0D2K8L)$L5,49!4,?Y^G=/T MM<4% J!5O*P,8;H39O?LFP)3WST(:W5H*?2>OP[BXW*7]Z9V,/&P+ISM<;*@ M&T .H!O0SD_Y)-#4KK(Q0%ED^/$_B4X 8Z/J&\+KE]K^TEU0( 3)HO,\P/B M!W^Z8L^WM@ZR8-&_)S/TQ,X.*Q>%8Z0*IVT;..< O;&<-J17C]6C6*B4'I>@ MZVIKCFP"P_<4SLNX74@X/_M>J1:11(*."!/^Z.<^OR\QI$QDM\_*1AZ*%FF_ MWR<*)CP>]R7G6TJK.K(*!Z1)-2.QYA6I!8 02='L::'I5"!"=$08! M]!@A0'9&;>2@E>DCSW_:5@[,G,_KH>U$N=C;+Y*'$^FTPKY8!YO2SV![.5ME+YI>_>AB)=-A^^R6IHG#'<@:?(2(U[.UZUZ%PSVFY MRYKU7I1[HW0ED6^I7-*:[A+HG((F<^00A9AA"T>+7W.4)&L2M[C MD-I_3/Z/\<$8@0!$)SZ??!(X&S$]_^D%"4(MPDDOD,TTN540WX#_]@K553#* M3@0O5F/79[;>CBTLQ+!)4\;-346M5_G;=23/$*#E>FA=;EM''3R29-EE^Y3( M.0_5JF?[4#1"#_2T+\&-9/9PI 4S4@Y' \VMKC.7&-Y$?D_9! ]_ M__I70UD3=;W#?']A]1@H]-R=)3W<<@!>:3XC,CY'-2+_+OJGB[ XZ5/EJ=JU MYYM#GN)V*PS;*^@+RM/*2.BDO"Z@JU:,W*+,LN 6HIL,_L 9Z%0K_A!L,Y2& M=D1\.C)>&?YFF2-*LE5Z)6N?UG8JO>=7XIRC;J(7=A! D/+1L P!Q&;$I^-Z MM_NCH'^N$.JYB@G=""F\_Y-8%%!5QVX*X='["F+U4?'6, <'4]RS<^*MJ#R' M?J;4SDE>UK$H7J@W;PSD2DZ5.\[#--8WQ%9)B6_;$8O3F?3(Z!%B%P^%- MQN;WOW:#BN$_(!$T50,4HK ;\Z)PMQ=MV9>R%0APC<,Q?,*-_5_Y0 =/>PJ[@9?K6U?JONXYF KM M!S1!WWBKO@>O7H/=X^W0RXB-]-:'PT2.83,_O)7HJK&.<8VENAW+]#DN(^6D M=+2;Z1A^WV1LI9JV\HON@GGTGWI:,@\S-^1M8(G1'FU\4[[/3*W/#4)QT7%5 MZQ"=WQ_8;1ANXMV9^W,(,!H(R(N@5]QY"]^&W0T!$D7R#K#O8[5>&"<; 7FNX*H73XU;F3!F.Y M$\/'&5B3/RQ65;XZ?/]HN6CE5Y\4DD:NY\IC]<60O417+-%_ZM K>(4+AO4R MO6<^.OLQBE=J<#HGCC=/]AV]<83PQ-Y#$>Z^MGUU&N_+'(7(=Z)9O,?80,?? M4HL=_1V3-GCDKOJ7<.ZS1-N MIK[_80[;6EQ*[D-G'5^<71>:@:7R<$M2(>;W"_4 M_7F1V,BH8XFN=L9:!FE,IZ=SU)HB"P(@-ROR-L6;_7^$, MBGM#'4,]0+TH_.5/TFA0N[,V!TO8;N2+8SF&I063&")8F5(U'JY9M"32RX// M3?3EMOA#X.,R[!]YFR=6([[47HU]&;&[M;[@;9W#H^PE 0AL3\/TI7JUBWPI M,E2QV:AD]XO;$4&Q1E,P.'W1%>G"&M/ P]-KE%;Y_9T7#;0( 8 :%]X2V#@ MS\ZSK' NRFYU:17]V(P@U581WDFB'T7=%1ZAGN<7]+)U1AF37(3X_M9S- MC\(N7S?.<55:NC:+:71,W21TWF*871K%ER>C&I?6P#C!_I<808_M;-US% MR3C73S(&70M4=98LD\\0IQLH8U^N->T8T)]ZK^97^?CA^-XI%.TUX$0OOTT@ M5]RCRU]XZGU$O!5*^TIY+"&RXW5VG-^"VE;BGZT_90>KLLSTBW,HXGQA 2FL M3G91@C'9"$Q?3'W7MV== *]IR+KYN(J9;C'N4V$D *8JR1@U;R;QS8E0+3!F M!Y*PX_# 7=%^]U7(WY?R3[9OT!''DLU.+NZ?GX\.[^TT9J@*B+5>[_LD35>E MI7K&+)Q5UI+CWKK/,[8,'4"+U?UX2$Y,[&"A.*#;LJFY=GFR_ *1/8TW,C4IN&*T>V7TB*X-O!0FZPE87():RV%P$1?O^MM,0)<>-TL5N M6.A(T!Q:C%:@-^&"S=AK&I=\3P3MKV,=Z/:4NJ@2Z(8V/WQ5HZ)8&/!'=?X) M$@ ?"O1DT.9.U,XT5C(*<%ON&OJ&DWB_*;S-C;0[!R-F1>^H-[ S*-]'7<;* M&K^GAV.,QHQJC56HL 1&,E^UQH((G&.?)(=WN[%&\6I68Q*O]MY5B<#4LW-E M%;Y!X5.K;O++:0CK[^YC 1G^! BX */63U%$CB-L6(_3T1CMV@T!IKNW;;6U MUN_A;N6<=AZ*]J3WN^M-(YE\6G'N3WRZ:] -MV['?):I[\R!KI'+1UWP6>%J M%!26>?33(:O,8S TCO!2V,/U3V>L?OO&%_D-!'!GOEW_Z8@5;M/#F=YEWT\G MK%@=[K?;CN(>.(#_!VF^$X[\M=3M,K3%R\7$BS+R(V5S,161TQ:R!ZI=EX-* M\42M@A&B;_C:R.M#/C0$<^%9+>4W)0Q)+J&4*9J8A[QX/;JS919?)=ZL=:L[ M6=J?:9%G_2[6=##NGR?L2-2;FB1E:SY!R:D*S&A#8(N\<&]FKB)6QD%;=/;0 M_#=&EC#_HP,!385#]"*3P^=14R">W4QH^VG_47)&BK?(E5QRRG:CM4DF?-S( M>5:: -FQ/-G04DR@L%V%E-K96.^.O3K.[,)I8M[H* 3NAW,MA5/<.C_:,U(SY,S,$*VQ:QH'=]B M0L-=&Z\L4E/56;="LLLOP\ 1:XY< M ZC]R>C@:57.XS'QP7X98'/Z?18YQT MMC3?P[[(SVEJ)1"4'1Z5HJ_IU.7:&+# 9_=!@ ":-!! .'BZ^G+7C?SS&8N' MQ\0=QIBFJ[A854,HYD16W !_0']6 M="Y1!'=<6&)Y[LU^UB A2!0JF*LKD!^ZQDP8YE:X-D3YZ38*:O)I$>8#N)DO@[=$X#8>?MQM PMM2\3IP/.DVXY3 M,+0]!'#U=@1L]([0AGW_Q[]Y]*_%;9_(.G-^5P"L-2!/%LT1G-QVC+DD,X7Q-3'0AMIVB?AB; MU%COH^TONH"_SAPOYHB=VAW<,S*A[).W[]QM^(F=5MH_(C"<\(<6":N5>X$1 MTJ>O[L31!9I] BU>I:96XZNS";"#%2A7CN$^M;0/Y9ON2FL06>1] JC'QN7W@)H4 0K-9H\K3J"L#7I'Y':J5DZNG M#.6KZ3[?;*0FG;#>9Z]]HBS!OORI_>(N3/=LP'=N8MG^U['.TH=YP3D\M+)YF49QQ\3AGO+/ MOA"-RY.ZD6 T]GKG>B>$[\J[$041PP>[U&QRE7EJKB;6A:2VCP_*0F_"T1%' M-O9@6>8>_$@;;S>(SSQBL/I:M)<2E+#Y.8DR?(<%!?M\F<)URW0E?&MF=+K2 MNDPU$O]LY97:^Z90[@P2LL,GO8=4^(X6SP0*-CH(T@,]DF"0,T W4\GXSCA\ M"<,53/CBU@0G%'[M[Y'@^W$(MH2G?S![8%Q3P&^17($482RUJ'# M_@1#,=G=+?L#&(K9?\!0OO\')&#D=TB Z^\8@Z^_8PPR?L<8_/@=8V#V.\9 MX'>,P?_/"?(N>G3QO0J' *:AL"UM-MA+6#!;"QTH9M'NL6>MTAHD,1'J7/+SZW#U]R]: M'Y09AE)N%V?7RU :N]6DY5_G'O9Y_\KY-<6?WJC!&2=Y?I&)E,-=#NI<.U^V M@VVZ%7AN8XYR_2L'D4RE5B&RF1PE]E-;&TELRGV[!R_WZ2FJ[":2U\YC.$>V MJ:^;K(6E0@0I&^?;HXQT!67'2YC-I#8'M3]_2'85ZM0./*5\9G2O;_/06'". M[UQWCOI"[>GR]@O*^^HES4B8WAS[*)^'MJW7!_0&9T7%ASAV"XO5F0J3I*>, M+06$W6,QYUBSKW+IZ+OBTP=^:P6]:$3L\+3YH/W\BVWW$A*R%.=OJ&9*5UYY M"])F$TLZ?&N%Y@H#USZ!UO@G6G+*DYG*09[:*Q#@ZJHF0+-6;TVBT]=;\QY% MM4C!&M>C=&Q"P&3E7K23+;"Z<=NH4:3EWEU%]OU:?;:=^8[:S6;F^>.J](;3S@+$C;P.K]\=I!/BJ7_YT1R$& MYL6HCM3&@EALOD.PH@0@>>,4'UY&FK+#'&TL:V'!NWY^4Y]2CJ.5ML:#-'@:R3R0"L0Y2UNMYQ&*ZCZ[S\>%^' M3E]'XP4$V/-VBN(H]N0C'U,I-. L.9*K&MT6PIIPA%F$\;;NN[U\:K]U1R_] M6O';>D5HD9Y7\W.GK/[_>S]67&/J@$.>3VZ@82ZLO7!WJQ)+,> GF\PK2"R? MJ=,* =ZG=I)(V00XE=7<3^H.^HP(>M%;UI'+"E1YE^9/JL84<$XMAYA:69&- M6NS:473:/W3<"?,=Y_&N9C)P1#D0FE2UF1C9%LPS8&]CP;]>R'RM4[O3'>]F MJ*S&,!V [BL*8TPT"0KV6.D\_3R5+_OV4$J8>5$XV'*U*%!],W>_SVY?RG85 M<3\/>VX2#F>;2BG!,GG51/YD6NT4A[.!>RV&,L(X8FKT!.^5:/GZA+I$9/ZC ME_XIPR]O#T'M9IA7NV8-61ACZ(T9S=ON5"F.)=0I1U.V*P?-6,Z]"ZN !.&) ML[+66I/J[1+-8,$]WJE MX9!O\KD::NHBO5_CP_WY,-32IT9[;8Y(JR.(3/4)VVE4&.2(OB#I,[9.XBA2 M_.@EXL*#\R4R"3=CH_GZ=2OK#(Q07D%2$[B1\*#2_9V7G!HZJMOW.>'=4\W[ M(I?D2ZP51(H@^E&'2448X7EW[V_?%!*\':H^ZSK?+7BV' _S@F&M3;\2CN63 ME-N=<.$&^.-$):_[^:4 -=9.* NZ;QF;[%76T44)T$77\0&FOX"'4GN6SB=1 M_Y$T/AJ:W7J$G%PP! _O$HRL5Y\P?M;COVEE''F@[[KN9-CA/?[$!YTHIPS0 M"CW(.GY"OF@ZN^J\J;B+%-/W_6VW].4=#323E]8)#?8J?SZ[K*EF3B\9EMH7 M?7Y];S\QQ?,B$_Z?LG:1'T4OKN% &NK->AN<1!@I.U!B 8X MI88 F3YWGHJ@385'?^\G50>&'LQ\\(( Q\O0XU*& P&,JON(<6S"\0F[EZ?K M4@%KP6I4RVF6(P=K?BM[E.!-H>434,[$U)VS*L47N*R$#0$6"^KY M[_F4\-5=,G**(I1TA_TW]$)F2N3P8>04B^$ 9 "K:K/!J^>_I0]@=:14Y>FZ MY08Z,3IPUX\>@T:B_&)6>V=QV:UG, ZNH?NN43I1 ^-9PMOU@PO<382/*W"\ MKD0-UUSK(8\KN]3ZPU&+'%D?A35JY6X M^5-.7"1<.]WWAMFE8=\TF71Q!V.[J[+/3:,!NG';%RCS#M$U5T%)[KN:3TCJ MQV4V+<1#T(/$C&Z,SG/>/G!E5\ES4J\WC+/*9J S9D'N MPNT[UR6Y?RS7J$*]E99&X=#)@"0GN=YO_:EC\D<=*NZ"-F]-6==4\U2<[L"$ MB1=SPF(1KMLY9&5/&.TZO[LO8. R?6/!;N>L)%U&P:Y^MN+WD2KM_,/! !&, MRZ_+/$3=45_U_!6LEI&>JQ.SS=)*A8UBPX^2'T()?:^1BN52/\:N.3!=?CVI M$K=V?7-F*[!%+$:?D@_;%J3GQ@2;?$>.WUWL]"1:9,M*WQLK^TON9RHA994PBZI(,/[? \+>UL'VU+!&]-_).V M6]FJQCA_WCYGD18)'JM<$YUK:]R%H0C3_ZX2H% MZAJRAP5,M_AS%*+0=' MSH7UY@>P*TTPK4K=6\O_SM7D0]SGWBV.L^G/))(F+-GWF@X$]J?],NE5F(+/62.=+NIJ/K/=F=3M=T MD$\J#O^O'I+_Q""OG'16OU)HLQDS<_@1IXS6%$JHVYYYV&.OTQ(RWW;4>[:3LFLX9UT3U8J7MQ;73*R^[YDBN? MPS@?0WX??*3UNK=<2V?L'M#=3C0^3(4WP'^6'.HAHNZE"[+DV:Q&8:G/.O*9&^[Z1[U\U^PNG5?8A]P0W@=F!3H+.T>SX)M\\@W*]W_7@(T(-!1^"%S\($)?T3F$P'(;+CMUHJ.0J580>? M2M,H:(M9,)Y8NEX/7>"O>(XS=[; ^O2 R/_88I06&(Z\)HG15^ MWK7[ Y3,TL\HF9SG'Y._@^2I%J.)3(HLJUV;E=4>WDQ4 M?(A$%2C1K$Y5U#7]EBDWAF?+.9\\-.Y+5AMN<^*[#169,!3T9:J,V>JU^A5Y MBBHYBO$YSJUMYQ+IM:,5R,#29V-SK8@([./+N7M+Q_&9VV46[U:V3@C66*OJ M!V7*T$69[JK.J^V3E[D'Q($OJI3KP*6AD82ZIU/I+Q5[8*P(6$OM*D J^FCM M3=JV:HX4B1^\2 ,?Y\"(E2[:A)/+Z>1SN:_](VCP0FMMI^6AKB$3$XY&?*P9 MS>PDE@^D/TH0SI-1LPHB82?UW*3:'M70:5EK.MW-.N\M6YSG")W#0# M9Y@/7_>&">%,#O.D<[GF1 *W!7GVL_"IU8&ICP8BN#=1P645Q".^J599O;%" MO)=8 ^I/\#Z;;_?9-HE+V:%6(,82A3G@CFQI%)_3\*MIN6#-+2S5?_(_ MQ&!L*2$CVK7Z]#.UUKYBWY^[_V_80MTXM\6M3RJ2,^60NXUB)FZ)$%);$U [ MSAFL<%2.&+;2O@HK*NFL5V,V9$V\?>EF>N.A-MK14](DBS#9V?LII?3ZP:"1[*Y^1Z60Y-H@MO:@BW1<>F]I(7:#G MWOYNW;FUS[*+O@V]LJ7A4^BFWO[V.%>L3K.(45QE.:\9+C08?F$28:*R>=+& MR4V$[;GY5@P%ZSZ\IF3N^;,G=9V$K=\ M@;X!:*"T_O(N+>D4Z>G9SNO][+VLD[!]QH ,-*,=$;PH@R((8#HGYCS"X$)/ MRR;7#WX;N!B5O!8^"M/LA&#+=+19JVF,8-0@O3&,0PZ-^SVN3[!2D 8J?@YV M_^)X'CM$^5OOL=!O<,ZJ/1%4+V(E:[%;142$V!MBTFPV@A_](X>_1:OE$'1"Y.' MN\S+63#T_L#]M?#/^,2DVQ.?95-?M!KFR_5?T':_50>$!MN6XW[&+G[T::.^ MOS ';MD@@+?"S_"\_P9*T#:AB&S2P-$F/K!:)XR^:-DPE'.ET<>P2-G,Y"PI M&'5^5X*H8N]9*9"75?S P+X@]ETEZY3PL+[J%:-';:!=:3M MK*"X*_7!U:ZUUIS:]-A9@J103XVY5S9^];Q74573-VGQ MCS*7)@9Z<7=^VO0S(^ GT,K\"-/[1?^&B+8_G:_\9*%(.+X5*:V=YF=]W^AY?XP<'%(T/8E,1 M.G(>.-W#G4(1ZB *IA@6G)>:B.6ZA!27P-=PDD?BJ3LZU%04]TN7IEC93WSN M^/QKKP7]?1T)-T# TCD^P)YKSC8XC@YDT6_[GAQX:,5USN3/S6[H4&&?4PPN M-3Z(U1:]WMV11#HG&FA()<@M*FD=N#$+/)]OS].^I9I$ 6>>YWK!*XPG('%4 M'LVI7.X*M6+T#*CE[+<]*YP0P,K9>2]-9A7FUY>BUC=R@E7V4D)FQX-<0_$] MRLAOX^^0^H_."D%N_S>Q E. M$YVU3:;ED6ZC\DOX;.%"%),<,HD3G1?"689M.];%:>MJE%PV2YJDY%+FAZ_%O=%+X5.(3QH1_%3/74##-GE2*J=^5 M-"W:@B.E!AI:<93H*T7+V&8BCE)BB QI<-T[U8Y/+NDXMF0$UL7D/SHO+ZM? M,>5^7%%D&>PT:*7Y.EG$=5V/4#\<]^MDUO4S^"_S&SEE\<53SQ.OB3NS\;]V MV*W"R<#,$UUGKH-'/.$4G0NMWJ*(9[_]@AJ@"U0$" !^92C^, VFM9-#,DUT M M\.'@X0O\R@5I#H&MQMOW<)U[^8WS#! M'H01M31R<'!V=T^3)YE/O3(N.'P]'/2F0MB]0.+;:&WM]&M96J2NE2%"25TI MX58?>_>X:W5'4K&H9F*W# FMQC25IMQ]TV\[>O,XC/#!!XMK\,\LDXPH;@X( MVS+'Z]+5L8[:8IEPW1W/W6M&'=&>6-S : 9ZSN<3"YS8]^QLTXGVCO^YC%W?X@##[9N5$;*^,YIY7)(=.# MMW*FCV#7Q,% C=8%VYUM"8_7JF9?JIW!#S"'X.$HREAD'BS#2>XL>1 4WGRW MNRLQG_0Q]'%+[1A/$DUT_HS68G!!:'HJEWE;+;3@+2BL5:!6?97],:R=\D>] M;0_X*A'FJ44�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a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

*G*F>?L0E8%!7E5JFM MC"G/2CT,9:BZ#^_)%$^*P%23J.=@P$IYCT7W >1#=>)O,+KTP2A6(O\$X,A, MA=('T=Z5^@JT.%8^VO'0IKP#((7I=4$@;XJ!,[Q6ZM9ST\F=B"VX%A.U&<7I M'"P\KX1$@3]M*M?(*>( @YD(9Z0O\T,T=.GA8 M^896ZJ/*E"2)5>AA[+)]#;RL) @09 ,KOC_MR0]1D.]4TTR4H$R; :,7_BCB M^DEU]MSJ3E^TZL'TG>$C3'W&3YEKI6BLM*=#S,S$6&_G/_=AN6J-/+#2B\N\ M_TV"[^-OI^/*7&/%L@?E9J6Q&-5J\872BR:4Z M"5CS9-S2\X[ MT?DTS(A I$QPCO?\58A^?DS4[#H#)1\@^KTD=>0R)08^O,@M2 KK@7#&=V@X M*@HEPQ]"C@>7!&D #?H]=$;@$<+*)LK:[27IUP].\%TFP]@=J5G+A [6#U&8 M&U7U11H)'POOUM>?/Z1Z"?0M7WFF5FMN:I2\AJF@J_Y'>7:E8F&<%L4YM[Z" M0L](84D7NIG/XT[-+(S)5U,)GD08I2;!@<823!TO-0& MY8?AQLLHF9IHF+9$M35M>F^Z=LIQ2TV_8$A7#RQRV>O6U M5:O4:J_SQ?54TTRKQY1)D:F8*(PO7W$I6%7K'[;;2E(/K,7?(0;7]VO M7[K69UAT@$U;O?OU,C'M/4W#36!= -;\?)=FC/N%"-,05KE>F$1^&B($<^@J MA],%2$;>V$U7NJF;+=WGH_-+P^@3O0;LF,;Y;A,9)>J N5H0*^?%S8O47#Q) M,:U9=^L[:<,Y&XN6(_]J\OQ$0SZ,LJC8( 2G*0%+IUJ&?T-?+0W$^%W=Y.$U MC,)=WO.QG(.) 7_L+/RA]+SR&KR>IW3K+[,]@1<6C%304]Z>KQ9RC[D)':\% MQI%<2ZD.^#%;YL'".7@]'_W.;2RL'<9Q]055EG$4_IUV(U4QCYX$AT4MNH$P MCV:DGDR83TCZ72HD>6 \2L!\/"M7LS +^5"\P4# J.-L/#XX\KE+FC>;S7+: M,'P9X.TJ9J3?@$5"VDQCSIG#[$(/LD#[9!6L#&XT-JGSS(=>QND/XO$QCX6E MX9:9QU^GZ_-T":1"]:K1-#*:(CM'9[7U-M7. ^5/JD*)N;H.U/:ER,>A7IEF M*V2Q(U>H]BKGK5:G.8ZUCI?KQ3?],IGQ24O1M!9CE+\IG0LGZJ=Q-4\DZE6/ M,BO.I$(72]\/4G611?2CQ(]GAQZE N]%49*N(BWG"6;N*8L3@\E^;5>KK]LU M>U7O8:CICIC,.%WL^=[##/?3@::^H)/MRL!8E>PYZ49/9JGU%9K2(S/;13@L M%U\[$'$_3 V[,]T<,C#9MF: MN@JN]KCRUY6"Q%@LTPBM XO,S)]1"%).T&2-G*G%='T$8X!O87V=N;P3\@D7 M_'$4(I>7=)ZB;*)D'LKP/0=\JGS- AU1VZTJL-7+ W^>6HSZF6\[[5>4J\$T M,IA#N-#TN?7;.(;W.M^L6N31E#.O\RYE3$K["&-[DF$RC+)XD8J_2)%V6S6= M&ZJQ^G-5<#[O0=;.+V'!-8Q^S>-!*LZ;3TI&JFR>HLWG!X0$9+^GPLUY-]1[ M%K^=F[=?LS<-G.]J89KM4:J^9[&<8N?2KU-4SG%" 1L3#P_A(M*?\6M"N3$_ MH5-JPCRE)KQ'+XU9++P^"PCVH:MC5V'K I3;<[7PRW=+@2RWZ9/E7\8;I5?$ M3T%+8?DXQ,]41F2U4<9@Y0!?5 MVP^UU50(6NT@$R%V?IX]@F'-ARQ%*)]@R?&?J5>D>M>'=2>LPMU4/P#,@-'> M1"XG;$MM17%!H]2SZTCI95*?9ZDS-%/0.#O2W<> MW<7'K]/7%]:*9GT_O[[/'+1 S/EGRG*HHXQC!WA^B9"BUUG/HJSISZ5YOVD:^W3^$M9X3J"=A39(9EF$(70); MU$O<8M_S'?IT.[20T?(HL@T9M>^1RB8X\UD8=$E/AC/QB)F$#$<]$LI1OFLT MK:D_F93Q)G$RV33!FBA.W<7XG0N3]SI?ORF'(/?,MC1$M=([MRM_5*GJS"QNFLF M#+HZ#(KL[1R$OL2WI>;B\L87E^)S:AM=,Q@$J_GE.H#]*MPRSB,JBT*5Y SD3'A.5 M1CRU@+WQPC4J\D7%EB]OK=NK(+M*>WC_X5)M="JQL!+HJ]I53;], M57TQGU!U) W#9#%L'X"2)_JI(/)PJ!(%?&&7#A3-MSR9+0=";! MJ:%-&TLCOR"J? MW7C5MKO'L]UC/[9['/L1)(HBVB# P44RY]>_>3*S;B HR;9D228B=J3EY4C[Z58Y8- >R'ZEJ(B/&]A "\ ZYCDEBX[E6>1D I[ MQRX;AL<.Q>0[7*I4ZZU_1&'$O<$/QYU3' [WB%%%8_Y.\S M7@K*\\ [VIS[R=\$82%Y.""19M:^F /?:SO#S]XO)_\P;%L3/HR@(Z<^RJD(AAD$&_4[W]\T,.MYM;XII_!XF[4 M]=A6=9"KS\E#18 [+P _HYG*9WT8')_^D@*0" MLH]M^OA1C"G?R$$\.B"9QC##6@@+#7<604\L.-*-^+P*2*UE%9KO4OV[DM,3 M&D(G_=>BFO:0/'"9TVQSJT&?+_>3YP+EPR*2*<33T)YSM]XXS[AB9RFU:.H MQU4[RYSVDU'@9HJ4(K]T#E<,459,8F,,P[ K1HW3*G]_V)OM'KC:3OXA3>XF M_&1GS*K^(0J)@996G:!8=4:N-3'@C?[PLWUT8+=3:.0&\QHD<3;;?$7O(]ZU4%-4'PP..Q)*(A E;(SE]*R MU:59RY&6NK8"'EIL*V::1=45F46W(68@J/; T'>E E&%S(U;%.^-B$)M?,'" M>28%T"P]VPM8WDB6W$$ZZ+*I=@KTT:"13[,%"X8W\,RL7/*&;O[USV49S-\[ MLBJ.#@Y_A!5AX4:335M4%9VU6NQ.BM7RU5?@5GMDYML26)I6KOKZS?D40O4J MBO39RY^?)>^KND";3:UG(?N B\7*CH9'KV8/#MA ]YD5A@0RC-U&P)S+$ M#P]:>#ZSVGUB3XJH#[AJ?AM_?$[^2A->HT40.&?9X:.=CWS%QHBL_\Z/MS@@ MHWZUUB39(I3,S/)&C$(]V/HKZ8 N-K2S'8KID YP6\5(2W1BD MC)/U=XX: [6QU-'DPB0M]*E04+X.PQH20] 2.EOV1MZVPBL0H+"0@;4\TB'B M/(V %_9FLQ@S<@KC_2(:,39Z%&:EYK!4=P##+8,GR; M\$LML+>GMT*EBZBK M2_#@C"B#&]A@1R/*X!M &>PLU]9P[$5MHU]ZYC9=Z2##TX-TI8N1B/P0/U&:I'G MDC]4,&JVK?S+&ONN(%E*(2R"DMZ&?C+E(%#?#F<$L$NAR10TON":ZUSMTVE% MEVE>,A138@*&3!JY*PP,3S@20<6W9J?"22&K"3F8C@VCS #[+Y!;?A#B$,V" M#=;-,JQ);P)Y5-YGF-.B"2L*HPG2C[:LV[E.*/UTD7,2Z,8L ]:!<]Y-4CZ> M02 >1[H6L@YY,(R=TE%<;"QT?VEE?KTYZ<6Q1LFZ+@=JV=>RSLVV8D,5.%M% M*!9AG0N@-T?2!NY&/D^8"0GOC").LTB+N< XJL8,TBQP1 ?"@3I9*<5U-QQ! M&A>HR=]H+4D<;AFB[;U1%Z('"M/!>NTMA2U#0:A-*-C@SV#P>P 8N>5T178C*48$36VM1%VMTZ)=,^K9O1YO*.'R*=.E"2CF;+TR=J7]]-5OQ_9S M?Q[DC9\DAM?Q=*:^>,@^ )/"^6+<1A['89$J*2JI'AG"3UE06K"[C^,U&4;3 M),Q#HI[A?O+*0^OY(AP*3%I2R2O8NC6=&'X1YBK@MREIC.8$IX5]J> H#R;+ M%W>'<\7ONA7O/2H&B6 EKUS(>WTK-,,-S494/Z$X#0=.D(1B2*)T(2U5&'[- M-X 6 8[CRTBH/"V85BE:1I]6LKD8%.)PW:JP-9,#2!8;:"J-UK7-"_.1+;>& MMOE,0B*.VBMD#-/:2;9J$'/OVC_X2S$J?B5=_\^#R?,*LK!]OO]7AEEMM'\.WQ ;\=6L??M_"L&<9 M2[E0-V7L$G9Y(PDT^,%=T=HR5O@1MH!1-8:E98MXWM\O3Q9ZD=J85?3>)61-A+R%#A3)MO(;C Q0T%,,( M.9/N7@CO@[II4E.2;&4D8]/F;:<%TZ+4JEHC\ UBR6RF>%:K(I7R<+YUD9,. MSQS6I>^Q\EPX5*1FQ7I>D"^-0[6\_":S_$T!PE5&P']Y\AX;[K9GB);=A3D; M>9."JT?Q/-'_7"C>^;MSK42 J0URZ<5Z/_F=7A8>JL#%R)G+G(];L$]IX9Z" ML R3%8ZULM#)DC8E?=P(CU* # )?FYLS!]VT@G3!L_RI35545PK3FX'\]P)(]DHK\ [*6I*L;8SXX)8R*8_T%OI*J M!56O(5MM?))%[+PRH@ "]^C@8 ,#=_$ ,2P^7Y$8]:=5,*H@[3[JLE&7C;KL MKNNR")+H:2-9 P@I)-O58L,='1P][$,; RV6F26G)"K'ZQOKK&-90<9#H516 M"(V"@6D3<147G%D3_$ JS5&-.11S$* M*/09 T[3TS0O9,L+I$/A+)NF'ANBB. R+2<;V6$$ K2K>VGV9\=:UV9FG+'. MX.TW [^Q'*V-S^:^RUG_IW'3?&**GVEC]NZ1J'%5EA5 ; M9KI!#C6<@&;1CWA6TK*5O<4N(< M(;M?$Y"C>U[O( [2.S-R+I:9FEF*S)7X\T&X1=G7- ;D RPN4"!Y^EF!_UZ+ M/?QMXT_?63KN7MQ,T@KJ9D7"5P6)HSCF=26Y$=RX)FMD88(DR&S17A5/[>E6[W8L:)*(]H%EPC<'Z@- MO1'*H,F7%9].+C-7!GA=3U*AU7S<_:TWB3T&BCMHZ=V$QRIEHRF>,0P;VRT[ M[QUCNY7?@ADWN.U!3&WAD]O/?$]-R^#SNJ ])UA.*?5'MR7A:^=)1H34-['M M>4P:&=6R@;6E+WM&EZ%>?I+\8_^XU^-8KOA%KX@:[3!H%-RZ;U__D]O'7/"T M\+ZX9,N]1=M\_Z37[8Z38?;6^J2R@@)%0R1P#$4/X _^'PZ+Q' M1/=^V+_WPPON_<.E;_VH?^M'%]SZW(F);OVX?^O'%]RZWTCRPCE_TG_"DXOF M_,&E1S]P[[>&&\C]LOTA'&KWF0"/1.1"B2!MXGIHY$$!A,MCH&!C+0@2/C)R MB;WU:P[B/CE]XHAM[;WEP MQ& '$O""B*M,UR3M?BQ!CS]7).'CL$M*(J8@RZBDD4HDFW[J#^!H,7) M^C89L\H@M4>JA\QR4RH'YL;0:3!S4!YS'QF\GBW7VOBE9>0[K^W8T.LR.\;A MCX?[C_X2*1JI^Y/>";16S#X('J"P!ZA/0'@M.!BV2M)FP!+JL_3'*A+MB7P= MB9#P-$:;SDN K-2.#VMQ:IP>YQ?1#JE I,9OX]]#72$)O'7(9.\G?ZO.#(,4 M2<"RBA?)^W'0[O -T0/$^2GGJG\=F#Y9:_ADF]QY.N&OJYY?UQ4YMJ8%/\5; MX$^M&_/XLK\?=Z7D?EQL00W8/FV-LK%5OC(%$^\.VL2VK*P\I M5PUC(>/QR_:")/1"*=?G B;"\/$F%(^ PC+6..T%5(8AS6Q4I3Q,;[9!F.-I MTV14RD3T-4A]+F!9VF28^E5:^(Q*Z (E]$]P(+58S7<^0(2DEB5&99'[A>ND MQ _&:NBVOSW*Z>837Y^F#J&9G$T^K:LTZS/[I#K=Z)A=IV?2,QE4=(,4X$;: M5$NC .T"Q83?C5&V8D\;&NH,LAY1R:+MLF=*RUB(12$6KG46?6\_"]V-B$@9 M.U>R#54AK\'L!\!M2"$%0\R ]RJ*<^F'!%&6TC(L5VUP4[Y5#T!F\6$)^_4* M%9-Z&S6FR83Y4S5QZ#W7YJ0KG$Y,P4WK[&_C-.+/TYF:"=>Y^DD#!G[Q6ZTFV4IG=AG9(PV$KA@ZBHQY4-' MQ5%?R#-&\_"2FOG%6H+$@LLU%NQ2QC!>6QAEF\4L7E[]/$@14'' M;!U>E"+KC=4$-G-@O[&'U=A.)C(?_V:$:F/2>B9]4>GGQ9KF:;B9 A<8L%8$ MQ;+VZ75Q,"B :VN")S.RUZWB_G?BW9A9GM#6A#8T6W7&2$R^>@)(- Y_)C*?5;6U_WRSHX'8H9#U M XM&EY$&TWIL$"X@Y;>E7T*;?F!U(#9QT LS958Z(X;%/!6Z7^9+U-1FO&)L M\R^E^:_[=$_FB,4'=R?%E6M(ZG9<#T9?:QCEH MJY'BI]LC'5\K?>-[YU,S30>S\-;M'B.B0Q^A!6ZP[>/'PV)-.<$;/<)%6+?6 ME@<]UKEWI4&01D("HP-Y M9#LC:3D1%MX(N>U>\&64E8S#P/ _)@[:/YSUM(]EBH^*26#CYZI2&#LI=4-[_18M+*!T';OY'I^.];%?S_HT0E^1 0[Y0>W-4>K,"$)9[@#*;Q M- [$(.#/3@MMHBI#X,?RKHOQJO284H%.&G:VB#X*JFQ(EZP0D0EXH>R]9-]: M I7^/D10Q_Z2JQQAS7)$Q=6KZW4(P'#_^JGQWU4V2+?L&GX]&;GF;!U;BF0Z MK\'!7-5F3[C^U*>$XZ7SN5FB"LT[#P*X'-7Z$,()#X)?5E("179J2&<7/MOBDZS<\",NLY%R+A#$I*=5S::3K4L-DX\) M5EE"8BZIXZ4#.&+B8OSZ(4+]_ U;EOARHL:>0$QQ5 #;(8^3:X2*6&?9G"KM M<0Z6*?ICM@Y@'?W1]VZCO2.57GIN4+9O!04P(@4T!8UF-O([Z$TCY:B@I"+E M0T/G6)N&'24K38==*4 A,IW) I2@%; Y9:I-3I5B( MFS%5!QB_A*:!-BGB6 M>ZR?*4V1.'.J.@TV/+70$!P)T<:I2D7 L-R$43'SAVP1KQC>RJT&A21 M!.VE)*+]KG>*#>^QN]GA@4G==XC4CBWG*Q2:+ML?4;-<";=$8]\%.#T$MS7N MW>L_]"Y66#;%Y@MZXQ+NFA\SW/"(-(B_T7D_E"PDZ;:N\#3D*1.]8;NX#0D% MWUBP<-#,F67#\F?HU[ZYTR8Q\)]=^<%^VJ\*QFI-C0N_FRRZ(3:TO3+0N;_C4"SFM0F7;WRLB_7E;9TGI1S-9^SRN+G9J+"H(S1Q&;&365%#0-15WGZ>JD/ MMQORRHWW,T3D]VAL:KOS:=&;&FWVHRJWF2U,UJ':0>AQD';Y8V4]%C@H,T'T MS8S3(_1.!:82-CT:_M5; 7U=N4KS+*@2DP@+^,H;F3:&'OA'OX\T5;?",!\< MN,;%(1:0=RD&>8[&\@:":$?.NG#LYUJ8RX$7TIF7_$XS";U3B'Z1LS9T]-]! MWK\B=7:B>7\+'0@*5@"K%0/J>-;N7G,ORW8O?B/M[9!15;:J$IH.^*";8 B^ MQ92-0PN4C?P]JR>=9MA0<&FD>R/\S6Q1YO_J%&\"*HX0!KQ,&2QB&T\X0 M3 M@/!^\@!LWX$W4A\6J=L$8PX2L2Q2&C;&; M8IQWO+"JC)G"L(>\\AZ4MJA3O\BB:QC6P*B ("YEC3S=&\SI"/MMB>*;6,,C M/);3VZ:UW$KRNA91P:%=%GL7[U S,=J1-[Q^>M)T@"C\VT16B/6Q:/B,@("F M0>8 (3LY"TDL5ZJHPP.-@TK-6;KBX![_+SBME#]W7E1PQRQ?)EJTFPQP?^5" MFQ=PB5('M/)87M(OG'%O-BUVC^7@2H$9&=LG@HUR0S4?Y5-AEP^I?*.![J<-"6'B2X&' ^;76"[DD\L9*!8"2*0I5UO[!6 MGC)9'EDEK05A#TU<,-*-B=-@M!UBQ"?-VQQ]@1@]LA'1Q"[C@6Y,"_YB Z)8 MQS@;_[9*?VAU.1T-+3]/8^NR;J+(8VGE[M:!8"6<60HW0K#(&HQJT#+%N]^^ M0"2F%<*S[>G!6>I$6]L,S$XB/'\@35\)P1TI&R3:O**)XK'Z7 M0P_"P*S8=[J[4P?5D\2:>MFZ,%RD#VM&8]$"7YWSIND=^?D%BRP^$S:>C R+ MI>ONU$JTAU-I8ZHC\]+N/5G2Y]52>=%(5J_;_M9AE^#M"D34!H M;-_-B"'N\[461";E:$6JM72#DS*BB&X?BNC1B"+:BB*R#RII\S^-K##AWSP' M9)1<($/7CS*Z2JOQUDGM*[&A-8;"P5;HJ]9U"AR.!0]SFTED/C@.0U@%6<7^ M?+9GHF V^H%6ET458^+4>"!-8],DTM,C# U)Z$;Z8O!@V9+4^/K@TWT,U0] M33*CY2V#+^.1/%O:K($#1R/+(4)G-_W*=Q&=7BZGGI9;:R%PWEC(TN L1TF& MG[[I=E0R1"%'%O5TV^F2@]OY;S<(D!]]RA"_^^]/HC^6];R:^S\XNBL#/?R, M@3+7[N;J75[37)8;>YBA>JO.VSOFH+[*M7C*!&?(Q%Y MG?Q2\PA#F?BM.N$\53-*Q8Y*!;X>5W\W5Q_>C\RE)X =16$G18'6K\6C85:'X.:\80E05UT=*,0[*00+,P24=IQ^7=S^3TGZ5M3G^8S M$]F*;]$>-A^=R-T5CJY40I%F=!QV71I*J:LD88C\R9)>Q7 #E5$P=E4P.CI% M+(/Q* 4[*@5MF@LMD%<.K]/9!R9#'(5B%X7B.7K=Y=,.J.91 G93 L <@HK$ M+'$'A74U1I'8=9'XQ75R&&5BE F1B3>&Q.%% ^X+-'K*3[F$9I2+'9<+F=%W M8$Z)XA+:Z654'SLL)B^R3FEO1SG8:3D@__-D[2.542Q[E(P=EHQ?JBH;\]T[ M+P*10FC3%;A5WY@VS8LQ1K6[8M&>F;0>5W\75_]OY&RVB^09F$&&S88Q!3Z* M!XO'+W2C8HQ%C+) LO!:F!'B9-?H88SB(>+Q;D18[[8L5*U!RYLW(/SJ:K"( M1V6Z)F^Z^LJ $H]7 (?_0M M=EHT\KE)WLZ8?[5)WE55,09M1^%0X?@=I/>EJ<V\-NK D?]/&.J,H[*(HO,J+2?)K&AT0 M4K_(5/Z_=&:DS-E-R9"2=M0N5E46&Q F'8,,NRH4*_2A][+P2\6MZL;0TTY+ MQ8AN&,6 Q&"1TJAFIFM'IKW=%8*ZFINFR5D?C$'G71:%-Z8Q:3U;;/@6!?82EX1Q.%+CZ3Y'BU M(EU01&4DW<>N7B>_(@XUBL=.BL>BSN=Q;='O5=V>I"=F9&/=:<&H4^[P\+M./]LTQVN\N6J2' M_<[F%_3E*7*#>9G0U-"FR[7ZD1Z8IQA#-T MMLA;PTMHL!_/ZG3UZ0L[J_;\0&45DA;':SJ3?8-)H VW6]O$MNG"YT'!A.]!7V=TNWNX@/70P=/PQ_S1X=/[+"TIK6I9RKLU& C=F<=< M=9&(5-,_#>^/2;*JFISG'O\L2 XPVR1@-.TG5N*0G:]S72(:TYDI"OR7WK8K M4K*,U_3/?W6D#T4J<8V(Y0J4 .BJFLQ3 ,7HWOARU=5-E]*GN@-HN)F, N^. M3Y85;?K:S'"I^6B6*]G--::NFG+SA"R9U]62?_WVQ;.$ENGO7:EU;H&3:-I>N/N\PGWLS.TGKWO#Z?UPXM2,VZ%7OC/:2@;N=HC\B<73?8(E]#L" MRB^U+Z:3G]'J_UF1IECKJR7W:)$R,^?)RL'W&C2D>?3D7G7?3C?$#=+$'XBP M9&9E6"$F&=V;%X_N_\&X[4F+1MJEX563/TNYOXC341;D>9=I&UR[_"^7D\S0$-9.NF[\K&O*NS%/"T^ZQWL M'FG HB1>"$GJE 0RS;,)BV9M4J G +?#!ING>8W?=+H9:46;MII] *6$55=9 MQ=-" ZD*[*U34]>&2SQ.L)ZTZ5=&E!'=A33BQDTJ.9YP?N!7:;G&#FE$7\Y0 M?IK)=K]W%$STSC(_!!S]&7ZEE MP[-YEC8ZU?3;!P?[/_R%U5#:+))Y49V1V53F)+9L/=$OBBK%(4<_/. ?IDUC MVKUIVM!W0S]-_BHG/7V0HXRZZ.2 NJ=*UW]I#Q*]0KBM9MB5QS__IA_^3(JR MA+,@E]"K/]A_PN,PM@JS/XJYM'LH3^Q07+VF#5=&8PFJ.=UP_@=73^L\.S$. MHCU)?OOMF;OR?W[^F_L])O7PT?XC'E:!2L!&*@&W3"4&#[.,IIP,B25I(/XV M;47]G*9%9]C4-!]9D[#2C1?[+"=+XA+N\P^7=9^W>LH_7).GK%Q',%1,_45[ M]A->Z>MLV?Z9.GM'$PS#19U&;^7]_]!YT)W_WW.SYK246AEQ>L MWO_[U_1R,A*OI[[L#_N/1!B,<](5FOW9\5%8F[:KZ67H M1Z'YLI^\6YC(=VXT&,&3ZI_2MY6#\ .]V*J;DI?8.XHS,VV')P^7^-\6U8P# M"U77PI:UYO8?)3_L+;K8W'R0YJ:"7HN\,-'J#]J1.2_L,OU(*_1O\@JY$H66W>$OUX7;09V$NXY&;P3@^."5*$T4[<3='X3>SAJ8%9BRW*+D>UHN.B MW&H>!X%2,7+%72/#S%MG&MWQX5,$G.#$X:A"7AR+5[$PP5KFX ]]-&S(\\T& MOSK\Z?R%.\^&^OQDP]'#RZ^CGO5\U&],_PVM^KM7KY-W+_Z1O'[UYMTOKWY[ M^2IY]NKWU\?_>/GB;7+\C^?)RW\\_^/MNS?\Y]ODU2_)\Q?/7OS^\XLWO64Y MWWP+AWGTQ5:VW.++S6SPBK*!-3-%L<+A6Y[\UW<'W_'?>E_^.S)"^?YJ(TTY M5BB?J))DZ_%IHA;7XQ_Z:N+3EE,>L$K7K9WGVK]VI*:B?]9"K>TE>Y*VKN(4NF10%C;/\K^^.OKOHSM'B M[ 7NKU^8^"=VPV^L[!X_Z2=9VZ=/@W-WT"W]U/G\M#7_B\Q)-8_F>UK_]2N. MX1WL&AG',1LWU['V7ZIYY*C9JGK(LIM]."'+OLQ"X3@Z>(@ XP_T/X\>W;]( M0;47T71_=130X:T#@ Q%@O_/9PG,IY*HGW=\1%+VV7<)=0&'F>B^AX?[#[]T M;'_Y*EM@%.XO%NZM68)O6<)_W#^X&P(^ZOBOJ.,W4FS?\A9X=%>VP"C<5R+< MO1STMRS:#_8?W0W1'K7[U\*?U#,RVYODYYSS&>F*&4;(SGE9SO:_X9UPM/_D M;NR$4<:_6,9_9AN>)#P1%IUO7K@/]Q_?#>$>U?Q7V@*_8(HEY2T,E*9.?J[3 M,A./]IO>"V/$9E>D_(6 ?S)7A_(KJ9;5*.&W1,)';?^5]L&KKFU,FZ S W# M 1@3E$DH5@R;_^Z__\_E^E,/7+D-GBAX_.M62[=*"3TW9<7%IC%J6 #K6A2; M&;-42/I'4\_RACX.:ZOI@GG1<1D12@RENC$%V5R[NF,N(E04ZYJ+GX/: MU;!*=9)D4A P-27] M1OQ3JISDJN]S2Y ):Y:K7@8FZ+?JY*U! GRZHV8<5W M4#'/7[5D79.-]A>+70940_:$61M^6.#\8\9JCT/="NTU7;[1>^=:D?E3BNR+/*"\QLT5).N-D_4W+ M]!V).XZ:_ 9B\ YZOP/AF*.[LA-&&?_R"+S)\O0;EN7KJ*?Z[(\*]DQR! MAX=W);8S*OF1)'!$FXW"_67"_::;YEV#/D&[Q(]V1T@P1Q7_U=!EZ]]-EOSN M:Y2_=5J='^[&#AAE^\O-^%=O7B3O\]J@$9YEC?K&-?R=D>]1PW^E7?"L6BZ[ M$HT*A1HP>9TB]_.L^O89U$8RV%T1\ATD@[TCPCWJ^9$,=MP+HZ*_JI#DJV?) M.S+HER;; 1U_&P%JWP8^:N0*'+D"1Z[ ;Y$K\-) KZTZZ;/P4YLJZ9-0O1=; M%9_Y2E]G/SP9 M5NS$+4>!ZF1?\5S#*RGJ9F3E)'FJ\X2]>-7_A%W5-_HJRM MA@]V#_Z 1=' ]U__&1@K/KQTQ!7E3"PBH:9 M)HO:S/_KN_]HJ]EW__V.#R;:#627MU 5__>OZ>5D)%Y/"X+=?Y23@&QJ8!UA M+6,1U&]DSO%'WXU8XA%+/&*)1RSQ2&'Y;4&(1PK+,59Y1Z(XNT;N=W1P5[A M1N'^\MC SO*S/AD1Q.->&"DL>]OBA[L"NASE_0K@E+M"UG=GH/*CKA\I_:Y* MZ!_N']X-H1_%^4I-EUUE([XS\CXJ^9'R;SI%8/NQ#<#X-!A?ACV\%#NZM:>DF-?F-4U-49TG>)&DRK7,S3S+3 MS.I\Q69%-4],.ELD*T>ZIN#."$2Z2$^!",U,DI8!BA(HS#:IS:HV#0-/3TA= MM P@I=\).+/JZ$]DY).4D_' C-+'S\W,+*>FC@@QCWJPS*N9N6B=?KC\.MU& MXM$ALJL+6$2O4LP?WS8I?V]!O8) #J:'Q(QE-3,KPR\/P5X"_4RB.!<"&2?K M+,].TH:_2,DMF:;-( MYMALO=37HO^+= Q=]/W#QP?[3Z*?[0E^\H+TQZR%@OS%3.N.+I&!'ST2:NW)!7?@'8P!U*9( MV[# 1"IF*NPD-V+2NH/RLM_[.-\X=(S[[OPS9_"DP1C)I&VB,XG4Q1_[;_<3 M.7>"T^1=L%+N4*03X,?]'V-M28< 'U6H!^)IY.5L2>,WZ0R3-L%ZR@I^?_CP MT?Y!?/U9VD2G+J[&>Y*FI.OB&7%E/60&1FM-HL%@59[\-OW(90"A +SXY=FK M-Z_=6IU_@_C"U\=OW[H+OW_\L#\!>(%.5>^JJV=TJJ($H6Y3>AN=<)Y[7H6% M*3+HW.$7"QYWF?/1WP!'Y.�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